<SEC-DOCUMENT>0001090872-22-000007.txt : 20220303
<SEC-HEADER>0001090872-22-000007.hdr.sgml : 20220303
<ACCEPTANCE-DATETIME>20220303170217
ACCESSION NUMBER:		0001090872-22-000007
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		93
CONFORMED PERIOD OF REPORT:	20220131
FILED AS OF DATE:		20220303
DATE AS OF CHANGE:		20220303

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AGILENT TECHNOLOGIES, INC.
		CENTRAL INDEX KEY:			0001090872
		STANDARD INDUSTRIAL CLASSIFICATION:	LABORATORY ANALYTICAL INSTRUMENTS [3826]
		IRS NUMBER:				770518772
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1031

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-15405
		FILM NUMBER:		22710044

	BUSINESS ADDRESS:	
		STREET 1:		5301 STEVENS CREEK BLVD
		CITY:			SANTA CLARA
		STATE:			CA
		ZIP:			95051
		BUSINESS PHONE:		(408) 345-8886

	MAIL ADDRESS:	
		STREET 1:		5301 STEVENS CREEK BLVD, MS 1A-LC
		STREET 2:		P.O. BOX 58059
		CITY:			SANTA CLARA
		STATE:			CA
		ZIP:			95052-8059

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AGILENT TECHNOLOGIES INC
		DATE OF NAME CHANGE:	19990816

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	HP MEASUREMENT INC
		DATE OF NAME CHANGE:	19990716
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>a-20220131.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2022 Workiva--><!--r:b57f1026-9350-4429-b363-875dec110646,g:1024445c-b98f-4ee2-b278-e07339a70979,d:f825c91f15a047ec9e67e0189634a349--><html xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:a="http://www.agilent.com/20220131" xmlns="http://www.w3.org/1999/xhtml" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:currency="http://xbrl.sec.gov/currency/2021" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:srt="http://fasb.org/srt/2021-01-31" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>a-20220131</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80L2ZyYWc6YjE4ZDBjNWUzMmZkNDQzNGE5ZTNjZjEwMWE3N2M3MDIvdGFibGU6MTIxYjA1Yzg2NTVkNDc2ZGE3OWQ4MDg5MDJmNDFhMGQvdGFibGVyYW5nZToxMjFiMDVjODY1NWQ0NzZkYTc5ZDgwODkwMmY0MWEwZF8xLTEtMS0xLTMwMTE0_001a52ba-a250-42c8-a9fa-a3995dfd1ac0">0001090872</ix:nonNumeric><ix:nonNumeric contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" name="dei:CurrentFiscalYearEndDate" format="ixt:date-monthname-day-en" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80L2ZyYWc6YjE4ZDBjNWUzMmZkNDQzNGE5ZTNjZjEwMWE3N2M3MDIvdGFibGU6MTIxYjA1Yzg2NTVkNDc2ZGE3OWQ4MDg5MDJmNDFhMGQvdGFibGVyYW5nZToxMjFiMDVjODY1NWQ0NzZkYTc5ZDgwODkwMmY0MWEwZF8zLTEtMS0xLTMwMTE0_a4a9c7be-7b61-433d-80b8-e823852e8b3f">October 31</ix:nonNumeric><ix:nonNumeric contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80L2ZyYWc6YjE4ZDBjNWUzMmZkNDQzNGE5ZTNjZjEwMWE3N2M3MDIvdGFibGU6MTIxYjA1Yzg2NTVkNDc2ZGE3OWQ4MDg5MDJmNDFhMGQvdGFibGVyYW5nZToxMjFiMDVjODY1NWQ0NzZkYTc5ZDgwODkwMmY0MWEwZF80LTEtMS0xLTMwMTE0_17e5d8d1-3f3c-40a9-8b1d-100c5d4b04d0">2022</ix:nonNumeric><ix:nonNumeric contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80L2ZyYWc6YjE4ZDBjNWUzMmZkNDQzNGE5ZTNjZjEwMWE3N2M3MDIvdGFibGU6MTIxYjA1Yzg2NTVkNDc2ZGE3OWQ4MDg5MDJmNDFhMGQvdGFibGVyYW5nZToxMjFiMDVjODY1NWQ0NzZkYTc5ZDgwODkwMmY0MWEwZF81LTEtMS0xLTMwMTE0_7e6f7cb4-fb45-425a-a1da-daebad33975e">Q1</ix:nonNumeric><ix:nonNumeric contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80L2ZyYWc6YjE4ZDBjNWUzMmZkNDQzNGE5ZTNjZjEwMWE3N2M3MDIvdGFibGU6MTIxYjA1Yzg2NTVkNDc2ZGE3OWQ4MDg5MDJmNDFhMGQvdGFibGVyYW5nZToxMjFiMDVjODY1NWQ0NzZkYTc5ZDgwODkwMmY0MWEwZF82LTEtMS0xLTMwMTE0_d43687b3-867d-437a-a5c9-4ec8791f1fd6">false</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="a-20220131.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia1e0ec64d140483ab50b26a38f74482e_I20220225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-02-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i805a3796c4d346d19353b262791e3f84_D20211101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i97c9b6fdcd4541e69ddf24ca1c06ce50_D20201101-20210131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2021-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2e96a3d7152643bbb7d3308a81aed7d8_D20211101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic06fd2b5991a4b23ae6db3209ddc24bc_D20201101-20210131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2021-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2021-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6390807210d74c6f9cae496ea2122a5a_I20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id69612e49fa546c0bf63ff5ad436ccc6_I20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9b47b15753c94f0b80143556347e39b7_I20210131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i44a18d7ed2a546f2b1a0a2f797a1b4fe_D20211101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8ceb97e232da4995b0c42477e20b5b4e_D20201101-20210131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2021-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i99b29a6a5e4443e6830ecda74b1090c7_I20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iea1be62040754a539970b84f8eac1b6f_I20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9dbcbe02abb3453190aa9f44125cf5ae_I20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iff5df0d7cf1048858d49c438dfd29807_I20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib34d00c8a21a42028bfbffd3fd179e61_I20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4a9450e8c23c4155b219185f8e60d29a_D20211101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia0fd838af6c44d0ea866658c71b3dc7d_D20211101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2aec23e974cd4bedb6e13b41b9375b78_D20211101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8344a08116e2475d8630eff99a4f60e4_D20211101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0fcc3b5cded94fed9c8505ac4005e3a0_D20211101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3137580680de43e8ae49a1ddbc453b8b_I20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib3fb881f611641bf8690679c64de1aaf_I20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i57656528186c4372ae07486570f387e9_I20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i27134d71dd424779ab254848725e52c6_I20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic1e6a76918c24df4abe13257fdfcdea9_I20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i482974eb49534930b9164c76d7ed1578_I20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i64d7c2dd15f64641ba78382251046b62_I20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i154f991a704349d59b962b4dd9d48c7e_I20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i375472e47a0b4ca3b7720d165b3c1035_I20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i34129239eb114151a36af1066ee3079f_I20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i604f8a60030549769dd5a3f2943b52bb_D20201101-20210131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2021-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2331e3a5c61640af8f9c694b08630d9e_D20201101-20210131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2021-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7f2ff5551bff49caba634f1bf4245966_D20201101-20210131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2021-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1bd14aef64584a21865d2ec3dfd5e629_D20201101-20210131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2021-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0afeb8dd36084a53aec0f9c3a708c97c_D20201101-20210131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2021-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9aec1350d194433d9ba1d2d5b214d83d_I20210131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1c25caed3b0b4859a0d9e2aea3c18f22_I20210131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4a4f445b002141b5ad863186edfae11b_I20210131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i36c64c32e7194082966d03edc3758994_I20210131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib3fb564fc37141f6bcd78ffd8a2e8e27_I20210131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i56114721e4604d11a4408ead150dd13f_I20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i546995bf0aca4c98814acb076a2c6be8_I20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8abcbdeb47ef4c469a915f28a2a7bebb_I20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">a:OtherAccruedAndLongTermLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5e51aa894fb04654a6979cdafafe70f0_I20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">a:OtherAccruedAndLongTermLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i242c1754cce3428296265ac5bafa4022_I20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i81363376d3bd42f8a95d654a9f58325e_I20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i608256c6a24a4ef084558bc988b75d6a_I20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0f82edc5fbba4f499a5dfb9aaa21a637_I20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id98e410db6d64a60ad4a6f2802e93f0f_D20211101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:LifeSciencesandAppliedMarketsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic9b276a4ef0142669a77891f22aafa63_D20211101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:AgilentCrossLabMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib2270a60792d4c44aaf50ded4d6e6053_D20211101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:DiagnosticsAndGenomicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8b6e655997ee46b5b0ca774029d951f0_D20211101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia94002b251cf482785fce6c05237c8c7_D20201101-20210131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:LifeSciencesandAppliedMarketsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2021-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7f6dcf92a3b2409b913e60f71c87523b_D20201101-20210131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:AgilentCrossLabMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2021-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i21a438b755494983a6ca6de8bc637763_D20201101-20210131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:DiagnosticsAndGenomicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2021-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1fb0b045601b4b149adb5a3c59cddd0a_D20201101-20210131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2021-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i200743d5cfa44c4697228dfbf963685f_D20211101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:LifeSciencesandAppliedMarketsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2b68e96853384e99aa6ee8f64e043a52_D20211101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:AgilentCrossLabMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia48ede266ff94d568a8b81576e800821_D20211101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:DiagnosticsAndGenomicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i621dbedf1b6f42ae8f8a2f84b5287957_D20211101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i56152fd0f65346c88b619fa6fbc25760_D20201101-20210131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:LifeSciencesandAppliedMarketsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2021-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9b2a7c6211084a08b6b244978eb790e2_D20201101-20210131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:AgilentCrossLabMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2021-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icda076e98d344aa6b5d575ac1c693ad4_D20201101-20210131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:DiagnosticsAndGenomicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2021-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4ea6946ae07b4db194a25f0b0b7d96e5_D20201101-20210131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2021-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia6990515accb4b6a8e12491c430b6e15_D20211101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:LifeSciencesandAppliedMarketsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib5aa3111b40146c693795bc54d4360d2_D20211101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:AgilentCrossLabMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6fcd3ec546c34f0a8138948fa2a41702_D20211101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:DiagnosticsAndGenomicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iabdeb90dd9a5436a92c8c53c49cf18aa_D20211101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib98cc4f61db94e0d8269c2035a8ea0a7_D20201101-20210131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:LifeSciencesandAppliedMarketsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2021-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iccaab3323ff4402984b385de50fcb653_D20201101-20210131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:AgilentCrossLabMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2021-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i659f816f99fa413eb7fb6bcef0c8191a_D20201101-20210131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:DiagnosticsAndGenomicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2021-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia563ff7d707142c1bd1a6c4540fe8e3b_D20201101-20210131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2021-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6d58196320f34869a29143308907c47f_D20211101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:LifeSciencesandAppliedMarketsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i30a463a582ff4b16971b766059a24eb9_D20211101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:AgilentCrossLabMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie43c9572619448f8a6ea6d852ea0af23_D20211101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:DiagnosticsAndGenomicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if71b40dd3f5f49bf86fbcfa04c9c081e_D20201101-20210131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:LifeSciencesandAppliedMarketsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2021-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i02afafae5dac4c4eb5370132cc85ab08_D20201101-20210131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:AgilentCrossLabMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2021-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i18473ba8bdd846b583460be774dcc8c2_D20201101-20210131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:DiagnosticsAndGenomicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2021-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id5a6ff22f0f64b46ac2eca9fc0c63a58_D20211101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="a:EndMarketsAxis">a:PharmaceuticalandBiopharmaceuticalMarketMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i52a37802a4474ca2ae708288d1606203_D20201101-20210131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="a:EndMarketsAxis">a:PharmaceuticalandBiopharmaceuticalMarketMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2021-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i00b6a666687d43fc80adb8b7c25a62c8_D20211101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="a:EndMarketsAxis">a:ChemicalandEnergyMarketMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i926a81018f214c9e97712dd13af6648e_D20201101-20210131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="a:EndMarketsAxis">a:ChemicalandEnergyMarketMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2021-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i284ab20841704e569e5c116ce20ebb54_D20211101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="a:EndMarketsAxis">a:DiagnosticsandClinicalMarketMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i07d7ce8930c74841be3d4ec974bc2ab8_D20201101-20210131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="a:EndMarketsAxis">a:DiagnosticsandClinicalMarketMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2021-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie0a218c3ab7b4c16ac8e0200091a5569_D20211101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="a:EndMarketsAxis">a:FoodMarketMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8da687ebb1cd4f17b77ceaa5e1137bd2_D20201101-20210131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="a:EndMarketsAxis">a:FoodMarketMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2021-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9c164cdf4217439d878a2e3ef209db83_D20211101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="a:EndMarketsAxis">a:AcademiaandGovernmentMarketMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i329996789d6240848cf6e6b04372d1aa_D20201101-20210131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="a:EndMarketsAxis">a:AcademiaandGovernmentMarketMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2021-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i49bfbec43e6f47b587bd6854c9e180fd_D20211101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="a:EndMarketsAxis">a:EnvironmentalandForensicsMarketMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ife69be53bb3f4276a6bb4df53fec04cc_D20201101-20210131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="a:EndMarketsAxis">a:EnvironmentalandForensicsMarketMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2021-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i931db477735742ad8a7854c47ecedf86_D20211101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">a:InstrumentationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i47dcfc0179de4e7d85d70bbddc34d760_D20201101-20210131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">a:InstrumentationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2021-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if362cbaedf1a426589671690d5a8d3b1_D20211101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">a:NonInstrumentationandOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia68ebbb6be4b4d8ba32cec1a9bcc02ba_D20201101-20210131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">a:NonInstrumentationandOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2021-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i54fd0d780e894d15abb38be115f904fc_I20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2022-01-31</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iae4a69f538454c80a80c725dcb6771c3_D20201101-20210131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2021-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i8ca5ba2eb51246a9894d8e9981e851fc_D20211101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4234dc38e5b84ef38ecd7c8b2af056d7_D20211101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i311fec97745e4c5782f4816c9e6d9ea3_D20201101-20210131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2021-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i316c350db7ff4688a76e3821c97ef7e5_D20211101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1ea2e447d0a14715a3edc8a2285fae18_D20201101-20210131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2021-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0320d16146c74425913fe2d4102de305_D20211101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if67aad121f6a462fb9bd2e05dc5b978e_D20201101-20210131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2021-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic76564bc7be64253830f89477bbf29cb_D20211101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if825187b5c3d4f688e0c4a074679fd80_D20201101-20210131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2021-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4535eece62c1411ab965c726896d4585_D20211101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7f82fd5225d94d7db0f34592fd4d9e70_D20201101-20210131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2021-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2b0f854e4792405b9d4a4ae010c5c2ad_D20211101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib7739872a76e499dad8a316f0e7cd808_D20201101-20210131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2021-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ief4838c7f61041b2b6eef53b20ed9d80_D20211101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PublicUtilitiesInventoryTypeDomain</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic14d2081148241ed947bffd3bb60c599_D20201101-20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PublicUtilitiesInventoryTypeDomain</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2021-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5acd8d66594844e1bea57bc50343b797_D20211101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">a:LtppMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie97ad2be4ba94b6f983f36fa69ecd859_D20201101-20210131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">a:LtppMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2021-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifb9c990647d348b7aea2ac54abe5e341_D20211101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">a:LTPPRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i89bc983fc1ee42d3a7c27d1122dfa162_D20201101-20210131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">a:LTPPRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2021-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i944f468c66a14978a1d1787de51efa6c_I20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:LifeSciencesandAppliedMarketsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib2f7270de94a4e99a7412adaded44a2d_I20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:DiagnosticsAndGenomicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib1434e5353934a0ebeb33b6c28613a50_I20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:AgilentCrossLabMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifa12471462934aa683c02dac2a2b2a70_I20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:LifeSciencesandAppliedMarketsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idcc96fc9ea6041bab3a0329c8a379a8d_I20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:DiagnosticsAndGenomicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia895e40152014164ae9414ff9f88a43e_I20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:AgilentCrossLabMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i62b4b85a6eb042808ab856394d83600f_I20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie3e5ec69c4a64648a675263b06182b48_I20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OrderOrProductionBacklogMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icca833cf758b4ec9adfaeb6e650d7c76_I20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ice63f8e3b57a458885f621065c24dd64_I20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i05ef46e1fee74f6eb0ef89af56b45fa8_I20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">a:ThirdPartyTechnologyandLicensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7b9447a5f8df4edc80c1ead0839fe3f6_I20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i210ca0088a2d4da59dbd86d6befab37d_I20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id6e2c0d55bcc4c6da40d65348178b171_I20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie65c749bc8fc42cd83d412fb98863517_I20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iacb3dbfe9a644ba4921bcd62e4831e5a_I20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OrderOrProductionBacklogMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i184afb63fb8e4731adf46510d25f3e7b_I20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">a:ThirdPartyTechnologyandLicensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i984d425948d34baea35894f126c09e37_I20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ife0901356f05422493cedbc99aaae757_I20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2071cdd246ee432b9ba0ffbd965b049b_I20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2ac569d010c5484d81397da751f5a61d_I20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if9bf63f60c78455792ba1de12fa4a127_I20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if5392f611be5496a9be81fc8bdf7afcc_I20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icf52874ae50c45a8a6ec86f9bab6ff9c_I20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibbcff4391c4341629230e4c9ce6b165c_I20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i94ff2c672a7b4ed9aee4690b84b849d7_I20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i33fe9961080d4147aae99b460ab50ecb_I20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if7c916269c054d37a6d9689d02baa352_I20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i31669f2cab12460b9f221115aa18666e_I20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8fa89a7423444291b6668e498df2d2d9_I20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i84e4835292ec4d75be7d497aef9738bf_I20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id2a2d84dda324165b0e39abf1e0999ee_I20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2c9abff20f8e48ec8631ac63a1274d21_I20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1b18bec55ca844fd9f7f27fe6c7b883b_I20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8e7130166b8246129cb9366c9e725c1d_I20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">a:ResolutionBioscienceIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6bfe36108f6442d88bb175e8a900971e_I20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id4d67bb87ecf49e9a34b390f9870efba_I20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i91b145cad93a40e6b17d080186760c04_I20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i11e4f5ef79704e5dab3b21061086d8e2_I20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if7cd365418ea4001be8171374346f5d4_I20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">a:ResolutionBioscienceIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i79dd2028aecf413fbe4f1d871c963827_I20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib476e9fd5af245d488939d04e35e54b1_I20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id1cf4d72cb954647a51527f90aeeb40b_I20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8690b9426888489bb9c9185bfdee22df_I20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4e39ecebbd8d4eeb970728db4d14f8c6_I20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaf311ad8bbc94cee9ca4b52f8c685019_I20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i101bd4dfad2f444c893fb78c50710bf6_I20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib53b527a87f34ca1a28449997f71d948_I20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie085dfbe93fe4451a8b8d84aad0e35d5_I20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idf80390ad3e448c4bce98cb60bfbca2c_I20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia4a3dda3866f4f3db20f204f127ccde3_I20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3a3d3d46764b449d8f6eccfe5e6a43b5_I20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6f394c9f978d46f7a4b1aca902fb05a9_I20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib292bc46e71c4b11a0a9f03de4f3b2fa_I20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if753f01b6fb74e4b82725e20f4211138_I20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i765ac03acc794ee0adca232fcb5a3e42_I20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if2ea1c6637aa4f78a6d53fd7fee549a8_I20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">a:ResolutionBioscienceIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i55d8c6d05fa4483c93279a0c9f44754d_I20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i167b08689113447eb86bceea035eecd1_I20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaff97c5b6ded4379888e10b33df96a9a_I20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i242b61736b4c44cebd07a140cbb7dda7_I20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8b752274839a498a9ba656f68620fcdb_I20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">a:ResolutionBioscienceIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8b540551877547fb8e1e4b0e4801b542_I20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">a:MeasurementInputAssetVolatilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i434180e34a724e439604a72f345ea6fd_I20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">a:MeasurementInputRevenueVolatilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i91a30a8c91a44f6eb18a935a5bb6d39f_I20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">a:MeasurementInputRevenueVolatilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id313ef0eb3db435cabb1861abacdf1d0_D20211101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">a:ResolutionBioscienceIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4da29d667bc84895ab281da0a1ff518e_I20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">a:ResolutionBioscienceIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic292fe4ddbdc4b1f85e1bac3f0ab2387_I20160201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">a:SeniorNotes2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2016-02-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="contracts"><xbrli:measure>a:contracts</xbrli:measure></xbrli:unit><xbrli:context id="ifb765ebd38d444b1857a41d784a28b5e_D20160914-20160915"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">a:SeniorNotes2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2016-09-14</xbrli:startDate><xbrli:endDate>2016-09-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if325814ac8de45f5b8f83e932e8509f8_I20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">a:SeniorNotes2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iad105ebf0fa5490194840a7fe0fd1664_I20190816"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">a:SeniorNotes2029Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-08-16</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3fae7ee4803141fab6fa85ebe7ee5491_D20190906-20190906"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">a:SeniorNotes2029Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-06</xbrli:startDate><xbrli:endDate>2019-09-06</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i042e0c2ce85c41bc9011ef45825cadd8_I20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">a:SeniorNotes2029Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3d4fb6e9c35b4a259523bf637621e885_I20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9309ceb43d6d4d7c95d0816fd752eca7_I20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1b3f43743319451cb90947e0304374dd_I20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8c42cc94490742e7b13ea5fd23157b27_I20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib6775d0eafba4fbcb9f4699180a8061e_I20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4a3c2b906dba466d90605db0ba3c44a4_I20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0f9ec320b33848c3a9839b24a1239ed8_I20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:GBP</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6497616d037845fca0c005ebc475212b_I20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:GBP</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i75d2660ff14040b3b96c724f268ab729_I20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CAD</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ica71b83ef3a1418d9d27756803812b2b_I20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CAD</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieb2fe08defb64136976421e01523b7ef_I20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:JPY</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4c6f0473f9864b389ca06abc0cf5ee78_I20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:JPY</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3355616638084c1584622a5e3613f202_I20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:DKK</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaeb7bd13400342f287179313ecad6bd5_I20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:KRW</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic4671a036f85446594c33199993572bf_I20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:KRW</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if316a64c264f481b862d74033659d9c1_I20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:SGD</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7306551b82684e7286c2efe86019758b_I20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:SGD</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i83b2d38c99874faa95b7ac2a3be10565_I20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CHF</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i72dfae202fe64d0d9194ac25adbe6324_I20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CNY</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icbb1793fb3ba4308a7a1bc073a3e737b_I20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CNY</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6881a3da71ef45248c11dd3d5d7aa897_I20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:TWD</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i039748d0e2f64eb98ec1fe2ea5b6d315_I20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:INR</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id105be7d8a724d71956a551b0fe22d54_I20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:BRL</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idcd3e8c2579941ef810c7c628510a603_I20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:XXX</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6caf21f7567843c6ac1d733aab0be98d_I20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:XXX</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8b3e8db945ae4a1a940922af0327692d_I20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibdea3a47f24e4e8590f368a0dfb94d45_I20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6736f6223d0f4203b9239c59f7463674_I20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i56c53f4c438544d8b06e4f41bad8c0db_I20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3c381f194b4e4d6884993233f9ef427b_I20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1fc3e3648d0b4efb976f2e9afc2cb0eb_I20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i50f69072160f4204bc684248a5c4d361_I20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if88446467ba74964bae3a43bab960c67_I20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iadfd46dace544484ab93d3f265e422a2_I20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia4aa7c9ade4a48b9afaa9ef1eb2c28d2_I20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifd354181dada4d4a900aa6600da1b6e0_I20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie5e458b01a414961bd824ffcfc393961_I20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia022050d3b32425cbcc3bee5435edaef_I20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i781e47792a004141abc5f44af8501b55_I20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i16900d24231046f1afce9ad394e43007_I20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ica123646e5544ebdbe2fa02d65eb9294_D20211101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i829319a2b5fb4d8fa6a9365861cbc737_D20201101-20210131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2021-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib54e90d3ce874df2836c9d7cf1ec6c25_D20211101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i151bd62ec0bd4c12b07d74d87ebe764b_D20201101-20210131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2021-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i01e3cab750934c929073437446f9cf98_D20211101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8dc3d15e75274d38a8a189554e496d08_D20201101-20210131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2021-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifa4aa5fe8b844efcb5e77e57cf2ac70e_D20211101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5cba63bb8ec2484285a9f87f393f6773_D20201101-20210131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2021-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i00a135183f5b41b092943e066055e800_D20211101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i61e53d96c9094ec5b9192e40de4357d8_D20211101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8454ff09d8134a2fb231984b395af89d_D20211101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i151e64785a6246818b5fa21ee1ee8f21_D20201101-20210131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2021-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id63140b493914a99a6c71088f76848c1_D20211101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2cb1409c861e47b69fd591e421c1d29a_D20201101-20210131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2021-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibd0876ed5c6643f9b68e30357fcb75c5_D20211101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic152b46d63194d6f8f761363250e0cde_D20201101-20210131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2021-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i39672334328841558d3a18821db61895_I20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iea4e6dcfdd864c84addac4f7be206f60_I20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6353332b36004c5c9db76cacfa73e855_D20190313-20190313"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">a:A5YrUnsecuredCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-03-13</xbrli:startDate><xbrli:endDate>2019-03-13</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8297b19666824b1083fbcdc032757e96_I20190313"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">a:A5YrUnsecuredCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-13</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic4c5e106421a497fb99105e140c6fd6c_I20191021"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">a:AdditionalIncrementalTermLoanFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-10-21</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0a3fbf71b5484a8c9274ae6020d3080e_I20210421"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">a:A5YrUnsecuredCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-21</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id62809c6a49144e4bae80c1fce300e42_I20210421"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">a:AdditionalIncrementalTermLoanFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-21</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4f579a58da844fa8ab292e8b3f4f6961_I20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">a:A5YrUnsecuredCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifbbc3ea9576a4f2eba2f7f1808345734_I20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">a:AdditionalIncrementalTermLoanFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i87ff5a86228e4f9b8b972888d1067302_I20210618"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-18</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ica23bb0f88b84e40a5cf6dce93ac3016_I20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie8601e6d640c4cdbaf6e7e979a3badb4_I20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">a:SeniorNotes2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie230dae4aa294d5b840b36798467586f_I20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">a:SeniorNotes2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2ff56f3c0b054dd0b0c0f6d3e90df039_I20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">a:SeniorNotes2026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i21c87c57472646b18bfda7e117eca64a_I20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">a:SeniorNotes2026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i35a5d7927ffc44debd0874726bf6a844_I20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">a:SeniorNotes2029Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8088c733be554ef0a2d2ce49c54cb56a_I20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">a:SeniorNotes2029Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i340410db81954133842fda25bab46456_I20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">a:SeniorNotes2030Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4505f8e4f0714a489cb047cfbb537298_I20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">a:SeniorNotes2030Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6ebf24f01a4e49d69ecb2c5a5f3230d0_I20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">a:SeniorNotes2031Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i02856e1853de45f185faca871ffc1d85_I20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">a:SeniorNotes2031Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i629b697ae777498d9e2c067c3e5a581e_I20181119"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">a:A2019RepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-11-19</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id3f922976d404efe924b23253513f94b_D20201101-20210131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">a:A2019RepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2021-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i11897c2b4a354e80b2f66e86e5b8bf11_I20210218"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">a:A2019RepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-02-18</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if65151f0282a48c5b160bfa0fd1f9626_I20210218"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">a:A2021RepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-02-18</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icdcacaffa00940c38eefae4a25b246ce_D20211101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">a:A2021RepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib67bf4635858449bb282042383b1fa3e_I20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">a:A2021RepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5c54dd5009274b448e1a0f238519873c_I20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iec127ccabccf4e1d8b1b9f0e177d0a6d_I20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i02b0508da50d4d36aa148cd391ab89a2_I20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i375e95e148364bec829da83e15fb30a0_I20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociDerivativeQualifyingAsHedgeExcludedComponentParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7e403833679541eab73046fd37fcdd94_D20211101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if6e4cf075aaa4d27853c6c516de6dd2c_D20211101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia6ec07697746456e8221275738907dd8_D20211101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icdcbd30df39641a4b5f2503519f860b9_D20211101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociDerivativeQualifyingAsHedgeExcludedComponentParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia1ee3187242a414db3687c2b9fc4d82f_I20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0dc39ee7c49e4d6cb473aef9858b6b88_I20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i70983fa542cf4b018a1bb84cfd674246_I20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2563947f2b6142d4a03ded6e410372c8_I20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociDerivativeQualifyingAsHedgeExcludedComponentParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5987fc4c9ed94d95b32a6ba071848996_D20211101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:SegmentTotalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i59f03109bfe04c92a404a9157747174a_D20201101-20210131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:SegmentTotalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2021-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if9eb3aa4cefc47e4b1504ff02a1447b6_I20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:SegmentTotalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i105ea30704ee4603b6db5fd253f01d92_I20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:SegmentTotalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="if825c91f15a047ec9e67e0189634a349_1"></div><div style="min-height:49.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#if825c91f15a047ec9e67e0189634a349_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">WASHINGTON, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM&#160;<ix:nonNumeric contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xL2ZyYWc6MDE0YTMxNWQ3YTI3NDg1MDkxNjVjZDFlMmE0ZTJiMGMvdGV4dHJlZ2lvbjowMTRhMzE1ZDdhMjc0ODUwOTE2NWNkMWUyYTRlMmIwY18yMjU2_661be8c7-63c5-4987-b32e-be22ef0c101b">10-Q</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(MARK ONE)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" name="dei:DocumentQuarterlyReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xL2ZyYWc6MDE0YTMxNWQ3YTI3NDg1MDkxNjVjZDFlMmE0ZTJiMGMvdGV4dHJlZ2lvbjowMTRhMzE1ZDdhMjc0ODUwOTE2NWNkMWUyYTRlMmIwY18yMjQ2_f707cb36-177f-4870-b641-dc60cd0d0b16">&#9746;</ix:nonNumeric> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)&#160;OF THE SECURITIES EXCHANGE ACT OF 1934.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">For the quarterly period ended <ix:nonNumeric contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xL2ZyYWc6MDE0YTMxNWQ3YTI3NDg1MDkxNjVjZDFlMmE0ZTJiMGMvdGV4dHJlZ2lvbjowMTRhMzE1ZDdhMjc0ODUwOTE2NWNkMWUyYTRlMmIwY18yMjU_a20b1a65-5175-4725-a473-1ef61e32bf1d">January 31, 2022</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">OR</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" name="dei:DocumentTransitionReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xL2ZyYWc6MDE0YTMxNWQ3YTI3NDg1MDkxNjVjZDFlMmE0ZTJiMGMvdGV4dHJlZ2lvbjowMTRhMzE1ZDdhMjc0ODUwOTE2NWNkMWUyYTRlMmIwY18yMjQ3_a7d49b15-7d45-403e-b279-744833189ae7">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">TRANSITION REPORT PURSUANT TO SECTION&#160;13 OR 15(d)&#160;OF THE SECURITIES EXCHANGE ACT OF 1934.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For transition period from &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; to&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission File Number: <ix:nonNumeric contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xL2ZyYWc6MDE0YTMxNWQ3YTI3NDg1MDkxNjVjZDFlMmE0ZTJiMGMvdGV4dHJlZ2lvbjowMTRhMzE1ZDdhMjc0ODUwOTE2NWNkMWUyYTRlMmIwY18yMjUx_46ef5fa5-7e18-411d-87af-9b4cca5784b5">001-15405</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xL2ZyYWc6MDE0YTMxNWQ3YTI3NDg1MDkxNjVjZDFlMmE0ZTJiMGMvdGV4dHJlZ2lvbjowMTRhMzE1ZDdhMjc0ODUwOTE2NWNkMWUyYTRlMmIwY18yMjQ4_e3c97a3d-de81-4fbe-a443-197fa17f1a10">AGILENT TECHNOLOGIES,&#160;INC.</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(Exact Name of registrant as specified in its charter)</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:19.191%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.097%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.191%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.440%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.264%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.848%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.269%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xL2ZyYWc6MDE0YTMxNWQ3YTI3NDg1MDkxNjVjZDFlMmE0ZTJiMGMvdGFibGU6NTRlZjQ1ODY5YmUyNGNhYmFiZjNmMzU0ZTdlN2JmODcvdGFibGVyYW5nZTo1NGVmNDU4NjliZTI0Y2FiYWJmM2YzNTRlN2U3YmY4N18wLTEtMS0xLTMwMTE0_a0cd4d73-26dc-4f15-859c-e64275165384">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xL2ZyYWc6MDE0YTMxNWQ3YTI3NDg1MDkxNjVjZDFlMmE0ZTJiMGMvdGFibGU6NTRlZjQ1ODY5YmUyNGNhYmFiZjNmMzU0ZTdlN2JmODcvdGFibGVyYW5nZTo1NGVmNDU4NjliZTI0Y2FiYWJmM2YzNTRlN2U3YmY4N18wLTUtMS0xLTMwMTE0_07df39e9-5d7a-41a1-8f5f-b463736082ff">77-0518772</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(State or other jurisdiction of incorporation or organization)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(IRS Employer Identification No.)</span></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xL2ZyYWc6MDE0YTMxNWQ3YTI3NDg1MDkxNjVjZDFlMmE0ZTJiMGMvdGV4dHJlZ2lvbjowMTRhMzE1ZDdhMjc0ODUwOTE2NWNkMWUyYTRlMmIwY18yMjUy_127e0761-37f7-4dec-ad66-399d60cedfe6">5301 Stevens Creek Blvd.,</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xL2ZyYWc6MDE0YTMxNWQ3YTI3NDg1MDkxNjVjZDFlMmE0ZTJiMGMvdGV4dHJlZ2lvbjowMTRhMzE1ZDdhMjc0ODUwOTE2NWNkMWUyYTRlMmIwY18yMjU3_89f9ba2f-f440-4ca5-a426-add41c5f85f3">Santa Clara,</ix:nonNumeric> <ix:nonNumeric contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xL2ZyYWc6MDE0YTMxNWQ3YTI3NDg1MDkxNjVjZDFlMmE0ZTJiMGMvdGV4dHJlZ2lvbjowMTRhMzE1ZDdhMjc0ODUwOTE2NWNkMWUyYTRlMmIwY18yMjU4_704995c0-ec46-48ac-8822-03c3056f6581">California</ix:nonNumeric> <ix:nonNumeric contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xL2ZyYWc6MDE0YTMxNWQ3YTI3NDg1MDkxNjVjZDFlMmE0ZTJiMGMvdGV4dHJlZ2lvbjowMTRhMzE1ZDdhMjc0ODUwOTE2NWNkMWUyYTRlMmIwY18yMjQ5_e270b355-913c-4a44-95ca-64e7e47cdae7">95051</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Address of principal executive offices)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Registrant&#8217;s telephone number, including area code:&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xL2ZyYWc6MDE0YTMxNWQ3YTI3NDg1MDkxNjVjZDFlMmE0ZTJiMGMvdGV4dHJlZ2lvbjowMTRhMzE1ZDdhMjc0ODUwOTE2NWNkMWUyYTRlMmIwY18yMjUz_423c51a4-5004-4f46-9c31-fe626162515e">(800)</ix:nonNumeric> <ix:nonNumeric contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xL2ZyYWc6MDE0YTMxNWQ3YTI3NDg1MDkxNjVjZDFlMmE0ZTJiMGMvdGV4dHJlZ2lvbjowMTRhMzE1ZDdhMjc0ODUwOTE2NWNkMWUyYTRlMmIwY18yMjUw_fd016219-bc53-4215-aee4-989ebd5d64a4">227-9770</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;</span></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:4pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:27.993%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.186%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.139%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.186%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.607%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.090%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Title of each Class</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Trading Symbol</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name of each Exchange on which registered</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xL2ZyYWc6MDE0YTMxNWQ3YTI3NDg1MDkxNjVjZDFlMmE0ZTJiMGMvdGFibGU6MmNkZDZkZjllYmU5NGFkY2JmNGYwMzVlNmFlZGM4NTUvdGFibGVyYW5nZToyY2RkNmRmOWViZTk0YWRjYmY0ZjAzNWU2YWVkYzg1NV8xLTAtMS0xLTMwMTE0_e3ac777c-0849-41e7-abc3-996aa58b0c61">Common Stock, $0.01 par value</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xL2ZyYWc6MDE0YTMxNWQ3YTI3NDg1MDkxNjVjZDFlMmE0ZTJiMGMvdGFibGU6MmNkZDZkZjllYmU5NGFkY2JmNGYwMzVlNmFlZGM4NTUvdGFibGVyYW5nZToyY2RkNmRmOWViZTk0YWRjYmY0ZjAzNWU2YWVkYzg1NV8xLTMtMS0xLTMwMTE0_8abfec7a-1d6a-48d9-a4a8-3b8d922acd61">A</ix:nonNumeric></span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xL2ZyYWc6MDE0YTMxNWQ3YTI3NDg1MDkxNjVjZDFlMmE0ZTJiMGMvdGFibGU6MmNkZDZkZjllYmU5NGFkY2JmNGYwMzVlNmFlZGM4NTUvdGFibGVyYW5nZToyY2RkNmRmOWViZTk0YWRjYmY0ZjAzNWU2YWVkYzg1NV8xLTctMS0xLTMwMTE0_8f6bb026-0784-4f14-a8a1-c79d4e972f76">New York Stock Exchange</ix:nonNumeric></span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by section&#160;13 or 15(d)&#160;of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90 days.&#160;&#160;<ix:nonNumeric contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xL2ZyYWc6MDE0YTMxNWQ3YTI3NDg1MDkxNjVjZDFlMmE0ZTJiMGMvdGV4dHJlZ2lvbjowMTRhMzE1ZDdhMjc0ODUwOTE2NWNkMWUyYTRlMmIwY18yMjU0_f036289f-6536-4ac5-bfc2-55bae182eca1">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;No&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-bottom:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule&#160;405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).&#160;&#160;<ix:nonNumeric contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xL2ZyYWc6MDE0YTMxNWQ3YTI3NDg1MDkxNjVjZDFlMmE0ZTJiMGMvdGV4dHJlZ2lvbjowMTRhMzE1ZDdhMjc0ODUwOTE2NWNkMWUyYTRlMmIwY18yMjU1_1ee36ec2-df3f-478d-bf10-66cb2fa12fdc">Yes</ix:nonNumeric>&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company&#8221; and "emerging growth company" in Rule&#160;12b-2 of the Exchange Act.</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:21.593%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.170%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.099%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.102%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.170%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.099%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.593%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.170%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.104%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xL2ZyYWc6MDE0YTMxNWQ3YTI3NDg1MDkxNjVjZDFlMmE0ZTJiMGMvdGFibGU6NTFjNmFhYjlhZTY4NGY3NGFkODdkZGUzYmY4ODA3NDIvdGFibGVyYW5nZTo1MWM2YWFiOWFlNjg0Zjc0YWQ4N2RkZTNiZjg4MDc0Ml8wLTAtMS0xLTMwMTE0_6dce4a90-7d21-4a5a-8a83-b798a5a9af4d">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right;text-indent:18pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#9746;</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right;text-indent:18pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#9744;</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right;text-indent:18pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#9744;</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smaller reporting company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right;text-indent:18pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" name="dei:EntitySmallBusiness" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xL2ZyYWc6MDE0YTMxNWQ3YTI3NDg1MDkxNjVjZDFlMmE0ZTJiMGMvdGFibGU6NTFjNmFhYjlhZTY4NGY3NGFkODdkZGUzYmY4ODA3NDIvdGFibGVyYW5nZTo1MWM2YWFiOWFlNjg0Zjc0YWQ4N2RkZTNiZjg4MDc0Ml8xLTEtMS0xLTMwMTE0_86e7c6cf-5ad9-4313-bd09-9397bac09941">&#9744;</ix:nonNumeric></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right;text-indent:18pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xL2ZyYWc6MDE0YTMxNWQ3YTI3NDg1MDkxNjVjZDFlMmE0ZTJiMGMvdGFibGU6NTFjNmFhYjlhZTY4NGY3NGFkODdkZGUzYmY4ODA3NDIvdGFibGVyYW5nZTo1MWM2YWFiOWFlNjg0Zjc0YWQ4N2RkZTNiZjg4MDc0Ml8xLTctMS0xLTMwMTE0_5f2b408a-e162-47c9-acd9-625036466d0c">&#9744;</ix:nonNumeric></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:2pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule&#160;12b-2 of the Exchange Act).&#160;&#160;Yes&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:11pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" name="dei:EntityShellCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xL2ZyYWc6MDE0YTMxNWQ3YTI3NDg1MDkxNjVjZDFlMmE0ZTJiMGMvdGV4dHJlZ2lvbjowMTRhMzE1ZDdhMjc0ODUwOTE2NWNkMWUyYTRlMmIwY18yMjU5_eb1afe61-0199-420e-97e8-7a0adc4c1e47">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> As of&#160;February&#160;25, 2022, the registrant had&#160;<ix:nonFraction unitRef="shares" contextRef="ia1e0ec64d140483ab50b26a38f74482e_I20220225" decimals="0" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xL2ZyYWc6MDE0YTMxNWQ3YTI3NDg1MDkxNjVjZDFlMmE0ZTJiMGMvdGV4dHJlZ2lvbjowMTRhMzE1ZDdhMjc0ODUwOTE2NWNkMWUyYTRlMmIwY18yMTgx_abe16948-5a80-445d-829c-8cffb6da5e4b">300,113,377</ix:nonFraction> shares of common stock, $0.01 par value per share, outstanding.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="if825c91f15a047ec9e67e0189634a349_7"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#if825c91f15a047ec9e67e0189634a349_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AGILENT TECHNOLOGIES,&#160;INC.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">TABLE OF CONTENTS</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:10.776%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.228%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:59.897%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.699%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Page<br/>Number</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if825c91f15a047ec9e67e0189634a349_10">Part&#160;I.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if825c91f15a047ec9e67e0189634a349_10">Financial Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if825c91f15a047ec9e67e0189634a349_10">3</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if825c91f15a047ec9e67e0189634a349_13">Item&#160;1.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if825c91f15a047ec9e67e0189634a349_13">Condensed Consolidated Financial Statements (Unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if825c91f15a047ec9e67e0189634a349_13">3</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if825c91f15a047ec9e67e0189634a349_16">Condensed Consolidated Statement of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if825c91f15a047ec9e67e0189634a349_16">3</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if825c91f15a047ec9e67e0189634a349_19">Condensed Consolidated Statement of Comprehensive Income (Loss)</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if825c91f15a047ec9e67e0189634a349_19">4</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if825c91f15a047ec9e67e0189634a349_22">Condensed Consolidated Balance Sheet</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if825c91f15a047ec9e67e0189634a349_22">5</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if825c91f15a047ec9e67e0189634a349_25">Condensed Consolidated Statement of Cash Flows</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if825c91f15a047ec9e67e0189634a349_25">6</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if825c91f15a047ec9e67e0189634a349_28">Condensed Consolidated Statement of Equity</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if825c91f15a047ec9e67e0189634a349_28">7</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if825c91f15a047ec9e67e0189634a349_31">Notes to Condensed Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if825c91f15a047ec9e67e0189634a349_31">8</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if825c91f15a047ec9e67e0189634a349_82">Item&#160;2.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if825c91f15a047ec9e67e0189634a349_82">Management&#8217;s Discussion and Analysis of Financial Condition and Results&#160;of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if825c91f15a047ec9e67e0189634a349_82">30</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if825c91f15a047ec9e67e0189634a349_124">Item&#160;3.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if825c91f15a047ec9e67e0189634a349_124">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if825c91f15a047ec9e67e0189634a349_124">42</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if825c91f15a047ec9e67e0189634a349_127">Item&#160;4.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if825c91f15a047ec9e67e0189634a349_127">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if825c91f15a047ec9e67e0189634a349_127">43</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if825c91f15a047ec9e67e0189634a349_130">Part&#160;II.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if825c91f15a047ec9e67e0189634a349_130">Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if825c91f15a047ec9e67e0189634a349_130">44</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if825c91f15a047ec9e67e0189634a349_133">Item&#160;1.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if825c91f15a047ec9e67e0189634a349_133">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if825c91f15a047ec9e67e0189634a349_133">44</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if825c91f15a047ec9e67e0189634a349_136">Item&#160;1A.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if825c91f15a047ec9e67e0189634a349_136">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if825c91f15a047ec9e67e0189634a349_136">44</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if825c91f15a047ec9e67e0189634a349_139">Item 2.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if825c91f15a047ec9e67e0189634a349_139">Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if825c91f15a047ec9e67e0189634a349_139">56</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Item&#160;6.</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibits</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if825c91f15a047ec9e67e0189634a349_142">57</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if825c91f15a047ec9e67e0189634a349_145">Signature</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if825c91f15a047ec9e67e0189634a349_145">58</a></span></div></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="if825c91f15a047ec9e67e0189634a349_10"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#if825c91f15a047ec9e67e0189634a349_7">Table of Contents</a></span></div></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:2.41pt">&#8212; FINANCIAL INFORMATION</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="if825c91f15a047ec9e67e0189634a349_13"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1. CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="if825c91f15a047ec9e67e0189634a349_16"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AGILENT TECHNOLOGIES,&#160;INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions, except per share amounts)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:78.285%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.844%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenue:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Products</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i805a3796c4d346d19353b262791e3f84_D20211101-20220131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xNi9mcmFnOjkyZTk5YzBiMjc2MDRjYWNiOGI1MzU4ZDdjYzUwZDRlL3RhYmxlOmRkYTU4NGE3YTU5ZDRkOTY5ZjI0YzVkN2MxOWNhNGY4L3RhYmxlcmFuZ2U6ZGRhNTg0YTdhNTlkNGQ5NjlmMjRjNWQ3YzE5Y2E0ZjhfNC01LTEtMS0zMDExNA_4a218de2-7e2d-4d37-b46d-5a71d9c5e8bb">1,263</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97c9b6fdcd4541e69ddf24ca1c06ce50_D20201101-20210131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xNi9mcmFnOjkyZTk5YzBiMjc2MDRjYWNiOGI1MzU4ZDdjYzUwZDRlL3RhYmxlOmRkYTU4NGE3YTU5ZDRkOTY5ZjI0YzVkN2MxOWNhNGY4L3RhYmxlcmFuZ2U6ZGRhNTg0YTdhNTlkNGQ5NjlmMjRjNWQ3YzE5Y2E0ZjhfNC03LTEtMS0zMDExNA_50c40f71-6428-4851-a4ca-8d5e69998f3c">1,172</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services and other</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e96a3d7152643bbb7d3308a81aed7d8_D20211101-20220131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xNi9mcmFnOjkyZTk5YzBiMjc2MDRjYWNiOGI1MzU4ZDdjYzUwZDRlL3RhYmxlOmRkYTU4NGE3YTU5ZDRkOTY5ZjI0YzVkN2MxOWNhNGY4L3RhYmxlcmFuZ2U6ZGRhNTg0YTdhNTlkNGQ5NjlmMjRjNWQ3YzE5Y2E0ZjhfNS01LTEtMS0zMDExNA_348674d4-243d-41e9-8b54-ca5d02da90a6">411</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic06fd2b5991a4b23ae6db3209ddc24bc_D20201101-20210131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xNi9mcmFnOjkyZTk5YzBiMjc2MDRjYWNiOGI1MzU4ZDdjYzUwZDRlL3RhYmxlOmRkYTU4NGE3YTU5ZDRkOTY5ZjI0YzVkN2MxOWNhNGY4L3RhYmxlcmFuZ2U6ZGRhNTg0YTdhNTlkNGQ5NjlmMjRjNWQ3YzE5Y2E0ZjhfNS03LTEtMS0zMDExNA_832c3133-7bcf-4a3d-be95-756f6536d841">376</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net revenue</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xNi9mcmFnOjkyZTk5YzBiMjc2MDRjYWNiOGI1MzU4ZDdjYzUwZDRlL3RhYmxlOmRkYTU4NGE3YTU5ZDRkOTY5ZjI0YzVkN2MxOWNhNGY4L3RhYmxlcmFuZ2U6ZGRhNTg0YTdhNTlkNGQ5NjlmMjRjNWQ3YzE5Y2E0ZjhfNi01LTEtMS0zMDExNA_2860c08d-3f10-496d-8b06-62ffaba51961">1,674</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xNi9mcmFnOjkyZTk5YzBiMjc2MDRjYWNiOGI1MzU4ZDdjYzUwZDRlL3RhYmxlOmRkYTU4NGE3YTU5ZDRkOTY5ZjI0YzVkN2MxOWNhNGY4L3RhYmxlcmFuZ2U6ZGRhNTg0YTdhNTlkNGQ5NjlmMjRjNWQ3YzE5Y2E0ZjhfNi03LTEtMS0zMDExNA_b6b730df-1b0b-4e7a-9c1b-0dcbdcdbf5ef">1,548</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Costs and expenses:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i805a3796c4d346d19353b262791e3f84_D20211101-20220131" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xNi9mcmFnOjkyZTk5YzBiMjc2MDRjYWNiOGI1MzU4ZDdjYzUwZDRlL3RhYmxlOmRkYTU4NGE3YTU5ZDRkOTY5ZjI0YzVkN2MxOWNhNGY4L3RhYmxlcmFuZ2U6ZGRhNTg0YTdhNTlkNGQ5NjlmMjRjNWQ3YzE5Y2E0ZjhfOC01LTEtMS0zMDExNA_49ffd3d1-343a-4287-9b10-7d535685b558">545</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97c9b6fdcd4541e69ddf24ca1c06ce50_D20201101-20210131" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xNi9mcmFnOjkyZTk5YzBiMjc2MDRjYWNiOGI1MzU4ZDdjYzUwZDRlL3RhYmxlOmRkYTU4NGE3YTU5ZDRkOTY5ZjI0YzVkN2MxOWNhNGY4L3RhYmxlcmFuZ2U6ZGRhNTg0YTdhNTlkNGQ5NjlmMjRjNWQ3YzE5Y2E0ZjhfOC03LTEtMS0zMDExNA_81ea394f-2d64-4830-8b4b-1a42dbc0ac90">509</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of services and other</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e96a3d7152643bbb7d3308a81aed7d8_D20211101-20220131" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xNi9mcmFnOjkyZTk5YzBiMjc2MDRjYWNiOGI1MzU4ZDdjYzUwZDRlL3RhYmxlOmRkYTU4NGE3YTU5ZDRkOTY5ZjI0YzVkN2MxOWNhNGY4L3RhYmxlcmFuZ2U6ZGRhNTg0YTdhNTlkNGQ5NjlmMjRjNWQ3YzE5Y2E0ZjhfOS01LTEtMS0zMDExNA_9529d10f-ea3b-4d0e-a820-c2de64ba3bb2">219</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic06fd2b5991a4b23ae6db3209ddc24bc_D20201101-20210131" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xNi9mcmFnOjkyZTk5YzBiMjc2MDRjYWNiOGI1MzU4ZDdjYzUwZDRlL3RhYmxlOmRkYTU4NGE3YTU5ZDRkOTY5ZjI0YzVkN2MxOWNhNGY4L3RhYmxlcmFuZ2U6ZGRhNTg0YTdhNTlkNGQ5NjlmMjRjNWQ3YzE5Y2E0ZjhfOS03LTEtMS0zMDExNA_b6374261-5f80-4af1-99a9-444fe441e8cb">201</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total costs</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xNi9mcmFnOjkyZTk5YzBiMjc2MDRjYWNiOGI1MzU4ZDdjYzUwZDRlL3RhYmxlOmRkYTU4NGE3YTU5ZDRkOTY5ZjI0YzVkN2MxOWNhNGY4L3RhYmxlcmFuZ2U6ZGRhNTg0YTdhNTlkNGQ5NjlmMjRjNWQ3YzE5Y2E0ZjhfMTAtNS0xLTEtMzAxMTQ_25553823-6b19-41dc-930b-1caa1a7590ab">764</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xNi9mcmFnOjkyZTk5YzBiMjc2MDRjYWNiOGI1MzU4ZDdjYzUwZDRlL3RhYmxlOmRkYTU4NGE3YTU5ZDRkOTY5ZjI0YzVkN2MxOWNhNGY4L3RhYmxlcmFuZ2U6ZGRhNTg0YTdhNTlkNGQ5NjlmMjRjNWQ3YzE5Y2E0ZjhfMTAtNy0xLTEtMzAxMTQ_caedfaac-8f75-4bbf-93a6-09b1b6607b5b">710</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" decimals="-6" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xNi9mcmFnOjkyZTk5YzBiMjc2MDRjYWNiOGI1MzU4ZDdjYzUwZDRlL3RhYmxlOmRkYTU4NGE3YTU5ZDRkOTY5ZjI0YzVkN2MxOWNhNGY4L3RhYmxlcmFuZ2U6ZGRhNTg0YTdhNTlkNGQ5NjlmMjRjNWQ3YzE5Y2E0ZjhfMTEtNS0xLTEtMzAxMTQ_1841ec56-28a1-49d5-ab25-57e32715ba77">117</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131" decimals="-6" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xNi9mcmFnOjkyZTk5YzBiMjc2MDRjYWNiOGI1MzU4ZDdjYzUwZDRlL3RhYmxlOmRkYTU4NGE3YTU5ZDRkOTY5ZjI0YzVkN2MxOWNhNGY4L3RhYmxlcmFuZ2U6ZGRhNTg0YTdhNTlkNGQ5NjlmMjRjNWQ3YzE5Y2E0ZjhfMTEtNy0xLTEtMzAxMTQ_818b88fa-2864-4fa4-8bb1-5176156f2452">103</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xNi9mcmFnOjkyZTk5YzBiMjc2MDRjYWNiOGI1MzU4ZDdjYzUwZDRlL3RhYmxlOmRkYTU4NGE3YTU5ZDRkOTY5ZjI0YzVkN2MxOWNhNGY4L3RhYmxlcmFuZ2U6ZGRhNTg0YTdhNTlkNGQ5NjlmMjRjNWQ3YzE5Y2E0ZjhfMTItNS0xLTEtMzAxMTQ_41d740dc-bdf9-4dad-855b-f017788203c0">417</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xNi9mcmFnOjkyZTk5YzBiMjc2MDRjYWNiOGI1MzU4ZDdjYzUwZDRlL3RhYmxlOmRkYTU4NGE3YTU5ZDRkOTY5ZjI0YzVkN2MxOWNhNGY4L3RhYmxlcmFuZ2U6ZGRhNTg0YTdhNTlkNGQ5NjlmMjRjNWQ3YzE5Y2E0ZjhfMTItNy0xLTEtMzAxMTQ_41e4116c-30a7-477d-a7c5-22d15591cccf">407</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total costs and expenses</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" decimals="-6" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xNi9mcmFnOjkyZTk5YzBiMjc2MDRjYWNiOGI1MzU4ZDdjYzUwZDRlL3RhYmxlOmRkYTU4NGE3YTU5ZDRkOTY5ZjI0YzVkN2MxOWNhNGY4L3RhYmxlcmFuZ2U6ZGRhNTg0YTdhNTlkNGQ5NjlmMjRjNWQ3YzE5Y2E0ZjhfMTMtNS0xLTEtMzAxMTQ_0da84f22-3c71-45c0-8ad1-ad1dda077a69">1,298</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131" decimals="-6" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xNi9mcmFnOjkyZTk5YzBiMjc2MDRjYWNiOGI1MzU4ZDdjYzUwZDRlL3RhYmxlOmRkYTU4NGE3YTU5ZDRkOTY5ZjI0YzVkN2MxOWNhNGY4L3RhYmxlcmFuZ2U6ZGRhNTg0YTdhNTlkNGQ5NjlmMjRjNWQ3YzE5Y2E0ZjhfMTMtNy0xLTEtMzAxMTQ_6a2ff993-3064-4758-9169-c4f4037754d8">1,220</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from operations</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xNi9mcmFnOjkyZTk5YzBiMjc2MDRjYWNiOGI1MzU4ZDdjYzUwZDRlL3RhYmxlOmRkYTU4NGE3YTU5ZDRkOTY5ZjI0YzVkN2MxOWNhNGY4L3RhYmxlcmFuZ2U6ZGRhNTg0YTdhNTlkNGQ5NjlmMjRjNWQ3YzE5Y2E0ZjhfMTQtNS0xLTEtMzAxMTQ_3c24e737-f1ee-4672-a641-bee2585737f0">376</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xNi9mcmFnOjkyZTk5YzBiMjc2MDRjYWNiOGI1MzU4ZDdjYzUwZDRlL3RhYmxlOmRkYTU4NGE3YTU5ZDRkOTY5ZjI0YzVkN2MxOWNhNGY4L3RhYmxlcmFuZ2U6ZGRhNTg0YTdhNTlkNGQ5NjlmMjRjNWQ3YzE5Y2E0ZjhfMTQtNy0xLTEtMzAxMTQ_628dea35-addf-47d3-bd6a-6b3ec9f0e879">328</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" decimals="-6" name="us-gaap:InvestmentIncomeInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xNi9mcmFnOjkyZTk5YzBiMjc2MDRjYWNiOGI1MzU4ZDdjYzUwZDRlL3RhYmxlOmRkYTU4NGE3YTU5ZDRkOTY5ZjI0YzVkN2MxOWNhNGY4L3RhYmxlcmFuZ2U6ZGRhNTg0YTdhNTlkNGQ5NjlmMjRjNWQ3YzE5Y2E0ZjhfMTUtNS0xLTEtMzAxMTQ_e6b8c965-5c7c-48b3-9cd0-2c82d88b75d4">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131" decimals="-6" name="us-gaap:InvestmentIncomeInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xNi9mcmFnOjkyZTk5YzBiMjc2MDRjYWNiOGI1MzU4ZDdjYzUwZDRlL3RhYmxlOmRkYTU4NGE3YTU5ZDRkOTY5ZjI0YzVkN2MxOWNhNGY4L3RhYmxlcmFuZ2U6ZGRhNTg0YTdhNTlkNGQ5NjlmMjRjNWQ3YzE5Y2E0ZjhfMTUtNy0xLTEtMzAxMTQ_c66d6ea1-4aca-4a9d-9e73-86917d2dfde9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xNi9mcmFnOjkyZTk5YzBiMjc2MDRjYWNiOGI1MzU4ZDdjYzUwZDRlL3RhYmxlOmRkYTU4NGE3YTU5ZDRkOTY5ZjI0YzVkN2MxOWNhNGY4L3RhYmxlcmFuZ2U6ZGRhNTg0YTdhNTlkNGQ5NjlmMjRjNWQ3YzE5Y2E0ZjhfMTYtNS0xLTEtMzAxMTQ_c1743f04-da48-4239-8331-98896642d453">21</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xNi9mcmFnOjkyZTk5YzBiMjc2MDRjYWNiOGI1MzU4ZDdjYzUwZDRlL3RhYmxlOmRkYTU4NGE3YTU5ZDRkOTY5ZjI0YzVkN2MxOWNhNGY4L3RhYmxlcmFuZ2U6ZGRhNTg0YTdhNTlkNGQ5NjlmMjRjNWQ3YzE5Y2E0ZjhfMTYtNy0xLTEtMzAxMTQ_245c9d6a-a029-4f41-baa0-c2797c28bf5a">19</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" decimals="-6" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xNi9mcmFnOjkyZTk5YzBiMjc2MDRjYWNiOGI1MzU4ZDdjYzUwZDRlL3RhYmxlOmRkYTU4NGE3YTU5ZDRkOTY5ZjI0YzVkN2MxOWNhNGY4L3RhYmxlcmFuZ2U6ZGRhNTg0YTdhNTlkNGQ5NjlmMjRjNWQ3YzE5Y2E0ZjhfMTctNS0xLTEtMzAxMTQ_4e65b7a7-4051-4abc-a843-c51fe1df1ee9">37</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xNi9mcmFnOjkyZTk5YzBiMjc2MDRjYWNiOGI1MzU4ZDdjYzUwZDRlL3RhYmxlOmRkYTU4NGE3YTU5ZDRkOTY5ZjI0YzVkN2MxOWNhNGY4L3RhYmxlcmFuZ2U6ZGRhNTg0YTdhNTlkNGQ5NjlmMjRjNWQ3YzE5Y2E0ZjhfMTctNy0xLTEtMzAxMTQ_08407a3c-7290-4367-baee-017cd362e2fd">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before taxes</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xNi9mcmFnOjkyZTk5YzBiMjc2MDRjYWNiOGI1MzU4ZDdjYzUwZDRlL3RhYmxlOmRkYTU4NGE3YTU5ZDRkOTY5ZjI0YzVkN2MxOWNhNGY4L3RhYmxlcmFuZ2U6ZGRhNTg0YTdhNTlkNGQ5NjlmMjRjNWQ3YzE5Y2E0ZjhfMTgtNS0xLTEtMzAxMTQ_09084735-755b-4c1c-a5f4-dfcdce014a12">319</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xNi9mcmFnOjkyZTk5YzBiMjc2MDRjYWNiOGI1MzU4ZDdjYzUwZDRlL3RhYmxlOmRkYTU4NGE3YTU5ZDRkOTY5ZjI0YzVkN2MxOWNhNGY4L3RhYmxlcmFuZ2U6ZGRhNTg0YTdhNTlkNGQ5NjlmMjRjNWQ3YzE5Y2E0ZjhfMTgtNy0xLTEtMzAxMTQ_0c2b7d04-1a4a-4b13-9fab-39d8ea21e376">312</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xNi9mcmFnOjkyZTk5YzBiMjc2MDRjYWNiOGI1MzU4ZDdjYzUwZDRlL3RhYmxlOmRkYTU4NGE3YTU5ZDRkOTY5ZjI0YzVkN2MxOWNhNGY4L3RhYmxlcmFuZ2U6ZGRhNTg0YTdhNTlkNGQ5NjlmMjRjNWQ3YzE5Y2E0ZjhfMTktNS0xLTEtMzAxMTQ_38806faf-53cf-40c1-bf05-c19d0e2b6a60">36</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xNi9mcmFnOjkyZTk5YzBiMjc2MDRjYWNiOGI1MzU4ZDdjYzUwZDRlL3RhYmxlOmRkYTU4NGE3YTU5ZDRkOTY5ZjI0YzVkN2MxOWNhNGY4L3RhYmxlcmFuZ2U6ZGRhNTg0YTdhNTlkNGQ5NjlmMjRjNWQ3YzE5Y2E0ZjhfMTktNy0xLTEtMzAxMTQ_038d5418-59e8-4458-9967-12311c3162f4">24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xNi9mcmFnOjkyZTk5YzBiMjc2MDRjYWNiOGI1MzU4ZDdjYzUwZDRlL3RhYmxlOmRkYTU4NGE3YTU5ZDRkOTY5ZjI0YzVkN2MxOWNhNGY4L3RhYmxlcmFuZ2U6ZGRhNTg0YTdhNTlkNGQ5NjlmMjRjNWQ3YzE5Y2E0ZjhfMjAtNS0xLTEtMzAxMTQ_2c43b895-b866-49b9-b604-ec8f182de6f9">283</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xNi9mcmFnOjkyZTk5YzBiMjc2MDRjYWNiOGI1MzU4ZDdjYzUwZDRlL3RhYmxlOmRkYTU4NGE3YTU5ZDRkOTY5ZjI0YzVkN2MxOWNhNGY4L3RhYmxlcmFuZ2U6ZGRhNTg0YTdhNTlkNGQ5NjlmMjRjNWQ3YzE5Y2E0ZjhfMjAtNy0xLTEtMzAxMTQ_099481d5-ea8c-4b81-be86-16fd4bb9b3aa">288</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income per share:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xNi9mcmFnOjkyZTk5YzBiMjc2MDRjYWNiOGI1MzU4ZDdjYzUwZDRlL3RhYmxlOmRkYTU4NGE3YTU5ZDRkOTY5ZjI0YzVkN2MxOWNhNGY4L3RhYmxlcmFuZ2U6ZGRhNTg0YTdhNTlkNGQ5NjlmMjRjNWQ3YzE5Y2E0ZjhfMjMtNS0xLTEtMzAxMTQ_1f17e9dc-aeb1-46cc-af49-d28b1102ba6a">0.94</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xNi9mcmFnOjkyZTk5YzBiMjc2MDRjYWNiOGI1MzU4ZDdjYzUwZDRlL3RhYmxlOmRkYTU4NGE3YTU5ZDRkOTY5ZjI0YzVkN2MxOWNhNGY4L3RhYmxlcmFuZ2U6ZGRhNTg0YTdhNTlkNGQ5NjlmMjRjNWQ3YzE5Y2E0ZjhfMjMtNy0xLTEtMzAxMTQ_b5fda9ca-577e-4abe-9295-720f937903eb">0.94</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xNi9mcmFnOjkyZTk5YzBiMjc2MDRjYWNiOGI1MzU4ZDdjYzUwZDRlL3RhYmxlOmRkYTU4NGE3YTU5ZDRkOTY5ZjI0YzVkN2MxOWNhNGY4L3RhYmxlcmFuZ2U6ZGRhNTg0YTdhNTlkNGQ5NjlmMjRjNWQ3YzE5Y2E0ZjhfMjQtNS0xLTEtMzAxMTQ_33f7dbe2-a368-4446-94f0-a58011799877">0.93</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xNi9mcmFnOjkyZTk5YzBiMjc2MDRjYWNiOGI1MzU4ZDdjYzUwZDRlL3RhYmxlOmRkYTU4NGE3YTU5ZDRkOTY5ZjI0YzVkN2MxOWNhNGY4L3RhYmxlcmFuZ2U6ZGRhNTg0YTdhNTlkNGQ5NjlmMjRjNWQ3YzE5Y2E0ZjhfMjQtNy0xLTEtMzAxMTQ_218e097a-b56f-4292-9bec-ff7e5aa934eb">0.93</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares used in computing net income per share:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xNi9mcmFnOjkyZTk5YzBiMjc2MDRjYWNiOGI1MzU4ZDdjYzUwZDRlL3RhYmxlOmRkYTU4NGE3YTU5ZDRkOTY5ZjI0YzVkN2MxOWNhNGY4L3RhYmxlcmFuZ2U6ZGRhNTg0YTdhNTlkNGQ5NjlmMjRjNWQ3YzE5Y2E0ZjhfMjctNS0xLTEtMzAxMTQ_8281d61f-e3a4-43cb-87c2-dafaa38ee1b8">301</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xNi9mcmFnOjkyZTk5YzBiMjc2MDRjYWNiOGI1MzU4ZDdjYzUwZDRlL3RhYmxlOmRkYTU4NGE3YTU5ZDRkOTY5ZjI0YzVkN2MxOWNhNGY4L3RhYmxlcmFuZ2U6ZGRhNTg0YTdhNTlkNGQ5NjlmMjRjNWQ3YzE5Y2E0ZjhfMjctNy0xLTEtMzAxMTQ_a6d85005-ff00-40dd-b1fe-e6b22bba87d0">306</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xNi9mcmFnOjkyZTk5YzBiMjc2MDRjYWNiOGI1MzU4ZDdjYzUwZDRlL3RhYmxlOmRkYTU4NGE3YTU5ZDRkOTY5ZjI0YzVkN2MxOWNhNGY4L3RhYmxlcmFuZ2U6ZGRhNTg0YTdhNTlkNGQ5NjlmMjRjNWQ3YzE5Y2E0ZjhfMjgtNS0xLTEtMzAxMTQ_832f939f-f130-4371-96ce-e5ea0cad3bb9">303</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xNi9mcmFnOjkyZTk5YzBiMjc2MDRjYWNiOGI1MzU4ZDdjYzUwZDRlL3RhYmxlOmRkYTU4NGE3YTU5ZDRkOTY5ZjI0YzVkN2MxOWNhNGY4L3RhYmxlcmFuZ2U6ZGRhNTg0YTdhNTlkNGQ5NjlmMjRjNWQ3YzE5Y2E0ZjhfMjgtNy0xLTEtMzAxMTQ_e663c9fb-0470-4882-993b-2c808af4898a">309</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="if825c91f15a047ec9e67e0189634a349_19"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#if825c91f15a047ec9e67e0189634a349_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AGILENT TECHNOLOGIES,&#160;INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME (LOSS)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.410%"><tr><td style="width:1.0%"></td><td style="width:82.431%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.763%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.541%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.765%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xOS9mcmFnOmQ5ZWE0MmNiNWRiNjRhMjZhYWIzOGYyMmM0MDk5ODNmL3RhYmxlOjVhYTFkOTQyZTk5MTQ2ZmNiOTc3YTdjNzZiNmE2NzViL3RhYmxlcmFuZ2U6NWFhMWQ5NDJlOTkxNDZmY2I5NzdhN2M3NmI2YTY3NWJfNC0xLTEtMS0zMDExNA_0771d00e-0edf-4c70-a561-a8a9a771607e">283</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xOS9mcmFnOmQ5ZWE0MmNiNWRiNjRhMjZhYWIzOGYyMmM0MDk5ODNmL3RhYmxlOjVhYTFkOTQyZTk5MTQ2ZmNiOTc3YTdjNzZiNmE2NzViL3RhYmxlcmFuZ2U6NWFhMWQ5NDJlOTkxNDZmY2I5NzdhN2M3NmI2YTY3NWJfNC0zLTEtMS0zMDExNA_1f6a4689-a841-4ec8-9c80-80df7e340164">288</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gain (loss) on derivative instruments, net of tax expense (benefit) of $<ix:nonFraction unitRef="usd" contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xOS9mcmFnOmQ5ZWE0MmNiNWRiNjRhMjZhYWIzOGYyMmM0MDk5ODNmL3RhYmxlOjVhYTFkOTQyZTk5MTQ2ZmNiOTc3YTdjNzZiNmE2NzViL3RhYmxlcmFuZ2U6NWFhMWQ5NDJlOTkxNDZmY2I5NzdhN2M3NmI2YTY3NWJfOC0wLTEtMS0zMDExNC90ZXh0cmVnaW9uOjBiNmI4NThkNzQzZTRkY2M4YTE4MWNmNDI2ZDRhZjM5Xzg2_aa1e348b-629b-4e4d-90a3-d1977c982cea">2</ix:nonFraction> and $(<ix:nonFraction unitRef="usd" contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xOS9mcmFnOmQ5ZWE0MmNiNWRiNjRhMjZhYWIzOGYyMmM0MDk5ODNmL3RhYmxlOjVhYTFkOTQyZTk5MTQ2ZmNiOTc3YTdjNzZiNmE2NzViL3RhYmxlcmFuZ2U6NWFhMWQ5NDJlOTkxNDZmY2I5NzdhN2M3NmI2YTY3NWJfOC0wLTEtMS0zMDExNC90ZXh0cmVnaW9uOjBiNmI4NThkNzQzZTRkY2M4YTE4MWNmNDI2ZDRhZjM5Xzkw_828f8b5a-2361-42ac-8cad-e75292ca0546">2</ix:nonFraction>)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xOS9mcmFnOmQ5ZWE0MmNiNWRiNjRhMjZhYWIzOGYyMmM0MDk5ODNmL3RhYmxlOjVhYTFkOTQyZTk5MTQ2ZmNiOTc3YTdjNzZiNmE2NzViL3RhYmxlcmFuZ2U6NWFhMWQ5NDJlOTkxNDZmY2I5NzdhN2M3NmI2YTY3NWJfOC0xLTEtMS0zMDExNA_54856ece-8c43-462f-b895-bf95e1dbced0">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xOS9mcmFnOmQ5ZWE0MmNiNWRiNjRhMjZhYWIzOGYyMmM0MDk5ODNmL3RhYmxlOjVhYTFkOTQyZTk5MTQ2ZmNiOTc3YTdjNzZiNmE2NzViL3RhYmxlcmFuZ2U6NWFhMWQ5NDJlOTkxNDZmY2I5NzdhN2M3NmI2YTY3NWJfOC0zLTEtMS0zMDExNA_ec54340a-a998-4221-aa69-cd35c3c699b2">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified into earnings related to derivative instruments, net of tax expense (benefit) of $(<ix:nonFraction unitRef="usd" contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xOS9mcmFnOmQ5ZWE0MmNiNWRiNjRhMjZhYWIzOGYyMmM0MDk5ODNmL3RhYmxlOjVhYTFkOTQyZTk5MTQ2ZmNiOTc3YTdjNzZiNmE2NzViL3RhYmxlcmFuZ2U6NWFhMWQ5NDJlOTkxNDZmY2I5NzdhN2M3NmI2YTY3NWJfOS0wLTEtMS0zMDExNC90ZXh0cmVnaW9uOjNkZTY2MWY4NjBjYTRkN2Y4M2E3MjdlZTRiZGQwY2JlXzk2_bbbf6fbc-1b16-4196-aecd-240691e25ad5">1</ix:nonFraction>) and $<ix:nonFraction unitRef="usd" contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xOS9mcmFnOmQ5ZWE0MmNiNWRiNjRhMjZhYWIzOGYyMmM0MDk5ODNmL3RhYmxlOjVhYTFkOTQyZTk5MTQ2ZmNiOTc3YTdjNzZiNmE2NzViL3RhYmxlcmFuZ2U6NWFhMWQ5NDJlOTkxNDZmY2I5NzdhN2M3NmI2YTY3NWJfOS0wLTEtMS0zMDExNC90ZXh0cmVnaW9uOjNkZTY2MWY4NjBjYTRkN2Y4M2E3MjdlZTRiZGQwY2JlXzEwMA_f7491024-e4ed-4b95-83f7-ef627c670119">2</ix:nonFraction></span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xOS9mcmFnOmQ5ZWE0MmNiNWRiNjRhMjZhYWIzOGYyMmM0MDk5ODNmL3RhYmxlOjVhYTFkOTQyZTk5MTQ2ZmNiOTc3YTdjNzZiNmE2NzViL3RhYmxlcmFuZ2U6NWFhMWQ5NDJlOTkxNDZmY2I5NzdhN2M3NmI2YTY3NWJfOS0xLTEtMS0zMDExNA_c00f976c-97af-462b-be47-c83c5c6e28e9">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xOS9mcmFnOmQ5ZWE0MmNiNWRiNjRhMjZhYWIzOGYyMmM0MDk5ODNmL3RhYmxlOjVhYTFkOTQyZTk5MTQ2ZmNiOTc3YTdjNzZiNmE2NzViL3RhYmxlcmFuZ2U6NWFhMWQ5NDJlOTkxNDZmY2I5NzdhN2M3NmI2YTY3NWJfOS0zLTEtMS0zMDExNA_d1c5878b-582b-4c38-b5ab-61d29b127444">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation, net of tax expense of $<ix:nonFraction unitRef="usd" contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xOS9mcmFnOmQ5ZWE0MmNiNWRiNjRhMjZhYWIzOGYyMmM0MDk5ODNmL3RhYmxlOjVhYTFkOTQyZTk5MTQ2ZmNiOTc3YTdjNzZiNmE2NzViL3RhYmxlcmFuZ2U6NWFhMWQ5NDJlOTkxNDZmY2I5NzdhN2M3NmI2YTY3NWJfMTAtMC0xLTEtMzAxMTQvdGV4dHJlZ2lvbjpiMDI1NDFhZjNjMTA0Mzk5OTM0Yjg0Y2EyNTUyMTI0MV81Ng_c1341c31-e61b-4dce-b690-785f006b4e03">0</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xOS9mcmFnOmQ5ZWE0MmNiNWRiNjRhMjZhYWIzOGYyMmM0MDk5ODNmL3RhYmxlOjVhYTFkOTQyZTk5MTQ2ZmNiOTc3YTdjNzZiNmE2NzViL3RhYmxlcmFuZ2U6NWFhMWQ5NDJlOTkxNDZmY2I5NzdhN2M3NmI2YTY3NWJfMTAtMC0xLTEtMzAxMTQvdGV4dHJlZ2lvbjpiMDI1NDFhZjNjMTA0Mzk5OTM0Yjg0Y2EyNTUyMTI0MV82MA_6977b8dd-980c-4bc5-8239-bce9aee729dd">0</ix:nonFraction></span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xOS9mcmFnOmQ5ZWE0MmNiNWRiNjRhMjZhYWIzOGYyMmM0MDk5ODNmL3RhYmxlOjVhYTFkOTQyZTk5MTQ2ZmNiOTc3YTdjNzZiNmE2NzViL3RhYmxlcmFuZ2U6NWFhMWQ5NDJlOTkxNDZmY2I5NzdhN2M3NmI2YTY3NWJfMTAtMS0xLTEtMzAxMTQ_49826544-2c14-44b3-93a4-182d0f74a896">27</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131" decimals="-6" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xOS9mcmFnOmQ5ZWE0MmNiNWRiNjRhMjZhYWIzOGYyMmM0MDk5ODNmL3RhYmxlOjVhYTFkOTQyZTk5MTQ2ZmNiOTc3YTdjNzZiNmE2NzViL3RhYmxlcmFuZ2U6NWFhMWQ5NDJlOTkxNDZmY2I5NzdhN2M3NmI2YTY3NWJfMTAtMy0xLTEtMzAxMTQ_6cccd429-719e-4c34-8f6f-7925224cf393">42</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net defined benefit pension cost and post retirement plan costs:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in actuarial net loss, net of tax expense of $<ix:nonFraction unitRef="usd" contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" decimals="-6" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xOS9mcmFnOmQ5ZWE0MmNiNWRiNjRhMjZhYWIzOGYyMmM0MDk5ODNmL3RhYmxlOjVhYTFkOTQyZTk5MTQ2ZmNiOTc3YTdjNzZiNmE2NzViL3RhYmxlcmFuZ2U6NWFhMWQ5NDJlOTkxNDZmY2I5NzdhN2M3NmI2YTY3NWJfMTItMC0xLTEtMzAxMTQvdGV4dHJlZ2lvbjpiMjI3OGIxZDU5ZTI0Njc1YmJkYjZhNWE3OGI3NzgyOF81Ng_eab6a10e-1ae6-4b91-88ce-a70b668fe13f">2</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131" decimals="-6" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xOS9mcmFnOmQ5ZWE0MmNiNWRiNjRhMjZhYWIzOGYyMmM0MDk5ODNmL3RhYmxlOjVhYTFkOTQyZTk5MTQ2ZmNiOTc3YTdjNzZiNmE2NzViL3RhYmxlcmFuZ2U6NWFhMWQ5NDJlOTkxNDZmY2I5NzdhN2M3NmI2YTY3NWJfMTItMC0xLTEtMzAxMTQvdGV4dHJlZ2lvbjpiMjI3OGIxZDU5ZTI0Njc1YmJkYjZhNWE3OGI3NzgyOF82MA_094cd1da-03ba-47dd-b81d-a7430a09ceef">4</ix:nonFraction></span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" decimals="-6" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xOS9mcmFnOmQ5ZWE0MmNiNWRiNjRhMjZhYWIzOGYyMmM0MDk5ODNmL3RhYmxlOjVhYTFkOTQyZTk5MTQ2ZmNiOTc3YTdjNzZiNmE2NzViL3RhYmxlcmFuZ2U6NWFhMWQ5NDJlOTkxNDZmY2I5NzdhN2M3NmI2YTY3NWJfMTItMS0xLTEtMzAxMTQ_297a3c69-a72a-4483-bdc6-44776202193a">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131" decimals="-6" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xOS9mcmFnOmQ5ZWE0MmNiNWRiNjRhMjZhYWIzOGYyMmM0MDk5ODNmL3RhYmxlOjVhYTFkOTQyZTk5MTQ2ZmNiOTc3YTdjNzZiNmE2NzViL3RhYmxlcmFuZ2U6NWFhMWQ5NDJlOTkxNDZmY2I5NzdhN2M3NmI2YTY3NWJfMTItMy0xLTEtMzAxMTQ_0e11ac35-2cf1-4394-ae05-e0fb3f946db9">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xOS9mcmFnOmQ5ZWE0MmNiNWRiNjRhMjZhYWIzOGYyMmM0MDk5ODNmL3RhYmxlOjVhYTFkOTQyZTk5MTQ2ZmNiOTc3YTdjNzZiNmE2NzViL3RhYmxlcmFuZ2U6NWFhMWQ5NDJlOTkxNDZmY2I5NzdhN2M3NmI2YTY3NWJfMTQtMS0xLTEtMzAxMTQ_eed243e9-16a2-48b7-90b8-d267467030d6">16</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xOS9mcmFnOmQ5ZWE0MmNiNWRiNjRhMjZhYWIzOGYyMmM0MDk5ODNmL3RhYmxlOjVhYTFkOTQyZTk5MTQ2ZmNiOTc3YTdjNzZiNmE2NzViL3RhYmxlcmFuZ2U6NWFhMWQ5NDJlOTkxNDZmY2I5NzdhN2M3NmI2YTY3NWJfMTQtMy0xLTEtMzAxMTQ_df6f6ed6-3c3d-4b68-b9af-f93a913bb092">53</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total comprehensive income</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xOS9mcmFnOmQ5ZWE0MmNiNWRiNjRhMjZhYWIzOGYyMmM0MDk5ODNmL3RhYmxlOjVhYTFkOTQyZTk5MTQ2ZmNiOTc3YTdjNzZiNmE2NzViL3RhYmxlcmFuZ2U6NWFhMWQ5NDJlOTkxNDZmY2I5NzdhN2M3NmI2YTY3NWJfMTUtMS0xLTEtMzAxMTQ_d3184396-32c8-4752-b0d1-0f1450b119b5">267</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xOS9mcmFnOmQ5ZWE0MmNiNWRiNjRhMjZhYWIzOGYyMmM0MDk5ODNmL3RhYmxlOjVhYTFkOTQyZTk5MTQ2ZmNiOTc3YTdjNzZiNmE2NzViL3RhYmxlcmFuZ2U6NWFhMWQ5NDJlOTkxNDZmY2I5NzdhN2M3NmI2YTY3NWJfMTUtMy0xLTEtMzAxMTQ_cf21d978-835e-4ffb-9e48-4b7abcd67add">341</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><div id="if825c91f15a047ec9e67e0189634a349_22"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#if825c91f15a047ec9e67e0189634a349_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AGILENT TECHNOLOGIES,&#160;INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED BALANCE SHEET</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions, except par value and share amounts)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:72.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfMy0xLTEtMS0zMDExNA_5966a8f4-ef2f-4c4e-b515-7304053779a6">1,113</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6390807210d74c6f9cae496ea2122a5a_I20211031" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfMy0zLTEtMS0zMDExNA_ce44c1a9-4863-46a3-87e2-71e2261a42af">1,484</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfNC0xLTEtMS0zMDExNA_64d1abf4-88a7-4ec5-8318-619279782d1b">45</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6390807210d74c6f9cae496ea2122a5a_I20211031" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfNC0zLTEtMS0zMDExNA_106d5b26-7102-4b1f-b292-ab953d589d4e">91</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131" decimals="-6" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfNS0xLTEtMS0zMDExNA_a3754fe4-e61f-45a5-90b9-b94183efd856">1,205</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6390807210d74c6f9cae496ea2122a5a_I20211031" decimals="-6" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfNS0zLTEtMS0zMDExNA_4647d75b-22de-4c18-95f9-e5671eeab9a0">1,172</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131" decimals="-6" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfNi0xLTEtMS0zMDExNA_30ca8007-021d-4c65-954a-d5f3e7ecfecb">879</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6390807210d74c6f9cae496ea2122a5a_I20211031" decimals="-6" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfNi0zLTEtMS0zMDExNA_fdf0476d-160b-410b-845e-1d0f314e8bbf">830</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131" decimals="-6" name="us-gaap:OtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfNy0xLTEtMS0zMDExNA_6fc11f1d-5475-4490-9bac-49f8a6100929">232</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6390807210d74c6f9cae496ea2122a5a_I20211031" decimals="-6" name="us-gaap:OtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfNy0zLTEtMS0zMDExNA_af3622b8-f9cd-4f48-b41c-af3ac98ceb3a">222</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131" decimals="-6" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfOC0xLTEtMS0zMDExNA_4c7317f1-06d4-4363-b60a-7daa7178b142">3,474</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6390807210d74c6f9cae496ea2122a5a_I20211031" decimals="-6" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfOC0zLTEtMS0zMDExNA_9d139c2c-6ab2-486c-a792-c9ed6fd4c009">3,799</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfOS0xLTEtMS0zMDExNA_bf41f2f4-1f4c-4756-a8df-e04dd1aa2589">974</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6390807210d74c6f9cae496ea2122a5a_I20211031" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfOS0zLTEtMS0zMDExNA_cac39f48-c1f2-4978-9bb9-66cd8174420f">945</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfMTAtMS0xLTEtMzAxMTQ_fdfdc4ac-e8f4-4f4b-8493-8f08fa66aab9">3,964</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6390807210d74c6f9cae496ea2122a5a_I20211031" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfMTAtMy0xLTEtMzAxMTQ_01bebf52-9f8b-4b6f-959d-56332de9dc63">3,975</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfMTEtMS0xLTEtMzAxMTQ_3464ff67-1522-4a26-900a-674d042c454d">929</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6390807210d74c6f9cae496ea2122a5a_I20211031" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfMTEtMy0xLTEtMzAxMTQ_3c640282-7751-441c-a8d0-6bd047818009">981</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131" decimals="-6" name="us-gaap:LongTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfMTItMS0xLTEtMzAxMTQ_64dca2dc-2ccb-4ab1-bbec-9304adf40dec">191</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6390807210d74c6f9cae496ea2122a5a_I20211031" decimals="-6" name="us-gaap:LongTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfMTItMy0xLTEtMzAxMTQ_5f390459-1b10-4e64-be81-5a5727c86885">185</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfMTMtMS0xLTEtMzAxMTQ_90570dd1-c189-4201-b286-27d0549fa002">795</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6390807210d74c6f9cae496ea2122a5a_I20211031" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfMTMtMy0xLTEtMzAxMTQ_55be2b02-da24-4f4b-b5c6-b2ddb1b1270d">820</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfMTQtMS0xLTEtMzAxMTQ_ece6bb32-0c38-4a55-ac54-e2267cf7a6d8">10,327</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6390807210d74c6f9cae496ea2122a5a_I20211031" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfMTQtMy0xLTEtMzAxMTQ_ac4f5889-845a-43c8-8971-b5c04b8ea489">10,705</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LIABILITIES AND EQUITY</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131" decimals="-6" name="us-gaap:AccountsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfMTctMS0xLTEtMzAxMTQ_3e319d26-436a-4f38-9e0f-df1cbb1e007b">475</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6390807210d74c6f9cae496ea2122a5a_I20211031" decimals="-6" name="us-gaap:AccountsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfMTctMy0xLTEtMzAxMTQ_65efa63b-055e-4e88-9c4e-08a1fb04c70d">446</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee compensation and benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131" decimals="-6" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfMTgtMS0xLTEtMzAxMTQ_906f9557-952a-445b-8ee0-dc075dbf5001">290</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6390807210d74c6f9cae496ea2122a5a_I20211031" decimals="-6" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfMTgtMy0xLTEtMzAxMTQ_c3b8ef32-c792-4524-84e3-ac6dc4a05269">493</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131" decimals="-6" name="us-gaap:DeferredRevenueCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfMTktMS0xLTEtMzAxMTQ_0530b4f0-f7fc-459e-9f57-a9517c89ec6f">493</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6390807210d74c6f9cae496ea2122a5a_I20211031" decimals="-6" name="us-gaap:DeferredRevenueCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfMTktMy0xLTEtMzAxMTQ_a75bec78-2aa9-4096-868d-80e1eed796d3">441</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131" decimals="-6" name="us-gaap:OtherAccruedLiabilitiesCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfMjEtMS0xLTEtMzAxMTQ_09293d29-037d-4169-a63f-ddca0a7805ea">326</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6390807210d74c6f9cae496ea2122a5a_I20211031" decimals="-6" name="us-gaap:OtherAccruedLiabilitiesCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfMjEtMy0xLTEtMzAxMTQ_c06a10a0-a430-4106-92f6-2ee4c7060e66">328</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131" decimals="-6" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfMjItMS0xLTEtMzAxMTQ_6dfacc1f-5101-453a-8ced-e066fba855cf">1,584</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6390807210d74c6f9cae496ea2122a5a_I20211031" decimals="-6" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfMjItMy0xLTEtMzAxMTQ_f8a70634-4202-4bcc-b534-ac1a31f0f245">1,708</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfMjMtMS0xLTEtMzAxMTQ_b65144d3-e7f1-4d9a-a47b-3dcbb10e46a5">2,730</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6390807210d74c6f9cae496ea2122a5a_I20211031" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfMjMtMy0xLTEtMzAxMTQ_01537f40-97d3-499c-8d27-6936adf2fe5d">2,729</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retirement and post-retirement benefits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131" decimals="-6" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfMjQtMS0xLTEtMzAxMTQ_19667380-b319-4f71-ac6b-cd865d4a781c">206</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6390807210d74c6f9cae496ea2122a5a_I20211031" decimals="-6" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfMjQtMy0xLTEtMzAxMTQ_78bca5a7-3800-4665-a4f1-1b256b89e8ee">220</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfMjUtMS0xLTEtMzAxMTQ_c6f67bd7-e876-4f10-a657-e6ae1b706f08">653</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6390807210d74c6f9cae496ea2122a5a_I20211031" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfMjUtMy0xLTEtMzAxMTQ_0550ff84-8410-4aeb-a8b9-aa7c53bf6d21">659</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131" decimals="-6" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfMjYtMS0xLTEtMzAxMTQ_90ab103b-192d-45e3-9b82-14d1ceb555a3">5,173</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6390807210d74c6f9cae496ea2122a5a_I20211031" decimals="-6" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfMjYtMy0xLTEtMzAxMTQ_db805533-e89e-416b-abde-deb531f3888d">5,316</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commitments and contingencies (Notes 9 and 12)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfMjctMS0xLTEtMzAxMTQ_6f9081c4-c535-4e70-a67e-887474bd74ba"></ix:nonFraction></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i6390807210d74c6f9cae496ea2122a5a_I20211031" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfMjctMy0xLTEtMzAxMTQ_9b8862a4-75ed-4cb8-b750-a160e877c8c5"></ix:nonFraction></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total equity:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stockholders&#8217; equity:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock; $<ix:nonFraction unitRef="usdPerShare" contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131" decimals="2" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfMzAtMC0xLTEtMzAxMTQvdGV4dHJlZ2lvbjo2MTQ2NDA0MDFmNDc0MWQzODE4YWY4MjgyOTAyNDEzN18yMQ_7a70d0ed-fd84-438f-a929-32cb2612690b"><ix:nonFraction unitRef="usdPerShare" contextRef="i6390807210d74c6f9cae496ea2122a5a_I20211031" decimals="2" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfMzAtMC0xLTEtMzAxMTQvdGV4dHJlZ2lvbjo2MTQ2NDA0MDFmNDc0MWQzODE4YWY4MjgyOTAyNDEzN18yMQ_ec10249a-83ce-47a8-bb8c-790d4bf402b6">0.01</ix:nonFraction></ix:nonFraction> par value; <ix:nonFraction unitRef="shares" contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131" decimals="-3" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfMzAtMC0xLTEtMzAxMTQvdGV4dHJlZ2lvbjo2MTQ2NDA0MDFmNDc0MWQzODE4YWY4MjgyOTAyNDEzN18zNQ_f2b618b5-11ec-4dba-86b5-e909153f3d85"><ix:nonFraction unitRef="shares" contextRef="i6390807210d74c6f9cae496ea2122a5a_I20211031" decimals="-3" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfMzAtMC0xLTEtMzAxMTQvdGV4dHJlZ2lvbjo2MTQ2NDA0MDFmNDc0MWQzODE4YWY4MjgyOTAyNDEzN18zNQ_f4c3bee5-1f14-4b6a-9f99-3feacd8541b6">125</ix:nonFraction></ix:nonFraction> million shares authorized; <ix:nonFraction unitRef="shares" contextRef="i6390807210d74c6f9cae496ea2122a5a_I20211031" decimals="-3" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfMzAtMC0xLTEtMzAxMTQvdGV4dHJlZ2lvbjo2MTQ2NDA0MDFmNDc0MWQzODE4YWY4MjgyOTAyNDEzN181Nw_0cd9be11-0c79-48fa-89d3-38a67a56f55a"><ix:nonFraction unitRef="shares" contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131" decimals="-3" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfMzAtMC0xLTEtMzAxMTQvdGV4dHJlZ2lvbjo2MTQ2NDA0MDFmNDc0MWQzODE4YWY4MjgyOTAyNDEzN181Nw_2e95fb4e-ea95-4c5f-9ffd-004def7eb624"><ix:nonFraction unitRef="shares" contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131" decimals="-3" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfMzAtMC0xLTEtMzAxMTQvdGV4dHJlZ2lvbjo2MTQ2NDA0MDFmNDc0MWQzODE4YWY4MjgyOTAyNDEzN181Nw_5ad27187-8c75-41a0-ae01-3e314ba06fc0"><ix:nonFraction unitRef="shares" contextRef="i6390807210d74c6f9cae496ea2122a5a_I20211031" decimals="-3" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfMzAtMC0xLTEtMzAxMTQvdGV4dHJlZ2lvbjo2MTQ2NDA0MDFmNDc0MWQzODE4YWY4MjgyOTAyNDEzN181Nw_84ba3ff0-3872-40a1-9c85-76c6cc53d75b">none</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> issued and outstanding at January&#160;31, 2022 and October&#160;31, 2021 </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131" decimals="-6" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfMzAtMS0xLTEtMzAxMTQ_41908b7e-27ba-4711-ad45-6625d2056406">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6390807210d74c6f9cae496ea2122a5a_I20211031" decimals="-6" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfMzAtMy0xLTEtMzAxMTQ_6f9dafbf-ffa1-489a-99ae-3f03fa29d5ff">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock; $<ix:nonFraction unitRef="usdPerShare" contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131" decimals="2" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfMzEtMC0xLTEtMzAxMTQvdGV4dHJlZ2lvbjoyYWU2NTVjZjBlNTQ0MDRmOGUxMDFmZmVhZWYwOWJmMV8xOA_a9086665-43a4-461d-b9e6-cc6359b8df64"><ix:nonFraction unitRef="usdPerShare" contextRef="i6390807210d74c6f9cae496ea2122a5a_I20211031" decimals="2" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfMzEtMC0xLTEtMzAxMTQvdGV4dHJlZ2lvbjoyYWU2NTVjZjBlNTQ0MDRmOGUxMDFmZmVhZWYwOWJmMV8xOA_fcc9236d-368f-404f-82ac-c5707091ca2f">0.01</ix:nonFraction></ix:nonFraction> par value; <ix:nonFraction unitRef="shares" contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131" decimals="-3" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfMzEtMC0xLTEtMzAxMTQvdGV4dHJlZ2lvbjoyYWU2NTVjZjBlNTQ0MDRmOGUxMDFmZmVhZWYwOWJmMV8zMg_13b6f28a-e77a-4393-9edf-f66299e4d3bd"><ix:nonFraction unitRef="shares" contextRef="i6390807210d74c6f9cae496ea2122a5a_I20211031" decimals="-3" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfMzEtMC0xLTEtMzAxMTQvdGV4dHJlZ2lvbjoyYWU2NTVjZjBlNTQ0MDRmOGUxMDFmZmVhZWYwOWJmMV8zMg_4d87900e-d46a-4ac8-98cd-34d627256870">2</ix:nonFraction></ix:nonFraction> billion shares authorized; <ix:nonFraction unitRef="shares" contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131" decimals="-3" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfMzEtMC0xLTEtMzAxMTQvdGV4dHJlZ2lvbjoyYWU2NTVjZjBlNTQ0MDRmOGUxMDFmZmVhZWYwOWJmMV81NA_6accc244-57ac-422d-a120-420ec5b94c34"><ix:nonFraction unitRef="shares" contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfMzEtMC0xLTEtMzAxMTQvdGV4dHJlZ2lvbjoyYWU2NTVjZjBlNTQ0MDRmOGUxMDFmZmVhZWYwOWJmMV81NA_ca561a8d-cf87-489b-bad6-351d6defceb3">300</ix:nonFraction></ix:nonFraction> million shares at January&#160;31, 2022 and <ix:nonFraction unitRef="shares" contextRef="i6390807210d74c6f9cae496ea2122a5a_I20211031" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfMzEtMC0xLTEtMzAxMTQvdGV4dHJlZ2lvbjoyYWU2NTVjZjBlNTQ0MDRmOGUxMDFmZmVhZWYwOWJmMV83NA_2852935b-2dea-4499-ad8a-1c9f44d7d3b3"><ix:nonFraction unitRef="shares" contextRef="i6390807210d74c6f9cae496ea2122a5a_I20211031" decimals="-3" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfMzEtMC0xLTEtMzAxMTQvdGV4dHJlZ2lvbjoyYWU2NTVjZjBlNTQ0MDRmOGUxMDFmZmVhZWYwOWJmMV83NA_4aa6a830-918a-4db0-ba20-ee83181501e0">302</ix:nonFraction></ix:nonFraction> million shares at October&#160;31, 2021 issued and outstanding</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131" decimals="-6" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfMzEtMS0xLTEtMzAxMTQ_da4338c1-5fed-424e-b0db-f3dd5a2e20dd">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6390807210d74c6f9cae496ea2122a5a_I20211031" decimals="-6" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfMzEtMy0xLTEtMzAxMTQ_ed3e2522-1e28-4ca4-a0b2-abe5222ffe69">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in-capital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131" decimals="-6" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfMzItMS0xLTEtMzAxMTQ_f82279df-589b-4d53-b8fa-f634123770ba">5,290</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6390807210d74c6f9cae496ea2122a5a_I20211031" decimals="-6" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfMzItMy0xLTEtMzAxMTQ_7df87258-63c3-4902-ae45-f4c246c2cbc0">5,320</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Retained earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131" decimals="-6" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfMzMtMS0xLTEtMzAxMTQ_747ee004-7c90-4761-abf8-c33b7c79de44">159</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6390807210d74c6f9cae496ea2122a5a_I20211031" decimals="-6" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfMzMtMy0xLTEtMzAxMTQ_953e3582-a35f-4f42-8657-c3f0717874ef">348</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfMzQtMS0xLTEtMzAxMTQ_049d29fd-025d-44b3-a5b1-6dd35f27b1f8">298</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6390807210d74c6f9cae496ea2122a5a_I20211031" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfMzQtMy0xLTEtMzAxMTQ_901fbc96-8824-4704-99d3-75afed307649">282</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stockholders' equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfMzUtMS0xLTEtMzAxMTQ_7315f4d5-5f65-44b1-a00b-017fa3d56912">5,154</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6390807210d74c6f9cae496ea2122a5a_I20211031" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfMzUtMy0xLTEtMzAxMTQ_de83723b-f614-4f09-ad46-5df597627558">5,389</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities and stockholders' equity</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131" decimals="-6" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfMzgtMS0xLTEtMzAxMTQ_36490229-cf4c-493e-8010-b6f2759d4a40">10,327</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6390807210d74c6f9cae496ea2122a5a_I20211031" decimals="-6" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfMzgtMy0xLTEtMzAxMTQ_4629e6bb-9928-49a1-ad9e-167cfacde9ff">10,705</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><div id="if825c91f15a047ec9e67e0189634a349_25"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#if825c91f15a047ec9e67e0189634a349_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AGILENT TECHNOLOGIES,&#160;INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:72.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows from operating activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfNC0xLTEtMS0zMDExNA_5af4de50-0f0e-4691-9599-07f51d5cc6e0">283</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfNC0zLTEtMS0zMDExNA_74bdfa83-dc91-4a9a-b6a0-f61c0a2a3f57">288</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reconcile net income to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfNi0xLTEtMS0zMDExNA_f56f6416-f5f2-47e5-b93f-31c2dcd7fcb4">82</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfNi0zLTEtMS0zMDExNA_b09510fd-9ed9-486d-8c4d-f9dd67925f39">76</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfOC0xLTEtMS0zMDExNA_69e87b6c-4022-4787-b025-21fa67fab277">44</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfOC0zLTEtMS0zMDExNA_1bb11bdd-8b30-4912-a6c7-4d08806967cb">40</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" decimals="-6" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfOS0xLTEtMS0zMDExNA_bf35ac35-0a16-4773-8fae-1f1d93f9d653">24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131" decimals="-6" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfOS0zLTEtMS0zMDExNA_c1d8cb81-b260-4538-8cea-15c2446f8f31">29</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Excess and obsolete inventory related charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" decimals="-6" name="us-gaap:InventoryWriteDown" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfMTAtMS0xLTEtMzAxMTQ_c6fc7a3b-2588-47a8-988e-999c8b80b1f6">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131" decimals="-6" name="us-gaap:InventoryWriteDown" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfMTAtMy0xLTEtMzAxMTQ_e7152002-0236-42f1-ae92-7768153eee8f">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on extinguishment of debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" decimals="-6" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfMTEtMS0xLTEtMzAxMTQ_d6e7d5c8-b716-48e8-b91e-14c2eb01d490">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131" decimals="-6" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfMTEtMy0xLTEtMzAxMTQ_7d42d360-d651-47f0-95e4-dd301eef458f">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (gain) loss on equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" decimals="-6" sign="-" name="us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfMTItMS0xLTEtMzAxMTQ_07e8a3a7-68e3-4e79-a53b-d359662058d2">47</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131" decimals="-6" name="us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfMTItMy0xLTEtMzAxMTQ_d2f16882-531a-45b7-b8d2-0ca5af98f76e">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfMTQtMS0xLTEtMzAxMTQ_97f42054-47a8-484f-b8f9-bd9ebd95f352">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfMTQtMy0xLTEtMzAxMTQ_dcc241f5-74e2-4392-9521-64753122cb88">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-cash expense, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" decimals="-6" name="us-gaap:OtherNoncashIncomeExpense" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfMTUtMS0xLTEtMzAxMTQ_4b175bba-9081-472c-8a09-07c5beb245a9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131" decimals="-6" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfMTUtMy0xLTEtMzAxMTQ_78f5cb81-ed83-4873-9293-dc983a9e3b65">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in assets and liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfMTctMS0xLTEtMzAxMTQ_b2c9cd43-f53b-48cc-b4fc-2f7aea34226f">46</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfMTctMy0xLTEtMzAxMTQ_91f574a2-5003-4a5e-80b9-d2a58772f1fb">31</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" decimals="-6" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfMTgtMS0xLTEtMzAxMTQ_483ccd6e-d1c7-4455-893c-59f7032d1090">54</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131" decimals="-6" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfMTgtMy0xLTEtMzAxMTQ_2a300c0e-4730-4673-be07-512a32b7660c">35</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfMTktMS0xLTEtMzAxMTQ_39a28d63-4000-4e22-9d4d-9bdd02afe082">37</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfMTktMy0xLTEtMzAxMTQ_85a0d10d-cd0b-43a1-9858-3a838bcdd7fd">43</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee compensation and benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfMjAtMS0xLTEtMzAxMTQ_f404c679-f36f-437b-b26a-21fe4850e0db">210</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfMjAtMy0xLTEtMzAxMTQ_84bc67f9-63f9-4b7c-81c8-d321c5636b1f">88</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets and liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfMjEtMS0xLTEtMzAxMTQ_574c6698-804f-4a39-97a1-99cd636f3bb6">40</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfMjEtMy0xLTEtMzAxMTQ_181b9bdb-f2ad-4fe0-94ca-6eace00720ef">95</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfMjItMS0xLTEtMzAxMTQ_b5272137-e74f-4102-aad7-0e94dfbec8f3">255</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfMjItMy0xLTEtMzAxMTQ_664884ac-c36a-4725-a850-c81a6ef5e3c1">238</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows from investing activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments in property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfMjUtMS0xLTEtMzAxMTQ_37b7fdf0-7453-4ccf-9e52-7dbba864d6fa">75</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfMjUtMy0xLTEtMzAxMTQ_c711aa2d-0215-4084-a4dc-a0fc77bcb9ab">41</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payment to acquire equity investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" decimals="-6" name="us-gaap:PaymentsToAcquireEquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfMzAtMS0xLTEtMzAxMTQ_598e8949-5efb-42b2-91de-78a91c43f4bc">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131" decimals="-6" name="us-gaap:PaymentsToAcquireEquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfMzAtMy0xLTEtMzAxMTQ_47cd3a24-b9ec-448f-a29f-986caa9f149b">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payment in exchange for convertible note</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" decimals="-6" name="us-gaap:PaymentsToAcquireNotesReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfMzEtMS0xLTEtMzAxMTQ_599fd79d-7afb-4a50-aa57-c9b4cf6988e1">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131" decimals="-6" name="us-gaap:PaymentsToAcquireNotesReceivable" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfMzEtMy0xLTEtMzAxMTQ_6939e4a3-55f0-477f-b103-073584d5e1e8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfMzgtMS0xLTEtMzAxMTQ_c8b5fde7-e810-4e2c-aee4-342a7c6a3709">79</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfMzgtMy0xLTEtMzAxMTQ_78703c3e-b7ef-4b5d-879a-6d3e605e306b">42</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows from financing activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of common stock under employee stock plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfNDEtMS0xLTEtMzAxMTQ_0bf39ff2-5f07-43b8-b9a5-f4de64168cd2">27</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfNDEtMy0xLTEtMzAxMTQ_3efe82b4-47a6-4e88-88ae-84a3079005f9">25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payment of taxes related to net share settlement of equity awards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" decimals="-6" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfNDItMS0xLTEtMzAxMTQ_2e4a67aa-5671-4371-b2ba-3fe9c57944e6">63</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131" decimals="-6" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfNDItMy0xLTEtMzAxMTQ_75d6d31f-7170-45a2-94fd-afe471715eec">72</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payment of dividends</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" decimals="-6" name="us-gaap:PaymentsOfOrdinaryDividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfNDMtMS0xLTEtMzAxMTQ_a3eb6211-1ba2-4e2c-9f24-dbf8fdf1a179">63</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131" decimals="-6" name="us-gaap:PaymentsOfOrdinaryDividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfNDMtMy0xLTEtMzAxMTQ_a3648409-ec04-41ef-99f4-4dd4f3c2f5b0">59</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repayment of senior notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" decimals="-6" name="us-gaap:EarlyRepaymentOfSeniorDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfNTAtMS0xLTEtMzAxMTQ_97152e0a-fbd9-490a-a1e9-28e5003a82e8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131" decimals="-6" name="us-gaap:EarlyRepaymentOfSeniorDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfNTAtMy0xLTEtMzAxMTQ_d0f515f8-59f8-41f7-855c-bd99ff8513ac">105</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfCommercialPaper" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfNTItMS0xLTEtMzAxMTQ_109b4c9e-d79a-4d35-b47c-a6168b0bf93e"><ix:nonFraction unitRef="usd" contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" decimals="-6" name="us-gaap:RepaymentsOfCommercialPaper" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfNTItMS0xLTEtMzAxMTQ_bb4aa28a-1dcd-4dd3-95a2-d6f5a2b27318">240</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfCommercialPaper" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfNTItMy0xLTEtMzAxMTQ_2334d733-3ce9-4766-9548-09b4b004e980">785</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repayment of commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" decimals="-6" name="us-gaap:RepaymentsOfCommercialPaper" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfNTMtMS0xLTEtMzAxMTQ_679b2851-0829-4528-94d5-9a33a7aca84c">240</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131" decimals="-6" name="us-gaap:RepaymentsOfCommercialPaper" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfNTMtMy0xLTEtMzAxMTQ_4f915c6b-cdef-47c5-bc60-48316e78ed3c">546</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Treasury stock repurchases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfNTUtMS0xLTEtMzAxMTQ_fad26b34-dd2b-4712-8bec-2e5ad97f8ef9">447</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfNTUtMy0xLTEtMzAxMTQ_27862542-aaa5-4db2-befc-45f7ae8f1dbb">344</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in financing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfNTYtMS0xLTEtMzAxMTQ_26e4a94e-555b-4d16-9c51-ee051881616d">546</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfNTYtMy0xLTEtMzAxMTQ_21c85a18-2e93-425b-aa50-0f35faa89257">316</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of exchange rate movements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" decimals="-6" sign="-" name="us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfNTgtMS0xLTEtMzAxMTQ_219d6d38-bcb6-451a-8215-63b4f62d9fa8">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131" decimals="-6" name="us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfNTgtMy0xLTEtMzAxMTQ_2606995b-d2c7-4258-aeaf-8818a63359da">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net decrease in cash, cash equivalents and restricted cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" decimals="-6" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfNjAtMS0xLTEtMzAxMTQ_eb58080c-e3c7-44a2-b58c-e7762e79163c">374</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131" decimals="-6" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfNjAtMy0xLTEtMzAxMTQ_475ae43e-0b70-4157-91f3-544ee8a3cbcc">111</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash at beginning of period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6390807210d74c6f9cae496ea2122a5a_I20211031" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfNjItMS0xLTEtMzAxMTQ_1cd75876-bf10-4c79-b21d-d835e8f01d6a">1,490</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id69612e49fa546c0bf63ff5ad436ccc6_I20201031" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfNjItMy0xLTEtMzAxMTQ_3dd613c1-9ab9-47ac-b718-b199ba2f3bf2">1,447</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash at end of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfNjMtMS0xLTEtMzAxMTQ_4dc1cc3c-bae5-41a7-812d-903eafcc9383">1,116</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b47b15753c94f0b80143556347e39b7_I20210131" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfNjMtMy0xLTEtMzAxMTQ_281a9997-0cea-4767-8fc8-9874add12dcb">1,336</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Supplemental cash flow information:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax paid, net</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" decimals="-6" name="us-gaap:IncomeTaxesPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfNjYtMS0xLTEtMzAxMTQ_dfe7a483-18af-4ed1-b7ec-b25c594826ae">22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131" decimals="-6" name="us-gaap:IncomeTaxesPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfNjYtMy0xLTEtMzAxMTQ_1cac5847-54f9-4903-9eed-0aa6e959c2a8">52</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest payments</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" decimals="-6" name="us-gaap:InterestPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfNjctMS0xLTEtMzAxMTQ_565e8c10-4fb8-411d-99b6-285b0480acd2">18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131" decimals="-6" name="us-gaap:InterestPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfNjctMy0xLTEtMzAxMTQ_76bc35d9-a5fc-4094-b7bc-5b8c35fec1b4">19</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in property, plant and equipment included in accounts payable and accrued liabilities-increase (decrease)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i44a18d7ed2a546f2b1a0a2f797a1b4fe_D20211101-20220131" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfNjgtMS0xLTEtMzAxMTQ_196691ef-0224-4158-b5b1-ee11de2a74f5">7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8ceb97e232da4995b0c42477e20b5b4e_D20201101-20210131" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfNjgtMy0xLTEtMzAxMTQ_bd4fac81-7ecd-4bd3-9cd9-c5da8d302721">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><div id="if825c91f15a047ec9e67e0189634a349_28"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#if825c91f15a047ec9e67e0189634a349_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AGILENT TECHNOLOGIES,&#160;INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENT OF EQUITY</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions, except number of shares in thousands)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.891%"><tr><td style="width:1.0%"></td><td style="width:42.236%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.892%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.892%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.892%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.892%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.892%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.899%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.298%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.882%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.882%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.882%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.882%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.882%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.887%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Loss</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:35pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Three Months Ended January 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number<br/>of<br/>Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Par<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional<br/>Paid-in<br/>Capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained Earnings</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Stockholders' Equity</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of October 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i99b29a6a5e4443e6830ecda74b1090c7_I20211031" decimals="-3" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yOC9mcmFnOjdmZjA3MzdmMjAzNzRjYjdhYmQ3ZjJlNTk4NWI4YTRkL3RhYmxlOjkxNDM0MDZkNTUyZDQyOTM4MDVhZTQwYThmNzE1Zjk1L3RhYmxlcmFuZ2U6OTE0MzQwNmQ1NTJkNDI5MzgwNWFlNDBhOGY3MTVmOTVfMy0xLTEtMS0zMDExNA_78c88054-7d58-405d-8871-e63debb82f2b">302,208</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99b29a6a5e4443e6830ecda74b1090c7_I20211031" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yOC9mcmFnOjdmZjA3MzdmMjAzNzRjYjdhYmQ3ZjJlNTk4NWI4YTRkL3RhYmxlOjkxNDM0MDZkNTUyZDQyOTM4MDVhZTQwYThmNzE1Zjk1L3RhYmxlcmFuZ2U6OTE0MzQwNmQ1NTJkNDI5MzgwNWFlNDBhOGY3MTVmOTVfMy0zLTEtMS0zMDExNA_711c3727-0bfa-4361-ade2-8d4c3d329c8f">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea1be62040754a539970b84f8eac1b6f_I20211031" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yOC9mcmFnOjdmZjA3MzdmMjAzNzRjYjdhYmQ3ZjJlNTk4NWI4YTRkL3RhYmxlOjkxNDM0MDZkNTUyZDQyOTM4MDVhZTQwYThmNzE1Zjk1L3RhYmxlcmFuZ2U6OTE0MzQwNmQ1NTJkNDI5MzgwNWFlNDBhOGY3MTVmOTVfMy01LTEtMS0zMDExNA_7137866d-ceea-4e87-b56a-84b2d6c18791">5,320</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dbcbe02abb3453190aa9f44125cf5ae_I20211031" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yOC9mcmFnOjdmZjA3MzdmMjAzNzRjYjdhYmQ3ZjJlNTk4NWI4YTRkL3RhYmxlOjkxNDM0MDZkNTUyZDQyOTM4MDVhZTQwYThmNzE1Zjk1L3RhYmxlcmFuZ2U6OTE0MzQwNmQ1NTJkNDI5MzgwNWFlNDBhOGY3MTVmOTVfMy03LTEtMS0zMDExNA_bc6bd130-706c-4515-a1c8-bf9da728abc7">348</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff5df0d7cf1048858d49c438dfd29807_I20211031" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yOC9mcmFnOjdmZjA3MzdmMjAzNzRjYjdhYmQ3ZjJlNTk4NWI4YTRkL3RhYmxlOjkxNDM0MDZkNTUyZDQyOTM4MDVhZTQwYThmNzE1Zjk1L3RhYmxlcmFuZ2U6OTE0MzQwNmQ1NTJkNDI5MzgwNWFlNDBhOGY3MTVmOTVfMy05LTEtMS0zMDExNA_a1936385-896e-48cb-9a3d-9b8890f5d10b">282</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib34d00c8a21a42028bfbffd3fd179e61_I20211031" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yOC9mcmFnOjdmZjA3MzdmMjAzNzRjYjdhYmQ3ZjJlNTk4NWI4YTRkL3RhYmxlOjkxNDM0MDZkNTUyZDQyOTM4MDVhZTQwYThmNzE1Zjk1L3RhYmxlcmFuZ2U6OTE0MzQwNmQ1NTJkNDI5MzgwNWFlNDBhOGY3MTVmOTVfMy0xMS0xLTEtMzAxMTQ_727c0330-d6ed-4d65-8ee0-e5c5a964554d">5,389</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Components of comprehensive income, net of tax:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a9450e8c23c4155b219185f8e60d29a_D20211101-20220131" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yOC9mcmFnOjdmZjA3MzdmMjAzNzRjYjdhYmQ3ZjJlNTk4NWI4YTRkL3RhYmxlOjkxNDM0MDZkNTUyZDQyOTM4MDVhZTQwYThmNzE1Zjk1L3RhYmxlcmFuZ2U6OTE0MzQwNmQ1NTJkNDI5MzgwNWFlNDBhOGY3MTVmOTVfNi03LTEtMS0zMDExNA_1b60a786-20ac-485e-b507-5fdf4a36802d">283</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0fd838af6c44d0ea866658c71b3dc7d_D20211101-20220131" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yOC9mcmFnOjdmZjA3MzdmMjAzNzRjYjdhYmQ3ZjJlNTk4NWI4YTRkL3RhYmxlOjkxNDM0MDZkNTUyZDQyOTM4MDVhZTQwYThmNzE1Zjk1L3RhYmxlcmFuZ2U6OTE0MzQwNmQ1NTJkNDI5MzgwNWFlNDBhOGY3MTVmOTVfNi0xMS0xLTEtMzAxMTQ_d18cbac0-cef0-4f36-af68-64559d0bb570">283</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2aec23e974cd4bedb6e13b41b9375b78_D20211101-20220131" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yOC9mcmFnOjdmZjA3MzdmMjAzNzRjYjdhYmQ3ZjJlNTk4NWI4YTRkL3RhYmxlOjkxNDM0MDZkNTUyZDQyOTM4MDVhZTQwYThmNzE1Zjk1L3RhYmxlcmFuZ2U6OTE0MzQwNmQ1NTJkNDI5MzgwNWFlNDBhOGY3MTVmOTVfNy05LTEtMS0zMDExNA_20bcea0c-bc7f-4e0e-824f-0bacd261bf06">16</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia0fd838af6c44d0ea866658c71b3dc7d_D20211101-20220131" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yOC9mcmFnOjdmZjA3MzdmMjAzNzRjYjdhYmQ3ZjJlNTk4NWI4YTRkL3RhYmxlOjkxNDM0MDZkNTUyZDQyOTM4MDVhZTQwYThmNzE1Zjk1L3RhYmxlcmFuZ2U6OTE0MzQwNmQ1NTJkNDI5MzgwNWFlNDBhOGY3MTVmOTVfNy0xMS0xLTEtMzAxMTQ_c8b96924-7a11-474c-91f8-133ca32f51b9">16</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total comprehensive income</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0fd838af6c44d0ea866658c71b3dc7d_D20211101-20220131" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yOC9mcmFnOjdmZjA3MzdmMjAzNzRjYjdhYmQ3ZjJlNTk4NWI4YTRkL3RhYmxlOjkxNDM0MDZkNTUyZDQyOTM4MDVhZTQwYThmNzE1Zjk1L3RhYmxlcmFuZ2U6OTE0MzQwNmQ1NTJkNDI5MzgwNWFlNDBhOGY3MTVmOTVfOC0xMS0xLTEtMzAxMTQ_98498386-3c19-4ef1-a5bf-a01fce15c888">267</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash dividends declared ($<ix:nonFraction unitRef="usdPerShare" contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" decimals="3" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yOC9mcmFnOjdmZjA3MzdmMjAzNzRjYjdhYmQ3ZjJlNTk4NWI4YTRkL3RhYmxlOjkxNDM0MDZkNTUyZDQyOTM4MDVhZTQwYThmNzE1Zjk1L3RhYmxlcmFuZ2U6OTE0MzQwNmQ1NTJkNDI5MzgwNWFlNDBhOGY3MTVmOTVfMTAtMC0xLTEtMzAxMTQvdGV4dHJlZ2lvbjplYzNkMTliY2E2MjM0NWY3OTQzZjc3MmNlYjMwMmM4M18yOQ_e82a31e2-e69b-4866-9705-0e3d368269eb">0.210</ix:nonFraction> per common share)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a9450e8c23c4155b219185f8e60d29a_D20211101-20220131" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yOC9mcmFnOjdmZjA3MzdmMjAzNzRjYjdhYmQ3ZjJlNTk4NWI4YTRkL3RhYmxlOjkxNDM0MDZkNTUyZDQyOTM4MDVhZTQwYThmNzE1Zjk1L3RhYmxlcmFuZ2U6OTE0MzQwNmQ1NTJkNDI5MzgwNWFlNDBhOGY3MTVmOTVfMTAtNy0xLTEtMzAxMTQ_26091341-87a3-45b2-a99b-9b64ffe207dd">63</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia0fd838af6c44d0ea866658c71b3dc7d_D20211101-20220131" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yOC9mcmFnOjdmZjA3MzdmMjAzNzRjYjdhYmQ3ZjJlNTk4NWI4YTRkL3RhYmxlOjkxNDM0MDZkNTUyZDQyOTM4MDVhZTQwYThmNzE1Zjk1L3RhYmxlcmFuZ2U6OTE0MzQwNmQ1NTJkNDI5MzgwNWFlNDBhOGY3MTVmOTVfMTAtMTEtMS0xLTMwMTE0_1b950979-9af9-41b8-96e7-a8475f99880f">63</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based awards issued, net of tax of $<ix:nonFraction unitRef="usd" contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" decimals="-6" name="a:Taxrelatedtosharesissued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yOC9mcmFnOjdmZjA3MzdmMjAzNzRjYjdhYmQ3ZjJlNTk4NWI4YTRkL3RhYmxlOjkxNDM0MDZkNTUyZDQyOTM4MDVhZTQwYThmNzE1Zjk1L3RhYmxlcmFuZ2U6OTE0MzQwNmQ1NTJkNDI5MzgwNWFlNDBhOGY3MTVmOTVfMTEtMC0xLTEtMzAxMTQvdGV4dHJlZ2lvbjoyMWE4MzgxMTk4Y2I0NzFmYjA0NTk3NGE4NmFhY2FlMl80NQ_1e935791-76a7-44bc-96c1-2d158679f188">63</ix:nonFraction></span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8344a08116e2475d8630eff99a4f60e4_D20211101-20220131" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yOC9mcmFnOjdmZjA3MzdmMjAzNzRjYjdhYmQ3ZjJlNTk4NWI4YTRkL3RhYmxlOjkxNDM0MDZkNTUyZDQyOTM4MDVhZTQwYThmNzE1Zjk1L3RhYmxlcmFuZ2U6OTE0MzQwNmQ1NTJkNDI5MzgwNWFlNDBhOGY3MTVmOTVfMTEtMS0xLTEtMzAxMTQ_b5ddeca4-3855-4e34-b4bf-bf900a55c411">972</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0fcc3b5cded94fed9c8505ac4005e3a0_D20211101-20220131" decimals="-6" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yOC9mcmFnOjdmZjA3MzdmMjAzNzRjYjdhYmQ3ZjJlNTk4NWI4YTRkL3RhYmxlOjkxNDM0MDZkNTUyZDQyOTM4MDVhZTQwYThmNzE1Zjk1L3RhYmxlcmFuZ2U6OTE0MzQwNmQ1NTJkNDI5MzgwNWFlNDBhOGY3MTVmOTVfMTEtNS0xLTEtMzAxMTQ_6642cb7e-70e4-4171-ad77-8b88c88c0c0d">36</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia0fd838af6c44d0ea866658c71b3dc7d_D20211101-20220131" decimals="-6" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yOC9mcmFnOjdmZjA3MzdmMjAzNzRjYjdhYmQ3ZjJlNTk4NWI4YTRkL3RhYmxlOjkxNDM0MDZkNTUyZDQyOTM4MDVhZTQwYThmNzE1Zjk1L3RhYmxlcmFuZ2U6OTE0MzQwNmQ1NTJkNDI5MzgwNWFlNDBhOGY3MTVmOTVfMTEtMTEtMS0xLTMwMTE0_b8c5c6ab-1f0a-42dc-b9bc-a6ab005c63b4">36</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i8344a08116e2475d8630eff99a4f60e4_D20211101-20220131" decimals="-3" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yOC9mcmFnOjdmZjA3MzdmMjAzNzRjYjdhYmQ3ZjJlNTk4NWI4YTRkL3RhYmxlOjkxNDM0MDZkNTUyZDQyOTM4MDVhZTQwYThmNzE1Zjk1L3RhYmxlcmFuZ2U6OTE0MzQwNmQ1NTJkNDI5MzgwNWFlNDBhOGY3MTVmOTVfMTItMS0xLTEtMzAxMTQ_bef82d76-c6d4-4ee5-9d4c-3a2457773221">2,907</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0fcc3b5cded94fed9c8505ac4005e3a0_D20211101-20220131" decimals="-6" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yOC9mcmFnOjdmZjA3MzdmMjAzNzRjYjdhYmQ3ZjJlNTk4NWI4YTRkL3RhYmxlOjkxNDM0MDZkNTUyZDQyOTM4MDVhZTQwYThmNzE1Zjk1L3RhYmxlcmFuZ2U6OTE0MzQwNmQ1NTJkNDI5MzgwNWFlNDBhOGY3MTVmOTVfMTItNS0xLTEtMzAxMTQ_655f4c5d-75d4-4f8a-aee9-7d84ea7b0ccd">38</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a9450e8c23c4155b219185f8e60d29a_D20211101-20220131" decimals="-6" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yOC9mcmFnOjdmZjA3MzdmMjAzNzRjYjdhYmQ3ZjJlNTk4NWI4YTRkL3RhYmxlOjkxNDM0MDZkNTUyZDQyOTM4MDVhZTQwYThmNzE1Zjk1L3RhYmxlcmFuZ2U6OTE0MzQwNmQ1NTJkNDI5MzgwNWFlNDBhOGY3MTVmOTVfMTItNy0xLTEtMzAxMTQ_6482eed4-27d7-4b49-827e-8309298deacb">409</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia0fd838af6c44d0ea866658c71b3dc7d_D20211101-20220131" decimals="-6" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yOC9mcmFnOjdmZjA3MzdmMjAzNzRjYjdhYmQ3ZjJlNTk4NWI4YTRkL3RhYmxlOjkxNDM0MDZkNTUyZDQyOTM4MDVhZTQwYThmNzE1Zjk1L3RhYmxlcmFuZ2U6OTE0MzQwNmQ1NTJkNDI5MzgwNWFlNDBhOGY3MTVmOTVfMTItMTEtMS0xLTMwMTE0_ea0ee5ab-bdc9-44f1-9766-33bc93d6f456">447</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0fcc3b5cded94fed9c8505ac4005e3a0_D20211101-20220131" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yOC9mcmFnOjdmZjA3MzdmMjAzNzRjYjdhYmQ3ZjJlNTk4NWI4YTRkL3RhYmxlOjkxNDM0MDZkNTUyZDQyOTM4MDVhZTQwYThmNzE1Zjk1L3RhYmxlcmFuZ2U6OTE0MzQwNmQ1NTJkNDI5MzgwNWFlNDBhOGY3MTVmOTVfMTMtNS0xLTEtMzAxMTQ_082f121b-8a67-4224-9739-6fcba582fbc2">44</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0fd838af6c44d0ea866658c71b3dc7d_D20211101-20220131" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yOC9mcmFnOjdmZjA3MzdmMjAzNzRjYjdhYmQ3ZjJlNTk4NWI4YTRkL3RhYmxlOjkxNDM0MDZkNTUyZDQyOTM4MDVhZTQwYThmNzE1Zjk1L3RhYmxlcmFuZ2U6OTE0MzQwNmQ1NTJkNDI5MzgwNWFlNDBhOGY3MTVmOTVfMTMtMTEtMS0xLTMwMTE0_63e9648f-1c4f-40df-9c94-f97ad4ee6007">44</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of January 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3137580680de43e8ae49a1ddbc453b8b_I20220131" decimals="-3" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yOC9mcmFnOjdmZjA3MzdmMjAzNzRjYjdhYmQ3ZjJlNTk4NWI4YTRkL3RhYmxlOjkxNDM0MDZkNTUyZDQyOTM4MDVhZTQwYThmNzE1Zjk1L3RhYmxlcmFuZ2U6OTE0MzQwNmQ1NTJkNDI5MzgwNWFlNDBhOGY3MTVmOTVfMTQtMS0xLTEtMzAxMTQ_e991c44b-169b-4859-b61d-44b5e55fc4b6">300,273</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3137580680de43e8ae49a1ddbc453b8b_I20220131" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yOC9mcmFnOjdmZjA3MzdmMjAzNzRjYjdhYmQ3ZjJlNTk4NWI4YTRkL3RhYmxlOjkxNDM0MDZkNTUyZDQyOTM4MDVhZTQwYThmNzE1Zjk1L3RhYmxlcmFuZ2U6OTE0MzQwNmQ1NTJkNDI5MzgwNWFlNDBhOGY3MTVmOTVfMTQtMy0xLTEtMzAxMTQ_29685cb6-e8cb-40ab-a680-8643d03feb31">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3fb881f611641bf8690679c64de1aaf_I20220131" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yOC9mcmFnOjdmZjA3MzdmMjAzNzRjYjdhYmQ3ZjJlNTk4NWI4YTRkL3RhYmxlOjkxNDM0MDZkNTUyZDQyOTM4MDVhZTQwYThmNzE1Zjk1L3RhYmxlcmFuZ2U6OTE0MzQwNmQ1NTJkNDI5MzgwNWFlNDBhOGY3MTVmOTVfMTQtNS0xLTEtMzAxMTQ_71b524cf-a5f9-4fb4-8ba3-784d26f64f34">5,290</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57656528186c4372ae07486570f387e9_I20220131" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yOC9mcmFnOjdmZjA3MzdmMjAzNzRjYjdhYmQ3ZjJlNTk4NWI4YTRkL3RhYmxlOjkxNDM0MDZkNTUyZDQyOTM4MDVhZTQwYThmNzE1Zjk1L3RhYmxlcmFuZ2U6OTE0MzQwNmQ1NTJkNDI5MzgwNWFlNDBhOGY3MTVmOTVfMTQtNy0xLTEtMzAxMTQ_39c0d4ac-d5bf-48ed-a4d1-088c6ed3ea92">159</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i27134d71dd424779ab254848725e52c6_I20220131" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yOC9mcmFnOjdmZjA3MzdmMjAzNzRjYjdhYmQ3ZjJlNTk4NWI4YTRkL3RhYmxlOjkxNDM0MDZkNTUyZDQyOTM4MDVhZTQwYThmNzE1Zjk1L3RhYmxlcmFuZ2U6OTE0MzQwNmQ1NTJkNDI5MzgwNWFlNDBhOGY3MTVmOTVfMTQtOS0xLTEtMzAxMTQ_aae5d0f0-68b6-4fa9-8ccb-82926102af68">298</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1e6a76918c24df4abe13257fdfcdea9_I20220131" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yOC9mcmFnOjdmZjA3MzdmMjAzNzRjYjdhYmQ3ZjJlNTk4NWI4YTRkL3RhYmxlOjkxNDM0MDZkNTUyZDQyOTM4MDVhZTQwYThmNzE1Zjk1L3RhYmxlcmFuZ2U6OTE0MzQwNmQ1NTJkNDI5MzgwNWFlNDBhOGY3MTVmOTVfMTQtMTEtMS0xLTMwMTE0_0d8d44a5-f8fd-44f7-b049-c338ef5acd21">5,154</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.298%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.882%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.882%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.882%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.882%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.882%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.887%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.298%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.882%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.882%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.882%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.882%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.882%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.887%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Loss</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:35pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Three Months Ended January 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number<br/>of<br/>Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Par<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional<br/>Paid-in<br/>Capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained Earnings</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Stockholders' Equity</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of October 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i482974eb49534930b9164c76d7ed1578_I20201031" decimals="-3" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yOC9mcmFnOjdmZjA3MzdmMjAzNzRjYjdhYmQ3ZjJlNTk4NWI4YTRkL3RhYmxlOjFkYWE3OTE0MGU0YzQ1YThiZDk0YTc2MGQ0Zjc2ZjkyL3RhYmxlcmFuZ2U6MWRhYTc5MTQwZTRjNDVhOGJkOTRhNzYwZDRmNzZmOTJfNC0xLTEtMS0zMDExNA_95bec27b-5a10-4be9-9e8f-7a8150eb9a83">306,198</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i482974eb49534930b9164c76d7ed1578_I20201031" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yOC9mcmFnOjdmZjA3MzdmMjAzNzRjYjdhYmQ3ZjJlNTk4NWI4YTRkL3RhYmxlOjFkYWE3OTE0MGU0YzQ1YThiZDk0YTc2MGQ0Zjc2ZjkyL3RhYmxlcmFuZ2U6MWRhYTc5MTQwZTRjNDVhOGJkOTRhNzYwZDRmNzZmOTJfNC0zLTEtMS0zMDExNA_c661c591-fc94-4eb5-a63f-731c25e8c52e">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64d7c2dd15f64641ba78382251046b62_I20201031" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yOC9mcmFnOjdmZjA3MzdmMjAzNzRjYjdhYmQ3ZjJlNTk4NWI4YTRkL3RhYmxlOjFkYWE3OTE0MGU0YzQ1YThiZDk0YTc2MGQ0Zjc2ZjkyL3RhYmxlcmFuZ2U6MWRhYTc5MTQwZTRjNDVhOGJkOTRhNzYwZDRmNzZmOTJfNC01LTEtMS0zMDExNA_8b2debff-30df-482b-bd15-142f91b449be">5,311</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i154f991a704349d59b962b4dd9d48c7e_I20201031" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yOC9mcmFnOjdmZjA3MzdmMjAzNzRjYjdhYmQ3ZjJlNTk4NWI4YTRkL3RhYmxlOjFkYWE3OTE0MGU0YzQ1YThiZDk0YTc2MGQ0Zjc2ZjkyL3RhYmxlcmFuZ2U6MWRhYTc5MTQwZTRjNDVhOGJkOTRhNzYwZDRmNzZmOTJfNC03LTEtMS0zMDExNA_faa5eaa9-6cc6-44c3-af76-23c268274ab3">81</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i375472e47a0b4ca3b7720d165b3c1035_I20201031" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yOC9mcmFnOjdmZjA3MzdmMjAzNzRjYjdhYmQ3ZjJlNTk4NWI4YTRkL3RhYmxlOjFkYWE3OTE0MGU0YzQ1YThiZDk0YTc2MGQ0Zjc2ZjkyL3RhYmxlcmFuZ2U6MWRhYTc5MTQwZTRjNDVhOGJkOTRhNzYwZDRmNzZmOTJfNC05LTEtMS0zMDExNA_7a3f985a-e1c0-40dd-8244-7c909165b5bf">522</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34129239eb114151a36af1066ee3079f_I20201031" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yOC9mcmFnOjdmZjA3MzdmMjAzNzRjYjdhYmQ3ZjJlNTk4NWI4YTRkL3RhYmxlOjFkYWE3OTE0MGU0YzQ1YThiZDk0YTc2MGQ0Zjc2ZjkyL3RhYmxlcmFuZ2U6MWRhYTc5MTQwZTRjNDVhOGJkOTRhNzYwZDRmNzZmOTJfNC0xMS0xLTEtMzAxMTQ_8f0f12f0-aa77-40be-b065-9467f55c4695">4,873</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Components of comprehensive income, net of tax:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i604f8a60030549769dd5a3f2943b52bb_D20201101-20210131" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yOC9mcmFnOjdmZjA3MzdmMjAzNzRjYjdhYmQ3ZjJlNTk4NWI4YTRkL3RhYmxlOjFkYWE3OTE0MGU0YzQ1YThiZDk0YTc2MGQ0Zjc2ZjkyL3RhYmxlcmFuZ2U6MWRhYTc5MTQwZTRjNDVhOGJkOTRhNzYwZDRmNzZmOTJfNy03LTEtMS0zMDExNA_066aa6a3-3fee-4c16-bc2d-5c77eeb05b35">288</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2331e3a5c61640af8f9c694b08630d9e_D20201101-20210131" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yOC9mcmFnOjdmZjA3MzdmMjAzNzRjYjdhYmQ3ZjJlNTk4NWI4YTRkL3RhYmxlOjFkYWE3OTE0MGU0YzQ1YThiZDk0YTc2MGQ0Zjc2ZjkyL3RhYmxlcmFuZ2U6MWRhYTc5MTQwZTRjNDVhOGJkOTRhNzYwZDRmNzZmOTJfNy0xMS0xLTEtMzAxMTQ_ef340cbd-b9a3-4d70-b11b-deb67fcab4e3">288</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f2ff5551bff49caba634f1bf4245966_D20201101-20210131" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yOC9mcmFnOjdmZjA3MzdmMjAzNzRjYjdhYmQ3ZjJlNTk4NWI4YTRkL3RhYmxlOjFkYWE3OTE0MGU0YzQ1YThiZDk0YTc2MGQ0Zjc2ZjkyL3RhYmxlcmFuZ2U6MWRhYTc5MTQwZTRjNDVhOGJkOTRhNzYwZDRmNzZmOTJfOC05LTEtMS0zMDExNA_c18bd521-7fb1-4d9e-98d2-9345f64ac8b7">53</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2331e3a5c61640af8f9c694b08630d9e_D20201101-20210131" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yOC9mcmFnOjdmZjA3MzdmMjAzNzRjYjdhYmQ3ZjJlNTk4NWI4YTRkL3RhYmxlOjFkYWE3OTE0MGU0YzQ1YThiZDk0YTc2MGQ0Zjc2ZjkyL3RhYmxlcmFuZ2U6MWRhYTc5MTQwZTRjNDVhOGJkOTRhNzYwZDRmNzZmOTJfOC0xMS0xLTEtMzAxMTQ_bdc8113c-8582-450d-a446-ae843eee8803">53</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total comprehensive income</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2331e3a5c61640af8f9c694b08630d9e_D20201101-20210131" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yOC9mcmFnOjdmZjA3MzdmMjAzNzRjYjdhYmQ3ZjJlNTk4NWI4YTRkL3RhYmxlOjFkYWE3OTE0MGU0YzQ1YThiZDk0YTc2MGQ0Zjc2ZjkyL3RhYmxlcmFuZ2U6MWRhYTc5MTQwZTRjNDVhOGJkOTRhNzYwZDRmNzZmOTJfOS0xMS0xLTEtMzAxMTQ_46003df7-c8b4-43f1-882b-d0aa771db243">341</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash dividends declared ($<ix:nonFraction unitRef="usdPerShare" contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131" decimals="3" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yOC9mcmFnOjdmZjA3MzdmMjAzNzRjYjdhYmQ3ZjJlNTk4NWI4YTRkL3RhYmxlOjFkYWE3OTE0MGU0YzQ1YThiZDk0YTc2MGQ0Zjc2ZjkyL3RhYmxlcmFuZ2U6MWRhYTc5MTQwZTRjNDVhOGJkOTRhNzYwZDRmNzZmOTJfMTEtMC0xLTEtMzAxMTQvdGV4dHJlZ2lvbjo0NGMwNDZhMTQ2N2U0MzdlYTljNDAyMDIxN2QwOTRiMl8yOQ_6c9a3b51-3489-4422-822f-a9e6ef87c5ea">0.194</ix:nonFraction> per common share)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i604f8a60030549769dd5a3f2943b52bb_D20201101-20210131" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yOC9mcmFnOjdmZjA3MzdmMjAzNzRjYjdhYmQ3ZjJlNTk4NWI4YTRkL3RhYmxlOjFkYWE3OTE0MGU0YzQ1YThiZDk0YTc2MGQ0Zjc2ZjkyL3RhYmxlcmFuZ2U6MWRhYTc5MTQwZTRjNDVhOGJkOTRhNzYwZDRmNzZmOTJfMTEtNy0xLTEtMzAxMTQ_f9b557e5-e49b-4274-aec3-2bde49edcb08">59</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2331e3a5c61640af8f9c694b08630d9e_D20201101-20210131" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yOC9mcmFnOjdmZjA3MzdmMjAzNzRjYjdhYmQ3ZjJlNTk4NWI4YTRkL3RhYmxlOjFkYWE3OTE0MGU0YzQ1YThiZDk0YTc2MGQ0Zjc2ZjkyL3RhYmxlcmFuZ2U6MWRhYTc5MTQwZTRjNDVhOGJkOTRhNzYwZDRmNzZmOTJfMTEtMTEtMS0xLTMwMTE0_d6a29272-f5b1-4287-b1b4-c64380478376">59</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based awards issued, net of tax of $<ix:nonFraction unitRef="usd" contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131" decimals="-6" name="a:Taxrelatedtosharesissued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yOC9mcmFnOjdmZjA3MzdmMjAzNzRjYjdhYmQ3ZjJlNTk4NWI4YTRkL3RhYmxlOjFkYWE3OTE0MGU0YzQ1YThiZDk0YTc2MGQ0Zjc2ZjkyL3RhYmxlcmFuZ2U6MWRhYTc5MTQwZTRjNDVhOGJkOTRhNzYwZDRmNzZmOTJfMTItMC0xLTEtMzAxMTQvdGV4dHJlZ2lvbjowMDYzODhkNGM0NTA0ZTA3ODA1MmM0MDNiMTNmOGQxNV80NQ_476dbd09-e1c7-4715-8614-dcb1811371d5">72</ix:nonFraction></span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1bd14aef64584a21865d2ec3dfd5e629_D20201101-20210131" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yOC9mcmFnOjdmZjA3MzdmMjAzNzRjYjdhYmQ3ZjJlNTk4NWI4YTRkL3RhYmxlOjFkYWE3OTE0MGU0YzQ1YThiZDk0YTc2MGQ0Zjc2ZjkyL3RhYmxlcmFuZ2U6MWRhYTc5MTQwZTRjNDVhOGJkOTRhNzYwZDRmNzZmOTJfMTItMS0xLTEtMzAxMTQ_0a826878-be07-4e85-82df-82bd4556bbfb">1,592</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0afeb8dd36084a53aec0f9c3a708c97c_D20201101-20210131" decimals="-6" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yOC9mcmFnOjdmZjA3MzdmMjAzNzRjYjdhYmQ3ZjJlNTk4NWI4YTRkL3RhYmxlOjFkYWE3OTE0MGU0YzQ1YThiZDk0YTc2MGQ0Zjc2ZjkyL3RhYmxlcmFuZ2U6MWRhYTc5MTQwZTRjNDVhOGJkOTRhNzYwZDRmNzZmOTJfMTItNS0xLTEtMzAxMTQ_d7d67afc-738c-4a72-b79f-bff37ed5cca6">47</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2331e3a5c61640af8f9c694b08630d9e_D20201101-20210131" decimals="-6" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yOC9mcmFnOjdmZjA3MzdmMjAzNzRjYjdhYmQ3ZjJlNTk4NWI4YTRkL3RhYmxlOjFkYWE3OTE0MGU0YzQ1YThiZDk0YTc2MGQ0Zjc2ZjkyL3RhYmxlcmFuZ2U6MWRhYTc5MTQwZTRjNDVhOGJkOTRhNzYwZDRmNzZmOTJfMTItMTEtMS0xLTMwMTE0_fb42ac18-57bc-439b-b969-0a85e979a7bb">47</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i1bd14aef64584a21865d2ec3dfd5e629_D20201101-20210131" decimals="-3" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yOC9mcmFnOjdmZjA3MzdmMjAzNzRjYjdhYmQ3ZjJlNTk4NWI4YTRkL3RhYmxlOjFkYWE3OTE0MGU0YzQ1YThiZDk0YTc2MGQ0Zjc2ZjkyL3RhYmxlcmFuZ2U6MWRhYTc5MTQwZTRjNDVhOGJkOTRhNzYwZDRmNzZmOTJfMTMtMS0xLTEtMzAxMTQ_75ceebd3-0f28-4d52-a455-b65b4c14f0e3">2,885</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0afeb8dd36084a53aec0f9c3a708c97c_D20201101-20210131" decimals="-6" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yOC9mcmFnOjdmZjA3MzdmMjAzNzRjYjdhYmQ3ZjJlNTk4NWI4YTRkL3RhYmxlOjFkYWE3OTE0MGU0YzQ1YThiZDk0YTc2MGQ0Zjc2ZjkyL3RhYmxlcmFuZ2U6MWRhYTc5MTQwZTRjNDVhOGJkOTRhNzYwZDRmNzZmOTJfMTMtNS0xLTEtMzAxMTQ_95124562-458f-4309-8428-f86115140032">38</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i604f8a60030549769dd5a3f2943b52bb_D20201101-20210131" decimals="-6" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yOC9mcmFnOjdmZjA3MzdmMjAzNzRjYjdhYmQ3ZjJlNTk4NWI4YTRkL3RhYmxlOjFkYWE3OTE0MGU0YzQ1YThiZDk0YTc2MGQ0Zjc2ZjkyL3RhYmxlcmFuZ2U6MWRhYTc5MTQwZTRjNDVhOGJkOTRhNzYwZDRmNzZmOTJfMTMtNy0xLTEtMzAxMTQ_fb0d787e-9151-4926-81fd-5798b8b10986">306</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2331e3a5c61640af8f9c694b08630d9e_D20201101-20210131" decimals="-6" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yOC9mcmFnOjdmZjA3MzdmMjAzNzRjYjdhYmQ3ZjJlNTk4NWI4YTRkL3RhYmxlOjFkYWE3OTE0MGU0YzQ1YThiZDk0YTc2MGQ0Zjc2ZjkyL3RhYmxlcmFuZ2U6MWRhYTc5MTQwZTRjNDVhOGJkOTRhNzYwZDRmNzZmOTJfMTMtMTEtMS0xLTMwMTE0_cc32718b-3d27-4cbd-8856-adbebdd4564d">344</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0afeb8dd36084a53aec0f9c3a708c97c_D20201101-20210131" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yOC9mcmFnOjdmZjA3MzdmMjAzNzRjYjdhYmQ3ZjJlNTk4NWI4YTRkL3RhYmxlOjFkYWE3OTE0MGU0YzQ1YThiZDk0YTc2MGQ0Zjc2ZjkyL3RhYmxlcmFuZ2U6MWRhYTc5MTQwZTRjNDVhOGJkOTRhNzYwZDRmNzZmOTJfMTQtNS0xLTEtMzAxMTQ_84d58063-38a5-46b2-876d-7c47ccc20c4b">40</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2331e3a5c61640af8f9c694b08630d9e_D20201101-20210131" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yOC9mcmFnOjdmZjA3MzdmMjAzNzRjYjdhYmQ3ZjJlNTk4NWI4YTRkL3RhYmxlOjFkYWE3OTE0MGU0YzQ1YThiZDk0YTc2MGQ0Zjc2ZjkyL3RhYmxlcmFuZ2U6MWRhYTc5MTQwZTRjNDVhOGJkOTRhNzYwZDRmNzZmOTJfMTQtMTEtMS0xLTMwMTE0_8de14f76-df16-4d7b-b9ec-9e18016922ec">40</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of January 31, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9aec1350d194433d9ba1d2d5b214d83d_I20210131" decimals="-3" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yOC9mcmFnOjdmZjA3MzdmMjAzNzRjYjdhYmQ3ZjJlNTk4NWI4YTRkL3RhYmxlOjFkYWE3OTE0MGU0YzQ1YThiZDk0YTc2MGQ0Zjc2ZjkyL3RhYmxlcmFuZ2U6MWRhYTc5MTQwZTRjNDVhOGJkOTRhNzYwZDRmNzZmOTJfMTUtMS0xLTEtMzAxMTQ_d95585df-3c48-4e50-929a-8939f752cf9f">304,905</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9aec1350d194433d9ba1d2d5b214d83d_I20210131" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yOC9mcmFnOjdmZjA3MzdmMjAzNzRjYjdhYmQ3ZjJlNTk4NWI4YTRkL3RhYmxlOjFkYWE3OTE0MGU0YzQ1YThiZDk0YTc2MGQ0Zjc2ZjkyL3RhYmxlcmFuZ2U6MWRhYTc5MTQwZTRjNDVhOGJkOTRhNzYwZDRmNzZmOTJfMTUtMy0xLTEtMzAxMTQ_99851b1e-737b-4a55-b702-a56058834f34">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c25caed3b0b4859a0d9e2aea3c18f22_I20210131" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yOC9mcmFnOjdmZjA3MzdmMjAzNzRjYjdhYmQ3ZjJlNTk4NWI4YTRkL3RhYmxlOjFkYWE3OTE0MGU0YzQ1YThiZDk0YTc2MGQ0Zjc2ZjkyL3RhYmxlcmFuZ2U6MWRhYTc5MTQwZTRjNDVhOGJkOTRhNzYwZDRmNzZmOTJfMTUtNS0xLTEtMzAxMTQ_973b8dc4-1e72-4c63-868a-fff0c41f0a3c">5,266</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a4f445b002141b5ad863186edfae11b_I20210131" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yOC9mcmFnOjdmZjA3MzdmMjAzNzRjYjdhYmQ3ZjJlNTk4NWI4YTRkL3RhYmxlOjFkYWE3OTE0MGU0YzQ1YThiZDk0YTc2MGQ0Zjc2ZjkyL3RhYmxlcmFuZ2U6MWRhYTc5MTQwZTRjNDVhOGJkOTRhNzYwZDRmNzZmOTJfMTUtNy0xLTEtMzAxMTQ_4af68fa0-a4c7-4a1e-a177-fc30c899b569">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i36c64c32e7194082966d03edc3758994_I20210131" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yOC9mcmFnOjdmZjA3MzdmMjAzNzRjYjdhYmQ3ZjJlNTk4NWI4YTRkL3RhYmxlOjFkYWE3OTE0MGU0YzQ1YThiZDk0YTc2MGQ0Zjc2ZjkyL3RhYmxlcmFuZ2U6MWRhYTc5MTQwZTRjNDVhOGJkOTRhNzYwZDRmNzZmOTJfMTUtOS0xLTEtMzAxMTQ_f2eac40f-234d-4045-a70e-c9e5026ee474">469</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3fb564fc37141f6bcd78ffd8a2e8e27_I20210131" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yOC9mcmFnOjdmZjA3MzdmMjAzNzRjYjdhYmQ3ZjJlNTk4NWI4YTRkL3RhYmxlOjFkYWE3OTE0MGU0YzQ1YThiZDk0YTc2MGQ0Zjc2ZjkyL3RhYmxlcmFuZ2U6MWRhYTc5MTQwZTRjNDVhOGJkOTRhNzYwZDRmNzZmOTJfMTUtMTEtMS0xLTMwMTE0_9a18d376-c0e7-4e14-856e-9e38481c70ff">4,804</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><div id="if825c91f15a047ec9e67e0189634a349_31"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#if825c91f15a047ec9e67e0189634a349_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AGILENT TECHNOLOGIES,&#160;INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div><div style="text-align:center"><span><br/></span></div><div id="if825c91f15a047ec9e67e0189634a349_34"></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt"> <ix:nonNumeric contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" name="us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8zNC9mcmFnOjZlZDA2OGNhMmZmODQyNTNhNDM3MTNmNGMzZmNlOThlL3RleHRyZWdpb246NmVkMDY4Y2EyZmY4NDI1M2E0MzcxM2Y0YzNmY2U5OGVfNzAxNw_0b364d37-c861-40a4-a982-c1602c777767" continuedAt="i7c71ced788e44078b53550d1c0dfa730" escape="true">OVERVIEW, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</ix:nonNumeric></span></div><ix:continuation id="i7c71ced788e44078b53550d1c0dfa730" continuedAt="i5b3a348dbce646bebae1809d0da4ae87"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><ix:nonNumeric contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" name="us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8zNC9mcmFnOjZlZDA2OGNhMmZmODQyNTNhNDM3MTNmNGMzZmNlOThlL3RleHRyZWdpb246NmVkMDY4Y2EyZmY4NDI1M2E0MzcxM2Y0YzNmY2U5OGVfNzAyNw_d4013953-cf73-451e-93da-11e34934d854" escape="true"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Overview. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Agilent Technologies, Inc. ("we," "Agilent" or the "company"), incorporated in Delaware in May 1999, is a global leader in life sciences, diagnostics and applied chemical markets, providing application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our fiscal year-end is October&#160;31, and our fiscal quarters end on January&#160;31, April&#160;30 and July&#160;31. Unless otherwise stated, these dates refer to our fiscal year and fiscal quarters.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">New Segment Structure.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In the first quarter of fiscal year 2022, we announced a change in organizational structure designed to enable our growth strategies and strengthen our focus on customers. Our chemistries and supplies business and our remarketed instruments business moved from our Agilent CrossLab business segment to our life sciences and applied markets business segment. Service revenue and cost of sales related to the previous acquisition of BioTek moved from our life sciences and applied markets business segment to our Agilent CrossLab business segment. Following this reorganization, we continue to have three business segments (life sciences and applied markets, diagnostics and genomics and Agilent CrossLab), each of which continues to comprise a reportable segment. We are reporting under this new structure beginning with this Quarterly Report on Form 10-Q for the period ended January 31, 2022 and historical financial segment information has been recast to conform to this new presentation in our financial statements and accompanying notes. There was no change to our diagnostics and genomics business segment.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Basis of Presentation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We have prepared the accompanying financial data for the three months ended January&#160;31, 2022 and 2021 pursuant to the rules&#160;and regulations of the U.S. Securities and Exchange Commission (&#8220;SEC&#8221;). Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles (&#8220;GAAP&#8221;) in the U.S. have been condensed or omitted pursuant to such rules&#160;and regulations. The October&#160;31, 2021 condensed balance sheet data was derived from audited financial statements but does not include all the disclosures required in audited financial statements by U.S. GAAP. The accompanying financial data and information should be read in conjunction with our Annual Report on Form 10-K for the fiscal year ended October&#160;31, 2021.  </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the opinion of management, the accompanying condensed consolidated financial statements contain all normal and recurring adjustments necessary for a fair statement of our condensed consolidated balance sheet as of January&#160;31, 2022 and October&#160;31, 2021, condensed consolidated statement of comprehensive income (loss) for the three months ended January&#160;31, 2022 and 2021, condensed consolidated statement of operations for the three months ended January&#160;31, 2022 and 2021, condensed consolidated statement of cash flows for the three months ended January&#160;31, 2022 and 2021 and condensed consolidated statement of equity for the three months ended January&#160;31, 2022 and 2021.</span></div></ix:nonNumeric><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><ix:nonNumeric contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8zNC9mcmFnOjZlZDA2OGNhMmZmODQyNTNhNDM3MTNmNGMzZmNlOThlL3RleHRyZWdpb246NmVkMDY4Y2EyZmY4NDI1M2E0MzcxM2Y0YzNmY2U5OGVfNzAxMg_e6843207-9692-4e3b-a906-4a4d92045913" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Use of Estimates.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The preparation of condensed consolidated financial statements in accordance with GAAP in the U.S. requires management to make estimates and assumptions that affect the amounts reported in our condensed consolidated financial statements and accompanying notes. Management bases its estimates on historical experience and various other assumptions believed to be reasonable. Although these estimates are based on management&#8217;s best knowledge of current events and actions that may impact the company in the future, actual results may be different from the estimates. Our critical accounting policies are those that affect our financial statements materially and involve difficult, subjective or complex judgments by management. Those policies are revenue recognition, inventory valuation, retirement and post-retirement benefit plan assumptions, valuation of goodwill and purchased intangible assets and accounting for income taxes.</span></ix:nonNumeric></div></ix:continuation><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AGILENT TECHNOLOGIES, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) - (Continued) </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i5b3a348dbce646bebae1809d0da4ae87"><ix:nonNumeric contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" name="us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8zNC9mcmFnOjZlZDA2OGNhMmZmODQyNTNhNDM3MTNmNGMzZmNlOThlL3RleHRyZWdpb246NmVkMDY4Y2EyZmY4NDI1M2E0MzcxM2Y0YzNmY2U5OGVfNzAyNg_8ccf5a4f-22a4-4cc6-a8fc-19bb2ce84af7" escape="true"><ix:nonNumeric contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" name="us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8zNC9mcmFnOjZlZDA2OGNhMmZmODQyNTNhNDM3MTNmNGMzZmNlOThlL3RleHRyZWdpb246NmVkMDY4Y2EyZmY4NDI1M2E0MzcxM2Y0YzNmY2U5OGVfNzAyNg_a64d3795-4ced-4e24-82ad-64bf673bc54f" escape="true"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restricted Cash and Restricted Cash Equivalents. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted cash and restricted cash equivalents are included with cash and cash equivalents when reconciling the beginning-of-period and end-of-period total amounts shown on the statement of cash flows.  A reconciliation of cash, cash equivalents and restricted cash to the condensed consolidated balance sheet follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.863%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.053%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 31</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8zNC9mcmFnOjZlZDA2OGNhMmZmODQyNTNhNDM3MTNmNGMzZmNlOThlL3RhYmxlOjM4MDUzMGFhNTIyYTQ1MjliZjQyMzAzMzg0MzNhM2Q2L3RhYmxlcmFuZ2U6MzgwNTMwYWE1MjJhNDUyOWJmNDIzMDMzODQzM2EzZDZfMy0xLTEtMS0zMDExNA_19f91b26-409a-4ac2-9595-6cb42f0740d4">1,113</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6390807210d74c6f9cae496ea2122a5a_I20211031" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8zNC9mcmFnOjZlZDA2OGNhMmZmODQyNTNhNDM3MTNmNGMzZmNlOThlL3RhYmxlOjM4MDUzMGFhNTIyYTQ1MjliZjQyMzAzMzg0MzNhM2Q2L3RhYmxlcmFuZ2U6MzgwNTMwYWE1MjJhNDUyOWJmNDIzMDMzODQzM2EzZDZfMy0zLTEtMS0zMDExNA_925233fe-cdd7-447b-9bba-23794703e822">1,484</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash included in other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131" decimals="-6" name="us-gaap:RestrictedCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8zNC9mcmFnOjZlZDA2OGNhMmZmODQyNTNhNDM3MTNmNGMzZmNlOThlL3RhYmxlOjM4MDUzMGFhNTIyYTQ1MjliZjQyMzAzMzg0MzNhM2Q2L3RhYmxlcmFuZ2U6MzgwNTMwYWE1MjJhNDUyOWJmNDIzMDMzODQzM2EzZDZfNC0xLTEtMS0zMDExNA_1df65067-16d3-46ce-a14e-e4659f3660f9">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6390807210d74c6f9cae496ea2122a5a_I20211031" decimals="-6" name="us-gaap:RestrictedCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8zNC9mcmFnOjZlZDA2OGNhMmZmODQyNTNhNDM3MTNmNGMzZmNlOThlL3RhYmxlOjM4MDUzMGFhNTIyYTQ1MjliZjQyMzAzMzg0MzNhM2Q2L3RhYmxlcmFuZ2U6MzgwNTMwYWE1MjJhNDUyOWJmNDIzMDMzODQzM2EzZDZfNC0zLTEtMS0zMDExNA_b0869820-4954-4a10-aa09-26c85a196b14">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents and restricted cash</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8zNC9mcmFnOjZlZDA2OGNhMmZmODQyNTNhNDM3MTNmNGMzZmNlOThlL3RhYmxlOjM4MDUzMGFhNTIyYTQ1MjliZjQyMzAzMzg0MzNhM2Q2L3RhYmxlcmFuZ2U6MzgwNTMwYWE1MjJhNDUyOWJmNDIzMDMzODQzM2EzZDZfNS0xLTEtMS0zMDExNA_0e0cea4e-fa75-4865-a1e8-baa9113013c3">1,116</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6390807210d74c6f9cae496ea2122a5a_I20211031" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8zNC9mcmFnOjZlZDA2OGNhMmZmODQyNTNhNDM3MTNmNGMzZmNlOThlL3RhYmxlOjM4MDUzMGFhNTIyYTQ1MjliZjQyMzAzMzg0MzNhM2Q2L3RhYmxlcmFuZ2U6MzgwNTMwYWE1MjJhNDUyOWJmNDIzMDMzODQzM2EzZDZfNS0zLTEtMS0zMDExNA_3246c6d1-c60b-4478-bae4-44276fcc581e">1,490</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:nonNumeric><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" name="us-gaap:LesseeLeasesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8zNC9mcmFnOjZlZDA2OGNhMmZmODQyNTNhNDM3MTNmNGMzZmNlOThlL3RleHRyZWdpb246NmVkMDY4Y2EyZmY4NDI1M2E0MzcxM2Y0YzNmY2U5OGVfNzAxNA_d9a34902-4d94-4250-9715-1f8e4cdc4d63" continuedAt="i1b7f9a3527dc4384b2160efb112373d7" escape="true">Leases. </ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i1b7f9a3527dc4384b2160efb112373d7">As of January&#160;31, 2022 and October&#160;31, 2021, operating lease right-of-use assets where we are the lessee were  $<ix:nonFraction unitRef="usd" contextRef="i56114721e4604d11a4408ead150dd13f_I20220131" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8zNC9mcmFnOjZlZDA2OGNhMmZmODQyNTNhNDM3MTNmNGMzZmNlOThlL3RleHRyZWdpb246NmVkMDY4Y2EyZmY4NDI1M2E0MzcxM2Y0YzNmY2U5OGVfMzM1OQ_804565c3-9fa0-4cc0-9f50-a515399aa898">170</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i546995bf0aca4c98814acb076a2c6be8_I20211031" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8zNC9mcmFnOjZlZDA2OGNhMmZmODQyNTNhNDM3MTNmNGMzZmNlOThlL3RleHRyZWdpb246NmVkMDY4Y2EyZmY4NDI1M2E0MzcxM2Y0YzNmY2U5OGVfMzM2Ng_638a321a-5e58-4d3f-8cb9-823afa635040">178</ix:nonFraction>&#160;million, respectively, and were included within other assets in the accompanying condensed consolidated balance sheet. The associated operating lease liabilities were $<ix:nonFraction unitRef="usd" contextRef="i8abcbdeb47ef4c469a915f28a2a7bebb_I20220131" decimals="-6" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8zNC9mcmFnOjZlZDA2OGNhMmZmODQyNTNhNDM3MTNmNGMzZmNlOThlL3RleHRyZWdpb246NmVkMDY4Y2EyZmY4NDI1M2E0MzcxM2Y0YzNmY2U5OGVfMzUyOA_4b2065fd-a972-4795-8867-69e831c12b8d">174</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i5e51aa894fb04654a6979cdafafe70f0_I20211031" decimals="-6" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8zNC9mcmFnOjZlZDA2OGNhMmZmODQyNTNhNDM3MTNmNGMzZmNlOThlL3RleHRyZWdpb246NmVkMDY4Y2EyZmY4NDI1M2E0MzcxM2Y0YzNmY2U5OGVfMzUzNQ_4cc84c12-c73e-49b4-b4e0-da8f7213bfa2">182</ix:nonFraction>&#160;million as of January&#160;31, 2022 and October&#160;31, 2021, respectively, and were included in other accrued liabilities and other long-term liabilities in the accompanying condensed consolidated balance sheet.</ix:continuation> </span></div><div style="margin-top:5pt;text-align:center"><span><br/></span></div><ix:nonNumeric contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" name="us-gaap:ConsolidationVariableInterestEntityPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8zNC9mcmFnOjZlZDA2OGNhMmZmODQyNTNhNDM3MTNmNGMzZmNlOThlL3RleHRyZWdpb246NmVkMDY4Y2EyZmY4NDI1M2E0MzcxM2Y0YzNmY2U5OGVfNzAzMg_4abc1647-e99e-41b7-b5a0-358f23501785" escape="true"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Variable Interest Entities. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We make a determination upon entering into an arrangement whether an entity in which we have made an investment is considered a Variable Interest Entity (&#8220;VIE&#8221;). We evaluate our investments in privately held companies on an ongoing basis. We have determined that as of January&#160;31, 2022 and October&#160;31, 2021, there were no VIEs required to be consolidated in our consolidated financial statements because we do not have a controlling financial interest in any of the VIEs in which we have invested nor are we the primary beneficiary. We account for these investments under either the equity method or as equity investments without readily determinable fair value ("RDFV"), depending on the circumstances. We periodically reassess whether we are the primary beneficiary of a VIE. The reassessment process considers whether we have acquired the power to direct the most significant activities of the VIE through changes in governing documents or other circumstances. We also reconsider whether entities previously determined not to be VIEs have become VIEs and vice-versa, based on changes in facts and circumstances including changes in contractual arrangements and capital structure.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of January&#160;31, 2022 and October&#160;31, 2021, the total carrying value of investments and loans in privately held companies considered as VIEs was $<ix:nonFraction unitRef="usd" contextRef="i242c1754cce3428296265ac5bafa4022_I20220131" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8zNC9mcmFnOjZlZDA2OGNhMmZmODQyNTNhNDM3MTNmNGMzZmNlOThlL3RleHRyZWdpb246NmVkMDY4Y2EyZmY4NDI1M2E0MzcxM2Y0YzNmY2U5OGVfNTAwMQ_09e2465b-063b-4188-a64a-ad1a680a1613">79</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i81363376d3bd42f8a95d654a9f58325e_I20211031" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8zNC9mcmFnOjZlZDA2OGNhMmZmODQyNTNhNDM3MTNmNGMzZmNlOThlL3RleHRyZWdpb246NmVkMDY4Y2EyZmY4NDI1M2E0MzcxM2Y0YzNmY2U5OGVfNTAwOA_f05ed436-05b8-431f-8f1c-3c5f4def0182">76</ix:nonFraction> million respectively. The maximum exposure is equal to the carrying value because we do not have future funding commitments. The investments are included on the long-term investments line and the loans on the other current assets and other assets lines (depending upon tenure of loan) on the condensed consolidated balance sheet.</span></div></ix:nonNumeric><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><ix:nonNumeric contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" name="us-gaap:FairValueOfFinancialInstrumentsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8zNC9mcmFnOjZlZDA2OGNhMmZmODQyNTNhNDM3MTNmNGMzZmNlOThlL3RleHRyZWdpb246NmVkMDY4Y2EyZmY4NDI1M2E0MzcxM2Y0YzNmY2U5OGVfNzAzMw_0a010c13-75b7-44ec-ac29-b994d426789f" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value of Financial Instruments.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The carrying values of certain of our financial instruments including cash and cash equivalents, accounts receivable, accounts payable, accrued compensation and other accrued liabilities approximate fair value because of their short maturities. The fair value of short-term and long-term equity investments which are readily determinable, and which are not accounted under the equity method are reported at fair value using quoted market prices for those securities when available with gains and losses included in net income. The fair value of long-term equity investments which are not readily determinable, and which are not accounted under the equity method are reported at cost with adjustments for observable changes in prices or impairments included in net income. As of January&#160;31, 2022, the fair value of our senior notes was $<ix:nonFraction unitRef="usd" contextRef="i608256c6a24a4ef084558bc988b75d6a_I20220131" decimals="-6" name="us-gaap:LongTermDebtFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8zNC9mcmFnOjZlZDA2OGNhMmZmODQyNTNhNDM3MTNmNGMzZmNlOThlL3RleHRyZWdpb246NmVkMDY4Y2EyZmY4NDI1M2E0MzcxM2Y0YzNmY2U5OGVfMTA5OTUxMTYzNTA0OA_9d3b7b83-4fe4-4bd4-a489-fc18c525eabf">2,710</ix:nonFraction>&#160;million with a carrying value of $<ix:nonFraction unitRef="usd" contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8zNC9mcmFnOjZlZDA2OGNhMmZmODQyNTNhNDM3MTNmNGMzZmNlOThlL3RleHRyZWdpb246NmVkMDY4Y2EyZmY4NDI1M2E0MzcxM2Y0YzNmY2U5OGVfMTY0OTI2NzQ1Nzg0MQ_b65144d3-e7f1-4d9a-a47b-3dcbb10e46a5">2,730</ix:nonFraction> million.  This compares to a fair value of $<ix:nonFraction unitRef="usd" contextRef="i0f82edc5fbba4f499a5dfb9aaa21a637_I20211031" decimals="-6" name="us-gaap:LongTermDebtFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8zNC9mcmFnOjZlZDA2OGNhMmZmODQyNTNhNDM3MTNmNGMzZmNlOThlL3RleHRyZWdpb246NmVkMDY4Y2EyZmY4NDI1M2E0MzcxM2Y0YzNmY2U5OGVfMTA5OTUxMTYzNTExNA_2d242f54-a104-410a-8af8-5d062f1ed100">2,806</ix:nonFraction>&#160;million with a carrying value of $<ix:nonFraction unitRef="usd" contextRef="i6390807210d74c6f9cae496ea2122a5a_I20211031" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8zNC9mcmFnOjZlZDA2OGNhMmZmODQyNTNhNDM3MTNmNGMzZmNlOThlL3RleHRyZWdpb246NmVkMDY4Y2EyZmY4NDI1M2E0MzcxM2Y0YzNmY2U5OGVfMTY0OTI2NzQ1Nzg5MA_01537f40-97d3-499c-8d27-6936adf2fe5d">2,729</ix:nonFraction> million as of October&#160;31, 2021. The change in the fair value over carrying value in the three months ended January&#160;31, 2022 is primarily due to increased market interest rates. The fair value was calculated from quoted prices which are primarily Level 1 inputs under the accounting guidance. The fair value of foreign currency contracts used for hedging purposes is estimated internally by using inputs tied to active markets. These inputs, for example, interest rate yield curves, foreign exchange rates, and forward and spot prices for currencies are observable in the market or&#160;can be corroborated by observable market data for substantially the full term of the assets or liabilities. See also Note&#160;9, "Fair Value Measurements" for additional information on the fair value of financial instruments and contingent consideration.</span></ix:nonNumeric></div></ix:continuation><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><div id="if825c91f15a047ec9e67e0189634a349_37"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AGILENT TECHNOLOGIES, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) - (Continued) </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;2.   <ix:nonNumeric contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" name="us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8zNy9mcmFnOjc4NjgxNDE1Yzc4NDQ4MTc5MjI3ZGY3MjVhYjg3MDNiL3RleHRyZWdpb246Nzg2ODE0MTVjNzg0NDgxNzkyMjdkZjcyNWFiODcwM2JfNTEyMA_c748a080-e3ef-4a84-a6c3-10c7aa942685" continuedAt="i758320c5cd8445fe9deae9e5c153b273" escape="true">NEW ACCOUNTING PRONOUNCEMENTS</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i758320c5cd8445fe9deae9e5c153b273"><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2020, accounting guidance was issued that clarifies the accounting guidance for equity method investments, joint ventures, and derivatives and hedging. The guidance clarifies the interaction between different sections of the accounting guidance that could be applicable and which guidance should be applied in certain situations which should increase relevance and comparability of financial statement information. On November 1, 2021 we adopted this guidance which did not have a material impact on our condensed consolidated financial statements and disclosures.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2021, the FASB issued an update to improve the accounting for acquired revenue contracts with customers in a business combination.  The amendments require an acquirer to use the guidance in ASC 606, Revenue from Contracts with Customers, rather than using fair value, when recognizing and measuring contract assets and contract liabilities related to customer contracts assumed in a business combination. On November 1, 2021 we early adopted this guidance which did not have a material impact on our condensed consolidated financial statements and disclosures.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting Pronouncements Not Yet Adopted</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no additions to the new accounting pronouncements not yet adopted as described in our Annual Report on Form 10-K for the fiscal year ended October 31, 2021.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other amendments to GAAP in the U.S. that have been issued by the FASB or other standards-setting bodies that do not require adoption until a future date are not expected to have a material impact on our condensed consolidated financial statements upon adoption.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="if825c91f15a047ec9e67e0189634a349_40"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.   <ix:nonNumeric contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RleHRyZWdpb246ZDY1YzFhNDg4MjRmNDMzMjlkNTMwOGMyMTg1MzQzZjlfMzc2Mw_2673d5b1-b6a9-498e-822f-7c934a9b408d" continuedAt="ibe0d5da19faa473a8a322aea09ac25a3" escape="true">REVENUE </ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ibe0d5da19faa473a8a322aea09ac25a3" continuedAt="i53c5627333344a1496415287196c6ec9"><ix:nonNumeric contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RleHRyZWdpb246ZDY1YzFhNDg4MjRmNDMzMjlkNTMwOGMyMTg1MzQzZjlfMzc2NQ_a4d33ae1-bb39-4ab0-a145-988847578a7b" continuedAt="i52a5ef7d8438485b8cf0b5d8ac53e110" escape="true"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the company&#8217;s total revenue and segment revenue disaggregated by geographical region: </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:15.859%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.261%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.953%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="45" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended January 31</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Life Sciences and Applied Markets</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Agilent CrossLab<br/></span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Diagnostics and Genomics<br/></span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Life Sciences and Applied Markets</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Agilent CrossLab<br/></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Diagnostics and Genomics<br/></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="45" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Revenue by Region</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Americas</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id98e410db6d64a60ad4a6f2802e93f0f_D20211101-20220131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RhYmxlOmUxMjc0OTVlZDU5NDQ3YTc4NWQ2MWY2ZjQ1MmJkODQzL3RhYmxlcmFuZ2U6ZTEyNzQ5NWVkNTk0NDdhNzg1ZDYxZjZmNDUyYmQ4NDNfNS0xLTEtMS0zMDExNA_922ba64a-e0ce-4092-bc87-973e9a0712e5">317</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9b276a4ef0142669a77891f22aafa63_D20211101-20220131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RhYmxlOmUxMjc0OTVlZDU5NDQ3YTc4NWQ2MWY2ZjQ1MmJkODQzL3RhYmxlcmFuZ2U6ZTEyNzQ5NWVkNTk0NDdhNzg1ZDYxZjZmNDUyYmQ4NDNfNS0zLTEtMS0zMDExNA_a1e5adcf-c740-4592-ade4-53dcee22da89">132</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2270a60792d4c44aaf50ded4d6e6053_D20211101-20220131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RhYmxlOmUxMjc0OTVlZDU5NDQ3YTc4NWQ2MWY2ZjQ1MmJkODQzL3RhYmxlcmFuZ2U6ZTEyNzQ5NWVkNTk0NDdhNzg1ZDYxZjZmNDUyYmQ4NDNfNS01LTEtMS0zMDExNA_5d529862-d7a2-4b9c-b149-7cada81890da">188</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b6e655997ee46b5b0ca774029d951f0_D20211101-20220131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RhYmxlOmUxMjc0OTVlZDU5NDQ3YTc4NWQ2MWY2ZjQ1MmJkODQzL3RhYmxlcmFuZ2U6ZTEyNzQ5NWVkNTk0NDdhNzg1ZDYxZjZmNDUyYmQ4NDNfNS03LTEtMS0zMDExNA_a3c57e26-804e-4196-974d-592d64098904">637</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia94002b251cf482785fce6c05237c8c7_D20201101-20210131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RhYmxlOmUxMjc0OTVlZDU5NDQ3YTc4NWQ2MWY2ZjQ1MmJkODQzL3RhYmxlcmFuZ2U6ZTEyNzQ5NWVkNTk0NDdhNzg1ZDYxZjZmNDUyYmQ4NDNfNS05LTEtMS0zMDExNA_b096ee3d-50b9-4a36-99b2-e0f85ba427a4">279</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f6dcf92a3b2409b913e60f71c87523b_D20201101-20210131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RhYmxlOmUxMjc0OTVlZDU5NDQ3YTc4NWQ2MWY2ZjQ1MmJkODQzL3RhYmxlcmFuZ2U6ZTEyNzQ5NWVkNTk0NDdhNzg1ZDYxZjZmNDUyYmQ4NDNfNS0xMS0xLTEtMzAxMTQ_a483eb60-644d-4f4c-ba9d-abab33dca75b">124</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21a438b755494983a6ca6de8bc637763_D20201101-20210131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RhYmxlOmUxMjc0OTVlZDU5NDQ3YTc4NWQ2MWY2ZjQ1MmJkODQzL3RhYmxlcmFuZ2U6ZTEyNzQ5NWVkNTk0NDdhNzg1ZDYxZjZmNDUyYmQ4NDNfNS0xMy0xLTEtMzAxMTQ_61954d57-8b54-437c-83b9-2ed020194d08">152</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fb0b045601b4b149adb5a3c59cddd0a_D20201101-20210131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RhYmxlOmUxMjc0OTVlZDU5NDQ3YTc4NWQ2MWY2ZjQ1MmJkODQzL3RhYmxlcmFuZ2U6ZTEyNzQ5NWVkNTk0NDdhNzg1ZDYxZjZmNDUyYmQ4NDNfNS0xNS0xLTEtMzAxMTQ_a5901673-b3c4-47fc-af94-88a004464352">555</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i200743d5cfa44c4697228dfbf963685f_D20211101-20220131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RhYmxlOmUxMjc0OTVlZDU5NDQ3YTc4NWQ2MWY2ZjQ1MmJkODQzL3RhYmxlcmFuZ2U6ZTEyNzQ5NWVkNTk0NDdhNzg1ZDYxZjZmNDUyYmQ4NDNfNi0xLTEtMS0zMDExNA_6402df4d-3559-4802-ac7e-9843ccbe5f24">252</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b68e96853384e99aa6ee8f64e043a52_D20211101-20220131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RhYmxlOmUxMjc0OTVlZDU5NDQ3YTc4NWQ2MWY2ZjQ1MmJkODQzL3RhYmxlcmFuZ2U6ZTEyNzQ5NWVkNTk0NDdhNzg1ZDYxZjZmNDUyYmQ4NDNfNi0zLTEtMS0zMDExNA_9242a13c-6f93-4b5a-ac6e-89d0472eac04">98</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia48ede266ff94d568a8b81576e800821_D20211101-20220131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RhYmxlOmUxMjc0OTVlZDU5NDQ3YTc4NWQ2MWY2ZjQ1MmJkODQzL3RhYmxlcmFuZ2U6ZTEyNzQ5NWVkNTk0NDdhNzg1ZDYxZjZmNDUyYmQ4NDNfNi01LTEtMS0zMDExNA_e2ebcccb-e3f6-4708-8469-c360d5582966">101</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i621dbedf1b6f42ae8f8a2f84b5287957_D20211101-20220131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RhYmxlOmUxMjc0OTVlZDU5NDQ3YTc4NWQ2MWY2ZjQ1MmJkODQzL3RhYmxlcmFuZ2U6ZTEyNzQ5NWVkNTk0NDdhNzg1ZDYxZjZmNDUyYmQ4NDNfNi03LTEtMS0zMDExNA_f135ba7d-461b-4783-9048-16c3b9f712dc">451</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56152fd0f65346c88b619fa6fbc25760_D20201101-20210131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RhYmxlOmUxMjc0OTVlZDU5NDQ3YTc4NWQ2MWY2ZjQ1MmJkODQzL3RhYmxlcmFuZ2U6ZTEyNzQ5NWVkNTk0NDdhNzg1ZDYxZjZmNDUyYmQ4NDNfNi05LTEtMS0zMDExNA_211689dc-c8d4-4575-b336-54f6a7c51411">245</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b2a7c6211084a08b6b244978eb790e2_D20201101-20210131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RhYmxlOmUxMjc0OTVlZDU5NDQ3YTc4NWQ2MWY2ZjQ1MmJkODQzL3RhYmxlcmFuZ2U6ZTEyNzQ5NWVkNTk0NDdhNzg1ZDYxZjZmNDUyYmQ4NDNfNi0xMS0xLTEtMzAxMTQ_d6327ed5-a6bd-4f57-a217-b7f07b0d5f43">92</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icda076e98d344aa6b5d575ac1c693ad4_D20201101-20210131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RhYmxlOmUxMjc0OTVlZDU5NDQ3YTc4NWQ2MWY2ZjQ1MmJkODQzL3RhYmxlcmFuZ2U6ZTEyNzQ5NWVkNTk0NDdhNzg1ZDYxZjZmNDUyYmQ4NDNfNi0xMy0xLTEtMzAxMTQ_fca750ec-e9d9-44c0-9e51-768b4027473d">100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ea6946ae07b4db194a25f0b0b7d96e5_D20201101-20210131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RhYmxlOmUxMjc0OTVlZDU5NDQ3YTc4NWQ2MWY2ZjQ1MmJkODQzL3RhYmxlcmFuZ2U6ZTEyNzQ5NWVkNTk0NDdhNzg1ZDYxZjZmNDUyYmQ4NDNfNi0xNS0xLTEtMzAxMTQ_6e8cf4ec-59d3-4b84-9873-25a7e36ece57">437</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia Pacific</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6990515accb4b6a8e12491c430b6e15_D20211101-20220131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RhYmxlOmUxMjc0OTVlZDU5NDQ3YTc4NWQ2MWY2ZjQ1MmJkODQzL3RhYmxlcmFuZ2U6ZTEyNzQ5NWVkNTk0NDdhNzg1ZDYxZjZmNDUyYmQ4NDNfNy0xLTEtMS0zMDExNA_9b046598-d2a2-4826-a98c-1e6f45b36b2d">407</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5aa3111b40146c693795bc54d4360d2_D20211101-20220131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RhYmxlOmUxMjc0OTVlZDU5NDQ3YTc4NWQ2MWY2ZjQ1MmJkODQzL3RhYmxlcmFuZ2U6ZTEyNzQ5NWVkNTk0NDdhNzg1ZDYxZjZmNDUyYmQ4NDNfNy0zLTEtMS0zMDExNA_8298c61c-adc4-4760-890c-b806a97b4159">129</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6fcd3ec546c34f0a8138948fa2a41702_D20211101-20220131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RhYmxlOmUxMjc0OTVlZDU5NDQ3YTc4NWQ2MWY2ZjQ1MmJkODQzL3RhYmxlcmFuZ2U6ZTEyNzQ5NWVkNTk0NDdhNzg1ZDYxZjZmNDUyYmQ4NDNfNy01LTEtMS0zMDExNA_29d4c965-8eb6-4a03-9244-93a298ffb0a1">50</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iabdeb90dd9a5436a92c8c53c49cf18aa_D20211101-20220131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RhYmxlOmUxMjc0OTVlZDU5NDQ3YTc4NWQ2MWY2ZjQ1MmJkODQzL3RhYmxlcmFuZ2U6ZTEyNzQ5NWVkNTk0NDdhNzg1ZDYxZjZmNDUyYmQ4NDNfNy03LTEtMS0zMDExNA_f10c2dc7-bbac-43e6-ad16-4c1e052aca09">586</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib98cc4f61db94e0d8269c2035a8ea0a7_D20201101-20210131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RhYmxlOmUxMjc0OTVlZDU5NDQ3YTc4NWQ2MWY2ZjQ1MmJkODQzL3RhYmxlcmFuZ2U6ZTEyNzQ5NWVkNTk0NDdhNzg1ZDYxZjZmNDUyYmQ4NDNfNy05LTEtMS0zMDExNA_5d757cb9-36d2-4205-914e-d2523b623376">399</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iccaab3323ff4402984b385de50fcb653_D20201101-20210131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RhYmxlOmUxMjc0OTVlZDU5NDQ3YTc4NWQ2MWY2ZjQ1MmJkODQzL3RhYmxlcmFuZ2U6ZTEyNzQ5NWVkNTk0NDdhNzg1ZDYxZjZmNDUyYmQ4NDNfNy0xMS0xLTEtMzAxMTQ_b90771a2-4144-4c74-8ed6-bc67965b85b2">115</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i659f816f99fa413eb7fb6bcef0c8191a_D20201101-20210131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RhYmxlOmUxMjc0OTVlZDU5NDQ3YTc4NWQ2MWY2ZjQ1MmJkODQzL3RhYmxlcmFuZ2U6ZTEyNzQ5NWVkNTk0NDdhNzg1ZDYxZjZmNDUyYmQ4NDNfNy0xMy0xLTEtMzAxMTQ_436b9bc1-76f4-446e-b7b9-92fe6a7baa93">42</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia563ff7d707142c1bd1a6c4540fe8e3b_D20201101-20210131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RhYmxlOmUxMjc0OTVlZDU5NDQ3YTc4NWQ2MWY2ZjQ1MmJkODQzL3RhYmxlcmFuZ2U6ZTEyNzQ5NWVkNTk0NDdhNzg1ZDYxZjZmNDUyYmQ4NDNfNy0xNS0xLTEtMzAxMTQ_6c74a425-d040-4d7e-a2a4-dbc3a301abbb">556</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d58196320f34869a29143308907c47f_D20211101-20220131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RhYmxlOmUxMjc0OTVlZDU5NDQ3YTc4NWQ2MWY2ZjQ1MmJkODQzL3RhYmxlcmFuZ2U6ZTEyNzQ5NWVkNTk0NDdhNzg1ZDYxZjZmNDUyYmQ4NDNfOC0xLTEtMS0zMDExNA_bbba74e2-1082-4f86-a4ab-5328e9c52e64">976</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30a463a582ff4b16971b766059a24eb9_D20211101-20220131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RhYmxlOmUxMjc0OTVlZDU5NDQ3YTc4NWQ2MWY2ZjQ1MmJkODQzL3RhYmxlcmFuZ2U6ZTEyNzQ5NWVkNTk0NDdhNzg1ZDYxZjZmNDUyYmQ4NDNfOC0zLTEtMS0zMDExNA_0eaada0c-d2ba-4db2-8aa0-d622eb7ba15a">359</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie43c9572619448f8a6ea6d852ea0af23_D20211101-20220131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RhYmxlOmUxMjc0OTVlZDU5NDQ3YTc4NWQ2MWY2ZjQ1MmJkODQzL3RhYmxlcmFuZ2U6ZTEyNzQ5NWVkNTk0NDdhNzg1ZDYxZjZmNDUyYmQ4NDNfOC01LTEtMS0zMDExNA_2902c5e5-c5fe-4edf-b76d-4ca7c49811b2">339</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RhYmxlOmUxMjc0OTVlZDU5NDQ3YTc4NWQ2MWY2ZjQ1MmJkODQzL3RhYmxlcmFuZ2U6ZTEyNzQ5NWVkNTk0NDdhNzg1ZDYxZjZmNDUyYmQ4NDNfOC03LTEtMS0zMDExNA_b1eccfdc-2c16-48af-9054-bfb9bd669508">1,674</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if71b40dd3f5f49bf86fbcfa04c9c081e_D20201101-20210131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RhYmxlOmUxMjc0OTVlZDU5NDQ3YTc4NWQ2MWY2ZjQ1MmJkODQzL3RhYmxlcmFuZ2U6ZTEyNzQ5NWVkNTk0NDdhNzg1ZDYxZjZmNDUyYmQ4NDNfOC05LTEtMS0zMDExNA_18f26529-7a4b-4d4a-a94e-13ca3257d512">923</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02afafae5dac4c4eb5370132cc85ab08_D20201101-20210131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RhYmxlOmUxMjc0OTVlZDU5NDQ3YTc4NWQ2MWY2ZjQ1MmJkODQzL3RhYmxlcmFuZ2U6ZTEyNzQ5NWVkNTk0NDdhNzg1ZDYxZjZmNDUyYmQ4NDNfOC0xMS0xLTEtMzAxMTQ_688ea0b6-5dd1-45ad-8bb0-cc7075d0484b">331</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18473ba8bdd846b583460be774dcc8c2_D20201101-20210131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RhYmxlOmUxMjc0OTVlZDU5NDQ3YTc4NWQ2MWY2ZjQ1MmJkODQzL3RhYmxlcmFuZ2U6ZTEyNzQ5NWVkNTk0NDdhNzg1ZDYxZjZmNDUyYmQ4NDNfOC0xMy0xLTEtMzAxMTQ_3d69624d-bbca-4a27-9222-d9227c9844d7">294</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RhYmxlOmUxMjc0OTVlZDU5NDQ3YTc4NWQ2MWY2ZjQ1MmJkODQzL3RhYmxlcmFuZ2U6ZTEyNzQ5NWVkNTk0NDdhNzg1ZDYxZjZmNDUyYmQ4NDNfOC0xNS0xLTEtMzAxMTQ_64eda019-b49b-439b-9d51-512130159658">1,548</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:16.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.953%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AGILENT TECHNOLOGIES, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) - (Continued) </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i53c5627333344a1496415287196c6ec9" continuedAt="i03cef166de3446f48bced62e00621437"><ix:continuation id="i52a5ef7d8438485b8cf0b5d8ac53e110"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the company&#8217;s total revenue disaggregated by end markets and by revenue type:</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.777%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Revenue by End Markets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmaceutical and Biopharmaceutical</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5a6ff22f0f64b46ac2eca9fc0c63a58_D20211101-20220131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RhYmxlOmZmY2NjZmUyM2JhOTQyMjA4ZTNhMTZhOTg4MmRjYTExL3RhYmxlcmFuZ2U6ZmZjY2NmZTIzYmE5NDIyMDhlM2ExNmE5ODgyZGNhMTFfNS0xLTEtMS0zMDExNA_e8eb9150-a954-4c2a-b0ec-8612474187f4">602</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52a37802a4474ca2ae708288d1606203_D20201101-20210131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RhYmxlOmZmY2NjZmUyM2JhOTQyMjA4ZTNhMTZhOTg4MmRjYTExL3RhYmxlcmFuZ2U6ZmZjY2NmZTIzYmE5NDIyMDhlM2ExNmE5ODgyZGNhMTFfNS0zLTEtMS0zMDExNA_185ecab4-353b-4c3f-a41d-bf5d03bd3127">521</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chemical and Energy</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00b6a666687d43fc80adb8b7c25a62c8_D20211101-20220131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RhYmxlOmZmY2NjZmUyM2JhOTQyMjA4ZTNhMTZhOTg4MmRjYTExL3RhYmxlcmFuZ2U6ZmZjY2NmZTIzYmE5NDIyMDhlM2ExNmE5ODgyZGNhMTFfNi0xLTEtMS0zMDExNA_4622fd1a-7d55-434f-bd64-b6ccf58c834a">373</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i926a81018f214c9e97712dd13af6648e_D20201101-20210131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RhYmxlOmZmY2NjZmUyM2JhOTQyMjA4ZTNhMTZhOTg4MmRjYTExL3RhYmxlcmFuZ2U6ZmZjY2NmZTIzYmE5NDIyMDhlM2ExNmE5ODgyZGNhMTFfNi0zLTEtMS0zMDExNA_86b0f32c-30f7-4b34-8275-b02a19f12057">328</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics and Clinical</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i284ab20841704e569e5c116ce20ebb54_D20211101-20220131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RhYmxlOmZmY2NjZmUyM2JhOTQyMjA4ZTNhMTZhOTg4MmRjYTExL3RhYmxlcmFuZ2U6ZmZjY2NmZTIzYmE5NDIyMDhlM2ExNmE5ODgyZGNhMTFfNy0xLTEtMS0zMDExNA_3350646e-3273-4daa-9fed-169d30aeec08">243</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07d7ce8930c74841be3d4ec974bc2ab8_D20201101-20210131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RhYmxlOmZmY2NjZmUyM2JhOTQyMjA4ZTNhMTZhOTg4MmRjYTExL3RhYmxlcmFuZ2U6ZmZjY2NmZTIzYmE5NDIyMDhlM2ExNmE5ODgyZGNhMTFfNy0zLTEtMS0zMDExNA_6b1dba94-4f99-461d-9090-b8b21e1aab60">216</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Food</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie0a218c3ab7b4c16ac8e0200091a5569_D20211101-20220131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RhYmxlOmZmY2NjZmUyM2JhOTQyMjA4ZTNhMTZhOTg4MmRjYTExL3RhYmxlcmFuZ2U6ZmZjY2NmZTIzYmE5NDIyMDhlM2ExNmE5ODgyZGNhMTFfOC0xLTEtMS0zMDExNA_68b7d9e2-220a-40e3-9d4f-e4cddecfb0f7">158</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8da687ebb1cd4f17b77ceaa5e1137bd2_D20201101-20210131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RhYmxlOmZmY2NjZmUyM2JhOTQyMjA4ZTNhMTZhOTg4MmRjYTExL3RhYmxlcmFuZ2U6ZmZjY2NmZTIzYmE5NDIyMDhlM2ExNmE5ODgyZGNhMTFfOC0zLTEtMS0zMDExNA_e8a0b5e5-8e18-47a4-95ab-6d0a95fd72a5">162</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Academia and Government</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c164cdf4217439d878a2e3ef209db83_D20211101-20220131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RhYmxlOmZmY2NjZmUyM2JhOTQyMjA4ZTNhMTZhOTg4MmRjYTExL3RhYmxlcmFuZ2U6ZmZjY2NmZTIzYmE5NDIyMDhlM2ExNmE5ODgyZGNhMTFfOS0xLTEtMS0zMDExNA_45763ff9-cb21-4509-af2f-7df3ff8c8bbf">141</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i329996789d6240848cf6e6b04372d1aa_D20201101-20210131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RhYmxlOmZmY2NjZmUyM2JhOTQyMjA4ZTNhMTZhOTg4MmRjYTExL3RhYmxlcmFuZ2U6ZmZjY2NmZTIzYmE5NDIyMDhlM2ExNmE5ODgyZGNhMTFfOS0zLTEtMS0zMDExNA_5145710a-2068-4619-8782-1b973bb2ba38">142</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Environmental and Forensics</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49bfbec43e6f47b587bd6854c9e180fd_D20211101-20220131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RhYmxlOmZmY2NjZmUyM2JhOTQyMjA4ZTNhMTZhOTg4MmRjYTExL3RhYmxlcmFuZ2U6ZmZjY2NmZTIzYmE5NDIyMDhlM2ExNmE5ODgyZGNhMTFfMTAtMS0xLTEtMzAxMTQ_eecd3325-6dd6-4058-894b-d8c673177b75">157</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife69be53bb3f4276a6bb4df53fec04cc_D20201101-20210131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RhYmxlOmZmY2NjZmUyM2JhOTQyMjA4ZTNhMTZhOTg4MmRjYTExL3RhYmxlcmFuZ2U6ZmZjY2NmZTIzYmE5NDIyMDhlM2ExNmE5ODgyZGNhMTFfMTAtMy0xLTEtMzAxMTQ_8477455b-cc5b-48e3-857a-3399dfcac816">179</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RhYmxlOmZmY2NjZmUyM2JhOTQyMjA4ZTNhMTZhOTg4MmRjYTExL3RhYmxlcmFuZ2U6ZmZjY2NmZTIzYmE5NDIyMDhlM2ExNmE5ODgyZGNhMTFfMTEtMS0xLTEtMzAxMTQ_4042cbc4-b42c-410a-9600-ce2295f8c869">1,674</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RhYmxlOmZmY2NjZmUyM2JhOTQyMjA4ZTNhMTZhOTg4MmRjYTExL3RhYmxlcmFuZ2U6ZmZjY2NmZTIzYmE5NDIyMDhlM2ExNmE5ODgyZGNhMTFfMTEtMy0xLTEtMzAxMTQ_561e9b51-c2b9-45ce-ade7-f1b06af32674">1,548</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Revenue by Type</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Instrumentation</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i931db477735742ad8a7854c47ecedf86_D20211101-20220131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RhYmxlOmZmY2NjZmUyM2JhOTQyMjA4ZTNhMTZhOTg4MmRjYTExL3RhYmxlcmFuZ2U6ZmZjY2NmZTIzYmE5NDIyMDhlM2ExNmE5ODgyZGNhMTFfMTQtMS0xLTEtMzAxMTQ_77981bc8-206b-4d40-b9d1-086fe6d41569">691</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47dcfc0179de4e7d85d70bbddc34d760_D20201101-20210131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RhYmxlOmZmY2NjZmUyM2JhOTQyMjA4ZTNhMTZhOTg4MmRjYTExL3RhYmxlcmFuZ2U6ZmZjY2NmZTIzYmE5NDIyMDhlM2ExNmE5ODgyZGNhMTFfMTQtMy0xLTEtMzAxMTQ_c9810435-ceff-491f-9794-6bc5fd550333">681</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-instrumentation and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if362cbaedf1a426589671690d5a8d3b1_D20211101-20220131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RhYmxlOmZmY2NjZmUyM2JhOTQyMjA4ZTNhMTZhOTg4MmRjYTExL3RhYmxlcmFuZ2U6ZmZjY2NmZTIzYmE5NDIyMDhlM2ExNmE5ODgyZGNhMTFfMTUtMS0xLTEtMzAxMTQ_41d81730-2b21-41b8-b18b-e75511bdd87c">983</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia68ebbb6be4b4d8ba32cec1a9bcc02ba_D20201101-20210131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RhYmxlOmZmY2NjZmUyM2JhOTQyMjA4ZTNhMTZhOTg4MmRjYTExL3RhYmxlcmFuZ2U6ZmZjY2NmZTIzYmE5NDIyMDhlM2ExNmE5ODgyZGNhMTFfMTUtMy0xLTEtMzAxMTQ_2b4b45dc-98e0-4dd2-b51d-5ce5646df652">867</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RhYmxlOmZmY2NjZmUyM2JhOTQyMjA4ZTNhMTZhOTg4MmRjYTExL3RhYmxlcmFuZ2U6ZmZjY2NmZTIzYmE5NDIyMDhlM2ExNmE5ODgyZGNhMTFfMTYtMS0xLTEtMzAxMTQ_d126d277-2a49-45e5-a448-18c5127993f6">1,674</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RhYmxlOmZmY2NjZmUyM2JhOTQyMjA4ZTNhMTZhOTg4MmRjYTExL3RhYmxlcmFuZ2U6ZmZjY2NmZTIzYmE5NDIyMDhlM2ExNmE5ODgyZGNhMTFfMTYtMy0xLTEtMzAxMTQ_3f1c1e0b-c7ad-442c-808e-f76ebbcdd262">1,548</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:continuation><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue by region is based on the ship to location of the customer. Revenue by end market is determined by the market indicator of the customer and by customer type. Instrumentation revenue includes sales from instruments, remarketed instruments and third-party products. Non-instrumentation and other revenue include sales from contract and per incident services, our companion diagnostics and our nucleic acid solutions businesses as well as sales from spare parts, consumables, reagents, vacuum pumps, subscriptions, software licenses and associated services.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contract Balances</span></div><div><span><br/></span></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contract Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract assets (unbilled accounts receivable) primarily relate to the company's right to consideration for work completed but not billed at the reporting date. The unbilled receivables are reclassified to trade receivables when billed to customers. Contract assets are generally classified as current assets and are included in "Accounts receivable, net" in the condensed consolidated balance sheet. The balances of contract assets as of January&#160;31, 2022 and October&#160;31, 2021 were $<ix:nonFraction unitRef="usd" contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131" decimals="-6" name="us-gaap:ContractWithCustomerAssetNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RleHRyZWdpb246ZDY1YzFhNDg4MjRmNDMzMjlkNTMwOGMyMTg1MzQzZjlfMTMwNw_7faa3267-ba86-4e02-a691-80fa7cb8fa5b">207</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i6390807210d74c6f9cae496ea2122a5a_I20211031" decimals="-6" name="us-gaap:ContractWithCustomerAssetNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RleHRyZWdpb246ZDY1YzFhNDg4MjRmNDMzMjlkNTMwOGMyMTg1MzQzZjlfMTMxNA_3c5b20fb-7fa9-4b11-9b22-d99b650c554b">197</ix:nonFraction> million, respectively. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contract Liabilities</span></div><div style="text-indent:27pt"><span><br/></span></div><ix:nonNumeric contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" name="us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RleHRyZWdpb246ZDY1YzFhNDg4MjRmNDMzMjlkNTMwOGMyMTg1MzQzZjlfMzc3MQ_567c6711-7ee8-4a80-b83a-9075f5b32cc6" escape="true"><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information about contract liabilities (deferred revenue) and the significant changes in the balances during the three months ended January&#160;31, 2022: </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:78.078%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.119%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.403%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Contract <br/>Liabilities</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance as of October 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6390807210d74c6f9cae496ea2122a5a_I20211031" decimals="-6" name="us-gaap:ContractWithCustomerLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RhYmxlOjk2NzVjNGZkODU0ZTRhMzhiNDNmZmFmMmM3Zjg3YzYxL3RhYmxlcmFuZ2U6OTY3NWM0ZmQ4NTRlNGEzOGI0M2ZmYWYyYzdmODdjNjFfMy0yLTEtMS0zMDExNA_6c0920bb-cf27-437f-9a8a-cca62cefce4c">519</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenue deferred in the period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" decimals="-6" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RhYmxlOjk2NzVjNGZkODU0ZTRhMzhiNDNmZmFmMmM3Zjg3YzYxL3RhYmxlcmFuZ2U6OTY3NWM0ZmQ4NTRlNGEzOGI0M2ZmYWYyYzdmODdjNjFfNC0yLTEtMS0zMDExNA_f63024cd-5868-4e88-b570-cc4d854e03c5">220</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue recognized that was included in the contract liability balance at the beginning of the period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" decimals="-6" sign="-" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RhYmxlOjk2NzVjNGZkODU0ZTRhMzhiNDNmZmFmMmM3Zjg3YzYxL3RhYmxlcmFuZ2U6OTY3NWM0ZmQ4NTRlNGEzOGI0M2ZmYWYyYzdmODdjNjFfNS0yLTEtMS0zMDExNA_eee965fd-53cf-4e7c-8d64-4f0d961ee1f6">191</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in deferrals from customer cash advances, net of revenue recognized</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" decimals="-6" name="a:IncreasedecreaseinDeferredRevenuefromCustomerCashAdvancesNetofRevenuerecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RhYmxlOjk2NzVjNGZkODU0ZTRhMzhiNDNmZmFmMmM3Zjg3YzYxL3RhYmxlcmFuZ2U6OTY3NWM0ZmQ4NTRlNGEzOGI0M2ZmYWYyYzdmODdjNjFfNi0yLTEtMS0zMDExNA_72b5d404-49e2-4801-b6c5-e467344783fb">34</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation and other adjustments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" decimals="-6" sign="-" name="us-gaap:TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RhYmxlOjk2NzVjNGZkODU0ZTRhMzhiNDNmZmFmMmM3Zjg3YzYxL3RhYmxlcmFuZ2U6OTY3NWM0ZmQ4NTRlNGEzOGI0M2ZmYWYyYzdmODdjNjFfOC0yLTEtMS0zMDExNA_0a3b8b1a-79f2-4154-b9c9-3a18e12a4ebf">6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance as of January 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131" decimals="-6" name="us-gaap:ContractWithCustomerLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RhYmxlOjk2NzVjNGZkODU0ZTRhMzhiNDNmZmFmMmM3Zjg3YzYxL3RhYmxlcmFuZ2U6OTY3NWM0ZmQ4NTRlNGEzOGI0M2ZmYWYyYzdmODdjNjFfOS0yLTEtMS0zMDExNA_f0f58400-bd07-43ca-80cb-d99ccf1b890e">576</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended January&#160;31, 2021 revenue recognized that was included in the contract liability balance at October&#160;31, 2020 was $<ix:nonFraction unitRef="usd" contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131" decimals="-6" sign="-" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RleHRyZWdpb246ZDY1YzFhNDg4MjRmNDMzMjlkNTMwOGMyMTg1MzQzZjlfMTYzMw_28d9179c-79bc-48f5-aead-847b278adbe8">186</ix:nonFraction> million.</span></div></ix:continuation><div style="text-indent:27pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AGILENT TECHNOLOGIES, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) - (Continued) </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i03cef166de3446f48bced62e00621437" continuedAt="i314ed7448b584a6cabf3002529551c2a"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract liabilities primarily relate to multiple element arrangements for which billing has occurred but transfer of control of all elements to the customer has either partially or not occurred at the balance sheet date. This includes cash received from customers for products and related installation and services in advance of the transfer of control. Contract liabilities are classified as either current in deferred revenue or long-term in other long-term liabilities in the condensed consolidated balance sheet based on the timing of when we expect to complete our performance obligation.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contract Costs</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Incremental costs of obtaining a contract with a customer are recognized as an asset if we expect the benefit of those costs to be longer than one year. We have determined that certain sales incentive programs meet the requirements to be capitalized. The change in total capitalized costs to obtain a contract was immaterial during the three months ended January&#160;31, 2022 and was included in other current and long-term assets on the condensed consolidated balance sheet. We have applied the practical expedient to expense costs as incurred for costs to obtain a contract with a customer when the amortization period would have been one year or less. These costs include the company's internal sales force compensation program, as we have determined that annual compensation is commensurate with annual sales activities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Transaction Price Allocated to the Remaining Performance Obligations   </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have applied the practical expedient in ASC 606-10-50-14 and have not disclosed information about transaction price allocated to remaining performance obligations that have original expected durations of one year or less.</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></ix:continuation><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i314ed7448b584a6cabf3002529551c2a">The estimated revenue expected to be recognized for remaining performance obligations that have an original term of more than one year, as of January&#160;31, 2022, was $<ix:nonFraction unitRef="usd" contextRef="i54fd0d780e894d15abb38be115f904fc_I20220131" decimals="-6" name="us-gaap:RevenueRemainingPerformanceObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RleHRyZWdpb246ZDY1YzFhNDg4MjRmNDMzMjlkNTMwOGMyMTg1MzQzZjlfMzUwNQ_636efaec-338a-41a7-8740-dca73abf203a">347</ix:nonFraction> million, the majority of which is expected to be recognized over the next <ix:nonNumeric contextRef="i54fd0d780e894d15abb38be115f904fc_I20220131" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RleHRyZWdpb246ZDY1YzFhNDg4MjRmNDMzMjlkNTMwOGMyMTg1MzQzZjlfMzU3NA_89ea0f6a-d428-4c59-a53c-e0a4de491eb4">12</ix:nonNumeric> months. Remaining performance obligations primarily include extended warranty, customer manufacturing contracts, software maintenance contracts and revenue associated with lease arrangements.</ix:continuation>  </span></div><div><span><br/></span></div><div id="if825c91f15a047ec9e67e0189634a349_43"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.  &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RleHRyZWdpb246ZjdkZTkyNTFlNjE5NGQxZWI0YjdmNDU5NzA2NGJmOGZfNDg4Mg_c9993115-35a6-40b1-92d3-f22f3bfab514" continuedAt="i824ee35b3cb047b2993bc7f53289969d" escape="true">SHARE-BASED COMPENSATION</ix:nonNumeric></span></div><ix:continuation id="i824ee35b3cb047b2993bc7f53289969d" continuedAt="ia59526b573664b5495d6aff29d31bfd5"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We account for share-based awards in accordance with the provisions of the authoritative accounting guidance which requires the measurement and recognition of compensation expense for all share-based payment awards made to our employees and directors including employee stock options, restricted stock units, employee stock purchases made under our employee stock purchase plan and performance share awards granted to selected members of our senior management under the long-term performance plan (&#8220;LTPP&#8221;) based on estimated fair values. </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have two LTPP performance stock award programs, which are administered under the 2018 Stock Plan, for our executive officers and other key employees. Participants in our LTPP Total Stockholders&#8217; Return (&#8220;TSR&#8221;) and LTPP Earnings Per Share (&#8220;EPS&#8221;) programs are entitled to receive shares of the company's stock after the end of a three-year period, if specified performance targets for the programs are met. The LTPP-TSR awards are generally designed to meet the criteria of a performance award with the performance metrics and peer group comparison based on the TSR set at the beginning of the performance period. The LTPP-EPS awards are based on the company&#8217;s EPS performance over a three-year period. The performance targets for the LTPP-EPS for year 2 and year 3 of the performance period are set in the first quarter of year 2 and year 3, respectively. All LTPP awards are subject to a one-year post-vest holding period.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The final LTPP award may vary from <ix:nonFraction unitRef="number" contextRef="iae4a69f538454c80a80c725dcb6771c3_D20201101-20210131" decimals="3" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RleHRyZWdpb246ZjdkZTkyNTFlNjE5NGQxZWI0YjdmNDU5NzA2NGJmOGZfMTU0MA_490618a1-df59-4c70-bc70-397457e0a682"><ix:nonFraction unitRef="number" contextRef="iae4a69f538454c80a80c725dcb6771c3_D20201101-20210131" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RleHRyZWdpb246ZjdkZTkyNTFlNjE5NGQxZWI0YjdmNDU5NzA2NGJmOGZfMTU0MA_7ff2f2de-3d18-47ce-ba8b-a34556cf469f"><ix:nonFraction unitRef="number" contextRef="i8ca5ba2eb51246a9894d8e9981e851fc_D20211101-20220131" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RleHRyZWdpb246ZjdkZTkyNTFlNjE5NGQxZWI0YjdmNDU5NzA2NGJmOGZfMTU0MA_a7d6d6b0-bfcf-4d40-8eed-58e713aea1b4"><ix:nonFraction unitRef="number" contextRef="i8ca5ba2eb51246a9894d8e9981e851fc_D20211101-20220131" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RleHRyZWdpb246ZjdkZTkyNTFlNjE5NGQxZWI0YjdmNDU5NzA2NGJmOGZfMTU0MA_d28c9177-c71d-48ad-ac13-4d019f965f2e">0</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> percent to <ix:nonFraction unitRef="number" contextRef="i4234dc38e5b84ef38ecd7c8b2af056d7_D20211101-20220131" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RleHRyZWdpb246ZjdkZTkyNTFlNjE5NGQxZWI0YjdmNDU5NzA2NGJmOGZfMTU0Ng_88d057e5-fa47-4b4f-93f4-b9d31c67277a"><ix:nonFraction unitRef="number" contextRef="i311fec97745e4c5782f4816c9e6d9ea3_D20201101-20210131" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RleHRyZWdpb246ZjdkZTkyNTFlNjE5NGQxZWI0YjdmNDU5NzA2NGJmOGZfMTU0Ng_9e4ebf1e-2eb1-48d9-9157-439372dcc04d"><ix:nonFraction unitRef="number" contextRef="i311fec97745e4c5782f4816c9e6d9ea3_D20201101-20210131" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RleHRyZWdpb246ZjdkZTkyNTFlNjE5NGQxZWI0YjdmNDU5NzA2NGJmOGZfMTU0Ng_ac3f5572-9aed-4474-b8be-85c81d24373d"><ix:nonFraction unitRef="number" contextRef="i4234dc38e5b84ef38ecd7c8b2af056d7_D20211101-20220131" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RleHRyZWdpb246ZjdkZTkyNTFlNjE5NGQxZWI0YjdmNDU5NzA2NGJmOGZfMTU0Ng_b5d19421-ab41-466d-b7b3-12da758a9875">200</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> percent of the target award. We consider the dilutive impact of these programs in our diluted net income per share calculation only to the extent that the performance conditions are expected to be met. Restricted stock units generally vest, with some exceptions, at a rate of <ix:nonFraction unitRef="number" contextRef="i316c350db7ff4688a76e3821c97ef7e5_D20211101-20220131" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RleHRyZWdpb246ZjdkZTkyNTFlNjE5NGQxZWI0YjdmNDU5NzA2NGJmOGZfMTgxNw_4ac8f4a1-3c7d-4542-9c03-d0155e040cbe"><ix:nonFraction unitRef="number" contextRef="i1ea2e447d0a14715a3edc8a2285fae18_D20201101-20210131" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RleHRyZWdpb246ZjdkZTkyNTFlNjE5NGQxZWI0YjdmNDU5NzA2NGJmOGZfMTgxNw_7b681eff-592e-4e67-9324-0b7769b6d81a"><ix:nonFraction unitRef="number" contextRef="i316c350db7ff4688a76e3821c97ef7e5_D20211101-20220131" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RleHRyZWdpb246ZjdkZTkyNTFlNjE5NGQxZWI0YjdmNDU5NzA2NGJmOGZfMTgxNw_a775be38-d2ec-4ba6-b0b9-e1758eda6d15"><ix:nonFraction unitRef="number" contextRef="i1ea2e447d0a14715a3edc8a2285fae18_D20201101-20210131" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RleHRyZWdpb246ZjdkZTkyNTFlNjE5NGQxZWI0YjdmNDU5NzA2NGJmOGZfMTgxNw_b4b1faf3-3d42-4c92-9629-e3ee01b1d91e">25</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> percent per year over a period of <ix:nonNumeric contextRef="i316c350db7ff4688a76e3821c97ef7e5_D20211101-20220131" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RleHRyZWdpb246ZjdkZTkyNTFlNjE5NGQxZWI0YjdmNDU5NzA2NGJmOGZfMTg0Ng_0483c060-c5ab-4292-9d49-936b49e0051c"><ix:nonNumeric contextRef="i1ea2e447d0a14715a3edc8a2285fae18_D20201101-20210131" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RleHRyZWdpb246ZjdkZTkyNTFlNjE5NGQxZWI0YjdmNDU5NzA2NGJmOGZfMTg0Ng_31856662-b5df-4c95-9d45-8baf5833a956"><ix:nonNumeric contextRef="i316c350db7ff4688a76e3821c97ef7e5_D20211101-20220131" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RleHRyZWdpb246ZjdkZTkyNTFlNjE5NGQxZWI0YjdmNDU5NzA2NGJmOGZfMTg0Ng_85cfbc1f-b5a8-4b0a-9378-b041ebc2e58f"><ix:nonNumeric contextRef="i1ea2e447d0a14715a3edc8a2285fae18_D20201101-20210131" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RleHRyZWdpb246ZjdkZTkyNTFlNjE5NGQxZWI0YjdmNDU5NzA2NGJmOGZfMTg0Ng_9bb4eae7-14f5-4047-a496-e3869dfb9f66">four years</ix:nonNumeric></ix:nonNumeric></ix:nonNumeric></ix:nonNumeric> from the date of grant.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In fiscal year 2021, we resumed granting stock options. Stock options granted under the 2018 Stock Plan may be either "incentive stock options", as defined in Section 422 of the Internal Revenue Code, or non-statutory. Options generally vest at a rate of <ix:nonFraction unitRef="number" contextRef="i0320d16146c74425913fe2d4102de305_D20211101-20220131" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RleHRyZWdpb246ZjdkZTkyNTFlNjE5NGQxZWI0YjdmNDU5NzA2NGJmOGZfMjEyOQ_431c666d-df93-40b6-9308-5b7ecac28044"><ix:nonFraction unitRef="number" contextRef="i0320d16146c74425913fe2d4102de305_D20211101-20220131" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RleHRyZWdpb246ZjdkZTkyNTFlNjE5NGQxZWI0YjdmNDU5NzA2NGJmOGZfMjEyOQ_43b0259e-f69a-40f6-a733-72dce0177db0"><ix:nonFraction unitRef="number" contextRef="if67aad121f6a462fb9bd2e05dc5b978e_D20201101-20210131" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RleHRyZWdpb246ZjdkZTkyNTFlNjE5NGQxZWI0YjdmNDU5NzA2NGJmOGZfMjEyOQ_d1426df5-0988-4989-854b-6d6e498eb0eb"><ix:nonFraction unitRef="number" contextRef="if67aad121f6a462fb9bd2e05dc5b978e_D20201101-20210131" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RleHRyZWdpb246ZjdkZTkyNTFlNjE5NGQxZWI0YjdmNDU5NzA2NGJmOGZfMjEyOQ_efceccab-7809-4833-bda4-9500a5523422">25</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> percent per year over a period of <ix:nonNumeric contextRef="i0320d16146c74425913fe2d4102de305_D20211101-20220131" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RleHRyZWdpb246ZjdkZTkyNTFlNjE5NGQxZWI0YjdmNDU5NzA2NGJmOGZfMjE1OA_1ab5b725-f2c5-444e-a729-63dbd0a4f248"><ix:nonNumeric contextRef="if67aad121f6a462fb9bd2e05dc5b978e_D20201101-20210131" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RleHRyZWdpb246ZjdkZTkyNTFlNjE5NGQxZWI0YjdmNDU5NzA2NGJmOGZfMjE1OA_360b6d63-8fba-43e7-a085-fe3461d4db5a"><ix:nonNumeric contextRef="i0320d16146c74425913fe2d4102de305_D20211101-20220131" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RleHRyZWdpb246ZjdkZTkyNTFlNjE5NGQxZWI0YjdmNDU5NzA2NGJmOGZfMjE1OA_4e2b72d9-098e-4ab5-a11a-85c5f000d04f"><ix:nonNumeric contextRef="if67aad121f6a462fb9bd2e05dc5b978e_D20201101-20210131" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RleHRyZWdpb246ZjdkZTkyNTFlNjE5NGQxZWI0YjdmNDU5NzA2NGJmOGZfMjE1OA_fdfefeba-65d5-434b-b6ed-3154a4072e42">four years</ix:nonNumeric></ix:nonNumeric></ix:nonNumeric></ix:nonNumeric> from the date of grant with a maximum contractual term of <ix:nonNumeric contextRef="if67aad121f6a462fb9bd2e05dc5b978e_D20201101-20210131" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RleHRyZWdpb246ZjdkZTkyNTFlNjE5NGQxZWI0YjdmNDU5NzA2NGJmOGZfMjIxOQ_0394d76d-d862-4fa2-8179-ac391e801498"><ix:nonNumeric contextRef="i0320d16146c74425913fe2d4102de305_D20211101-20220131" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RleHRyZWdpb246ZjdkZTkyNTFlNjE5NGQxZWI0YjdmNDU5NzA2NGJmOGZfMjIxOQ_07997f03-34d9-4270-a52c-72266dd359a9"><ix:nonNumeric contextRef="if67aad121f6a462fb9bd2e05dc5b978e_D20201101-20210131" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RleHRyZWdpb246ZjdkZTkyNTFlNjE5NGQxZWI0YjdmNDU5NzA2NGJmOGZfMjIxOQ_2f8c84ab-fded-4aa7-a675-40f161ca2fce"><ix:nonNumeric contextRef="i0320d16146c74425913fe2d4102de305_D20211101-20220131" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RleHRyZWdpb246ZjdkZTkyNTFlNjE5NGQxZWI0YjdmNDU5NzA2NGJmOGZfMjIxOQ_3a607a7f-3a3c-43e0-a5cc-2c8d2efc80aa">ten years</ix:nonNumeric></ix:nonNumeric></ix:nonNumeric></ix:nonNumeric>. The exercise price for stock options is generally not less than <ix:nonFraction unitRef="number" contextRef="i0320d16146c74425913fe2d4102de305_D20211101-20220131" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RleHRyZWdpb246ZjdkZTkyNTFlNjE5NGQxZWI0YjdmNDU5NzA2NGJmOGZfMjI4Nw_15a4469f-4876-4202-9128-c5913cf245bd"><ix:nonFraction unitRef="number" contextRef="if67aad121f6a462fb9bd2e05dc5b978e_D20201101-20210131" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RleHRyZWdpb246ZjdkZTkyNTFlNjE5NGQxZWI0YjdmNDU5NzA2NGJmOGZfMjI4Nw_67855332-d4c2-4bc5-a1b6-d0f5aedd5cee"><ix:nonFraction unitRef="number" contextRef="i0320d16146c74425913fe2d4102de305_D20211101-20220131" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RleHRyZWdpb246ZjdkZTkyNTFlNjE5NGQxZWI0YjdmNDU5NzA2NGJmOGZfMjI4Nw_c200989a-ffed-458d-b340-d62e3c704c3e"><ix:nonFraction unitRef="number" contextRef="if67aad121f6a462fb9bd2e05dc5b978e_D20201101-20210131" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RleHRyZWdpb246ZjdkZTkyNTFlNjE5NGQxZWI0YjdmNDU5NzA2NGJmOGZfMjI4Nw_f95094f7-57ec-4d22-81d4-cd776f47dffb">100</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> percent of the fair market value of our common stock on the date the stock award is granted. We issue new shares of common stock when employee stock options are exercised. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AGILENT TECHNOLOGIES, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) - (Continued) </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="ia59526b573664b5495d6aff29d31bfd5" continuedAt="ibcfcaf24772c4407816c05a9a35eb6d8"><ix:nonNumeric contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RleHRyZWdpb246ZjdkZTkyNTFlNjE5NGQxZWI0YjdmNDU5NzA2NGJmOGZfNDg3Mg_7ca43c14-e920-4447-ae85-2540b13c32d9" escape="true"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The impact on our results for share-based compensation was as follows:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products and services</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic76564bc7be64253830f89477bbf29cb_D20211101-20220131" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RhYmxlOjNlZjQ3OTA1N2IyOTRkMDI4NzExM2FlNDM3OGZkODVmL3RhYmxlcmFuZ2U6M2VmNDc5MDU3YjI5NGQwMjg3MTEzYWU0Mzc4ZmQ4NWZfNC0xLTEtMS0zMDExNA_95465d6a-fa9f-4202-a7d4-48cb61122ae8">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if825187b5c3d4f688e0c4a074679fd80_D20201101-20210131" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RhYmxlOjNlZjQ3OTA1N2IyOTRkMDI4NzExM2FlNDM3OGZkODVmL3RhYmxlcmFuZ2U6M2VmNDc5MDU3YjI5NGQwMjg3MTEzYWU0Mzc4ZmQ4NWZfNC0zLTEtMS0zMDExNA_708754da-9c28-4bf1-ae92-a225b06a94b2">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4535eece62c1411ab965c726896d4585_D20211101-20220131" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RhYmxlOjNlZjQ3OTA1N2IyOTRkMDI4NzExM2FlNDM3OGZkODVmL3RhYmxlcmFuZ2U6M2VmNDc5MDU3YjI5NGQwMjg3MTEzYWU0Mzc4ZmQ4NWZfNS0xLTEtMS0zMDExNA_c84afc91-a189-459a-bd34-fee8fd578876">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f82fd5225d94d7db0f34592fd4d9e70_D20201101-20210131" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RhYmxlOjNlZjQ3OTA1N2IyOTRkMDI4NzExM2FlNDM3OGZkODVmL3RhYmxlcmFuZ2U6M2VmNDc5MDU3YjI5NGQwMjg3MTEzYWU0Mzc4ZmQ4NWZfNS0zLTEtMS0zMDExNA_8283c77a-c836-4700-b7a5-6bd9e10d9820">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b0f854e4792405b9d4a4ae010c5c2ad_D20211101-20220131" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RhYmxlOjNlZjQ3OTA1N2IyOTRkMDI4NzExM2FlNDM3OGZkODVmL3RhYmxlcmFuZ2U6M2VmNDc5MDU3YjI5NGQwMjg3MTEzYWU0Mzc4ZmQ4NWZfNi0xLTEtMS0zMDExNA_13dddfd8-adbe-4135-8886-16dbeaf11159">28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7739872a76e499dad8a316f0e7cd808_D20201101-20210131" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RhYmxlOjNlZjQ3OTA1N2IyOTRkMDI4NzExM2FlNDM3OGZkODVmL3RhYmxlcmFuZ2U6M2VmNDc5MDU3YjI5NGQwMjg3MTEzYWU0Mzc4ZmQ4NWZfNi0zLTEtMS0zMDExNA_cf696d6d-e8f2-4fdb-b38c-a808728d3b57">27</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total share-based compensation expense</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RhYmxlOjNlZjQ3OTA1N2IyOTRkMDI4NzExM2FlNDM3OGZkODVmL3RhYmxlcmFuZ2U6M2VmNDc5MDU3YjI5NGQwMjg3MTEzYWU0Mzc4ZmQ4NWZfNy0xLTEtMS0zMDExNA_18f3bc68-f486-49b1-8a38-9b3e45b9785e">45</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RhYmxlOjNlZjQ3OTA1N2IyOTRkMDI4NzExM2FlNDM3OGZkODVmL3RhYmxlcmFuZ2U6M2VmNDc5MDU3YjI5NGQwMjg3MTEzYWU0Mzc4ZmQ4NWZfNy0zLTEtMS0zMDExNA_28348ace-0c60-4d72-b261-30c567db0371">40</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At January&#160;31, 2022 and October&#160;31, 2021, <ix:nonFraction unitRef="usd" contextRef="ief4838c7f61041b2b6eef53b20ed9d80_D20211101-20220131" decimals="-6" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RleHRyZWdpb246ZjdkZTkyNTFlNjE5NGQxZWI0YjdmNDU5NzA2NGJmOGZfMjU1OA_bdf65589-bf54-4d89-aae3-35c205edb422"><ix:nonFraction unitRef="usd" contextRef="ic14d2081148241ed947bffd3bb60c599_D20201101-20211031" decimals="-6" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RleHRyZWdpb246ZjdkZTkyNTFlNjE5NGQxZWI0YjdmNDU5NzA2NGJmOGZfMjU1OA_c28eac11-d748-4d45-935d-aba1aa4d8f8e">no</ix:nonFraction></ix:nonFraction> share-based compensation was capitalized within inventory. </span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">                                               </span></div><ix:nonNumeric contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" name="a:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RleHRyZWdpb246ZjdkZTkyNTFlNjE5NGQxZWI0YjdmNDU5NzA2NGJmOGZfNDg4NQ_9ec74c4f-ba51-407d-ad6a-b1d034e2fdf9" escape="true"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following assumptions were used to estimate the fair value of awards granted.</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:75.215%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock Option Plans:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average risk-free interest rate</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0320d16146c74425913fe2d4102de305_D20211101-20220131" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RhYmxlOjY1MDVkOWNiYjc0NTQwNjk5YTQxYjg0MWI3YmZkNjQ5L3RhYmxlcmFuZ2U6NjUwNWQ5Y2JiNzQ1NDA2OTlhNDFiODQxYjdiZmQ2NDlfNC0xLTEtMS0zMDExNA_5c7915a3-d5c8-4630-93d4-91b3161307c0">1.3</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if67aad121f6a462fb9bd2e05dc5b978e_D20201101-20210131" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RhYmxlOjY1MDVkOWNiYjc0NTQwNjk5YTQxYjg0MWI3YmZkNjQ5L3RhYmxlcmFuZ2U6NjUwNWQ5Y2JiNzQ1NDA2OTlhNDFiODQxYjdiZmQ2NDlfNC0zLTEtMS0zMDExNA_1287e742-5117-4482-a059-ebf12032d3cd">0.5</ix:nonFraction>%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0320d16146c74425913fe2d4102de305_D20211101-20220131" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RhYmxlOjY1MDVkOWNiYjc0NTQwNjk5YTQxYjg0MWI3YmZkNjQ5L3RhYmxlcmFuZ2U6NjUwNWQ5Y2JiNzQ1NDA2OTlhNDFiODQxYjdiZmQ2NDlfNS0xLTEtMS0zMDExNA_4f901c3a-2117-4116-a1f1-3a21ddb64bf7">0.5</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if67aad121f6a462fb9bd2e05dc5b978e_D20201101-20210131" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RhYmxlOjY1MDVkOWNiYjc0NTQwNjk5YTQxYjg0MWI3YmZkNjQ5L3RhYmxlcmFuZ2U6NjUwNWQ5Y2JiNzQ1NDA2OTlhNDFiODQxYjdiZmQ2NDlfNS0zLTEtMS0zMDExNA_94e66b62-8a4d-47a9-bd34-f1e1b748f79b">0.7</ix:nonFraction>%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average volatility</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0320d16146c74425913fe2d4102de305_D20211101-20220131" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RhYmxlOjY1MDVkOWNiYjc0NTQwNjk5YTQxYjg0MWI3YmZkNjQ5L3RhYmxlcmFuZ2U6NjUwNWQ5Y2JiNzQ1NDA2OTlhNDFiODQxYjdiZmQ2NDlfNi0xLTEtMS0zMDExNA_e31e316d-224b-4c11-b6ee-7ad7bdf9bc2d">26</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if67aad121f6a462fb9bd2e05dc5b978e_D20201101-20210131" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RhYmxlOjY1MDVkOWNiYjc0NTQwNjk5YTQxYjg0MWI3YmZkNjQ5L3RhYmxlcmFuZ2U6NjUwNWQ5Y2JiNzQ1NDA2OTlhNDFiODQxYjdiZmQ2NDlfNi0zLTEtMS0zMDExNA_b35c57b1-5447-4d9f-b782-ecae66558888">26</ix:nonFraction>%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0320d16146c74425913fe2d4102de305_D20211101-20220131" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RhYmxlOjY1MDVkOWNiYjc0NTQwNjk5YTQxYjg0MWI3YmZkNjQ5L3RhYmxlcmFuZ2U6NjUwNWQ5Y2JiNzQ1NDA2OTlhNDFiODQxYjdiZmQ2NDlfNy0xLTEtMS0zMDExNA_5180c275-3fa7-4a5d-9c66-2352d7ea26b5">5.5</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if67aad121f6a462fb9bd2e05dc5b978e_D20201101-20210131" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RhYmxlOjY1MDVkOWNiYjc0NTQwNjk5YTQxYjg0MWI3YmZkNjQ5L3RhYmxlcmFuZ2U6NjUwNWQ5Y2JiNzQ1NDA2OTlhNDFiODQxYjdiZmQ2NDlfNy0zLTEtMS0zMDExNA_c4df8678-dd22-472a-b238-83bd264c235a">5.5</ix:nonNumeric> years</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LTPP:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Volatility of Agilent shares</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5acd8d66594844e1bea57bc50343b797_D20211101-20220131" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RhYmxlOjY1MDVkOWNiYjc0NTQwNjk5YTQxYjg0MWI3YmZkNjQ5L3RhYmxlcmFuZ2U6NjUwNWQ5Y2JiNzQ1NDA2OTlhNDFiODQxYjdiZmQ2NDlfOS0xLTEtMS0zMDExNA_095f1bf5-505e-42c5-a53f-9d23499f8756">29</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie97ad2be4ba94b6f983f36fa69ecd859_D20201101-20210131" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RhYmxlOjY1MDVkOWNiYjc0NTQwNjk5YTQxYjg0MWI3YmZkNjQ5L3RhYmxlcmFuZ2U6NjUwNWQ5Y2JiNzQ1NDA2OTlhNDFiODQxYjdiZmQ2NDlfOS0zLTEtMS0zMDExNA_a3116c1b-c606-4ebe-8dd2-f3cc885e34a5">30</ix:nonFraction>%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Volatility of selected peer-company shares</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5acd8d66594844e1bea57bc50343b797_D20211101-20220131" decimals="2" name="a:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesVolatilityRateRangeMinimum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RhYmxlOjY1MDVkOWNiYjc0NTQwNjk5YTQxYjg0MWI3YmZkNjQ5L3RhYmxlcmFuZ2U6NjUwNWQ5Y2JiNzQ1NDA2OTlhNDFiODQxYjdiZmQ2NDlfMTAtMS0xLTEtMzAxMTQvdGV4dHJlZ2lvbjo1MWE3YjY2NGM0Mzg0MDQyYTYzMmYzZDc3NDllYWU5Ml80_a4bdc03c-a6d4-4e2b-b92a-ec42987b0f26">23</ix:nonFraction>%-<ix:nonFraction unitRef="number" contextRef="i5acd8d66594844e1bea57bc50343b797_D20211101-20220131" decimals="2" name="a:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesVolatilityRateRangeMaximum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RhYmxlOjY1MDVkOWNiYjc0NTQwNjk5YTQxYjg0MWI3YmZkNjQ5L3RhYmxlcmFuZ2U6NjUwNWQ5Y2JiNzQ1NDA2OTlhNDFiODQxYjdiZmQ2NDlfMTAtMS0xLTEtMzAxMTQvdGV4dHJlZ2lvbjo1MWE3YjY2NGM0Mzg0MDQyYTYzMmYzZDc3NDllYWU5Ml83_73cfdda4-6326-4d2d-ac39-5e924abd55f0">81</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie97ad2be4ba94b6f983f36fa69ecd859_D20201101-20210131" decimals="2" name="a:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesVolatilityRateRangeMinimum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RhYmxlOjY1MDVkOWNiYjc0NTQwNjk5YTQxYjg0MWI3YmZkNjQ5L3RhYmxlcmFuZ2U6NjUwNWQ5Y2JiNzQ1NDA2OTlhNDFiODQxYjdiZmQ2NDlfMTAtMy0xLTEtMzAxMTQvdGV4dHJlZ2lvbjo1ZWMwN2MxYThiNTk0ODhmOWRkNTIyNWUzZGI5MjUyMF80_b80b8244-c0c9-4723-a9c1-19240f9f3426">24</ix:nonFraction>%-<ix:nonFraction unitRef="number" contextRef="ie97ad2be4ba94b6f983f36fa69ecd859_D20201101-20210131" decimals="2" name="a:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesVolatilityRateRangeMaximum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RhYmxlOjY1MDVkOWNiYjc0NTQwNjk5YTQxYjg0MWI3YmZkNjQ5L3RhYmxlcmFuZ2U6NjUwNWQ5Y2JiNzQ1NDA2OTlhNDFiODQxYjdiZmQ2NDlfMTAtMy0xLTEtMzAxMTQvdGV4dHJlZ2lvbjo1ZWMwN2MxYThiNTk0ODhmOWRkNTIyNWUzZGI5MjUyMF83_bde44c83-963b-4822-b75b-8730ebb2fc57">57</ix:nonFraction>%</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pair-wise correlation with selected peers</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5acd8d66594844e1bea57bc50343b797_D20211101-20220131" decimals="2" name="a:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesPriceWiseCorrelationyRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RhYmxlOjY1MDVkOWNiYjc0NTQwNjk5YTQxYjg0MWI3YmZkNjQ5L3RhYmxlcmFuZ2U6NjUwNWQ5Y2JiNzQ1NDA2OTlhNDFiODQxYjdiZmQ2NDlfMTEtMS0xLTEtMzAxMTQ_35010ae2-6be5-4e33-9615-cfb679e1571f">41</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie97ad2be4ba94b6f983f36fa69ecd859_D20201101-20210131" decimals="2" name="a:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesPriceWiseCorrelationyRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RhYmxlOjY1MDVkOWNiYjc0NTQwNjk5YTQxYjg0MWI3YmZkNjQ5L3RhYmxlcmFuZ2U6NjUwNWQ5Y2JiNzQ1NDA2OTlhNDFiODQxYjdiZmQ2NDlfMTEtMy0xLTEtMzAxMTQ_822bb50c-51bb-4227-af2a-7f115ba3da2a">45</ix:nonFraction>%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Post-vest holding restriction discount for all executive awards</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ifb9c990647d348b7aea2ac54abe5e341_D20211101-20220131" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RhYmxlOjY1MDVkOWNiYjc0NTQwNjk5YTQxYjg0MWI3YmZkNjQ5L3RhYmxlcmFuZ2U6NjUwNWQ5Y2JiNzQ1NDA2OTlhNDFiODQxYjdiZmQ2NDlfMTMtMS0xLTEtMzAxMTQ_bfcddc11-1d5e-4d1e-863c-582074ec9dd2">6.5</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i89bc983fc1ee42d3a7c27d1122dfa162_D20201101-20210131" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RhYmxlOjY1MDVkOWNiYjc0NTQwNjk5YTQxYjg0MWI3YmZkNjQ5L3RhYmxlcmFuZ2U6NjUwNWQ5Y2JiNzQ1NDA2OTlhNDFiODQxYjdiZmQ2NDlfMTMtMy0xLTEtMzAxMTQ_d01d9e36-5e99-4987-a4c6-3197f1e1e729">6.8</ix:nonFraction>%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of share-based awards for our employee stock option awards was estimated using the Black-Scholes option pricing model. Shares granted under the LTPP (TSR) were valued using a Monte Carlo simulation model. The Monte Carlo simulation fair value model requires the use of highly subjective and complex assumptions, including the price volatility of the underlying stock. &#160;For the volatility of our LTPP (TSR) grants, we used our own historical stock price volatility.&#160;&#160;</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ESPP allows eligible employees to purchase shares of our common stock at <ix:nonFraction unitRef="number" contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RleHRyZWdpb246ZjdkZTkyNTFlNjE5NGQxZWI0YjdmNDU5NzA2NGJmOGZfMzMxMw_1416e2cc-0d61-4d54-a492-d46067e3df18"><ix:nonFraction unitRef="number" contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RleHRyZWdpb246ZjdkZTkyNTFlNjE5NGQxZWI0YjdmNDU5NzA2NGJmOGZfMzMxMw_2e276c90-bf31-4799-9622-4fbd4f22b9bb"><ix:nonFraction unitRef="number" contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RleHRyZWdpb246ZjdkZTkyNTFlNjE5NGQxZWI0YjdmNDU5NzA2NGJmOGZfMzMxMw_7d9774a8-049d-4177-a009-6757948611ef"><ix:nonFraction unitRef="number" contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RleHRyZWdpb246ZjdkZTkyNTFlNjE5NGQxZWI0YjdmNDU5NzA2NGJmOGZfMzMxMw_f54b8dff-077a-4cb9-8a32-a296fb298f2f">85</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> percent of the price at purchase and uses the purchase date to establish the fair market value. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use historical volatility to estimate the expected stock price volatility assumption for employee stock option awards. In reaching the conclusion, we have considered many factors including the extent to which our options are currently traded and our ability to find traded options in the current market with similar terms and prices to the options we are valuing. In estimating the expected life of our options granted we considered the historical option exercise behavior of our executives, which we believe is representative of future behavior.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of restricted stock units and LTPP (EPS) awards is determined based on the market price of our common stock on the date of grant adjusted for expected dividend yield. The compensation cost for LTPP (EPS) reflects the cost of awards that are probable to vest at the end of the performance period. </span></div></ix:continuation><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ibcfcaf24772c4407816c05a9a35eb6d8">All LTPP awards granted to our senior management employees have a one-year post-vest holding restriction. The estimated discount associated with post-vest holding restrictions is calculated using the Finnerty model. The model calculates the potential lost value if the employees were able to sell the shares during the lack of marketability period, instead of being required to hold the shares. The model used the same historical stock price volatility and dividend yield assumption used for the Monte Carlo simulation model and an expected dividend yield to compute the discount.</ix:continuation> </span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><div id="if825c91f15a047ec9e67e0189634a349_46"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AGILENT TECHNOLOGIES, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) - (Continued) </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80Ni9mcmFnOjdkNzVkNGEwY2Y4ZDQ4OTA5NDhlMzNjYzRkYzA0YWZkL3RleHRyZWdpb246N2Q3NWQ0YTBjZjhkNDg5MDk0OGUzM2NjNGRjMDRhZmRfMjI5NQ_2adeba7f-9f14-4d00-a8c3-a058fc9f0478" continuedAt="i01a50f6415d749fe8d2d917b69cdac44" escape="true">INCOME TAXES </ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i01a50f6415d749fe8d2d917b69cdac44"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended January&#160;31, 2022, our income tax expense was $<ix:nonFraction unitRef="usd" contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80Ni9mcmFnOjdkNzVkNGEwY2Y4ZDQ4OTA5NDhlMzNjYzRkYzA0YWZkL3RleHRyZWdpb246N2Q3NWQ0YTBjZjhkNDg5MDk0OGUzM2NjNGRjMDRhZmRfNzk_34003e00-94a2-4f43-8e54-dd68c1316ee4">36</ix:nonFraction> million with an effective tax rate of <ix:nonFraction unitRef="number" contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80Ni9mcmFnOjdkNzVkNGEwY2Y4ZDQ4OTA5NDhlMzNjYzRkYzA0YWZkL3RleHRyZWdpb246N2Q3NWQ0YTBjZjhkNDg5MDk0OGUzM2NjNGRjMDRhZmRfMTEy_048c569c-5e45-4642-a8bf-5a2bbbe37700">11.3</ix:nonFraction> percent. The income taxes for the three months ended January&#160;31, 2022 include the excess tax benefits from stock-based compensation of $<ix:nonFraction unitRef="usd" contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80Ni9mcmFnOjdkNzVkNGEwY2Y4ZDQ4OTA5NDhlMzNjYzRkYzA0YWZkL3RleHRyZWdpb246N2Q3NWQ0YTBjZjhkNDg5MDk0OGUzM2NjNGRjMDRhZmRfMTA5OTUxMTYzMTk2NA_a102e3f9-df5d-4ba4-aabb-bc97892c0ee2">16</ix:nonFraction>&#160;million. For the three months ended January&#160;31, 2022, our effective tax rate and the resulting provision for income taxes were also impacted by the expiration of various foreign statutes of limitations which resulted in the recognition of previously unrecognized tax benefits of $<ix:nonFraction unitRef="usd" contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80Ni9mcmFnOjdkNzVkNGEwY2Y4ZDQ4OTA5NDhlMzNjYzRkYzA0YWZkL3RleHRyZWdpb246N2Q3NWQ0YTBjZjhkNDg5MDk0OGUzM2NjNGRjMDRhZmRfMTA5OTUxMTYzMjE0OA_cdd7ddea-8836-43f3-9a7d-c331d95d6d05">8</ix:nonFraction>&#160;million.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our calculation of income tax expense for the&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">three</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> months ended </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">January&#160;31, 2022</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is dependent in part on forecasts of full year results. The impact of the COVID-19 outbreak on the economic environment is uncertain and may change these forecasts, which could impact tax expense.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended January&#160;31, 2021, our income tax expense was $<ix:nonFraction unitRef="usd" contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80Ni9mcmFnOjdkNzVkNGEwY2Y4ZDQ4OTA5NDhlMzNjYzRkYzA0YWZkL3RleHRyZWdpb246N2Q3NWQ0YTBjZjhkNDg5MDk0OGUzM2NjNGRjMDRhZmRfODgw_3848619f-dd8e-40cc-951e-5280fe5e7105">24</ix:nonFraction> million with an effective tax rate of <ix:nonFraction unitRef="number" contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80Ni9mcmFnOjdkNzVkNGEwY2Y4ZDQ4OTA5NDhlMzNjYzRkYzA0YWZkL3RleHRyZWdpb246N2Q3NWQ0YTBjZjhkNDg5MDk0OGUzM2NjNGRjMDRhZmRfOTEz_c1f60542-f43e-486d-9cd6-feec78d15b01">7.7</ix:nonFraction> percent. The income taxes for the three months ended January&#160;31, 2021 include the excess tax benefits from stock-based compensation of $<ix:nonFraction unitRef="usd" contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80Ni9mcmFnOjdkNzVkNGEwY2Y4ZDQ4OTA5NDhlMzNjYzRkYzA0YWZkL3RleHRyZWdpb246N2Q3NWQ0YTBjZjhkNDg5MDk0OGUzM2NjNGRjMDRhZmRfMTA5OTUxMTYzMTIwNw_189af7ad-2c3b-4d23-8840-e61af0cb6be6">20</ix:nonFraction>&#160;million. For the three months ended January&#160;31, 2021, our effective tax rate and the resulting provision for income taxes were also impacted by the expiration of various foreign statutes of limitations which resulted in the recognition of previously unrecognized tax benefits of $<ix:nonFraction unitRef="usd" contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80Ni9mcmFnOjdkNzVkNGEwY2Y4ZDQ4OTA5NDhlMzNjYzRkYzA0YWZkL3RleHRyZWdpb246N2Q3NWQ0YTBjZjhkNDg5MDk0OGUzM2NjNGRjMDRhZmRfMTA5OTUxMTYzMzE0Mw_3dcb175b-222d-4375-a49d-c6bec5c88be4"><ix:nonFraction unitRef="usd" contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80Ni9mcmFnOjdkNzVkNGEwY2Y4ZDQ4OTA5NDhlMzNjYzRkYzA0YWZkL3RleHRyZWdpb246N2Q3NWQ0YTBjZjhkNDg5MDk0OGUzM2NjNGRjMDRhZmRfMTA5OTUxMTYzMzE0Mw_c149b1a5-ac4b-4ff1-ab21-b772019439fe">16</ix:nonFraction></ix:nonFraction>&#160;million. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In the U.S., tax years remain open back to the year 2018 for federal income tax purposes and for significant states. In other major jurisdictions where the company conducts business, the tax years generally remain open back to the year 2012.  </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With these jurisdictions and the U.S., it is reasonably possible there could be significant changes to our unrecognized tax benefits in the next twelve months due to either the expiration of a statute of limitation or a tax audit settlement which will be partially offset by an anticipated tax liability related to unremitted foreign earnings, where applicable. Given the number of years and numerous matters that remain subject to examination in various tax jurisdictions, management is unable to estimate the range of possible changes to the balance of our unrecognized tax benefits.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="if825c91f15a047ec9e67e0189634a349_49"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.   <ix:nonNumeric contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80OS9mcmFnOmNlNGQyNjU5MTYxMTQ0MzRhMjIyYmZlMzIwNGY3NmYxL3RleHRyZWdpb246Y2U0ZDI2NTkxNjExNDQzNGEyMjJiZmUzMjA0Zjc2ZjFfMTUxMQ_49e19599-b216-48a7-b4d3-1ebf6df22f05" continuedAt="i3409e5907157468cafffb3fe7d17afde" escape="true">NET INCOME PER SHARE</ix:nonNumeric></span></div><ix:continuation id="i3409e5907157468cafffb3fe7d17afde" continuedAt="iec900eec1afa41efac76ab2b1237810c"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><ix:nonNumeric contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80OS9mcmFnOmNlNGQyNjU5MTYxMTQ0MzRhMjIyYmZlMzIwNGY3NmYxL3RleHRyZWdpb246Y2U0ZDI2NTkxNjExNDQzNGEyMjJiZmUzMjA0Zjc2ZjFfMTUxNw_bec6b21d-1c65-46c8-a137-cef9d0fad926" escape="true"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of the numerator and denominator of the basic and diluted net income per share computations for the periods presented below:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:80.625%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.674%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80OS9mcmFnOmNlNGQyNjU5MTYxMTQ0MzRhMjIyYmZlMzIwNGY3NmYxL3RhYmxlOmZjYjZlOWQ3ZTVmNTRhNmI5YzgxNDNjMDkwYWJjNzBmL3RhYmxlcmFuZ2U6ZmNiNmU5ZDdlNWY1NGE2YjljODE0M2MwOTBhYmM3MGZfNS0xLTEtMS0zMDExNA_0771d00e-0edf-4c70-a561-a8a9a771607e">283</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80OS9mcmFnOmNlNGQyNjU5MTYxMTQ0MzRhMjIyYmZlMzIwNGY3NmYxL3RhYmxlOmZjYjZlOWQ3ZTVmNTRhNmI5YzgxNDNjMDkwYWJjNzBmL3RhYmxlcmFuZ2U6ZmNiNmU5ZDdlNWY1NGE2YjljODE0M2MwOTBhYmM3MGZfNS0zLTEtMS0zMDExNA_1f6a4689-a841-4ec8-9c80-80df7e340164">288</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic weighted-average shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80OS9mcmFnOmNlNGQyNjU5MTYxMTQ0MzRhMjIyYmZlMzIwNGY3NmYxL3RhYmxlOmZjYjZlOWQ3ZTVmNTRhNmI5YzgxNDNjMDkwYWJjNzBmL3RhYmxlcmFuZ2U6ZmNiNmU5ZDdlNWY1NGE2YjljODE0M2MwOTBhYmM3MGZfNy0xLTEtMS0zMDExNA_718f6890-3f3e-4d90-9234-87afe5f8a1d9">301</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80OS9mcmFnOmNlNGQyNjU5MTYxMTQ0MzRhMjIyYmZlMzIwNGY3NmYxL3RhYmxlOmZjYjZlOWQ3ZTVmNTRhNmI5YzgxNDNjMDkwYWJjNzBmL3RhYmxlcmFuZ2U6ZmNiNmU5ZDdlNWY1NGE2YjljODE0M2MwOTBhYmM3MGZfNy0zLTEtMS0zMDExNA_92c5c1a3-171d-4c4a-9088-fc15b98ec1ec">306</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Potential common shares&#8212; stock&#160;options and other employee stock plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" decimals="-6" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80OS9mcmFnOmNlNGQyNjU5MTYxMTQ0MzRhMjIyYmZlMzIwNGY3NmYxL3RhYmxlOmZjYjZlOWQ3ZTVmNTRhNmI5YzgxNDNjMDkwYWJjNzBmL3RhYmxlcmFuZ2U6ZmNiNmU5ZDdlNWY1NGE2YjljODE0M2MwOTBhYmM3MGZfOC0xLTEtMS0zMDExNA_4fb65ab7-a965-46f3-be8c-4510dc7e8a1c">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131" decimals="-6" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80OS9mcmFnOmNlNGQyNjU5MTYxMTQ0MzRhMjIyYmZlMzIwNGY3NmYxL3RhYmxlOmZjYjZlOWQ3ZTVmNTRhNmI5YzgxNDNjMDkwYWJjNzBmL3RhYmxlcmFuZ2U6ZmNiNmU5ZDdlNWY1NGE2YjljODE0M2MwOTBhYmM3MGZfOC0zLTEtMS0zMDExNA_816eb8ec-1ba5-4351-a209-b09c5fdbe1d9">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted weighted-average shares</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80OS9mcmFnOmNlNGQyNjU5MTYxMTQ0MzRhMjIyYmZlMzIwNGY3NmYxL3RhYmxlOmZjYjZlOWQ3ZTVmNTRhNmI5YzgxNDNjMDkwYWJjNzBmL3RhYmxlcmFuZ2U6ZmNiNmU5ZDdlNWY1NGE2YjljODE0M2MwOTBhYmM3MGZfOS0xLTEtMS0zMDExNA_9f343369-0fa3-41fe-8333-c9dddf4d19c0">303</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80OS9mcmFnOmNlNGQyNjU5MTYxMTQ0MzRhMjIyYmZlMzIwNGY3NmYxL3RhYmxlOmZjYjZlOWQ3ZTVmNTRhNmI5YzgxNDNjMDkwYWJjNzBmL3RhYmxlcmFuZ2U6ZmNiNmU5ZDdlNWY1NGE2YjljODE0M2MwOTBhYmM3MGZfOS0zLTEtMS0zMDExNA_40a414b2-8626-48ab-9cb7-05df93a3ae59">309</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The dilutive effect of share-based awards is reflected in diluted net income per share by application of the treasury stock method, which includes consideration of unamortized share-based compensation expense and the dilutive effect of in-the-money options and non-vested restricted stock units. Under the treasury stock method, the amount the employee must pay for exercising stock options and unamortized share-based compensation expense collectively are assumed proceeds to be used to repurchase hypothetical shares. An increase in the fair market value of the company's common stock can result in a greater dilutive effect from potentially dilutive awards.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We exclude stock options with exercise prices greater than the average market price of our common stock from the calculation of diluted earnings per share because their effect would be anti-dilutive. In addition, we exclude from the calculation of diluted earnings per share stock options, ESPP, LTPP and restricted stock awards whose combined exercise price and unamortized fair value were greater than the average market price of our common stock because their effect would also be anti-dilutive. &#160; </span></div></ix:continuation><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AGILENT TECHNOLOGIES, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) - (Continued) </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="iec900eec1afa41efac76ab2b1237810c">For both the three months ended January&#160;31, 2022 and 2021, potential common shares excluded from the calculation of diluted earnings per share were <ix:nonFraction unitRef="shares" contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" decimals="-6" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80OS9mcmFnOmNlNGQyNjU5MTYxMTQ0MzRhMjIyYmZlMzIwNGY3NmYxL3RleHRyZWdpb246Y2U0ZDI2NTkxNjExNDQzNGEyMjJiZmUzMjA0Zjc2ZjFfMTQ5Mg_7dabcb1a-e863-420f-8fe7-238ae5dff046"><ix:nonFraction unitRef="shares" contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" decimals="-6" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80OS9mcmFnOmNlNGQyNjU5MTYxMTQ0MzRhMjIyYmZlMzIwNGY3NmYxL3RleHRyZWdpb246Y2U0ZDI2NTkxNjExNDQzNGEyMjJiZmUzMjA0Zjc2ZjFfMTQ5Mg_e55de7e2-c40c-49ff-8273-06eddc817762"><ix:nonFraction unitRef="shares" contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131" decimals="-6" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80OS9mcmFnOmNlNGQyNjU5MTYxMTQ0MzRhMjIyYmZlMzIwNGY3NmYxL3RleHRyZWdpb246Y2U0ZDI2NTkxNjExNDQzNGEyMjJiZmUzMjA0Zjc2ZjFfMTQ5Mg_f035c932-2bd7-4730-b72b-6d6cd9758db1"><ix:nonFraction unitRef="shares" contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131" decimals="-6" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80OS9mcmFnOmNlNGQyNjU5MTYxMTQ0MzRhMjIyYmZlMzIwNGY3NmYxL3RleHRyZWdpb246Y2U0ZDI2NTkxNjExNDQzNGEyMjJiZmUzMjA0Zjc2ZjFfMTQ5Mg_fbd9c8b7-5636-4666-a25b-9c14f2a1a899">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction>t material.</ix:continuation> </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div id="if825c91f15a047ec9e67e0189634a349_52"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.   <ix:nonNumeric contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" name="us-gaap:InventoryDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81Mi9mcmFnOmY2OTRkZWU4ZDg1OTQ0Yjk4MjdjZTk3NDM1NDg4NmUyL3RleHRyZWdpb246ZjY5NGRlZThkODU5NDRiOTgyN2NlOTc0MzU0ODg2ZTJfODY_2f4c5bc3-5386-4fed-95ce-767c1b8c7e50" continuedAt="i2a5296c221e84c829ed069903ccdb897" escape="true"><ix:nonNumeric contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81Mi9mcmFnOmY2OTRkZWU4ZDg1OTQ0Yjk4MjdjZTk3NDM1NDg4NmUyL3RleHRyZWdpb246ZjY5NGRlZThkODU5NDRiOTgyN2NlOTc0MzU0ODg2ZTJfODE_0bff8cec-087b-42a0-86ce-2f7be71d0e3a" continuedAt="i4b79bb82fa5546a5bdae9194961e052e" escape="true">INVENTORY</ix:nonNumeric></ix:nonNumeric></span></div><ix:continuation id="i2a5296c221e84c829ed069903ccdb897"><ix:continuation id="i4b79bb82fa5546a5bdae9194961e052e"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory as of January&#160;31, 2022 and October&#160;31, 2021 consisted of the following:</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:74.119%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.218%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 31,<br/>2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131" decimals="-6" name="us-gaap:InventoryFinishedGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81Mi9mcmFnOmY2OTRkZWU4ZDg1OTQ0Yjk4MjdjZTk3NDM1NDg4NmUyL3RhYmxlOmFkOWIwMTU3YjZjMjQ2OTlhYjI5YTJkM2IzMDhlNzA3L3RhYmxlcmFuZ2U6YWQ5YjAxNTdiNmMyNDY5OWFiMjlhMmQzYjMwOGU3MDdfMi0xLTEtMS0zMDExNA_e216c20f-70ce-44d0-a920-4b0174567e5f">488</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6390807210d74c6f9cae496ea2122a5a_I20211031" decimals="-6" name="us-gaap:InventoryFinishedGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81Mi9mcmFnOmY2OTRkZWU4ZDg1OTQ0Yjk4MjdjZTk3NDM1NDg4NmUyL3RhYmxlOmFkOWIwMTU3YjZjMjQ2OTlhYjI5YTJkM2IzMDhlNzA3L3RhYmxlcmFuZ2U6YWQ5YjAxNTdiNmMyNDY5OWFiMjlhMmQzYjMwOGU3MDdfMi0zLTEtMS0zMDExNA_2d98f8be-15b3-45ce-bae2-141814f6cc08">463</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchased parts and fabricated assemblies</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131" decimals="-6" name="us-gaap:InventoryWorkInProcessAndRawMaterials" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81Mi9mcmFnOmY2OTRkZWU4ZDg1OTQ0Yjk4MjdjZTk3NDM1NDg4NmUyL3RhYmxlOmFkOWIwMTU3YjZjMjQ2OTlhYjI5YTJkM2IzMDhlNzA3L3RhYmxlcmFuZ2U6YWQ5YjAxNTdiNmMyNDY5OWFiMjlhMmQzYjMwOGU3MDdfMy0xLTEtMS0zMDExNA_3133c77e-cfa7-481c-b06d-36612cd027e2">391</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6390807210d74c6f9cae496ea2122a5a_I20211031" decimals="-6" name="us-gaap:InventoryWorkInProcessAndRawMaterials" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81Mi9mcmFnOmY2OTRkZWU4ZDg1OTQ0Yjk4MjdjZTk3NDM1NDg4NmUyL3RhYmxlOmFkOWIwMTU3YjZjMjQ2OTlhYjI5YTJkM2IzMDhlNzA3L3RhYmxlcmFuZ2U6YWQ5YjAxNTdiNmMyNDY5OWFiMjlhMmQzYjMwOGU3MDdfMy0zLTEtMS0zMDExNA_49a97343-e54d-4efc-9b78-f708323dd5f0">367</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131" decimals="-6" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81Mi9mcmFnOmY2OTRkZWU4ZDg1OTQ0Yjk4MjdjZTk3NDM1NDg4NmUyL3RhYmxlOmFkOWIwMTU3YjZjMjQ2OTlhYjI5YTJkM2IzMDhlNzA3L3RhYmxlcmFuZ2U6YWQ5YjAxNTdiNmMyNDY5OWFiMjlhMmQzYjMwOGU3MDdfNC0xLTEtMS0zMDExNA_49e7a6ff-649d-4412-87c4-1dcbc8726bf8">879</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6390807210d74c6f9cae496ea2122a5a_I20211031" decimals="-6" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81Mi9mcmFnOmY2OTRkZWU4ZDg1OTQ0Yjk4MjdjZTk3NDM1NDg4NmUyL3RhYmxlOmFkOWIwMTU3YjZjMjQ2OTlhYjI5YTJkM2IzMDhlNzA3L3RhYmxlcmFuZ2U6YWQ5YjAxNTdiNmMyNDY5OWFiMjlhMmQzYjMwOGU3MDdfNC0zLTEtMS0zMDExNA_36846562-e59e-4d2a-9a0c-3885b2cf2f07">830</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation></ix:continuation><div><span><br/></span></div><div id="if825c91f15a047ec9e67e0189634a349_55"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.   <ix:nonNumeric contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RleHRyZWdpb246MjVlZWM3MzYwN2E2NDcxMzkzZDkyZWJlODZiZTQ4MWVfMzk2Mw_c2f4e130-21ec-426c-a00f-2b365a418093" continuedAt="ida55ff0b41644c1499c40bc77c81a747" escape="true">GOODWILL AND OTHER INTANGIBLE ASSETS</ix:nonNumeric></span></div><ix:continuation id="ida55ff0b41644c1499c40bc77c81a747" continuedAt="i2cb057bcf1964e91ba77520edee281f4"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><ix:nonNumeric contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" name="us-gaap:ScheduleOfGoodwillTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RleHRyZWdpb246MjVlZWM3MzYwN2E2NDcxMzkzZDkyZWJlODZiZTQ4MWVfMzk2OA_d6fbd39b-bc5c-4ff5-9b76-2de51b0a1533" escape="true"><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents goodwill balances and the movements for each of our reportable segments during the three months ended January&#160;31, 2022:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:50.512%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.457%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.070%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.632%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Life Sciences and Applied Markets</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Diagnostics and Genomics</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Agilent CrossLab</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill as of October 31, 2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i944f468c66a14978a1d1787de51efa6c_I20211031" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RhYmxlOmUzMzZhOGM1ZmVlZTQ4ZmZhOGJmZTA3Y2FjMDI3N2EwL3RhYmxlcmFuZ2U6ZTMzNmE4YzVmZWVlNDhmZmE4YmZlMDdjYWMwMjc3YTBfMi0xLTEtMS0zMDExNA_f7fb818c-98af-44bf-b5a1-fd8d012110fb">1,743</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2f7270de94a4e99a7412adaded44a2d_I20211031" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RhYmxlOmUzMzZhOGM1ZmVlZTQ4ZmZhOGJmZTA3Y2FjMDI3N2EwL3RhYmxlcmFuZ2U6ZTMzNmE4YzVmZWVlNDhmZmE4YmZlMDdjYWMwMjc3YTBfMi0zLTEtMS0zMDExNA_b23ce176-92dd-4753-a025-2aab8da8b5c8">1,964</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1434e5353934a0ebeb33b6c28613a50_I20211031" decimals="-6" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RhYmxlOmUzMzZhOGM1ZmVlZTQ4ZmZhOGJmZTA3Y2FjMDI3N2EwL3RhYmxlcmFuZ2U6ZTMzNmE4YzVmZWVlNDhmZmE4YmZlMDdjYWMwMjc3YTBfMi01LTEtMS0zMDExNA_b5451bac-398a-4696-a90f-5009c8582430">268</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6390807210d74c6f9cae496ea2122a5a_I20211031" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RhYmxlOmUzMzZhOGM1ZmVlZTQ4ZmZhOGJmZTA3Y2FjMDI3N2EwL3RhYmxlcmFuZ2U6ZTMzNmE4YzVmZWVlNDhmZmE4YmZlMDdjYWMwMjc3YTBfMi03LTEtMS0zMDExNA_b2149795-7e16-4abb-9f4d-b9271fa98d3e">3,975</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation impact</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6d58196320f34869a29143308907c47f_D20211101-20220131" decimals="-6" sign="-" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RhYmxlOmUzMzZhOGM1ZmVlZTQ4ZmZhOGJmZTA3Y2FjMDI3N2EwL3RhYmxlcmFuZ2U6ZTMzNmE4YzVmZWVlNDhmZmE4YmZlMDdjYWMwMjc3YTBfMy0xLTEtMS0zMDExNA_a5f6f5f2-15ea-4c0f-b445-3da7d4d9af76">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie43c9572619448f8a6ea6d852ea0af23_D20211101-20220131" decimals="-6" sign="-" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RhYmxlOmUzMzZhOGM1ZmVlZTQ4ZmZhOGJmZTA3Y2FjMDI3N2EwL3RhYmxlcmFuZ2U6ZTMzNmE4YzVmZWVlNDhmZmE4YmZlMDdjYWMwMjc3YTBfMy0zLTEtMS0zMDExNA_2ab69385-e3a4-4ede-945b-e1ae9d59cb22">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i30a463a582ff4b16971b766059a24eb9_D20211101-20220131" decimals="-6" sign="-" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RhYmxlOmUzMzZhOGM1ZmVlZTQ4ZmZhOGJmZTA3Y2FjMDI3N2EwL3RhYmxlcmFuZ2U6ZTMzNmE4YzVmZWVlNDhmZmE4YmZlMDdjYWMwMjc3YTBfMy01LTEtMS0zMDExNA_a5d4af9b-2576-4713-814a-4f8e63c3d23c">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" decimals="-6" sign="-" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RhYmxlOmUzMzZhOGM1ZmVlZTQ4ZmZhOGJmZTA3Y2FjMDI3N2EwL3RhYmxlcmFuZ2U6ZTMzNmE4YzVmZWVlNDhmZmE4YmZlMDdjYWMwMjc3YTBfMy03LTEtMS0zMDExNA_17fa533b-45fe-47b4-a746-d1047d486d46">11</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill as of January 31, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa12471462934aa683c02dac2a2b2a70_I20220131" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RhYmxlOmUzMzZhOGM1ZmVlZTQ4ZmZhOGJmZTA3Y2FjMDI3N2EwL3RhYmxlcmFuZ2U6ZTMzNmE4YzVmZWVlNDhmZmE4YmZlMDdjYWMwMjc3YTBfNS0xLTEtMS0zMDExNA_ca77aad4-231d-4188-8664-47c3359b5053">1,739</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idcc96fc9ea6041bab3a0329c8a379a8d_I20220131" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RhYmxlOmUzMzZhOGM1ZmVlZTQ4ZmZhOGJmZTA3Y2FjMDI3N2EwL3RhYmxlcmFuZ2U6ZTMzNmE4YzVmZWVlNDhmZmE4YmZlMDdjYWMwMjc3YTBfNS0zLTEtMS0zMDExNA_50b129e4-8821-4b91-bfea-cd9d397a7ae8">1,961</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia895e40152014164ae9414ff9f88a43e_I20220131" decimals="-6" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RhYmxlOmUzMzZhOGM1ZmVlZTQ4ZmZhOGJmZTA3Y2FjMDI3N2EwL3RhYmxlcmFuZ2U6ZTMzNmE4YzVmZWVlNDhmZmE4YmZlMDdjYWMwMjc3YTBfNS01LTEtMS0zMDExNA_7ae88ac3-26a9-4e6f-b3ef-c535d9d95f6d">264</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RhYmxlOmUzMzZhOGM1ZmVlZTQ4ZmZhOGJmZTA3Y2FjMDI3N2EwL3RhYmxlcmFuZ2U6ZTMzNmE4YzVmZWVlNDhmZmE4YmZlMDdjYWMwMjc3YTBfNS03LTEtMS0zMDExNA_d70c5a90-9f25-43c8-8d49-733f52ad23f5">3,964</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:5pt;text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="margin-top:5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of fiscal year 2022, we reorganized our operating segments and moved our chemistries and supplies business and our remarketed instruments business from our Agilent CrossLab business segment to our life sciences and applied markets business segment. As a result, we reassigned approximately $<ix:nonFraction unitRef="usd" contextRef="i6d58196320f34869a29143308907c47f_D20211101-20220131" decimals="-6" name="us-gaap:GoodwillTransfers" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RleHRyZWdpb246MjVlZWM3MzYwN2E2NDcxMzkzZDkyZWJlODZiZTQ4MWVfMTY0OTI2NzQ1NTc4OA_be607f7d-3d2b-477e-8e9a-cf6ecba48749">307</ix:nonFraction>&#160;million of goodwill from our Agilent Crosslab business segment to our life sciences and applied markets business segment using the relative fair value allocation approach. In addition, we moved service revenue and cost of sales related to the previous acquisition of BioTek from our life sciences and applied markets business segment to our Agilent CrossLab business segment. As a result, we reassigned approximately $<ix:nonFraction unitRef="usd" contextRef="i30a463a582ff4b16971b766059a24eb9_D20211101-20220131" decimals="-6" name="us-gaap:GoodwillTransfers" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RleHRyZWdpb246MjVlZWM3MzYwN2E2NDcxMzkzZDkyZWJlODZiZTQ4MWVfMTY0OTI2NzQ1NTgwMg_0053aead-58bb-41fa-a2e9-f240ce6c0609">10</ix:nonFraction>&#160;million of goodwill from our life sciences and applied markets segment to our Agilent Crosslab business segment using the relative fair value allocation approach. Goodwill balances as of October 31, 2021, have been recast to conform to this new presentation.  As a result of the reorganization there was no change to our reporting units. In addition, we performed a goodwill impairment test, and the results of the analysis indicated that the fair values for all three of our reporting units were in excess of their carrying values by substantial amounts; therefore, <ix:nonFraction unitRef="usd" contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RleHRyZWdpb246MjVlZWM3MzYwN2E2NDcxMzkzZDkyZWJlODZiZTQ4MWVfMTY0OTI2NzQ1NzAwMw_54018186-82af-4a55-bb90-16310526fdeb">no</ix:nonFraction> impairment was indicated. </span></div></ix:continuation><div style="margin-top:5pt;text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AGILENT TECHNOLOGIES, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) - (Continued) </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i2cb057bcf1964e91ba77520edee281f4"><ix:nonNumeric contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RleHRyZWdpb246MjVlZWM3MzYwN2E2NDcxMzkzZDkyZWJlODZiZTQ4MWVfMzk3MA_26271f1f-c270-4e23-8bd4-c488d6d3d382" escape="true"><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The component parts of other intangible assets as of January&#160;31, 2022 and October&#160;31, 2021 are shown in the table below:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other&#160;Intangible&#160;Assets</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net&#160;Book<br/>Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of October 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchased technology</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62b4b85a6eb042808ab856394d83600f_I20211031" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RhYmxlOmIwMGE5ZjQ4NWUxODQyOTI5ZTU3YzExNDVkZmU5MTBlL3RhYmxlcmFuZ2U6YjAwYTlmNDg1ZTE4NDI5MjllNTdjMTE0NWRmZTkxMGVfNC0xLTEtMS0zMDExNA_81c1b68c-c1ef-45b4-9ae8-0728a7fba567">1,742</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62b4b85a6eb042808ab856394d83600f_I20211031" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RhYmxlOmIwMGE5ZjQ4NWUxODQyOTI5ZTU3YzExNDVkZmU5MTBlL3RhYmxlcmFuZ2U6YjAwYTlmNDg1ZTE4NDI5MjllNTdjMTE0NWRmZTkxMGVfNC0zLTEtMS0zMDExNA_885bc207-ee46-4b92-a5c1-c46542c82288">972</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62b4b85a6eb042808ab856394d83600f_I20211031" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RhYmxlOmIwMGE5ZjQ4NWUxODQyOTI5ZTU3YzExNDVkZmU5MTBlL3RhYmxlcmFuZ2U6YjAwYTlmNDg1ZTE4NDI5MjllNTdjMTE0NWRmZTkxMGVfNC01LTEtMS0zMDExNA_79758531-a8b3-4884-99e9-763e3d91d602">770</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Backlog</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3e5ec69c4a64648a675263b06182b48_I20211031" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RhYmxlOmIwMGE5ZjQ4NWUxODQyOTI5ZTU3YzExNDVkZmU5MTBlL3RhYmxlcmFuZ2U6YjAwYTlmNDg1ZTE4NDI5MjllNTdjMTE0NWRmZTkxMGVfNS0xLTEtMS0zMDExNA_55e9954f-9e6f-4d55-bb4c-62d67d573ce5">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3e5ec69c4a64648a675263b06182b48_I20211031" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RhYmxlOmIwMGE5ZjQ4NWUxODQyOTI5ZTU3YzExNDVkZmU5MTBlL3RhYmxlcmFuZ2U6YjAwYTlmNDg1ZTE4NDI5MjllNTdjMTE0NWRmZTkxMGVfNS0zLTEtMS0zMDExNA_dcc0599a-7863-44e0-adfe-d4a9e45cf6ea">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3e5ec69c4a64648a675263b06182b48_I20211031" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RhYmxlOmIwMGE5ZjQ4NWUxODQyOTI5ZTU3YzExNDVkZmU5MTBlL3RhYmxlcmFuZ2U6YjAwYTlmNDg1ZTE4NDI5MjllNTdjMTE0NWRmZTkxMGVfNS01LTEtMS0zMDExNA_4c283109-d652-4f6e-8fa1-952c3adea65a">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademark/Tradename</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icca833cf758b4ec9adfaeb6e650d7c76_I20211031" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RhYmxlOmIwMGE5ZjQ4NWUxODQyOTI5ZTU3YzExNDVkZmU5MTBlL3RhYmxlcmFuZ2U6YjAwYTlmNDg1ZTE4NDI5MjllNTdjMTE0NWRmZTkxMGVfNi0xLTEtMS0zMDExNA_34658d00-1e05-4927-9a81-970aa1d67da3">196</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icca833cf758b4ec9adfaeb6e650d7c76_I20211031" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RhYmxlOmIwMGE5ZjQ4NWUxODQyOTI5ZTU3YzExNDVkZmU5MTBlL3RhYmxlcmFuZ2U6YjAwYTlmNDg1ZTE4NDI5MjllNTdjMTE0NWRmZTkxMGVfNi0zLTEtMS0zMDExNA_49edda36-b356-40af-b471-a8f60e01bb0e">133</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icca833cf758b4ec9adfaeb6e650d7c76_I20211031" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RhYmxlOmIwMGE5ZjQ4NWUxODQyOTI5ZTU3YzExNDVkZmU5MTBlL3RhYmxlcmFuZ2U6YjAwYTlmNDg1ZTE4NDI5MjllNTdjMTE0NWRmZTkxMGVfNi01LTEtMS0zMDExNA_876d0f07-ab7f-44d6-a05f-da06a14aba67">63</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice63f8e3b57a458885f621065c24dd64_I20211031" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RhYmxlOmIwMGE5ZjQ4NWUxODQyOTI5ZTU3YzExNDVkZmU5MTBlL3RhYmxlcmFuZ2U6YjAwYTlmNDg1ZTE4NDI5MjllNTdjMTE0NWRmZTkxMGVfNy0xLTEtMS0zMDExNA_2b1ad8c1-7958-4777-b3aa-d89e7503d0ec">357</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice63f8e3b57a458885f621065c24dd64_I20211031" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RhYmxlOmIwMGE5ZjQ4NWUxODQyOTI5ZTU3YzExNDVkZmU5MTBlL3RhYmxlcmFuZ2U6YjAwYTlmNDg1ZTE4NDI5MjllNTdjMTE0NWRmZTkxMGVfNy0zLTEtMS0zMDExNA_581aab48-c4ca-4e74-8f11-1ae884a37c19">228</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice63f8e3b57a458885f621065c24dd64_I20211031" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RhYmxlOmIwMGE5ZjQ4NWUxODQyOTI5ZTU3YzExNDVkZmU5MTBlL3RhYmxlcmFuZ2U6YjAwYTlmNDg1ZTE4NDI5MjllNTdjMTE0NWRmZTkxMGVfNy01LTEtMS0zMDExNA_112fb8fa-c666-42f1-a470-5ab27d9b2276">129</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Third-party technology and licenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05ef46e1fee74f6eb0ef89af56b45fa8_I20211031" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RhYmxlOmIwMGE5ZjQ4NWUxODQyOTI5ZTU3YzExNDVkZmU5MTBlL3RhYmxlcmFuZ2U6YjAwYTlmNDg1ZTE4NDI5MjllNTdjMTE0NWRmZTkxMGVfOC0xLTEtMS0zMDExNA_d1964ffc-6cfc-418d-bfc3-6d43163062e1">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05ef46e1fee74f6eb0ef89af56b45fa8_I20211031" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RhYmxlOmIwMGE5ZjQ4NWUxODQyOTI5ZTU3YzExNDVkZmU5MTBlL3RhYmxlcmFuZ2U6YjAwYTlmNDg1ZTE4NDI5MjllNTdjMTE0NWRmZTkxMGVfOC0zLTEtMS0zMDExNA_8e91ddc1-212a-4b98-b373-3d0bcc5eddd5">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05ef46e1fee74f6eb0ef89af56b45fa8_I20211031" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RhYmxlOmIwMGE5ZjQ4NWUxODQyOTI5ZTU3YzExNDVkZmU5MTBlL3RhYmxlcmFuZ2U6YjAwYTlmNDg1ZTE4NDI5MjllNTdjMTE0NWRmZTkxMGVfOC01LTEtMS0zMDExNA_39c5d9e3-4041-4f8c-8a97-654ee49f069b">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total amortizable intangible assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6390807210d74c6f9cae496ea2122a5a_I20211031" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RhYmxlOmIwMGE5ZjQ4NWUxODQyOTI5ZTU3YzExNDVkZmU5MTBlL3RhYmxlcmFuZ2U6YjAwYTlmNDg1ZTE4NDI5MjllNTdjMTE0NWRmZTkxMGVfOS0xLTEtMS0zMDExNA_a0b3333d-90e7-481b-afc1-0fe18709b7ed">2,314</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6390807210d74c6f9cae496ea2122a5a_I20211031" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RhYmxlOmIwMGE5ZjQ4NWUxODQyOTI5ZTU3YzExNDVkZmU5MTBlL3RhYmxlcmFuZ2U6YjAwYTlmNDg1ZTE4NDI5MjllNTdjMTE0NWRmZTkxMGVfOS0zLTEtMS0zMDExNA_351f65bd-50d5-438d-afb3-1484fccc956f">1,344</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6390807210d74c6f9cae496ea2122a5a_I20211031" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RhYmxlOmIwMGE5ZjQ4NWUxODQyOTI5ZTU3YzExNDVkZmU5MTBlL3RhYmxlcmFuZ2U6YjAwYTlmNDg1ZTE4NDI5MjllNTdjMTE0NWRmZTkxMGVfOS01LTEtMS0zMDExNA_42a97a7f-3b71-4e38-b8ba-57cbf6dbbacc">970</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-Process R&amp;D</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b9447a5f8df4edc80c1ead0839fe3f6_I20211031" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RhYmxlOmIwMGE5ZjQ4NWUxODQyOTI5ZTU3YzExNDVkZmU5MTBlL3RhYmxlcmFuZ2U6YjAwYTlmNDg1ZTE4NDI5MjllNTdjMTE0NWRmZTkxMGVfMTAtMS0xLTEtMzAxMTQ_bd83b30e-bb10-4bb1-a6e6-53b1d54a064f">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b9447a5f8df4edc80c1ead0839fe3f6_I20211031" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RhYmxlOmIwMGE5ZjQ4NWUxODQyOTI5ZTU3YzExNDVkZmU5MTBlL3RhYmxlcmFuZ2U6YjAwYTlmNDg1ZTE4NDI5MjllNTdjMTE0NWRmZTkxMGVfMTAtNS0xLTEtMzAxMTQ_65533a31-4d2d-4126-aa0e-030b69d83a15">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6390807210d74c6f9cae496ea2122a5a_I20211031" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RhYmxlOmIwMGE5ZjQ4NWUxODQyOTI5ZTU3YzExNDVkZmU5MTBlL3RhYmxlcmFuZ2U6YjAwYTlmNDg1ZTE4NDI5MjllNTdjMTE0NWRmZTkxMGVfMTEtMS0xLTEtMzAxMTQ_d0edb4a0-0839-4097-b640-5cdb63bb7685">2,325</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6390807210d74c6f9cae496ea2122a5a_I20211031" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RhYmxlOmIwMGE5ZjQ4NWUxODQyOTI5ZTU3YzExNDVkZmU5MTBlL3RhYmxlcmFuZ2U6YjAwYTlmNDg1ZTE4NDI5MjllNTdjMTE0NWRmZTkxMGVfMTEtMy0xLTEtMzAxMTQ_3175c92e-4664-474e-b4e2-5f7f2e4fc54b">1,344</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6390807210d74c6f9cae496ea2122a5a_I20211031" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RhYmxlOmIwMGE5ZjQ4NWUxODQyOTI5ZTU3YzExNDVkZmU5MTBlL3RhYmxlcmFuZ2U6YjAwYTlmNDg1ZTE4NDI5MjllNTdjMTE0NWRmZTkxMGVfMTEtNS0xLTEtMzAxMTQ_5883630d-fbc7-4203-8ae7-86f288ceda13">981</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of January 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchased technology</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i210ca0088a2d4da59dbd86d6befab37d_I20220131" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RhYmxlOmIwMGE5ZjQ4NWUxODQyOTI5ZTU3YzExNDVkZmU5MTBlL3RhYmxlcmFuZ2U6YjAwYTlmNDg1ZTE4NDI5MjllNTdjMTE0NWRmZTkxMGVfMTMtMS0xLTEtMzAxMTQ_29fdc986-5da0-43e8-9e16-d87bb9410c7e">1,738</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i210ca0088a2d4da59dbd86d6befab37d_I20220131" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RhYmxlOmIwMGE5ZjQ4NWUxODQyOTI5ZTU3YzExNDVkZmU5MTBlL3RhYmxlcmFuZ2U6YjAwYTlmNDg1ZTE4NDI5MjllNTdjMTE0NWRmZTkxMGVfMTMtMy0xLTEtMzAxMTQ_05c9f7db-022f-4c98-9a65-920b0de746bd">997</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i210ca0088a2d4da59dbd86d6befab37d_I20220131" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RhYmxlOmIwMGE5ZjQ4NWUxODQyOTI5ZTU3YzExNDVkZmU5MTBlL3RhYmxlcmFuZ2U6YjAwYTlmNDg1ZTE4NDI5MjllNTdjMTE0NWRmZTkxMGVfMTMtNS0xLTEtMzAxMTQ_ec60c5da-e753-46c6-8062-d29329e4a32b">741</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademark/Tradename</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6e2c0d55bcc4c6da40d65348178b171_I20220131" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RhYmxlOmIwMGE5ZjQ4NWUxODQyOTI5ZTU3YzExNDVkZmU5MTBlL3RhYmxlcmFuZ2U6YjAwYTlmNDg1ZTE4NDI5MjllNTdjMTE0NWRmZTkxMGVfMTQtMS0xLTEtMzAxMTQ_7b0ac11e-2912-49bb-817d-1e524ea36516">196</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6e2c0d55bcc4c6da40d65348178b171_I20220131" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RhYmxlOmIwMGE5ZjQ4NWUxODQyOTI5ZTU3YzExNDVkZmU5MTBlL3RhYmxlcmFuZ2U6YjAwYTlmNDg1ZTE4NDI5MjllNTdjMTE0NWRmZTkxMGVfMTQtMy0xLTEtMzAxMTQ_954f1452-111f-42e4-ae9a-e9ae79390bd0">137</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6e2c0d55bcc4c6da40d65348178b171_I20220131" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RhYmxlOmIwMGE5ZjQ4NWUxODQyOTI5ZTU3YzExNDVkZmU5MTBlL3RhYmxlcmFuZ2U6YjAwYTlmNDg1ZTE4NDI5MjllNTdjMTE0NWRmZTkxMGVfMTQtNS0xLTEtMzAxMTQ_20ceddf7-690e-41b3-a8ba-b7a3c0426860">59</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie65c749bc8fc42cd83d412fb98863517_I20220131" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RhYmxlOmIwMGE5ZjQ4NWUxODQyOTI5ZTU3YzExNDVkZmU5MTBlL3RhYmxlcmFuZ2U6YjAwYTlmNDg1ZTE4NDI5MjllNTdjMTE0NWRmZTkxMGVfMTUtMS0xLTEtMzAxMTQ_4f913c72-21f1-4269-a6d2-207a3531b595">355</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie65c749bc8fc42cd83d412fb98863517_I20220131" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RhYmxlOmIwMGE5ZjQ4NWUxODQyOTI5ZTU3YzExNDVkZmU5MTBlL3RhYmxlcmFuZ2U6YjAwYTlmNDg1ZTE4NDI5MjllNTdjMTE0NWRmZTkxMGVfMTUtMy0xLTEtMzAxMTQ_1175d52c-c54f-440d-9638-fd70a9d43544">244</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie65c749bc8fc42cd83d412fb98863517_I20220131" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RhYmxlOmIwMGE5ZjQ4NWUxODQyOTI5ZTU3YzExNDVkZmU5MTBlL3RhYmxlcmFuZ2U6YjAwYTlmNDg1ZTE4NDI5MjllNTdjMTE0NWRmZTkxMGVfMTUtNS0xLTEtMzAxMTQ_1a466709-a9db-4e65-8de0-e180b5d09038">111</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Backlog</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iacb3dbfe9a644ba4921bcd62e4831e5a_I20220131" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RhYmxlOmIwMGE5ZjQ4NWUxODQyOTI5ZTU3YzExNDVkZmU5MTBlL3RhYmxlcmFuZ2U6YjAwYTlmNDg1ZTE4NDI5MjllNTdjMTE0NWRmZTkxMGVfMTYtMS0xLTEtMzAxMTQ_2958029b-4186-4be3-96b1-803c85424c03">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iacb3dbfe9a644ba4921bcd62e4831e5a_I20220131" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RhYmxlOmIwMGE5ZjQ4NWUxODQyOTI5ZTU3YzExNDVkZmU5MTBlL3RhYmxlcmFuZ2U6YjAwYTlmNDg1ZTE4NDI5MjllNTdjMTE0NWRmZTkxMGVfMTYtMy0xLTEtMzAxMTQ_98ac11bd-a029-4224-8c51-c34294931439">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iacb3dbfe9a644ba4921bcd62e4831e5a_I20220131" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RhYmxlOmIwMGE5ZjQ4NWUxODQyOTI5ZTU3YzExNDVkZmU5MTBlL3RhYmxlcmFuZ2U6YjAwYTlmNDg1ZTE4NDI5MjllNTdjMTE0NWRmZTkxMGVfMTYtNS0xLTEtMzAxMTQ_202cdedf-94bc-4fd2-9d3f-d961d196af22">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Third-party technology and licenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i184afb63fb8e4731adf46510d25f3e7b_I20220131" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RhYmxlOmIwMGE5ZjQ4NWUxODQyOTI5ZTU3YzExNDVkZmU5MTBlL3RhYmxlcmFuZ2U6YjAwYTlmNDg1ZTE4NDI5MjllNTdjMTE0NWRmZTkxMGVfMTctMS0xLTEtMzAxMTQ_9d7359f2-c772-4dfe-9cb7-5213114d9daf">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i184afb63fb8e4731adf46510d25f3e7b_I20220131" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RhYmxlOmIwMGE5ZjQ4NWUxODQyOTI5ZTU3YzExNDVkZmU5MTBlL3RhYmxlcmFuZ2U6YjAwYTlmNDg1ZTE4NDI5MjllNTdjMTE0NWRmZTkxMGVfMTctMy0xLTEtMzAxMTQ_b849b28a-ea61-4e29-bdb0-90af9c97e018">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i184afb63fb8e4731adf46510d25f3e7b_I20220131" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RhYmxlOmIwMGE5ZjQ4NWUxODQyOTI5ZTU3YzExNDVkZmU5MTBlL3RhYmxlcmFuZ2U6YjAwYTlmNDg1ZTE4NDI5MjllNTdjMTE0NWRmZTkxMGVfMTctNS0xLTEtMzAxMTQ_91eccda6-5a51-40f8-a1b5-e21e0b56ff50">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total amortizable intangible assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RhYmxlOmIwMGE5ZjQ4NWUxODQyOTI5ZTU3YzExNDVkZmU5MTBlL3RhYmxlcmFuZ2U6YjAwYTlmNDg1ZTE4NDI5MjllNTdjMTE0NWRmZTkxMGVfMTgtMS0xLTEtMzAxMTQ_760ba595-94a7-45d9-9eb3-4bfbb5ede3bc">2,308</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RhYmxlOmIwMGE5ZjQ4NWUxODQyOTI5ZTU3YzExNDVkZmU5MTBlL3RhYmxlcmFuZ2U6YjAwYTlmNDg1ZTE4NDI5MjllNTdjMTE0NWRmZTkxMGVfMTgtMy0xLTEtMzAxMTQ_6bc60d74-c1f2-4284-b8dd-261bd5bfc21d">1,390</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RhYmxlOmIwMGE5ZjQ4NWUxODQyOTI5ZTU3YzExNDVkZmU5MTBlL3RhYmxlcmFuZ2U6YjAwYTlmNDg1ZTE4NDI5MjllNTdjMTE0NWRmZTkxMGVfMTgtNS0xLTEtMzAxMTQ_ffd3fae2-ce3d-4590-b97d-be486f03e8b7">918</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-Process R&amp;D</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i984d425948d34baea35894f126c09e37_I20220131" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RhYmxlOmIwMGE5ZjQ4NWUxODQyOTI5ZTU3YzExNDVkZmU5MTBlL3RhYmxlcmFuZ2U6YjAwYTlmNDg1ZTE4NDI5MjllNTdjMTE0NWRmZTkxMGVfMTktMS0xLTEtMzAxMTQ_d6bc5475-631c-43b4-b60c-8aa4a1c530d0">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i984d425948d34baea35894f126c09e37_I20220131" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RhYmxlOmIwMGE5ZjQ4NWUxODQyOTI5ZTU3YzExNDVkZmU5MTBlL3RhYmxlcmFuZ2U6YjAwYTlmNDg1ZTE4NDI5MjllNTdjMTE0NWRmZTkxMGVfMTktNS0xLTEtMzAxMTQ_a56c3332-63e5-4bb0-8900-45195f14c32b">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RhYmxlOmIwMGE5ZjQ4NWUxODQyOTI5ZTU3YzExNDVkZmU5MTBlL3RhYmxlcmFuZ2U6YjAwYTlmNDg1ZTE4NDI5MjllNTdjMTE0NWRmZTkxMGVfMjAtMS0xLTEtMzAxMTQ_93a7b309-55e6-4749-888c-e409ab3b6e0c">2,319</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RhYmxlOmIwMGE5ZjQ4NWUxODQyOTI5ZTU3YzExNDVkZmU5MTBlL3RhYmxlcmFuZ2U6YjAwYTlmNDg1ZTE4NDI5MjllNTdjMTE0NWRmZTkxMGVfMjAtMy0xLTEtMzAxMTQ_c3c1bbe3-56de-4663-aaea-697b898cd665">1,390</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RhYmxlOmIwMGE5ZjQ4NWUxODQyOTI5ZTU3YzExNDVkZmU5MTBlL3RhYmxlcmFuZ2U6YjAwYTlmNDg1ZTE4NDI5MjllNTdjMTE0NWRmZTkxMGVfMjAtNS0xLTEtMzAxMTQ_b37af0e9-a105-4d69-b88c-18e82469d07a">929</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended January&#160;31, 2022, there were <ix:nonFraction unitRef="usd" contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RleHRyZWdpb246MjVlZWM3MzYwN2E2NDcxMzkzZDkyZWJlODZiZTQ4MWVfMTg1MQ_51158fbb-44c1-4e1f-8600-579f886a28ff"><ix:nonFraction unitRef="usd" contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsPeriodIncreaseDecrease" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RleHRyZWdpb246MjVlZWM3MzYwN2E2NDcxMzkzZDkyZWJlODZiZTQ4MWVfMTg1MQ_c8828290-b74f-4436-bd59-5c18c78adca2">no</ix:nonFraction></ix:nonFraction> additions to goodwill or other intangible assets.  During the three months ended January&#160;31, 2022, other intangible assets in total decreased $<ix:nonFraction unitRef="usd" contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" decimals="-6" sign="-" name="us-gaap:FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RleHRyZWdpb246MjVlZWM3MzYwN2E2NDcxMzkzZDkyZWJlODZiZTQ4MWVfMjY2Ng_63f11eae-9324-4553-9613-f5730438eb39">1</ix:nonFraction> million due to the impact of foreign currency translation. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In general, for U.S. federal tax purposes, goodwill from asset purchases is deductible; however, any goodwill created as part of a stock acquisition is not deductible.&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each quarter we review the events and circumstances to determine if impairment of indefinite-lived intangible assets and goodwill is indicated. During the three months ended January&#160;31, 2022 and 2021 we did <ix:nonFraction unitRef="usd" contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RleHRyZWdpb246MjVlZWM3MzYwN2E2NDcxMzkzZDkyZWJlODZiZTQ4MWVfMzA4MA_2d3535ab-8f19-4af8-8178-c1732e0da9b6"><ix:nonFraction unitRef="usd" contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131" decimals="-6" name="us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RleHRyZWdpb246MjVlZWM3MzYwN2E2NDcxMzkzZDkyZWJlODZiZTQ4MWVfMzA4MA_30b88f1f-9907-4561-b0b0-243378c71618"><ix:nonFraction unitRef="usd" contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131" decimals="-6" name="us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RleHRyZWdpb246MjVlZWM3MzYwN2E2NDcxMzkzZDkyZWJlODZiZTQ4MWVfMzA4MA_6653d8a5-6a8a-40ef-b20d-d2d9f2c3bdcd"><ix:nonFraction unitRef="usd" contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RleHRyZWdpb246MjVlZWM3MzYwN2E2NDcxMzkzZDkyZWJlODZiZTQ4MWVfMzA4MA_66e9c883-efcb-4ac2-a9fe-477522731ef9"><ix:nonFraction unitRef="usd" contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RleHRyZWdpb246MjVlZWM3MzYwN2E2NDcxMzkzZDkyZWJlODZiZTQ4MWVfMzA4MA_ab112c9e-63bb-42a2-918c-647c9a48c373"><ix:nonFraction unitRef="usd" contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" decimals="-6" name="us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RleHRyZWdpb246MjVlZWM3MzYwN2E2NDcxMzkzZDkyZWJlODZiZTQ4MWVfMzA4MA_c249eb3b-4ba2-453d-a501-4547dc057e41"><ix:nonFraction unitRef="usd" contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" decimals="-6" name="us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RleHRyZWdpb246MjVlZWM3MzYwN2E2NDcxMzkzZDkyZWJlODZiZTQ4MWVfMzA4MA_d674737b-cee6-4924-90bf-e2909bd15b2e"><ix:nonFraction unitRef="usd" contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RleHRyZWdpb246MjVlZWM3MzYwN2E2NDcxMzkzZDkyZWJlODZiZTQ4MWVfMzA4MA_d8237981-8303-4f77-a9bc-40235d499272">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction>t identify any triggering events or circumstances, including impacts due to COVID-19, which would indicate an impairment of goodwill or indefinite-lived intangible assets. </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense of intangible assets was $<ix:nonFraction unitRef="usd" contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RleHRyZWdpb246MjVlZWM3MzYwN2E2NDcxMzkzZDkyZWJlODZiZTQ4MWVfMzU5OA_e5ab1335-04ab-4595-8e41-33de4c8db2de">51</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RleHRyZWdpb246MjVlZWM3MzYwN2E2NDcxMzkzZDkyZWJlODZiZTQ4MWVfMTA5OTUxMTY0MjczOQ_7cc183ea-8409-4486-8e1f-166d12697467">45</ix:nonFraction> million for the three months ended January&#160;31, 2022 and 2021, respectively. </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><ix:nonNumeric contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" name="us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RleHRyZWdpb246MjVlZWM3MzYwN2E2NDcxMzkzZDkyZWJlODZiZTQ4MWVfMzk2MA_9218b424-cb6d-4e1f-865c-8046919cd14e" escape="true"><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future amortization expense related to existing finite-lived purchased intangible assets for the remainder of fiscal year 2022 and for each of the next five fiscal years and thereafter is estimated below:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:90.859%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.941%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Estimated future amortization expense:</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of 2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RhYmxlOmQ5NTMxZDliZjFjYjRlMWM4ZWY0M2NkNWI1YmM5NGNhL3RhYmxlcmFuZ2U6ZDk1MzFkOWJmMWNiNGUxYzhlZjQzY2Q1YjViYzk0Y2FfMi0xLTEtMS0zMDExNA_888ff558-ae49-41ff-8fb0-415c3ff761b5">141</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RhYmxlOmQ5NTMxZDliZjFjYjRlMWM4ZWY0M2NkNWI1YmM5NGNhL3RhYmxlcmFuZ2U6ZDk1MzFkOWJmMWNiNGUxYzhlZjQzY2Q1YjViYzk0Y2FfMy0xLTEtMS0zMDExNA_f66bced1-46cb-4b92-af06-1d767a67407b">141</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RhYmxlOmQ5NTMxZDliZjFjYjRlMWM4ZWY0M2NkNWI1YmM5NGNhL3RhYmxlcmFuZ2U6ZDk1MzFkOWJmMWNiNGUxYzhlZjQzY2Q1YjViYzk0Y2FfNC0xLTEtMS0zMDExNA_57f53e56-e639-4520-9530-88bc33268bac">121</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RhYmxlOmQ5NTMxZDliZjFjYjRlMWM4ZWY0M2NkNWI1YmM5NGNhL3RhYmxlcmFuZ2U6ZDk1MzFkOWJmMWNiNGUxYzhlZjQzY2Q1YjViYzk0Y2FfNS0xLTEtMS0zMDExNA_2670e127-f726-49db-9610-2ca84f46dd80">96</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RhYmxlOmQ5NTMxZDliZjFjYjRlMWM4ZWY0M2NkNWI1YmM5NGNhL3RhYmxlcmFuZ2U6ZDk1MzFkOWJmMWNiNGUxYzhlZjQzY2Q1YjViYzk0Y2FfNi0xLTEtMS0zMDExNA_d78f185e-8b91-49ee-b950-7c423688fde5">66</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RhYmxlOmQ5NTMxZDliZjFjYjRlMWM4ZWY0M2NkNWI1YmM5NGNhL3RhYmxlcmFuZ2U6ZDk1MzFkOWJmMWNiNGUxYzhlZjQzY2Q1YjViYzk0Y2FfNy0xLTEtMS0zMDExNA_ecb598fc-f8b8-46db-a9d3-eca68a6ed223">65</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RhYmxlOmQ5NTMxZDliZjFjYjRlMWM4ZWY0M2NkNWI1YmM5NGNhL3RhYmxlcmFuZ2U6ZDk1MzFkOWJmMWNiNGUxYzhlZjQzY2Q1YjViYzk0Y2FfOC0xLTEtMS0zMDExNA_82124a9d-7111-4e43-9fa1-4ebab76e06e9">288</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><div id="if825c91f15a047ec9e67e0189634a349_58"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AGILENT TECHNOLOGIES, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) - (Continued) </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.   <ix:nonNumeric contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RleHRyZWdpb246NGFjODFlMzQ2MGVjNGFiMTg4NmZkZTE5MzdlNjEzZmVfNzg3Ng_ab009dfc-47c2-414c-9478-f63fde6e3d1f" continuedAt="if43a004279c7406bbb72acbd660d4bbd" escape="true">FAIR VALUE MEASUREMENTS</ix:nonNumeric></span></div><ix:continuation id="if43a004279c7406bbb72acbd660d4bbd" continuedAt="ica418d3508d4423f8b9eb890647ea480"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The authoritative guidance defines fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities required or permitted to be recorded at fair value, we consider the principal or most advantageous market and assumptions that market participants would use when pricing the asset or liability.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value Hierarchy</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The guidance establishes a fair value hierarchy that prioritizes the use of inputs used in valuation techniques into three levels. A financial instrument&#8217;s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. There are three levels of inputs that may be used to measure fair value:</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Level 1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Level 2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- applies to assets or liabilities for which there are inputs other than quoted prices included within level 1 that are observable, either directly or indirectly, for the asset or liability such as: quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in less active markets; or other inputs that can be derived principally from, or corroborated by, observable market data.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Level 3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- applies to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities.</span></div></ix:continuation><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AGILENT TECHNOLOGIES, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) - (Continued) </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="ica418d3508d4423f8b9eb890647ea480" continuedAt="i2ff2c2a7e3904448a7b518c609d9b074"><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><ix:nonNumeric contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RleHRyZWdpb246NGFjODFlMzQ2MGVjNGFiMTg4NmZkZTE5MzdlNjEzZmVfNzg4Ng_ff13ca47-9519-4ec4-9c84-123189be143b" escape="true"><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial assets and liabilities measured at fair value on a recurring basis as of January&#160;31, 2022 were as follows:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.584%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.186%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurement at January 31, 2022 Using</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted&#160;Prices</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">in&#160;Active</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Markets&#160;for</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Identical&#160;Assets</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Level&#160;1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Observable</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Inputs</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Level&#160;2)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unobservable</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Inputs</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Level&#160;3)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents (money market funds)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife0901356f05422493cedbc99aaae757_I20220131" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOmIzZjgxOTEzMDNiMjQzNGZhYzhjYmEyZGUxNzkyYmZkL3RhYmxlcmFuZ2U6YjNmODE5MTMwM2IyNDM0ZmFjOGNiYTJkZTE3OTJiZmRfNS0xLTEtMS0zMDExNA_5152b9cd-6b19-47aa-b203-97962d343b57">465</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2071cdd246ee432b9ba0ffbd965b049b_I20220131" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOmIzZjgxOTEzMDNiMjQzNGZhYzhjYmEyZGUxNzkyYmZkL3RhYmxlcmFuZ2U6YjNmODE5MTMwM2IyNDM0ZmFjOGNiYTJkZTE3OTJiZmRfNS0zLTEtMS0zMDExNA_12ff6150-3325-462e-9fa1-17e552e84bdf">465</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ac569d010c5484d81397da751f5a61d_I20220131" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOmIzZjgxOTEzMDNiMjQzNGZhYzhjYmEyZGUxNzkyYmZkL3RhYmxlcmFuZ2U6YjNmODE5MTMwM2IyNDM0ZmFjOGNiYTJkZTE3OTJiZmRfNS01LTEtMS0zMDExNA_6867bd51-ebfe-4adf-a7b9-1cb6d6c0536d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9bf63f60c78455792ba1de12fa4a127_I20220131" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOmIzZjgxOTEzMDNiMjQzNGZhYzhjYmEyZGUxNzkyYmZkL3RhYmxlcmFuZ2U6YjNmODE5MTMwM2IyNDM0ZmFjOGNiYTJkZTE3OTJiZmRfNS03LTEtMS0zMDExNA_7d237e21-16bc-48ff-9f4a-cf2e5abe138a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative instruments (foreign exchange contracts)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife0901356f05422493cedbc99aaae757_I20220131" decimals="-6" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOmIzZjgxOTEzMDNiMjQzNGZhYzhjYmEyZGUxNzkyYmZkL3RhYmxlcmFuZ2U6YjNmODE5MTMwM2IyNDM0ZmFjOGNiYTJkZTE3OTJiZmRfNi0xLTEtMS0zMDExNA_823a73ba-3b10-4bd6-acb0-3966f26f4f0e">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2071cdd246ee432b9ba0ffbd965b049b_I20220131" decimals="-6" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOmIzZjgxOTEzMDNiMjQzNGZhYzhjYmEyZGUxNzkyYmZkL3RhYmxlcmFuZ2U6YjNmODE5MTMwM2IyNDM0ZmFjOGNiYTJkZTE3OTJiZmRfNi0zLTEtMS0zMDExNA_4b4b2027-8a27-48f0-aeb2-49306c951230">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ac569d010c5484d81397da751f5a61d_I20220131" decimals="-6" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOmIzZjgxOTEzMDNiMjQzNGZhYzhjYmEyZGUxNzkyYmZkL3RhYmxlcmFuZ2U6YjNmODE5MTMwM2IyNDM0ZmFjOGNiYTJkZTE3OTJiZmRfNi01LTEtMS0zMDExNA_e02642e4-9def-4c29-b5d6-8d37e095ca47">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9bf63f60c78455792ba1de12fa4a127_I20220131" decimals="-6" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOmIzZjgxOTEzMDNiMjQzNGZhYzhjYmEyZGUxNzkyYmZkL3RhYmxlcmFuZ2U6YjNmODE5MTMwM2IyNDM0ZmFjOGNiYTJkZTE3OTJiZmRfNi03LTEtMS0zMDExNA_dea76f10-702e-4379-b8c4-9c48da5d6f40">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments - Equity securities with RDFV</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife0901356f05422493cedbc99aaae757_I20220131" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOmIzZjgxOTEzMDNiMjQzNGZhYzhjYmEyZGUxNzkyYmZkL3RhYmxlcmFuZ2U6YjNmODE5MTMwM2IyNDM0ZmFjOGNiYTJkZTE3OTJiZmRfNy0xLTEtMS00ODAxMA_eeb0a724-7dde-452e-a8ab-f69553018dcd">45</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2071cdd246ee432b9ba0ffbd965b049b_I20220131" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOmIzZjgxOTEzMDNiMjQzNGZhYzhjYmEyZGUxNzkyYmZkL3RhYmxlcmFuZ2U6YjNmODE5MTMwM2IyNDM0ZmFjOGNiYTJkZTE3OTJiZmRfNy0zLTEtMS00ODAxMA_d6c9caf8-c33f-46d8-a2e1-2c61d257e6a4">40</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ac569d010c5484d81397da751f5a61d_I20220131" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOmIzZjgxOTEzMDNiMjQzNGZhYzhjYmEyZGUxNzkyYmZkL3RhYmxlcmFuZ2U6YjNmODE5MTMwM2IyNDM0ZmFjOGNiYTJkZTE3OTJiZmRfNy01LTEtMS00ODAxMA_588cb99a-0384-4d5d-8fed-77c52813fca0">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9bf63f60c78455792ba1de12fa4a127_I20220131" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOmIzZjgxOTEzMDNiMjQzNGZhYzhjYmEyZGUxNzkyYmZkL3RhYmxlcmFuZ2U6YjNmODE5MTMwM2IyNDM0ZmFjOGNiYTJkZTE3OTJiZmRfNy03LTEtMS00OTg0MQ_058bb9db-5e0f-4418-a421-fc4272562718">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trading securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5392f611be5496a9be81fc8bdf7afcc_I20220131" decimals="-6" name="us-gaap:TradingSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOmIzZjgxOTEzMDNiMjQzNGZhYzhjYmEyZGUxNzkyYmZkL3RhYmxlcmFuZ2U6YjNmODE5MTMwM2IyNDM0ZmFjOGNiYTJkZTE3OTJiZmRfOC0xLTEtMS0zMDExNA_93908400-3030-4bbb-993a-09da6e317f3d">37</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf52874ae50c45a8a6ec86f9bab6ff9c_I20220131" decimals="-6" name="us-gaap:TradingSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOmIzZjgxOTEzMDNiMjQzNGZhYzhjYmEyZGUxNzkyYmZkL3RhYmxlcmFuZ2U6YjNmODE5MTMwM2IyNDM0ZmFjOGNiYTJkZTE3OTJiZmRfOC0zLTEtMS0zMDExNA_b407cc67-f156-43b0-84da-9b271905c4b2">37</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbcff4391c4341629230e4c9ce6b165c_I20220131" decimals="-6" name="us-gaap:TradingSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOmIzZjgxOTEzMDNiMjQzNGZhYzhjYmEyZGUxNzkyYmZkL3RhYmxlcmFuZ2U6YjNmODE5MTMwM2IyNDM0ZmFjOGNiYTJkZTE3OTJiZmRfOC01LTEtMS0zMDExNA_a6f2976d-f56b-4c38-841c-bbeabd0086bc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94ff2c672a7b4ed9aee4690b84b849d7_I20220131" decimals="-6" name="us-gaap:TradingSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOmIzZjgxOTEzMDNiMjQzNGZhYzhjYmEyZGUxNzkyYmZkL3RhYmxlcmFuZ2U6YjNmODE5MTMwM2IyNDM0ZmFjOGNiYTJkZTE3OTJiZmRfOC03LTEtMS0zMDExNA_ff70ff1a-c925-4c3a-b23c-1857d65c0922">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5392f611be5496a9be81fc8bdf7afcc_I20220131" decimals="-6" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOmIzZjgxOTEzMDNiMjQzNGZhYzhjYmEyZGUxNzkyYmZkL3RhYmxlcmFuZ2U6YjNmODE5MTMwM2IyNDM0ZmFjOGNiYTJkZTE3OTJiZmRfOS0xLTEtMS0zMDExNA_dcb15eb9-5d82-45aa-adcd-6bc42c8c59c0">29</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf52874ae50c45a8a6ec86f9bab6ff9c_I20220131" decimals="-6" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOmIzZjgxOTEzMDNiMjQzNGZhYzhjYmEyZGUxNzkyYmZkL3RhYmxlcmFuZ2U6YjNmODE5MTMwM2IyNDM0ZmFjOGNiYTJkZTE3OTJiZmRfOS0zLTEtMS0zMDExNA_7c06f830-f7fb-437c-99a3-7547884784ad">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbcff4391c4341629230e4c9ce6b165c_I20220131" decimals="-6" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOmIzZjgxOTEzMDNiMjQzNGZhYzhjYmEyZGUxNzkyYmZkL3RhYmxlcmFuZ2U6YjNmODE5MTMwM2IyNDM0ZmFjOGNiYTJkZTE3OTJiZmRfOS01LTEtMS0zMDExNA_7bb394a2-b4f4-46ef-9428-1a4f48b91c01">29</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94ff2c672a7b4ed9aee4690b84b849d7_I20220131" decimals="-6" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOmIzZjgxOTEzMDNiMjQzNGZhYzhjYmEyZGUxNzkyYmZkL3RhYmxlcmFuZ2U6YjNmODE5MTMwM2IyNDM0ZmFjOGNiYTJkZTE3OTJiZmRfOS03LTEtMS0zMDExNA_2d013392-04ea-410f-9433-5b9b06bc6bca">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets measured at fair value</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33fe9961080d4147aae99b460ab50ecb_I20220131" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOmIzZjgxOTEzMDNiMjQzNGZhYzhjYmEyZGUxNzkyYmZkL3RhYmxlcmFuZ2U6YjNmODE5MTMwM2IyNDM0ZmFjOGNiYTJkZTE3OTJiZmRfMTEtMS0xLTEtMzAxMTQ_b07ee9a5-99fc-4270-b478-14defd5eaab8">592</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7c916269c054d37a6d9689d02baa352_I20220131" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOmIzZjgxOTEzMDNiMjQzNGZhYzhjYmEyZGUxNzkyYmZkL3RhYmxlcmFuZ2U6YjNmODE5MTMwM2IyNDM0ZmFjOGNiYTJkZTE3OTJiZmRfMTEtMy0xLTEtMzAxMTQ_c3ed93bc-b6d1-4658-b359-be1dbf09b686">542</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31669f2cab12460b9f221115aa18666e_I20220131" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOmIzZjgxOTEzMDNiMjQzNGZhYzhjYmEyZGUxNzkyYmZkL3RhYmxlcmFuZ2U6YjNmODE5MTMwM2IyNDM0ZmFjOGNiYTJkZTE3OTJiZmRfMTEtNS0xLTEtMzAxMTQ_3b2fa43e-9aa3-4e7b-b393-385f52d8c01f">50</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fa89a7423444291b6668e498df2d2d9_I20220131" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOmIzZjgxOTEzMDNiMjQzNGZhYzhjYmEyZGUxNzkyYmZkL3RhYmxlcmFuZ2U6YjNmODE5MTMwM2IyNDM0ZmFjOGNiYTJkZTE3OTJiZmRfMTEtNy0xLTEtMzAxMTQ_a9dea623-830b-4b8c-a40b-1d539d19ae22">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative instruments (foreign exchange contracts) </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84e4835292ec4d75be7d497aef9738bf_I20220131" decimals="-6" name="us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOmIzZjgxOTEzMDNiMjQzNGZhYzhjYmEyZGUxNzkyYmZkL3RhYmxlcmFuZ2U6YjNmODE5MTMwM2IyNDM0ZmFjOGNiYTJkZTE3OTJiZmRfMTQtMS0xLTEtMzAxMTQ_2c5ae65a-e84d-4086-a482-86752babb500">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id2a2d84dda324165b0e39abf1e0999ee_I20220131" decimals="-6" name="us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOmIzZjgxOTEzMDNiMjQzNGZhYzhjYmEyZGUxNzkyYmZkL3RhYmxlcmFuZ2U6YjNmODE5MTMwM2IyNDM0ZmFjOGNiYTJkZTE3OTJiZmRfMTQtMy0xLTEtMzAxMTQ_8b324940-1607-4dbf-9b5f-77f92315c764">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c9abff20f8e48ec8631ac63a1274d21_I20220131" decimals="-6" name="us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOmIzZjgxOTEzMDNiMjQzNGZhYzhjYmEyZGUxNzkyYmZkL3RhYmxlcmFuZ2U6YjNmODE5MTMwM2IyNDM0ZmFjOGNiYTJkZTE3OTJiZmRfMTQtNS0xLTEtMzAxMTQ_9142a80a-5634-4da9-935b-c379b0e0889c">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b18bec55ca844fd9f7f27fe6c7b883b_I20220131" decimals="-6" name="us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOmIzZjgxOTEzMDNiMjQzNGZhYzhjYmEyZGUxNzkyYmZkL3RhYmxlcmFuZ2U6YjNmODE5MTMwM2IyNDM0ZmFjOGNiYTJkZTE3OTJiZmRfMTQtNy0xLTEtMzAxMTQ_1764991f-c79f-4fb4-a7d2-1cff0d74750c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84e4835292ec4d75be7d497aef9738bf_I20220131" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOmIzZjgxOTEzMDNiMjQzNGZhYzhjYmEyZGUxNzkyYmZkL3RhYmxlcmFuZ2U6YjNmODE5MTMwM2IyNDM0ZmFjOGNiYTJkZTE3OTJiZmRfMTUtMS0xLTEtMzAxMTQ_75f8fbda-1608-4817-8d04-ca45bc20ba26">65</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id2a2d84dda324165b0e39abf1e0999ee_I20220131" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOmIzZjgxOTEzMDNiMjQzNGZhYzhjYmEyZGUxNzkyYmZkL3RhYmxlcmFuZ2U6YjNmODE5MTMwM2IyNDM0ZmFjOGNiYTJkZTE3OTJiZmRfMTUtMy0xLTEtMzAxMTQ_2e6f1693-8e27-458a-aa68-05ac98698ed2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c9abff20f8e48ec8631ac63a1274d21_I20220131" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOmIzZjgxOTEzMDNiMjQzNGZhYzhjYmEyZGUxNzkyYmZkL3RhYmxlcmFuZ2U6YjNmODE5MTMwM2IyNDM0ZmFjOGNiYTJkZTE3OTJiZmRfMTUtNS0xLTEtMzAxMTQ_ad96fdf3-dc03-4a75-8079-7f03f146be5b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e7130166b8246129cb9366c9e725c1d_I20220131" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOmIzZjgxOTEzMDNiMjQzNGZhYzhjYmEyZGUxNzkyYmZkL3RhYmxlcmFuZ2U6YjNmODE5MTMwM2IyNDM0ZmFjOGNiYTJkZTE3OTJiZmRfMTUtNy0xLTEtMzAxMTQ_1d0f2d6c-167e-4f24-b538-cd9c8dc5e21f">65</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6bfe36108f6442d88bb175e8a900971e_I20220131" decimals="-6" name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOmIzZjgxOTEzMDNiMjQzNGZhYzhjYmEyZGUxNzkyYmZkL3RhYmxlcmFuZ2U6YjNmODE5MTMwM2IyNDM0ZmFjOGNiYTJkZTE3OTJiZmRfMTctMS0xLTEtMzAxMTQ_e29c6b36-06db-45b1-9925-95720c6ddde9">37</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4d67bb87ecf49e9a34b390f9870efba_I20220131" decimals="-6" name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOmIzZjgxOTEzMDNiMjQzNGZhYzhjYmEyZGUxNzkyYmZkL3RhYmxlcmFuZ2U6YjNmODE5MTMwM2IyNDM0ZmFjOGNiYTJkZTE3OTJiZmRfMTctMy0xLTEtMzAxMTQ_58a2f469-f28d-4e7b-8e8c-ef6c7d0174a6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91b145cad93a40e6b17d080186760c04_I20220131" decimals="-6" name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOmIzZjgxOTEzMDNiMjQzNGZhYzhjYmEyZGUxNzkyYmZkL3RhYmxlcmFuZ2U6YjNmODE5MTMwM2IyNDM0ZmFjOGNiYTJkZTE3OTJiZmRfMTctNS0xLTEtMzAxMTQ_3d86c243-eb04-4e1a-8f9e-4146a4e2112e">37</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11e4f5ef79704e5dab3b21061086d8e2_I20220131" decimals="-6" name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOmIzZjgxOTEzMDNiMjQzNGZhYzhjYmEyZGUxNzkyYmZkL3RhYmxlcmFuZ2U6YjNmODE5MTMwM2IyNDM0ZmFjOGNiYTJkZTE3OTJiZmRfMTctNy0xLTEtMzAxMTQ_75281806-5911-4c69-a5e7-fb54e0061a68">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6bfe36108f6442d88bb175e8a900971e_I20220131" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOmIzZjgxOTEzMDNiMjQzNGZhYzhjYmEyZGUxNzkyYmZkL3RhYmxlcmFuZ2U6YjNmODE5MTMwM2IyNDM0ZmFjOGNiYTJkZTE3OTJiZmRfMTgtMS0xLTEtMzAxMTQ_945a7b2d-e9bd-4fff-ba4b-9ba348656036">27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4d67bb87ecf49e9a34b390f9870efba_I20220131" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOmIzZjgxOTEzMDNiMjQzNGZhYzhjYmEyZGUxNzkyYmZkL3RhYmxlcmFuZ2U6YjNmODE5MTMwM2IyNDM0ZmFjOGNiYTJkZTE3OTJiZmRfMTgtMy0xLTEtMzAxMTQ_17272854-b94f-432d-8a03-60f624e71073">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91b145cad93a40e6b17d080186760c04_I20220131" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOmIzZjgxOTEzMDNiMjQzNGZhYzhjYmEyZGUxNzkyYmZkL3RhYmxlcmFuZ2U6YjNmODE5MTMwM2IyNDM0ZmFjOGNiYTJkZTE3OTJiZmRfMTgtNS0xLTEtMzAxMTQ_4598cee3-d61a-4eba-a4d7-0e4a7f480eb0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7cd365418ea4001be8171374346f5d4_I20220131" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOmIzZjgxOTEzMDNiMjQzNGZhYzhjYmEyZGUxNzkyYmZkL3RhYmxlcmFuZ2U6YjNmODE5MTMwM2IyNDM0ZmFjOGNiYTJkZTE3OTJiZmRfMTgtNy0xLTEtMzAxMTQ_19837a79-b12f-4360-bf96-084cdf698201">27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities measured at fair value</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33fe9961080d4147aae99b460ab50ecb_I20220131" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOmIzZjgxOTEzMDNiMjQzNGZhYzhjYmEyZGUxNzkyYmZkL3RhYmxlcmFuZ2U6YjNmODE5MTMwM2IyNDM0ZmFjOGNiYTJkZTE3OTJiZmRfMTktMS0xLTEtMzAxMTQ_c5d7be6d-8d86-4917-adaf-01d66c7516ef">134</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7c916269c054d37a6d9689d02baa352_I20220131" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOmIzZjgxOTEzMDNiMjQzNGZhYzhjYmEyZGUxNzkyYmZkL3RhYmxlcmFuZ2U6YjNmODE5MTMwM2IyNDM0ZmFjOGNiYTJkZTE3OTJiZmRfMTktMy0xLTEtMzAxMTQ_cf6c700d-988d-4236-bea3-3620f5259deb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31669f2cab12460b9f221115aa18666e_I20220131" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOmIzZjgxOTEzMDNiMjQzNGZhYzhjYmEyZGUxNzkyYmZkL3RhYmxlcmFuZ2U6YjNmODE5MTMwM2IyNDM0ZmFjOGNiYTJkZTE3OTJiZmRfMTktNS0xLTEtMzAxMTQ_6f534957-3828-4327-a94c-be94e9d4d61d">42</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fa89a7423444291b6668e498df2d2d9_I20220131" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOmIzZjgxOTEzMDNiMjQzNGZhYzhjYmEyZGUxNzkyYmZkL3RhYmxlcmFuZ2U6YjNmODE5MTMwM2IyNDM0ZmFjOGNiYTJkZTE3OTJiZmRfMTktNy0xLTEtMzAxMTQ_910cd525-a3ea-469e-8b37-c1c115c1f560">92</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial assets and liabilities measured at fair value on a recurring basis as of October&#160;31, 2021 were as follows:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.584%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.186%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurement at October 31, 2021 Using</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 31,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted&#160;Prices</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">in&#160;Active</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Markets&#160;for</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Identical&#160;Assets</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Level&#160;1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Observable</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Inputs</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Level&#160;2)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unobservable</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Inputs</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Level&#160;3)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents (money market funds)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79dd2028aecf413fbe4f1d871c963827_I20211031" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOjQ0OTUxOWUzMjViMzRiMDU4NzBmOGVhM2U2YWZmYzQyL3RhYmxlcmFuZ2U6NDQ5NTE5ZTMyNWIzNGIwNTg3MGY4ZWEzZTZhZmZjNDJfNS0xLTEtMS0zMDExNA_e4e7cdcf-4807-4a42-a160-b4c3798f2675">919</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib476e9fd5af245d488939d04e35e54b1_I20211031" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOjQ0OTUxOWUzMjViMzRiMDU4NzBmOGVhM2U2YWZmYzQyL3RhYmxlcmFuZ2U6NDQ5NTE5ZTMyNWIzNGIwNTg3MGY4ZWEzZTZhZmZjNDJfNS0zLTEtMS0zMDExNA_430cd9a5-1623-4dbd-894c-97ac71d2387a">919</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1cf4d72cb954647a51527f90aeeb40b_I20211031" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOjQ0OTUxOWUzMjViMzRiMDU4NzBmOGVhM2U2YWZmYzQyL3RhYmxlcmFuZ2U6NDQ5NTE5ZTMyNWIzNGIwNTg3MGY4ZWEzZTZhZmZjNDJfNS01LTEtMS0zMDExNA_7cfedbd6-8ce1-48ce-ab03-9d6a6eccf11f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8690b9426888489bb9c9185bfdee22df_I20211031" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOjQ0OTUxOWUzMjViMzRiMDU4NzBmOGVhM2U2YWZmYzQyL3RhYmxlcmFuZ2U6NDQ5NTE5ZTMyNWIzNGIwNTg3MGY4ZWEzZTZhZmZjNDJfNS03LTEtMS0zMDExNA_c62b8298-1543-493f-9776-259885eafdcc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative instruments (foreign exchange contracts)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79dd2028aecf413fbe4f1d871c963827_I20211031" decimals="-6" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOjQ0OTUxOWUzMjViMzRiMDU4NzBmOGVhM2U2YWZmYzQyL3RhYmxlcmFuZ2U6NDQ5NTE5ZTMyNWIzNGIwNTg3MGY4ZWEzZTZhZmZjNDJfNi0xLTEtMS0zMDExNA_7e5f7d25-0ac6-4d0c-b292-9a572799936b">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib476e9fd5af245d488939d04e35e54b1_I20211031" decimals="-6" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOjQ0OTUxOWUzMjViMzRiMDU4NzBmOGVhM2U2YWZmYzQyL3RhYmxlcmFuZ2U6NDQ5NTE5ZTMyNWIzNGIwNTg3MGY4ZWEzZTZhZmZjNDJfNi0zLTEtMS0zMDExNA_e7822d81-38e4-460c-8427-c52c9f213e9d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1cf4d72cb954647a51527f90aeeb40b_I20211031" decimals="-6" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOjQ0OTUxOWUzMjViMzRiMDU4NzBmOGVhM2U2YWZmYzQyL3RhYmxlcmFuZ2U6NDQ5NTE5ZTMyNWIzNGIwNTg3MGY4ZWEzZTZhZmZjNDJfNi01LTEtMS0zMDExNA_989c7778-6938-49e0-87b0-f8a1f1de36ff">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8690b9426888489bb9c9185bfdee22df_I20211031" decimals="-6" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOjQ0OTUxOWUzMjViMzRiMDU4NzBmOGVhM2U2YWZmYzQyL3RhYmxlcmFuZ2U6NDQ5NTE5ZTMyNWIzNGIwNTg3MGY4ZWEzZTZhZmZjNDJfNi03LTEtMS0zMDExNA_c25d6a12-7fb3-4332-aeb2-734349a9332e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments - Equity securities with RDFV</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79dd2028aecf413fbe4f1d871c963827_I20211031" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOjQ0OTUxOWUzMjViMzRiMDU4NzBmOGVhM2U2YWZmYzQyL3RhYmxlcmFuZ2U6NDQ5NTE5ZTMyNWIzNGIwNTg3MGY4ZWEzZTZhZmZjNDJfNy0xLTEtMS00MzAzMg_5812999c-43e9-47f7-a21e-e1f8b2df1bbe">91</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib476e9fd5af245d488939d04e35e54b1_I20211031" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOjQ0OTUxOWUzMjViMzRiMDU4NzBmOGVhM2U2YWZmYzQyL3RhYmxlcmFuZ2U6NDQ5NTE5ZTMyNWIzNGIwNTg3MGY4ZWEzZTZhZmZjNDJfNy0zLTEtMS00MzAzMg_183ea341-e844-4401-81dc-095fe39aa75c">83</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1cf4d72cb954647a51527f90aeeb40b_I20211031" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOjQ0OTUxOWUzMjViMzRiMDU4NzBmOGVhM2U2YWZmYzQyL3RhYmxlcmFuZ2U6NDQ5NTE5ZTMyNWIzNGIwNTg3MGY4ZWEzZTZhZmZjNDJfNy01LTEtMS00MzAzMg_0309f6c1-5125-415e-a503-eee8421e2501">8</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8690b9426888489bb9c9185bfdee22df_I20211031" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOjQ0OTUxOWUzMjViMzRiMDU4NzBmOGVhM2U2YWZmYzQyL3RhYmxlcmFuZ2U6NDQ5NTE5ZTMyNWIzNGIwNTg3MGY4ZWEzZTZhZmZjNDJfNy03LTEtMS00MzAzMg_bd8eb1d5-e1b9-4b2b-9be7-88acfa1b6efb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trading securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e39ecebbd8d4eeb970728db4d14f8c6_I20211031" decimals="-6" name="us-gaap:TradingSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOjQ0OTUxOWUzMjViMzRiMDU4NzBmOGVhM2U2YWZmYzQyL3RhYmxlcmFuZ2U6NDQ5NTE5ZTMyNWIzNGIwNTg3MGY4ZWEzZTZhZmZjNDJfOC0xLTEtMS0zMDExNA_fcc33ada-4115-41e5-9072-ce79414d6e2d">34</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf311ad8bbc94cee9ca4b52f8c685019_I20211031" decimals="-6" name="us-gaap:TradingSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOjQ0OTUxOWUzMjViMzRiMDU4NzBmOGVhM2U2YWZmYzQyL3RhYmxlcmFuZ2U6NDQ5NTE5ZTMyNWIzNGIwNTg3MGY4ZWEzZTZhZmZjNDJfOC0zLTEtMS0zMDExNA_c92498e0-b9c6-40b1-b7bd-b347ec64da16">34</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i101bd4dfad2f444c893fb78c50710bf6_I20211031" decimals="-6" name="us-gaap:TradingSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOjQ0OTUxOWUzMjViMzRiMDU4NzBmOGVhM2U2YWZmYzQyL3RhYmxlcmFuZ2U6NDQ5NTE5ZTMyNWIzNGIwNTg3MGY4ZWEzZTZhZmZjNDJfOC01LTEtMS0zMDExNA_abb792d4-ad5c-442e-b7e7-bad9a8f9811d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib53b527a87f34ca1a28449997f71d948_I20211031" decimals="-6" name="us-gaap:TradingSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOjQ0OTUxOWUzMjViMzRiMDU4NzBmOGVhM2U2YWZmYzQyL3RhYmxlcmFuZ2U6NDQ5NTE5ZTMyNWIzNGIwNTg3MGY4ZWEzZTZhZmZjNDJfOC03LTEtMS0zMDExNA_b3740056-b1e7-4014-8da9-feaee9e251ff">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e39ecebbd8d4eeb970728db4d14f8c6_I20211031" decimals="-6" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOjQ0OTUxOWUzMjViMzRiMDU4NzBmOGVhM2U2YWZmYzQyL3RhYmxlcmFuZ2U6NDQ5NTE5ZTMyNWIzNGIwNTg3MGY4ZWEzZTZhZmZjNDJfOS0xLTEtMS0zMDExNA_dc97bd71-dd09-495f-ab39-904bd4fb2feb">31</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf311ad8bbc94cee9ca4b52f8c685019_I20211031" decimals="-6" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOjQ0OTUxOWUzMjViMzRiMDU4NzBmOGVhM2U2YWZmYzQyL3RhYmxlcmFuZ2U6NDQ5NTE5ZTMyNWIzNGIwNTg3MGY4ZWEzZTZhZmZjNDJfOS0zLTEtMS0zMDExNA_8065a923-8e5e-4c7f-acc7-c31fab2040bc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i101bd4dfad2f444c893fb78c50710bf6_I20211031" decimals="-6" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOjQ0OTUxOWUzMjViMzRiMDU4NzBmOGVhM2U2YWZmYzQyL3RhYmxlcmFuZ2U6NDQ5NTE5ZTMyNWIzNGIwNTg3MGY4ZWEzZTZhZmZjNDJfOS01LTEtMS0zMDExNA_124e1f4c-b804-4287-9dc8-46f8a1b81b5e">31</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib53b527a87f34ca1a28449997f71d948_I20211031" decimals="-6" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOjQ0OTUxOWUzMjViMzRiMDU4NzBmOGVhM2U2YWZmYzQyL3RhYmxlcmFuZ2U6NDQ5NTE5ZTMyNWIzNGIwNTg3MGY4ZWEzZTZhZmZjNDJfOS03LTEtMS0zMDExNA_92662655-613b-4daf-8bf7-4bc04b35d674">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets measured at fair value</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie085dfbe93fe4451a8b8d84aad0e35d5_I20211031" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOjQ0OTUxOWUzMjViMzRiMDU4NzBmOGVhM2U2YWZmYzQyL3RhYmxlcmFuZ2U6NDQ5NTE5ZTMyNWIzNGIwNTg3MGY4ZWEzZTZhZmZjNDJfMTAtMS0xLTEtMzAxMTQ_1a5a2392-9a11-445a-8142-60d94485a1e0">1,084</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf80390ad3e448c4bce98cb60bfbca2c_I20211031" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOjQ0OTUxOWUzMjViMzRiMDU4NzBmOGVhM2U2YWZmYzQyL3RhYmxlcmFuZ2U6NDQ5NTE5ZTMyNWIzNGIwNTg3MGY4ZWEzZTZhZmZjNDJfMTAtMy0xLTEtMzAxMTQ_fb7f964a-4256-4b38-898f-275a173cb94d">1,036</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4a3dda3866f4f3db20f204f127ccde3_I20211031" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOjQ0OTUxOWUzMjViMzRiMDU4NzBmOGVhM2U2YWZmYzQyL3RhYmxlcmFuZ2U6NDQ5NTE5ZTMyNWIzNGIwNTg3MGY4ZWEzZTZhZmZjNDJfMTAtNS0xLTEtMzAxMTQ_5ca16d1d-a1bb-4bd4-9bb3-0b4af06159b6">48</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a3d3d46764b449d8f6eccfe5e6a43b5_I20211031" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOjQ0OTUxOWUzMjViMzRiMDU4NzBmOGVhM2U2YWZmYzQyL3RhYmxlcmFuZ2U6NDQ5NTE5ZTMyNWIzNGIwNTg3MGY4ZWEzZTZhZmZjNDJfMTAtNy0xLTEtMzAxMTQ_4135b799-e33a-4fdc-80bd-5803841a1df3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative instruments (foreign exchange contracts)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f394c9f978d46f7a4b1aca902fb05a9_I20211031" decimals="-6" name="us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOjQ0OTUxOWUzMjViMzRiMDU4NzBmOGVhM2U2YWZmYzQyL3RhYmxlcmFuZ2U6NDQ5NTE5ZTMyNWIzNGIwNTg3MGY4ZWEzZTZhZmZjNDJfMTMtMS0xLTEtMzAxMTQ_e2a23aa2-8120-4f55-ad4e-2e3b1f4865e8">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib292bc46e71c4b11a0a9f03de4f3b2fa_I20211031" decimals="-6" name="us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOjQ0OTUxOWUzMjViMzRiMDU4NzBmOGVhM2U2YWZmYzQyL3RhYmxlcmFuZ2U6NDQ5NTE5ZTMyNWIzNGIwNTg3MGY4ZWEzZTZhZmZjNDJfMTMtMy0xLTEtMzAxMTQ_56f64a83-4961-4e53-963c-161da160dfb5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if753f01b6fb74e4b82725e20f4211138_I20211031" decimals="-6" name="us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOjQ0OTUxOWUzMjViMzRiMDU4NzBmOGVhM2U2YWZmYzQyL3RhYmxlcmFuZ2U6NDQ5NTE5ZTMyNWIzNGIwNTg3MGY4ZWEzZTZhZmZjNDJfMTMtNS0xLTEtMzAxMTQ_24fd39a4-789d-41fd-8c79-c7a93eb13c84">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i765ac03acc794ee0adca232fcb5a3e42_I20211031" decimals="-6" name="us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOjQ0OTUxOWUzMjViMzRiMDU4NzBmOGVhM2U2YWZmYzQyL3RhYmxlcmFuZ2U6NDQ5NTE5ZTMyNWIzNGIwNTg3MGY4ZWEzZTZhZmZjNDJfMTMtNy0xLTEtMzAxMTQ_db2133d2-8a77-4da9-8ac5-e47f6effda80">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f394c9f978d46f7a4b1aca902fb05a9_I20211031" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOjQ0OTUxOWUzMjViMzRiMDU4NzBmOGVhM2U2YWZmYzQyL3RhYmxlcmFuZ2U6NDQ5NTE5ZTMyNWIzNGIwNTg3MGY4ZWEzZTZhZmZjNDJfMTQtMS0xLTEtMzAxMTQ_72129015-a6d6-4d2e-b453-a9a9fff0a180">62</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib292bc46e71c4b11a0a9f03de4f3b2fa_I20211031" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOjQ0OTUxOWUzMjViMzRiMDU4NzBmOGVhM2U2YWZmYzQyL3RhYmxlcmFuZ2U6NDQ5NTE5ZTMyNWIzNGIwNTg3MGY4ZWEzZTZhZmZjNDJfMTQtMy0xLTEtMzAxMTQ_e80ad73f-8f64-4a8c-bfe0-3e8fab2ad19c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if753f01b6fb74e4b82725e20f4211138_I20211031" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOjQ0OTUxOWUzMjViMzRiMDU4NzBmOGVhM2U2YWZmYzQyL3RhYmxlcmFuZ2U6NDQ5NTE5ZTMyNWIzNGIwNTg3MGY4ZWEzZTZhZmZjNDJfMTQtNS0xLTEtMzAxMTQ_3e429c3e-fd7a-4313-ac1b-c4b9be89d383">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2ea1c6637aa4f78a6d53fd7fee549a8_I20211031" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOjQ0OTUxOWUzMjViMzRiMDU4NzBmOGVhM2U2YWZmYzQyL3RhYmxlcmFuZ2U6NDQ5NTE5ZTMyNWIzNGIwNTg3MGY4ZWEzZTZhZmZjNDJfMTQtNy0xLTEtMzAxMTQ_2e108b8f-33a9-4eea-aa14-a522192c8bc0">62</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55d8c6d05fa4483c93279a0c9f44754d_I20211031" decimals="-6" name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOjQ0OTUxOWUzMjViMzRiMDU4NzBmOGVhM2U2YWZmYzQyL3RhYmxlcmFuZ2U6NDQ5NTE5ZTMyNWIzNGIwNTg3MGY4ZWEzZTZhZmZjNDJfMTYtMS0xLTEtMzAxMTQ_5816003e-8cba-4643-902f-9b77170ea439">34</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i167b08689113447eb86bceea035eecd1_I20211031" decimals="-6" name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOjQ0OTUxOWUzMjViMzRiMDU4NzBmOGVhM2U2YWZmYzQyL3RhYmxlcmFuZ2U6NDQ5NTE5ZTMyNWIzNGIwNTg3MGY4ZWEzZTZhZmZjNDJfMTYtMy0xLTEtMzAxMTQ_8934edec-3377-449f-8e67-731ab225fdcb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaff97c5b6ded4379888e10b33df96a9a_I20211031" decimals="-6" name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOjQ0OTUxOWUzMjViMzRiMDU4NzBmOGVhM2U2YWZmYzQyL3RhYmxlcmFuZ2U6NDQ5NTE5ZTMyNWIzNGIwNTg3MGY4ZWEzZTZhZmZjNDJfMTYtNS0xLTEtMzAxMTQ_435ddb26-5693-4dd4-953b-ab496392e766">34</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i242b61736b4c44cebd07a140cbb7dda7_I20211031" decimals="-6" name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOjQ0OTUxOWUzMjViMzRiMDU4NzBmOGVhM2U2YWZmYzQyL3RhYmxlcmFuZ2U6NDQ5NTE5ZTMyNWIzNGIwNTg3MGY4ZWEzZTZhZmZjNDJfMTYtNy0xLTEtMzAxMTQ_e173ed3f-ec63-4106-ad4f-561ecc057233">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55d8c6d05fa4483c93279a0c9f44754d_I20211031" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOjQ0OTUxOWUzMjViMzRiMDU4NzBmOGVhM2U2YWZmYzQyL3RhYmxlcmFuZ2U6NDQ5NTE5ZTMyNWIzNGIwNTg3MGY4ZWEzZTZhZmZjNDJfMTctMS0xLTEtMzAxMTQ_29eb2a02-6ac6-4969-a0e6-306ca47774b5">27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i167b08689113447eb86bceea035eecd1_I20211031" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOjQ0OTUxOWUzMjViMzRiMDU4NzBmOGVhM2U2YWZmYzQyL3RhYmxlcmFuZ2U6NDQ5NTE5ZTMyNWIzNGIwNTg3MGY4ZWEzZTZhZmZjNDJfMTctMy0xLTEtMzAxMTQ_c00ee08e-5175-4132-b351-4153cc606131">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaff97c5b6ded4379888e10b33df96a9a_I20211031" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOjQ0OTUxOWUzMjViMzRiMDU4NzBmOGVhM2U2YWZmYzQyL3RhYmxlcmFuZ2U6NDQ5NTE5ZTMyNWIzNGIwNTg3MGY4ZWEzZTZhZmZjNDJfMTctNS0xLTEtMzAxMTQ_8c1633f0-c98d-4675-9b5c-5905c9f63d8d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b752274839a498a9ba656f68620fcdb_I20211031" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOjQ0OTUxOWUzMjViMzRiMDU4NzBmOGVhM2U2YWZmYzQyL3RhYmxlcmFuZ2U6NDQ5NTE5ZTMyNWIzNGIwNTg3MGY4ZWEzZTZhZmZjNDJfMTctNy0xLTEtMzAxMTQ_3286fd53-5669-4c0b-845c-0c673a4dd37f">27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities measured at fair value</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie085dfbe93fe4451a8b8d84aad0e35d5_I20211031" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOjQ0OTUxOWUzMjViMzRiMDU4NzBmOGVhM2U2YWZmYzQyL3RhYmxlcmFuZ2U6NDQ5NTE5ZTMyNWIzNGIwNTg3MGY4ZWEzZTZhZmZjNDJfMTgtMS0xLTEtMzAxMTQ_b20d8da6-a384-4b27-b4e4-195c51b30569">128</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf80390ad3e448c4bce98cb60bfbca2c_I20211031" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOjQ0OTUxOWUzMjViMzRiMDU4NzBmOGVhM2U2YWZmYzQyL3RhYmxlcmFuZ2U6NDQ5NTE5ZTMyNWIzNGIwNTg3MGY4ZWEzZTZhZmZjNDJfMTgtMy0xLTEtMzAxMTQ_37039c8c-cb68-4478-be0b-72c272cf9c3e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4a3dda3866f4f3db20f204f127ccde3_I20211031" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOjQ0OTUxOWUzMjViMzRiMDU4NzBmOGVhM2U2YWZmYzQyL3RhYmxlcmFuZ2U6NDQ5NTE5ZTMyNWIzNGIwNTg3MGY4ZWEzZTZhZmZjNDJfMTgtNS0xLTEtMzAxMTQ_cfccee0c-80f0-4e55-9a5a-fcf584ff4857">39</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a3d3d46764b449d8f6eccfe5e6a43b5_I20211031" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOjQ0OTUxOWUzMjViMzRiMDU4NzBmOGVhM2U2YWZmYzQyL3RhYmxlcmFuZ2U6NDQ5NTE5ZTMyNWIzNGIwNTg3MGY4ZWEzZTZhZmZjNDJfMTgtNy0xLTEtMzAxMTQ_63c3fd70-2af0-4a88-b0bb-0dc29a400629">89</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AGILENT TECHNOLOGIES, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) - (Continued) </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i2ff2c2a7e3904448a7b518c609d9b074" continuedAt="i539ddb530de043bea896737e463cbc4b"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our money market funds and trading securities are generally valued using quoted market prices and therefore are classified within level&#160;1 of the fair value hierarchy. Our derivative financial instruments are classified within level 2, as there is not an active market for each hedge contract, but the inputs used to calculate the value of the instruments are tied to active markets.  Our deferred compensation liability is classified as level&#160;2 because, although the values are not directly based on quoted market prices, the inputs used in the calculations are observable. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short- term investments - equity securities with readily determinable fair value ("RDFV") are shares in marketable equity securities which are classified as level 1 in the fair value hierarchy as they are measured based on quotes in active markets. Equity securities with RDFV also includes potential shares received from an equity investment in a company that went public and can vest under certain stock performance circumstances, and these have been classified as level 2 because the fair value was calculated using the Monte Carlo simulation method in which quoted market price and other observable inputs are used.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other investments represent shares we own in a special fund that targets underlying investments of approximately 40 percent in debt securities and 60 percent in equity securities. These shares have been classified as level 2 because, although the shares of the fund are not traded on any active stock exchange, each of the individual underlying securities are or can be derived from and hence we have a readily determinable value for the underlying securities, from which we are able to determine the fair market value for the special fund itself. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trading securities, which are comprised of mutual funds, bonds and other similar instruments, other investments and deferred compensation liability are reported at fair value, with gains or losses resulting from changes in fair value recognized currently in net income. Certain derivative instruments are reported at fair value, with unrealized gains and losses, net of tax, included in accumulated other comprehensive income (loss) within stockholders' equity. Realized gains and losses from the sale of these instruments are recorded in net income.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended January&#160;31, 2022 and 2021, an unrealized loss of $<ix:nonFraction unitRef="usd" contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" decimals="-6" sign="-" name="us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RleHRyZWdpb246NGFjODFlMzQ2MGVjNGFiMTg4NmZkZTE5MzdlNjEzZmVfMTY0OTI2NzQ1NzYxNg_eff08c85-6bf2-4e6d-81f0-2742fd4602c1">47</ix:nonFraction> million and an unrealized gain of $<ix:nonFraction unitRef="usd" contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131" decimals="-6" name="us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RleHRyZWdpb246NGFjODFlMzQ2MGVjNGFiMTg4NmZkZTE5MzdlNjEzZmVfMTY0OTI2NzQ1NzY0OA_403617e2-ac71-4ff9-bf68-d4ab612e8341">2</ix:nonFraction> million, respectively, were included in other income (expense), net as an adjustment to the carrying value of equity securities. </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:78.724%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.697%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingent Consideration.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The fair value of the contingent consideration liability relates to milestone payments in connection with the April 2021 acquisition of Resolution Bioscience. The fair value of the potential future milestone payments, which are set to certain revenue and technical targets, was based on (i) the probability of achieving the relevant revenue targets and technical milestones and (ii) the timing of achieving such milestones, which are significant unobservable inputs, and has been classified as Level 3. We used the Monte Carlo simulation approach to estimate the fair value of the revenue component with an asset volatility of <ix:nonFraction unitRef="number" contextRef="i8b540551877547fb8e1e4b0e4801b542_I20220131" decimals="INF" name="a:BusinessCombinationContingentConsiderationFairValueMeasurementInput" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RleHRyZWdpb246NGFjODFlMzQ2MGVjNGFiMTg4NmZkZTE5MzdlNjEzZmVfNDc5MA_5b321237-5482-4d66-8224-e6d829fb6fb9">54.9</ix:nonFraction> percent and revenue volatilities ranging from <ix:nonFraction unitRef="number" contextRef="i434180e34a724e439604a72f345ea6fd_I20220131" decimals="INF" name="a:BusinessCombinationContingentConsiderationFairValueMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RleHRyZWdpb246NGFjODFlMzQ2MGVjNGFiMTg4NmZkZTE5MzdlNjEzZmVfNDgzMQ_2a092af4-8e1b-4eb3-8ba3-3f84b4dfa083">12.2</ix:nonFraction> to <ix:nonFraction unitRef="number" contextRef="i91a30a8c91a44f6eb18a935a5bb6d39f_I20220131" decimals="INF" name="a:BusinessCombinationContingentConsiderationFairValueMeasurementInput" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RleHRyZWdpb246NGFjODFlMzQ2MGVjNGFiMTg4NmZkZTE5MzdlNjEzZmVfNDgzNw_30a253e4-6e88-4cbb-a293-cee60687650d">13.9</ix:nonFraction> percent. The probability-weighted expected return method was used to estimate the fair value of the technical target component. Assumptions used in the calculations include probability of success, duration of the earn-out and discount rate. A change in any of these unobservable inputs can significantly change the fair value of the contingent consideration. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of January&#160;31, 2022, the expected maximum earn-out period for the contingent payments does not exceed <ix:nonNumeric contextRef="id313ef0eb3db435cabb1861abacdf1d0_D20211101-20220131" name="a:BusinessCombinationsContingentConsiderationArrangements" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RleHRyZWdpb246NGFjODFlMzQ2MGVjNGFiMTg4NmZkZTE5MzdlNjEzZmVfMTA5OTUxMTY0MTMxMw_52e93234-8e2c-4013-9eeb-e9d0e1378f68">2.9</ix:nonNumeric> years and potential future payments will not exceed $<ix:nonFraction unitRef="usd" contextRef="i4da29d667bc84895ab281da0a1ff518e_I20220131" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RleHRyZWdpb246NGFjODFlMzQ2MGVjNGFiMTg4NmZkZTE5MzdlNjEzZmVfMTA5OTUxMTY0MTM2Mw_f672d008-3d91-4a37-af0b-699a97b47ec1">145</ix:nonFraction>&#160;million. The fair value of the contingent consideration liability as of January&#160;31, 2022 was estimated to be $<ix:nonFraction unitRef="usd" contextRef="i8fa89a7423444291b6668e498df2d2d9_I20220131" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RleHRyZWdpb246NGFjODFlMzQ2MGVjNGFiMTg4NmZkZTE5MzdlNjEzZmVfMTA5OTUxMTY0MTg0NA_910cd525-a3ea-469e-8b37-c1c115c1f560">92</ix:nonFraction> million of which $<ix:nonFraction unitRef="usd" contextRef="i8e7130166b8246129cb9366c9e725c1d_I20220131" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RleHRyZWdpb246NGFjODFlMzQ2MGVjNGFiMTg4NmZkZTE5MzdlNjEzZmVfMTA5OTUxMTY0MTgxMA_1d0f2d6c-167e-4f24-b538-cd9c8dc5e21f">65</ix:nonFraction> million was recorded in other accrued liabilities and $<ix:nonFraction unitRef="usd" contextRef="if7cd365418ea4001be8171374346f5d4_I20220131" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RleHRyZWdpb246NGFjODFlMzQ2MGVjNGFiMTg4NmZkZTE5MzdlNjEzZmVfMTA5OTUxMTY0MTgyNw_19837a79-b12f-4360-bf96-084cdf698201">27</ix:nonFraction> million was recorded in other long-term liabilities on the condensed consolidated balance sheet. The increase in the fair value of the contingent consideration was primarily driven by a change in the probability of achieving the technical milestone.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><ix:nonNumeric contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RleHRyZWdpb246NGFjODFlMzQ2MGVjNGFiMTg4NmZkZTE5MzdlNjEzZmVfNzg4OQ_41cab86b-1f07-494e-b55d-9142a58c7fd2" escape="true"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The contingent consideration liability is our only Level 3 asset or liability.  A summary of the Level 3 activity follows:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:78.724%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.697%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6390807210d74c6f9cae496ea2122a5a_I20211031" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOjFiYWVkMzkzYzM2ZjQ2OGNiZDNlZGEzYmM3YWU5MDU2L3RhYmxlcmFuZ2U6MWJhZWQzOTNjMzZmNDY4Y2JkM2VkYTNiYzdhZTkwNTZfNC0xLTEtMS0zMDExNA_0eb616fd-749b-4230-8fe6-a464a9dd3de8">89</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id69612e49fa546c0bf63ff5ad436ccc6_I20201031" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOjFiYWVkMzkzYzM2ZjQ2OGNiZDNlZGEzYmM3YWU5MDU2L3RhYmxlcmFuZ2U6MWJhZWQzOTNjMzZmNDY4Y2JkM2VkYTNiYzdhZTkwNTZfNC0zLTEtMS0zMDExNA_0d362116-1fc2-42d2-b5ca-b4488693f735">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value (included within selling, general and administrative expenses)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOjFiYWVkMzkzYzM2ZjQ2OGNiZDNlZGEzYmM3YWU5MDU2L3RhYmxlcmFuZ2U6MWJhZWQzOTNjMzZmNDY4Y2JkM2VkYTNiYzdhZTkwNTZfNi0xLTEtMS0zMDExNA_3a1cb955-8c53-43bf-99e3-4ad6b61346e8">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOjFiYWVkMzkzYzM2ZjQ2OGNiZDNlZGEzYmM3YWU5MDU2L3RhYmxlcmFuZ2U6MWJhZWQzOTNjMzZmNDY4Y2JkM2VkYTNiYzdhZTkwNTZfNi0zLTEtMS0zMDExNA_3a00767d-5a0d-4489-bfe0-a7b9c1823749">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOjFiYWVkMzkzYzM2ZjQ2OGNiZDNlZGEzYmM3YWU5MDU2L3RhYmxlcmFuZ2U6MWJhZWQzOTNjMzZmNDY4Y2JkM2VkYTNiYzdhZTkwNTZfNy0xLTEtMS0zMDExNA_b0241b6c-8d0a-4164-aab9-5d615c0a28fc">92</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b47b15753c94f0b80143556347e39b7_I20210131" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOjFiYWVkMzkzYzM2ZjQ2OGNiZDNlZGEzYmM3YWU5MDU2L3RhYmxlcmFuZ2U6MWJhZWQzOTNjMzZmNDY4Y2JkM2VkYTNiYzdhZTkwNTZfNy0zLTEtMS0zMDExNA_973e1d77-0dea-4b55-aabe-257255ac76f1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Impairment of Investments.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> There were <ix:nonFraction unitRef="usd" contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131" decimals="-6" name="us-gaap:ImpairmentOfInvestments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RleHRyZWdpb246NGFjODFlMzQ2MGVjNGFiMTg4NmZkZTE5MzdlNjEzZmVfMTA5OTUxMTY0MjI2OA_6500ada0-d89e-45e8-b9d1-b7d255d53bae"><ix:nonFraction unitRef="usd" contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131" decimals="-6" name="us-gaap:ImpairmentOfInvestments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RleHRyZWdpb246NGFjODFlMzQ2MGVjNGFiMTg4NmZkZTE5MzdlNjEzZmVfMTA5OTUxMTY0MjI2OA_71460f0f-7597-4fb7-90e4-62fbbc9e5972"><ix:nonFraction unitRef="usd" contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" decimals="-6" name="us-gaap:ImpairmentOfInvestments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RleHRyZWdpb246NGFjODFlMzQ2MGVjNGFiMTg4NmZkZTE5MzdlNjEzZmVfMTA5OTUxMTY0MjI2OA_8594a99e-ed00-4db5-8451-e88d798f4d2c"><ix:nonFraction unitRef="usd" contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" decimals="-6" name="us-gaap:ImpairmentOfInvestments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RleHRyZWdpb246NGFjODFlMzQ2MGVjNGFiMTg4NmZkZTE5MzdlNjEzZmVfMTA5OTUxMTY0MjI2OA_951e0bc7-4cf4-4778-9a67-9124a2c7a922">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> impairments of investments for the three months ended January&#160;31, 2022 and 2021.</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AGILENT TECHNOLOGIES, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) - (Continued) </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i539ddb530de043bea896737e463cbc4b"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Assets and Liabilities Measured at Fair Value on a Non-Recurring Basis</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended January&#160;31, 2022 and 2021, there were <ix:nonFraction unitRef="usd" contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131" decimals="-6" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RleHRyZWdpb246NGFjODFlMzQ2MGVjNGFiMTg4NmZkZTE5MzdlNjEzZmVfNTk0Mg_4c768970-a7fc-4902-8db7-29f20b9ea0ff"><ix:nonFraction unitRef="usd" contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131" decimals="-6" name="us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RleHRyZWdpb246NGFjODFlMzQ2MGVjNGFiMTg4NmZkZTE5MzdlNjEzZmVfNTk0Mg_521b94c9-001d-4964-b0d0-0356bc69f937"><ix:nonFraction unitRef="usd" contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" decimals="-6" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RleHRyZWdpb246NGFjODFlMzQ2MGVjNGFiMTg4NmZkZTE5MzdlNjEzZmVfNTk0Mg_5605c602-54da-44cd-867b-6120fbcb5400"><ix:nonFraction unitRef="usd" contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131" decimals="-6" name="us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RleHRyZWdpb246NGFjODFlMzQ2MGVjNGFiMTg4NmZkZTE5MzdlNjEzZmVfNTk0Mg_a35358c6-1a65-45a6-b99c-d85be4712da6"><ix:nonFraction unitRef="usd" contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" decimals="-6" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RleHRyZWdpb246NGFjODFlMzQ2MGVjNGFiMTg4NmZkZTE5MzdlNjEzZmVfNTk0Mg_c75f168f-a3fc-4638-bfd3-2193082558f2"><ix:nonFraction unitRef="usd" contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131" decimals="-6" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RleHRyZWdpb246NGFjODFlMzQ2MGVjNGFiMTg4NmZkZTE5MzdlNjEzZmVfNTk0Mg_c920c995-ed6c-40fb-966d-89568a3907ad"><ix:nonFraction unitRef="usd" contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" decimals="-6" name="us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RleHRyZWdpb246NGFjODFlMzQ2MGVjNGFiMTg4NmZkZTE5MzdlNjEzZmVfNTk0Mg_de2154c7-e1ec-4c27-a5a8-609f402337a3"><ix:nonFraction unitRef="usd" contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" decimals="-6" name="us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RleHRyZWdpb246NGFjODFlMzQ2MGVjNGFiMTg4NmZkZTE5MzdlNjEzZmVfNTk0Mg_f1bffb8a-d670-4eba-beaf-0888372a8342">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> impairments of long-lived assets held and used or long-lived assets held for sale. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended January&#160;31, 2022 and 2021, there were <ix:nonFraction unitRef="usd" contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131" decimals="-6" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RleHRyZWdpb246NGFjODFlMzQ2MGVjNGFiMTg4NmZkZTE5MzdlNjEzZmVfNjU2NA_064faff8-14c6-4589-b5c6-b9b82ab9eb97"><ix:nonFraction unitRef="usd" contextRef="i9b47b15753c94f0b80143556347e39b7_I20210131" decimals="-6" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RleHRyZWdpb246NGFjODFlMzQ2MGVjNGFiMTg4NmZkZTE5MzdlNjEzZmVfNjU2NA_adf7cc58-359a-4e2f-af13-6dc17b09e029">no</ix:nonFraction></ix:nonFraction> impairments or adjustments to the carrying value of non-marketable securities without readily determinable fair value based on an observable market transaction. As of January&#160;31, 2022 and October&#160;31, 2021, the carrying amount of non-marketable equity securities without readily determinable fair values was $<ix:nonFraction unitRef="usd" contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131" decimals="-6" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RleHRyZWdpb246NGFjODFlMzQ2MGVjNGFiMTg4NmZkZTE5MzdlNjEzZmVfNzI4OA_83c58ca3-0061-4bb6-9933-c599c35e4cc2">125</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i6390807210d74c6f9cae496ea2122a5a_I20211031" decimals="-6" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RleHRyZWdpb246NGFjODFlMzQ2MGVjNGFiMTg4NmZkZTE5MzdlNjEzZmVfNzI5NQ_6024bcfb-951b-4fc4-b2e2-2c4e316dc88f">120</ix:nonFraction> million, respectively.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair values for the non-marketable securities included in long-term investments on the condensed consolidated balance sheet were measured using Level 3 inputs because they are primarily equity stock issued by private companies without quoted market prices. To estimate the fair value of our non-marketable securities, we use the measurement alternative to record these investments at cost and adjust for impairments and observable price changes (orderly transactions for the identical or a similar security from the same issuer) as and when they occur.</span></div></ix:continuation><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div id="if825c91f15a047ec9e67e0189634a349_61"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.   <ix:nonNumeric contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" name="us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RleHRyZWdpb246ZWI4YjIxYmVmODkxNDhlYWFkMTU5MmM3YThjMGU5YTdfOTA2NQ_f21e2e85-8476-45e6-8ebe-d0f1c02c812d" continuedAt="i1812e481aa7f4e9e8e404b5b6dc41d5d" escape="true">DERIVATIVES</ix:nonNumeric></span></div><ix:continuation id="i1812e481aa7f4e9e8e404b5b6dc41d5d" continuedAt="if6d57c5d473d4b59909d7428399b906d"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are exposed to foreign currency exchange rate fluctuations and interest rate changes in the normal course of our business. As part of our risk management strategy, we use derivative instruments, primarily forward contracts and purchased options to hedge economic and/or accounting exposures resulting from changes in foreign currency exchange rates.</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Flow Hedges</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We enter into foreign exchange contracts to hedge our forecasted operational cash flow exposures resulting from changes in foreign currency exchange rates. These foreign exchange contracts, carried at fair value, have maturities between one and twelve months. These derivative instruments are designated and qualify as cash flow hedges under the criteria prescribed in the authoritative guidance and are assessed for effectiveness against the underlying exposure every reporting period. For open contracts as of January&#160;31, 2022, changes in the time value of the foreign exchange contract are excluded from the assessment of hedge effectiveness and are recognized in cost of sales over the life of the foreign exchange contract. The changes in fair value of the effective portion of the derivative instrument are recognized in accumulated other comprehensive income (loss). Amounts associated with cash flow hedges are reclassified to cost of sales in the condensed consolidated statement of operations when the forecasted transaction occurs. If it becomes probable that the forecasted transaction will not occur, the hedge relationship will be de-designated and amounts accumulated in other comprehensive income (loss) will be reclassified to other income (expense), net in the current period. Changes in the fair value of the ineffective portion of derivative instruments are recognized in other income (expense), net in the condensed consolidated statement of operations in the current period. We record the premium paid (time value) of an option on the date of purchase as an asset. For options designated as cash flow hedges, changes in the time value are excluded from the assessment of hedge effectiveness and are recognized in cost of sales over the life of the option contract. For the three months ended January&#160;31, 2022 and 2021, ineffectiveness and gains and losses recognized in other income (expense), net due to de-designation of cash flow hedge contracts were not significant.  </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2016, Agilent executed <ix:nonFraction unitRef="contracts" contextRef="ic292fe4ddbdc4b1f85e1bac3f0ab2387_I20160201" decimals="0" name="us-gaap:NumberOfInterestRateDerivativesHeld" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RleHRyZWdpb246ZWI4YjIxYmVmODkxNDhlYWFkMTU5MmM3YThjMGU5YTdfMzI0MQ_9f360b0d-4d97-49a5-946d-f24fa8e2e873">three</ix:nonFraction> forward-starting pay fixed/receive variable interest rate swaps for the notional amount of $<ix:nonFraction unitRef="usd" contextRef="ic292fe4ddbdc4b1f85e1bac3f0ab2387_I20160201" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RleHRyZWdpb246ZWI4YjIxYmVmODkxNDhlYWFkMTU5MmM3YThjMGU5YTdfMzMzNQ_a4064f95-d415-4691-9981-cd212a2c7953">300</ix:nonFraction> million in connection with future interest payments to be made on our 2026 senior notes issued on September 15, 2016. These derivative instruments were designated and qualified as cash flow hedges under the criteria prescribed in the authoritative guidance. The swap arrangements were terminated on September 15, 2016 with a payment of $<ix:nonFraction unitRef="usd" contextRef="ifb765ebd38d444b1857a41d784a28b5e_D20160914-20160915" decimals="-6" name="a:Interestrateswappayments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RleHRyZWdpb246ZWI4YjIxYmVmODkxNDhlYWFkMTU5MmM3YThjMGU5YTdfMzY2Ng_415e7ea4-1471-49bd-852b-aa7446da74ed">10</ix:nonFraction> million, and we recognized this as a deferred loss in accumulated other comprehensive income (loss) which is being amortized to interest expense over the life of the 2026 senior notes. The remaining loss to be amortized related to the interest rate swap agreements at January&#160;31, 2022 was $<ix:nonFraction unitRef="usd" contextRef="if325814ac8de45f5b8f83e932e8509f8_I20220131" decimals="-6" name="a:Remaininggainlosstobeamortizedonderivative" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RleHRyZWdpb246ZWI4YjIxYmVmODkxNDhlYWFkMTU5MmM3YThjMGU5YTdfMzkzNg_9c6c7726-52cc-4a18-a380-5f2278508d7a">4</ix:nonFraction> million. </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2019, Agilent executed treasury lock agreements for $<ix:nonFraction unitRef="usd" contextRef="iad105ebf0fa5490194840a7fe0fd1664_I20190816" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RleHRyZWdpb246ZWI4YjIxYmVmODkxNDhlYWFkMTU5MmM3YThjMGU5YTdfNDAwNA_605b04e1-756e-4bf6-87e9-f26cf49a5840">250</ix:nonFraction> million in connection with future interest payments to be made on our 2029 senior notes issued on September 16, 2019. We designated the treasury lock as a cash flow hedge. The treasury lock contracts were terminated on September 6, 2019, and we recognized a deferred loss of $<ix:nonFraction unitRef="usd" contextRef="i3fae7ee4803141fab6fa85ebe7ee5491_D20190906-20190906" decimals="-6" name="a:Interestrateswappayments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RleHRyZWdpb246ZWI4YjIxYmVmODkxNDhlYWFkMTU5MmM3YThjMGU5YTdfNDI3NA_3e52cb81-e121-44eb-85f1-904b4c75c0f6">6</ix:nonFraction>&#160;million in accumulated other comprehensive income (loss) which is being amortized to interest expense over the life of the 2029 senior notes. The remaining loss to be amortized related to the treasury lock agreements at January&#160;31, 2022 was $<ix:nonFraction unitRef="usd" contextRef="i042e0c2ce85c41bc9011ef45825cadd8_I20220131" decimals="-6" name="a:Remaininggainlosstobeamortizedonderivative" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RleHRyZWdpb246ZWI4YjIxYmVmODkxNDhlYWFkMTU5MmM3YThjMGU5YTdfNDQ5Ng_3c5ef89b-ebd5-43b8-bec5-5ad72d68b2dc">4</ix:nonFraction> million. </span></div></ix:continuation><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AGILENT TECHNOLOGIES, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) - (Continued) </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="if6d57c5d473d4b59909d7428399b906d" continuedAt="i71eeab902f8f4cfbb9318a242841c753"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Investment Hedges </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We enter into foreign exchange contracts to hedge net investments in foreign operations to mitigate the risk of adverse movements in exchange rates. These foreign exchange contracts are carried at fair value and are designated and qualify as net investment hedges under the criteria prescribed in the authoritative guidance. Changes in fair value of the effective portion of the derivative instrument are recognized in accumulated other comprehensive income (loss) and are assessed for effectiveness against the underlying exposure every reporting period. If the company&#8217;s net investment changes during the year, the hedge relationship will be assessed and de-designated if the hedge notional amount is outside of prescribed tolerance with a gain/loss reclassified from other comprehensive income (loss) to other income (expense) in the current period. For the three months ended January&#160;31, 2022, ineffectiveness and the resultant effect of any gains or losses recognized in other income (expense) due to de-designation of the hedge contracts were not significant.  </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Hedges</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, we enter into foreign exchange contracts to hedge monetary assets and liabilities that are denominated in currencies other than the functional currency of our subsidiaries. These foreign exchange contracts are carried at fair value and do not qualify for hedge accounting treatment and are not designated as hedging instruments. Changes in value of the derivative instruments are recognized in other income (expense), net in the condensed consolidated statement of operations, in the current period, along with the offsetting foreign currency gain or loss on the underlying assets or liabilities.</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our use of derivative instruments exposes us to credit risk to the extent that the counterparties may be unable to meet the terms of the agreement. We do, however, seek to mitigate such risks by limiting our counterparties to major financial institutions which are selected based on their credit ratings and other factors.&#160;We have established policies and procedures for mitigating credit risk that include establishing counterparty credit limits, monitoring credit exposures, and continually assessing the creditworthiness of counterparties.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A number of our derivative agreements contain threshold limits to the net liability position with counterparties and are dependent on our corporate credit rating determined by the major credit rating agencies. The counterparties to the derivative instruments may request collateralization, in accordance with derivative agreements, on derivative instruments in net liability positions.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate fair value of all derivative instruments with credit-risk-related contingent features that were in a net liability position as of January&#160;31, 2022, was $<ix:nonFraction unitRef="usd" contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131" decimals="-6" name="us-gaap:DerivativeNetLiabilityPositionAggregateFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RleHRyZWdpb246ZWI4YjIxYmVmODkxNDhlYWFkMTU5MmM3YThjMGU5YTdfNzc5OQ_32f003c1-025b-48fc-b279-b12bfad1d85e">2</ix:nonFraction>&#160;million. The credit-risk-related contingent features underlying these agreements had not been triggered as of January&#160;31, 2022.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were <ix:nonFraction unitRef="contracts" contextRef="i3d4fb6e9c35b4a259523bf637621e885_I20220131" decimals="0" name="us-gaap:NumberOfForeignCurrencyDerivativesHeld" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RleHRyZWdpb246ZWI4YjIxYmVmODkxNDhlYWFkMTU5MmM3YThjMGU5YTdfNzkyMA_e64322ad-a8ed-49ba-94b0-1aae2ff5d901">261</ix:nonFraction> foreign exchange forward contracts open as of January&#160;31, 2022 and designated as cash flow hedges. There were <ix:nonFraction unitRef="contracts" contextRef="i9309ceb43d6d4d7c95d0816fd752eca7_I20220131" decimals="0" name="us-gaap:NumberOfForeignCurrencyDerivativesHeld" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RleHRyZWdpb246ZWI4YjIxYmVmODkxNDhlYWFkMTU5MmM3YThjMGU5YTdfODAxOQ_8c262c7f-2405-4038-ad2e-78ab0a0422cc">177</ix:nonFraction> foreign exchange forward contracts open as of January&#160;31, 2022 and not designated as hedging instruments. There were <ix:nonFraction unitRef="contracts" contextRef="i1b3f43743319451cb90947e0304374dd_I20220131" decimals="0" name="us-gaap:NumberOfForeignCurrencyDerivativesHeld" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RleHRyZWdpb246ZWI4YjIxYmVmODkxNDhlYWFkMTU5MmM3YThjMGU5YTdfODEyNQ_da006b26-3522-40d6-880e-d2955f065254">7</ix:nonFraction> foreign exchange forward contracts open as of January&#160;31, 2022 and designated as a net investment hedge.</span></div></ix:continuation><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AGILENT TECHNOLOGIES, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) - (Continued) </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i71eeab902f8f4cfbb9318a242841c753" continuedAt="if69f16d8a1cf443483eb200ac550da7c"><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> <ix:nonNumeric contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" name="us-gaap:ScheduleOfDerivativeInstrumentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RleHRyZWdpb246ZWI4YjIxYmVmODkxNDhlYWFkMTU5MmM3YThjMGU5YTdfOTA5Nw_52c58703-281c-480f-8680-2ab026ac0cfc" continuedAt="i08fec6c51fe04a9092b4bccd42b499bd" escape="true">The aggregated notional amounts by currency and designation as of January&#160;31, 2022 were as follows:</ix:nonNumeric></span></div><div style="margin-top:5pt"><ix:continuation id="i08fec6c51fe04a9092b4bccd42b499bd"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:44.274%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.786%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.080%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.258%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivatives&#160;<br/>Designated as <br/>Cash&#160;Flow Hedges</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivatives <br/>Designated as <br/>Net Investment Hedges</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivatives <br/>Not Designated as&#160;<br/>Hedging Instruments</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Forward<br/>Contracts USD</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Forward<br/>Contracts USD</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Forward<br/>Contracts USD</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Currency</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Buy/(Sell)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Buy/(Sell)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Buy/(Sell)</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Euro</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8c42cc94490742e7b13ea5fd23157b27_I20220131" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RhYmxlOmU3Njk1OTI0OTRmMDRhNDNiYWUyY2RhNmYyMjFlMmY4L3RhYmxlcmFuZ2U6ZTc2OTU5MjQ5NGYwNGE0M2JhZTJjZGE2ZjIyMWUyZjhfNC0yLTEtMS0zMDExNA_bf529aa7-e734-4014-a6a2-d74be935b8c8">71</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib6775d0eafba4fbcb9f4699180a8061e_I20220131" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RhYmxlOmU3Njk1OTI0OTRmMDRhNDNiYWUyY2RhNmYyMjFlMmY4L3RhYmxlcmFuZ2U6ZTc2OTU5MjQ5NGYwNGE0M2JhZTJjZGE2ZjIyMWUyZjhfNC02LTEtMS0zMDExNA_af706a10-1e99-4210-9f2a-9f69336dbdd1">15</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a3c2b906dba466d90605db0ba3c44a4_I20220131" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RhYmxlOmU3Njk1OTI0OTRmMDRhNDNiYWUyY2RhNmYyMjFlMmY4L3RhYmxlcmFuZ2U6ZTc2OTU5MjQ5NGYwNGE0M2JhZTJjZGE2ZjIyMWUyZjhfNC04LTEtMS0zMDExNA_8ab3a544-c5f2-4f78-9e77-042cec60a775">27</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">British Pound</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0f9ec320b33848c3a9839b24a1239ed8_I20220131" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RhYmxlOmU3Njk1OTI0OTRmMDRhNDNiYWUyY2RhNmYyMjFlMmY4L3RhYmxlcmFuZ2U6ZTc2OTU5MjQ5NGYwNGE0M2JhZTJjZGE2ZjIyMWUyZjhfNS0yLTEtMS0zMDExNA_197a34b7-a117-4dc0-8807-4a18644dcf8e">68</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6497616d037845fca0c005ebc475212b_I20220131" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RhYmxlOmU3Njk1OTI0OTRmMDRhNDNiYWUyY2RhNmYyMjFlMmY4L3RhYmxlcmFuZ2U6ZTc2OTU5MjQ5NGYwNGE0M2JhZTJjZGE2ZjIyMWUyZjhfNS04LTEtMS0zMDExNA_160d79d8-b6cf-4e81-a50d-4d47ba18d618">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canadian Dollar</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i75d2660ff14040b3b96c724f268ab729_I20220131" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RhYmxlOmU3Njk1OTI0OTRmMDRhNDNiYWUyY2RhNmYyMjFlMmY4L3RhYmxlcmFuZ2U6ZTc2OTU5MjQ5NGYwNGE0M2JhZTJjZGE2ZjIyMWUyZjhfNi0yLTEtMS0zMDExNA_6207c4bd-1292-4f52-88ce-489a0da3e331">42</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ica71b83ef3a1418d9d27756803812b2b_I20220131" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RhYmxlOmU3Njk1OTI0OTRmMDRhNDNiYWUyY2RhNmYyMjFlMmY4L3RhYmxlcmFuZ2U6ZTc2OTU5MjQ5NGYwNGE0M2JhZTJjZGE2ZjIyMWUyZjhfNi04LTEtMS0zMDExNA_db2d20a6-b1e8-427e-8b71-52a2139e91fe">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Japanese Yen</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieb2fe08defb64136976421e01523b7ef_I20220131" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RhYmxlOmU3Njk1OTI0OTRmMDRhNDNiYWUyY2RhNmYyMjFlMmY4L3RhYmxlcmFuZ2U6ZTc2OTU5MjQ5NGYwNGE0M2JhZTJjZGE2ZjIyMWUyZjhfOS0yLTEtMS0zMDExNA_262271b9-4442-4ffc-ab9f-eb901095ee95">88</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4c6f0473f9864b389ca06abc0cf5ee78_I20220131" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RhYmxlOmU3Njk1OTI0OTRmMDRhNDNiYWUyY2RhNmYyMjFlMmY4L3RhYmxlcmFuZ2U6ZTc2OTU5MjQ5NGYwNGE0M2JhZTJjZGE2ZjIyMWUyZjhfOS04LTEtMS0zMDExNA_0eb42710-daa7-4ffd-a1d2-e990549f239c">41</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Danish Krone</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3355616638084c1584622a5e3613f202_I20220131" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RhYmxlOmU3Njk1OTI0OTRmMDRhNDNiYWUyY2RhNmYyMjFlMmY4L3RhYmxlcmFuZ2U6ZTc2OTU5MjQ5NGYwNGE0M2JhZTJjZGE2ZjIyMWUyZjhfMTAtOC0xLTEtMzAxMTQ_22b3c552-e5bd-4d11-801b-9fd3473dbb33">27</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Korean Won</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaeb7bd13400342f287179313ecad6bd5_I20220131" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RhYmxlOmU3Njk1OTI0OTRmMDRhNDNiYWUyY2RhNmYyMjFlMmY4L3RhYmxlcmFuZ2U6ZTc2OTU5MjQ5NGYwNGE0M2JhZTJjZGE2ZjIyMWUyZjhfMTEtMi0xLTEtMzAxMTQ_3ac64abf-8b66-4c65-8cf7-0e6e73ac2f8b">65</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic4671a036f85446594c33199993572bf_I20220131" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RhYmxlOmU3Njk1OTI0OTRmMDRhNDNiYWUyY2RhNmYyMjFlMmY4L3RhYmxlcmFuZ2U6ZTc2OTU5MjQ5NGYwNGE0M2JhZTJjZGE2ZjIyMWUyZjhfMTEtOC0xLTEtMzAxMTQ_0eef9f67-8150-41bf-8e13-01ad98a4d099">20</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Singapore Dollar</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if316a64c264f481b862d74033659d9c1_I20220131" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RhYmxlOmU3Njk1OTI0OTRmMDRhNDNiYWUyY2RhNmYyMjFlMmY4L3RhYmxlcmFuZ2U6ZTc2OTU5MjQ5NGYwNGE0M2JhZTJjZGE2ZjIyMWUyZjhfMTItMi0xLTEtMzAxMTQ_199373ca-2904-496a-8f57-d1e85490ae0e">18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7306551b82684e7286c2efe86019758b_I20220131" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RhYmxlOmU3Njk1OTI0OTRmMDRhNDNiYWUyY2RhNmYyMjFlMmY4L3RhYmxlcmFuZ2U6ZTc2OTU5MjQ5NGYwNGE0M2JhZTJjZGE2ZjIyMWUyZjhfMTItOC0xLTEtMzAxMTQ_2027b9c5-623d-4f90-945b-7f0dd4498d7f">21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Swiss Franc</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i83b2d38c99874faa95b7ac2a3be10565_I20220131" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RhYmxlOmU3Njk1OTI0OTRmMDRhNDNiYWUyY2RhNmYyMjFlMmY4L3RhYmxlcmFuZ2U6ZTc2OTU5MjQ5NGYwNGE0M2JhZTJjZGE2ZjIyMWUyZjhfMTMtOC0xLTEtMzAxMTQ_2356aef6-dfb5-4154-b8ed-bcd1ac84d251">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chinese Yuan Renminbi</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i72dfae202fe64d0d9194ac25adbe6324_I20220131" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RhYmxlOmU3Njk1OTI0OTRmMDRhNDNiYWUyY2RhNmYyMjFlMmY4L3RhYmxlcmFuZ2U6ZTc2OTU5MjQ5NGYwNGE0M2JhZTJjZGE2ZjIyMWUyZjhfMTQtMi0xLTEtMzAxMTQ_a0cb1013-4585-4c12-8ac1-536f09b7a06d">84</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icbb1793fb3ba4308a7a1bc073a3e737b_I20220131" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RhYmxlOmU3Njk1OTI0OTRmMDRhNDNiYWUyY2RhNmYyMjFlMmY4L3RhYmxlcmFuZ2U6ZTc2OTU5MjQ5NGYwNGE0M2JhZTJjZGE2ZjIyMWUyZjhfMTQtOC0xLTEtMzAxMTQ_1976ddb7-715e-460d-8d83-9db163694b93">101</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Taiwan Dollar</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6881a3da71ef45248c11dd3d5d7aa897_I20220131" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RhYmxlOmU3Njk1OTI0OTRmMDRhNDNiYWUyY2RhNmYyMjFlMmY4L3RhYmxlcmFuZ2U6ZTc2OTU5MjQ5NGYwNGE0M2JhZTJjZGE2ZjIyMWUyZjhfMTctOC0xLTEtMzAxMTQ_c6bd20b0-6af3-450f-b190-6354e109a2fc">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indian Rupee</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i039748d0e2f64eb98ec1fe2ea5b6d315_I20220131" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RhYmxlOmU3Njk1OTI0OTRmMDRhNDNiYWUyY2RhNmYyMjFlMmY4L3RhYmxlcmFuZ2U6ZTc2OTU5MjQ5NGYwNGE0M2JhZTJjZGE2ZjIyMWUyZjhfMTgtOC0xLTEtMzAxMTQ_a7a17489-972c-4488-b962-1a9e903accf4">13</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazilian Real</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id105be7d8a724d71956a551b0fe22d54_I20220131" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RhYmxlOmU3Njk1OTI0OTRmMDRhNDNiYWUyY2RhNmYyMjFlMmY4L3RhYmxlcmFuZ2U6ZTc2OTU5MjQ5NGYwNGE0M2JhZTJjZGE2ZjIyMWUyZjhfMTktOC0xLTEtMzAxMTQ_ca6e28a2-a855-437d-b2ca-eebed3c1627f">10</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idcd3e8c2579941ef810c7c628510a603_I20220131" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RhYmxlOmU3Njk1OTI0OTRmMDRhNDNiYWUyY2RhNmYyMjFlMmY4L3RhYmxlcmFuZ2U6ZTc2OTU5MjQ5NGYwNGE0M2JhZTJjZGE2ZjIyMWUyZjhfMjEtMi0xLTEtMzAxMTQ_3051fb40-96e3-4756-993b-cecacb6adcf4">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6caf21f7567843c6ac1d733aab0be98d_I20220131" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RhYmxlOmU3Njk1OTI0OTRmMDRhNDNiYWUyY2RhNmYyMjFlMmY4L3RhYmxlcmFuZ2U6ZTc2OTU5MjQ5NGYwNGE0M2JhZTJjZGE2ZjIyMWUyZjhfMjEtOC0xLTEtMzAxMTQ_bdcb484d-d3c2-42f1-ac01-4a993ecc1f9c">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Totals</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b3e8db945ae4a1a940922af0327692d_I20220131" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RhYmxlOmU3Njk1OTI0OTRmMDRhNDNiYWUyY2RhNmYyMjFlMmY4L3RhYmxlcmFuZ2U6ZTc2OTU5MjQ5NGYwNGE0M2JhZTJjZGE2ZjIyMWUyZjhfMjItMi0xLTEtMzAxMTQ_675e2988-e5f2-4b0d-8ecc-f241677ae84d">396</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibdea3a47f24e4e8590f368a0dfb94d45_I20220131" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RhYmxlOmU3Njk1OTI0OTRmMDRhNDNiYWUyY2RhNmYyMjFlMmY4L3RhYmxlcmFuZ2U6ZTc2OTU5MjQ5NGYwNGE0M2JhZTJjZGE2ZjIyMWUyZjhfMjItNi0xLTEtMzAxMTQ_14b1e238-2249-4f0a-b30d-974795c12f8a">15</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6736f6223d0f4203b9239c59f7463674_I20220131" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RhYmxlOmU3Njk1OTI0OTRmMDRhNDNiYWUyY2RhNmYyMjFlMmY4L3RhYmxlcmFuZ2U6ZTc2OTU5MjQ5NGYwNGE0M2JhZTJjZGE2ZjIyMWUyZjhfMjItOC0xLTEtMzAxMTQ_aa9165bc-d39a-4f51-9e82-32c14285b3a3">118</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-top:5pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> <ix:nonNumeric contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" name="us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RleHRyZWdpb246ZWI4YjIxYmVmODkxNDhlYWFkMTU5MmM3YThjMGU5YTdfOTEwMw_411d269e-0399-41a8-aecf-361cb4567c0d" continuedAt="icd411cc2d76340cea769c966a9be3ef1" escape="true">Derivative instruments are subject to master netting arrangements and are disclosed gross in the balance sheet in accordance with the authoritative guidance. The gross fair values and balance sheet location of derivative instruments held in the condensed consolidated balance sheet as of January&#160;31, 2022 and October&#160;31, 2021 were as follows:</ix:nonNumeric></span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="margin-top:5pt"><ix:continuation id="icd411cc2d76340cea769c966a9be3ef1"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:29.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.164%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.311%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.875%"></td><td style="width:0.1%"></td></tr><tr><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair&#160;Values&#160;of&#160;Derivative&#160;Instruments</span></td></tr><tr><td colspan="15" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Asset&#160;Derivatives</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="15" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Liability&#160;Derivatives</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair&#160;Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair&#160;Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance&#160;Sheet&#160;Location</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31,<br/>2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance&#160;Sheet&#160;Location</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31,<br/>2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 31,<br/>2021</span></td></tr><tr><td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives designated as hedging instruments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Cash flow hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56c53f4c438544d8b06e4f41bad8c0db_I20220131" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RhYmxlOjU2Y2ZmNmEzZDc5NzRiNzRiOWE0NzgxNDEzZGU3YjNmL3RhYmxlcmFuZ2U6NTZjZmY2YTNkNzk3NGI3NGI5YTQ3ODE0MTNkZTdiM2ZfOC0yLTEtMS0zMDExNA_083c2721-789f-4928-9e74-e6223d6f9da2">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c381f194b4e4d6884993233f9ef427b_I20211031" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RhYmxlOjU2Y2ZmNmEzZDc5NzRiNzRiOWE0NzgxNDEzZGU3YjNmL3RhYmxlcmFuZ2U6NTZjZmY2YTNkNzk3NGI3NGI5YTQ3ODE0MTNkZTdiM2ZfOC00LTEtMS0zMDExNA_83d15f24-e72f-4394-b6a6-21ed9b21b639">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fc3e3648d0b4efb976f2e9afc2cb0eb_I20220131" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RhYmxlOjU2Y2ZmNmEzZDc5NzRiNzRiOWE0NzgxNDEzZGU3YjNmL3RhYmxlcmFuZ2U6NTZjZmY2YTNkNzk3NGI3NGI5YTQ3ODE0MTNkZTdiM2ZfOC04LTEtMS0zMDExNA_dd228cdf-9d5d-474b-a430-013c2155328d">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50f69072160f4204bc684248a5c4d361_I20211031" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RhYmxlOjU2Y2ZmNmEzZDc5NzRiNzRiOWE0NzgxNDEzZGU3YjNmL3RhYmxlcmFuZ2U6NTZjZmY2YTNkNzk3NGI3NGI5YTQ3ODE0MTNkZTdiM2ZfOC0xMC0xLTEtMzAxMTQ_fb944eef-753e-4dbd-b2e3-2dab076f529a">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Net investment hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if88446467ba74964bae3a43bab960c67_I20220131" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RhYmxlOjU2Y2ZmNmEzZDc5NzRiNzRiOWE0NzgxNDEzZGU3YjNmL3RhYmxlcmFuZ2U6NTZjZmY2YTNkNzk3NGI3NGI5YTQ3ODE0MTNkZTdiM2ZfMTItMi0xLTEtMzAxMTQ_b39d0d29-2237-4940-b53a-4647f437f85a">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadfd46dace544484ab93d3f265e422a2_I20211031" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RhYmxlOjU2Y2ZmNmEzZDc5NzRiNzRiOWE0NzgxNDEzZGU3YjNmL3RhYmxlcmFuZ2U6NTZjZmY2YTNkNzk3NGI3NGI5YTQ3ODE0MTNkZTdiM2ZfMTItNC0xLTEtMzAxMTQ_0e9bb9be-def5-47f4-957c-ccc49be82725">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4aa7c9ade4a48b9afaa9ef1eb2c28d2_I20220131" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RhYmxlOjU2Y2ZmNmEzZDc5NzRiNzRiOWE0NzgxNDEzZGU3YjNmL3RhYmxlcmFuZ2U6NTZjZmY2YTNkNzk3NGI3NGI5YTQ3ODE0MTNkZTdiM2ZfMTItOC0xLTEtMzAxMTQ_35eb2ee7-252c-4397-ae79-08dd3ad1be7e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd354181dada4d4a900aa6600da1b6e0_I20211031" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RhYmxlOjU2Y2ZmNmEzZDc5NzRiNzRiOWE0NzgxNDEzZGU3YjNmL3RhYmxlcmFuZ2U6NTZjZmY2YTNkNzk3NGI3NGI5YTQ3ODE0MTNkZTdiM2ZfMTItMTAtMS0xLTMwMTE0_4cc8d1a0-db8d-463c-a920-46b6e5921323">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives not designated as hedging instruments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5e458b01a414961bd824ffcfc393961_I20220131" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RhYmxlOjU2Y2ZmNmEzZDc5NzRiNzRiOWE0NzgxNDEzZGU3YjNmL3RhYmxlcmFuZ2U6NTZjZmY2YTNkNzk3NGI3NGI5YTQ3ODE0MTNkZTdiM2ZfMTctMi0xLTEtMzAxMTQ_e860cde6-454a-489a-af15-7d77da9f604b">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia022050d3b32425cbcc3bee5435edaef_I20211031" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RhYmxlOjU2Y2ZmNmEzZDc5NzRiNzRiOWE0NzgxNDEzZGU3YjNmL3RhYmxlcmFuZ2U6NTZjZmY2YTNkNzk3NGI3NGI5YTQ3ODE0MTNkZTdiM2ZfMTctNC0xLTEtMzAxMTQ_1c36d057-940d-4b33-90de-0b034afed105">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i781e47792a004141abc5f44af8501b55_I20220131" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RhYmxlOjU2Y2ZmNmEzZDc5NzRiNzRiOWE0NzgxNDEzZGU3YjNmL3RhYmxlcmFuZ2U6NTZjZmY2YTNkNzk3NGI3NGI5YTQ3ODE0MTNkZTdiM2ZfMTctOC0xLTEtMzAxMTQ_852ccb16-604e-42a2-b0f8-580f1ce01293">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16900d24231046f1afce9ad394e43007_I20211031" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RhYmxlOjU2Y2ZmNmEzZDc5NzRiNzRiOWE0NzgxNDEzZGU3YjNmL3RhYmxlcmFuZ2U6NTZjZmY2YTNkNzk3NGI3NGI5YTQ3ODE0MTNkZTdiM2ZfMTctMTAtMS0xLTMwMTE0_d11ce890-e9b9-4a0a-b84a-0e229cb09004">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total derivatives</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RhYmxlOjU2Y2ZmNmEzZDc5NzRiNzRiOWE0NzgxNDEzZGU3YjNmL3RhYmxlcmFuZ2U6NTZjZmY2YTNkNzk3NGI3NGI5YTQ3ODE0MTNkZTdiM2ZfMTgtMi0xLTEtMzAxMTQ_54efd30e-9ca2-4279-9c08-15082afe1961">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6390807210d74c6f9cae496ea2122a5a_I20211031" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RhYmxlOjU2Y2ZmNmEzZDc5NzRiNzRiOWE0NzgxNDEzZGU3YjNmL3RhYmxlcmFuZ2U6NTZjZmY2YTNkNzk3NGI3NGI5YTQ3ODE0MTNkZTdiM2ZfMTgtNC0xLTEtMzAxMTQ_4c2080e3-8246-42a3-8fac-4b795187ce46">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RhYmxlOjU2Y2ZmNmEzZDc5NzRiNzRiOWE0NzgxNDEzZGU3YjNmL3RhYmxlcmFuZ2U6NTZjZmY2YTNkNzk3NGI3NGI5YTQ3ODE0MTNkZTdiM2ZfMTgtOC0xLTEtMzAxMTQ_ecae4dd9-107f-406c-a6fd-14bebe885531">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6390807210d74c6f9cae496ea2122a5a_I20211031" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RhYmxlOjU2Y2ZmNmEzZDc5NzRiNzRiOWE0NzgxNDEzZGU3YjNmL3RhYmxlcmFuZ2U6NTZjZmY2YTNkNzk3NGI3NGI5YTQ3ODE0MTNkZTdiM2ZfMTgtMTAtMS0xLTMwMTE0_092a9d84-0d4e-41c5-8056-965f9da1b0f7">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AGILENT TECHNOLOGIES, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) - (Continued) </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="if69f16d8a1cf443483eb200ac550da7c"><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" name="us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RleHRyZWdpb246ZWI4YjIxYmVmODkxNDhlYWFkMTU5MmM3YThjMGU5YTdfOTA2OA_4994be0a-3dd7-4a76-a187-c6d0bac94889" continuedAt="i7a021f82208c46e184ff47c6c4ca5b99" escape="true">The effects of derivative instruments for foreign exchange contracts designated as hedging instruments and not designated as hedging instruments in our condensed consolidated statement of operations were as follows:</ix:nonNumeric></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:justify"><ix:continuation id="i7a021f82208c46e184ff47c6c4ca5b99"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:82.087%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.943%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives designated as hedging instruments:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Cash Flow Hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) recognized in accumulated other comprehensive&#160;loss</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica123646e5544ebdbe2fa02d65eb9294_D20211101-20220131" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RhYmxlOjNjOTExNmI5MzcwYjQ5MjFiYzY5NTI0NmQ0ZGNjNDVkL3RhYmxlcmFuZ2U6M2M5MTE2YjkzNzBiNDkyMWJjNjk1MjQ2ZDRkY2M0NWRfMTAtMS0xLTEtMzAxMTQ_2af3ff98-f4e9-4bdc-8d00-b823fe383774">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i829319a2b5fb4d8fa6a9365861cbc737_D20201101-20210131" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RhYmxlOjNjOTExNmI5MzcwYjQ5MjFiYzY5NTI0NmQ0ZGNjNDVkL3RhYmxlcmFuZ2U6M2M5MTE2YjkzNzBiNDkyMWJjNjk1MjQ2ZDRkY2M0NWRfMTAtMy0xLTEtMzAxMTQ_e20d2074-3c10-45f8-9214-d14f8c7788c6">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) reclassified from accumulated other comprehensive&#160;loss into cost of sales</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib54e90d3ce874df2836c9d7cf1ec6c25_D20211101-20220131" decimals="-6" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RhYmxlOjNjOTExNmI5MzcwYjQ5MjFiYzY5NTI0NmQ0ZGNjNDVkL3RhYmxlcmFuZ2U6M2M5MTE2YjkzNzBiNDkyMWJjNjk1MjQ2ZDRkY2M0NWRfMTItMS0xLTEtMzAxMTQ_9b22a9d0-f99b-46b7-b7fb-ea4e4df591ef">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i151bd62ec0bd4c12b07d74d87ebe764b_D20201101-20210131" decimals="-6" sign="-" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RhYmxlOjNjOTExNmI5MzcwYjQ5MjFiYzY5NTI0NmQ0ZGNjNDVkL3RhYmxlcmFuZ2U6M2M5MTE2YjkzNzBiNDkyMWJjNjk1MjQ2ZDRkY2M0NWRfMTItMy0xLTEtMzAxMTQ_e12b8548-e3d7-42bd-bc3c-799c09ac4ac0">8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Net Investment Hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) recognized in accumulated other comprehensive loss - translation adjustment</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01e3cab750934c929073437446f9cf98_D20211101-20220131" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RhYmxlOjNjOTExNmI5MzcwYjQ5MjFiYzY5NTI0NmQ0ZGNjNDVkL3RhYmxlcmFuZ2U6M2M5MTE2YjkzNzBiNDkyMWJjNjk1MjQ2ZDRkY2M0NWRfMjEtMS0xLTEtMzAxMTQ_d1982cc7-6cc3-441e-8160-ee42934d6d87">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8dc3d15e75274d38a8a189554e496d08_D20201101-20210131" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RhYmxlOjNjOTExNmI5MzcwYjQ5MjFiYzY5NTI0NmQ0ZGNjNDVkL3RhYmxlcmFuZ2U6M2M5MTE2YjkzNzBiNDkyMWJjNjk1MjQ2ZDRkY2M0NWRfMjEtMy0xLTEtMzAxMTQ_7b7d39b2-30f4-44e5-80b3-493a02ca2726">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives not designated as hedging instruments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) recognized in other income (expense)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifa4aa5fe8b844efcb5e77e57cf2ac70e_D20211101-20220131" decimals="-6" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RhYmxlOjNjOTExNmI5MzcwYjQ5MjFiYzY5NTI0NmQ0ZGNjNDVkL3RhYmxlcmFuZ2U6M2M5MTE2YjkzNzBiNDkyMWJjNjk1MjQ2ZDRkY2M0NWRfMjUtMS0xLTEtMzAxMTQ_6285d7ed-cf99-4288-8d44-76dcc5d16186">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5cba63bb8ec2484285a9f87f393f6773_D20201101-20210131" decimals="-6" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RhYmxlOjNjOTExNmI5MzcwYjQ5MjFiYzY5NTI0NmQ0ZGNjNDVkL3RhYmxlcmFuZ2U6M2M5MTE2YjkzNzBiNDkyMWJjNjk1MjQ2ZDRkY2M0NWRfMjUtMy0xLTEtMzAxMTQ_93f11177-d9a6-4d9c-b47c-db70c332038b">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At January&#160;31, 2022, the amount of existing net gain that is expected to be reclassified from accumulated other comprehensive income (loss) is $<ix:nonFraction unitRef="usd" contextRef="i00a135183f5b41b092943e066055e800_D20211101-20220131" decimals="-6" name="us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RleHRyZWdpb246ZWI4YjIxYmVmODkxNDhlYWFkMTU5MmM3YThjMGU5YTdfODk3MQ_34bf1d24-3520-4663-b73e-36d13269bf43">6</ix:nonFraction> million. Within the next twelve months it is estimated that $<ix:nonFraction unitRef="usd" contextRef="i61e53d96c9094ec5b9192e40de4357d8_D20211101-20220131" decimals="-6" name="us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RleHRyZWdpb246ZWI4YjIxYmVmODkxNDhlYWFkMTU5MmM3YThjMGU5YTdfODk4Mw_60722ada-50ed-4069-bdd5-890bf19417ab">9</ix:nonFraction> million of gain included within the net amount of accumulated other comprehensive income (loss) will be reclassified to cost of sales in respect of cash flow hedges.</span></div></ix:continuation><div style="text-indent:24.75pt"><span><br/></span></div><div id="if825c91f15a047ec9e67e0189634a349_64"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.   <ix:nonNumeric contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" name="us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82NC9mcmFnOjZmNDZlYmExMzAxNTQ1YWNiY2MwODUxMjllZDlhZmI3L3RleHRyZWdpb246NmY0NmViYTEzMDE1NDVhY2JjYzA4NTEyOWVkOWFmYjdfNjMx_974f79c4-18e5-47ea-91ac-71d79e3c92fd" continuedAt="i133482ab65144d82b3401cba39cd8e57" escape="true">RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS</ix:nonNumeric></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><ix:continuation id="i133482ab65144d82b3401cba39cd8e57"><ix:nonNumeric contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" name="us-gaap:ScheduleOfDefinedBenefitPlansDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82NC9mcmFnOjZmNDZlYmExMzAxNTQ1YWNiY2MwODUxMjllZDlhZmI3L3RleHRyZWdpb246NmY0NmViYTEzMDE1NDVhY2JjYzA4NTEyOWVkOWFmYjdfNjI2_76f81b75-f1ba-448f-948a-f46bcdba2aea" escape="true"><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Components of net periodic costs (benefits).</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> For the three months ended January&#160;31, 2022 and 2021, our net pension and post retirement benefit costs (benefits) were comprised of the following:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:42.365%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.710%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.710%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.710%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.710%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.710%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.715%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended January 31</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">U.S. <br/>Pension&#160;Plans</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-U.S.<br/>Pension Plans</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">U.S.&#160;Post&#160;Retirement<br/>Benefit&#160;Plans</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost&#8212;benefits earned during the period</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8454ff09d8134a2fb231984b395af89d_D20211101-20220131" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82NC9mcmFnOjZmNDZlYmExMzAxNTQ1YWNiY2MwODUxMjllZDlhZmI3L3RhYmxlOjQ3NmQ1ZDRjNzM2YTQ2YzA4Y2Q3ZTMwODc1MTFjYzM5L3RhYmxlcmFuZ2U6NDc2ZDVkNGM3MzZhNDZjMDhjZDdlMzA4NzUxMWNjMzlfNC0xLTEtMS0zMDExNA_48ddd0ab-d9cb-4d87-82a4-082b0f7a729c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i151e64785a6246818b5fa21ee1ee8f21_D20201101-20210131" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82NC9mcmFnOjZmNDZlYmExMzAxNTQ1YWNiY2MwODUxMjllZDlhZmI3L3RhYmxlOjQ3NmQ1ZDRjNzM2YTQ2YzA4Y2Q3ZTMwODc1MTFjYzM5L3RhYmxlcmFuZ2U6NDc2ZDVkNGM3MzZhNDZjMDhjZDdlMzA4NzUxMWNjMzlfNC0zLTEtMS0zMDExNA_ebf1e12f-0666-4116-b453-0847f16bceb7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id63140b493914a99a6c71088f76848c1_D20211101-20220131" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82NC9mcmFnOjZmNDZlYmExMzAxNTQ1YWNiY2MwODUxMjllZDlhZmI3L3RhYmxlOjQ3NmQ1ZDRjNzM2YTQ2YzA4Y2Q3ZTMwODc1MTFjYzM5L3RhYmxlcmFuZ2U6NDc2ZDVkNGM3MzZhNDZjMDhjZDdlMzA4NzUxMWNjMzlfNC01LTEtMS0zMDExNA_f03ba42c-71d5-42ea-b918-0dd7d27d64a1">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2cb1409c861e47b69fd591e421c1d29a_D20201101-20210131" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82NC9mcmFnOjZmNDZlYmExMzAxNTQ1YWNiY2MwODUxMjllZDlhZmI3L3RhYmxlOjQ3NmQ1ZDRjNzM2YTQ2YzA4Y2Q3ZTMwODc1MTFjYzM5L3RhYmxlcmFuZ2U6NDc2ZDVkNGM3MzZhNDZjMDhjZDdlMzA4NzUxMWNjMzlfNC03LTEtMS0zMDExNA_b6fcc9af-2aa8-46f0-bbb2-f0d099ae0849">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd0876ed5c6643f9b68e30357fcb75c5_D20211101-20220131" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82NC9mcmFnOjZmNDZlYmExMzAxNTQ1YWNiY2MwODUxMjllZDlhZmI3L3RhYmxlOjQ3NmQ1ZDRjNzM2YTQ2YzA4Y2Q3ZTMwODc1MTFjYzM5L3RhYmxlcmFuZ2U6NDc2ZDVkNGM3MzZhNDZjMDhjZDdlMzA4NzUxMWNjMzlfNC05LTEtMS0zMDExNA_79ffa77f-3588-431c-9f12-901275b180cf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic152b46d63194d6f8f761363250e0cde_D20201101-20210131" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82NC9mcmFnOjZmNDZlYmExMzAxNTQ1YWNiY2MwODUxMjllZDlhZmI3L3RhYmxlOjQ3NmQ1ZDRjNzM2YTQ2YzA4Y2Q3ZTMwODc1MTFjYzM5L3RhYmxlcmFuZ2U6NDc2ZDVkNGM3MzZhNDZjMDhjZDdlMzA4NzUxMWNjMzlfNC0xMS0xLTEtMzAxMTQ_5662a6a2-fb69-4f24-a980-840adfffbdcc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost on benefit obligation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8454ff09d8134a2fb231984b395af89d_D20211101-20220131" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82NC9mcmFnOjZmNDZlYmExMzAxNTQ1YWNiY2MwODUxMjllZDlhZmI3L3RhYmxlOjQ3NmQ1ZDRjNzM2YTQ2YzA4Y2Q3ZTMwODc1MTFjYzM5L3RhYmxlcmFuZ2U6NDc2ZDVkNGM3MzZhNDZjMDhjZDdlMzA4NzUxMWNjMzlfNS0xLTEtMS0zMDExNA_efbd3d91-40b4-4788-a753-0ad65ba526d3">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i151e64785a6246818b5fa21ee1ee8f21_D20201101-20210131" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82NC9mcmFnOjZmNDZlYmExMzAxNTQ1YWNiY2MwODUxMjllZDlhZmI3L3RhYmxlOjQ3NmQ1ZDRjNzM2YTQ2YzA4Y2Q3ZTMwODc1MTFjYzM5L3RhYmxlcmFuZ2U6NDc2ZDVkNGM3MzZhNDZjMDhjZDdlMzA4NzUxMWNjMzlfNS0zLTEtMS0zMDExNA_c286deb5-ff7b-4047-a150-c73606dc0944">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id63140b493914a99a6c71088f76848c1_D20211101-20220131" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82NC9mcmFnOjZmNDZlYmExMzAxNTQ1YWNiY2MwODUxMjllZDlhZmI3L3RhYmxlOjQ3NmQ1ZDRjNzM2YTQ2YzA4Y2Q3ZTMwODc1MTFjYzM5L3RhYmxlcmFuZ2U6NDc2ZDVkNGM3MzZhNDZjMDhjZDdlMzA4NzUxMWNjMzlfNS01LTEtMS0zMDExNA_675ee209-269e-4f8b-9a88-02466e4f2388">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2cb1409c861e47b69fd591e421c1d29a_D20201101-20210131" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82NC9mcmFnOjZmNDZlYmExMzAxNTQ1YWNiY2MwODUxMjllZDlhZmI3L3RhYmxlOjQ3NmQ1ZDRjNzM2YTQ2YzA4Y2Q3ZTMwODc1MTFjYzM5L3RhYmxlcmFuZ2U6NDc2ZDVkNGM3MzZhNDZjMDhjZDdlMzA4NzUxMWNjMzlfNS03LTEtMS0zMDExNA_ba36fb22-7f3f-4723-9d78-79439c45f1e0">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd0876ed5c6643f9b68e30357fcb75c5_D20211101-20220131" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82NC9mcmFnOjZmNDZlYmExMzAxNTQ1YWNiY2MwODUxMjllZDlhZmI3L3RhYmxlOjQ3NmQ1ZDRjNzM2YTQ2YzA4Y2Q3ZTMwODc1MTFjYzM5L3RhYmxlcmFuZ2U6NDc2ZDVkNGM3MzZhNDZjMDhjZDdlMzA4NzUxMWNjMzlfNS05LTEtMS0zMDExNA_892d0bf8-3b5c-4618-934d-73bfd1d621aa">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic152b46d63194d6f8f761363250e0cde_D20201101-20210131" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82NC9mcmFnOjZmNDZlYmExMzAxNTQ1YWNiY2MwODUxMjllZDlhZmI3L3RhYmxlOjQ3NmQ1ZDRjNzM2YTQ2YzA4Y2Q3ZTMwODc1MTFjYzM5L3RhYmxlcmFuZ2U6NDc2ZDVkNGM3MzZhNDZjMDhjZDdlMzA4NzUxMWNjMzlfNS0xMS0xLTEtMzAxMTQ_d3a29b4f-071b-4bdf-b60b-2e921898288b">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8454ff09d8134a2fb231984b395af89d_D20211101-20220131" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82NC9mcmFnOjZmNDZlYmExMzAxNTQ1YWNiY2MwODUxMjllZDlhZmI3L3RhYmxlOjQ3NmQ1ZDRjNzM2YTQ2YzA4Y2Q3ZTMwODc1MTFjYzM5L3RhYmxlcmFuZ2U6NDc2ZDVkNGM3MzZhNDZjMDhjZDdlMzA4NzUxMWNjMzlfNi0xLTEtMS0zMDExNA_7bf224e6-b2de-4055-bdf2-d4df42a2371e">6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i151e64785a6246818b5fa21ee1ee8f21_D20201101-20210131" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82NC9mcmFnOjZmNDZlYmExMzAxNTQ1YWNiY2MwODUxMjllZDlhZmI3L3RhYmxlOjQ3NmQ1ZDRjNzM2YTQ2YzA4Y2Q3ZTMwODc1MTFjYzM5L3RhYmxlcmFuZ2U6NDc2ZDVkNGM3MzZhNDZjMDhjZDdlMzA4NzUxMWNjMzlfNi0zLTEtMS0zMDExNA_5b1426cf-fe87-46fc-bb61-06e3fd6f7731">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id63140b493914a99a6c71088f76848c1_D20211101-20220131" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82NC9mcmFnOjZmNDZlYmExMzAxNTQ1YWNiY2MwODUxMjllZDlhZmI3L3RhYmxlOjQ3NmQ1ZDRjNzM2YTQ2YzA4Y2Q3ZTMwODc1MTFjYzM5L3RhYmxlcmFuZ2U6NDc2ZDVkNGM3MzZhNDZjMDhjZDdlMzA4NzUxMWNjMzlfNi01LTEtMS0zMDExNA_8667e7cd-736c-4b18-ab20-73ceaed997bc">11</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2cb1409c861e47b69fd591e421c1d29a_D20201101-20210131" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82NC9mcmFnOjZmNDZlYmExMzAxNTQ1YWNiY2MwODUxMjllZDlhZmI3L3RhYmxlOjQ3NmQ1ZDRjNzM2YTQ2YzA4Y2Q3ZTMwODc1MTFjYzM5L3RhYmxlcmFuZ2U6NDc2ZDVkNGM3MzZhNDZjMDhjZDdlMzA4NzUxMWNjMzlfNi03LTEtMS0zMDExNA_fff16b87-1d1b-434b-a780-0f0798f69aa0">12</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibd0876ed5c6643f9b68e30357fcb75c5_D20211101-20220131" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82NC9mcmFnOjZmNDZlYmExMzAxNTQ1YWNiY2MwODUxMjllZDlhZmI3L3RhYmxlOjQ3NmQ1ZDRjNzM2YTQ2YzA4Y2Q3ZTMwODc1MTFjYzM5L3RhYmxlcmFuZ2U6NDc2ZDVkNGM3MzZhNDZjMDhjZDdlMzA4NzUxMWNjMzlfNi05LTEtMS0zMDExNA_9df6e206-30b0-445c-b951-9c71113c6605">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic152b46d63194d6f8f761363250e0cde_D20201101-20210131" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82NC9mcmFnOjZmNDZlYmExMzAxNTQ1YWNiY2MwODUxMjllZDlhZmI3L3RhYmxlOjQ3NmQ1ZDRjNzM2YTQ2YzA4Y2Q3ZTMwODc1MTFjYzM5L3RhYmxlcmFuZ2U6NDc2ZDVkNGM3MzZhNDZjMDhjZDdlMzA4NzUxMWNjMzlfNi0xMS0xLTEtMzAxMTQ_770de573-842f-4e15-bc24-b23006a3342c">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8454ff09d8134a2fb231984b395af89d_D20211101-20220131" decimals="-6" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82NC9mcmFnOjZmNDZlYmExMzAxNTQ1YWNiY2MwODUxMjllZDlhZmI3L3RhYmxlOjQ3NmQ1ZDRjNzM2YTQ2YzA4Y2Q3ZTMwODc1MTFjYzM5L3RhYmxlcmFuZ2U6NDc2ZDVkNGM3MzZhNDZjMDhjZDdlMzA4NzUxMWNjMzlfOC0xLTEtMS0zMDExNA_4268d3a9-5fae-470b-a285-a49e86649f4a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i151e64785a6246818b5fa21ee1ee8f21_D20201101-20210131" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82NC9mcmFnOjZmNDZlYmExMzAxNTQ1YWNiY2MwODUxMjllZDlhZmI3L3RhYmxlOjQ3NmQ1ZDRjNzM2YTQ2YzA4Y2Q3ZTMwODc1MTFjYzM5L3RhYmxlcmFuZ2U6NDc2ZDVkNGM3MzZhNDZjMDhjZDdlMzA4NzUxMWNjMzlfOC0zLTEtMS0zMDExNA_046f0378-1988-4d9a-a5c8-452f76d88d6d">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id63140b493914a99a6c71088f76848c1_D20211101-20220131" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82NC9mcmFnOjZmNDZlYmExMzAxNTQ1YWNiY2MwODUxMjllZDlhZmI3L3RhYmxlOjQ3NmQ1ZDRjNzM2YTQ2YzA4Y2Q3ZTMwODc1MTFjYzM5L3RhYmxlcmFuZ2U6NDc2ZDVkNGM3MzZhNDZjMDhjZDdlMzA4NzUxMWNjMzlfOC01LTEtMS0zMDExNA_bfdd04b8-dfac-43bb-a439-75886b42229d">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2cb1409c861e47b69fd591e421c1d29a_D20201101-20210131" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82NC9mcmFnOjZmNDZlYmExMzAxNTQ1YWNiY2MwODUxMjllZDlhZmI3L3RhYmxlOjQ3NmQ1ZDRjNzM2YTQ2YzA4Y2Q3ZTMwODc1MTFjYzM5L3RhYmxlcmFuZ2U6NDc2ZDVkNGM3MzZhNDZjMDhjZDdlMzA4NzUxMWNjMzlfOC03LTEtMS0zMDExNA_90987f6c-d467-4223-a0d7-3e72545def0a">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibd0876ed5c6643f9b68e30357fcb75c5_D20211101-20220131" decimals="-6" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82NC9mcmFnOjZmNDZlYmExMzAxNTQ1YWNiY2MwODUxMjllZDlhZmI3L3RhYmxlOjQ3NmQ1ZDRjNzM2YTQ2YzA4Y2Q3ZTMwODc1MTFjYzM5L3RhYmxlcmFuZ2U6NDc2ZDVkNGM3MzZhNDZjMDhjZDdlMzA4NzUxMWNjMzlfOC05LTEtMS0zMDExNA_2d10bb5b-8194-4eed-8312-8ee4039a1091">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic152b46d63194d6f8f761363250e0cde_D20201101-20210131" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82NC9mcmFnOjZmNDZlYmExMzAxNTQ1YWNiY2MwODUxMjllZDlhZmI3L3RhYmxlOjQ3NmQ1ZDRjNzM2YTQ2YzA4Y2Q3ZTMwODc1MTFjYzM5L3RhYmxlcmFuZ2U6NDc2ZDVkNGM3MzZhNDZjMDhjZDdlMzA4NzUxMWNjMzlfOC0xMS0xLTEtMzAxMTQ_eb11ed03-a171-401b-9276-5109ad730db2">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net plan costs (benefits)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8454ff09d8134a2fb231984b395af89d_D20211101-20220131" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82NC9mcmFnOjZmNDZlYmExMzAxNTQ1YWNiY2MwODUxMjllZDlhZmI3L3RhYmxlOjQ3NmQ1ZDRjNzM2YTQ2YzA4Y2Q3ZTMwODc1MTFjYzM5L3RhYmxlcmFuZ2U6NDc2ZDVkNGM3MzZhNDZjMDhjZDdlMzA4NzUxMWNjMzlfMTAtMS0xLTEtMzAxMTQ_bbdb2662-d5f8-4859-907a-78814cc0c8a2">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i151e64785a6246818b5fa21ee1ee8f21_D20201101-20210131" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82NC9mcmFnOjZmNDZlYmExMzAxNTQ1YWNiY2MwODUxMjllZDlhZmI3L3RhYmxlOjQ3NmQ1ZDRjNzM2YTQ2YzA4Y2Q3ZTMwODc1MTFjYzM5L3RhYmxlcmFuZ2U6NDc2ZDVkNGM3MzZhNDZjMDhjZDdlMzA4NzUxMWNjMzlfMTAtMy0xLTEtMzAxMTQ_4ab93471-0db2-41ae-a989-fcc474305653">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id63140b493914a99a6c71088f76848c1_D20211101-20220131" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82NC9mcmFnOjZmNDZlYmExMzAxNTQ1YWNiY2MwODUxMjllZDlhZmI3L3RhYmxlOjQ3NmQ1ZDRjNzM2YTQ2YzA4Y2Q3ZTMwODc1MTFjYzM5L3RhYmxlcmFuZ2U6NDc2ZDVkNGM3MzZhNDZjMDhjZDdlMzA4NzUxMWNjMzlfMTAtNS0xLTEtMzAxMTQ_12fe7db3-d6af-47b3-8ff5-9f9565d682b6">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2cb1409c861e47b69fd591e421c1d29a_D20201101-20210131" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82NC9mcmFnOjZmNDZlYmExMzAxNTQ1YWNiY2MwODUxMjllZDlhZmI3L3RhYmxlOjQ3NmQ1ZDRjNzM2YTQ2YzA4Y2Q3ZTMwODc1MTFjYzM5L3RhYmxlcmFuZ2U6NDc2ZDVkNGM3MzZhNDZjMDhjZDdlMzA4NzUxMWNjMzlfMTAtNy0xLTEtMzAxMTQ_fe309643-3c96-4e96-a0ad-35c5b69ab4f2">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibd0876ed5c6643f9b68e30357fcb75c5_D20211101-20220131" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82NC9mcmFnOjZmNDZlYmExMzAxNTQ1YWNiY2MwODUxMjllZDlhZmI3L3RhYmxlOjQ3NmQ1ZDRjNzM2YTQ2YzA4Y2Q3ZTMwODc1MTFjYzM5L3RhYmxlcmFuZ2U6NDc2ZDVkNGM3MzZhNDZjMDhjZDdlMzA4NzUxMWNjMzlfMTAtOS0xLTEtMzAxMTQ_be38b86d-f963-4e9b-9d4f-7199db5e8db8">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic152b46d63194d6f8f761363250e0cde_D20201101-20210131" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82NC9mcmFnOjZmNDZlYmExMzAxNTQ1YWNiY2MwODUxMjllZDlhZmI3L3RhYmxlOjQ3NmQ1ZDRjNzM2YTQ2YzA4Y2Q3ZTMwODc1MTFjYzM5L3RhYmxlcmFuZ2U6NDc2ZDVkNGM3MzZhNDZjMDhjZDdlMzA4NzUxMWNjMzlfMTAtMTEtMS0xLTMwMTE0_09d347a6-9f43-42d9-a354-b2e78c41e508">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:42.365%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.710%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.710%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.710%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.710%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.710%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.715%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The service cost component is recorded in cost of sales and operating expenses in the condensed consolidated statement of operations. All other cost components are recorded in other income (expense), net in the condensed consolidated statement of operations.</span></div></ix:nonNumeric><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><ix:nonNumeric contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" name="a:EmployerContributionsAndExpectedEmployerContributionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82NC9mcmFnOjZmNDZlYmExMzAxNTQ1YWNiY2MwODUxMjllZDlhZmI3L3RleHRyZWdpb246NmY0NmViYTEzMDE1NDVhY2JjYzA4NTEyOWVkOWFmYjdfNjIy_ba2213d5-28a6-42f9-8155-e90c786ba5dd" escape="true"><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Employer contributions and expected future employer contributions for the remainder of the year were as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.771%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.724%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.729%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Employer Contributions</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For Remainder of Year</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. defined benefit plans</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8454ff09d8134a2fb231984b395af89d_D20211101-20220131" decimals="-6" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82NC9mcmFnOjZmNDZlYmExMzAxNTQ1YWNiY2MwODUxMjllZDlhZmI3L3RhYmxlOjkxODkyM2U0YTU2MzQ0NzVhOWFjNjYwY2YyZjE0MDIwL3RhYmxlcmFuZ2U6OTE4OTIzZTRhNTYzNDQ3NWE5YWM2NjBjZjJmMTQwMjBfNC0xLTEtMS0zMDExNA_1b042d81-4866-45c1-9294-8ea215459cb4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i151e64785a6246818b5fa21ee1ee8f21_D20201101-20210131" decimals="-6" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82NC9mcmFnOjZmNDZlYmExMzAxNTQ1YWNiY2MwODUxMjllZDlhZmI3L3RhYmxlOjkxODkyM2U0YTU2MzQ0NzVhOWFjNjYwY2YyZjE0MDIwL3RhYmxlcmFuZ2U6OTE4OTIzZTRhNTYzNDQ3NWE5YWM2NjBjZjJmMTQwMjBfNC0zLTEtMS0zMDExNA_9afb043f-dedf-4d64-b292-d1813283b129">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39672334328841558d3a18821db61895_I20220131" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82NC9mcmFnOjZmNDZlYmExMzAxNTQ1YWNiY2MwODUxMjllZDlhZmI3L3RhYmxlOjkxODkyM2U0YTU2MzQ0NzVhOWFjNjYwY2YyZjE0MDIwL3RhYmxlcmFuZ2U6OTE4OTIzZTRhNTYzNDQ3NWE5YWM2NjBjZjJmMTQwMjBfNC0xMC0xLTEtMzAxMTQ_2c69d901-9404-49be-9e64-00f149f5b219">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. defined benefit plans</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id63140b493914a99a6c71088f76848c1_D20211101-20220131" decimals="-6" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82NC9mcmFnOjZmNDZlYmExMzAxNTQ1YWNiY2MwODUxMjllZDlhZmI3L3RhYmxlOjkxODkyM2U0YTU2MzQ0NzVhOWFjNjYwY2YyZjE0MDIwL3RhYmxlcmFuZ2U6OTE4OTIzZTRhNTYzNDQ3NWE5YWM2NjBjZjJmMTQwMjBfNS0xLTEtMS0zMDExNA_25d140fa-d448-4bd5-9707-275d039c487e">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2cb1409c861e47b69fd591e421c1d29a_D20201101-20210131" decimals="-6" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82NC9mcmFnOjZmNDZlYmExMzAxNTQ1YWNiY2MwODUxMjllZDlhZmI3L3RhYmxlOjkxODkyM2U0YTU2MzQ0NzVhOWFjNjYwY2YyZjE0MDIwL3RhYmxlcmFuZ2U6OTE4OTIzZTRhNTYzNDQ3NWE5YWM2NjBjZjJmMTQwMjBfNS0zLTEtMS0zMDExNA_d90fa266-8205-4b3f-83a9-bd8c197ae596">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea4e6dcfdd864c84addac4f7be206f60_I20220131" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82NC9mcmFnOjZmNDZlYmExMzAxNTQ1YWNiY2MwODUxMjllZDlhZmI3L3RhYmxlOjkxODkyM2U0YTU2MzQ0NzVhOWFjNjYwY2YyZjE0MDIwL3RhYmxlcmFuZ2U6OTE4OTIzZTRhNTYzNDQ3NWE5YWM2NjBjZjJmMTQwMjBfNS0xMC0xLTEtMzAxMTQ_79bb2616-b6e7-4d00-a453-328be5b848ef">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AGILENT TECHNOLOGIES, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) - (Continued) </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div id="if825c91f15a047ec9e67e0189634a349_67"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12.   <ix:nonNumeric contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82Ny9mcmFnOjA0OGVkNDI0ZTQwNDQ3MzlhODJmMThlNjU4YjU1YTJjL3RleHRyZWdpb246MDQ4ZWQ0MjRlNDA0NDczOWE4MmYxOGU2NThiNTVhMmNfMTU3NA_9a6af9bf-c5bf-41ba-abef-57eca8c795a0" continuedAt="i25fa06b03f174b23aefc10d64e9b916f" escape="true">WARRANTIES AND CONTINGENCIES</ix:nonNumeric></span></div><ix:continuation id="i25fa06b03f174b23aefc10d64e9b916f"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Warranties</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We accrue for standard warranty costs based on historical trends in actual warranty charges over the past 12 months. The accrual is reviewed regularly and periodically adjusted to reflect changes in warranty cost over the period. The standard warranty accrual balances are held in other accrued and other long-term liabilities on our condensed consolidated balance sheet. Our standard warranty terms typically extend to one year from the date of delivery, depending on the product.  </span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><ix:nonNumeric contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" name="us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82Ny9mcmFnOjA0OGVkNDI0ZTQwNDQ3MzlhODJmMThlNjU4YjU1YTJjL3RleHRyZWdpb246MDQ4ZWQ0MjRlNDA0NDczOWE4MmYxOGU2NThiNTVhMmNfMTU3OA_07bddd64-9620-4399-a25f-857d4f4604e6" escape="true"><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the standard warranty accrual activity is shown in the table below:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:72.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended </span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Standard warranty accrual, beginning balance</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6390807210d74c6f9cae496ea2122a5a_I20211031" decimals="-6" name="us-gaap:StandardProductWarrantyAccrual" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82Ny9mcmFnOjA0OGVkNDI0ZTQwNDQ3MzlhODJmMThlNjU4YjU1YTJjL3RhYmxlOmU1NDUzNDE1ZDhiZjRkZWRhNzkxNTVkNDg1NDU5ZjAzL3RhYmxlcmFuZ2U6ZTU0NTM0MTVkOGJmNGRlZGE3OTE1NWQ0ODU0NTlmMDNfNC0xLTEtMS0zMDExNA_5e14af41-a96e-4e3a-91b3-820631b06997">30</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id69612e49fa546c0bf63ff5ad436ccc6_I20201031" decimals="-6" name="us-gaap:StandardProductWarrantyAccrual" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82Ny9mcmFnOjA0OGVkNDI0ZTQwNDQ3MzlhODJmMThlNjU4YjU1YTJjL3RhYmxlOmU1NDUzNDE1ZDhiZjRkZWRhNzkxNTVkNDg1NDU5ZjAzL3RhYmxlcmFuZ2U6ZTU0NTM0MTVkOGJmNGRlZGE3OTE1NWQ0ODU0NTlmMDNfNC0zLTEtMS0zMDExNA_062a976c-a1c5-4d17-8e04-fd61f930c087">32</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accruals for warranties including change in estimates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" decimals="-6" name="us-gaap:StandardProductWarrantyAccrualWarrantiesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82Ny9mcmFnOjA0OGVkNDI0ZTQwNDQ3MzlhODJmMThlNjU4YjU1YTJjL3RhYmxlOmU1NDUzNDE1ZDhiZjRkZWRhNzkxNTVkNDg1NDU5ZjAzL3RhYmxlcmFuZ2U6ZTU0NTM0MTVkOGJmNGRlZGE3OTE1NWQ0ODU0NTlmMDNfNS0xLTEtMS0zMDExNA_1c340f66-35e9-4204-843e-73483c9d0a69">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131" decimals="-6" name="us-gaap:StandardProductWarrantyAccrualWarrantiesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82Ny9mcmFnOjA0OGVkNDI0ZTQwNDQ3MzlhODJmMThlNjU4YjU1YTJjL3RhYmxlOmU1NDUzNDE1ZDhiZjRkZWRhNzkxNTVkNDg1NDU5ZjAzL3RhYmxlcmFuZ2U6ZTU0NTM0MTVkOGJmNGRlZGE3OTE1NWQ0ODU0NTlmMDNfNS0zLTEtMS0zMDExNA_0450b587-3480-4298-bdeb-ca0cf7d59db5">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements made during the period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" decimals="-6" name="us-gaap:StandardProductWarrantyAccrualPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82Ny9mcmFnOjA0OGVkNDI0ZTQwNDQ3MzlhODJmMThlNjU4YjU1YTJjL3RhYmxlOmU1NDUzNDE1ZDhiZjRkZWRhNzkxNTVkNDg1NDU5ZjAzL3RhYmxlcmFuZ2U6ZTU0NTM0MTVkOGJmNGRlZGE3OTE1NWQ0ODU0NTlmMDNfNi0xLTEtMS0zMDExNA_003c629e-d217-4fc5-8d66-d79819b73ce2">13</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131" decimals="-6" name="us-gaap:StandardProductWarrantyAccrualPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82Ny9mcmFnOjA0OGVkNDI0ZTQwNDQ3MzlhODJmMThlNjU4YjU1YTJjL3RhYmxlOmU1NDUzNDE1ZDhiZjRkZWRhNzkxNTVkNDg1NDU5ZjAzL3RhYmxlcmFuZ2U6ZTU0NTM0MTVkOGJmNGRlZGE3OTE1NWQ0ODU0NTlmMDNfNi0zLTEtMS0zMDExNA_c685600f-ddd1-41c5-8aed-faa402ef8077">15</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Standard warranty accrual, ending balance</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131" decimals="-6" name="us-gaap:StandardProductWarrantyAccrual" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82Ny9mcmFnOjA0OGVkNDI0ZTQwNDQ3MzlhODJmMThlNjU4YjU1YTJjL3RhYmxlOmU1NDUzNDE1ZDhiZjRkZWRhNzkxNTVkNDg1NDU5ZjAzL3RhYmxlcmFuZ2U6ZTU0NTM0MTVkOGJmNGRlZGE3OTE1NWQ0ODU0NTlmMDNfNy0xLTEtMS0zMDExNA_db4cb288-feda-4ccc-a4e8-d7cefa2a0fe8">30</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b47b15753c94f0b80143556347e39b7_I20210131" decimals="-6" name="us-gaap:StandardProductWarrantyAccrual" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82Ny9mcmFnOjA0OGVkNDI0ZTQwNDQ3MzlhODJmMThlNjU4YjU1YTJjL3RhYmxlOmU1NDUzNDE1ZDhiZjRkZWRhNzkxNTVkNDg1NDU5ZjAzL3RhYmxlcmFuZ2U6ZTU0NTM0MTVkOGJmNGRlZGE3OTE1NWQ0ODU0NTlmMDNfNy0zLTEtMS0zMDExNA_40c31e78-5e3d-4a02-92eb-f925b476d5e6">32</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accruals for warranties due within one year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131" decimals="-6" name="us-gaap:StandardProductWarrantyAccrualCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82Ny9mcmFnOjA0OGVkNDI0ZTQwNDQ3MzlhODJmMThlNjU4YjU1YTJjL3RhYmxlOmU1NDUzNDE1ZDhiZjRkZWRhNzkxNTVkNDg1NDU5ZjAzL3RhYmxlcmFuZ2U6ZTU0NTM0MTVkOGJmNGRlZGE3OTE1NWQ0ODU0NTlmMDNfOS0xLTEtMS0zMDExNA_8bdb4468-cb68-410e-a9c1-9cfc10461ffa">29</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b47b15753c94f0b80143556347e39b7_I20210131" decimals="-6" name="us-gaap:StandardProductWarrantyAccrualCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82Ny9mcmFnOjA0OGVkNDI0ZTQwNDQ3MzlhODJmMThlNjU4YjU1YTJjL3RhYmxlOmU1NDUzNDE1ZDhiZjRkZWRhNzkxNTVkNDg1NDU5ZjAzL3RhYmxlcmFuZ2U6ZTU0NTM0MTVkOGJmNGRlZGE3OTE1NWQ0ODU0NTlmMDNfOS0zLTEtMS0zMDExNA_0e63f8d5-3a8e-4d44-b3a6-61d6e4216235">31</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accruals for warranties due after one year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131" decimals="-6" name="us-gaap:StandardProductWarrantyAccrualNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82Ny9mcmFnOjA0OGVkNDI0ZTQwNDQ3MzlhODJmMThlNjU4YjU1YTJjL3RhYmxlOmU1NDUzNDE1ZDhiZjRkZWRhNzkxNTVkNDg1NDU5ZjAzL3RhYmxlcmFuZ2U6ZTU0NTM0MTVkOGJmNGRlZGE3OTE1NWQ0ODU0NTlmMDNfMTAtMS0xLTEtMzAxMTQ_74049db4-2f16-430e-bb5a-9bd3d26e9cc3">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b47b15753c94f0b80143556347e39b7_I20210131" decimals="-6" name="us-gaap:StandardProductWarrantyAccrualNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82Ny9mcmFnOjA0OGVkNDI0ZTQwNDQ3MzlhODJmMThlNjU4YjU1YTJjL3RhYmxlOmU1NDUzNDE1ZDhiZjRkZWRhNzkxNTVkNDg1NDU5ZjAzL3RhYmxlcmFuZ2U6ZTU0NTM0MTVkOGJmNGRlZGE3OTE1NWQ0ODU0NTlmMDNfMTAtMy0xLTEtMzAxMTQ_685e0466-5904-422c-acc8-9825c80758de">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Standard warranty accrual, ending balance</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131" decimals="-6" name="us-gaap:StandardProductWarrantyAccrual" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82Ny9mcmFnOjA0OGVkNDI0ZTQwNDQ3MzlhODJmMThlNjU4YjU1YTJjL3RhYmxlOmU1NDUzNDE1ZDhiZjRkZWRhNzkxNTVkNDg1NDU5ZjAzL3RhYmxlcmFuZ2U6ZTU0NTM0MTVkOGJmNGRlZGE3OTE1NWQ0ODU0NTlmMDNfMTEtMS0xLTEtMzAxMTQ_43e0a824-cda7-430f-9f4d-f71067f7d6b1">30</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b47b15753c94f0b80143556347e39b7_I20210131" decimals="-6" name="us-gaap:StandardProductWarrantyAccrual" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82Ny9mcmFnOjA0OGVkNDI0ZTQwNDQ3MzlhODJmMThlNjU4YjU1YTJjL3RhYmxlOmU1NDUzNDE1ZDhiZjRkZWRhNzkxNTVkNDg1NDU5ZjAzL3RhYmxlcmFuZ2U6ZTU0NTM0MTVkOGJmNGRlZGE3OTE1NWQ0ODU0NTlmMDNfMTEtMy0xLTEtMzAxMTQ_138c70d1-e195-449f-b29f-43bcb0fcacbc">32</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Bank Guarantees</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Guarantees consist primarily of outstanding standby letters of credit and bank guarantees and were approximately $<ix:nonFraction unitRef="usd" contextRef="i6390807210d74c6f9cae496ea2122a5a_I20211031" decimals="-6" name="us-gaap:BankAcceptancesExecuted" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82Ny9mcmFnOjA0OGVkNDI0ZTQwNDQ3MzlhODJmMThlNjU4YjU1YTJjL3RleHRyZWdpb246MDQ4ZWQ0MjRlNDA0NDczOWE4MmYxOGU2NThiNTVhMmNfNzc0_05914232-1998-4e43-8274-f5e10e1a49b2"><ix:nonFraction unitRef="usd" contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131" decimals="-6" name="us-gaap:BankAcceptancesExecuted" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82Ny9mcmFnOjA0OGVkNDI0ZTQwNDQ3MzlhODJmMThlNjU4YjU1YTJjL3RleHRyZWdpb246MDQ4ZWQ0MjRlNDA0NDczOWE4MmYxOGU2NThiNTVhMmNfNzc0_1498f49f-ce04-4ed2-8c33-33bf33f3672f">46</ix:nonFraction></ix:nonFraction> million as of January&#160;31, 2022 and October&#160;31, 2021, respectively. A standby letter of credit is a guarantee of payment issued by a bank on behalf of us that is used as payment of last resort should we fail to fulfill a contractual commitment with a third party. A bank guarantee is a promise from a bank or other lending institution that if we default on a loan, the bank will cover the loss.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contingencies</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are involved in lawsuits, claims, investigations and proceedings, including, but not limited to, intellectual property, commercial, real estate, environmental and employment matters, which arise in the ordinary course of business. There are no matters pending that we currently believe are reasonably possible of having a material impact to our business, condensed consolidated financial condition, results of operations or cash flows.</span></div></ix:continuation><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div id="if825c91f15a047ec9e67e0189634a349_70"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13.   <ix:nonNumeric contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" name="us-gaap:ShortTermDebtTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83MC9mcmFnOjAyNGIzODNkZjRjNTRhYzNiM2NhOTBiYWY5NDJjMmY0L3RleHRyZWdpb246MDI0YjM4M2RmNGM1NGFjM2IzY2E5MGJhZjk0MmMyZjRfMTczMA_ed120276-dbbd-428a-844c-ce780f56e819" continuedAt="ied96a9e3d82f44dcbbdb1581d95af756" escape="true">SHORT-TERM DEBT</ix:nonNumeric></span></div><ix:continuation id="ied96a9e3d82f44dcbbdb1581d95af756" continuedAt="i3c591f02860e490bbfbc4aacdcac7037"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Credit Facilities</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On <ix:nonNumeric contextRef="i6353332b36004c5c9db76cacfa73e855_D20190313-20190313" name="us-gaap:LineOfCreditFacilityInitiationDate1" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83MC9mcmFnOjAyNGIzODNkZjRjNTRhYzNiM2NhOTBiYWY5NDJjMmY0L3RleHRyZWdpb246MDI0YjM4M2RmNGM1NGFjM2IzY2E5MGJhZjk0MmMyZjRfNTI_b7888151-4173-4da1-998c-ff3b2c691254">March 13, 2019</ix:nonNumeric>, we entered into a credit agreement with a group of financial institutions which, as amended, provided for a $<ix:nonFraction unitRef="usd" contextRef="i8297b19666824b1083fbcdc032757e96_I20190313" decimals="-9" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83MC9mcmFnOjAyNGIzODNkZjRjNTRhYzNiM2NhOTBiYWY5NDJjMmY0L3RleHRyZWdpb246MDI0YjM4M2RmNGM1NGFjM2IzY2E5MGJhZjk0MmMyZjRfMTY0_33a784f2-ed1d-418b-90ec-dd5d5900d569">1</ix:nonFraction> billion <ix:nonNumeric contextRef="i6353332b36004c5c9db76cacfa73e855_D20190313-20190313" name="us-gaap:ShortTermDebtTerms" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83MC9mcmFnOjAyNGIzODNkZjRjNTRhYzNiM2NhOTBiYWY5NDJjMmY0L3RleHRyZWdpb246MDI0YjM4M2RmNGM1NGFjM2IzY2E5MGJhZjk0MmMyZjRfMTczMw_728af604-35c5-46e0-b593-f343b9ecdc79">five</ix:nonNumeric>-year unsecured credit facility that will expire on <ix:nonNumeric contextRef="i6353332b36004c5c9db76cacfa73e855_D20190313-20190313" name="us-gaap:LineOfCreditFacilityExpirationDate1" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83MC9mcmFnOjAyNGIzODNkZjRjNTRhYzNiM2NhOTBiYWY5NDJjMmY0L3RleHRyZWdpb246MDI0YjM4M2RmNGM1NGFjM2IzY2E5MGJhZjk0MmMyZjRfMjIz_ce0431b1-eff2-4df0-ba65-0126ad0c196c">March 13, 2024</ix:nonNumeric> and incremental term loan facilities in an aggregate amount of up to $<ix:nonFraction unitRef="usd" contextRef="ic4c5e106421a497fb99105e140c6fd6c_I20191021" decimals="-6" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83MC9mcmFnOjAyNGIzODNkZjRjNTRhYzNiM2NhOTBiYWY5NDJjMmY0L3RleHRyZWdpb246MDI0YjM4M2RmNGM1NGFjM2IzY2E5MGJhZjk0MmMyZjRfMjk1_d4873a52-74e8-42e1-ad8f-e1f185363e08">500</ix:nonFraction> million.&#160;On April 21, 2021, we entered into an incremental assumption agreement, pursuant to which the aggregate amount available for borrowing under the revolving credit facility was increased to $<ix:nonFraction unitRef="usd" contextRef="i0a3fbf71b5484a8c9274ae6020d3080e_I20210421" decimals="-7" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83MC9mcmFnOjAyNGIzODNkZjRjNTRhYzNiM2NhOTBiYWY5NDJjMmY0L3RleHRyZWdpb246MDI0YjM4M2RmNGM1NGFjM2IzY2E5MGJhZjk0MmMyZjRfNDg3_b5a9993f-3099-4611-9e25-a87b648d8f6f">1.35</ix:nonFraction>&#160;billion and the aggregate amount available for incremental facilities was refreshed to remain at $<ix:nonFraction unitRef="usd" contextRef="id62809c6a49144e4bae80c1fce300e42_I20210421" decimals="-6" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83MC9mcmFnOjAyNGIzODNkZjRjNTRhYzNiM2NhOTBiYWY5NDJjMmY0L3RleHRyZWdpb246MDI0YjM4M2RmNGM1NGFjM2IzY2E5MGJhZjk0MmMyZjRfNTc5_285b8b8d-3824-44fc-bc39-e654a16c3051">500</ix:nonFraction>&#160;million. As of January&#160;31, 2022, we had <ix:nonFraction unitRef="usd" contextRef="i4f579a58da844fa8ab292e8b3f4f6961_I20220131" decimals="-6" name="us-gaap:LineOfCreditFacilityFairValueOfAmountOutstanding" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83MC9mcmFnOjAyNGIzODNkZjRjNTRhYzNiM2NhOTBiYWY5NDJjMmY0L3RleHRyZWdpb246MDI0YjM4M2RmNGM1NGFjM2IzY2E5MGJhZjk0MmMyZjRfNjAw_690e1470-b6a5-4391-a915-592cb9a9ec01">no</ix:nonFraction> borrowings outstanding under the credit facility and <ix:nonFraction unitRef="usd" contextRef="ifbbc3ea9576a4f2eba2f7f1808345734_I20220131" decimals="-9" name="us-gaap:LineOfCreditFacilityFairValueOfAmountOutstanding" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83MC9mcmFnOjAyNGIzODNkZjRjNTRhYzNiM2NhOTBiYWY5NDJjMmY0L3RleHRyZWdpb246MDI0YjM4M2RmNGM1NGFjM2IzY2E5MGJhZjk0MmMyZjRfNjU2_26893a2b-ec05-4aa8-8f66-d64143ac2265">no</ix:nonFraction> borrowings under the incremental facilities. We were in compliance with the covenants for the credit facility during the three months ended January&#160;31, 2022.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AGILENT TECHNOLOGIES, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) - (Continued) </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:continuation id="i3c591f02860e490bbfbc4aacdcac7037" continuedAt="i4007af2fe37d4356981e28e3e844365b">Commercial Paper</ix:continuation></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><ix:continuation id="i4007af2fe37d4356981e28e3e844365b" continuedAt="ic3cdb4ebd78940c297c25c71e514050a"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under our U.S. commercial paper program, the company may issue and sell unsecured, short-term promissory notes in the aggregate principal amount not to exceed $<ix:nonFraction unitRef="usd" contextRef="i87ff5a86228e4f9b8b972888d1067302_I20210618" decimals="7" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83MC9mcmFnOjAyNGIzODNkZjRjNTRhYzNiM2NhOTBiYWY5NDJjMmY0L3RleHRyZWdpb246MDI0YjM4M2RmNGM1NGFjM2IzY2E5MGJhZjk0MmMyZjRfMTE0MQ_d7ab7911-dee3-4cea-8d1f-6c6be9cbf468">1.35</ix:nonFraction>&#160;billion with up to 397-day maturities. At any point in time, the company intends to maintain available commitments under its revolving credit facility in an amount at least equal to the amount of the commercial paper notes outstanding. Amounts available under the program may be borrowed, repaid and re-borrowed from time to time. The proceeds from issuances under the program may be used for general corporate purposes. During the three months ended January&#160;31, 2022, we borrowed and repaid $<ix:nonFraction unitRef="usd" contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfCommercialPaper" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83MC9mcmFnOjAyNGIzODNkZjRjNTRhYzNiM2NhOTBiYWY5NDJjMmY0L3RleHRyZWdpb246MDI0YjM4M2RmNGM1NGFjM2IzY2E5MGJhZjk0MmMyZjRfMTA5OTUxMTYzMDAzOQ_109b4c9e-d79a-4d35-b47c-a6168b0bf93e"><ix:nonFraction unitRef="usd" contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" decimals="-6" name="us-gaap:RepaymentsOfCommercialPaper" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83MC9mcmFnOjAyNGIzODNkZjRjNTRhYzNiM2NhOTBiYWY5NDJjMmY0L3RleHRyZWdpb246MDI0YjM4M2RmNGM1NGFjM2IzY2E5MGJhZjk0MmMyZjRfMTA5OTUxMTYzMDAzOQ_bb4aa28a-1dcd-4dd3-95a2-d6f5a2b27318">240</ix:nonFraction></ix:nonFraction> million. As </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">January&#160;31, 2022</span></ix:continuation><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ic3cdb4ebd78940c297c25c71e514050a">, we had <ix:nonFraction unitRef="usd" contextRef="ica23bb0f88b84e40a5cf6dce93ac3016_I20220131" decimals="-6" name="us-gaap:LineOfCreditFacilityFairValueOfAmountOutstanding" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83MC9mcmFnOjAyNGIzODNkZjRjNTRhYzNiM2NhOTBiYWY5NDJjMmY0L3RleHRyZWdpb246MDI0YjM4M2RmNGM1NGFjM2IzY2E5MGJhZjk0MmMyZjRfMTU1MQ_0da2b2a2-b8a1-42d3-9294-1223dd3c3104">no</ix:nonFraction> borrowings outstanding under our U.S. commercial paper program.</ix:continuation> </span></div><div style="text-align:justify"><span><br/></span></div><div id="if825c91f15a047ec9e67e0189634a349_73"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14.   <ix:nonNumeric contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" name="us-gaap:LongTermDebtTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83My9mcmFnOjA4YmFhZmE5OWVjZTQ1MjA4ODQ5NGY1MzA2NWYwYzAzL3RleHRyZWdpb246MDhiYWFmYTk5ZWNlNDUyMDg4NDk0ZjUzMDY1ZjBjMDNfMjI5OQ_ccf4c467-0e93-4eff-8e80-05de9ef468ed" continuedAt="i80fef28f611e4e5483033c0a038da1c9" escape="true">LONG-TERM DEBT</ix:nonNumeric></span></div><ix:continuation id="i80fef28f611e4e5483033c0a038da1c9" continuedAt="if853f2e17c124463ac0f1e9fed9e54b1"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Senior Notes</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><ix:nonNumeric contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" name="us-gaap:ScheduleOfDebtInstrumentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83My9mcmFnOjA4YmFhZmE5OWVjZTQ1MjA4ODQ5NGY1MzA2NWYwYzAzL3RleHRyZWdpb246MDhiYWFmYTk5ZWNlNDUyMDg4NDk0ZjUzMDY1ZjBjMDNfMjMwNw_93438e43-3637-43f7-a097-3296f4a7030e" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the company&#8217;s long-term senior notes:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.807%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.469%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.853%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.471%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized <br/>Principal</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Principal</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023 Senior Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8601e6d640c4cdbaf6e7e979a3badb4_I20220131" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83My9mcmFnOjA4YmFhZmE5OWVjZTQ1MjA4ODQ5NGY1MzA2NWYwYzAzL3RhYmxlOjQyYjcwODMzNjk0ZDQ5MDI5NTI3ZGMxZjVhYzRmODY1L3RhYmxlcmFuZ2U6NDJiNzA4MzM2OTRkNDkwMjk1MjdkYzFmNWFjNGY4NjVfNC0xLTEtMS0zMDExNA_fb1c3dee-853d-4f5f-a66b-482a4232221e">599</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie230dae4aa294d5b840b36798467586f_I20211031" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83My9mcmFnOjA4YmFhZmE5OWVjZTQ1MjA4ODQ5NGY1MzA2NWYwYzAzL3RhYmxlOjQyYjcwODMzNjk0ZDQ5MDI5NTI3ZGMxZjVhYzRmODY1L3RhYmxlcmFuZ2U6NDJiNzA4MzM2OTRkNDkwMjk1MjdkYzFmNWFjNGY4NjVfNC0zLTEtMS0zMDExNA_71814eb9-285b-40eb-9cf0-55ee6613b936">599</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026 Senior Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ff56f3c0b054dd0b0c0f6d3e90df039_I20220131" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83My9mcmFnOjA4YmFhZmE5OWVjZTQ1MjA4ODQ5NGY1MzA2NWYwYzAzL3RhYmxlOjQyYjcwODMzNjk0ZDQ5MDI5NTI3ZGMxZjVhYzRmODY1L3RhYmxlcmFuZ2U6NDJiNzA4MzM2OTRkNDkwMjk1MjdkYzFmNWFjNGY4NjVfNS0xLTEtMS0zMDExNA_f2d91fc5-4643-4d66-b73c-b7d5df5d4db5">299</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21c87c57472646b18bfda7e117eca64a_I20211031" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83My9mcmFnOjA4YmFhZmE5OWVjZTQ1MjA4ODQ5NGY1MzA2NWYwYzAzL3RhYmxlOjQyYjcwODMzNjk0ZDQ5MDI5NTI3ZGMxZjVhYzRmODY1L3RhYmxlcmFuZ2U6NDJiNzA4MzM2OTRkNDkwMjk1MjdkYzFmNWFjNGY4NjVfNS0zLTEtMS0zMDExNA_0d54ad5b-7b8d-47f2-b86f-fff3acf14dc3">298</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2029 Senior Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35a5d7927ffc44debd0874726bf6a844_I20220131" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83My9mcmFnOjA4YmFhZmE5OWVjZTQ1MjA4ODQ5NGY1MzA2NWYwYzAzL3RhYmxlOjQyYjcwODMzNjk0ZDQ5MDI5NTI3ZGMxZjVhYzRmODY1L3RhYmxlcmFuZ2U6NDJiNzA4MzM2OTRkNDkwMjk1MjdkYzFmNWFjNGY4NjVfNi0xLTEtMS0zMDExNA_d1636dc7-a7c8-4efd-a32e-e11c004ba769">494</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8088c733be554ef0a2d2ce49c54cb56a_I20211031" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83My9mcmFnOjA4YmFhZmE5OWVjZTQ1MjA4ODQ5NGY1MzA2NWYwYzAzL3RhYmxlOjQyYjcwODMzNjk0ZDQ5MDI5NTI3ZGMxZjVhYzRmODY1L3RhYmxlcmFuZ2U6NDJiNzA4MzM2OTRkNDkwMjk1MjdkYzFmNWFjNGY4NjVfNi0zLTEtMS0zMDExNA_3945cbeb-90bc-4fd0-8100-53297ea117ba">494</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2030 Senior Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i340410db81954133842fda25bab46456_I20220131" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83My9mcmFnOjA4YmFhZmE5OWVjZTQ1MjA4ODQ5NGY1MzA2NWYwYzAzL3RhYmxlOjQyYjcwODMzNjk0ZDQ5MDI5NTI3ZGMxZjVhYzRmODY1L3RhYmxlcmFuZ2U6NDJiNzA4MzM2OTRkNDkwMjk1MjdkYzFmNWFjNGY4NjVfNy0xLTEtMS0zMDExNA_c76a4769-e5eb-4e1d-8382-73b92fd687f6">496</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4505f8e4f0714a489cb047cfbb537298_I20211031" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83My9mcmFnOjA4YmFhZmE5OWVjZTQ1MjA4ODQ5NGY1MzA2NWYwYzAzL3RhYmxlOjQyYjcwODMzNjk0ZDQ5MDI5NTI3ZGMxZjVhYzRmODY1L3RhYmxlcmFuZ2U6NDJiNzA4MzM2OTRkNDkwMjk1MjdkYzFmNWFjNGY4NjVfNy0zLTEtMS0zMDExNA_ff5898e8-0adb-4382-9d12-c11afddfefab">496</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2031 Senior Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ebf24f01a4e49d69ecb2c5a5f3230d0_I20220131" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83My9mcmFnOjA4YmFhZmE5OWVjZTQ1MjA4ODQ5NGY1MzA2NWYwYzAzL3RhYmxlOjQyYjcwODMzNjk0ZDQ5MDI5NTI3ZGMxZjVhYzRmODY1L3RhYmxlcmFuZ2U6NDJiNzA4MzM2OTRkNDkwMjk1MjdkYzFmNWFjNGY4NjVfOC0xLTEtMS0zMDExNA_6cf98521-6d86-4f3c-8823-922485ae1dd2">842</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02856e1853de45f185faca871ffc1d85_I20211031" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83My9mcmFnOjA4YmFhZmE5OWVjZTQ1MjA4ODQ5NGY1MzA2NWYwYzAzL3RhYmxlOjQyYjcwODMzNjk0ZDQ5MDI5NTI3ZGMxZjVhYzRmODY1L3RhYmxlcmFuZ2U6NDJiNzA4MzM2OTRkNDkwMjk1MjdkYzFmNWFjNGY4NjVfOC0zLTEtMS0zMDExNA_b77305ba-d386-4b61-959d-7c8e8f64cce5">842</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83My9mcmFnOjA4YmFhZmE5OWVjZTQ1MjA4ODQ5NGY1MzA2NWYwYzAzL3RhYmxlOjQyYjcwODMzNjk0ZDQ5MDI5NTI3ZGMxZjVhYzRmODY1L3RhYmxlcmFuZ2U6NDJiNzA4MzM2OTRkNDkwMjk1MjdkYzFmNWFjNGY4NjVfOS0xLTEtMS0zMDExNA_3bbb6123-9667-4843-8e5d-02eb40cedb1b">2,730</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6390807210d74c6f9cae496ea2122a5a_I20211031" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83My9mcmFnOjA4YmFhZmE5OWVjZTQ1MjA4ODQ5NGY1MzA2NWYwYzAzL3RhYmxlOjQyYjcwODMzNjk0ZDQ5MDI5NTI3ZGMxZjVhYzRmODY1L3RhYmxlcmFuZ2U6NDJiNzA4MzM2OTRkNDkwMjk1MjdkYzFmNWFjNGY4NjVfOS0zLTEtMS0zMDExNA_be8b0646-8716-4d3d-9a42-f516bb934f69">2,729</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="if853f2e17c124463ac0f1e9fed9e54b1">All outstanding notes listed above are unsecured and rank equally in right of payment with all of Agilent&#8217;s other senior unsecured indebtedness. There have been no other changes to the principal, maturity, interest rates and interest payment terms of the Agilent senior notes, detailed in the table above, in the three months ended January&#160;31, 2022 as compared to the senior notes described in our Annual Report on Form 10-K for the fiscal year ended October&#160;31, 2021.</ix:continuation>  </span></div><div style="text-align:justify"><span><br/></span></div><div id="if825c91f15a047ec9e67e0189634a349_76"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15.   <ix:nonNumeric contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83Ni9mcmFnOjQ2ZDI2ZThkOTg2NjRiNmViMWM5MjA1ODhjNzU0NzI4L3RleHRyZWdpb246NDZkMjZlOGQ5ODY2NGI2ZWIxYzkyMDU4OGM3NTQ3MjhfMzMzMg_dc04c43d-2a57-4fac-80ea-1ef353e6e378" continuedAt="iccac3e76e0f249b3ba9cdd7ba3c45128" escape="true">STOCKHOLDERS' EQUITY </ix:nonNumeric></span></div><ix:continuation id="iccac3e76e0f249b3ba9cdd7ba3c45128" continuedAt="i4e41e92144ea488283d56db1da88b4a5"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock Repurchase Program </span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 19, 2018 we announced that our board of directors had approved a share repurchase program (the "2019 repurchase program") designed, among other things, to reduce or eliminate dilution resulting from issuance of stock under the company's employee equity incentive programs. The 2019 repurchase program authorizes the purchase of up to $<ix:nonFraction unitRef="usd" contextRef="i629b697ae777498d9e2c067c3e5a581e_I20181119" decimals="-7" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83Ni9mcmFnOjQ2ZDI2ZThkOTg2NjRiNmViMWM5MjA1ODhjNzU0NzI4L3RleHRyZWdpb246NDZkMjZlOGQ5ODY2NGI2ZWIxYzkyMDU4OGM3NTQ3MjhfNDA5_3a91b664-8be7-4cac-8c07-316c5f53d084">1.75</ix:nonFraction> billion of our common stock at the company's discretion and has no fixed termination date. The 2019 repurchase program does not require the company to acquire a specific number of shares and may be suspended, amended or discontinued at any time. During the three months ended January&#160;31, 2021, we repurchased and retired <ix:nonFraction unitRef="shares" contextRef="id3f922976d404efe924b23253513f94b_D20201101-20210131" decimals="0" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83Ni9mcmFnOjQ2ZDI2ZThkOTg2NjRiNmViMWM5MjA1ODhjNzU0NzI4L3RleHRyZWdpb246NDZkMjZlOGQ5ODY2NGI2ZWIxYzkyMDU4OGM3NTQ3MjhfMTY0OTI2NzQ0NTkyMg_402b2489-f5ef-4144-8e01-380bff151aae">2.9</ix:nonFraction> million shares for $<ix:nonFraction unitRef="usd" contextRef="id3f922976d404efe924b23253513f94b_D20201101-20210131" decimals="-6" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83Ni9mcmFnOjQ2ZDI2ZThkOTg2NjRiNmViMWM5MjA1ODhjNzU0NzI4L3RleHRyZWdpb246NDZkMjZlOGQ5ODY2NGI2ZWIxYzkyMDU4OGM3NTQ3MjhfMTY0OTI2NzQ0NTkzMQ_caf47e9f-dceb-4ef0-9757-d0fae9b498e3">344</ix:nonFraction> million under this authorization. Effective February 18, 2021, the 2019 repurchase program was terminated and replaced by the new share repurchase program. The remaining authorization under the 2019 repurchase plan of $<ix:nonFraction unitRef="usd" contextRef="i11897c2b4a354e80b2f66e86e5b8bf11_I20210218" decimals="-6" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83Ni9mcmFnOjQ2ZDI2ZThkOTg2NjRiNmViMWM5MjA1ODhjNzU0NzI4L3RleHRyZWdpb246NDZkMjZlOGQ5ODY2NGI2ZWIxYzkyMDU4OGM3NTQ3MjhfMTA4Ng_8758a296-445d-4f1e-9af4-78a6f4c1d813">193</ix:nonFraction>&#160;million expired on February 18, 2021.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 16, 2021 we announced that our board of directors had approved a new share repurchase program (the "2021 repurchase program") designed, among other things, to reduce or eliminate dilution resulting from issuance of stock under the company's employee equity incentive programs. The 2021 repurchase program authorizes the purchase of up to $<ix:nonFraction unitRef="usd" contextRef="if65151f0282a48c5b160bfa0fd1f9626_I20210218" decimals="-7" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83Ni9mcmFnOjQ2ZDI2ZThkOTg2NjRiNmViMWM5MjA1ODhjNzU0NzI4L3RleHRyZWdpb246NDZkMjZlOGQ5ODY2NGI2ZWIxYzkyMDU4OGM3NTQ3MjhfMTQ3MA_4dd846c7-25da-405e-bd81-95d8d6f349d2">2.0</ix:nonFraction>&#160;billion of our common stock at the company's discretion and has no fixed termination date. The 2021 repurchase program which became effective on February 18, 2021, replaced and terminated the 2019 repurchase program on that date. The 2021 repurchase program does not require the company to acquire a specific number of shares and may be suspended, amended or discontinued at any time. During the three months ended January&#160;31, 2022, we repurchased and retired <ix:nonFraction unitRef="shares" contextRef="icdcacaffa00940c38eefae4a25b246ce_D20211101-20220131" decimals="0" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83Ni9mcmFnOjQ2ZDI2ZThkOTg2NjRiNmViMWM5MjA1ODhjNzU0NzI4L3RleHRyZWdpb246NDZkMjZlOGQ5ODY2NGI2ZWIxYzkyMDU4OGM3NTQ3MjhfMTkyOQ_38fe97b6-9a41-4f21-8274-0bcf0b467f7c">2.9</ix:nonFraction> million shares for $<ix:nonFraction unitRef="usd" contextRef="icdcacaffa00940c38eefae4a25b246ce_D20211101-20220131" decimals="-6" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83Ni9mcmFnOjQ2ZDI2ZThkOTg2NjRiNmViMWM5MjA1ODhjNzU0NzI4L3RleHRyZWdpb246NDZkMjZlOGQ5ODY2NGI2ZWIxYzkyMDU4OGM3NTQ3MjhfMTk1MQ_9edc333c-f275-4c18-b160-d3eafe93a9d0">447</ix:nonFraction> million under this authorization. As of January&#160;31, 2022, we had remaining authorization to repurchase up to approximately $<ix:nonFraction unitRef="usd" contextRef="ib67bf4635858449bb282042383b1fa3e_I20220131" decimals="-6" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83Ni9mcmFnOjQ2ZDI2ZThkOTg2NjRiNmViMWM5MjA1ODhjNzU0NzI4L3RleHRyZWdpb246NDZkMjZlOGQ5ODY2NGI2ZWIxYzkyMDU4OGM3NTQ3MjhfMjA3MA_b1c473c8-7f4b-45d4-8d90-e425ef09a41c">1.13</ix:nonFraction> billion of our common stock under the 2021 repurchase program.</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AGILENT TECHNOLOGIES, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) - (Continued) </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i4e41e92144ea488283d56db1da88b4a5" continuedAt="i9342e1a13cbf4532986cc4298e44167c"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash Dividends on Shares of Common Stock</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended January&#160;31, 2022, we paid cash dividends of $<ix:nonFraction unitRef="usdPerShare" contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" decimals="3" name="us-gaap:CommonStockDividendsPerShareCashPaid" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83Ni9mcmFnOjQ2ZDI2ZThkOTg2NjRiNmViMWM5MjA1ODhjNzU0NzI4L3RleHRyZWdpb246NDZkMjZlOGQ5ODY2NGI2ZWIxYzkyMDU4OGM3NTQ3MjhfMjIzMA_bba77d6b-7e30-49f3-a58f-9e4a81f9516d">0.210</ix:nonFraction> per common share or $<ix:nonFraction unitRef="usd" contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" decimals="-6" name="us-gaap:PaymentsOfDividendsCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83Ni9mcmFnOjQ2ZDI2ZThkOTg2NjRiNmViMWM5MjA1ODhjNzU0NzI4L3RleHRyZWdpb246NDZkMjZlOGQ5ODY2NGI2ZWIxYzkyMDU4OGM3NTQ3MjhfMjI1Mw_ae5a2a8b-5daf-48b2-bb1f-4d56dd38b24d">63</ix:nonFraction> million on the company's common stock. During the three months ended January&#160;31, 2021, we paid cash dividends of $<ix:nonFraction unitRef="usdPerShare" contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131" decimals="3" name="us-gaap:CommonStockDividendsPerShareCashPaid" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83Ni9mcmFnOjQ2ZDI2ZThkOTg2NjRiNmViMWM5MjA1ODhjNzU0NzI4L3RleHRyZWdpb246NDZkMjZlOGQ5ODY2NGI2ZWIxYzkyMDU4OGM3NTQ3MjhfMjM4OQ_8bd972dc-b2a6-4f55-9d71-7d159e0a2489">0.194</ix:nonFraction> per common share or $<ix:nonFraction unitRef="usd" contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131" decimals="-6" name="us-gaap:PaymentsOfDividendsCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83Ni9mcmFnOjQ2ZDI2ZThkOTg2NjRiNmViMWM5MjA1ODhjNzU0NzI4L3RleHRyZWdpb246NDZkMjZlOGQ5ODY2NGI2ZWIxYzkyMDU4OGM3NTQ3MjhfMjQxMg_7801a26c-7e79-41fd-9ff7-f1748c6a778a">59</ix:nonFraction> million  on the company's common stock. The timing and amounts of any future dividends are subject to determination and approval by our board of directors.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accumulated Other Comprehensive Income (Loss)</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83Ni9mcmFnOjQ2ZDI2ZThkOTg2NjRiNmViMWM5MjA1ODhjNzU0NzI4L3RleHRyZWdpb246NDZkMjZlOGQ5ODY2NGI2ZWIxYzkyMDU4OGM3NTQ3MjhfMzMxOQ_6b485678-3ed7-4a28-8166-b8207b3e862b" escape="true"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in accumulated other comprehensive income (loss) by component and related tax effects were as follows (in millions):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:36.126%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.113%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:9.848%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.697%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.556%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.551%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.848%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.551%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.848%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.405%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.857%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net defined benefit pension cost and post retirement plan costs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended January 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign currency translation</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Prior service credits</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Actuarial Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized gains (losses) on derivatives</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="27" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of October 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5c54dd5009274b448e1a0f238519873c_I20211031" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83Ni9mcmFnOjQ2ZDI2ZThkOTg2NjRiNmViMWM5MjA1ODhjNzU0NzI4L3RhYmxlOjU5NTJlMTZjMjE1ODQ1ZjViZGE0OTdmM2NmYjZmMjRmL3RhYmxlcmFuZ2U6NTk1MmUxNmMyMTU4NDVmNWJkYTQ5N2YzY2ZiNmYyNGZfMy00LTEtMS0zMDExNA_be1901fa-939b-4161-9a19-e6fc5c44a479">185</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec127ccabccf4e1d8b1b9f0e177d0a6d_I20211031" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83Ni9mcmFnOjQ2ZDI2ZThkOTg2NjRiNmViMWM5MjA1ODhjNzU0NzI4L3RhYmxlOjU5NTJlMTZjMjE1ODQ1ZjViZGE0OTdmM2NmYjZmMjRmL3RhYmxlcmFuZ2U6NTk1MmUxNmMyMTU4NDVmNWJkYTQ5N2YzY2ZiNmYyNGZfMy02LTEtMS0zMDExNA_a07d6bf5-c8b3-4821-8aa6-04ea7d76b6d9">124</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i02b0508da50d4d36aa148cd391ab89a2_I20211031" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83Ni9mcmFnOjQ2ZDI2ZThkOTg2NjRiNmViMWM5MjA1ODhjNzU0NzI4L3RhYmxlOjU5NTJlMTZjMjE1ODQ1ZjViZGE0OTdmM2NmYjZmMjRmL3RhYmxlcmFuZ2U6NTk1MmUxNmMyMTU4NDVmNWJkYTQ5N2YzY2ZiNmYyNGZfMy04LTEtMS0zMDExNA_5441ed22-e1dc-4665-bfa7-1bae86357d28">224</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i375e95e148364bec829da83e15fb30a0_I20211031" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83Ni9mcmFnOjQ2ZDI2ZThkOTg2NjRiNmViMWM5MjA1ODhjNzU0NzI4L3RhYmxlOjU5NTJlMTZjMjE1ODQ1ZjViZGE0OTdmM2NmYjZmMjRmL3RhYmxlcmFuZ2U6NTk1MmUxNmMyMTU4NDVmNWJkYTQ5N2YzY2ZiNmYyNGZfMy0xMC0xLTEtMzAxMTQ_ad73f744-34f4-4e62-8e85-3195b8f63fce">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6390807210d74c6f9cae496ea2122a5a_I20211031" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83Ni9mcmFnOjQ2ZDI2ZThkOTg2NjRiNmViMWM5MjA1ODhjNzU0NzI4L3RhYmxlOjU5NTJlMTZjMjE1ODQ1ZjViZGE0OTdmM2NmYjZmMjRmL3RhYmxlcmFuZ2U6NTk1MmUxNmMyMTU4NDVmNWJkYTQ5N2YzY2ZiNmYyNGZfMy0xMi0xLTEtMzAxMTQ_d4f71843-d848-4095-ba94-dc95f28cbfcc">282</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7e403833679541eab73046fd37fcdd94_D20211101-20220131" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83Ni9mcmFnOjQ2ZDI2ZThkOTg2NjRiNmViMWM5MjA1ODhjNzU0NzI4L3RhYmxlOjU5NTJlMTZjMjE1ODQ1ZjViZGE0OTdmM2NmYjZmMjRmL3RhYmxlcmFuZ2U6NTk1MmUxNmMyMTU4NDVmNWJkYTQ5N2YzY2ZiNmYyNGZfNS00LTEtMS0zMDExNA_65bff23b-480d-4058-9a05-c898863ba789">27</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6e4cf075aaa4d27853c6c516de6dd2c_D20211101-20220131" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83Ni9mcmFnOjQ2ZDI2ZThkOTg2NjRiNmViMWM5MjA1ODhjNzU0NzI4L3RhYmxlOjU5NTJlMTZjMjE1ODQ1ZjViZGE0OTdmM2NmYjZmMjRmL3RhYmxlcmFuZ2U6NTk1MmUxNmMyMTU4NDVmNWJkYTQ5N2YzY2ZiNmYyNGZfNS02LTEtMS0zMDExNA_23a70eae-8aec-4cdf-9e52-142ce0f545ad">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6ec07697746456e8221275738907dd8_D20211101-20220131" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83Ni9mcmFnOjQ2ZDI2ZThkOTg2NjRiNmViMWM5MjA1ODhjNzU0NzI4L3RhYmxlOjU5NTJlMTZjMjE1ODQ1ZjViZGE0OTdmM2NmYjZmMjRmL3RhYmxlcmFuZ2U6NTk1MmUxNmMyMTU4NDVmNWJkYTQ5N2YzY2ZiNmYyNGZfNS04LTEtMS0zMDExNA_2aded676-912c-4580-bda7-c85184699475">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdcbd30df39641a4b5f2503519f860b9_D20211101-20220131" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83Ni9mcmFnOjQ2ZDI2ZThkOTg2NjRiNmViMWM5MjA1ODhjNzU0NzI4L3RhYmxlOjU5NTJlMTZjMjE1ODQ1ZjViZGE0OTdmM2NmYjZmMjRmL3RhYmxlcmFuZ2U6NTk1MmUxNmMyMTU4NDVmNWJkYTQ5N2YzY2ZiNmYyNGZfNS0xMC0xLTEtMzAxMTQ_3fa06b47-caf4-422e-9769-30dec3f8ffea">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83Ni9mcmFnOjQ2ZDI2ZThkOTg2NjRiNmViMWM5MjA1ODhjNzU0NzI4L3RhYmxlOjU5NTJlMTZjMjE1ODQ1ZjViZGE0OTdmM2NmYjZmMjRmL3RhYmxlcmFuZ2U6NTk1MmUxNmMyMTU4NDVmNWJkYTQ5N2YzY2ZiNmYyNGZfNS0xMi0xLTEtMzAxMTQ_e2fa8a33-2c74-4149-82be-4d7b11c9238d">16</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified out of accumulated other comprehensive income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e403833679541eab73046fd37fcdd94_D20211101-20220131" decimals="-6" name="us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83Ni9mcmFnOjQ2ZDI2ZThkOTg2NjRiNmViMWM5MjA1ODhjNzU0NzI4L3RhYmxlOjU5NTJlMTZjMjE1ODQ1ZjViZGE0OTdmM2NmYjZmMjRmL3RhYmxlcmFuZ2U6NTk1MmUxNmMyMTU4NDVmNWJkYTQ5N2YzY2ZiNmYyNGZfNy00LTEtMS0zMDExNA_d7b24139-dc9b-4a95-b99f-eaeef12e5e28">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6e4cf075aaa4d27853c6c516de6dd2c_D20211101-20220131" decimals="-6" name="us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83Ni9mcmFnOjQ2ZDI2ZThkOTg2NjRiNmViMWM5MjA1ODhjNzU0NzI4L3RhYmxlOjU5NTJlMTZjMjE1ODQ1ZjViZGE0OTdmM2NmYjZmMjRmL3RhYmxlcmFuZ2U6NTk1MmUxNmMyMTU4NDVmNWJkYTQ5N2YzY2ZiNmYyNGZfNy02LTEtMS0zMDExNA_c704b562-71ff-46ac-8385-599c01e35bab">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6ec07697746456e8221275738907dd8_D20211101-20220131" decimals="-6" name="us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83Ni9mcmFnOjQ2ZDI2ZThkOTg2NjRiNmViMWM5MjA1ODhjNzU0NzI4L3RhYmxlOjU5NTJlMTZjMjE1ODQ1ZjViZGE0OTdmM2NmYjZmMjRmL3RhYmxlcmFuZ2U6NTk1MmUxNmMyMTU4NDVmNWJkYTQ5N2YzY2ZiNmYyNGZfNy04LTEtMS0zMDExNA_3d680454-dd1f-4cac-b0c4-de55527f5211">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icdcbd30df39641a4b5f2503519f860b9_D20211101-20220131" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83Ni9mcmFnOjQ2ZDI2ZThkOTg2NjRiNmViMWM5MjA1ODhjNzU0NzI4L3RhYmxlOjU5NTJlMTZjMjE1ODQ1ZjViZGE0OTdmM2NmYjZmMjRmL3RhYmxlcmFuZ2U6NTk1MmUxNmMyMTU4NDVmNWJkYTQ5N2YzY2ZiNmYyNGZfNy0xMC0xLTEtMzAxMTQ_3b359ee0-f9a5-43f5-9e6f-7a2e8a7fd384">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" decimals="-6" name="us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83Ni9mcmFnOjQ2ZDI2ZThkOTg2NjRiNmViMWM5MjA1ODhjNzU0NzI4L3RhYmxlOjU5NTJlMTZjMjE1ODQ1ZjViZGE0OTdmM2NmYjZmMjRmL3RhYmxlcmFuZ2U6NTk1MmUxNmMyMTU4NDVmNWJkYTQ5N2YzY2ZiNmYyNGZfNy0xMi0xLTEtMzAxMTQ_761c3e01-20b2-446c-bdcf-213059f68451">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e403833679541eab73046fd37fcdd94_D20211101-20220131" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83Ni9mcmFnOjQ2ZDI2ZThkOTg2NjRiNmViMWM5MjA1ODhjNzU0NzI4L3RhYmxlOjU5NTJlMTZjMjE1ODQ1ZjViZGE0OTdmM2NmYjZmMjRmL3RhYmxlcmFuZ2U6NTk1MmUxNmMyMTU4NDVmNWJkYTQ5N2YzY2ZiNmYyNGZfOS00LTEtMS0zMDExNA_9b161915-f440-4700-adad-1c8dbeeb32a1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6e4cf075aaa4d27853c6c516de6dd2c_D20211101-20220131" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83Ni9mcmFnOjQ2ZDI2ZThkOTg2NjRiNmViMWM5MjA1ODhjNzU0NzI4L3RhYmxlOjU5NTJlMTZjMjE1ODQ1ZjViZGE0OTdmM2NmYjZmMjRmL3RhYmxlcmFuZ2U6NTk1MmUxNmMyMTU4NDVmNWJkYTQ5N2YzY2ZiNmYyNGZfOS02LTEtMS0zMDExNA_0665c493-fae3-4247-b8f6-058e6ac6d895">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia6ec07697746456e8221275738907dd8_D20211101-20220131" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83Ni9mcmFnOjQ2ZDI2ZThkOTg2NjRiNmViMWM5MjA1ODhjNzU0NzI4L3RhYmxlOjU5NTJlMTZjMjE1ODQ1ZjViZGE0OTdmM2NmYjZmMjRmL3RhYmxlcmFuZ2U6NTk1MmUxNmMyMTU4NDVmNWJkYTQ5N2YzY2ZiNmYyNGZfOS04LTEtMS0zMDExNA_439b0336-b8e4-4db0-b8f2-b72ab0d569c9">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icdcbd30df39641a4b5f2503519f860b9_D20211101-20220131" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83Ni9mcmFnOjQ2ZDI2ZThkOTg2NjRiNmViMWM5MjA1ODhjNzU0NzI4L3RhYmxlOjU5NTJlMTZjMjE1ODQ1ZjViZGE0OTdmM2NmYjZmMjRmL3RhYmxlcmFuZ2U6NTk1MmUxNmMyMTU4NDVmNWJkYTQ5N2YzY2ZiNmYyNGZfOS0xMC0xLTEtMzAxMTQ_0b4dda26-6729-4cd3-8432-2ee3c2910824">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83Ni9mcmFnOjQ2ZDI2ZThkOTg2NjRiNmViMWM5MjA1ODhjNzU0NzI4L3RhYmxlOjU5NTJlMTZjMjE1ODQ1ZjViZGE0OTdmM2NmYjZmMjRmL3RhYmxlcmFuZ2U6NTk1MmUxNmMyMTU4NDVmNWJkYTQ5N2YzY2ZiNmYyNGZfOS0xMi0xLTEtMzAxMTQ_510ee199-5f4f-4acd-a02f-ba96220fe7be">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7e403833679541eab73046fd37fcdd94_D20211101-20220131" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83Ni9mcmFnOjQ2ZDI2ZThkOTg2NjRiNmViMWM5MjA1ODhjNzU0NzI4L3RhYmxlOjU5NTJlMTZjMjE1ODQ1ZjViZGE0OTdmM2NmYjZmMjRmL3RhYmxlcmFuZ2U6NTk1MmUxNmMyMTU4NDVmNWJkYTQ5N2YzY2ZiNmYyNGZfMTEtNC0xLTEtMzAxMTQ_031123be-e1f5-454a-8029-42d42044049d">27</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6e4cf075aaa4d27853c6c516de6dd2c_D20211101-20220131" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83Ni9mcmFnOjQ2ZDI2ZThkOTg2NjRiNmViMWM5MjA1ODhjNzU0NzI4L3RhYmxlOjU5NTJlMTZjMjE1ODQ1ZjViZGE0OTdmM2NmYjZmMjRmL3RhYmxlcmFuZ2U6NTk1MmUxNmMyMTU4NDVmNWJkYTQ5N2YzY2ZiNmYyNGZfMTEtNi0xLTEtMzAxMTQ_81009912-a58d-41a5-8f4a-c69ff5a71824">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6ec07697746456e8221275738907dd8_D20211101-20220131" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83Ni9mcmFnOjQ2ZDI2ZThkOTg2NjRiNmViMWM5MjA1ODhjNzU0NzI4L3RhYmxlOjU5NTJlMTZjMjE1ODQ1ZjViZGE0OTdmM2NmYjZmMjRmL3RhYmxlcmFuZ2U6NTk1MmUxNmMyMTU4NDVmNWJkYTQ5N2YzY2ZiNmYyNGZfMTEtOC0xLTEtMzAxMTQ_bd43dc31-ea1f-4ceb-853b-714f24e0bf36">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdcbd30df39641a4b5f2503519f860b9_D20211101-20220131" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83Ni9mcmFnOjQ2ZDI2ZThkOTg2NjRiNmViMWM5MjA1ODhjNzU0NzI4L3RhYmxlOjU5NTJlMTZjMjE1ODQ1ZjViZGE0OTdmM2NmYjZmMjRmL3RhYmxlcmFuZ2U6NTk1MmUxNmMyMTU4NDVmNWJkYTQ5N2YzY2ZiNmYyNGZfMTEtMTAtMS0xLTMwMTE0_4a1d6687-4b04-40ac-8e05-5627017ae715">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83Ni9mcmFnOjQ2ZDI2ZThkOTg2NjRiNmViMWM5MjA1ODhjNzU0NzI4L3RhYmxlOjU5NTJlMTZjMjE1ODQ1ZjViZGE0OTdmM2NmYjZmMjRmL3RhYmxlcmFuZ2U6NTk1MmUxNmMyMTU4NDVmNWJkYTQ5N2YzY2ZiNmYyNGZfMTEtMTItMS0xLTMwMTE0_959c6d09-a716-4af9-916f-3260533fa2c2">16</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of January 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia1ee3187242a414db3687c2b9fc4d82f_I20220131" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83Ni9mcmFnOjQ2ZDI2ZThkOTg2NjRiNmViMWM5MjA1ODhjNzU0NzI4L3RhYmxlOjU5NTJlMTZjMjE1ODQ1ZjViZGE0OTdmM2NmYjZmMjRmL3RhYmxlcmFuZ2U6NTk1MmUxNmMyMTU4NDVmNWJkYTQ5N2YzY2ZiNmYyNGZfMTMtNC0xLTEtMzAxMTQ_2cb46531-f347-4da4-84f4-e770addef8c0">212</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0dc39ee7c49e4d6cb473aef9858b6b88_I20220131" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83Ni9mcmFnOjQ2ZDI2ZThkOTg2NjRiNmViMWM5MjA1ODhjNzU0NzI4L3RhYmxlOjU5NTJlMTZjMjE1ODQ1ZjViZGE0OTdmM2NmYjZmMjRmL3RhYmxlcmFuZ2U6NTk1MmUxNmMyMTU4NDVmNWJkYTQ5N2YzY2ZiNmYyNGZfMTMtNi0xLTEtMzAxMTQ_4a28284c-1154-42ba-885d-12e996f362fc">124</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i70983fa542cf4b018a1bb84cfd674246_I20220131" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83Ni9mcmFnOjQ2ZDI2ZThkOTg2NjRiNmViMWM5MjA1ODhjNzU0NzI4L3RhYmxlOjU5NTJlMTZjMjE1ODQ1ZjViZGE0OTdmM2NmYjZmMjRmL3RhYmxlcmFuZ2U6NTk1MmUxNmMyMTU4NDVmNWJkYTQ5N2YzY2ZiNmYyNGZfMTMtOC0xLTEtMzAxMTQ_6e93379f-5410-43b5-8eaa-6bef7a0dbf06">217</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2563947f2b6142d4a03ded6e410372c8_I20220131" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83Ni9mcmFnOjQ2ZDI2ZThkOTg2NjRiNmViMWM5MjA1ODhjNzU0NzI4L3RhYmxlOjU5NTJlMTZjMjE1ODQ1ZjViZGE0OTdmM2NmYjZmMjRmL3RhYmxlcmFuZ2U6NTk1MmUxNmMyMTU4NDVmNWJkYTQ5N2YzY2ZiNmYyNGZfMTMtMTAtMS0xLTMwMTE0_e617b660-6e96-4677-82fa-865bee9299b7">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83Ni9mcmFnOjQ2ZDI2ZThkOTg2NjRiNmViMWM5MjA1ODhjNzU0NzI4L3RhYmxlOjU5NTJlMTZjMjE1ODQ1ZjViZGE0OTdmM2NmYjZmMjRmL3RhYmxlcmFuZ2U6NTk1MmUxNmMyMTU4NDVmNWJkYTQ5N2YzY2ZiNmYyNGZfMTMtMTItMS0xLTMwMTE0_508c9118-967b-4d06-9f1f-db2957a5a751">298</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><ix:nonNumeric contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" name="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83Ni9mcmFnOjQ2ZDI2ZThkOTg2NjRiNmViMWM5MjA1ODhjNzU0NzI4L3RleHRyZWdpb246NDZkMjZlOGQ5ODY2NGI2ZWIxYzkyMDU4OGM3NTQ3MjhfMzM0MQ_5c16d622-e954-42b0-94d7-b05f418993fa" escape="true"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reclassifications out of accumulated other comprehensive income (loss) for the three months ended January&#160;31, 2022 and 2021 were as follows (in millions):</span></div><div style="margin-top:5pt;text-align:center;text-indent:4.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:36.769%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Details about accumulated other <br/>comprehensive income (loss) components</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amounts Reclassified from <br/>other comprehensive income (loss)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Affected line item in<br/>statement of operations</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:11pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gain (loss) on derivatives</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic76564bc7be64253830f89477bbf29cb_D20211101-20220131" decimals="-6" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83Ni9mcmFnOjQ2ZDI2ZThkOTg2NjRiNmViMWM5MjA1ODhjNzU0NzI4L3RhYmxlOmYwZTM4YjQyY2UwYTRiMTc4YTc4ODhkZjdhNWIyMDI1L3RhYmxlcmFuZ2U6ZjBlMzhiNDJjZTBhNGIxNzhhNzg4OGRmN2E1YjIwMjVfMTItMi0xLTEtMzAxMTQ_b6386aad-0939-4c4b-b931-0e49bbe38328">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if825187b5c3d4f688e0c4a074679fd80_D20201101-20210131" decimals="-6" sign="-" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83Ni9mcmFnOjQ2ZDI2ZThkOTg2NjRiNmViMWM5MjA1ODhjNzU0NzI4L3RhYmxlOmYwZTM4YjQyY2UwYTRiMTc4YTc4ODhkZjdhNWIyMDI1L3RhYmxlcmFuZ2U6ZjBlMzhiNDJjZTBhNGIxNzhhNzg4OGRmN2E1YjIwMjVfMTItNC0xLTEtMzAxMTQ_eff2b6c7-77cd-45f7-be15-196efc17018f">8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" decimals="-6" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83Ni9mcmFnOjQ2ZDI2ZThkOTg2NjRiNmViMWM5MjA1ODhjNzU0NzI4L3RhYmxlOmYwZTM4YjQyY2UwYTRiMTc4YTc4ODhkZjdhNWIyMDI1L3RhYmxlcmFuZ2U6ZjBlMzhiNDJjZTBhNGIxNzhhNzg4OGRmN2E1YjIwMjVfMTQtMi0xLTEtMzAxMTQ_7725acb9-ac0a-4f32-b605-bda538cc2cf3">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131" decimals="-6" sign="-" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83Ni9mcmFnOjQ2ZDI2ZThkOTg2NjRiNmViMWM5MjA1ODhjNzU0NzI4L3RhYmxlOmYwZTM4YjQyY2UwYTRiMTc4YTc4ODhkZjdhNWIyMDI1L3RhYmxlcmFuZ2U6ZjBlMzhiNDJjZTBhNGIxNzhhNzg4OGRmN2E1YjIwMjVfMTQtNC0xLTEtMzAxMTQ_a17f8435-a1be-4dbc-86ac-2d968e9e3db4">8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total before income tax</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83Ni9mcmFnOjQ2ZDI2ZThkOTg2NjRiNmViMWM5MjA1ODhjNzU0NzI4L3RhYmxlOmYwZTM4YjQyY2UwYTRiMTc4YTc4ODhkZjdhNWIyMDI1L3RhYmxlcmFuZ2U6ZjBlMzhiNDJjZTBhNGIxNzhhNzg4OGRmN2E1YjIwMjVfMTUtMi0xLTEtMzAxMTQ_56beaaad-3c0d-4216-af2d-13352d74be0a">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83Ni9mcmFnOjQ2ZDI2ZThkOTg2NjRiNmViMWM5MjA1ODhjNzU0NzI4L3RhYmxlOmYwZTM4YjQyY2UwYTRiMTc4YTc4ODhkZjdhNWIyMDI1L3RhYmxlcmFuZ2U6ZjBlMzhiNDJjZTBhNGIxNzhhNzg4OGRmN2E1YjIwMjVfMTUtNC0xLTEtMzAxMTQ_28ee4394-bcd6-4260-9f32-fa5b7e317bd7">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Provision) benefit for income tax</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83Ni9mcmFnOjQ2ZDI2ZThkOTg2NjRiNmViMWM5MjA1ODhjNzU0NzI4L3RhYmxlOmYwZTM4YjQyY2UwYTRiMTc4YTc4ODhkZjdhNWIyMDI1L3RhYmxlcmFuZ2U6ZjBlMzhiNDJjZTBhNGIxNzhhNzg4OGRmN2E1YjIwMjVfMTYtMi0xLTEtMzAxMTQ_3c0f716e-351e-44b5-8b32-09991f759a4f">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83Ni9mcmFnOjQ2ZDI2ZThkOTg2NjRiNmViMWM5MjA1ODhjNzU0NzI4L3RhYmxlOmYwZTM4YjQyY2UwYTRiMTc4YTc4ODhkZjdhNWIyMDI1L3RhYmxlcmFuZ2U6ZjBlMzhiNDJjZTBhNGIxNzhhNzg4OGRmN2E1YjIwMjVfMTYtNC0xLTEtMzAxMTQ_fe35838e-4cfd-45ec-9593-20cd4fe5546f">6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net of income tax</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net defined benefit pension cost and post retirement plan costs:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial net loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83Ni9mcmFnOjQ2ZDI2ZThkOTg2NjRiNmViMWM5MjA1ODhjNzU0NzI4L3RhYmxlOmYwZTM4YjQyY2UwYTRiMTc4YTc4ODhkZjdhNWIyMDI1L3RhYmxlcmFuZ2U6ZjBlMzhiNDJjZTBhNGIxNzhhNzg4OGRmN2E1YjIwMjVfMTktMi0xLTEtMzAxMTQ_047ff24f-03ec-4ed8-8124-91d6368653ae">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83Ni9mcmFnOjQ2ZDI2ZThkOTg2NjRiNmViMWM5MjA1ODhjNzU0NzI4L3RhYmxlOmYwZTM4YjQyY2UwYTRiMTc4YTc4ODhkZjdhNWIyMDI1L3RhYmxlcmFuZ2U6ZjBlMzhiNDJjZTBhNGIxNzhhNzg4OGRmN2E1YjIwMjVfMTktNC0xLTEtMzAxMTQ_f6a4ad52-cde5-440f-8974-63450c0a8763">16</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service benefit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83Ni9mcmFnOjQ2ZDI2ZThkOTg2NjRiNmViMWM5MjA1ODhjNzU0NzI4L3RhYmxlOmYwZTM4YjQyY2UwYTRiMTc4YTc4ODhkZjdhNWIyMDI1L3RhYmxlcmFuZ2U6ZjBlMzhiNDJjZTBhNGIxNzhhNzg4OGRmN2E1YjIwMjVfMjAtMi0xLTEtMzAxMTQ_d5c7fee8-54cd-4f3a-8155-4c7da8e2f244">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83Ni9mcmFnOjQ2ZDI2ZThkOTg2NjRiNmViMWM5MjA1ODhjNzU0NzI4L3RhYmxlOmYwZTM4YjQyY2UwYTRiMTc4YTc4ODhkZjdhNWIyMDI1L3RhYmxlcmFuZ2U6ZjBlMzhiNDJjZTBhNGIxNzhhNzg4OGRmN2E1YjIwMjVfMjAtNC0xLTEtMzAxMTQ_5850bf83-cb26-41e2-a799-07081251febe">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83Ni9mcmFnOjQ2ZDI2ZThkOTg2NjRiNmViMWM5MjA1ODhjNzU0NzI4L3RhYmxlOmYwZTM4YjQyY2UwYTRiMTc4YTc4ODhkZjdhNWIyMDI1L3RhYmxlcmFuZ2U6ZjBlMzhiNDJjZTBhNGIxNzhhNzg4OGRmN2E1YjIwMjVfMjEtMi0xLTEtMzAxMTQ_59f90862-f9ee-4bb7-98bf-db6e982a76ec">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83Ni9mcmFnOjQ2ZDI2ZThkOTg2NjRiNmViMWM5MjA1ODhjNzU0NzI4L3RhYmxlOmYwZTM4YjQyY2UwYTRiMTc4YTc4ODhkZjdhNWIyMDI1L3RhYmxlcmFuZ2U6ZjBlMzhiNDJjZTBhNGIxNzhhNzg4OGRmN2E1YjIwMjVfMjEtNC0xLTEtMzAxMTQ_74684c05-193d-44b4-a887-af2660641c7f">16</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total before income tax</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83Ni9mcmFnOjQ2ZDI2ZThkOTg2NjRiNmViMWM5MjA1ODhjNzU0NzI4L3RhYmxlOmYwZTM4YjQyY2UwYTRiMTc4YTc4ODhkZjdhNWIyMDI1L3RhYmxlcmFuZ2U6ZjBlMzhiNDJjZTBhNGIxNzhhNzg4OGRmN2E1YjIwMjVfMjItMi0xLTEtMzAxMTQ_2c936bf2-3820-4737-99cd-89aedba2e381">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83Ni9mcmFnOjQ2ZDI2ZThkOTg2NjRiNmViMWM5MjA1ODhjNzU0NzI4L3RhYmxlOmYwZTM4YjQyY2UwYTRiMTc4YTc4ODhkZjdhNWIyMDI1L3RhYmxlcmFuZ2U6ZjBlMzhiNDJjZTBhNGIxNzhhNzg4OGRmN2E1YjIwMjVfMjItNC0xLTEtMzAxMTQ_7c67a0ed-0467-4973-9c9d-2f4bb1ff86cf">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit for income tax</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83Ni9mcmFnOjQ2ZDI2ZThkOTg2NjRiNmViMWM5MjA1ODhjNzU0NzI4L3RhYmxlOmYwZTM4YjQyY2UwYTRiMTc4YTc4ODhkZjdhNWIyMDI1L3RhYmxlcmFuZ2U6ZjBlMzhiNDJjZTBhNGIxNzhhNzg4OGRmN2E1YjIwMjVfMjMtMi0xLTEtMzAxMTQ_ffc6c2d3-a3d9-49f5-888f-69400f368659">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83Ni9mcmFnOjQ2ZDI2ZThkOTg2NjRiNmViMWM5MjA1ODhjNzU0NzI4L3RhYmxlOmYwZTM4YjQyY2UwYTRiMTc4YTc4ODhkZjdhNWIyMDI1L3RhYmxlcmFuZ2U6ZjBlMzhiNDJjZTBhNGIxNzhhNzg4OGRmN2E1YjIwMjVfMjMtNC0xLTEtMzAxMTQ_8dec3c85-84c7-4190-9f9a-370aed1c1dd6">12</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net of income tax</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total reclassifications for the period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83Ni9mcmFnOjQ2ZDI2ZThkOTg2NjRiNmViMWM5MjA1ODhjNzU0NzI4L3RhYmxlOmYwZTM4YjQyY2UwYTRiMTc4YTc4ODhkZjdhNWIyMDI1L3RhYmxlcmFuZ2U6ZjBlMzhiNDJjZTBhNGIxNzhhNzg4OGRmN2E1YjIwMjVfMjUtMi0xLTEtMzAxMTQ_01248b7a-e677-4848-a9ca-6bee52097e4c">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83Ni9mcmFnOjQ2ZDI2ZThkOTg2NjRiNmViMWM5MjA1ODhjNzU0NzI4L3RhYmxlOmYwZTM4YjQyY2UwYTRiMTc4YTc4ODhkZjdhNWIyMDI1L3RhYmxlcmFuZ2U6ZjBlMzhiNDJjZTBhNGIxNzhhNzg4OGRmN2E1YjIwMjVfMjUtNC0xLTEtMzAxMTQ_e53dfa1e-169c-46b7-84c2-a72f62a3388b">18</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts in parentheses indicate reductions to income and increases to other comprehensive income (loss).</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AGILENT TECHNOLOGIES, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) - (Continued) </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i9342e1a13cbf4532986cc4298e44167c">Reclassifications out of accumulated other comprehensive income (loss) of prior service benefit and actuarial net loss in respect of retirement plans and post retirement pension plans are included in the computation of net periodic cost (see Note 11, "Retirement Plans and Post Retirement Pension Plans").</ix:continuation></span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div id="if825c91f15a047ec9e67e0189634a349_79"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16.   <ix:nonNumeric contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83OS9mcmFnOjZjOGY3YzEwNmQwMDQ5MDc5OTkxYjhhOTE1MDZmOGNjL3RleHRyZWdpb246NmM4ZjdjMTA2ZDAwNDkwNzk5OTFiOGE5MTUwNmY4Y2NfODMzOA_04c8da81-63a0-4e83-867a-4522d0f3f638" continuedAt="i14f2054f333c46d9a49bb6b2862c630b" escape="true">SEGMENT INFORMATION</ix:nonNumeric></span></div><ix:continuation id="i14f2054f333c46d9a49bb6b2862c630b" continuedAt="id9df23e5ecd04428ac184849a16aedf9"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Description of segments.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  We are a global leader in life sciences, diagnostics and applied chemical markets, providing application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow.  </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of fiscal year 2022, we announced a change in organizational structure designed to enable our growth strategies and strengthen our focus on customers. Our chemistries and supplies business and our remarketed instruments business moved from our Agilent CrossLab business segment to our life sciences and applied markets business segment. Service revenue and cost of sales related to the previous acquisition of BioTek moved from our life sciences and applied markets business segment to our Agilent CrossLab business segment. The historical financial segment information has been recast to conform to this new presentation. There was no change to our diagnostics and genomics business segment.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following this reorganization, we continue to have three business segments comprised of life sciences and applied markets, diagnostics and genomics and Agilent CrossLab, each of which continues to comprise a reportable segment.  The <ix:nonFraction unitRef="number" contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" decimals="INF" name="us-gaap:NumberOfOperatingSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83OS9mcmFnOjZjOGY3YzEwNmQwMDQ5MDc5OTkxYjhhOTE1MDZmOGNjL3RleHRyZWdpb246NmM4ZjdjMTA2ZDAwNDkwNzk5OTFiOGE5MTUwNmY4Y2NfNDk1_3641017e-3b69-4bce-8e11-585f7b6d1a68">three</ix:nonFraction> operating segments were determined based primarily on how the chief operating decision maker views and evaluates our operations. Operating results are regularly reviewed by the chief operating decision maker to make decisions about resources to be allocated to the segment and to assess its performance. Other factors, including market separation and customer specific applications, go-to-market channels, products and services and manufacturing are considered in determining the formation of these operating segments.</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A description of our three reportable segments is as follows:</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our life sciences and applied markets business provides application-focused solutions that include instruments and software that enable customers to identify, quantify and analyze the physical and biological properties of substances and products, as well as enable customers in the clinical and life sciences research areas to interrogate samples at the molecular and cellular level. Key product categories include: liquid chromatography ("LC") systems and components; liquid chromatography mass spectrometry ("LCMS") systems; gas chromatography ("GC") systems and components; gas chromatography mass spectrometry ("GCMS") systems; inductively coupled plasma mass spectrometry ("ICP-MS") instruments; atomic absorption ("AA") instruments; microwave plasma-atomic emission spectrometry ("MP-AES") instruments; inductively coupled plasma optical emission spectrometry ("ICP-OES") instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software for sample tracking; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps and measurement technologies. Our consumables portfolio is designed to improve customer outcomes. Most of the portfolio is vendor neutral, meaning Agilent can serve and supply customers regardless of their instrument purchase choices. Solutions range from chemistries to supplies. Key product categories in consumables include GC and LC columns, sample preparation products, custom chemistries, and a large selection of laboratory instrument supplies. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our diagnostics and genomics business is comprised of six areas of activity providing active pharmaceutical ingredients ("APIs") for oligo-based therapeutics as well as solutions that include reagents, instruments, software and consumables, which enable customers in the clinical and life sciences research areas to interrogate samples at the cellular and molecular level.&#160;First, our genomics business includes arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, gene expression profiling, as well as next generation sequencing ("NGS") target enrichment and genetic data management and interpretation support software. This business also includes solutions that enable clinical labs to identify DNA variants associated with genetic disease and help direct cancer therapy. Second, our nucleic acid solutions business provides equipment and expertise focused on production of synthesized oligonucleotides under pharmaceutical good manufacturing practices ("GMP") conditions for use as API in an emerging class of drugs that utilize nucleic acid molecules for disease therapy. Third, our pathology solutions business is focused on product offerings for cancer diagnostics and anatomic pathology workflows. The broad portfolio of offerings includes immunohistochemistry ("IHC"), in situ hybridization ("ISH"), hematoxylin and eosin ("H&amp;E") staining and special staining. Fourth, we also collaborate with a number of major pharmaceutical companies to develop new potential tissue and liquid-based pharmacodiagnostics, also known as companion diagnostics, which may be used to identify patients most likely to benefit from a specific targeted therapy. Fifth, the reagent partnership business is a provider of reagents used for turbidimetry and flow cytometry. Finally, our biomolecular analysis business provides complete workflow solutions, including instruments, </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AGILENT TECHNOLOGIES, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) - (Continued) </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="id9df23e5ecd04428ac184849a16aedf9" continuedAt="i83dd9c9ea36947ec885a8edcd2a963d7"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">consumables and software, for quality control analysis of nucleic acid samples.&#160; Samples are analyzed using quantitative and qualitative techniques to ensure accuracy in further genomics analysis techniques utilized in clinical and life science research applications.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Agilent CrossLab business spans the entire lab with its extensive services portfolio, which is designed to improve customer outcomes.  The majority of the portfolio is vendor neutral, meaning we can serve and supply customers regardless of their instrument purchase choices.  </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The services portfolio include repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, consulting and various other custom services to support the customers' laboratory operations.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  Custom services are tailored to meet the specific application needs of various industries and to keep instruments fully operational and compliant with the respective industry requirements.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A significant portion of the segments' expenses arise from shared services and infrastructure that we have historically provided to the segments in order to realize economies of scale and to efficiently use resources. These expenses, collectively called corporate charges, include legal, accounting, tax, real estate, insurance services, information technology services, treasury, order administration, other corporate infrastructure expenses, costs of centralized research and development and joint sales and marketing costs. Charges are allocated to the segments, and the allocations have been determined on a basis that we consider to be a reasonable reflection of the utilization of services provided to or benefits received by the segments. In addition, we do not allocate asset impairments, amortization of acquisition-related intangible assets, change in the fair value of acquisition-related contingent consideration, acquisition and integration costs, restructuring and transformational initiatives expenses, acceleration of share-based compensation expense related to workforce reduction, business exit and divestiture costs, special compliance costs, some nucleic acid solutions division ("NASD") site costs and certain other charges to the operating margin for each segment because management does not include this information in its measurement of the performance of the operating segments. Transformational initiatives include expenses associated with targeted cost reduction activities such as manufacturing transfers, site consolidations, legal entity and other business reorganizations, in-sourcing or outsourcing of activities. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables reflect the results of our reportable segments under our management reporting system. The performance of each segment is measured based on several metrics, including segment income from operations. These results are used, in part, by the chief operating decision maker in evaluating the performance of, and in allocating resources to, each of the segments.</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83OS9mcmFnOjZjOGY3YzEwNmQwMDQ5MDc5OTkxYjhhOTE1MDZmOGNjL3RleHRyZWdpb246NmM4ZjdjMTA2ZDAwNDkwNzk5OTFiOGE5MTUwNmY4Y2NfODM2NA_72db3f60-385f-4737-8b90-63fd3968b484" continuedAt="i46151d996f494d399d708f6ea9a6e7af" escape="true"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The profitability of each of the segments is measured after excluding items such as transformational initiatives, acquisition and integration costs, amortization of intangible assets related to business combinations, interest income, interest expense and other items as noted in the reconciliations below:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:77.116%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.428%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Revenue:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Life Sciences and Applied Markets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d58196320f34869a29143308907c47f_D20211101-20220131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83OS9mcmFnOjZjOGY3YzEwNmQwMDQ5MDc5OTkxYjhhOTE1MDZmOGNjL3RhYmxlOmJjN2Q3NTE5ZDdjODQyMWY5NjdjYjU3ZGYwNTVhNDYyL3RhYmxlcmFuZ2U6YmM3ZDc1MTlkN2M4NDIxZjk2N2NiNTdkZjA1NWE0NjJfNS0xLTEtMS0zMDExNA_3a64e83e-2691-4aec-9ee6-d8cc49913662">976</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if71b40dd3f5f49bf86fbcfa04c9c081e_D20201101-20210131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83OS9mcmFnOjZjOGY3YzEwNmQwMDQ5MDc5OTkxYjhhOTE1MDZmOGNjL3RhYmxlOmJjN2Q3NTE5ZDdjODQyMWY5NjdjYjU3ZGYwNTVhNDYyL3RhYmxlcmFuZ2U6YmM3ZDc1MTlkN2M4NDIxZjk2N2NiNTdkZjA1NWE0NjJfNS0zLTEtMS0zMDExNA_d47bbe47-2632-46d7-bcfa-c122ee4fee6c">923</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics and Genomics</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie43c9572619448f8a6ea6d852ea0af23_D20211101-20220131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83OS9mcmFnOjZjOGY3YzEwNmQwMDQ5MDc5OTkxYjhhOTE1MDZmOGNjL3RhYmxlOmJjN2Q3NTE5ZDdjODQyMWY5NjdjYjU3ZGYwNTVhNDYyL3RhYmxlcmFuZ2U6YmM3ZDc1MTlkN2M4NDIxZjk2N2NiNTdkZjA1NWE0NjJfNi0xLTEtMS0zMDExNA_c58ac205-f165-47eb-a078-3ed982dddfa0">339</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18473ba8bdd846b583460be774dcc8c2_D20201101-20210131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83OS9mcmFnOjZjOGY3YzEwNmQwMDQ5MDc5OTkxYjhhOTE1MDZmOGNjL3RhYmxlOmJjN2Q3NTE5ZDdjODQyMWY5NjdjYjU3ZGYwNTVhNDYyL3RhYmxlcmFuZ2U6YmM3ZDc1MTlkN2M4NDIxZjk2N2NiNTdkZjA1NWE0NjJfNi0zLTEtMS0zMDExNA_d3284a2c-36e1-49e7-9789-dc7394fce290">294</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agilent CrossLab</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30a463a582ff4b16971b766059a24eb9_D20211101-20220131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83OS9mcmFnOjZjOGY3YzEwNmQwMDQ5MDc5OTkxYjhhOTE1MDZmOGNjL3RhYmxlOmJjN2Q3NTE5ZDdjODQyMWY5NjdjYjU3ZGYwNTVhNDYyL3RhYmxlcmFuZ2U6YmM3ZDc1MTlkN2M4NDIxZjk2N2NiNTdkZjA1NWE0NjJfNy0xLTEtMS0zMDExNA_0977fb05-3e06-4181-8629-0b1187ed5f7c">359</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02afafae5dac4c4eb5370132cc85ab08_D20201101-20210131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83OS9mcmFnOjZjOGY3YzEwNmQwMDQ5MDc5OTkxYjhhOTE1MDZmOGNjL3RhYmxlOmJjN2Q3NTE5ZDdjODQyMWY5NjdjYjU3ZGYwNTVhNDYyL3RhYmxlcmFuZ2U6YmM3ZDc1MTlkN2M4NDIxZjk2N2NiNTdkZjA1NWE0NjJfNy0zLTEtMS0zMDExNA_96b28f93-0e01-47d4-97e9-87ffd33154c4">331</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5987fc4c9ed94d95b32a6ba071848996_D20211101-20220131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83OS9mcmFnOjZjOGY3YzEwNmQwMDQ5MDc5OTkxYjhhOTE1MDZmOGNjL3RhYmxlOmJjN2Q3NTE5ZDdjODQyMWY5NjdjYjU3ZGYwNTVhNDYyL3RhYmxlcmFuZ2U6YmM3ZDc1MTlkN2M4NDIxZjk2N2NiNTdkZjA1NWE0NjJfOC0xLTEtMS0zMDExNA_4f27f6fc-4b0b-4a5c-8668-51df155a3782">1,674</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59f03109bfe04c92a404a9157747174a_D20201101-20210131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83OS9mcmFnOjZjOGY3YzEwNmQwMDQ5MDc5OTkxYjhhOTE1MDZmOGNjL3RhYmxlOmJjN2Q3NTE5ZDdjODQyMWY5NjdjYjU3ZGYwNTVhNDYyL3RhYmxlcmFuZ2U6YmM3ZDc1MTlkN2M4NDIxZjk2N2NiNTdkZjA1NWE0NjJfOC0zLTEtMS0zMDExNA_56c802f3-146f-4775-bfd7-7c62f2a47c82">1,548</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment Income From Operations:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Life Sciences and Applied Markets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d58196320f34869a29143308907c47f_D20211101-20220131" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83OS9mcmFnOjZjOGY3YzEwNmQwMDQ5MDc5OTkxYjhhOTE1MDZmOGNjL3RhYmxlOmJjN2Q3NTE5ZDdjODQyMWY5NjdjYjU3ZGYwNTVhNDYyL3RhYmxlcmFuZ2U6YmM3ZDc1MTlkN2M4NDIxZjk2N2NiNTdkZjA1NWE0NjJfMTEtMS0xLTEtMzAxMTQ_347d6652-2c9b-43ba-a64b-0621e754457c">282</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if71b40dd3f5f49bf86fbcfa04c9c081e_D20201101-20210131" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83OS9mcmFnOjZjOGY3YzEwNmQwMDQ5MDc5OTkxYjhhOTE1MDZmOGNjL3RhYmxlOmJjN2Q3NTE5ZDdjODQyMWY5NjdjYjU3ZGYwNTVhNDYyL3RhYmxlcmFuZ2U6YmM3ZDc1MTlkN2M4NDIxZjk2N2NiNTdkZjA1NWE0NjJfMTEtMy0xLTEtMzAxMTQ_a22980a3-f2c9-41fe-b9a8-c844869a7084">265</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics and Genomics</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie43c9572619448f8a6ea6d852ea0af23_D20211101-20220131" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83OS9mcmFnOjZjOGY3YzEwNmQwMDQ5MDc5OTkxYjhhOTE1MDZmOGNjL3RhYmxlOmJjN2Q3NTE5ZDdjODQyMWY5NjdjYjU3ZGYwNTVhNDYyL3RhYmxlcmFuZ2U6YmM3ZDc1MTlkN2M4NDIxZjk2N2NiNTdkZjA1NWE0NjJfMTItMS0xLTEtMzAxMTQ_64db14ac-719d-4a0d-9c10-09697e7f449b">68</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18473ba8bdd846b583460be774dcc8c2_D20201101-20210131" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83OS9mcmFnOjZjOGY3YzEwNmQwMDQ5MDc5OTkxYjhhOTE1MDZmOGNjL3RhYmxlOmJjN2Q3NTE5ZDdjODQyMWY5NjdjYjU3ZGYwNTVhNDYyL3RhYmxlcmFuZ2U6YmM3ZDc1MTlkN2M4NDIxZjk2N2NiNTdkZjA1NWE0NjJfMTItMy0xLTEtMzAxMTQ_570c91dd-fc83-4227-bd2f-825e845f9e57">55</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agilent CrossLab</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30a463a582ff4b16971b766059a24eb9_D20211101-20220131" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83OS9mcmFnOjZjOGY3YzEwNmQwMDQ5MDc5OTkxYjhhOTE1MDZmOGNjL3RhYmxlOmJjN2Q3NTE5ZDdjODQyMWY5NjdjYjU3ZGYwNTVhNDYyL3RhYmxlcmFuZ2U6YmM3ZDc1MTlkN2M4NDIxZjk2N2NiNTdkZjA1NWE0NjJfMTMtMS0xLTEtMzAxMTQ_e6d969f1-44da-4897-a206-f36f1abdd9c6">91</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02afafae5dac4c4eb5370132cc85ab08_D20201101-20210131" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83OS9mcmFnOjZjOGY3YzEwNmQwMDQ5MDc5OTkxYjhhOTE1MDZmOGNjL3RhYmxlOmJjN2Q3NTE5ZDdjODQyMWY5NjdjYjU3ZGYwNTVhNDYyL3RhYmxlcmFuZ2U6YmM3ZDc1MTlkN2M4NDIxZjk2N2NiNTdkZjA1NWE0NjJfMTMtMy0xLTEtMzAxMTQ_f0d60acb-dffc-417c-84c0-cf4d50fa8e97">76</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment income from operations</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5987fc4c9ed94d95b32a6ba071848996_D20211101-20220131" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83OS9mcmFnOjZjOGY3YzEwNmQwMDQ5MDc5OTkxYjhhOTE1MDZmOGNjL3RhYmxlOmJjN2Q3NTE5ZDdjODQyMWY5NjdjYjU3ZGYwNTVhNDYyL3RhYmxlcmFuZ2U6YmM3ZDc1MTlkN2M4NDIxZjk2N2NiNTdkZjA1NWE0NjJfMTQtMS0xLTEtMzAxMTQ_ec4895db-7bac-4615-9889-58b25385aeb1">441</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59f03109bfe04c92a404a9157747174a_D20201101-20210131" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83OS9mcmFnOjZjOGY3YzEwNmQwMDQ5MDc5OTkxYjhhOTE1MDZmOGNjL3RhYmxlOmJjN2Q3NTE5ZDdjODQyMWY5NjdjYjU3ZGYwNTVhNDYyL3RhYmxlcmFuZ2U6YmM3ZDc1MTlkN2M4NDIxZjk2N2NiNTdkZjA1NWE0NjJfMTQtMy0xLTEtMzAxMTQ_30f3e155-2cba-4a51-acb6-437cfa4cec9d">396</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AGILENT TECHNOLOGIES, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) - (Continued) </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i83dd9c9ea36947ec885a8edcd2a963d7"><ix:nonNumeric contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" name="us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83OS9mcmFnOjZjOGY3YzEwNmQwMDQ5MDc5OTkxYjhhOTE1MDZmOGNjL3RleHRyZWdpb246NmM4ZjdjMTA2ZDAwNDkwNzk5OTFiOGE5MTUwNmY4Y2NfODM1Mg_cf6bb0ad-acdd-4ae1-be0f-4e9cb047703f" escape="true"><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table reconciles segment income from operations to Agilent&#8217;s total enterprise income before taxes:&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:77.116%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.428%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment income from operations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" decimals="-6" name="a:Segmentincomelossfromoperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83OS9mcmFnOjZjOGY3YzEwNmQwMDQ5MDc5OTkxYjhhOTE1MDZmOGNjL3RhYmxlOmJjYTBlMWU5ZGNhMDRmMzhiYjk2YjRjZGI2ZWQ3NTcyL3RhYmxlcmFuZ2U6YmNhMGUxZTlkY2EwNGYzOGJiOTZiNGNkYjZlZDc1NzJfNC0xLTEtMS0zMDExNA_b0a15e65-9f57-4fb2-a4b6-1905916bb886">441</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131" decimals="-6" name="a:Segmentincomelossfromoperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83OS9mcmFnOjZjOGY3YzEwNmQwMDQ5MDc5OTkxYjhhOTE1MDZmOGNjL3RhYmxlOmJjYTBlMWU5ZGNhMDRmMzhiYjk2YjRjZGI2ZWQ3NTcyL3RhYmxlcmFuZ2U6YmNhMGUxZTlkY2EwNGYzOGJiOTZiNGNkYjZlZDc1NzJfNC0zLTEtMS0zMDExNA_b5fa16e1-cf4d-4401-af48-f582cc077d2b">396</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transformational initiatives</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" decimals="-6" name="a:TransformationalPrograms" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83OS9mcmFnOjZjOGY3YzEwNmQwMDQ5MDc5OTkxYjhhOTE1MDZmOGNjL3RhYmxlOmJjYTBlMWU5ZGNhMDRmMzhiYjk2YjRjZGI2ZWQ3NTcyL3RhYmxlcmFuZ2U6YmNhMGUxZTlkY2EwNGYzOGJiOTZiNGNkYjZlZDc1NzJfNS0xLTEtMS0zMDExNA_9968f028-80dd-4121-9c3f-8dad8ccdbff0">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131" decimals="-6" name="a:TransformationalPrograms" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83OS9mcmFnOjZjOGY3YzEwNmQwMDQ5MDc5OTkxYjhhOTE1MDZmOGNjL3RhYmxlOmJjYTBlMWU5ZGNhMDRmMzhiYjk2YjRjZGI2ZWQ3NTcyL3RhYmxlcmFuZ2U6YmNhMGUxZTlkY2EwNGYzOGJiOTZiNGNkYjZlZDc1NzJfNS0zLTEtMS0zMDExNA_50a2b8fa-03f4-419d-8a41-e6813c17c050">11</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets related to business combinations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" decimals="-6" name="us-gaap:AdjustmentForAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83OS9mcmFnOjZjOGY3YzEwNmQwMDQ5MDc5OTkxYjhhOTE1MDZmOGNjL3RhYmxlOmJjYTBlMWU5ZGNhMDRmMzhiYjk2YjRjZGI2ZWQ3NTcyL3RhYmxlcmFuZ2U6YmNhMGUxZTlkY2EwNGYzOGJiOTZiNGNkYjZlZDc1NzJfNi0xLTEtMS0zMDExNA_4a8b6085-28f2-4308-82cf-806cf5d821bc">51</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131" decimals="-6" name="us-gaap:AdjustmentForAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83OS9mcmFnOjZjOGY3YzEwNmQwMDQ5MDc5OTkxYjhhOTE1MDZmOGNjL3RhYmxlOmJjYTBlMWU5ZGNhMDRmMzhiYjk2YjRjZGI2ZWQ3NTcyL3RhYmxlcmFuZ2U6YmNhMGUxZTlkY2EwNGYzOGJiOTZiNGNkYjZlZDc1NzJfNi0zLTEtMS0zMDExNA_6f8146cb-20dc-49d8-b8e3-5ad60561b6ed">44</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition and integration costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" decimals="-6" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83OS9mcmFnOjZjOGY3YzEwNmQwMDQ5MDc5OTkxYjhhOTE1MDZmOGNjL3RhYmxlOmJjYTBlMWU5ZGNhMDRmMzhiYjk2YjRjZGI2ZWQ3NTcyL3RhYmxlcmFuZ2U6YmNhMGUxZTlkY2EwNGYzOGJiOTZiNGNkYjZlZDc1NzJfNy0xLTEtMS0zMDExNA_759110d7-6f22-4669-945b-2b99e082a9e5">7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131" decimals="-6" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83OS9mcmFnOjZjOGY3YzEwNmQwMDQ5MDc5OTkxYjhhOTE1MDZmOGNjL3RhYmxlOmJjYTBlMWU5ZGNhMDRmMzhiYjk2YjRjZGI2ZWQ3NTcyL3RhYmxlcmFuZ2U6YmNhMGUxZTlkY2EwNGYzOGJiOTZiNGNkYjZlZDc1NzJfNy0zLTEtMS0zMDExNA_557d7939-15ff-46bc-b03e-3092bbacc25b">9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83OS9mcmFnOjZjOGY3YzEwNmQwMDQ5MDc5OTkxYjhhOTE1MDZmOGNjL3RhYmxlOmJjYTBlMWU5ZGNhMDRmMzhiYjk2YjRjZGI2ZWQ3NTcyL3RhYmxlcmFuZ2U6YmNhMGUxZTlkY2EwNGYzOGJiOTZiNGNkYjZlZDc1NzJfOS0xLTEtMS00NjI1NA_80ddbcab-f351-44b0-a8d3-fafee20ada21">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83OS9mcmFnOjZjOGY3YzEwNmQwMDQ5MDc5OTkxYjhhOTE1MDZmOGNjL3RhYmxlOmJjYTBlMWU5ZGNhMDRmMzhiYjk2YjRjZGI2ZWQ3NTcyL3RhYmxlcmFuZ2U6YmNhMGUxZTlkY2EwNGYzOGJiOTZiNGNkYjZlZDc1NzJfOS0zLTEtMS00NjI1NA_12ad8b15-cf4a-4d67-a65b-edc59de6255d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" decimals="-6" name="a:Other" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83OS9mcmFnOjZjOGY3YzEwNmQwMDQ5MDc5OTkxYjhhOTE1MDZmOGNjL3RhYmxlOmJjYTBlMWU5ZGNhMDRmMzhiYjk2YjRjZGI2ZWQ3NTcyL3RhYmxlcmFuZ2U6YmNhMGUxZTlkY2EwNGYzOGJiOTZiNGNkYjZlZDc1NzJfMTQtMS0xLTEtMzAxMTQ_541cb2b7-bf08-4377-959f-937a51e94674">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131" decimals="-6" sign="-" name="a:Other" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83OS9mcmFnOjZjOGY3YzEwNmQwMDQ5MDc5OTkxYjhhOTE1MDZmOGNjL3RhYmxlOmJjYTBlMWU5ZGNhMDRmMzhiYjk2YjRjZGI2ZWQ3NTcyL3RhYmxlcmFuZ2U6YmNhMGUxZTlkY2EwNGYzOGJiOTZiNGNkYjZlZDc1NzJfMTQtMy0xLTEtMzAxMTQ_819f1f88-37aa-4b80-8d27-0f63f1e6e7fa">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" decimals="-6" name="us-gaap:InvestmentIncomeInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83OS9mcmFnOjZjOGY3YzEwNmQwMDQ5MDc5OTkxYjhhOTE1MDZmOGNjL3RhYmxlOmJjYTBlMWU5ZGNhMDRmMzhiYjk2YjRjZGI2ZWQ3NTcyL3RhYmxlcmFuZ2U6YmNhMGUxZTlkY2EwNGYzOGJiOTZiNGNkYjZlZDc1NzJfMTUtMS0xLTEtMzAxMTQ_e7e34303-19c7-4756-bddb-702c505fde6e">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131" decimals="-6" name="us-gaap:InvestmentIncomeInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83OS9mcmFnOjZjOGY3YzEwNmQwMDQ5MDc5OTkxYjhhOTE1MDZmOGNjL3RhYmxlOmJjYTBlMWU5ZGNhMDRmMzhiYjk2YjRjZGI2ZWQ3NTcyL3RhYmxlcmFuZ2U6YmNhMGUxZTlkY2EwNGYzOGJiOTZiNGNkYjZlZDc1NzJfMTUtMy0xLTEtMzAxMTQ_1f6e1604-d099-4460-9c18-87bd433361f1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83OS9mcmFnOjZjOGY3YzEwNmQwMDQ5MDc5OTkxYjhhOTE1MDZmOGNjL3RhYmxlOmJjYTBlMWU5ZGNhMDRmMzhiYjk2YjRjZGI2ZWQ3NTcyL3RhYmxlcmFuZ2U6YmNhMGUxZTlkY2EwNGYzOGJiOTZiNGNkYjZlZDc1NzJfMTYtMS0xLTEtMzAxMTQ_1a5ff83e-9b52-474a-88d5-509d89731701">21</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83OS9mcmFnOjZjOGY3YzEwNmQwMDQ5MDc5OTkxYjhhOTE1MDZmOGNjL3RhYmxlOmJjYTBlMWU5ZGNhMDRmMzhiYjk2YjRjZGI2ZWQ3NTcyL3RhYmxlcmFuZ2U6YmNhMGUxZTlkY2EwNGYzOGJiOTZiNGNkYjZlZDc1NzJfMTYtMy0xLTEtMzAxMTQ_1b161b87-91bb-4524-9290-b31123a9cc70">19</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense), net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" decimals="-6" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83OS9mcmFnOjZjOGY3YzEwNmQwMDQ5MDc5OTkxYjhhOTE1MDZmOGNjL3RhYmxlOmJjYTBlMWU5ZGNhMDRmMzhiYjk2YjRjZGI2ZWQ3NTcyL3RhYmxlcmFuZ2U6YmNhMGUxZTlkY2EwNGYzOGJiOTZiNGNkYjZlZDc1NzJfMTctMS0xLTEtMzAxMTQ_b0cfbf81-24f9-495e-a5c9-f045123d944e">37</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83OS9mcmFnOjZjOGY3YzEwNmQwMDQ5MDc5OTkxYjhhOTE1MDZmOGNjL3RhYmxlOmJjYTBlMWU5ZGNhMDRmMzhiYjk2YjRjZGI2ZWQ3NTcyL3RhYmxlcmFuZ2U6YmNhMGUxZTlkY2EwNGYzOGJiOTZiNGNkYjZlZDc1NzJfMTctMy0xLTEtMzAxMTQ_7fa540ea-970d-48ea-8e6d-43c92e0cd529">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before taxes, as reported</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83OS9mcmFnOjZjOGY3YzEwNmQwMDQ5MDc5OTkxYjhhOTE1MDZmOGNjL3RhYmxlOmJjYTBlMWU5ZGNhMDRmMzhiYjk2YjRjZGI2ZWQ3NTcyL3RhYmxlcmFuZ2U6YmNhMGUxZTlkY2EwNGYzOGJiOTZiNGNkYjZlZDc1NzJfMTgtMS0xLTEtMzAxMTQ_166073cc-1924-4c5b-b930-995811fa1c06">319</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83OS9mcmFnOjZjOGY3YzEwNmQwMDQ5MDc5OTkxYjhhOTE1MDZmOGNjL3RhYmxlOmJjYTBlMWU5ZGNhMDRmMzhiYjk2YjRjZGI2ZWQ3NTcyL3RhYmxlcmFuZ2U6YmNhMGUxZTlkY2EwNGYzOGJiOTZiNGNkYjZlZDc1NzJfMTgtMy0xLTEtMzAxMTQ_9c36e742-2df5-4079-8920-3f67b64f13cf">312</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="padding-left:9pt;text-indent:4.5pt"><span><br/></span></div><div style="padding-left:9pt;text-indent:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) For the three months ended January&#160;31, 2022 and 2021, other income (expense), net includes net (gains) losses on the fair value of equity securities.</span></div></ix:nonNumeric><div style="padding-left:9pt;text-indent:4.5pt"><span><br/></span></div><ix:continuation id="i46151d996f494d399d708f6ea9a6e7af"><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table reflects segment assets under our management reporting system. Segment assets include allocations of corporate assets, goodwill, net other intangibles and other assets. Unallocated assets primarily consist of cash, cash equivalents, short-term and long-term investments, deferred tax assets, right-of-use assets and other assets. &#160;</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:72.576%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.694%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.695%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 31,<br/>2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Life Sciences and Applied Markets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa12471462934aa683c02dac2a2b2a70_I20220131" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83OS9mcmFnOjZjOGY3YzEwNmQwMDQ5MDc5OTkxYjhhOTE1MDZmOGNjL3RhYmxlOmVkY2IyMTg2ZTU1NjQ2MDlhMWNjZWJkMjVhOGRmN2VkL3RhYmxlcmFuZ2U6ZWRjYjIxODZlNTU2NDYwOWExY2NlYmQyNWE4ZGY3ZWRfMy0xLTEtMS0zMDExNA_1485ff02-3970-4991-adba-ca1bbc1b8240">3,752</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i944f468c66a14978a1d1787de51efa6c_I20211031" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83OS9mcmFnOjZjOGY3YzEwNmQwMDQ5MDc5OTkxYjhhOTE1MDZmOGNjL3RhYmxlOmVkY2IyMTg2ZTU1NjQ2MDlhMWNjZWJkMjVhOGRmN2VkL3RhYmxlcmFuZ2U6ZWRjYjIxODZlNTU2NDYwOWExY2NlYmQyNWE4ZGY3ZWRfMy0zLTEtMS0zMDExNA_52b7e76a-a1b7-4c64-81d4-b0339c8c9601">3,741</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics and Genomics</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idcc96fc9ea6041bab3a0329c8a379a8d_I20220131" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83OS9mcmFnOjZjOGY3YzEwNmQwMDQ5MDc5OTkxYjhhOTE1MDZmOGNjL3RhYmxlOmVkY2IyMTg2ZTU1NjQ2MDlhMWNjZWJkMjVhOGRmN2VkL3RhYmxlcmFuZ2U6ZWRjYjIxODZlNTU2NDYwOWExY2NlYmQyNWE4ZGY3ZWRfNC0xLTEtMS0zMDExNA_acf484f4-138b-4076-a14b-26ca3acbab2a">3,325</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2f7270de94a4e99a7412adaded44a2d_I20211031" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83OS9mcmFnOjZjOGY3YzEwNmQwMDQ5MDc5OTkxYjhhOTE1MDZmOGNjL3RhYmxlOmVkY2IyMTg2ZTU1NjQ2MDlhMWNjZWJkMjVhOGRmN2VkL3RhYmxlcmFuZ2U6ZWRjYjIxODZlNTU2NDYwOWExY2NlYmQyNWE4ZGY3ZWRfNC0zLTEtMS0zMDExNA_d8962ab3-4364-433f-b05a-16bb7bcb1124">3,320</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agilent CrossLab</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia895e40152014164ae9414ff9f88a43e_I20220131" decimals="-6" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83OS9mcmFnOjZjOGY3YzEwNmQwMDQ5MDc5OTkxYjhhOTE1MDZmOGNjL3RhYmxlOmVkY2IyMTg2ZTU1NjQ2MDlhMWNjZWJkMjVhOGRmN2VkL3RhYmxlcmFuZ2U6ZWRjYjIxODZlNTU2NDYwOWExY2NlYmQyNWE4ZGY3ZWRfNS0xLTEtMS0zMDExNA_cf627d9b-a43c-446c-b626-252e07b75749">870</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1434e5353934a0ebeb33b6c28613a50_I20211031" decimals="-6" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83OS9mcmFnOjZjOGY3YzEwNmQwMDQ5MDc5OTkxYjhhOTE1MDZmOGNjL3RhYmxlOmVkY2IyMTg2ZTU1NjQ2MDlhMWNjZWJkMjVhOGRmN2VkL3RhYmxlcmFuZ2U6ZWRjYjIxODZlNTU2NDYwOWExY2NlYmQyNWE4ZGY3ZWRfNS0zLTEtMS0zMDExNA_503b0eee-fd62-4800-8c38-a9881d883ce6">839</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9eb3aa4cefc47e4b1504ff02a1447b6_I20220131" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83OS9mcmFnOjZjOGY3YzEwNmQwMDQ5MDc5OTkxYjhhOTE1MDZmOGNjL3RhYmxlOmVkY2IyMTg2ZTU1NjQ2MDlhMWNjZWJkMjVhOGRmN2VkL3RhYmxlcmFuZ2U6ZWRjYjIxODZlNTU2NDYwOWExY2NlYmQyNWE4ZGY3ZWRfNi0xLTEtMS0zMDExNA_c856beaa-f186-46f3-a4cd-3b0e542ba22f">7,947</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i105ea30704ee4603b6db5fd253f01d92_I20211031" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83OS9mcmFnOjZjOGY3YzEwNmQwMDQ5MDc5OTkxYjhhOTE1MDZmOGNjL3RhYmxlOmVkY2IyMTg2ZTU1NjQ2MDlhMWNjZWJkMjVhOGRmN2VkL3RhYmxlcmFuZ2U6ZWRjYjIxODZlNTU2NDYwOWExY2NlYmQyNWE4ZGY3ZWRfNi0zLTEtMS0zMDExNA_41a0036a-2198-43d4-804c-c39357409530">7,900</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation></ix:continuation><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><div id="if825c91f15a047ec9e67e0189634a349_82"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#if825c91f15a047ec9e67e0189634a349_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 2. MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS  (UNAUDITED)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following discussion should be read in conjunction with the condensed consolidated financial statements and notes thereto included elsewhere in this Form&#160;10-Q and our Annual Report on Form 10-K. This report contains forward-looking statements including, without limitation, statements regarding growth opportunities, including for revenue and our end markets, strength and drivers of the markets into which we sell, sales funnels, our strategic direction, new product and service introductions and the position of our current products and services, market demand for and adoption of our products, the ability of our products and solutions to address customer needs and meet industry requirements, our focus on differentiating our product solutions, improving our customers&#8217; experience and growing our earnings, future financial results, our operating margin, mix, our investments, including in manufacturing infrastructure, research and development and expanding and improving our applications and solutions portfolios, expanding our position in developing countries and emerging markets, our focus on balanced capital allocation, our contributions to our pension and other defined benefit plans, impairment of goodwill and other intangible assets, the impact of foreign currency movements, our hedging programs and other actions to offset the effects of tariffs and foreign currency movements, our future effective tax rate, tax valuation allowance and unrecognized tax benefits, the impact of local government regulations on our ability to pay vendors or conduct operations, our ability to satisfy our liquidity requirements, including through cash generated from operations, the potential impact of adopting new accounting pronouncements, indemnification, source and supply of materials used in our products, our sales, our purchase commitments, our capital expenditures, the integration and effects of our acquisitions and other transactions, our stock repurchase program and dividends and the potential or anticipated direct or indirect impact of COVID-19 on our business that involve risks and uncertainties. Our actual results could differ materially from the results contemplated by these forward-looking statements due to various factors, including those discussed in Part II Item&#160;1A and elsewhere in this Form&#160;10-Q.</span></div><div><span><br/></span></div><div id="if825c91f15a047ec9e67e0189634a349_85"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis of Presentation</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The financial information presented in this Form&#160;10-Q is not audited and is not necessarily indicative of our future consolidated financial position, results of operations, comprehensive income (loss) or cash flows. Our fiscal year-end is October&#160;31, and our fiscal quarters end on January&#160;31, April&#160;30 and July&#160;31. Unless otherwise stated, these dates refer to our fiscal year and fiscal periods.</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="if825c91f15a047ec9e67e0189634a349_88"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Executive Summary</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Agilent Technologies, Inc. ("we," "Agilent" or the "company"), incorporated in Delaware in May 1999, is a global leader in life sciences, diagnostics and applied chemical markets, providing application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of fiscal year 2022, we announced a change in organizational structure designed to enable our growth strategies and strengthen our focus on customers. Our chemistries and supplies business and our remarketed instruments business moved from our Agilent CrossLab business segment to our life sciences and applied markets business segment. Service revenue and cost of sales related to the previous acquisition of BioTek moved from our life sciences and applied markets business segment to our Agilent CrossLab business segment. We are reporting under this new structure beginning with this Quarterly Report on Form 10-Q for the period ended January 31, 2022 and historical financial segment information has been recast to conform to this new presentation in our financial statements and accompanying notes. There was no change to our diagnostics and genomics business segment.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">COVID-19 Pandemic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </span></div><div style="text-align:justify;text-indent:9pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Both our domestic and international operations have been and continue to be affected by the ongoing global pandemic of a novel strain of coronavirus (&#8220;COVID-19&#8221;) and the resulting volatility and uncertainty it has caused in the U.S. and international markets. During the three months ended January&#160;31, 2022, many businesses and countries, including the U.S., continued applying preventative and precautionary measures to mitigate the spread of the virus such as quarantine, shelter-in-place, travel and activity restrictions and similar isolation measures, including government orders and other restrictions on the conduct of business operations. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic continues to be dynamic, and near-term challenges across the economy remain. The ongoing effects of COVID-19 remain difficult to predict due to numerous uncertainties, including the severity, duration and resurgence of the outbreak, new variants and the contagiousness of these new variants, the effectiveness of health and safety measures including vaccines, managing the different pace of return-to-office in different locations, the pace and strength of the economic </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#if825c91f15a047ec9e67e0189634a349_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">recovery, supply chain pressures, delivery and installation delays due to variable access to customer sites,  among others. We will continue to actively monitor the effects of the pandemic and will continue to take appropriate steps to mitigate the impacts to our employees and on our business results.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Actual Results</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net revenue of $1,674 million for the three months ended January&#160;31, 2022 increased 8 percent when compared to the same period last year. This revenue growth came from increases in all of our segments, geographies and from our three largest end markets. Foreign currency movements for the three months ended January&#160;31, 2022 had an overall unfavorable impact on revenue growth of 1 percentage point when compared to the same period last year. Revenue generated by our life sciences and applied markets business in the three months ended January&#160;31, 2022 increased 6 percent when compared to the same period last year. Foreign currency movements for the three months ended January&#160;31, 2022, had an overall unfavorable impact on revenue growth of 1 percentage point when compared to the same period last year. Revenue generated by our diagnostics and genomics business for the three months ended January&#160;31, 2022 increased 15 percent when compared to the same period last year.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Foreign currency movements for the three months ended January&#160;31, 2022 had an overall unfavorable impact on revenue growth of 2 percentage points when compared to the same period last year. Revenue generated by our Agilent CrossLab business in the three months ended January&#160;31, 2022 increased 8 percent when compared to the same period last year. Foreign currency movements for the three months ended January&#160;31, 2022 had an overall unfavorable impact on revenue growth of 2&#160;percentage points when compared to the same period last year. </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income for the three months ended January&#160;31, 2022 was $283 million compared to net income of $288 million for the corresponding period last year. In the three months ended January&#160;31, 2022, cash provided by operations was $255 million compared to cash provided by operations of $238 million in the same period last year.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended January&#160;31, 2022 and 2021, we paid cash dividends on the company's outstanding common stock of $63 million and $59 million, respectively.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 16, 2021 we announced that our board of directors had approved a new share repurchase program (the "2021 repurchase program") designed, among other things, to reduce or eliminate dilution resulting from issuance of stock under the company's employee equity incentive programs. The 2021 repurchase program authorizes the purchase of up to $2.0&#160;billion of our common stock at the company's discretion and has no fixed termination date. The 2021 repurchase program which became effective on February 18, 2021, replaced and terminated the 2019 repurchase program on that date. The 2021 repurchase program does not require the company to acquire a specific number of shares and may be suspended, amended or discontinued at any time. During the three months ended January&#160;31, 2022, we repurchased and retired 2.9 million shares for $447 million under this authorization. As of January&#160;31, 2022, we had remaining authorization to repurchase up to approximately $1.13 billion of our common stock under the 2021 repurchase program.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> During the three months ended January&#160;31, 2021, we repurchased and retired 2.9 million shares for $344 million under the 2019 repurchase program. Effective February 18, 2021, the 2019 repurchase program was terminated and was replaced by the 2021 share repurchase program. The remaining authorization under the 2019 repurchase plan of $193&#160;million expired on February 18, 2021.</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;  Looking forward, as we continue to navigate the impacts of the COVID-19 pandemic, our top priority continues to be the health and safety of our employees, customers and community, as well as supporting our customers' operations. We expect to face continued logistical pressures, such as longer lead times and limited sources of supply in the near term that we will continue to mitigate through various sourcing strategies. We also remain focused on improving our customers&#8217; experience, differentiating product solutions and productivity. With our strong results in the first quarter of fiscal year 2022 and the continued recovery in our end markets, we remain optimistic about our long-term growth opportunities in all of our end markets.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><div id="if825c91f15a047ec9e67e0189634a349_91"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#if825c91f15a047ec9e67e0189634a349_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Policies and Estimates </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations is based upon our condensed consolidated financial statements, which have been prepared in accordance with generally accepted accounting principles (&#8220;GAAP&#8221;) in the U.S. The preparation of condensed consolidated financial statements in conformity with GAAP in the U.S. requires management to make estimates, judgments and assumptions that affect the amounts reported in our condensed consolidated financial statements and accompanying notes. Our critical accounting policies are those that affect our financial statements materially and involve difficult, subjective or complex judgments by management. Those policies are revenue recognition, inventory valuation, retirement and post-retirement benefit plan assumptions, valuation of goodwill and purchased intangible assets and accounting for income taxes. There have been no significant changes to our critical accounting policies as described in our Annual Report on Form 10-K for the fiscal year ended October&#160;31, 2021. Management bases its estimates on historical experience and various other assumptions believed to be reasonable. Although these estimates are based on management&#8217;s best knowledge of current events and actions that may impact the company in the future, actual results may be different from the estimates.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An accounting policy is deemed to be critical if it requires an accounting estimate to be made based on assumptions about matters that are highly uncertain at the time the estimate is made and if different estimates that reasonably could have been used or changes in the accounting estimate that are reasonably likely to occur could materially change the financial statements.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div id="if825c91f15a047ec9e67e0189634a349_94"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Adoption of New Pronouncements</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 2, &#8220;New Accounting Pronouncements,&#8221; to the condensed consolidated financial statements for a description of new accounting pronouncements.</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="if825c91f15a047ec9e67e0189634a349_97"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Foreign Currency</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenues, costs and expenses, and monetary assets and liabilities and equity are exposed to changes in foreign currency exchange rates as a result of our global operating and financing activities. Foreign currency movements for the three months ended January&#160;31, 2022 had an overall unfavorable impact on revenue of 1 percentage point when compared to the same period last year. When movements in foreign currency exchange rates have a negative impact on revenue, they will also have a positive impact by reducing our costs and expenses. We calculate the impact of movements in foreign currency exchange rates by applying the actual foreign currency exchange rates in effect during the last month of each quarter of the current year to both the applicable current and prior year periods. We hedge revenues, expenses and balance sheet exposures that are not denominated in the functional currencies of our subsidiaries on a short term and anticipated basis. We do experience some fluctuations within individual lines of the condensed consolidated statement of operations and balance sheet because our hedging program is not designed to offset the currency movements in each category of revenues, expenses, monetary assets and liabilities. Our hedging program is designed to hedge currency movements on a relatively short-term basis (up to a rolling thirteen-month period). We may also hedge equity balances denominated in foreign currency on a long-term basis. To the extent that we are required to pay for all, or portions, of an acquisition price in foreign currencies, we may enter into foreign exchange contracts to reduce the risk that currency movements will impact the U.S. dollar cost of the transaction.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="if825c91f15a047ec9e67e0189634a349_100"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results from Operations</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net Revenue</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.157%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:16.301%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year&#160;over&#160;Year&#160;Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Months</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenue:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Products</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,263&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,172&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">411&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">376&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net revenue</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,674&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,548&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net revenue of $1,674 million for the three months ended January&#160;31, 2022 increased 8 percent when compared to the same period last year. Foreign currency movements for the three months ended January&#160;31, 2022 had an overall unfavorable </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#if825c91f15a047ec9e67e0189634a349_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">impact on revenue growth of 1 percentage point when compared to the same period last year. In the three months ended January&#160;31, 2022, net revenue increased in all three of our business segments, geographic regions and from our three largest end markets;  the pharmaceutical, chemical and energy and diagnostics and clinical markets when compared to the same periods last year.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue from products increased 8 percent for the three months ended January&#160;31, 2022 when compared to the same period last year. The growth in product revenue was primarily driven by increased sales within our liquid chromatography mass spectrometry business with continued strong growth in our nucleic acid solutions business. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Services and other revenue increased 9 percent for the three months ended January&#160;31, 2022 when compared to the same period last year.&#160;Services and other revenue consist of contract repair, preventive maintenance, compliance services, repair and maintenance, installation services and consulting services related to the companion diagnostics and nucleic acid solutions businesses. For the three months ended January&#160;31, 2022, service revenue increases reflected solid growth from contract repair services and consultative services.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net Revenue By Segment</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.625%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:19.518%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year&#160;over&#160;Year&#160;Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Months</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net revenue by segment:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Life sciences and applied markets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">976&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">923&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics and genomics</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">339&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">294&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agilent CrossLab</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">359&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">331&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,674&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,548&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue in the life sciences and applied markets business for the three months ended January&#160;31, 2022 increased 6 percent when compared to the same period last year.  Foreign currency movements for the three months ended January&#160;31, 2022 had an overall unfavorable impact on revenue growth of 1 percentage point when compared to the same period last year. For the three months ended January&#160;31, 2022, we saw strong revenue growth within the pharmaceutical, chemical and energy and diagnostics and clinical markets partially offset by a decline in the food, academia and government and environmental and forensics markets when compared to the same periods last year. </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue in the diagnostics and genomics business for the three months ended January&#160;31, 2022, increased 15 percent  when compared to the same period last year. Foreign currency movements for the three months ended January&#160;31, 2022 had an overall unfavorable impact on revenue growth of 2 percentage points when compared to the same period last year. For the three months ended January&#160;31, 2022, revenue growth was strong within the pharmaceutical market led by performance from our nucleic acid solutions business. Revenue growth was strong within the diagnostics and clinical markets led by performance from our pathology business. </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue generated by Agilent CrossLab in the three months ended January&#160;31, 2022, increased 8 percent when compared to the same period last year. Foreign currency movements for the three months ended January&#160;31, 2022 had an overall unfavorable impact on revenue growth of 2 percentage points when compared to the same period last year.  For the three months ended January&#160;31, 2022, we saw strong revenue growth from the pharmaceutical, chemical and energy and food markets when compared to the same periods last year.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><div id="if825c91f15a047ec9e67e0189634a349_103"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#if825c91f15a047ec9e67e0189634a349_7">Table of Contents</a></span></div></div><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Operating Results</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:16.302%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year&#160;over&#160;Year&#160;Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Months</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions, except margin data)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total gross margin</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212; </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">417&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">407&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating margin</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 ppt</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from operations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">376&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">328&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total gross margin for the three months ended January&#160;31, 2022 was flat when compared to the same period last year. Gross margin for the three months ended January&#160;31, 2022 was impacted by higher sales volume and price increases which were offset by higher wages, logistics costs, intangible amortization expense and share-based compensation expense. </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expenses for the three months ended January&#160;31, 2022 increased 13 percent when compared to the same period last year. Research and development expenses for the three months ended January&#160;31, 2022 increased due to higher wages and variable pay, program investments in our diagnostics and genomics and our life sciences and applied markets segments, and additional expenses related to our acquisition of Resolution Bioscience. </span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selling, general and administrative expenses for the three months ended January&#160;31, 2022 increased 2 percent when compared to the same period last year. The increase in selling, general and administrative expenses for the three months ended January&#160;31, 2022 was due to higher wages, the change in the fair value of an acquisition-related contingent consideration, higher share-based compensation expense and amortization of intangible assets partially offset by lower transformational initiatives expenses. </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total operating margin for the three months ended January&#160;31, 2022 increased 1 percentage point when compared to the same period last year. Operating margin for the three months ended January&#160;31, 2022 increased due to higher sales volume  partially offset by increases in operating expenses.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income from operations for the three months ended January&#160;31, 2022 increased $48 million or 15 percent on a corresponding revenue increase of $126 million. </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At January&#160;31, 2022, our headcount was approximately 17,200 as compared to approximately 16,400 at January&#160;31, 2021. </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other income (expense), net</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the three months ended January&#160;31, 2022 other income and expense, net includes income of $3 million related to the provision of site service costs to, and lease income from Keysight Technologies, Inc. The costs associated with these services are reported within income from operations. In the three months ended January&#160;31, 2022 other income and expense, net also includes net loss on the fair value of equity investments of approximately $47 million. </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In the three months ended January&#160;31, 2021 other income and expense, net includes a $5 million loss on the extinguishment of debt. In the three months ended January&#160;31, 2021 other income and expense also includes income of $3 million related to the provision of site service costs to, and lease income from Keysight Technologies, Inc. The costs associated with these services are reported within income from operations. </span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><div id="if825c91f15a047ec9e67e0189634a349_106"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#if825c91f15a047ec9e67e0189634a349_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income Taxes </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended January&#160;31, 2022, our income tax expense was $36 million with an effective tax rate of 11.3 percent. The income taxes for the three months ended January&#160;31, 2022 include the excess tax benefits from stock-based compensation of $16&#160;million. For the three months ended January&#160;31, 2022, our effective tax rate and the resulting provision for income taxes were also impacted by the expiration of various foreign statutes of limitations which resulted in the recognition of previously unrecognized tax benefits of $8&#160;million.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our calculation of income tax expense for the&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">three</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> months ended </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">January&#160;31, 2022</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is dependent in part on forecasts of full year results. The impact of the COVID-19 outbreak on the economic environment is uncertain and may change these forecasts, which could impact tax expense.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended January&#160;31, 2021, our income tax expense was $24 million with an effective tax rate of 7.7 percent. The income taxes for the three months ended January&#160;31, 2021 include the excess tax benefits from stock-based compensation of $20&#160;million. For the three months ended January&#160;31, 2021, our effective tax rate and the resulting provision for income taxes were also impacted by the expiration of various foreign statutes of limitations which resulted in the recognition of previously unrecognized tax benefits of $16&#160;million. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In the U.S., tax years remain open back to the year 2018 for federal income tax purposes and for significant states. In other major jurisdictions where the company conducts business, the tax years generally remain open back to the year 2012.  </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With these jurisdictions and the U.S., it is reasonably possible there could be significant changes to our unrecognized tax benefits in the next twelve months due to either the expiration of a statute of limitation or a tax audit settlement which will be partially offset by an anticipated tax liability related to unremitted foreign earnings, where applicable. Given the number of years and numerous matters that remain subject to examination in various tax jurisdictions, management is unable to estimate the range of possible changes to the balance of our unrecognized tax benefits.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div id="if825c91f15a047ec9e67e0189634a349_109"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Segment Overview</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of fiscal year 2022, we announced a change in organizational structure designed to enable our growth strategies and strengthen our focus on customers. Our chemistries and supplies business and our remarketed instruments business moved from our Agilent CrossLab business segment to our life sciences and applied markets business segment. Service revenue and cost of sales related to the previous acquisition of BioTek moved from our life sciences and applied markets business segment to our Agilent CrossLab business segment. Following this reorganization, we continue to have three business segments (life sciences and applied markets, diagnostics and genomics and Agilent CrossLab), each of which continues to comprise a reportable segment. We are reporting under this new structure beginning with this Quarterly Report on Form 10-Q for the period ended January 31, 2022 and historical financial segment information has been recast to conform to this new presentation in our financial statements and accompanying notes. There was no change to our diagnostics and genomics business segment. </span></div><div><span><br/></span></div><div id="if825c91f15a047ec9e67e0189634a349_112"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Life Sciences and Applied Markets</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our life sciences and applied markets business provides application-focused solutions that include instruments and software that enable customers to identify, quantify and analyze the physical and biological properties of substances and products, as well as enable customers in the clinical and life sciences research areas to interrogate samples at the molecular and cellular level. Key product categories include: liquid chromatography ("LC") systems and components; liquid chromatography mass spectrometry ("LCMS") systems; gas chromatography ("GC") systems and components; gas chromatography mass spectrometry ("GCMS") systems; inductively coupled plasma mass spectrometry ("ICP-MS") instruments; atomic absorption ("AA") instruments; microwave plasma-atomic emission spectrometry ("MP-AES") instruments; inductively coupled plasma optical emission spectrometry ("ICP-OES") instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software for sample tracking; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps and measurement technologies. Our consumables portfolio is designed to improve customer outcomes. Most of the portfolio is vendor neutral, meaning Agilent can serve and supply customers regardless of their instrument purchase choices. Solutions range from chemistries to supplies. Key product categories in consumables include GC and LC columns, sample preparation products, custom chemistries, and a large selection of laboratory instrument supplies. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#if825c91f15a047ec9e67e0189634a349_7">Table of Contents</a></span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Revenue</span></div><div><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.391%"><tr><td style="width:1.0%"></td><td style="width:66.061%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.542%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.558%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.542%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.558%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:10.939%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year&#160;over&#160;Year&#160;Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Months</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">976&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">923&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Life sciences and applied markets business revenue for the three months ended January&#160;31, 2022 increased 6 percent when compared to the same period last year. For the three months ended January&#160;31, 2022, foreign currency movements had an overall unfavorable impact on revenue growth of 1 percentage point when compared to the same period last year. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Geographically, revenue increased 14 percent in the Americas with no currency impact, increased 3 percent in Europe with a 3 percentage point unfavorable currency impact and increased 2 percent in Asia Pacific with a 1 percentage point unfavorable currency impact for the three months ended January&#160;31, 2022 compared to the same period last year. For the three months ended January&#160;31, 2022, revenue growth was strong across all businesses. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended January&#160;31, 2022, results by end markets were mixed with pharmaceutical, chemical and energy and diagnostics and clinical markets delivering strong revenue growth while forensics and environmental, food and academia declined when compared to the same period last year. Revenue growth in the pharmaceutical end market was primarily driven by our liquid chromatography, consumables, liquid chromatography mass spectrometry and spectroscopy businesses. Revenue growth in chemical and energy was mainly driven by strength in our gas chromatography, spectroscopy and consumables portfolio while diagnostics and clinical growth was mainly led by liquid chromatography mass spectrometry products. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended January&#160;31, 2022, the food end market declined mainly due to weakness in liquid chromatography mass spectrometry and gas chromatography applications in China partially offset by consumables products when compared to the same period last year. Forensics and environmental weakness was mainly driven by declines in gas chromatography mass spectrometry and gas chromatography spectroscopy products. Academia and government decline was mainly in the U.S. and China. In the U.S., the decline was due to the impact of the Omicron surge as many universities went back to remote-learning after the holidays. In China, the declines were due to both the Omicron surge and the Lunar New Year impacting delays in delivery of our instruments. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Looking forward, despite supply chain uncertainties and the adverse effects of the COVID-19 pandemic, we are optimistic about our long-term growth opportunities in the life sciences and applied markets as our broad portfolio of products and solutions are well suited to address customer needs. We anticipate growth from our new product introductions and acquisitions in the last couple of years as we continue to invest in expanding and improving our applications and solutions portfolio. While we anticipate volatility in our markets, we expect continued growth across most end markets in the long term.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Results</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.812%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:11.038%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year&#160;over&#160;Year&#160;Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Months</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions, except margin data)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross margin</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212; </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">227&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating margin</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212; </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from operations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">282&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">265&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gross margin for products and services for the three months ended January&#160;31, 2022, was flat when compared to the same period last year. Gross margin for the three months ended January&#160;31, 2022 was impacted by higher sales volume, price increases and favorable hedging gains which were mostly offset by higher materials costs, wages and variable pay. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#if825c91f15a047ec9e67e0189634a349_7">Table of Contents</a></span></div></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expenses for the three months ended January&#160;31, 2022, increased 13 percent when compared to the same period last year. Research and development expenses for the three months ended January&#160;31, 2022 increased due to higher wages and program investments in software and informatics and higher share-based compensation expense partially offset by favorable currency impact.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Selling, general and administrative expenses for the three months ended January&#160;31, 2022, increased 3 percent when compared to the same period last year. Selling, general and administrative expenses for the three months ended January&#160;31, 2022 increased due to higher wages, commissions and share-based compensation expense partially offset by favorable currency movements.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating margin for products and services for the three months ended January&#160;31, 2022 was flat when compared to the same period last year. Operating margin for the three months ended January&#160;31, 2022 increased due to higher sales volume  which was partially offset by higher material costs,  program expenses, wages and share-based compensation expense.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income from operations for the three months ended January&#160;31, 2022, increased $17 million or 7 percent on a corresponding revenue increase of $53 million. Income from operations for the three months ended January&#160;31, 2022 increased primarily due to higher sales volume.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div id="if825c91f15a047ec9e67e0189634a349_115"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Diagnostics and Genomics</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our diagnostics and genomics business includes the genomics, nucleic acid contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership and biomolecular analysis businesses.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our diagnostics and genomics business is comprised of six areas of activity providing active pharmaceutical ingredients ("APIs") for oligo-based therapeutics as well as solutions that include reagents, instruments, software and consumables, which enable customers in the clinical and life sciences research areas to interrogate samples at the cellular and molecular level.&#160;First, our genomics business includes arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, gene expression profiling, as well as next generation sequencing ("NGS") target enrichment and genetic data management and interpretation support software. This business also includes solutions that enable clinical labs to identify DNA variants associated with genetic disease and help direct cancer therapy. Second, our nucleic acid solutions business provides equipment and expertise focused on production of synthesized oligonucleotides under pharmaceutical good manufacturing practices ("GMP") conditions for use as API in an emerging class of drugs that utilize nucleic acid molecules for disease therapy. Third, our pathology solutions business is focused on product offerings for cancer diagnostics and anatomic pathology workflows. The broad portfolio of offerings includes immunohistochemistry ("IHC"), in situ hybridization ("ISH"), hematoxylin and eosin ("H&amp;E") staining and special staining. Fourth, we also collaborate with a number of major pharmaceutical companies to develop new potential tissue and liquid-based pharmacodiagnostics, also known as companion diagnostics, which may be used to identify patients most likely to benefit from a specific targeted therapy. Fifth, the reagent partnership business is a provider of reagents used for turbidimetry and flow cytometry. Finally, our biomolecular analysis business provides complete workflow solutions, including instruments, consumables and software, for quality control analysis of nucleic acid samples.&#160;Samples are analyzed using quantitative and qualitative techniques to ensure accuracy in further genomics analysis techniques utilized in clinical and life science research applications.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Revenue</span></div><div><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.992%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:11.185%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year&#160;over&#160;Year&#160;Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Months</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">339&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">294&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diagnostics and genomics business revenue for the three months ended January&#160;31, 2022 increased 15 percent when compared to the same period last year.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended January&#160;31, 2022, foreign currency movements had an overall unfavorable impact on revenue growth of 2 percentage points when compared to the same period last year. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#if825c91f15a047ec9e67e0189634a349_7">Table of Contents</a></span></div></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Geographically, revenue increased 24 percent in the Americas with no currency impact, increased 1 percent in Europe with a 3 percentage point unfavorable currency impact and increased 17 percent in Asia Pacific with a 4 percentage point unfavorable currency impact for the three months ended January&#160;31, 2022 compared to the same period last year.  For the three months ended January&#160;31, 2022, the increase in the Americas was driven by strong performance in our nucleic acid solutions and genomics portfolios. In Europe, revenue growth from the pathology business was mostly offset by a decline in the genomics portfolio, driven by the COVID-19 related instrument and reagents sales decreasing from the prior year. The growth in Asia Pacific was driven by strong performance across the genomics and pathology portfolio.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended January&#160;31, 2022, revenue performance in the diagnostics and genomics business was led by strong revenue growth in our nucleic acid solutions business. All key end markets had revenue increases when compared to the same periods last year.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Looking forward, we are optimistic about our long-term growth opportunities in our end markets and continue to invest in expanding and improving our applications and solutions portfolio. We remain positive about our growth in our end markets as our product portfolio around OMNIS, PD-L1 assays and SureFISH continues to gain strength with our customers in clinical oncology applications, and our next generation sequencing target enrichment solutions continue to be adopted. Market demand in the nucleic acid solutions business related to therapeutic oligo programs continues, and with our newly opened and planned extension of our nucleic acid solutions production facility in Frederick, Colorado, we are well positioned to serve more of the market demand. The acquisition of Resolution Bioscience will expand our capabilities in NGS-based cancer diagnostics and provide innovative technology to further serve the needs of the fast-growing precision medicine market. We will continue to invest in research and development and seek to expand our position in developing countries and emerging markets.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Results</span></div><div><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.992%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:11.185%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year&#160;over&#160;Year&#160;Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Months</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions, except margin data)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross margin</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> 1 ppt</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating margin</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 ppts </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from operations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gross margin for products and services for the three months ended January&#160;31, 2022, increased 1 percentage point when compared to the same period last year. Gross margin in the three months ended January&#160;31, 2022 increased due to higher sales volume more than offsetting higher wages and variable pay.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expenses for the three months ended January&#160;31, 2022, increased 18 percent when compared to the same period last year. Research and development expenses for the three months ended January&#160;31, 2022 included higher pathology and genomics program investments, higher wages and variable pay and additional expenses related to the Resolution Bioscience acquisition.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selling, general and administrative expenses for the three months ended January&#160;31, 2022, increased 13 percent when compared to the same period last year. Selling, general and administrative expenses for the three months ended January&#160;31, 2022 increased due to an increase in share based compensation expenses, higher wages and variable pay and additional expenses related to the Resolution Bioscience acquisition.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating margin for products and services for the three months ended January&#160;31, 2022 increased 2 percentage points when compared to the same period last year. Operating margin for the three months ended January&#160;31, 2022 improved as the revenue growth more than offset the increase in program investments, wages and variable pay.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#if825c91f15a047ec9e67e0189634a349_7">Table of Contents</a></span></div></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income from operations for the three months ended January&#160;31, 2022 increased $13 million or 25 percent on a corresponding revenue increase of $45 million. Income from operations for the three months ended January&#160;31, 2022 increased due to strong revenue performance.</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div id="if825c91f15a047ec9e67e0189634a349_118"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Agilent CrossLab</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Agilent CrossLab business spans the entire lab with its extensive services portfolio, which is designed to improve customer outcomes.  The majority of the portfolio is vendor neutral, meaning we can serve and supply customers regardless of their instrument purchase choices. The services portfolio includes repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, consulting and various other custom services to support the customers' laboratory operations.  Custom services are tailored to meet the specific application needs of various industries and to keep instruments fully operational and compliant with the respective industry requirements.</span></div><div style="text-indent:27pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Revenue</span></div><div><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:87.280%"><tr><td style="width:1.0%"></td><td style="width:60.541%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.642%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.787%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.787%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:12.806%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year&#160;over&#160;Year&#160;Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Months</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">359&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">331&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Agilent CrossLab business revenue for the three months ended January&#160;31, 2022 increased 8 percent when compared to the same period last year. Foreign currency movements for the three months ended January&#160;31, 2022 had an overall unfavorable impact on revenue growth of 2 percentage points when compared to the same period last year. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Geographically, revenue increased 6 percent in the Americas with no currency impact, increased 6 percent in Europe with a 4 percentage point unfavorable currency impact and increased 12 percent in Asia Pacific with a 2 percentage point unfavorable currency impact for the three months ended January&#160;31, 2022 compared to the same period last year. During the three months ended January&#160;31, 2022, the solid growth in all three regions was driven by contract repair services and consultative services.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended January&#160;31, 2022, the Agilent CrossLab business continued to see low double digit revenue growth from the pharmaceutical market, chemical and energy market and the food market, which together accounts for three-quarters of the Agilent CrossLab business revenues. The environmental and forensics market, as well as the academia and government market, remained subdued with flat growth, following the weakness in the growth of instrument sales in those two markets.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Looking forward, Agilent CrossLab services are well positioned to continue their success in our key end markets by supporting a growing installed base of instruments. Digital and remote capabilities will continue to be a key factor in improving the service quality and the experience to customers. Geographically, the business is well diversified across all regions to take advantage of local market opportunities and to hedge against weakness in any one region.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Results</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:10.600%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year&#160;over&#160;Year&#160;Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Months</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions, except margin data)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross margin</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 ppt</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating margin</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 ppts</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from operations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#if825c91f15a047ec9e67e0189634a349_7">Table of Contents</a></span></div></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gross margin for the three months ended January&#160;31, 2022 increased 1 percentage point when compared to the same period last year.  Higher cash flow hedging gains, higher sales volumes and targeted price increases improved margins which were partially offset by higher service delivery costs, such as logistics, parts and labor.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expenses for the three months ended January&#160;31, 2022 decreased 5 percent when compared to the same period last year.  Delays in certain research and development projects led to lower expenditures in the three months ended January 31, 2022.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selling, general and administrative expenses for the three months ended January&#160;31, 2022 increased 2 percent when compared to the same period last year, primarily due to higher wages and higher sales commissions.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating margin for products and services for the three months ended January&#160;31, 2022 increased 2 percentage points when compared to the same period last year, mostly driven by higher cash flow hedging gains and higher sales volume.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income from operations for the three months ended January&#160;31, 2022 increased $15 million or 19 percent on a corresponding revenue increase of $28 million.  Income from operations for the three months ended January&#160;31, 2022 increased primarily due to higher sales volume.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div id="if825c91f15a047ec9e67e0189634a349_121"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL CONDITION</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div style="text-align:justify;text-indent:9pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe our cash and cash equivalents, cash generated from operations, and ability to access capital markets and credit lines will satisfy, for at least the next twelve months, our liquidity requirements, both globally and domestically, including the following: working capital needs, capital expenditures, business acquisitions, stock repurchases, cash dividends, contractual obligations, commitments, principal and interest payments on debt, and other liquidity requirements associated with our operations. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our financial position as of January&#160;31, 2022 consisted of cash and cash equivalents of $1,113 million as compared to $1,484 million as of October&#160;31, 2021.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may, from time to time, retire certain outstanding debt of ours through open market cash purchases, privately-negotiated transactions or otherwise. Such transactions, if any, will depend on prevailing market conditions, our liquidity requirements, contractual restrictions and other factors.</span></div><div style="text-align:justify;text-indent:13.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net Cash Provided by Operating Activities</span></div><div style="text-align:justify;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash inflow from operating activities was $255 million for the three months ended January&#160;31, 2022 compared to cash inflow of $238 million for the same period in 2021.  Net cash paid for income taxes in the three months ended January&#160;31, 2022 was approximately $22 million compared to income taxes paid of $52 million for the same period in 2021. Other assets and liabilities, for the three months ended January&#160;31, 2022, had cash inflow of $40 million compared to cash outflow of $95 million for the same period in 2021. Cash inflow in the three months ended January&#160;31, 2022 compared to cash outflow in 2021 was largely the result of higher Non U.S. transaction tax refunds, lower income tax payments and higher deferred revenue accrual in 2022.</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the three months ended January&#160;31, 2022, accounts receivable used cash of $46 million compared to cash used of $31 million for the same period in 2021.&#160;Days&#8217; sales outstanding as of January&#160;31, 2022 and 2021 was 65 days and 63 days, respectively. Cash used for inventory was $54 million for the three months ended January&#160;31, 2022 compared to cash used of $35 million for the same period in 2021. Inventory days on-hand was 103 days as of January&#160;31, 2022 compared to 96 days as of January&#160;31, 2021 mainly due to increased inventory levels to meet customer needs and to compensate for long lead time in ordering from our suppliers. In the three months ended January&#160;31, 2022, accounts payable provided cash of $37 million compared to cash provided of $43 million for the same period in 2021. The change in the employee compensation and benefits liability was $210 million for the three months ended January&#160;31, 2022 compared to cash used of $88 million for the same period in 2021. This was largely due to an increase in  variable and incentive payments of $201 million in 2022 compared to $119&#160;million in 2021.</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We contributed approximately $5 million to our defined benefit plans in both the three months ended January&#160;31, 2022 and 2021, respectively. Our annual contributions are highly dependent on the relative performance of our assets versus our </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#if825c91f15a047ec9e67e0189634a349_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">projected liabilities, among other factors. We expect to contribute approximately $14 million to our defined benefit plans during the remainder of 2022.</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net Cash Used in Investing Activities</span></div><div style="text-align:justify;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in investing activities was $79 million for the three months ended January&#160;31, 2022 as compared to net cash used in investing activities of $42 million in the same period of 2021. Investments in property, plant and equipment were $75 million for the three months ended January&#160;31, 2022 compared to $41 million in the same period of 2021. The increase in our investments in property plant and equipment is primarily due to the expansion of our Frederick, Colorado site. We expect that total capital expenditures for the current year will be approximately $300&#160;million. Cash used to purchase fair value investments for the three months ended January&#160;31, 2022 was $3 million compared to $1 million in the same period in 2021. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net Cash Used in Financing Activities</span></div><div style="text-align:justify;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in financing activities for the three months ended January&#160;31, 2022 was $546 million compared to net cash used in financing activities of $316 million for the same period of 2021. </span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Treasury Stock Repurchases </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our 2021 repurchase program authorizes the purchase of up to $2.0&#160;billion of our common stock at the company's discretion and has no fixed termination date. During the three months ended January&#160;31, 2022, we repurchased and retired 2.9 million shares for $447 million under this authorization. As of January&#160;31, 2022, we had remaining authorization to repurchase up to approximately $1.13 billion of our common stock under the 2021 repurchase program. </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> During the three months ended January&#160;31, 2021, we repurchased and retired 2.9 million shares for $344 million under the 2019 repurchase program. Effective February 18, 2021, the 2019 repurchase program was terminated and was replaced by the 2021 share repurchase program. The remaining authorization under the 2019 repurchase plan of $193&#160;million expired on February 18, 2021.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dividends</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended January&#160;31, 2022 and 2021, we paid cash dividends of $0.210 per common share or $63 million, and $0.194 per common share or $59 million, respectively, on the company's common stock. The timing and amounts of any future dividends are subject to determination and approval by our board of directors.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Credit Facilities and Short-Term Debt</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March&#160;13, 2019, we entered into a credit agreement with a group of financial institutions which, as amended, provided for a $1 billion five-year unsecured credit facility that will expire on March&#160;13, 2024 and incremental term loan facilities in an aggregate amount of up to $500 million.&#160;On April 21, 2021, we entered into an incremental assumption agreement, pursuant to which the aggregate amount available for borrowing under the revolving credit facility was increased to $1.35&#160;billion and the aggregate amount available for incremental facilities was refreshed to remain at $500&#160;million. As of January&#160;31, 2022, we had no borrowings outstanding under the credit facility and no borrowings under the incremental facilities. We were in compliance with the covenants for the credit facility during the three months ended January&#160;31, 2022.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#if825c91f15a047ec9e67e0189634a349_7">Table of Contents</a></span></div></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Commercial Paper</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under our U.S. commercial paper program, the company may issue and sell unsecured, short-term promissory notes in the aggregate principal amount not to exceed $1.35&#160;billion with up to 397-day maturities. At any point in time, the company intends to maintain available commitments under its revolving credit facility in an amount at least equal to the amount of the commercial paper notes outstanding. Amounts available under the program may be borrowed, repaid and re-borrowed from time to time. The proceeds from issuances under the program may be used for general corporate purposes. During the three months ended January&#160;31, 2022, we borrowed and repaid $240 million. As </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">January&#160;31, 2022</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, we had no borrowings outstanding under our U.S. commercial paper program. </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-Term Debt</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no changes to the principal, maturity, interest rates and interest payment terms of the Agilent outstanding senior notes in the three months ended January&#160;31, 2022 as compared to the senior notes as described in our Annual Report on Form 10-K for the fiscal year ended October&#160;31, 2021.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other </span></div><div style="padding-left:36pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our commitments for indirect material and services increased by $59&#160;million from $83 million as reported in our Annual Report on Form 10-K for the fiscal year ended October&#160;31, 2021. These commitments are related to a variety of suppliers including IT support service providers. Our commitments to contract manufacturers and suppliers increased by $129 million from $901 million as reported in our Annual Report on Form 10-K for the fiscal year ended October&#160;31, 2021.These commitments are related to a variety of suppliers, and we use several contract manufacturers to provide manufacturing services for our products. During the normal course of business, we issue purchase orders with estimates of our requirements several months ahead of the delivery dates. These open purchase orders with our suppliers have not yet been received and our agreements usually provide us the option to cancel, reschedule and adjust our requirements based on our business needs prior to the firm orders being placed. There were no other substantial changes from our Annual Report on Form 10-K for the fiscal year ended October&#160;31, 2021 to our contractual commitments in the first three months of fiscal year 2022. We have no other material non-cancelable guarantees or commitments.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other long-term liabilities as of January&#160;31, 2022 and October&#160;31, 2021 include $234&#160;million and $241 million, respectively, related to long-term income tax liabilities.  Of these amounts, $110&#160;million and $117 million related to uncertain tax positions as of January&#160;31, 2022 and October&#160;31, 2021, respectively.&#160;We are unable to accurately predict when these amounts will be realized or released. However, it is reasonably possible that there could be significant changes to our unrecognized tax benefits in the next twelve months due to either the expiration of a statute of limitations or a tax audit settlement.  The remaining $124&#160;million in other long-term liabilities relates to the U.S. transition tax payment which is due in installments over the next four years.</span></div><div><span><br/></span></div><div id="if825c91f15a047ec9e67e0189634a349_124"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are exposed to foreign currency exchange rate risks inherent in our sales commitments, anticipated sales, and assets and liabilities and equity denominated in currencies other than the functional currency of our subsidiaries. We hedge future cash flows denominated in currencies other than the functional currency using sales forecasts up to twelve months in advance. Our exposure to exchange rate risks is mainly managed on an enterprise-wide basis. This strategy utilizes derivative financial instruments, including option and forward contracts, to hedge certain foreign currency exposures with the intent of offsetting gains and losses that occur on the underlying exposures with gains and losses on the derivative contracts hedging them. We may also hedge equity balances denominated in foreign currency on a long-term basis. We do not currently and do not intend to utilize derivative financial instruments for speculative trading purposes. To the extent that we are required to pay for all, or portions, of an acquisition price in foreign currencies, we may enter into foreign exchange contracts to reduce the risk that currency movements will impact the cost of the transaction.</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operations generate non-functional currency cash flows such as revenues, third party vendor payments and inter-company payments. In anticipation of these foreign currency cash flows and in view of volatility of the currency market, we enter into such foreign exchange contracts as are described above to manage our currency risk. Approximately 54 percent and 52 percent of our revenue was generated in U.S. dollars during the three months ended January&#160;31, 2022 and 2021, respectively. The overall unfavorable effect of changes in foreign currency exchange rates, principally as a result of the strength of the U.S. dollar, has decreased revenue by 1 percentage point in the three months ended January&#160;31, 2022. We calculate the impact of </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#if825c91f15a047ec9e67e0189634a349_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">movements in our foreign currency exchange rates by applying the actual foreign currency exchange rates in effect during the last month of each quarter of the current year to both the applicable current and prior year periods. </span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We performed a sensitivity analysis assuming a hypothetical 10&#160;percent adverse movement in foreign exchange rates to the hedging contracts and the underlying exposures described above. As of January&#160;31, 2022, the analysis indicated that these hypothetical market movements would not have a material effect on our condensed consolidated financial position, results of operations, statement of comprehensive income or cash flows.</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are also exposed to interest rate risk due to the mismatch between the interest expense we pay on our loans at fixed rates and the variable rates of interest we receive from cash, cash equivalents and other short-term investments. We have issued long-term debt in U.S. dollars or foreign currencies at fixed interest rates based on the market conditions at the time of financing. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We performed a sensitivity analysis assuming a hypothetical 10&#160;percent adverse movement in interest rates relating to the underlying fair value of our fixed rate debt. As of January&#160;31, 2022, the sensitivity analyses indicated that a hypothetical 10 percent adverse movement in interest rates would result in an immaterial impact to the fair value of our fixed interest rate debt.</span></div><div><span><br/></span></div><div id="if825c91f15a047ec9e67e0189634a349_127"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 4. CONTROLS AND PROCEDURES</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Evaluation of Disclosure Controls and Procedures</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the supervision and with the participation of our management, including the Chief Executive Officer and Chief Financial Officer, we have evaluated the effectiveness of our disclosure controls and procedures as required by the Securities Exchange Act of 1934 (the "Exchange Act") Rule&#160;13a-15(b)&#160;as&#160;of the end of the period covered by this report. Based on that evaluation, the Chief Executive Officer and Chief Financial Officer have concluded that these disclosure controls and procedures are effective at ensuring that information is accumulated and communicated to management, including the Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding such required disclosure to the SEC.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Changes in Internal Control over Financial Reporting</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no changes in our internal control over financial reporting during the quarter ended January&#160;31, 2022 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting. </span></div><div><span><br/></span></div><div style="text-indent:27pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><div id="if825c91f15a047ec9e67e0189634a349_130"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#if825c91f15a047ec9e67e0189634a349_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II &#8212; OTHER INFORMATION</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="if825c91f15a047ec9e67e0189634a349_133"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1. LEGAL PROCEEDINGS</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are involved in lawsuits, claims, investigations and proceedings, including, but not limited to, intellectual property, commercial, real estate, environmental and employment matters, which arise in the ordinary course of business. There are no matters pending that we currently believe are probable and reasonably possible of having a material impact to our business, consolidated financial condition, results of operations or cash flows.</span></div><div style="text-align:justify"><span><br/></span></div><div id="if825c91f15a047ec9e67e0189634a349_136"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1A.&#160; RISK FACTORS</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:174%">Business and Strategic Risks</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">T</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">he COVID-19 pandemic has adversely impacted, and continues to pose risks to, certain elements of our business, results of operations and financial condition, the nature and extent of which are highly uncertain and unpredictable.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our global operations expose us to risks associated with public health crises, including epidemics and pandemics such as COVID-19. The global spread of COVID-19 had, and may continue to have, an adverse impact on our operations, sales and delivery and supply chains.&#160;</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many countries including the United States implemented measures such as quarantine,&#160;shelter-in-place,&#160;curfew, travel and activity restrictions and similar isolation measures, including government orders and other restrictions on the conduct of business operations.&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to these measures we experienced significant and unpredictable reductions or increases in demand for certain of our products. Moreover, these measures caused delays in installations and significantly impacted our ability to service our customers on site. </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The&#160;COVID-19&#160;pandemic also impacted our supply chain as we experienced </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">disruptions or delays in shipments of certain materials or components of our products. While many of our customers have returned to work and economic activity continues to ramp up, we are unable to accurately predict the full extent and duration of the impact of the COVID-19 pandemic on our business and operations due to numerous uncertainties, including the duration and severity of the pandemic, the efficacy and distribution of vaccines, containment measures and additional waves of infections. As COVID-19 conditions improved, there have been increases in demand for certain of our products, which posed challenges to our supply chain. If there are supply shortages or delays and we are not able to meet increasing product demand, our results would be adversely affected.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, the COVID-19 pandemic caused significant volatility in U.S. and international markets. The impact of the pandemic may increase the possibility of uncertainty in the global financial markets, high inflation and extended economic downturn, which could reduce our ability to incur debt or access capital and impact our results and financial condition even after local conditions improve. </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are no assurances that the credit markets or the capital markets will be available to us in the future or that the lenders participating in our credit facilities will be able to provide financing in accordance with their contractual obligations. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the extent COVID-19 conditions improve, the duration and sustainability of any such improvements will be uncertain and continuing adverse impacts and/or the degree of improvement may vary dramatically by geography and by business. The actions we take in response to any improvements in conditions, such as our return-to-office plans, may also vary widely by geography and by business and will likely be made with incomplete information; pose the risk that such actions may prove to be premature, incorrect or insufficient; and could have a material, adverse impact on our business and results of operations. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding legal and timing uncertainties relating to federal regulations, we have implemented a mandatory vaccination policy subject to state and local legal requirements for U.S., Puerto Rico and Canada based covered employees, subject to approved exemptions. Additional vaccine and testing mandates may be announced in other jurisdictions in which we operate our business. While it is not currently possible to predict with any certainty the exact impact the new regulations would have on us, our suppliers and our customers, its implementation may impact our ability to retain current employees and attract new employees and result in labor disruptions. Further, implementation could also have similar consequences for our subcontractors, which may impact their ability to deliver the goods and services we need from them.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#if825c91f15a047ec9e67e0189634a349_7">Table of Contents</a></span></div></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our operating results and financial condition could be harmed if the markets into which we sell our products decline or do not grow as anticipated.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Visibility into our markets is limited. Our quarterly sales and operating results are highly dependent on the volume and timing of orders received during the fiscal quarter, which are difficult to forecast and may be cancelled by our customers. In addition, our revenue and earnings forecasts for future fiscal quarters are often based on the expected seasonality of our markets. However, the markets we serve do not always experience the seasonality that we expect as customer spending policies and budget allocations, particularly for capital items, may change. Any decline in our customers' markets or in general economic conditions would likely result in a reduction in demand for our products and services. Also, if our customers' markets decline, we may not be able to collect on outstanding amounts due to us. Such declines could harm our consolidated financial position, results of operations, cash flows and stock price, and could limit our profitability. Also, in such an environment, pricing pressures could intensify. Since a significant portion of our operating expenses is relatively fixed in nature due to sales, research and development and manufacturing costs, if we were unable to respond quickly enough these pricing pressures could further reduce our operating margins.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:20.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we do not introduce successful new products and services in a timely manner to address increased competition through frequent new product and service introductions, rapid technological changes and changing industry standards, our products and services may become obsolete, and our operating results may suffer.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generally sell our products in industries that are characterized by increased competition through frequent new product and service introductions, rapid technological changes and changing industry standards. Without the timely introduction of new products, services and enhancements, our products and services may become technologically obsolete over time, in which case our revenue and operating results could suffer. The success of our new products and services will depend on several factors, including our ability to:</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="padding-left:63pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">properly identify customer needs and predict future needs;</span></div><div style="padding-left:63pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">innovate and develop new technologies, services and applications;</span></div><div style="padding-left:63pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">appropriately allocate our research and development spending to products and services with higher growth prospects;</span></div><div style="padding-left:63pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">successfully commercialize new technologies in a timely manner;</span></div><div style="padding-left:63pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">manufacture and deliver new products in sufficient volumes and on time;</span></div><div style="padding-left:63pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">differentiate our offerings from our competitors' offerings;</span></div><div style="padding-left:63pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">price our products competitively;</span></div><div style="padding-left:63pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">anticipate our competitors' development of new products, services or technological innovations; and</span></div><div style="padding-left:63pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">control product quality in our manufacturing process.</span></div><div style="text-align:justify;text-indent:20.25pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, if we fail to accurately predict future customer needs and preferences or fail to produce viable technologies, we may invest in research and development of products and services that do not lead to significant revenue, which would adversely affect our profitability. Even if we successfully innovate and develop new and enhanced products and services, we may incur substantial costs in doing so, and our operating results may suffer. In addition, promising new products may fail to reach the market or realize only limited commercial success because of real or perceived concerns of our customers. Furthermore, as we collaborate with pharmaceutical customers to develop drugs such as companion diagnostics assays or provide drug components like active pharmaceutical ingredients, we face risks that those drug programs may be cancelled upon clinical trial failures.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:20.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">General economic conditions may adversely affect our operating results and financial condition.</span></div><div style="text-align:justify;text-indent:20.25pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business is sensitive to negative changes in general economic conditions, both inside and outside the United States. Slower global economic growth, inflationary pressures and uncertainty in the markets in which we operate may adversely impact our business resulting in:</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="padding-left:63pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">reduced demand for our products, delays in the shipment of orders, or increases in order cancellations;</span></div><div style="padding-left:63pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">increased risk of excess and obsolete inventories;</span></div><div style="padding-left:63pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">increased price pressure for our products and services; and</span></div><div style="padding-left:63pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">greater risk of impairment to the value, and a detriment to the liquidity, of our investment portfolio.</span></div><div style="padding-left:27pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#if825c91f15a047ec9e67e0189634a349_7">Table of Contents</a></span></div></div><div style="text-align:justify;text-indent:20.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Failure to adjust our purchases due to changing market conditions or failure to accurately estimate our customers' demand could adversely affect our income.</span></div><div style="text-align:justify;text-indent:20.25pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our income could be harmed if we are unable to adjust our purchases to reflect market fluctuations, including those caused by the seasonal nature of the markets in which we operate. The sale of our products and services are dependent, to a large degree, on customers whose industries are subject to seasonal trends in the demand for their products. During a market upturn, we may not be able to purchase sufficient supplies or components to meet increasing product demand, which could materially affect our results. In the past, we have experienced a shortage of parts for some of our products. In addition, some of the parts that require custom design are not readily available from alternate suppliers due to their unique design or the length of time necessary for design work. Should a supplier cease manufacturing such a component, we would be forced to reengineer our product. In addition to discontinuing parts, suppliers may also extend lead times, limit supplies or increase prices due to capacity constraints or other factors. In order to secure components for the production of products, we may continue to enter into non-cancelable purchase commitments with vendors, or at times make advance payments to suppliers, which could impact our ability to adjust our inventory to declining market demands. If demand for our products is less than we expect, we may experience additional excess and obsolete inventories and be forced to incur additional expenses.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:20.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Demand for some of our products and services depends on the capital spending policies of our customers, research and development budgets and on government funding policies.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our customers include pharmaceutical companies, laboratories, universities, healthcare providers, government agencies and public and private research institutions. Many factors, including public policy spending priorities, available resources, mergers and consolidations, institutional and governmental budgetary policies and spending priorities, and product and economic cycles, have a significant effect on the capital spending policies of these entities. Fluctuations in the research and development budgets at these organizations could have a significant effect on the demand for our products and services. Research and development budgets fluctuate due to changes in available resources, consolidation, spending priorities, general economic conditions and institutional and governmental budgetary policies. The timing and amount of revenue from customers that rely on government funding or research may vary significantly due to factors that can be difficult to forecast, including changes in spending authorizations and budgetary priorities for our products and services. If demand for our products and services is adversely affected, our revenue and operating results would suffer.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:20.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our business will suffer if we are not able to retain and hire key personnel.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our future success depends partly on the continued service of our key research, engineering, sales, marketing, manufacturing, executive and administrative personnel. If we fail to retain and hire a sufficient number of these personnel, we will not be able to maintain or expand our business. The markets in which we operate are very dynamic, and our businesses continue to respond with reorganizations, workforce reductions and site closures. We believe our pay levels are very competitive within the regions that we operate. However, there is intense competition for certain highly technical specialties in geographic areas where we continue to recruit, and it may become more difficult to hire and retain our key employees.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:20.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Economic, political, foreign currency and other risks associated with international sales and operations could adversely affect our results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because we sell our products worldwide, our business is subject to risks associated with doing business internationally. We anticipate that revenue from international operations will continue to represent a majority of our total revenue. International revenue and costs are subject to the risk that fluctuations in foreign currency exchange rates could adversely affect our financial results when translated into U.S. dollars for financial reporting purposes. Foreign currency movements for the three months ended January&#160;31, 2022 had an overall unfavorable impact on revenue of approximately 1 percentage points when compared to the same period last year. When movements in foreign currency exchange rates have a negative impact on revenue, they will also have a  positive impact by reducing our costs and expenses. In addition, many of our employees, contract manufacturers, suppliers, job functions, outsourcing activities and manufacturing facilities are located outside the United States. Accordingly, our future results could be harmed by a variety of factors, including:</span></div><div style="padding-left:36pt;text-align:justify;text-indent:27pt"><span><br/></span></div><div style="padding-left:63pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">interruption to transportation flows for delivery of parts to us and finished goods to our customers;</span></div><div style="padding-left:63pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in a specific country's or region's political, economic or other conditions;</span></div><div style="padding-left:63pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in diplomatic and trade relationships, as well as, new tariffs, trade protection measures, import or export licensing requirements, new or different customs duties, trade embargoes and sanctions and other trade barriers;</span></div><div style="padding-left:63pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">tariffs imposed by the U.S. on goods from other countries and tariffs imposed by other countries on U.S. goods, including the tariffs enacted by the U.S. government on various imports from China and by the Chinese </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#if825c91f15a047ec9e67e0189634a349_7">Table of Contents</a></span></div></div><div style="padding-left:63pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">government on certain U.S. goods;</span></div><div style="padding-left:63pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">negative consequences from changes in or differing interpretations of laws and regulations, including those related to tax and import/export;</span></div><div style="padding-left:63pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">difficulty in staffing and managing widespread operations;</span></div><div style="padding-left:63pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">differing labor regulations;</span></div><div style="padding-left:63pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">differing protection of intellectual property;</span></div><div style="padding-left:63pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">unexpected changes in regulatory requirements; </span></div><div style="padding-left:63pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">geopolitical uncertainty or turmoil, terrorism and war; and</span></div><div style="padding-left:63pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">impact of public health crises, including pandemics and epidemics, such as COVID-19 on the global economy.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We sell our products into many countries and we also source many components and materials for our products from and manufacture our products in various countries. Future tariffs and tariffs already implemented could have negative impact on our business, results of operations and financial condition. It may be time-consuming and expensive for us to alter our business operations in order to adapt to any such change. Further, additional tariffs, the scope and duration of which, if implemented, remains uncertain, which have been proposed or threatened and the potential escalation of a trade war and retaliatory measures could have a material adverse effect on our business, results of operations and financial condition.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Most of our accounting and tax processes including general accounting, cost accounting, accounts payable, accounts receivable and tax functions are centralized at locations in India and Malaysia. If economical, political, health or other conditions change in those countries, it may adversely affect operations, including impairing our ability to pay our suppliers and collect our receivables. Our results of operations, as well as our liquidity, may be adversely affected and possible delays may occur in reporting financial results.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, although the majority of our products are priced and paid for in U.S. dollars, a significant amount of certain types of expenses, such as payroll, utilities, tax, and marketing expenses, are paid in local currencies. Our hedging programs reduce, but do not always entirely eliminate, within any given twelve-month period, the impact of currency exchange rate movements, and therefore fluctuations in exchange rates, including those caused by currency controls, could impact our business, operating results and financial condition by resulting in lower revenue or increased expenses. For expenses beyond that twelve-month period, our hedging strategy does not mitigate our exposure. In addition, our currency hedging programs involve third-party financial institutions as counterparties. The weakening or failure of financial institution counterparties may adversely affect our hedging programs and our financial condition through, among other things, a reduction in available counterparties, increasingly unfavorable terms, and the failure of the counterparties to perform under hedging contracts.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:20.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our strategic initiatives to adjust our cost structure could have long-term adverse effects on our business, and we may not realize the operational or financial benefits from such actions.</span></div><div style="text-align:justify;text-indent:20.25pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have implemented multiple strategic initiatives across our businesses to adjust our cost structure, and we may engage in similar activities in the future. These strategic initiatives and our regular ongoing cost reduction activities may distract management, could slow improvements in our products and services and limit our ability to increase production quickly if demand for our products increases. In addition, delays in implementing our strategic initiatives, unexpected costs or failure to meet targeted improvements may diminish the operational and financial benefits we realize from such actions. Any of the above circumstances could have an adverse effect on our business and operating results and financial condition.</span></div><div style="text-align:justify;text-indent:20.25pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#if825c91f15a047ec9e67e0189634a349_7">Table of Contents</a></span></div></div><div style="text-align:justify;text-indent:20.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our acquisitions, strategic investments and alliances, joint ventures, exiting of businesses and divestitures may result in financial results that are different than expected.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the normal course of business, we frequently engage in discussions with third parties relating to possible acquisitions, strategic investments and alliances, joint ventures and divestitures, and generally expect to complete several transactions per year. In addition, we may decide to exit a particular business within our product portfolio. As a result of such transactions, our financial results may differ from our own or the investment community's expectations in a given fiscal quarter or over the long term.  We may have difficulty developing, manufacturing and marketing the products of a newly acquired company in a way that enhances the performance of our combined businesses or product lines. Acquired businesses may also expose us to new risks and new markets, and we may have difficulty addressing these risks in a cost effective and timely manner. Transactions such as acquisitions have resulted, and may in the future result in, unexpected significant costs and expenses. In the future, we may be required to record charges to earnings during the period if we determine there is an impairment of goodwill or intangible assets, up to the full amount of the value of the assets, or, in the case of strategic investments and alliances, consolidate results, including losses, of third parties or write down investment values or loans and convertible notes related to the strategic investment. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Integrating the operations of acquired businesses within Agilent could be a difficult, costly and time-consuming process that involves a number of risks.  Acquisitions and strategic investments and alliances may require us to integrate and collaborate with a different company culture, management team, business model, business infrastructure and sales and distribution methodology and assimilate and retain geographically dispersed, decentralized operations and personnel. Depending on the size and complexity of an acquisition, our successful integration of the entity depends on a variety of factors, including introducing new products and meeting revenue targets as expected, the retention of key employees and key customers, increased exposure to certain governmental regulations and compliance requirements and increased costs and use of resources. Further, the integration of acquired businesses is likely to result in our systems and internal controls becoming increasingly complex and more difficult to manage. Any difficulties in the assimilation of acquired businesses into our control system could harm our operating results or cause us to fail to meet our financial reporting obligations.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Even if we are able to successfully integrate acquired businesses within Agilent, we may not be able to realize the revenue and other synergies and growth that we anticipated from the acquisition in the time frame that we expected, and the costs of achieving these benefits may be higher than what we expected. As a result, the acquisition and integration of acquired businesses may not contribute to our earnings as expected, we may not achieve our operating margin targets when expected, or at all, and we may not achieve the other anticipated strategic and financial benefits of such transactions.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A successful divestiture depends on various factors, including our ability to effectively transfer liabilities, contracts, facilities and employees to the purchaser, identify and separate the intellectual property to be divested from the intellectual property that we wish to keep and reduce fixed costs previously associated with the divested assets or business.  In addition, if customers of the divested business do not receive the same level of service from the new owners, this may adversely affect our other businesses to the extent that these customers also purchase other Agilent products. In exiting a business, we may still retain liabilities associated with the support and warranty of those businesses and other indemnification obligations. All of these efforts require varying levels of management resources, which may divert our attention from other business operations. If we do not realize the expected benefits or synergies of such transactions, our consolidated financial position, results of operations, cash flows and stock price could be negatively impacted.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:20.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The impact of consolidation and acquisitions of competitors is difficult to predict and may harm our business.</span></div><div style="text-align:justify;text-indent:29.25pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The life sciences industry is intensely competitive and has been subject to increasing consolidation. Consolidation in our industries could result in existing competitors increasing their market share through business combinations and result in stronger competitors, which could have a material adverse effect on our business, financial condition and results of operations. We may not be able to compete successfully in increasingly consolidated industries and cannot predict with certainty how industry consolidation will affect our competitors or us.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#if825c91f15a047ec9e67e0189634a349_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Regulatory, Legal and Compliance Risks</span></div><div style="text-align:justify;text-indent:20.25pt"><span><br/></span></div><div style="text-align:justify;text-indent:20.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we fail to maintain an effective system of internal controls, we may not be able to accurately report our financial results, which could lead to a loss of investor confidence in our financial statements and have an adverse effect on our stock price.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective internal controls are necessary for us to provide reliable and accurate financial statements and to effectively prevent fraud.  We devote significant resources and time to comply with the internal control over financial reporting requirements of the Sarbanes Oxley Act of 2002 and continue to enhance our controls. However, we cannot be certain that we will be able to prevent future significant deficiencies or material weaknesses.  Inadequate internal controls could cause investors to lose confidence in our reported financial information, which could have a negative effect on investor confidence in our financial statements, the trading price of our stock and our access to capital.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:20.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our customers and we are subject to various governmental regulations. Compliance with or changes in such regulations may cause us to incur significant expenses, and if we fail to maintain satisfactory compliance with certain regulations, we may be forced to recall products and cease their manufacture and distribution, and we could be subject to civil or criminal penalties.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our customers and we are subject to various significant international, federal, state and local regulations, including but not limited to regulations in the areas of health and safety, packaging, product content, employment, labor and immigration, import/export controls, trade restrictions and anti-competition. In addition, as a global organization, we are subject to data privacy and security laws, regulations, and customer-imposed controls in numerous jurisdictions as a result of having access to and processing confidential, personal, sensitive and/or patient health data in the course of our business. Global privacy laws, including the EU's General Data Protection Regulation ("GDPR&#8221;), Brazil&#8217;s Lei Geral de Protecao de Dados, and the California Consumer Privacy Act, apply to our activities involving the processing of personal data, both in relation to our product and service offerings and the management of our workforce. The global proliferation of privacy laws, with governmental authorities around the world passing or considering passing legislative and regulatory proposals concerning privacy and data protection, continues to result in new requirements regarding the handling of personal data, with many such laws imposing significant penalties for non-compliance (including possible fines of up to four percent of total company revenue under the GDPR). Each of these privacy, security and data protection laws and regulations could impose significant limitations and increase our cost of providing our products and services where we process end user personal data and could harm our results of operations and expose us to significant fines, penalties and other damages.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We must also comply with complex foreign and U.S. laws and regulations, such as the U.S. Foreign Corrupt Practices Act, the U.K. Bribery Act, and other local laws prohibiting corrupt payments to governmental officials, anti-competition regulations and sanctions imposed by the U.S. Office of Foreign Assets Control and other similar laws and regulations. Violations of these laws and regulations could result in fines and penalties, criminal sanctions, restrictions on our business conduct and on our ability to offer our products in one or more countries, and could also materially affect our brand, our ability to attract and retain employees, our international operations, our business and our operating results. Although we have implemented policies and procedures designed to ensure compliance with these laws and regulations, there can be no assurance that our employees, contractors, or agents will not violate our policies.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These regulations are complex, change frequently and have tended to become more stringent over time. We may be required to incur significant expenses to comply with these regulations or to remedy any violations of these regulations. Any failure by us to comply with applicable government regulations could also result in the cessation of our operations or portions of our operations, product recalls or impositions of fines and restrictions on our ability to carry on or expand our operations. In addition, because many of our products are regulated or sold into regulated industries, we must comply with additional regulations in marketing our products. We develop, configure and market our products to meet customer needs created by these regulations. Any significant change in these regulations could reduce demand for our products, force us to modify our products to comply with new regulations or increase our costs of producing these products. If demand for our products is adversely affected or our costs increase, our operating results and business would suffer.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our products and operations are also often subject to the rules of industrial standards bodies, like the International Standards Organization, as well as regulation by other agencies such as the FDA. We also must comply with work safety rules. If we fail to adequately address any of these regulations, our businesses could be harmed.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#if825c91f15a047ec9e67e0189634a349_7">Table of Contents</a></span></div></div><div style="text-align:justify;text-indent:20.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are subject to extensive regulation by the FDA and certain similar foreign regulatory agencies, and failure to comply with such regulations could harm our reputation, business, financial condition and results of operations.</span></div><div style="text-align:justify;text-indent:20.25pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A number of our products and services are subject to regulation by the FDA, the U.S. Department of Health and Human Services, the Centers for Medicare &amp; Medicaid Services and certain similar foreign regulatory agencies. In addition, a number of our products and services may in the future be subject to regulation by the FDA and certain similar foreign regulatory agencies.  These regulations govern a wide variety of product and service-related activities, from quality management, design and development to labeling, manufacturing, promotion, sales and distribution. In addition, we are subject to inspections by these and other regulatory authorities.  If we or any of our suppliers, distributors or customers fail to comply with FDA and other applicable regulatory requirements or are perceived to potentially have failed to comply, we may face, among other things, warning letters; adverse publicity affecting both us and our customers; investigations or notices of non-compliance, fines, injunctions, and civil or criminal penalties; import or export restrictions; partial suspensions or total shutdown of production facilities or the imposition of operating restrictions; suspension or revocation of our license to operate, increased difficulty in obtaining required FDA clearances or approvals or foreign equivalents; seizures or recalls of our products or those of our customers; or the inability to sell our products. Any such FDA or other regulatory agency actions could disrupt our business and operations, lead to significant remedial costs and have a material adverse impact on our financial position and results of operations. In addition, the global regulatory environment has become increasingly stringent for our products and services. For example, the EU is going to enforce new requirements, known as the EU In Vitro Diagnostic Regulation (the &#8220;EU IVDR&#8221;), which imposes stricter requirements for the marketing and sale of in vitro diagnostics in the European Union.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These new regulations are more stringent in a variety of areas, including clinical requirements, quality systems and post-market surveillance activities. The new EU IVDR requirements become effective in May 2022. Failure to meet these requirements could adversely impact our business in the EU and other regions that tie their product registrations to the EU requirements.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:20.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Some of our products are subject to particularly complex regulations such as regulations of toxic substances, and failure to comply with such regulations could harm our business.</span></div><div style="text-align:justify;text-indent:20.25pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some of our products and related consumables are used in conjunction with chemicals whose manufacture, processing, distribution and notification requirements are regulated by the U.S. Environmental Protection Agency (&#8220;EPA&#8221;) under the Toxic Substances Control Act and by regulatory bodies in other countries under similar laws. The Toxic Substances Control Act regulations govern, among other things, the testing, manufacture, processing and distribution of chemicals, the testing of regulated chemicals for their effects on human health and safety and the import and export of chemicals. The Toxic Substances Control Act prohibits persons from manufacturing any chemical in the United States that has not been reviewed by the EPA for its effect on health and safety and placed on an EPA inventory of chemical substances. We must ensure conformance of the manufacturing, processing, distribution of and notification about these chemicals to these laws and adapt to regulatory requirements in all applicable countries as these requirements change. If we fail to comply with the notification, record-keeping and other requirements in the manufacture or distribution of our products, then we could be subject to civil penalties, criminal prosecution and, in some cases, prohibition from distributing or marketing our products until the products or component substances are brought into compliance.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:20.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our business may suffer if we fail to comply with government contracting laws and regulations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We derive a portion of our revenue from direct and indirect sales to U.S. federal, state, local, and foreign governments and their respective agencies. Such contracts are subject to various procurement laws and regulations and contract provisions relating to their formation, administration and performance. Failure to comply with these laws, regulations or provisions in our government contracts could result in the imposition of various civil and criminal penalties, termination of contracts, forfeiture of profits, suspension of payments, increased pricing pressure or suspension from future government contracting. If our government contracts are terminated, if we are suspended from government work, or if our ability to compete for new contracts is adversely affected, our business could suffer.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#if825c91f15a047ec9e67e0189634a349_7">Table of Contents</a></span></div></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our reputation, ability to do business and financial statements may be harmed by improper conduct by any of our employees, agents or business partners.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We cannot provide assurance that our internal controls and compliance systems will always protect us from acts committed by employees, agents or business partners of ours (or of businesses we acquire or partner with) that would violate U.S. and/or non-U.S. laws, including the laws governing payments to government officials, bribery, fraud, kickbacks and false claims, pricing, sales and marketing practices, conflicts of interest, competition, employment practices and workplace behavior, export and import compliance, money laundering and data privacy. In particular, the U.S. Foreign Corrupt Practices Act, the U.K. Bribery Act and similar anti-bribery laws in other jurisdictions generally prohibit companies and their intermediaries from making improper payments to government officials for the purpose of obtaining or retaining business, and we operate in many parts of the world that have experienced governmental corruption to some degree. Any such improper actions or allegations of such acts could damage our reputation and subject us to civil or criminal investigations in the United States and in other jurisdictions, and related shareholder lawsuits could lead to substantial civil and criminal, monetary and non-monetary penalties and could cause us to incur significant legal and investigatory fees. In addition, the government may seek to hold us liable as a successor for violations committed by companies in which we invest or that we acquire. We also rely on our suppliers to adhere to our supplier standards of conduct, and material violations of such standards of conduct could occur that could have a material effect on our business, reputation and financial statements.</span></div><div style="text-align:justify;text-indent:20.25pt"><span><br/></span></div><div style="text-align:justify;text-indent:20.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Environmental contamination from past and ongoing operations could subject us to substantial liabilities.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain properties we have previously owned or leased are undergoing remediation for subsurface contamination.&#160; Although we are indemnified for liability relating to the required remediation at some of those properties, we may be subject to liability if these indemnification obligations are not fulfilled.&#160; In other cases, we have agreed to indemnify the current owners of certain properties for liabilities related to contamination, including companies with which we have previously been affiliated such as HP, Inc., Hewlett-Packard Enterprise (formerly Hewlett-Packard Company) and Siemens Healthineers (formerly Varian Medical Systems, Inc.)&#160; Further, other properties we have previously owned or leased at which we have operated in the past, or for which we have otherwise contractually assumed, or provided indemnities for, certain actual or contingent environmental liabilities may or do require remediation. While we are not aware of any material liabilities associated with any potential environmental contamination at any of those properties or facilities, we may be exposed to material liability if environmental contamination at material levels is found to exist. In addition, in connection with the acquisition of certain companies, we have assumed other costs and potential or contingent liabilities for environmental matters.&#160; Any significant costs or liabilities could have an adverse effect on results of operations.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are subject to environmental laws and regulations that expose us to a number of risks and could result in significant liabilities and costs.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our current and historical manufacturing and research and development processes and facilities are subject to various foreign, federal, state and local environment protection and health and safety laws and regulations. As a result, we may become subject to liabilities for environmental contamination, and these liabilities may be substantial. Although our policy is to apply strict standards for environmental protection and health and safety at our sites inside and outside the United States, we may not be aware of all conditions that could subject us to liability.  Further, in the event that any future climate change legislation would require that stricter standards be imposed by domestic or international environmental regulatory authorities, we may be required to make certain changes and adaptations to our manufacturing processes and facilities. We cannot predict how changes will affect our business operations or the cost of compliance to us, our customers or our suppliers. Failure to comply with these environmental protection and health and safety laws and regulations could result in civil, criminal, regulatory, administrative or contractual sanction, including fines, penalties or suspensions, restrictions on our operations and reputational damage.  If we have any violations of, or incur liabilities pursuant to these laws or regulations, our financial condition and operating results could be adversely affected.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Third parties may claim that we are infringing their intellectual property, and we could suffer significant litigation or licensing expenses or be prevented from selling products or services.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, third parties may claim that one or more of our products or services infringe their intellectual property rights. We analyze and take action in response to such claims on a case by case basis. Any dispute or litigation regarding patents or other intellectual property could be costly and time-consuming due to the complexity of our technology and the uncertainty of intellectual property litigation and could divert our management and key personnel from our business operations. A claim of intellectual property infringement could force us to enter into a costly or restrictive license agreement, which might not be available under acceptable terms or at all, could require us to redesign our products, which would be costly and time-</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#if825c91f15a047ec9e67e0189634a349_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">consuming, and/or could subject us to significant damages or to an injunction against the development and sale of certain of our products or services. Our intellectual property portfolio may not be useful in asserting a counterclaim, or negotiating a license, in response to a claim of intellectual property infringement. In certain of our businesses, we rely on third-party intellectual property licenses, and we cannot ensure that these licenses will continue to be available to us in the future or can be expanded to cover new products on favorable terms or at all.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:20.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Third parties may infringe our intellectual property, and we may suffer competitive injury or expend significant resources enforcing our rights.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our success depends in large part on our proprietary technology, including technology we obtained through acquisitions. We rely on various intellectual property rights, including patents, copyrights, trademarks and trade secrets, as well as confidentiality provisions and licensing arrangements, to establish our proprietary rights. If we do not enforce our intellectual property rights successfully, our competitive position may suffer, which could harm our operating results.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our pending patent, copyright and trademark registration applications may not be allowed, or competitors may challenge the validity or scope of our patents, copyrights or trademarks. In addition, our patents, copyrights, trademarks and other intellectual property rights may not provide us with a significant competitive advantage.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may need to spend significant resources monitoring and enforcing our intellectual property rights, and we may not be aware of or able to detect or prove infringement by third parties. Our competitive position may be harmed if we cannot detect infringement and enforce our intellectual property rights quickly or at all. In some circumstances, we may choose to not pursue enforcement because an infringer has a dominant intellectual property position or for other business reasons. In addition, competitors might avoid infringement by designing around our intellectual property rights or by developing non-infringing competing technologies. Intellectual property rights and our ability to enforce them may be unavailable or limited in some countries, which could make it easier for competitors to capture market share and could result in lost revenues. Furthermore, some of our intellectual property is licensed to others which may allow them to compete with us using that intellectual property.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:20.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are subject to evolving corporate governance and public disclosure expectations and regulations that impact compliance costs and risks of noncompliance.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to changing rules and regulations promulgated by a number of governmental and self-regulatory organizations, including the SEC and NYSE, as well as evolving investor expectations around corporate governance and environmental and social practices and disclosures. These rules and regulations continue to evolve in scope and complexity, and many new requirements have been created in response to laws enacted by the U.S. and foreign governments, making compliance more difficult and uncertain. The increase in costs to comply with such evolving expectations, rules and regulations, as well as any risk of noncompliance, could adversely impact us.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:20.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Regulations related to &#8220;conflict minerals&#8221; may cause us to incur additional expenses and could limit the supply and increase the cost of certain metals used in manufacturing our products.</span></div><div style="text-align:justify;text-indent:20.25pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to the rules of the SEC which require disclosures by public companies of specified minerals, known as conflict minerals, that are necessary to the functionality or production of products manufactured or contracted to be manufactured. The rule, which requires an annual disclosure report to be filed with the SEC by May 31st of each year, requires companies to perform due diligence, disclose and report whether or not such minerals originate from the Democratic Republic of Congo or an adjoining country. Our ongoing implementation of these rules could affect sourcing at competitive prices and availability in sufficient quantities of certain minerals used in the manufacture of our products, including tin, tantalum, gold and tungsten. The number of suppliers who provide conflict-free minerals may be limited. In addition, there may be material costs associated with complying with the disclosure requirements, such as costs related to the due diligence process of determining the source of certain minerals used in our products, as well as costs of possible changes to products, processes, or sources of supply as a consequence of such verification activities. As our supply chain is complex and we use contract manufacturers for some of our products, we may not be able to sufficiently verify the origins of the relevant minerals used in our products through the due diligence procedures that we implement, which may harm our reputation. We may also encounter challenges to satisfy those customers who require that all of the components of our products be certified as conflict-free, which could place us at a competitive disadvantage if we are unable to do so.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#if825c91f15a047ec9e67e0189634a349_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Operational Risks</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:20.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we are unable to successfully manage the consolidation and streamlining of our manufacturing operations, we may not achieve desired efficiencies, and our ability to deliver products to our customers could be disrupted.</span></div><div style="text-align:justify;text-indent:29.25pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although we utilize manufacturing facilities throughout the world, we have consolidated, and may further consolidate, our manufacturing operations to certain of our plants to achieve efficiencies and gross margin improvements. Additionally, we typically consolidate the production of products from our acquisitions into our supply chain and manufacturing processes, which are technically complex and require expertise to operate. If we are unable to establish processes to efficiently and effectively produce high quality products in the consolidated locations, we may not achieve the anticipated synergies and production may be disrupted, which could adversely affect our business and operating results.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:20.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our operating results may suffer if our manufacturing capacity does not match the demand for our products.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because we cannot immediately adapt our production capacity and related cost structures to rapidly changing market conditions, when demand does not meet our expectations, our manufacturing capacity may exceed our production requirements. If during an economic downturn we had excess manufacturing capacity, then our fixed costs associated with excess manufacturing capacity would adversely affect our gross margins and operating results. If, during a general market upturn or an upturn in one of our segments, we cannot increase our manufacturing capacity to meet product demand, we may not be able to fulfill orders in a timely manner which could lead to order cancellations, contract breaches or indemnification obligations. This inability could materially and adversely limit our ability to improve our results. </span></div><div style="text-align:justify;text-indent:20.25pt"><span><br/></span></div><div style="text-align:justify;text-indent:20.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Dependence on contract manufacturing and outsourcing other portions of our supply chain, including logistics and third-party package delivery services, may adversely affect our ability to bring products to market and damage our reputation. Dependence on outsourced information technology and other administrative functions may impair our ability to operate effectively.</span></div><div style="text-align:justify;text-indent:20.25pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of our efforts to streamline operations and to manage costs, we outsource aspects of our manufacturing processes and other functions and continue to evaluate additional outsourcing. If our contract manufacturers or other outsourcers fail to perform their obligations in a timely manner or at satisfactory quality levels, our ability to bring products to market and our reputation could suffer. For example, during a market upturn, our contract manufacturers may be unable to meet our demand requirements, which may preclude us from fulfilling our customers' orders on a timely basis. The ability of these manufacturers to perform is largely outside of our control. If one or more of the third-party package delivery providers experiences a significant disruption in services or institutes a significant price increase, we may have to seek alternative providers, our costs could increase, and the delivery of our products could be prevented or delayed. Additionally, changing or replacing our contract manufacturers, logistics providers or other outsourcers could cause disruptions or delays. In addition, we outsource significant portions of our information technology ("IT") and other administrative functions. Since IT is critical to our operations, any failure to perform on the part of our IT providers could impair our ability to operate effectively. In addition to the risks outlined above, problems with manufacturing or IT outsourcing could result in lower revenue and unexecuted efficiencies and impact our results of operations and our stock price. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:20.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we suffer a loss to our factories, facilities or distribution system due to catastrophe, our operations could be seriously harmed.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our factories, facilities and distribution system are subject to catastrophic loss due to fire, flood, terrorism, public health crises, increasing severity or frequency of extreme weather events, or other climate-change related risks. For example, in the first quarter of fiscal year 2020, the outbreak of COVID-19 in China led to an extension of the Lunar New Year holiday, which adversely impacted our business and results, reduced the number of selling days and otherwise impacted our supply chain. In addition, several of our facilities could be subject to a catastrophic loss caused by earthquake due to their locations. Our production facilities, headquarters and laboratories in California, and our production facilities in Japan, are all located in areas with above-average seismic activity. If any of our facilities were to experience a catastrophic loss, it could disrupt our operations, delay production, shipments and revenue and result in large expenses to repair or replace the facility. If such a disruption were to occur, we could breach agreements, our reputation could be harmed, and our business and operating results could be adversely affected. In addition, because we have consolidated our manufacturing facilities and we may not have redundant manufacturing capability readily available, we are more likely to experience an interruption to our operations in the event of a catastrophe in any one location. Although we carry insurance for property damage and business interruption, we do not carry insurance or financial reserves for interruptions or potential losses arising from earthquakes or terrorism. Also, our third-party insurance coverage will vary from time to time in both type and amount depending on availability, cost and our </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#if825c91f15a047ec9e67e0189634a349_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">decisions with respect to risk retention. Economic conditions and uncertainties in global markets may adversely affect the cost and other terms upon which we are able to obtain third-party insurance. If our third-party insurance coverage is adversely affected or to the extent we have elected to self-insure, we may be at a greater risk that our financial condition will be harmed by a catastrophic loss.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:20.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we experience a significant disruption in, or breach in security of, our information technology systems, or if we fail to implement new systems and software successfully, our business could be adversely affected.</span></div><div style="text-align:justify;text-indent:29.25pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We rely on several centralized information technology systems throughout our company to provide products and services, keep financial records, process orders, manage inventory, process shipments to customers and operate other critical functions. Our information technology systems may be susceptible to damage, disruptions or shutdowns due to power outages, hardware failures, computer viruses, attacks by computer hackers, telecommunication failures, user errors, catastrophes or other unforeseen events. For example, in December 2020 it was widely reported that SolarWinds, an information technology company, was the subject of a cyberattack that created security vulnerabilities for thousands of its clients. We identified an impacted SolarWinds server and promptly took steps to contain and remediate the incidents. While we believe that there were no disruptions to our operations as a result of this attack, other similar attacks could have a significant negative impact on our systems and operations. Our information technology systems also may experience interruptions, delays or cessations of service or produce errors in connection with system integration, software upgrades or system migration work that takes place from time to time.  If we were to experience a prolonged system disruption in the information technology systems that involve our interactions with customers or suppliers, it could result in the loss of sales and customers and significant incremental costs, which could adversely affect our business. In addition, security breaches of our information technology systems could result in the misappropriation or unauthorized disclosure of confidential information belonging to us or to our employees, partners, customers or suppliers, which could result in our suffering significant financial or reputational damage.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financial and Tax Risks</span></div><div style="text-align:justify;text-indent:20.25pt"><span><br/></span></div><div style="text-align:justify;text-indent:20.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our retirement and post retirement pension plans are subject to financial market risks that could adversely affect our future results of operations and cash flows.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have significant retirement and post retirement pension plan assets and obligations. The performance of the financial markets and interest rates impact our plan expenses and funding obligations. Significant decreases in market interest rates, decreases in the fair value of plan assets and investment losses on plan assets will increase our funding obligations and adversely impact our results of operations and cash flows.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in tax laws, unfavorable resolution of tax examinations, or exposure to additional tax liabilities could have a material adverse effect on our results of operations, financial condition and liquidity.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to taxes in the U.S., Singapore and various foreign jurisdictions. Governments in the jurisdictions in which we operate implement changes to tax laws and regulations periodically. Any implementation of tax laws that fundamentally change the taxation of corporations in the U.S. or Singapore could materially impact our effective tax rate and could have a significant adverse impact on our financial results.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are also subject to examinations of our tax returns by tax authorities in various jurisdictions around the world. We regularly assess the likelihood of adverse outcomes resulting from ongoing tax examinations to determine the adequacy of our provision for taxes. These assessments can require a high degree of judgment and estimation. Intercompany transactions associated with the sale of inventory, services, intellectual property and cost share arrangements are complex and affect our tax liabilities. The calculation of our tax liabilities involves dealing with uncertainties in the application of complex tax laws and regulations in multiple jurisdictions. There can be no assurance that the outcomes from ongoing tax examinations will not have an adverse effect on our operating results and financial condition. A difference in the ultimate resolution of tax uncertainties from what is currently estimated could have an adverse effect on our financial results and condition.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#if825c91f15a047ec9e67e0189634a349_7">Table of Contents</a></span></div></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:20.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If tax incentives change or cease to be in effect, our income taxes could increase significantly.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We benefit from tax incentives extended to our foreign subsidiaries to encourage investment or employment. Singapore has granted us tax incentives which require renewal at various times in the future. The incentives are conditioned on achieving various thresholds of investments and employment or specific types of income. Our taxes could increase if the incentives are not renewed upon expiration. If we cannot or do not wish to satisfy all or parts of the tax incentive conditions, we may lose the related tax incentive and could be required to refund tax incentives previously realized. As a result, our effective tax rate could be higher than it would have been had we maintained the benefits of the tax incentives.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:20.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We have outstanding debt and may incur other debt in the future, which could adversely affect our financial condition, liquidity and results of operations.</span></div><div style="text-align:justify;text-indent:20.25pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are party to a $1.35&#160;billion five-year unsecured credit facility that will expire on March&#160;13, 2024.  Furthermore, we are permitted pursuant to the credit agreement to establish incremental facilities of up to $500 million.&#160;As of January&#160;31, 2022, we had no borrowings outstanding under the credit facility and we had no borrowings under the incremental facilities. On June 18, 2021, we increased the maximum amount of our commercial paper program to $1.35&#160;billion.  As of  January&#160;31, 2022, we had </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">no</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> borrowings outstanding under our U.S. commercial paper program. We also currently have outstanding an aggregate principal amount of $2.7 billion in senior unsecured notes. We may borrow additional amounts in the future and use the proceeds from any future borrowing for general corporate purposes, future acquisitions, expansion of our business or repurchases of our outstanding shares of common stock.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our incurrence of this debt, and increases in our aggregate levels of debt, may adversely affect our operating results and financial condition by, among other things:</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="padding-left:63pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">increasing our vulnerability to downturns in our business, to competitive pressures and to adverse economic and industry conditions;&#160;</span></div><div style="padding-left:63pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">requiring the dedication of an increased portion of our expected cash flows from operations to service our indebtedness, thereby reducing the amount of expected cash flows available for other purposes, including capital expenditures, acquisitions, stock repurchases and dividends; and&#160;</span></div><div style="padding-left:63pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">limiting our flexibility in planning for or reacting to changes in our business and our industry.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our credit facility imposes restrictions on us, including restrictions on our ability to create liens on our assets and engage in certain types of sale and leaseback transactions and the ability of our subsidiaries to incur indebtedness, and requires us to maintain compliance with specified financial ratios. Our ability to comply with these ratios may be affected by events beyond our control. In addition, the indentures governing our senior notes contain covenants that may adversely affect our ability to incur certain liens or engage in certain types of sale and leaseback transactions. If we breach any of the covenants and do not obtain a waiver from the lenders or noteholders, then, subject to applicable cure periods, our outstanding indebtedness could be declared immediately due and payable.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We cannot assure that we will continue to pay dividends on our common stock.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since the first quarter of fiscal year 2012, we have paid a quarterly dividend on our common stock. The timing, declaration, amount and payment of any future dividends fall within the discretion of our Board of Directors and will depend on many factors, including our available cash, estimated cash needs, earnings, financial condition, operating results, capital requirements, as well as limitations in our contractual agreements, applicable law, regulatory constraints, industry practice and other business considerations that our Board of Directors considers relevant. A change in our dividend program could have an adverse effect on the market price of our common stock.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Adverse conditions in the global banking industry and credit markets may adversely impact the value of our cash investments or impair our liquidity.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of January&#160;31, 2022, we had cash and cash equivalents of approximately $1.1 billion invested or held in a mix of money market funds, time deposit accounts and bank demand deposit accounts. Disruptions in the financial markets may, in some cases, result in an inability to access assets such as money market funds that traditionally have been viewed as highly liquid. Any failure of our counterparty financial institutions or funds in which we have invested may adversely impact our cash and cash equivalent positions and, in turn, our operating results and financial condition.</span></div><div style="text-align:justify;text-indent:20.25pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55</span></div></div></div><div id="if825c91f15a047ec9e67e0189634a349_139"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#if825c91f15a047ec9e67e0189634a349_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160;2.&#160; UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ISSUER PURCHASES OF EQUITY SECURITIES</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below summarizes information about the company&#8217;s purchases, based on trade date, of its equity securities registered pursuant to Section&#160;12 of the Exchange Act during the quarterly period ended January&#160;31, 2022.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:28.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.493%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.493%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.493%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.376%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Period</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total&#160;Number&#160;of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares&#160;of&#160;Common</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Stock&#160;Purchased&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5pt;font-weight:700;line-height:100%">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted&#160;Average<br/>Price&#160;Paid&#160;per&#160;Share<br/>of<br/>Common&#160;Stock&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">(2)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Number&#160;of<br/>Shares&#160;of&#160;Common<br/>Stock&#160;Purchased&#160;as<br/>Part&#160;of&#160;Publicly<br/>Announced&#160;Plans&#160;or<br/>Programs&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5pt;font-weight:700;line-height:100%">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maximum<br/>Approximate&#160;Dollar<br/>Value&#160;of&#160;Shares&#160;of<br/>Common&#160;Stock&#160;that<br/>May&#160;Yet&#160;Be<br/>Purchased&#160;Under&#160;the<br/>Plans&#160;or&#160;Programs<br/>(in&#160;millions) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(1)</span></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(a)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(b)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(c)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(d)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">2021 Repurchase Program</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 1, 2021 through November  30, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">675,100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154.93&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">675,100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,473&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 1, 2021 through December&#160;31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,038,115&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154.45&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,038,115&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,158&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 1, 2022 through January 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193,607&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143.35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193,607&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,130&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,906,822&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153.82&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,906,822&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,130&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:22.5pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.68pt">On February 16, 2021 we announced that our board of directors had approved a new share repurchase program (the "2021 repurchase program") designed, among other things, to reduce or eliminate dilution resulting from issuance of stock under the company's employee equity incentive programs. The 2021 repurchase program authorizes the purchase of up to $2.0&#160;billion of our common stock at the company's discretion and has no fixed termination date. The 2021 repurchase program which became effective on February 18, 2021, replaced and terminated the 2019 repurchase program on that date. The 2021 repurchase program does not require the company to acquire a specific number of shares and may be suspended, amended or discontinued at any time. As of January&#160;31, 2022, all repurchased shares to date have been retired.</span></div><div style="padding-left:22.5pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div style="padding-left:22.5pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.68pt">The weighted average price paid per share of common stock does not include the cost of commissions.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56</span></div></div></div><div id="if825c91f15a047ec9e67e0189634a349_142"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#if825c91f15a047ec9e67e0189634a349_7">Table of Contents</a></span></div></div><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> ITEM 6. EXHIBITS</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Exhibits:</span></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:13.980%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.088%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Description</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1090872/000156459021060015/a-ex101_6.htm">Amendment No. 4 to Credit Agreement dated December 8, 2021, by and among the Company, the Lenders party thereto and BNP Paribas, as Administrative Agent.</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a-01312022xex311.htm">Certification of Chief Executive Officer pursuant to Section&#160;302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a-01312022xex312.htm">Certification of Chief Financial Officer pursuant to Section&#160;302 of the Sarbanes-Oxley Act of 2002</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a-01312022xex321.htm">Certification of Chief Executive Officer pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a-01312022xex322.htm">Certification of Chief Financial Officer pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.INS XBRL</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH XBRL</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Schema Document</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL XBRL</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Calculation Linkbase Document</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB XBRL</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Labels Linkbase Document</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE XBRL</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Presentation Linkbase Document</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF XBRL</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Definition Linkbase Document</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57</span></div></div></div><div id="if825c91f15a047ec9e67e0189634a349_145"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#if825c91f15a047ec9e67e0189634a349_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AGILENT TECHNOLOGIES,&#160;INC.</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURE</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:5.351%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.583%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.755%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 3, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Robert W. McMahon</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Robert W. McMahon</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Vice President and Chief Financial Officer</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Financial Officer)</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 3, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Rodney Gonsalves</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rodney Gonsalves</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vice President, Corporate Controllership</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Accounting Officer)</span></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>a-01312022xex311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i348903d40e2847499d5fb19e8e6fb87a_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Exhibit&#160;31.1</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">SECTION&#160;302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">I, Michael R. McMullen, certify that&#58;</font></div><div><font><br></font></div><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:1.5pt">I have reviewed this Form&#160;10-Q of Agilent Technologies,&#160;Inc.&#59;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:1.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:1.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:1.5pt">The registrant&#8217;s other certifying officer(s)&#160;and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules&#160;13a-15(e)&#160;and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules&#160;13a-15(f)&#160;and 15d-15(f)) for the registrant and have&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(a)&#160;Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(b)&#160;Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(c)&#160;Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(d)&#160;Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:1.5pt">The registrant&#8217;s other certifying officer(s)&#160;and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(a)&#160;All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(b)&#160;Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:9pt"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.024%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.898%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.778%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 3, 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#47;s&#47; Michael R. McMullen</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Michael R. McMullen</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Director, President and Chief Executive Officer</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>3
<FILENAME>a-01312022xex312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i2231dec9fe9a4f418b0a88e0acaa07a0_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Exhibit&#160;31.2</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">SECTION&#160;302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">I, Robert W. McMahon, certify that&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:2.25pt">I have reviewed this Form&#160;10-Q of Agilent Technologies,&#160;Inc.&#59;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:2.25pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:2.25pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:2.25pt">The registrant&#8217;s other certifying officer(s)&#160;and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules&#160;13a-15(e)&#160;and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules&#160;13a-15(f)&#160;and 15d-15(f)) for the registrant and have&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(a)&#160;Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(b)&#160;Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(c)&#160;Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(d)&#160;Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:2.25pt">The registrant&#8217;s other certifying officer(s)&#160;and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(a)&#160;All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(b)&#160;Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.024%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.898%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.778%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 3, 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#47;s&#47; Robert W. McMahon</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Robert W. McMahon</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Senior Vice President and Chief Financial Officer</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>4
<FILENAME>a-01312022xex321.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i820750e7e0704e91b1e7652ae7affe3f_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Exhibit&#160;32.1</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">18 U.S.C. SECTION&#160;1350,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">AS ADOPTED PURSUANT TO SECTION&#160;906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In connection with the Quarterly Report of Agilent Technologies,&#160;Inc. (the &#8220;Company&#8221;) on Form&#160;10-Q for the period ended January&#160;31, 2022, as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;),&#160;I, Michael R. McMullen, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section&#160;1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002, that&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;The Report fully complies with the requirements of Section&#160;13(a)&#160;or 15(d)&#160;of the Securities Exchange Act of 1934&#59; and</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)&#160;The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;</font></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.024%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.898%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.778%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 3, 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#47;s&#47; Michael R. McMullen</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Michael R. McMullen</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Director, President and Chief Executive Officer</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>5
<FILENAME>a-01312022xex322.htm
<DESCRIPTION>EX-32.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i69186791e8e749cb85168ab33323fb85_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Exhibit&#160;32.2</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">18 U.S.C. SECTION&#160;1350,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">AS ADOPTED PURSUANT TO SECTION&#160;906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In connection with the Quarterly Report of Agilent Technologies,&#160;Inc. (the &#8220;Company&#8221;) on Form&#160;10-Q for the period ended January&#160;31, 2022, as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;),&#160;I, Robert W. McMahon, Senior Vice President and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section&#160;1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002, that&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;The Report fully complies with the requirements of Section&#160;13(a)&#160;or 15(d)&#160;of the Securities Exchange Act of 1934&#59; and</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)&#160;The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div><font><br></font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.024%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.143%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 3, 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#47;s&#47; Robert W. McMahon</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Robert W. McMahon</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Senior Vice President and Chief Financial Officer</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>a-20220131.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:b57f1026-9350-4429-b363-875dec110646,g:1024445c-b98f-4ee2-b278-e07339a70979-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:a="http://www.agilent.com/20220131" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.agilent.com/20220131">
  <xs:import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/currency/2021" schemaLocation="https://xbrl.sec.gov/currency/2021/currency-2021.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2021q4" schemaLocation="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="a-20220131_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="a-20220131_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="a-20220131_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="a-20220131_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="DocumentandEntityInformation" roleURI="http://www.agilent.com/role/DocumentandEntityInformation">
        <link:definition>0001001 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTOFOPERATIONSUnaudited" roleURI="http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFOPERATIONSUnaudited">
        <link:definition>1001002 - Statement - CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOMEUnaudited" roleURI="http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOMEUnaudited">
        <link:definition>1002003 - Statement - CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOMELOSSUnauditedParenthetical" roleURI="http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOMELOSSUnauditedParenthetical">
        <link:definition>1003004 - Statement - CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME (LOSS) (Unaudited) (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited" roleURI="http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited">
        <link:definition>1004005 - Statement - CONDENSED CONSOLIDATED BALANCE SHEET (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDBALANCESHEETUnauditedParenthetical" roleURI="http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnauditedParenthetical">
        <link:definition>1005006 - Statement - CONDENSED CONSOLIDATED BALANCE SHEET (Unaudited) (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited" roleURI="http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited">
        <link:definition>1006007 - Statement - CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTOFEQUITY" roleURI="http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFEQUITY">
        <link:definition>1007008 - Statement - CONDENSED CONSOLIDATED STATEMENT OF EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATESTATEMENTOFEQUITYPARENTHETICAL" roleURI="http://www.agilent.com/role/CONDENSEDCONSOLIDATESTATEMENTOFEQUITYPARENTHETICAL">
        <link:definition>1008009 - Statement - CONDENSED CONSOLIDATE STATEMENT OF EQUITY - (PARENTHETICAL)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNotes" roleURI="http://www.agilent.com/role/OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNotes">
        <link:definition>2101101 - Disclosure - OVERVIEW, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" roleURI="http://www.agilent.com/role/OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies">
        <link:definition>2202201 - Disclosure - OVERVIEW, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables" roleURI="http://www.agilent.com/role/OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables">
        <link:definition>2303301 - Disclosure - OVERVIEW, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails" roleURI="http://www.agilent.com/role/OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails">
        <link:definition>2404401 - Disclosure - OVERVIEW, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NEWACCOUNTINGPRONOUNCEMENTSNotes" roleURI="http://www.agilent.com/role/NEWACCOUNTINGPRONOUNCEMENTSNotes">
        <link:definition>2105102 - Disclosure - NEW ACCOUNTING PRONOUNCEMENTS (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NEWACCOUNTINGPRONOUNCEMENTSTables" roleURI="http://www.agilent.com/role/NEWACCOUNTINGPRONOUNCEMENTSTables">
        <link:definition>2306302 - Disclosure - NEW ACCOUNTING PRONOUNCEMENTS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUENotes" roleURI="http://www.agilent.com/role/REVENUENotes">
        <link:definition>2107103 - Disclosure - REVENUE (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUETables" roleURI="http://www.agilent.com/role/REVENUETables">
        <link:definition>2308303 - Disclosure - REVENUE (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUERevenuebyRegionDetails" roleURI="http://www.agilent.com/role/REVENUERevenuebyRegionDetails">
        <link:definition>2409402 - Disclosure - REVENUE- Revenue by Region (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUERevenuebyEndMarketsDetails" roleURI="http://www.agilent.com/role/REVENUERevenuebyEndMarketsDetails">
        <link:definition>2410403 - Disclosure - REVENUE - Revenue by End Markets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUERevenuebyTypeDetails" roleURI="http://www.agilent.com/role/REVENUERevenuebyTypeDetails">
        <link:definition>2411404 - Disclosure - REVENUE - Revenue by Type (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUEContractAssetsandLiabilityDetails" roleURI="http://www.agilent.com/role/REVENUEContractAssetsandLiabilityDetails">
        <link:definition>2412405 - Disclosure - REVENUE - Contract Assets and Liability (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUERemainingPerformanceObligationDetails" roleURI="http://www.agilent.com/role/REVENUERemainingPerformanceObligationDetails">
        <link:definition>2413406 - Disclosure - REVENUE - Remaining Performance Obligation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUERemainingPerformanceObligationDetails_1" roleURI="http://www.agilent.com/role/REVENUERemainingPerformanceObligationDetails_1">
        <link:definition>2413406 - Disclosure - REVENUE - Remaining Performance Obligation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SHAREBASEDCOMPENSATIONNotes" roleURI="http://www.agilent.com/role/SHAREBASEDCOMPENSATIONNotes">
        <link:definition>2114104 - Disclosure - SHARE-BASED COMPENSATION (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SHAREBASEDCOMPENSATIONTables" roleURI="http://www.agilent.com/role/SHAREBASEDCOMPENSATIONTables">
        <link:definition>2315304 - Disclosure - SHARE-BASED COMPENSATION (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SHAREBASEDCOMPENSATIONTextDetails" roleURI="http://www.agilent.com/role/SHAREBASEDCOMPENSATIONTextDetails">
        <link:definition>2416407 - Disclosure - SHARE-BASED COMPENSATION Text (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SHAREBASEDCOMPENSATIONAllocatedSharebasedcompensationexpenseDetails" roleURI="http://www.agilent.com/role/SHAREBASEDCOMPENSATIONAllocatedSharebasedcompensationexpenseDetails">
        <link:definition>2417408 - Disclosure - SHARE-BASED COMPENSATION Allocated Share-based compensation expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SHAREBASEDCOMPENSATIONFairValueAssumptionsDetails" roleURI="http://www.agilent.com/role/SHAREBASEDCOMPENSATIONFairValueAssumptionsDetails">
        <link:definition>2418409 - Disclosure - SHARE-BASED COMPENSATION Fair Value Assumptions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESNotes" roleURI="http://www.agilent.com/role/INCOMETAXESNotes">
        <link:definition>2119105 - Disclosure - INCOME TAXES (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESDetails" roleURI="http://www.agilent.com/role/INCOMETAXESDetails">
        <link:definition>2420410 - Disclosure - INCOME TAXES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NETINCOMEPERSHARENotes" roleURI="http://www.agilent.com/role/NETINCOMEPERSHARENotes">
        <link:definition>2121106 - Disclosure - NET INCOME PER SHARE (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NETINCOMEPERSHARETables" roleURI="http://www.agilent.com/role/NETINCOMEPERSHARETables">
        <link:definition>2322305 - Disclosure - NET INCOME PER SHARE (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NETINCOMEPERSHAREDetails" roleURI="http://www.agilent.com/role/NETINCOMEPERSHAREDetails">
        <link:definition>2423411 - Disclosure - NET INCOME PER SHARE (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVENTORYNotes" roleURI="http://www.agilent.com/role/INVENTORYNotes">
        <link:definition>2124107 - Disclosure - INVENTORY (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVENTORYTables" roleURI="http://www.agilent.com/role/INVENTORYTables">
        <link:definition>2325306 - Disclosure - INVENTORY (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVENTORYDetails" roleURI="http://www.agilent.com/role/INVENTORYDetails">
        <link:definition>2426412 - Disclosure - INVENTORY (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDOTHERINTANGIBLEASSETSNotes" roleURI="http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNotes">
        <link:definition>2127108 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDOTHERINTANGIBLEASSETSTables" roleURI="http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables">
        <link:definition>2328307 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDOTHERINTANGIBLEASSETSGoodwillRollforwardDetails" roleURI="http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSGoodwillRollforwardDetails">
        <link:definition>2429413 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS Goodwill Roll forward (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDOTHERINTANGIBLEASSETSDisclosuresandComponentsofPurchasedOtherIntangiblesDetails" roleURI="http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDisclosuresandComponentsofPurchasedOtherIntangiblesDetails">
        <link:definition>2430414 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS Disclosures and Components of Purchased Other Intangibles (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDOTHERINTANGIBLEASSETSTextualsDetails" roleURI="http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTextualsDetails">
        <link:definition>2431415 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS Textuals (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDOTHERINTANGIBLEASSETSEstimatedFutureAmortizationDetails" roleURI="http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSEstimatedFutureAmortizationDetails">
        <link:definition>2432416 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - Estimated Future Amortization (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEMEASUREMENTSNotes" roleURI="http://www.agilent.com/role/FAIRVALUEMEASUREMENTSNotes">
        <link:definition>2133109 - Disclosure - FAIR VALUE MEASUREMENTS (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEMEASUREMENTSTables" roleURI="http://www.agilent.com/role/FAIRVALUEMEASUREMENTSTables">
        <link:definition>2334308 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEMEASUREMENTSFairvalueofassetsandliabilitiesmeasuredonarecurringbasisDetails" roleURI="http://www.agilent.com/role/FAIRVALUEMEASUREMENTSFairvalueofassetsandliabilitiesmeasuredonarecurringbasisDetails">
        <link:definition>2435417 - Disclosure - FAIR VALUE MEASUREMENTS, Fair value of assets and liabilities measured on a recurring basis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEMEASUREMENTSNonMarketableSecuritiesandInvestmentImpairmentsDetails" roleURI="http://www.agilent.com/role/FAIRVALUEMEASUREMENTSNonMarketableSecuritiesandInvestmentImpairmentsDetails">
        <link:definition>2436418 - Disclosure - FAIR VALUE MEASUREMENTS, Non Marketable Securities and Investment Impairments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEMEASUREMENTSContingentConsiderationDetails" roleURI="http://www.agilent.com/role/FAIRVALUEMEASUREMENTSContingentConsiderationDetails">
        <link:definition>2437419 - Disclosure - FAIR VALUE MEASUREMENTS, Contingent Consideration (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingLevel3ContingentConsiderationLiabilityDetails" roleURI="http://www.agilent.com/role/FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingLevel3ContingentConsiderationLiabilityDetails">
        <link:definition>2438420 - Disclosure - FAIR VALUE MEASUREMENTS - Reconciliation of Beginning and Ending Level 3 Contingent Consideration Liability (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEMEASUREMENTSAssetsandLiabilitiesmeasuredatFairValueonaNonRecurringBasisDetails" roleURI="http://www.agilent.com/role/FAIRVALUEMEASUREMENTSAssetsandLiabilitiesmeasuredatFairValueonaNonRecurringBasisDetails">
        <link:definition>2439421 - Disclosure - FAIR VALUE MEASUREMENTS, Assets and Liabilities measured at Fair Value on a Non-Recurring Basis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DERIVATIVESNotes" roleURI="http://www.agilent.com/role/DERIVATIVESNotes">
        <link:definition>2140110 - Disclosure - DERIVATIVES (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DERIVATIVESTables" roleURI="http://www.agilent.com/role/DERIVATIVESTables">
        <link:definition>2341309 - Disclosure - DERIVATIVES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DERIVATIVESTextDetails" roleURI="http://www.agilent.com/role/DERIVATIVESTextDetails">
        <link:definition>2442422 - Disclosure - DERIVATIVES- Text (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DERIVATIVESForeignExchangeForwardContractsDetails" roleURI="http://www.agilent.com/role/DERIVATIVESForeignExchangeForwardContractsDetails">
        <link:definition>2443423 - Disclosure - DERIVATIVES- Foreign Exchange Forward Contracts (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DERIVATIVESFairvalueofderivativeinstrumentsandConsolidatedBalanceSheetlocationDetails" roleURI="http://www.agilent.com/role/DERIVATIVESFairvalueofderivativeinstrumentsandConsolidatedBalanceSheetlocationDetails">
        <link:definition>2444424 - Disclosure - DERIVATIVES, Fair value of derivative instruments and Consolidated Balance Sheet location (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DERIVATIVESEffectofderivativeinstrumentsonConsolidatedStatementofOperationsDetails" roleURI="http://www.agilent.com/role/DERIVATIVESEffectofderivativeinstrumentsonConsolidatedStatementofOperationsDetails">
        <link:definition>2445425 - Disclosure - DERIVATIVES, Effect of derivative instruments on Consolidated Statement of Operations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSNotes" roleURI="http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSNotes">
        <link:definition>2146111 - Disclosure - RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSTables" roleURI="http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSTables">
        <link:definition>2347310 - Disclosure - RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSComponentsofnetperiodiccostsDetails" roleURI="http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSComponentsofnetperiodiccostsDetails">
        <link:definition>2448426 - Disclosure - RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS- Components of net periodic costs (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSDetailsEmployerContributions" roleURI="http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSDetailsEmployerContributions">
        <link:definition>2449427 - Disclosure - RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS (Details) (Employer Contributions))</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="WARRANTIESANDCONTINGENCIESNotes" roleURI="http://www.agilent.com/role/WARRANTIESANDCONTINGENCIESNotes">
        <link:definition>2150112 - Disclosure - WARRANTIES AND CONTINGENCIES (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="WARRANTIESANDCONTINGENCIESTable" roleURI="http://www.agilent.com/role/WARRANTIESANDCONTINGENCIESTable">
        <link:definition>2351311 - Disclosure - WARRANTIES AND CONTINGENCIES (Table)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="WARRANTIESANDCONTINGENCIESDetails" roleURI="http://www.agilent.com/role/WARRANTIESANDCONTINGENCIESDetails">
        <link:definition>2452428 - Disclosure - WARRANTIES AND CONTINGENCIES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SHORTTERMDEBTNotes" roleURI="http://www.agilent.com/role/SHORTTERMDEBTNotes">
        <link:definition>2153113 - Disclosure - SHORT-TERM DEBT (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SHORTTERMDEBTCreditFacilityDetails" roleURI="http://www.agilent.com/role/SHORTTERMDEBTCreditFacilityDetails">
        <link:definition>2454429 - Disclosure - SHORT-TERM DEBT - Credit Facility (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LONGTERMDEBTNotes" roleURI="http://www.agilent.com/role/LONGTERMDEBTNotes">
        <link:definition>2155114 - Disclosure - LONG-TERM DEBT (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LONGTERMDEBTTables" roleURI="http://www.agilent.com/role/LONGTERMDEBTTables">
        <link:definition>2356312 - Disclosure - LONG-TERM DEBT (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LONGTERMDEBTDetails" roleURI="http://www.agilent.com/role/LONGTERMDEBTDetails">
        <link:definition>2457430 - Disclosure - LONG-TERM DEBT (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITYNotes" roleURI="http://www.agilent.com/role/STOCKHOLDERSEQUITYNotes">
        <link:definition>2158115 - Disclosure - STOCKHOLDERS' EQUITY (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITYTables" roleURI="http://www.agilent.com/role/STOCKHOLDERSEQUITYTables">
        <link:definition>2359313 - Disclosure - STOCKHOLDERS' EQUITY (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITYStockRepurchaseProgramDetails" roleURI="http://www.agilent.com/role/STOCKHOLDERSEQUITYStockRepurchaseProgramDetails">
        <link:definition>2460431 - Disclosure - STOCKHOLDERS' EQUITY - Stock Repurchase Program (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITYDividendsDetails" roleURI="http://www.agilent.com/role/STOCKHOLDERSEQUITYDividendsDetails">
        <link:definition>2461432 - Disclosure - STOCKHOLDER"S EQUITY - Dividends (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITYAccumulatedOtherComprehensiveIncomeDetails" roleURI="http://www.agilent.com/role/STOCKHOLDERSEQUITYAccumulatedOtherComprehensiveIncomeDetails">
        <link:definition>2462433 - Disclosure - STOCKHOLDER'S EQUITY - Accumulated Other Comprehensive Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITYReclassificationsoutofaccumulatedcomprehensiveincomeDetails" roleURI="http://www.agilent.com/role/STOCKHOLDERSEQUITYReclassificationsoutofaccumulatedcomprehensiveincomeDetails">
        <link:definition>2463434 - Disclosure - STOCKHOLDERS' EQUITY - Reclassifications out of accumulated comprehensive income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTINFORMATIONNotes" roleURI="http://www.agilent.com/role/SEGMENTINFORMATIONNotes">
        <link:definition>2164116 - Disclosure - SEGMENT INFORMATION (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTINFORMATIONTables" roleURI="http://www.agilent.com/role/SEGMENTINFORMATIONTables">
        <link:definition>2365314 - Disclosure - SEGMENT INFORMATION (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTINFORMATIONProfitabilityDetails" roleURI="http://www.agilent.com/role/SEGMENTINFORMATIONProfitabilityDetails">
        <link:definition>2466435 - Disclosure - SEGMENT INFORMATION - Profitability (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTINFORMATIONReconciliationofReportableResultsDetails" roleURI="http://www.agilent.com/role/SEGMENTINFORMATIONReconciliationofReportableResultsDetails">
        <link:definition>2467436 - Disclosure - SEGMENT INFORMATION - Reconciliation of Reportable Results (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTINFORMATIONSegmentAssetsDetails" roleURI="http://www.agilent.com/role/SEGMENTINFORMATIONSegmentAssetsDetails">
        <link:definition>2468437 - Disclosure - SEGMENT INFORMATION - Segment Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="a_AssetsLongLivedAbstract" abstract="true" name="AssetsLongLivedAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="a_IncreaseinContractAssetBalance" abstract="false" name="IncreaseinContractAssetBalance" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="a_IncreasedecreaseinDeferredRevenuefromCustomerCashAdvancesNetofRevenuerecognized" abstract="false" name="IncreasedecreaseinDeferredRevenuefromCustomerCashAdvancesNetofRevenuerecognized" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="a_DocumentAndEntityInformationAbstract" abstract="true" name="DocumentAndEntityInformationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="a_AcademiaandGovernmentMarketMember" abstract="true" name="AcademiaandGovernmentMarketMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="a_SeniorNotes2031Member" abstract="true" name="SeniorNotes2031Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="a_TransformationalPrograms" abstract="false" name="TransformationalPrograms" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="a_EmployerContributionsAndExpectedEmployerContributionsTableTextBlock" abstract="false" name="EmployerContributionsAndExpectedEmployerContributionsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="a_AdditionalIncrementalTermLoanFacilityMember" abstract="true" name="AdditionalIncrementalTermLoanFacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="a_Interestrateswappayments" abstract="false" name="Interestrateswappayments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="a_A2019RepurchaseProgramMember" abstract="true" name="A2019RepurchaseProgramMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="a_BusinessCombinationsContingentConsiderationArrangements" abstract="false" name="BusinessCombinationsContingentConsiderationArrangements" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="a_LifeSciencesandAppliedMarketsMember" abstract="true" name="LifeSciencesandAppliedMarketsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="a_SegmentTotalMember" abstract="true" name="SegmentTotalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="a_PharmaceuticalandBiopharmaceuticalMarketMember" abstract="true" name="PharmaceuticalandBiopharmaceuticalMarketMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="a_EndMarketsDomain" abstract="true" name="EndMarketsDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesPriceWiseCorrelationyRate" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesPriceWiseCorrelationyRate" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="a_BusinessCombinationContingentConsiderationFairValueMeasurementInput" abstract="false" name="BusinessCombinationContingentConsiderationFairValueMeasurementInput" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="a_SeniorNotes2029Member" abstract="true" name="SeniorNotes2029Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="a_DenominatorsAbstract" abstract="true" name="DenominatorsAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="a_DiagnosticsAndGenomicsMember" abstract="true" name="DiagnosticsAndGenomicsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="a_A5YrUnsecuredCreditFacilityMember" abstract="true" name="A5YrUnsecuredCreditFacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="a_LTPPRSUMember" abstract="true" name="LTPPRSUMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyTextBlock" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="a_AmortizationAndDeferralsAbstract" abstract="true" name="AmortizationAndDeferralsAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="a_InstrumentationMember" abstract="true" name="InstrumentationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesVolatilityRateRangeMaximum" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesVolatilityRateRangeMaximum" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="a_Segmentincomelossfromoperations" abstract="false" name="Segmentincomelossfromoperations" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="a_DiagnosticsandClinicalMarketMember" abstract="true" name="DiagnosticsandClinicalMarketMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="a_NonInstrumentationandOtherMember" abstract="true" name="NonInstrumentationandOtherMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="a_ThirdPartyTechnologyandLicensesMember" abstract="true" name="ThirdPartyTechnologyandLicensesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="a_A2021RepurchaseProgramMember" abstract="true" name="A2021RepurchaseProgramMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="a_MeasurementInputRevenueVolatilityMember" abstract="true" name="MeasurementInputRevenueVolatilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="a_AgilentCrossLabMember" abstract="true" name="AgilentCrossLabMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="a_EndMarketsAxis" abstract="true" name="EndMarketsAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="a_SeniorNotes2023Member" abstract="true" name="SeniorNotes2023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="a_LtppMember" abstract="true" name="LtppMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="a_ChemicalandEnergyMarketMember" abstract="true" name="ChemicalandEnergyMarketMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="a_WeightedAverageMaturityDateatPointinTime" abstract="false" name="WeightedAverageMaturityDateatPointinTime" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="a_MeasurementInputAssetVolatilityMember" abstract="true" name="MeasurementInputAssetVolatilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="a_FoodMarketMember" abstract="true" name="FoodMarketMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="a_WeightedAverageMaturityDateAtAPointInTime" abstract="false" name="WeightedAverageMaturityDateAtAPointInTime" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="a_NumeratorAbstract" abstract="true" name="NumeratorAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="a_EnvironmentalandForensicsMarketMember" abstract="true" name="EnvironmentalandForensicsMarketMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="a_SeniorNotes2026Member" abstract="true" name="SeniorNotes2026Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="a_Taxrelatedtosharesissued" abstract="false" name="Taxrelatedtosharesissued" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="a_OtherAccruedAndLongTermLiabilitiesMember" abstract="true" name="OtherAccruedAndLongTermLiabilitiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="a_ResolutionBioscienceIncMember" abstract="true" name="ResolutionBioscienceIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="a_Other" abstract="false" name="Other" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="a_Fairvalueoflongtermdebtinexcessofcarryingvalue" abstract="false" name="Fairvalueoflongtermdebtinexcessofcarryingvalue" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="a_Remaininggainlosstobeamortizedonderivative" abstract="false" name="Remaininggainlosstobeamortizedonderivative" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesVolatilityRateRangeMinimum" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesVolatilityRateRangeMinimum" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="a_SeniorNotes2030Member" abstract="true" name="SeniorNotes2030Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="a_SeniorNotes2022Member" abstract="true" name="SeniorNotes2022Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>7
<FILENAME>a-20220131_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:b57f1026-9350-4429-b363-875dec110646,g:1024445c-b98f-4ee2-b278-e07339a70979-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFOPERATIONSUnaudited" xlink:type="simple" xlink:href="a-20220131.xsd#CONDENSEDCONSOLIDATEDSTATEMENTOFOPERATIONSUnaudited"/>
  <link:calculationLink xlink:role="http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFOPERATIONSUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_31085e3c-19b0-4b5c-b5a4-fb06f0afb5fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_c02b3d7a-203c-459a-952a-f018381032b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_31085e3c-19b0-4b5c-b5a4-fb06f0afb5fb" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_c02b3d7a-203c-459a-952a-f018381032b6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_4f4129bf-fee0-44bd-85e8-d621ce48053c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_31085e3c-19b0-4b5c-b5a4-fb06f0afb5fb" xlink:to="loc_us-gaap_CostsAndExpenses_4f4129bf-fee0-44bd-85e8-d621ce48053c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_206150b5-87b7-423a-9054-e4af3491d77b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_efe20e71-96b1-4c2b-a8b7-696fdb95f069" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_206150b5-87b7-423a-9054-e4af3491d77b" xlink:to="loc_us-gaap_OperatingIncomeLoss_efe20e71-96b1-4c2b-a8b7-696fdb95f069" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_8fee9050-e47a-4a1f-a44d-7609af0f3a97" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_206150b5-87b7-423a-9054-e4af3491d77b" xlink:to="loc_us-gaap_InvestmentIncomeInterest_8fee9050-e47a-4a1f-a44d-7609af0f3a97" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_46760ed9-041f-487f-bce2-9b6a8d164a86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_206150b5-87b7-423a-9054-e4af3491d77b" xlink:to="loc_us-gaap_InterestExpense_46760ed9-041f-487f-bce2-9b6a8d164a86" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_beca44ab-fe6f-49b2-9f52-3da97d6f572e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_206150b5-87b7-423a-9054-e4af3491d77b" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_beca44ab-fe6f-49b2-9f52-3da97d6f572e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_80cd69f5-c400-48a8-83fc-c91c8cf7f6df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2a2b5048-42df-4337-955b-74f87bcd37a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_80cd69f5-c400-48a8-83fc-c91c8cf7f6df" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2a2b5048-42df-4337-955b-74f87bcd37a2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_86bbd7ce-9f23-4209-add6-939b311beb10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_80cd69f5-c400-48a8-83fc-c91c8cf7f6df" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_86bbd7ce-9f23-4209-add6-939b311beb10" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_94bccf38-83bf-49a8-8fd1-aa9aa95b5dfd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_7e4de1cb-829b-485b-a3cd-c8e00afee266" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_94bccf38-83bf-49a8-8fd1-aa9aa95b5dfd" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_7e4de1cb-829b-485b-a3cd-c8e00afee266" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_dfd4db20-b95b-42ae-b48f-8916c4a6c462" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_94bccf38-83bf-49a8-8fd1-aa9aa95b5dfd" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_dfd4db20-b95b-42ae-b48f-8916c4a6c462" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_940d1885-f438-485d-8f10-997c3a298f8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_94bccf38-83bf-49a8-8fd1-aa9aa95b5dfd" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_940d1885-f438-485d-8f10-997c3a298f8d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOMEUnaudited" xlink:type="simple" xlink:href="a-20220131.xsd#CONDENSEDCONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOMEUnaudited"/>
  <link:calculationLink xlink:role="http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOMEUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_9919bf85-6c69-4596-99e8-c6ba86c4d3a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_82f6a64b-cec2-4b34-a981-986a951ffe98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_9919bf85-6c69-4596-99e8-c6ba86c4d3a5" xlink:to="loc_us-gaap_NetIncomeLoss_82f6a64b-cec2-4b34-a981-986a951ffe98" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_af6a6af1-060c-4f00-8b7e-663423032441" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_9919bf85-6c69-4596-99e8-c6ba86c4d3a5" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_af6a6af1-060c-4f00-8b7e-663423032441" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_3a3a735d-dc5f-431d-9ce3-3d73e20651b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_f8352af3-3dd3-40b3-8470-4218818d1659" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_3a3a735d-dc5f-431d-9ce3-3d73e20651b7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_f8352af3-3dd3-40b3-8470-4218818d1659" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_a66845fc-181d-4e1b-bc86-642ae52dd1bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_3a3a735d-dc5f-431d-9ce3-3d73e20651b7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_a66845fc-181d-4e1b-bc86-642ae52dd1bf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_63fe5bc5-4ff5-4923-8969-0fc9a593d07b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_3a3a735d-dc5f-431d-9ce3-3d73e20651b7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_63fe5bc5-4ff5-4923-8969-0fc9a593d07b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_80513778-786b-469b-8ae3-fc3cb74941db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_3a3a735d-dc5f-431d-9ce3-3d73e20651b7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_80513778-786b-469b-8ae3-fc3cb74941db" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited" xlink:type="simple" xlink:href="a-20220131.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited"/>
  <link:calculationLink xlink:role="http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_ef64906e-410a-410a-8573-4e0f9df2b3c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_bd745ec3-5847-4ebe-a05c-6aa551b655bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_ef64906e-410a-410a-8573-4e0f9df2b3c8" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_bd745ec3-5847-4ebe-a05c-6aa551b655bc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_7630e9a2-6e10-4c96-ae78-14b7518c1053" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_ef64906e-410a-410a-8573-4e0f9df2b3c8" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_7630e9a2-6e10-4c96-ae78-14b7518c1053" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_360fb85a-24be-4ec8-bb38-9abc71f02390" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_ef64906e-410a-410a-8573-4e0f9df2b3c8" xlink:to="loc_us-gaap_InventoryNet_360fb85a-24be-4ec8-bb38-9abc71f02390" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_3f88cf79-1ddc-495a-af60-5aeb2bda2773" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_ef64906e-410a-410a-8573-4e0f9df2b3c8" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_3f88cf79-1ddc-495a-af60-5aeb2bda2773" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_fb2dbc52-c1ba-447d-a917-df11f441ef8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_ef64906e-410a-410a-8573-4e0f9df2b3c8" xlink:to="loc_us-gaap_OtherAssetsCurrent_fb2dbc52-c1ba-447d-a917-df11f441ef8d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_090a6eee-2fa8-4db8-9b17-eb6d2e40360a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_1f45712d-a02e-4b56-8209-37e4c104e794" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_090a6eee-2fa8-4db8-9b17-eb6d2e40360a" xlink:to="loc_us-gaap_AssetsCurrent_1f45712d-a02e-4b56-8209-37e4c104e794" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_f38d70ff-e05b-4dea-8971-6a418ea51018" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_090a6eee-2fa8-4db8-9b17-eb6d2e40360a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_f38d70ff-e05b-4dea-8971-6a418ea51018" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_d1f12a36-a818-4429-b8db-b5a8987b0233" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_090a6eee-2fa8-4db8-9b17-eb6d2e40360a" xlink:to="loc_us-gaap_Goodwill_d1f12a36-a818-4429-b8db-b5a8987b0233" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_8acad24c-6b75-4e96-8390-25b478a45f4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_090a6eee-2fa8-4db8-9b17-eb6d2e40360a" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_8acad24c-6b75-4e96-8390-25b478a45f4b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestments_23b35f03-3018-4cb4-966e-e08bf23d1955" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermInvestments"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_090a6eee-2fa8-4db8-9b17-eb6d2e40360a" xlink:to="loc_us-gaap_LongTermInvestments_23b35f03-3018-4cb4-966e-e08bf23d1955" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_27d8ded1-8f81-4ae5-950a-f76c643bc064" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_090a6eee-2fa8-4db8-9b17-eb6d2e40360a" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_27d8ded1-8f81-4ae5-950a-f76c643bc064" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_1558581d-e3e0-4e21-8ae6-4bd1a9ea452e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_ec8cd9d4-a2be-4e38-97fc-a322c81aa411" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_1558581d-e3e0-4e21-8ae6-4bd1a9ea452e" xlink:to="loc_us-gaap_Liabilities_ec8cd9d4-a2be-4e38-97fc-a322c81aa411" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_07b1f974-3e96-452f-a068-b5a0aec6c41b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_1558581d-e3e0-4e21-8ae6-4bd1a9ea452e" xlink:to="loc_us-gaap_StockholdersEquity_07b1f974-3e96-452f-a068-b5a0aec6c41b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_42771f8f-93df-4e0e-92d2-2668b135a77c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_493092ed-2a91-417e-9822-d2aaf25c5e7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_42771f8f-93df-4e0e-92d2-2668b135a77c" xlink:to="loc_us-gaap_PreferredStockValue_493092ed-2a91-417e-9822-d2aaf25c5e7c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_cbce1ccb-1a12-47df-b140-2c4df5903887" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_42771f8f-93df-4e0e-92d2-2668b135a77c" xlink:to="loc_us-gaap_CommonStockValue_cbce1ccb-1a12-47df-b140-2c4df5903887" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_0ca00188-5c19-4cbf-ad69-c9ed1fc8074e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_42771f8f-93df-4e0e-92d2-2668b135a77c" xlink:to="loc_us-gaap_AdditionalPaidInCapital_0ca00188-5c19-4cbf-ad69-c9ed1fc8074e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_3eae4bce-2f02-4d10-95fe-37cfa6f72a53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_42771f8f-93df-4e0e-92d2-2668b135a77c" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_3eae4bce-2f02-4d10-95fe-37cfa6f72a53" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_25656268-14f3-4ef7-aac5-c281fb8da305" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_42771f8f-93df-4e0e-92d2-2668b135a77c" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_25656268-14f3-4ef7-aac5-c281fb8da305" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_c776067a-a07e-4b1f-8fd3-387008fd18d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_9401dbb7-9217-4187-ab32-4267852ced97" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_c776067a-a07e-4b1f-8fd3-387008fd18d5" xlink:to="loc_us-gaap_LiabilitiesCurrent_9401dbb7-9217-4187-ab32-4267852ced97" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_86810eed-eefc-447b-b028-2f911817cd75" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_c776067a-a07e-4b1f-8fd3-387008fd18d5" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_86810eed-eefc-447b-b028-2f911817cd75" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_6e573e80-70f7-44d3-9ed0-a6a34a7aa010" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_c776067a-a07e-4b1f-8fd3-387008fd18d5" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_6e573e80-70f7-44d3-9ed0-a6a34a7aa010" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_e1725e2e-6668-4486-b1eb-531652c89731" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_c776067a-a07e-4b1f-8fd3-387008fd18d5" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_e1725e2e-6668-4486-b1eb-531652c89731" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_6b3cb9b7-8388-404a-965f-71e0810647f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_5631bd81-875c-46a3-98a1-4391b2ea97c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_6b3cb9b7-8388-404a-965f-71e0810647f4" xlink:to="loc_us-gaap_AccountsPayableCurrent_5631bd81-875c-46a3-98a1-4391b2ea97c3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_2b0b34e0-e38d-4842-bf3f-d3f8361f427a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_6b3cb9b7-8388-404a-965f-71e0810647f4" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_2b0b34e0-e38d-4842-bf3f-d3f8361f427a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueCurrent_446a977d-352f-42b8-9dd2-be1525445d7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredRevenueCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_6b3cb9b7-8388-404a-965f-71e0810647f4" xlink:to="loc_us-gaap_DeferredRevenueCurrent_446a977d-352f-42b8-9dd2-be1525445d7c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent_3b0de4b0-d1b5-43bd-a639-bc0e555c1823" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_6b3cb9b7-8388-404a-965f-71e0810647f4" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent_3b0de4b0-d1b5-43bd-a639-bc0e555c1823" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited" xlink:type="simple" xlink:href="a-20220131.xsd#CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited"/>
  <link:calculationLink xlink:role="http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e8f67cf1-4946-4ee9-9a7e-90ec165b4486" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_bf0f991c-4c7e-4095-aa24-a57dbf33e996" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e8f67cf1-4946-4ee9-9a7e-90ec165b4486" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_bf0f991c-4c7e-4095-aa24-a57dbf33e996" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_457a6e1c-e2e9-41b3-843b-4b7abd41de4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e8f67cf1-4946-4ee9-9a7e-90ec165b4486" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_457a6e1c-e2e9-41b3-843b-4b7abd41de4c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfOrdinaryDividends_b55cb8fc-aef4-44e8-b871-e9dcbe8588ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfOrdinaryDividends"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e8f67cf1-4946-4ee9-9a7e-90ec165b4486" xlink:to="loc_us-gaap_PaymentsOfOrdinaryDividends_b55cb8fc-aef4-44e8-b871-e9dcbe8588ed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarlyRepaymentOfSeniorDebt_764d904c-53f6-4ce9-a72b-367d3fe8d083" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarlyRepaymentOfSeniorDebt"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e8f67cf1-4946-4ee9-9a7e-90ec165b4486" xlink:to="loc_us-gaap_EarlyRepaymentOfSeniorDebt_764d904c-53f6-4ce9-a72b-367d3fe8d083" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommercialPaper_09c445ae-536b-4d85-8ca7-e437375ce2db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommercialPaper"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e8f67cf1-4946-4ee9-9a7e-90ec165b4486" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommercialPaper_09c445ae-536b-4d85-8ca7-e437375ce2db" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfCommercialPaper_7464258d-abda-4aef-bc9a-f0c8cfb3eab2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfCommercialPaper"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e8f67cf1-4946-4ee9-9a7e-90ec165b4486" xlink:to="loc_us-gaap_RepaymentsOfCommercialPaper_7464258d-abda-4aef-bc9a-f0c8cfb3eab2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_d788382d-827d-4c5c-b3b1-238cd04c6abf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e8f67cf1-4946-4ee9-9a7e-90ec165b4486" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_d788382d-827d-4c5c-b3b1-238cd04c6abf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_aa7f96ab-5fd7-4f53-beb0-aadf10514016" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_fd41e094-a079-4eb1-8d8d-0d7c0d7185e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_aa7f96ab-5fd7-4f53-beb0-aadf10514016" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_fd41e094-a079-4eb1-8d8d-0d7c0d7185e1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_2860feaf-e6ba-4b9c-9d6b-545943139ae5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_aa7f96ab-5fd7-4f53-beb0-aadf10514016" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_2860feaf-e6ba-4b9c-9d6b-545943139ae5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a7569ff8-1b92-4164-97b2-4d256de114a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_aa7f96ab-5fd7-4f53-beb0-aadf10514016" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a7569ff8-1b92-4164-97b2-4d256de114a9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_fddc26ef-392e-4187-bab3-6dadb345f54b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_aa7f96ab-5fd7-4f53-beb0-aadf10514016" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_fddc26ef-392e-4187-bab3-6dadb345f54b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_637ad73e-b92e-4f75-a2b2-af9e1480e3c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_d39ed8d1-7685-42b0-a1e9-05424485dcbe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_637ad73e-b92e-4f75-a2b2-af9e1480e3c6" xlink:to="loc_us-gaap_NetIncomeLoss_d39ed8d1-7685-42b0-a1e9-05424485dcbe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_833dfd75-09a3-4f08-bbbb-2d4700683409" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_637ad73e-b92e-4f75-a2b2-af9e1480e3c6" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_833dfd75-09a3-4f08-bbbb-2d4700683409" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_a2e6f4be-c811-4ceb-8c15-362b2d342509" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_637ad73e-b92e-4f75-a2b2-af9e1480e3c6" xlink:to="loc_us-gaap_ShareBasedCompensation_a2e6f4be-c811-4ceb-8c15-362b2d342509" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_e0eea064-01e0-4f6a-b862-8c36533a5ac0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_637ad73e-b92e-4f75-a2b2-af9e1480e3c6" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_e0eea064-01e0-4f6a-b862-8c36533a5ac0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWriteDown_9007c369-9313-4dc4-b21c-21abf7d3a663" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWriteDown"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_637ad73e-b92e-4f75-a2b2-af9e1480e3c6" xlink:to="loc_us-gaap_InventoryWriteDown_9007c369-9313-4dc4-b21c-21abf7d3a663" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_1db60824-4c7e-4d46-b30f-80e93b7a372f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_637ad73e-b92e-4f75-a2b2-af9e1480e3c6" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_1db60824-4c7e-4d46-b30f-80e93b7a372f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_96f30bfb-78db-4f50-85cc-028a37e79349" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_637ad73e-b92e-4f75-a2b2-af9e1480e3c6" xlink:to="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_96f30bfb-78db-4f50-85cc-028a37e79349" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_10ad3519-ea00-4942-8b9d-fb953694b215" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_637ad73e-b92e-4f75-a2b2-af9e1480e3c6" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_10ad3519-ea00-4942-8b9d-fb953694b215" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_d9754292-b8b4-419b-b33e-861c76fc7d78" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_637ad73e-b92e-4f75-a2b2-af9e1480e3c6" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_d9754292-b8b4-419b-b33e-861c76fc7d78" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_55877704-d800-4d6f-8894-8de1758359e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_637ad73e-b92e-4f75-a2b2-af9e1480e3c6" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_55877704-d800-4d6f-8894-8de1758359e8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_84becde4-f1c5-4b2b-977b-aea6d38812b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_637ad73e-b92e-4f75-a2b2-af9e1480e3c6" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_84becde4-f1c5-4b2b-977b-aea6d38812b0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_59b42ef3-cd54-450a-aa84-ce1f66415c37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_637ad73e-b92e-4f75-a2b2-af9e1480e3c6" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_59b42ef3-cd54-450a-aa84-ce1f66415c37" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_d9adefb8-48a1-47cd-9780-9460a16ba56c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_637ad73e-b92e-4f75-a2b2-af9e1480e3c6" xlink:to="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_d9adefb8-48a1-47cd-9780-9460a16ba56c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_2e3c0d2e-59a6-472d-9f34-e89fa784aac5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:calculationArc order="14" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_637ad73e-b92e-4f75-a2b2-af9e1480e3c6" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_2e3c0d2e-59a6-472d-9f34-e89fa784aac5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_bd2e468c-99db-4007-ac40-de34c7ae1ec7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_815dc681-a27c-4981-b58f-8b7563ec9c3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_bd2e468c-99db-4007-ac40-de34c7ae1ec7" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_815dc681-a27c-4981-b58f-8b7563ec9c3a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquitySecuritiesFvNi_cc5e361c-167c-48e3-9ac6-db0d3f7fff11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireEquitySecuritiesFvNi"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_bd2e468c-99db-4007-ac40-de34c7ae1ec7" xlink:to="loc_us-gaap_PaymentsToAcquireEquitySecuritiesFvNi_cc5e361c-167c-48e3-9ac6-db0d3f7fff11" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireNotesReceivable_602da789-496c-4ea7-89b2-b442d6e031d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireNotesReceivable"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_bd2e468c-99db-4007-ac40-de34c7ae1ec7" xlink:to="loc_us-gaap_PaymentsToAcquireNotesReceivable_602da789-496c-4ea7-89b2-b442d6e031d2" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFEQUITY" xlink:type="simple" xlink:href="a-20220131.xsd#CONDENSEDCONSOLIDATEDSTATEMENTOFEQUITY"/>
  <link:calculationLink xlink:role="http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFEQUITY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_a118e1c4-c245-48e9-8486-3670241e2fa3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_81e14d9c-91d2-4414-99f7-7f20045dcc4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_a118e1c4-c245-48e9-8486-3670241e2fa3" xlink:to="loc_us-gaap_NetIncomeLoss_81e14d9c-91d2-4414-99f7-7f20045dcc4a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_95a13a1a-b959-4a51-aa58-de046f5fffe7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_a118e1c4-c245-48e9-8486-3670241e2fa3" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_95a13a1a-b959-4a51-aa58-de046f5fffe7" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/NETINCOMEPERSHAREDetails" xlink:type="simple" xlink:href="a-20220131.xsd#NETINCOMEPERSHAREDetails"/>
  <link:calculationLink xlink:role="http://www.agilent.com/role/NETINCOMEPERSHAREDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_9bd8e27f-add3-457f-814c-d022bb43737a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_250a9b8d-e692-4303-a816-ad8cbab7401f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_9bd8e27f-add3-457f-814c-d022bb43737a" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_250a9b8d-e692-4303-a816-ad8cbab7401f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_1619a8de-29ed-4dd6-b5ea-3474044fa452" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_9bd8e27f-add3-457f-814c-d022bb43737a" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_1619a8de-29ed-4dd6-b5ea-3474044fa452" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/INVENTORYDetails" xlink:type="simple" xlink:href="a-20220131.xsd#INVENTORYDetails"/>
  <link:calculationLink xlink:role="http://www.agilent.com/role/INVENTORYDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_4dbbfbd5-40ab-4e8a-86fe-b4beaa8ee4f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoods_93cb28aa-2f34-470f-acde-acef17201b0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoods"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_4dbbfbd5-40ab-4e8a-86fe-b4beaa8ee4f1" xlink:to="loc_us-gaap_InventoryFinishedGoods_93cb28aa-2f34-470f-acde-acef17201b0b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessAndRawMaterials_23972504-c86d-49bf-813e-1391ff647176" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWorkInProcessAndRawMaterials"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_4dbbfbd5-40ab-4e8a-86fe-b4beaa8ee4f1" xlink:to="loc_us-gaap_InventoryWorkInProcessAndRawMaterials_23972504-c86d-49bf-813e-1391ff647176" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/FAIRVALUEMEASUREMENTSFairvalueofassetsandliabilitiesmeasuredonarecurringbasisDetails" xlink:type="simple" xlink:href="a-20220131.xsd#FAIRVALUEMEASUREMENTSFairvalueofassetsandliabilitiesmeasuredonarecurringbasisDetails"/>
  <link:calculationLink xlink:role="http://www.agilent.com/role/FAIRVALUEMEASUREMENTSFairvalueofassetsandliabilitiesmeasuredonarecurringbasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_6f5ecf14-db7d-42c9-87e6-b914dc6ebdbf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_c5cbc369-451d-4a77-910e-302ef4242335" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_6f5ecf14-db7d-42c9-87e6-b914dc6ebdbf" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_c5cbc369-451d-4a77-910e-302ef4242335" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_5817b615-456f-47f3-95a3-5da3996cf749" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyContractAssetFairValueDisclosure"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_6f5ecf14-db7d-42c9-87e6-b914dc6ebdbf" xlink:to="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_5817b615-456f-47f3-95a3-5da3996cf749" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecurities_cb8076ec-07d3-4c1d-99bf-2a9e4aaba364" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradingSecurities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_6f5ecf14-db7d-42c9-87e6-b914dc6ebdbf" xlink:to="loc_us-gaap_TradingSecurities_cb8076ec-07d3-4c1d-99bf-2a9e4aaba364" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_45030c8a-80c0-407f-bd31-8d75c7de6379" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_6f5ecf14-db7d-42c9-87e6-b914dc6ebdbf" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_45030c8a-80c0-407f-bd31-8d75c7de6379" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_950aa6a8-b3ef-4e20-8a22-30d873be9a33" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_28062242-7304-42db-9012-03706b15288c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure_950aa6a8-b3ef-4e20-8a22-30d873be9a33" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_28062242-7304-42db-9012-03706b15288c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_205673f8-ab32-4ed5-a0c2-3c8258027a71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure_950aa6a8-b3ef-4e20-8a22-30d873be9a33" xlink:to="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_205673f8-ab32-4ed5-a0c2-3c8258027a71" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_3c679578-2370-4de3-8154-4f84bdc26c17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure_950aa6a8-b3ef-4e20-8a22-30d873be9a33" xlink:to="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_3c679578-2370-4de3-8154-4f84bdc26c17" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSComponentsofnetperiodiccostsDetails" xlink:type="simple" xlink:href="a-20220131.xsd#RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSComponentsofnetperiodiccostsDetails"/>
  <link:calculationLink xlink:role="http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSComponentsofnetperiodiccostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_817c02e5-e83d-433c-941f-673409ee223b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_8853298b-2cc3-4694-baed-d4cc023407fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_817c02e5-e83d-433c-941f-673409ee223b" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_8853298b-2cc3-4694-baed-d4cc023407fd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_779265b5-cdc0-4178-98e7-44b5cbc921bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_817c02e5-e83d-433c-941f-673409ee223b" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_779265b5-cdc0-4178-98e7-44b5cbc921bf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_3f942df8-1a2d-4d3f-856f-52a939d271dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_817c02e5-e83d-433c-941f-673409ee223b" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_3f942df8-1a2d-4d3f-856f-52a939d271dd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_354db6cc-8870-4c01-895d-b35b45ac1abb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_817c02e5-e83d-433c-941f-673409ee223b" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_354db6cc-8870-4c01-895d-b35b45ac1abb" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/SEGMENTINFORMATIONReconciliationofReportableResultsDetails" xlink:type="simple" xlink:href="a-20220131.xsd#SEGMENTINFORMATIONReconciliationofReportableResultsDetails"/>
  <link:calculationLink xlink:role="http://www.agilent.com/role/SEGMENTINFORMATIONReconciliationofReportableResultsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_d9418d88-0759-46ef-9eee-33d764550170" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_Segmentincomelossfromoperations_0e932a02-fb8f-4a32-ae26-9de10b70a9c9" xlink:href="a-20220131.xsd#a_Segmentincomelossfromoperations"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_d9418d88-0759-46ef-9eee-33d764550170" xlink:to="loc_a_Segmentincomelossfromoperations_0e932a02-fb8f-4a32-ae26-9de10b70a9c9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_TransformationalPrograms_d5647b68-b155-49c7-9f3d-afb8ef4dc672" xlink:href="a-20220131.xsd#a_TransformationalPrograms"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_d9418d88-0759-46ef-9eee-33d764550170" xlink:to="loc_a_TransformationalPrograms_d5647b68-b155-49c7-9f3d-afb8ef4dc672" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization_6a3b274e-a9a9-4059-9699-1bc5bbf959be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_d9418d88-0759-46ef-9eee-33d764550170" xlink:to="loc_us-gaap_AdjustmentForAmortization_6a3b274e-a9a9-4059-9699-1bc5bbf959be" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_ef74fd5e-3441-432a-85a2-97b9d96188bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_d9418d88-0759-46ef-9eee-33d764550170" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_ef74fd5e-3441-432a-85a2-97b9d96188bb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_0d9b8d17-a783-4230-92bc-98bed7184f40" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_d9418d88-0759-46ef-9eee-33d764550170" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_0d9b8d17-a783-4230-92bc-98bed7184f40" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_Other_ad06b347-c38d-43cc-aeaf-be250e5b3bee" xlink:href="a-20220131.xsd#a_Other"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_d9418d88-0759-46ef-9eee-33d764550170" xlink:to="loc_a_Other_ad06b347-c38d-43cc-aeaf-be250e5b3bee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_6412bf4f-3dc9-4179-b4a6-cb1d0c4e50db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_d9418d88-0759-46ef-9eee-33d764550170" xlink:to="loc_us-gaap_InvestmentIncomeInterest_6412bf4f-3dc9-4179-b4a6-cb1d0c4e50db" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_9d6c5361-ba2b-48c1-80f8-7d0b60651e5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_d9418d88-0759-46ef-9eee-33d764550170" xlink:to="loc_us-gaap_InterestExpense_9d6c5361-ba2b-48c1-80f8-7d0b60651e5b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_1994286a-7a8e-4aec-a183-7daf894176ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_d9418d88-0759-46ef-9eee-33d764550170" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_1994286a-7a8e-4aec-a183-7daf894176ce" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>8
<FILENAME>a-20220131_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:b57f1026-9350-4429-b363-875dec110646,g:1024445c-b98f-4ee2-b278-e07339a70979-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFOPERATIONSUnaudited" xlink:type="simple" xlink:href="a-20220131.xsd#CONDENSEDCONSOLIDATEDSTATEMENTOFOPERATIONSUnaudited"/>
  <link:definitionLink xlink:role="http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFOPERATIONSUnaudited" xlink:type="extended" id="i9d9283e70ef04ff28b6799a53bb1c69c_CONDENSEDCONSOLIDATEDSTATEMENTOFOPERATIONSUnaudited">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_cf766036-7f5e-45d2-a6ba-3049e98bf698" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_a271fe1a-4591-4718-9b12-7c48cfa59440" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_cf766036-7f5e-45d2-a6ba-3049e98bf698" xlink:to="loc_us-gaap_RevenuesAbstract_a271fe1a-4591-4718-9b12-7c48cfa59440" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_438f2f7f-8050-4ed5-a4aa-296c234e4a02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_a271fe1a-4591-4718-9b12-7c48cfa59440" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_438f2f7f-8050-4ed5-a4aa-296c234e4a02" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpensesAbstract_79f03798-3819-45d6-b128-088541d14a53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpensesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_cf766036-7f5e-45d2-a6ba-3049e98bf698" xlink:to="loc_us-gaap_CostsAndExpensesAbstract_79f03798-3819-45d6-b128-088541d14a53" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_94a3d43a-e006-455f-9c8c-dd01ea6d9e28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_79f03798-3819-45d6-b128-088541d14a53" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_94a3d43a-e006-455f-9c8c-dd01ea6d9e28" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_bd732b96-3d02-4553-9aa3-471689370ade" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_79f03798-3819-45d6-b128-088541d14a53" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_bd732b96-3d02-4553-9aa3-471689370ade" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_77cecce3-ab10-46a7-b6a6-af88d5a7e5fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_79f03798-3819-45d6-b128-088541d14a53" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_77cecce3-ab10-46a7-b6a6-af88d5a7e5fd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_b64f4ac8-5e7e-4a09-8c8f-24414d9f9154" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_79f03798-3819-45d6-b128-088541d14a53" xlink:to="loc_us-gaap_CostsAndExpenses_b64f4ac8-5e7e-4a09-8c8f-24414d9f9154" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_3fcb1381-7dfb-4877-b69f-b27b9ccd3601" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_cf766036-7f5e-45d2-a6ba-3049e98bf698" xlink:to="loc_us-gaap_OperatingIncomeLoss_3fcb1381-7dfb-4877-b69f-b27b9ccd3601" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_635545ab-6db9-4da0-b850-f0ef720048d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_cf766036-7f5e-45d2-a6ba-3049e98bf698" xlink:to="loc_us-gaap_InvestmentIncomeInterest_635545ab-6db9-4da0-b850-f0ef720048d7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_a8699c62-0a63-40a2-b5be-afcc1c83f72d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_cf766036-7f5e-45d2-a6ba-3049e98bf698" xlink:to="loc_us-gaap_InterestExpense_a8699c62-0a63-40a2-b5be-afcc1c83f72d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_1a0f235f-4170-4daf-b3c0-13262fd7854b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_cf766036-7f5e-45d2-a6ba-3049e98bf698" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_1a0f235f-4170-4daf-b3c0-13262fd7854b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_dbdda36d-f5d5-4291-9cfd-9655186b82f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_cf766036-7f5e-45d2-a6ba-3049e98bf698" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_dbdda36d-f5d5-4291-9cfd-9655186b82f5" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_d03caf00-6866-414b-b8bf-5d60eb907d14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_cf766036-7f5e-45d2-a6ba-3049e98bf698" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_d03caf00-6866-414b-b8bf-5d60eb907d14" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_62b9b217-f31e-4dc1-95dc-188d54dc5411" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_cf766036-7f5e-45d2-a6ba-3049e98bf698" xlink:to="loc_us-gaap_NetIncomeLoss_62b9b217-f31e-4dc1-95dc-188d54dc5411" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_eb6b8b12-90dc-4745-b4e3-795191821cec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_cf766036-7f5e-45d2-a6ba-3049e98bf698" xlink:to="loc_us-gaap_EarningsPerShareAbstract_eb6b8b12-90dc-4745-b4e3-795191821cec" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_dbf9dcb5-1502-4d57-8665-1c630e26d1c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareAbstract_eb6b8b12-90dc-4745-b4e3-795191821cec" xlink:to="loc_us-gaap_EarningsPerShareBasic_dbf9dcb5-1502-4d57-8665-1c630e26d1c4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_228aa287-7654-4985-b093-47060de60363" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareAbstract_eb6b8b12-90dc-4745-b4e3-795191821cec" xlink:to="loc_us-gaap_EarningsPerShareDiluted_228aa287-7654-4985-b093-47060de60363" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_5528dc8f-8d46-46b9-b7fe-e6a16a9e019a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_cf766036-7f5e-45d2-a6ba-3049e98bf698" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_5528dc8f-8d46-46b9-b7fe-e6a16a9e019a" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_a928db04-6239-41bc-bab9-15712b3af342" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_5528dc8f-8d46-46b9-b7fe-e6a16a9e019a" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_a928db04-6239-41bc-bab9-15712b3af342" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_b3218191-6567-4b03-9951-eea46bc50ae9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_5528dc8f-8d46-46b9-b7fe-e6a16a9e019a" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_b3218191-6567-4b03-9951-eea46bc50ae9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_9cedc1e8-eb8b-4c3c-bfbc-99a0a58da296" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_cf766036-7f5e-45d2-a6ba-3049e98bf698" xlink:to="loc_us-gaap_StatementTable_9cedc1e8-eb8b-4c3c-bfbc-99a0a58da296" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_e16bf9ad-9689-4ea8-9f2e-ba4fd6fd874d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_9cedc1e8-eb8b-4c3c-bfbc-99a0a58da296" xlink:to="loc_srt_ProductOrServiceAxis_e16bf9ad-9689-4ea8-9f2e-ba4fd6fd874d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_e16bf9ad-9689-4ea8-9f2e-ba4fd6fd874d_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_e16bf9ad-9689-4ea8-9f2e-ba4fd6fd874d" xlink:to="loc_srt_ProductsAndServicesDomain_e16bf9ad-9689-4ea8-9f2e-ba4fd6fd874d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_70839715-aaee-4a36-85f4-df9607d9af8f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_e16bf9ad-9689-4ea8-9f2e-ba4fd6fd874d" xlink:to="loc_srt_ProductsAndServicesDomain_70839715-aaee-4a36-85f4-df9607d9af8f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_bea291c5-c5ef-4a33-9609-33932ddb7596" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_70839715-aaee-4a36-85f4-df9607d9af8f" xlink:to="loc_us-gaap_ProductMember_bea291c5-c5ef-4a33-9609-33932ddb7596" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceOtherMember_f046dcb6-6be0-4861-884b-6158352eb6e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ServiceOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_70839715-aaee-4a36-85f4-df9607d9af8f" xlink:to="loc_us-gaap_ServiceOtherMember_f046dcb6-6be0-4861-884b-6158352eb6e0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_bb98c24c-55c8-4773-9b6e-1fd41772a643" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_9cedc1e8-eb8b-4c3c-bfbc-99a0a58da296" xlink:to="loc_srt_StatementScenarioAxis_bb98c24c-55c8-4773-9b6e-1fd41772a643" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_bb98c24c-55c8-4773-9b6e-1fd41772a643_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_bb98c24c-55c8-4773-9b6e-1fd41772a643" xlink:to="loc_srt_ScenarioUnspecifiedDomain_bb98c24c-55c8-4773-9b6e-1fd41772a643_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_86c45af7-4f96-4c5e-8696-cf3758169950" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_bb98c24c-55c8-4773-9b6e-1fd41772a643" xlink:to="loc_srt_ScenarioUnspecifiedDomain_86c45af7-4f96-4c5e-8696-cf3758169950" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOMEUnaudited" xlink:type="simple" xlink:href="a-20220131.xsd#CONDENSEDCONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOMEUnaudited"/>
  <link:definitionLink xlink:role="http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOMEUnaudited" xlink:type="extended" id="i09a50d1307c24cb2bf3820af29723725_CONDENSEDCONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOMEUnaudited">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_4bbde4ba-8ee0-49a1-9fb9-6018b7a019be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_3bebd609-9d38-4052-b488-9d30da030355" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_4bbde4ba-8ee0-49a1-9fb9-6018b7a019be" xlink:to="loc_us-gaap_NetIncomeLoss_3bebd609-9d38-4052-b488-9d30da030355" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_a747e38a-a1d8-405c-badd-079c73778844" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_4bbde4ba-8ee0-49a1-9fb9-6018b7a019be" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_a747e38a-a1d8-405c-badd-079c73778844" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_cc6b2138-6d4d-4d24-8187-5cd4d76825aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_a747e38a-a1d8-405c-badd-079c73778844" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_cc6b2138-6d4d-4d24-8187-5cd4d76825aa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_b50258b2-acc2-44ec-8b2a-e539738fb081" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_a747e38a-a1d8-405c-badd-079c73778844" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_b50258b2-acc2-44ec-8b2a-e539738fb081" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_799de47d-3393-40f5-bf02-9267bcec5465" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_a747e38a-a1d8-405c-badd-079c73778844" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_799de47d-3393-40f5-bf02-9267bcec5465" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract_0ebff38d-b507-49e8-9528-7961e3fab8ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_a747e38a-a1d8-405c-badd-079c73778844" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract_0ebff38d-b507-49e8-9528-7961e3fab8ff" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_74642272-8fd2-4c79-b51c-887ece339632" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract_0ebff38d-b507-49e8-9528-7961e3fab8ff" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_74642272-8fd2-4c79-b51c-887ece339632" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_42648f95-e6cb-4139-ba5d-feb3b92277e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_a747e38a-a1d8-405c-badd-079c73778844" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_42648f95-e6cb-4139-ba5d-feb3b92277e0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_ab367f8b-911b-4ccc-b0e9-37fab0b6a8a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_4bbde4ba-8ee0-49a1-9fb9-6018b7a019be" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_ab367f8b-911b-4ccc-b0e9-37fab0b6a8a2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_004dc904-4b2c-452d-9432-682064637979" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_4bbde4ba-8ee0-49a1-9fb9-6018b7a019be" xlink:to="loc_us-gaap_StatementTable_004dc904-4b2c-452d-9432-682064637979" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_7b4926ee-dbbd-4df6-84a6-2b577d41061e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_004dc904-4b2c-452d-9432-682064637979" xlink:to="loc_srt_StatementScenarioAxis_7b4926ee-dbbd-4df6-84a6-2b577d41061e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_7b4926ee-dbbd-4df6-84a6-2b577d41061e_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_7b4926ee-dbbd-4df6-84a6-2b577d41061e" xlink:to="loc_srt_ScenarioUnspecifiedDomain_7b4926ee-dbbd-4df6-84a6-2b577d41061e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_61215f8e-ecd3-46fb-bc73-83e4768553f4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_7b4926ee-dbbd-4df6-84a6-2b577d41061e" xlink:to="loc_srt_ScenarioUnspecifiedDomain_61215f8e-ecd3-46fb-bc73-83e4768553f4" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOMELOSSUnauditedParenthetical" xlink:type="simple" xlink:href="a-20220131.xsd#CONDENSEDCONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOMELOSSUnauditedParenthetical"/>
  <link:definitionLink xlink:role="http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOMELOSSUnauditedParenthetical" xlink:type="extended" id="i8925f60fb18c41a9867bbab9074aaa2f_CONDENSEDCONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOMELOSSUnauditedParenthetical">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_f64d437c-b537-4659-884e-353db743575f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTaxParentheticalDisclosuresAbstract_00c4862d-adae-4190-8faa-84b20f960196" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossTaxParentheticalDisclosuresAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f64d437c-b537-4659-884e-353db743575f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossTaxParentheticalDisclosuresAbstract_00c4862d-adae-4190-8faa-84b20f960196" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_898d1b0e-129d-4b15-a9c0-1f09fde50b4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTaxParentheticalDisclosuresAbstract_00c4862d-adae-4190-8faa-84b20f960196" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_898d1b0e-129d-4b15-a9c0-1f09fde50b4b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_0258559a-5fef-45d0-b1b2-a40aa6bf1796" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTaxParentheticalDisclosuresAbstract_00c4862d-adae-4190-8faa-84b20f960196" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_0258559a-5fef-45d0-b1b2-a40aa6bf1796" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_d0254e1b-c77d-4f76-8a64-2fbbd6c22159" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTaxParentheticalDisclosuresAbstract_00c4862d-adae-4190-8faa-84b20f960196" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_d0254e1b-c77d-4f76-8a64-2fbbd6c22159" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansTaxAbstract_2e78f946-5f54-4fac-af7f-2f08e518821b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansTaxAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTaxParentheticalDisclosuresAbstract_00c4862d-adae-4190-8faa-84b20f960196" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansTaxAbstract_2e78f946-5f54-4fac-af7f-2f08e518821b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax_21522ef6-74db-4ced-8569-e710a717b993" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansTaxAbstract_2e78f946-5f54-4fac-af7f-2f08e518821b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax_21522ef6-74db-4ced-8569-e710a717b993" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax_942045d4-efb3-474b-b781-3a041deb6bcd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansTaxAbstract_2e78f946-5f54-4fac-af7f-2f08e518821b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax_942045d4-efb3-474b-b781-3a041deb6bcd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_c13bc22f-9f30-4d74-945d-e5485ac029d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_f64d437c-b537-4659-884e-353db743575f" xlink:to="loc_us-gaap_StatementTable_c13bc22f-9f30-4d74-945d-e5485ac029d4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_295f6e22-436d-4c32-bb71-da4aac858182" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_c13bc22f-9f30-4d74-945d-e5485ac029d4" xlink:to="loc_srt_StatementScenarioAxis_295f6e22-436d-4c32-bb71-da4aac858182" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_295f6e22-436d-4c32-bb71-da4aac858182_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_295f6e22-436d-4c32-bb71-da4aac858182" xlink:to="loc_srt_ScenarioUnspecifiedDomain_295f6e22-436d-4c32-bb71-da4aac858182_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_238a4823-bcc8-483e-9823-195186ba2673" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_295f6e22-436d-4c32-bb71-da4aac858182" xlink:to="loc_srt_ScenarioUnspecifiedDomain_238a4823-bcc8-483e-9823-195186ba2673" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited" xlink:type="simple" xlink:href="a-20220131.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited"/>
  <link:definitionLink xlink:role="http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited" xlink:type="extended" id="ibb054fe39e3c47bcb0b5b877d872b94d_CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_e2994a49-9ac3-4820-a4c6-b6deaea69909" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_0f36deb9-4f87-441b-9efc-50fb73a2ec92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e2994a49-9ac3-4820-a4c6-b6deaea69909" xlink:to="loc_us-gaap_AssetsAbstract_0f36deb9-4f87-441b-9efc-50fb73a2ec92" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_7291e9f2-046e-434c-9b32-18d130acdbb8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_0f36deb9-4f87-441b-9efc-50fb73a2ec92" xlink:to="loc_us-gaap_AssetsCurrentAbstract_7291e9f2-046e-434c-9b32-18d130acdbb8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_ca2c8a62-9409-470c-929c-47633bc15b01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_7291e9f2-046e-434c-9b32-18d130acdbb8" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_ca2c8a62-9409-470c-929c-47633bc15b01" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_6667946e-11b8-4442-9247-c665f63a0f10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_7291e9f2-046e-434c-9b32-18d130acdbb8" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_6667946e-11b8-4442-9247-c665f63a0f10" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_c7c27ab2-480a-4301-b168-6bb3a9e4aada" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_7291e9f2-046e-434c-9b32-18d130acdbb8" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_c7c27ab2-480a-4301-b168-6bb3a9e4aada" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_52870b8b-ad0f-4b51-97a7-222d85aea872" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_7291e9f2-046e-434c-9b32-18d130acdbb8" xlink:to="loc_us-gaap_InventoryNet_52870b8b-ad0f-4b51-97a7-222d85aea872" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_428f558e-1dc3-48ed-b92f-79472a8e3f89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_7291e9f2-046e-434c-9b32-18d130acdbb8" xlink:to="loc_us-gaap_OtherAssetsCurrent_428f558e-1dc3-48ed-b92f-79472a8e3f89" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_115577d3-be28-4b5b-8c7b-563211abbf12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_7291e9f2-046e-434c-9b32-18d130acdbb8" xlink:to="loc_us-gaap_AssetsCurrent_115577d3-be28-4b5b-8c7b-563211abbf12" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_6eb17bf6-be39-407a-b074-04f8cb6f2d5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_0f36deb9-4f87-441b-9efc-50fb73a2ec92" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_6eb17bf6-be39-407a-b074-04f8cb6f2d5d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_f5a09286-c944-4347-8eb2-eb9f606a3e81" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_0f36deb9-4f87-441b-9efc-50fb73a2ec92" xlink:to="loc_us-gaap_Goodwill_f5a09286-c944-4347-8eb2-eb9f606a3e81" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_c6fda761-6980-4165-a4f3-7d6afefa0791" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_0f36deb9-4f87-441b-9efc-50fb73a2ec92" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_c6fda761-6980-4165-a4f3-7d6afefa0791" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestments_2c894e43-4959-4ab1-bb02-d5f4512691e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_0f36deb9-4f87-441b-9efc-50fb73a2ec92" xlink:to="loc_us-gaap_LongTermInvestments_2c894e43-4959-4ab1-bb02-d5f4512691e1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_65bf2a09-9231-4ebd-9d4b-4be1b1929ec0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_0f36deb9-4f87-441b-9efc-50fb73a2ec92" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_65bf2a09-9231-4ebd-9d4b-4be1b1929ec0" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_16fe8a1f-629f-42f4-a798-5893295ed1f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_0f36deb9-4f87-441b-9efc-50fb73a2ec92" xlink:to="loc_us-gaap_Assets_16fe8a1f-629f-42f4-a798-5893295ed1f6" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_ffae9b6c-a54b-47c3-b4d3-6e8435780e11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e2994a49-9ac3-4820-a4c6-b6deaea69909" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_ffae9b6c-a54b-47c3-b4d3-6e8435780e11" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_7dc437b1-1e29-499e-a526-1c02176003a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_ffae9b6c-a54b-47c3-b4d3-6e8435780e11" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_7dc437b1-1e29-499e-a526-1c02176003a6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_6cd0986b-3b49-456d-a225-1deb2c61ca6b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_7dc437b1-1e29-499e-a526-1c02176003a6" xlink:to="loc_us-gaap_AccountsPayableCurrent_6cd0986b-3b49-456d-a225-1deb2c61ca6b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_f38e965b-8dd3-4c05-8542-b36ab9305112" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_7dc437b1-1e29-499e-a526-1c02176003a6" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_f38e965b-8dd3-4c05-8542-b36ab9305112" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueCurrent_72aea0c2-4c18-402c-89a9-9e8774671467" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredRevenueCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_7dc437b1-1e29-499e-a526-1c02176003a6" xlink:to="loc_us-gaap_DeferredRevenueCurrent_72aea0c2-4c18-402c-89a9-9e8774671467" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent_34d4633e-4dec-4fee-8026-5d54c08a4ffc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_7dc437b1-1e29-499e-a526-1c02176003a6" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent_34d4633e-4dec-4fee-8026-5d54c08a4ffc" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_e05dba75-bf15-4036-9d71-3121ef91ce7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_7dc437b1-1e29-499e-a526-1c02176003a6" xlink:to="loc_us-gaap_LiabilitiesCurrent_e05dba75-bf15-4036-9d71-3121ef91ce7c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_20d282c9-7212-460d-9ece-0dfae4a2c8d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_ffae9b6c-a54b-47c3-b4d3-6e8435780e11" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_20d282c9-7212-460d-9ece-0dfae4a2c8d1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_e4da3c7d-4cc8-4bc3-b9ff-5896b7c080f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_ffae9b6c-a54b-47c3-b4d3-6e8435780e11" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_e4da3c7d-4cc8-4bc3-b9ff-5896b7c080f0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_854f4d09-7cf3-44ed-bc0a-bb6c6f4a4c8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_ffae9b6c-a54b-47c3-b4d3-6e8435780e11" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_854f4d09-7cf3-44ed-bc0a-bb6c6f4a4c8a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_69467984-f991-495f-860e-4759dc70340b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_ffae9b6c-a54b-47c3-b4d3-6e8435780e11" xlink:to="loc_us-gaap_Liabilities_69467984-f991-495f-860e-4759dc70340b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_77ee76ef-0671-4e63-a831-599d67091cf1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_ffae9b6c-a54b-47c3-b4d3-6e8435780e11" xlink:to="loc_us-gaap_CommitmentsAndContingencies_77ee76ef-0671-4e63-a831-599d67091cf1" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_6c7b17e3-40e1-4300-a51f-0f6e365b8e39" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_ffae9b6c-a54b-47c3-b4d3-6e8435780e11" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_6c7b17e3-40e1-4300-a51f-0f6e365b8e39" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_3a2765af-6984-4648-a15b-07009544f4d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_6c7b17e3-40e1-4300-a51f-0f6e365b8e39" xlink:to="loc_us-gaap_StockholdersEquityAbstract_3a2765af-6984-4648-a15b-07009544f4d1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_a702605e-8e96-4c31-97b8-e86c7b2a4814" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_3a2765af-6984-4648-a15b-07009544f4d1" xlink:to="loc_us-gaap_PreferredStockValue_a702605e-8e96-4c31-97b8-e86c7b2a4814" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_8893b904-ce7f-4e7a-b0b7-fc7ea4e33f24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_3a2765af-6984-4648-a15b-07009544f4d1" xlink:to="loc_us-gaap_CommonStockValue_8893b904-ce7f-4e7a-b0b7-fc7ea4e33f24" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_86695a4a-f947-42e4-a4c0-67ceb1b870db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_3a2765af-6984-4648-a15b-07009544f4d1" xlink:to="loc_us-gaap_AdditionalPaidInCapital_86695a4a-f947-42e4-a4c0-67ceb1b870db" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_025ccf0f-af81-4501-8647-4fcfeed73e08" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_3a2765af-6984-4648-a15b-07009544f4d1" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_025ccf0f-af81-4501-8647-4fcfeed73e08" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_29ee8cf5-d463-4c15-8026-edb9fb94bdae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_3a2765af-6984-4648-a15b-07009544f4d1" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_29ee8cf5-d463-4c15-8026-edb9fb94bdae" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_451f7c55-e40a-4959-aaa1-1e3f8ce5b0d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_3a2765af-6984-4648-a15b-07009544f4d1" xlink:to="loc_us-gaap_StockholdersEquity_451f7c55-e40a-4959-aaa1-1e3f8ce5b0d5" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_2c295f85-e220-4580-8d89-7aa7de8485dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_ffae9b6c-a54b-47c3-b4d3-6e8435780e11" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_2c295f85-e220-4580-8d89-7aa7de8485dd" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_30bd3115-1e1b-459b-a157-ee47df589532" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_e2994a49-9ac3-4820-a4c6-b6deaea69909" xlink:to="loc_us-gaap_StatementTable_30bd3115-1e1b-459b-a157-ee47df589532" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_1a6af245-e71b-4511-b19c-a384d47f43c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_30bd3115-1e1b-459b-a157-ee47df589532" xlink:to="loc_us-gaap_StatementClassOfStockAxis_1a6af245-e71b-4511-b19c-a384d47f43c2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_1a6af245-e71b-4511-b19c-a384d47f43c2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1a6af245-e71b-4511-b19c-a384d47f43c2" xlink:to="loc_us-gaap_ClassOfStockDomain_1a6af245-e71b-4511-b19c-a384d47f43c2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_991e4e67-6162-4f73-aae2-1a6e6a8cf4ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1a6af245-e71b-4511-b19c-a384d47f43c2" xlink:to="loc_us-gaap_ClassOfStockDomain_991e4e67-6162-4f73-aae2-1a6e6a8cf4ea" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited" xlink:type="simple" xlink:href="a-20220131.xsd#CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited"/>
  <link:definitionLink xlink:role="http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited" xlink:type="extended" id="ie00d34836db7435a9354c3a3fb8379fc_CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_4a1bf905-f8d1-4261-a3f6-9eb0133adddc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_9979f334-f745-4530-a031-fc1d0478379b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_4a1bf905-f8d1-4261-a3f6-9eb0133adddc" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_9979f334-f745-4530-a031-fc1d0478379b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_a0560543-5ed2-42ed-b3e5-10f2f286e41a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_9979f334-f745-4530-a031-fc1d0478379b" xlink:to="loc_us-gaap_NetIncomeLoss_a0560543-5ed2-42ed-b3e5-10f2f286e41a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_624fe49c-8c0f-483d-8bdf-6f5f9aaa0174" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_9979f334-f745-4530-a031-fc1d0478379b" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_624fe49c-8c0f-483d-8bdf-6f5f9aaa0174" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_f6532256-e659-4804-ac26-d870ee4e3efb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_624fe49c-8c0f-483d-8bdf-6f5f9aaa0174" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_f6532256-e659-4804-ac26-d870ee4e3efb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_c32e03eb-0e12-46ec-ac74-3280416b34b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_624fe49c-8c0f-483d-8bdf-6f5f9aaa0174" xlink:to="loc_us-gaap_ShareBasedCompensation_c32e03eb-0e12-46ec-ac74-3280416b34b6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_c78867da-2655-4e89-bfa6-d55443b6ef83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_624fe49c-8c0f-483d-8bdf-6f5f9aaa0174" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_c78867da-2655-4e89-bfa6-d55443b6ef83" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWriteDown_b6a0cdee-3bb3-4f28-8a18-dcb72efe9074" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWriteDown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_624fe49c-8c0f-483d-8bdf-6f5f9aaa0174" xlink:to="loc_us-gaap_InventoryWriteDown_b6a0cdee-3bb3-4f28-8a18-dcb72efe9074" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_6baebe08-d39b-4b64-9300-643c9496b6da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_624fe49c-8c0f-483d-8bdf-6f5f9aaa0174" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_6baebe08-d39b-4b64-9300-643c9496b6da" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_21fb4cd5-3c21-4c30-a140-ba05df678198" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_624fe49c-8c0f-483d-8bdf-6f5f9aaa0174" xlink:to="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_21fb4cd5-3c21-4c30-a140-ba05df678198" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_c63998d7-507e-486f-9769-06e7fa31f2d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_624fe49c-8c0f-483d-8bdf-6f5f9aaa0174" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_c63998d7-507e-486f-9769-06e7fa31f2d7" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_df6260d4-5c8b-4e17-9098-d2384160de77" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_624fe49c-8c0f-483d-8bdf-6f5f9aaa0174" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_df6260d4-5c8b-4e17-9098-d2384160de77" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_ac262cf5-ddfe-4686-9b02-0d16b9864427" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_9979f334-f745-4530-a031-fc1d0478379b" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_ac262cf5-ddfe-4686-9b02-0d16b9864427" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_15423885-4bca-4106-98e1-370dc6a4b1be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_ac262cf5-ddfe-4686-9b02-0d16b9864427" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_15423885-4bca-4106-98e1-370dc6a4b1be" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_8c35b552-21d0-44a3-93b3-495c5c091db7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_ac262cf5-ddfe-4686-9b02-0d16b9864427" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_8c35b552-21d0-44a3-93b3-495c5c091db7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_c3e24149-3a9e-44ce-b92e-7d26e104d3cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_ac262cf5-ddfe-4686-9b02-0d16b9864427" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_c3e24149-3a9e-44ce-b92e-7d26e104d3cd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_60f3ac2a-adb3-434e-bbbc-e6439b7750a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_ac262cf5-ddfe-4686-9b02-0d16b9864427" xlink:to="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_60f3ac2a-adb3-434e-bbbc-e6439b7750a2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_6f1552db-53ae-4d3c-8a71-2da8f0648bb0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_ac262cf5-ddfe-4686-9b02-0d16b9864427" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_6f1552db-53ae-4d3c-8a71-2da8f0648bb0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_cd816a34-133f-48dc-bc30-25f5640475d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_9979f334-f745-4530-a031-fc1d0478379b" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_cd816a34-133f-48dc-bc30-25f5640475d6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_6b3a0da1-62b4-4ed9-ba68-aef375317f95" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_4a1bf905-f8d1-4261-a3f6-9eb0133adddc" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_6b3a0da1-62b4-4ed9-ba68-aef375317f95" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_1b2a186a-2e0d-44d6-bd19-d47074fc35a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_6b3a0da1-62b4-4ed9-ba68-aef375317f95" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_1b2a186a-2e0d-44d6-bd19-d47074fc35a5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquitySecuritiesFvNi_83618df8-4311-4564-9e5c-d5b1b7e36442" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireEquitySecuritiesFvNi"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_6b3a0da1-62b4-4ed9-ba68-aef375317f95" xlink:to="loc_us-gaap_PaymentsToAcquireEquitySecuritiesFvNi_83618df8-4311-4564-9e5c-d5b1b7e36442" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireNotesReceivable_bf16a90a-e915-4908-a2df-6f3342975727" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireNotesReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_6b3a0da1-62b4-4ed9-ba68-aef375317f95" xlink:to="loc_us-gaap_PaymentsToAcquireNotesReceivable_bf16a90a-e915-4908-a2df-6f3342975727" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_ed7e8ea3-7e1e-40a1-ac13-602c45cc3928" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_4a1bf905-f8d1-4261-a3f6-9eb0133adddc" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_ed7e8ea3-7e1e-40a1-ac13-602c45cc3928" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_56a41e93-d692-4d59-a338-1e5d6aab1464" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_4a1bf905-f8d1-4261-a3f6-9eb0133adddc" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_56a41e93-d692-4d59-a338-1e5d6aab1464" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_e05cc372-c26e-4c3a-b97c-a2c39b125b0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_56a41e93-d692-4d59-a338-1e5d6aab1464" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_e05cc372-c26e-4c3a-b97c-a2c39b125b0b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_53aa6ffa-55fb-4428-aef7-ef92ef29d09a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_56a41e93-d692-4d59-a338-1e5d6aab1464" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_53aa6ffa-55fb-4428-aef7-ef92ef29d09a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfOrdinaryDividends_e295d465-5c27-4ff5-b113-ab9446e92f3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfOrdinaryDividends"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_56a41e93-d692-4d59-a338-1e5d6aab1464" xlink:to="loc_us-gaap_PaymentsOfOrdinaryDividends_e295d465-5c27-4ff5-b113-ab9446e92f3b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarlyRepaymentOfSeniorDebt_c0d80029-6ddd-4ff4-b488-f71f4683c9b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarlyRepaymentOfSeniorDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_56a41e93-d692-4d59-a338-1e5d6aab1464" xlink:to="loc_us-gaap_EarlyRepaymentOfSeniorDebt_c0d80029-6ddd-4ff4-b488-f71f4683c9b9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommercialPaper_17e73c1f-0565-43e3-b048-e3728e3cbff7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommercialPaper"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_56a41e93-d692-4d59-a338-1e5d6aab1464" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommercialPaper_17e73c1f-0565-43e3-b048-e3728e3cbff7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfCommercialPaper_19bb1c30-778d-4fae-9ef2-37c05b1b37f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfCommercialPaper"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_56a41e93-d692-4d59-a338-1e5d6aab1464" xlink:to="loc_us-gaap_RepaymentsOfCommercialPaper_19bb1c30-778d-4fae-9ef2-37c05b1b37f7" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_68df5c95-34e8-4dfa-8cbc-3d123c1fd18b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_56a41e93-d692-4d59-a338-1e5d6aab1464" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_68df5c95-34e8-4dfa-8cbc-3d123c1fd18b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c900fc7d-f06c-4bf7-a78f-02b44d3697bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_56a41e93-d692-4d59-a338-1e5d6aab1464" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c900fc7d-f06c-4bf7-a78f-02b44d3697bc" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_845f2671-f35a-45e5-b165-e3dbe8e30f87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_56a41e93-d692-4d59-a338-1e5d6aab1464" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_845f2671-f35a-45e5-b165-e3dbe8e30f87" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_28b7c93c-eb1b-4345-9209-e58099a15e25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_4a1bf905-f8d1-4261-a3f6-9eb0133adddc" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_28b7c93c-eb1b-4345-9209-e58099a15e25" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0360327a-93db-4760-8c0e-0f8a19b77ac2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_4a1bf905-f8d1-4261-a3f6-9eb0133adddc" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0360327a-93db-4760-8c0e-0f8a19b77ac2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f69722f1-2af6-4f54-b9ad-f146aa009ff9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_b0a066db-8153-4c5c-9228-7991fdf4f021" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_4a1bf905-f8d1-4261-a3f6-9eb0133adddc" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_b0a066db-8153-4c5c-9228-7991fdf4f021" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_082ee17b-0301-4d8a-a57b-25520fab05db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_b0a066db-8153-4c5c-9228-7991fdf4f021" xlink:to="loc_us-gaap_IncomeTaxesPaidNet_082ee17b-0301-4d8a-a57b-25520fab05db" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_90339a31-53d0-4937-923e-f5bd9f25b3d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_b0a066db-8153-4c5c-9228-7991fdf4f021" xlink:to="loc_us-gaap_InterestPaidNet_90339a31-53d0-4937-923e-f5bd9f25b3d0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_adefd021-ce6e-40ab-9435-d3f182a1cd1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_b0a066db-8153-4c5c-9228-7991fdf4f021" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_adefd021-ce6e-40ab-9435-d3f182a1cd1a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_9c77f225-449e-432e-bc67-25e9b382faf9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_4a1bf905-f8d1-4261-a3f6-9eb0133adddc" xlink:to="loc_us-gaap_StatementTable_9c77f225-449e-432e-bc67-25e9b382faf9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_c171ad26-c12c-4ff1-8c5c-30ec9c3864b0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_9c77f225-449e-432e-bc67-25e9b382faf9" xlink:to="loc_srt_StatementScenarioAxis_c171ad26-c12c-4ff1-8c5c-30ec9c3864b0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_c171ad26-c12c-4ff1-8c5c-30ec9c3864b0_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_c171ad26-c12c-4ff1-8c5c-30ec9c3864b0" xlink:to="loc_srt_ScenarioUnspecifiedDomain_c171ad26-c12c-4ff1-8c5c-30ec9c3864b0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_dfb2b68d-f11a-4491-a74b-4dabbdb0b9db" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_c171ad26-c12c-4ff1-8c5c-30ec9c3864b0" xlink:to="loc_srt_ScenarioUnspecifiedDomain_dfb2b68d-f11a-4491-a74b-4dabbdb0b9db" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_7a8439bf-b07e-4f15-9ce2-a3c5c96e3e4f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_9c77f225-449e-432e-bc67-25e9b382faf9" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_7a8439bf-b07e-4f15-9ce2-a3c5c96e3e4f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_7a8439bf-b07e-4f15-9ce2-a3c5c96e3e4f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_7a8439bf-b07e-4f15-9ce2-a3c5c96e3e4f" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_7a8439bf-b07e-4f15-9ce2-a3c5c96e3e4f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_e7529213-fe0b-45c1-a420-266bf161382b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_7a8439bf-b07e-4f15-9ce2-a3c5c96e3e4f" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_e7529213-fe0b-45c1-a420-266bf161382b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentMember_22abe160-6f56-41c5-92c3-039adb4f6475" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_e7529213-fe0b-45c1-a420-266bf161382b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentMember_22abe160-6f56-41c5-92c3-039adb4f6475" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFEQUITY" xlink:type="simple" xlink:href="a-20220131.xsd#CONDENSEDCONSOLIDATEDSTATEMENTOFEQUITY"/>
  <link:definitionLink xlink:role="http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFEQUITY" xlink:type="extended" id="i68d42cf4ef4141dfbc2a210668219503_CONDENSEDCONSOLIDATEDSTATEMENTOFEQUITY">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_c905ff23-dffb-4abf-a655-fba4646152a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_0d56735d-ecc2-463f-9458-6d14972a449c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_c905ff23-dffb-4abf-a655-fba4646152a8" xlink:to="loc_us-gaap_SharesIssued_0d56735d-ecc2-463f-9458-6d14972a449c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_c4980711-4f6c-4ea6-a264-6c97cf1d657a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_c905ff23-dffb-4abf-a655-fba4646152a8" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_c4980711-4f6c-4ea6-a264-6c97cf1d657a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_5d88f55b-9687-4f47-b6ea-743cc902139b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_c905ff23-dffb-4abf-a655-fba4646152a8" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_5d88f55b-9687-4f47-b6ea-743cc902139b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_f4b79abb-48b7-43b9-bd2b-1ec9c691e8f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_5d88f55b-9687-4f47-b6ea-743cc902139b" xlink:to="loc_us-gaap_NetIncomeLoss_f4b79abb-48b7-43b9-bd2b-1ec9c691e8f4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_883c63b1-3e40-4f74-99ba-a610a244066e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_5d88f55b-9687-4f47-b6ea-743cc902139b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_883c63b1-3e40-4f74-99ba-a610a244066e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_4f64aee1-6493-4b00-beae-8ee965bbc29c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_5d88f55b-9687-4f47-b6ea-743cc902139b" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_4f64aee1-6493-4b00-beae-8ee965bbc29c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestPeriodIncreaseDecrease_6003f895-6b73-44b1-b714-5138bc6bb132" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestPeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_c905ff23-dffb-4abf-a655-fba4646152a8" xlink:to="loc_us-gaap_MinorityInterestPeriodIncreaseDecrease_6003f895-6b73-44b1-b714-5138bc6bb132" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_ef94ef99-35d8-49f9-8053-dfcf491203c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_c905ff23-dffb-4abf-a655-fba4646152a8" xlink:to="loc_us-gaap_DividendsCommonStockCash_ef94ef99-35d8-49f9-8053-dfcf491203c5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_0cd23b87-92d9-4ed2-9d6a-6515c4bae5c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_c905ff23-dffb-4abf-a655-fba4646152a8" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_0cd23b87-92d9-4ed2-9d6a-6515c4bae5c0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_b60aea33-4906-48d5-b5c6-f92cae753da8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_c905ff23-dffb-4abf-a655-fba4646152a8" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_b60aea33-4906-48d5-b5c6-f92cae753da8" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_f88228e0-5c75-4a42-b7e1-656115bf2c66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_c905ff23-dffb-4abf-a655-fba4646152a8" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_f88228e0-5c75-4a42-b7e1-656115bf2c66" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_19ff0a47-3dea-4e95-b277-0de800433db7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_c905ff23-dffb-4abf-a655-fba4646152a8" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_19ff0a47-3dea-4e95-b277-0de800433db7" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_5e05b51f-4627-4407-9304-3cf7778e6dc9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_c905ff23-dffb-4abf-a655-fba4646152a8" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_5e05b51f-4627-4407-9304-3cf7778e6dc9" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_28e2a86b-261c-408b-bd5b-c3e992f61cfa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssued"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_ec697854-9b9c-4811-84ef-3b1533138898" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_67eff9fe-6229-4224-8596-977603328b9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_c905ff23-dffb-4abf-a655-fba4646152a8" xlink:to="loc_us-gaap_StatementTable_67eff9fe-6229-4224-8596-977603328b9c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis_dd5e2bd4-20d5-4451-a399-55e23737fd60" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_67eff9fe-6229-4224-8596-977603328b9c" xlink:to="loc_srt_RestatementAxis_dd5e2bd4-20d5-4451-a399-55e23737fd60" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_dd5e2bd4-20d5-4451-a399-55e23737fd60_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RestatementAxis_dd5e2bd4-20d5-4451-a399-55e23737fd60" xlink:to="loc_srt_RestatementDomain_dd5e2bd4-20d5-4451-a399-55e23737fd60_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_5087f2b6-770d-4f64-b161-2fb07c0356a2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RestatementAxis_dd5e2bd4-20d5-4451-a399-55e23737fd60" xlink:to="loc_srt_RestatementDomain_5087f2b6-770d-4f64-b161-2fb07c0356a2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember_43b385ab-e479-42a9-b8f0-7abbdf958090" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RestatementDomain_5087f2b6-770d-4f64-b161-2fb07c0356a2" xlink:to="loc_srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember_43b385ab-e479-42a9-b8f0-7abbdf958090" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_a46b3fd9-330d-458e-9cbd-62676fcbc0cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_67eff9fe-6229-4224-8596-977603328b9c" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_a46b3fd9-330d-458e-9cbd-62676fcbc0cc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_a46b3fd9-330d-458e-9cbd-62676fcbc0cc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_a46b3fd9-330d-458e-9cbd-62676fcbc0cc" xlink:to="loc_us-gaap_EquityComponentDomain_a46b3fd9-330d-458e-9cbd-62676fcbc0cc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_51f0f64d-02fb-486f-8bca-51bcf1f1f414" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_a46b3fd9-330d-458e-9cbd-62676fcbc0cc" xlink:to="loc_us-gaap_EquityComponentDomain_51f0f64d-02fb-486f-8bca-51bcf1f1f414" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_6d402680-b55a-44ce-8bea-26a8db7b4e96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_51f0f64d-02fb-486f-8bca-51bcf1f1f414" xlink:to="loc_us-gaap_CommonStockMember_6d402680-b55a-44ce-8bea-26a8db7b4e96" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_e5085aaa-81ab-4538-a219-e2446a208a39" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_51f0f64d-02fb-486f-8bca-51bcf1f1f414" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_e5085aaa-81ab-4538-a219-e2446a208a39" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_c8a89543-2c75-4bf9-9a2c-0b0ae612e20a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_51f0f64d-02fb-486f-8bca-51bcf1f1f414" xlink:to="loc_us-gaap_TreasuryStockMember_c8a89543-2c75-4bf9-9a2c-0b0ae612e20a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_f16ceaad-3917-4677-a3c3-9c01e605378c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_51f0f64d-02fb-486f-8bca-51bcf1f1f414" xlink:to="loc_us-gaap_RetainedEarningsMember_f16ceaad-3917-4677-a3c3-9c01e605378c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_9050192a-43f8-45e0-a242-49dca15e7256" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_51f0f64d-02fb-486f-8bca-51bcf1f1f414" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_9050192a-43f8-45e0-a242-49dca15e7256" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember_6523ffc3-c5bb-43ad-87ff-c160b4b8d0d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_51f0f64d-02fb-486f-8bca-51bcf1f1f414" xlink:to="loc_us-gaap_ParentMember_6523ffc3-c5bb-43ad-87ff-c160b4b8d0d4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_5a0d046f-f792-4eed-901f-1a92365f4373" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_51f0f64d-02fb-486f-8bca-51bcf1f1f414" xlink:to="loc_us-gaap_NoncontrollingInterestMember_5a0d046f-f792-4eed-901f-1a92365f4373" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_daa7397e-6d04-4c10-9768-651d85727d5f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_67eff9fe-6229-4224-8596-977603328b9c" xlink:to="loc_us-gaap_StatementClassOfStockAxis_daa7397e-6d04-4c10-9768-651d85727d5f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_daa7397e-6d04-4c10-9768-651d85727d5f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_daa7397e-6d04-4c10-9768-651d85727d5f" xlink:to="loc_us-gaap_ClassOfStockDomain_daa7397e-6d04-4c10-9768-651d85727d5f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_a15c9ebc-b51c-48bc-8dee-8bee00ea48e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_daa7397e-6d04-4c10-9768-651d85727d5f" xlink:to="loc_us-gaap_ClassOfStockDomain_a15c9ebc-b51c-48bc-8dee-8bee00ea48e7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_664ac78e-e417-44f0-9a9d-bd7090ec8060" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_67eff9fe-6229-4224-8596-977603328b9c" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_664ac78e-e417-44f0-9a9d-bd7090ec8060" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_664ac78e-e417-44f0-9a9d-bd7090ec8060_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_664ac78e-e417-44f0-9a9d-bd7090ec8060" xlink:to="loc_us-gaap_TypeOfAdoptionMember_664ac78e-e417-44f0-9a9d-bd7090ec8060_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_2818902e-a148-4e1a-8319-e5e51daddbd1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_664ac78e-e417-44f0-9a9d-bd7090ec8060" xlink:to="loc_us-gaap_TypeOfAdoptionMember_2818902e-a148-4e1a-8319-e5e51daddbd1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForChangeInAccountingPrincipleAxis_c34d8a2c-6e97-499d-a0a8-327dab4f8fc8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForChangeInAccountingPrincipleAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_67eff9fe-6229-4224-8596-977603328b9c" xlink:to="loc_us-gaap_AdjustmentsForChangeInAccountingPrincipleAxis_c34d8a2c-6e97-499d-a0a8-327dab4f8fc8" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInAccountingPrincipleMember_c34d8a2c-6e97-499d-a0a8-327dab4f8fc8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ChangeInAccountingPrincipleMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AdjustmentsForChangeInAccountingPrincipleAxis_c34d8a2c-6e97-499d-a0a8-327dab4f8fc8" xlink:to="loc_us-gaap_ChangeInAccountingPrincipleMember_c34d8a2c-6e97-499d-a0a8-327dab4f8fc8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInAccountingPrincipleMember_73454ef7-bc3b-44eb-8c37-23e26b6d7e98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ChangeInAccountingPrincipleMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AdjustmentsForChangeInAccountingPrincipleAxis_c34d8a2c-6e97-499d-a0a8-327dab4f8fc8" xlink:to="loc_us-gaap_ChangeInAccountingPrincipleMember_73454ef7-bc3b-44eb-8c37-23e26b6d7e98" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis_e83513cf-d32f-44fc-899f-0f1a6401aab6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_67eff9fe-6229-4224-8596-977603328b9c" xlink:to="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis_e83513cf-d32f-44fc-899f-0f1a6401aab6" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForErrorCorrectionDomain_e83513cf-d32f-44fc-899f-0f1a6401aab6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForErrorCorrectionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis_e83513cf-d32f-44fc-899f-0f1a6401aab6" xlink:to="loc_us-gaap_AdjustmentsForErrorCorrectionDomain_e83513cf-d32f-44fc-899f-0f1a6401aab6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForErrorCorrectionDomain_5a9eff82-2a6c-491e-afda-a22c3e5e074c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForErrorCorrectionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis_e83513cf-d32f-44fc-899f-0f1a6401aab6" xlink:to="loc_us-gaap_AdjustmentsForErrorCorrectionDomain_5a9eff82-2a6c-491e-afda-a22c3e5e074c" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.agilent.com/role/OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails" xlink:type="simple" xlink:href="a-20220131.xsd#OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"/>
  <link:definitionLink xlink:role="http://www.agilent.com/role/OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails" xlink:type="extended" id="i3452f184c6a64ca4b2b36541fe676ce3_OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems_b609a94b-7280-4aa5-8664-d14d45ab9296" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_39315700-e9c4-4aee-b76c-5f16fa4a1e10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_b609a94b-7280-4aa5-8664-d14d45ab9296" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_39315700-e9c4-4aee-b76c-5f16fa4a1e10" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_947b97c0-0a11-4281-adc8-66736d0dddb8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_39315700-e9c4-4aee-b76c-5f16fa4a1e10" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_947b97c0-0a11-4281-adc8-66736d0dddb8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCash_581f3a8b-419f-4288-ad14-5f1eb9e791e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_39315700-e9c4-4aee-b76c-5f16fa4a1e10" xlink:to="loc_us-gaap_RestrictedCash_581f3a8b-419f-4288-ad14-5f1eb9e791e6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_ba101be3-04cb-4f11-8282-629fe2b47406" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_39315700-e9c4-4aee-b76c-5f16fa4a1e10" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_ba101be3-04cb-4f11-8282-629fe2b47406" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesOperatingAbstract_95e07d02-07a4-4276-8179-3b855afd7370" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesOperatingAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_b609a94b-7280-4aa5-8664-d14d45ab9296" xlink:to="loc_us-gaap_LeasesOperatingAbstract_95e07d02-07a4-4276-8179-3b855afd7370" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_2f30f993-a8fa-49f3-a226-6ed49f1798f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LeasesOperatingAbstract_95e07d02-07a4-4276-8179-3b855afd7370" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_2f30f993-a8fa-49f3-a226-6ed49f1798f6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_89076731-d804-4f5e-b672-13eaa85be657" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LeasesOperatingAbstract_95e07d02-07a4-4276-8179-3b855afd7370" xlink:to="loc_us-gaap_OperatingLeaseLiability_89076731-d804-4f5e-b672-13eaa85be657" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryDisclosuresAbstract_1d79a3c1-f2e9-4915-bcee-4d6f60f588fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityNotPrimaryBeneficiaryDisclosuresAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_b609a94b-7280-4aa5-8664-d14d45ab9296" xlink:to="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryDisclosuresAbstract_1d79a3c1-f2e9-4915-bcee-4d6f60f588fc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_97bf875c-0271-4ef9-8989-2493b36e282e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryDisclosuresAbstract_1d79a3c1-f2e9-4915-bcee-4d6f60f588fc" xlink:to="loc_us-gaap_Assets_97bf875c-0271-4ef9-8989-2493b36e282e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_993b2ee9-565a-4e2c-998e-8213ce46e0a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_b609a94b-7280-4aa5-8664-d14d45ab9296" xlink:to="loc_us-gaap_FairValueDisclosuresAbstract_993b2ee9-565a-4e2c-998e-8213ce46e0a6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_Fairvalueoflongtermdebtinexcessofcarryingvalue_9660a832-9124-48ec-9f6d-7a75e4bb0c98" xlink:href="a-20220131.xsd#a_Fairvalueoflongtermdebtinexcessofcarryingvalue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_993b2ee9-565a-4e2c-998e-8213ce46e0a6" xlink:to="loc_a_Fairvalueoflongtermdebtinexcessofcarryingvalue_9660a832-9124-48ec-9f6d-7a75e4bb0c98" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_Fairvalueoflongtermdebtinexcessofcarryingvalue_33c7989f-63ae-43a4-8439-c90931d5012d" xlink:href="a-20220131.xsd#a_Fairvalueoflongtermdebtinexcessofcarryingvalue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_cb100e41-3a29-4093-ac66-10bd35568a52" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_b609a94b-7280-4aa5-8664-d14d45ab9296" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_cb100e41-3a29-4093-ac66-10bd35568a52" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtFairValue_0ea1fc09-6230-4952-8fe7-66b6b6231280" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_b609a94b-7280-4aa5-8664-d14d45ab9296" xlink:to="loc_us-gaap_LongTermDebtFairValue_0ea1fc09-6230-4952-8fe7-66b6b6231280" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_b4734f85-24f1-4a9f-aa1b-9b1cf850868a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_b609a94b-7280-4aa5-8664-d14d45ab9296" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_b4734f85-24f1-4a9f-aa1b-9b1cf850868a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_0dae6f4f-3eb5-43ca-90c9-7f3e4952bafc" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_b4734f85-24f1-4a9f-aa1b-9b1cf850868a" xlink:to="loc_srt_ConsolidatedEntitiesAxis_0dae6f4f-3eb5-43ca-90c9-7f3e4952bafc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_0dae6f4f-3eb5-43ca-90c9-7f3e4952bafc_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_0dae6f4f-3eb5-43ca-90c9-7f3e4952bafc" xlink:to="loc_srt_ConsolidatedEntitiesDomain_0dae6f4f-3eb5-43ca-90c9-7f3e4952bafc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_aa655c91-9561-4b95-aa3d-9735a12564c9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_0dae6f4f-3eb5-43ca-90c9-7f3e4952bafc" xlink:to="loc_srt_ConsolidatedEntitiesDomain_aa655c91-9561-4b95-aa3d-9735a12564c9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_b41d0d40-430c-454c-b912-0a214f0d3985" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_aa655c91-9561-4b95-aa3d-9735a12564c9" xlink:to="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_b41d0d40-430c-454c-b912-0a214f0d3985" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PledgedStatusAxis_0c18e3e3-25a1-498d-8635-d92349b9c295" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PledgedStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_b4734f85-24f1-4a9f-aa1b-9b1cf850868a" xlink:to="loc_us-gaap_PledgedStatusAxis_0c18e3e3-25a1-498d-8635-d92349b9c295" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PledgedStatusDomain_0c18e3e3-25a1-498d-8635-d92349b9c295_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PledgedStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PledgedStatusAxis_0c18e3e3-25a1-498d-8635-d92349b9c295" xlink:to="loc_us-gaap_PledgedStatusDomain_0c18e3e3-25a1-498d-8635-d92349b9c295_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PledgedStatusDomain_7570b28b-9bec-4c45-856f-a618ef075854" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PledgedStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PledgedStatusAxis_0c18e3e3-25a1-498d-8635-d92349b9c295" xlink:to="loc_us-gaap_PledgedStatusDomain_7570b28b-9bec-4c45-856f-a618ef075854" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RecourseStatusAxis_0938f9ae-77c5-479e-9836-3e731af12ff6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RecourseStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_b4734f85-24f1-4a9f-aa1b-9b1cf850868a" xlink:to="loc_us-gaap_RecourseStatusAxis_0938f9ae-77c5-479e-9836-3e731af12ff6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RecourseStatusDomain_0938f9ae-77c5-479e-9836-3e731af12ff6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RecourseStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RecourseStatusAxis_0938f9ae-77c5-479e-9836-3e731af12ff6" xlink:to="loc_us-gaap_RecourseStatusDomain_0938f9ae-77c5-479e-9836-3e731af12ff6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RecourseStatusDomain_353f9b6b-800b-4262-8889-c3455bc2faa1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RecourseStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RecourseStatusAxis_0938f9ae-77c5-479e-9836-3e731af12ff6" xlink:to="loc_us-gaap_RecourseStatusDomain_353f9b6b-800b-4262-8889-c3455bc2faa1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_2ad9441e-1ec9-47d0-b35c-a322ea794d4f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_b4734f85-24f1-4a9f-aa1b-9b1cf850868a" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_2ad9441e-1ec9-47d0-b35c-a322ea794d4f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_2ad9441e-1ec9-47d0-b35c-a322ea794d4f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_2ad9441e-1ec9-47d0-b35c-a322ea794d4f" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_2ad9441e-1ec9-47d0-b35c-a322ea794d4f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_b544329e-9c73-4444-a78c-db556e6332a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_2ad9441e-1ec9-47d0-b35c-a322ea794d4f" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_b544329e-9c73-4444-a78c-db556e6332a4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember_fb11f2a0-2948-4559-aa28-9fed53a725ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_b544329e-9c73-4444-a78c-db556e6332a4" xlink:to="loc_us-gaap_OtherAssetsMember_fb11f2a0-2948-4559-aa28-9fed53a725ce" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_OtherAccruedAndLongTermLiabilitiesMember_70ce098c-2dbb-41a7-9542-4b6171bf3b1e" xlink:href="a-20220131.xsd#a_OtherAccruedAndLongTermLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_b544329e-9c73-4444-a78c-db556e6332a4" xlink:to="loc_a_OtherAccruedAndLongTermLiabilitiesMember_70ce098c-2dbb-41a7-9542-4b6171bf3b1e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_d5f8fc82-4ce7-40fb-8329-1957f7389c4a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_d5f8fc82-4ce7-40fb-8329-1957f7389c4a_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_c2b450da-0bf9-440d-917c-0a7e2287220d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_518a4819-c5a7-4916-87eb-8c6250acf815" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_5e2ebe6e-5797-461c-9601-f96ca189dd15" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_b4734f85-24f1-4a9f-aa1b-9b1cf850868a" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_5e2ebe6e-5797-461c-9601-f96ca189dd15" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5e2ebe6e-5797-461c-9601-f96ca189dd15_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_5e2ebe6e-5797-461c-9601-f96ca189dd15" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5e2ebe6e-5797-461c-9601-f96ca189dd15_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2b26ccb2-c468-469b-bfff-f25ba18b9c09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_5e2ebe6e-5797-461c-9601-f96ca189dd15" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2b26ccb2-c468-469b-bfff-f25ba18b9c09" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_8d9c8e9c-234f-4d41-8c57-7f8e19014056" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2b26ccb2-c468-469b-bfff-f25ba18b9c09" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_8d9c8e9c-234f-4d41-8c57-7f8e19014056" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.agilent.com/role/REVENUERevenuebyRegionDetails" xlink:type="simple" xlink:href="a-20220131.xsd#REVENUERevenuebyRegionDetails"/>
  <link:definitionLink xlink:role="http://www.agilent.com/role/REVENUERevenuebyRegionDetails" xlink:type="extended" id="id2ac8f8c7cbd42b19ee65c5ad7202038_REVENUERevenuebyRegionDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_ec2cb642-2299-4fce-8f3c-9f35dfd08d35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_8cc8d1aa-5232-408e-8465-9f131e3d6b34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ec2cb642-2299-4fce-8f3c-9f35dfd08d35" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_8cc8d1aa-5232-408e-8465-9f131e3d6b34" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_0bd68672-0b82-4532-8243-300df37662bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_ec2cb642-2299-4fce-8f3c-9f35dfd08d35" xlink:to="loc_us-gaap_StatementTable_0bd68672-0b82-4532-8243-300df37662bf" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_c0761078-db75-47ab-8ae4-853b06d79e95" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_0bd68672-0b82-4532-8243-300df37662bf" xlink:to="loc_srt_StatementGeographicalAxis_c0761078-db75-47ab-8ae4-853b06d79e95" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_c0761078-db75-47ab-8ae4-853b06d79e95_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_c0761078-db75-47ab-8ae4-853b06d79e95" xlink:to="loc_srt_SegmentGeographicalDomain_c0761078-db75-47ab-8ae4-853b06d79e95_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_63e50db6-0723-4a28-9372-d50fdc0b1b8a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_c0761078-db75-47ab-8ae4-853b06d79e95" xlink:to="loc_srt_SegmentGeographicalDomain_63e50db6-0723-4a28-9372-d50fdc0b1b8a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AmericasMember_d576df25-7961-487c-95e5-6afa30299458" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_AmericasMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_63e50db6-0723-4a28-9372-d50fdc0b1b8a" xlink:to="loc_srt_AmericasMember_d576df25-7961-487c-95e5-6afa30299458" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_81163098-8f0c-4dd3-911e-779d134fa7ce" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EuropeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_63e50db6-0723-4a28-9372-d50fdc0b1b8a" xlink:to="loc_srt_EuropeMember_81163098-8f0c-4dd3-911e-779d134fa7ce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember_fe51f065-bd04-400e-bd4b-bb2ad35166ef" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_AsiaPacificMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_63e50db6-0723-4a28-9372-d50fdc0b1b8a" xlink:to="loc_srt_AsiaPacificMember_fe51f065-bd04-400e-bd4b-bb2ad35166ef" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_00e90a3a-8855-4a2e-a019-156a909aa59c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_0bd68672-0b82-4532-8243-300df37662bf" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_00e90a3a-8855-4a2e-a019-156a909aa59c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_00e90a3a-8855-4a2e-a019-156a909aa59c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_00e90a3a-8855-4a2e-a019-156a909aa59c" xlink:to="loc_us-gaap_SegmentDomain_00e90a3a-8855-4a2e-a019-156a909aa59c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_f709515b-5d23-4fed-89fa-27b73ae03324" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_00e90a3a-8855-4a2e-a019-156a909aa59c" xlink:to="loc_us-gaap_SegmentDomain_f709515b-5d23-4fed-89fa-27b73ae03324" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_LifeSciencesandAppliedMarketsMember_b2b23f9a-6a60-4089-adc3-f4bfaac93364" xlink:href="a-20220131.xsd#a_LifeSciencesandAppliedMarketsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_f709515b-5d23-4fed-89fa-27b73ae03324" xlink:to="loc_a_LifeSciencesandAppliedMarketsMember_b2b23f9a-6a60-4089-adc3-f4bfaac93364" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_AgilentCrossLabMember_422f8647-7154-463a-bfc1-21ff654d8e3e" xlink:href="a-20220131.xsd#a_AgilentCrossLabMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_f709515b-5d23-4fed-89fa-27b73ae03324" xlink:to="loc_a_AgilentCrossLabMember_422f8647-7154-463a-bfc1-21ff654d8e3e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_DiagnosticsAndGenomicsMember_5cdd1219-c504-4860-9ffa-3ddf2ffea694" xlink:href="a-20220131.xsd#a_DiagnosticsAndGenomicsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_f709515b-5d23-4fed-89fa-27b73ae03324" xlink:to="loc_a_DiagnosticsAndGenomicsMember_5cdd1219-c504-4860-9ffa-3ddf2ffea694" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.agilent.com/role/REVENUERevenuebyEndMarketsDetails" xlink:type="simple" xlink:href="a-20220131.xsd#REVENUERevenuebyEndMarketsDetails"/>
  <link:definitionLink xlink:role="http://www.agilent.com/role/REVENUERevenuebyEndMarketsDetails" xlink:type="extended" id="if94056027cab42c39978b756a71ff3c3_REVENUERevenuebyEndMarketsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_bf43aa67-260a-4a38-a89f-4cc806c73d47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_930fa45b-09bb-4c4e-b9c8-43a1fe53a4e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bf43aa67-260a-4a38-a89f-4cc806c73d47" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_930fa45b-09bb-4c4e-b9c8-43a1fe53a4e5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_8fdcf95f-e661-465c-8949-e7686105e0e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_bf43aa67-260a-4a38-a89f-4cc806c73d47" xlink:to="loc_us-gaap_StatementTable_8fdcf95f-e661-465c-8949-e7686105e0e4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_EndMarketsAxis_cc480933-edaa-47a9-81fa-3dbfa640725e" xlink:href="a-20220131.xsd#a_EndMarketsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_8fdcf95f-e661-465c-8949-e7686105e0e4" xlink:to="loc_a_EndMarketsAxis_cc480933-edaa-47a9-81fa-3dbfa640725e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_EndMarketsDomain_cc480933-edaa-47a9-81fa-3dbfa640725e_default" xlink:href="a-20220131.xsd#a_EndMarketsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_a_EndMarketsAxis_cc480933-edaa-47a9-81fa-3dbfa640725e" xlink:to="loc_a_EndMarketsDomain_cc480933-edaa-47a9-81fa-3dbfa640725e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_EndMarketsDomain_744eb290-1582-4b28-944c-9a860a3db7f6" xlink:href="a-20220131.xsd#a_EndMarketsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_a_EndMarketsAxis_cc480933-edaa-47a9-81fa-3dbfa640725e" xlink:to="loc_a_EndMarketsDomain_744eb290-1582-4b28-944c-9a860a3db7f6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_PharmaceuticalandBiopharmaceuticalMarketMember_577a111b-da6c-4a3d-95c6-65099320cec0" xlink:href="a-20220131.xsd#a_PharmaceuticalandBiopharmaceuticalMarketMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_a_EndMarketsDomain_744eb290-1582-4b28-944c-9a860a3db7f6" xlink:to="loc_a_PharmaceuticalandBiopharmaceuticalMarketMember_577a111b-da6c-4a3d-95c6-65099320cec0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_ChemicalandEnergyMarketMember_04ebf281-2656-460c-87a8-0d4ef876a522" xlink:href="a-20220131.xsd#a_ChemicalandEnergyMarketMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_a_EndMarketsDomain_744eb290-1582-4b28-944c-9a860a3db7f6" xlink:to="loc_a_ChemicalandEnergyMarketMember_04ebf281-2656-460c-87a8-0d4ef876a522" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_DiagnosticsandClinicalMarketMember_e49c0ae6-993f-4dec-8842-0b0515c73f2f" xlink:href="a-20220131.xsd#a_DiagnosticsandClinicalMarketMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_a_EndMarketsDomain_744eb290-1582-4b28-944c-9a860a3db7f6" xlink:to="loc_a_DiagnosticsandClinicalMarketMember_e49c0ae6-993f-4dec-8842-0b0515c73f2f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_FoodMarketMember_822c97b4-14f3-4f34-8d95-60f12e195071" xlink:href="a-20220131.xsd#a_FoodMarketMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_a_EndMarketsDomain_744eb290-1582-4b28-944c-9a860a3db7f6" xlink:to="loc_a_FoodMarketMember_822c97b4-14f3-4f34-8d95-60f12e195071" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_AcademiaandGovernmentMarketMember_898339b4-ee71-4b32-b4c1-cf56ebb85175" xlink:href="a-20220131.xsd#a_AcademiaandGovernmentMarketMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_a_EndMarketsDomain_744eb290-1582-4b28-944c-9a860a3db7f6" xlink:to="loc_a_AcademiaandGovernmentMarketMember_898339b4-ee71-4b32-b4c1-cf56ebb85175" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_EnvironmentalandForensicsMarketMember_07e84c5c-ed77-4f7a-8e56-cde2e3cda43c" xlink:href="a-20220131.xsd#a_EnvironmentalandForensicsMarketMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_a_EndMarketsDomain_744eb290-1582-4b28-944c-9a860a3db7f6" xlink:to="loc_a_EnvironmentalandForensicsMarketMember_07e84c5c-ed77-4f7a-8e56-cde2e3cda43c" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.agilent.com/role/REVENUERevenuebyTypeDetails" xlink:type="simple" xlink:href="a-20220131.xsd#REVENUERevenuebyTypeDetails"/>
  <link:definitionLink xlink:role="http://www.agilent.com/role/REVENUERevenuebyTypeDetails" xlink:type="extended" id="i4d19cf10e390441c9dc510c355bfed7c_REVENUERevenuebyTypeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_c04d166f-335b-4a6c-9dfa-69e0977ab27d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_c856a836-3b2e-4d48-8fac-83f620860321" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_c04d166f-335b-4a6c-9dfa-69e0977ab27d" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_c856a836-3b2e-4d48-8fac-83f620860321" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_a3d99283-ae31-4cc0-b3b5-dafecbf326a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_c04d166f-335b-4a6c-9dfa-69e0977ab27d" xlink:to="loc_us-gaap_StatementTable_a3d99283-ae31-4cc0-b3b5-dafecbf326a4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_62269aba-ffa0-40cc-893a-7bc5877ceff7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_a3d99283-ae31-4cc0-b3b5-dafecbf326a4" xlink:to="loc_srt_ProductOrServiceAxis_62269aba-ffa0-40cc-893a-7bc5877ceff7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_62269aba-ffa0-40cc-893a-7bc5877ceff7_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_62269aba-ffa0-40cc-893a-7bc5877ceff7" xlink:to="loc_srt_ProductsAndServicesDomain_62269aba-ffa0-40cc-893a-7bc5877ceff7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_a9d30c1f-8ff2-4c67-872d-ac9070f5f741" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_62269aba-ffa0-40cc-893a-7bc5877ceff7" xlink:to="loc_srt_ProductsAndServicesDomain_a9d30c1f-8ff2-4c67-872d-ac9070f5f741" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_InstrumentationMember_c9053410-fee3-47ca-a1a9-c097b0d0ec33" xlink:href="a-20220131.xsd#a_InstrumentationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_a9d30c1f-8ff2-4c67-872d-ac9070f5f741" xlink:to="loc_a_InstrumentationMember_c9053410-fee3-47ca-a1a9-c097b0d0ec33" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_NonInstrumentationandOtherMember_94c002e6-c3dd-473e-916d-74273f57bd16" xlink:href="a-20220131.xsd#a_NonInstrumentationandOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_a9d30c1f-8ff2-4c67-872d-ac9070f5f741" xlink:to="loc_a_NonInstrumentationandOtherMember_94c002e6-c3dd-473e-916d-74273f57bd16" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.agilent.com/role/REVENUERemainingPerformanceObligationDetails" xlink:type="simple" xlink:href="a-20220131.xsd#REVENUERemainingPerformanceObligationDetails"/>
  <link:definitionLink xlink:role="http://www.agilent.com/role/REVENUERemainingPerformanceObligationDetails" xlink:type="extended" id="ib2cda8d40b0e4be7a71b9d1458cf9314_REVENUERemainingPerformanceObligationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_34ed9c2f-e6c0-454c-ab38-813430efb8a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_5af0cfcc-0c0a-4ef8-a84e-2185cc0278ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_34ed9c2f-e6c0-454c-ab38-813430efb8a1" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_5af0cfcc-0c0a-4ef8-a84e-2185cc0278ef" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_16af69e6-302d-4928-9968-7d952e717781" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_34ed9c2f-e6c0-454c-ab38-813430efb8a1" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_16af69e6-302d-4928-9968-7d952e717781" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_5766b361-96ed-4154-87f5-743a720d52f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_34ed9c2f-e6c0-454c-ab38-813430efb8a1" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_5766b361-96ed-4154-87f5-743a720d52f2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_aebdbfbe-ba87-43d0-bf17-c406c0254248" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_5766b361-96ed-4154-87f5-743a720d52f2" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_aebdbfbe-ba87-43d0-bf17-c406c0254248" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.agilent.com/role/REVENUERemainingPerformanceObligationDetails_1" xlink:type="simple" xlink:href="a-20220131.xsd#REVENUERemainingPerformanceObligationDetails_1"/>
  <link:definitionLink xlink:role="http://www.agilent.com/role/REVENUERemainingPerformanceObligationDetails_1" xlink:type="extended" id="iebf4de2c5f37424ba812c22643fccebe_REVENUERemainingPerformanceObligationDetails_1">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_34ed9c2f-e6c0-454c-ab38-813430efb8a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_5af0cfcc-0c0a-4ef8-a84e-2185cc0278ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_34ed9c2f-e6c0-454c-ab38-813430efb8a1" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_5af0cfcc-0c0a-4ef8-a84e-2185cc0278ef" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_16af69e6-302d-4928-9968-7d952e717781" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_34ed9c2f-e6c0-454c-ab38-813430efb8a1" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_16af69e6-302d-4928-9968-7d952e717781" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_5766b361-96ed-4154-87f5-743a720d52f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_34ed9c2f-e6c0-454c-ab38-813430efb8a1" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_5766b361-96ed-4154-87f5-743a720d52f2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.agilent.com/role/SHAREBASEDCOMPENSATIONTextDetails" xlink:type="simple" xlink:href="a-20220131.xsd#SHAREBASEDCOMPENSATIONTextDetails"/>
  <link:definitionLink xlink:role="http://www.agilent.com/role/SHAREBASEDCOMPENSATIONTextDetails" xlink:type="extended" id="i5b49e34d89d3403b97db4b5dabf47d79_SHAREBASEDCOMPENSATIONTextDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5f92a3dd-267c-421f-9faf-ec57f325adfc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_e31e4968-87da-4312-8576-c1a5a48bae09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5f92a3dd-267c-421f-9faf-ec57f325adfc" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_e31e4968-87da-4312-8576-c1a5a48bae09" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_22e0aada-c583-42fb-8949-d8b88bd8bb3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5f92a3dd-267c-421f-9faf-ec57f325adfc" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_22e0aada-c583-42fb-8949-d8b88bd8bb3b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_3e0a6496-3d87-48da-8c92-e35893c0c2b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5f92a3dd-267c-421f-9faf-ec57f325adfc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_3e0a6496-3d87-48da-8c92-e35893c0c2b1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1_742fed84-be41-42f3-94bf-511fd2c234a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5f92a3dd-267c-421f-9faf-ec57f325adfc" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1_742fed84-be41-42f3-94bf-511fd2c234a8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate_dbd670c8-acea-40c3-8fff-74cf026546d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5f92a3dd-267c-421f-9faf-ec57f325adfc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate_dbd670c8-acea-40c3-8fff-74cf026546d2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_12b5bc24-d3d7-4eae-8cf7-57014aa74e34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5f92a3dd-267c-421f-9faf-ec57f325adfc" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_12b5bc24-d3d7-4eae-8cf7-57014aa74e34" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_52f310ef-199d-40e0-96ed-28a5282c54c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5f92a3dd-267c-421f-9faf-ec57f325adfc" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_52f310ef-199d-40e0-96ed-28a5282c54c3" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_49d54959-0946-4a71-bc87-a201feea435d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5f92a3dd-267c-421f-9faf-ec57f325adfc" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_49d54959-0946-4a71-bc87-a201feea435d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_7839b348-09cc-4352-9c84-9ba59e46156f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_49d54959-0946-4a71-bc87-a201feea435d" xlink:to="loc_srt_RangeAxis_7839b348-09cc-4352-9c84-9ba59e46156f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_7839b348-09cc-4352-9c84-9ba59e46156f_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_7839b348-09cc-4352-9c84-9ba59e46156f" xlink:to="loc_srt_RangeMember_7839b348-09cc-4352-9c84-9ba59e46156f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_f2d4f226-fc14-4ad8-b740-36eb1f93f91e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_7839b348-09cc-4352-9c84-9ba59e46156f" xlink:to="loc_srt_RangeMember_f2d4f226-fc14-4ad8-b740-36eb1f93f91e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_c9f883d8-3b4e-4b1f-b05d-1954156bc159" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_f2d4f226-fc14-4ad8-b740-36eb1f93f91e" xlink:to="loc_srt_MinimumMember_c9f883d8-3b4e-4b1f-b05d-1954156bc159" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_9f7b84a0-d141-4f65-a96d-c9785acaaff2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_f2d4f226-fc14-4ad8-b740-36eb1f93f91e" xlink:to="loc_srt_MaximumMember_9f7b84a0-d141-4f65-a96d-c9785acaaff2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_4af0fc96-0321-49f5-aa07-c412e796825e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_49d54959-0946-4a71-bc87-a201feea435d" xlink:to="loc_us-gaap_AwardTypeAxis_4af0fc96-0321-49f5-aa07-c412e796825e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4af0fc96-0321-49f5-aa07-c412e796825e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_4af0fc96-0321-49f5-aa07-c412e796825e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4af0fc96-0321-49f5-aa07-c412e796825e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_76ffdfb4-58c4-4734-96c0-5eed30fb1bfc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_4af0fc96-0321-49f5-aa07-c412e796825e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_76ffdfb4-58c4-4734-96c0-5eed30fb1bfc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_dc6b826e-2563-495f-a9fd-413dd9ff6ed8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_76ffdfb4-58c4-4734-96c0-5eed30fb1bfc" xlink:to="loc_us-gaap_EmployeeStockMember_dc6b826e-2563-495f-a9fd-413dd9ff6ed8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_07cde7d3-d0be-4969-9736-8327e3dbc36a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_76ffdfb4-58c4-4734-96c0-5eed30fb1bfc" xlink:to="loc_us-gaap_EmployeeStockOptionMember_07cde7d3-d0be-4969-9736-8327e3dbc36a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_363d9cf5-d202-4349-a012-deff24706582" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_76ffdfb4-58c4-4734-96c0-5eed30fb1bfc" xlink:to="loc_us-gaap_PerformanceSharesMember_363d9cf5-d202-4349-a012-deff24706582" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_94d18fc6-25db-45b2-bc31-61bfbf155794" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_76ffdfb4-58c4-4734-96c0-5eed30fb1bfc" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_94d18fc6-25db-45b2-bc31-61bfbf155794" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_58c448aa-b64c-4be3-a052-64798dfc9473" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_49d54959-0946-4a71-bc87-a201feea435d" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_58c448aa-b64c-4be3-a052-64798dfc9473" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_58c448aa-b64c-4be3-a052-64798dfc9473_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_58c448aa-b64c-4be3-a052-64798dfc9473" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_58c448aa-b64c-4be3-a052-64798dfc9473_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_16555769-f50a-4c6b-8cc7-a727ac4bcef0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_58c448aa-b64c-4be3-a052-64798dfc9473" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_16555769-f50a-4c6b-8cc7-a727ac4bcef0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PublicUtilitiesInventoryTypeDomain_f4f0f55b-8b53-4a99-879f-0c1fbf1bad58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PublicUtilitiesInventoryTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_16555769-f50a-4c6b-8cc7-a727ac4bcef0" xlink:to="loc_us-gaap_PublicUtilitiesInventoryTypeDomain_f4f0f55b-8b53-4a99-879f-0c1fbf1bad58" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.agilent.com/role/SHAREBASEDCOMPENSATIONAllocatedSharebasedcompensationexpenseDetails" xlink:type="simple" xlink:href="a-20220131.xsd#SHAREBASEDCOMPENSATIONAllocatedSharebasedcompensationexpenseDetails"/>
  <link:definitionLink xlink:role="http://www.agilent.com/role/SHAREBASEDCOMPENSATIONAllocatedSharebasedcompensationexpenseDetails" xlink:type="extended" id="i94fbd4e708e047e8b19326894119b53b_SHAREBASEDCOMPENSATIONAllocatedSharebasedcompensationexpenseDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_9dbf982d-5fa6-4b21-8613-41874f570120" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_978769cf-4be5-4682-a65b-ac21a4635ccc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_9dbf982d-5fa6-4b21-8613-41874f570120" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_978769cf-4be5-4682-a65b-ac21a4635ccc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_5de31506-c9b6-4f36-b9b0-e9df9b81286a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_9dbf982d-5fa6-4b21-8613-41874f570120" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_5de31506-c9b6-4f36-b9b0-e9df9b81286a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_5223ba23-ae7e-4db4-a58e-c8d38c0fe65f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_5de31506-c9b6-4f36-b9b0-e9df9b81286a" xlink:to="loc_us-gaap_AwardTypeAxis_5223ba23-ae7e-4db4-a58e-c8d38c0fe65f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5223ba23-ae7e-4db4-a58e-c8d38c0fe65f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_5223ba23-ae7e-4db4-a58e-c8d38c0fe65f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5223ba23-ae7e-4db4-a58e-c8d38c0fe65f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c59ccfc0-657e-4621-895f-d9f995df0a06" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_5223ba23-ae7e-4db4-a58e-c8d38c0fe65f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c59ccfc0-657e-4621-895f-d9f995df0a06" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_LtppMember_25e77e4e-4c47-470a-b15b-f916bdced807" xlink:href="a-20220131.xsd#a_LtppMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c59ccfc0-657e-4621-895f-d9f995df0a06" xlink:to="loc_a_LtppMember_25e77e4e-4c47-470a-b15b-f916bdced807" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_3f344f80-0c4b-4f82-becb-ba39095f82a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_5de31506-c9b6-4f36-b9b0-e9df9b81286a" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_3f344f80-0c4b-4f82-becb-ba39095f82a9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_3f344f80-0c4b-4f82-becb-ba39095f82a9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_3f344f80-0c4b-4f82-becb-ba39095f82a9" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_3f344f80-0c4b-4f82-becb-ba39095f82a9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_de1823dd-1d50-4fa9-817c-f948a7ad8389" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_3f344f80-0c4b-4f82-becb-ba39095f82a9" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_de1823dd-1d50-4fa9-817c-f948a7ad8389" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_18ecf4e2-90d1-44f7-8ca6-ee21f370a36f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_de1823dd-1d50-4fa9-817c-f948a7ad8389" xlink:to="loc_us-gaap_CostOfSalesMember_18ecf4e2-90d1-44f7-8ca6-ee21f370a36f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_98966345-7618-4e45-8b55-1423da01890b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_de1823dd-1d50-4fa9-817c-f948a7ad8389" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_98966345-7618-4e45-8b55-1423da01890b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_37c416da-cc0c-4739-896a-c52ceb729fc5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_de1823dd-1d50-4fa9-817c-f948a7ad8389" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_37c416da-cc0c-4739-896a-c52ceb729fc5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_03d66238-709d-4181-a25b-efe9819c8a69" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_5de31506-c9b6-4f36-b9b0-e9df9b81286a" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_03d66238-709d-4181-a25b-efe9819c8a69" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_03d66238-709d-4181-a25b-efe9819c8a69_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_03d66238-709d-4181-a25b-efe9819c8a69" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_03d66238-709d-4181-a25b-efe9819c8a69_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_c3534afa-20b5-4c9a-aab3-bafe5efe693e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_03d66238-709d-4181-a25b-efe9819c8a69" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_c3534afa-20b5-4c9a-aab3-bafe5efe693e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PublicUtilitiesInventoryTypeDomain_3505d2a4-c9f1-4e2f-8839-047c2e1abff6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PublicUtilitiesInventoryTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_c3534afa-20b5-4c9a-aab3-bafe5efe693e" xlink:to="loc_us-gaap_PublicUtilitiesInventoryTypeDomain_3505d2a4-c9f1-4e2f-8839-047c2e1abff6" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.agilent.com/role/SHAREBASEDCOMPENSATIONFairValueAssumptionsDetails" xlink:type="simple" xlink:href="a-20220131.xsd#SHAREBASEDCOMPENSATIONFairValueAssumptionsDetails"/>
  <link:definitionLink xlink:role="http://www.agilent.com/role/SHAREBASEDCOMPENSATIONFairValueAssumptionsDetails" xlink:type="extended" id="i0356122e81404e9989144abd9829f9b9_SHAREBASEDCOMPENSATIONFairValueAssumptionsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d8e7a66d-51f9-4e66-9826-215c0c52305a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_0a709f7e-5a5a-41ab-91ce-6661ac98125c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d8e7a66d-51f9-4e66-9826-215c0c52305a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_0a709f7e-5a5a-41ab-91ce-6661ac98125c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesVolatilityRateRangeMinimum_8a71a7a5-5070-4b91-8d63-63af6d3c61c1" xlink:href="a-20220131.xsd#a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesVolatilityRateRangeMinimum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d8e7a66d-51f9-4e66-9826-215c0c52305a" xlink:to="loc_a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesVolatilityRateRangeMinimum_8a71a7a5-5070-4b91-8d63-63af6d3c61c1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesVolatilityRateRangeMaximum_72c80792-a52c-48a7-84f8-169644948280" xlink:href="a-20220131.xsd#a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesVolatilityRateRangeMaximum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d8e7a66d-51f9-4e66-9826-215c0c52305a" xlink:to="loc_a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesVolatilityRateRangeMaximum_72c80792-a52c-48a7-84f8-169644948280" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesPriceWiseCorrelationyRate_3d6053cb-bd0d-410d-a61a-38b89b90e27a" xlink:href="a-20220131.xsd#a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesPriceWiseCorrelationyRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d8e7a66d-51f9-4e66-9826-215c0c52305a" xlink:to="loc_a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesPriceWiseCorrelationyRate_3d6053cb-bd0d-410d-a61a-38b89b90e27a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions_6591c49d-30a7-49c4-9251-ba8082674fe4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d8e7a66d-51f9-4e66-9826-215c0c52305a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions_6591c49d-30a7-49c4-9251-ba8082674fe4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_50667ee0-5ce3-41bd-be89-9ef4ae24f230" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d8e7a66d-51f9-4e66-9826-215c0c52305a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_50667ee0-5ce3-41bd-be89-9ef4ae24f230" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_d21e2623-9dff-4d15-9672-d243105c2c8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d8e7a66d-51f9-4e66-9826-215c0c52305a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_d21e2623-9dff-4d15-9672-d243105c2c8e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_2d847091-f753-46db-9744-c6e2e8ed55e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d8e7a66d-51f9-4e66-9826-215c0c52305a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_2d847091-f753-46db-9744-c6e2e8ed55e7" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_0961de93-2d87-4201-a289-7eff046be35b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d8e7a66d-51f9-4e66-9826-215c0c52305a" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_0961de93-2d87-4201-a289-7eff046be35b" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_de91b770-bebb-47e2-8c1b-3769b25c6902" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d8e7a66d-51f9-4e66-9826-215c0c52305a" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_de91b770-bebb-47e2-8c1b-3769b25c6902" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_df778e0f-721e-4fc1-816c-67f8c50c41e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_de91b770-bebb-47e2-8c1b-3769b25c6902" xlink:to="loc_us-gaap_AwardTypeAxis_df778e0f-721e-4fc1-816c-67f8c50c41e1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_df778e0f-721e-4fc1-816c-67f8c50c41e1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_df778e0f-721e-4fc1-816c-67f8c50c41e1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_df778e0f-721e-4fc1-816c-67f8c50c41e1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3a101146-0e44-4975-8111-978636e3e393" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_df778e0f-721e-4fc1-816c-67f8c50c41e1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3a101146-0e44-4975-8111-978636e3e393" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_58178ce2-8819-459f-be8e-76bd4bb310b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3a101146-0e44-4975-8111-978636e3e393" xlink:to="loc_us-gaap_EmployeeStockOptionMember_58178ce2-8819-459f-be8e-76bd4bb310b6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_LtppMember_894fc249-9315-4c85-a6b3-dfd6b426a4c7" xlink:href="a-20220131.xsd#a_LtppMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3a101146-0e44-4975-8111-978636e3e393" xlink:to="loc_a_LtppMember_894fc249-9315-4c85-a6b3-dfd6b426a4c7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_LTPPRSUMember_080cc00e-6ca2-4858-b884-653a1bf525be" xlink:href="a-20220131.xsd#a_LTPPRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3a101146-0e44-4975-8111-978636e3e393" xlink:to="loc_a_LTPPRSUMember_080cc00e-6ca2-4858-b884-653a1bf525be" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.agilent.com/role/INCOMETAXESDetails" xlink:type="simple" xlink:href="a-20220131.xsd#INCOMETAXESDetails"/>
  <link:definitionLink xlink:role="http://www.agilent.com/role/INCOMETAXESDetails" xlink:type="extended" id="i901097f5dbaf440d90eba99a62764570_INCOMETAXESDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationLineItems_6fec1499-c031-4157-b0c1-2328d9677d2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExaminationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_949bc17b-4627-4f0f-beb6-9cbb512e09bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems_6fec1499-c031-4157-b0c1-2328d9677d2c" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_949bc17b-4627-4f0f-beb6-9cbb512e09bf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_f72ae2fe-766b-4ce2-a773-185d95d39ff0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems_6fec1499-c031-4157-b0c1-2328d9677d2c" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_f72ae2fe-766b-4ce2-a773-185d95d39ff0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_3668e38f-0a3e-4ed4-838a-dda3fe2a2b72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems_6fec1499-c031-4157-b0c1-2328d9677d2c" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_3668e38f-0a3e-4ed4-838a-dda3fe2a2b72" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherTaxExpenseBenefit_f89b9847-042c-4635-a986-45573ca1d997" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems_6fec1499-c031-4157-b0c1-2328d9677d2c" xlink:to="loc_us-gaap_OtherTaxExpenseBenefit_f89b9847-042c-4635-a986-45573ca1d997" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_be5d9f57-1b78-4185-ac8b-7cec57c8c180" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems_6fec1499-c031-4157-b0c1-2328d9677d2c" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_be5d9f57-1b78-4185-ac8b-7cec57c8c180" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_47f5af4b-d9b2-41b4-b3cd-0080d9468179" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems_6fec1499-c031-4157-b0c1-2328d9677d2c" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_47f5af4b-d9b2-41b4-b3cd-0080d9468179" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_473cc5c5-b7c4-4374-988a-1ff7507975e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems_6fec1499-c031-4157-b0c1-2328d9677d2c" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_473cc5c5-b7c4-4374-988a-1ff7507975e7" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationTable_f5cceb1e-77a6-4d46-b2ba-1fb30ab5d5f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExaminationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems_6fec1499-c031-4157-b0c1-2328d9677d2c" xlink:to="loc_us-gaap_IncomeTaxExaminationTable_f5cceb1e-77a6-4d46-b2ba-1fb30ab5d5f9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_97adbdbf-5a1f-49f0-bfeb-fb6e36ab942a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxExaminationTable_f5cceb1e-77a6-4d46-b2ba-1fb30ab5d5f9" xlink:to="loc_srt_StatementScenarioAxis_97adbdbf-5a1f-49f0-bfeb-fb6e36ab942a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_97adbdbf-5a1f-49f0-bfeb-fb6e36ab942a_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_97adbdbf-5a1f-49f0-bfeb-fb6e36ab942a" xlink:to="loc_srt_ScenarioUnspecifiedDomain_97adbdbf-5a1f-49f0-bfeb-fb6e36ab942a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_81029c82-be51-4063-978d-05afe505ade6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_97adbdbf-5a1f-49f0-bfeb-fb6e36ab942a" xlink:to="loc_srt_ScenarioUnspecifiedDomain_81029c82-be51-4063-978d-05afe505ade6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis_d4604682-af2d-445d-9f2f-6be783642d36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxExaminationTable_f5cceb1e-77a6-4d46-b2ba-1fb30ab5d5f9" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameAxis_d4604682-af2d-445d-9f2f-6be783642d36" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_d4604682-af2d-445d-9f2f-6be783642d36_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_d4604682-af2d-445d-9f2f-6be783642d36" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_d4604682-af2d-445d-9f2f-6be783642d36_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_8e01ce5b-65cc-4575-ac1c-633f84fbb50f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_d4604682-af2d-445d-9f2f-6be783642d36" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_8e01ce5b-65cc-4575-ac1c-633f84fbb50f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodAxis_35295071-36ca-4200-9d6c-2cedad6fff1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxPeriodAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxExaminationTable_f5cceb1e-77a6-4d46-b2ba-1fb30ab5d5f9" xlink:to="loc_us-gaap_TaxPeriodAxis_35295071-36ca-4200-9d6c-2cedad6fff1b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain_35295071-36ca-4200-9d6c-2cedad6fff1b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TaxPeriodAxis_35295071-36ca-4200-9d6c-2cedad6fff1b" xlink:to="loc_us-gaap_TaxPeriodDomain_35295071-36ca-4200-9d6c-2cedad6fff1b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain_ef1d94de-0b15-4e20-be5b-abd2a7edfff0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TaxPeriodAxis_35295071-36ca-4200-9d6c-2cedad6fff1b" xlink:to="loc_us-gaap_TaxPeriodDomain_ef1d94de-0b15-4e20-be5b-abd2a7edfff0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_b21c4b7b-ffec-4bf8-ae71-414b555c2499" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxExaminationTable_f5cceb1e-77a6-4d46-b2ba-1fb30ab5d5f9" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_b21c4b7b-ffec-4bf8-ae71-414b555c2499" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_b21c4b7b-ffec-4bf8-ae71-414b555c2499_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_b21c4b7b-ffec-4bf8-ae71-414b555c2499" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_b21c4b7b-ffec-4bf8-ae71-414b555c2499_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_04cbb9b7-fa57-4053-851a-04bb45ee8d37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_b21c4b7b-ffec-4bf8-ae71-414b555c2499" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_04cbb9b7-fa57-4053-851a-04bb45ee8d37" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.agilent.com/role/NETINCOMEPERSHAREDetails" xlink:type="simple" xlink:href="a-20220131.xsd#NETINCOMEPERSHAREDetails"/>
  <link:definitionLink xlink:role="http://www.agilent.com/role/NETINCOMEPERSHAREDetails" xlink:type="extended" id="ifa80d107b63f4073875f8987660d5d10_NETINCOMEPERSHAREDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_d2a1386f-e3b5-4c6e-89ec-c244a3ee17eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_NumeratorAbstract_e8cb42ec-a9ff-470b-94a7-06a5b62d5486" xlink:href="a-20220131.xsd#a_NumeratorAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_d2a1386f-e3b5-4c6e-89ec-c244a3ee17eb" xlink:to="loc_a_NumeratorAbstract_e8cb42ec-a9ff-470b-94a7-06a5b62d5486" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_93d12211-7fef-40ec-8891-e39fb26f58f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_a_NumeratorAbstract_e8cb42ec-a9ff-470b-94a7-06a5b62d5486" xlink:to="loc_us-gaap_NetIncomeLoss_93d12211-7fef-40ec-8891-e39fb26f58f8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_DenominatorsAbstract_2a15f39a-e9c0-430a-a6a5-b30fb34f6c5a" xlink:href="a-20220131.xsd#a_DenominatorsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_d2a1386f-e3b5-4c6e-89ec-c244a3ee17eb" xlink:to="loc_a_DenominatorsAbstract_2a15f39a-e9c0-430a-a6a5-b30fb34f6c5a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_0b7b4d0c-70b0-4c9e-bd7d-eee39284c9b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_a_DenominatorsAbstract_2a15f39a-e9c0-430a-a6a5-b30fb34f6c5a" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_0b7b4d0c-70b0-4c9e-bd7d-eee39284c9b2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_c0101b9b-e9f3-4a6c-9d19-b1458877868e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_a_DenominatorsAbstract_2a15f39a-e9c0-430a-a6a5-b30fb34f6c5a" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_c0101b9b-e9f3-4a6c-9d19-b1458877868e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_c2e244bd-28ea-4496-80e3-17bf624ebf23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_a_DenominatorsAbstract_2a15f39a-e9c0-430a-a6a5-b30fb34f6c5a" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_c2e244bd-28ea-4496-80e3-17bf624ebf23" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_ed9f364c-3b57-4cd5-8650-c0c09b0e5f3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_d2a1386f-e3b5-4c6e-89ec-c244a3ee17eb" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_ed9f364c-3b57-4cd5-8650-c0c09b0e5f3e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_9ad00815-90f7-4bf9-9188-02aacc9c2e28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_d2a1386f-e3b5-4c6e-89ec-c244a3ee17eb" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_9ad00815-90f7-4bf9-9188-02aacc9c2e28" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_3adc23ea-43d0-41eb-8199-252767c2baba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_9ad00815-90f7-4bf9-9188-02aacc9c2e28" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_3adc23ea-43d0-41eb-8199-252767c2baba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_3adc23ea-43d0-41eb-8199-252767c2baba_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_3adc23ea-43d0-41eb-8199-252767c2baba" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_3adc23ea-43d0-41eb-8199-252767c2baba_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_c10ae78a-d027-4ac1-9af9-c7f772b652a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_3adc23ea-43d0-41eb-8199-252767c2baba" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_c10ae78a-d027-4ac1-9af9-c7f772b652a0" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSGoodwillRollforwardDetails" xlink:type="simple" xlink:href="a-20220131.xsd#GOODWILLANDOTHERINTANGIBLEASSETSGoodwillRollforwardDetails"/>
  <link:definitionLink xlink:role="http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSGoodwillRollforwardDetails" xlink:type="extended" id="i784d9569e3644fb2a0f1ac2becbc8fea_GOODWILLANDOTHERINTANGIBLEASSETSGoodwillRollforwardDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_ba80d176-18d9-4b47-b2d9-3691af95e0b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_35c973bc-2b08-453b-a105-b3dbcca1613f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_ba80d176-18d9-4b47-b2d9-3691af95e0b9" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_35c973bc-2b08-453b-a105-b3dbcca1613f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_44764497-cb3b-426e-b506-b4ebd38df7f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_ba80d176-18d9-4b47-b2d9-3691af95e0b9" xlink:to="loc_us-gaap_GoodwillRollForward_44764497-cb3b-426e-b506-b4ebd38df7f8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTransfers_bfca3ed7-8f73-44d9-b2c4-c591c7bee20d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillTransfers"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_44764497-cb3b-426e-b506-b4ebd38df7f8" xlink:to="loc_us-gaap_GoodwillTransfers_bfca3ed7-8f73-44d9-b2c4-c591c7bee20d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_95577016-e3ce-4af8-ae4b-c19fef68b9db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_44764497-cb3b-426e-b506-b4ebd38df7f8" xlink:to="loc_us-gaap_Goodwill_95577016-e3ce-4af8-ae4b-c19fef68b9db" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_d19ad55b-0584-40d7-97d5-3fba7ef5eb83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_44764497-cb3b-426e-b506-b4ebd38df7f8" xlink:to="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_d19ad55b-0584-40d7-97d5-3fba7ef5eb83" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_3d7921fd-c241-4672-b691-7b3cac16c181" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_44764497-cb3b-426e-b506-b4ebd38df7f8" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_3d7921fd-c241-4672-b691-7b3cac16c181" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_a1cbb32a-37f6-4e15-a638-73311097862d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_f8f477d0-a8c6-492d-9dcc-1e34037fda03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_ba80d176-18d9-4b47-b2d9-3691af95e0b9" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_f8f477d0-a8c6-492d-9dcc-1e34037fda03" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_279245d6-3acd-4165-965c-55b04454f87c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_f8f477d0-a8c6-492d-9dcc-1e34037fda03" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_279245d6-3acd-4165-965c-55b04454f87c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_279245d6-3acd-4165-965c-55b04454f87c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_279245d6-3acd-4165-965c-55b04454f87c" xlink:to="loc_us-gaap_SegmentDomain_279245d6-3acd-4165-965c-55b04454f87c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_c317d751-ffe7-45bb-83b0-57915981439a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_279245d6-3acd-4165-965c-55b04454f87c" xlink:to="loc_us-gaap_SegmentDomain_c317d751-ffe7-45bb-83b0-57915981439a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_LifeSciencesandAppliedMarketsMember_00174006-fc73-46f9-8b79-7c47302e69fc" xlink:href="a-20220131.xsd#a_LifeSciencesandAppliedMarketsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_c317d751-ffe7-45bb-83b0-57915981439a" xlink:to="loc_a_LifeSciencesandAppliedMarketsMember_00174006-fc73-46f9-8b79-7c47302e69fc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_DiagnosticsAndGenomicsMember_7d63b7d3-eb58-4b87-a8a8-173f94691f2c" xlink:href="a-20220131.xsd#a_DiagnosticsAndGenomicsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_c317d751-ffe7-45bb-83b0-57915981439a" xlink:to="loc_a_DiagnosticsAndGenomicsMember_7d63b7d3-eb58-4b87-a8a8-173f94691f2c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_AgilentCrossLabMember_9012d539-3a10-40fb-9bc0-3d2d3dec615c" xlink:href="a-20220131.xsd#a_AgilentCrossLabMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_c317d751-ffe7-45bb-83b0-57915981439a" xlink:to="loc_a_AgilentCrossLabMember_9012d539-3a10-40fb-9bc0-3d2d3dec615c" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDisclosuresandComponentsofPurchasedOtherIntangiblesDetails" xlink:type="simple" xlink:href="a-20220131.xsd#GOODWILLANDOTHERINTANGIBLEASSETSDisclosuresandComponentsofPurchasedOtherIntangiblesDetails"/>
  <link:definitionLink xlink:role="http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDisclosuresandComponentsofPurchasedOtherIntangiblesDetails" xlink:type="extended" id="i47bfbe7c880b435d8f1f0778b2dd216b_GOODWILLANDOTHERINTANGIBLEASSETSDisclosuresandComponentsofPurchasedOtherIntangiblesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_96653994-2c54-4a5c-a4fe-4b694d6d1010" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_fa074c34-976a-467b-b41c-946708e78579" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_96653994-2c54-4a5c-a4fe-4b694d6d1010" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_fa074c34-976a-467b-b41c-946708e78579" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_f89ece54-70cc-44f7-b7a7-0e7572a7cddb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNetAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_96653994-2c54-4a5c-a4fe-4b694d6d1010" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_f89ece54-70cc-44f7-b7a7-0e7572a7cddb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_144e49c0-eb96-4198-ad87-01941526d730" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_f89ece54-70cc-44f7-b7a7-0e7572a7cddb" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_144e49c0-eb96-4198-ad87-01941526d730" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_1eb579d8-06af-48f0-b9bc-75e4e05d96d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_f89ece54-70cc-44f7-b7a7-0e7572a7cddb" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_1eb579d8-06af-48f0-b9bc-75e4e05d96d1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_bc5f98fe-dbd3-415e-9c71-f51aacf3d953" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_f89ece54-70cc-44f7-b7a7-0e7572a7cddb" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_bc5f98fe-dbd3-415e-9c71-f51aacf3d953" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_14bddb32-2ac0-4af6-9880-7ec14ebd357c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_f89ece54-70cc-44f7-b7a7-0e7572a7cddb" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_14bddb32-2ac0-4af6-9880-7ec14ebd357c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_d25b4a2d-ba36-44c2-807a-a71c2cce738a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_f89ece54-70cc-44f7-b7a7-0e7572a7cddb" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_d25b4a2d-ba36-44c2-807a-a71c2cce738a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract_323a737d-d7dc-4249-a619-ac10ff0adadc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_96653994-2c54-4a5c-a4fe-4b694d6d1010" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract_323a737d-d7dc-4249-a619-ac10ff0adadc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_b5a9fc5e-ee6b-498f-bfb2-ed3dd1589035" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract_323a737d-d7dc-4249-a619-ac10ff0adadc" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_b5a9fc5e-ee6b-498f-bfb2-ed3dd1589035" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_42494cb1-ec4d-4d29-8bdc-d21e830cf72e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_96653994-2c54-4a5c-a4fe-4b694d6d1010" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_42494cb1-ec4d-4d29-8bdc-d21e830cf72e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_a6514b41-6470-4303-9beb-9a8f334cfe48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_42494cb1-ec4d-4d29-8bdc-d21e830cf72e" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_a6514b41-6470-4303-9beb-9a8f334cfe48" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_a6514b41-6470-4303-9beb-9a8f334cfe48_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_a6514b41-6470-4303-9beb-9a8f334cfe48" xlink:to="loc_us-gaap_SegmentDomain_a6514b41-6470-4303-9beb-9a8f334cfe48_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_938fdf8f-437b-4c06-8b09-7ef04421e3b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_a6514b41-6470-4303-9beb-9a8f334cfe48" xlink:to="loc_us-gaap_SegmentDomain_938fdf8f-437b-4c06-8b09-7ef04421e3b0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_a40aee32-e47d-4157-949a-84a5f0d84e9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_42494cb1-ec4d-4d29-8bdc-d21e830cf72e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_a40aee32-e47d-4157-949a-84a5f0d84e9c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a40aee32-e47d-4157-949a-84a5f0d84e9c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_a40aee32-e47d-4157-949a-84a5f0d84e9c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a40aee32-e47d-4157-949a-84a5f0d84e9c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_30a94eb8-2124-4287-8175-8b958a9e69cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_a40aee32-e47d-4157-949a-84a5f0d84e9c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_30a94eb8-2124-4287-8175-8b958a9e69cb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_52f0f1aa-808a-4851-a7b1-f4077d4aa7cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_30a94eb8-2124-4287-8175-8b958a9e69cb" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_52f0f1aa-808a-4851-a7b1-f4077d4aa7cb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrderOrProductionBacklogMember_a153ab53-ba4b-479a-a4f1-fee430992775" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrderOrProductionBacklogMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_30a94eb8-2124-4287-8175-8b958a9e69cb" xlink:to="loc_us-gaap_OrderOrProductionBacklogMember_a153ab53-ba4b-479a-a4f1-fee430992775" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember_956317a3-fbbc-42a9-a657-1f76ed16fe94" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TrademarksMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_30a94eb8-2124-4287-8175-8b958a9e69cb" xlink:to="loc_us-gaap_TrademarksMember_956317a3-fbbc-42a9-a657-1f76ed16fe94" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_5eef454d-8131-4b94-8b7d-c55b27801584" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_30a94eb8-2124-4287-8175-8b958a9e69cb" xlink:to="loc_us-gaap_CustomerRelationshipsMember_5eef454d-8131-4b94-8b7d-c55b27801584" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_ThirdPartyTechnologyandLicensesMember_dee780b3-c662-4563-9d0f-6ec663b8d034" xlink:href="a-20220131.xsd#a_ThirdPartyTechnologyandLicensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_30a94eb8-2124-4287-8175-8b958a9e69cb" xlink:to="loc_a_ThirdPartyTechnologyandLicensesMember_dee780b3-c662-4563-9d0f-6ec663b8d034" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_842f98fe-e496-486d-a52e-63687c92f01f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_30a94eb8-2124-4287-8175-8b958a9e69cb" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_842f98fe-e496-486d-a52e-63687c92f01f" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTextualsDetails" xlink:type="simple" xlink:href="a-20220131.xsd#GOODWILLANDOTHERINTANGIBLEASSETSTextualsDetails"/>
  <link:definitionLink xlink:role="http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTextualsDetails" xlink:type="extended" id="ie8e79fba43f246b5bbfbc51302181a31_GOODWILLANDOTHERINTANGIBLEASSETSTextualsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_bd2b5d76-b568-4d23-91f2-bed4374ac113" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease_5fd323ef-64ea-4efe-a22c-218e71598e39" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_bd2b5d76-b568-4d23-91f2-bed4374ac113" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease_5fd323ef-64ea-4efe-a22c-218e71598e39" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_4fafc653-2af5-4f0d-bc4e-f17829cb0717" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_bd2b5d76-b568-4d23-91f2-bed4374ac113" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_4fafc653-2af5-4f0d-bc4e-f17829cb0717" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss_f97b3e07-77a0-4608-be54-a4611cbe3a3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_bd2b5d76-b568-4d23-91f2-bed4374ac113" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss_f97b3e07-77a0-4608-be54-a4611cbe3a3d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_3889918e-25ff-4039-889a-904ccc38b682" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_bd2b5d76-b568-4d23-91f2-bed4374ac113" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_3889918e-25ff-4039-889a-904ccc38b682" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_43d0774d-aaba-41ff-b292-6eb29df0460a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_bd2b5d76-b568-4d23-91f2-bed4374ac113" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_43d0774d-aaba-41ff-b292-6eb29df0460a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_0cf8fb6e-e79c-4f6d-827f-f7cd58056262" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_bd2b5d76-b568-4d23-91f2-bed4374ac113" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_0cf8fb6e-e79c-4f6d-827f-f7cd58056262" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_45165381-ecff-4f29-a391-19ce5b8814d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_bd2b5d76-b568-4d23-91f2-bed4374ac113" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_45165381-ecff-4f29-a391-19ce5b8814d0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_537b1646-f890-40e0-a732-4b3d46e2574b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_45165381-ecff-4f29-a391-19ce5b8814d0" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_537b1646-f890-40e0-a732-4b3d46e2574b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_537b1646-f890-40e0-a732-4b3d46e2574b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_537b1646-f890-40e0-a732-4b3d46e2574b" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_537b1646-f890-40e0-a732-4b3d46e2574b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1fd6ec70-56d3-4bc9-9653-1dc3dd20179b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_537b1646-f890-40e0-a732-4b3d46e2574b" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1fd6ec70-56d3-4bc9-9653-1dc3dd20179b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_ResolutionBioscienceIncMember_34a0ac1c-e6d7-4a51-baba-ac087a8644cf" xlink:href="a-20220131.xsd#a_ResolutionBioscienceIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1fd6ec70-56d3-4bc9-9653-1dc3dd20179b" xlink:to="loc_a_ResolutionBioscienceIncMember_34a0ac1c-e6d7-4a51-baba-ac087a8644cf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ce0547e2-64de-4ad3-aa94-d5da849c7ab3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_45165381-ecff-4f29-a391-19ce5b8814d0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ce0547e2-64de-4ad3-aa94-d5da849c7ab3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ce0547e2-64de-4ad3-aa94-d5da849c7ab3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ce0547e2-64de-4ad3-aa94-d5da849c7ab3" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ce0547e2-64de-4ad3-aa94-d5da849c7ab3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_36509482-5a13-4ca2-840c-00cf51290216" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ce0547e2-64de-4ad3-aa94-d5da849c7ab3" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_36509482-5a13-4ca2-840c-00cf51290216" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_ThirdPartyTechnologyandLicensesMember_8ef288a2-90b9-49f2-af61-d2729580213e" xlink:href="a-20220131.xsd#a_ThirdPartyTechnologyandLicensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_36509482-5a13-4ca2-840c-00cf51290216" xlink:to="loc_a_ThirdPartyTechnologyandLicensesMember_8ef288a2-90b9-49f2-af61-d2729580213e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_d90b0ee2-bdc2-43cc-ad57-64dd0c5a6190" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_45165381-ecff-4f29-a391-19ce5b8814d0" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_d90b0ee2-bdc2-43cc-ad57-64dd0c5a6190" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_d90b0ee2-bdc2-43cc-ad57-64dd0c5a6190_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_d90b0ee2-bdc2-43cc-ad57-64dd0c5a6190" xlink:to="loc_us-gaap_SegmentDomain_d90b0ee2-bdc2-43cc-ad57-64dd0c5a6190_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_78b8c5aa-042e-4e19-b3eb-7c4cd2fcd318" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_d90b0ee2-bdc2-43cc-ad57-64dd0c5a6190" xlink:to="loc_us-gaap_SegmentDomain_78b8c5aa-042e-4e19-b3eb-7c4cd2fcd318" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_LifeSciencesandAppliedMarketsMember_70f76849-5a63-425b-a006-0e1233473e6c" xlink:href="a-20220131.xsd#a_LifeSciencesandAppliedMarketsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_78b8c5aa-042e-4e19-b3eb-7c4cd2fcd318" xlink:to="loc_a_LifeSciencesandAppliedMarketsMember_70f76849-5a63-425b-a006-0e1233473e6c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_DiagnosticsAndGenomicsMember_5d72bab9-d799-4855-a165-bde93f76df2a" xlink:href="a-20220131.xsd#a_DiagnosticsAndGenomicsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_78b8c5aa-042e-4e19-b3eb-7c4cd2fcd318" xlink:to="loc_a_DiagnosticsAndGenomicsMember_5d72bab9-d799-4855-a165-bde93f76df2a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_AgilentCrossLabMember_5ae59489-e32e-4101-969b-dfc4896d8cfa" xlink:href="a-20220131.xsd#a_AgilentCrossLabMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_78b8c5aa-042e-4e19-b3eb-7c4cd2fcd318" xlink:to="loc_a_AgilentCrossLabMember_5ae59489-e32e-4101-969b-dfc4896d8cfa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_16c2b148-4b37-4302-813e-332fa238af66" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_45165381-ecff-4f29-a391-19ce5b8814d0" xlink:to="loc_srt_RangeAxis_16c2b148-4b37-4302-813e-332fa238af66" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_16c2b148-4b37-4302-813e-332fa238af66_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_16c2b148-4b37-4302-813e-332fa238af66" xlink:to="loc_srt_RangeMember_16c2b148-4b37-4302-813e-332fa238af66_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_64037d0d-9acb-490a-a494-4435ff293522" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_16c2b148-4b37-4302-813e-332fa238af66" xlink:to="loc_srt_RangeMember_64037d0d-9acb-490a-a494-4435ff293522" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_03767688-fe27-41c2-93f0-8c46e2e3083f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_45165381-ecff-4f29-a391-19ce5b8814d0" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_03767688-fe27-41c2-93f0-8c46e2e3083f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_03767688-fe27-41c2-93f0-8c46e2e3083f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_03767688-fe27-41c2-93f0-8c46e2e3083f" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_03767688-fe27-41c2-93f0-8c46e2e3083f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_d29bbdd6-6280-4440-bd4e-1861fc17cb31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_03767688-fe27-41c2-93f0-8c46e2e3083f" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_d29bbdd6-6280-4440-bd4e-1861fc17cb31" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_be1e0d02-77f1-4f55-81c4-69e85e37452a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_d29bbdd6-6280-4440-bd4e-1861fc17cb31" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_be1e0d02-77f1-4f55-81c4-69e85e37452a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_3be02b87-acbf-4408-9283-3fecd682a6c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_d29bbdd6-6280-4440-bd4e-1861fc17cb31" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_3be02b87-acbf-4408-9283-3fecd682a6c4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillMember_371a4e57-6384-4dab-8d5f-45243551d679" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_d29bbdd6-6280-4440-bd4e-1861fc17cb31" xlink:to="loc_us-gaap_GoodwillMember_371a4e57-6384-4dab-8d5f-45243551d679" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_d20d006a-ce79-4fe7-838e-5c530c06339a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_d29bbdd6-6280-4440-bd4e-1861fc17cb31" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_d20d006a-ce79-4fe7-838e-5c530c06339a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_57725309-87d9-4e59-9ee5-c325d6273b8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_45165381-ecff-4f29-a391-19ce5b8814d0" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_57725309-87d9-4e59-9ee5-c325d6273b8b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_57725309-87d9-4e59-9ee5-c325d6273b8b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_57725309-87d9-4e59-9ee5-c325d6273b8b" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_57725309-87d9-4e59-9ee5-c325d6273b8b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5609eea3-fa33-4a09-b28c-58a049ab7be0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_57725309-87d9-4e59-9ee5-c325d6273b8b" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5609eea3-fa33-4a09-b28c-58a049ab7be0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_1741de59-2b70-47e1-a4bf-e3f759c2a060" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5609eea3-fa33-4a09-b28c-58a049ab7be0" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_1741de59-2b70-47e1-a4bf-e3f759c2a060" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_bd4d96d7-aed3-4306-a442-2c849f6eead9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_45165381-ecff-4f29-a391-19ce5b8814d0" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_bd4d96d7-aed3-4306-a442-2c849f6eead9" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_bd4d96d7-aed3-4306-a442-2c849f6eead9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_bd4d96d7-aed3-4306-a442-2c849f6eead9" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_bd4d96d7-aed3-4306-a442-2c849f6eead9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_5a596f82-877b-4334-a5df-293eacdb455b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_bd4d96d7-aed3-4306-a442-2c849f6eead9" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_5a596f82-877b-4334-a5df-293eacdb455b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_699caff4-6892-42c4-9e62-eb98dd2633ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_5a596f82-877b-4334-a5df-293eacdb455b" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_699caff4-6892-42c4-9e62-eb98dd2633ac" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.agilent.com/role/FAIRVALUEMEASUREMENTSFairvalueofassetsandliabilitiesmeasuredonarecurringbasisDetails" xlink:type="simple" xlink:href="a-20220131.xsd#FAIRVALUEMEASUREMENTSFairvalueofassetsandliabilitiesmeasuredonarecurringbasisDetails"/>
  <link:definitionLink xlink:role="http://www.agilent.com/role/FAIRVALUEMEASUREMENTSFairvalueofassetsandliabilitiesmeasuredonarecurringbasisDetails" xlink:type="extended" id="ib16ea927259349dd9b0ffab794ca2664_FAIRVALUEMEASUREMENTSFairvalueofassetsandliabilitiesmeasuredonarecurringbasisDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6f28b65a-96e6-4692-acea-9e669db70747" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_3031258e-1486-4990-8a8e-2f3b7e699529" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6f28b65a-96e6-4692-acea-9e669db70747" xlink:to="loc_us-gaap_AssetsCurrentAbstract_3031258e-1486-4990-8a8e-2f3b7e699529" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_d379a36c-132f-4985-919f-d8c57fb34402" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_3031258e-1486-4990-8a8e-2f3b7e699529" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_d379a36c-132f-4985-919f-d8c57fb34402" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_fe76625e-76c2-47cc-9d4d-f212ba9e052b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyContractAssetFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_3031258e-1486-4990-8a8e-2f3b7e699529" xlink:to="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_fe76625e-76c2-47cc-9d4d-f212ba9e052b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_14cb25da-27c3-4167-b66c-da462b1a79b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_3031258e-1486-4990-8a8e-2f3b7e699529" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_14cb25da-27c3-4167-b66c-da462b1a79b2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecurities_e1a99980-b5ea-4c45-bd47-33e19fec0cd6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradingSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_3031258e-1486-4990-8a8e-2f3b7e699529" xlink:to="loc_us-gaap_TradingSecurities_e1a99980-b5ea-4c45-bd47-33e19fec0cd6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_1a92e20f-dd3e-40ba-9f9d-de648d56ee3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_3031258e-1486-4990-8a8e-2f3b7e699529" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_1a92e20f-dd3e-40ba-9f9d-de648d56ee3d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_c3cf88a1-dc34-4bea-9b10-3e72ea03bf09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_3031258e-1486-4990-8a8e-2f3b7e699529" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_c3cf88a1-dc34-4bea-9b10-3e72ea03bf09" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_d72e0ae8-52e9-4c45-be39-0f647901663b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_3031258e-1486-4990-8a8e-2f3b7e699529" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_d72e0ae8-52e9-4c45-be39-0f647901663b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract_e92501c0-a099-4811-8f35-3036c55c5a56" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6f28b65a-96e6-4692-acea-9e669db70747" xlink:to="loc_us-gaap_LiabilitiesAbstract_e92501c0-a099-4811-8f35-3036c55c5a56" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_e4255ae5-7c59-4716-877a-b7a13c39688a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAbstract_e92501c0-a099-4811-8f35-3036c55c5a56" xlink:to="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_e4255ae5-7c59-4716-877a-b7a13c39688a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_11975786-2e1b-4f04-8a5a-1292e0c4f799" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAbstract_e92501c0-a099-4811-8f35-3036c55c5a56" xlink:to="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_11975786-2e1b-4f04-8a5a-1292e0c4f799" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_ccedd92c-f340-4268-8910-6f1abe21889a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAbstract_e92501c0-a099-4811-8f35-3036c55c5a56" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_ccedd92c-f340-4268-8910-6f1abe21889a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_34edffce-d928-4104-adb5-bbf186f4105a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6f28b65a-96e6-4692-acea-9e669db70747" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_34edffce-d928-4104-adb5-bbf186f4105a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_cadbc1c0-4e63-4467-b7ba-1aef5e96f88d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_34edffce-d928-4104-adb5-bbf186f4105a" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_cadbc1c0-4e63-4467-b7ba-1aef5e96f88d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_cadbc1c0-4e63-4467-b7ba-1aef5e96f88d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_cadbc1c0-4e63-4467-b7ba-1aef5e96f88d" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_cadbc1c0-4e63-4467-b7ba-1aef5e96f88d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_cc057abf-73b4-4d37-8ca7-9e74b0a0b137" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_cadbc1c0-4e63-4467-b7ba-1aef5e96f88d" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_cc057abf-73b4-4d37-8ca7-9e74b0a0b137" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_d2c66c79-1936-491d-a95b-e9a4aaf94fe4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_cc057abf-73b4-4d37-8ca7-9e74b0a0b137" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_d2c66c79-1936-491d-a95b-e9a4aaf94fe4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsNonrecurringMember_94b87b56-a229-4078-85c2-48e49ce9431c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsNonrecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_cc057abf-73b4-4d37-8ca7-9e74b0a0b137" xlink:to="loc_us-gaap_FairValueMeasurementsNonrecurringMember_94b87b56-a229-4078-85c2-48e49ce9431c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_362821d1-40f7-4574-b3e2-feb8578369f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_34edffce-d928-4104-adb5-bbf186f4105a" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_362821d1-40f7-4574-b3e2-feb8578369f5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_362821d1-40f7-4574-b3e2-feb8578369f5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_362821d1-40f7-4574-b3e2-feb8578369f5" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_362821d1-40f7-4574-b3e2-feb8578369f5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0369e5f2-ddf2-4c84-9621-d7cd9c016922" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_362821d1-40f7-4574-b3e2-feb8578369f5" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0369e5f2-ddf2-4c84-9621-d7cd9c016922" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_03583b82-1b49-456f-9f7f-38d4ae3b6023" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0369e5f2-ddf2-4c84-9621-d7cd9c016922" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_03583b82-1b49-456f-9f7f-38d4ae3b6023" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_f9dbe59a-3295-4dbf-85a9-55d93ed3bcda" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0369e5f2-ddf2-4c84-9621-d7cd9c016922" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_f9dbe59a-3295-4dbf-85a9-55d93ed3bcda" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_474f6c5f-03ba-4b0d-9ebe-11ce347a477c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0369e5f2-ddf2-4c84-9621-d7cd9c016922" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_474f6c5f-03ba-4b0d-9ebe-11ce347a477c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_46d1a827-be58-4ebe-81f3-0a4fd4811e16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_34edffce-d928-4104-adb5-bbf186f4105a" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_46d1a827-be58-4ebe-81f3-0a4fd4811e16" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_46d1a827-be58-4ebe-81f3-0a4fd4811e16_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_46d1a827-be58-4ebe-81f3-0a4fd4811e16" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_46d1a827-be58-4ebe-81f3-0a4fd4811e16_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_c224c12d-fd0b-4802-8554-9b0cc4a19e4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_46d1a827-be58-4ebe-81f3-0a4fd4811e16" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_c224c12d-fd0b-4802-8554-9b0cc4a19e4a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentAssetsMember_f358a5c3-0f5b-41a6-8000-0f081c15ba52" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_c224c12d-fd0b-4802-8554-9b0cc4a19e4a" xlink:to="loc_us-gaap_OtherCurrentAssetsMember_f358a5c3-0f5b-41a6-8000-0f081c15ba52" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember_143b821f-d57c-45a9-a8f8-51d5a4125df1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_c224c12d-fd0b-4802-8554-9b0cc4a19e4a" xlink:to="loc_us-gaap_OtherNoncurrentAssetsMember_143b821f-d57c-45a9-a8f8-51d5a4125df1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_b3662e47-98a3-4be8-a97d-7e6787d64798" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_c224c12d-fd0b-4802-8554-9b0cc4a19e4a" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_b3662e47-98a3-4be8-a97d-7e6787d64798" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_b970f3d1-e292-4551-a3e4-63b07402a021" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_c224c12d-fd0b-4802-8554-9b0cc4a19e4a" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_b970f3d1-e292-4551-a3e4-63b07402a021" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_54e61dc3-5ac6-48d5-985e-fab738641e36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_34edffce-d928-4104-adb5-bbf186f4105a" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_54e61dc3-5ac6-48d5-985e-fab738641e36" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_54e61dc3-5ac6-48d5-985e-fab738641e36_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_54e61dc3-5ac6-48d5-985e-fab738641e36" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_54e61dc3-5ac6-48d5-985e-fab738641e36_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_392c0a59-8ca2-41b5-b39e-be14abd63ad4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_54e61dc3-5ac6-48d5-985e-fab738641e36" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_392c0a59-8ca2-41b5-b39e-be14abd63ad4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_ResolutionBioscienceIncMember_1db9f0d4-079e-4adf-9fe1-b3846b99075c" xlink:href="a-20220131.xsd#a_ResolutionBioscienceIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_392c0a59-8ca2-41b5-b39e-be14abd63ad4" xlink:to="loc_a_ResolutionBioscienceIncMember_1db9f0d4-079e-4adf-9fe1-b3846b99075c" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.agilent.com/role/FAIRVALUEMEASUREMENTSContingentConsiderationDetails" xlink:type="simple" xlink:href="a-20220131.xsd#FAIRVALUEMEASUREMENTSContingentConsiderationDetails"/>
  <link:definitionLink xlink:role="http://www.agilent.com/role/FAIRVALUEMEASUREMENTSContingentConsiderationDetails" xlink:type="extended" id="i235e290fab944b3a9139f3fa4366ced6_FAIRVALUEMEASUREMENTSContingentConsiderationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_16efd401-8e15-47ca-93b1-21e13dd387b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_BusinessCombinationContingentConsiderationFairValueMeasurementInput_b90d5592-bd73-4975-9198-001848766a37" xlink:href="a-20220131.xsd#a_BusinessCombinationContingentConsiderationFairValueMeasurementInput"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_16efd401-8e15-47ca-93b1-21e13dd387b5" xlink:to="loc_a_BusinessCombinationContingentConsiderationFairValueMeasurementInput_b90d5592-bd73-4975-9198-001848766a37" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_BusinessCombinationsContingentConsiderationArrangements_5f65d625-4282-44f6-808c-c6a4a395bea9" xlink:href="a-20220131.xsd#a_BusinessCombinationsContingentConsiderationArrangements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_16efd401-8e15-47ca-93b1-21e13dd387b5" xlink:to="loc_a_BusinessCombinationsContingentConsiderationArrangements_5f65d625-4282-44f6-808c-c6a4a395bea9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_4ead0644-2a6a-4145-aff7-6c017fca482b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_16efd401-8e15-47ca-93b1-21e13dd387b5" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_4ead0644-2a6a-4145-aff7-6c017fca482b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_dbafacdc-96c1-4005-98cd-c6fd6a884779" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_16efd401-8e15-47ca-93b1-21e13dd387b5" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_dbafacdc-96c1-4005-98cd-c6fd6a884779" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_cb7bb6fa-b4d1-4999-8a83-7343f32c48db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_dbafacdc-96c1-4005-98cd-c6fd6a884779" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_cb7bb6fa-b4d1-4999-8a83-7343f32c48db" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_cb7bb6fa-b4d1-4999-8a83-7343f32c48db_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_cb7bb6fa-b4d1-4999-8a83-7343f32c48db" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_cb7bb6fa-b4d1-4999-8a83-7343f32c48db_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_95263ebd-df98-4382-a509-851d9963fe01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_cb7bb6fa-b4d1-4999-8a83-7343f32c48db" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_95263ebd-df98-4382-a509-851d9963fe01" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_MeasurementInputAssetVolatilityMember_ed0182b9-5b45-4c8f-8b79-89aa27791b3c" xlink:href="a-20220131.xsd#a_MeasurementInputAssetVolatilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_95263ebd-df98-4382-a509-851d9963fe01" xlink:to="loc_a_MeasurementInputAssetVolatilityMember_ed0182b9-5b45-4c8f-8b79-89aa27791b3c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_MeasurementInputRevenueVolatilityMember_049063a6-e63f-44f5-8c43-87862fe78564" xlink:href="a-20220131.xsd#a_MeasurementInputRevenueVolatilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_95263ebd-df98-4382-a509-851d9963fe01" xlink:to="loc_a_MeasurementInputRevenueVolatilityMember_049063a6-e63f-44f5-8c43-87862fe78564" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_fe2173bf-de52-428d-a700-a7d89567ad4e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_dbafacdc-96c1-4005-98cd-c6fd6a884779" xlink:to="loc_srt_RangeAxis_fe2173bf-de52-428d-a700-a7d89567ad4e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_fe2173bf-de52-428d-a700-a7d89567ad4e_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_fe2173bf-de52-428d-a700-a7d89567ad4e" xlink:to="loc_srt_RangeMember_fe2173bf-de52-428d-a700-a7d89567ad4e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_6b434512-15eb-4f24-80a7-e8dcebeecfbc" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_fe2173bf-de52-428d-a700-a7d89567ad4e" xlink:to="loc_srt_RangeMember_6b434512-15eb-4f24-80a7-e8dcebeecfbc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_77b80cb6-e72f-4f52-9443-05d31131bc5b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_6b434512-15eb-4f24-80a7-e8dcebeecfbc" xlink:to="loc_srt_MinimumMember_77b80cb6-e72f-4f52-9443-05d31131bc5b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_6a19bec7-3a37-4924-8464-958b887ac65f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_6b434512-15eb-4f24-80a7-e8dcebeecfbc" xlink:to="loc_srt_MaximumMember_6a19bec7-3a37-4924-8464-958b887ac65f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_3f9ea11b-a51a-4cfd-8f27-139fdaa9baa2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_dbafacdc-96c1-4005-98cd-c6fd6a884779" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_3f9ea11b-a51a-4cfd-8f27-139fdaa9baa2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3f9ea11b-a51a-4cfd-8f27-139fdaa9baa2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_3f9ea11b-a51a-4cfd-8f27-139fdaa9baa2" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3f9ea11b-a51a-4cfd-8f27-139fdaa9baa2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_98c2d41b-b4c2-463c-a1b3-dd0fe8891d35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_3f9ea11b-a51a-4cfd-8f27-139fdaa9baa2" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_98c2d41b-b4c2-463c-a1b3-dd0fe8891d35" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_ResolutionBioscienceIncMember_eb661d60-ddab-4382-931d-6ec34923cd8d" xlink:href="a-20220131.xsd#a_ResolutionBioscienceIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_98c2d41b-b4c2-463c-a1b3-dd0fe8891d35" xlink:to="loc_a_ResolutionBioscienceIncMember_eb661d60-ddab-4382-931d-6ec34923cd8d" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.agilent.com/role/FAIRVALUEMEASUREMENTSAssetsandLiabilitiesmeasuredatFairValueonaNonRecurringBasisDetails" xlink:type="simple" xlink:href="a-20220131.xsd#FAIRVALUEMEASUREMENTSAssetsandLiabilitiesmeasuredatFairValueonaNonRecurringBasisDetails"/>
  <link:definitionLink xlink:role="http://www.agilent.com/role/FAIRVALUEMEASUREMENTSAssetsandLiabilitiesmeasuredatFairValueonaNonRecurringBasisDetails" xlink:type="extended" id="i5d6c2bd892794b6598d11905ade45521_FAIRVALUEMEASUREMENTSAssetsandLiabilitiesmeasuredatFairValueonaNonRecurringBasisDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_7e295ad1-3e53-4cf2-8e0c-d73e87ddf9c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_AssetsLongLivedAbstract_87f63437-2de0-4286-acf9-68fa6bf6498b" xlink:href="a-20220131.xsd#a_AssetsLongLivedAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_7e295ad1-3e53-4cf2-8e0c-d73e87ddf9c3" xlink:to="loc_a_AssetsLongLivedAbstract_87f63437-2de0-4286-acf9-68fa6bf6498b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairedAssetsToBeDisposedOfByMethodOtherThanSaleCarryingValueOfAsset_c2de9ae8-33e9-4daa-a97c-8e2d0d556aa9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairedAssetsToBeDisposedOfByMethodOtherThanSaleCarryingValueOfAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_a_AssetsLongLivedAbstract_87f63437-2de0-4286-acf9-68fa6bf6498b" xlink:to="loc_us-gaap_ImpairedAssetsToBeDisposedOfByMethodOtherThanSaleCarryingValueOfAsset_c2de9ae8-33e9-4daa-a97c-8e2d0d556aa9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsFairValueDisclosure_16fef99b-0fb3-40c8-9dd6-9162a3e93c6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_a_AssetsLongLivedAbstract_87f63437-2de0-4286-acf9-68fa6bf6498b" xlink:to="loc_us-gaap_OtherAssetsFairValueDisclosure_16fef99b-0fb3-40c8-9dd6-9162a3e93c6c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_3347a349-4566-485f-a3bb-7d18d5f74cdb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_a_AssetsLongLivedAbstract_87f63437-2de0-4286-acf9-68fa6bf6498b" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_3347a349-4566-485f-a3bb-7d18d5f74cdb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_c5f64791-abb2-45e5-9bd4-cb5af62ac53c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_a_AssetsLongLivedAbstract_87f63437-2de0-4286-acf9-68fa6bf6498b" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_c5f64791-abb2-45e5-9bd4-cb5af62ac53c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiGainLossAbstract_6ab85966-4340-49f5-8234-0ff2629ba671" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNiGainLossAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_7e295ad1-3e53-4cf2-8e0c-d73e87ddf9c3" xlink:to="loc_us-gaap_EquitySecuritiesFvNiGainLossAbstract_6ab85966-4340-49f5-8234-0ff2629ba671" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount_ab1cbadd-1cbe-4a83-be60-33aaf2adc530" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquitySecuritiesFvNiGainLossAbstract_6ab85966-4340-49f5-8234-0ff2629ba671" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount_ab1cbadd-1cbe-4a83-be60-33aaf2adc530" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_15ed8e6e-397e-46f9-ba0b-ae37c5da05fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquitySecuritiesFvNiGainLossAbstract_6ab85966-4340-49f5-8234-0ff2629ba671" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_15ed8e6e-397e-46f9-ba0b-ae37c5da05fa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_00e6613d-654b-41f1-8c1e-fe96e2e6d80d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_7e295ad1-3e53-4cf2-8e0c-d73e87ddf9c3" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_00e6613d-654b-41f1-8c1e-fe96e2e6d80d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_2c3182db-1c78-4312-a682-a106c6f58a33" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_00e6613d-654b-41f1-8c1e-fe96e2e6d80d" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_2c3182db-1c78-4312-a682-a106c6f58a33" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_2c3182db-1c78-4312-a682-a106c6f58a33_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_2c3182db-1c78-4312-a682-a106c6f58a33" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_2c3182db-1c78-4312-a682-a106c6f58a33_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_3ce1dae5-b38f-4fa1-98f1-b04b9bc57716" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_2c3182db-1c78-4312-a682-a106c6f58a33" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_3ce1dae5-b38f-4fa1-98f1-b04b9bc57716" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsNonrecurringMember_98caf8af-1db8-47d2-92b8-6a3f36151f2d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsNonrecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_3ce1dae5-b38f-4fa1-98f1-b04b9bc57716" xlink:to="loc_us-gaap_FairValueMeasurementsNonrecurringMember_98caf8af-1db8-47d2-92b8-6a3f36151f2d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_6b5b2dd9-be9d-4955-b7e9-1e6649ed3928" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_3ce1dae5-b38f-4fa1-98f1-b04b9bc57716" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_6b5b2dd9-be9d-4955-b7e9-1e6649ed3928" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_575afa07-17d3-499d-ad10-44ddd846ee3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_00e6613d-654b-41f1-8c1e-fe96e2e6d80d" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_575afa07-17d3-499d-ad10-44ddd846ee3e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_575afa07-17d3-499d-ad10-44ddd846ee3e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_575afa07-17d3-499d-ad10-44ddd846ee3e" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_575afa07-17d3-499d-ad10-44ddd846ee3e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_383a88c3-6713-4e9a-9cda-667ce9bacdd3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_575afa07-17d3-499d-ad10-44ddd846ee3e" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_383a88c3-6713-4e9a-9cda-667ce9bacdd3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_a5843b7f-779e-409f-80d0-47debfb2cb50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_00e6613d-654b-41f1-8c1e-fe96e2e6d80d" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_a5843b7f-779e-409f-80d0-47debfb2cb50" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_a5843b7f-779e-409f-80d0-47debfb2cb50_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_a5843b7f-779e-409f-80d0-47debfb2cb50" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_a5843b7f-779e-409f-80d0-47debfb2cb50_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_755bbff2-bfdc-4d25-ac88-66f333abafbf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_a5843b7f-779e-409f-80d0-47debfb2cb50" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_755bbff2-bfdc-4d25-ac88-66f333abafbf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_MeasurementInputAssetVolatilityMember_cab414f9-d51b-418d-8537-fda589794b24" xlink:href="a-20220131.xsd#a_MeasurementInputAssetVolatilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_755bbff2-bfdc-4d25-ac88-66f333abafbf" xlink:to="loc_a_MeasurementInputAssetVolatilityMember_cab414f9-d51b-418d-8537-fda589794b24" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_MeasurementInputRevenueVolatilityMember_83b56800-674e-44cb-bce6-64da0462b6ae" xlink:href="a-20220131.xsd#a_MeasurementInputRevenueVolatilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_755bbff2-bfdc-4d25-ac88-66f333abafbf" xlink:to="loc_a_MeasurementInputRevenueVolatilityMember_83b56800-674e-44cb-bce6-64da0462b6ae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_d814de7e-265e-4a57-a583-1b137d1864c2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_00e6613d-654b-41f1-8c1e-fe96e2e6d80d" xlink:to="loc_srt_RangeAxis_d814de7e-265e-4a57-a583-1b137d1864c2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d814de7e-265e-4a57-a583-1b137d1864c2_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_d814de7e-265e-4a57-a583-1b137d1864c2" xlink:to="loc_srt_RangeMember_d814de7e-265e-4a57-a583-1b137d1864c2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_add9e4ab-4026-4def-80f9-fcc33a939d1a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_d814de7e-265e-4a57-a583-1b137d1864c2" xlink:to="loc_srt_RangeMember_add9e4ab-4026-4def-80f9-fcc33a939d1a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_0ac4fd77-6960-4585-962a-638be8b06237" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_add9e4ab-4026-4def-80f9-fcc33a939d1a" xlink:to="loc_srt_MinimumMember_0ac4fd77-6960-4585-962a-638be8b06237" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_29a2d627-28f9-4127-b9f2-5ae27e356430" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_add9e4ab-4026-4def-80f9-fcc33a939d1a" xlink:to="loc_srt_MaximumMember_29a2d627-28f9-4127-b9f2-5ae27e356430" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.agilent.com/role/DERIVATIVESTextDetails" xlink:type="simple" xlink:href="a-20220131.xsd#DERIVATIVESTextDetails"/>
  <link:definitionLink xlink:role="http://www.agilent.com/role/DERIVATIVESTextDetails" xlink:type="extended" id="ifdd770fad1e740249c78ee125b97507d_DERIVATIVESTextDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_62f2dee5-7f77-459b-b35d-f0118e4f97aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentDetailAbstract_99a9bcdb-6c21-4ed3-8ca8-4cb90bcc5e74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentDetailAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_62f2dee5-7f77-459b-b35d-f0118e4f97aa" xlink:to="loc_us-gaap_DerivativeInstrumentDetailAbstract_99a9bcdb-6c21-4ed3-8ca8-4cb90bcc5e74" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNetLiabilityPositionAggregateFairValue_f28a6bc0-2141-442c-b1b0-16807b8ebfdb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeNetLiabilityPositionAggregateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentDetailAbstract_99a9bcdb-6c21-4ed3-8ca8-4cb90bcc5e74" xlink:to="loc_us-gaap_DerivativeNetLiabilityPositionAggregateFairValue_f28a6bc0-2141-442c-b1b0-16807b8ebfdb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateDerivativesAbstract_e3fe3289-f5e1-4d8d-a61b-e463d3db3ae5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateDerivativesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentDetailAbstract_99a9bcdb-6c21-4ed3-8ca8-4cb90bcc5e74" xlink:to="loc_us-gaap_InterestRateDerivativesAbstract_e3fe3289-f5e1-4d8d-a61b-e463d3db3ae5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfInterestRateDerivativesHeld_024580ea-acd8-4dde-8eb3-e5663e73848b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfInterestRateDerivativesHeld"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InterestRateDerivativesAbstract_e3fe3289-f5e1-4d8d-a61b-e463d3db3ae5" xlink:to="loc_us-gaap_NumberOfInterestRateDerivativesHeld_024580ea-acd8-4dde-8eb3-e5663e73848b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_5f6f7f57-0358-4270-a7d8-0a6a826ba6be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InterestRateDerivativesAbstract_e3fe3289-f5e1-4d8d-a61b-e463d3db3ae5" xlink:to="loc_us-gaap_DerivativeNotionalAmount_5f6f7f57-0358-4270-a7d8-0a6a826ba6be" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_Interestrateswappayments_c8cddb8c-780d-425d-b734-ffe48e1467c6" xlink:href="a-20220131.xsd#a_Interestrateswappayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InterestRateDerivativesAbstract_e3fe3289-f5e1-4d8d-a61b-e463d3db3ae5" xlink:to="loc_a_Interestrateswappayments_c8cddb8c-780d-425d-b734-ffe48e1467c6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSeniorDebt_a45c6c93-d67c-4e0b-ba9d-e3cab636f141" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfSeniorDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InterestRateDerivativesAbstract_e3fe3289-f5e1-4d8d-a61b-e463d3db3ae5" xlink:to="loc_us-gaap_RepaymentsOfSeniorDebt_a45c6c93-d67c-4e0b-ba9d-e3cab636f141" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_88883d63-d999-4675-adc8-473b2fbbd40d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InterestRateDerivativesAbstract_e3fe3289-f5e1-4d8d-a61b-e463d3db3ae5" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_88883d63-d999-4675-adc8-473b2fbbd40d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_Remaininggainlosstobeamortizedonderivative_14027b30-c09e-4cb8-85a0-e585d0d82c91" xlink:href="a-20220131.xsd#a_Remaininggainlosstobeamortizedonderivative"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InterestRateDerivativesAbstract_e3fe3289-f5e1-4d8d-a61b-e463d3db3ae5" xlink:to="loc_a_Remaininggainlosstobeamortizedonderivative_14027b30-c09e-4cb8-85a0-e585d0d82c91" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfNetInvestmentHedgeActivityAbstract_804a47dc-203e-4e2d-98c8-7b57fdaf954f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SummaryOfNetInvestmentHedgeActivityAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentDetailAbstract_99a9bcdb-6c21-4ed3-8ca8-4cb90bcc5e74" xlink:to="loc_us-gaap_SummaryOfNetInvestmentHedgeActivityAbstract_804a47dc-203e-4e2d-98c8-7b57fdaf954f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_58fcc982-6751-4e2d-bdb4-2248be314da6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SummaryOfNetInvestmentHedgeActivityAbstract_804a47dc-203e-4e2d-98c8-7b57fdaf954f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_58fcc982-6751-4e2d-bdb4-2248be314da6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_98ad562e-6e33-4eca-95c0-f68978e854be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_62f2dee5-7f77-459b-b35d-f0118e4f97aa" xlink:to="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_98ad562e-6e33-4eca-95c0-f68978e854be" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_f6a072f8-915e-405d-ac63-84ecfd6bc28d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_62f2dee5-7f77-459b-b35d-f0118e4f97aa" xlink:to="loc_us-gaap_DerivativeTable_f6a072f8-915e-405d-ac63-84ecfd6bc28d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_904a097a-99f3-4ae4-9c68-08548b7fccb7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_f6a072f8-915e-405d-ac63-84ecfd6bc28d" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_904a097a-99f3-4ae4-9c68-08548b7fccb7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_904a097a-99f3-4ae4-9c68-08548b7fccb7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_904a097a-99f3-4ae4-9c68-08548b7fccb7" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_904a097a-99f3-4ae4-9c68-08548b7fccb7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_47ba13ea-7838-4b6f-b551-04cac9f76fea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_904a097a-99f3-4ae4-9c68-08548b7fccb7" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_47ba13ea-7838-4b6f-b551-04cac9f76fea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_fe038ef9-f199-419f-9d04-55895037a724" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_47ba13ea-7838-4b6f-b551-04cac9f76fea" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_fe038ef9-f199-419f-9d04-55895037a724" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_24c22b53-5a0f-4f6d-975a-4b1dd92887fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_f6a072f8-915e-405d-ac63-84ecfd6bc28d" xlink:to="loc_us-gaap_DebtInstrumentAxis_24c22b53-5a0f-4f6d-975a-4b1dd92887fa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_24c22b53-5a0f-4f6d-975a-4b1dd92887fa_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_24c22b53-5a0f-4f6d-975a-4b1dd92887fa" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_24c22b53-5a0f-4f6d-975a-4b1dd92887fa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_b1ac5bef-b1f4-4fcd-9966-7bbe5e9bbd74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_24c22b53-5a0f-4f6d-975a-4b1dd92887fa" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_b1ac5bef-b1f4-4fcd-9966-7bbe5e9bbd74" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_SeniorNotes2022Member_83de3a60-35c0-49f8-b6f2-38e996112102" xlink:href="a-20220131.xsd#a_SeniorNotes2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b1ac5bef-b1f4-4fcd-9966-7bbe5e9bbd74" xlink:to="loc_a_SeniorNotes2022Member_83de3a60-35c0-49f8-b6f2-38e996112102" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_SeniorNotes2026Member_38f787dc-a9e4-47c5-9460-aea5684f622c" xlink:href="a-20220131.xsd#a_SeniorNotes2026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b1ac5bef-b1f4-4fcd-9966-7bbe5e9bbd74" xlink:to="loc_a_SeniorNotes2026Member_38f787dc-a9e4-47c5-9460-aea5684f622c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_SeniorNotes2029Member_c82005b8-f541-4dfe-9251-fc97593cc570" xlink:href="a-20220131.xsd#a_SeniorNotes2029Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b1ac5bef-b1f4-4fcd-9966-7bbe5e9bbd74" xlink:to="loc_a_SeniorNotes2029Member_c82005b8-f541-4dfe-9251-fc97593cc570" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_0beb2894-7bf2-4593-9929-b8468e0825a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_f6a072f8-915e-405d-ac63-84ecfd6bc28d" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_0beb2894-7bf2-4593-9929-b8468e0825a4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_0beb2894-7bf2-4593-9929-b8468e0825a4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_0beb2894-7bf2-4593-9929-b8468e0825a4" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_0beb2894-7bf2-4593-9929-b8468e0825a4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_0ea05ed9-08f6-4cbd-8072-6e19581e9da7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_0beb2894-7bf2-4593-9929-b8468e0825a4" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_0ea05ed9-08f6-4cbd-8072-6e19581e9da7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_becbcee2-f930-4642-a26e-0a20f7874686" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_0ea05ed9-08f6-4cbd-8072-6e19581e9da7" xlink:to="loc_us-gaap_InterestRateSwapMember_becbcee2-f930-4642-a26e-0a20f7874686" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryLockMember_57de031d-e7c2-4d64-9f9d-033191193b5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryLockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_0ea05ed9-08f6-4cbd-8072-6e19581e9da7" xlink:to="loc_us-gaap_TreasuryLockMember_57de031d-e7c2-4d64-9f9d-033191193b5b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_e118dbb0-b319-439b-ba6a-209556c80cad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_0ea05ed9-08f6-4cbd-8072-6e19581e9da7" xlink:to="loc_us-gaap_ForeignExchangeContractMember_e118dbb0-b319-439b-ba6a-209556c80cad" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_61f90dd0-f38b-4c57-ae2f-15128058c19f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_f6a072f8-915e-405d-ac63-84ecfd6bc28d" xlink:to="loc_us-gaap_HedgingDesignationAxis_61f90dd0-f38b-4c57-ae2f-15128058c19f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_61f90dd0-f38b-4c57-ae2f-15128058c19f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_61f90dd0-f38b-4c57-ae2f-15128058c19f" xlink:to="loc_us-gaap_HedgingDesignationDomain_61f90dd0-f38b-4c57-ae2f-15128058c19f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_409e40c8-5be2-44cd-922f-72fc75a9e6b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_61f90dd0-f38b-4c57-ae2f-15128058c19f" xlink:to="loc_us-gaap_HedgingDesignationDomain_409e40c8-5be2-44cd-922f-72fc75a9e6b1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_9ab731bd-370a-4af1-98cb-74be0b944cfd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_409e40c8-5be2-44cd-922f-72fc75a9e6b1" xlink:to="loc_us-gaap_NondesignatedMember_9ab731bd-370a-4af1-98cb-74be0b944cfd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_7c1baa6b-ca0a-4542-86f4-0520eee3c5d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_409e40c8-5be2-44cd-922f-72fc75a9e6b1" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_7c1baa6b-ca0a-4542-86f4-0520eee3c5d2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_9e5ef8ef-0672-4f8a-abdc-b89b899fb72b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_f6a072f8-915e-405d-ac63-84ecfd6bc28d" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_9e5ef8ef-0672-4f8a-abdc-b89b899fb72b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_9e5ef8ef-0672-4f8a-abdc-b89b899fb72b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_9e5ef8ef-0672-4f8a-abdc-b89b899fb72b" xlink:to="loc_us-gaap_HedgingRelationshipDomain_9e5ef8ef-0672-4f8a-abdc-b89b899fb72b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_879d3db0-32c5-49ce-8d3e-4bddc11ac687" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_9e5ef8ef-0672-4f8a-abdc-b89b899fb72b" xlink:to="loc_us-gaap_HedgingRelationshipDomain_879d3db0-32c5-49ce-8d3e-4bddc11ac687" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_014e5a75-8ffd-446f-874c-719f4f679f98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_879d3db0-32c5-49ce-8d3e-4bddc11ac687" xlink:to="loc_us-gaap_CashFlowHedgingMember_014e5a75-8ffd-446f-874c-719f4f679f98" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_c56c0ec0-20a3-4aa6-96a0-b16b501c9162" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_879d3db0-32c5-49ce-8d3e-4bddc11ac687" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_c56c0ec0-20a3-4aa6-96a0-b16b501c9162" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_58e5c970-0bdb-4633-a1c0-bf684604e275" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_f6a072f8-915e-405d-ac63-84ecfd6bc28d" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_58e5c970-0bdb-4633-a1c0-bf684604e275" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_58e5c970-0bdb-4633-a1c0-bf684604e275_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_58e5c970-0bdb-4633-a1c0-bf684604e275" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_58e5c970-0bdb-4633-a1c0-bf684604e275_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_a2d457de-23bf-46d4-93f4-f243447ab542" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_58e5c970-0bdb-4633-a1c0-bf684604e275" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_a2d457de-23bf-46d4-93f4-f243447ab542" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_a58e78ff-e590-4c23-8a72-7c71ca25db26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_a2d457de-23bf-46d4-93f4-f243447ab542" xlink:to="loc_us-gaap_CostOfSalesMember_a58e78ff-e590-4c23-8a72-7c71ca25db26" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.agilent.com/role/DERIVATIVESForeignExchangeForwardContractsDetails" xlink:type="simple" xlink:href="a-20220131.xsd#DERIVATIVESForeignExchangeForwardContractsDetails"/>
  <link:definitionLink xlink:role="http://www.agilent.com/role/DERIVATIVESForeignExchangeForwardContractsDetails" xlink:type="extended" id="ic213a161790a4a41883322cfb37dade2_DERIVATIVESForeignExchangeForwardContractsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_f4879726-c575-49e3-951e-d2b136db2a01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfForeignCurrencyDerivativesHeld_7ef99e28-67e6-408b-b234-ca98abed3044" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfForeignCurrencyDerivativesHeld"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_f4879726-c575-49e3-951e-d2b136db2a01" xlink:to="loc_us-gaap_NumberOfForeignCurrencyDerivativesHeld_7ef99e28-67e6-408b-b234-ca98abed3044" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_52e68fe3-9ae2-43a0-9ab6-839221eee2c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_f4879726-c575-49e3-951e-d2b136db2a01" xlink:to="loc_us-gaap_DerivativeNotionalAmount_52e68fe3-9ae2-43a0-9ab6-839221eee2c3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_55a91cbd-dc1d-4453-819e-819feb3f4090" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_f4879726-c575-49e3-951e-d2b136db2a01" xlink:to="loc_us-gaap_DerivativeTable_55a91cbd-dc1d-4453-819e-819feb3f4090" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionAxis_318f26a9-8a76-4218-b077-5b07fd8e5b26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PositionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_55a91cbd-dc1d-4453-819e-819feb3f4090" xlink:to="loc_us-gaap_PositionAxis_318f26a9-8a76-4218-b077-5b07fd8e5b26" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionDomain_318f26a9-8a76-4218-b077-5b07fd8e5b26_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PositionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PositionAxis_318f26a9-8a76-4218-b077-5b07fd8e5b26" xlink:to="loc_us-gaap_PositionDomain_318f26a9-8a76-4218-b077-5b07fd8e5b26_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionDomain_db2a63c2-5bf0-40ed-885f-29a3f8e4c8ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PositionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PositionAxis_318f26a9-8a76-4218-b077-5b07fd8e5b26" xlink:to="loc_us-gaap_PositionDomain_db2a63c2-5bf0-40ed-885f-29a3f8e4c8ad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortMember_ee19638b-799f-4361-9755-95cba5d53bd7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PositionDomain_db2a63c2-5bf0-40ed-885f-29a3f8e4c8ad" xlink:to="loc_us-gaap_ShortMember_ee19638b-799f-4361-9755-95cba5d53bd7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongMember_b87873cc-e437-444f-99e9-67907db5e05e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PositionDomain_db2a63c2-5bf0-40ed-885f-29a3f8e4c8ad" xlink:to="loc_us-gaap_LongMember_b87873cc-e437-444f-99e9-67907db5e05e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_1f5d7e1a-5f6d-4764-82e0-9f611f448d9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_55a91cbd-dc1d-4453-819e-819feb3f4090" xlink:to="loc_us-gaap_HedgingDesignationAxis_1f5d7e1a-5f6d-4764-82e0-9f611f448d9b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_1f5d7e1a-5f6d-4764-82e0-9f611f448d9b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_1f5d7e1a-5f6d-4764-82e0-9f611f448d9b" xlink:to="loc_us-gaap_HedgingDesignationDomain_1f5d7e1a-5f6d-4764-82e0-9f611f448d9b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_d73e3134-4a94-4696-b33a-45acdae93189" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_1f5d7e1a-5f6d-4764-82e0-9f611f448d9b" xlink:to="loc_us-gaap_HedgingDesignationDomain_d73e3134-4a94-4696-b33a-45acdae93189" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_0eec809b-5030-4ffc-b724-d056129e3d7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_d73e3134-4a94-4696-b33a-45acdae93189" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_0eec809b-5030-4ffc-b724-d056129e3d7e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_4f6db523-78d2-431e-b4e9-2c10ddc5f143" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_d73e3134-4a94-4696-b33a-45acdae93189" xlink:to="loc_us-gaap_NondesignatedMember_4f6db523-78d2-431e-b4e9-2c10ddc5f143" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_3292843f-2a17-4b9f-8f92-5d9a92284429" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_55a91cbd-dc1d-4453-819e-819feb3f4090" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_3292843f-2a17-4b9f-8f92-5d9a92284429" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_3292843f-2a17-4b9f-8f92-5d9a92284429_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_3292843f-2a17-4b9f-8f92-5d9a92284429" xlink:to="loc_us-gaap_HedgingRelationshipDomain_3292843f-2a17-4b9f-8f92-5d9a92284429_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_dfc96713-6853-4b0c-b7d5-7e621df27260" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_3292843f-2a17-4b9f-8f92-5d9a92284429" xlink:to="loc_us-gaap_HedgingRelationshipDomain_dfc96713-6853-4b0c-b7d5-7e621df27260" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_c68ac275-4703-4b8f-af74-091031b44a6b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_dfc96713-6853-4b0c-b7d5-7e621df27260" xlink:to="loc_us-gaap_CashFlowHedgingMember_c68ac275-4703-4b8f-af74-091031b44a6b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_d2169389-19b7-4487-855e-0a0da9bca145" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_dfc96713-6853-4b0c-b7d5-7e621df27260" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_d2169389-19b7-4487-855e-0a0da9bca145" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CurrencyAxis_3a740330-f2db-4403-836a-802d4d2d649e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CurrencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_55a91cbd-dc1d-4453-819e-819feb3f4090" xlink:to="loc_srt_CurrencyAxis_3a740330-f2db-4403-836a-802d4d2d649e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_3a740330-f2db-4403-836a-802d4d2d649e_default" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_AllCurrenciesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CurrencyAxis_3a740330-f2db-4403-836a-802d4d2d649e" xlink:to="loc_currency_AllCurrenciesDomain_3a740330-f2db-4403-836a-802d4d2d649e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_722008ab-2c05-43c2-a356-6c2d61e603c0" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_AllCurrenciesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CurrencyAxis_3a740330-f2db-4403-836a-802d4d2d649e" xlink:to="loc_currency_AllCurrenciesDomain_722008ab-2c05-43c2-a356-6c2d61e603c0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_EUR_7aa7ed3e-b37e-4a1b-acdb-de2c536ad24d" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_EUR"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_722008ab-2c05-43c2-a356-6c2d61e603c0" xlink:to="loc_currency_EUR_7aa7ed3e-b37e-4a1b-acdb-de2c536ad24d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_GBP_317e1a3c-e72e-47ed-9c49-b397305376b7" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_GBP"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_722008ab-2c05-43c2-a356-6c2d61e603c0" xlink:to="loc_currency_GBP_317e1a3c-e72e-47ed-9c49-b397305376b7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_CAD_dd6b703d-9d90-4f77-9a94-5c494712a3ba" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_CAD"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_722008ab-2c05-43c2-a356-6c2d61e603c0" xlink:to="loc_currency_CAD_dd6b703d-9d90-4f77-9a94-5c494712a3ba" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AUD_40583f75-97c6-4c6e-b55c-3a4208bf0d4d" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_AUD"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_722008ab-2c05-43c2-a356-6c2d61e603c0" xlink:to="loc_currency_AUD_40583f75-97c6-4c6e-b55c-3a4208bf0d4d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_MYR_d1d0874c-9b7b-40d5-8f13-445853bfaf24" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_MYR"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_722008ab-2c05-43c2-a356-6c2d61e603c0" xlink:to="loc_currency_MYR_d1d0874c-9b7b-40d5-8f13-445853bfaf24" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_JPY_abf95433-c768-41b0-a10a-1b903aea7eae" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_JPY"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_722008ab-2c05-43c2-a356-6c2d61e603c0" xlink:to="loc_currency_JPY_abf95433-c768-41b0-a10a-1b903aea7eae" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_DKK_f9bacfd0-0583-437d-9728-9f576b296041" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_DKK"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_722008ab-2c05-43c2-a356-6c2d61e603c0" xlink:to="loc_currency_DKK_f9bacfd0-0583-437d-9728-9f576b296041" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_KRW_08c796e5-4cd3-44ec-b6fe-9e2d803b33ce" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_KRW"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_722008ab-2c05-43c2-a356-6c2d61e603c0" xlink:to="loc_currency_KRW_08c796e5-4cd3-44ec-b6fe-9e2d803b33ce" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_SGD_a54c9eac-133b-4c04-b250-efb3c9d2044b" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_SGD"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_722008ab-2c05-43c2-a356-6c2d61e603c0" xlink:to="loc_currency_SGD_a54c9eac-133b-4c04-b250-efb3c9d2044b" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_CHF_33a5715a-e2d2-432a-9e23-a4481576ab01" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_CHF"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_722008ab-2c05-43c2-a356-6c2d61e603c0" xlink:to="loc_currency_CHF_33a5715a-e2d2-432a-9e23-a4481576ab01" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_CNY_d9aab4be-e37f-42b9-b75e-f1a2e5400f7c" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_CNY"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_722008ab-2c05-43c2-a356-6c2d61e603c0" xlink:to="loc_currency_CNY_d9aab4be-e37f-42b9-b75e-f1a2e5400f7c" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_PLN_ddd8f287-7a4c-4adb-ba62-0e9571a25aae" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_PLN"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_722008ab-2c05-43c2-a356-6c2d61e603c0" xlink:to="loc_currency_PLN_ddd8f287-7a4c-4adb-ba62-0e9571a25aae" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_SEK_3e704bef-e125-4a4b-8e02-f39150bbd679" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_SEK"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_722008ab-2c05-43c2-a356-6c2d61e603c0" xlink:to="loc_currency_SEK_3e704bef-e125-4a4b-8e02-f39150bbd679" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_TWD_f7192e3c-5291-422c-bf2e-d91bd0fcce3e" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_TWD"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_722008ab-2c05-43c2-a356-6c2d61e603c0" xlink:to="loc_currency_TWD_f7192e3c-5291-422c-bf2e-d91bd0fcce3e" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_INR_074498ed-f487-48b3-ae78-e0936755cbf1" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_INR"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_722008ab-2c05-43c2-a356-6c2d61e603c0" xlink:to="loc_currency_INR_074498ed-f487-48b3-ae78-e0936755cbf1" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_XXX_8257b5ad-2e2c-4184-bd93-2cd8b155d104" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_XXX"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_722008ab-2c05-43c2-a356-6c2d61e603c0" xlink:to="loc_currency_XXX_8257b5ad-2e2c-4184-bd93-2cd8b155d104" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_BRL_91e6c556-621d-470a-8942-faebd7723029" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_BRL"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_722008ab-2c05-43c2-a356-6c2d61e603c0" xlink:to="loc_currency_BRL_91e6c556-621d-470a-8942-faebd7723029" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_THB_89d7ffa9-d198-44e7-857e-603fcb99b2b4" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_THB"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_722008ab-2c05-43c2-a356-6c2d61e603c0" xlink:to="loc_currency_THB_89d7ffa9-d198-44e7-857e-603fcb99b2b4" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_8198c761-4a83-4c01-92c1-849d54e9d8d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_55a91cbd-dc1d-4453-819e-819feb3f4090" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_8198c761-4a83-4c01-92c1-849d54e9d8d9" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_8198c761-4a83-4c01-92c1-849d54e9d8d9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_8198c761-4a83-4c01-92c1-849d54e9d8d9" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_8198c761-4a83-4c01-92c1-849d54e9d8d9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_d070c396-c1da-41c8-a058-28c74272d1b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_8198c761-4a83-4c01-92c1-849d54e9d8d9" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_d070c396-c1da-41c8-a058-28c74272d1b2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_9f6143bb-bb16-4142-b5c1-258630d3a129" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_d070c396-c1da-41c8-a058-28c74272d1b2" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_9f6143bb-bb16-4142-b5c1-258630d3a129" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForwardContractsMember_a767379b-08e5-41d5-8919-30466be10633" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForwardContractsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_d070c396-c1da-41c8-a058-28c74272d1b2" xlink:to="loc_us-gaap_ForwardContractsMember_a767379b-08e5-41d5-8919-30466be10633" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.agilent.com/role/DERIVATIVESFairvalueofderivativeinstrumentsandConsolidatedBalanceSheetlocationDetails" xlink:type="simple" xlink:href="a-20220131.xsd#DERIVATIVESFairvalueofderivativeinstrumentsandConsolidatedBalanceSheetlocationDetails"/>
  <link:definitionLink xlink:role="http://www.agilent.com/role/DERIVATIVESFairvalueofderivativeinstrumentsandConsolidatedBalanceSheetlocationDetails" xlink:type="extended" id="i2f6be8f44a0c4270b41c9526a8944c90_DERIVATIVESFairvalueofderivativeinstrumentsandConsolidatedBalanceSheetlocationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_1b06f25a-6a04-4acd-a1de-5e00791c367b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeNetAbstract_4ce44609-e1d7-4da2-9974-ba064e809869" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeNetAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_1b06f25a-6a04-4acd-a1de-5e00791c367b" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeNetAbstract_4ce44609-e1d7-4da2-9974-ba064e809869" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_fa842738-39bc-4add-b84d-180d82ff7fa0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeNetAbstract_4ce44609-e1d7-4da2-9974-ba064e809869" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_fa842738-39bc-4add-b84d-180d82ff7fa0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_f7ec4e73-0ecf-4c61-bacc-0c79eaa19d2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeNetAbstract_4ce44609-e1d7-4da2-9974-ba064e809869" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_f7ec4e73-0ecf-4c61-bacc-0c79eaa19d2f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_e14b367f-5be9-4c16-97d0-f1994c06fca9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_1b06f25a-6a04-4acd-a1de-5e00791c367b" xlink:to="loc_us-gaap_DerivativeTable_e14b367f-5be9-4c16-97d0-f1994c06fca9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_1b2f053f-7b47-43f1-ac1c-94862a58ed54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_e14b367f-5be9-4c16-97d0-f1994c06fca9" xlink:to="loc_us-gaap_HedgingDesignationAxis_1b2f053f-7b47-43f1-ac1c-94862a58ed54" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_1b2f053f-7b47-43f1-ac1c-94862a58ed54_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_1b2f053f-7b47-43f1-ac1c-94862a58ed54" xlink:to="loc_us-gaap_HedgingDesignationDomain_1b2f053f-7b47-43f1-ac1c-94862a58ed54_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_0ed336f6-586a-427a-aa95-7e2fcacf2be5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_1b2f053f-7b47-43f1-ac1c-94862a58ed54" xlink:to="loc_us-gaap_HedgingDesignationDomain_0ed336f6-586a-427a-aa95-7e2fcacf2be5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_4cb5f2f3-08b7-4ed8-8f39-ed0cbdc711cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_0ed336f6-586a-427a-aa95-7e2fcacf2be5" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_4cb5f2f3-08b7-4ed8-8f39-ed0cbdc711cc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_e8d2ba87-929b-45cf-a740-ee6cb36afe63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_0ed336f6-586a-427a-aa95-7e2fcacf2be5" xlink:to="loc_us-gaap_NondesignatedMember_e8d2ba87-929b-45cf-a740-ee6cb36afe63" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_1ec907a3-017b-498d-b624-08e854c2f5b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_e14b367f-5be9-4c16-97d0-f1994c06fca9" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_1ec907a3-017b-498d-b624-08e854c2f5b5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_1ec907a3-017b-498d-b624-08e854c2f5b5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_1ec907a3-017b-498d-b624-08e854c2f5b5" xlink:to="loc_us-gaap_HedgingRelationshipDomain_1ec907a3-017b-498d-b624-08e854c2f5b5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_860e628e-ced3-4be8-8119-ece2dfd219bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_1ec907a3-017b-498d-b624-08e854c2f5b5" xlink:to="loc_us-gaap_HedgingRelationshipDomain_860e628e-ced3-4be8-8119-ece2dfd219bc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_93d7cf4c-5549-4f70-96da-7ef32cd324b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_860e628e-ced3-4be8-8119-ece2dfd219bc" xlink:to="loc_us-gaap_CashFlowHedgingMember_93d7cf4c-5549-4f70-96da-7ef32cd324b7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_a8bddaba-a062-44a8-a95f-f3993f954a04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_860e628e-ced3-4be8-8119-ece2dfd219bc" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_a8bddaba-a062-44a8-a95f-f3993f954a04" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_7db0ac13-92da-4761-9b1a-43cd7305cd68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_e14b367f-5be9-4c16-97d0-f1994c06fca9" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_7db0ac13-92da-4761-9b1a-43cd7305cd68" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_7db0ac13-92da-4761-9b1a-43cd7305cd68_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_7db0ac13-92da-4761-9b1a-43cd7305cd68" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_7db0ac13-92da-4761-9b1a-43cd7305cd68_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_5a4526ff-4e80-48e1-9b8d-f77e0109d3fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_7db0ac13-92da-4761-9b1a-43cd7305cd68" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_5a4526ff-4e80-48e1-9b8d-f77e0109d3fa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_dd7fdcab-9e3c-469f-986c-10be9e6b175a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_5a4526ff-4e80-48e1-9b8d-f77e0109d3fa" xlink:to="loc_us-gaap_ForeignExchangeContractMember_dd7fdcab-9e3c-469f-986c-10be9e6b175a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_b99e48d7-24ad-452f-95d4-6e3b9abb9141" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_5a4526ff-4e80-48e1-9b8d-f77e0109d3fa" xlink:to="loc_us-gaap_InterestRateSwapMember_b99e48d7-24ad-452f-95d4-6e3b9abb9141" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_d3075e74-8f66-4591-9eeb-f9b28df3c555" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_e14b367f-5be9-4c16-97d0-f1994c06fca9" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_d3075e74-8f66-4591-9eeb-f9b28df3c555" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_d3075e74-8f66-4591-9eeb-f9b28df3c555_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_d3075e74-8f66-4591-9eeb-f9b28df3c555" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_d3075e74-8f66-4591-9eeb-f9b28df3c555_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_1ecd1e10-b3b5-4062-b20b-9b40abf3bd36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_d3075e74-8f66-4591-9eeb-f9b28df3c555" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_1ecd1e10-b3b5-4062-b20b-9b40abf3bd36" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentAssetsMember_2e5bd540-5177-40dd-8e5f-5e4aaa233393" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_1ecd1e10-b3b5-4062-b20b-9b40abf3bd36" xlink:to="loc_us-gaap_OtherCurrentAssetsMember_2e5bd540-5177-40dd-8e5f-5e4aaa233393" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesMember_bdd629fd-a460-4bd0-8a90-fc3dc141361d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_1ecd1e10-b3b5-4062-b20b-9b40abf3bd36" xlink:to="loc_us-gaap_AccruedLiabilitiesMember_bdd629fd-a460-4bd0-8a90-fc3dc141361d" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.agilent.com/role/DERIVATIVESEffectofderivativeinstrumentsonConsolidatedStatementofOperationsDetails" xlink:type="simple" xlink:href="a-20220131.xsd#DERIVATIVESEffectofderivativeinstrumentsonConsolidatedStatementofOperationsDetails"/>
  <link:definitionLink xlink:role="http://www.agilent.com/role/DERIVATIVESEffectofderivativeinstrumentsonConsolidatedStatementofOperationsDetails" xlink:type="extended" id="i64bdaf05d7714d8097f4f521e4043ed2_DERIVATIVESEffectofderivativeinstrumentsonConsolidatedStatementofOperationsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_044d128f-d34d-4071-82f9-a760883c60c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_e6a28e4f-b8e0-4f88-bd23-e672a82273f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_044d128f-d34d-4071-82f9-a760883c60c4" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_e6a28e4f-b8e0-4f88-bd23-e672a82273f6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_52c84e98-0acf-40e1-abd2-c18ca2200686" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_044d128f-d34d-4071-82f9-a760883c60c4" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_52c84e98-0acf-40e1-abd2-c18ca2200686" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_c2a737ed-36a7-4f41-9d83-2ad4efcbbca9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_044d128f-d34d-4071-82f9-a760883c60c4" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_c2a737ed-36a7-4f41-9d83-2ad4efcbbca9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_9bd04778-ecbf-461b-a62e-33a0e3af49aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_044d128f-d34d-4071-82f9-a760883c60c4" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_9bd04778-ecbf-461b-a62e-33a0e3af49aa" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_c9a9f1ff-ba6d-4252-8fc4-9485696baec6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_044d128f-d34d-4071-82f9-a760883c60c4" xlink:to="loc_us-gaap_DerivativeTable_c9a9f1ff-ba6d-4252-8fc4-9485696baec6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_4d6778c9-7309-4ef7-8f00-f00a9b3404a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_c9a9f1ff-ba6d-4252-8fc4-9485696baec6" xlink:to="loc_us-gaap_HedgingDesignationAxis_4d6778c9-7309-4ef7-8f00-f00a9b3404a3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_4d6778c9-7309-4ef7-8f00-f00a9b3404a3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_4d6778c9-7309-4ef7-8f00-f00a9b3404a3" xlink:to="loc_us-gaap_HedgingDesignationDomain_4d6778c9-7309-4ef7-8f00-f00a9b3404a3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_2d0adfc6-cbb9-4fe2-af1a-e9c413517a44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_4d6778c9-7309-4ef7-8f00-f00a9b3404a3" xlink:to="loc_us-gaap_HedgingDesignationDomain_2d0adfc6-cbb9-4fe2-af1a-e9c413517a44" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_293c461c-7b36-447f-8e9e-864616456445" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_2d0adfc6-cbb9-4fe2-af1a-e9c413517a44" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_293c461c-7b36-447f-8e9e-864616456445" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_845b472b-c50b-41a9-9520-5766edd3923a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_2d0adfc6-cbb9-4fe2-af1a-e9c413517a44" xlink:to="loc_us-gaap_NondesignatedMember_845b472b-c50b-41a9-9520-5766edd3923a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_9350b996-2272-44a8-92ff-6aae59338f17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_c9a9f1ff-ba6d-4252-8fc4-9485696baec6" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_9350b996-2272-44a8-92ff-6aae59338f17" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_9350b996-2272-44a8-92ff-6aae59338f17_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_9350b996-2272-44a8-92ff-6aae59338f17" xlink:to="loc_us-gaap_HedgingRelationshipDomain_9350b996-2272-44a8-92ff-6aae59338f17_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_71d75b53-b85d-4970-9275-bae95d47bd02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_9350b996-2272-44a8-92ff-6aae59338f17" xlink:to="loc_us-gaap_HedgingRelationshipDomain_71d75b53-b85d-4970-9275-bae95d47bd02" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_b8d6e416-2372-49d5-8702-5a600839845d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_71d75b53-b85d-4970-9275-bae95d47bd02" xlink:to="loc_us-gaap_CashFlowHedgingMember_b8d6e416-2372-49d5-8702-5a600839845d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_5f8ea966-b730-4f74-aafa-6a55732b9f4f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_71d75b53-b85d-4970-9275-bae95d47bd02" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_5f8ea966-b730-4f74-aafa-6a55732b9f4f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_c961e60e-ad49-4ba7-906e-fccd96daa60a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_c9a9f1ff-ba6d-4252-8fc4-9485696baec6" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_c961e60e-ad49-4ba7-906e-fccd96daa60a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_c961e60e-ad49-4ba7-906e-fccd96daa60a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_c961e60e-ad49-4ba7-906e-fccd96daa60a" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_c961e60e-ad49-4ba7-906e-fccd96daa60a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_ed080c3c-1b0b-455e-8755-1c898207d33d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_c961e60e-ad49-4ba7-906e-fccd96daa60a" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_ed080c3c-1b0b-455e-8755-1c898207d33d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_40a27dc9-7872-46ee-82d5-47acfd3966e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_ed080c3c-1b0b-455e-8755-1c898207d33d" xlink:to="loc_us-gaap_ForeignExchangeContractMember_40a27dc9-7872-46ee-82d5-47acfd3966e8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_f5296ec7-c0bf-42b8-9f81-e26aaaea11f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_c9a9f1ff-ba6d-4252-8fc4-9485696baec6" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_f5296ec7-c0bf-42b8-9f81-e26aaaea11f6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_f5296ec7-c0bf-42b8-9f81-e26aaaea11f6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_f5296ec7-c0bf-42b8-9f81-e26aaaea11f6" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_f5296ec7-c0bf-42b8-9f81-e26aaaea11f6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_737bb00e-76e5-46b9-ba42-669d205a30c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_f5296ec7-c0bf-42b8-9f81-e26aaaea11f6" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_737bb00e-76e5-46b9-ba42-669d205a30c8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_018b1871-f1d0-478a-9c64-4c11c42f2e24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_737bb00e-76e5-46b9-ba42-669d205a30c8" xlink:to="loc_us-gaap_InterestExpenseMember_018b1871-f1d0-478a-9c64-4c11c42f2e24" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_4eedd51b-78c8-489a-af15-538e232c1cd6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_737bb00e-76e5-46b9-ba42-669d205a30c8" xlink:to="loc_us-gaap_CostOfSalesMember_4eedd51b-78c8-489a-af15-538e232c1cd6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_792bec57-8a87-426d-ba93-5d0ad08531a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_737bb00e-76e5-46b9-ba42-669d205a30c8" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_792bec57-8a87-426d-ba93-5d0ad08531a5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_ed6cbe98-a6df-46ca-affe-3acb3029f452" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_c9a9f1ff-ba6d-4252-8fc4-9485696baec6" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_ed6cbe98-a6df-46ca-affe-3acb3029f452" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_ed6cbe98-a6df-46ca-affe-3acb3029f452_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_ed6cbe98-a6df-46ca-affe-3acb3029f452" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_ed6cbe98-a6df-46ca-affe-3acb3029f452_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_1e3ef4b4-1f3a-43b2-82b7-3fe329c1d03c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_ed6cbe98-a6df-46ca-affe-3acb3029f452" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_1e3ef4b4-1f3a-43b2-82b7-3fe329c1d03c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_3b94f7a5-5686-4b36-ab1c-c904ac47c544" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_1e3ef4b4-1f3a-43b2-82b7-3fe329c1d03c" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_3b94f7a5-5686-4b36-ab1c-c904ac47c544" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_4f0faee6-a78c-44b7-85c2-29ad79a82ad2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_c9a9f1ff-ba6d-4252-8fc4-9485696baec6" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_4f0faee6-a78c-44b7-85c2-29ad79a82ad2" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_4f0faee6-a78c-44b7-85c2-29ad79a82ad2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_4f0faee6-a78c-44b7-85c2-29ad79a82ad2" xlink:to="loc_us-gaap_EquityComponentDomain_4f0faee6-a78c-44b7-85c2-29ad79a82ad2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_1fde4413-742e-46ee-a12a-83bb31e9376b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_4f0faee6-a78c-44b7-85c2-29ad79a82ad2" xlink:to="loc_us-gaap_EquityComponentDomain_1fde4413-742e-46ee-a12a-83bb31e9376b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_397798e7-7d3b-461b-8b9c-26dfd7c60792" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_1fde4413-742e-46ee-a12a-83bb31e9376b" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_397798e7-7d3b-461b-8b9c-26dfd7c60792" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSComponentsofnetperiodiccostsDetails" xlink:type="simple" xlink:href="a-20220131.xsd#RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSComponentsofnetperiodiccostsDetails"/>
  <link:definitionLink xlink:role="http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSComponentsofnetperiodiccostsDetails" xlink:type="extended" id="ieaf52cb839e8452991b33a54a723d8b1_RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSComponentsofnetperiodiccostsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5e4c05a3-5c86-4ebc-ac29-6c519f7877d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_9502c653-9bb1-4016-bf58-293c5875daff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5e4c05a3-5c86-4ebc-ac29-6c519f7877d0" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_9502c653-9bb1-4016-bf58-293c5875daff" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_3aa2d48e-8f5f-46b1-9603-5f4b755f409d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_9502c653-9bb1-4016-bf58-293c5875daff" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_3aa2d48e-8f5f-46b1-9603-5f4b755f409d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_e98d36c6-2741-4523-b43b-9a4cf9481d50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_9502c653-9bb1-4016-bf58-293c5875daff" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_e98d36c6-2741-4523-b43b-9a4cf9481d50" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_5fdf3b2e-5e79-46f0-ba3d-f952b1e44fb7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_9502c653-9bb1-4016-bf58-293c5875daff" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_5fdf3b2e-5e79-46f0-ba3d-f952b1e44fb7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_AmortizationAndDeferralsAbstract_a72f6c3a-6dfb-4b81-bbc5-7d7c5ac2b0e5" xlink:href="a-20220131.xsd#a_AmortizationAndDeferralsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_9502c653-9bb1-4016-bf58-293c5875daff" xlink:to="loc_a_AmortizationAndDeferralsAbstract_a72f6c3a-6dfb-4b81-bbc5-7d7c5ac2b0e5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_36fc1c56-88a7-40a5-bbb8-35f9aebfd98e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_a_AmortizationAndDeferralsAbstract_a72f6c3a-6dfb-4b81-bbc5-7d7c5ac2b0e5" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_36fc1c56-88a7-40a5-bbb8-35f9aebfd98e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_299ab774-9fb4-434e-992c-46a165e8572f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_a_AmortizationAndDeferralsAbstract_a72f6c3a-6dfb-4b81-bbc5-7d7c5ac2b0e5" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_299ab774-9fb4-434e-992c-46a165e8572f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_3c6f11ed-d9e1-4b77-ae15-671a30ca8e23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_9502c653-9bb1-4016-bf58-293c5875daff" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_3c6f11ed-d9e1-4b77-ae15-671a30ca8e23" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanSettlementsAndCurtailmentsAbstract_5c5d5fd9-2500-493e-ac06-d5c11d5baf57" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanSettlementsAndCurtailmentsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5e4c05a3-5c86-4ebc-ac29-6c519f7877d0" xlink:to="loc_us-gaap_DefinedBenefitPlanSettlementsAndCurtailmentsAbstract_5c5d5fd9-2500-493e-ac06-d5c11d5baf57" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_4a100169-7cf0-44b5-b2e7-a30a8d76cda7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanSettlementsAndCurtailmentsAbstract_5c5d5fd9-2500-493e-ac06-d5c11d5baf57" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_4a100169-7cf0-44b5-b2e7-a30a8d76cda7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_21689241-8473-4863-a797-19e419dd1f2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5e4c05a3-5c86-4ebc-ac29-6c519f7877d0" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_21689241-8473-4863-a797-19e419dd1f2f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_77dbd90a-85c3-4a0b-b37c-ea1bdda5d488" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_21689241-8473-4863-a797-19e419dd1f2f" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_77dbd90a-85c3-4a0b-b37c-ea1bdda5d488" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_77dbd90a-85c3-4a0b-b37c-ea1bdda5d488_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_77dbd90a-85c3-4a0b-b37c-ea1bdda5d488" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_77dbd90a-85c3-4a0b-b37c-ea1bdda5d488_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_3d0ea589-3702-4ed6-88cc-25581f04729e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_77dbd90a-85c3-4a0b-b37c-ea1bdda5d488" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_3d0ea589-3702-4ed6-88cc-25581f04729e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_d8435df3-f19e-49d8-ac02-3d670dcf4ca2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_3d0ea589-3702-4ed6-88cc-25581f04729e" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_d8435df3-f19e-49d8-ac02-3d670dcf4ca2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_044466dc-7e2f-49a2-ac5c-a597adeeec0a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_3d0ea589-3702-4ed6-88cc-25581f04729e" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_044466dc-7e2f-49a2-ac5c-a597adeeec0a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_c2f33db0-1659-4f9f-93f2-8eae06882814" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_21689241-8473-4863-a797-19e419dd1f2f" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_c2f33db0-1659-4f9f-93f2-8eae06882814" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_c2f33db0-1659-4f9f-93f2-8eae06882814_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_c2f33db0-1659-4f9f-93f2-8eae06882814" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_c2f33db0-1659-4f9f-93f2-8eae06882814_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_69c942df-6019-4326-a7a0-13aa237c7af2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_c2f33db0-1659-4f9f-93f2-8eae06882814" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_69c942df-6019-4326-a7a0-13aa237c7af2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_a6911f6a-b717-4b49-8c1b-4a185573aa78" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_69c942df-6019-4326-a7a0-13aa237c7af2" xlink:to="loc_country_US_a6911f6a-b717-4b49-8c1b-4a185573aa78" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_2cc72cb5-b0db-4ca2-8ec4-c2332e9938c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_69c942df-6019-4326-a7a0-13aa237c7af2" xlink:to="loc_us-gaap_ForeignPlanMember_2cc72cb5-b0db-4ca2-8ec4-c2332e9938c7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_58507e32-4b89-4178-96f6-a62d2aecd5eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOperatingActivitiesSegmentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_21689241-8473-4863-a797-19e419dd1f2f" xlink:to="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_58507e32-4b89-4178-96f6-a62d2aecd5eb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentOperatingActivitiesDomain_58507e32-4b89-4178-96f6-a62d2aecd5eb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentOperatingActivitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_58507e32-4b89-4178-96f6-a62d2aecd5eb" xlink:to="loc_us-gaap_SegmentOperatingActivitiesDomain_58507e32-4b89-4178-96f6-a62d2aecd5eb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentOperatingActivitiesDomain_2d7d57bf-eece-40b8-b3f1-999e22b4f308" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentOperatingActivitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_58507e32-4b89-4178-96f6-a62d2aecd5eb" xlink:to="loc_us-gaap_SegmentOperatingActivitiesDomain_2d7d57bf-eece-40b8-b3f1-999e22b4f308" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSDetailsEmployerContributions" xlink:type="simple" xlink:href="a-20220131.xsd#RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSDetailsEmployerContributions"/>
  <link:definitionLink xlink:role="http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSDetailsEmployerContributions" xlink:type="extended" id="ia8eb57b058094e3dbd8fb18a4917bcf2_RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSDetailsEmployerContributions">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1edd3ae6-53aa-4159-a63f-934a382d7cb2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_6b39d66b-f52c-44f7-893c-ad194d5edccd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1edd3ae6-53aa-4159-a63f-934a382d7cb2" xlink:to="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_6b39d66b-f52c-44f7-893c-ad194d5edccd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear_bc456b55-548b-4358-bd54-14d0b2efcf4e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1edd3ae6-53aa-4159-a63f-934a382d7cb2" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear_bc456b55-548b-4358-bd54-14d0b2efcf4e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_374d7377-c138-45cf-8401-7c0cec10eb5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1edd3ae6-53aa-4159-a63f-934a382d7cb2" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_374d7377-c138-45cf-8401-7c0cec10eb5c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_b1c5cf56-fdfd-4159-9155-bc585ced4a46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_374d7377-c138-45cf-8401-7c0cec10eb5c" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_b1c5cf56-fdfd-4159-9155-bc585ced4a46" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_b1c5cf56-fdfd-4159-9155-bc585ced4a46_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_b1c5cf56-fdfd-4159-9155-bc585ced4a46" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_b1c5cf56-fdfd-4159-9155-bc585ced4a46_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_e59e16ab-d5c7-41bb-b298-5ea9e37e5f54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_b1c5cf56-fdfd-4159-9155-bc585ced4a46" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_e59e16ab-d5c7-41bb-b298-5ea9e37e5f54" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_6ad7c490-7eca-4197-a4f4-364b9b602b1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_e59e16ab-d5c7-41bb-b298-5ea9e37e5f54" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_6ad7c490-7eca-4197-a4f4-364b9b602b1c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_c7e3a1dd-ec2f-4c4c-84c2-bc027236d003" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_374d7377-c138-45cf-8401-7c0cec10eb5c" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_c7e3a1dd-ec2f-4c4c-84c2-bc027236d003" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_c7e3a1dd-ec2f-4c4c-84c2-bc027236d003_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_c7e3a1dd-ec2f-4c4c-84c2-bc027236d003" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_c7e3a1dd-ec2f-4c4c-84c2-bc027236d003_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_9cc63d57-8ee4-494d-970d-d0c2f202301b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_c7e3a1dd-ec2f-4c4c-84c2-bc027236d003" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_9cc63d57-8ee4-494d-970d-d0c2f202301b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_2f7d0583-6a63-4d68-b093-b114fb0ca891" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_9cc63d57-8ee4-494d-970d-d0c2f202301b" xlink:to="loc_country_US_2f7d0583-6a63-4d68-b093-b114fb0ca891" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_08f74f0b-72a9-4c30-bf6b-1e000c067854" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_9cc63d57-8ee4-494d-970d-d0c2f202301b" xlink:to="loc_us-gaap_ForeignPlanMember_08f74f0b-72a9-4c30-bf6b-1e000c067854" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.agilent.com/role/SHORTTERMDEBTCreditFacilityDetails" xlink:type="simple" xlink:href="a-20220131.xsd#SHORTTERMDEBTCreditFacilityDetails"/>
  <link:definitionLink xlink:role="http://www.agilent.com/role/SHORTTERMDEBTCreditFacilityDetails" xlink:type="extended" id="i756bd8b19f4e4cb6aa152ba689481811_SHORTTERMDEBTCreditFacilityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtLineItems_2958bc3a-1a9d-4694-a7c5-f8e025efe501" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityInitiationDate1_d37aa1ed-3317-45c1-8f21-c4978b711da0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityInitiationDate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_2958bc3a-1a9d-4694-a7c5-f8e025efe501" xlink:to="loc_us-gaap_LineOfCreditFacilityInitiationDate1_d37aa1ed-3317-45c1-8f21-c4978b711da0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_10213ac6-bd49-4618-8ecd-0bd478b6bd0e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_2958bc3a-1a9d-4694-a7c5-f8e025efe501" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_10213ac6-bd49-4618-8ecd-0bd478b6bd0e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTerms_1459db5a-fbdd-4a83-b41f-0382461a406e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTerms"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_2958bc3a-1a9d-4694-a7c5-f8e025efe501" xlink:to="loc_us-gaap_ShortTermDebtTerms_1459db5a-fbdd-4a83-b41f-0382461a406e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityExpirationDate1_aed9c405-9840-4c15-967c-2ec1a4b3efe4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityExpirationDate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_2958bc3a-1a9d-4694-a7c5-f8e025efe501" xlink:to="loc_us-gaap_LineOfCreditFacilityExpirationDate1_aed9c405-9840-4c15-967c-2ec1a4b3efe4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_ade4da8b-a367-40d8-b988-e8297f551647" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_2958bc3a-1a9d-4694-a7c5-f8e025efe501" xlink:to="loc_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_ade4da8b-a367-40d8-b988-e8297f551647" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtWeightedAverageInterestRate_d5d2c330-1341-4332-9d2a-957c8abc07a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtWeightedAverageInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_2958bc3a-1a9d-4694-a7c5-f8e025efe501" xlink:to="loc_us-gaap_ShortTermDebtWeightedAverageInterestRate_d5d2c330-1341-4332-9d2a-957c8abc07a8" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_WeightedAverageMaturityDateatPointinTime_e88d79f2-21a6-494f-8772-9464a70b47f1" xlink:href="a-20220131.xsd#a_WeightedAverageMaturityDateatPointinTime"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_2958bc3a-1a9d-4694-a7c5-f8e025efe501" xlink:to="loc_a_WeightedAverageMaturityDateatPointinTime_e88d79f2-21a6-494f-8772-9464a70b47f1" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_WeightedAverageMaturityDateAtAPointInTime_f91e1500-3cfc-48f9-bd9c-ca876e03d114" xlink:href="a-20220131.xsd#a_WeightedAverageMaturityDateAtAPointInTime"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_2958bc3a-1a9d-4694-a7c5-f8e025efe501" xlink:to="loc_a_WeightedAverageMaturityDateAtAPointInTime_f91e1500-3cfc-48f9-bd9c-ca876e03d114" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfCommercialPaper_ff9e3cac-f847-44c2-88db-3b1110cec2a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfCommercialPaper"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_2958bc3a-1a9d-4694-a7c5-f8e025efe501" xlink:to="loc_us-gaap_RepaymentsOfCommercialPaper_ff9e3cac-f847-44c2-88db-3b1110cec2a8" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommercialPaper_5a3a1247-35ee-4f4d-b726-1e314c9650bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommercialPaper"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_2958bc3a-1a9d-4694-a7c5-f8e025efe501" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommercialPaper_5a3a1247-35ee-4f4d-b726-1e314c9650bd" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShortTermDebtTable_8aba902f-3fe3-4651-b5d9-19e35376988c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShortTermDebtTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShortTermDebtLineItems_2958bc3a-1a9d-4694-a7c5-f8e025efe501" xlink:to="loc_us-gaap_ScheduleOfShortTermDebtTable_8aba902f-3fe3-4651-b5d9-19e35376988c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_9703d69c-75b6-4175-bc18-f7ee61c2867a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_8aba902f-3fe3-4651-b5d9-19e35376988c" xlink:to="loc_us-gaap_CreditFacilityAxis_9703d69c-75b6-4175-bc18-f7ee61c2867a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_9703d69c-75b6-4175-bc18-f7ee61c2867a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_9703d69c-75b6-4175-bc18-f7ee61c2867a" xlink:to="loc_us-gaap_CreditFacilityDomain_9703d69c-75b6-4175-bc18-f7ee61c2867a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_fe84f907-bdad-4b8c-a616-0fb224ddc8ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_9703d69c-75b6-4175-bc18-f7ee61c2867a" xlink:to="loc_us-gaap_CreditFacilityDomain_fe84f907-bdad-4b8c-a616-0fb224ddc8ed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_b3fd97c0-fb73-4624-a728-ec3b8d21d9d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_fe84f907-bdad-4b8c-a616-0fb224ddc8ed" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_b3fd97c0-fb73-4624-a728-ec3b8d21d9d3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_54d9767d-5920-49ae-8810-3b73b07806e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_fe84f907-bdad-4b8c-a616-0fb224ddc8ed" xlink:to="loc_us-gaap_LineOfCreditMember_54d9767d-5920-49ae-8810-3b73b07806e7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_c6d7ac3a-58b8-47d8-a7c9-35bc096eba04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_8aba902f-3fe3-4651-b5d9-19e35376988c" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_c6d7ac3a-58b8-47d8-a7c9-35bc096eba04" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_c6d7ac3a-58b8-47d8-a7c9-35bc096eba04_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_c6d7ac3a-58b8-47d8-a7c9-35bc096eba04" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_c6d7ac3a-58b8-47d8-a7c9-35bc096eba04_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_aaf0e967-d9d7-45b0-bc78-8a5ff8b94446" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_c6d7ac3a-58b8-47d8-a7c9-35bc096eba04" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_aaf0e967-d9d7-45b0-bc78-8a5ff8b94446" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_fad24e35-3293-451d-bbb9-1bce0e24dfa3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_8aba902f-3fe3-4651-b5d9-19e35376988c" xlink:to="loc_us-gaap_DebtInstrumentAxis_fad24e35-3293-451d-bbb9-1bce0e24dfa3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_fad24e35-3293-451d-bbb9-1bce0e24dfa3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_fad24e35-3293-451d-bbb9-1bce0e24dfa3" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_fad24e35-3293-451d-bbb9-1bce0e24dfa3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_3b9f4ba7-c5fe-427e-b8e4-6c0f23a47c2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_fad24e35-3293-451d-bbb9-1bce0e24dfa3" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_3b9f4ba7-c5fe-427e-b8e4-6c0f23a47c2b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_A5YrUnsecuredCreditFacilityMember_b09d0936-f7ca-402f-a25f-9c5822095b86" xlink:href="a-20220131.xsd#a_A5YrUnsecuredCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3b9f4ba7-c5fe-427e-b8e4-6c0f23a47c2b" xlink:to="loc_a_A5YrUnsecuredCreditFacilityMember_b09d0936-f7ca-402f-a25f-9c5822095b86" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_AdditionalIncrementalTermLoanFacilityMember_b75623bc-25da-49b5-818d-be131f53c480" xlink:href="a-20220131.xsd#a_AdditionalIncrementalTermLoanFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3b9f4ba7-c5fe-427e-b8e4-6c0f23a47c2b" xlink:to="loc_a_AdditionalIncrementalTermLoanFacilityMember_b75623bc-25da-49b5-818d-be131f53c480" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_f79b1472-301d-4f6c-acce-cc0e266baa70" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3b9f4ba7-c5fe-427e-b8e4-6c0f23a47c2b" xlink:to="loc_us-gaap_CommercialPaperMember_f79b1472-301d-4f6c-acce-cc0e266baa70" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.agilent.com/role/LONGTERMDEBTDetails" xlink:type="simple" xlink:href="a-20220131.xsd#LONGTERMDEBTDetails"/>
  <link:definitionLink xlink:role="http://www.agilent.com/role/LONGTERMDEBTDetails" xlink:type="extended" id="i05d24be97f984903bf881ffbebbb4fe9_LONGTERMDEBTDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_6edf1fe5-c13a-455d-ba5e-6cf7d228d161" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_707be481-92bb-4f63-a1c5-c172903e80c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6edf1fe5-c13a-455d-ba5e-6cf7d228d161" xlink:to="loc_us-gaap_LongTermDebt_707be481-92bb-4f63-a1c5-c172903e80c7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_ab81715c-7961-4f99-bdbe-8b70c54909b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6edf1fe5-c13a-455d-ba5e-6cf7d228d161" xlink:to="loc_us-gaap_DebtInstrumentTable_ab81715c-7961-4f99-bdbe-8b70c54909b6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_7cf06617-3757-4537-b021-316433de3dad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_ab81715c-7961-4f99-bdbe-8b70c54909b6" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_7cf06617-3757-4537-b021-316433de3dad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_7cf06617-3757-4537-b021-316433de3dad_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_7cf06617-3757-4537-b021-316433de3dad" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_7cf06617-3757-4537-b021-316433de3dad_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_aa0bded4-c98f-4739-8ae2-092c6e699971" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_7cf06617-3757-4537-b021-316433de3dad" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_aa0bded4-c98f-4739-8ae2-092c6e699971" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_c3e1749f-4a9f-4b60-a00e-17042208a2ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_ab81715c-7961-4f99-bdbe-8b70c54909b6" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_c3e1749f-4a9f-4b60-a00e-17042208a2ac" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_c3e1749f-4a9f-4b60-a00e-17042208a2ac_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_c3e1749f-4a9f-4b60-a00e-17042208a2ac" xlink:to="loc_us-gaap_TypeOfAdoptionMember_c3e1749f-4a9f-4b60-a00e-17042208a2ac_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_40a10c44-450b-4604-9b08-4988b39ee527" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_c3e1749f-4a9f-4b60-a00e-17042208a2ac" xlink:to="loc_us-gaap_TypeOfAdoptionMember_40a10c44-450b-4604-9b08-4988b39ee527" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_6918587e-95e1-404b-a540-816798740d34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_ab81715c-7961-4f99-bdbe-8b70c54909b6" xlink:to="loc_us-gaap_DebtInstrumentAxis_6918587e-95e1-404b-a540-816798740d34" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_6918587e-95e1-404b-a540-816798740d34_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_6918587e-95e1-404b-a540-816798740d34" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_6918587e-95e1-404b-a540-816798740d34_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_ec09b7fa-3a43-4787-a71d-a3bb13148391" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_6918587e-95e1-404b-a540-816798740d34" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_ec09b7fa-3a43-4787-a71d-a3bb13148391" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_SeniorNotes2023Member_e48b6c6a-2a4f-449b-8a5a-0c4e9119f5af" xlink:href="a-20220131.xsd#a_SeniorNotes2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ec09b7fa-3a43-4787-a71d-a3bb13148391" xlink:to="loc_a_SeniorNotes2023Member_e48b6c6a-2a4f-449b-8a5a-0c4e9119f5af" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_SeniorNotes2026Member_786d4228-fa0c-4da1-8472-85a514435f2d" xlink:href="a-20220131.xsd#a_SeniorNotes2026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ec09b7fa-3a43-4787-a71d-a3bb13148391" xlink:to="loc_a_SeniorNotes2026Member_786d4228-fa0c-4da1-8472-85a514435f2d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_SeniorNotes2029Member_0e87d561-46f5-4171-a4ef-1b54c5b3c260" xlink:href="a-20220131.xsd#a_SeniorNotes2029Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ec09b7fa-3a43-4787-a71d-a3bb13148391" xlink:to="loc_a_SeniorNotes2029Member_0e87d561-46f5-4171-a4ef-1b54c5b3c260" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_SeniorNotes2030Member_a2e48953-a106-4fe5-ac13-6a5b6cedf96b" xlink:href="a-20220131.xsd#a_SeniorNotes2030Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ec09b7fa-3a43-4787-a71d-a3bb13148391" xlink:to="loc_a_SeniorNotes2030Member_a2e48953-a106-4fe5-ac13-6a5b6cedf96b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_SeniorNotes2031Member_d9ffa9b8-ac28-467e-b42a-ca20e4b4d1a2" xlink:href="a-20220131.xsd#a_SeniorNotes2031Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ec09b7fa-3a43-4787-a71d-a3bb13148391" xlink:to="loc_a_SeniorNotes2031Member_d9ffa9b8-ac28-467e-b42a-ca20e4b4d1a2" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.agilent.com/role/STOCKHOLDERSEQUITYTables" xlink:type="simple" xlink:href="a-20220131.xsd#STOCKHOLDERSEQUITYTables"/>
  <link:definitionLink xlink:role="http://www.agilent.com/role/STOCKHOLDERSEQUITYTables" xlink:type="extended" id="ic1798a5dae0141f5b3778e3db0a82912_STOCKHOLDERSEQUITYTables">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_f6ba072d-a915-4507-894e-810b00a66a2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_6b1090d2-4067-4f6a-9768-87e95c827e29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f6ba072d-a915-4507-894e-810b00a66a2f" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_6b1090d2-4067-4f6a-9768-87e95c827e29" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock_e429dbfc-c82f-4e25-ae1d-3b580180a88d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f6ba072d-a915-4507-894e-810b00a66a2f" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock_e429dbfc-c82f-4e25-ae1d-3b580180a88d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_a852747e-35b8-4674-a102-bfb82f1aa23d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_f6ba072d-a915-4507-894e-810b00a66a2f" xlink:to="loc_us-gaap_StatementTable_a852747e-35b8-4674-a102-bfb82f1aa23d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_d68ad47d-000c-43cf-a4bf-1cfe2cd708ce" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_a852747e-35b8-4674-a102-bfb82f1aa23d" xlink:to="loc_srt_StatementScenarioAxis_d68ad47d-000c-43cf-a4bf-1cfe2cd708ce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_d68ad47d-000c-43cf-a4bf-1cfe2cd708ce_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_d68ad47d-000c-43cf-a4bf-1cfe2cd708ce" xlink:to="loc_srt_ScenarioUnspecifiedDomain_d68ad47d-000c-43cf-a4bf-1cfe2cd708ce_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_c0079647-1021-421b-b41a-d5b6df29b0eb" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_d68ad47d-000c-43cf-a4bf-1cfe2cd708ce" xlink:to="loc_srt_ScenarioUnspecifiedDomain_c0079647-1021-421b-b41a-d5b6df29b0eb" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.agilent.com/role/STOCKHOLDERSEQUITYStockRepurchaseProgramDetails" xlink:type="simple" xlink:href="a-20220131.xsd#STOCKHOLDERSEQUITYStockRepurchaseProgramDetails"/>
  <link:definitionLink xlink:role="http://www.agilent.com/role/STOCKHOLDERSEQUITYStockRepurchaseProgramDetails" xlink:type="extended" id="i6346f63d7b7b4acdb56938f79a56e81f_STOCKHOLDERSEQUITYStockRepurchaseProgramDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems_37b77ef3-4c3a-49c4-a9b2-887892c0bf48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_63a9fddd-6a0f-48d6-bd9a-66e3faf1f9ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_37b77ef3-4c3a-49c4-a9b2-887892c0bf48" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_63a9fddd-6a0f-48d6-bd9a-66e3faf1f9ef" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_f181a28a-b0a1-43df-97a7-99164216117c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_37b77ef3-4c3a-49c4-a9b2-887892c0bf48" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_f181a28a-b0a1-43df-97a7-99164216117c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_91c2b064-5d69-43c9-a6eb-beae318046bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_37b77ef3-4c3a-49c4-a9b2-887892c0bf48" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_91c2b064-5d69-43c9-a6eb-beae318046bf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_9be862ad-9f43-44df-a04e-75f8f4e286cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_37b77ef3-4c3a-49c4-a9b2-887892c0bf48" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_9be862ad-9f43-44df-a04e-75f8f4e286cc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable_7c040fe9-5d8c-468e-8bbd-a0ef3b265911" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_37b77ef3-4c3a-49c4-a9b2-887892c0bf48" xlink:to="loc_us-gaap_ClassOfTreasuryStockTable_7c040fe9-5d8c-468e-8bbd-a0ef3b265911" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_c4f1f17d-7bff-42f5-b954-764ddc44ca5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_7c040fe9-5d8c-468e-8bbd-a0ef3b265911" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_c4f1f17d-7bff-42f5-b954-764ddc44ca5c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_c4f1f17d-7bff-42f5-b954-764ddc44ca5c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_c4f1f17d-7bff-42f5-b954-764ddc44ca5c" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_c4f1f17d-7bff-42f5-b954-764ddc44ca5c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_ce269d5b-7832-4804-9c04-74dd4cdf90a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_c4f1f17d-7bff-42f5-b954-764ddc44ca5c" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_ce269d5b-7832-4804-9c04-74dd4cdf90a6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_094a24cf-e291-4202-8557-6391878da08d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_7c040fe9-5d8c-468e-8bbd-a0ef3b265911" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_094a24cf-e291-4202-8557-6391878da08d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_094a24cf-e291-4202-8557-6391878da08d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_094a24cf-e291-4202-8557-6391878da08d" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_094a24cf-e291-4202-8557-6391878da08d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_0b16d324-d4cf-4fbc-b4cc-9c4eacf6d9fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_094a24cf-e291-4202-8557-6391878da08d" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_0b16d324-d4cf-4fbc-b4cc-9c4eacf6d9fb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_A2019RepurchaseProgramMember_331dfcb9-f6f1-4fbf-97a4-9303bacddd88" xlink:href="a-20220131.xsd#a_A2019RepurchaseProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_0b16d324-d4cf-4fbc-b4cc-9c4eacf6d9fb" xlink:to="loc_a_A2019RepurchaseProgramMember_331dfcb9-f6f1-4fbf-97a4-9303bacddd88" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_A2021RepurchaseProgramMember_4693870b-5aef-418d-9982-5d460674b1e2" xlink:href="a-20220131.xsd#a_A2021RepurchaseProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_0b16d324-d4cf-4fbc-b4cc-9c4eacf6d9fb" xlink:to="loc_a_A2021RepurchaseProgramMember_4693870b-5aef-418d-9982-5d460674b1e2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_f86ba596-f08e-4dab-8b28-eabc4780ef17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_7c040fe9-5d8c-468e-8bbd-a0ef3b265911" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_f86ba596-f08e-4dab-8b28-eabc4780ef17" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_f86ba596-f08e-4dab-8b28-eabc4780ef17_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_f86ba596-f08e-4dab-8b28-eabc4780ef17" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_f86ba596-f08e-4dab-8b28-eabc4780ef17_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_adbcb10a-b673-47d1-8e4b-b312a04e0bb3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_f86ba596-f08e-4dab-8b28-eabc4780ef17" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_adbcb10a-b673-47d1-8e4b-b312a04e0bb3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_5f906dbc-bcd6-4efb-a589-2042b9e4bbee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_adbcb10a-b673-47d1-8e4b-b312a04e0bb3" xlink:to="loc_us-gaap_SubsequentEventMember_5f906dbc-bcd6-4efb-a589-2042b9e4bbee" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.agilent.com/role/STOCKHOLDERSEQUITYDividendsDetails" xlink:type="simple" xlink:href="a-20220131.xsd#STOCKHOLDERSEQUITYDividendsDetails"/>
  <link:definitionLink xlink:role="http://www.agilent.com/role/STOCKHOLDERSEQUITYDividendsDetails" xlink:type="extended" id="i074eb3acaba54e928bb36a3bbe28fbb3_STOCKHOLDERSEQUITYDividendsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableLineItems_a3b3d274-a426-4790-a614-c5d6a84ff235" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsPayableLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsAbstract_8e15fefd-9142-4c8f-a670-0568fcb896db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividendsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DividendsPayableLineItems_a3b3d274-a426-4790-a614-c5d6a84ff235" xlink:to="loc_us-gaap_PaymentsOfDividendsAbstract_8e15fefd-9142-4c8f-a670-0568fcb896db" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareCashPaid_4e2cac27-5dad-48e8-abed-585ba994cc9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockDividendsPerShareCashPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PaymentsOfDividendsAbstract_8e15fefd-9142-4c8f-a670-0568fcb896db" xlink:to="loc_us-gaap_CommonStockDividendsPerShareCashPaid_4e2cac27-5dad-48e8-abed-585ba994cc9e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_8ca153de-da3e-4e25-9d5a-3aeaa284888e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PaymentsOfDividendsAbstract_8e15fefd-9142-4c8f-a670-0568fcb896db" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_8ca153de-da3e-4e25-9d5a-3aeaa284888e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockAbstract_0911fccd-945c-4b22-9341-aec3f4ddbf75" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsCommonStockAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DividendsPayableLineItems_a3b3d274-a426-4790-a614-c5d6a84ff235" xlink:to="loc_us-gaap_DividendsCommonStockAbstract_0911fccd-945c-4b22-9341-aec3f4ddbf75" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableDateDeclaredDayMonthAndYear_402c8484-80d9-4313-a6fe-62f85f18eeca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsPayableDateDeclaredDayMonthAndYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DividendsCommonStockAbstract_0911fccd-945c-4b22-9341-aec3f4ddbf75" xlink:to="loc_us-gaap_DividendsPayableDateDeclaredDayMonthAndYear_402c8484-80d9-4313-a6fe-62f85f18eeca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_309b31f9-982a-47f4-b754-616be9a65bd7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DividendsCommonStockAbstract_0911fccd-945c-4b22-9341-aec3f4ddbf75" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_309b31f9-982a-47f4-b754-616be9a65bd7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_8724c7de-12c6-42b4-8fa8-2a8542712165" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DividendsCommonStockAbstract_0911fccd-945c-4b22-9341-aec3f4ddbf75" xlink:to="loc_us-gaap_DividendsCommonStockCash_8724c7de-12c6-42b4-8fa8-2a8542712165" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendPayableDateToBePaidDayMonthAndYear_431474b4-646e-45dd-b408-790b6c89e36f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendPayableDateToBePaidDayMonthAndYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DividendsCommonStockAbstract_0911fccd-945c-4b22-9341-aec3f4ddbf75" xlink:to="loc_us-gaap_DividendPayableDateToBePaidDayMonthAndYear_431474b4-646e-45dd-b408-790b6c89e36f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableDateOfRecordDayMonthAndYear_aff6f5dd-512f-4070-985b-08a0bd4ab424" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsPayableDateOfRecordDayMonthAndYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DividendsCommonStockAbstract_0911fccd-945c-4b22-9341-aec3f4ddbf75" xlink:to="loc_us-gaap_DividendsPayableDateOfRecordDayMonthAndYear_aff6f5dd-512f-4070-985b-08a0bd4ab424" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableTable_dac5eb31-5526-45d9-ac0e-230fbcde87b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsPayableTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DividendsPayableLineItems_a3b3d274-a426-4790-a614-c5d6a84ff235" xlink:to="loc_us-gaap_DividendsPayableTable_dac5eb31-5526-45d9-ac0e-230fbcde87b0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_b14b8d94-eed4-48fe-b212-2b791071b15f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DividendsPayableTable_dac5eb31-5526-45d9-ac0e-230fbcde87b0" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_b14b8d94-eed4-48fe-b212-2b791071b15f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_b14b8d94-eed4-48fe-b212-2b791071b15f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_b14b8d94-eed4-48fe-b212-2b791071b15f" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_b14b8d94-eed4-48fe-b212-2b791071b15f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_7f5478fc-2aed-4e3c-8d35-bb2ef60b8e19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_b14b8d94-eed4-48fe-b212-2b791071b15f" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_7f5478fc-2aed-4e3c-8d35-bb2ef60b8e19" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_52819b88-5b58-4342-9fdc-ee1070882d81" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_7f5478fc-2aed-4e3c-8d35-bb2ef60b8e19" xlink:to="loc_us-gaap_SubsequentEventMember_52819b88-5b58-4342-9fdc-ee1070882d81" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsAxis_bec9f179-851c-4f4a-b410-e2ff3bb605dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DividendsPayableTable_dac5eb31-5526-45d9-ac0e-230fbcde87b0" xlink:to="loc_us-gaap_DividendsAxis_bec9f179-851c-4f4a-b410-e2ff3bb605dc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsDomain_bec9f179-851c-4f4a-b410-e2ff3bb605dc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DividendsAxis_bec9f179-851c-4f4a-b410-e2ff3bb605dc" xlink:to="loc_us-gaap_DividendsDomain_bec9f179-851c-4f4a-b410-e2ff3bb605dc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsDomain_a06fc719-ed48-4753-9cbc-65424caa7cfa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DividendsAxis_bec9f179-851c-4f4a-b410-e2ff3bb605dc" xlink:to="loc_us-gaap_DividendsDomain_a06fc719-ed48-4753-9cbc-65424caa7cfa" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.agilent.com/role/STOCKHOLDERSEQUITYAccumulatedOtherComprehensiveIncomeDetails" xlink:type="simple" xlink:href="a-20220131.xsd#STOCKHOLDERSEQUITYAccumulatedOtherComprehensiveIncomeDetails"/>
  <link:definitionLink xlink:role="http://www.agilent.com/role/STOCKHOLDERSEQUITYAccumulatedOtherComprehensiveIncomeDetails" xlink:type="extended" id="if2f0934f28104dc29f84be8a745d3e14_STOCKHOLDERSEQUITYAccumulatedOtherComprehensiveIncomeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_656d8ccc-5a77-4430-a096-6b5db2809bb8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_fcee1932-659b-492e-8887-e5eb1812c52d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_656d8ccc-5a77-4430-a096-6b5db2809bb8" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_fcee1932-659b-492e-8887-e5eb1812c52d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_2bc6ceb5-6099-4b0d-b720-16609ec80050" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_656d8ccc-5a77-4430-a096-6b5db2809bb8" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_2bc6ceb5-6099-4b0d-b720-16609ec80050" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_4664fddc-1f9d-4c49-85fd-788bfde85fbe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_656d8ccc-5a77-4430-a096-6b5db2809bb8" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_4664fddc-1f9d-4c49-85fd-788bfde85fbe" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent_7583cf0b-a859-497b-bfb4-790c811728c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_656d8ccc-5a77-4430-a096-6b5db2809bb8" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent_7583cf0b-a859-497b-bfb4-790c811728c4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTax_bb0642de-1c3c-4f37-a783-33d854290109" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_656d8ccc-5a77-4430-a096-6b5db2809bb8" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossTax_bb0642de-1c3c-4f37-a783-33d854290109" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_a395512d-bb86-4702-8ad3-2ed66b0d41ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_656d8ccc-5a77-4430-a096-6b5db2809bb8" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_a395512d-bb86-4702-8ad3-2ed66b0d41ac" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_7eacbabf-21fc-4384-a4fc-be073c6ccd50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_20f84da0-3dd5-4255-8e27-aee129aff13c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_656d8ccc-5a77-4430-a096-6b5db2809bb8" xlink:to="loc_us-gaap_StatementTable_20f84da0-3dd5-4255-8e27-aee129aff13c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_a566782e-02ab-439d-9dda-ac1662f03cb8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_20f84da0-3dd5-4255-8e27-aee129aff13c" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_a566782e-02ab-439d-9dda-ac1662f03cb8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_a566782e-02ab-439d-9dda-ac1662f03cb8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_a566782e-02ab-439d-9dda-ac1662f03cb8" xlink:to="loc_us-gaap_EquityComponentDomain_a566782e-02ab-439d-9dda-ac1662f03cb8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_50af4f9d-c7d6-4631-ae50-cdf189750166" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_a566782e-02ab-439d-9dda-ac1662f03cb8" xlink:to="loc_us-gaap_EquityComponentDomain_50af4f9d-c7d6-4631-ae50-cdf189750166" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_4c624ddb-b4e5-4ef7-92d8-eb0122f6e480" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_50af4f9d-c7d6-4631-ae50-cdf189750166" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_4c624ddb-b4e5-4ef7-92d8-eb0122f6e480" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember_a84be63e-5472-42a3-b381-bcad9ba331bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_50af4f9d-c7d6-4631-ae50-cdf189750166" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember_a84be63e-5472-42a3-b381-bcad9ba331bf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember_f6b73029-9614-461f-a188-b13e90b761bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_50af4f9d-c7d6-4631-ae50-cdf189750166" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember_f6b73029-9614-461f-a188-b13e90b761bb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociDerivativeQualifyingAsHedgeExcludedComponentParentMember_a5efd90b-7ac8-4436-b2c0-9556b374b218" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AociDerivativeQualifyingAsHedgeExcludedComponentParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_50af4f9d-c7d6-4631-ae50-cdf189750166" xlink:to="loc_us-gaap_AociDerivativeQualifyingAsHedgeExcludedComponentParentMember_a5efd90b-7ac8-4436-b2c0-9556b374b218" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_8bc197d7-e24c-4116-998f-ef0e792f45fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOperatingActivitiesSegmentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_20f84da0-3dd5-4255-8e27-aee129aff13c" xlink:to="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_8bc197d7-e24c-4116-998f-ef0e792f45fd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentOperatingActivitiesDomain_8bc197d7-e24c-4116-998f-ef0e792f45fd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentOperatingActivitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_8bc197d7-e24c-4116-998f-ef0e792f45fd" xlink:to="loc_us-gaap_SegmentOperatingActivitiesDomain_8bc197d7-e24c-4116-998f-ef0e792f45fd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentOperatingActivitiesDomain_ec3adda1-931a-417c-9755-8ef732ad9c45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentOperatingActivitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_8bc197d7-e24c-4116-998f-ef0e792f45fd" xlink:to="loc_us-gaap_SegmentOperatingActivitiesDomain_ec3adda1-931a-417c-9755-8ef732ad9c45" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.agilent.com/role/STOCKHOLDERSEQUITYReclassificationsoutofaccumulatedcomprehensiveincomeDetails" xlink:type="simple" xlink:href="a-20220131.xsd#STOCKHOLDERSEQUITYReclassificationsoutofaccumulatedcomprehensiveincomeDetails"/>
  <link:definitionLink xlink:role="http://www.agilent.com/role/STOCKHOLDERSEQUITYReclassificationsoutofaccumulatedcomprehensiveincomeDetails" xlink:type="extended" id="ia095468622c041af901606600df38b0f_STOCKHOLDERSEQUITYReclassificationsoutofaccumulatedcomprehensiveincomeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_db606c9c-f42d-4459-afc8-0dfe8cf26d17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_e73d14ee-f9b8-4eb1-89e5-c0a350326799" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_db606c9c-f42d-4459-afc8-0dfe8cf26d17" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_e73d14ee-f9b8-4eb1-89e5-c0a350326799" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_d09a18d4-d46e-4a03-8fa5-58116fcb468a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_db606c9c-f42d-4459-afc8-0dfe8cf26d17" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_d09a18d4-d46e-4a03-8fa5-58116fcb468a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_56fe4322-4bd6-49bd-929e-e42fa86f46d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_db606c9c-f42d-4459-afc8-0dfe8cf26d17" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_56fe4322-4bd6-49bd-929e-e42fa86f46d0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_f323d520-2644-44a3-b75c-8c01ee10e861" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_db606c9c-f42d-4459-afc8-0dfe8cf26d17" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_f323d520-2644-44a3-b75c-8c01ee10e861" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_a438ee61-3175-4f15-81e4-71a61e8f4403" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_db606c9c-f42d-4459-afc8-0dfe8cf26d17" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_a438ee61-3175-4f15-81e4-71a61e8f4403" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax_fdd7d972-99bb-401e-badc-4df5f8ef91fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_db606c9c-f42d-4459-afc8-0dfe8cf26d17" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax_fdd7d972-99bb-401e-badc-4df5f8ef91fc" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansTax_01cba5ce-2fd2-4af6-98be-1298c5fb17ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_db606c9c-f42d-4459-afc8-0dfe8cf26d17" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansTax_01cba5ce-2fd2-4af6-98be-1298c5fb17ab" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax_499cd8bf-94c5-448a-b97f-49e09306feb1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_db606c9c-f42d-4459-afc8-0dfe8cf26d17" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax_499cd8bf-94c5-448a-b97f-49e09306feb1" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_ce898e21-a849-4198-a7a8-4f6b9f35c0d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_db606c9c-f42d-4459-afc8-0dfe8cf26d17" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_ce898e21-a849-4198-a7a8-4f6b9f35c0d7" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_8e0c4dae-a1bc-4e1a-8464-e754952cb704" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_db606c9c-f42d-4459-afc8-0dfe8cf26d17" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_8e0c4dae-a1bc-4e1a-8464-e754952cb704" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_89d7afd3-75b3-4759-aa0d-bdb9ecf9d570" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_8e0c4dae-a1bc-4e1a-8464-e754952cb704" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_89d7afd3-75b3-4759-aa0d-bdb9ecf9d570" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_89d7afd3-75b3-4759-aa0d-bdb9ecf9d570_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_89d7afd3-75b3-4759-aa0d-bdb9ecf9d570" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_89d7afd3-75b3-4759-aa0d-bdb9ecf9d570_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_c36ff848-37a8-49f5-8873-d90b5843298b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_89d7afd3-75b3-4759-aa0d-bdb9ecf9d570" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_c36ff848-37a8-49f5-8873-d90b5843298b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_6151ea2b-a21b-4f90-8284-2e22d8b59be5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_c36ff848-37a8-49f5-8873-d90b5843298b" xlink:to="loc_us-gaap_CostOfSalesMember_6151ea2b-a21b-4f90-8284-2e22d8b59be5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_4a3a35b4-0406-4646-868f-a689b0d81b99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_c36ff848-37a8-49f5-8873-d90b5843298b" xlink:to="loc_us-gaap_InterestExpenseMember_4a3a35b4-0406-4646-868f-a689b0d81b99" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_4f719f68-91b0-48d2-a82d-e2772cf4f690" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_8e0c4dae-a1bc-4e1a-8464-e754952cb704" xlink:to="loc_srt_StatementScenarioAxis_4f719f68-91b0-48d2-a82d-e2772cf4f690" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_4f719f68-91b0-48d2-a82d-e2772cf4f690_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_4f719f68-91b0-48d2-a82d-e2772cf4f690" xlink:to="loc_srt_ScenarioUnspecifiedDomain_4f719f68-91b0-48d2-a82d-e2772cf4f690_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_be53e97e-a731-437e-a058-67be61c800e8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_4f719f68-91b0-48d2-a82d-e2772cf4f690" xlink:to="loc_srt_ScenarioUnspecifiedDomain_be53e97e-a731-437e-a058-67be61c800e8" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.agilent.com/role/SEGMENTINFORMATIONProfitabilityDetails" xlink:type="simple" xlink:href="a-20220131.xsd#SEGMENTINFORMATIONProfitabilityDetails"/>
  <link:definitionLink xlink:role="http://www.agilent.com/role/SEGMENTINFORMATIONProfitabilityDetails" xlink:type="extended" id="i9c2d97387e254058b3ebe62fbef3ecff_SEGMENTINFORMATIONProfitabilityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_f7e1964d-6b9a-4fd4-acda-b8948267d59d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_cfa6586c-7f9b-4a71-86c5-4d9b3d35fc2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_f7e1964d-6b9a-4fd4-acda-b8948267d59d" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_cfa6586c-7f9b-4a71-86c5-4d9b3d35fc2a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_e377d911-47a7-4bcd-99a6-36a1323c194d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_f7e1964d-6b9a-4fd4-acda-b8948267d59d" xlink:to="loc_us-gaap_OperatingIncomeLoss_e377d911-47a7-4bcd-99a6-36a1323c194d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_de26436b-2c33-4c4b-a8f2-ffb451be1bc1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_f7e1964d-6b9a-4fd4-acda-b8948267d59d" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_de26436b-2c33-4c4b-a8f2-ffb451be1bc1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_73f1773f-74e2-4507-9f49-9a8f12919f68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_de26436b-2c33-4c4b-a8f2-ffb451be1bc1" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_73f1773f-74e2-4507-9f49-9a8f12919f68" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_73f1773f-74e2-4507-9f49-9a8f12919f68_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_73f1773f-74e2-4507-9f49-9a8f12919f68" xlink:to="loc_us-gaap_SegmentDomain_73f1773f-74e2-4507-9f49-9a8f12919f68_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_42513f48-d682-4fc9-b008-328beb1de84e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_73f1773f-74e2-4507-9f49-9a8f12919f68" xlink:to="loc_us-gaap_SegmentDomain_42513f48-d682-4fc9-b008-328beb1de84e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_LifeSciencesandAppliedMarketsMember_5e3fbdee-033c-4220-a7c7-f0e66031ff8e" xlink:href="a-20220131.xsd#a_LifeSciencesandAppliedMarketsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_42513f48-d682-4fc9-b008-328beb1de84e" xlink:to="loc_a_LifeSciencesandAppliedMarketsMember_5e3fbdee-033c-4220-a7c7-f0e66031ff8e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_DiagnosticsAndGenomicsMember_dd67d28f-f0b1-4396-8c8b-3bbc475c8a5f" xlink:href="a-20220131.xsd#a_DiagnosticsAndGenomicsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_42513f48-d682-4fc9-b008-328beb1de84e" xlink:to="loc_a_DiagnosticsAndGenomicsMember_dd67d28f-f0b1-4396-8c8b-3bbc475c8a5f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_AgilentCrossLabMember_99756650-0e08-49cb-ad64-8c0c966e5de2" xlink:href="a-20220131.xsd#a_AgilentCrossLabMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_42513f48-d682-4fc9-b008-328beb1de84e" xlink:to="loc_a_AgilentCrossLabMember_99756650-0e08-49cb-ad64-8c0c966e5de2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_SegmentTotalMember_90989e48-bb06-45c0-a05f-4c1fa4ca5a83" xlink:href="a-20220131.xsd#a_SegmentTotalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_42513f48-d682-4fc9-b008-328beb1de84e" xlink:to="loc_a_SegmentTotalMember_90989e48-bb06-45c0-a05f-4c1fa4ca5a83" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.agilent.com/role/SEGMENTINFORMATIONReconciliationofReportableResultsDetails" xlink:type="simple" xlink:href="a-20220131.xsd#SEGMENTINFORMATIONReconciliationofReportableResultsDetails"/>
  <link:definitionLink xlink:role="http://www.agilent.com/role/SEGMENTINFORMATIONReconciliationofReportableResultsDetails" xlink:type="extended" id="i7c057e24ea4140af8f3fa9ecde4a9cdc_SEGMENTINFORMATIONReconciliationofReportableResultsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_f6e49823-79a0-4fa0-973f-a41afe87dbb3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_1bb9e903-63cf-4133-9c86-5e9ad1f7be9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_f6e49823-79a0-4fa0-973f-a41afe87dbb3" xlink:to="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_1bb9e903-63cf-4133-9c86-5e9ad1f7be9b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_Segmentincomelossfromoperations_73488258-e79a-4e3d-b319-a699da8bfc0d" xlink:href="a-20220131.xsd#a_Segmentincomelossfromoperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_1bb9e903-63cf-4133-9c86-5e9ad1f7be9b" xlink:to="loc_a_Segmentincomelossfromoperations_73488258-e79a-4e3d-b319-a699da8bfc0d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_TransformationalPrograms_3954b098-894c-47b1-8452-8ffadbe4066d" xlink:href="a-20220131.xsd#a_TransformationalPrograms"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_1bb9e903-63cf-4133-9c86-5e9ad1f7be9b" xlink:to="loc_a_TransformationalPrograms_3954b098-894c-47b1-8452-8ffadbe4066d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization_a82249cf-4a93-40e7-9666-16e80cc6430f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_1bb9e903-63cf-4133-9c86-5e9ad1f7be9b" xlink:to="loc_us-gaap_AdjustmentForAmortization_a82249cf-4a93-40e7-9666-16e80cc6430f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_df678b14-1d2e-4a8a-8d26-e746e9186d3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_1bb9e903-63cf-4133-9c86-5e9ad1f7be9b" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_df678b14-1d2e-4a8a-8d26-e746e9186d3d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_9e1d8d5a-192e-498f-a94c-6be5d82a449f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_1bb9e903-63cf-4133-9c86-5e9ad1f7be9b" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_9e1d8d5a-192e-498f-a94c-6be5d82a449f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_Other_323a5834-eeaf-43d3-b4f2-415811b42634" xlink:href="a-20220131.xsd#a_Other"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_1bb9e903-63cf-4133-9c86-5e9ad1f7be9b" xlink:to="loc_a_Other_323a5834-eeaf-43d3-b4f2-415811b42634" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_f9e9050b-6290-4ceb-8ddf-72bb3ff9f335" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_1bb9e903-63cf-4133-9c86-5e9ad1f7be9b" xlink:to="loc_us-gaap_InvestmentIncomeInterest_f9e9050b-6290-4ceb-8ddf-72bb3ff9f335" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_e340a136-e55c-4625-87cf-5a5289470aa2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_1bb9e903-63cf-4133-9c86-5e9ad1f7be9b" xlink:to="loc_us-gaap_InterestExpense_e340a136-e55c-4625-87cf-5a5289470aa2" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_fcf06ebb-fd6e-4a3d-b99f-b9eb59cf30a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_1bb9e903-63cf-4133-9c86-5e9ad1f7be9b" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_fcf06ebb-fd6e-4a3d-b99f-b9eb59cf30a9" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_bd274858-3b69-4ddb-b5ef-5d27ddee0038" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_1bb9e903-63cf-4133-9c86-5e9ad1f7be9b" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_bd274858-3b69-4ddb-b5ef-5d27ddee0038" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_c670c0f4-77ec-426b-802d-7b49bfc26b40" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_f6e49823-79a0-4fa0-973f-a41afe87dbb3" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_c670c0f4-77ec-426b-802d-7b49bfc26b40" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_fceefbd1-9a92-46ba-88f2-04a8b7cb3a97" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_c670c0f4-77ec-426b-802d-7b49bfc26b40" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_fceefbd1-9a92-46ba-88f2-04a8b7cb3a97" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_fceefbd1-9a92-46ba-88f2-04a8b7cb3a97_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_fceefbd1-9a92-46ba-88f2-04a8b7cb3a97" xlink:to="loc_us-gaap_SegmentDomain_fceefbd1-9a92-46ba-88f2-04a8b7cb3a97_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_e585e68d-23d4-4433-8f60-a153c163e0fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_fceefbd1-9a92-46ba-88f2-04a8b7cb3a97" xlink:to="loc_us-gaap_SegmentDomain_e585e68d-23d4-4433-8f60-a153c163e0fb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_86426ba5-fd21-4b88-a511-97b39f7bdf1a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_c670c0f4-77ec-426b-802d-7b49bfc26b40" xlink:to="loc_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_86426ba5-fd21-4b88-a511-97b39f7bdf1a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_86426ba5-fd21-4b88-a511-97b39f7bdf1a_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_86426ba5-fd21-4b88-a511-97b39f7bdf1a" xlink:to="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_86426ba5-fd21-4b88-a511-97b39f7bdf1a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_3916914f-0041-44ec-829d-3c2f089792ef" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_86426ba5-fd21-4b88-a511-97b39f7bdf1a" xlink:to="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_3916914f-0041-44ec-829d-3c2f089792ef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsConsolidationItemsAxis_eb2d4e9d-7c07-4a3d-8e9a-08f62075ba7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsegmentsConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_c670c0f4-77ec-426b-802d-7b49bfc26b40" xlink:to="loc_us-gaap_SubsegmentsConsolidationItemsAxis_eb2d4e9d-7c07-4a3d-8e9a-08f62075ba7d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsConsolidationItemsDomain_eb2d4e9d-7c07-4a3d-8e9a-08f62075ba7d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsegmentsConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsegmentsConsolidationItemsAxis_eb2d4e9d-7c07-4a3d-8e9a-08f62075ba7d" xlink:to="loc_us-gaap_SubsegmentsConsolidationItemsDomain_eb2d4e9d-7c07-4a3d-8e9a-08f62075ba7d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsConsolidationItemsDomain_16f5f5fd-42b5-498b-b140-0ecb3e9bce48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsegmentsConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsegmentsConsolidationItemsAxis_eb2d4e9d-7c07-4a3d-8e9a-08f62075ba7d" xlink:to="loc_us-gaap_SubsegmentsConsolidationItemsDomain_16f5f5fd-42b5-498b-b140-0ecb3e9bce48" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.agilent.com/role/SEGMENTINFORMATIONSegmentAssetsDetails" xlink:type="simple" xlink:href="a-20220131.xsd#SEGMENTINFORMATIONSegmentAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.agilent.com/role/SEGMENTINFORMATIONSegmentAssetsDetails" xlink:type="extended" id="i87a8e982dea34167afe4f8a883707184_SEGMENTINFORMATIONSegmentAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_7aaac5f6-b0f1-48fe-999d-8c93c1881867" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_cb3fb93f-fb54-4afb-8367-1986a32efba2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_7aaac5f6-b0f1-48fe-999d-8c93c1881867" xlink:to="loc_us-gaap_Assets_cb3fb93f-fb54-4afb-8367-1986a32efba2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_72cf9ac3-a384-49c8-a316-75763a576150" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_7aaac5f6-b0f1-48fe-999d-8c93c1881867" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_72cf9ac3-a384-49c8-a316-75763a576150" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_3ed09f21-98e1-4c3f-879e-9d362787dbca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_72cf9ac3-a384-49c8-a316-75763a576150" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_3ed09f21-98e1-4c3f-879e-9d362787dbca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_3ed09f21-98e1-4c3f-879e-9d362787dbca_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_3ed09f21-98e1-4c3f-879e-9d362787dbca" xlink:to="loc_us-gaap_SegmentDomain_3ed09f21-98e1-4c3f-879e-9d362787dbca_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_49a5cb08-33f7-40f4-85c9-69525680dc99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_3ed09f21-98e1-4c3f-879e-9d362787dbca" xlink:to="loc_us-gaap_SegmentDomain_49a5cb08-33f7-40f4-85c9-69525680dc99" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_LifeSciencesandAppliedMarketsMember_6bcacea3-3f88-4fef-95c3-959ec71d7433" xlink:href="a-20220131.xsd#a_LifeSciencesandAppliedMarketsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_49a5cb08-33f7-40f4-85c9-69525680dc99" xlink:to="loc_a_LifeSciencesandAppliedMarketsMember_6bcacea3-3f88-4fef-95c3-959ec71d7433" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_DiagnosticsAndGenomicsMember_c49e14b9-0d90-41de-907a-7e4afc61c382" xlink:href="a-20220131.xsd#a_DiagnosticsAndGenomicsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_49a5cb08-33f7-40f4-85c9-69525680dc99" xlink:to="loc_a_DiagnosticsAndGenomicsMember_c49e14b9-0d90-41de-907a-7e4afc61c382" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_AgilentCrossLabMember_22d2428d-8460-4374-9dc2-24c5507657c2" xlink:href="a-20220131.xsd#a_AgilentCrossLabMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_49a5cb08-33f7-40f4-85c9-69525680dc99" xlink:to="loc_a_AgilentCrossLabMember_22d2428d-8460-4374-9dc2-24c5507657c2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_SegmentTotalMember_b205f388-3e2a-43a3-a93f-d05b62adb17b" xlink:href="a-20220131.xsd#a_SegmentTotalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_49a5cb08-33f7-40f4-85c9-69525680dc99" xlink:to="loc_a_SegmentTotalMember_b205f388-3e2a-43a3-a93f-d05b62adb17b" xlink:type="arc" order="3"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>a-20220131_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:b57f1026-9350-4429-b363-875dec110646,g:1024445c-b98f-4ee2-b278-e07339a70979-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_PositionAxis_40ef4ec5-8052-42e6-a9a0-8214d7e48ca3_terseLabel_en-US" xlink:label="lab_us-gaap_PositionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Position [Axis]</link:label>
    <link:label id="lab_us-gaap_PositionAxis_label_en-US" xlink:label="lab_us-gaap_PositionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Position [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PositionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PositionAxis" xlink:to="lab_us-gaap_PositionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsAxis_5f071c69-7466-40be-9828-dc94651f8d4d_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends [Axis]</link:label>
    <link:label id="lab_us-gaap_DividendsAxis_label_en-US" xlink:label="lab_us-gaap_DividendsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsAxis" xlink:to="lab_us-gaap_DividendsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_b9dfa6cf-d6c4-4141-a561-7839d2211e01_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share repurchase program authorized amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Authorized Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_cda99262-18b3-449b-a71e-b20379bacb17_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationDomain" xlink:to="lab_us-gaap_HedgingDesignationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_11e1e467-e74e-4869-8211-9335ca7f5f8d_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental cash flow information:</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsAbstract_514272c0-3068-41b5-a595-51c49c1e5ba1_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends [Abstract]</link:label>
    <link:label id="lab_us-gaap_DividendsAbstract_label_en-US" xlink:label="lab_us-gaap_DividendsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsAbstract" xlink:to="lab_us-gaap_DividendsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a3cdc6d3-51e7-41f8-99fa-9f97f338c8e4_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_ed2b054a-20ee-49ee-b7b4-b5adfd0371c3_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_5d0b215b-2f5a-44f9-b019-c3ffb99e0459_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidatedEntitiesAxis_d68609f7-07ce-4630-a6a5-40347cfa736d_terseLabel_en-US" xlink:label="lab_srt_ConsolidatedEntitiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Axis]</link:label>
    <link:label id="lab_srt_ConsolidatedEntitiesAxis_label_en-US" xlink:label="lab_srt_ConsolidatedEntitiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidatedEntitiesAxis" xlink:to="lab_srt_ConsolidatedEntitiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_b9ce4511-7756-44c9-93c3-e23b9126b1c6_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_40f97314-7f83-440e-b412-ae691e8eff92_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_061f29a5-25ec-4edd-a6c4-17d759c40544_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest cost on benefit obligation</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Interest Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanInterestCost" xlink:to="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_d46c0130-9e82-4f6d-900a-32b6eb822fb6_verboseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee compensation and benefits</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_d0956c5a-1a99-41e2-ac8b-1b8371c0aae9_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_d65beb70-714b-4db1-9cd7-a832e24e9c53_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) by Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts_b0e511f9-0013-4880-a723-d2a62ece7349_negatedLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition and integration costs</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Acquisition Related Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:to="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentDetailAbstract_5b356dc7-d4a7-44cc-b985-6807ce7b2188_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentDetailAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentDetailAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentDetailAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument Detail [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentDetailAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentDetailAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentDetailAbstract" xlink:to="lab_us-gaap_DerivativeInstrumentDetailAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_d2212275-1aa1-48b3-bc7c-da0ea5350065_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_123bc969-56eb-4868-a65d-149b94b03081_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIntangibleAssetsMember_32214285-a7dc-495b-ade5-9c6029828efe_terseLabel_en-US" xlink:label="lab_us-gaap_OtherIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Intangible Assets</link:label>
    <link:label id="lab_us-gaap_OtherIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIntangibleAssetsMember" xlink:to="lab_us-gaap_OtherIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_a_SeniorNotes2022Member_0feb9c52-8a31-47f0-9186-7df61f30abd1_terseLabel_en-US" xlink:label="lab_a_SeniorNotes2022Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2022</link:label>
    <link:label id="lab_a_SeniorNotes2022Member_label_en-US" xlink:label="lab_a_SeniorNotes2022Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2022 [Member]</link:label>
    <link:label id="lab_a_SeniorNotes2022Member_documentation_en-US" xlink:label="lab_a_SeniorNotes2022Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bond that takes priority over other debt securities by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for (must receive) repayment prior to (relative to) junior and unsecured ( general) creditors.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_a_SeniorNotes2022Member" xlink:href="a-20220131.xsd#a_SeniorNotes2022Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_a_SeniorNotes2022Member" xlink:to="lab_a_SeniorNotes2022Member" xlink:type="arc" order="1"/>
    <link:label id="lab_a_BusinessCombinationContingentConsiderationFairValueMeasurementInput_aac39f34-a8ca-45a1-8339-ef3d6b965ea2_terseLabel_en-US" xlink:label="lab_a_BusinessCombinationContingentConsiderationFairValueMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Contingent Consideration Liability Measurement Input</link:label>
    <link:label id="lab_a_BusinessCombinationContingentConsiderationFairValueMeasurementInput_label_en-US" xlink:label="lab_a_BusinessCombinationContingentConsiderationFairValueMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Contingent Consideration Fair Value Measurement Input</link:label>
    <link:label id="lab_a_BusinessCombinationContingentConsiderationFairValueMeasurementInput_documentation_en-US" xlink:label="lab_a_BusinessCombinationContingentConsiderationFairValueMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage input used to measure contingent consideration liability from business combination.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_a_BusinessCombinationContingentConsiderationFairValueMeasurementInput" xlink:href="a-20220131.xsd#a_BusinessCombinationContingentConsiderationFairValueMeasurementInput"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_a_BusinessCombinationContingentConsiderationFairValueMeasurementInput" xlink:to="lab_a_BusinessCombinationContingentConsiderationFairValueMeasurementInput" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_f107bc74-0073-45d9-b5b1-634cb9c40587_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash dividends declared</link:label>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_5723a3f2-10b6-41b9-80c3-5c756933423d_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate dividends declared</link:label>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_label_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Common Stock, Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsCommonStockCash" xlink:to="lab_us-gaap_DividendsCommonStockCash" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_a2a747e6-6353-41ad-b687-53d5d36db6e0_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_0160ae1e-d1c0-402e-9765-25e982e1d724_verboseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short term investments</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_8e8020cd-94f9-4758-8e73-5260136b0cf6_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short term investments</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNi" xlink:to="lab_us-gaap_EquitySecuritiesFvNi" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_ed1850f4-de46-4e93-bd00-9fb7d408dc29_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_037ba5cf-5c6f-45dc-ac55-4cce09cbb3aa_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate_8cb35768-dd8a-43cb-af18-bedffdd4d072_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ESPP plan purchase price (in hundredths)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Discount from Market Price, Purchase Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_e5f1bfce-6ffd-43a8-ab64-b2558032d4e8_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_a_EmployerContributionsAndExpectedEmployerContributionsTableTextBlock_5e403739-2314-497d-b174-cf2472b15960_terseLabel_en-US" xlink:label="lab_a_EmployerContributionsAndExpectedEmployerContributionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employer Contributions and Expected Employer Contributions</link:label>
    <link:label id="lab_a_EmployerContributionsAndExpectedEmployerContributionsTableTextBlock_label_en-US" xlink:label="lab_a_EmployerContributionsAndExpectedEmployerContributionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employer Contributions and Expected Employer Contributions [Table Text Block]</link:label>
    <link:label id="lab_a_EmployerContributionsAndExpectedEmployerContributionsTableTextBlock_documentation_en-US" xlink:label="lab_a_EmployerContributionsAndExpectedEmployerContributionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tabular disclosure of amount of contributions received by defined benefit plan from employer which increases plan assets and amount of contribution expected to be received by defined benefit plan from employer in the remainder of current fiscal year.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_a_EmployerContributionsAndExpectedEmployerContributionsTableTextBlock" xlink:href="a-20220131.xsd#a_EmployerContributionsAndExpectedEmployerContributionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_a_EmployerContributionsAndExpectedEmployerContributionsTableTextBlock" xlink:to="lab_a_EmployerContributionsAndExpectedEmployerContributionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_a00ab3d0-9838-401d-9e9a-491ed404f5e1_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract Liabilities and Changes in Balances</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:to="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredRevenuePeriodIncreaseDecrease_9f08e8b3-1894-4d21-bcab-c03d7899f046_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredRevenuePeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Revenue, Period Increase (Decrease)</link:label>
    <link:label id="lab_us-gaap_DeferredRevenuePeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_DeferredRevenuePeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Revenue, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenuePeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredRevenuePeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredRevenuePeriodIncreaseDecrease" xlink:to="lab_us-gaap_DeferredRevenuePeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_c29a8bbe-eedb-4864-b84c-4b42fbc8d87e_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_9521041a-292d-4a5c-81bc-6f3d7347fa81_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract" xlink:to="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_207bc2a2-138f-41c7-8551-e0666d82cf13_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_dbdccb53-ff25-4148-9f18-9bece7b29654_negatedLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected return on plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Return (Loss) on Plan Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_d628ce98-1ee3-4806-96ec-a34fe7a2b4f3_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_3e1a064b-6897-46e2-881a-d3951853c10e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividend yield</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InProcessResearchAndDevelopmentMember_cdb78e51-73ef-43c7-a054-4ba7d91b1a59_terseLabel_en-US" xlink:label="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In-Process R&amp;D</link:label>
    <link:label id="lab_us-gaap_InProcessResearchAndDevelopmentMember_label_en-US" xlink:label="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In Process Research and Development [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InProcessResearchAndDevelopmentMember" xlink:to="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_fc7bd8ce-0127-4ee5-a369-f5722cf1c5c0_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net decrease in cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_f051ff1c-cf12-4e59-8d9e-c96aec1a930b_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_TWD_d5091055-0040-40b2-bbdc-52d61bb79ca8_terseLabel_en-US" xlink:label="lab_currency_TWD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taiwan, New Dollars</link:label>
    <link:label id="lab_currency_TWD_label_en-US" xlink:label="lab_currency_TWD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taiwan, New Dollars</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_TWD" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_TWD"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_TWD" xlink:to="lab_currency_TWD" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_0064511f-1d57-448d-8032-1c837272e5ad_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Volatility of Agilent shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_bb72d15b-15ad-42a0-b703-ffe733a1f535_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityInitiationDate1_d0dae947-3337-4d5f-8d43-89f33ef72ed3_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityInitiationDate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initiation date of credit facility</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityInitiationDate1_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityInitiationDate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Initiation Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityInitiationDate1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityInitiationDate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityInitiationDate1" xlink:to="lab_us-gaap_LineOfCreditFacilityInitiationDate1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_13330c9d-51d0-4cfa-ba6c-95c35ec50360_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative instruments (foreign exchange contracts)</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Contracts, Liability, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure" xlink:to="lab_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock_23495a0c-204e-4c47-a1cc-de1491310a88_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_a_IncreaseinContractAssetBalance_03f14dfe-604c-49da-8cbe-4db95943754c_terseLabel_en-US" xlink:label="lab_a_IncreaseinContractAssetBalance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in Contract Asset Balance</link:label>
    <link:label id="lab_a_IncreaseinContractAssetBalance_label_en-US" xlink:label="lab_a_IncreaseinContractAssetBalance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in Contract Asset Balance</link:label>
    <link:label id="lab_a_IncreaseinContractAssetBalance_documentation_en-US" xlink:label="lab_a_IncreaseinContractAssetBalance" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (decrease) in Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_a_IncreaseinContractAssetBalance" xlink:href="a-20220131.xsd#a_IncreaseinContractAssetBalance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_a_IncreaseinContractAssetBalance" xlink:to="lab_a_IncreaseinContractAssetBalance" xlink:type="arc" order="1"/>
    <link:label id="lab_a_NumeratorAbstract_7df8c979-28f9-424c-8f46-bb2f340ff7f9_terseLabel_en-US" xlink:label="lab_a_NumeratorAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Numerator:</link:label>
    <link:label id="lab_a_NumeratorAbstract_label_en-US" xlink:label="lab_a_NumeratorAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Numerator [Abstract]</link:label>
    <link:label id="lab_a_NumeratorAbstract_documentation_en-US" xlink:label="lab_a_NumeratorAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Numerator [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_a_NumeratorAbstract" xlink:href="a-20220131.xsd#a_NumeratorAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_a_NumeratorAbstract" xlink:to="lab_a_NumeratorAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsCommonStockAbstract_01fa521e-7c75-4245-9e3b-2c02f48e60ee_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsCommonStockAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Declared</link:label>
    <link:label id="lab_us-gaap_DividendsCommonStockAbstract_label_en-US" xlink:label="lab_us-gaap_DividendsCommonStockAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Common Stock [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsCommonStockAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsCommonStockAbstract" xlink:to="lab_us-gaap_DividendsCommonStockAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_6a92acd3-299b-46ac-8aa5-310b576cbc3f_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_3c8256e1-4a58-4ecd-8cb1-52adba0810d8_verboseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of intangible assets during the period</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_872cd6bd-a63f-4132-b3e2-7409419fc236_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining authorized repurchase amount under share repurchase program</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Remaining Authorized Repurchase Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_75dc17df-ec43-40eb-9a97-da93f09b5fb8_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Long-Lived assets Held for sale</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Long-Lived Assets to be Disposed of</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:to="lab_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCurrentAssetsMember_16daede4-5b2d-4c90-9d13-ba7a815f4277_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Assets</link:label>
    <link:label id="lab_us-gaap_OtherCurrentAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCurrentAssetsMember" xlink:to="lab_us-gaap_OtherCurrentAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_6bb033f9-8130-4dc3-929b-d9fccb3700bf_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INVENTORY</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_91c500fc-00ba-40d7-a383-a68fb074e245_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Anti-dilutive shares excluded from computation of dilutive earnings per share (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_1fa0e146-69af-4cd7-b6a8-0e543fa4fac6_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue recognized that was included in the contract liability balance at the beginning of the period</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Revenue Recognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_872642da-2156-4be9-966c-dda3085a66fc_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_abf90af4-8b54-49e3-8991-9f42776b42e2_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in actuarial net loss, net of tax expense of $2 and $4</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_BRL_7a6d38ab-261e-42a6-ac14-3ccbb35901f6_terseLabel_en-US" xlink:label="lab_currency_BRL" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Brazil, Brazil Real</link:label>
    <link:label id="lab_currency_BRL_label_en-US" xlink:label="lab_currency_BRL" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Brazil, Brazil Real</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_BRL" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_BRL"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_BRL" xlink:to="lab_currency_BRL" xlink:type="arc" order="1"/>
    <link:label id="lab_a_A2019RepurchaseProgramMember_abe522bc-d92e-467a-a945-dd6feeaca49e_terseLabel_en-US" xlink:label="lab_a_A2019RepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 Repurchase Program [Member]</link:label>
    <link:label id="lab_a_A2019RepurchaseProgramMember_label_en-US" xlink:label="lab_a_A2019RepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 Repurchase Program [Member]</link:label>
    <link:label id="lab_a_A2019RepurchaseProgramMember_documentation_en-US" xlink:label="lab_a_A2019RepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 Repurchase Program [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_a_A2019RepurchaseProgramMember" xlink:href="a-20220131.xsd#a_A2019RepurchaseProgramMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_a_A2019RepurchaseProgramMember" xlink:to="lab_a_A2019RepurchaseProgramMember" xlink:type="arc" order="1"/>
    <link:label id="lab_a_Taxrelatedtosharesissued_b92c3b5e-ba55-4f4d-b15d-0f4b20bef0c9_terseLabel_en-US" xlink:label="lab_a_Taxrelatedtosharesissued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax related to shares issued</link:label>
    <link:label id="lab_a_Taxrelatedtosharesissued_label_en-US" xlink:label="lab_a_Taxrelatedtosharesissued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax related to shares issued</link:label>
    <link:label id="lab_a_Taxrelatedtosharesissued_documentation_en-US" xlink:label="lab_a_Taxrelatedtosharesissued" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax related to shares issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_a_Taxrelatedtosharesissued" xlink:href="a-20220131.xsd#a_Taxrelatedtosharesissued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_a_Taxrelatedtosharesissued" xlink:to="lab_a_Taxrelatedtosharesissued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_e67c744d-c848-485e-8841-496ded6cefc5_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:to="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_be0f1786-f55d-445e-9e4c-9f7183a1a7ce_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_e9c1d50f-0c3e-45b8-bed9-69daac66458f_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_label_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowHedgingMember" xlink:to="lab_us-gaap_CashFlowHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExaminationTable_926de26f-0d82-4c98-a2fb-f8ca9aacc783_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExaminationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Examination [Table]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExaminationTable_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExaminationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Examination [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExaminationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExaminationTable" xlink:to="lab_us-gaap_IncomeTaxExaminationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_7956eeac-8d7d-4002-8085-1c8ae22e9c53_verboseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement and post-retirement benefits</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability, Defined Benefit Plan, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:to="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameAxis_c74fa4de-bec6-4736-aa20-8df664184fd6_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameAxis_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b734b743-2fe7-4b09-a3f6-b5e3ffda9263_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramDomain_fee89d50-0b50-4ed7-90bb-710bdf212192_terseLabel_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramDomain_label_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain" xlink:to="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_8cc6c533-7404-4f23-b12d-dc4e690ef0bb_terseLabel_en-US" xlink:label="lab_us-gaap_MovementInStandardProductWarrantyAccrualRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Movement in Standard Product Warranty Accrual</link:label>
    <link:label id="lab_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_label_en-US" xlink:label="lab_us-gaap_MovementInStandardProductWarrantyAccrualRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Movement in Standard Product Warranty Accrual [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MovementInStandardProductWarrantyAccrualRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward" xlink:to="lab_us-gaap_MovementInStandardProductWarrantyAccrualRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_53fe23d3-ec19-490f-8d45-dbaf75f03d06_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_23593779-253c-4ca8-aabb-3fb9ddce3b94_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_53da09e3-f58a-4b42-9046-7f5992272c44_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsNonrecurringMember_dd3c8369-b781-4ad5-b988-78ea42c57bd7_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Nonrecurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsNonrecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Nonrecurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsNonrecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_677e15a3-ecba-4e95-8074-01e1d65c16d8_negatedLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actuarial losses</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Amortization of Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:to="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAbstract_54dea303-bb99-411f-be18-4cf8a07591f6_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash [Abstract]</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAbstract_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAbstract" xlink:to="lab_us-gaap_RestrictedCashAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_4a85c8ec-1421-4ce6-ab75-97d22ea965fe_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DERIVATIVES</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_dd892ff0-756f-4dfe-bca3-0555efad55a7_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GOODWILL AND OTHER INTANGIBLE ASSETS</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_ebc21f44-87cc-466c-be89-4ccb964f8fda_verboseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock; $0.01 par value; 125 million shares authorized; none issued and outstanding</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_733b370d-b465-420e-b0ea-4f911eb50d97_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock under employee stock plans</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_a_DenominatorsAbstract_71b4ec44-650c-4ebe-83af-db9dcf7a1c48_terseLabel_en-US" xlink:label="lab_a_DenominatorsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Denominators:</link:label>
    <link:label id="lab_a_DenominatorsAbstract_label_en-US" xlink:label="lab_a_DenominatorsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Denominators [Abstract]</link:label>
    <link:label id="lab_a_DenominatorsAbstract_documentation_en-US" xlink:label="lab_a_DenominatorsAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Denominators [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_a_DenominatorsAbstract" xlink:href="a-20220131.xsd#a_DenominatorsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_a_DenominatorsAbstract" xlink:to="lab_a_DenominatorsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfCommercialPaper_7c54dcdd-26cd-4e8f-82ee-41bbcbe56caa_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfCommercialPaper" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of commercial paper</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfCommercialPaper_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfCommercialPaper" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Commercial Paper</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfCommercialPaper" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfCommercialPaper"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfCommercialPaper" xlink:to="lab_us-gaap_RepaymentsOfCommercialPaper" xlink:type="arc" order="1"/>
    <link:label id="lab_a_AgilentCrossLabMember_7cc71ce6-4c3c-4a4d-ad87-b724ce71c217_terseLabel_en-US" xlink:label="lab_a_AgilentCrossLabMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Agilent CrossLab</link:label>
    <link:label id="lab_a_AgilentCrossLabMember_label_en-US" xlink:label="lab_a_AgilentCrossLabMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Agilent CrossLab [Member]</link:label>
    <link:label id="lab_a_AgilentCrossLabMember_documentation_en-US" xlink:label="lab_a_AgilentCrossLabMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Agilent CrossLab [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_a_AgilentCrossLabMember" xlink:href="a-20220131.xsd#a_AgilentCrossLabMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_a_AgilentCrossLabMember" xlink:to="lab_a_AgilentCrossLabMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CurrencyAxis_3e229251-dc1a-459e-b420-e33b92454a3f_terseLabel_en-US" xlink:label="lab_srt_CurrencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency [Axis]</link:label>
    <link:label id="lab_srt_CurrencyAxis_label_en-US" xlink:label="lab_srt_CurrencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CurrencyAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CurrencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CurrencyAxis" xlink:to="lab_srt_CurrencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_ecb16b06-fa4b-44d7-a132-c3e7e6bf208a_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Not Primary Beneficiary [Member]</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Not Primary Beneficiary [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:to="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_381efeb3-9271-472b-bb6d-eb459d04c7c4_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_dfb08af5-7198-4c72-9160-c7b8ff59bf91_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_a_SeniorNotes2029Member_9344a196-3ea0-4cd8-9c28-eec5790ddc44_terseLabel_en-US" xlink:label="lab_a_SeniorNotes2029Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2029</link:label>
    <link:label id="lab_a_SeniorNotes2029Member_label_en-US" xlink:label="lab_a_SeniorNotes2029Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2029 [Member]</link:label>
    <link:label id="lab_a_SeniorNotes2029Member_documentation_en-US" xlink:label="lab_a_SeniorNotes2029Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2029 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_a_SeniorNotes2029Member" xlink:href="a-20220131.xsd#a_SeniorNotes2029Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_a_SeniorNotes2029Member" xlink:to="lab_a_SeniorNotes2029Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StandardProductWarrantyAccrualPayments_da10ed63-54d0-4d63-b9fe-13b8a4587e05_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StandardProductWarrantyAccrualPayments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlements made during the period</link:label>
    <link:label id="lab_us-gaap_StandardProductWarrantyAccrualPayments_label_en-US" xlink:label="lab_us-gaap_StandardProductWarrantyAccrualPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard Product Warranty Accrual, Decrease for Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandardProductWarrantyAccrualPayments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StandardProductWarrantyAccrualPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StandardProductWarrantyAccrualPayments" xlink:to="lab_us-gaap_StandardProductWarrantyAccrualPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_1407df25-bdf4-4b53-a696-49b6062822d8_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">WARRANTIES AND CONTINGENCIES</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease_e75ab9a2-145d-4a63-924f-ee6fd473cba7_terseLabel_en-US" xlink:label="lab_us-gaap_TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency Translation and Other Adjustment</link:label>
    <link:label id="lab_us-gaap_TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Translation Adjustment Functional to Reporting Currency, Net of Tax, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease" xlink:to="lab_us-gaap_TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfOrdinaryDividends_10d5e536-fd06-4f66-9a86-c6b4d90c7b98_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfOrdinaryDividends" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of dividends</link:label>
    <link:label id="lab_us-gaap_PaymentsOfOrdinaryDividends_label_en-US" xlink:label="lab_us-gaap_PaymentsOfOrdinaryDividends" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Ordinary Dividends</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfOrdinaryDividends" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfOrdinaryDividends"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfOrdinaryDividends" xlink:to="lab_us-gaap_PaymentsOfOrdinaryDividends" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_de8af1e7-62e6-407a-81a8-a9286829ea7f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesOperatingAbstract_6f9db2b6-85f0-44e5-ade3-b33bc37584ff_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesOperatingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases</link:label>
    <link:label id="lab_us-gaap_LeasesOperatingAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesOperatingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases, Operating [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesOperatingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesOperatingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesOperatingAbstract" xlink:to="lab_us-gaap_LeasesOperatingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount_af5b4d38-618f-4afd-a120-d6fe5c750d42_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of non-marketable securities</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value, Impairment Loss, Cumulative Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount" xlink:to="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_cafe1e4a-9506-4df0-b80c-ebfeb50b41aa_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior service credits</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Amortization of Prior Service Cost (Credit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:to="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_833232f8-7ea7-4cdf-841b-b7d9506e4c2d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased and Retired During Period, Value</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_dd543b70-4816-45b0-9f6f-5b5e27c15692_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares repurchased and retired during period, (Value)</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased and Retired During Period, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:to="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_16fe57e6-89b5-49f0-9b7f-79e1a6b50643_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsPayableDateOfRecordDayMonthAndYear_72b98a03-de42-4fb6-9f99-40563a0c8d9a_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsPayableDateOfRecordDayMonthAndYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Declared Date of Record</link:label>
    <link:label id="lab_us-gaap_DividendsPayableDateOfRecordDayMonthAndYear_label_en-US" xlink:label="lab_us-gaap_DividendsPayableDateOfRecordDayMonthAndYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Payable, Date of Record</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableDateOfRecordDayMonthAndYear" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsPayableDateOfRecordDayMonthAndYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsPayableDateOfRecordDayMonthAndYear" xlink:to="lab_us-gaap_DividendsPayableDateOfRecordDayMonthAndYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract_626c937a-3bbf-417c-be74-ceeee3f0e181_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net defined benefit pension cost and post retirement plan costs:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_28da054d-e9ac-49ab-af8a-bca519bc9b39_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_8c0abf56-3780-4678-8d75-2f428f68a7ec_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting percentage</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_3738b889-1e37-4ce3-8f75-a4fb4e44a780_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_4ad60265-8bd4-40be-b090-1c09a9ecb31c_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total comprehensive income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_77e90bfe-bf13-4c9c-b568-b89c2eb1cf0e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxPeriodDomain_8977be2b-54ac-444f-902f-be52c73995c5_terseLabel_en-US" xlink:label="lab_us-gaap_TaxPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Period [Domain]</link:label>
    <link:label id="lab_us-gaap_TaxPeriodDomain_label_en-US" xlink:label="lab_us-gaap_TaxPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Period [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxPeriodDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxPeriodDomain" xlink:to="lab_us-gaap_TaxPeriodDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfInterestRateDerivativesHeld_8909e7ab-d29b-44cb-ae5b-1cce33208138_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfInterestRateDerivativesHeld" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of interest rate swap contracts terminated</link:label>
    <link:label id="lab_us-gaap_NumberOfInterestRateDerivativesHeld_label_en-US" xlink:label="lab_us-gaap_NumberOfInterestRateDerivativesHeld" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Interest Rate Derivatives Held</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfInterestRateDerivativesHeld" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfInterestRateDerivativesHeld"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfInterestRateDerivativesHeld" xlink:to="lab_us-gaap_NumberOfInterestRateDerivativesHeld" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherTaxExpenseBenefit_e0dbded5-e505-42f3-95b4-13194f571444_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discrete tax expense (benefit)</link:label>
    <link:label id="lab_us-gaap_OtherTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_OtherTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherTaxExpenseBenefit" xlink:to="lab_us-gaap_OtherTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_7fff4eeb-08aa-4c6c-a319-f09e74c1db9e_verboseLabel_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of operating segments</link:label>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Operating Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfOperatingSegments" xlink:to="lab_us-gaap_NumberOfOperatingSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GuaranteesAbstract_6ad44192-6bb7-412b-ad96-f9eb1d09e4f1_terseLabel_en-US" xlink:label="lab_us-gaap_GuaranteesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantees</link:label>
    <link:label id="lab_us-gaap_GuaranteesAbstract_label_en-US" xlink:label="lab_us-gaap_GuaranteesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantees [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GuaranteesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GuaranteesAbstract" xlink:to="lab_us-gaap_GuaranteesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseMember_eeb1aadf-10f7-4d46-8f4a-54c2aaaeb577_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (expense)</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseMember_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_81bff850-fd17-47a6-90c3-1be2fdc4ef3d_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Service Share-based Compensation, Allocation of Recognized Period Costs</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_1d08f527-d8c5-46d6-90a5-e1f8e9fe6adf_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_7770ba33-2fd7-4b0a-9251-34dd67ab152b_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_c71b2fec-4cba-480b-a5d8-fc09f019303e_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_9713d644-03f0-4592-a9d2-0b54f4fb3da2_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_b88b310b-3b04-4ac4-b90f-69b1d818fd78_periodStartLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Contingent Consideration, Beginning Balance</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_75c9cd2b-474c-4e7e-b409-5a027882eabe_periodEndLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Contingent Consideration, Ending Balance</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireEquitySecuritiesFvNi_c1e11541-e4ee-4149-a3e9-67cb2205728b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireEquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to acquire equity investments</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireEquitySecuritiesFvNi_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireEquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Equity Securities, FV-NI</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquitySecuritiesFvNi" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireEquitySecuritiesFvNi"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireEquitySecuritiesFvNi" xlink:to="lab_us-gaap_PaymentsToAcquireEquitySecuritiesFvNi" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_3f2dd2a8-f10b-4bb2-8e46-3b48dc9dd013_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions_7b0a51bb-f4da-41c4-907c-8bac54d58485_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Post-vest holding restriction discount for all executive awards</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Discount for Postvesting Restrictions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialPaperMember_73aa1d65-bbd6-42fa-bedf-b95b716da1f2_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper</link:label>
    <link:label id="lab_us-gaap_CommercialPaperMember_label_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialPaperMember" xlink:to="lab_us-gaap_CommercialPaperMember" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_AUD_e5578f56-9ca0-49ae-90df-0051153c9c09_verboseLabel_en-US" xlink:label="lab_currency_AUD" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Australian Dollar</link:label>
    <link:label id="lab_currency_AUD_label_en-US" xlink:label="lab_currency_AUD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Australia, Dollars</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AUD" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_AUD"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_AUD" xlink:to="lab_currency_AUD" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_e039e5d4-bd62-478e-aba4-5ab59c35a786_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-cash expense, net</link:label>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncash Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncashIncomeExpense" xlink:to="lab_us-gaap_OtherNoncashIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_296104ec-f70d-472e-8b5d-55c2fba26e05_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives asset fair value</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Fair Value, Gross Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StandardProductWarrantyAccrualCurrent_20dc076f-5ab0-4bd7-afaa-1d3789135906_terseLabel_en-US" xlink:label="lab_us-gaap_StandardProductWarrantyAccrualCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accruals for warranties due within one year</link:label>
    <link:label id="lab_us-gaap_StandardProductWarrantyAccrualCurrent_label_en-US" xlink:label="lab_us-gaap_StandardProductWarrantyAccrualCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard Product Warranty Accrual, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandardProductWarrantyAccrualCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StandardProductWarrantyAccrualCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StandardProductWarrantyAccrualCurrent" xlink:to="lab_us-gaap_StandardProductWarrantyAccrualCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_4dd17b1c-04c8-43a5-a371-76f82152a6f6_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (loss) recognized in accumulated other comprehensive&#160;loss</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_3d6af1c9-53ce-4efb-bb47-ba9c6276f6fa_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss) before reclassifications</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_a_EndMarketsAxis_f1854fc7-3c57-4f71-8359-a2fb2d83dc74_terseLabel_en-US" xlink:label="lab_a_EndMarketsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">End Markets [Axis]</link:label>
    <link:label id="lab_a_EndMarketsAxis_label_en-US" xlink:label="lab_a_EndMarketsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">End Markets [Axis]</link:label>
    <link:label id="lab_a_EndMarketsAxis_documentation_en-US" xlink:label="lab_a_EndMarketsAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">End Markets [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_a_EndMarketsAxis" xlink:href="a-20220131.xsd#a_EndMarketsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_a_EndMarketsAxis" xlink:to="lab_a_EndMarketsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_a_Fairvalueoflongtermdebtinexcessofcarryingvalue_d83558c1-e824-49d0-9d06-d66082f9785a_terseLabel_en-US" xlink:label="lab_a_Fairvalueoflongtermdebtinexcessofcarryingvalue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of senior notes in excess of carrying value</link:label>
    <link:label id="lab_a_Fairvalueoflongtermdebtinexcessofcarryingvalue_label_en-US" xlink:label="lab_a_Fairvalueoflongtermdebtinexcessofcarryingvalue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of long term debt in excess of carrying value</link:label>
    <link:label id="lab_a_Fairvalueoflongtermdebtinexcessofcarryingvalue_documentation_en-US" xlink:label="lab_a_Fairvalueoflongtermdebtinexcessofcarryingvalue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of fair value of long term debt in excess of carrying value.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_a_Fairvalueoflongtermdebtinexcessofcarryingvalue" xlink:href="a-20220131.xsd#a_Fairvalueoflongtermdebtinexcessofcarryingvalue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_a_Fairvalueoflongtermdebtinexcessofcarryingvalue" xlink:to="lab_a_Fairvalueoflongtermdebtinexcessofcarryingvalue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_eb734cb3-db4c-4933-a128-4442a19e700b_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradingSecurities_f028d024-dbf0-450d-bd57-ea47e4a9fa8d_terseLabel_en-US" xlink:label="lab_us-gaap_TradingSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading securities</link:label>
    <link:label id="lab_us-gaap_TradingSecurities_label_en-US" xlink:label="lab_us-gaap_TradingSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Trading, and Equity Securities, FV-NI</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradingSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradingSecurities" xlink:to="lab_us-gaap_TradingSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_dd339bb6-22e4-4230-9f31-0a7d510aabe8_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill Roll Forward</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_fde303aa-6557-441e-b80d-13a66618aa3d_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_cb51cd81-2e23-4720-83af-035df80ca884_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets measured at fair value</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_53039120-19ca-4e47-a672-1c960a478cc5_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quoted Prices in Active Markets for Identical Assets (Level 1)</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_8fe21c10-ac7f-4e3f-9b34-ab21c10b1db5_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from Investing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_64286d83-4d13-4960-8c18-e1f333ad0ed2_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill impairment</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairmentLoss" xlink:to="lab_us-gaap_GoodwillImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PledgedStatusDomain_203e8950-db39-426d-a4d6-e84f19a14951_terseLabel_en-US" xlink:label="lab_us-gaap_PledgedStatusDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pledged Status [Domain]</link:label>
    <link:label id="lab_us-gaap_PledgedStatusDomain_label_en-US" xlink:label="lab_us-gaap_PledgedStatusDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pledged Status [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PledgedStatusDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PledgedStatusDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PledgedStatusDomain" xlink:to="lab_us-gaap_PledgedStatusDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StandardProductWarrantyAccrualWarrantiesIssued_683152ec-7c4a-4c31-90c2-ba8d73d314b8_terseLabel_en-US" xlink:label="lab_us-gaap_StandardProductWarrantyAccrualWarrantiesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accruals for warranties including change in estimate</link:label>
    <link:label id="lab_us-gaap_StandardProductWarrantyAccrualWarrantiesIssued_label_en-US" xlink:label="lab_us-gaap_StandardProductWarrantyAccrualWarrantiesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard Product Warranty Accrual, Increase for Warranties Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandardProductWarrantyAccrualWarrantiesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StandardProductWarrantyAccrualWarrantiesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StandardProductWarrantyAccrualWarrantiesIssued" xlink:to="lab_us-gaap_StandardProductWarrantyAccrualWarrantiesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfInvestments_f25bba39-d5a2-4985-a64a-ae32aa86e6a4_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Investments</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfInvestments_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other than Temporary Impairment Losses, Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfInvestments" xlink:to="lab_us-gaap_ImpairmentOfInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_64fb271c-d573-45c4-adf7-faf045110610_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_70c06361-4aa1-44ab-b6ec-c391fe08c6b6_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_82a4a205-0fed-4d33-b39e-421e454b0d24_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_ccc5dd16-7e46-4366-9834-a8f49a6cb29f_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsForChangeInAccountingPrincipleAxis_97322677-01f7-4880-8a30-e42c6303119a_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsForChangeInAccountingPrincipleAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Accounting Principle, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AdjustmentsForChangeInAccountingPrincipleAxis_label_en-US" xlink:label="lab_us-gaap_AdjustmentsForChangeInAccountingPrincipleAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Accounting Principle, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForChangeInAccountingPrincipleAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForChangeInAccountingPrincipleAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsForChangeInAccountingPrincipleAxis" xlink:to="lab_us-gaap_AdjustmentsForChangeInAccountingPrincipleAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_AmericasMember_fab2a566-0233-4327-b5ef-38f6a0f268e1_terseLabel_en-US" xlink:label="lab_srt_AmericasMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Americas</link:label>
    <link:label id="lab_srt_AmericasMember_label_en-US" xlink:label="lab_srt_AmericasMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Americas [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AmericasMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_AmericasMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_AmericasMember" xlink:to="lab_srt_AmericasMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_db7b4d42-190b-41d4-8066-2aa5b7152914_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Excess tax benefit from stock based compensation</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementScenarioAxis_600f4b05-1eb5-4259-a6fe-599e4f62fd92_terseLabel_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:label id="lab_srt_StatementScenarioAxis_label_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementScenarioAxis" xlink:to="lab_srt_StatementScenarioAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommercialPaper_51d1a9ee-3a6b-46e8-bd95-4c0d0d0406f5_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommercialPaper" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Commercial Paper</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommercialPaper_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommercialPaper" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Commercial Paper</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommercialPaper" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommercialPaper"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfCommercialPaper" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfCommercialPaper" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCash_38d44fdd-ec6b-4a76-87f5-c34a40e04538_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash</link:label>
    <link:label id="lab_us-gaap_RestrictedCash_label_en-US" xlink:label="lab_us-gaap_RestrictedCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCash" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCash" xlink:to="lab_us-gaap_RestrictedCash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_917dcedd-7ac3-49b2-83dd-7b1e14fb593f_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in-capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock_c1921cdb-c6cb-4f59-8f64-c4034468e2d6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of net pension and post-retirement benefit costs</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock" xlink:to="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_b3f7f933-858e-46b2-ab8e-8ddf7fd640d4_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of IPR&amp;D</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:to="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_ae5de0b8-d6fb-4326-af15-479c290390a0_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_34ca96f3-6663-4ce1-a254-6a77d4de8a54_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLineItems_39d8ab3f-87f4-4dce-8fc9-704590de3329_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative</link:label>
    <link:label id="lab_us-gaap_DerivativeLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLineItems" xlink:to="lab_us-gaap_DerivativeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_f4f75b49-8675-4194-9aa9-2f6afd2f3aa6_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_label_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingRelationshipDomain" xlink:to="lab_us-gaap_HedgingRelationshipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateSwapMember_787abfcc-2572-4017-bc52-dfa89e8d01c3_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap</link:label>
    <link:label id="lab_us-gaap_InterestRateSwapMember_label_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateSwapMember" xlink:to="lab_us-gaap_InterestRateSwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3_54eec43e-1c4d-4164-8bfb-c7c158282c02_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers Into Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers Into Level 3</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_0b4ef0e5-299e-40f5-9135-c6b156b4a0db_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative instruments (foreign exchange contracts)</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Contract, Asset, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyContractAssetFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure" xlink:to="lab_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_58731ca3-261e-4ac8-bb33-adbe759a5bf4_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Overview and Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Description and Basis of Presentation [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:to="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermDebtTypeDomain_ee90e675-3a52-4fdd-9f55-c083acf3ef5e_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShortTermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain" xlink:to="lab_us-gaap_ShortTermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_580e8acd-c4b6-4a9f-b323-03b5e1f19c0d_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NET INCOME PER SHARE</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_fdfc9ccd-03f5-4c10-8e89-f56157081547_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignPlanMember_71a75fcf-02ff-4728-b9bb-bdfc3f8a6b79_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Plan</link:label>
    <link:label id="lab_us-gaap_ForeignPlanMember_label_en-US" xlink:label="lab_us-gaap_ForeignPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignPlanMember" xlink:to="lab_us-gaap_ForeignPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_581794c3-6220-476b-9159-960852af186c_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationProfitLossAbstract_9e12b1d9-5463-46d1-9503-b91c05989cb9_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationProfitLossAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationProfitLossAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationProfitLossAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information, Profit (Loss) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationProfitLossAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationProfitLossAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract" xlink:to="lab_us-gaap_SegmentReportingInformationProfitLossAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_b2045554-07d5-498c-b8a7-8515c408910d_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis_f9a110e1-c36c-40b6-b22f-91660b951e59_terseLabel_en-US" xlink:label="lab_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Error Correction, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis_label_en-US" xlink:label="lab_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Error Correction, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis" xlink:to="lab_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_d09d6703-b9a6-4d96-91ef-8dec8d5f7cb2_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlement gain</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" xlink:to="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" xlink:type="arc" order="1"/>
    <link:label id="lab_a_Interestrateswappayments_4485b3a1-01ce-41c2-9b30-79177f5ead2d_terseLabel_en-US" xlink:label="lab_a_Interestrateswappayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate swap payments</link:label>
    <link:label id="lab_a_Interestrateswappayments_label_en-US" xlink:label="lab_a_Interestrateswappayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">interest rate swap payments</link:label>
    <link:label id="lab_a_Interestrateswappayments_documentation_en-US" xlink:label="lab_a_Interestrateswappayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">interest rate swap payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_a_Interestrateswappayments" xlink:href="a-20220131.xsd#a_Interestrateswappayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_a_Interestrateswappayments" xlink:to="lab_a_Interestrateswappayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_c11a4b88-3e56-4c13-bf70-40c954997806_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets and liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets and Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_eefbdcb0-cd1c-488b-9c01-a0b2045ca00a_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in fair value of contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_d8bbdc1a-3260-462b-93f9-93b85f7278e3_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_596c18b5-809d-4002-93b1-52f26e09ceb7_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities measured at fair value</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial and Nonfinancial Liabilities, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_61d73a86-da66-4776-aee4-569b00721d86_verboseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_ec280a10-a4d0-4638-912c-ed45ce0fb400_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_324859de-be0e-4ec7-92c4-0af37f542462_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives</link:label>
    <link:label id="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_label_en-US" xlink:label="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems" xlink:to="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_ea21bad6-9563-4bae-a920-1a7d5142ba14_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ServiceOtherMember_945a146f-756e-4552-b415-d99a4a533e3a_terseLabel_en-US" xlink:label="lab_us-gaap_ServiceOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service and Other</link:label>
    <link:label id="lab_us-gaap_ServiceOtherMember_label_en-US" xlink:label="lab_us-gaap_ServiceOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service, Other [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceOtherMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ServiceOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ServiceOtherMember" xlink:to="lab_us-gaap_ServiceOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_6fb763f7-fe5f-4353-92b7-2abd2c59fafd_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_607540bd-54c6-4528-b59e-ab6050cb7969_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average volatility</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiGainLossAbstract_4634d4bb-6384-4d92-892f-0476569eb31f_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiGainLossAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiGainLossAbstract_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiGainLossAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Gain (Loss) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiGainLossAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNiGainLossAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNiGainLossAbstract" xlink:to="lab_us-gaap_EquitySecuritiesFvNiGainLossAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_a9e9947a-8e35-471f-8031-1c4807921ee4_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_7d053103-bd5c-423e-a958-3b7811b5cb38_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_78ccf2a9-e92f-4336-8a85-6fea0a3d3b1e_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss) before reclassifications</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Reclassifications, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresAbstract_2e0c5e0c-b890-40f1-96a2-38dee1602759_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresAbstract" xlink:to="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_b6ff9304-8019-4142-8f39-88fca721f5ba_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StandardProductWarrantyAccrualNoncurrent_40c3b890-b6b6-4405-b761-5bc7e026c26f_terseLabel_en-US" xlink:label="lab_us-gaap_StandardProductWarrantyAccrualNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrual for warranties due after one year</link:label>
    <link:label id="lab_us-gaap_StandardProductWarrantyAccrualNoncurrent_label_en-US" xlink:label="lab_us-gaap_StandardProductWarrantyAccrualNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard Product Warranty Accrual, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandardProductWarrantyAccrualNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StandardProductWarrantyAccrualNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StandardProductWarrantyAccrualNoncurrent" xlink:to="lab_us-gaap_StandardProductWarrantyAccrualNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDividendsAbstract_774de6bb-83b9-4491-8ac0-c9a2e51ba71f_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Paid</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividendsAbstract_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Dividends [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividendsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividendsAbstract" xlink:to="lab_us-gaap_PaymentsOfDividendsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RestatementAxis_bc0538df-46e2-4dd4-906e-e69310932656_terseLabel_en-US" xlink:label="lab_srt_RestatementAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period [Axis]</link:label>
    <link:label id="lab_srt_RestatementAxis_label_en-US" xlink:label="lab_srt_RestatementAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RestatementAxis" xlink:to="lab_srt_RestatementAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarlyRepaymentOfSeniorDebt_0f629d97-26f2-4fe0-b42f-f10a79593520_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_EarlyRepaymentOfSeniorDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment of senior notes</link:label>
    <link:label id="lab_us-gaap_EarlyRepaymentOfSeniorDebt_label_en-US" xlink:label="lab_us-gaap_EarlyRepaymentOfSeniorDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Early Repayment of Senior Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarlyRepaymentOfSeniorDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarlyRepaymentOfSeniorDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarlyRepaymentOfSeniorDebt" xlink:to="lab_us-gaap_EarlyRepaymentOfSeniorDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_6181ec39-c9ea-46ad-9667-eba7b980062b_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Translation</link:label>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Foreign Currency Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditMember_2726da19-a576-43c0-9900-533675ad374b_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit [Member]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditMember" xlink:to="lab_us-gaap_LineOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_6f90c7d7-fe83-4ba7-bb39-fdfc4fd322b7_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SHARE-BASED COMPENSATION</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanSettlementsAndCurtailmentsAbstract_aa34d5c9-c916-4eab-8ec1-a7e76f9d080c_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanSettlementsAndCurtailmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Curtailments and Settlements</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanSettlementsAndCurtailmentsAbstract_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanSettlementsAndCurtailmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Settlement and Curtailment [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanSettlementsAndCurtailmentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanSettlementsAndCurtailmentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanSettlementsAndCurtailmentsAbstract" xlink:to="lab_us-gaap_DefinedBenefitPlanSettlementsAndCurtailmentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_4e7b1594-6468-4db6-8c3a-ac3cba411cf4_verboseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate amount of cash dividends paid</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Ordinary Dividends, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividendsCommonStock" xlink:to="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_e93d4c35-2888-4660-813f-7b0a4c63dd57_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Unobservable Inputs (Level 3)</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_7c620d69-fe55-47a1-9b97-1bf3f22c9753_verboseLabel_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INVENTORY</link:label>
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureTextBlock" xlink:to="lab_us-gaap_InventoryDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_437cef71-5587-4d63-9921-1cc839439643_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Leases [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_01ff4109-9681-49bf-a375-dafb7116fb42_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_f507079e-d0c0-4cce-84cb-44c66feecbea_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_23eb4591-e657-4aa9-808e-dee7fd99a3aa_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanSponsorLocationAxis_a3abb062-1821-4eaa-95f6-aa33fe860bce_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanSponsorLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Sponsor Location [Axis]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanSponsorLocationAxis_label_en-US" xlink:label="lab_us-gaap_RetirementPlanSponsorLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Sponsor Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis" xlink:to="lab_us-gaap_RetirementPlanSponsorLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_d2d893d0-bb12-430c-845f-889332f22a1d_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Present value of future minimum lease payments</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_9688d7e1-b313-4f4c-b5a4-cd1470c1a82c_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_5e5f0e48-53b3-491c-8d6e-18e66149b1f3_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock; $0.01 par value; 2 billion shares authorized; 300 million shares at January 31, 2022 and 302 million shares at October 31, 2021, issued and outstanding</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_a_DiagnosticsandClinicalMarketMember_1e27af43-8279-4d92-b3ef-be6a3babcca4_terseLabel_en-US" xlink:label="lab_a_DiagnosticsandClinicalMarketMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diagnostics and Clinical</link:label>
    <link:label id="lab_a_DiagnosticsandClinicalMarketMember_label_en-US" xlink:label="lab_a_DiagnosticsandClinicalMarketMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diagnostics and Clinical Market [Member]</link:label>
    <link:label id="lab_a_DiagnosticsandClinicalMarketMember_documentation_en-US" xlink:label="lab_a_DiagnosticsandClinicalMarketMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diagnostics and Clinical Market [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_a_DiagnosticsandClinicalMarketMember" xlink:href="a-20220131.xsd#a_DiagnosticsandClinicalMarketMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_a_DiagnosticsandClinicalMarketMember" xlink:to="lab_a_DiagnosticsandClinicalMarketMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNetAbstract_8063543b-1da2-4dbe-be62-fd0e6c73e6fe_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net [Abstract]</link:label>
    <link:label id="lab_us-gaap_InventoryNetAbstract_label_en-US" xlink:label="lab_us-gaap_InventoryNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNetAbstract" xlink:to="lab_us-gaap_InventoryNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember_b35c2132-998f-487e-92a7-89c15990ddcc_terseLabel_en-US" xlink:label="lab_srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period Adjustment, Accounting Standards Update</link:label>
    <link:label id="lab_srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember_label_en-US" xlink:label="lab_srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period, Accounting Standards Update, Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember" xlink:to="lab_srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireNotesReceivable_56286642-a182-470e-af51-3beff1710a79_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireNotesReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment in exchange for convertible note</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireNotesReceivable_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireNotesReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Notes Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireNotesReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireNotesReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireNotesReceivable" xlink:to="lab_us-gaap_PaymentsToAcquireNotesReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_88fd7554-ccc5-4bf4-80a6-ac9ca6c95823_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill arising from acquisitions</link:label>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_602b82dc-099d-4c46-8759-fa62d6cc9f21_verboseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions to goodwill</link:label>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_label_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:to="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_abd1650f-33fb-4e7d-a6d7-12ed3795ad8e_terseLabel_en-US" xlink:label="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Postretirement Benefits Plan</link:label>
    <link:label id="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_label_en-US" xlink:label="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Postretirement Benefits Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:to="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PerformanceSharesMember_3831247d-faf2-4b61-b7cd-6d92fc2ea594_terseLabel_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Shares [LTPP]</link:label>
    <link:label id="lab_us-gaap_PerformanceSharesMember_label_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Shares [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PerformanceSharesMember" xlink:to="lab_us-gaap_PerformanceSharesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_2a9a6244-e434-4602-aea4-4c17fbfe1590_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies (Note 9 and 12)</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_1cd477dc-c475-42d3-8aba-41353aa82dc8_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_26dfc83c-e660-447d-83bf-c1a54b1faa85_periodStartLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning Balance</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_2a59efef-05c2-4887-bf25-d5ae87a5ccec_periodEndLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending Balance</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_4869ab6b-211a-4901-ae75-a3145c0c6972_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfTreasuryStockTable_05125ada-3ac5-4ef8-ad37-307840b03fd7_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfTreasuryStockTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Treasury Stock [Table]</link:label>
    <link:label id="lab_us-gaap_ClassOfTreasuryStockTable_label_en-US" xlink:label="lab_us-gaap_ClassOfTreasuryStockTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Treasury Stock [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable" xlink:to="lab_us-gaap_ClassOfTreasuryStockTable" xlink:type="arc" order="1"/>
    <link:label id="lab_a_AdditionalIncrementalTermLoanFacilityMember_ff7a6959-f8d3-41d5-99fc-b57374af0fb3_terseLabel_en-US" xlink:label="lab_a_AdditionalIncrementalTermLoanFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Incremental Term Loan Facility</link:label>
    <link:label id="lab_a_AdditionalIncrementalTermLoanFacilityMember_label_en-US" xlink:label="lab_a_AdditionalIncrementalTermLoanFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Incremental Term Loan Facility [Member]</link:label>
    <link:label id="lab_a_AdditionalIncrementalTermLoanFacilityMember_documentation_en-US" xlink:label="lab_a_AdditionalIncrementalTermLoanFacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Incremental Term Loan Facility</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_a_AdditionalIncrementalTermLoanFacilityMember" xlink:href="a-20220131.xsd#a_AdditionalIncrementalTermLoanFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_a_AdditionalIncrementalTermLoanFacilityMember" xlink:to="lab_a_AdditionalIncrementalTermLoanFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWriteDown_15d30c65-87e6-484d-9509-6a4d26ab6245_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWriteDown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Excess and obsolete inventory related charges</link:label>
    <link:label id="lab_us-gaap_InventoryWriteDown_label_en-US" xlink:label="lab_us-gaap_InventoryWriteDown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Write-down</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWriteDown" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWriteDown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWriteDown" xlink:to="lab_us-gaap_InventoryWriteDown" xlink:type="arc" order="1"/>
    <link:label id="lab_a_FoodMarketMember_3365944b-c8ff-4412-83f0-684a0df4d62e_terseLabel_en-US" xlink:label="lab_a_FoodMarketMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Food</link:label>
    <link:label id="lab_a_FoodMarketMember_label_en-US" xlink:label="lab_a_FoodMarketMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Food Market [Member]</link:label>
    <link:label id="lab_a_FoodMarketMember_documentation_en-US" xlink:label="lab_a_FoodMarketMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Food Market [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_a_FoodMarketMember" xlink:href="a-20220131.xsd#a_FoodMarketMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_a_FoodMarketMember" xlink:to="lab_a_FoodMarketMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_3fa6979b-82e4-4fb1-a41f-3b3f2db1921a_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assumptions used to estimate fair value for LTPP</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortMember_a46c1c62-d739-4459-a8ec-2643d4f0ea1b_terseLabel_en-US" xlink:label="lab_us-gaap_ShortMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sell</link:label>
    <link:label id="lab_us-gaap_ShortMember_label_en-US" xlink:label="lab_us-gaap_ShortMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortMember" xlink:to="lab_us-gaap_ShortMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_78c19e5d-e785-4dbd-b1c7-a29fd8724842_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts reclassified into earnings related to derivative instruments, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_0187a4d9-8ae6-4679-ad3b-41e467c86ba8_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RecourseStatusDomain_848652d6-b685-4ecb-811c-4dbec1ad48a2_terseLabel_en-US" xlink:label="lab_us-gaap_RecourseStatusDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recourse Status [Domain]</link:label>
    <link:label id="lab_us-gaap_RecourseStatusDomain_label_en-US" xlink:label="lab_us-gaap_RecourseStatusDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recourse Status [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RecourseStatusDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RecourseStatusDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RecourseStatusDomain" xlink:to="lab_us-gaap_RecourseStatusDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_85579fa2-63ed-42bd-aa4b-28dc06e4f67d_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Potential common shares - stock options and other employee stock plans</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillLineItems_5d5c446f-3e26-42d8-ab41-7b1b2920ccea_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:label id="lab_us-gaap_GoodwillLineItems_label_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillLineItems" xlink:to="lab_us-gaap_GoodwillLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAndExpenses_e09a8734-6481-4d97-a20c-c3f448535542_totalLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total costs and expenses</link:label>
    <link:label id="lab_us-gaap_CostsAndExpenses_label_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpenses" xlink:to="lab_us-gaap_CostsAndExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_cd364e24-77f1-4862-a9ab-f6b6a7216265_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_GBP_7815d207-b57b-429e-a116-47d9cde50d92_terseLabel_en-US" xlink:label="lab_currency_GBP" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">British Pound</link:label>
    <link:label id="lab_currency_GBP_label_en-US" xlink:label="lab_currency_GBP" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United Kingdom, Pounds</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_GBP" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_GBP"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_GBP" xlink:to="lab_currency_GBP" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsDomain_099cc6d3-8d4c-436b-a64e-7ea231d14164_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends [Domain]</link:label>
    <link:label id="lab_us-gaap_DividendsDomain_label_en-US" xlink:label="lab_us-gaap_DividendsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsDomain" xlink:to="lab_us-gaap_DividendsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax_be8ef897-cc94-4796-ba4d-630faf1a5731_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in actuarial net loss, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityAbstract_7fedef06-1ec9-46c4-ac1c-d8da8df64795_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract Asset</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityAbstract_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Contract Asset, Contract Liability, and Receivable [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetAndLiabilityAbstract" xlink:to="lab_us-gaap_ContractWithCustomerAssetAndLiabilityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentOperatingActivitiesDomain_5148c5aa-d43d-47fa-aa88-83a471e1a907_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentOperatingActivitiesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Activities [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentOperatingActivitiesDomain_label_en-US" xlink:label="lab_us-gaap_SegmentOperatingActivitiesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Activities [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentOperatingActivitiesDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentOperatingActivitiesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentOperatingActivitiesDomain" xlink:to="lab_us-gaap_SegmentOperatingActivitiesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_18559cb7-4637-4bca-bdc8-23282b718dcb_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PledgedStatusAxis_48a302a3-db9d-4459-a786-07af3ee82633_terseLabel_en-US" xlink:label="lab_us-gaap_PledgedStatusAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pledged Status [Axis]</link:label>
    <link:label id="lab_us-gaap_PledgedStatusAxis_label_en-US" xlink:label="lab_us-gaap_PledgedStatusAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pledged Status [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PledgedStatusAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PledgedStatusAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PledgedStatusAxis" xlink:to="lab_us-gaap_PledgedStatusAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_INR_6d71294d-52b0-45a3-ae2d-fd4c490921f2_terseLabel_en-US" xlink:label="lab_currency_INR" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">India, Rupees</link:label>
    <link:label id="lab_currency_INR_label_en-US" xlink:label="lab_currency_INR" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">India, Rupees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_INR" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_INR"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_INR" xlink:to="lab_currency_INR" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_KRW_f90ea0c7-9a19-4d07-9c96-ebcb1bc5105a_terseLabel_en-US" xlink:label="lab_currency_KRW" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Korean Won</link:label>
    <link:label id="lab_currency_KRW_label_en-US" xlink:label="lab_currency_KRW" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Korea (South), Won</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_KRW" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_KRW"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_KRW" xlink:to="lab_currency_KRW" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_2537ea05-e507-46a4-b3e5-c04e2c5e4432_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of comprehensive income, net of tax</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermDebtLineItems_53bc0823-c0d3-4035-be25-08e6783cbbc6_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermDebtLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt</link:label>
    <link:label id="lab_us-gaap_ShortTermDebtLineItems_label_en-US" xlink:label="lab_us-gaap_ShortTermDebtLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtLineItems" xlink:to="lab_us-gaap_ShortTermDebtLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_80bb6b60-cacc-47c5-9033-09966dbf2dbf_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expenses [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_d7fb4ab3-8199-42b8-9e11-d0342a0226e7_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Declared per share</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_label_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Dividends, Per Share, Declared</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:to="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_5088727d-cd08-45eb-89aa-9989562b62e6_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_a_LTPPRSUMember_db6a832c-714b-4a7d-a1b8-af748250c3e8_terseLabel_en-US" xlink:label="lab_a_LTPPRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LTPP &amp; RSU</link:label>
    <link:label id="lab_a_LTPPRSUMember_label_en-US" xlink:label="lab_a_LTPPRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LTPP &amp; RSU [Member]</link:label>
    <link:label id="lab_a_LTPPRSUMember_documentation_en-US" xlink:label="lab_a_LTPPRSUMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LTPP &amp; RSU [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_a_LTPPRSUMember" xlink:href="a-20220131.xsd#a_LTPPRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_a_LTPPRSUMember" xlink:to="lab_a_LTPPRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_952b242b-17bc-4b5e-ba8e-3841aa9b59cd_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Operating Profit from Segments to Consolidated</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract" xlink:to="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_fc479091-c342-4cf2-99ce-093dfffac201_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option [Member]</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_1bc8cb57-32cf-44a7-8a99-97dbf9265fa3_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_ae2a5596-8556-43be-8574-c373edbd457e_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_a_PharmaceuticalandBiopharmaceuticalMarketMember_6b50ea6f-7e65-4a0d-ad7d-e3926d0d2264_terseLabel_en-US" xlink:label="lab_a_PharmaceuticalandBiopharmaceuticalMarketMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmaceutical and Biopharmaceutical</link:label>
    <link:label id="lab_a_PharmaceuticalandBiopharmaceuticalMarketMember_label_en-US" xlink:label="lab_a_PharmaceuticalandBiopharmaceuticalMarketMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmaceutical and Biopharmaceutical Market [Member]</link:label>
    <link:label id="lab_a_PharmaceuticalandBiopharmaceuticalMarketMember_documentation_en-US" xlink:label="lab_a_PharmaceuticalandBiopharmaceuticalMarketMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmaceutical and Biopharmaceutical Market [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_a_PharmaceuticalandBiopharmaceuticalMarketMember" xlink:href="a-20220131.xsd#a_PharmaceuticalandBiopharmaceuticalMarketMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_a_PharmaceuticalandBiopharmaceuticalMarketMember" xlink:to="lab_a_PharmaceuticalandBiopharmaceuticalMarketMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_62ed5d87-d6a2-422d-b918-d9c48d6a6f7b_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeDomain" xlink:to="lab_us-gaap_MeasurementInputTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_8389f032-95f1-4709-a2ec-f6af27c60d10_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of exchange rate movements</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash and Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_a_Other_f389333b-6bf2-48fb-a644-aba04eaeb2c9_terseLabel_en-US" xlink:label="lab_a_Other" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_a_Other_label_en-US" xlink:label="lab_a_Other" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_a_Other_documentation_en-US" xlink:label="lab_a_Other" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of an item in the reconciliation of total profit or loss from reportable segments, to the entity's consolidated income before income taxes, extraordinary items, discontinued operations.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_a_Other" xlink:href="a-20220131.xsd#a_Other"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_a_Other" xlink:to="lab_a_Other" xlink:type="arc" order="1"/>
    <link:label id="lab_a_SeniorNotes2023Member_5007c87d-1517-4a9c-95cb-44b8cf1fd9b5_terseLabel_en-US" xlink:label="lab_a_SeniorNotes2023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2023</link:label>
    <link:label id="lab_a_SeniorNotes2023Member_label_en-US" xlink:label="lab_a_SeniorNotes2023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2023 [Member]</link:label>
    <link:label id="lab_a_SeniorNotes2023Member_documentation_en-US" xlink:label="lab_a_SeniorNotes2023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2023 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_a_SeniorNotes2023Member" xlink:href="a-20220131.xsd#a_SeniorNotes2023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_a_SeniorNotes2023Member" xlink:to="lab_a_SeniorNotes2023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_c4711c1a-b8d7-412f-af9a-b80f797d787b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (loss) recognized in accumulated other comprehensive loss - translation adjustment</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_583c0218-576d-4674-9b98-4fa78e4b1248_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_6b034ca3-4a7b-4da7-8048-1acc3cf443fa_verboseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeInterest" xlink:to="lab_us-gaap_InvestmentIncomeInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_a_IncreasedecreaseinDeferredRevenuefromCustomerCashAdvancesNetofRevenuerecognized_23dee1d9-94b2-4275-b1b5-92b1e23883d4_terseLabel_en-US" xlink:label="lab_a_IncreasedecreaseinDeferredRevenuefromCustomerCashAdvancesNetofRevenuerecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in deferrals from customer cash advances, net of revenue recognized</link:label>
    <link:label id="lab_a_IncreasedecreaseinDeferredRevenuefromCustomerCashAdvancesNetofRevenuerecognized_label_en-US" xlink:label="lab_a_IncreasedecreaseinDeferredRevenuefromCustomerCashAdvancesNetofRevenuerecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (decrease) in Deferred Revenue from Customer Cash Advances, Net of Revenue recognized</link:label>
    <link:label id="lab_a_IncreasedecreaseinDeferredRevenuefromCustomerCashAdvancesNetofRevenuerecognized_documentation_en-US" xlink:label="lab_a_IncreasedecreaseinDeferredRevenuefromCustomerCashAdvancesNetofRevenuerecognized" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (decrease) in Deferred Revenue from Customer Cash Advances, Net of Revenue recognized in the period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_a_IncreasedecreaseinDeferredRevenuefromCustomerCashAdvancesNetofRevenuerecognized" xlink:href="a-20220131.xsd#a_IncreasedecreaseinDeferredRevenuefromCustomerCashAdvancesNetofRevenuerecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_a_IncreasedecreaseinDeferredRevenuefromCustomerCashAdvancesNetofRevenuerecognized" xlink:to="lab_a_IncreasedecreaseinDeferredRevenuefromCustomerCashAdvancesNetofRevenuerecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_a_OtherAccruedAndLongTermLiabilitiesMember_3503a75a-1ddd-4eb1-901a-62431ab0efc4_terseLabel_en-US" xlink:label="lab_a_OtherAccruedAndLongTermLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other accrued and long-term liabilities</link:label>
    <link:label id="lab_a_OtherAccruedAndLongTermLiabilitiesMember_label_en-US" xlink:label="lab_a_OtherAccruedAndLongTermLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other accrued and long-term liabilities [Member]</link:label>
    <link:label id="lab_a_OtherAccruedAndLongTermLiabilitiesMember_documentation_en-US" xlink:label="lab_a_OtherAccruedAndLongTermLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other accrued and long-term liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_a_OtherAccruedAndLongTermLiabilitiesMember" xlink:href="a-20220131.xsd#a_OtherAccruedAndLongTermLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_a_OtherAccruedAndLongTermLiabilitiesMember" xlink:to="lab_a_OtherAccruedAndLongTermLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_6ce275d9-a655-47bc-9bf2-0cfdadb09263_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEGMENT INFORMATION</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_d1a6c4a6-d269-46e7-932e-1b678b8721b3_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_1f69a34f-9733-4803-8892-cca0eded3fdc_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_CAD_adc2ad43-fa73-4b03-a2d0-e7e34457379e_terseLabel_en-US" xlink:label="lab_currency_CAD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canadian Dollar</link:label>
    <link:label id="lab_currency_CAD_label_en-US" xlink:label="lab_currency_CAD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canada, Dollars</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_CAD" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_CAD"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_CAD" xlink:to="lab_currency_CAD" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_24528cf7-b50d-4430-bded-13614c9a27fb_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OVERVIEW AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_7933c792-4e7f-45cf-b914-98cff280c1a4_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_e139c0ec-43c2-4bc7-96d0-1cac0db8cada_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationAxis" xlink:to="lab_us-gaap_HedgingDesignationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_5f80c8f5-ef52-424e-bb04-44c4cec06b21_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_b8e9ef33-79ba-4b4b-b2d0-f3625bd10db9_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_462f1210-f1a1-4dcf-99a5-489da5d09176_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_b08adae4-f0c2-46f1-acd7-dc0c6ace62d2_verboseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossTaxParentheticalDisclosuresAbstract_9c017fbe-c88b-4be6-bbef-efd1e596dde9_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossTaxParentheticalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss), tax, parenthetical disclosures</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossTaxParentheticalDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossTaxParentheticalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Tax, Parenthetical Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTaxParentheticalDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossTaxParentheticalDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTaxParentheticalDisclosuresAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossTaxParentheticalDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareCashPaid_cfcfe76c-f8b9-438d-b5bd-41f0a6653016_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash dividends paid per common share</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareCashPaid_label_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Dividends, Per Share, Cash Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockDividendsPerShareCashPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:to="lab_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockMember_ea2b02e8-c9f9-44b2-baa0-fef7e4e70be9_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockMember" xlink:to="lab_us-gaap_TreasuryStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_a_SeniorNotes2031Member_00d4eece-1963-4f47-9003-7ba37553518f_terseLabel_en-US" xlink:label="lab_a_SeniorNotes2031Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2031</link:label>
    <link:label id="lab_a_SeniorNotes2031Member_label_en-US" xlink:label="lab_a_SeniorNotes2031Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2031 [Member]</link:label>
    <link:label id="lab_a_SeniorNotes2031Member_documentation_en-US" xlink:label="lab_a_SeniorNotes2031Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2031</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_a_SeniorNotes2031Member" xlink:href="a-20220131.xsd#a_SeniorNotes2031Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_a_SeniorNotes2031Member" xlink:to="lab_a_SeniorNotes2031Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_4a8c69bf-9431-4191-8318-b9aa61faa993_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_ec10cf69-e682-465a-bef5-7daf5fdfbf32_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred compensation liability</link:label>
    <link:label id="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_label_en-US" xlink:label="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Liability, Classified, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:to="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock_95ac0839-e203-44fa-a8b3-034adbd5514c_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard warranty</link:label>
    <link:label id="lab_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Product Warranty Liability [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_a_SeniorNotes2026Member_7a86bd3c-514f-4a23-bc57-8b3384cc88d7_terseLabel_en-US" xlink:label="lab_a_SeniorNotes2026Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2026</link:label>
    <link:label id="lab_a_SeniorNotes2026Member_label_en-US" xlink:label="lab_a_SeniorNotes2026Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2026 [Member]</link:label>
    <link:label id="lab_a_SeniorNotes2026Member_documentation_en-US" xlink:label="lab_a_SeniorNotes2026Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2026</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_a_SeniorNotes2026Member" xlink:href="a-20220131.xsd#a_SeniorNotes2026Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_a_SeniorNotes2026Member" xlink:to="lab_a_SeniorNotes2026Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillTransfers_7376ffd5-66fa-4909-bb17-7e7d93159016_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillTransfers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill reassigned to segment</link:label>
    <link:label id="lab_us-gaap_GoodwillTransfers_label_en-US" xlink:label="lab_us-gaap_GoodwillTransfers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Transfers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTransfers" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillTransfers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillTransfers" xlink:to="lab_us-gaap_GoodwillTransfers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember_f20ae28b-70f4-40d6-9df3-c5c91bad63cc_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actuarial Losses</link:label>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment, Net Gain (Loss) Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember" xlink:to="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_724afa14-bc3d-467b-b366-9b5153ad3075_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of New Accounting Pronouncements</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:to="lab_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_95971c5f-c21c-470b-a9c4-f59c84ddc4a4_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNotionalAmount" xlink:to="lab_us-gaap_DerivativeNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsMember_0f225848-eb17-4000-8f5e-b02debb686dd_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsMember" xlink:to="lab_us-gaap_OtherAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_90fbe4e6-2cea-4f25-a9d6-bc3e000ce115_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:to="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_6b664473-6dbd-463e-a925-d7b0626d2664_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (expense), net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_6c850be0-6734-478b-9f01-218fd878a2a8_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (expense), net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtFairValue_8189bf89-dc37-4b57-9ba0-0ace3b9d2c8e_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Fair Value</link:label>
    <link:label id="lab_us-gaap_LongTermDebtFairValue_label_en-US" xlink:label="lab_us-gaap_LongTermDebtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtFairValue" xlink:to="lab_us-gaap_LongTermDebtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_a_A2021RepurchaseProgramMember_bea91245-20af-4737-9424-7f30a462c60a_terseLabel_en-US" xlink:label="lab_a_A2021RepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 Repurchase Program [Member]</link:label>
    <link:label id="lab_a_A2021RepurchaseProgramMember_label_en-US" xlink:label="lab_a_A2021RepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 Repurchase Program [Member]</link:label>
    <link:label id="lab_a_A2021RepurchaseProgramMember_documentation_en-US" xlink:label="lab_a_A2021RepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 Repurchase Program</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_a_A2021RepurchaseProgramMember" xlink:href="a-20220131.xsd#a_A2021RepurchaseProgramMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_a_A2021RepurchaseProgramMember" xlink:to="lab_a_A2021RepurchaseProgramMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_db28f4d8-0519-4631-ba53-ad11106541b1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased and Retired During Period, Shares</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_5bba041d-542c-41d2-9262-fc6926797448_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares repurchased and retired during period, (Shares)</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased and Retired During Period, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:to="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_1bf86620-e943-4d41-ae15-a4d6777459ea_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentMember_5be20a25-dbbf-4014-a01a-dfcdd6a346ad_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentMember_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentMember" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer_63ba6389-7597-4556-9c0f-74214aa773c5_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employer Contributions</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Contributions by Employer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:to="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_219f83b4-2a5a-49dc-9fc2-876fd6bd30b5_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_a_SeniorNotes2030Member_593f0410-6636-4a1f-b750-26cb95b1ba86_terseLabel_en-US" xlink:label="lab_a_SeniorNotes2030Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2030</link:label>
    <link:label id="lab_a_SeniorNotes2030Member_label_en-US" xlink:label="lab_a_SeniorNotes2030Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2030 [Member]</link:label>
    <link:label id="lab_a_SeniorNotes2030Member_documentation_en-US" xlink:label="lab_a_SeniorNotes2030Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2030</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_a_SeniorNotes2030Member" xlink:href="a-20220131.xsd#a_SeniorNotes2030Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_a_SeniorNotes2030Member" xlink:to="lab_a_SeniorNotes2030Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_16366a06-4db9-4a3d-9908-d800beded981_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_cbe47447-4736-42df-9056-f1cb70e78694_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsPayableDateDeclaredDayMonthAndYear_50e2625d-2cf7-4763-95fc-27a3f3002571_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsPayableDateDeclaredDayMonthAndYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Date Dividends Declared</link:label>
    <link:label id="lab_us-gaap_DividendsPayableDateDeclaredDayMonthAndYear_label_en-US" xlink:label="lab_us-gaap_DividendsPayableDateDeclaredDayMonthAndYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Payable, Date Declared</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableDateDeclaredDayMonthAndYear" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsPayableDateDeclaredDayMonthAndYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsPayableDateDeclaredDayMonthAndYear" xlink:to="lab_us-gaap_DividendsPayableDateDeclaredDayMonthAndYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_64fc67e7-cc79-4f0f-ae29-117cbce06022_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_7f9aa444-c8a4-4911-b2e7-3f5fb53cb0ae_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0492bf07-b8f7-4178-8dda-33e745833b10_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from financing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1_cffef1d0-5829-470f-b2b6-31a53f6bfd6c_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation capitalized in inventory</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ChangeInAccountingPrincipleMember_c09f36d8-8ebc-44f5-9080-d59500b05be1_terseLabel_en-US" xlink:label="lab_us-gaap_ChangeInAccountingPrincipleMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Accounting Principle, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ChangeInAccountingPrincipleMember_label_en-US" xlink:label="lab_us-gaap_ChangeInAccountingPrincipleMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Accounting Principle, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInAccountingPrincipleMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ChangeInAccountingPrincipleMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ChangeInAccountingPrincipleMember" xlink:to="lab_us-gaap_ChangeInAccountingPrincipleMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_735f3da2-740c-451c-b8e2-08e5293ad27d_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeAxis" xlink:to="lab_us-gaap_MeasurementInputTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_8a6f81e0-214b-4eec-80da-fe8536cd7d96_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stockholder's equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_8c63cbca-a332-4907-9ad3-090e0a893950_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_04cff39c-9f08-4a9f-8071-5870e07bfedc_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_503ccaf1-c5cb-4795-8cf1-c8839f06e23b_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_c1f25b4e-b161-4de8-8a37-f54b3319a260_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net change in property, plant and equipment included in Accounts Payable and Accrued Liabilities increase (decrease)</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_c95de3ce-7d7c-4b3a-a61d-8b73b3d4b1d0_terseLabel_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives Designated as Hedging Instrument</link:label>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_4e1cafd1-5378-4848-ac26-1bc5762e5ad1_verboseLabel_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives Designated as Hedging Instruments</link:label>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_label_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:to="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_47c2dd8e-619e-455d-becf-eb4898e25a14_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RecourseStatusAxis_aed34180-cb17-43c6-a14a-80ae95bdd359_terseLabel_en-US" xlink:label="lab_us-gaap_RecourseStatusAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recourse Status [Axis]</link:label>
    <link:label id="lab_us-gaap_RecourseStatusAxis_label_en-US" xlink:label="lab_us-gaap_RecourseStatusAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recourse Status [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RecourseStatusAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RecourseStatusAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RecourseStatusAxis" xlink:to="lab_us-gaap_RecourseStatusAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_28b7a55d-cc53-4610-bae7-16122aa85bc2_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfSeniorDebt_7949e79b-25d9-4afd-884f-fe250181835f_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfSeniorDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Senior Debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfSeniorDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfSeniorDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Senior Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSeniorDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfSeniorDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfSeniorDebt" xlink:to="lab_us-gaap_RepaymentsOfSeniorDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_6461369b-429d-44f8-afd9-4fbe28e0bca5_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on extinguishment of debt</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_label_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationVariableInterestEntityPolicy_1bf3cdb1-c688-4bb7-84e5-592c06a3ebeb_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity</link:label>
    <link:label id="lab_us-gaap_ConsolidationVariableInterestEntityPolicy_label_en-US" xlink:label="lab_us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Variable Interest Entity, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationVariableInterestEntityPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:to="lab_us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_9c5feef3-541a-4975-9bf4-4b14347da122_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock repurchases</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_fae4625c-0700-4cd8-9b3a-7d86d3297560_verboseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_3a9da518-b2bf-4ee5-9ad0-089db2117f74_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanTypeAxis_79016d28-d25d-433f-820e-b6ca3fd7d40d_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanTypeAxis_label_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanTypeAxis" xlink:to="lab_us-gaap_RetirementPlanTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityClassOfTreasuryStockLineItems_3805ff7a-4a70-404d-9192-95568667d23c_terseLabel_en-US" xlink:label="lab_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share repurchase program</link:label>
    <link:label id="lab_us-gaap_EquityClassOfTreasuryStockLineItems_label_en-US" xlink:label="lab_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Class of Treasury Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:to="lab_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_THB_19b57dd0-b3b6-4e1f-be3f-f9a7131d9614_terseLabel_en-US" xlink:label="lab_currency_THB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thailand, Baht</link:label>
    <link:label id="lab_currency_THB_label_en-US" xlink:label="lab_currency_THB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thailand, Baht</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_THB" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_THB"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_THB" xlink:to="lab_currency_THB" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameDomain_e6292f34-a69a-473b-9255-9da151c59c16_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameDomain_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationAbstract_96aa78a1-f82c-41b5-aebc-64bb851c25ad_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense [Abstract]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationAbstract_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationAbstract" xlink:to="lab_us-gaap_ShareBasedCompensationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_9d4e0c5f-7bfd-48d2-8912-bf2130e2e073_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsegmentsConsolidationItemsDomain_dac2a736-4f26-4b93-b421-a7b0ad798366_terseLabel_en-US" xlink:label="lab_us-gaap_SubsegmentsConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments Consolidation Items [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsegmentsConsolidationItemsDomain_label_en-US" xlink:label="lab_us-gaap_SubsegmentsConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsConsolidationItemsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsegmentsConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsegmentsConsolidationItemsDomain" xlink:to="lab_us-gaap_SubsegmentsConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShortTermDebtTable_310d576c-2d02-4b0d-9067-b5ad75c69732_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShortTermDebtTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Short-term Debt [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShortTermDebtTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShortTermDebtTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Short-term Debt [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShortTermDebtTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShortTermDebtTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable" xlink:to="lab_us-gaap_ScheduleOfShortTermDebtTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateDerivativesAbstract_b6c799c0-74c3-4c83-b94b-654449cf48f4_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateDerivativesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Terminated Derivative Contracts</link:label>
    <link:label id="lab_us-gaap_InterestRateDerivativesAbstract_label_en-US" xlink:label="lab_us-gaap_InterestRateDerivativesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Derivatives [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateDerivativesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateDerivativesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateDerivativesAbstract" xlink:to="lab_us-gaap_InterestRateDerivativesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesMember_5eae97a9-973f-44a9-b4b4-591a62359c31_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesMember" xlink:to="lab_us-gaap_AccruedLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_5b3ab543-e586-41e1-8bcb-48f1aa683fba_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Axis]</link:label>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_label_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_862e2ced-5b3a-4513-aafd-9ab971a5d8b5_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_829ebd63-d5a8-49d2-8a45-2e57cba8dc17_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate face amount of debt</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_34fc32a8-10d6-4bdc-ac7c-610f57893ddd_negatedLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermDebtWeightedAverageInterestRate_a5346c33-f5a5-465e-9efa-9cdc258308da_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermDebtWeightedAverageInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Interest Rate, at Point in Time</link:label>
    <link:label id="lab_us-gaap_ShortTermDebtWeightedAverageInterestRate_label_en-US" xlink:label="lab_us-gaap_ShortTermDebtWeightedAverageInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt, Weighted Average Interest Rate, at Point in Time</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtWeightedAverageInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtWeightedAverageInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtWeightedAverageInterestRate" xlink:to="lab_us-gaap_ShortTermDebtWeightedAverageInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_b217fbd1-1cf9-4d7c-95fd-bd2f3cdb22c8_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee compensation and benefits</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Employee Related Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_e717c0b3-4838-46c8-ae9f-53a99636be54_totalLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total net plan costs (benefits)</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:to="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_c5c7d307-fe0d-42bb-b079-2652242c32b4_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expense, Tax Benefit</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expense, Tax Benefit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StandardProductWarrantyDisclosureAbstract_6b3d9d28-66f1-45d7-93da-4bdf964d7178_terseLabel_en-US" xlink:label="lab_us-gaap_StandardProductWarrantyDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard Product Warranty Disclosure</link:label>
    <link:label id="lab_us-gaap_StandardProductWarrantyDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_StandardProductWarrantyDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard Product Warranty Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandardProductWarrantyDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StandardProductWarrantyDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StandardProductWarrantyDisclosureAbstract" xlink:to="lab_us-gaap_StandardProductWarrantyDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_641aeed4-dfb2-48d2-94d8-a83d8c665c3b_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_a_BusinessCombinationsContingentConsiderationArrangements_fe012b49-429c-4ab4-8756-0decbef9f383_terseLabel_en-US" xlink:label="lab_a_BusinessCombinationsContingentConsiderationArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration maximum earn-out period</link:label>
    <link:label id="lab_a_BusinessCombinationsContingentConsiderationArrangements_label_en-US" xlink:label="lab_a_BusinessCombinationsContingentConsiderationArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">business combinations, contingent consideration, arrangements</link:label>
    <link:label id="lab_a_BusinessCombinationsContingentConsiderationArrangements_documentation_en-US" xlink:label="lab_a_BusinessCombinationsContingentConsiderationArrangements" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">business combinations, contingent consideration, arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_a_BusinessCombinationsContingentConsiderationArrangements" xlink:href="a-20220131.xsd#a_BusinessCombinationsContingentConsiderationArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_a_BusinessCombinationsContingentConsiderationArrangements" xlink:to="lab_a_BusinessCombinationsContingentConsiderationArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_bef1c65a-e67a-44de-95a1-3a09aae71aa0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease_fe137a47-f000-44ff-9fc7-618df421580d_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Addition to other intangible assets</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExaminationLineItems_3c112a6a-206a-4a5a-a773-f08aac4c138b_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExaminationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExaminationLineItems_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExaminationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Examination [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExaminationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems" xlink:to="lab_us-gaap_IncomeTaxExaminationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_e609a770-f111-4022-9256-a6759d047e54_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_faffb436-0927-48ec-930f-322a472bfb90_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum contractual term, Expiration Period</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_fd2333e4-33d8-4391-81e9-a6cf65fff192_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs)</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_3535b427-5e44-4c9e-a8ad-1a6e9c921cfd_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RestatementDomain_d884fb45-c655-472f-a059-091bab855c1d_terseLabel_en-US" xlink:label="lab_srt_RestatementDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period [Domain]</link:label>
    <link:label id="lab_srt_RestatementDomain_label_en-US" xlink:label="lab_srt_RestatementDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RestatementDomain" xlink:to="lab_srt_RestatementDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_ce7bf69a-81d0-4c63-9e50-10b4ad102ea0_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_c238f86a-d022-495f-b05d-09757c688477_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount outstanding on credit facility</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Fair Value of Amount Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding" xlink:to="lab_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_SEK_815cbd4b-0f37-438c-a4a4-461ac19424cf_terseLabel_en-US" xlink:label="lab_currency_SEK" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Swedish Krona</link:label>
    <link:label id="lab_currency_SEK_label_en-US" xlink:label="lab_currency_SEK" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sweden, Kronor</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_SEK" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_SEK"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_SEK" xlink:to="lab_currency_SEK" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_c253b674-d751-43ea-b11a-4f08eded7fc3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of derivative instruments for foreign exchange contracts in the consolidated statement of operations</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_3b7c0790-bb7d-4472-ad9c-9b9f1dd2f582_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average risk-free interest rate</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramAxis_76effce0-4782-439e-908a-dc7ccec5cb89_terseLabel_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramAxis_label_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis" xlink:to="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrderOrProductionBacklogMember_efc1773a-4ca7-47bf-a9e2-c6da184fdf31_terseLabel_en-US" xlink:label="lab_us-gaap_OrderOrProductionBacklogMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Backlog</link:label>
    <link:label id="lab_us-gaap_OrderOrProductionBacklogMember_label_en-US" xlink:label="lab_us-gaap_OrderOrProductionBacklogMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Order or Production Backlog [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrderOrProductionBacklogMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrderOrProductionBacklogMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrderOrProductionBacklogMember" xlink:to="lab_us-gaap_OrderOrProductionBacklogMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_c965ebb3-5877-4b26-8c91-f6685bdf0d05_terseLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_18381804-1ac2-46e6-8156-76b3a5ecd333_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restrictions on Cash and Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restrictions on Cash and Cash Equivalents [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_261f2414-9aee-478b-95a2-93ef79f56bc1_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_5349a677-fb81-4993-a6bc-3991a65f199d_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermDebtTextBlock_967de32b-5c7c-43dc-9110-c768979f1a97_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SHORT-TERM DEBT</link:label>
    <link:label id="lab_us-gaap_ShortTermDebtTextBlock_label_en-US" xlink:label="lab_us-gaap_ShortTermDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtTextBlock" xlink:to="lab_us-gaap_ShortTermDebtTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_MYR_2ffa7157-f51d-4383-837b-de2ea035b2bc_terseLabel_en-US" xlink:label="lab_currency_MYR" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Malaysian Ringgit</link:label>
    <link:label id="lab_currency_MYR_label_en-US" xlink:label="lab_currency_MYR" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Malaysia, Ringgits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_MYR" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_MYR"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_MYR" xlink:to="lab_currency_MYR" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_948de35c-576e-4e8e-826b-66bb6103f25d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_a_SegmentTotalMember_101a21c1-e3be-475c-ac13-6b456655789d_terseLabel_en-US" xlink:label="lab_a_SegmentTotalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Total</link:label>
    <link:label id="lab_a_SegmentTotalMember_label_en-US" xlink:label="lab_a_SegmentTotalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Total [Member]</link:label>
    <link:label id="lab_a_SegmentTotalMember_documentation_en-US" xlink:label="lab_a_SegmentTotalMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reportable amounts associated with all reporting segments included in a reconciliation from segment reporting to consolidated income from operations, before taxes.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_a_SegmentTotalMember" xlink:href="a-20220131.xsd#a_SegmentTotalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_a_SegmentTotalMember" xlink:to="lab_a_SegmentTotalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_854cd122-08f4-47ce-beab-d6f8ae754205_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NEW ACCOUNTING PRONOUNCEMENTS</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentAssetsMember_c320fac7-2694-43a0-9afd-f597d360ee2a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentAssetsMember" xlink:to="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_ff505ada-783a-4aef-8c84-bb3cad6c6a03_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In-Process R&amp;D</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_5a5e54fd-e034-4aa5-a4b6-05f7cd2db52e_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_09043310-e79c-43e1-b1c9-465c1380c235_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning Balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_cbc5b391-7d57-41e5-b0cd-518da6176e7d_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending Balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_04a33585-57cd-4186-a3c1-2d7117358f98_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_39efb796-7f18-408d-a92a-6d7a3e9e9c44_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision (benefit) for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_4e54f1bb-bb69-4038-84ef-ca5641d483e5_verboseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_639c7720-b74f-439d-b3e9-c00a7c2d0024_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_a_ChemicalandEnergyMarketMember_7ea12d58-fc35-43ce-ba8f-3213deb6f88a_terseLabel_en-US" xlink:label="lab_a_ChemicalandEnergyMarketMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Chemical and Energy</link:label>
    <link:label id="lab_a_ChemicalandEnergyMarketMember_label_en-US" xlink:label="lab_a_ChemicalandEnergyMarketMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Chemical and Energy Market [Member]</link:label>
    <link:label id="lab_a_ChemicalandEnergyMarketMember_documentation_en-US" xlink:label="lab_a_ChemicalandEnergyMarketMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Chemical and Energy Market [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_a_ChemicalandEnergyMarketMember" xlink:href="a-20220131.xsd#a_ChemicalandEnergyMarketMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_a_ChemicalandEnergyMarketMember" xlink:to="lab_a_ChemicalandEnergyMarketMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_AsiaPacificMember_80053ec2-7a24-43ab-b256-ae7b9dba4e72_terseLabel_en-US" xlink:label="lab_srt_AsiaPacificMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asia Pacific</link:label>
    <link:label id="lab_srt_AsiaPacificMember_label_en-US" xlink:label="lab_srt_AsiaPacificMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asia Pacific [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_AsiaPacificMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_AsiaPacificMember" xlink:to="lab_srt_AsiaPacificMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_496fda2d-738b-4345-844a-625fa4ecf1bb_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsPayableTable_c2183199-3f4a-4620-9eb9-e5e217f0dc2a_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsPayableTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Payable [Table]</link:label>
    <link:label id="lab_us-gaap_DividendsPayableTable_label_en-US" xlink:label="lab_us-gaap_DividendsPayableTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Payable [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsPayableTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsPayableTable" xlink:to="lab_us-gaap_DividendsPayableTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_f828373a-ea43-479c-9cc9-35044517b191_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_3bc6c11b-1540-49b8-9316-38ff3e8a6c25_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Financial Instruments</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_147bba7a-c2df-4b14-845c-ca57215c546c_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_54839267-4e0b-4b21-9085-a0813704a437_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyTextBlock_1b0822db-e7cc-44f4-b98f-1fc3b2b39ec7_terseLabel_en-US" xlink:label="lab_a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions And Methodology [Text Block]</link:label>
    <link:label id="lab_a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyTextBlock_label_en-US" xlink:label="lab_a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions And Methodology [Text Block]</link:label>
    <link:label id="lab_a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyTextBlock_documentation_en-US" xlink:label="lab_a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, and long-term performance plan grants.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyTextBlock" xlink:href="a-20220131.xsd#a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyTextBlock" xlink:to="lab_a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_9c3c40eb-61d6-49a1-9074-f2de2b84509f_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_3f683e98-4cec-442c-a50c-654550d82215_verboseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_InventoryNet_3b0ca7cc-094e-46c5-a8e3-4f8465da784c_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_3645f61b-eca4-4225-a72c-cc2f09f84921_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount reclassified into earnings related to derivative instruments, net of tas expense (benefit) of $(1) and $2</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_692c3fac-b79d-4e8a-bced-34dcf444fecd_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gain (loss) on derivatives after reclassification and after Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_2ce04bc1-a545-408b-8495-433cb190efc5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Profitability and Segment Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_a_DiagnosticsAndGenomicsMember_8aac3891-1bed-49ab-91c5-2f303fd3b39d_terseLabel_en-US" xlink:label="lab_a_DiagnosticsAndGenomicsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diagnostics and Genomics</link:label>
    <link:label id="lab_a_DiagnosticsAndGenomicsMember_label_en-US" xlink:label="lab_a_DiagnosticsAndGenomicsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diagnostics and Genomics [Member]</link:label>
    <link:label id="lab_a_DiagnosticsAndGenomicsMember_documentation_en-US" xlink:label="lab_a_DiagnosticsAndGenomicsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diagnostics and Genomics segment includes; DNA mutation detection; genotyping; gene copy number determination; identification of gene rearrangements; DNA methylation profiling; gene expression profiling; and automated gel electrophoresis-based sample analysis systems.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_a_DiagnosticsAndGenomicsMember" xlink:href="a-20220131.xsd#a_DiagnosticsAndGenomicsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_a_DiagnosticsAndGenomicsMember" xlink:to="lab_a_DiagnosticsAndGenomicsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsFairValueDisclosure_b39e88c5-48d5-46a2-a4cf-9e6897c9a85c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of impaired long-lived assets held for use</link:label>
    <link:label id="lab_us-gaap_OtherAssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_OtherAssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsFairValueDisclosure" xlink:to="lab_us-gaap_OtherAssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_ced2ef11-7f40-4425-b524-402d313e7599_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_ce2c7186-8160-4682-a3cc-72561e1afcd7_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable_3ceb37a3-09c6-4ba6-a45d-c8425becf432_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Variable Interest Entities [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Variable Interest Entities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:to="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_851a5684-6253-47e7-a99a-90722fe7f7cf_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_a_EndMarketsDomain_8e729f46-5039-48e3-a86c-38ad0e2b6d40_terseLabel_en-US" xlink:label="lab_a_EndMarketsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">End Markets [Domain]</link:label>
    <link:label id="lab_a_EndMarketsDomain_label_en-US" xlink:label="lab_a_EndMarketsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">End Markets [Domain]</link:label>
    <link:label id="lab_a_EndMarketsDomain_documentation_en-US" xlink:label="lab_a_EndMarketsDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Domain] for End Markets [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_a_EndMarketsDomain" xlink:href="a-20220131.xsd#a_EndMarketsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_a_EndMarketsDomain" xlink:to="lab_a_EndMarketsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_1468d499-cce3-44c5-9c2b-74d552caafdf_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation, net of tax expense of $0 and $0</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_a_AssetsLongLivedAbstract_582d1ea2-7b69-4953-9ba9-c94b9ffcd91d_terseLabel_en-US" xlink:label="lab_a_AssetsLongLivedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Assets</link:label>
    <link:label id="lab_a_AssetsLongLivedAbstract_label_en-US" xlink:label="lab_a_AssetsLongLivedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets Long Lived [Abstract]</link:label>
    <link:label id="lab_a_AssetsLongLivedAbstract_documentation_en-US" xlink:label="lab_a_AssetsLongLivedAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets Long Lived [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_a_AssetsLongLivedAbstract" xlink:href="a-20220131.xsd#a_AssetsLongLivedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_a_AssetsLongLivedAbstract" xlink:to="lab_a_AssetsLongLivedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_afb5ff55-42e8-4cd5-9344-1598bc72429a_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_434b6f18-8175-49b9-8761-3906e4915184_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-marketable equity securities carrying amount</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:to="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_1b586a7e-dbe6-4813-9f56-9aa430351885_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryLockMember_9beb498a-ed0e-4988-ab1b-b18b80edeac0_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryLockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Lock [Member]</link:label>
    <link:label id="lab_us-gaap_TreasuryLockMember_label_en-US" xlink:label="lab_us-gaap_TreasuryLockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Lock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryLockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryLockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryLockMember" xlink:to="lab_us-gaap_TreasuryLockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_036c3637-7163-45d8-8d05-dc28cd41ae93_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Abstract]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:to="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsForErrorCorrectionDomain_0bc23a0e-a9c4-40f1-97d1-485ddebf19a8_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsForErrorCorrectionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Error Correction, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_AdjustmentsForErrorCorrectionDomain_label_en-US" xlink:label="lab_us-gaap_AdjustmentsForErrorCorrectionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Error Correction, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForErrorCorrectionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForErrorCorrectionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsForErrorCorrectionDomain" xlink:to="lab_us-gaap_AdjustmentsForErrorCorrectionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_4769d11c-02ab-439f-96b5-d8d6c11e0d18_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_a_WeightedAverageMaturityDateatPointinTime_eb049a2b-06fc-4a60-8391-f9626f6a0490_terseLabel_en-US" xlink:label="lab_a_WeightedAverageMaturityDateatPointinTime" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Maturity Date at Point in Time</link:label>
    <link:label id="lab_a_WeightedAverageMaturityDateatPointinTime_label_en-US" xlink:label="lab_a_WeightedAverageMaturityDateatPointinTime" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Maturity Date at Point in Time</link:label>
    <link:label id="lab_a_WeightedAverageMaturityDateatPointinTime_documentation_en-US" xlink:label="lab_a_WeightedAverageMaturityDateatPointinTime" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Maturity Date at Point in Time.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_a_WeightedAverageMaturityDateatPointinTime" xlink:href="a-20220131.xsd#a_WeightedAverageMaturityDateatPointinTime"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_a_WeightedAverageMaturityDateatPointinTime" xlink:to="lab_a_WeightedAverageMaturityDateatPointinTime" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_e17b4c50-a587-492b-9fce-89776a840b54_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based awards issued, net of tax (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermDebtTerms_63680c4d-0840-45f5-8208-2d189009221a_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermDebtTerms" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit faciity terms (in years)</link:label>
    <link:label id="lab_us-gaap_ShortTermDebtTerms_label_en-US" xlink:label="lab_us-gaap_ShortTermDebtTerms" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt, Terms</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTerms" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTerms"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtTerms" xlink:to="lab_us-gaap_ShortTermDebtTerms" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityLineItems_65f75e89-9c02-4453-97cf-2e2de2bce512_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity [Line Items]</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityLineItems_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityLineItems" xlink:to="lab_us-gaap_VariableInterestEntityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_0f9997ce-3cd8-4cd6-adc6-57af3e5cc2d8_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement Line Items</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_c5688a9d-e6b1-41de-97ab-e20dfb1bdf73_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gain (loss) on derivative instruments, net of tax expense (benefit) of $2 and $(2)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_efdfaadf-847a-4cc9-9bcc-432546dadd7e_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net revenue deferred in the period</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:to="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_ed37ac2c-3804-44b3-aa2e-892f4356da8e_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Intangible Assets, Finite-lived</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Intangible Assets, Finite-lived</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:to="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsPayableLineItems_40a29379-43f6-4d4e-b429-b7ea69d31214_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsPayableLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Payable [Line Items]</link:label>
    <link:label id="lab_us-gaap_DividendsPayableLineItems_label_en-US" xlink:label="lab_us-gaap_DividendsPayableLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Payable [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsPayableLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsPayableLineItems" xlink:to="lab_us-gaap_DividendsPayableLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_addb9248-8cd1-4518-afc4-cdef1e62daea_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining performance obligation amount</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_6359dc0b-30be-4fd1-8ec0-49b409147649_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based awards issued</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermDebtTypeAxis_54a82a40-9196-4e5c-87f1-ff71ccf138ca_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ShortTermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis" xlink:to="lab_us-gaap_ShortTermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanTypeDomain_0164a147-f918-4610-89a6-b29b68a2fa37_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Domain]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanTypeDomain_label_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanTypeDomain" xlink:to="lab_us-gaap_RetirementPlanTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAbstract_52f72c74-b284-43eb-97fc-202529105d0b_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAbstract" xlink:to="lab_us-gaap_LiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_JPY_3666d7c9-7bf6-4282-844f-e27e7d051a4b_terseLabel_en-US" xlink:label="lab_currency_JPY" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Japanese Yen</link:label>
    <link:label id="lab_currency_JPY_label_en-US" xlink:label="lab_currency_JPY" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Japan, Yen</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_JPY" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_JPY"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_JPY" xlink:to="lab_currency_JPY" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_a0545c4a-fe26-4800-accd-d41e7d443df3_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Arrangement - Maximum</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_cecefdac-5a0b-4576-b698-898dd9aa67dd_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Intangible Assets</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Gross (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_b385d2b3-f5ca-40a2-b672-e5c338442678_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxPeriodAxis_0809c42f-8318-4c9c-b4d4-11b71e8f6673_terseLabel_en-US" xlink:label="lab_us-gaap_TaxPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Period [Axis]</link:label>
    <link:label id="lab_us-gaap_TaxPeriodAxis_label_en-US" xlink:label="lab_us-gaap_TaxPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Period [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxPeriodAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxPeriodAxis" xlink:to="lab_us-gaap_TaxPeriodAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_7c162fb5-3499-4dce-8448-70e03c4460e8_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price of Common Stock, Percent of FMV</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_589f6729-2205-458d-ad52-2bb5766ee0cc_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income before taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2e30f518-c6c3-43cb-95d2-32c807371460_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income before taxes, as reported</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_bdddd523-5ede-40f7-9d3f-6da7a90b9474_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Other Observable Inputs (Level 2)</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_87f7cb02-2f57-4f12-8916-e28113e61131_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_label_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfAdoptionMember" xlink:to="lab_us-gaap_TypeOfAdoptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeGainLossOnDerivativeNet_a665dba4-14e6-4911-a984-25e49d214f31_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (loss) recognized in other income (expense)</link:label>
    <link:label id="lab_us-gaap_DerivativeGainLossOnDerivativeNet_label_en-US" xlink:label="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Gain (Loss) on Derivative, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:to="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_7ff03403-d9a6-4b59-ae96-9e2a8a7182a2_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_d963d0e5-b2d0-43da-87a8-e68ed687d840_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:to="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_92983609-200b-499a-a70a-8af4d1f37aa6_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_304fa5f9-3fc7-4fe7-9b5a-be03c1fa68ad_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of the numerators and denominators of the basic and diluted net income per share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_9ff738b0-a72a-48b4-b5ed-1c3b7c9cbd53_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allocated share-based compensation expense disclosure</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_81d0f87a-6c6d-4e4a-b111-95c4316e07e3_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net gain to be reclassified within next Twelve Months</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_label_en-US" xlink:label="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedge Gain (Loss) to be Reclassified within Twelve Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:to="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_4e72558c-d66d-4e1d-823f-8b20af0e651f_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation impact</link:label>
    <link:label id="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_label_en-US" xlink:label="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Translation and Purchase Accounting Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:to="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_a_TransformationalPrograms_10f00563-2b44-4222-a631-6891e4f075ae_negatedLabel_en-US" xlink:label="lab_a_TransformationalPrograms" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transformational initiatives</link:label>
    <link:label id="lab_a_TransformationalPrograms_label_en-US" xlink:label="lab_a_TransformationalPrograms" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transformational Programs</link:label>
    <link:label id="lab_a_TransformationalPrograms_documentation_en-US" xlink:label="lab_a_TransformationalPrograms" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The charge against earnings in the period, comprised of costs associated with restructuring activities not otherwise specified in the taxonomy that are not part of a specific plan as required by GAAP.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_a_TransformationalPrograms" xlink:href="a-20220131.xsd#a_TransformationalPrograms"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_a_TransformationalPrograms" xlink:to="lab_a_TransformationalPrograms" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_4d5bc77c-2470-48bb-8ef7-d208b39dc3d7_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossTax_7e08e176-d3fc-4657-89dd-644ec92f9868_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax expense (benefit)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_83eb0aab-f1f9-48cf-b1f5-58c75aa2d772_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_844f6ee7-46ba-4a73-bc9e-79be525683df_terseLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax_5513d360-db1d-48cf-aadc-d4918a8d3b21_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actuarial net loss and prior service benefit reclassified, before tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, Reclassification Adjustment from AOCI, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryDisclosuresAbstract_69c512e6-4719-4f62-a26d-640a74eac501_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Not Primary Beneficiary, Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityNotPrimaryBeneficiaryDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryDisclosuresAbstract" xlink:to="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_86682d03-d3fc-456e-9d93-9b67bea98d60_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendPayableDateToBePaidDayMonthAndYear_3512341f-80c8-41ad-b95d-30a2f61d9e64_terseLabel_en-US" xlink:label="lab_us-gaap_DividendPayableDateToBePaidDayMonthAndYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment Date of Declared Dividends</link:label>
    <link:label id="lab_us-gaap_DividendPayableDateToBePaidDayMonthAndYear_label_en-US" xlink:label="lab_us-gaap_DividendPayableDateToBePaidDayMonthAndYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Payable, Date to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendPayableDateToBePaidDayMonthAndYear" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendPayableDateToBePaidDayMonthAndYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendPayableDateToBePaidDayMonthAndYear" xlink:to="lab_us-gaap_DividendPayableDateToBePaidDayMonthAndYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermBorrowingsAbstract_852bd8c6-203b-4727-a511-b0cfc8a025f9_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermBorrowingsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt [Abstract]</link:label>
    <link:label id="lab_us-gaap_ShortTermBorrowingsAbstract_label_en-US" xlink:label="lab_us-gaap_ShortTermBorrowingsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowingsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermBorrowingsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermBorrowingsAbstract" xlink:to="lab_us-gaap_ShortTermBorrowingsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_9caa4ec4-cec4-4b93-b93b-b1b96d2d7eb6_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest payments</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_928c484b-14ee-4e4a-ac07-10939cdbec68_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_DKK_d21a59ae-11b7-4923-8a46-3094f12fa20f_terseLabel_en-US" xlink:label="lab_currency_DKK" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Danish Krone</link:label>
    <link:label id="lab_currency_DKK_label_en-US" xlink:label="lab_currency_DKK" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Denmark, Kroner</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_DKK" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_DKK"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_DKK" xlink:to="lab_currency_DKK" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestPeriodIncreaseDecrease_c7d7fdc0-360b-4d1a-8487-aa6c293bdd5e_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of non-controlling interest increase (decrease)</link:label>
    <link:label id="lab_us-gaap_MinorityInterestPeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_MinorityInterestPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestPeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestPeriodIncreaseDecrease" xlink:to="lab_us-gaap_MinorityInterestPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_641aec80-4588-446c-8cdb-c31ee86adb5a_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_dbe7e00b-e631-4ec0-9abf-d78494b931ab_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-controlling Interest</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestMember" xlink:to="lab_us-gaap_NoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_e950a817-856d-4702-bfb1-06c6858bb2cb_verboseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_a752aecc-68b1-403f-ae4d-74f9d210faa8_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_7fcf8d4b-b740-40ed-8521-17e1839854e1_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss_9e2e5fde-5926-462e-812c-2432814e02a3_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation impact on other intangible assets</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite Lived Intangible Assets, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_a_ResolutionBioscienceIncMember_278ef8e0-d775-4ac4-bc80-2f5941b2812b_terseLabel_en-US" xlink:label="lab_a_ResolutionBioscienceIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Resolution Bioscience, Inc.</link:label>
    <link:label id="lab_a_ResolutionBioscienceIncMember_label_en-US" xlink:label="lab_a_ResolutionBioscienceIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Resolution Bioscience, Inc. [Member]</link:label>
    <link:label id="lab_a_ResolutionBioscienceIncMember_documentation_en-US" xlink:label="lab_a_ResolutionBioscienceIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Resolution Bioscience, Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_a_ResolutionBioscienceIncMember" xlink:href="a-20220131.xsd#a_ResolutionBioscienceIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_a_ResolutionBioscienceIncMember" xlink:to="lab_a_ResolutionBioscienceIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6bd5250e-4fc1-4f53-a9fc-4b50f07c3f04_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_9e0bfb90-1d31-4674-9c6b-42b499f943af_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_85dc2821-465d-4cac-96ae-fce9908a69c5_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining performance obligation expected timing of satisfaction period</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_AllCurrenciesDomain_a891db9a-a64e-4442-853b-0286c9ae99de_terseLabel_en-US" xlink:label="lab_currency_AllCurrenciesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Currencies [Domain]</link:label>
    <link:label id="lab_currency_AllCurrenciesDomain_label_en-US" xlink:label="lab_currency_AllCurrenciesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Currencies [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_AllCurrenciesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_AllCurrenciesDomain" xlink:to="lab_currency_AllCurrenciesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_29169839-b865-4bb5-ae70-3c69f1bff4d7_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_a587ee4b-afee-444a-9e44-f6f3a76f6e0c_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_97978808-9cd7-428a-b4b7-2415e6d63b39_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_87abc849-9885-4a00-a356-b6ca1a00e238_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_ab4687ca-5170-4c5e-9b82-a8167c31311a_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_fe92604e-d175-4bf6-98d6-b99e378853a9_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_4a78bb18-c0b4-4d9a-950e-4a2fd807783b_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic weighted-average shares</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_7332362b-ed59-4b5b-9845-e18dd9d047c1_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_a_WeightedAverageMaturityDateAtAPointInTime_ae8e97f8-8223-4bdf-841a-4662edeb0883_terseLabel_en-US" xlink:label="lab_a_WeightedAverageMaturityDateAtAPointInTime" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average maturity date at a point in time</link:label>
    <link:label id="lab_a_WeightedAverageMaturityDateAtAPointInTime_label_en-US" xlink:label="lab_a_WeightedAverageMaturityDateAtAPointInTime" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average maturity date at a point in time</link:label>
    <link:label id="lab_a_WeightedAverageMaturityDateAtAPointInTime_documentation_en-US" xlink:label="lab_a_WeightedAverageMaturityDateAtAPointInTime" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average maturity date at a point in time</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_a_WeightedAverageMaturityDateAtAPointInTime" xlink:href="a-20220131.xsd#a_WeightedAverageMaturityDateAtAPointInTime"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_a_WeightedAverageMaturityDateAtAPointInTime" xlink:to="lab_a_WeightedAverageMaturityDateAtAPointInTime" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityExpirationDate1_4556baa0-5d36-46fe-89b2-1437a3444737_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityExpirationDate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expiration date of credit facility</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityExpirationDate1_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityExpirationDate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Expiration Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityExpirationDate1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityExpirationDate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityExpirationDate1" xlink:to="lab_us-gaap_LineOfCreditFacilityExpirationDate1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_4f047988-0348-45b1-bd1a-715e541d7077_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductMember_19db78fa-d897-4ee2-8fbd-d664dfae2646_terseLabel_en-US" xlink:label="lab_us-gaap_ProductMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product</link:label>
    <link:label id="lab_us-gaap_ProductMember_label_en-US" xlink:label="lab_us-gaap_ProductMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductMember" xlink:to="lab_us-gaap_ProductMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanServiceCost_ab48558f-2715-4348-beca-a84b3a28fb0e_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service cost - benefits earned during the period</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanServiceCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Service Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanServiceCost" xlink:to="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetInvestmentHedgingMember_6596c6bd-cc98-4f8e-8cb0-3e65ffae0363_terseLabel_en-US" xlink:label="lab_us-gaap_NetInvestmentHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment Hedging [Member]</link:label>
    <link:label id="lab_us-gaap_NetInvestmentHedgingMember_label_en-US" xlink:label="lab_us-gaap_NetInvestmentHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetInvestmentHedgingMember" xlink:to="lab_us-gaap_NetInvestmentHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_2aec4e95-b3e6-4212-920e-5016c3d42828_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (loss) reclassified from accumulated other comprehensive&#160;loss into cost of sales</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_dacdc78f-c927-4ee4-bc5a-ed5317d5d227_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gain (loss) on derivatives</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_5dd1f901-53f4-4512-a88f-a78111afca72_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_ff512002-ae60-41ac-8e64-be8a21b71560_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax paid, net</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaidNet" xlink:to="lab_us-gaap_IncomeTaxesPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_CHF_8d056ef1-591f-4f8d-89ad-b373aeab5452_terseLabel_en-US" xlink:label="lab_currency_CHF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Swiss Franc</link:label>
    <link:label id="lab_currency_CHF_label_en-US" xlink:label="lab_currency_CHF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Switzerland, Francs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_CHF" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_CHF"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_CHF" xlink:to="lab_currency_CHF" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseMember_4d69485f-2ef3-4f34-8e6e-e0da6dff3613_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:label id="lab_us-gaap_InterestExpenseMember_label_en-US" xlink:label="lab_us-gaap_InterestExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseMember" xlink:to="lab_us-gaap_InterestExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_a_InstrumentationMember_48ced45f-1b05-4f2c-9d1c-0f6acd31a076_terseLabel_en-US" xlink:label="lab_a_InstrumentationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Instrumentation</link:label>
    <link:label id="lab_a_InstrumentationMember_label_en-US" xlink:label="lab_a_InstrumentationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Instrumentation [Member]</link:label>
    <link:label id="lab_a_InstrumentationMember_documentation_en-US" xlink:label="lab_a_InstrumentationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Instrumentation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_a_InstrumentationMember" xlink:href="a-20220131.xsd#a_InstrumentationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_a_InstrumentationMember" xlink:to="lab_a_InstrumentationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent_48a689a6-eb6e-4046-a04a-1b9df8a1cf16_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other accrued liabilities</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_bedc5143-fb88-4031-a67a-c588350d4b71_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior service benefit</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_3834e0bf-e1ef-4220-a0c7-7a3dc0045695_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total comprehensive income, net of tax</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_35eb2b33-c1d6-48b5-b360-e612b5c8884a_verboseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_6a1643d5-bdd1-47f4-b34b-4ffb5fec859c_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Book Value</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_d74d8bdf-6963-4c39-a4ae-77086e8e7f67_periodStartLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract liability ending balance as of October 31, 2021</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_85313b70-4852-41e7-8753-6079751f4c0a_periodEndLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract liability ending balance as of January 31, 2022</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiability" xlink:to="lab_us-gaap_ContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember_4d619415-2e15-4dca-8464-24046d967e52_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior Service Credits</link:label>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment, Net Prior Service Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember" xlink:to="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_c9b1e87a-31b7-4736-840c-cfbe81adff58_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_6b7365ed-f0ee-48e3-8901-136a6984d86a_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss):</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract_c70e7680-d2f2-4c95-a7d5-87a7e0db6569_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets (Excluding Goodwill)</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets (Excluding Goodwill) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_a5470ccd-b988-4d02-92ee-23f4e9b3a8a8_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares used in computing net income per share:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_SGD_17576eef-47e1-494f-85c2-444d2c71e101_terseLabel_en-US" xlink:label="lab_currency_SGD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Singapore Dollar</link:label>
    <link:label id="lab_currency_SGD_label_en-US" xlink:label="lab_currency_SGD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Singapore, Dollars</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_SGD" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_SGD"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_SGD" xlink:to="lab_currency_SGD" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_da8899f3-109a-426b-a0cd-851e2c80abeb_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting Period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_a_A5YrUnsecuredCreditFacilityMember_b0fa54e5-a898-463a-b04c-59819242d4f8_terseLabel_en-US" xlink:label="lab_a_A5YrUnsecuredCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5 yr Unsecured Credit Facility</link:label>
    <link:label id="lab_a_A5YrUnsecuredCreditFacilityMember_label_en-US" xlink:label="lab_a_A5YrUnsecuredCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5 yr Unsecured Credit Facility [Member]</link:label>
    <link:label id="lab_a_A5YrUnsecuredCreditFacilityMember_documentation_en-US" xlink:label="lab_a_A5YrUnsecuredCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5 yr Unsecured Credit Facility</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_a_A5YrUnsecuredCreditFacilityMember" xlink:href="a-20220131.xsd#a_A5YrUnsecuredCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_a_A5YrUnsecuredCreditFacilityMember" xlink:to="lab_a_A5YrUnsecuredCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_58316f2a-6201-4e34-bae5-b9e0afb8b955_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:to="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_159f55cd-5e59-41f9-b8d2-2aeffd862409_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_ac518aa4-1a44-4378-ad92-9f8b890c126e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FAIR VALUE MEASUREMENTS</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_920c4738-7a2e-440d-b031-f795d011e9f7_verboseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_a0a975d9-51a0-4581-b781-8a5c59954f6c_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Long-Lived Assets Held-for-use</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment, Long-Lived Asset, Held-for-Use</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:to="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ParentMember_ccf243c0-789f-42ae-99e4-139444ad29eb_terseLabel_en-US" xlink:label="lab_us-gaap_ParentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Stockholder's Equity</link:label>
    <link:label id="lab_us-gaap_ParentMember_label_en-US" xlink:label="lab_us-gaap_ParentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ParentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ParentMember" xlink:to="lab_us-gaap_ParentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_65d3569e-238d-4858-a83b-b0cf953374dd_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_12d37746-8e36-47c9-bca5-bfeed3990447_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Assets And Liabilities Measured On Recurring Basis</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_1a119bc4-b53f-476d-8a76-f6334fd4797d_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_a_DocumentAndEntityInformationAbstract_1333f098-979f-4c74-b107-66b8b2ab72ae_terseLabel_en-US" xlink:label="lab_a_DocumentAndEntityInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document and Entity Information [Abstract]</link:label>
    <link:label id="lab_a_DocumentAndEntityInformationAbstract_label_en-US" xlink:label="lab_a_DocumentAndEntityInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document and Entity Information [Abstract]</link:label>
    <link:label id="lab_a_DocumentAndEntityInformationAbstract_documentation_en-US" xlink:label="lab_a_DocumentAndEntityInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document and Entity Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_a_DocumentAndEntityInformationAbstract" xlink:href="a-20220131.xsd#a_DocumentAndEntityInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_a_DocumentAndEntityInformationAbstract" xlink:to="lab_a_DocumentAndEntityInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_CNY_3a684625-d8d9-4acc-9917-64d14995a801_terseLabel_en-US" xlink:label="lab_currency_CNY" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Chinese Yuan Renminbi</link:label>
    <link:label id="lab_currency_CNY_label_en-US" xlink:label="lab_currency_CNY" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">China, Yuan Renminbi</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_CNY" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_CNY"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_CNY" xlink:to="lab_currency_CNY" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_9e87a145-d082-4ebe-8fc9-252dd741a310_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_6a887628-e4b1-4a03-888a-a957e42de23b_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_78a49479-2d97-45bd-8c0a-9d07aec93f2a_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remainder of 2022</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_8266ac6f-93e7-4641-84cc-906c9aa91a29_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNet_3783eb5c-86ae-4bd0-b950-946bac605802_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract Assets (Unbilled Accounts Receivable)</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNet_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset, after Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetNet" xlink:to="lab_us-gaap_ContractWithCustomerAssetNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_c70e2e7b-0f58-4069-8fe3-608f4ad97824_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermInvestments_e3f3ae01-c25f-420e-b581-a8783f7b015b_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermInvestments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term investments</link:label>
    <link:label id="lab_us-gaap_LongTermInvestments_label_en-US" xlink:label="lab_us-gaap_LongTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermInvestments" xlink:to="lab_us-gaap_LongTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeTable_a0a9014a-5f7a-4ce5-9c1b-670e7d1a34ad_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeTable_label_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeTable" xlink:to="lab_us-gaap_DerivativeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongMember_edd0c246-12a4-47c5-8136-abf62aaead06_terseLabel_en-US" xlink:label="lab_us-gaap_LongMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Buy</link:label>
    <link:label id="lab_us-gaap_LongMember_label_en-US" xlink:label="lab_us-gaap_LongMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongMember" xlink:to="lab_us-gaap_LongMember" xlink:type="arc" order="1"/>
    <link:label id="lab_a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesPriceWiseCorrelationyRate_468e9bfa-e7f1-450d-a53b-05df18516660_verboseLabel_en-US" xlink:label="lab_a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesPriceWiseCorrelationyRate" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pair-wise correlation with selected peers (in hundredths)</link:label>
    <link:label id="lab_a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesPriceWiseCorrelationyRate_label_en-US" xlink:label="lab_a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesPriceWiseCorrelationyRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Peer Company Shares Price Wise Correlationy Rate</link:label>
    <link:label id="lab_a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesPriceWiseCorrelationyRate_documentation_en-US" xlink:label="lab_a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesPriceWiseCorrelationyRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The measure of the percentage amount of share price correlation during the period with a selected group of peer companies. Pair-wise correlations with selected peers is calculated as the correlation between each pair and the sum of correlations divided by the number of pairs to produce the average correlation between each pair.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesPriceWiseCorrelationyRate" xlink:href="a-20220131.xsd#a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesPriceWiseCorrelationyRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesPriceWiseCorrelationyRate" xlink:to="lab_a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesPriceWiseCorrelationyRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_5b8cd4b8-9b67-4e01-bbda-2ea1c1ec95bb_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of revenue</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesAbstract_7d622790-7151-46de-9639-94ff84d14c8b_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net revenue:</link:label>
    <link:label id="lab_us-gaap_RevenuesAbstract_label_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesAbstract" xlink:to="lab_us-gaap_RevenuesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear_1508a4bb-d9cc-4e3e-a472-d810e21a50c8_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected future employer contributions</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Employer Contributions, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_491339df-6019-4211-93a1-522dcaafd599_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_2175341f-042a-4bee-b4bc-5a6da3019833_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (loss) recognized in accumulated other comprehensive&#160;loss</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_fee0a8a5-9a3e-455d-a99f-78c628aadc2d_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_9a58031e-fa42-4b5d-b44b-4330c3d3d308_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from EPS Computation</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PublicUtilitiesInventoryTypeDomain_322bd71b-1404-4595-a727-bbdf7cb9ec54_terseLabel_en-US" xlink:label="lab_us-gaap_PublicUtilitiesInventoryTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_PublicUtilitiesInventoryTypeDomain_label_en-US" xlink:label="lab_us-gaap_PublicUtilitiesInventoryTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PublicUtilitiesInventoryTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PublicUtilitiesInventoryTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PublicUtilitiesInventoryTypeDomain" xlink:to="lab_us-gaap_PublicUtilitiesInventoryTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidatedEntitiesDomain_f1235fce-0455-4eef-9f4c-43660c3f99e6_terseLabel_en-US" xlink:label="lab_srt_ConsolidatedEntitiesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Domain]</link:label>
    <link:label id="lab_srt_ConsolidatedEntitiesDomain_label_en-US" xlink:label="lab_srt_ConsolidatedEntitiesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidatedEntitiesDomain" xlink:to="lab_srt_ConsolidatedEntitiesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_3b3681dd-ea53-4586-8864-fd18147c00de_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_e3e1452e-9b27-426f-9728-8b8e80e120ad_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement and Other Comprehensive Income (Loss) Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_7719d2f9-f07e-4200-bd5f-b550ce3db1eb_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsFairValueDisclosure_d6d66bcd-dc9d-4110-827b-731eb37670dd_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other investments</link:label>
    <link:label id="lab_us-gaap_InvestmentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_InvestmentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsFairValueDisclosure" xlink:to="lab_us-gaap_InvestmentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax_a926eb27-8c50-4f24-a9f6-07338364383c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in net prior service benefit, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_e3802484-d509-4599-b035-b378d1202896_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelationshipsMember" xlink:to="lab_us-gaap_CustomerRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_7abc4f88-2cdc-4260-9395-9ae4e46e84e4_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_787b19d4-fd71-4bdc-8541-660c3a99d0e8_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOperatingActivitiesSegmentAxis_53f4ee97-247b-40bc-9448-b0f545d7c751_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOperatingActivitiesSegmentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Activities [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementOperatingActivitiesSegmentAxis_label_en-US" xlink:label="lab_us-gaap_StatementOperatingActivitiesSegmentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Activities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOperatingActivitiesSegmentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOperatingActivitiesSegmentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOperatingActivitiesSegmentAxis" xlink:to="lab_us-gaap_StatementOperatingActivitiesSegmentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_a_NonInstrumentationandOtherMember_e3f3134b-6e08-44ed-acb7-c30acf065eb3_terseLabel_en-US" xlink:label="lab_a_NonInstrumentationandOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Instrumentation and Other</link:label>
    <link:label id="lab_a_NonInstrumentationandOtherMember_label_en-US" xlink:label="lab_a_NonInstrumentationandOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Instrumentation and Other [Member]</link:label>
    <link:label id="lab_a_NonInstrumentationandOtherMember_documentation_en-US" xlink:label="lab_a_NonInstrumentationandOtherMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Instrumentation and Other[Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_a_NonInstrumentationandOtherMember" xlink:href="a-20220131.xsd#a_NonInstrumentationandOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_a_NonInstrumentationandOtherMember" xlink:to="lab_a_NonInstrumentationandOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_9c883a23-314e-4ca6-96b3-9baa44d9dce1_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Senior Notes and Related Interest Rate Swaps</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_da640cc8-cedd-4622-86b3-32acff8008ab_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of estimated future amortization expense of finite-lived intangible assets</link:label>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:to="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_5ce85788-4afa-4ba4-b650-d1fe42f0e95d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_bacab5d4-8e4c-42e9-84ca-52d9cc82baf5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_3293c100-f6af-4443-82ce-a2b25295b29f_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_aa965934-36d6-4ef8-abc7-c3f1e55d6ad5_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income per share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BankAcceptancesExecuted_6ff4f436-27ec-4d05-b6b2-86af88a07f6b_terseLabel_en-US" xlink:label="lab_us-gaap_BankAcceptancesExecuted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantees</link:label>
    <link:label id="lab_us-gaap_BankAcceptancesExecuted_label_en-US" xlink:label="lab_us-gaap_BankAcceptancesExecuted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bank Acceptances Executed</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BankAcceptancesExecuted" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BankAcceptancesExecuted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BankAcceptancesExecuted" xlink:to="lab_us-gaap_BankAcceptancesExecuted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_308f95a6-b823-442b-825d-fa3b1f4b5e25_verboseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net gain (loss) on equity securities</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_2312a2aa-a65c-450b-99c2-619638de3555_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gain (loss) on equity securities</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Unrealized Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:to="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_7ae7b71e-8e34-4f00-9ccf-e027c0e12d93_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:to="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TrademarksMember_e6c4901c-0de0-4ff5-9cec-37e13861843e_terseLabel_en-US" xlink:label="lab_us-gaap_TrademarksMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademark/Tradenames</link:label>
    <link:label id="lab_us-gaap_TrademarksMember_label_en-US" xlink:label="lab_us-gaap_TrademarksMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TrademarksMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TrademarksMember" xlink:to="lab_us-gaap_TrademarksMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesMember_7b3bec60-8ca4-4805-852b-82622857e04d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other accrued liabilities</link:label>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCurrentLiabilitiesMember" xlink:to="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_463604e7-d75b-4b22-977d-be17a7e7fe30_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Contracts</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Contract [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeContractMember" xlink:to="lab_us-gaap_ForeignExchangeContractMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoods_74711984-7e57-4285-a65f-93f5eec576b9_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoods" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finished goods</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoods_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoods" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoods" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoods"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoods" xlink:to="lab_us-gaap_InventoryFinishedGoods" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_e17a6569-b748-4f39-8795-b1551d8801ce_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actuarial net loss</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_a_ThirdPartyTechnologyandLicensesMember_95dc2c64-e310-4cc1-83f7-32c0309e3591_terseLabel_en-US" xlink:label="lab_a_ThirdPartyTechnologyandLicensesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Third-Party Technology and Licenses</link:label>
    <link:label id="lab_a_ThirdPartyTechnologyandLicensesMember_label_en-US" xlink:label="lab_a_ThirdPartyTechnologyandLicensesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Third-Party Technology and Licenses [Member]</link:label>
    <link:label id="lab_a_ThirdPartyTechnologyandLicensesMember_documentation_en-US" xlink:label="lab_a_ThirdPartyTechnologyandLicensesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Third-Party Technology and Licenses [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_a_ThirdPartyTechnologyandLicensesMember" xlink:href="a-20220131.xsd#a_ThirdPartyTechnologyandLicensesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_a_ThirdPartyTechnologyandLicensesMember" xlink:to="lab_a_ThirdPartyTechnologyandLicensesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_a_LifeSciencesandAppliedMarketsMember_41547ae6-678c-4575-8614-d48454eca6d7_terseLabel_en-US" xlink:label="lab_a_LifeSciencesandAppliedMarketsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Life Sciences and Applied Markets</link:label>
    <link:label id="lab_a_LifeSciencesandAppliedMarketsMember_label_en-US" xlink:label="lab_a_LifeSciencesandAppliedMarketsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Life Sciences and Applied Markets [Member]</link:label>
    <link:label id="lab_a_LifeSciencesandAppliedMarketsMember_documentation_en-US" xlink:label="lab_a_LifeSciencesandAppliedMarketsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Life Sciences and Applied Markets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_a_LifeSciencesandAppliedMarketsMember" xlink:href="a-20220131.xsd#a_LifeSciencesandAppliedMarketsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_a_LifeSciencesandAppliedMarketsMember" xlink:to="lab_a_LifeSciencesandAppliedMarketsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_032e177a-d987-453c-9f18-c85a3513c786_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Table]</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAndExpensesAbstract_be4b3a7f-c701-421a-9f38-74e30b679ec8_verboseLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and expenses:</link:label>
    <link:label id="lab_us-gaap_CostsAndExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_CostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpensesAbstract" xlink:to="lab_us-gaap_CostsAndExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_5f928d4f-7e3d-43c3-8ae7-d02c3eb27c05_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gain (loss) on derivative instruments, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" xlink:type="arc" order="1"/>
    <link:label id="lab_a_MeasurementInputAssetVolatilityMember_13de575a-f9e1-40b2-84c1-d0ff5e5a4ebb_terseLabel_en-US" xlink:label="lab_a_MeasurementInputAssetVolatilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Asset Volatility</link:label>
    <link:label id="lab_a_MeasurementInputAssetVolatilityMember_label_en-US" xlink:label="lab_a_MeasurementInputAssetVolatilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Asset Volatility [Member]</link:label>
    <link:label id="lab_a_MeasurementInputAssetVolatilityMember_documentation_en-US" xlink:label="lab_a_MeasurementInputAssetVolatilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Asset Volatility</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_a_MeasurementInputAssetVolatilityMember" xlink:href="a-20220131.xsd#a_MeasurementInputAssetVolatilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_a_MeasurementInputAssetVolatilityMember" xlink:to="lab_a_MeasurementInputAssetVolatilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuePerformanceObligationAbstract_192f34c1-b935-45fe-87c0-0dff4c8508a5_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuePerformanceObligationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Performance Obligation [Abstract]</link:label>
    <link:label id="lab_us-gaap_RevenuePerformanceObligationAbstract_label_en-US" xlink:label="lab_us-gaap_RevenuePerformanceObligationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Performance Obligation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuePerformanceObligationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuePerformanceObligationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuePerformanceObligationAbstract" xlink:to="lab_us-gaap_RevenuePerformanceObligationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_712def1a-dc80-4413-b789-ad1d3c65de20_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent" xlink:to="lab_us-gaap_LongTermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_d697f571-cc8a-4f44-bf02-43814592e8cd_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable" xlink:to="lab_us-gaap_ScheduleOfGoodwillTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_bf052fe0-9c18-41a5-bcf3-a8f68fd4bf61_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EuropeMember_c71aee2b-ae08-4754-81f1-c2fb23ce626d_terseLabel_en-US" xlink:label="lab_srt_EuropeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe</link:label>
    <link:label id="lab_srt_EuropeMember_label_en-US" xlink:label="lab_srt_EuropeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EuropeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EuropeMember" xlink:to="lab_srt_EuropeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_42f81f08-ada9-4e8a-b497-911364237ea4_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_c45ccba3-c4c9-444a-ab42-f02cb3523688_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective income tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_a_MeasurementInputRevenueVolatilityMember_6c62ad45-bb61-4e46-b7df-726c6843b85c_terseLabel_en-US" xlink:label="lab_a_MeasurementInputRevenueVolatilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Revenue Volatility</link:label>
    <link:label id="lab_a_MeasurementInputRevenueVolatilityMember_label_en-US" xlink:label="lab_a_MeasurementInputRevenueVolatilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Revenue Volatility [Member]</link:label>
    <link:label id="lab_a_MeasurementInputRevenueVolatilityMember_documentation_en-US" xlink:label="lab_a_MeasurementInputRevenueVolatilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Revenue Volatility</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_a_MeasurementInputRevenueVolatilityMember" xlink:href="a-20220131.xsd#a_MeasurementInputRevenueVolatilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_a_MeasurementInputRevenueVolatilityMember" xlink:to="lab_a_MeasurementInputRevenueVolatilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_477d9a4b-7380-4d51-88ef-61a20a25f508_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash at beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_97a7e0cf-a2ff-46dc-ac5d-5aec9fdd83b9_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash at end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_877ee1ee-5ce0-43f5-a5c6-a6506cc0f55c_terseLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents, restricted cash and restricted cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_dc8a414e-3dea-436e-83ea-b6cdf6c86562_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregated notional amounts by currency and designation</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesIssued_1af89f8e-b579-465a-98fb-2b79611591b8_periodStartLabel_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning Balance (in Shares)</link:label>
    <link:label id="lab_us-gaap_SharesIssued_99af2564-9ef4-4bc8-9566-3d155a2d6226_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending Balance (in Shares)</link:label>
    <link:label id="lab_us-gaap_SharesIssued_label_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesIssued" xlink:to="lab_us-gaap_SharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesVolatilityRateRangeMaximum_91bbe2be-17d2-4b5e-a401-b0d0a7547c93_terseLabel_en-US" xlink:label="lab_a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesVolatilityRateRangeMaximum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Volatility of selected peer-company shares - Maximum</link:label>
    <link:label id="lab_a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesVolatilityRateRangeMaximum_label_en-US" xlink:label="lab_a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesVolatilityRateRangeMaximum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Peer Company Shares Volatility Rate Range Maximum</link:label>
    <link:label id="lab_a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesVolatilityRateRangeMaximum_documentation_en-US" xlink:label="lab_a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesVolatilityRateRangeMaximum" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The measure of the percentage amount by which a share price fluctuates during a period for peer companies - maximum range. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesVolatilityRateRangeMaximum" xlink:href="a-20220131.xsd#a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesVolatilityRateRangeMaximum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesVolatilityRateRangeMaximum" xlink:to="lab_a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesVolatilityRateRangeMaximum" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_ff6577c0-ba28-4e73-b566-c0402eb93109_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_2c7704c3-7041-4be0-a235-f0f06d0e0c60_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems_4998cb2c-f4ee-4802-be72-64dd633b0eec_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Disclosure</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:to="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_acff5504-5fd1-4c1a-a414-151562a72257_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_c71f143f-96fc-4ca1-b23a-e8a4abac8475_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_5fe59bc6-2367-4c36-937e-6014a61ec1c4_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_0f548514-b1ab-4a00-8aa5-343ac54efb75_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Carrying Amount</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_3bf3cb1e-fccf-47bb-8d85-f53c8ff3ca67_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Common shares available for future issuance</link:label>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_label_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Capital Shares Reserved for Future Issuance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_60462afb-c13e-45e6-a529-1e4bf8d29b6f_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_cde143b0-dd0a-4a37-8aad-1799f290b688_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of other intangible assets during the period</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredRevenueCurrent_e8f38cf7-42e0-47fb-ad7d-3df680563abf_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredRevenueCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_DeferredRevenueCurrent_label_en-US" xlink:label="lab_us-gaap_DeferredRevenueCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Revenue, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredRevenueCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredRevenueCurrent" xlink:to="lab_us-gaap_DeferredRevenueCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent_14bd8859-f55b-44ef-a962-93025fcfc074_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts reclassified out of accumulated other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from AOCI, Current Period, before Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" xlink:to="lab_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_b83de578-1663-44bc-abe8-ae8458d60a6a_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash equivalents (money market funds)</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesVolatilityRateRangeMinimum_9d992d3f-cdfe-41d4-b9b8-0153fd4f7b10_terseLabel_en-US" xlink:label="lab_a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesVolatilityRateRangeMinimum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Volatility of selected peer-company shares - Minimum</link:label>
    <link:label id="lab_a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesVolatilityRateRangeMinimum_label_en-US" xlink:label="lab_a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesVolatilityRateRangeMinimum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Peer Company Shares Volatility Rate Range Minimum</link:label>
    <link:label id="lab_a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesVolatilityRateRangeMinimum_documentation_en-US" xlink:label="lab_a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesVolatilityRateRangeMinimum" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The measure of the percentage amount by which a share price fluctuates during a period for peer companies - minimum range. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesVolatilityRateRangeMinimum" xlink:href="a-20220131.xsd#a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesVolatilityRateRangeMinimum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesVolatilityRateRangeMinimum" xlink:to="lab_a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesVolatilityRateRangeMinimum" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_7192f513-ee1a-4e12-a24f-30bdcbff817d_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_PLN_7aecc265-39af-4811-adf8-4871d937a3da_terseLabel_en-US" xlink:label="lab_currency_PLN" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Polish Zloty</link:label>
    <link:label id="lab_currency_PLN_label_en-US" xlink:label="lab_currency_PLN" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Poland, Zlotych</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_PLN" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_PLN"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_PLN" xlink:to="lab_currency_PLN" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_98ed43c6-bc13-4fe1-ae37-3d569ccaff98_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_6ac8d277-6440-4ed1-a00b-fbde9c7f01f5_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted weighted average shares</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_a5233d66-72f9-4f35-971a-3caa6ae2180d_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_b1789cea-0146-4653-8c7c-bd09385d1642_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentForAmortization_b444f551-aa25-4db4-be30-773e768437ad_negatedLabel_en-US" xlink:label="lab_us-gaap_AdjustmentForAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of intangible assets related to business combinations</link:label>
    <link:label id="lab_us-gaap_AdjustmentForAmortization_label_en-US" xlink:label="lab_us-gaap_AdjustmentForAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentForAmortization" xlink:to="lab_us-gaap_AdjustmentForAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_75a4640e-bcac-4cec-a481-d82c8ce2f9c2_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurements, Recurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_427d8a6a-0c28-4006-9d6b-bea7f136422d_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INCOME TAXES</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansTaxAbstract_fbb16d45-ce11-40df-bdae-d4c2afd1e873_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net defined benefit pension cost and post retirement plan costs, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansTaxAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansTaxAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansTaxAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansTaxAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansTaxAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfForeignCurrencyDerivativesHeld_8c147da6-be7d-4e48-a92a-31a51cb4ebf3_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfForeignCurrencyDerivativesHeld" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of foreign exchange forward contracts (in units)</link:label>
    <link:label id="lab_us-gaap_NumberOfForeignCurrencyDerivativesHeld_label_en-US" xlink:label="lab_us-gaap_NumberOfForeignCurrencyDerivativesHeld" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Foreign Currency Derivatives Held</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfForeignCurrencyDerivativesHeld" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfForeignCurrencyDerivativesHeld"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfForeignCurrencyDerivativesHeld" xlink:to="lab_us-gaap_NumberOfForeignCurrencyDerivativesHeld" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_628950aa-2d50-4ba2-8b11-7af5ba76274f_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">STOCKHOLDERS EQUITY</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_16dd968c-73fe-4a33-bbb0-04bf77bd502d_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_e8731d0c-d054-4759-8a17-d54fa26e81c4_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy_86f3b5cd-7108-4380-9668-40f1c65cbd1e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Financial Instruments</link:label>
    <link:label id="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy_label_en-US" xlink:label="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Financial Instruments, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_a92115fe-b140-4d61-acaf-842f90f1716a_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_6476e47d-b7f2-404d-bd4b-cb94f436861f_terseLabel_en-US" xlink:label="lab_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Name of Property [Axis]</link:label>
    <link:label id="lab_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_label_en-US" xlink:label="lab_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Name of Property [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis" xlink:to="lab_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_c61c5af7-df50-4c8c-8ef4-a4546227acf1_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NondesignatedMember_5415a032-6fff-47b3-9fbd-8500078f0584_verboseLabel_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not Designated as Hedging Instruments</link:label>
    <link:label id="lab_us-gaap_NondesignatedMember_462ae9a4-75c7-492c-bfea-14b4eda66e1d_terseLabel_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives Not Designated as Hedging Instruments</link:label>
    <link:label id="lab_us-gaap_NondesignatedMember_label_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NondesignatedMember" xlink:to="lab_us-gaap_NondesignatedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_de5c4a55-064e-4d0d-b269-001a58746ac3_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWorkInProcessAndRawMaterials_42c06a6d-c3cc-4fe7-a578-19470d6f1d3d_verboseLabel_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessAndRawMaterials" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchased parts and fabricated assemblies</link:label>
    <link:label id="lab_us-gaap_InventoryWorkInProcessAndRawMaterials_label_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessAndRawMaterials" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Work in Process and Raw Materials</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessAndRawMaterials" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWorkInProcessAndRawMaterials"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWorkInProcessAndRawMaterials" xlink:to="lab_us-gaap_InventoryWorkInProcessAndRawMaterials" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_5f4bc7ac-deb2-4f93-9886-395d18bb9be4_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_9b07d6a8-5e7f-45dc-abbd-c2bd17d9e4ab_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_8acdca29-b352-414c-a0bd-a9c154fd8eae_verboseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of segment results to total enterprise results</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:to="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d20889ea-3f1c-4ce1-b8f3-d772db648a61_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanSponsorLocationDomain_05510095-d3bd-41f3-b367-8b20e25dba12_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanSponsorLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Sponsor Location [Domain]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanSponsorLocationDomain_label_en-US" xlink:label="lab_us-gaap_RetirementPlanSponsorLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Sponsor Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain" xlink:to="lab_us-gaap_RetirementPlanSponsorLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_a_Remaininggainlosstobeamortizedonderivative_b796a1c1-121f-4be7-bd49-9d02e14c027f_terseLabel_en-US" xlink:label="lab_a_Remaininggainlosstobeamortizedonderivative" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining gain (loss) to be amortized on derivative</link:label>
    <link:label id="lab_a_Remaininggainlosstobeamortizedonderivative_label_en-US" xlink:label="lab_a_Remaininggainlosstobeamortizedonderivative" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining gain loss to be amortized on derivative</link:label>
    <link:label id="lab_a_Remaininggainlosstobeamortizedonderivative_documentation_en-US" xlink:label="lab_a_Remaininggainlosstobeamortizedonderivative" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining gain loss to be amortized on derivative</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_a_Remaininggainlosstobeamortizedonderivative" xlink:href="a-20220131.xsd#a_Remaininggainlosstobeamortizedonderivative"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_a_Remaininggainlosstobeamortizedonderivative" xlink:to="lab_a_Remaininggainlosstobeamortizedonderivative" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_eca432bc-9efa-4f76-b0ac-2494ad5bd9d5_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsegmentsConsolidationItemsAxis_740025cd-d053-45e9-ba8b-117a8ed4290c_terseLabel_en-US" xlink:label="lab_us-gaap_SubsegmentsConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments Consolidation Items [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsegmentsConsolidationItemsAxis_label_en-US" xlink:label="lab_us-gaap_SubsegmentsConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsConsolidationItemsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsegmentsConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsegmentsConsolidationItemsAxis" xlink:to="lab_us-gaap_SubsegmentsConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_11a0bccd-8583-4e42-b3c7-f967a6f41362_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_6f1c5c33-1ad6-477b-9d9d-8cb9ef50b0d5_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected Life</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_b7d43d6a-9028-43ea-aa8f-43bdb686a4e0_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockMember_5a1b34c7-0c6e-45eb-8de6-221621a7db17_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock [ESPP]</link:label>
    <link:label id="lab_us-gaap_EmployeeStockMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockMember" xlink:to="lab_us-gaap_EmployeeStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_b78c12ab-3a6f-4f8b-ae2d-a484ce8a8cfc_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of taxes related to net share settlement of equity awards</link:label>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment, Tax Withholding, Share-based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDomain_6fb020a8-4b7e-4418-bbce-92c3fe707c65_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_EUR_c709870c-4984-4087-92c8-836c96b384df_terseLabel_en-US" xlink:label="lab_currency_EUR" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Euro</link:label>
    <link:label id="lab_currency_EUR_label_en-US" xlink:label="lab_currency_EUR" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Euro Member Countries, Euro</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_EUR" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_EUR"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_EUR" xlink:to="lab_currency_EUR" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairedAssetsToBeDisposedOfByMethodOtherThanSaleCarryingValueOfAsset_c6858167-ed18-4cb7-9a55-61858eadf914_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairedAssetsToBeDisposedOfByMethodOtherThanSaleCarryingValueOfAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying value of impaired long-lived assets held for use</link:label>
    <link:label id="lab_us-gaap_ImpairedAssetsToBeDisposedOfByMethodOtherThanSaleCarryingValueOfAsset_label_en-US" xlink:label="lab_us-gaap_ImpairedAssetsToBeDisposedOfByMethodOtherThanSaleCarryingValueOfAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impaired Assets to be Disposed of by Method Other than Sale, Carrying Value of Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairedAssetsToBeDisposedOfByMethodOtherThanSaleCarryingValueOfAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairedAssetsToBeDisposedOfByMethodOtherThanSaleCarryingValueOfAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairedAssetsToBeDisposedOfByMethodOtherThanSaleCarryingValueOfAsset" xlink:to="lab_us-gaap_ImpairedAssetsToBeDisposedOfByMethodOtherThanSaleCarryingValueOfAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignExchangeForwardMember_c0bdea87-95e6-479d-b15d-5919fd9a6124_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeForwardMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Forward</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeForwardMember_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeForwardMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Forward [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeForwardMember" xlink:to="lab_us-gaap_ForeignExchangeForwardMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_dcc8f499-72a5-4318-8c53-2fdd902bf41e_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum borrowing capacity of credit facility</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_dd4b9b1f-ffe4-4e69-ae49-bb2b80479819_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_a_EnvironmentalandForensicsMarketMember_ae93476f-b0ad-4fef-87ef-fc039e46fde1_terseLabel_en-US" xlink:label="lab_a_EnvironmentalandForensicsMarketMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Environmental and Forensics</link:label>
    <link:label id="lab_a_EnvironmentalandForensicsMarketMember_label_en-US" xlink:label="lab_a_EnvironmentalandForensicsMarketMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Environmental and Forensics Market [Member]</link:label>
    <link:label id="lab_a_EnvironmentalandForensicsMarketMember_documentation_en-US" xlink:label="lab_a_EnvironmentalandForensicsMarketMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Environmental and Forensics Market [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_a_EnvironmentalandForensicsMarketMember" xlink:href="a-20220131.xsd#a_EnvironmentalandForensicsMarketMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_a_EnvironmentalandForensicsMarketMember" xlink:to="lab_a_EnvironmentalandForensicsMarketMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PositionDomain_19ef9358-4641-4e9c-aff4-1eab71f1fbe7_terseLabel_en-US" xlink:label="lab_us-gaap_PositionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Position [Domain]</link:label>
    <link:label id="lab_us-gaap_PositionDomain_label_en-US" xlink:label="lab_us-gaap_PositionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Position [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PositionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PositionDomain" xlink:to="lab_us-gaap_PositionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_47e43f82-5268-43c3-879a-ba1fb14f0081_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_a_AcademiaandGovernmentMarketMember_221b0bcc-cb51-4c53-9d8c-e1a90e41c278_terseLabel_en-US" xlink:label="lab_a_AcademiaandGovernmentMarketMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Academia and Government</link:label>
    <link:label id="lab_a_AcademiaandGovernmentMarketMember_label_en-US" xlink:label="lab_a_AcademiaandGovernmentMarketMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Academia and Government Market [Member]</link:label>
    <link:label id="lab_a_AcademiaandGovernmentMarketMember_documentation_en-US" xlink:label="lab_a_AcademiaandGovernmentMarketMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Academia and Government Market [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_a_AcademiaandGovernmentMarketMember" xlink:href="a-20220131.xsd#a_AcademiaandGovernmentMarketMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_a_AcademiaandGovernmentMarketMember" xlink:to="lab_a_AcademiaandGovernmentMarketMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeNetAbstract_9995cf75-876c-4a61-bfce-0dbac76837c1_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Fair Value by Balance Sheet Location</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeNetAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Fair Value, Net [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeNetAbstract" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_f8028482-b550-4af6-8478-5d1eadfe0975_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_3664d6a6-0814-44d7-a92a-749e23e11daf_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsCurrent" xlink:to="lab_us-gaap_OtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_54d8a3e4-32c5-4126-9e6c-f7b3696c24ba_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillMember_f2ec67de-7711-46fe-bbfb-464af776602f_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_GoodwillMember_label_en-US" xlink:label="lab_us-gaap_GoodwillMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillMember" xlink:to="lab_us-gaap_GoodwillMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_77ebd293-2fe0-43e1-a3a2-893e10cb0eab_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityAbstract_18248f66-f767-40f7-854e-bc0cc33eda70_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract Liability</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityAbstract_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityAbstract" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_a_Segmentincomelossfromoperations_efb9c439-fc3c-4712-912d-199c44079c98_terseLabel_en-US" xlink:label="lab_a_Segmentincomelossfromoperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total reportable segment's income from operations</link:label>
    <link:label id="lab_a_Segmentincomelossfromoperations_label_en-US" xlink:label="lab_a_Segmentincomelossfromoperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment income (loss) from operations</link:label>
    <link:label id="lab_a_Segmentincomelossfromoperations_documentation_en-US" xlink:label="lab_a_Segmentincomelossfromoperations" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The net result for the period of deducting segment operating expenses from segment operating revenues.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_a_Segmentincomelossfromoperations" xlink:href="a-20220131.xsd#a_Segmentincomelossfromoperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_a_Segmentincomelossfromoperations" xlink:to="lab_a_Segmentincomelossfromoperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_3a68218a-cee6-49f7-8260-fd08e60a4712_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives liabilities fair value</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Fair Value, Gross Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_0dcc4953-b6b1-4ca9-ac29-d1bd29476c59_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteAbstract_09119d2f-e114-41c7-9948-72a382c14378_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note [Abstract]</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract" xlink:to="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SummaryOfNetInvestmentHedgeActivityAbstract_f84a0e30-9174-4782-b91d-679a1a2ff824_terseLabel_en-US" xlink:label="lab_us-gaap_SummaryOfNetInvestmentHedgeActivityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment Hedge</link:label>
    <link:label id="lab_us-gaap_SummaryOfNetInvestmentHedgeActivityAbstract_label_en-US" xlink:label="lab_us-gaap_SummaryOfNetInvestmentHedgeActivityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Net Investment Hedge Activity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfNetInvestmentHedgeActivityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SummaryOfNetInvestmentHedgeActivityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SummaryOfNetInvestmentHedgeActivityAbstract" xlink:to="lab_us-gaap_SummaryOfNetInvestmentHedgeActivityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_b9251837-e4ea-4f4d-b69f-e21eaba3930d_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_53e18fb9-025b-4109-837f-76ac5db5c312_verboseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_64a0cac2-6053-42b7-b1e8-aa439877319b_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill beginning balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_4e67d7e0-d45d-4c2d-938e-cfc302a0e401_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill ending balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StandardProductWarrantyAccrual_2d146544-5c8b-437a-9cdd-0a30fcc3b8d7_periodStartLabel_en-US" xlink:label="lab_us-gaap_StandardProductWarrantyAccrual" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StandardProductWarrantyAccrual_4da0a201-590a-4ea3-88b8-4f45ed3b3bdf_periodEndLabel_en-US" xlink:label="lab_us-gaap_StandardProductWarrantyAccrual" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance at end of period</link:label>
    <link:label id="lab_us-gaap_StandardProductWarrantyAccrual_label_en-US" xlink:label="lab_us-gaap_StandardProductWarrantyAccrual" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard Product Warranty Accrual</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandardProductWarrantyAccrual" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StandardProductWarrantyAccrual"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StandardProductWarrantyAccrual" xlink:to="lab_us-gaap_StandardProductWarrantyAccrual" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AociDerivativeQualifyingAsHedgeExcludedComponentParentMember_6f3c79ba-5772-4630-895f-d1f8288b0c36_terseLabel_en-US" xlink:label="lab_us-gaap_AociDerivativeQualifyingAsHedgeExcludedComponentParentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gains (Losses) on Derivatives</link:label>
    <link:label id="lab_us-gaap_AociDerivativeQualifyingAsHedgeExcludedComponentParentMember_label_en-US" xlink:label="lab_us-gaap_AociDerivativeQualifyingAsHedgeExcludedComponentParentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Derivative Qualifying as Hedge, Excluded Component, Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociDerivativeQualifyingAsHedgeExcludedComponentParentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AociDerivativeQualifyingAsHedgeExcludedComponentParentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AociDerivativeQualifyingAsHedgeExcludedComponentParentMember" xlink:to="lab_us-gaap_AociDerivativeQualifyingAsHedgeExcludedComponentParentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfSalesMember_090e1589-de88-48ad-8dbd-7da84c75fa07_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Products and Services</link:label>
    <link:label id="lab_us-gaap_CostOfSalesMember_52c5a179-d0e0-4608-816b-b429e44184e4_verboseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Products and Services</link:label>
    <link:label id="lab_us-gaap_CostOfSalesMember_label_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesMember" xlink:to="lab_us-gaap_CostOfSalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_63ee6f4f-05eb-4f10-947d-be69a2959a67_terseLabel_en-US" xlink:label="lab_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Name of Property [Domain]</link:label>
    <link:label id="lab_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_label_en-US" xlink:label="lab_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Name of Property [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain" xlink:to="lab_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax_356a2251-26e2-43e2-9388-e49b09616119_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actuarial net loss and prior service benefit reclassified, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, Reclassification Adjustment from AOCI, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansTax_193de16f-cd0d-4ac3-a0a3-cba52378817d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax on actuarial net loss and prior service benefit reclassified</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, Reclassification Adjustment from AOCI, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForwardContractsMember_fff72b87-9767-4239-b121-4968563f2d08_terseLabel_en-US" xlink:label="lab_us-gaap_ForwardContractsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward Contracts USD</link:label>
    <link:label id="lab_us-gaap_ForwardContractsMember_label_en-US" xlink:label="lab_us-gaap_ForwardContractsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward Contracts [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForwardContractsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForwardContractsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForwardContractsMember" xlink:to="lab_us-gaap_ForwardContractsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_91d7f747-21a5-46e0-805a-ddb82dda967f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in fair value (included within SG&amp;A)</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_dbd86fdd-ae5b-4ea6-a4ed-9b3d6303a984_negatedLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in fair value of contingent consideration</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_7df2ec40-5374-418c-8f50-437a8034a719_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill balances and movements for each reportable segment during the period</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_43f60efe-cbbf-49fa-a341-e5052ae98423_verboseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net income to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_fd4f4435-dc8a-4918-ab51-de9f4dbeabb3_terseLabel_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_label_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioUnspecifiedDomain" xlink:to="lab_srt_ScenarioUnspecifiedDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionPlansDefinedBenefitMember_66644601-f455-4369-96e5-4856c674a6b6_terseLabel_en-US" xlink:label="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension Plan</link:label>
    <link:label id="lab_us-gaap_PensionPlansDefinedBenefitMember_label_en-US" xlink:label="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionPlansDefinedBenefitMember" xlink:to="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_1076d579-f524-4fcf-b018-55ecfb0a0efd_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_a_AmortizationAndDeferralsAbstract_103bce2d-c308-49eb-83a2-cfd4b6a18c0c_terseLabel_en-US" xlink:label="lab_a_AmortizationAndDeferralsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization:</link:label>
    <link:label id="lab_a_AmortizationAndDeferralsAbstract_label_en-US" xlink:label="lab_a_AmortizationAndDeferralsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization and deferrals [Abstract]</link:label>
    <link:label id="lab_a_AmortizationAndDeferralsAbstract_documentation_en-US" xlink:label="lab_a_AmortizationAndDeferralsAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization and deferrals [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_a_AmortizationAndDeferralsAbstract" xlink:href="a-20220131.xsd#a_AmortizationAndDeferralsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_a_AmortizationAndDeferralsAbstract" xlink:to="lab_a_AmortizationAndDeferralsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_e01a6bfa-4714-4a97-ad60-e555a0de5c04_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross fair values and balance sheet location of derivative instruments held in the consolidated balance sheet</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DevelopedTechnologyRightsMember_24170d87-48af-435d-bbdc-ac35d470503f_terseLabel_en-US" xlink:label="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchased Technology</link:label>
    <link:label id="lab_us-gaap_DevelopedTechnologyRightsMember_label_en-US" xlink:label="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed Technology Rights [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DevelopedTechnologyRightsMember" xlink:to="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeNetLiabilityPositionAggregateFairValue_22eb858d-1985-4e3b-9c6f-7edc912293b8_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNetLiabilityPositionAggregateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate fair value of all derivative instruments with credit-risk-related contingent features that were in a net liability position</link:label>
    <link:label id="lab_us-gaap_DerivativeNetLiabilityPositionAggregateFairValue_label_en-US" xlink:label="lab_us-gaap_DerivativeNetLiabilityPositionAggregateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Net Liability Position, Aggregate Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNetLiabilityPositionAggregateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeNetLiabilityPositionAggregateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNetLiabilityPositionAggregateFairValue" xlink:to="lab_us-gaap_DerivativeNetLiabilityPositionAggregateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_3f6af3d5-0331-4bb6-a16c-a3eeb5659631_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtTextBlock_79d69562-26fc-4d4b-a0a9-269299840770_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LONG-TERM DEBT</link:label>
    <link:label id="lab_us-gaap_LongTermDebtTextBlock_label_en-US" xlink:label="lab_us-gaap_LongTermDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtTextBlock" xlink:to="lab_us-gaap_LongTermDebtTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination_5a7ed5d1-1a10-4bdb-9cf5-534950d89599_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract liabilities acquired in business combinations</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Increase (Decrease) for Contract Acquired in Business Combination</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_64841a46-d2c5-4e7e-9e7d-704680a7573d_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_a_LtppMember_0af5787f-f0e8-4840-8eaa-856bd84f5de2_terseLabel_en-US" xlink:label="lab_a_LtppMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LTPP</link:label>
    <link:label id="lab_a_LtppMember_label_en-US" xlink:label="lab_a_LtppMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LTPP [Member]</link:label>
    <link:label id="lab_a_LtppMember_documentation_en-US" xlink:label="lab_a_LtppMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long Term Performance Plan.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_a_LtppMember" xlink:href="a-20220131.xsd#a_LtppMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_a_LtppMember" xlink:to="lab_a_LtppMember" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_XXX_2e7e983f-2ac9-4754-b559-4ae3216f97ae_terseLabel_en-US" xlink:label="lab_currency_XXX" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_currency_XXX_label_en-US" xlink:label="lab_currency_XXX" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">No currency</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_XXX" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_XXX"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_XXX" xlink:to="lab_currency_XXX" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>10
<FILENAME>a-20220131_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:b57f1026-9350-4429-b363-875dec110646,g:1024445c-b98f-4ee2-b278-e07339a70979-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.agilent.com/role/DocumentandEntityInformation" xlink:type="simple" xlink:href="a-20220131.xsd#DocumentandEntityInformation"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/DocumentandEntityInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_a_DocumentAndEntityInformationAbstract_efea542b-7360-4f6d-910d-39cd002fec6c" xlink:href="a-20220131.xsd#a_DocumentAndEntityInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_d8807e18-0408-442d-90ad-dafd2811a109" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_a_DocumentAndEntityInformationAbstract_efea542b-7360-4f6d-910d-39cd002fec6c" xlink:to="loc_dei_EntityRegistrantName_d8807e18-0408-442d-90ad-dafd2811a109" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_4ea3d53a-4632-4e52-9a39-86ee71879ee4" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_a_DocumentAndEntityInformationAbstract_efea542b-7360-4f6d-910d-39cd002fec6c" xlink:to="loc_dei_DocumentType_4ea3d53a-4632-4e52-9a39-86ee71879ee4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_07341857-2b2b-41ae-b013-5c7c571b8d0f" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_a_DocumentAndEntityInformationAbstract_efea542b-7360-4f6d-910d-39cd002fec6c" xlink:to="loc_dei_DocumentFiscalPeriodFocus_07341857-2b2b-41ae-b013-5c7c571b8d0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_6d216f31-733f-4e3b-8ccb-d04ef4b45684" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_a_DocumentAndEntityInformationAbstract_efea542b-7360-4f6d-910d-39cd002fec6c" xlink:to="loc_dei_DocumentPeriodEndDate_6d216f31-733f-4e3b-8ccb-d04ef4b45684" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_a6d2d087-7911-4d67-9691-f11dfbee2563" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_a_DocumentAndEntityInformationAbstract_efea542b-7360-4f6d-910d-39cd002fec6c" xlink:to="loc_dei_CurrentFiscalYearEndDate_a6d2d087-7911-4d67-9691-f11dfbee2563" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_46fade24-a91c-40fc-97f0-93a287040b54" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_a_DocumentAndEntityInformationAbstract_efea542b-7360-4f6d-910d-39cd002fec6c" xlink:to="loc_dei_DocumentFiscalYearFocus_46fade24-a91c-40fc-97f0-93a287040b54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_49fdee65-7e07-4ead-b099-365c857c6c61" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_a_DocumentAndEntityInformationAbstract_efea542b-7360-4f6d-910d-39cd002fec6c" xlink:to="loc_dei_AmendmentFlag_49fdee65-7e07-4ead-b099-365c857c6c61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_8482ef5d-f937-4ce3-aa73-fde44b83b204" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_a_DocumentAndEntityInformationAbstract_efea542b-7360-4f6d-910d-39cd002fec6c" xlink:to="loc_dei_DocumentQuarterlyReport_8482ef5d-f937-4ce3-aa73-fde44b83b204" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_c689993e-7dd4-41e7-9190-6c1f151b758e" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_a_DocumentAndEntityInformationAbstract_efea542b-7360-4f6d-910d-39cd002fec6c" xlink:to="loc_dei_DocumentTransitionReport_c689993e-7dd4-41e7-9190-6c1f151b758e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_a9102029-f537-4a92-ac6d-b0a5c50daf0c" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_a_DocumentAndEntityInformationAbstract_efea542b-7360-4f6d-910d-39cd002fec6c" xlink:to="loc_dei_EntityCentralIndexKey_a9102029-f537-4a92-ac6d-b0a5c50daf0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_94686835-5d26-4645-ba1b-f6494c09792a" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_a_DocumentAndEntityInformationAbstract_efea542b-7360-4f6d-910d-39cd002fec6c" xlink:to="loc_dei_EntityFileNumber_94686835-5d26-4645-ba1b-f6494c09792a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_7dff4841-ea5d-43c1-94b5-d0b93d1462e5" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_a_DocumentAndEntityInformationAbstract_efea542b-7360-4f6d-910d-39cd002fec6c" xlink:to="loc_dei_EntityIncorporationStateCountryCode_7dff4841-ea5d-43c1-94b5-d0b93d1462e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_6153731b-b202-4088-bc51-88287ab331ac" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_a_DocumentAndEntityInformationAbstract_efea542b-7360-4f6d-910d-39cd002fec6c" xlink:to="loc_dei_EntityTaxIdentificationNumber_6153731b-b202-4088-bc51-88287ab331ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_ff07f82a-78ee-4ba4-93eb-9eef295d6063" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_a_DocumentAndEntityInformationAbstract_efea542b-7360-4f6d-910d-39cd002fec6c" xlink:to="loc_dei_EntityAddressAddressLine1_ff07f82a-78ee-4ba4-93eb-9eef295d6063" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_977c5a46-2d92-4adc-ab0e-14cb82e2dae9" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_a_DocumentAndEntityInformationAbstract_efea542b-7360-4f6d-910d-39cd002fec6c" xlink:to="loc_dei_EntityAddressCityOrTown_977c5a46-2d92-4adc-ab0e-14cb82e2dae9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_57614021-a427-482c-8f6a-1e8877b64b75" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_a_DocumentAndEntityInformationAbstract_efea542b-7360-4f6d-910d-39cd002fec6c" xlink:to="loc_dei_EntityAddressStateOrProvince_57614021-a427-482c-8f6a-1e8877b64b75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_3a05b0f9-cbc1-498f-9b73-61c62595db96" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_a_DocumentAndEntityInformationAbstract_efea542b-7360-4f6d-910d-39cd002fec6c" xlink:to="loc_dei_EntityAddressPostalZipCode_3a05b0f9-cbc1-498f-9b73-61c62595db96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_d17fe47a-17e5-4efb-a3bb-c5a44c1df771" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_a_DocumentAndEntityInformationAbstract_efea542b-7360-4f6d-910d-39cd002fec6c" xlink:to="loc_dei_CityAreaCode_d17fe47a-17e5-4efb-a3bb-c5a44c1df771" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_55480be4-ccfe-4eec-9da0-552664c99f17" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_a_DocumentAndEntityInformationAbstract_efea542b-7360-4f6d-910d-39cd002fec6c" xlink:to="loc_dei_LocalPhoneNumber_55480be4-ccfe-4eec-9da0-552664c99f17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_7240282e-2aca-4b65-87d6-06e73268ad75" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_a_DocumentAndEntityInformationAbstract_efea542b-7360-4f6d-910d-39cd002fec6c" xlink:to="loc_dei_Security12bTitle_7240282e-2aca-4b65-87d6-06e73268ad75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_b72ff3cb-df10-4f7e-83f4-cd4af3c25c2e" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_a_DocumentAndEntityInformationAbstract_efea542b-7360-4f6d-910d-39cd002fec6c" xlink:to="loc_dei_TradingSymbol_b72ff3cb-df10-4f7e-83f4-cd4af3c25c2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_4f66e3fa-e109-4ba0-a8c4-c8fa772abcf0" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_a_DocumentAndEntityInformationAbstract_efea542b-7360-4f6d-910d-39cd002fec6c" xlink:to="loc_dei_SecurityExchangeName_4f66e3fa-e109-4ba0-a8c4-c8fa772abcf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_1bf8a8d6-2428-4ff5-ba36-d44363f8d4b4" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_a_DocumentAndEntityInformationAbstract_efea542b-7360-4f6d-910d-39cd002fec6c" xlink:to="loc_dei_EntityCurrentReportingStatus_1bf8a8d6-2428-4ff5-ba36-d44363f8d4b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_bbf63a04-1f07-421f-8a96-9c52b74bc3c9" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_a_DocumentAndEntityInformationAbstract_efea542b-7360-4f6d-910d-39cd002fec6c" xlink:to="loc_dei_EntityInteractiveDataCurrent_bbf63a04-1f07-421f-8a96-9c52b74bc3c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_f2deaa47-bb02-48ac-a153-2e7b35544dbc" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_a_DocumentAndEntityInformationAbstract_efea542b-7360-4f6d-910d-39cd002fec6c" xlink:to="loc_dei_EntityFilerCategory_f2deaa47-bb02-48ac-a153-2e7b35544dbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_8803ab54-46ba-4cbf-a46c-dfdd401a6c18" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_a_DocumentAndEntityInformationAbstract_efea542b-7360-4f6d-910d-39cd002fec6c" xlink:to="loc_dei_EntitySmallBusiness_8803ab54-46ba-4cbf-a46c-dfdd401a6c18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_d105cba7-56ce-4cbe-818f-c9b894c400cc" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_a_DocumentAndEntityInformationAbstract_efea542b-7360-4f6d-910d-39cd002fec6c" xlink:to="loc_dei_EntityEmergingGrowthCompany_d105cba7-56ce-4cbe-818f-c9b894c400cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_edab44c4-d394-46aa-828d-9e0d575d48ba" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_a_DocumentAndEntityInformationAbstract_efea542b-7360-4f6d-910d-39cd002fec6c" xlink:to="loc_dei_EntityShellCompany_edab44c4-d394-46aa-828d-9e0d575d48ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_530d1af1-4723-4e51-8aa1-338e3a89efca" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_a_DocumentAndEntityInformationAbstract_efea542b-7360-4f6d-910d-39cd002fec6c" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_530d1af1-4723-4e51-8aa1-338e3a89efca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFOPERATIONSUnaudited" xlink:type="simple" xlink:href="a-20220131.xsd#CONDENSEDCONSOLIDATEDSTATEMENTOFOPERATIONSUnaudited"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFOPERATIONSUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_f8453f21-5c1f-4531-8caf-ac88a1e08814" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_9cedc1e8-eb8b-4c3c-bfbc-99a0a58da296" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_f8453f21-5c1f-4531-8caf-ac88a1e08814" xlink:to="loc_us-gaap_StatementTable_9cedc1e8-eb8b-4c3c-bfbc-99a0a58da296" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_e16bf9ad-9689-4ea8-9f2e-ba4fd6fd874d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_9cedc1e8-eb8b-4c3c-bfbc-99a0a58da296" xlink:to="loc_srt_ProductOrServiceAxis_e16bf9ad-9689-4ea8-9f2e-ba4fd6fd874d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_70839715-aaee-4a36-85f4-df9607d9af8f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_e16bf9ad-9689-4ea8-9f2e-ba4fd6fd874d" xlink:to="loc_srt_ProductsAndServicesDomain_70839715-aaee-4a36-85f4-df9607d9af8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_bea291c5-c5ef-4a33-9609-33932ddb7596" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_70839715-aaee-4a36-85f4-df9607d9af8f" xlink:to="loc_us-gaap_ProductMember_bea291c5-c5ef-4a33-9609-33932ddb7596" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceOtherMember_f046dcb6-6be0-4861-884b-6158352eb6e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ServiceOtherMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_70839715-aaee-4a36-85f4-df9607d9af8f" xlink:to="loc_us-gaap_ServiceOtherMember_f046dcb6-6be0-4861-884b-6158352eb6e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_bb98c24c-55c8-4773-9b6e-1fd41772a643" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_9cedc1e8-eb8b-4c3c-bfbc-99a0a58da296" xlink:to="loc_srt_StatementScenarioAxis_bb98c24c-55c8-4773-9b6e-1fd41772a643" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_86c45af7-4f96-4c5e-8696-cf3758169950" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_bb98c24c-55c8-4773-9b6e-1fd41772a643" xlink:to="loc_srt_ScenarioUnspecifiedDomain_86c45af7-4f96-4c5e-8696-cf3758169950" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_cf766036-7f5e-45d2-a6ba-3049e98bf698" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_9cedc1e8-eb8b-4c3c-bfbc-99a0a58da296" xlink:to="loc_us-gaap_StatementLineItems_cf766036-7f5e-45d2-a6ba-3049e98bf698" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_a271fe1a-4591-4718-9b12-7c48cfa59440" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_cf766036-7f5e-45d2-a6ba-3049e98bf698" xlink:to="loc_us-gaap_RevenuesAbstract_a271fe1a-4591-4718-9b12-7c48cfa59440" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_438f2f7f-8050-4ed5-a4aa-296c234e4a02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_a271fe1a-4591-4718-9b12-7c48cfa59440" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_438f2f7f-8050-4ed5-a4aa-296c234e4a02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpensesAbstract_79f03798-3819-45d6-b128-088541d14a53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpensesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_cf766036-7f5e-45d2-a6ba-3049e98bf698" xlink:to="loc_us-gaap_CostsAndExpensesAbstract_79f03798-3819-45d6-b128-088541d14a53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_94a3d43a-e006-455f-9c8c-dd01ea6d9e28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_79f03798-3819-45d6-b128-088541d14a53" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_94a3d43a-e006-455f-9c8c-dd01ea6d9e28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_bd732b96-3d02-4553-9aa3-471689370ade" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_79f03798-3819-45d6-b128-088541d14a53" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_bd732b96-3d02-4553-9aa3-471689370ade" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_77cecce3-ab10-46a7-b6a6-af88d5a7e5fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_79f03798-3819-45d6-b128-088541d14a53" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_77cecce3-ab10-46a7-b6a6-af88d5a7e5fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_b64f4ac8-5e7e-4a09-8c8f-24414d9f9154" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_79f03798-3819-45d6-b128-088541d14a53" xlink:to="loc_us-gaap_CostsAndExpenses_b64f4ac8-5e7e-4a09-8c8f-24414d9f9154" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_3fcb1381-7dfb-4877-b69f-b27b9ccd3601" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_cf766036-7f5e-45d2-a6ba-3049e98bf698" xlink:to="loc_us-gaap_OperatingIncomeLoss_3fcb1381-7dfb-4877-b69f-b27b9ccd3601" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_635545ab-6db9-4da0-b850-f0ef720048d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_cf766036-7f5e-45d2-a6ba-3049e98bf698" xlink:to="loc_us-gaap_InvestmentIncomeInterest_635545ab-6db9-4da0-b850-f0ef720048d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_a8699c62-0a63-40a2-b5be-afcc1c83f72d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_cf766036-7f5e-45d2-a6ba-3049e98bf698" xlink:to="loc_us-gaap_InterestExpense_a8699c62-0a63-40a2-b5be-afcc1c83f72d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_1a0f235f-4170-4daf-b3c0-13262fd7854b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_cf766036-7f5e-45d2-a6ba-3049e98bf698" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_1a0f235f-4170-4daf-b3c0-13262fd7854b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_dbdda36d-f5d5-4291-9cfd-9655186b82f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_cf766036-7f5e-45d2-a6ba-3049e98bf698" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_dbdda36d-f5d5-4291-9cfd-9655186b82f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_d03caf00-6866-414b-b8bf-5d60eb907d14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_cf766036-7f5e-45d2-a6ba-3049e98bf698" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_d03caf00-6866-414b-b8bf-5d60eb907d14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_62b9b217-f31e-4dc1-95dc-188d54dc5411" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_cf766036-7f5e-45d2-a6ba-3049e98bf698" xlink:to="loc_us-gaap_NetIncomeLoss_62b9b217-f31e-4dc1-95dc-188d54dc5411" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_eb6b8b12-90dc-4745-b4e3-795191821cec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_cf766036-7f5e-45d2-a6ba-3049e98bf698" xlink:to="loc_us-gaap_EarningsPerShareAbstract_eb6b8b12-90dc-4745-b4e3-795191821cec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_dbf9dcb5-1502-4d57-8665-1c630e26d1c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_eb6b8b12-90dc-4745-b4e3-795191821cec" xlink:to="loc_us-gaap_EarningsPerShareBasic_dbf9dcb5-1502-4d57-8665-1c630e26d1c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_228aa287-7654-4985-b093-47060de60363" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_eb6b8b12-90dc-4745-b4e3-795191821cec" xlink:to="loc_us-gaap_EarningsPerShareDiluted_228aa287-7654-4985-b093-47060de60363" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_5528dc8f-8d46-46b9-b7fe-e6a16a9e019a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_cf766036-7f5e-45d2-a6ba-3049e98bf698" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_5528dc8f-8d46-46b9-b7fe-e6a16a9e019a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_a928db04-6239-41bc-bab9-15712b3af342" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_5528dc8f-8d46-46b9-b7fe-e6a16a9e019a" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_a928db04-6239-41bc-bab9-15712b3af342" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_b3218191-6567-4b03-9951-eea46bc50ae9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_5528dc8f-8d46-46b9-b7fe-e6a16a9e019a" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_b3218191-6567-4b03-9951-eea46bc50ae9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOMEUnaudited" xlink:type="simple" xlink:href="a-20220131.xsd#CONDENSEDCONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOMEUnaudited"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOMEUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_261a2827-0e74-4429-9abe-5fa971822621" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_004dc904-4b2c-452d-9432-682064637979" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_261a2827-0e74-4429-9abe-5fa971822621" xlink:to="loc_us-gaap_StatementTable_004dc904-4b2c-452d-9432-682064637979" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_7b4926ee-dbbd-4df6-84a6-2b577d41061e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_004dc904-4b2c-452d-9432-682064637979" xlink:to="loc_srt_StatementScenarioAxis_7b4926ee-dbbd-4df6-84a6-2b577d41061e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_61215f8e-ecd3-46fb-bc73-83e4768553f4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_7b4926ee-dbbd-4df6-84a6-2b577d41061e" xlink:to="loc_srt_ScenarioUnspecifiedDomain_61215f8e-ecd3-46fb-bc73-83e4768553f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_4bbde4ba-8ee0-49a1-9fb9-6018b7a019be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_004dc904-4b2c-452d-9432-682064637979" xlink:to="loc_us-gaap_StatementLineItems_4bbde4ba-8ee0-49a1-9fb9-6018b7a019be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_3bebd609-9d38-4052-b488-9d30da030355" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4bbde4ba-8ee0-49a1-9fb9-6018b7a019be" xlink:to="loc_us-gaap_NetIncomeLoss_3bebd609-9d38-4052-b488-9d30da030355" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_a747e38a-a1d8-405c-badd-079c73778844" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4bbde4ba-8ee0-49a1-9fb9-6018b7a019be" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_a747e38a-a1d8-405c-badd-079c73778844" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_cc6b2138-6d4d-4d24-8187-5cd4d76825aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_a747e38a-a1d8-405c-badd-079c73778844" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_cc6b2138-6d4d-4d24-8187-5cd4d76825aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_b50258b2-acc2-44ec-8b2a-e539738fb081" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_a747e38a-a1d8-405c-badd-079c73778844" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_b50258b2-acc2-44ec-8b2a-e539738fb081" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_799de47d-3393-40f5-bf02-9267bcec5465" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_a747e38a-a1d8-405c-badd-079c73778844" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_799de47d-3393-40f5-bf02-9267bcec5465" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract_0ebff38d-b507-49e8-9528-7961e3fab8ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_a747e38a-a1d8-405c-badd-079c73778844" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract_0ebff38d-b507-49e8-9528-7961e3fab8ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_74642272-8fd2-4c79-b51c-887ece339632" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract_0ebff38d-b507-49e8-9528-7961e3fab8ff" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_74642272-8fd2-4c79-b51c-887ece339632" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_42648f95-e6cb-4139-ba5d-feb3b92277e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_a747e38a-a1d8-405c-badd-079c73778844" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_42648f95-e6cb-4139-ba5d-feb3b92277e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_ab367f8b-911b-4ccc-b0e9-37fab0b6a8a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4bbde4ba-8ee0-49a1-9fb9-6018b7a019be" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_ab367f8b-911b-4ccc-b0e9-37fab0b6a8a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOMELOSSUnauditedParenthetical" xlink:type="simple" xlink:href="a-20220131.xsd#CONDENSEDCONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOMELOSSUnauditedParenthetical"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOMELOSSUnauditedParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_54a4edf7-1257-422d-87b8-3e79182dede9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_c13bc22f-9f30-4d74-945d-e5485ac029d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_54a4edf7-1257-422d-87b8-3e79182dede9" xlink:to="loc_us-gaap_StatementTable_c13bc22f-9f30-4d74-945d-e5485ac029d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_295f6e22-436d-4c32-bb71-da4aac858182" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_c13bc22f-9f30-4d74-945d-e5485ac029d4" xlink:to="loc_srt_StatementScenarioAxis_295f6e22-436d-4c32-bb71-da4aac858182" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_238a4823-bcc8-483e-9823-195186ba2673" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_295f6e22-436d-4c32-bb71-da4aac858182" xlink:to="loc_srt_ScenarioUnspecifiedDomain_238a4823-bcc8-483e-9823-195186ba2673" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_f64d437c-b537-4659-884e-353db743575f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_c13bc22f-9f30-4d74-945d-e5485ac029d4" xlink:to="loc_us-gaap_StatementLineItems_f64d437c-b537-4659-884e-353db743575f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTaxParentheticalDisclosuresAbstract_00c4862d-adae-4190-8faa-84b20f960196" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossTaxParentheticalDisclosuresAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f64d437c-b537-4659-884e-353db743575f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossTaxParentheticalDisclosuresAbstract_00c4862d-adae-4190-8faa-84b20f960196" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_898d1b0e-129d-4b15-a9c0-1f09fde50b4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTaxParentheticalDisclosuresAbstract_00c4862d-adae-4190-8faa-84b20f960196" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_898d1b0e-129d-4b15-a9c0-1f09fde50b4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_0258559a-5fef-45d0-b1b2-a40aa6bf1796" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTaxParentheticalDisclosuresAbstract_00c4862d-adae-4190-8faa-84b20f960196" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_0258559a-5fef-45d0-b1b2-a40aa6bf1796" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_d0254e1b-c77d-4f76-8a64-2fbbd6c22159" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTaxParentheticalDisclosuresAbstract_00c4862d-adae-4190-8faa-84b20f960196" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_d0254e1b-c77d-4f76-8a64-2fbbd6c22159" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansTaxAbstract_2e78f946-5f54-4fac-af7f-2f08e518821b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansTaxAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTaxParentheticalDisclosuresAbstract_00c4862d-adae-4190-8faa-84b20f960196" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansTaxAbstract_2e78f946-5f54-4fac-af7f-2f08e518821b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax_21522ef6-74db-4ced-8569-e710a717b993" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansTaxAbstract_2e78f946-5f54-4fac-af7f-2f08e518821b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax_21522ef6-74db-4ced-8569-e710a717b993" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax_942045d4-efb3-474b-b781-3a041deb6bcd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansTaxAbstract_2e78f946-5f54-4fac-af7f-2f08e518821b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax_942045d4-efb3-474b-b781-3a041deb6bcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited" xlink:type="simple" xlink:href="a-20220131.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_ad5ea253-2931-42ac-b916-f290d2e7ee66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_30bd3115-1e1b-459b-a157-ee47df589532" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_ad5ea253-2931-42ac-b916-f290d2e7ee66" xlink:to="loc_us-gaap_StatementTable_30bd3115-1e1b-459b-a157-ee47df589532" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_1a6af245-e71b-4511-b19c-a384d47f43c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_30bd3115-1e1b-459b-a157-ee47df589532" xlink:to="loc_us-gaap_StatementClassOfStockAxis_1a6af245-e71b-4511-b19c-a384d47f43c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_991e4e67-6162-4f73-aae2-1a6e6a8cf4ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1a6af245-e71b-4511-b19c-a384d47f43c2" xlink:to="loc_us-gaap_ClassOfStockDomain_991e4e67-6162-4f73-aae2-1a6e6a8cf4ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_e2994a49-9ac3-4820-a4c6-b6deaea69909" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_30bd3115-1e1b-459b-a157-ee47df589532" xlink:to="loc_us-gaap_StatementLineItems_e2994a49-9ac3-4820-a4c6-b6deaea69909" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_0f36deb9-4f87-441b-9efc-50fb73a2ec92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e2994a49-9ac3-4820-a4c6-b6deaea69909" xlink:to="loc_us-gaap_AssetsAbstract_0f36deb9-4f87-441b-9efc-50fb73a2ec92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_7291e9f2-046e-434c-9b32-18d130acdbb8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_0f36deb9-4f87-441b-9efc-50fb73a2ec92" xlink:to="loc_us-gaap_AssetsCurrentAbstract_7291e9f2-046e-434c-9b32-18d130acdbb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_ca2c8a62-9409-470c-929c-47633bc15b01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_7291e9f2-046e-434c-9b32-18d130acdbb8" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_ca2c8a62-9409-470c-929c-47633bc15b01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_6667946e-11b8-4442-9247-c665f63a0f10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_7291e9f2-046e-434c-9b32-18d130acdbb8" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_6667946e-11b8-4442-9247-c665f63a0f10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_c7c27ab2-480a-4301-b168-6bb3a9e4aada" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_7291e9f2-046e-434c-9b32-18d130acdbb8" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_c7c27ab2-480a-4301-b168-6bb3a9e4aada" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_52870b8b-ad0f-4b51-97a7-222d85aea872" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_7291e9f2-046e-434c-9b32-18d130acdbb8" xlink:to="loc_us-gaap_InventoryNet_52870b8b-ad0f-4b51-97a7-222d85aea872" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_428f558e-1dc3-48ed-b92f-79472a8e3f89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_7291e9f2-046e-434c-9b32-18d130acdbb8" xlink:to="loc_us-gaap_OtherAssetsCurrent_428f558e-1dc3-48ed-b92f-79472a8e3f89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_115577d3-be28-4b5b-8c7b-563211abbf12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_7291e9f2-046e-434c-9b32-18d130acdbb8" xlink:to="loc_us-gaap_AssetsCurrent_115577d3-be28-4b5b-8c7b-563211abbf12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_6eb17bf6-be39-407a-b074-04f8cb6f2d5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_0f36deb9-4f87-441b-9efc-50fb73a2ec92" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_6eb17bf6-be39-407a-b074-04f8cb6f2d5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_f5a09286-c944-4347-8eb2-eb9f606a3e81" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_0f36deb9-4f87-441b-9efc-50fb73a2ec92" xlink:to="loc_us-gaap_Goodwill_f5a09286-c944-4347-8eb2-eb9f606a3e81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_c6fda761-6980-4165-a4f3-7d6afefa0791" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_0f36deb9-4f87-441b-9efc-50fb73a2ec92" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_c6fda761-6980-4165-a4f3-7d6afefa0791" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestments_2c894e43-4959-4ab1-bb02-d5f4512691e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermInvestments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_0f36deb9-4f87-441b-9efc-50fb73a2ec92" xlink:to="loc_us-gaap_LongTermInvestments_2c894e43-4959-4ab1-bb02-d5f4512691e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_65bf2a09-9231-4ebd-9d4b-4be1b1929ec0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_0f36deb9-4f87-441b-9efc-50fb73a2ec92" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_65bf2a09-9231-4ebd-9d4b-4be1b1929ec0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_16fe8a1f-629f-42f4-a798-5893295ed1f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_0f36deb9-4f87-441b-9efc-50fb73a2ec92" xlink:to="loc_us-gaap_Assets_16fe8a1f-629f-42f4-a798-5893295ed1f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_ffae9b6c-a54b-47c3-b4d3-6e8435780e11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e2994a49-9ac3-4820-a4c6-b6deaea69909" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_ffae9b6c-a54b-47c3-b4d3-6e8435780e11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_7dc437b1-1e29-499e-a526-1c02176003a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_ffae9b6c-a54b-47c3-b4d3-6e8435780e11" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_7dc437b1-1e29-499e-a526-1c02176003a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_6cd0986b-3b49-456d-a225-1deb2c61ca6b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_7dc437b1-1e29-499e-a526-1c02176003a6" xlink:to="loc_us-gaap_AccountsPayableCurrent_6cd0986b-3b49-456d-a225-1deb2c61ca6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_f38e965b-8dd3-4c05-8542-b36ab9305112" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_7dc437b1-1e29-499e-a526-1c02176003a6" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_f38e965b-8dd3-4c05-8542-b36ab9305112" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueCurrent_72aea0c2-4c18-402c-89a9-9e8774671467" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredRevenueCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_7dc437b1-1e29-499e-a526-1c02176003a6" xlink:to="loc_us-gaap_DeferredRevenueCurrent_72aea0c2-4c18-402c-89a9-9e8774671467" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent_34d4633e-4dec-4fee-8026-5d54c08a4ffc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_7dc437b1-1e29-499e-a526-1c02176003a6" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent_34d4633e-4dec-4fee-8026-5d54c08a4ffc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_e05dba75-bf15-4036-9d71-3121ef91ce7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_7dc437b1-1e29-499e-a526-1c02176003a6" xlink:to="loc_us-gaap_LiabilitiesCurrent_e05dba75-bf15-4036-9d71-3121ef91ce7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_20d282c9-7212-460d-9ece-0dfae4a2c8d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_ffae9b6c-a54b-47c3-b4d3-6e8435780e11" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_20d282c9-7212-460d-9ece-0dfae4a2c8d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_e4da3c7d-4cc8-4bc3-b9ff-5896b7c080f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_ffae9b6c-a54b-47c3-b4d3-6e8435780e11" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_e4da3c7d-4cc8-4bc3-b9ff-5896b7c080f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_854f4d09-7cf3-44ed-bc0a-bb6c6f4a4c8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_ffae9b6c-a54b-47c3-b4d3-6e8435780e11" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_854f4d09-7cf3-44ed-bc0a-bb6c6f4a4c8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_69467984-f991-495f-860e-4759dc70340b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_ffae9b6c-a54b-47c3-b4d3-6e8435780e11" xlink:to="loc_us-gaap_Liabilities_69467984-f991-495f-860e-4759dc70340b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_77ee76ef-0671-4e63-a831-599d67091cf1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_ffae9b6c-a54b-47c3-b4d3-6e8435780e11" xlink:to="loc_us-gaap_CommitmentsAndContingencies_77ee76ef-0671-4e63-a831-599d67091cf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_6c7b17e3-40e1-4300-a51f-0f6e365b8e39" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_ffae9b6c-a54b-47c3-b4d3-6e8435780e11" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_6c7b17e3-40e1-4300-a51f-0f6e365b8e39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_3a2765af-6984-4648-a15b-07009544f4d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_6c7b17e3-40e1-4300-a51f-0f6e365b8e39" xlink:to="loc_us-gaap_StockholdersEquityAbstract_3a2765af-6984-4648-a15b-07009544f4d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_a702605e-8e96-4c31-97b8-e86c7b2a4814" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_3a2765af-6984-4648-a15b-07009544f4d1" xlink:to="loc_us-gaap_PreferredStockValue_a702605e-8e96-4c31-97b8-e86c7b2a4814" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_8893b904-ce7f-4e7a-b0b7-fc7ea4e33f24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_3a2765af-6984-4648-a15b-07009544f4d1" xlink:to="loc_us-gaap_CommonStockValue_8893b904-ce7f-4e7a-b0b7-fc7ea4e33f24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_86695a4a-f947-42e4-a4c0-67ceb1b870db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_3a2765af-6984-4648-a15b-07009544f4d1" xlink:to="loc_us-gaap_AdditionalPaidInCapital_86695a4a-f947-42e4-a4c0-67ceb1b870db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_025ccf0f-af81-4501-8647-4fcfeed73e08" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_3a2765af-6984-4648-a15b-07009544f4d1" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_025ccf0f-af81-4501-8647-4fcfeed73e08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_29ee8cf5-d463-4c15-8026-edb9fb94bdae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_3a2765af-6984-4648-a15b-07009544f4d1" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_29ee8cf5-d463-4c15-8026-edb9fb94bdae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_451f7c55-e40a-4959-aaa1-1e3f8ce5b0d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_3a2765af-6984-4648-a15b-07009544f4d1" xlink:to="loc_us-gaap_StockholdersEquity_451f7c55-e40a-4959-aaa1-1e3f8ce5b0d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_2c295f85-e220-4580-8d89-7aa7de8485dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_ffae9b6c-a54b-47c3-b4d3-6e8435780e11" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_2c295f85-e220-4580-8d89-7aa7de8485dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnauditedParenthetical" xlink:type="simple" xlink:href="a-20220131.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETUnauditedParenthetical"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnauditedParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_354fc3b5-2a99-404a-81e3-9bdbc9e65c9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_52d9cd0c-8f7b-4342-bdf7-98d216c3f309" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_354fc3b5-2a99-404a-81e3-9bdbc9e65c9d" xlink:to="loc_us-gaap_StockholdersEquityAbstract_52d9cd0c-8f7b-4342-bdf7-98d216c3f309" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_d21836d2-a04a-4939-a3aa-b91674d9d064" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_52d9cd0c-8f7b-4342-bdf7-98d216c3f309" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_d21836d2-a04a-4939-a3aa-b91674d9d064" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_eaa1460d-12b1-47f5-a54a-a50b73067f06" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_52d9cd0c-8f7b-4342-bdf7-98d216c3f309" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_eaa1460d-12b1-47f5-a54a-a50b73067f06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_958aa036-c730-4802-bdc2-483192a846f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_52d9cd0c-8f7b-4342-bdf7-98d216c3f309" xlink:to="loc_us-gaap_PreferredStockSharesIssued_958aa036-c730-4802-bdc2-483192a846f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_6a920338-c9d9-4e47-9aba-04148f521fd4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_52d9cd0c-8f7b-4342-bdf7-98d216c3f309" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_6a920338-c9d9-4e47-9aba-04148f521fd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_4ecde989-ac3e-4274-b5c0-1e810ac24af1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_52d9cd0c-8f7b-4342-bdf7-98d216c3f309" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_4ecde989-ac3e-4274-b5c0-1e810ac24af1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_951a177c-8c7d-4102-8b9a-3f6b0ff8ec31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_52d9cd0c-8f7b-4342-bdf7-98d216c3f309" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_951a177c-8c7d-4102-8b9a-3f6b0ff8ec31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_e9836b7a-c9ae-40ab-bf38-a0170e45c633" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_52d9cd0c-8f7b-4342-bdf7-98d216c3f309" xlink:to="loc_us-gaap_CommonStockSharesIssued_e9836b7a-c9ae-40ab-bf38-a0170e45c633" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_f214a5e9-2faf-47c7-bfec-07b542565fde" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_52d9cd0c-8f7b-4342-bdf7-98d216c3f309" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_f214a5e9-2faf-47c7-bfec-07b542565fde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited" xlink:type="simple" xlink:href="a-20220131.xsd#CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_bb9c7826-d072-4d17-94ef-27b449b73260" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_9c77f225-449e-432e-bc67-25e9b382faf9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_bb9c7826-d072-4d17-94ef-27b449b73260" xlink:to="loc_us-gaap_StatementTable_9c77f225-449e-432e-bc67-25e9b382faf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_c171ad26-c12c-4ff1-8c5c-30ec9c3864b0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_9c77f225-449e-432e-bc67-25e9b382faf9" xlink:to="loc_srt_StatementScenarioAxis_c171ad26-c12c-4ff1-8c5c-30ec9c3864b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_dfb2b68d-f11a-4491-a74b-4dabbdb0b9db" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_c171ad26-c12c-4ff1-8c5c-30ec9c3864b0" xlink:to="loc_srt_ScenarioUnspecifiedDomain_dfb2b68d-f11a-4491-a74b-4dabbdb0b9db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_7a8439bf-b07e-4f15-9ce2-a3c5c96e3e4f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_9c77f225-449e-432e-bc67-25e9b382faf9" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_7a8439bf-b07e-4f15-9ce2-a3c5c96e3e4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_e7529213-fe0b-45c1-a420-266bf161382b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_7a8439bf-b07e-4f15-9ce2-a3c5c96e3e4f" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_e7529213-fe0b-45c1-a420-266bf161382b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentMember_22abe160-6f56-41c5-92c3-039adb4f6475" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_e7529213-fe0b-45c1-a420-266bf161382b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentMember_22abe160-6f56-41c5-92c3-039adb4f6475" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_4a1bf905-f8d1-4261-a3f6-9eb0133adddc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_9c77f225-449e-432e-bc67-25e9b382faf9" xlink:to="loc_us-gaap_StatementLineItems_4a1bf905-f8d1-4261-a3f6-9eb0133adddc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_9979f334-f745-4530-a031-fc1d0478379b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4a1bf905-f8d1-4261-a3f6-9eb0133adddc" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_9979f334-f745-4530-a031-fc1d0478379b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_a0560543-5ed2-42ed-b3e5-10f2f286e41a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_9979f334-f745-4530-a031-fc1d0478379b" xlink:to="loc_us-gaap_NetIncomeLoss_a0560543-5ed2-42ed-b3e5-10f2f286e41a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_624fe49c-8c0f-483d-8bdf-6f5f9aaa0174" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_9979f334-f745-4530-a031-fc1d0478379b" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_624fe49c-8c0f-483d-8bdf-6f5f9aaa0174" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_f6532256-e659-4804-ac26-d870ee4e3efb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_624fe49c-8c0f-483d-8bdf-6f5f9aaa0174" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_f6532256-e659-4804-ac26-d870ee4e3efb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_c32e03eb-0e12-46ec-ac74-3280416b34b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_624fe49c-8c0f-483d-8bdf-6f5f9aaa0174" xlink:to="loc_us-gaap_ShareBasedCompensation_c32e03eb-0e12-46ec-ac74-3280416b34b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_c78867da-2655-4e89-bfa6-d55443b6ef83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_624fe49c-8c0f-483d-8bdf-6f5f9aaa0174" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_c78867da-2655-4e89-bfa6-d55443b6ef83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWriteDown_b6a0cdee-3bb3-4f28-8a18-dcb72efe9074" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWriteDown"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_624fe49c-8c0f-483d-8bdf-6f5f9aaa0174" xlink:to="loc_us-gaap_InventoryWriteDown_b6a0cdee-3bb3-4f28-8a18-dcb72efe9074" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_6baebe08-d39b-4b64-9300-643c9496b6da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_624fe49c-8c0f-483d-8bdf-6f5f9aaa0174" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_6baebe08-d39b-4b64-9300-643c9496b6da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_21fb4cd5-3c21-4c30-a140-ba05df678198" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_624fe49c-8c0f-483d-8bdf-6f5f9aaa0174" xlink:to="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_21fb4cd5-3c21-4c30-a140-ba05df678198" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_c63998d7-507e-486f-9769-06e7fa31f2d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_624fe49c-8c0f-483d-8bdf-6f5f9aaa0174" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_c63998d7-507e-486f-9769-06e7fa31f2d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_df6260d4-5c8b-4e17-9098-d2384160de77" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_624fe49c-8c0f-483d-8bdf-6f5f9aaa0174" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_df6260d4-5c8b-4e17-9098-d2384160de77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_ac262cf5-ddfe-4686-9b02-0d16b9864427" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_9979f334-f745-4530-a031-fc1d0478379b" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_ac262cf5-ddfe-4686-9b02-0d16b9864427" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_15423885-4bca-4106-98e1-370dc6a4b1be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_ac262cf5-ddfe-4686-9b02-0d16b9864427" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_15423885-4bca-4106-98e1-370dc6a4b1be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_8c35b552-21d0-44a3-93b3-495c5c091db7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_ac262cf5-ddfe-4686-9b02-0d16b9864427" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_8c35b552-21d0-44a3-93b3-495c5c091db7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_c3e24149-3a9e-44ce-b92e-7d26e104d3cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_ac262cf5-ddfe-4686-9b02-0d16b9864427" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_c3e24149-3a9e-44ce-b92e-7d26e104d3cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_60f3ac2a-adb3-434e-bbbc-e6439b7750a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_ac262cf5-ddfe-4686-9b02-0d16b9864427" xlink:to="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_60f3ac2a-adb3-434e-bbbc-e6439b7750a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_6f1552db-53ae-4d3c-8a71-2da8f0648bb0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_ac262cf5-ddfe-4686-9b02-0d16b9864427" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_6f1552db-53ae-4d3c-8a71-2da8f0648bb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_cd816a34-133f-48dc-bc30-25f5640475d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_9979f334-f745-4530-a031-fc1d0478379b" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_cd816a34-133f-48dc-bc30-25f5640475d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_6b3a0da1-62b4-4ed9-ba68-aef375317f95" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4a1bf905-f8d1-4261-a3f6-9eb0133adddc" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_6b3a0da1-62b4-4ed9-ba68-aef375317f95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_1b2a186a-2e0d-44d6-bd19-d47074fc35a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_6b3a0da1-62b4-4ed9-ba68-aef375317f95" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_1b2a186a-2e0d-44d6-bd19-d47074fc35a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquitySecuritiesFvNi_83618df8-4311-4564-9e5c-d5b1b7e36442" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireEquitySecuritiesFvNi"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_6b3a0da1-62b4-4ed9-ba68-aef375317f95" xlink:to="loc_us-gaap_PaymentsToAcquireEquitySecuritiesFvNi_83618df8-4311-4564-9e5c-d5b1b7e36442" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireNotesReceivable_bf16a90a-e915-4908-a2df-6f3342975727" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireNotesReceivable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_6b3a0da1-62b4-4ed9-ba68-aef375317f95" xlink:to="loc_us-gaap_PaymentsToAcquireNotesReceivable_bf16a90a-e915-4908-a2df-6f3342975727" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_ed7e8ea3-7e1e-40a1-ac13-602c45cc3928" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4a1bf905-f8d1-4261-a3f6-9eb0133adddc" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_ed7e8ea3-7e1e-40a1-ac13-602c45cc3928" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_56a41e93-d692-4d59-a338-1e5d6aab1464" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4a1bf905-f8d1-4261-a3f6-9eb0133adddc" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_56a41e93-d692-4d59-a338-1e5d6aab1464" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_e05cc372-c26e-4c3a-b97c-a2c39b125b0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_56a41e93-d692-4d59-a338-1e5d6aab1464" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_e05cc372-c26e-4c3a-b97c-a2c39b125b0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_53aa6ffa-55fb-4428-aef7-ef92ef29d09a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_56a41e93-d692-4d59-a338-1e5d6aab1464" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_53aa6ffa-55fb-4428-aef7-ef92ef29d09a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfOrdinaryDividends_e295d465-5c27-4ff5-b113-ab9446e92f3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfOrdinaryDividends"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_56a41e93-d692-4d59-a338-1e5d6aab1464" xlink:to="loc_us-gaap_PaymentsOfOrdinaryDividends_e295d465-5c27-4ff5-b113-ab9446e92f3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarlyRepaymentOfSeniorDebt_c0d80029-6ddd-4ff4-b488-f71f4683c9b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarlyRepaymentOfSeniorDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_56a41e93-d692-4d59-a338-1e5d6aab1464" xlink:to="loc_us-gaap_EarlyRepaymentOfSeniorDebt_c0d80029-6ddd-4ff4-b488-f71f4683c9b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommercialPaper_17e73c1f-0565-43e3-b048-e3728e3cbff7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommercialPaper"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_56a41e93-d692-4d59-a338-1e5d6aab1464" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommercialPaper_17e73c1f-0565-43e3-b048-e3728e3cbff7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfCommercialPaper_19bb1c30-778d-4fae-9ef2-37c05b1b37f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfCommercialPaper"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_56a41e93-d692-4d59-a338-1e5d6aab1464" xlink:to="loc_us-gaap_RepaymentsOfCommercialPaper_19bb1c30-778d-4fae-9ef2-37c05b1b37f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_68df5c95-34e8-4dfa-8cbc-3d123c1fd18b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_56a41e93-d692-4d59-a338-1e5d6aab1464" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_68df5c95-34e8-4dfa-8cbc-3d123c1fd18b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c900fc7d-f06c-4bf7-a78f-02b44d3697bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_56a41e93-d692-4d59-a338-1e5d6aab1464" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c900fc7d-f06c-4bf7-a78f-02b44d3697bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_845f2671-f35a-45e5-b165-e3dbe8e30f87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_56a41e93-d692-4d59-a338-1e5d6aab1464" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_845f2671-f35a-45e5-b165-e3dbe8e30f87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_28b7c93c-eb1b-4345-9209-e58099a15e25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4a1bf905-f8d1-4261-a3f6-9eb0133adddc" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_28b7c93c-eb1b-4345-9209-e58099a15e25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0360327a-93db-4760-8c0e-0f8a19b77ac2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4a1bf905-f8d1-4261-a3f6-9eb0133adddc" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0360327a-93db-4760-8c0e-0f8a19b77ac2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f69722f1-2af6-4f54-b9ad-f146aa009ff9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4a1bf905-f8d1-4261-a3f6-9eb0133adddc" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f69722f1-2af6-4f54-b9ad-f146aa009ff9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_b0a066db-8153-4c5c-9228-7991fdf4f021" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4a1bf905-f8d1-4261-a3f6-9eb0133adddc" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_b0a066db-8153-4c5c-9228-7991fdf4f021" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_082ee17b-0301-4d8a-a57b-25520fab05db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_b0a066db-8153-4c5c-9228-7991fdf4f021" xlink:to="loc_us-gaap_IncomeTaxesPaidNet_082ee17b-0301-4d8a-a57b-25520fab05db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_90339a31-53d0-4937-923e-f5bd9f25b3d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_b0a066db-8153-4c5c-9228-7991fdf4f021" xlink:to="loc_us-gaap_InterestPaidNet_90339a31-53d0-4937-923e-f5bd9f25b3d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_adefd021-ce6e-40ab-9435-d3f182a1cd1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_b0a066db-8153-4c5c-9228-7991fdf4f021" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_adefd021-ce6e-40ab-9435-d3f182a1cd1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFEQUITY" xlink:type="simple" xlink:href="a-20220131.xsd#CONDENSEDCONSOLIDATEDSTATEMENTOFEQUITY"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFEQUITY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_ed2185b0-4bd2-45dc-8849-eeb600a43641" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_67eff9fe-6229-4224-8596-977603328b9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_ed2185b0-4bd2-45dc-8849-eeb600a43641" xlink:to="loc_us-gaap_StatementTable_67eff9fe-6229-4224-8596-977603328b9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis_dd5e2bd4-20d5-4451-a399-55e23737fd60" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_67eff9fe-6229-4224-8596-977603328b9c" xlink:to="loc_srt_RestatementAxis_dd5e2bd4-20d5-4451-a399-55e23737fd60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_5087f2b6-770d-4f64-b161-2fb07c0356a2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementAxis_dd5e2bd4-20d5-4451-a399-55e23737fd60" xlink:to="loc_srt_RestatementDomain_5087f2b6-770d-4f64-b161-2fb07c0356a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember_43b385ab-e479-42a9-b8f0-7abbdf958090" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementDomain_5087f2b6-770d-4f64-b161-2fb07c0356a2" xlink:to="loc_srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember_43b385ab-e479-42a9-b8f0-7abbdf958090" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_a46b3fd9-330d-458e-9cbd-62676fcbc0cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_67eff9fe-6229-4224-8596-977603328b9c" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_a46b3fd9-330d-458e-9cbd-62676fcbc0cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_51f0f64d-02fb-486f-8bca-51bcf1f1f414" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_a46b3fd9-330d-458e-9cbd-62676fcbc0cc" xlink:to="loc_us-gaap_EquityComponentDomain_51f0f64d-02fb-486f-8bca-51bcf1f1f414" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_6d402680-b55a-44ce-8bea-26a8db7b4e96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_51f0f64d-02fb-486f-8bca-51bcf1f1f414" xlink:to="loc_us-gaap_CommonStockMember_6d402680-b55a-44ce-8bea-26a8db7b4e96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_e5085aaa-81ab-4538-a219-e2446a208a39" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_51f0f64d-02fb-486f-8bca-51bcf1f1f414" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_e5085aaa-81ab-4538-a219-e2446a208a39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_c8a89543-2c75-4bf9-9a2c-0b0ae612e20a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_51f0f64d-02fb-486f-8bca-51bcf1f1f414" xlink:to="loc_us-gaap_TreasuryStockMember_c8a89543-2c75-4bf9-9a2c-0b0ae612e20a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_f16ceaad-3917-4677-a3c3-9c01e605378c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_51f0f64d-02fb-486f-8bca-51bcf1f1f414" xlink:to="loc_us-gaap_RetainedEarningsMember_f16ceaad-3917-4677-a3c3-9c01e605378c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_9050192a-43f8-45e0-a242-49dca15e7256" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_51f0f64d-02fb-486f-8bca-51bcf1f1f414" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_9050192a-43f8-45e0-a242-49dca15e7256" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember_6523ffc3-c5bb-43ad-87ff-c160b4b8d0d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ParentMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_51f0f64d-02fb-486f-8bca-51bcf1f1f414" xlink:to="loc_us-gaap_ParentMember_6523ffc3-c5bb-43ad-87ff-c160b4b8d0d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_5a0d046f-f792-4eed-901f-1a92365f4373" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_51f0f64d-02fb-486f-8bca-51bcf1f1f414" xlink:to="loc_us-gaap_NoncontrollingInterestMember_5a0d046f-f792-4eed-901f-1a92365f4373" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_daa7397e-6d04-4c10-9768-651d85727d5f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_67eff9fe-6229-4224-8596-977603328b9c" xlink:to="loc_us-gaap_StatementClassOfStockAxis_daa7397e-6d04-4c10-9768-651d85727d5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_a15c9ebc-b51c-48bc-8dee-8bee00ea48e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_daa7397e-6d04-4c10-9768-651d85727d5f" xlink:to="loc_us-gaap_ClassOfStockDomain_a15c9ebc-b51c-48bc-8dee-8bee00ea48e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_664ac78e-e417-44f0-9a9d-bd7090ec8060" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_67eff9fe-6229-4224-8596-977603328b9c" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_664ac78e-e417-44f0-9a9d-bd7090ec8060" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_2818902e-a148-4e1a-8319-e5e51daddbd1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_664ac78e-e417-44f0-9a9d-bd7090ec8060" xlink:to="loc_us-gaap_TypeOfAdoptionMember_2818902e-a148-4e1a-8319-e5e51daddbd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForChangeInAccountingPrincipleAxis_c34d8a2c-6e97-499d-a0a8-327dab4f8fc8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForChangeInAccountingPrincipleAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_67eff9fe-6229-4224-8596-977603328b9c" xlink:to="loc_us-gaap_AdjustmentsForChangeInAccountingPrincipleAxis_c34d8a2c-6e97-499d-a0a8-327dab4f8fc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInAccountingPrincipleMember_73454ef7-bc3b-44eb-8c37-23e26b6d7e98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ChangeInAccountingPrincipleMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForChangeInAccountingPrincipleAxis_c34d8a2c-6e97-499d-a0a8-327dab4f8fc8" xlink:to="loc_us-gaap_ChangeInAccountingPrincipleMember_73454ef7-bc3b-44eb-8c37-23e26b6d7e98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis_e83513cf-d32f-44fc-899f-0f1a6401aab6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_67eff9fe-6229-4224-8596-977603328b9c" xlink:to="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis_e83513cf-d32f-44fc-899f-0f1a6401aab6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForErrorCorrectionDomain_5a9eff82-2a6c-491e-afda-a22c3e5e074c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForErrorCorrectionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis_e83513cf-d32f-44fc-899f-0f1a6401aab6" xlink:to="loc_us-gaap_AdjustmentsForErrorCorrectionDomain_5a9eff82-2a6c-491e-afda-a22c3e5e074c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_c905ff23-dffb-4abf-a655-fba4646152a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_67eff9fe-6229-4224-8596-977603328b9c" xlink:to="loc_us-gaap_StatementLineItems_c905ff23-dffb-4abf-a655-fba4646152a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_0d56735d-ecc2-463f-9458-6d14972a449c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssued"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_c905ff23-dffb-4abf-a655-fba4646152a8" xlink:to="loc_us-gaap_SharesIssued_0d56735d-ecc2-463f-9458-6d14972a449c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_c4980711-4f6c-4ea6-a264-6c97cf1d657a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_c905ff23-dffb-4abf-a655-fba4646152a8" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_c4980711-4f6c-4ea6-a264-6c97cf1d657a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_5d88f55b-9687-4f47-b6ea-743cc902139b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_c905ff23-dffb-4abf-a655-fba4646152a8" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_5d88f55b-9687-4f47-b6ea-743cc902139b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_f4b79abb-48b7-43b9-bd2b-1ec9c691e8f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_5d88f55b-9687-4f47-b6ea-743cc902139b" xlink:to="loc_us-gaap_NetIncomeLoss_f4b79abb-48b7-43b9-bd2b-1ec9c691e8f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_883c63b1-3e40-4f74-99ba-a610a244066e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_5d88f55b-9687-4f47-b6ea-743cc902139b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_883c63b1-3e40-4f74-99ba-a610a244066e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_4f64aee1-6493-4b00-beae-8ee965bbc29c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_5d88f55b-9687-4f47-b6ea-743cc902139b" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_4f64aee1-6493-4b00-beae-8ee965bbc29c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestPeriodIncreaseDecrease_6003f895-6b73-44b1-b714-5138bc6bb132" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestPeriodIncreaseDecrease"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_c905ff23-dffb-4abf-a655-fba4646152a8" xlink:to="loc_us-gaap_MinorityInterestPeriodIncreaseDecrease_6003f895-6b73-44b1-b714-5138bc6bb132" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_ef94ef99-35d8-49f9-8053-dfcf491203c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_c905ff23-dffb-4abf-a655-fba4646152a8" xlink:to="loc_us-gaap_DividendsCommonStockCash_ef94ef99-35d8-49f9-8053-dfcf491203c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_0cd23b87-92d9-4ed2-9d6a-6515c4bae5c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_c905ff23-dffb-4abf-a655-fba4646152a8" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_0cd23b87-92d9-4ed2-9d6a-6515c4bae5c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_b60aea33-4906-48d5-b5c6-f92cae753da8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_c905ff23-dffb-4abf-a655-fba4646152a8" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_b60aea33-4906-48d5-b5c6-f92cae753da8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_f88228e0-5c75-4a42-b7e1-656115bf2c66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_c905ff23-dffb-4abf-a655-fba4646152a8" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_f88228e0-5c75-4a42-b7e1-656115bf2c66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_19ff0a47-3dea-4e95-b277-0de800433db7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_c905ff23-dffb-4abf-a655-fba4646152a8" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_19ff0a47-3dea-4e95-b277-0de800433db7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_5e05b51f-4627-4407-9304-3cf7778e6dc9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_c905ff23-dffb-4abf-a655-fba4646152a8" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_5e05b51f-4627-4407-9304-3cf7778e6dc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_28e2a86b-261c-408b-bd5b-c3e992f61cfa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssued"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_c905ff23-dffb-4abf-a655-fba4646152a8" xlink:to="loc_us-gaap_SharesIssued_28e2a86b-261c-408b-bd5b-c3e992f61cfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_ec697854-9b9c-4811-84ef-3b1533138898" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_c905ff23-dffb-4abf-a655-fba4646152a8" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_ec697854-9b9c-4811-84ef-3b1533138898" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/CONDENSEDCONSOLIDATESTATEMENTOFEQUITYPARENTHETICAL" xlink:type="simple" xlink:href="a-20220131.xsd#CONDENSEDCONSOLIDATESTATEMENTOFEQUITYPARENTHETICAL"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/CONDENSEDCONSOLIDATESTATEMENTOFEQUITYPARENTHETICAL" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_c8b7b8c7-184a-4efe-aa0c-d00617813f66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_ccd5fca1-9c5a-4031-ab96-3dc1f68ef156" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_c8b7b8c7-184a-4efe-aa0c-d00617813f66" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_ccd5fca1-9c5a-4031-ab96-3dc1f68ef156" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_Taxrelatedtosharesissued_92f65fb9-e6f8-4171-b48b-96f004818358" xlink:href="a-20220131.xsd#a_Taxrelatedtosharesissued"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_c8b7b8c7-184a-4efe-aa0c-d00617813f66" xlink:to="loc_a_Taxrelatedtosharesissued_92f65fb9-e6f8-4171-b48b-96f004818358" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_f83cb873-e6f5-4ae8-a890-0c33c892292a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_c8b7b8c7-184a-4efe-aa0c-d00617813f66" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_f83cb873-e6f5-4ae8-a890-0c33c892292a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_48f0d6bb-b40b-41e3-b925-e47cac6e26bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_c8b7b8c7-184a-4efe-aa0c-d00617813f66" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_48f0d6bb-b40b-41e3-b925-e47cac6e26bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNotes" xlink:type="simple" xlink:href="a-20220131.xsd#OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNotes"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_0cd47883-ef73-49a9-9453-b5780de301d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_3d4e4da8-f62e-409d-8699-521c8387936e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0cd47883-ef73-49a9-9453-b5780de301d0" xlink:to="loc_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_3d4e4da8-f62e-409d-8699-521c8387936e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="simple" xlink:href="a-20220131.xsd#OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_0dc7c0f6-11ed-445c-9b92-484b75478482" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_08ba1928-fa4f-4ba3-803a-fa1ac604576b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0dc7c0f6-11ed-445c-9b92-484b75478482" xlink:to="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_08ba1928-fa4f-4ba3-803a-fa1ac604576b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_fb001410-e5b4-4e4b-973f-d49fed5d143a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0dc7c0f6-11ed-445c-9b92-484b75478482" xlink:to="loc_us-gaap_UseOfEstimates_fb001410-e5b4-4e4b-973f-d49fed5d143a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_34f6467a-5a1a-44a7-9f94-fe51c2798504" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0dc7c0f6-11ed-445c-9b92-484b75478482" xlink:to="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_34f6467a-5a1a-44a7-9f94-fe51c2798504" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock_14698856-b4de-47fb-9d35-0fdef5e99d6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0dc7c0f6-11ed-445c-9b92-484b75478482" xlink:to="loc_us-gaap_LesseeLeasesPolicyTextBlock_14698856-b4de-47fb-9d35-0fdef5e99d6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationVariableInterestEntityPolicy_1bf1d94c-293d-4c81-bf55-0bd6daca8e99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationVariableInterestEntityPolicy"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0dc7c0f6-11ed-445c-9b92-484b75478482" xlink:to="loc_us-gaap_ConsolidationVariableInterestEntityPolicy_1bf1d94c-293d-4c81-bf55-0bd6daca8e99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_116e496c-9138-4cf3-869c-6649a02804a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0dc7c0f6-11ed-445c-9b92-484b75478482" xlink:to="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_116e496c-9138-4cf3-869c-6649a02804a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables" xlink:type="simple" xlink:href="a-20220131.xsd#OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAbstract_8e98539b-33d5-46e4-8c5b-f4d6550b803e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_b33cd2af-259f-4c92-99c9-ff2b0de58f88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAbstract_8e98539b-33d5-46e4-8c5b-f4d6550b803e" xlink:to="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_b33cd2af-259f-4c92-99c9-ff2b0de58f88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails" xlink:type="simple" xlink:href="a-20220131.xsd#OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_6eb78b6d-3ec4-463a-b986-c0371891894c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_b4734f85-24f1-4a9f-aa1b-9b1cf850868a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6eb78b6d-3ec4-463a-b986-c0371891894c" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_b4734f85-24f1-4a9f-aa1b-9b1cf850868a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_0dae6f4f-3eb5-43ca-90c9-7f3e4952bafc" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_b4734f85-24f1-4a9f-aa1b-9b1cf850868a" xlink:to="loc_srt_ConsolidatedEntitiesAxis_0dae6f4f-3eb5-43ca-90c9-7f3e4952bafc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_aa655c91-9561-4b95-aa3d-9735a12564c9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_0dae6f4f-3eb5-43ca-90c9-7f3e4952bafc" xlink:to="loc_srt_ConsolidatedEntitiesDomain_aa655c91-9561-4b95-aa3d-9735a12564c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_b41d0d40-430c-454c-b912-0a214f0d3985" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_aa655c91-9561-4b95-aa3d-9735a12564c9" xlink:to="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_b41d0d40-430c-454c-b912-0a214f0d3985" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PledgedStatusAxis_0c18e3e3-25a1-498d-8635-d92349b9c295" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PledgedStatusAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_b4734f85-24f1-4a9f-aa1b-9b1cf850868a" xlink:to="loc_us-gaap_PledgedStatusAxis_0c18e3e3-25a1-498d-8635-d92349b9c295" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PledgedStatusDomain_7570b28b-9bec-4c45-856f-a618ef075854" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PledgedStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PledgedStatusAxis_0c18e3e3-25a1-498d-8635-d92349b9c295" xlink:to="loc_us-gaap_PledgedStatusDomain_7570b28b-9bec-4c45-856f-a618ef075854" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RecourseStatusAxis_0938f9ae-77c5-479e-9836-3e731af12ff6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RecourseStatusAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_b4734f85-24f1-4a9f-aa1b-9b1cf850868a" xlink:to="loc_us-gaap_RecourseStatusAxis_0938f9ae-77c5-479e-9836-3e731af12ff6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RecourseStatusDomain_353f9b6b-800b-4262-8889-c3455bc2faa1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RecourseStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RecourseStatusAxis_0938f9ae-77c5-479e-9836-3e731af12ff6" xlink:to="loc_us-gaap_RecourseStatusDomain_353f9b6b-800b-4262-8889-c3455bc2faa1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_2ad9441e-1ec9-47d0-b35c-a322ea794d4f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_b4734f85-24f1-4a9f-aa1b-9b1cf850868a" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_2ad9441e-1ec9-47d0-b35c-a322ea794d4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_b544329e-9c73-4444-a78c-db556e6332a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_2ad9441e-1ec9-47d0-b35c-a322ea794d4f" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_b544329e-9c73-4444-a78c-db556e6332a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember_fb11f2a0-2948-4559-aa28-9fed53a725ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_b544329e-9c73-4444-a78c-db556e6332a4" xlink:to="loc_us-gaap_OtherAssetsMember_fb11f2a0-2948-4559-aa28-9fed53a725ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_OtherAccruedAndLongTermLiabilitiesMember_70ce098c-2dbb-41a7-9542-4b6171bf3b1e" xlink:href="a-20220131.xsd#a_OtherAccruedAndLongTermLiabilitiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_b544329e-9c73-4444-a78c-db556e6332a4" xlink:to="loc_a_OtherAccruedAndLongTermLiabilitiesMember_70ce098c-2dbb-41a7-9542-4b6171bf3b1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_d5f8fc82-4ce7-40fb-8329-1957f7389c4a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_c2b450da-0bf9-440d-917c-0a7e2287220d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_518a4819-c5a7-4916-87eb-8c6250acf815" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_5e2ebe6e-5797-461c-9601-f96ca189dd15" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_b4734f85-24f1-4a9f-aa1b-9b1cf850868a" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_5e2ebe6e-5797-461c-9601-f96ca189dd15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2b26ccb2-c468-469b-bfff-f25ba18b9c09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_5e2ebe6e-5797-461c-9601-f96ca189dd15" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2b26ccb2-c468-469b-bfff-f25ba18b9c09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_8d9c8e9c-234f-4d41-8c57-7f8e19014056" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2b26ccb2-c468-469b-bfff-f25ba18b9c09" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_8d9c8e9c-234f-4d41-8c57-7f8e19014056" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems_b609a94b-7280-4aa5-8664-d14d45ab9296" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_b4734f85-24f1-4a9f-aa1b-9b1cf850868a" xlink:to="loc_us-gaap_VariableInterestEntityLineItems_b609a94b-7280-4aa5-8664-d14d45ab9296" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_39315700-e9c4-4aee-b76c-5f16fa4a1e10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_b609a94b-7280-4aa5-8664-d14d45ab9296" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_39315700-e9c4-4aee-b76c-5f16fa4a1e10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_947b97c0-0a11-4281-adc8-66736d0dddb8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_39315700-e9c4-4aee-b76c-5f16fa4a1e10" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_947b97c0-0a11-4281-adc8-66736d0dddb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCash_581f3a8b-419f-4288-ad14-5f1eb9e791e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCash"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_39315700-e9c4-4aee-b76c-5f16fa4a1e10" xlink:to="loc_us-gaap_RestrictedCash_581f3a8b-419f-4288-ad14-5f1eb9e791e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_ba101be3-04cb-4f11-8282-629fe2b47406" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_39315700-e9c4-4aee-b76c-5f16fa4a1e10" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_ba101be3-04cb-4f11-8282-629fe2b47406" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesOperatingAbstract_95e07d02-07a4-4276-8179-3b855afd7370" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesOperatingAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_b609a94b-7280-4aa5-8664-d14d45ab9296" xlink:to="loc_us-gaap_LeasesOperatingAbstract_95e07d02-07a4-4276-8179-3b855afd7370" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_2f30f993-a8fa-49f3-a226-6ed49f1798f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesOperatingAbstract_95e07d02-07a4-4276-8179-3b855afd7370" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_2f30f993-a8fa-49f3-a226-6ed49f1798f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_89076731-d804-4f5e-b672-13eaa85be657" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesOperatingAbstract_95e07d02-07a4-4276-8179-3b855afd7370" xlink:to="loc_us-gaap_OperatingLeaseLiability_89076731-d804-4f5e-b672-13eaa85be657" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryDisclosuresAbstract_1d79a3c1-f2e9-4915-bcee-4d6f60f588fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityNotPrimaryBeneficiaryDisclosuresAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_b609a94b-7280-4aa5-8664-d14d45ab9296" xlink:to="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryDisclosuresAbstract_1d79a3c1-f2e9-4915-bcee-4d6f60f588fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_97bf875c-0271-4ef9-8989-2493b36e282e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryDisclosuresAbstract_1d79a3c1-f2e9-4915-bcee-4d6f60f588fc" xlink:to="loc_us-gaap_Assets_97bf875c-0271-4ef9-8989-2493b36e282e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_993b2ee9-565a-4e2c-998e-8213ce46e0a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_b609a94b-7280-4aa5-8664-d14d45ab9296" xlink:to="loc_us-gaap_FairValueDisclosuresAbstract_993b2ee9-565a-4e2c-998e-8213ce46e0a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_Fairvalueoflongtermdebtinexcessofcarryingvalue_9660a832-9124-48ec-9f6d-7a75e4bb0c98" xlink:href="a-20220131.xsd#a_Fairvalueoflongtermdebtinexcessofcarryingvalue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_993b2ee9-565a-4e2c-998e-8213ce46e0a6" xlink:to="loc_a_Fairvalueoflongtermdebtinexcessofcarryingvalue_9660a832-9124-48ec-9f6d-7a75e4bb0c98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_Fairvalueoflongtermdebtinexcessofcarryingvalue_33c7989f-63ae-43a4-8439-c90931d5012d" xlink:href="a-20220131.xsd#a_Fairvalueoflongtermdebtinexcessofcarryingvalue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_cb100e41-3a29-4093-ac66-10bd35568a52" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_b609a94b-7280-4aa5-8664-d14d45ab9296" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_cb100e41-3a29-4093-ac66-10bd35568a52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtFairValue_0ea1fc09-6230-4952-8fe7-66b6b6231280" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtFairValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_b609a94b-7280-4aa5-8664-d14d45ab9296" xlink:to="loc_us-gaap_LongTermDebtFairValue_0ea1fc09-6230-4952-8fe7-66b6b6231280" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/NEWACCOUNTINGPRONOUNCEMENTSNotes" xlink:type="simple" xlink:href="a-20220131.xsd#NEWACCOUNTINGPRONOUNCEMENTSNotes"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/NEWACCOUNTINGPRONOUNCEMENTSNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_80778898-9522-4423-b8e4-697502a4b167" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_286b5f72-5226-41e7-a289-5d4218414cf6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_80778898-9522-4423-b8e4-697502a4b167" xlink:to="loc_us-gaap_AccountingPoliciesAbstract_286b5f72-5226-41e7-a289-5d4218414cf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_f47189a3-5cde-4751-9f2d-6acf8e9596e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_286b5f72-5226-41e7-a289-5d4218414cf6" xlink:to="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_f47189a3-5cde-4751-9f2d-6acf8e9596e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/NEWACCOUNTINGPRONOUNCEMENTSTables" xlink:type="simple" xlink:href="a-20220131.xsd#NEWACCOUNTINGPRONOUNCEMENTSTables"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/NEWACCOUNTINGPRONOUNCEMENTSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_8a8082ec-c142-49ec-8a56-be4d3d7d8586" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_7785e107-f2e5-4a1e-a58a-c44dca7d00d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_8a8082ec-c142-49ec-8a56-be4d3d7d8586" xlink:to="loc_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_7785e107-f2e5-4a1e-a58a-c44dca7d00d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_c7211f43-0975-4b4d-bf99-1e4458fabaff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_8a8082ec-c142-49ec-8a56-be4d3d7d8586" xlink:to="loc_us-gaap_AccountingPoliciesAbstract_c7211f43-0975-4b4d-bf99-1e4458fabaff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_73dde04a-def0-4a98-97fe-9cd5ab7bb4ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c7211f43-0975-4b4d-bf99-1e4458fabaff" xlink:to="loc_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_73dde04a-def0-4a98-97fe-9cd5ab7bb4ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/REVENUENotes" xlink:type="simple" xlink:href="a-20220131.xsd#REVENUENotes"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/REVENUENotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_4281528c-17e0-4d37-b9a3-f92b1914196d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_10dbf198-5aed-4530-b55f-b02a7edbf3f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_4281528c-17e0-4d37-b9a3-f92b1914196d" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_10dbf198-5aed-4530-b55f-b02a7edbf3f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/REVENUETables" xlink:type="simple" xlink:href="a-20220131.xsd#REVENUETables"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/REVENUETables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_4fa1d832-9857-4c28-b7e0-a4e51db464d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_7c778aca-06b0-43fb-8e79-97c1499c3a36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_4fa1d832-9857-4c28-b7e0-a4e51db464d9" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_7c778aca-06b0-43fb-8e79-97c1499c3a36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_c0040ec2-468c-458a-bc9e-fc6122b1456f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_4fa1d832-9857-4c28-b7e0-a4e51db464d9" xlink:to="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_c0040ec2-468c-458a-bc9e-fc6122b1456f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/REVENUERevenuebyRegionDetails" xlink:type="simple" xlink:href="a-20220131.xsd#REVENUERevenuebyRegionDetails"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/REVENUERevenuebyRegionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_87b9fc3c-0f5d-4568-a9ef-63a4a4663ff5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_0bd68672-0b82-4532-8243-300df37662bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_87b9fc3c-0f5d-4568-a9ef-63a4a4663ff5" xlink:to="loc_us-gaap_StatementTable_0bd68672-0b82-4532-8243-300df37662bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_c0761078-db75-47ab-8ae4-853b06d79e95" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_0bd68672-0b82-4532-8243-300df37662bf" xlink:to="loc_srt_StatementGeographicalAxis_c0761078-db75-47ab-8ae4-853b06d79e95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_63e50db6-0723-4a28-9372-d50fdc0b1b8a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_c0761078-db75-47ab-8ae4-853b06d79e95" xlink:to="loc_srt_SegmentGeographicalDomain_63e50db6-0723-4a28-9372-d50fdc0b1b8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AmericasMember_d576df25-7961-487c-95e5-6afa30299458" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_AmericasMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_63e50db6-0723-4a28-9372-d50fdc0b1b8a" xlink:to="loc_srt_AmericasMember_d576df25-7961-487c-95e5-6afa30299458" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_81163098-8f0c-4dd3-911e-779d134fa7ce" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EuropeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_63e50db6-0723-4a28-9372-d50fdc0b1b8a" xlink:to="loc_srt_EuropeMember_81163098-8f0c-4dd3-911e-779d134fa7ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember_fe51f065-bd04-400e-bd4b-bb2ad35166ef" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_AsiaPacificMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_63e50db6-0723-4a28-9372-d50fdc0b1b8a" xlink:to="loc_srt_AsiaPacificMember_fe51f065-bd04-400e-bd4b-bb2ad35166ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_00e90a3a-8855-4a2e-a019-156a909aa59c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_0bd68672-0b82-4532-8243-300df37662bf" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_00e90a3a-8855-4a2e-a019-156a909aa59c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_f709515b-5d23-4fed-89fa-27b73ae03324" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_00e90a3a-8855-4a2e-a019-156a909aa59c" xlink:to="loc_us-gaap_SegmentDomain_f709515b-5d23-4fed-89fa-27b73ae03324" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_LifeSciencesandAppliedMarketsMember_b2b23f9a-6a60-4089-adc3-f4bfaac93364" xlink:href="a-20220131.xsd#a_LifeSciencesandAppliedMarketsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_f709515b-5d23-4fed-89fa-27b73ae03324" xlink:to="loc_a_LifeSciencesandAppliedMarketsMember_b2b23f9a-6a60-4089-adc3-f4bfaac93364" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_AgilentCrossLabMember_422f8647-7154-463a-bfc1-21ff654d8e3e" xlink:href="a-20220131.xsd#a_AgilentCrossLabMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_f709515b-5d23-4fed-89fa-27b73ae03324" xlink:to="loc_a_AgilentCrossLabMember_422f8647-7154-463a-bfc1-21ff654d8e3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_DiagnosticsAndGenomicsMember_5cdd1219-c504-4860-9ffa-3ddf2ffea694" xlink:href="a-20220131.xsd#a_DiagnosticsAndGenomicsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_f709515b-5d23-4fed-89fa-27b73ae03324" xlink:to="loc_a_DiagnosticsAndGenomicsMember_5cdd1219-c504-4860-9ffa-3ddf2ffea694" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_ec2cb642-2299-4fce-8f3c-9f35dfd08d35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_0bd68672-0b82-4532-8243-300df37662bf" xlink:to="loc_us-gaap_StatementLineItems_ec2cb642-2299-4fce-8f3c-9f35dfd08d35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_8cc8d1aa-5232-408e-8465-9f131e3d6b34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ec2cb642-2299-4fce-8f3c-9f35dfd08d35" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_8cc8d1aa-5232-408e-8465-9f131e3d6b34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/REVENUERevenuebyEndMarketsDetails" xlink:type="simple" xlink:href="a-20220131.xsd#REVENUERevenuebyEndMarketsDetails"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/REVENUERevenuebyEndMarketsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_51460215-a2da-4af9-9eea-2701266950fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_8fdcf95f-e661-465c-8949-e7686105e0e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_51460215-a2da-4af9-9eea-2701266950fd" xlink:to="loc_us-gaap_StatementTable_8fdcf95f-e661-465c-8949-e7686105e0e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_EndMarketsAxis_cc480933-edaa-47a9-81fa-3dbfa640725e" xlink:href="a-20220131.xsd#a_EndMarketsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_8fdcf95f-e661-465c-8949-e7686105e0e4" xlink:to="loc_a_EndMarketsAxis_cc480933-edaa-47a9-81fa-3dbfa640725e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_EndMarketsDomain_744eb290-1582-4b28-944c-9a860a3db7f6" xlink:href="a-20220131.xsd#a_EndMarketsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_a_EndMarketsAxis_cc480933-edaa-47a9-81fa-3dbfa640725e" xlink:to="loc_a_EndMarketsDomain_744eb290-1582-4b28-944c-9a860a3db7f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_PharmaceuticalandBiopharmaceuticalMarketMember_577a111b-da6c-4a3d-95c6-65099320cec0" xlink:href="a-20220131.xsd#a_PharmaceuticalandBiopharmaceuticalMarketMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_a_EndMarketsDomain_744eb290-1582-4b28-944c-9a860a3db7f6" xlink:to="loc_a_PharmaceuticalandBiopharmaceuticalMarketMember_577a111b-da6c-4a3d-95c6-65099320cec0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_ChemicalandEnergyMarketMember_04ebf281-2656-460c-87a8-0d4ef876a522" xlink:href="a-20220131.xsd#a_ChemicalandEnergyMarketMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_a_EndMarketsDomain_744eb290-1582-4b28-944c-9a860a3db7f6" xlink:to="loc_a_ChemicalandEnergyMarketMember_04ebf281-2656-460c-87a8-0d4ef876a522" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_DiagnosticsandClinicalMarketMember_e49c0ae6-993f-4dec-8842-0b0515c73f2f" xlink:href="a-20220131.xsd#a_DiagnosticsandClinicalMarketMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_a_EndMarketsDomain_744eb290-1582-4b28-944c-9a860a3db7f6" xlink:to="loc_a_DiagnosticsandClinicalMarketMember_e49c0ae6-993f-4dec-8842-0b0515c73f2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_FoodMarketMember_822c97b4-14f3-4f34-8d95-60f12e195071" xlink:href="a-20220131.xsd#a_FoodMarketMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_a_EndMarketsDomain_744eb290-1582-4b28-944c-9a860a3db7f6" xlink:to="loc_a_FoodMarketMember_822c97b4-14f3-4f34-8d95-60f12e195071" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_AcademiaandGovernmentMarketMember_898339b4-ee71-4b32-b4c1-cf56ebb85175" xlink:href="a-20220131.xsd#a_AcademiaandGovernmentMarketMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_a_EndMarketsDomain_744eb290-1582-4b28-944c-9a860a3db7f6" xlink:to="loc_a_AcademiaandGovernmentMarketMember_898339b4-ee71-4b32-b4c1-cf56ebb85175" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_EnvironmentalandForensicsMarketMember_07e84c5c-ed77-4f7a-8e56-cde2e3cda43c" xlink:href="a-20220131.xsd#a_EnvironmentalandForensicsMarketMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_a_EndMarketsDomain_744eb290-1582-4b28-944c-9a860a3db7f6" xlink:to="loc_a_EnvironmentalandForensicsMarketMember_07e84c5c-ed77-4f7a-8e56-cde2e3cda43c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_bf43aa67-260a-4a38-a89f-4cc806c73d47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_8fdcf95f-e661-465c-8949-e7686105e0e4" xlink:to="loc_us-gaap_StatementLineItems_bf43aa67-260a-4a38-a89f-4cc806c73d47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_930fa45b-09bb-4c4e-b9c8-43a1fe53a4e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bf43aa67-260a-4a38-a89f-4cc806c73d47" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_930fa45b-09bb-4c4e-b9c8-43a1fe53a4e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/REVENUERevenuebyTypeDetails" xlink:type="simple" xlink:href="a-20220131.xsd#REVENUERevenuebyTypeDetails"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/REVENUERevenuebyTypeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_583facea-e1d0-4447-9fe7-3911a49dca7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_a3d99283-ae31-4cc0-b3b5-dafecbf326a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_583facea-e1d0-4447-9fe7-3911a49dca7d" xlink:to="loc_us-gaap_StatementTable_a3d99283-ae31-4cc0-b3b5-dafecbf326a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_62269aba-ffa0-40cc-893a-7bc5877ceff7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_a3d99283-ae31-4cc0-b3b5-dafecbf326a4" xlink:to="loc_srt_ProductOrServiceAxis_62269aba-ffa0-40cc-893a-7bc5877ceff7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_a9d30c1f-8ff2-4c67-872d-ac9070f5f741" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_62269aba-ffa0-40cc-893a-7bc5877ceff7" xlink:to="loc_srt_ProductsAndServicesDomain_a9d30c1f-8ff2-4c67-872d-ac9070f5f741" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_InstrumentationMember_c9053410-fee3-47ca-a1a9-c097b0d0ec33" xlink:href="a-20220131.xsd#a_InstrumentationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_a9d30c1f-8ff2-4c67-872d-ac9070f5f741" xlink:to="loc_a_InstrumentationMember_c9053410-fee3-47ca-a1a9-c097b0d0ec33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_NonInstrumentationandOtherMember_94c002e6-c3dd-473e-916d-74273f57bd16" xlink:href="a-20220131.xsd#a_NonInstrumentationandOtherMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_a9d30c1f-8ff2-4c67-872d-ac9070f5f741" xlink:to="loc_a_NonInstrumentationandOtherMember_94c002e6-c3dd-473e-916d-74273f57bd16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_c04d166f-335b-4a6c-9dfa-69e0977ab27d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_a3d99283-ae31-4cc0-b3b5-dafecbf326a4" xlink:to="loc_us-gaap_StatementLineItems_c04d166f-335b-4a6c-9dfa-69e0977ab27d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_c856a836-3b2e-4d48-8fac-83f620860321" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_c04d166f-335b-4a6c-9dfa-69e0977ab27d" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_c856a836-3b2e-4d48-8fac-83f620860321" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/REVENUEContractAssetsandLiabilityDetails" xlink:type="simple" xlink:href="a-20220131.xsd#REVENUEContractAssetsandLiabilityDetails"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/REVENUEContractAssetsandLiabilityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_c3fcd42c-caf2-4acd-ac00-ec9cd7f9da0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityAbstract_2902e4f9-2623-4606-ba8c-7c4158b3e507" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_c3fcd42c-caf2-4acd-ac00-ec9cd7f9da0b" xlink:to="loc_us-gaap_ContractWithCustomerAssetAndLiabilityAbstract_2902e4f9-2623-4606-ba8c-7c4158b3e507" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNet_de3e0a13-ae97-4c54-95a2-b857dd5c8dc1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerAssetAndLiabilityAbstract_2902e4f9-2623-4606-ba8c-7c4158b3e507" xlink:to="loc_us-gaap_ContractWithCustomerAssetNet_de3e0a13-ae97-4c54-95a2-b857dd5c8dc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_IncreaseinContractAssetBalance_14526f09-9a12-4ba9-93e5-395ed8c22c6a" xlink:href="a-20220131.xsd#a_IncreaseinContractAssetBalance"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerAssetAndLiabilityAbstract_2902e4f9-2623-4606-ba8c-7c4158b3e507" xlink:to="loc_a_IncreaseinContractAssetBalance_14526f09-9a12-4ba9-93e5-395ed8c22c6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityAbstract_7861a3bd-d51d-4f62-bc3b-5945521e3a68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_c3fcd42c-caf2-4acd-ac00-ec9cd7f9da0b" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityAbstract_7861a3bd-d51d-4f62-bc3b-5945521e3a68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_bece0132-1077-4a1c-874c-6b719b267539" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityAbstract_7861a3bd-d51d-4f62-bc3b-5945521e3a68" xlink:to="loc_us-gaap_ContractWithCustomerLiability_bece0132-1077-4a1c-874c-6b719b267539" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenuePeriodIncreaseDecrease_c87a76ca-3ebd-4b9a-bd46-eb40aac2b19c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredRevenuePeriodIncreaseDecrease"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityAbstract_7861a3bd-d51d-4f62-bc3b-5945521e3a68" xlink:to="loc_us-gaap_DeferredRevenuePeriodIncreaseDecrease_c87a76ca-3ebd-4b9a-bd46-eb40aac2b19c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_d850ec55-1d79-4493-bff9-13559be06957" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityAbstract_7861a3bd-d51d-4f62-bc3b-5945521e3a68" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_d850ec55-1d79-4493-bff9-13559be06957" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_f5600607-c7f5-4bec-8135-537c0659531d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityAbstract_7861a3bd-d51d-4f62-bc3b-5945521e3a68" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_f5600607-c7f5-4bec-8135-537c0659531d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_IncreasedecreaseinDeferredRevenuefromCustomerCashAdvancesNetofRevenuerecognized_38ca144a-c6d7-452c-a014-95a4e435ecb5" xlink:href="a-20220131.xsd#a_IncreasedecreaseinDeferredRevenuefromCustomerCashAdvancesNetofRevenuerecognized"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityAbstract_7861a3bd-d51d-4f62-bc3b-5945521e3a68" xlink:to="loc_a_IncreasedecreaseinDeferredRevenuefromCustomerCashAdvancesNetofRevenuerecognized_38ca144a-c6d7-452c-a014-95a4e435ecb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination_88cef0f5-ecff-4661-bcb0-1486edb073fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityAbstract_7861a3bd-d51d-4f62-bc3b-5945521e3a68" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination_88cef0f5-ecff-4661-bcb0-1486edb073fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease_7cdec9c4-71dc-45e0-9da3-df62291997eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityAbstract_7861a3bd-d51d-4f62-bc3b-5945521e3a68" xlink:to="loc_us-gaap_TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease_7cdec9c4-71dc-45e0-9da3-df62291997eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_9b6c3746-92a7-4697-bb2e-7183ba5718f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityAbstract_7861a3bd-d51d-4f62-bc3b-5945521e3a68" xlink:to="loc_us-gaap_ContractWithCustomerLiability_9b6c3746-92a7-4697-bb2e-7183ba5718f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/REVENUERemainingPerformanceObligationDetails" xlink:type="simple" xlink:href="a-20220131.xsd#REVENUERemainingPerformanceObligationDetails"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/REVENUERemainingPerformanceObligationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuePerformanceObligationAbstract_22df599c-3003-4fae-b199-582b36ed0073" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuePerformanceObligationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_5766b361-96ed-4154-87f5-743a720d52f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuePerformanceObligationAbstract_22df599c-3003-4fae-b199-582b36ed0073" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_5766b361-96ed-4154-87f5-743a720d52f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_aebdbfbe-ba87-43d0-bf17-c406c0254248" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_5766b361-96ed-4154-87f5-743a720d52f2" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_aebdbfbe-ba87-43d0-bf17-c406c0254248" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_34ed9c2f-e6c0-454c-ab38-813430efb8a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_5766b361-96ed-4154-87f5-743a720d52f2" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_34ed9c2f-e6c0-454c-ab38-813430efb8a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_5af0cfcc-0c0a-4ef8-a84e-2185cc0278ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_34ed9c2f-e6c0-454c-ab38-813430efb8a1" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_5af0cfcc-0c0a-4ef8-a84e-2185cc0278ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_16af69e6-302d-4928-9968-7d952e717781" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_34ed9c2f-e6c0-454c-ab38-813430efb8a1" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_16af69e6-302d-4928-9968-7d952e717781" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/REVENUERemainingPerformanceObligationDetails_1" xlink:type="simple" xlink:href="a-20220131.xsd#REVENUERemainingPerformanceObligationDetails_1"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/REVENUERemainingPerformanceObligationDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.agilent.com/role/SHAREBASEDCOMPENSATIONNotes" xlink:type="simple" xlink:href="a-20220131.xsd#SHAREBASEDCOMPENSATIONNotes"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/SHAREBASEDCOMPENSATIONNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAbstract_405a087f-c43f-407d-9307-df241a863319" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_7c4850b8-1313-4780-85a1-75e3b98f6952" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationAbstract_405a087f-c43f-407d-9307-df241a863319" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_7c4850b8-1313-4780-85a1-75e3b98f6952" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/SHAREBASEDCOMPENSATIONTables" xlink:type="simple" xlink:href="a-20220131.xsd#SHAREBASEDCOMPENSATIONTables"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/SHAREBASEDCOMPENSATIONTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAbstract_19869799-65e3-4bb3-84ce-e8ee6c8a6c87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_89d1797b-c167-4310-9b89-a6b46e012a1f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationAbstract_19869799-65e3-4bb3-84ce-e8ee6c8a6c87" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_89d1797b-c167-4310-9b89-a6b46e012a1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyTextBlock_fa7b2897-f371-4a4d-9d55-09f0e6840048" xlink:href="a-20220131.xsd#a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationAbstract_19869799-65e3-4bb3-84ce-e8ee6c8a6c87" xlink:to="loc_a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyTextBlock_fa7b2897-f371-4a4d-9d55-09f0e6840048" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_8fb88f7c-6593-42a2-8e95-e974c58e48bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationAbstract_19869799-65e3-4bb3-84ce-e8ee6c8a6c87" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_8fb88f7c-6593-42a2-8e95-e974c58e48bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/SHAREBASEDCOMPENSATIONTextDetails" xlink:type="simple" xlink:href="a-20220131.xsd#SHAREBASEDCOMPENSATIONTextDetails"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/SHAREBASEDCOMPENSATIONTextDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_dc0e4893-318f-4e6a-b6c5-6a6caa100686" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_49d54959-0946-4a71-bc87-a201feea435d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_dc0e4893-318f-4e6a-b6c5-6a6caa100686" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_49d54959-0946-4a71-bc87-a201feea435d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_7839b348-09cc-4352-9c84-9ba59e46156f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_49d54959-0946-4a71-bc87-a201feea435d" xlink:to="loc_srt_RangeAxis_7839b348-09cc-4352-9c84-9ba59e46156f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_f2d4f226-fc14-4ad8-b740-36eb1f93f91e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_7839b348-09cc-4352-9c84-9ba59e46156f" xlink:to="loc_srt_RangeMember_f2d4f226-fc14-4ad8-b740-36eb1f93f91e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_c9f883d8-3b4e-4b1f-b05d-1954156bc159" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_f2d4f226-fc14-4ad8-b740-36eb1f93f91e" xlink:to="loc_srt_MinimumMember_c9f883d8-3b4e-4b1f-b05d-1954156bc159" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_9f7b84a0-d141-4f65-a96d-c9785acaaff2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_f2d4f226-fc14-4ad8-b740-36eb1f93f91e" xlink:to="loc_srt_MaximumMember_9f7b84a0-d141-4f65-a96d-c9785acaaff2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_4af0fc96-0321-49f5-aa07-c412e796825e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_49d54959-0946-4a71-bc87-a201feea435d" xlink:to="loc_us-gaap_AwardTypeAxis_4af0fc96-0321-49f5-aa07-c412e796825e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_76ffdfb4-58c4-4734-96c0-5eed30fb1bfc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_4af0fc96-0321-49f5-aa07-c412e796825e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_76ffdfb4-58c4-4734-96c0-5eed30fb1bfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_dc6b826e-2563-495f-a9fd-413dd9ff6ed8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_76ffdfb4-58c4-4734-96c0-5eed30fb1bfc" xlink:to="loc_us-gaap_EmployeeStockMember_dc6b826e-2563-495f-a9fd-413dd9ff6ed8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_07cde7d3-d0be-4969-9736-8327e3dbc36a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_76ffdfb4-58c4-4734-96c0-5eed30fb1bfc" xlink:to="loc_us-gaap_EmployeeStockOptionMember_07cde7d3-d0be-4969-9736-8327e3dbc36a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_363d9cf5-d202-4349-a012-deff24706582" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_76ffdfb4-58c4-4734-96c0-5eed30fb1bfc" xlink:to="loc_us-gaap_PerformanceSharesMember_363d9cf5-d202-4349-a012-deff24706582" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_94d18fc6-25db-45b2-bc31-61bfbf155794" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_76ffdfb4-58c4-4734-96c0-5eed30fb1bfc" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_94d18fc6-25db-45b2-bc31-61bfbf155794" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_58c448aa-b64c-4be3-a052-64798dfc9473" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_49d54959-0946-4a71-bc87-a201feea435d" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_58c448aa-b64c-4be3-a052-64798dfc9473" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_16555769-f50a-4c6b-8cc7-a727ac4bcef0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_58c448aa-b64c-4be3-a052-64798dfc9473" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_16555769-f50a-4c6b-8cc7-a727ac4bcef0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PublicUtilitiesInventoryTypeDomain_f4f0f55b-8b53-4a99-879f-0c1fbf1bad58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PublicUtilitiesInventoryTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_16555769-f50a-4c6b-8cc7-a727ac4bcef0" xlink:to="loc_us-gaap_PublicUtilitiesInventoryTypeDomain_f4f0f55b-8b53-4a99-879f-0c1fbf1bad58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5f92a3dd-267c-421f-9faf-ec57f325adfc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_49d54959-0946-4a71-bc87-a201feea435d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5f92a3dd-267c-421f-9faf-ec57f325adfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_e31e4968-87da-4312-8576-c1a5a48bae09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5f92a3dd-267c-421f-9faf-ec57f325adfc" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_e31e4968-87da-4312-8576-c1a5a48bae09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_22e0aada-c583-42fb-8949-d8b88bd8bb3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5f92a3dd-267c-421f-9faf-ec57f325adfc" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_22e0aada-c583-42fb-8949-d8b88bd8bb3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_3e0a6496-3d87-48da-8c92-e35893c0c2b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5f92a3dd-267c-421f-9faf-ec57f325adfc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_3e0a6496-3d87-48da-8c92-e35893c0c2b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1_742fed84-be41-42f3-94bf-511fd2c234a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5f92a3dd-267c-421f-9faf-ec57f325adfc" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1_742fed84-be41-42f3-94bf-511fd2c234a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate_dbd670c8-acea-40c3-8fff-74cf026546d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5f92a3dd-267c-421f-9faf-ec57f325adfc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate_dbd670c8-acea-40c3-8fff-74cf026546d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_12b5bc24-d3d7-4eae-8cf7-57014aa74e34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5f92a3dd-267c-421f-9faf-ec57f325adfc" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_12b5bc24-d3d7-4eae-8cf7-57014aa74e34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_52f310ef-199d-40e0-96ed-28a5282c54c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5f92a3dd-267c-421f-9faf-ec57f325adfc" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_52f310ef-199d-40e0-96ed-28a5282c54c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/SHAREBASEDCOMPENSATIONAllocatedSharebasedcompensationexpenseDetails" xlink:type="simple" xlink:href="a-20220131.xsd#SHAREBASEDCOMPENSATIONAllocatedSharebasedcompensationexpenseDetails"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/SHAREBASEDCOMPENSATIONAllocatedSharebasedcompensationexpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAbstract_d9b40eda-92b9-4687-8e72-3f192d593b01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_5de31506-c9b6-4f36-b9b0-e9df9b81286a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationAbstract_d9b40eda-92b9-4687-8e72-3f192d593b01" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_5de31506-c9b6-4f36-b9b0-e9df9b81286a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_5223ba23-ae7e-4db4-a58e-c8d38c0fe65f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_5de31506-c9b6-4f36-b9b0-e9df9b81286a" xlink:to="loc_us-gaap_AwardTypeAxis_5223ba23-ae7e-4db4-a58e-c8d38c0fe65f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c59ccfc0-657e-4621-895f-d9f995df0a06" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_5223ba23-ae7e-4db4-a58e-c8d38c0fe65f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c59ccfc0-657e-4621-895f-d9f995df0a06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_LtppMember_25e77e4e-4c47-470a-b15b-f916bdced807" xlink:href="a-20220131.xsd#a_LtppMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c59ccfc0-657e-4621-895f-d9f995df0a06" xlink:to="loc_a_LtppMember_25e77e4e-4c47-470a-b15b-f916bdced807" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_3f344f80-0c4b-4f82-becb-ba39095f82a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_5de31506-c9b6-4f36-b9b0-e9df9b81286a" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_3f344f80-0c4b-4f82-becb-ba39095f82a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_de1823dd-1d50-4fa9-817c-f948a7ad8389" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_3f344f80-0c4b-4f82-becb-ba39095f82a9" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_de1823dd-1d50-4fa9-817c-f948a7ad8389" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_18ecf4e2-90d1-44f7-8ca6-ee21f370a36f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_de1823dd-1d50-4fa9-817c-f948a7ad8389" xlink:to="loc_us-gaap_CostOfSalesMember_18ecf4e2-90d1-44f7-8ca6-ee21f370a36f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_98966345-7618-4e45-8b55-1423da01890b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_de1823dd-1d50-4fa9-817c-f948a7ad8389" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_98966345-7618-4e45-8b55-1423da01890b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_37c416da-cc0c-4739-896a-c52ceb729fc5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_de1823dd-1d50-4fa9-817c-f948a7ad8389" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_37c416da-cc0c-4739-896a-c52ceb729fc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_03d66238-709d-4181-a25b-efe9819c8a69" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_5de31506-c9b6-4f36-b9b0-e9df9b81286a" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_03d66238-709d-4181-a25b-efe9819c8a69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_c3534afa-20b5-4c9a-aab3-bafe5efe693e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_03d66238-709d-4181-a25b-efe9819c8a69" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_c3534afa-20b5-4c9a-aab3-bafe5efe693e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PublicUtilitiesInventoryTypeDomain_3505d2a4-c9f1-4e2f-8839-047c2e1abff6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PublicUtilitiesInventoryTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_c3534afa-20b5-4c9a-aab3-bafe5efe693e" xlink:to="loc_us-gaap_PublicUtilitiesInventoryTypeDomain_3505d2a4-c9f1-4e2f-8839-047c2e1abff6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_9dbf982d-5fa6-4b21-8613-41874f570120" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_5de31506-c9b6-4f36-b9b0-e9df9b81286a" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_9dbf982d-5fa6-4b21-8613-41874f570120" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_978769cf-4be5-4682-a65b-ac21a4635ccc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_9dbf982d-5fa6-4b21-8613-41874f570120" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_978769cf-4be5-4682-a65b-ac21a4635ccc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/SHAREBASEDCOMPENSATIONFairValueAssumptionsDetails" xlink:type="simple" xlink:href="a-20220131.xsd#SHAREBASEDCOMPENSATIONFairValueAssumptionsDetails"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/SHAREBASEDCOMPENSATIONFairValueAssumptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAbstract_319e2756-4b96-43c7-bdc6-f0426b227231" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_de91b770-bebb-47e2-8c1b-3769b25c6902" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationAbstract_319e2756-4b96-43c7-bdc6-f0426b227231" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_de91b770-bebb-47e2-8c1b-3769b25c6902" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_df778e0f-721e-4fc1-816c-67f8c50c41e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_de91b770-bebb-47e2-8c1b-3769b25c6902" xlink:to="loc_us-gaap_AwardTypeAxis_df778e0f-721e-4fc1-816c-67f8c50c41e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3a101146-0e44-4975-8111-978636e3e393" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_df778e0f-721e-4fc1-816c-67f8c50c41e1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3a101146-0e44-4975-8111-978636e3e393" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_58178ce2-8819-459f-be8e-76bd4bb310b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3a101146-0e44-4975-8111-978636e3e393" xlink:to="loc_us-gaap_EmployeeStockOptionMember_58178ce2-8819-459f-be8e-76bd4bb310b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_LtppMember_894fc249-9315-4c85-a6b3-dfd6b426a4c7" xlink:href="a-20220131.xsd#a_LtppMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3a101146-0e44-4975-8111-978636e3e393" xlink:to="loc_a_LtppMember_894fc249-9315-4c85-a6b3-dfd6b426a4c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_LTPPRSUMember_080cc00e-6ca2-4858-b884-653a1bf525be" xlink:href="a-20220131.xsd#a_LTPPRSUMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3a101146-0e44-4975-8111-978636e3e393" xlink:to="loc_a_LTPPRSUMember_080cc00e-6ca2-4858-b884-653a1bf525be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d8e7a66d-51f9-4e66-9826-215c0c52305a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_de91b770-bebb-47e2-8c1b-3769b25c6902" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d8e7a66d-51f9-4e66-9826-215c0c52305a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_0a709f7e-5a5a-41ab-91ce-6661ac98125c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d8e7a66d-51f9-4e66-9826-215c0c52305a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_0a709f7e-5a5a-41ab-91ce-6661ac98125c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesVolatilityRateRangeMinimum_8a71a7a5-5070-4b91-8d63-63af6d3c61c1" xlink:href="a-20220131.xsd#a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesVolatilityRateRangeMinimum"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d8e7a66d-51f9-4e66-9826-215c0c52305a" xlink:to="loc_a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesVolatilityRateRangeMinimum_8a71a7a5-5070-4b91-8d63-63af6d3c61c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesVolatilityRateRangeMaximum_72c80792-a52c-48a7-84f8-169644948280" xlink:href="a-20220131.xsd#a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesVolatilityRateRangeMaximum"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d8e7a66d-51f9-4e66-9826-215c0c52305a" xlink:to="loc_a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesVolatilityRateRangeMaximum_72c80792-a52c-48a7-84f8-169644948280" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesPriceWiseCorrelationyRate_3d6053cb-bd0d-410d-a61a-38b89b90e27a" xlink:href="a-20220131.xsd#a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesPriceWiseCorrelationyRate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d8e7a66d-51f9-4e66-9826-215c0c52305a" xlink:to="loc_a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesPriceWiseCorrelationyRate_3d6053cb-bd0d-410d-a61a-38b89b90e27a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions_6591c49d-30a7-49c4-9251-ba8082674fe4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d8e7a66d-51f9-4e66-9826-215c0c52305a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions_6591c49d-30a7-49c4-9251-ba8082674fe4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_50667ee0-5ce3-41bd-be89-9ef4ae24f230" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d8e7a66d-51f9-4e66-9826-215c0c52305a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_50667ee0-5ce3-41bd-be89-9ef4ae24f230" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_d21e2623-9dff-4d15-9672-d243105c2c8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d8e7a66d-51f9-4e66-9826-215c0c52305a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_d21e2623-9dff-4d15-9672-d243105c2c8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_2d847091-f753-46db-9744-c6e2e8ed55e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d8e7a66d-51f9-4e66-9826-215c0c52305a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_2d847091-f753-46db-9744-c6e2e8ed55e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_0961de93-2d87-4201-a289-7eff046be35b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d8e7a66d-51f9-4e66-9826-215c0c52305a" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_0961de93-2d87-4201-a289-7eff046be35b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/INCOMETAXESNotes" xlink:type="simple" xlink:href="a-20220131.xsd#INCOMETAXESNotes"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/INCOMETAXESNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_878a1381-4c0f-45bd-84c2-7aaccfad6a0e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_107e3a71-6575-4f54-a00c-47b3b45c531e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_878a1381-4c0f-45bd-84c2-7aaccfad6a0e" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_107e3a71-6575-4f54-a00c-47b3b45c531e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/INCOMETAXESDetails" xlink:type="simple" xlink:href="a-20220131.xsd#INCOMETAXESDetails"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/INCOMETAXESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_a66308e7-4a17-4fcd-b748-9fe7a6237f8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationTable_f5cceb1e-77a6-4d46-b2ba-1fb30ab5d5f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExaminationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_a66308e7-4a17-4fcd-b748-9fe7a6237f8e" xlink:to="loc_us-gaap_IncomeTaxExaminationTable_f5cceb1e-77a6-4d46-b2ba-1fb30ab5d5f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_97adbdbf-5a1f-49f0-bfeb-fb6e36ab942a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExaminationTable_f5cceb1e-77a6-4d46-b2ba-1fb30ab5d5f9" xlink:to="loc_srt_StatementScenarioAxis_97adbdbf-5a1f-49f0-bfeb-fb6e36ab942a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_81029c82-be51-4063-978d-05afe505ade6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_97adbdbf-5a1f-49f0-bfeb-fb6e36ab942a" xlink:to="loc_srt_ScenarioUnspecifiedDomain_81029c82-be51-4063-978d-05afe505ade6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis_d4604682-af2d-445d-9f2f-6be783642d36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExaminationTable_f5cceb1e-77a6-4d46-b2ba-1fb30ab5d5f9" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameAxis_d4604682-af2d-445d-9f2f-6be783642d36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_8e01ce5b-65cc-4575-ac1c-633f84fbb50f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_d4604682-af2d-445d-9f2f-6be783642d36" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_8e01ce5b-65cc-4575-ac1c-633f84fbb50f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodAxis_35295071-36ca-4200-9d6c-2cedad6fff1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxPeriodAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExaminationTable_f5cceb1e-77a6-4d46-b2ba-1fb30ab5d5f9" xlink:to="loc_us-gaap_TaxPeriodAxis_35295071-36ca-4200-9d6c-2cedad6fff1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain_ef1d94de-0b15-4e20-be5b-abd2a7edfff0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxPeriodDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxPeriodAxis_35295071-36ca-4200-9d6c-2cedad6fff1b" xlink:to="loc_us-gaap_TaxPeriodDomain_ef1d94de-0b15-4e20-be5b-abd2a7edfff0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_b21c4b7b-ffec-4bf8-ae71-414b555c2499" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExaminationTable_f5cceb1e-77a6-4d46-b2ba-1fb30ab5d5f9" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_b21c4b7b-ffec-4bf8-ae71-414b555c2499" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_04cbb9b7-fa57-4053-851a-04bb45ee8d37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_b21c4b7b-ffec-4bf8-ae71-414b555c2499" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_04cbb9b7-fa57-4053-851a-04bb45ee8d37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationLineItems_6fec1499-c031-4157-b0c1-2328d9677d2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExaminationLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExaminationTable_f5cceb1e-77a6-4d46-b2ba-1fb30ab5d5f9" xlink:to="loc_us-gaap_IncomeTaxExaminationLineItems_6fec1499-c031-4157-b0c1-2328d9677d2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_949bc17b-4627-4f0f-beb6-9cbb512e09bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems_6fec1499-c031-4157-b0c1-2328d9677d2c" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_949bc17b-4627-4f0f-beb6-9cbb512e09bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_f72ae2fe-766b-4ce2-a773-185d95d39ff0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems_6fec1499-c031-4157-b0c1-2328d9677d2c" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_f72ae2fe-766b-4ce2-a773-185d95d39ff0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_3668e38f-0a3e-4ed4-838a-dda3fe2a2b72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems_6fec1499-c031-4157-b0c1-2328d9677d2c" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_3668e38f-0a3e-4ed4-838a-dda3fe2a2b72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherTaxExpenseBenefit_f89b9847-042c-4635-a986-45573ca1d997" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems_6fec1499-c031-4157-b0c1-2328d9677d2c" xlink:to="loc_us-gaap_OtherTaxExpenseBenefit_f89b9847-042c-4635-a986-45573ca1d997" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_be5d9f57-1b78-4185-ac8b-7cec57c8c180" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems_6fec1499-c031-4157-b0c1-2328d9677d2c" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_be5d9f57-1b78-4185-ac8b-7cec57c8c180" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_47f5af4b-d9b2-41b4-b3cd-0080d9468179" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems_6fec1499-c031-4157-b0c1-2328d9677d2c" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_47f5af4b-d9b2-41b4-b3cd-0080d9468179" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_473cc5c5-b7c4-4374-988a-1ff7507975e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems_6fec1499-c031-4157-b0c1-2328d9677d2c" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_473cc5c5-b7c4-4374-988a-1ff7507975e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/NETINCOMEPERSHARENotes" xlink:type="simple" xlink:href="a-20220131.xsd#NETINCOMEPERSHARENotes"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/NETINCOMEPERSHARENotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_b4207b4e-6ad5-4d5d-a08e-0c5c2e98f5af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_2da98e9f-591e-4fbc-8a83-ca7f2e21581f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_b4207b4e-6ad5-4d5d-a08e-0c5c2e98f5af" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_2da98e9f-591e-4fbc-8a83-ca7f2e21581f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/NETINCOMEPERSHARETables" xlink:type="simple" xlink:href="a-20220131.xsd#NETINCOMEPERSHARETables"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/NETINCOMEPERSHARETables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_a1c7ac11-d8e6-44cb-9d06-61c4e4a9bad3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_28619f72-3fc7-403e-ab25-b9c777636370" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_a1c7ac11-d8e6-44cb-9d06-61c4e4a9bad3" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_28619f72-3fc7-403e-ab25-b9c777636370" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/NETINCOMEPERSHAREDetails" xlink:type="simple" xlink:href="a-20220131.xsd#NETINCOMEPERSHAREDetails"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/NETINCOMEPERSHAREDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_5b99dad0-f047-4109-94e7-b0f5b20d0282" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_9ad00815-90f7-4bf9-9188-02aacc9c2e28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_5b99dad0-f047-4109-94e7-b0f5b20d0282" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_9ad00815-90f7-4bf9-9188-02aacc9c2e28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_3adc23ea-43d0-41eb-8199-252767c2baba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_9ad00815-90f7-4bf9-9188-02aacc9c2e28" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_3adc23ea-43d0-41eb-8199-252767c2baba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_c10ae78a-d027-4ac1-9af9-c7f772b652a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_3adc23ea-43d0-41eb-8199-252767c2baba" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_c10ae78a-d027-4ac1-9af9-c7f772b652a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_d2a1386f-e3b5-4c6e-89ec-c244a3ee17eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_9ad00815-90f7-4bf9-9188-02aacc9c2e28" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_d2a1386f-e3b5-4c6e-89ec-c244a3ee17eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_NumeratorAbstract_e8cb42ec-a9ff-470b-94a7-06a5b62d5486" xlink:href="a-20220131.xsd#a_NumeratorAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_d2a1386f-e3b5-4c6e-89ec-c244a3ee17eb" xlink:to="loc_a_NumeratorAbstract_e8cb42ec-a9ff-470b-94a7-06a5b62d5486" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_93d12211-7fef-40ec-8891-e39fb26f58f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_a_NumeratorAbstract_e8cb42ec-a9ff-470b-94a7-06a5b62d5486" xlink:to="loc_us-gaap_NetIncomeLoss_93d12211-7fef-40ec-8891-e39fb26f58f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_DenominatorsAbstract_2a15f39a-e9c0-430a-a6a5-b30fb34f6c5a" xlink:href="a-20220131.xsd#a_DenominatorsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_d2a1386f-e3b5-4c6e-89ec-c244a3ee17eb" xlink:to="loc_a_DenominatorsAbstract_2a15f39a-e9c0-430a-a6a5-b30fb34f6c5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_0b7b4d0c-70b0-4c9e-bd7d-eee39284c9b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_a_DenominatorsAbstract_2a15f39a-e9c0-430a-a6a5-b30fb34f6c5a" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_0b7b4d0c-70b0-4c9e-bd7d-eee39284c9b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_c0101b9b-e9f3-4a6c-9d19-b1458877868e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_a_DenominatorsAbstract_2a15f39a-e9c0-430a-a6a5-b30fb34f6c5a" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_c0101b9b-e9f3-4a6c-9d19-b1458877868e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_c2e244bd-28ea-4496-80e3-17bf624ebf23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_a_DenominatorsAbstract_2a15f39a-e9c0-430a-a6a5-b30fb34f6c5a" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_c2e244bd-28ea-4496-80e3-17bf624ebf23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_ed9f364c-3b57-4cd5-8650-c0c09b0e5f3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_d2a1386f-e3b5-4c6e-89ec-c244a3ee17eb" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_ed9f364c-3b57-4cd5-8650-c0c09b0e5f3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/INVENTORYNotes" xlink:type="simple" xlink:href="a-20220131.xsd#INVENTORYNotes"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/INVENTORYNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNetAbstract_da8ce2aa-5592-4d30-8748-637c56a91b96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNetAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock_0977d916-6f36-460f-a248-b20754c9ad92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetAbstract_da8ce2aa-5592-4d30-8748-637c56a91b96" xlink:to="loc_us-gaap_InventoryDisclosureTextBlock_0977d916-6f36-460f-a248-b20754c9ad92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/INVENTORYTables" xlink:type="simple" xlink:href="a-20220131.xsd#INVENTORYTables"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/INVENTORYTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNetAbstract_5e9ac3c0-f20a-4a83-8a1c-caac25194f31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNetAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_c41346b0-62c2-4390-ad37-aa9e64fba72c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetAbstract_5e9ac3c0-f20a-4a83-8a1c-caac25194f31" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_c41346b0-62c2-4390-ad37-aa9e64fba72c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/INVENTORYDetails" xlink:type="simple" xlink:href="a-20220131.xsd#INVENTORYDetails"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/INVENTORYDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNetAbstract_91d8a596-c5de-4a52-9013-fe68dc0fb6d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNetAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoods_f04c4a70-273d-4b96-a061-c6cd6181e925" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoods"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetAbstract_91d8a596-c5de-4a52-9013-fe68dc0fb6d4" xlink:to="loc_us-gaap_InventoryFinishedGoods_f04c4a70-273d-4b96-a061-c6cd6181e925" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessAndRawMaterials_956368e1-1f1f-420f-9e1e-ee770c5ab7d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWorkInProcessAndRawMaterials"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetAbstract_91d8a596-c5de-4a52-9013-fe68dc0fb6d4" xlink:to="loc_us-gaap_InventoryWorkInProcessAndRawMaterials_956368e1-1f1f-420f-9e1e-ee770c5ab7d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_97ee5031-c14b-4b84-9a2b-a0b1400c1fa5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetAbstract_91d8a596-c5de-4a52-9013-fe68dc0fb6d4" xlink:to="loc_us-gaap_InventoryNet_97ee5031-c14b-4b84-9a2b-a0b1400c1fa5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNotes" xlink:type="simple" xlink:href="a-20220131.xsd#GOODWILLANDOTHERINTANGIBLEASSETSNotes"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_40a4eb6b-1a67-40ab-830e-a2fbee1f593e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_32a616a8-cf65-47c2-9dbb-8793fc687be1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_40a4eb6b-1a67-40ab-830e-a2fbee1f593e" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_32a616a8-cf65-47c2-9dbb-8793fc687be1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables" xlink:type="simple" xlink:href="a-20220131.xsd#GOODWILLANDOTHERINTANGIBLEASSETSTables"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_da8501ef-9533-425a-898b-b00925b9c70a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_b20fd28f-b84f-4198-94b4-2900344a9e2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_da8501ef-9533-425a-898b-b00925b9c70a" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_b20fd28f-b84f-4198-94b4-2900344a9e2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_67b4be8b-ddb4-487b-99ff-853ad4edbbde" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_da8501ef-9533-425a-898b-b00925b9c70a" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_67b4be8b-ddb4-487b-99ff-853ad4edbbde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_a03885a9-943c-4aba-ae1d-039dc7dcd3e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_da8501ef-9533-425a-898b-b00925b9c70a" xlink:to="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_a03885a9-943c-4aba-ae1d-039dc7dcd3e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSGoodwillRollforwardDetails" xlink:type="simple" xlink:href="a-20220131.xsd#GOODWILLANDOTHERINTANGIBLEASSETSGoodwillRollforwardDetails"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSGoodwillRollforwardDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_1b17d4c4-4d1a-4da7-8f10-01fcf8407b34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_f8f477d0-a8c6-492d-9dcc-1e34037fda03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_1b17d4c4-4d1a-4da7-8f10-01fcf8407b34" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_f8f477d0-a8c6-492d-9dcc-1e34037fda03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_279245d6-3acd-4165-965c-55b04454f87c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_f8f477d0-a8c6-492d-9dcc-1e34037fda03" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_279245d6-3acd-4165-965c-55b04454f87c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_c317d751-ffe7-45bb-83b0-57915981439a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_279245d6-3acd-4165-965c-55b04454f87c" xlink:to="loc_us-gaap_SegmentDomain_c317d751-ffe7-45bb-83b0-57915981439a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_LifeSciencesandAppliedMarketsMember_00174006-fc73-46f9-8b79-7c47302e69fc" xlink:href="a-20220131.xsd#a_LifeSciencesandAppliedMarketsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_c317d751-ffe7-45bb-83b0-57915981439a" xlink:to="loc_a_LifeSciencesandAppliedMarketsMember_00174006-fc73-46f9-8b79-7c47302e69fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_DiagnosticsAndGenomicsMember_7d63b7d3-eb58-4b87-a8a8-173f94691f2c" xlink:href="a-20220131.xsd#a_DiagnosticsAndGenomicsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_c317d751-ffe7-45bb-83b0-57915981439a" xlink:to="loc_a_DiagnosticsAndGenomicsMember_7d63b7d3-eb58-4b87-a8a8-173f94691f2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_AgilentCrossLabMember_9012d539-3a10-40fb-9bc0-3d2d3dec615c" xlink:href="a-20220131.xsd#a_AgilentCrossLabMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_c317d751-ffe7-45bb-83b0-57915981439a" xlink:to="loc_a_AgilentCrossLabMember_9012d539-3a10-40fb-9bc0-3d2d3dec615c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_ba80d176-18d9-4b47-b2d9-3691af95e0b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_f8f477d0-a8c6-492d-9dcc-1e34037fda03" xlink:to="loc_us-gaap_GoodwillLineItems_ba80d176-18d9-4b47-b2d9-3691af95e0b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_35c973bc-2b08-453b-a105-b3dbcca1613f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_ba80d176-18d9-4b47-b2d9-3691af95e0b9" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_35c973bc-2b08-453b-a105-b3dbcca1613f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_44764497-cb3b-426e-b506-b4ebd38df7f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_ba80d176-18d9-4b47-b2d9-3691af95e0b9" xlink:to="loc_us-gaap_GoodwillRollForward_44764497-cb3b-426e-b506-b4ebd38df7f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTransfers_bfca3ed7-8f73-44d9-b2c4-c591c7bee20d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillTransfers"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_44764497-cb3b-426e-b506-b4ebd38df7f8" xlink:to="loc_us-gaap_GoodwillTransfers_bfca3ed7-8f73-44d9-b2c4-c591c7bee20d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_95577016-e3ce-4af8-ae4b-c19fef68b9db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_44764497-cb3b-426e-b506-b4ebd38df7f8" xlink:to="loc_us-gaap_Goodwill_95577016-e3ce-4af8-ae4b-c19fef68b9db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_d19ad55b-0584-40d7-97d5-3fba7ef5eb83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_44764497-cb3b-426e-b506-b4ebd38df7f8" xlink:to="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_d19ad55b-0584-40d7-97d5-3fba7ef5eb83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_3d7921fd-c241-4672-b691-7b3cac16c181" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_44764497-cb3b-426e-b506-b4ebd38df7f8" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_3d7921fd-c241-4672-b691-7b3cac16c181" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_a1cbb32a-37f6-4e15-a638-73311097862d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_44764497-cb3b-426e-b506-b4ebd38df7f8" xlink:to="loc_us-gaap_Goodwill_a1cbb32a-37f6-4e15-a638-73311097862d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDisclosuresandComponentsofPurchasedOtherIntangiblesDetails" xlink:type="simple" xlink:href="a-20220131.xsd#GOODWILLANDOTHERINTANGIBLEASSETSDisclosuresandComponentsofPurchasedOtherIntangiblesDetails"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDisclosuresandComponentsofPurchasedOtherIntangiblesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_1d895e85-ee06-4f01-9d13-5e11280166cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_42494cb1-ec4d-4d29-8bdc-d21e830cf72e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_1d895e85-ee06-4f01-9d13-5e11280166cc" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_42494cb1-ec4d-4d29-8bdc-d21e830cf72e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_a6514b41-6470-4303-9beb-9a8f334cfe48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_42494cb1-ec4d-4d29-8bdc-d21e830cf72e" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_a6514b41-6470-4303-9beb-9a8f334cfe48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_938fdf8f-437b-4c06-8b09-7ef04421e3b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_a6514b41-6470-4303-9beb-9a8f334cfe48" xlink:to="loc_us-gaap_SegmentDomain_938fdf8f-437b-4c06-8b09-7ef04421e3b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_a40aee32-e47d-4157-949a-84a5f0d84e9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_42494cb1-ec4d-4d29-8bdc-d21e830cf72e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_a40aee32-e47d-4157-949a-84a5f0d84e9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_30a94eb8-2124-4287-8175-8b958a9e69cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_a40aee32-e47d-4157-949a-84a5f0d84e9c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_30a94eb8-2124-4287-8175-8b958a9e69cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_52f0f1aa-808a-4851-a7b1-f4077d4aa7cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_30a94eb8-2124-4287-8175-8b958a9e69cb" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_52f0f1aa-808a-4851-a7b1-f4077d4aa7cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrderOrProductionBacklogMember_a153ab53-ba4b-479a-a4f1-fee430992775" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrderOrProductionBacklogMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_30a94eb8-2124-4287-8175-8b958a9e69cb" xlink:to="loc_us-gaap_OrderOrProductionBacklogMember_a153ab53-ba4b-479a-a4f1-fee430992775" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember_956317a3-fbbc-42a9-a657-1f76ed16fe94" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TrademarksMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_30a94eb8-2124-4287-8175-8b958a9e69cb" xlink:to="loc_us-gaap_TrademarksMember_956317a3-fbbc-42a9-a657-1f76ed16fe94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_5eef454d-8131-4b94-8b7d-c55b27801584" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_30a94eb8-2124-4287-8175-8b958a9e69cb" xlink:to="loc_us-gaap_CustomerRelationshipsMember_5eef454d-8131-4b94-8b7d-c55b27801584" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_ThirdPartyTechnologyandLicensesMember_dee780b3-c662-4563-9d0f-6ec663b8d034" xlink:href="a-20220131.xsd#a_ThirdPartyTechnologyandLicensesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_30a94eb8-2124-4287-8175-8b958a9e69cb" xlink:to="loc_a_ThirdPartyTechnologyandLicensesMember_dee780b3-c662-4563-9d0f-6ec663b8d034" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_842f98fe-e496-486d-a52e-63687c92f01f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_30a94eb8-2124-4287-8175-8b958a9e69cb" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_842f98fe-e496-486d-a52e-63687c92f01f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_96653994-2c54-4a5c-a4fe-4b694d6d1010" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_42494cb1-ec4d-4d29-8bdc-d21e830cf72e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_96653994-2c54-4a5c-a4fe-4b694d6d1010" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_fa074c34-976a-467b-b41c-946708e78579" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_96653994-2c54-4a5c-a4fe-4b694d6d1010" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_fa074c34-976a-467b-b41c-946708e78579" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_f89ece54-70cc-44f7-b7a7-0e7572a7cddb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNetAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_96653994-2c54-4a5c-a4fe-4b694d6d1010" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_f89ece54-70cc-44f7-b7a7-0e7572a7cddb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_144e49c0-eb96-4198-ad87-01941526d730" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_f89ece54-70cc-44f7-b7a7-0e7572a7cddb" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_144e49c0-eb96-4198-ad87-01941526d730" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_1eb579d8-06af-48f0-b9bc-75e4e05d96d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_f89ece54-70cc-44f7-b7a7-0e7572a7cddb" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_1eb579d8-06af-48f0-b9bc-75e4e05d96d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_bc5f98fe-dbd3-415e-9c71-f51aacf3d953" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_f89ece54-70cc-44f7-b7a7-0e7572a7cddb" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_bc5f98fe-dbd3-415e-9c71-f51aacf3d953" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_14bddb32-2ac0-4af6-9880-7ec14ebd357c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_f89ece54-70cc-44f7-b7a7-0e7572a7cddb" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_14bddb32-2ac0-4af6-9880-7ec14ebd357c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_d25b4a2d-ba36-44c2-807a-a71c2cce738a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_f89ece54-70cc-44f7-b7a7-0e7572a7cddb" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_d25b4a2d-ba36-44c2-807a-a71c2cce738a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract_323a737d-d7dc-4249-a619-ac10ff0adadc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_96653994-2c54-4a5c-a4fe-4b694d6d1010" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract_323a737d-d7dc-4249-a619-ac10ff0adadc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_b5a9fc5e-ee6b-498f-bfb2-ed3dd1589035" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract_323a737d-d7dc-4249-a619-ac10ff0adadc" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_b5a9fc5e-ee6b-498f-bfb2-ed3dd1589035" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTextualsDetails" xlink:type="simple" xlink:href="a-20220131.xsd#GOODWILLANDOTHERINTANGIBLEASSETSTextualsDetails"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTextualsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_b79d3d84-aa6a-43ba-9d2e-9641f96c45ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_45165381-ecff-4f29-a391-19ce5b8814d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_b79d3d84-aa6a-43ba-9d2e-9641f96c45ec" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_45165381-ecff-4f29-a391-19ce5b8814d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_537b1646-f890-40e0-a732-4b3d46e2574b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_45165381-ecff-4f29-a391-19ce5b8814d0" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_537b1646-f890-40e0-a732-4b3d46e2574b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1fd6ec70-56d3-4bc9-9653-1dc3dd20179b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_537b1646-f890-40e0-a732-4b3d46e2574b" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1fd6ec70-56d3-4bc9-9653-1dc3dd20179b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_ResolutionBioscienceIncMember_34a0ac1c-e6d7-4a51-baba-ac087a8644cf" xlink:href="a-20220131.xsd#a_ResolutionBioscienceIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1fd6ec70-56d3-4bc9-9653-1dc3dd20179b" xlink:to="loc_a_ResolutionBioscienceIncMember_34a0ac1c-e6d7-4a51-baba-ac087a8644cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ce0547e2-64de-4ad3-aa94-d5da849c7ab3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_45165381-ecff-4f29-a391-19ce5b8814d0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ce0547e2-64de-4ad3-aa94-d5da849c7ab3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_36509482-5a13-4ca2-840c-00cf51290216" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ce0547e2-64de-4ad3-aa94-d5da849c7ab3" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_36509482-5a13-4ca2-840c-00cf51290216" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_ThirdPartyTechnologyandLicensesMember_8ef288a2-90b9-49f2-af61-d2729580213e" xlink:href="a-20220131.xsd#a_ThirdPartyTechnologyandLicensesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_36509482-5a13-4ca2-840c-00cf51290216" xlink:to="loc_a_ThirdPartyTechnologyandLicensesMember_8ef288a2-90b9-49f2-af61-d2729580213e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_d90b0ee2-bdc2-43cc-ad57-64dd0c5a6190" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_45165381-ecff-4f29-a391-19ce5b8814d0" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_d90b0ee2-bdc2-43cc-ad57-64dd0c5a6190" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_78b8c5aa-042e-4e19-b3eb-7c4cd2fcd318" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_d90b0ee2-bdc2-43cc-ad57-64dd0c5a6190" xlink:to="loc_us-gaap_SegmentDomain_78b8c5aa-042e-4e19-b3eb-7c4cd2fcd318" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_LifeSciencesandAppliedMarketsMember_70f76849-5a63-425b-a006-0e1233473e6c" xlink:href="a-20220131.xsd#a_LifeSciencesandAppliedMarketsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_78b8c5aa-042e-4e19-b3eb-7c4cd2fcd318" xlink:to="loc_a_LifeSciencesandAppliedMarketsMember_70f76849-5a63-425b-a006-0e1233473e6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_DiagnosticsAndGenomicsMember_5d72bab9-d799-4855-a165-bde93f76df2a" xlink:href="a-20220131.xsd#a_DiagnosticsAndGenomicsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_78b8c5aa-042e-4e19-b3eb-7c4cd2fcd318" xlink:to="loc_a_DiagnosticsAndGenomicsMember_5d72bab9-d799-4855-a165-bde93f76df2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_AgilentCrossLabMember_5ae59489-e32e-4101-969b-dfc4896d8cfa" xlink:href="a-20220131.xsd#a_AgilentCrossLabMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_78b8c5aa-042e-4e19-b3eb-7c4cd2fcd318" xlink:to="loc_a_AgilentCrossLabMember_5ae59489-e32e-4101-969b-dfc4896d8cfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_16c2b148-4b37-4302-813e-332fa238af66" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_45165381-ecff-4f29-a391-19ce5b8814d0" xlink:to="loc_srt_RangeAxis_16c2b148-4b37-4302-813e-332fa238af66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_64037d0d-9acb-490a-a494-4435ff293522" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_16c2b148-4b37-4302-813e-332fa238af66" xlink:to="loc_srt_RangeMember_64037d0d-9acb-490a-a494-4435ff293522" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_03767688-fe27-41c2-93f0-8c46e2e3083f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_45165381-ecff-4f29-a391-19ce5b8814d0" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_03767688-fe27-41c2-93f0-8c46e2e3083f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_d29bbdd6-6280-4440-bd4e-1861fc17cb31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_03767688-fe27-41c2-93f0-8c46e2e3083f" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_d29bbdd6-6280-4440-bd4e-1861fc17cb31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_be1e0d02-77f1-4f55-81c4-69e85e37452a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_d29bbdd6-6280-4440-bd4e-1861fc17cb31" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_be1e0d02-77f1-4f55-81c4-69e85e37452a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_3be02b87-acbf-4408-9283-3fecd682a6c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_d29bbdd6-6280-4440-bd4e-1861fc17cb31" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_3be02b87-acbf-4408-9283-3fecd682a6c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillMember_371a4e57-6384-4dab-8d5f-45243551d679" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_d29bbdd6-6280-4440-bd4e-1861fc17cb31" xlink:to="loc_us-gaap_GoodwillMember_371a4e57-6384-4dab-8d5f-45243551d679" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_d20d006a-ce79-4fe7-838e-5c530c06339a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_d29bbdd6-6280-4440-bd4e-1861fc17cb31" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_d20d006a-ce79-4fe7-838e-5c530c06339a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_57725309-87d9-4e59-9ee5-c325d6273b8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_45165381-ecff-4f29-a391-19ce5b8814d0" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_57725309-87d9-4e59-9ee5-c325d6273b8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5609eea3-fa33-4a09-b28c-58a049ab7be0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_57725309-87d9-4e59-9ee5-c325d6273b8b" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5609eea3-fa33-4a09-b28c-58a049ab7be0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_1741de59-2b70-47e1-a4bf-e3f759c2a060" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5609eea3-fa33-4a09-b28c-58a049ab7be0" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_1741de59-2b70-47e1-a4bf-e3f759c2a060" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_bd4d96d7-aed3-4306-a442-2c849f6eead9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_45165381-ecff-4f29-a391-19ce5b8814d0" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_bd4d96d7-aed3-4306-a442-2c849f6eead9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_5a596f82-877b-4334-a5df-293eacdb455b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_bd4d96d7-aed3-4306-a442-2c849f6eead9" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_5a596f82-877b-4334-a5df-293eacdb455b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_699caff4-6892-42c4-9e62-eb98dd2633ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_5a596f82-877b-4334-a5df-293eacdb455b" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_699caff4-6892-42c4-9e62-eb98dd2633ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_bd2b5d76-b568-4d23-91f2-bed4374ac113" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_45165381-ecff-4f29-a391-19ce5b8814d0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_bd2b5d76-b568-4d23-91f2-bed4374ac113" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease_5fd323ef-64ea-4efe-a22c-218e71598e39" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_bd2b5d76-b568-4d23-91f2-bed4374ac113" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease_5fd323ef-64ea-4efe-a22c-218e71598e39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_4fafc653-2af5-4f0d-bc4e-f17829cb0717" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_bd2b5d76-b568-4d23-91f2-bed4374ac113" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_4fafc653-2af5-4f0d-bc4e-f17829cb0717" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss_f97b3e07-77a0-4608-be54-a4611cbe3a3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_bd2b5d76-b568-4d23-91f2-bed4374ac113" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss_f97b3e07-77a0-4608-be54-a4611cbe3a3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_3889918e-25ff-4039-889a-904ccc38b682" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_bd2b5d76-b568-4d23-91f2-bed4374ac113" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_3889918e-25ff-4039-889a-904ccc38b682" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_43d0774d-aaba-41ff-b292-6eb29df0460a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_bd2b5d76-b568-4d23-91f2-bed4374ac113" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_43d0774d-aaba-41ff-b292-6eb29df0460a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_0cf8fb6e-e79c-4f6d-827f-f7cd58056262" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_bd2b5d76-b568-4d23-91f2-bed4374ac113" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_0cf8fb6e-e79c-4f6d-827f-f7cd58056262" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSEstimatedFutureAmortizationDetails" xlink:type="simple" xlink:href="a-20220131.xsd#GOODWILLANDOTHERINTANGIBLEASSETSEstimatedFutureAmortizationDetails"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSEstimatedFutureAmortizationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_4fa25b97-b68b-4ece-a26a-181d55edd95e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_8044f4e0-ce63-46ab-bdf5-90eb8f6dbdc3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_4fa25b97-b68b-4ece-a26a-181d55edd95e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_8044f4e0-ce63-46ab-bdf5-90eb8f6dbdc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_4c8ca4e1-be09-4206-9e09-69adaf7ef32e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_4fa25b97-b68b-4ece-a26a-181d55edd95e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_4c8ca4e1-be09-4206-9e09-69adaf7ef32e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_df63ff66-24a9-421b-aed4-344e4a4c3385" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_4fa25b97-b68b-4ece-a26a-181d55edd95e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_df63ff66-24a9-421b-aed4-344e4a4c3385" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_c0958414-1085-41bb-b496-c317372122f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_4fa25b97-b68b-4ece-a26a-181d55edd95e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_c0958414-1085-41bb-b496-c317372122f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_1a77bd4c-1c54-4919-8677-5a237bd0af8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_4fa25b97-b68b-4ece-a26a-181d55edd95e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_1a77bd4c-1c54-4919-8677-5a237bd0af8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_38a98157-8fb2-4a06-8ab4-a9ebe669ac26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_4fa25b97-b68b-4ece-a26a-181d55edd95e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_38a98157-8fb2-4a06-8ab4-a9ebe669ac26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_3b68fb6e-4b63-4f59-9f9c-7ad3ee5654f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_4fa25b97-b68b-4ece-a26a-181d55edd95e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_3b68fb6e-4b63-4f59-9f9c-7ad3ee5654f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/FAIRVALUEMEASUREMENTSNotes" xlink:type="simple" xlink:href="a-20220131.xsd#FAIRVALUEMEASUREMENTSNotes"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/FAIRVALUEMEASUREMENTSNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_0239d741-7ccc-48bf-803f-4ebfbb57b8a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_f4037d34-3dcb-43ed-b55c-2a8a578e4d27" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_0239d741-7ccc-48bf-803f-4ebfbb57b8a5" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_f4037d34-3dcb-43ed-b55c-2a8a578e4d27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/FAIRVALUEMEASUREMENTSTables" xlink:type="simple" xlink:href="a-20220131.xsd#FAIRVALUEMEASUREMENTSTables"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/FAIRVALUEMEASUREMENTSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_e0505eb3-722e-455b-81c9-209442a29a34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_ede60882-8ae9-4da6-8249-b0957231f4a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_e0505eb3-722e-455b-81c9-209442a29a34" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_ede60882-8ae9-4da6-8249-b0957231f4a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_2eb031f6-abb4-4f27-a960-0ae2c24bf4ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_e0505eb3-722e-455b-81c9-209442a29a34" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_2eb031f6-abb4-4f27-a960-0ae2c24bf4ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/FAIRVALUEMEASUREMENTSFairvalueofassetsandliabilitiesmeasuredonarecurringbasisDetails" xlink:type="simple" xlink:href="a-20220131.xsd#FAIRVALUEMEASUREMENTSFairvalueofassetsandliabilitiesmeasuredonarecurringbasisDetails"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/FAIRVALUEMEASUREMENTSFairvalueofassetsandliabilitiesmeasuredonarecurringbasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_3df7039d-e0af-4e2d-9570-912de394da4e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_34edffce-d928-4104-adb5-bbf186f4105a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_3df7039d-e0af-4e2d-9570-912de394da4e" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_34edffce-d928-4104-adb5-bbf186f4105a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_cadbc1c0-4e63-4467-b7ba-1aef5e96f88d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_34edffce-d928-4104-adb5-bbf186f4105a" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_cadbc1c0-4e63-4467-b7ba-1aef5e96f88d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_cc057abf-73b4-4d37-8ca7-9e74b0a0b137" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_cadbc1c0-4e63-4467-b7ba-1aef5e96f88d" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_cc057abf-73b4-4d37-8ca7-9e74b0a0b137" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_d2c66c79-1936-491d-a95b-e9a4aaf94fe4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_cc057abf-73b4-4d37-8ca7-9e74b0a0b137" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_d2c66c79-1936-491d-a95b-e9a4aaf94fe4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsNonrecurringMember_94b87b56-a229-4078-85c2-48e49ce9431c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsNonrecurringMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_cc057abf-73b4-4d37-8ca7-9e74b0a0b137" xlink:to="loc_us-gaap_FairValueMeasurementsNonrecurringMember_94b87b56-a229-4078-85c2-48e49ce9431c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_362821d1-40f7-4574-b3e2-feb8578369f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_34edffce-d928-4104-adb5-bbf186f4105a" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_362821d1-40f7-4574-b3e2-feb8578369f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0369e5f2-ddf2-4c84-9621-d7cd9c016922" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_362821d1-40f7-4574-b3e2-feb8578369f5" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0369e5f2-ddf2-4c84-9621-d7cd9c016922" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_03583b82-1b49-456f-9f7f-38d4ae3b6023" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0369e5f2-ddf2-4c84-9621-d7cd9c016922" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_03583b82-1b49-456f-9f7f-38d4ae3b6023" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_f9dbe59a-3295-4dbf-85a9-55d93ed3bcda" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0369e5f2-ddf2-4c84-9621-d7cd9c016922" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_f9dbe59a-3295-4dbf-85a9-55d93ed3bcda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_474f6c5f-03ba-4b0d-9ebe-11ce347a477c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0369e5f2-ddf2-4c84-9621-d7cd9c016922" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_474f6c5f-03ba-4b0d-9ebe-11ce347a477c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_46d1a827-be58-4ebe-81f3-0a4fd4811e16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_34edffce-d928-4104-adb5-bbf186f4105a" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_46d1a827-be58-4ebe-81f3-0a4fd4811e16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_c224c12d-fd0b-4802-8554-9b0cc4a19e4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_46d1a827-be58-4ebe-81f3-0a4fd4811e16" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_c224c12d-fd0b-4802-8554-9b0cc4a19e4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentAssetsMember_f358a5c3-0f5b-41a6-8000-0f081c15ba52" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_c224c12d-fd0b-4802-8554-9b0cc4a19e4a" xlink:to="loc_us-gaap_OtherCurrentAssetsMember_f358a5c3-0f5b-41a6-8000-0f081c15ba52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember_143b821f-d57c-45a9-a8f8-51d5a4125df1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_c224c12d-fd0b-4802-8554-9b0cc4a19e4a" xlink:to="loc_us-gaap_OtherNoncurrentAssetsMember_143b821f-d57c-45a9-a8f8-51d5a4125df1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_b3662e47-98a3-4be8-a97d-7e6787d64798" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_c224c12d-fd0b-4802-8554-9b0cc4a19e4a" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_b3662e47-98a3-4be8-a97d-7e6787d64798" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_b970f3d1-e292-4551-a3e4-63b07402a021" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_c224c12d-fd0b-4802-8554-9b0cc4a19e4a" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_b970f3d1-e292-4551-a3e4-63b07402a021" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_54e61dc3-5ac6-48d5-985e-fab738641e36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_34edffce-d928-4104-adb5-bbf186f4105a" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_54e61dc3-5ac6-48d5-985e-fab738641e36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_392c0a59-8ca2-41b5-b39e-be14abd63ad4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_54e61dc3-5ac6-48d5-985e-fab738641e36" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_392c0a59-8ca2-41b5-b39e-be14abd63ad4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_ResolutionBioscienceIncMember_1db9f0d4-079e-4adf-9fe1-b3846b99075c" xlink:href="a-20220131.xsd#a_ResolutionBioscienceIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_392c0a59-8ca2-41b5-b39e-be14abd63ad4" xlink:to="loc_a_ResolutionBioscienceIncMember_1db9f0d4-079e-4adf-9fe1-b3846b99075c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6f28b65a-96e6-4692-acea-9e669db70747" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_34edffce-d928-4104-adb5-bbf186f4105a" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6f28b65a-96e6-4692-acea-9e669db70747" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_3031258e-1486-4990-8a8e-2f3b7e699529" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6f28b65a-96e6-4692-acea-9e669db70747" xlink:to="loc_us-gaap_AssetsCurrentAbstract_3031258e-1486-4990-8a8e-2f3b7e699529" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_d379a36c-132f-4985-919f-d8c57fb34402" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_3031258e-1486-4990-8a8e-2f3b7e699529" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_d379a36c-132f-4985-919f-d8c57fb34402" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_fe76625e-76c2-47cc-9d4d-f212ba9e052b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyContractAssetFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_3031258e-1486-4990-8a8e-2f3b7e699529" xlink:to="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_fe76625e-76c2-47cc-9d4d-f212ba9e052b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_14cb25da-27c3-4167-b66c-da462b1a79b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_3031258e-1486-4990-8a8e-2f3b7e699529" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_14cb25da-27c3-4167-b66c-da462b1a79b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecurities_e1a99980-b5ea-4c45-bd47-33e19fec0cd6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradingSecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_3031258e-1486-4990-8a8e-2f3b7e699529" xlink:to="loc_us-gaap_TradingSecurities_e1a99980-b5ea-4c45-bd47-33e19fec0cd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_1a92e20f-dd3e-40ba-9f9d-de648d56ee3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_3031258e-1486-4990-8a8e-2f3b7e699529" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_1a92e20f-dd3e-40ba-9f9d-de648d56ee3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_c3cf88a1-dc34-4bea-9b10-3e72ea03bf09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_3031258e-1486-4990-8a8e-2f3b7e699529" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_c3cf88a1-dc34-4bea-9b10-3e72ea03bf09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_d72e0ae8-52e9-4c45-be39-0f647901663b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_3031258e-1486-4990-8a8e-2f3b7e699529" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_d72e0ae8-52e9-4c45-be39-0f647901663b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract_e92501c0-a099-4811-8f35-3036c55c5a56" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6f28b65a-96e6-4692-acea-9e669db70747" xlink:to="loc_us-gaap_LiabilitiesAbstract_e92501c0-a099-4811-8f35-3036c55c5a56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_e4255ae5-7c59-4716-877a-b7a13c39688a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_e92501c0-a099-4811-8f35-3036c55c5a56" xlink:to="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_e4255ae5-7c59-4716-877a-b7a13c39688a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_11975786-2e1b-4f04-8a5a-1292e0c4f799" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_e92501c0-a099-4811-8f35-3036c55c5a56" xlink:to="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_11975786-2e1b-4f04-8a5a-1292e0c4f799" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_ccedd92c-f340-4268-8910-6f1abe21889a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_e92501c0-a099-4811-8f35-3036c55c5a56" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_ccedd92c-f340-4268-8910-6f1abe21889a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/FAIRVALUEMEASUREMENTSNonMarketableSecuritiesandInvestmentImpairmentsDetails" xlink:type="simple" xlink:href="a-20220131.xsd#FAIRVALUEMEASUREMENTSNonMarketableSecuritiesandInvestmentImpairmentsDetails"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/FAIRVALUEMEASUREMENTSNonMarketableSecuritiesandInvestmentImpairmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_42411afa-af5a-4bc1-a707-d5370de179c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_d18feed6-4815-4035-9603-16d81ad1cecc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_42411afa-af5a-4bc1-a707-d5370de179c4" xlink:to="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_d18feed6-4815-4035-9603-16d81ad1cecc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfInvestments_2fa919d3-9e90-4904-a63e-88432aeda0d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_42411afa-af5a-4bc1-a707-d5370de179c4" xlink:to="loc_us-gaap_ImpairmentOfInvestments_2fa919d3-9e90-4904-a63e-88432aeda0d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/FAIRVALUEMEASUREMENTSContingentConsiderationDetails" xlink:type="simple" xlink:href="a-20220131.xsd#FAIRVALUEMEASUREMENTSContingentConsiderationDetails"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/FAIRVALUEMEASUREMENTSContingentConsiderationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_3d302aae-4f09-4386-89ec-a6d7dd78929f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_dbafacdc-96c1-4005-98cd-c6fd6a884779" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_3d302aae-4f09-4386-89ec-a6d7dd78929f" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_dbafacdc-96c1-4005-98cd-c6fd6a884779" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_cb7bb6fa-b4d1-4999-8a83-7343f32c48db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_dbafacdc-96c1-4005-98cd-c6fd6a884779" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_cb7bb6fa-b4d1-4999-8a83-7343f32c48db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_95263ebd-df98-4382-a509-851d9963fe01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_cb7bb6fa-b4d1-4999-8a83-7343f32c48db" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_95263ebd-df98-4382-a509-851d9963fe01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_MeasurementInputAssetVolatilityMember_ed0182b9-5b45-4c8f-8b79-89aa27791b3c" xlink:href="a-20220131.xsd#a_MeasurementInputAssetVolatilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_95263ebd-df98-4382-a509-851d9963fe01" xlink:to="loc_a_MeasurementInputAssetVolatilityMember_ed0182b9-5b45-4c8f-8b79-89aa27791b3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_MeasurementInputRevenueVolatilityMember_049063a6-e63f-44f5-8c43-87862fe78564" xlink:href="a-20220131.xsd#a_MeasurementInputRevenueVolatilityMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_95263ebd-df98-4382-a509-851d9963fe01" xlink:to="loc_a_MeasurementInputRevenueVolatilityMember_049063a6-e63f-44f5-8c43-87862fe78564" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_fe2173bf-de52-428d-a700-a7d89567ad4e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_dbafacdc-96c1-4005-98cd-c6fd6a884779" xlink:to="loc_srt_RangeAxis_fe2173bf-de52-428d-a700-a7d89567ad4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_6b434512-15eb-4f24-80a7-e8dcebeecfbc" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_fe2173bf-de52-428d-a700-a7d89567ad4e" xlink:to="loc_srt_RangeMember_6b434512-15eb-4f24-80a7-e8dcebeecfbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_77b80cb6-e72f-4f52-9443-05d31131bc5b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_6b434512-15eb-4f24-80a7-e8dcebeecfbc" xlink:to="loc_srt_MinimumMember_77b80cb6-e72f-4f52-9443-05d31131bc5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_6a19bec7-3a37-4924-8464-958b887ac65f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_6b434512-15eb-4f24-80a7-e8dcebeecfbc" xlink:to="loc_srt_MaximumMember_6a19bec7-3a37-4924-8464-958b887ac65f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_3f9ea11b-a51a-4cfd-8f27-139fdaa9baa2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_dbafacdc-96c1-4005-98cd-c6fd6a884779" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_3f9ea11b-a51a-4cfd-8f27-139fdaa9baa2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_98c2d41b-b4c2-463c-a1b3-dd0fe8891d35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_3f9ea11b-a51a-4cfd-8f27-139fdaa9baa2" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_98c2d41b-b4c2-463c-a1b3-dd0fe8891d35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_ResolutionBioscienceIncMember_eb661d60-ddab-4382-931d-6ec34923cd8d" xlink:href="a-20220131.xsd#a_ResolutionBioscienceIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_98c2d41b-b4c2-463c-a1b3-dd0fe8891d35" xlink:to="loc_a_ResolutionBioscienceIncMember_eb661d60-ddab-4382-931d-6ec34923cd8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_16efd401-8e15-47ca-93b1-21e13dd387b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_dbafacdc-96c1-4005-98cd-c6fd6a884779" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_16efd401-8e15-47ca-93b1-21e13dd387b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_BusinessCombinationContingentConsiderationFairValueMeasurementInput_b90d5592-bd73-4975-9198-001848766a37" xlink:href="a-20220131.xsd#a_BusinessCombinationContingentConsiderationFairValueMeasurementInput"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_16efd401-8e15-47ca-93b1-21e13dd387b5" xlink:to="loc_a_BusinessCombinationContingentConsiderationFairValueMeasurementInput_b90d5592-bd73-4975-9198-001848766a37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_BusinessCombinationsContingentConsiderationArrangements_5f65d625-4282-44f6-808c-c6a4a395bea9" xlink:href="a-20220131.xsd#a_BusinessCombinationsContingentConsiderationArrangements"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_16efd401-8e15-47ca-93b1-21e13dd387b5" xlink:to="loc_a_BusinessCombinationsContingentConsiderationArrangements_5f65d625-4282-44f6-808c-c6a4a395bea9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_4ead0644-2a6a-4145-aff7-6c017fca482b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_16efd401-8e15-47ca-93b1-21e13dd387b5" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_4ead0644-2a6a-4145-aff7-6c017fca482b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingLevel3ContingentConsiderationLiabilityDetails" xlink:type="simple" xlink:href="a-20220131.xsd#FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingLevel3ContingentConsiderationLiabilityDetails"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingLevel3ContingentConsiderationLiabilityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_064f1221-a176-4481-9994-564d3e6b8c5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_55f8a568-dec4-4fc7-83c2-44966ff6446f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_064f1221-a176-4481-9994-564d3e6b8c5c" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_55f8a568-dec4-4fc7-83c2-44966ff6446f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3_ba08663a-a094-47bc-9c17-37b054900e71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_064f1221-a176-4481-9994-564d3e6b8c5c" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3_ba08663a-a094-47bc-9c17-37b054900e71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_f2dbde5d-fe7b-4175-93b6-791cee82dc4d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_064f1221-a176-4481-9994-564d3e6b8c5c" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_f2dbde5d-fe7b-4175-93b6-791cee82dc4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_68c98a2e-6e12-448c-b3a6-39bc3c9693be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_064f1221-a176-4481-9994-564d3e6b8c5c" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_68c98a2e-6e12-448c-b3a6-39bc3c9693be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_6fab415c-34bc-489e-b978-e2715b1d225d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_064f1221-a176-4481-9994-564d3e6b8c5c" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_6fab415c-34bc-489e-b978-e2715b1d225d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_BusinessCombinationsContingentConsiderationArrangements_b7ee495f-9be9-4a4a-b3a9-694f6b13cab5" xlink:href="a-20220131.xsd#a_BusinessCombinationsContingentConsiderationArrangements"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_064f1221-a176-4481-9994-564d3e6b8c5c" xlink:to="loc_a_BusinessCombinationsContingentConsiderationArrangements_b7ee495f-9be9-4a4a-b3a9-694f6b13cab5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/FAIRVALUEMEASUREMENTSAssetsandLiabilitiesmeasuredatFairValueonaNonRecurringBasisDetails" xlink:type="simple" xlink:href="a-20220131.xsd#FAIRVALUEMEASUREMENTSAssetsandLiabilitiesmeasuredatFairValueonaNonRecurringBasisDetails"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/FAIRVALUEMEASUREMENTSAssetsandLiabilitiesmeasuredatFairValueonaNonRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_cebbc194-672a-4f64-92b2-7ff9da916562" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_00e6613d-654b-41f1-8c1e-fe96e2e6d80d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_cebbc194-672a-4f64-92b2-7ff9da916562" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_00e6613d-654b-41f1-8c1e-fe96e2e6d80d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_2c3182db-1c78-4312-a682-a106c6f58a33" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_00e6613d-654b-41f1-8c1e-fe96e2e6d80d" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_2c3182db-1c78-4312-a682-a106c6f58a33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_3ce1dae5-b38f-4fa1-98f1-b04b9bc57716" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_2c3182db-1c78-4312-a682-a106c6f58a33" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_3ce1dae5-b38f-4fa1-98f1-b04b9bc57716" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsNonrecurringMember_98caf8af-1db8-47d2-92b8-6a3f36151f2d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsNonrecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_3ce1dae5-b38f-4fa1-98f1-b04b9bc57716" xlink:to="loc_us-gaap_FairValueMeasurementsNonrecurringMember_98caf8af-1db8-47d2-92b8-6a3f36151f2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_6b5b2dd9-be9d-4955-b7e9-1e6649ed3928" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_3ce1dae5-b38f-4fa1-98f1-b04b9bc57716" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_6b5b2dd9-be9d-4955-b7e9-1e6649ed3928" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_575afa07-17d3-499d-ad10-44ddd846ee3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_00e6613d-654b-41f1-8c1e-fe96e2e6d80d" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_575afa07-17d3-499d-ad10-44ddd846ee3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_383a88c3-6713-4e9a-9cda-667ce9bacdd3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_575afa07-17d3-499d-ad10-44ddd846ee3e" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_383a88c3-6713-4e9a-9cda-667ce9bacdd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_a5843b7f-779e-409f-80d0-47debfb2cb50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_00e6613d-654b-41f1-8c1e-fe96e2e6d80d" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_a5843b7f-779e-409f-80d0-47debfb2cb50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_755bbff2-bfdc-4d25-ac88-66f333abafbf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_a5843b7f-779e-409f-80d0-47debfb2cb50" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_755bbff2-bfdc-4d25-ac88-66f333abafbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_MeasurementInputAssetVolatilityMember_cab414f9-d51b-418d-8537-fda589794b24" xlink:href="a-20220131.xsd#a_MeasurementInputAssetVolatilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_755bbff2-bfdc-4d25-ac88-66f333abafbf" xlink:to="loc_a_MeasurementInputAssetVolatilityMember_cab414f9-d51b-418d-8537-fda589794b24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_MeasurementInputRevenueVolatilityMember_83b56800-674e-44cb-bce6-64da0462b6ae" xlink:href="a-20220131.xsd#a_MeasurementInputRevenueVolatilityMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_755bbff2-bfdc-4d25-ac88-66f333abafbf" xlink:to="loc_a_MeasurementInputRevenueVolatilityMember_83b56800-674e-44cb-bce6-64da0462b6ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_d814de7e-265e-4a57-a583-1b137d1864c2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_00e6613d-654b-41f1-8c1e-fe96e2e6d80d" xlink:to="loc_srt_RangeAxis_d814de7e-265e-4a57-a583-1b137d1864c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_add9e4ab-4026-4def-80f9-fcc33a939d1a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_d814de7e-265e-4a57-a583-1b137d1864c2" xlink:to="loc_srt_RangeMember_add9e4ab-4026-4def-80f9-fcc33a939d1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_0ac4fd77-6960-4585-962a-638be8b06237" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_add9e4ab-4026-4def-80f9-fcc33a939d1a" xlink:to="loc_srt_MinimumMember_0ac4fd77-6960-4585-962a-638be8b06237" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_29a2d627-28f9-4127-b9f2-5ae27e356430" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_add9e4ab-4026-4def-80f9-fcc33a939d1a" xlink:to="loc_srt_MaximumMember_29a2d627-28f9-4127-b9f2-5ae27e356430" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_7e295ad1-3e53-4cf2-8e0c-d73e87ddf9c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_00e6613d-654b-41f1-8c1e-fe96e2e6d80d" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_7e295ad1-3e53-4cf2-8e0c-d73e87ddf9c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_AssetsLongLivedAbstract_87f63437-2de0-4286-acf9-68fa6bf6498b" xlink:href="a-20220131.xsd#a_AssetsLongLivedAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_7e295ad1-3e53-4cf2-8e0c-d73e87ddf9c3" xlink:to="loc_a_AssetsLongLivedAbstract_87f63437-2de0-4286-acf9-68fa6bf6498b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairedAssetsToBeDisposedOfByMethodOtherThanSaleCarryingValueOfAsset_c2de9ae8-33e9-4daa-a97c-8e2d0d556aa9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairedAssetsToBeDisposedOfByMethodOtherThanSaleCarryingValueOfAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_a_AssetsLongLivedAbstract_87f63437-2de0-4286-acf9-68fa6bf6498b" xlink:to="loc_us-gaap_ImpairedAssetsToBeDisposedOfByMethodOtherThanSaleCarryingValueOfAsset_c2de9ae8-33e9-4daa-a97c-8e2d0d556aa9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsFairValueDisclosure_16fef99b-0fb3-40c8-9dd6-9162a3e93c6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_a_AssetsLongLivedAbstract_87f63437-2de0-4286-acf9-68fa6bf6498b" xlink:to="loc_us-gaap_OtherAssetsFairValueDisclosure_16fef99b-0fb3-40c8-9dd6-9162a3e93c6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_3347a349-4566-485f-a3bb-7d18d5f74cdb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_a_AssetsLongLivedAbstract_87f63437-2de0-4286-acf9-68fa6bf6498b" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_3347a349-4566-485f-a3bb-7d18d5f74cdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_c5f64791-abb2-45e5-9bd4-cb5af62ac53c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_a_AssetsLongLivedAbstract_87f63437-2de0-4286-acf9-68fa6bf6498b" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_c5f64791-abb2-45e5-9bd4-cb5af62ac53c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiGainLossAbstract_6ab85966-4340-49f5-8234-0ff2629ba671" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNiGainLossAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_7e295ad1-3e53-4cf2-8e0c-d73e87ddf9c3" xlink:to="loc_us-gaap_EquitySecuritiesFvNiGainLossAbstract_6ab85966-4340-49f5-8234-0ff2629ba671" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount_ab1cbadd-1cbe-4a83-be60-33aaf2adc530" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquitySecuritiesFvNiGainLossAbstract_6ab85966-4340-49f5-8234-0ff2629ba671" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount_ab1cbadd-1cbe-4a83-be60-33aaf2adc530" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_15ed8e6e-397e-46f9-ba0b-ae37c5da05fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquitySecuritiesFvNiGainLossAbstract_6ab85966-4340-49f5-8234-0ff2629ba671" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_15ed8e6e-397e-46f9-ba0b-ae37c5da05fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/DERIVATIVESNotes" xlink:type="simple" xlink:href="a-20220131.xsd#DERIVATIVESNotes"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/DERIVATIVESNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_6bf40b98-22d5-4b59-b875-8504e1d91820" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_d0611b09-5d3d-478a-ac47-998427f935a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_6bf40b98-22d5-4b59-b875-8504e1d91820" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_d0611b09-5d3d-478a-ac47-998427f935a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/DERIVATIVESTables" xlink:type="simple" xlink:href="a-20220131.xsd#DERIVATIVESTables"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/DERIVATIVESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_77c94297-152e-46cc-8f8e-b505718aedf3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_24380f16-2d6a-49b4-8ec0-a12d1d60645a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_77c94297-152e-46cc-8f8e-b505718aedf3" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_24380f16-2d6a-49b4-8ec0-a12d1d60645a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_68298616-32e5-4a1f-a9af-730366b44682" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_77c94297-152e-46cc-8f8e-b505718aedf3" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_68298616-32e5-4a1f-a9af-730366b44682" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_c790adc9-8ecb-44a4-aefd-27e01f34d5e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_77c94297-152e-46cc-8f8e-b505718aedf3" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_c790adc9-8ecb-44a4-aefd-27e01f34d5e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/DERIVATIVESTextDetails" xlink:type="simple" xlink:href="a-20220131.xsd#DERIVATIVESTextDetails"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/DERIVATIVESTextDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_ef9af236-355f-45d6-a6f2-c4a3bcd96149" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_f6a072f8-915e-405d-ac63-84ecfd6bc28d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_ef9af236-355f-45d6-a6f2-c4a3bcd96149" xlink:to="loc_us-gaap_DerivativeTable_f6a072f8-915e-405d-ac63-84ecfd6bc28d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_904a097a-99f3-4ae4-9c68-08548b7fccb7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_f6a072f8-915e-405d-ac63-84ecfd6bc28d" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_904a097a-99f3-4ae4-9c68-08548b7fccb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_47ba13ea-7838-4b6f-b551-04cac9f76fea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_904a097a-99f3-4ae4-9c68-08548b7fccb7" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_47ba13ea-7838-4b6f-b551-04cac9f76fea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_fe038ef9-f199-419f-9d04-55895037a724" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_47ba13ea-7838-4b6f-b551-04cac9f76fea" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_fe038ef9-f199-419f-9d04-55895037a724" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_24c22b53-5a0f-4f6d-975a-4b1dd92887fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_f6a072f8-915e-405d-ac63-84ecfd6bc28d" xlink:to="loc_us-gaap_DebtInstrumentAxis_24c22b53-5a0f-4f6d-975a-4b1dd92887fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_b1ac5bef-b1f4-4fcd-9966-7bbe5e9bbd74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_24c22b53-5a0f-4f6d-975a-4b1dd92887fa" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_b1ac5bef-b1f4-4fcd-9966-7bbe5e9bbd74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_SeniorNotes2022Member_83de3a60-35c0-49f8-b6f2-38e996112102" xlink:href="a-20220131.xsd#a_SeniorNotes2022Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b1ac5bef-b1f4-4fcd-9966-7bbe5e9bbd74" xlink:to="loc_a_SeniorNotes2022Member_83de3a60-35c0-49f8-b6f2-38e996112102" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_SeniorNotes2026Member_38f787dc-a9e4-47c5-9460-aea5684f622c" xlink:href="a-20220131.xsd#a_SeniorNotes2026Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b1ac5bef-b1f4-4fcd-9966-7bbe5e9bbd74" xlink:to="loc_a_SeniorNotes2026Member_38f787dc-a9e4-47c5-9460-aea5684f622c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_SeniorNotes2029Member_c82005b8-f541-4dfe-9251-fc97593cc570" xlink:href="a-20220131.xsd#a_SeniorNotes2029Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b1ac5bef-b1f4-4fcd-9966-7bbe5e9bbd74" xlink:to="loc_a_SeniorNotes2029Member_c82005b8-f541-4dfe-9251-fc97593cc570" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_0beb2894-7bf2-4593-9929-b8468e0825a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_f6a072f8-915e-405d-ac63-84ecfd6bc28d" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_0beb2894-7bf2-4593-9929-b8468e0825a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_0ea05ed9-08f6-4cbd-8072-6e19581e9da7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_0beb2894-7bf2-4593-9929-b8468e0825a4" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_0ea05ed9-08f6-4cbd-8072-6e19581e9da7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_becbcee2-f930-4642-a26e-0a20f7874686" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_0ea05ed9-08f6-4cbd-8072-6e19581e9da7" xlink:to="loc_us-gaap_InterestRateSwapMember_becbcee2-f930-4642-a26e-0a20f7874686" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryLockMember_57de031d-e7c2-4d64-9f9d-033191193b5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryLockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_0ea05ed9-08f6-4cbd-8072-6e19581e9da7" xlink:to="loc_us-gaap_TreasuryLockMember_57de031d-e7c2-4d64-9f9d-033191193b5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_e118dbb0-b319-439b-ba6a-209556c80cad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_0ea05ed9-08f6-4cbd-8072-6e19581e9da7" xlink:to="loc_us-gaap_ForeignExchangeContractMember_e118dbb0-b319-439b-ba6a-209556c80cad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_61f90dd0-f38b-4c57-ae2f-15128058c19f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_f6a072f8-915e-405d-ac63-84ecfd6bc28d" xlink:to="loc_us-gaap_HedgingDesignationAxis_61f90dd0-f38b-4c57-ae2f-15128058c19f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_409e40c8-5be2-44cd-922f-72fc75a9e6b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_61f90dd0-f38b-4c57-ae2f-15128058c19f" xlink:to="loc_us-gaap_HedgingDesignationDomain_409e40c8-5be2-44cd-922f-72fc75a9e6b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_9ab731bd-370a-4af1-98cb-74be0b944cfd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_409e40c8-5be2-44cd-922f-72fc75a9e6b1" xlink:to="loc_us-gaap_NondesignatedMember_9ab731bd-370a-4af1-98cb-74be0b944cfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_7c1baa6b-ca0a-4542-86f4-0520eee3c5d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_409e40c8-5be2-44cd-922f-72fc75a9e6b1" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_7c1baa6b-ca0a-4542-86f4-0520eee3c5d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_9e5ef8ef-0672-4f8a-abdc-b89b899fb72b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_f6a072f8-915e-405d-ac63-84ecfd6bc28d" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_9e5ef8ef-0672-4f8a-abdc-b89b899fb72b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_879d3db0-32c5-49ce-8d3e-4bddc11ac687" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_9e5ef8ef-0672-4f8a-abdc-b89b899fb72b" xlink:to="loc_us-gaap_HedgingRelationshipDomain_879d3db0-32c5-49ce-8d3e-4bddc11ac687" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_014e5a75-8ffd-446f-874c-719f4f679f98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_879d3db0-32c5-49ce-8d3e-4bddc11ac687" xlink:to="loc_us-gaap_CashFlowHedgingMember_014e5a75-8ffd-446f-874c-719f4f679f98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_c56c0ec0-20a3-4aa6-96a0-b16b501c9162" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_879d3db0-32c5-49ce-8d3e-4bddc11ac687" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_c56c0ec0-20a3-4aa6-96a0-b16b501c9162" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_58e5c970-0bdb-4633-a1c0-bf684604e275" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_f6a072f8-915e-405d-ac63-84ecfd6bc28d" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_58e5c970-0bdb-4633-a1c0-bf684604e275" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_a2d457de-23bf-46d4-93f4-f243447ab542" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_58e5c970-0bdb-4633-a1c0-bf684604e275" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_a2d457de-23bf-46d4-93f4-f243447ab542" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_a58e78ff-e590-4c23-8a72-7c71ca25db26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_a2d457de-23bf-46d4-93f4-f243447ab542" xlink:to="loc_us-gaap_CostOfSalesMember_a58e78ff-e590-4c23-8a72-7c71ca25db26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_62f2dee5-7f77-459b-b35d-f0118e4f97aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_f6a072f8-915e-405d-ac63-84ecfd6bc28d" xlink:to="loc_us-gaap_DerivativeLineItems_62f2dee5-7f77-459b-b35d-f0118e4f97aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentDetailAbstract_99a9bcdb-6c21-4ed3-8ca8-4cb90bcc5e74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentDetailAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_62f2dee5-7f77-459b-b35d-f0118e4f97aa" xlink:to="loc_us-gaap_DerivativeInstrumentDetailAbstract_99a9bcdb-6c21-4ed3-8ca8-4cb90bcc5e74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNetLiabilityPositionAggregateFairValue_f28a6bc0-2141-442c-b1b0-16807b8ebfdb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeNetLiabilityPositionAggregateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentDetailAbstract_99a9bcdb-6c21-4ed3-8ca8-4cb90bcc5e74" xlink:to="loc_us-gaap_DerivativeNetLiabilityPositionAggregateFairValue_f28a6bc0-2141-442c-b1b0-16807b8ebfdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateDerivativesAbstract_e3fe3289-f5e1-4d8d-a61b-e463d3db3ae5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateDerivativesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentDetailAbstract_99a9bcdb-6c21-4ed3-8ca8-4cb90bcc5e74" xlink:to="loc_us-gaap_InterestRateDerivativesAbstract_e3fe3289-f5e1-4d8d-a61b-e463d3db3ae5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfInterestRateDerivativesHeld_024580ea-acd8-4dde-8eb3-e5663e73848b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfInterestRateDerivativesHeld"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InterestRateDerivativesAbstract_e3fe3289-f5e1-4d8d-a61b-e463d3db3ae5" xlink:to="loc_us-gaap_NumberOfInterestRateDerivativesHeld_024580ea-acd8-4dde-8eb3-e5663e73848b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_5f6f7f57-0358-4270-a7d8-0a6a826ba6be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InterestRateDerivativesAbstract_e3fe3289-f5e1-4d8d-a61b-e463d3db3ae5" xlink:to="loc_us-gaap_DerivativeNotionalAmount_5f6f7f57-0358-4270-a7d8-0a6a826ba6be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_Interestrateswappayments_c8cddb8c-780d-425d-b734-ffe48e1467c6" xlink:href="a-20220131.xsd#a_Interestrateswappayments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InterestRateDerivativesAbstract_e3fe3289-f5e1-4d8d-a61b-e463d3db3ae5" xlink:to="loc_a_Interestrateswappayments_c8cddb8c-780d-425d-b734-ffe48e1467c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSeniorDebt_a45c6c93-d67c-4e0b-ba9d-e3cab636f141" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfSeniorDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InterestRateDerivativesAbstract_e3fe3289-f5e1-4d8d-a61b-e463d3db3ae5" xlink:to="loc_us-gaap_RepaymentsOfSeniorDebt_a45c6c93-d67c-4e0b-ba9d-e3cab636f141" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_88883d63-d999-4675-adc8-473b2fbbd40d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InterestRateDerivativesAbstract_e3fe3289-f5e1-4d8d-a61b-e463d3db3ae5" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_88883d63-d999-4675-adc8-473b2fbbd40d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_Remaininggainlosstobeamortizedonderivative_14027b30-c09e-4cb8-85a0-e585d0d82c91" xlink:href="a-20220131.xsd#a_Remaininggainlosstobeamortizedonderivative"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InterestRateDerivativesAbstract_e3fe3289-f5e1-4d8d-a61b-e463d3db3ae5" xlink:to="loc_a_Remaininggainlosstobeamortizedonderivative_14027b30-c09e-4cb8-85a0-e585d0d82c91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfNetInvestmentHedgeActivityAbstract_804a47dc-203e-4e2d-98c8-7b57fdaf954f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SummaryOfNetInvestmentHedgeActivityAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentDetailAbstract_99a9bcdb-6c21-4ed3-8ca8-4cb90bcc5e74" xlink:to="loc_us-gaap_SummaryOfNetInvestmentHedgeActivityAbstract_804a47dc-203e-4e2d-98c8-7b57fdaf954f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_58fcc982-6751-4e2d-bdb4-2248be314da6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SummaryOfNetInvestmentHedgeActivityAbstract_804a47dc-203e-4e2d-98c8-7b57fdaf954f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_58fcc982-6751-4e2d-bdb4-2248be314da6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_98ad562e-6e33-4eca-95c0-f68978e854be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_62f2dee5-7f77-459b-b35d-f0118e4f97aa" xlink:to="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_98ad562e-6e33-4eca-95c0-f68978e854be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/DERIVATIVESForeignExchangeForwardContractsDetails" xlink:type="simple" xlink:href="a-20220131.xsd#DERIVATIVESForeignExchangeForwardContractsDetails"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/DERIVATIVESForeignExchangeForwardContractsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_8eee00b3-02e8-4182-82ac-fcacb8339113" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_55a91cbd-dc1d-4453-819e-819feb3f4090" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_8eee00b3-02e8-4182-82ac-fcacb8339113" xlink:to="loc_us-gaap_DerivativeTable_55a91cbd-dc1d-4453-819e-819feb3f4090" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionAxis_318f26a9-8a76-4218-b077-5b07fd8e5b26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PositionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_55a91cbd-dc1d-4453-819e-819feb3f4090" xlink:to="loc_us-gaap_PositionAxis_318f26a9-8a76-4218-b077-5b07fd8e5b26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionDomain_db2a63c2-5bf0-40ed-885f-29a3f8e4c8ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PositionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PositionAxis_318f26a9-8a76-4218-b077-5b07fd8e5b26" xlink:to="loc_us-gaap_PositionDomain_db2a63c2-5bf0-40ed-885f-29a3f8e4c8ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortMember_ee19638b-799f-4361-9755-95cba5d53bd7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PositionDomain_db2a63c2-5bf0-40ed-885f-29a3f8e4c8ad" xlink:to="loc_us-gaap_ShortMember_ee19638b-799f-4361-9755-95cba5d53bd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongMember_b87873cc-e437-444f-99e9-67907db5e05e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PositionDomain_db2a63c2-5bf0-40ed-885f-29a3f8e4c8ad" xlink:to="loc_us-gaap_LongMember_b87873cc-e437-444f-99e9-67907db5e05e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_1f5d7e1a-5f6d-4764-82e0-9f611f448d9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_55a91cbd-dc1d-4453-819e-819feb3f4090" xlink:to="loc_us-gaap_HedgingDesignationAxis_1f5d7e1a-5f6d-4764-82e0-9f611f448d9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_d73e3134-4a94-4696-b33a-45acdae93189" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_1f5d7e1a-5f6d-4764-82e0-9f611f448d9b" xlink:to="loc_us-gaap_HedgingDesignationDomain_d73e3134-4a94-4696-b33a-45acdae93189" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_0eec809b-5030-4ffc-b724-d056129e3d7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_d73e3134-4a94-4696-b33a-45acdae93189" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_0eec809b-5030-4ffc-b724-d056129e3d7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_4f6db523-78d2-431e-b4e9-2c10ddc5f143" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_d73e3134-4a94-4696-b33a-45acdae93189" xlink:to="loc_us-gaap_NondesignatedMember_4f6db523-78d2-431e-b4e9-2c10ddc5f143" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_3292843f-2a17-4b9f-8f92-5d9a92284429" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_55a91cbd-dc1d-4453-819e-819feb3f4090" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_3292843f-2a17-4b9f-8f92-5d9a92284429" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_dfc96713-6853-4b0c-b7d5-7e621df27260" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_3292843f-2a17-4b9f-8f92-5d9a92284429" xlink:to="loc_us-gaap_HedgingRelationshipDomain_dfc96713-6853-4b0c-b7d5-7e621df27260" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_c68ac275-4703-4b8f-af74-091031b44a6b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_dfc96713-6853-4b0c-b7d5-7e621df27260" xlink:to="loc_us-gaap_CashFlowHedgingMember_c68ac275-4703-4b8f-af74-091031b44a6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_d2169389-19b7-4487-855e-0a0da9bca145" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_dfc96713-6853-4b0c-b7d5-7e621df27260" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_d2169389-19b7-4487-855e-0a0da9bca145" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CurrencyAxis_3a740330-f2db-4403-836a-802d4d2d649e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CurrencyAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_55a91cbd-dc1d-4453-819e-819feb3f4090" xlink:to="loc_srt_CurrencyAxis_3a740330-f2db-4403-836a-802d4d2d649e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_722008ab-2c05-43c2-a356-6c2d61e603c0" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_AllCurrenciesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CurrencyAxis_3a740330-f2db-4403-836a-802d4d2d649e" xlink:to="loc_currency_AllCurrenciesDomain_722008ab-2c05-43c2-a356-6c2d61e603c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_EUR_7aa7ed3e-b37e-4a1b-acdb-de2c536ad24d" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_EUR"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_722008ab-2c05-43c2-a356-6c2d61e603c0" xlink:to="loc_currency_EUR_7aa7ed3e-b37e-4a1b-acdb-de2c536ad24d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_GBP_317e1a3c-e72e-47ed-9c49-b397305376b7" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_GBP"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_722008ab-2c05-43c2-a356-6c2d61e603c0" xlink:to="loc_currency_GBP_317e1a3c-e72e-47ed-9c49-b397305376b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_CAD_dd6b703d-9d90-4f77-9a94-5c494712a3ba" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_CAD"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_722008ab-2c05-43c2-a356-6c2d61e603c0" xlink:to="loc_currency_CAD_dd6b703d-9d90-4f77-9a94-5c494712a3ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AUD_40583f75-97c6-4c6e-b55c-3a4208bf0d4d" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_AUD"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_722008ab-2c05-43c2-a356-6c2d61e603c0" xlink:to="loc_currency_AUD_40583f75-97c6-4c6e-b55c-3a4208bf0d4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_MYR_d1d0874c-9b7b-40d5-8f13-445853bfaf24" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_MYR"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_722008ab-2c05-43c2-a356-6c2d61e603c0" xlink:to="loc_currency_MYR_d1d0874c-9b7b-40d5-8f13-445853bfaf24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_JPY_abf95433-c768-41b0-a10a-1b903aea7eae" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_JPY"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_722008ab-2c05-43c2-a356-6c2d61e603c0" xlink:to="loc_currency_JPY_abf95433-c768-41b0-a10a-1b903aea7eae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_DKK_f9bacfd0-0583-437d-9728-9f576b296041" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_DKK"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_722008ab-2c05-43c2-a356-6c2d61e603c0" xlink:to="loc_currency_DKK_f9bacfd0-0583-437d-9728-9f576b296041" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_KRW_08c796e5-4cd3-44ec-b6fe-9e2d803b33ce" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_KRW"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_722008ab-2c05-43c2-a356-6c2d61e603c0" xlink:to="loc_currency_KRW_08c796e5-4cd3-44ec-b6fe-9e2d803b33ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_SGD_a54c9eac-133b-4c04-b250-efb3c9d2044b" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_SGD"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_722008ab-2c05-43c2-a356-6c2d61e603c0" xlink:to="loc_currency_SGD_a54c9eac-133b-4c04-b250-efb3c9d2044b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_CHF_33a5715a-e2d2-432a-9e23-a4481576ab01" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_CHF"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_722008ab-2c05-43c2-a356-6c2d61e603c0" xlink:to="loc_currency_CHF_33a5715a-e2d2-432a-9e23-a4481576ab01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_CNY_d9aab4be-e37f-42b9-b75e-f1a2e5400f7c" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_CNY"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_722008ab-2c05-43c2-a356-6c2d61e603c0" xlink:to="loc_currency_CNY_d9aab4be-e37f-42b9-b75e-f1a2e5400f7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_PLN_ddd8f287-7a4c-4adb-ba62-0e9571a25aae" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_PLN"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_722008ab-2c05-43c2-a356-6c2d61e603c0" xlink:to="loc_currency_PLN_ddd8f287-7a4c-4adb-ba62-0e9571a25aae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_SEK_3e704bef-e125-4a4b-8e02-f39150bbd679" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_SEK"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_722008ab-2c05-43c2-a356-6c2d61e603c0" xlink:to="loc_currency_SEK_3e704bef-e125-4a4b-8e02-f39150bbd679" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_TWD_f7192e3c-5291-422c-bf2e-d91bd0fcce3e" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_TWD"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_722008ab-2c05-43c2-a356-6c2d61e603c0" xlink:to="loc_currency_TWD_f7192e3c-5291-422c-bf2e-d91bd0fcce3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_INR_074498ed-f487-48b3-ae78-e0936755cbf1" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_INR"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_722008ab-2c05-43c2-a356-6c2d61e603c0" xlink:to="loc_currency_INR_074498ed-f487-48b3-ae78-e0936755cbf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_XXX_8257b5ad-2e2c-4184-bd93-2cd8b155d104" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_XXX"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_722008ab-2c05-43c2-a356-6c2d61e603c0" xlink:to="loc_currency_XXX_8257b5ad-2e2c-4184-bd93-2cd8b155d104" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_BRL_91e6c556-621d-470a-8942-faebd7723029" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_BRL"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_722008ab-2c05-43c2-a356-6c2d61e603c0" xlink:to="loc_currency_BRL_91e6c556-621d-470a-8942-faebd7723029" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_THB_89d7ffa9-d198-44e7-857e-603fcb99b2b4" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_THB"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_722008ab-2c05-43c2-a356-6c2d61e603c0" xlink:to="loc_currency_THB_89d7ffa9-d198-44e7-857e-603fcb99b2b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_8198c761-4a83-4c01-92c1-849d54e9d8d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_55a91cbd-dc1d-4453-819e-819feb3f4090" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_8198c761-4a83-4c01-92c1-849d54e9d8d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_d070c396-c1da-41c8-a058-28c74272d1b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_8198c761-4a83-4c01-92c1-849d54e9d8d9" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_d070c396-c1da-41c8-a058-28c74272d1b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_9f6143bb-bb16-4142-b5c1-258630d3a129" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_d070c396-c1da-41c8-a058-28c74272d1b2" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_9f6143bb-bb16-4142-b5c1-258630d3a129" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForwardContractsMember_a767379b-08e5-41d5-8919-30466be10633" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForwardContractsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_d070c396-c1da-41c8-a058-28c74272d1b2" xlink:to="loc_us-gaap_ForwardContractsMember_a767379b-08e5-41d5-8919-30466be10633" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_f4879726-c575-49e3-951e-d2b136db2a01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_55a91cbd-dc1d-4453-819e-819feb3f4090" xlink:to="loc_us-gaap_DerivativeLineItems_f4879726-c575-49e3-951e-d2b136db2a01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfForeignCurrencyDerivativesHeld_7ef99e28-67e6-408b-b234-ca98abed3044" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfForeignCurrencyDerivativesHeld"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_f4879726-c575-49e3-951e-d2b136db2a01" xlink:to="loc_us-gaap_NumberOfForeignCurrencyDerivativesHeld_7ef99e28-67e6-408b-b234-ca98abed3044" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_52e68fe3-9ae2-43a0-9ab6-839221eee2c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_f4879726-c575-49e3-951e-d2b136db2a01" xlink:to="loc_us-gaap_DerivativeNotionalAmount_52e68fe3-9ae2-43a0-9ab6-839221eee2c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/DERIVATIVESFairvalueofderivativeinstrumentsandConsolidatedBalanceSheetlocationDetails" xlink:type="simple" xlink:href="a-20220131.xsd#DERIVATIVESFairvalueofderivativeinstrumentsandConsolidatedBalanceSheetlocationDetails"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/DERIVATIVESFairvalueofderivativeinstrumentsandConsolidatedBalanceSheetlocationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_1f8f2f22-b460-4ac1-b6e9-d79f407c7ee9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_e14b367f-5be9-4c16-97d0-f1994c06fca9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_1f8f2f22-b460-4ac1-b6e9-d79f407c7ee9" xlink:to="loc_us-gaap_DerivativeTable_e14b367f-5be9-4c16-97d0-f1994c06fca9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_1b2f053f-7b47-43f1-ac1c-94862a58ed54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_e14b367f-5be9-4c16-97d0-f1994c06fca9" xlink:to="loc_us-gaap_HedgingDesignationAxis_1b2f053f-7b47-43f1-ac1c-94862a58ed54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_0ed336f6-586a-427a-aa95-7e2fcacf2be5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_1b2f053f-7b47-43f1-ac1c-94862a58ed54" xlink:to="loc_us-gaap_HedgingDesignationDomain_0ed336f6-586a-427a-aa95-7e2fcacf2be5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_4cb5f2f3-08b7-4ed8-8f39-ed0cbdc711cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_0ed336f6-586a-427a-aa95-7e2fcacf2be5" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_4cb5f2f3-08b7-4ed8-8f39-ed0cbdc711cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_e8d2ba87-929b-45cf-a740-ee6cb36afe63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_0ed336f6-586a-427a-aa95-7e2fcacf2be5" xlink:to="loc_us-gaap_NondesignatedMember_e8d2ba87-929b-45cf-a740-ee6cb36afe63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_1ec907a3-017b-498d-b624-08e854c2f5b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_e14b367f-5be9-4c16-97d0-f1994c06fca9" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_1ec907a3-017b-498d-b624-08e854c2f5b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_860e628e-ced3-4be8-8119-ece2dfd219bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_1ec907a3-017b-498d-b624-08e854c2f5b5" xlink:to="loc_us-gaap_HedgingRelationshipDomain_860e628e-ced3-4be8-8119-ece2dfd219bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_93d7cf4c-5549-4f70-96da-7ef32cd324b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_860e628e-ced3-4be8-8119-ece2dfd219bc" xlink:to="loc_us-gaap_CashFlowHedgingMember_93d7cf4c-5549-4f70-96da-7ef32cd324b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_a8bddaba-a062-44a8-a95f-f3993f954a04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_860e628e-ced3-4be8-8119-ece2dfd219bc" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_a8bddaba-a062-44a8-a95f-f3993f954a04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_7db0ac13-92da-4761-9b1a-43cd7305cd68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_e14b367f-5be9-4c16-97d0-f1994c06fca9" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_7db0ac13-92da-4761-9b1a-43cd7305cd68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_5a4526ff-4e80-48e1-9b8d-f77e0109d3fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_7db0ac13-92da-4761-9b1a-43cd7305cd68" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_5a4526ff-4e80-48e1-9b8d-f77e0109d3fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_dd7fdcab-9e3c-469f-986c-10be9e6b175a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_5a4526ff-4e80-48e1-9b8d-f77e0109d3fa" xlink:to="loc_us-gaap_ForeignExchangeContractMember_dd7fdcab-9e3c-469f-986c-10be9e6b175a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_b99e48d7-24ad-452f-95d4-6e3b9abb9141" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_5a4526ff-4e80-48e1-9b8d-f77e0109d3fa" xlink:to="loc_us-gaap_InterestRateSwapMember_b99e48d7-24ad-452f-95d4-6e3b9abb9141" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_d3075e74-8f66-4591-9eeb-f9b28df3c555" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_e14b367f-5be9-4c16-97d0-f1994c06fca9" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_d3075e74-8f66-4591-9eeb-f9b28df3c555" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_1ecd1e10-b3b5-4062-b20b-9b40abf3bd36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_d3075e74-8f66-4591-9eeb-f9b28df3c555" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_1ecd1e10-b3b5-4062-b20b-9b40abf3bd36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentAssetsMember_2e5bd540-5177-40dd-8e5f-5e4aaa233393" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_1ecd1e10-b3b5-4062-b20b-9b40abf3bd36" xlink:to="loc_us-gaap_OtherCurrentAssetsMember_2e5bd540-5177-40dd-8e5f-5e4aaa233393" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesMember_bdd629fd-a460-4bd0-8a90-fc3dc141361d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_1ecd1e10-b3b5-4062-b20b-9b40abf3bd36" xlink:to="loc_us-gaap_AccruedLiabilitiesMember_bdd629fd-a460-4bd0-8a90-fc3dc141361d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_1b06f25a-6a04-4acd-a1de-5e00791c367b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_e14b367f-5be9-4c16-97d0-f1994c06fca9" xlink:to="loc_us-gaap_DerivativeLineItems_1b06f25a-6a04-4acd-a1de-5e00791c367b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeNetAbstract_4ce44609-e1d7-4da2-9974-ba064e809869" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeNetAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_1b06f25a-6a04-4acd-a1de-5e00791c367b" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeNetAbstract_4ce44609-e1d7-4da2-9974-ba064e809869" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_fa842738-39bc-4add-b84d-180d82ff7fa0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeNetAbstract_4ce44609-e1d7-4da2-9974-ba064e809869" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_fa842738-39bc-4add-b84d-180d82ff7fa0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_f7ec4e73-0ecf-4c61-bacc-0c79eaa19d2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeNetAbstract_4ce44609-e1d7-4da2-9974-ba064e809869" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_f7ec4e73-0ecf-4c61-bacc-0c79eaa19d2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/DERIVATIVESEffectofderivativeinstrumentsonConsolidatedStatementofOperationsDetails" xlink:type="simple" xlink:href="a-20220131.xsd#DERIVATIVESEffectofderivativeinstrumentsonConsolidatedStatementofOperationsDetails"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/DERIVATIVESEffectofderivativeinstrumentsonConsolidatedStatementofOperationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_d66e4e4c-7446-4ceb-81e2-2ce94f1ec81f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_c9a9f1ff-ba6d-4252-8fc4-9485696baec6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_d66e4e4c-7446-4ceb-81e2-2ce94f1ec81f" xlink:to="loc_us-gaap_DerivativeTable_c9a9f1ff-ba6d-4252-8fc4-9485696baec6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_4d6778c9-7309-4ef7-8f00-f00a9b3404a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_c9a9f1ff-ba6d-4252-8fc4-9485696baec6" xlink:to="loc_us-gaap_HedgingDesignationAxis_4d6778c9-7309-4ef7-8f00-f00a9b3404a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_2d0adfc6-cbb9-4fe2-af1a-e9c413517a44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_4d6778c9-7309-4ef7-8f00-f00a9b3404a3" xlink:to="loc_us-gaap_HedgingDesignationDomain_2d0adfc6-cbb9-4fe2-af1a-e9c413517a44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_293c461c-7b36-447f-8e9e-864616456445" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_2d0adfc6-cbb9-4fe2-af1a-e9c413517a44" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_293c461c-7b36-447f-8e9e-864616456445" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_845b472b-c50b-41a9-9520-5766edd3923a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_2d0adfc6-cbb9-4fe2-af1a-e9c413517a44" xlink:to="loc_us-gaap_NondesignatedMember_845b472b-c50b-41a9-9520-5766edd3923a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_9350b996-2272-44a8-92ff-6aae59338f17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_c9a9f1ff-ba6d-4252-8fc4-9485696baec6" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_9350b996-2272-44a8-92ff-6aae59338f17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_71d75b53-b85d-4970-9275-bae95d47bd02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_9350b996-2272-44a8-92ff-6aae59338f17" xlink:to="loc_us-gaap_HedgingRelationshipDomain_71d75b53-b85d-4970-9275-bae95d47bd02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_b8d6e416-2372-49d5-8702-5a600839845d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_71d75b53-b85d-4970-9275-bae95d47bd02" xlink:to="loc_us-gaap_CashFlowHedgingMember_b8d6e416-2372-49d5-8702-5a600839845d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_5f8ea966-b730-4f74-aafa-6a55732b9f4f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_71d75b53-b85d-4970-9275-bae95d47bd02" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_5f8ea966-b730-4f74-aafa-6a55732b9f4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_c961e60e-ad49-4ba7-906e-fccd96daa60a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_c9a9f1ff-ba6d-4252-8fc4-9485696baec6" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_c961e60e-ad49-4ba7-906e-fccd96daa60a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_ed080c3c-1b0b-455e-8755-1c898207d33d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_c961e60e-ad49-4ba7-906e-fccd96daa60a" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_ed080c3c-1b0b-455e-8755-1c898207d33d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_40a27dc9-7872-46ee-82d5-47acfd3966e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_ed080c3c-1b0b-455e-8755-1c898207d33d" xlink:to="loc_us-gaap_ForeignExchangeContractMember_40a27dc9-7872-46ee-82d5-47acfd3966e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_f5296ec7-c0bf-42b8-9f81-e26aaaea11f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_c9a9f1ff-ba6d-4252-8fc4-9485696baec6" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_f5296ec7-c0bf-42b8-9f81-e26aaaea11f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_737bb00e-76e5-46b9-ba42-669d205a30c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_f5296ec7-c0bf-42b8-9f81-e26aaaea11f6" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_737bb00e-76e5-46b9-ba42-669d205a30c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_018b1871-f1d0-478a-9c64-4c11c42f2e24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_737bb00e-76e5-46b9-ba42-669d205a30c8" xlink:to="loc_us-gaap_InterestExpenseMember_018b1871-f1d0-478a-9c64-4c11c42f2e24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_4eedd51b-78c8-489a-af15-538e232c1cd6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_737bb00e-76e5-46b9-ba42-669d205a30c8" xlink:to="loc_us-gaap_CostOfSalesMember_4eedd51b-78c8-489a-af15-538e232c1cd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_792bec57-8a87-426d-ba93-5d0ad08531a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_737bb00e-76e5-46b9-ba42-669d205a30c8" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_792bec57-8a87-426d-ba93-5d0ad08531a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_ed6cbe98-a6df-46ca-affe-3acb3029f452" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_c9a9f1ff-ba6d-4252-8fc4-9485696baec6" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_ed6cbe98-a6df-46ca-affe-3acb3029f452" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_1e3ef4b4-1f3a-43b2-82b7-3fe329c1d03c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_ed6cbe98-a6df-46ca-affe-3acb3029f452" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_1e3ef4b4-1f3a-43b2-82b7-3fe329c1d03c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_3b94f7a5-5686-4b36-ab1c-c904ac47c544" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_1e3ef4b4-1f3a-43b2-82b7-3fe329c1d03c" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_3b94f7a5-5686-4b36-ab1c-c904ac47c544" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_4f0faee6-a78c-44b7-85c2-29ad79a82ad2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_c9a9f1ff-ba6d-4252-8fc4-9485696baec6" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_4f0faee6-a78c-44b7-85c2-29ad79a82ad2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_1fde4413-742e-46ee-a12a-83bb31e9376b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_4f0faee6-a78c-44b7-85c2-29ad79a82ad2" xlink:to="loc_us-gaap_EquityComponentDomain_1fde4413-742e-46ee-a12a-83bb31e9376b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_397798e7-7d3b-461b-8b9c-26dfd7c60792" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_1fde4413-742e-46ee-a12a-83bb31e9376b" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_397798e7-7d3b-461b-8b9c-26dfd7c60792" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_044d128f-d34d-4071-82f9-a760883c60c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_c9a9f1ff-ba6d-4252-8fc4-9485696baec6" xlink:to="loc_us-gaap_DerivativeLineItems_044d128f-d34d-4071-82f9-a760883c60c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_e6a28e4f-b8e0-4f88-bd23-e672a82273f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_044d128f-d34d-4071-82f9-a760883c60c4" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_e6a28e4f-b8e0-4f88-bd23-e672a82273f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_52c84e98-0acf-40e1-abd2-c18ca2200686" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_044d128f-d34d-4071-82f9-a760883c60c4" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_52c84e98-0acf-40e1-abd2-c18ca2200686" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_c2a737ed-36a7-4f41-9d83-2ad4efcbbca9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_044d128f-d34d-4071-82f9-a760883c60c4" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_c2a737ed-36a7-4f41-9d83-2ad4efcbbca9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_9bd04778-ecbf-461b-a62e-33a0e3af49aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_044d128f-d34d-4071-82f9-a760883c60c4" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_9bd04778-ecbf-461b-a62e-33a0e3af49aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSNotes" xlink:type="simple" xlink:href="a-20220131.xsd#RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSNotes"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresAbstract_69c7b0a8-a8c3-4a0c-b474-d683da57de2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_76398842-fc1c-48c5-b1ba-c51bbeb4d420" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresAbstract_69c7b0a8-a8c3-4a0c-b474-d683da57de2b" xlink:to="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_76398842-fc1c-48c5-b1ba-c51bbeb4d420" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSTables" xlink:type="simple" xlink:href="a-20220131.xsd#RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSTables"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresAbstract_46bef327-77f5-4d62-a5ed-3a163d1dc36a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_c482094d-32cc-43b7-8af0-cf4a3e80a530" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresAbstract_46bef327-77f5-4d62-a5ed-3a163d1dc36a" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_c482094d-32cc-43b7-8af0-cf4a3e80a530" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock_b1b4450a-0b8c-41eb-8024-aa410d35c135" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_c482094d-32cc-43b7-8af0-cf4a3e80a530" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock_b1b4450a-0b8c-41eb-8024-aa410d35c135" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_EmployerContributionsAndExpectedEmployerContributionsTableTextBlock_4e51b0e4-e589-49d7-9b90-2eacc86b0526" xlink:href="a-20220131.xsd#a_EmployerContributionsAndExpectedEmployerContributionsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresAbstract_46bef327-77f5-4d62-a5ed-3a163d1dc36a" xlink:to="loc_a_EmployerContributionsAndExpectedEmployerContributionsTableTextBlock_4e51b0e4-e589-49d7-9b90-2eacc86b0526" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSComponentsofnetperiodiccostsDetails" xlink:type="simple" xlink:href="a-20220131.xsd#RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSComponentsofnetperiodiccostsDetails"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSComponentsofnetperiodiccostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_21689241-8473-4863-a797-19e419dd1f2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_77dbd90a-85c3-4a0b-b37c-ea1bdda5d488" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_21689241-8473-4863-a797-19e419dd1f2f" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_77dbd90a-85c3-4a0b-b37c-ea1bdda5d488" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_3d0ea589-3702-4ed6-88cc-25581f04729e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_77dbd90a-85c3-4a0b-b37c-ea1bdda5d488" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_3d0ea589-3702-4ed6-88cc-25581f04729e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_d8435df3-f19e-49d8-ac02-3d670dcf4ca2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_3d0ea589-3702-4ed6-88cc-25581f04729e" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_d8435df3-f19e-49d8-ac02-3d670dcf4ca2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_044466dc-7e2f-49a2-ac5c-a597adeeec0a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_3d0ea589-3702-4ed6-88cc-25581f04729e" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_044466dc-7e2f-49a2-ac5c-a597adeeec0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_c2f33db0-1659-4f9f-93f2-8eae06882814" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_21689241-8473-4863-a797-19e419dd1f2f" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_c2f33db0-1659-4f9f-93f2-8eae06882814" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_69c942df-6019-4326-a7a0-13aa237c7af2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_c2f33db0-1659-4f9f-93f2-8eae06882814" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_69c942df-6019-4326-a7a0-13aa237c7af2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_a6911f6a-b717-4b49-8c1b-4a185573aa78" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_69c942df-6019-4326-a7a0-13aa237c7af2" xlink:to="loc_country_US_a6911f6a-b717-4b49-8c1b-4a185573aa78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_2cc72cb5-b0db-4ca2-8ec4-c2332e9938c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_69c942df-6019-4326-a7a0-13aa237c7af2" xlink:to="loc_us-gaap_ForeignPlanMember_2cc72cb5-b0db-4ca2-8ec4-c2332e9938c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_58507e32-4b89-4178-96f6-a62d2aecd5eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOperatingActivitiesSegmentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_21689241-8473-4863-a797-19e419dd1f2f" xlink:to="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_58507e32-4b89-4178-96f6-a62d2aecd5eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentOperatingActivitiesDomain_2d7d57bf-eece-40b8-b3f1-999e22b4f308" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentOperatingActivitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_58507e32-4b89-4178-96f6-a62d2aecd5eb" xlink:to="loc_us-gaap_SegmentOperatingActivitiesDomain_2d7d57bf-eece-40b8-b3f1-999e22b4f308" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5e4c05a3-5c86-4ebc-ac29-6c519f7877d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_21689241-8473-4863-a797-19e419dd1f2f" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5e4c05a3-5c86-4ebc-ac29-6c519f7877d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_9502c653-9bb1-4016-bf58-293c5875daff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5e4c05a3-5c86-4ebc-ac29-6c519f7877d0" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_9502c653-9bb1-4016-bf58-293c5875daff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_3aa2d48e-8f5f-46b1-9603-5f4b755f409d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_9502c653-9bb1-4016-bf58-293c5875daff" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_3aa2d48e-8f5f-46b1-9603-5f4b755f409d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_e98d36c6-2741-4523-b43b-9a4cf9481d50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_9502c653-9bb1-4016-bf58-293c5875daff" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_e98d36c6-2741-4523-b43b-9a4cf9481d50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_5fdf3b2e-5e79-46f0-ba3d-f952b1e44fb7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_9502c653-9bb1-4016-bf58-293c5875daff" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_5fdf3b2e-5e79-46f0-ba3d-f952b1e44fb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_AmortizationAndDeferralsAbstract_a72f6c3a-6dfb-4b81-bbc5-7d7c5ac2b0e5" xlink:href="a-20220131.xsd#a_AmortizationAndDeferralsAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_9502c653-9bb1-4016-bf58-293c5875daff" xlink:to="loc_a_AmortizationAndDeferralsAbstract_a72f6c3a-6dfb-4b81-bbc5-7d7c5ac2b0e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_36fc1c56-88a7-40a5-bbb8-35f9aebfd98e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_a_AmortizationAndDeferralsAbstract_a72f6c3a-6dfb-4b81-bbc5-7d7c5ac2b0e5" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_36fc1c56-88a7-40a5-bbb8-35f9aebfd98e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_299ab774-9fb4-434e-992c-46a165e8572f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_a_AmortizationAndDeferralsAbstract_a72f6c3a-6dfb-4b81-bbc5-7d7c5ac2b0e5" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_299ab774-9fb4-434e-992c-46a165e8572f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_3c6f11ed-d9e1-4b77-ae15-671a30ca8e23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_9502c653-9bb1-4016-bf58-293c5875daff" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_3c6f11ed-d9e1-4b77-ae15-671a30ca8e23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanSettlementsAndCurtailmentsAbstract_5c5d5fd9-2500-493e-ac06-d5c11d5baf57" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanSettlementsAndCurtailmentsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5e4c05a3-5c86-4ebc-ac29-6c519f7877d0" xlink:to="loc_us-gaap_DefinedBenefitPlanSettlementsAndCurtailmentsAbstract_5c5d5fd9-2500-493e-ac06-d5c11d5baf57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_4a100169-7cf0-44b5-b2e7-a30a8d76cda7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanSettlementsAndCurtailmentsAbstract_5c5d5fd9-2500-493e-ac06-d5c11d5baf57" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_4a100169-7cf0-44b5-b2e7-a30a8d76cda7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSDetailsEmployerContributions" xlink:type="simple" xlink:href="a-20220131.xsd#RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSDetailsEmployerContributions"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSDetailsEmployerContributions" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresAbstract_8e1de746-8a29-4959-87c5-5a60a331802c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_374d7377-c138-45cf-8401-7c0cec10eb5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresAbstract_8e1de746-8a29-4959-87c5-5a60a331802c" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_374d7377-c138-45cf-8401-7c0cec10eb5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_b1c5cf56-fdfd-4159-9155-bc585ced4a46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_374d7377-c138-45cf-8401-7c0cec10eb5c" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_b1c5cf56-fdfd-4159-9155-bc585ced4a46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_e59e16ab-d5c7-41bb-b298-5ea9e37e5f54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_b1c5cf56-fdfd-4159-9155-bc585ced4a46" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_e59e16ab-d5c7-41bb-b298-5ea9e37e5f54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_6ad7c490-7eca-4197-a4f4-364b9b602b1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_e59e16ab-d5c7-41bb-b298-5ea9e37e5f54" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_6ad7c490-7eca-4197-a4f4-364b9b602b1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_c7e3a1dd-ec2f-4c4c-84c2-bc027236d003" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_374d7377-c138-45cf-8401-7c0cec10eb5c" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_c7e3a1dd-ec2f-4c4c-84c2-bc027236d003" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_9cc63d57-8ee4-494d-970d-d0c2f202301b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_c7e3a1dd-ec2f-4c4c-84c2-bc027236d003" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_9cc63d57-8ee4-494d-970d-d0c2f202301b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_2f7d0583-6a63-4d68-b093-b114fb0ca891" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_9cc63d57-8ee4-494d-970d-d0c2f202301b" xlink:to="loc_country_US_2f7d0583-6a63-4d68-b093-b114fb0ca891" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_08f74f0b-72a9-4c30-bf6b-1e000c067854" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_9cc63d57-8ee4-494d-970d-d0c2f202301b" xlink:to="loc_us-gaap_ForeignPlanMember_08f74f0b-72a9-4c30-bf6b-1e000c067854" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1edd3ae6-53aa-4159-a63f-934a382d7cb2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_374d7377-c138-45cf-8401-7c0cec10eb5c" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1edd3ae6-53aa-4159-a63f-934a382d7cb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_6b39d66b-f52c-44f7-893c-ad194d5edccd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1edd3ae6-53aa-4159-a63f-934a382d7cb2" xlink:to="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_6b39d66b-f52c-44f7-893c-ad194d5edccd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear_bc456b55-548b-4358-bd54-14d0b2efcf4e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1edd3ae6-53aa-4159-a63f-934a382d7cb2" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear_bc456b55-548b-4358-bd54-14d0b2efcf4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/WARRANTIESANDCONTINGENCIESNotes" xlink:type="simple" xlink:href="a-20220131.xsd#WARRANTIESANDCONTINGENCIESNotes"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/WARRANTIESANDCONTINGENCIESNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_bf867f9b-1f1b-4c82-afab-85cce8adc26e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_2349ea8b-0e2f-482f-9a0e-66d1f4648c8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_bf867f9b-1f1b-4c82-afab-85cce8adc26e" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_2349ea8b-0e2f-482f-9a0e-66d1f4648c8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/WARRANTIESANDCONTINGENCIESTable" xlink:type="simple" xlink:href="a-20220131.xsd#WARRANTIESANDCONTINGENCIESTable"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/WARRANTIESANDCONTINGENCIESTable" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_8a4e1339-1483-495b-a0c9-2484aa7b1578" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock_7d1ff21a-02fa-48d4-97eb-18cb753b0ee7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_8a4e1339-1483-495b-a0c9-2484aa7b1578" xlink:to="loc_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock_7d1ff21a-02fa-48d4-97eb-18cb753b0ee7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/WARRANTIESANDCONTINGENCIESDetails" xlink:type="simple" xlink:href="a-20220131.xsd#WARRANTIESANDCONTINGENCIESDetails"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/WARRANTIESANDCONTINGENCIESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_6e1a14e2-b6e3-4102-a44b-f1c52821af20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_79b22709-0b18-4f81-b980-8dfbed546dc5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MovementInStandardProductWarrantyAccrualRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_6e1a14e2-b6e3-4102-a44b-f1c52821af20" xlink:to="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_79b22709-0b18-4f81-b980-8dfbed546dc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandardProductWarrantyAccrual_fd7cdd21-ab8b-481f-ad61-6158522008e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StandardProductWarrantyAccrual"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_79b22709-0b18-4f81-b980-8dfbed546dc5" xlink:to="loc_us-gaap_StandardProductWarrantyAccrual_fd7cdd21-ab8b-481f-ad61-6158522008e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandardProductWarrantyAccrualWarrantiesIssued_154d69f7-e5cc-4bb6-b289-12a5beda2cce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StandardProductWarrantyAccrualWarrantiesIssued"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_79b22709-0b18-4f81-b980-8dfbed546dc5" xlink:to="loc_us-gaap_StandardProductWarrantyAccrualWarrantiesIssued_154d69f7-e5cc-4bb6-b289-12a5beda2cce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandardProductWarrantyAccrualPayments_59c115df-16ad-477f-af09-a17f94474d86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StandardProductWarrantyAccrualPayments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_79b22709-0b18-4f81-b980-8dfbed546dc5" xlink:to="loc_us-gaap_StandardProductWarrantyAccrualPayments_59c115df-16ad-477f-af09-a17f94474d86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandardProductWarrantyAccrual_b32a74d6-5cf5-4afd-86a7-1071a7470f10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StandardProductWarrantyAccrual"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_79b22709-0b18-4f81-b980-8dfbed546dc5" xlink:to="loc_us-gaap_StandardProductWarrantyAccrual_b32a74d6-5cf5-4afd-86a7-1071a7470f10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandardProductWarrantyDisclosureAbstract_7c1f0eb4-6c34-4254-968d-c4420f42b259" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StandardProductWarrantyDisclosureAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_6e1a14e2-b6e3-4102-a44b-f1c52821af20" xlink:to="loc_us-gaap_StandardProductWarrantyDisclosureAbstract_7c1f0eb4-6c34-4254-968d-c4420f42b259" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandardProductWarrantyAccrualCurrent_2a15f94d-8159-4d5f-98ef-a727d58377dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StandardProductWarrantyAccrualCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StandardProductWarrantyDisclosureAbstract_7c1f0eb4-6c34-4254-968d-c4420f42b259" xlink:to="loc_us-gaap_StandardProductWarrantyAccrualCurrent_2a15f94d-8159-4d5f-98ef-a727d58377dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandardProductWarrantyAccrualNoncurrent_d7f53f4e-5cad-44b4-96a3-64c05c5879c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StandardProductWarrantyAccrualNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StandardProductWarrantyDisclosureAbstract_7c1f0eb4-6c34-4254-968d-c4420f42b259" xlink:to="loc_us-gaap_StandardProductWarrantyAccrualNoncurrent_d7f53f4e-5cad-44b4-96a3-64c05c5879c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteesAbstract_ab660cfe-cf5d-4d5a-9b59-74e51ddcb1e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GuaranteesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_6e1a14e2-b6e3-4102-a44b-f1c52821af20" xlink:to="loc_us-gaap_GuaranteesAbstract_ab660cfe-cf5d-4d5a-9b59-74e51ddcb1e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BankAcceptancesExecuted_3e22f530-3842-49da-a495-3add1c5ae460" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BankAcceptancesExecuted"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GuaranteesAbstract_ab660cfe-cf5d-4d5a-9b59-74e51ddcb1e6" xlink:to="loc_us-gaap_BankAcceptancesExecuted_3e22f530-3842-49da-a495-3add1c5ae460" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/SHORTTERMDEBTNotes" xlink:type="simple" xlink:href="a-20220131.xsd#SHORTTERMDEBTNotes"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/SHORTTERMDEBTNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowingsAbstract_308a2f13-820a-4a68-8fb7-9b3d67499e1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermBorrowingsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTextBlock_a772df71-6801-4f45-8495-27134dcdc416" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermBorrowingsAbstract_308a2f13-820a-4a68-8fb7-9b3d67499e1c" xlink:to="loc_us-gaap_ShortTermDebtTextBlock_a772df71-6801-4f45-8495-27134dcdc416" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/SHORTTERMDEBTCreditFacilityDetails" xlink:type="simple" xlink:href="a-20220131.xsd#SHORTTERMDEBTCreditFacilityDetails"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/SHORTTERMDEBTCreditFacilityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_59ec489e-89f0-461b-820c-26b6bc7e17c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShortTermDebtTable_8aba902f-3fe3-4651-b5d9-19e35376988c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShortTermDebtTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_59ec489e-89f0-461b-820c-26b6bc7e17c5" xlink:to="loc_us-gaap_ScheduleOfShortTermDebtTable_8aba902f-3fe3-4651-b5d9-19e35376988c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_9703d69c-75b6-4175-bc18-f7ee61c2867a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_8aba902f-3fe3-4651-b5d9-19e35376988c" xlink:to="loc_us-gaap_CreditFacilityAxis_9703d69c-75b6-4175-bc18-f7ee61c2867a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_fe84f907-bdad-4b8c-a616-0fb224ddc8ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_9703d69c-75b6-4175-bc18-f7ee61c2867a" xlink:to="loc_us-gaap_CreditFacilityDomain_fe84f907-bdad-4b8c-a616-0fb224ddc8ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_b3fd97c0-fb73-4624-a728-ec3b8d21d9d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_fe84f907-bdad-4b8c-a616-0fb224ddc8ed" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_b3fd97c0-fb73-4624-a728-ec3b8d21d9d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_54d9767d-5920-49ae-8810-3b73b07806e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_fe84f907-bdad-4b8c-a616-0fb224ddc8ed" xlink:to="loc_us-gaap_LineOfCreditMember_54d9767d-5920-49ae-8810-3b73b07806e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_c6d7ac3a-58b8-47d8-a7c9-35bc096eba04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_8aba902f-3fe3-4651-b5d9-19e35376988c" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_c6d7ac3a-58b8-47d8-a7c9-35bc096eba04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_aaf0e967-d9d7-45b0-bc78-8a5ff8b94446" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_c6d7ac3a-58b8-47d8-a7c9-35bc096eba04" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_aaf0e967-d9d7-45b0-bc78-8a5ff8b94446" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_fad24e35-3293-451d-bbb9-1bce0e24dfa3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_8aba902f-3fe3-4651-b5d9-19e35376988c" xlink:to="loc_us-gaap_DebtInstrumentAxis_fad24e35-3293-451d-bbb9-1bce0e24dfa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_3b9f4ba7-c5fe-427e-b8e4-6c0f23a47c2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_fad24e35-3293-451d-bbb9-1bce0e24dfa3" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_3b9f4ba7-c5fe-427e-b8e4-6c0f23a47c2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_A5YrUnsecuredCreditFacilityMember_b09d0936-f7ca-402f-a25f-9c5822095b86" xlink:href="a-20220131.xsd#a_A5YrUnsecuredCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3b9f4ba7-c5fe-427e-b8e4-6c0f23a47c2b" xlink:to="loc_a_A5YrUnsecuredCreditFacilityMember_b09d0936-f7ca-402f-a25f-9c5822095b86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_AdditionalIncrementalTermLoanFacilityMember_b75623bc-25da-49b5-818d-be131f53c480" xlink:href="a-20220131.xsd#a_AdditionalIncrementalTermLoanFacilityMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3b9f4ba7-c5fe-427e-b8e4-6c0f23a47c2b" xlink:to="loc_a_AdditionalIncrementalTermLoanFacilityMember_b75623bc-25da-49b5-818d-be131f53c480" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_f79b1472-301d-4f6c-acce-cc0e266baa70" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3b9f4ba7-c5fe-427e-b8e4-6c0f23a47c2b" xlink:to="loc_us-gaap_CommercialPaperMember_f79b1472-301d-4f6c-acce-cc0e266baa70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtLineItems_2958bc3a-1a9d-4694-a7c5-f8e025efe501" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_8aba902f-3fe3-4651-b5d9-19e35376988c" xlink:to="loc_us-gaap_ShortTermDebtLineItems_2958bc3a-1a9d-4694-a7c5-f8e025efe501" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityInitiationDate1_d37aa1ed-3317-45c1-8f21-c4978b711da0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityInitiationDate1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_2958bc3a-1a9d-4694-a7c5-f8e025efe501" xlink:to="loc_us-gaap_LineOfCreditFacilityInitiationDate1_d37aa1ed-3317-45c1-8f21-c4978b711da0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_10213ac6-bd49-4618-8ecd-0bd478b6bd0e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_2958bc3a-1a9d-4694-a7c5-f8e025efe501" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_10213ac6-bd49-4618-8ecd-0bd478b6bd0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTerms_1459db5a-fbdd-4a83-b41f-0382461a406e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTerms"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_2958bc3a-1a9d-4694-a7c5-f8e025efe501" xlink:to="loc_us-gaap_ShortTermDebtTerms_1459db5a-fbdd-4a83-b41f-0382461a406e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityExpirationDate1_aed9c405-9840-4c15-967c-2ec1a4b3efe4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityExpirationDate1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_2958bc3a-1a9d-4694-a7c5-f8e025efe501" xlink:to="loc_us-gaap_LineOfCreditFacilityExpirationDate1_aed9c405-9840-4c15-967c-2ec1a4b3efe4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_ade4da8b-a367-40d8-b988-e8297f551647" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_2958bc3a-1a9d-4694-a7c5-f8e025efe501" xlink:to="loc_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_ade4da8b-a367-40d8-b988-e8297f551647" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtWeightedAverageInterestRate_d5d2c330-1341-4332-9d2a-957c8abc07a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtWeightedAverageInterestRate"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_2958bc3a-1a9d-4694-a7c5-f8e025efe501" xlink:to="loc_us-gaap_ShortTermDebtWeightedAverageInterestRate_d5d2c330-1341-4332-9d2a-957c8abc07a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_WeightedAverageMaturityDateatPointinTime_e88d79f2-21a6-494f-8772-9464a70b47f1" xlink:href="a-20220131.xsd#a_WeightedAverageMaturityDateatPointinTime"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_2958bc3a-1a9d-4694-a7c5-f8e025efe501" xlink:to="loc_a_WeightedAverageMaturityDateatPointinTime_e88d79f2-21a6-494f-8772-9464a70b47f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_WeightedAverageMaturityDateAtAPointInTime_f91e1500-3cfc-48f9-bd9c-ca876e03d114" xlink:href="a-20220131.xsd#a_WeightedAverageMaturityDateAtAPointInTime"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_2958bc3a-1a9d-4694-a7c5-f8e025efe501" xlink:to="loc_a_WeightedAverageMaturityDateAtAPointInTime_f91e1500-3cfc-48f9-bd9c-ca876e03d114" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfCommercialPaper_ff9e3cac-f847-44c2-88db-3b1110cec2a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfCommercialPaper"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_2958bc3a-1a9d-4694-a7c5-f8e025efe501" xlink:to="loc_us-gaap_RepaymentsOfCommercialPaper_ff9e3cac-f847-44c2-88db-3b1110cec2a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommercialPaper_5a3a1247-35ee-4f4d-b726-1e314c9650bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommercialPaper"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_2958bc3a-1a9d-4694-a7c5-f8e025efe501" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommercialPaper_5a3a1247-35ee-4f4d-b726-1e314c9650bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/LONGTERMDEBTNotes" xlink:type="simple" xlink:href="a-20220131.xsd#LONGTERMDEBTNotes"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/LONGTERMDEBTNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_b8d80ab0-a118-4ab1-b555-2fd352866447" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtTextBlock_74233da1-2d12-4068-979f-28550be011a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_b8d80ab0-a118-4ab1-b555-2fd352866447" xlink:to="loc_us-gaap_LongTermDebtTextBlock_74233da1-2d12-4068-979f-28550be011a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/LONGTERMDEBTTables" xlink:type="simple" xlink:href="a-20220131.xsd#LONGTERMDEBTTables"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/LONGTERMDEBTTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_d0ad3deb-2104-4541-893c-5deab1f5001c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_c28e847d-27ff-4b6b-aefc-57090b17223b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_d0ad3deb-2104-4541-893c-5deab1f5001c" xlink:to="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_c28e847d-27ff-4b6b-aefc-57090b17223b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/LONGTERMDEBTDetails" xlink:type="simple" xlink:href="a-20220131.xsd#LONGTERMDEBTDetails"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/LONGTERMDEBTDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_91d5f314-321a-4bb1-b20c-dc1058c4d919" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_ab81715c-7961-4f99-bdbe-8b70c54909b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_91d5f314-321a-4bb1-b20c-dc1058c4d919" xlink:to="loc_us-gaap_DebtInstrumentTable_ab81715c-7961-4f99-bdbe-8b70c54909b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_7cf06617-3757-4537-b021-316433de3dad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_ab81715c-7961-4f99-bdbe-8b70c54909b6" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_7cf06617-3757-4537-b021-316433de3dad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_aa0bded4-c98f-4739-8ae2-092c6e699971" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_7cf06617-3757-4537-b021-316433de3dad" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_aa0bded4-c98f-4739-8ae2-092c6e699971" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_c3e1749f-4a9f-4b60-a00e-17042208a2ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_ab81715c-7961-4f99-bdbe-8b70c54909b6" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_c3e1749f-4a9f-4b60-a00e-17042208a2ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_40a10c44-450b-4604-9b08-4988b39ee527" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_c3e1749f-4a9f-4b60-a00e-17042208a2ac" xlink:to="loc_us-gaap_TypeOfAdoptionMember_40a10c44-450b-4604-9b08-4988b39ee527" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_6918587e-95e1-404b-a540-816798740d34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_ab81715c-7961-4f99-bdbe-8b70c54909b6" xlink:to="loc_us-gaap_DebtInstrumentAxis_6918587e-95e1-404b-a540-816798740d34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_ec09b7fa-3a43-4787-a71d-a3bb13148391" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_6918587e-95e1-404b-a540-816798740d34" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_ec09b7fa-3a43-4787-a71d-a3bb13148391" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_SeniorNotes2023Member_e48b6c6a-2a4f-449b-8a5a-0c4e9119f5af" xlink:href="a-20220131.xsd#a_SeniorNotes2023Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ec09b7fa-3a43-4787-a71d-a3bb13148391" xlink:to="loc_a_SeniorNotes2023Member_e48b6c6a-2a4f-449b-8a5a-0c4e9119f5af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_SeniorNotes2026Member_786d4228-fa0c-4da1-8472-85a514435f2d" xlink:href="a-20220131.xsd#a_SeniorNotes2026Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ec09b7fa-3a43-4787-a71d-a3bb13148391" xlink:to="loc_a_SeniorNotes2026Member_786d4228-fa0c-4da1-8472-85a514435f2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_SeniorNotes2029Member_0e87d561-46f5-4171-a4ef-1b54c5b3c260" xlink:href="a-20220131.xsd#a_SeniorNotes2029Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ec09b7fa-3a43-4787-a71d-a3bb13148391" xlink:to="loc_a_SeniorNotes2029Member_0e87d561-46f5-4171-a4ef-1b54c5b3c260" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_SeniorNotes2030Member_a2e48953-a106-4fe5-ac13-6a5b6cedf96b" xlink:href="a-20220131.xsd#a_SeniorNotes2030Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ec09b7fa-3a43-4787-a71d-a3bb13148391" xlink:to="loc_a_SeniorNotes2030Member_a2e48953-a106-4fe5-ac13-6a5b6cedf96b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_SeniorNotes2031Member_d9ffa9b8-ac28-467e-b42a-ca20e4b4d1a2" xlink:href="a-20220131.xsd#a_SeniorNotes2031Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ec09b7fa-3a43-4787-a71d-a3bb13148391" xlink:to="loc_a_SeniorNotes2031Member_d9ffa9b8-ac28-467e-b42a-ca20e4b4d1a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_6edf1fe5-c13a-455d-ba5e-6cf7d228d161" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_ab81715c-7961-4f99-bdbe-8b70c54909b6" xlink:to="loc_us-gaap_DebtInstrumentLineItems_6edf1fe5-c13a-455d-ba5e-6cf7d228d161" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_707be481-92bb-4f63-a1c5-c172903e80c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6edf1fe5-c13a-455d-ba5e-6cf7d228d161" xlink:to="loc_us-gaap_LongTermDebt_707be481-92bb-4f63-a1c5-c172903e80c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/STOCKHOLDERSEQUITYNotes" xlink:type="simple" xlink:href="a-20220131.xsd#STOCKHOLDERSEQUITYNotes"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/STOCKHOLDERSEQUITYNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_5c73ebca-3c61-48f2-9b37-9d72c7e8f42c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_7cc159c9-2a72-47c5-b069-2896b1a969c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_5c73ebca-3c61-48f2-9b37-9d72c7e8f42c" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_7cc159c9-2a72-47c5-b069-2896b1a969c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/STOCKHOLDERSEQUITYTables" xlink:type="simple" xlink:href="a-20220131.xsd#STOCKHOLDERSEQUITYTables"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/STOCKHOLDERSEQUITYTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_115d3109-f2da-4160-aa30-db889a1419be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_a852747e-35b8-4674-a102-bfb82f1aa23d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_115d3109-f2da-4160-aa30-db889a1419be" xlink:to="loc_us-gaap_StatementTable_a852747e-35b8-4674-a102-bfb82f1aa23d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_d68ad47d-000c-43cf-a4bf-1cfe2cd708ce" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_a852747e-35b8-4674-a102-bfb82f1aa23d" xlink:to="loc_srt_StatementScenarioAxis_d68ad47d-000c-43cf-a4bf-1cfe2cd708ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_c0079647-1021-421b-b41a-d5b6df29b0eb" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_d68ad47d-000c-43cf-a4bf-1cfe2cd708ce" xlink:to="loc_srt_ScenarioUnspecifiedDomain_c0079647-1021-421b-b41a-d5b6df29b0eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_f6ba072d-a915-4507-894e-810b00a66a2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_a852747e-35b8-4674-a102-bfb82f1aa23d" xlink:to="loc_us-gaap_StatementLineItems_f6ba072d-a915-4507-894e-810b00a66a2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_6b1090d2-4067-4f6a-9768-87e95c827e29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f6ba072d-a915-4507-894e-810b00a66a2f" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_6b1090d2-4067-4f6a-9768-87e95c827e29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock_e429dbfc-c82f-4e25-ae1d-3b580180a88d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f6ba072d-a915-4507-894e-810b00a66a2f" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock_e429dbfc-c82f-4e25-ae1d-3b580180a88d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/STOCKHOLDERSEQUITYStockRepurchaseProgramDetails" xlink:type="simple" xlink:href="a-20220131.xsd#STOCKHOLDERSEQUITYStockRepurchaseProgramDetails"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/STOCKHOLDERSEQUITYStockRepurchaseProgramDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_7b585310-2f2d-4ed0-b30d-9ba854cd07fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable_7c040fe9-5d8c-468e-8bbd-a0ef3b265911" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_7b585310-2f2d-4ed0-b30d-9ba854cd07fc" xlink:to="loc_us-gaap_ClassOfTreasuryStockTable_7c040fe9-5d8c-468e-8bbd-a0ef3b265911" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_c4f1f17d-7bff-42f5-b954-764ddc44ca5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_7c040fe9-5d8c-468e-8bbd-a0ef3b265911" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_c4f1f17d-7bff-42f5-b954-764ddc44ca5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_ce269d5b-7832-4804-9c04-74dd4cdf90a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_c4f1f17d-7bff-42f5-b954-764ddc44ca5c" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_ce269d5b-7832-4804-9c04-74dd4cdf90a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_094a24cf-e291-4202-8557-6391878da08d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_7c040fe9-5d8c-468e-8bbd-a0ef3b265911" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_094a24cf-e291-4202-8557-6391878da08d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_0b16d324-d4cf-4fbc-b4cc-9c4eacf6d9fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_094a24cf-e291-4202-8557-6391878da08d" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_0b16d324-d4cf-4fbc-b4cc-9c4eacf6d9fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_A2019RepurchaseProgramMember_331dfcb9-f6f1-4fbf-97a4-9303bacddd88" xlink:href="a-20220131.xsd#a_A2019RepurchaseProgramMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_0b16d324-d4cf-4fbc-b4cc-9c4eacf6d9fb" xlink:to="loc_a_A2019RepurchaseProgramMember_331dfcb9-f6f1-4fbf-97a4-9303bacddd88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_A2021RepurchaseProgramMember_4693870b-5aef-418d-9982-5d460674b1e2" xlink:href="a-20220131.xsd#a_A2021RepurchaseProgramMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_0b16d324-d4cf-4fbc-b4cc-9c4eacf6d9fb" xlink:to="loc_a_A2021RepurchaseProgramMember_4693870b-5aef-418d-9982-5d460674b1e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_f86ba596-f08e-4dab-8b28-eabc4780ef17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_7c040fe9-5d8c-468e-8bbd-a0ef3b265911" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_f86ba596-f08e-4dab-8b28-eabc4780ef17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_adbcb10a-b673-47d1-8e4b-b312a04e0bb3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_f86ba596-f08e-4dab-8b28-eabc4780ef17" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_adbcb10a-b673-47d1-8e4b-b312a04e0bb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_5f906dbc-bcd6-4efb-a589-2042b9e4bbee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_adbcb10a-b673-47d1-8e4b-b312a04e0bb3" xlink:to="loc_us-gaap_SubsequentEventMember_5f906dbc-bcd6-4efb-a589-2042b9e4bbee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems_37b77ef3-4c3a-49c4-a9b2-887892c0bf48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_7c040fe9-5d8c-468e-8bbd-a0ef3b265911" xlink:to="loc_us-gaap_EquityClassOfTreasuryStockLineItems_37b77ef3-4c3a-49c4-a9b2-887892c0bf48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_63a9fddd-6a0f-48d6-bd9a-66e3faf1f9ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_37b77ef3-4c3a-49c4-a9b2-887892c0bf48" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_63a9fddd-6a0f-48d6-bd9a-66e3faf1f9ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_f181a28a-b0a1-43df-97a7-99164216117c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_37b77ef3-4c3a-49c4-a9b2-887892c0bf48" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_f181a28a-b0a1-43df-97a7-99164216117c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_91c2b064-5d69-43c9-a6eb-beae318046bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_37b77ef3-4c3a-49c4-a9b2-887892c0bf48" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_91c2b064-5d69-43c9-a6eb-beae318046bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_9be862ad-9f43-44df-a04e-75f8f4e286cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_37b77ef3-4c3a-49c4-a9b2-887892c0bf48" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_9be862ad-9f43-44df-a04e-75f8f4e286cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/STOCKHOLDERSEQUITYDividendsDetails" xlink:type="simple" xlink:href="a-20220131.xsd#STOCKHOLDERSEQUITYDividendsDetails"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/STOCKHOLDERSEQUITYDividendsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsAbstract_ce2ffbbe-e1de-448c-af50-a6ada849c31a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableTable_dac5eb31-5526-45d9-ac0e-230fbcde87b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsPayableTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsAbstract_ce2ffbbe-e1de-448c-af50-a6ada849c31a" xlink:to="loc_us-gaap_DividendsPayableTable_dac5eb31-5526-45d9-ac0e-230fbcde87b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_b14b8d94-eed4-48fe-b212-2b791071b15f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsPayableTable_dac5eb31-5526-45d9-ac0e-230fbcde87b0" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_b14b8d94-eed4-48fe-b212-2b791071b15f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_7f5478fc-2aed-4e3c-8d35-bb2ef60b8e19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_b14b8d94-eed4-48fe-b212-2b791071b15f" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_7f5478fc-2aed-4e3c-8d35-bb2ef60b8e19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_52819b88-5b58-4342-9fdc-ee1070882d81" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_7f5478fc-2aed-4e3c-8d35-bb2ef60b8e19" xlink:to="loc_us-gaap_SubsequentEventMember_52819b88-5b58-4342-9fdc-ee1070882d81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsAxis_bec9f179-851c-4f4a-b410-e2ff3bb605dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsPayableTable_dac5eb31-5526-45d9-ac0e-230fbcde87b0" xlink:to="loc_us-gaap_DividendsAxis_bec9f179-851c-4f4a-b410-e2ff3bb605dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsDomain_a06fc719-ed48-4753-9cbc-65424caa7cfa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsAxis_bec9f179-851c-4f4a-b410-e2ff3bb605dc" xlink:to="loc_us-gaap_DividendsDomain_a06fc719-ed48-4753-9cbc-65424caa7cfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableLineItems_a3b3d274-a426-4790-a614-c5d6a84ff235" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsPayableLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsPayableTable_dac5eb31-5526-45d9-ac0e-230fbcde87b0" xlink:to="loc_us-gaap_DividendsPayableLineItems_a3b3d274-a426-4790-a614-c5d6a84ff235" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsAbstract_8e15fefd-9142-4c8f-a670-0568fcb896db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividendsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsPayableLineItems_a3b3d274-a426-4790-a614-c5d6a84ff235" xlink:to="loc_us-gaap_PaymentsOfDividendsAbstract_8e15fefd-9142-4c8f-a670-0568fcb896db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareCashPaid_4e2cac27-5dad-48e8-abed-585ba994cc9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockDividendsPerShareCashPaid"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PaymentsOfDividendsAbstract_8e15fefd-9142-4c8f-a670-0568fcb896db" xlink:to="loc_us-gaap_CommonStockDividendsPerShareCashPaid_4e2cac27-5dad-48e8-abed-585ba994cc9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_8ca153de-da3e-4e25-9d5a-3aeaa284888e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PaymentsOfDividendsAbstract_8e15fefd-9142-4c8f-a670-0568fcb896db" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_8ca153de-da3e-4e25-9d5a-3aeaa284888e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockAbstract_0911fccd-945c-4b22-9341-aec3f4ddbf75" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsCommonStockAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsPayableLineItems_a3b3d274-a426-4790-a614-c5d6a84ff235" xlink:to="loc_us-gaap_DividendsCommonStockAbstract_0911fccd-945c-4b22-9341-aec3f4ddbf75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableDateDeclaredDayMonthAndYear_402c8484-80d9-4313-a6fe-62f85f18eeca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsPayableDateDeclaredDayMonthAndYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsCommonStockAbstract_0911fccd-945c-4b22-9341-aec3f4ddbf75" xlink:to="loc_us-gaap_DividendsPayableDateDeclaredDayMonthAndYear_402c8484-80d9-4313-a6fe-62f85f18eeca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_309b31f9-982a-47f4-b754-616be9a65bd7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsCommonStockAbstract_0911fccd-945c-4b22-9341-aec3f4ddbf75" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_309b31f9-982a-47f4-b754-616be9a65bd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_8724c7de-12c6-42b4-8fa8-2a8542712165" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsCommonStockAbstract_0911fccd-945c-4b22-9341-aec3f4ddbf75" xlink:to="loc_us-gaap_DividendsCommonStockCash_8724c7de-12c6-42b4-8fa8-2a8542712165" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendPayableDateToBePaidDayMonthAndYear_431474b4-646e-45dd-b408-790b6c89e36f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendPayableDateToBePaidDayMonthAndYear"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsCommonStockAbstract_0911fccd-945c-4b22-9341-aec3f4ddbf75" xlink:to="loc_us-gaap_DividendPayableDateToBePaidDayMonthAndYear_431474b4-646e-45dd-b408-790b6c89e36f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableDateOfRecordDayMonthAndYear_aff6f5dd-512f-4070-985b-08a0bd4ab424" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsPayableDateOfRecordDayMonthAndYear"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsCommonStockAbstract_0911fccd-945c-4b22-9341-aec3f4ddbf75" xlink:to="loc_us-gaap_DividendsPayableDateOfRecordDayMonthAndYear_aff6f5dd-512f-4070-985b-08a0bd4ab424" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/STOCKHOLDERSEQUITYAccumulatedOtherComprehensiveIncomeDetails" xlink:type="simple" xlink:href="a-20220131.xsd#STOCKHOLDERSEQUITYAccumulatedOtherComprehensiveIncomeDetails"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/STOCKHOLDERSEQUITYAccumulatedOtherComprehensiveIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_7805ef55-ed85-4410-a59f-c0d72bd084c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_20f84da0-3dd5-4255-8e27-aee129aff13c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_7805ef55-ed85-4410-a59f-c0d72bd084c6" xlink:to="loc_us-gaap_StatementTable_20f84da0-3dd5-4255-8e27-aee129aff13c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_a566782e-02ab-439d-9dda-ac1662f03cb8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_20f84da0-3dd5-4255-8e27-aee129aff13c" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_a566782e-02ab-439d-9dda-ac1662f03cb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_50af4f9d-c7d6-4631-ae50-cdf189750166" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_a566782e-02ab-439d-9dda-ac1662f03cb8" xlink:to="loc_us-gaap_EquityComponentDomain_50af4f9d-c7d6-4631-ae50-cdf189750166" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_4c624ddb-b4e5-4ef7-92d8-eb0122f6e480" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_50af4f9d-c7d6-4631-ae50-cdf189750166" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_4c624ddb-b4e5-4ef7-92d8-eb0122f6e480" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember_a84be63e-5472-42a3-b381-bcad9ba331bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_50af4f9d-c7d6-4631-ae50-cdf189750166" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember_a84be63e-5472-42a3-b381-bcad9ba331bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember_f6b73029-9614-461f-a188-b13e90b761bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_50af4f9d-c7d6-4631-ae50-cdf189750166" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember_f6b73029-9614-461f-a188-b13e90b761bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociDerivativeQualifyingAsHedgeExcludedComponentParentMember_a5efd90b-7ac8-4436-b2c0-9556b374b218" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AociDerivativeQualifyingAsHedgeExcludedComponentParentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_50af4f9d-c7d6-4631-ae50-cdf189750166" xlink:to="loc_us-gaap_AociDerivativeQualifyingAsHedgeExcludedComponentParentMember_a5efd90b-7ac8-4436-b2c0-9556b374b218" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_8bc197d7-e24c-4116-998f-ef0e792f45fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOperatingActivitiesSegmentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_20f84da0-3dd5-4255-8e27-aee129aff13c" xlink:to="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_8bc197d7-e24c-4116-998f-ef0e792f45fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentOperatingActivitiesDomain_ec3adda1-931a-417c-9755-8ef732ad9c45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentOperatingActivitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_8bc197d7-e24c-4116-998f-ef0e792f45fd" xlink:to="loc_us-gaap_SegmentOperatingActivitiesDomain_ec3adda1-931a-417c-9755-8ef732ad9c45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_656d8ccc-5a77-4430-a096-6b5db2809bb8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_20f84da0-3dd5-4255-8e27-aee129aff13c" xlink:to="loc_us-gaap_StatementLineItems_656d8ccc-5a77-4430-a096-6b5db2809bb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_fcee1932-659b-492e-8887-e5eb1812c52d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_656d8ccc-5a77-4430-a096-6b5db2809bb8" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_fcee1932-659b-492e-8887-e5eb1812c52d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_2bc6ceb5-6099-4b0d-b720-16609ec80050" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_656d8ccc-5a77-4430-a096-6b5db2809bb8" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_2bc6ceb5-6099-4b0d-b720-16609ec80050" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_4664fddc-1f9d-4c49-85fd-788bfde85fbe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_656d8ccc-5a77-4430-a096-6b5db2809bb8" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_4664fddc-1f9d-4c49-85fd-788bfde85fbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent_7583cf0b-a859-497b-bfb4-790c811728c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_656d8ccc-5a77-4430-a096-6b5db2809bb8" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent_7583cf0b-a859-497b-bfb4-790c811728c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTax_bb0642de-1c3c-4f37-a783-33d854290109" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_656d8ccc-5a77-4430-a096-6b5db2809bb8" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossTax_bb0642de-1c3c-4f37-a783-33d854290109" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_a395512d-bb86-4702-8ad3-2ed66b0d41ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_656d8ccc-5a77-4430-a096-6b5db2809bb8" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_a395512d-bb86-4702-8ad3-2ed66b0d41ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_7eacbabf-21fc-4384-a4fc-be073c6ccd50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_656d8ccc-5a77-4430-a096-6b5db2809bb8" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_7eacbabf-21fc-4384-a4fc-be073c6ccd50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/STOCKHOLDERSEQUITYReclassificationsoutofaccumulatedcomprehensiveincomeDetails" xlink:type="simple" xlink:href="a-20220131.xsd#STOCKHOLDERSEQUITYReclassificationsoutofaccumulatedcomprehensiveincomeDetails"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/STOCKHOLDERSEQUITYReclassificationsoutofaccumulatedcomprehensiveincomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_9100d5c0-884b-4156-a9e4-d235c52ff3b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_8e0c4dae-a1bc-4e1a-8464-e754952cb704" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_9100d5c0-884b-4156-a9e4-d235c52ff3b8" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_8e0c4dae-a1bc-4e1a-8464-e754952cb704" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_89d7afd3-75b3-4759-aa0d-bdb9ecf9d570" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_8e0c4dae-a1bc-4e1a-8464-e754952cb704" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_89d7afd3-75b3-4759-aa0d-bdb9ecf9d570" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_c36ff848-37a8-49f5-8873-d90b5843298b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_89d7afd3-75b3-4759-aa0d-bdb9ecf9d570" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_c36ff848-37a8-49f5-8873-d90b5843298b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_6151ea2b-a21b-4f90-8284-2e22d8b59be5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_c36ff848-37a8-49f5-8873-d90b5843298b" xlink:to="loc_us-gaap_CostOfSalesMember_6151ea2b-a21b-4f90-8284-2e22d8b59be5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_4a3a35b4-0406-4646-868f-a689b0d81b99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_c36ff848-37a8-49f5-8873-d90b5843298b" xlink:to="loc_us-gaap_InterestExpenseMember_4a3a35b4-0406-4646-868f-a689b0d81b99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_4f719f68-91b0-48d2-a82d-e2772cf4f690" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_8e0c4dae-a1bc-4e1a-8464-e754952cb704" xlink:to="loc_srt_StatementScenarioAxis_4f719f68-91b0-48d2-a82d-e2772cf4f690" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_be53e97e-a731-437e-a058-67be61c800e8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_4f719f68-91b0-48d2-a82d-e2772cf4f690" xlink:to="loc_srt_ScenarioUnspecifiedDomain_be53e97e-a731-437e-a058-67be61c800e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_db606c9c-f42d-4459-afc8-0dfe8cf26d17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_8e0c4dae-a1bc-4e1a-8464-e754952cb704" xlink:to="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_db606c9c-f42d-4459-afc8-0dfe8cf26d17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_e73d14ee-f9b8-4eb1-89e5-c0a350326799" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_db606c9c-f42d-4459-afc8-0dfe8cf26d17" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_e73d14ee-f9b8-4eb1-89e5-c0a350326799" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_d09a18d4-d46e-4a03-8fa5-58116fcb468a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_db606c9c-f42d-4459-afc8-0dfe8cf26d17" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_d09a18d4-d46e-4a03-8fa5-58116fcb468a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_56fe4322-4bd6-49bd-929e-e42fa86f46d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_db606c9c-f42d-4459-afc8-0dfe8cf26d17" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_56fe4322-4bd6-49bd-929e-e42fa86f46d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_f323d520-2644-44a3-b75c-8c01ee10e861" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_db606c9c-f42d-4459-afc8-0dfe8cf26d17" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_f323d520-2644-44a3-b75c-8c01ee10e861" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_a438ee61-3175-4f15-81e4-71a61e8f4403" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_db606c9c-f42d-4459-afc8-0dfe8cf26d17" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_a438ee61-3175-4f15-81e4-71a61e8f4403" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax_fdd7d972-99bb-401e-badc-4df5f8ef91fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_db606c9c-f42d-4459-afc8-0dfe8cf26d17" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax_fdd7d972-99bb-401e-badc-4df5f8ef91fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansTax_01cba5ce-2fd2-4af6-98be-1298c5fb17ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_db606c9c-f42d-4459-afc8-0dfe8cf26d17" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansTax_01cba5ce-2fd2-4af6-98be-1298c5fb17ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax_499cd8bf-94c5-448a-b97f-49e09306feb1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_db606c9c-f42d-4459-afc8-0dfe8cf26d17" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax_499cd8bf-94c5-448a-b97f-49e09306feb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_ce898e21-a849-4198-a7a8-4f6b9f35c0d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_db606c9c-f42d-4459-afc8-0dfe8cf26d17" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_ce898e21-a849-4198-a7a8-4f6b9f35c0d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/SEGMENTINFORMATIONNotes" xlink:type="simple" xlink:href="a-20220131.xsd#SEGMENTINFORMATIONNotes"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/SEGMENTINFORMATIONNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_d76e8ca6-33d6-49f7-9565-900e975628f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_f1da2707-02bb-4e52-9f4d-390ae2a0762c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_d76e8ca6-33d6-49f7-9565-900e975628f0" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_f1da2707-02bb-4e52-9f4d-390ae2a0762c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/SEGMENTINFORMATIONTables" xlink:type="simple" xlink:href="a-20220131.xsd#SEGMENTINFORMATIONTables"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/SEGMENTINFORMATIONTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_3384717a-0ce4-4547-a1af-3ab3d8dfa4b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_b6174974-d09a-4cf2-9c23-3ec7b6bbae29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_3384717a-0ce4-4547-a1af-3ab3d8dfa4b8" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_b6174974-d09a-4cf2-9c23-3ec7b6bbae29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_8ecae8d5-63b3-40fd-8088-58ddf2ab948f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_3384717a-0ce4-4547-a1af-3ab3d8dfa4b8" xlink:to="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_8ecae8d5-63b3-40fd-8088-58ddf2ab948f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/SEGMENTINFORMATIONProfitabilityDetails" xlink:type="simple" xlink:href="a-20220131.xsd#SEGMENTINFORMATIONProfitabilityDetails"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/SEGMENTINFORMATIONProfitabilityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_65dd76ad-2134-45f6-a7b6-c2d38849cb5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_bdd198bd-99c4-476b-8961-e23d9ca48f2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationProfitLossAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_65dd76ad-2134-45f6-a7b6-c2d38849cb5b" xlink:to="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_bdd198bd-99c4-476b-8961-e23d9ca48f2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_e680778c-0df9-4ab0-8aeb-f3aa94711c46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_bdd198bd-99c4-476b-8961-e23d9ca48f2c" xlink:to="loc_us-gaap_NumberOfOperatingSegments_e680778c-0df9-4ab0-8aeb-f3aa94711c46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_de26436b-2c33-4c4b-a8f2-ffb451be1bc1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_65dd76ad-2134-45f6-a7b6-c2d38849cb5b" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_de26436b-2c33-4c4b-a8f2-ffb451be1bc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_73f1773f-74e2-4507-9f49-9a8f12919f68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_de26436b-2c33-4c4b-a8f2-ffb451be1bc1" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_73f1773f-74e2-4507-9f49-9a8f12919f68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_42513f48-d682-4fc9-b008-328beb1de84e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_73f1773f-74e2-4507-9f49-9a8f12919f68" xlink:to="loc_us-gaap_SegmentDomain_42513f48-d682-4fc9-b008-328beb1de84e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_LifeSciencesandAppliedMarketsMember_5e3fbdee-033c-4220-a7c7-f0e66031ff8e" xlink:href="a-20220131.xsd#a_LifeSciencesandAppliedMarketsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_42513f48-d682-4fc9-b008-328beb1de84e" xlink:to="loc_a_LifeSciencesandAppliedMarketsMember_5e3fbdee-033c-4220-a7c7-f0e66031ff8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_DiagnosticsAndGenomicsMember_dd67d28f-f0b1-4396-8c8b-3bbc475c8a5f" xlink:href="a-20220131.xsd#a_DiagnosticsAndGenomicsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_42513f48-d682-4fc9-b008-328beb1de84e" xlink:to="loc_a_DiagnosticsAndGenomicsMember_dd67d28f-f0b1-4396-8c8b-3bbc475c8a5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_AgilentCrossLabMember_99756650-0e08-49cb-ad64-8c0c966e5de2" xlink:href="a-20220131.xsd#a_AgilentCrossLabMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_42513f48-d682-4fc9-b008-328beb1de84e" xlink:to="loc_a_AgilentCrossLabMember_99756650-0e08-49cb-ad64-8c0c966e5de2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_SegmentTotalMember_90989e48-bb06-45c0-a05f-4c1fa4ca5a83" xlink:href="a-20220131.xsd#a_SegmentTotalMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_42513f48-d682-4fc9-b008-328beb1de84e" xlink:to="loc_a_SegmentTotalMember_90989e48-bb06-45c0-a05f-4c1fa4ca5a83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_f7e1964d-6b9a-4fd4-acda-b8948267d59d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_de26436b-2c33-4c4b-a8f2-ffb451be1bc1" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_f7e1964d-6b9a-4fd4-acda-b8948267d59d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_cfa6586c-7f9b-4a71-86c5-4d9b3d35fc2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_f7e1964d-6b9a-4fd4-acda-b8948267d59d" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_cfa6586c-7f9b-4a71-86c5-4d9b3d35fc2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_e377d911-47a7-4bcd-99a6-36a1323c194d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_f7e1964d-6b9a-4fd4-acda-b8948267d59d" xlink:to="loc_us-gaap_OperatingIncomeLoss_e377d911-47a7-4bcd-99a6-36a1323c194d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/SEGMENTINFORMATIONReconciliationofReportableResultsDetails" xlink:type="simple" xlink:href="a-20220131.xsd#SEGMENTINFORMATIONReconciliationofReportableResultsDetails"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/SEGMENTINFORMATIONReconciliationofReportableResultsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_af16d565-9752-4051-a652-126a80e606a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_c670c0f4-77ec-426b-802d-7b49bfc26b40" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_af16d565-9752-4051-a652-126a80e606a2" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_c670c0f4-77ec-426b-802d-7b49bfc26b40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_fceefbd1-9a92-46ba-88f2-04a8b7cb3a97" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_c670c0f4-77ec-426b-802d-7b49bfc26b40" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_fceefbd1-9a92-46ba-88f2-04a8b7cb3a97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_e585e68d-23d4-4433-8f60-a153c163e0fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_fceefbd1-9a92-46ba-88f2-04a8b7cb3a97" xlink:to="loc_us-gaap_SegmentDomain_e585e68d-23d4-4433-8f60-a153c163e0fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_86426ba5-fd21-4b88-a511-97b39f7bdf1a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_c670c0f4-77ec-426b-802d-7b49bfc26b40" xlink:to="loc_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_86426ba5-fd21-4b88-a511-97b39f7bdf1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_3916914f-0041-44ec-829d-3c2f089792ef" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_86426ba5-fd21-4b88-a511-97b39f7bdf1a" xlink:to="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_3916914f-0041-44ec-829d-3c2f089792ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsConsolidationItemsAxis_eb2d4e9d-7c07-4a3d-8e9a-08f62075ba7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsegmentsConsolidationItemsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_c670c0f4-77ec-426b-802d-7b49bfc26b40" xlink:to="loc_us-gaap_SubsegmentsConsolidationItemsAxis_eb2d4e9d-7c07-4a3d-8e9a-08f62075ba7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsConsolidationItemsDomain_16f5f5fd-42b5-498b-b140-0ecb3e9bce48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsegmentsConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsConsolidationItemsAxis_eb2d4e9d-7c07-4a3d-8e9a-08f62075ba7d" xlink:to="loc_us-gaap_SubsegmentsConsolidationItemsDomain_16f5f5fd-42b5-498b-b140-0ecb3e9bce48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_f6e49823-79a0-4fa0-973f-a41afe87dbb3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_c670c0f4-77ec-426b-802d-7b49bfc26b40" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_f6e49823-79a0-4fa0-973f-a41afe87dbb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_1bb9e903-63cf-4133-9c86-5e9ad1f7be9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_f6e49823-79a0-4fa0-973f-a41afe87dbb3" xlink:to="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_1bb9e903-63cf-4133-9c86-5e9ad1f7be9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_Segmentincomelossfromoperations_73488258-e79a-4e3d-b319-a699da8bfc0d" xlink:href="a-20220131.xsd#a_Segmentincomelossfromoperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_1bb9e903-63cf-4133-9c86-5e9ad1f7be9b" xlink:to="loc_a_Segmentincomelossfromoperations_73488258-e79a-4e3d-b319-a699da8bfc0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_TransformationalPrograms_3954b098-894c-47b1-8452-8ffadbe4066d" xlink:href="a-20220131.xsd#a_TransformationalPrograms"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_1bb9e903-63cf-4133-9c86-5e9ad1f7be9b" xlink:to="loc_a_TransformationalPrograms_3954b098-894c-47b1-8452-8ffadbe4066d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization_a82249cf-4a93-40e7-9666-16e80cc6430f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_1bb9e903-63cf-4133-9c86-5e9ad1f7be9b" xlink:to="loc_us-gaap_AdjustmentForAmortization_a82249cf-4a93-40e7-9666-16e80cc6430f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_df678b14-1d2e-4a8a-8d26-e746e9186d3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_1bb9e903-63cf-4133-9c86-5e9ad1f7be9b" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_df678b14-1d2e-4a8a-8d26-e746e9186d3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_9e1d8d5a-192e-498f-a94c-6be5d82a449f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_1bb9e903-63cf-4133-9c86-5e9ad1f7be9b" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_9e1d8d5a-192e-498f-a94c-6be5d82a449f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_Other_323a5834-eeaf-43d3-b4f2-415811b42634" xlink:href="a-20220131.xsd#a_Other"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_1bb9e903-63cf-4133-9c86-5e9ad1f7be9b" xlink:to="loc_a_Other_323a5834-eeaf-43d3-b4f2-415811b42634" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_f9e9050b-6290-4ceb-8ddf-72bb3ff9f335" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_1bb9e903-63cf-4133-9c86-5e9ad1f7be9b" xlink:to="loc_us-gaap_InvestmentIncomeInterest_f9e9050b-6290-4ceb-8ddf-72bb3ff9f335" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_e340a136-e55c-4625-87cf-5a5289470aa2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_1bb9e903-63cf-4133-9c86-5e9ad1f7be9b" xlink:to="loc_us-gaap_InterestExpense_e340a136-e55c-4625-87cf-5a5289470aa2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_fcf06ebb-fd6e-4a3d-b99f-b9eb59cf30a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_1bb9e903-63cf-4133-9c86-5e9ad1f7be9b" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_fcf06ebb-fd6e-4a3d-b99f-b9eb59cf30a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_bd274858-3b69-4ddb-b5ef-5d27ddee0038" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_1bb9e903-63cf-4133-9c86-5e9ad1f7be9b" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_bd274858-3b69-4ddb-b5ef-5d27ddee0038" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/SEGMENTINFORMATIONSegmentAssetsDetails" xlink:type="simple" xlink:href="a-20220131.xsd#SEGMENTINFORMATIONSegmentAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/SEGMENTINFORMATIONSegmentAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_781ddc3c-7785-401c-afab-4befbe81568a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_72cf9ac3-a384-49c8-a316-75763a576150" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_781ddc3c-7785-401c-afab-4befbe81568a" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_72cf9ac3-a384-49c8-a316-75763a576150" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_3ed09f21-98e1-4c3f-879e-9d362787dbca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_72cf9ac3-a384-49c8-a316-75763a576150" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_3ed09f21-98e1-4c3f-879e-9d362787dbca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_49a5cb08-33f7-40f4-85c9-69525680dc99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_3ed09f21-98e1-4c3f-879e-9d362787dbca" xlink:to="loc_us-gaap_SegmentDomain_49a5cb08-33f7-40f4-85c9-69525680dc99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_LifeSciencesandAppliedMarketsMember_6bcacea3-3f88-4fef-95c3-959ec71d7433" xlink:href="a-20220131.xsd#a_LifeSciencesandAppliedMarketsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_49a5cb08-33f7-40f4-85c9-69525680dc99" xlink:to="loc_a_LifeSciencesandAppliedMarketsMember_6bcacea3-3f88-4fef-95c3-959ec71d7433" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_DiagnosticsAndGenomicsMember_c49e14b9-0d90-41de-907a-7e4afc61c382" xlink:href="a-20220131.xsd#a_DiagnosticsAndGenomicsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_49a5cb08-33f7-40f4-85c9-69525680dc99" xlink:to="loc_a_DiagnosticsAndGenomicsMember_c49e14b9-0d90-41de-907a-7e4afc61c382" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_AgilentCrossLabMember_22d2428d-8460-4374-9dc2-24c5507657c2" xlink:href="a-20220131.xsd#a_AgilentCrossLabMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_49a5cb08-33f7-40f4-85c9-69525680dc99" xlink:to="loc_a_AgilentCrossLabMember_22d2428d-8460-4374-9dc2-24c5507657c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_SegmentTotalMember_b205f388-3e2a-43a3-a93f-d05b62adb17b" xlink:href="a-20220131.xsd#a_SegmentTotalMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_49a5cb08-33f7-40f4-85c9-69525680dc99" xlink:to="loc_a_SegmentTotalMember_b205f388-3e2a-43a3-a93f-d05b62adb17b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_7aaac5f6-b0f1-48fe-999d-8c93c1881867" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_72cf9ac3-a384-49c8-a316-75763a576150" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_7aaac5f6-b0f1-48fe-999d-8c93c1881867" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_cb3fb93f-fb54-4afb-8367-1986a32efba2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_7aaac5f6-b0f1-48fe-999d-8c93c1881867" xlink:to="loc_us-gaap_Assets_cb3fb93f-fb54-4afb-8367-1986a32efba2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140093763515592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document and Entity Information - shares<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jan. 31, 2022</div></th>
<th class="th"><div>Feb. 25, 2022</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_a_DocumentAndEntityInformationAbstract', window );"><strong>Document and Entity Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">AGILENT TECHNOLOGIES,&#160;INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jan. 31,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--10-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001090872<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-15405<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">77-0518772<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">5301 Stevens Creek Blvd.,<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Santa Clara,<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">95051<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(800)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">227-9770<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.01 par value<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">A<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,113,377<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_a_DocumentAndEntityInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Document and Entity Information [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">a_DocumentAndEntityInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>a_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140093763691000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS (Unaudited) - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jan. 31, 2022</div></th>
<th class="th"><div>Jan. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Net revenue:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">$ 1,674<span></span>
</td>
<td class="nump">$ 1,548<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpensesAbstract', window );"><strong>Costs and expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of revenue</a></td>
<td class="nump">764<span></span>
</td>
<td class="nump">710<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">117<span></span>
</td>
<td class="nump">103<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative</a></td>
<td class="nump">417<span></span>
</td>
<td class="nump">407<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total costs and expenses</a></td>
<td class="nump">1,298<span></span>
</td>
<td class="nump">1,220<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income from operations</a></td>
<td class="nump">376<span></span>
</td>
<td class="nump">328<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(21)<span></span>
</td>
<td class="num">(19)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income (expense), net</a></td>
<td class="num">(37)<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income before taxes</a></td>
<td class="nump">319<span></span>
</td>
<td class="nump">312<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="nump">36<span></span>
</td>
<td class="nump">24<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 283<span></span>
</td>
<td class="nump">$ 288<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Net income per share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic</a></td>
<td class="nump">$ 0.94<span></span>
</td>
<td class="nump">$ 0.94<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted</a></td>
<td class="nump">$ 0.93<span></span>
</td>
<td class="nump">$ 0.93<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted average shares used in computing net income per share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic</a></td>
<td class="nump">301<span></span>
</td>
<td class="nump">306<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted</a></td>
<td class="nump">303<span></span>
</td>
<td class="nump">309<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductMember', window );">Product</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Net revenue:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">$ 1,263<span></span>
</td>
<td class="nump">$ 1,172<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpensesAbstract', window );"><strong>Costs and expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of revenue</a></td>
<td class="nump">545<span></span>
</td>
<td class="nump">509<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceOtherMember', window );">Service and Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Net revenue:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">411<span></span>
</td>
<td class="nump">376<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpensesAbstract', window );"><strong>Costs and expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of revenue</a></td>
<td class="nump">$ 219<span></span>
</td>
<td class="nump">$ 201<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123384075&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ServiceOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ServiceOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140093762471384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME (Unaudited) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jan. 31, 2022</div></th>
<th class="th"><div>Jan. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 283<span></span>
</td>
<td class="nump">$ 288<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive income (loss):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Unrealized gain (loss) on derivative instruments, net of tax expense (benefit) of $2 and $(2)</a></td>
<td class="nump">6<span></span>
</td>
<td class="num">(4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Amount reclassified into earnings related to derivative instruments, net of tas expense (benefit) of $(1) and $2</a></td>
<td class="num">(2)<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax', window );">Foreign currency translation, net of tax expense of $0 and $0</a></td>
<td class="num">(27)<span></span>
</td>
<td class="nump">42<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Net defined benefit pension cost and post retirement plan costs:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax', window );">Change in actuarial net loss, net of tax expense of $2 and $4</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="num">(16)<span></span>
</td>
<td class="nump">53<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">Total comprehensive income</a></td>
<td class="nump">$ 267<span></span>
</td>
<td class="nump">$ 341<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of gain (loss) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 35<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123602790&amp;loc=d3e30304-110892<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=120253306&amp;loc=d3e28129-110885<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32022-110900<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a-c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e689-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140093763514856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME (LOSS) (Unaudited) (Parenthetical) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jan. 31, 2022</div></th>
<th class="th"><div>Jan. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTaxParentheticalDisclosuresAbstract', window );"><strong>Other comprehensive income (loss), tax, parenthetical disclosures</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax', window );">Unrealized gain (loss) on derivative instruments, tax</a></td>
<td class="nump">$ 2<span></span>
</td>
<td class="num">$ (2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax', window );">Amounts reclassified into earnings related to derivative instruments, tax</a></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax', window );">Foreign currency translation, tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansTaxAbstract', window );"><strong>Net defined benefit pension cost and post retirement plan costs, tax</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax', window );">Change in actuarial net loss, tax</a></td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit), after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32262-110900<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e640-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=125521441&amp;loc=d3e30755-110894<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossTaxParentheticalDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossTaxParentheticalDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140093759916104">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEET (Unaudited) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jan. 31, 2022</div></th>
<th class="th"><div>Oct. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 1,113<span></span>
</td>
<td class="nump">$ 1,484<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Short term investments</a></td>
<td class="nump">45<span></span>
</td>
<td class="nump">91<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net</a></td>
<td class="nump">1,205<span></span>
</td>
<td class="nump">1,172<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventory</a></td>
<td class="nump">879<span></span>
</td>
<td class="nump">830<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
<td class="nump">232<span></span>
</td>
<td class="nump">222<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">3,474<span></span>
</td>
<td class="nump">3,799<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">974<span></span>
</td>
<td class="nump">945<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">3,964<span></span>
</td>
<td class="nump">3,975<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Other intangible assets, net</a></td>
<td class="nump">929<span></span>
</td>
<td class="nump">981<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermInvestments', window );">Long-term investments</a></td>
<td class="nump">191<span></span>
</td>
<td class="nump">185<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">795<span></span>
</td>
<td class="nump">820<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">10,327<span></span>
</td>
<td class="nump">10,705<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">475<span></span>
</td>
<td class="nump">446<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Employee compensation and benefits</a></td>
<td class="nump">290<span></span>
</td>
<td class="nump">493<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenueCurrent', window );">Deferred revenue</a></td>
<td class="nump">493<span></span>
</td>
<td class="nump">441<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent', window );">Other accrued liabilities</a></td>
<td class="nump">326<span></span>
</td>
<td class="nump">328<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">1,584<span></span>
</td>
<td class="nump">1,708<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">2,730<span></span>
</td>
<td class="nump">2,729<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent', window );">Retirement and post-retirement benefits</a></td>
<td class="nump">206<span></span>
</td>
<td class="nump">220<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">653<span></span>
</td>
<td class="nump">659<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">5,173<span></span>
</td>
<td class="nump">5,316<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and Contingencies (Note 9 and 12)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock; $0.01 par value; 125 million shares authorized; none issued and outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock; $0.01 par value; 2 billion shares authorized; 300 million shares at January 31, 2022 and 302 million shares at October 31, 2021, issued and outstanding</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in-capital</a></td>
<td class="nump">5,290<span></span>
</td>
<td class="nump">5,320<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">159<span></span>
</td>
<td class="nump">348<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(298)<span></span>
</td>
<td class="num">(282)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholder's equity</a></td>
<td class="nump">5,154<span></span>
</td>
<td class="nump">5,389<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and equity</a></td>
<td class="nump">$ 10,327<span></span>
</td>
<td class="nump">$ 10,705<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=123594786&amp;loc=SL75136599-209740<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.15(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1703-114919<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1731-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140093762419656">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEET (Unaudited) (Parenthetical) - $ / shares<br> shares in Thousands</strong></div></th>
<th class="th"><div>Jan. 31, 2022</div></th>
<th class="th"><div>Oct. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (in shares)</a></td>
<td class="nump">125,000<span></span>
</td>
<td class="nump">125,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred Stock, Shares Issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, outstanding (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">2,000,000<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common Stock, Shares, Issued</a></td>
<td class="nump">300,000<span></span>
</td>
<td class="nump">302,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common Stock, Shares, Outstanding</a></td>
<td class="nump">300,000<span></span>
</td>
<td class="nump">302,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140093760969192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS (Unaudited) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jan. 31, 2022</div></th>
<th class="th"><div>Jan. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 283<span></span>
</td>
<td class="nump">$ 288<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">82<span></span>
</td>
<td class="nump">76<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">44<span></span>
</td>
<td class="nump">40<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred taxes</a></td>
<td class="nump">24<span></span>
</td>
<td class="nump">29<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWriteDown', window );">Excess and obsolete inventory related charges</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on extinguishment of debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss', window );">Net gain (loss) on equity securities</a></td>
<td class="num">(47)<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Change in fair value of contingent consideration</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNoncashIncomeExpense', window );">Other non-cash expense, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="num">(46)<span></span>
</td>
<td class="num">(31)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventory</a></td>
<td class="num">(54)<span></span>
</td>
<td class="num">(35)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="nump">37<span></span>
</td>
<td class="nump">43<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities', window );">Employee compensation and benefits</a></td>
<td class="num">(210)<span></span>
</td>
<td class="num">(88)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet', window );">Other assets and liabilities</a></td>
<td class="nump">40<span></span>
</td>
<td class="num">(95)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">255<span></span>
</td>
<td class="nump">238<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from Investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Investments in property, plant and equipment</a></td>
<td class="num">(75)<span></span>
</td>
<td class="num">(41)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireEquitySecuritiesFvNi', window );">Payments to acquire equity investments</a></td>
<td class="num">(3)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireNotesReceivable', window );">Payment in exchange for convertible note</a></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(79)<span></span>
</td>
<td class="num">(42)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions', window );">Issuance of common stock under employee stock plans</a></td>
<td class="nump">27<span></span>
</td>
<td class="nump">25<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Payment of taxes related to net share settlement of equity awards</a></td>
<td class="num">(63)<span></span>
</td>
<td class="num">(72)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfOrdinaryDividends', window );">Payment of dividends</a></td>
<td class="num">(63)<span></span>
</td>
<td class="num">(59)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarlyRepaymentOfSeniorDebt', window );">Repayment of senior notes</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(105)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommercialPaper', window );">Proceeds from Commercial Paper</a></td>
<td class="nump">240<span></span>
</td>
<td class="nump">785<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfCommercialPaper', window );">Repayments of commercial paper</a></td>
<td class="num">(240)<span></span>
</td>
<td class="num">(546)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Treasury stock repurchases</a></td>
<td class="num">(447)<span></span>
</td>
<td class="num">(344)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash used in financing activities</a></td>
<td class="num">(546)<span></span>
</td>
<td class="num">(316)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents', window );">Effect of exchange rate movements</a></td>
<td class="num">(4)<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net decrease in cash, cash equivalents and restricted cash</a></td>
<td class="num">(374)<span></span>
</td>
<td class="num">(111)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at beginning of period</a></td>
<td class="nump">1,490<span></span>
</td>
<td class="nump">1,447<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at end of period</a></td>
<td class="nump">1,116<span></span>
</td>
<td class="nump">1,336<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental cash flow information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Income tax paid, net</a></td>
<td class="nump">22<span></span>
</td>
<td class="nump">52<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest payments</a></td>
<td class="nump">18<span></span>
</td>
<td class="nump">19<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PropertyPlantAndEquipmentMember', window );">Property, Plant and Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental cash flow information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Net change in property, plant and equipment included in Accounts Payable and Accrued Liabilities increase (decrease)</a></td>
<td class="num">$ (7)<span></span>
</td>
<td class="num">$ (4)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarlyRepaymentOfSeniorDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the extinguishment of long-term borrowing, with the highest claim on the assets of the entity in case of bankruptcy or liquidation, before its maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarlyRepaymentOfSeniorDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from the effect of exchange rate changes on cash and cash equivalent balances held in foreign currencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123583765&amp;loc=SL75117546-209714<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWriteDown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4542-108314<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWriteDown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfOrdinaryDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash outflow in the form of ordinary dividends to common shareholders, preferred shareholders and noncontrolling interests, generally out of earnings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfOrdinaryDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireEquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to acquire investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as investing activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123583714&amp;loc=SL75117360-209713<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3444-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireEquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireNotesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to acquire an agreement for an unconditional promise by the maker to pay the entity (holder) a definite sum of money at a future date. Such amount may include accrued interest receivable in accordance with the terms of the note. The note also may contain provisions including a discount or premium, payable on demand, secured, or unsecured, interest bearing or noninterest bearing, among myriad other features and characteristics.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireNotesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommercialPaper">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from borrowing by issuing commercial paper.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommercialPaper</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfCommercialPaper">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow due to repaying amounts borrowed by issuing commercial paper.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfCommercialPaper</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PropertyPlantAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_PropertyPlantAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140093760769576">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENT OF EQUITY - USD ($)<br> shares in Thousands, $ in Millions</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid-in Capital</div></th>
<th class="th"><div>Retained Earnings</div></th>
<th class="th"><div>Accumulated Other Comprehensive Loss</div></th>
<th class="th"><div>Total Stockholder's Equity</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Beginning Balance (in Shares) at Oct. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">306,198<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning Balance at Oct. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">$ 5,311<span></span>
</td>
<td class="nump">$ 81<span></span>
</td>
<td class="num">$ (522)<span></span>
</td>
<td class="nump">$ 4,873<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAbstract', window );"><strong>Components of comprehensive income, net of tax</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 288<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">288<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">288<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="nump">53<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">53<span></span>
</td>
<td class="nump">53<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Total comprehensive income, net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">341<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Cash dividends declared</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(59)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(59)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Share-based awards issued, net of tax (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,592<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Share-based awards issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(47)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(47)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares', window );">Stock Repurchased and Retired During Period, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,885)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Stock Repurchased and Retired During Period, Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(38)<span></span>
</td>
<td class="num">(306)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(344)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Ending Balance (in Shares) at Jan. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">304,905<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending Balance at Jan. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">5,266<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="num">(469)<span></span>
</td>
<td class="nump">4,804<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Beginning Balance (in Shares) at Oct. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">302,208<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning Balance at Oct. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">5,320<span></span>
</td>
<td class="nump">348<span></span>
</td>
<td class="num">(282)<span></span>
</td>
<td class="nump">5,389<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAbstract', window );"><strong>Components of comprehensive income, net of tax</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">283<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">283<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">283<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="num">$ (16)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(16)<span></span>
</td>
<td class="num">(16)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Total comprehensive income, net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">267<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Cash dividends declared</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(63)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(63)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Share-based awards issued, net of tax (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">972<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Share-based awards issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(36)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(36)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares', window );">Stock Repurchased and Retired During Period, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,907)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Stock Repurchased and Retired During Period, Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(38)<span></span>
</td>
<td class="num">(409)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(447)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Ending Balance (in Shares) at Jan. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,273<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending Balance at Jan. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">$ 5,290<span></span>
</td>
<td class="nump">$ 159<span></span>
</td>
<td class="num">$ (298)<span></span>
</td>
<td class="nump">$ 5,154<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=122142933&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=122142933&amp;loc=d3e11178-113907<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123468992&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCommonStockCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCommonStockCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased and retired during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedAndRetiredDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedAndRetiredDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 24: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568447-111683<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(03)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140093765719400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATE STATEMENT OF EQUITY - (PARENTHETICAL) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jan. 31, 2022</div></th>
<th class="th"><div>Jan. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfStockholdersEquityAbstract', window );"><strong>Statement of Stockholders' Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Dividends Declared per share</a></td>
<td class="nump">$ 0.210<span></span>
</td>
<td class="nump">$ 0.194<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_a_Taxrelatedtosharesissued', window );">Tax related to shares issued</a></td>
<td class="nump">$ 63<span></span>
</td>
<td class="nump">$ 72<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_a_Taxrelatedtosharesissued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tax related to shares issued</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">a_Taxrelatedtosharesissued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>a_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfStockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfStockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140093762697000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OVERVIEW, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Notes)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jan. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock', window );">OVERVIEW AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</a></td>
<td class="text">OVERVIEW, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Overview. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Agilent Technologies, Inc. ("we," "Agilent" or the "company"), incorporated in Delaware in May 1999, is a global leader in life sciences, diagnostics and applied chemical markets, providing application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our fiscal year-end is October&#160;31, and our fiscal quarters end on January&#160;31, April&#160;30 and July&#160;31. Unless otherwise stated, these dates refer to our fiscal year and fiscal quarters.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">New Segment Structure.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In the first quarter of fiscal year 2022, we announced a change in organizational structure designed to enable our growth strategies and strengthen our focus on customers. Our chemistries and supplies business and our remarketed instruments business moved from our Agilent CrossLab business segment to our life sciences and applied markets business segment. Service revenue and cost of sales related to the previous acquisition of BioTek moved from our life sciences and applied markets business segment to our Agilent CrossLab business segment. Following this reorganization, we continue to have three business segments (life sciences and applied markets, diagnostics and genomics and Agilent CrossLab), each of which continues to comprise a reportable segment. We are reporting under this new structure beginning with this Quarterly Report on Form 10-Q for the period ended January 31, 2022 and historical financial segment information has been recast to conform to this new presentation in our financial statements and accompanying notes. There was no change to our diagnostics and genomics business segment.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Basis of Presentation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We have prepared the accompanying financial data for the three months ended January&#160;31, 2022 and 2021 pursuant to the rules&#160;and regulations of the U.S. Securities and Exchange Commission (&#8220;SEC&#8221;). Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles (&#8220;GAAP&#8221;) in the U.S. have been condensed or omitted pursuant to such rules&#160;and regulations. The October&#160;31, 2021 condensed balance sheet data was derived from audited financial statements but does not include all the disclosures required in audited financial statements by U.S. GAAP. The accompanying financial data and information should be read in conjunction with our Annual Report on Form 10-K for the fiscal year ended October&#160;31, 2021.  </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the opinion of management, the accompanying condensed consolidated financial statements contain all normal and recurring adjustments necessary for a fair statement of our condensed consolidated balance sheet as of January&#160;31, 2022 and October&#160;31, 2021, condensed consolidated statement of comprehensive income (loss) for the three months ended January&#160;31, 2022 and 2021, condensed consolidated statement of operations for the three months ended January&#160;31, 2022 and 2021, condensed consolidated statement of cash flows for the three months ended January&#160;31, 2022 and 2021 and condensed consolidated statement of equity for the three months ended January&#160;31, 2022 and 2021.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Use of Estimates.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The preparation of condensed consolidated financial statements in accordance with GAAP in the U.S. requires management to make estimates and assumptions that affect the amounts reported in our condensed consolidated financial statements and accompanying notes. Management bases its estimates on historical experience and various other assumptions believed to be reasonable. Although these estimates are based on management&#8217;s best knowledge of current events and actions that may impact the company in the future, actual results may be different from the estimates. Our critical accounting policies are those that affect our financial statements materially and involve difficult, subjective or complex judgments by management. Those policies are revenue recognition, inventory valuation, retirement and post-retirement benefit plan assumptions, valuation of goodwill and purchased intangible assets and accounting for income taxes.</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restricted Cash and Restricted Cash Equivalents. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted cash and restricted cash equivalents are included with cash and cash equivalents when reconciling the beginning-of-period and end-of-period total amounts shown on the statement of cash flows.  A reconciliation of cash, cash equivalents and restricted cash to the condensed consolidated balance sheet follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.863%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.053%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 31</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,113&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,484&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash included in other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents and restricted cash</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,116&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,490&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of January&#160;31, 2022 and October&#160;31, 2021, operating lease right-of-use assets where we are the lessee were  $170&#160;million and $178&#160;million, respectively, and were included within other assets in the accompanying condensed consolidated balance sheet. The associated operating lease liabilities were $174&#160;million and $182&#160;million as of January&#160;31, 2022 and October&#160;31, 2021, respectively, and were included in other accrued liabilities and other long-term liabilities in the accompanying condensed consolidated balance sheet. </span></div><div style="margin-top:5pt;text-align:center"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Variable Interest Entities. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We make a determination upon entering into an arrangement whether an entity in which we have made an investment is considered a Variable Interest Entity (&#8220;VIE&#8221;). We evaluate our investments in privately held companies on an ongoing basis. We have determined that as of January&#160;31, 2022 and October&#160;31, 2021, there were no VIEs required to be consolidated in our consolidated financial statements because we do not have a controlling financial interest in any of the VIEs in which we have invested nor are we the primary beneficiary. We account for these investments under either the equity method or as equity investments without readily determinable fair value ("RDFV"), depending on the circumstances. We periodically reassess whether we are the primary beneficiary of a VIE. The reassessment process considers whether we have acquired the power to direct the most significant activities of the VIE through changes in governing documents or other circumstances. We also reconsider whether entities previously determined not to be VIEs have become VIEs and vice-versa, based on changes in facts and circumstances including changes in contractual arrangements and capital structure.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of January&#160;31, 2022 and October&#160;31, 2021, the total carrying value of investments and loans in privately held companies considered as VIEs was $79 million and $76 million respectively. The maximum exposure is equal to the carrying value because we do not have future funding commitments. The investments are included on the long-term investments line and the loans on the other current assets and other assets lines (depending upon tenure of loan) on the condensed consolidated balance sheet.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value of Financial Instruments.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The carrying values of certain of our financial instruments including cash and cash equivalents, accounts receivable, accounts payable, accrued compensation and other accrued liabilities approximate fair value because of their short maturities. The fair value of short-term and long-term equity investments which are readily determinable, and which are not accounted under the equity method are reported at fair value using quoted market prices for those securities when available with gains and losses included in net income. The fair value of long-term equity investments which are not readily determinable, and which are not accounted under the equity method are reported at cost with adjustments for observable changes in prices or impairments included in net income. As of January&#160;31, 2022, the fair value of our senior notes was $2,710&#160;million with a carrying value of $2,730 million.  This compares to a fair value of $2,806&#160;million with a carrying value of $2,729 million as of October&#160;31, 2021. The change in the fair value over carrying value in the three months ended January&#160;31, 2022 is primarily due to increased market interest rates. The fair value was calculated from quoted prices which are primarily Level 1 inputs under the accounting guidance. The fair value of foreign currency contracts used for hedging purposes is estimated internally by using inputs tied to active markets. These inputs, for example, interest rate yield curves, foreign exchange rates, and forward and spot prices for currencies are observable in the market or&#160;can be corroborated by observable market data for substantially the full term of the assets or liabilities. See also Note&#160;9, "Fair Value Measurements" for additional information on the fair value of financial instruments and contingent consideration.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the general note to the financial statements for the reporting entity which may include, descriptions of the basis of presentation, business description, significant accounting policies, consolidations, reclassifications, new pronouncements not yet adopted and changes in accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -URI http://asc.fasb.org/topic&amp;trid=2122394<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140093762274328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NEW ACCOUNTING PRONOUNCEMENTS (Notes)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jan. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock', window );">NEW ACCOUNTING PRONOUNCEMENTS</a></td>
<td class="text">NEW ACCOUNTING PRONOUNCEMENTS<div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2020, accounting guidance was issued that clarifies the accounting guidance for equity method investments, joint ventures, and derivatives and hedging. The guidance clarifies the interaction between different sections of the accounting guidance that could be applicable and which guidance should be applied in certain situations which should increase relevance and comparability of financial statement information. On November 1, 2021 we adopted this guidance which did not have a material impact on our condensed consolidated financial statements and disclosures.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2021, the FASB issued an update to improve the accounting for acquired revenue contracts with customers in a business combination.  The amendments require an acquirer to use the guidance in ASC 606, Revenue from Contracts with Customers, rather than using fair value, when recognizing and measuring contract assets and contract liabilities related to customer contracts assumed in a business combination. On November 1, 2021 we early adopted this guidance which did not have a material impact on our condensed consolidated financial statements and disclosures.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting Pronouncements Not Yet Adopted</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no additions to the new accounting pronouncements not yet adopted as described in our Annual Report on Form 10-K for the fiscal year ended October 31, 2021.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other amendments to GAAP in the U.S. that have been issued by the FASB or other standards-setting bodies that do not require adoption until a future date are not expected to have a material impact on our condensed consolidated financial statements upon adoption.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for change in accounting principle. Includes, but is not limited to, nature, reason, and method of adopting amendment to accounting standards or other change in accounting principle.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123338486&amp;loc=SL49131195-203048<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -URI http://asc.fasb.org/topic&amp;trid=2122394<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123338486&amp;loc=SL49131195-203048<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section S99<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=122038215&amp;loc=SL108384541-122693<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124402435&amp;loc=SL124402458-218513<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL121967933-165497<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (i)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123338486&amp;loc=SL49131195-203048<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL121967933-165497<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124402435&amp;loc=SL124402458-218513<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (j)<br> -URI http://asc.fasb.org/extlink&amp;oid=123338486&amp;loc=SL49131195-203048<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120154821&amp;loc=SL120154904-197079<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 11.M.Q2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038215&amp;loc=d3e31137-122693<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120154821&amp;loc=SL120154904-197079<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120154821&amp;loc=SL120154904-197079<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL121967933-165497<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122150657&amp;loc=SL122150809-237846<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (c)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140093762696440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE (Notes)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jan. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">Revenue from Contract with Customer</a></td>
<td class="text">REVENUE <div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the company&#8217;s total revenue and segment revenue disaggregated by geographical region: </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:15.859%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.402%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.261%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.402%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.953%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="45" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended January 31</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Life Sciences and Applied Markets</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Agilent CrossLab<br/></span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Diagnostics and Genomics<br/></span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Life Sciences and Applied Markets</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Agilent CrossLab<br/></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Diagnostics and Genomics<br/></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="45" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Revenue by Region</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Americas</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">317&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">637&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">279&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">555&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">451&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">437&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia Pacific</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">407&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">586&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">399&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">556&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">976&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">359&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">339&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,674&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">923&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">331&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">294&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,548&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:16.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.402%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.969%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.402%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.953%"/><td style="width:0.1%"/></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the company&#8217;s total revenue disaggregated by end markets and by revenue type:</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.777%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Revenue by End Markets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmaceutical and Biopharmaceutical</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">602&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">521&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chemical and Energy</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">373&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">328&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics and Clinical</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">243&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Food</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Academia and Government</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Environmental and Forensics</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,674&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,548&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Revenue by Type</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Instrumentation</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">691&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">681&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-instrumentation and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">983&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">867&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,674&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,548&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue by region is based on the ship to location of the customer. Revenue by end market is determined by the market indicator of the customer and by customer type. Instrumentation revenue includes sales from instruments, remarketed instruments and third-party products. Non-instrumentation and other revenue include sales from contract and per incident services, our companion diagnostics and our nucleic acid solutions businesses as well as sales from spare parts, consumables, reagents, vacuum pumps, subscriptions, software licenses and associated services.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contract Balances</span></div><div><span><br/></span></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contract Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract assets (unbilled accounts receivable) primarily relate to the company's right to consideration for work completed but not billed at the reporting date. The unbilled receivables are reclassified to trade receivables when billed to customers. Contract assets are generally classified as current assets and are included in "Accounts receivable, net" in the condensed consolidated balance sheet. The balances of contract assets as of January&#160;31, 2022 and October&#160;31, 2021 were $207 million and $197 million, respectively. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contract Liabilities</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information about contract liabilities (deferred revenue) and the significant changes in the balances during the three months ended January&#160;31, 2022: </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:78.078%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.119%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.403%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Contract <br/>Liabilities</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance as of October 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">519&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenue deferred in the period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">220&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue recognized that was included in the contract liability balance at the beginning of the period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(191)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in deferrals from customer cash advances, net of revenue recognized</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation and other adjustments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance as of January 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">576&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended January&#160;31, 2021 revenue recognized that was included in the contract liability balance at October&#160;31, 2020 was $186 million.</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract liabilities primarily relate to multiple element arrangements for which billing has occurred but transfer of control of all elements to the customer has either partially or not occurred at the balance sheet date. This includes cash received from customers for products and related installation and services in advance of the transfer of control. Contract liabilities are classified as either current in deferred revenue or long-term in other long-term liabilities in the condensed consolidated balance sheet based on the timing of when we expect to complete our performance obligation.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contract Costs</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Incremental costs of obtaining a contract with a customer are recognized as an asset if we expect the benefit of those costs to be longer than one year. We have determined that certain sales incentive programs meet the requirements to be capitalized. The change in total capitalized costs to obtain a contract was immaterial during the three months ended January&#160;31, 2022 and was included in other current and long-term assets on the condensed consolidated balance sheet. We have applied the practical expedient to expense costs as incurred for costs to obtain a contract with a customer when the amortization period would have been one year or less. These costs include the company's internal sales force compensation program, as we have determined that annual compensation is commensurate with annual sales activities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Transaction Price Allocated to the Remaining Performance Obligations   </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have applied the practical expedient in ASC 606-10-50-14 and have not disclosed information about transaction price allocated to remaining performance obligations that have original expected durations of one year or less.</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div>The estimated revenue expected to be recognized for remaining performance obligations that have an original term of more than one year, as of January&#160;31, 2022, was $347 million, the majority of which is expected to be recognized over the next 12 months. Remaining performance obligations primarily include extended warranty, customer manufacturing contracts, software maintenance contracts and revenue associated with lease arrangements.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130551-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130556-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130550-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130558-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140093762275160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHARE-BASED COMPENSATION (Notes)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jan. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationAbstract', window );"><strong>Share-based Payment Arrangement, Noncash Expense [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">SHARE-BASED COMPENSATION</a></td>
<td class="text">SHARE-BASED COMPENSATION<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We account for share-based awards in accordance with the provisions of the authoritative accounting guidance which requires the measurement and recognition of compensation expense for all share-based payment awards made to our employees and directors including employee stock options, restricted stock units, employee stock purchases made under our employee stock purchase plan and performance share awards granted to selected members of our senior management under the long-term performance plan (&#8220;LTPP&#8221;) based on estimated fair values. </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have two LTPP performance stock award programs, which are administered under the 2018 Stock Plan, for our executive officers and other key employees. Participants in our LTPP Total Stockholders&#8217; Return (&#8220;TSR&#8221;) and LTPP Earnings Per Share (&#8220;EPS&#8221;) programs are entitled to receive shares of the company's stock after the end of a three-year period, if specified performance targets for the programs are met. The LTPP-TSR awards are generally designed to meet the criteria of a performance award with the performance metrics and peer group comparison based on the TSR set at the beginning of the performance period. The LTPP-EPS awards are based on the company&#8217;s EPS performance over a three-year period. The performance targets for the LTPP-EPS for year 2 and year 3 of the performance period are set in the first quarter of year 2 and year 3, respectively. All LTPP awards are subject to a one-year post-vest holding period.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The final LTPP award may vary from 0 percent to 200 percent of the target award. We consider the dilutive impact of these programs in our diluted net income per share calculation only to the extent that the performance conditions are expected to be met. Restricted stock units generally vest, with some exceptions, at a rate of 25 percent per year over a period of four years from the date of grant.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In fiscal year 2021, we resumed granting stock options. Stock options granted under the 2018 Stock Plan may be either "incentive stock options", as defined in Section 422 of the Internal Revenue Code, or non-statutory. Options generally vest at a rate of 25 percent per year over a period of four years from the date of grant with a maximum contractual term of ten years. The exercise price for stock options is generally not less than 100 percent of the fair market value of our common stock on the date the stock award is granted. We issue new shares of common stock when employee stock options are exercised. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The impact on our results for share-based compensation was as follows:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products and services</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total share-based compensation expense</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At January&#160;31, 2022 and October&#160;31, 2021, no share-based compensation was capitalized within inventory. </span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">                                               </span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following assumptions were used to estimate the fair value of awards granted.</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:75.215%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock Option Plans:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average risk-free interest rate</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average volatility</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5 years</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LTPP:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Volatility of Agilent shares</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Volatility of selected peer-company shares</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23%-81%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24%-57%</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pair-wise correlation with selected peers</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Post-vest holding restriction discount for all executive awards</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.5%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.8%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of share-based awards for our employee stock option awards was estimated using the Black-Scholes option pricing model. Shares granted under the LTPP (TSR) were valued using a Monte Carlo simulation model. The Monte Carlo simulation fair value model requires the use of highly subjective and complex assumptions, including the price volatility of the underlying stock. &#160;For the volatility of our LTPP (TSR) grants, we used our own historical stock price volatility.&#160;&#160;</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ESPP allows eligible employees to purchase shares of our common stock at 85 percent of the price at purchase and uses the purchase date to establish the fair market value. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use historical volatility to estimate the expected stock price volatility assumption for employee stock option awards. In reaching the conclusion, we have considered many factors including the extent to which our options are currently traded and our ability to find traded options in the current market with similar terms and prices to the options we are valuing. In estimating the expected life of our options granted we considered the historical option exercise behavior of our executives, which we believe is representative of future behavior.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of restricted stock units and LTPP (EPS) awards is determined based on the market price of our common stock on the date of grant adjusted for expected dividend yield. The compensation cost for LTPP (EPS) reflects the cost of awards that are probable to vest at the end of the performance period. </span></div>All LTPP awards granted to our senior management employees have a one-year post-vest holding restriction. The estimated discount associated with post-vest holding restrictions is calculated using the Finnerty model. The model calculates the potential lost value if the employees were able to sell the shares during the lack of marketability period, instead of being required to hold the shares. The model used the same historical stock price volatility and dividend yield assumption used for the Monte Carlo simulation model and an expected dividend yield to compute the discount.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140093762352328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Notes)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jan. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">INCOME TAXES</a></td>
<td class="text">INCOME TAXES <div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended January&#160;31, 2022, our income tax expense was $36 million with an effective tax rate of 11.3 percent. The income taxes for the three months ended January&#160;31, 2022 include the excess tax benefits from stock-based compensation of $16&#160;million. For the three months ended January&#160;31, 2022, our effective tax rate and the resulting provision for income taxes were also impacted by the expiration of various foreign statutes of limitations which resulted in the recognition of previously unrecognized tax benefits of $8&#160;million.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our calculation of income tax expense for the&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">three</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> months ended </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">January&#160;31, 2022</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is dependent in part on forecasts of full year results. The impact of the COVID-19 outbreak on the economic environment is uncertain and may change these forecasts, which could impact tax expense.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended January&#160;31, 2021, our income tax expense was $24 million with an effective tax rate of 7.7 percent. The income taxes for the three months ended January&#160;31, 2021 include the excess tax benefits from stock-based compensation of $20&#160;million. For the three months ended January&#160;31, 2021, our effective tax rate and the resulting provision for income taxes were also impacted by the expiration of various foreign statutes of limitations which resulted in the recognition of previously unrecognized tax benefits of $16&#160;million. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In the U.S., tax years remain open back to the year 2018 for federal income tax purposes and for significant states. In other major jurisdictions where the company conducts business, the tax years generally remain open back to the year 2012.  </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With these jurisdictions and the U.S., it is reasonably possible there could be significant changes to our unrecognized tax benefits in the next twelve months due to either the expiration of a statute of limitation or a tax audit settlement which will be partially offset by an anticipated tax liability related to unremitted foreign earnings, where applicable. Given the number of years and numerous matters that remain subject to examination in various tax jurisdictions, management is unable to estimate the range of possible changes to the balance of our unrecognized tax benefits.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140093762369080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NET INCOME PER SHARE (Notes)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jan. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">NET INCOME PER SHARE</a></td>
<td class="text">NET INCOME PER SHARE<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of the numerator and denominator of the basic and diluted net income per share computations for the periods presented below:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:80.625%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.674%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">283&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">288&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic weighted-average shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">301&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">306&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Potential common shares&#8212; stock&#160;options and other employee stock plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted weighted-average shares</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">303&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">309&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The dilutive effect of share-based awards is reflected in diluted net income per share by application of the treasury stock method, which includes consideration of unamortized share-based compensation expense and the dilutive effect of in-the-money options and non-vested restricted stock units. Under the treasury stock method, the amount the employee must pay for exercising stock options and unamortized share-based compensation expense collectively are assumed proceeds to be used to repurchase hypothetical shares. An increase in the fair market value of the company's common stock can result in a greater dilutive effect from potentially dilutive awards.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We exclude stock options with exercise prices greater than the average market price of our common stock from the calculation of diluted earnings per share because their effect would be anti-dilutive. In addition, we exclude from the calculation of diluted earnings per share stock options, ESPP, LTPP and restricted stock awards whose combined exercise price and unamortized fair value were greater than the average market price of our common stock because their effect would also be anti-dilutive. &#160; </span></div>For both the three months ended January&#160;31, 2022 and 2021, potential common shares excluded from the calculation of diluted earnings per share were not material.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140093762265096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVENTORY (Notes)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jan. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNetAbstract', window );"><strong>Inventory, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureTextBlock', window );">INVENTORY</a></td>
<td class="text">INVENTORY<div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory as of January&#160;31, 2022 and October&#160;31, 2021 consisted of the following:</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:74.119%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.218%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 31,<br/>2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">488&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">463&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchased parts and fabricated assemblies</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">391&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">367&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">879&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">830&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI http://asc.fasb.org/topic&amp;trid=2126998<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140093763503672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND OTHER INTANGIBLE ASSETS (Notes)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jan. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">GOODWILL AND OTHER INTANGIBLE ASSETS</a></td>
<td class="text">GOODWILL AND OTHER INTANGIBLE ASSETS<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents goodwill balances and the movements for each of our reportable segments during the three months ended January&#160;31, 2022:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:50.512%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.457%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.070%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.632%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Life Sciences and Applied Markets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Diagnostics and Genomics</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Agilent CrossLab</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill as of October 31, 2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,743&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,964&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">268&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,975&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation impact</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill as of January 31, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,739&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,961&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">264&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,964&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt;text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="margin-top:5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of fiscal year 2022, we reorganized our operating segments and moved our chemistries and supplies business and our remarketed instruments business from our Agilent CrossLab business segment to our life sciences and applied markets business segment. As a result, we reassigned approximately $307&#160;million of goodwill from our Agilent Crosslab business segment to our life sciences and applied markets business segment using the relative fair value allocation approach. In addition, we moved service revenue and cost of sales related to the previous acquisition of BioTek from our life sciences and applied markets business segment to our Agilent CrossLab business segment. As a result, we reassigned approximately $10&#160;million of goodwill from our life sciences and applied markets segment to our Agilent Crosslab business segment using the relative fair value allocation approach. Goodwill balances as of October 31, 2021, have been recast to conform to this new presentation.  As a result of the reorganization there was no change to our reporting units. In addition, we performed a goodwill impairment test, and the results of the analysis indicated that the fair values for all three of our reporting units were in excess of their carrying values by substantial amounts; therefore, no impairment was indicated. </span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The component parts of other intangible assets as of January&#160;31, 2022 and October&#160;31, 2021 are shown in the table below:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other&#160;Intangible&#160;Assets</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net&#160;Book<br/>Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of October 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchased technology</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,742&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">972&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">770&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Backlog</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademark/Tradename</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">357&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Third-party technology and licenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total amortizable intangible assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,314&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,344&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">970&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-Process R&amp;D</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,325&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,344&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">981&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of January 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchased technology</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,738&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">997&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">741&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademark/Tradename</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">355&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Backlog</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Third-party technology and licenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total amortizable intangible assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,308&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,390&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">918&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-Process R&amp;D</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,319&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,390&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">929&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended January&#160;31, 2022, there were no additions to goodwill or other intangible assets.  During the three months ended January&#160;31, 2022, other intangible assets in total decreased $1 million due to the impact of foreign currency translation. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In general, for U.S. federal tax purposes, goodwill from asset purchases is deductible; however, any goodwill created as part of a stock acquisition is not deductible.&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each quarter we review the events and circumstances to determine if impairment of indefinite-lived intangible assets and goodwill is indicated. During the three months ended January&#160;31, 2022 and 2021 we did not identify any triggering events or circumstances, including impacts due to COVID-19, which would indicate an impairment of goodwill or indefinite-lived intangible assets. </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense of intangible assets was $51 million and $45 million for the three months ended January&#160;31, 2022 and 2021, respectively. </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future amortization expense related to existing finite-lived purchased intangible assets for the remainder of fiscal year 2022 and for each of the next five fiscal years and thereafter is estimated below:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:90.859%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.941%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Estimated future amortization expense:</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of 2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">288&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI http://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140093762222296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS (Notes)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jan. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">FAIR VALUE MEASUREMENTS</a></td>
<td class="text">FAIR VALUE MEASUREMENTS<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The authoritative guidance defines fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities required or permitted to be recorded at fair value, we consider the principal or most advantageous market and assumptions that market participants would use when pricing the asset or liability.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value Hierarchy</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The guidance establishes a fair value hierarchy that prioritizes the use of inputs used in valuation techniques into three levels. A financial instrument&#8217;s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. There are three levels of inputs that may be used to measure fair value:</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Level 1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Level 2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- applies to assets or liabilities for which there are inputs other than quoted prices included within level 1 that are observable, either directly or indirectly, for the asset or liability such as: quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in less active markets; or other inputs that can be derived principally from, or corroborated by, observable market data.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Level 3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- applies to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities.</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial assets and liabilities measured at fair value on a recurring basis as of January&#160;31, 2022 were as follows:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.584%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.186%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurement at January 31, 2022 Using</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted&#160;Prices</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">in&#160;Active</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Markets&#160;for</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Identical&#160;Assets</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Level&#160;1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Observable</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Inputs</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Level&#160;2)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unobservable</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Inputs</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Level&#160;3)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents (money market funds)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">465&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">465&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative instruments (foreign exchange contracts)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments - Equity securities with RDFV</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trading securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets measured at fair value</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">592&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">542&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative instruments (foreign exchange contracts) </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities measured at fair value</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial assets and liabilities measured at fair value on a recurring basis as of October&#160;31, 2021 were as follows:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.584%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.186%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurement at October 31, 2021 Using</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 31,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted&#160;Prices</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">in&#160;Active</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Markets&#160;for</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Identical&#160;Assets</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Level&#160;1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Observable</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Inputs</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Level&#160;2)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unobservable</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Inputs</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Level&#160;3)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents (money market funds)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">919&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">919&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative instruments (foreign exchange contracts)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments - Equity securities with RDFV</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trading securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets measured at fair value</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,084&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,036&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative instruments (foreign exchange contracts)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities measured at fair value</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our money market funds and trading securities are generally valued using quoted market prices and therefore are classified within level&#160;1 of the fair value hierarchy. Our derivative financial instruments are classified within level 2, as there is not an active market for each hedge contract, but the inputs used to calculate the value of the instruments are tied to active markets.  Our deferred compensation liability is classified as level&#160;2 because, although the values are not directly based on quoted market prices, the inputs used in the calculations are observable. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short- term investments - equity securities with readily determinable fair value ("RDFV") are shares in marketable equity securities which are classified as level 1 in the fair value hierarchy as they are measured based on quotes in active markets. Equity securities with RDFV also includes potential shares received from an equity investment in a company that went public and can vest under certain stock performance circumstances, and these have been classified as level 2 because the fair value was calculated using the Monte Carlo simulation method in which quoted market price and other observable inputs are used.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other investments represent shares we own in a special fund that targets underlying investments of approximately 40 percent in debt securities and 60 percent in equity securities. These shares have been classified as level 2 because, although the shares of the fund are not traded on any active stock exchange, each of the individual underlying securities are or can be derived from and hence we have a readily determinable value for the underlying securities, from which we are able to determine the fair market value for the special fund itself. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trading securities, which are comprised of mutual funds, bonds and other similar instruments, other investments and deferred compensation liability are reported at fair value, with gains or losses resulting from changes in fair value recognized currently in net income. Certain derivative instruments are reported at fair value, with unrealized gains and losses, net of tax, included in accumulated other comprehensive income (loss) within stockholders' equity. Realized gains and losses from the sale of these instruments are recorded in net income.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended January&#160;31, 2022 and 2021, an unrealized loss of $47 million and an unrealized gain of $2 million, respectively, were included in other income (expense), net as an adjustment to the carrying value of equity securities. </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.724%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.697%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingent Consideration.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The fair value of the contingent consideration liability relates to milestone payments in connection with the April 2021 acquisition of Resolution Bioscience. The fair value of the potential future milestone payments, which are set to certain revenue and technical targets, was based on (i) the probability of achieving the relevant revenue targets and technical milestones and (ii) the timing of achieving such milestones, which are significant unobservable inputs, and has been classified as Level 3. We used the Monte Carlo simulation approach to estimate the fair value of the revenue component with an asset volatility of 54.9 percent and revenue volatilities ranging from 12.2 to 13.9 percent. The probability-weighted expected return method was used to estimate the fair value of the technical target component. Assumptions used in the calculations include probability of success, duration of the earn-out and discount rate. A change in any of these unobservable inputs can significantly change the fair value of the contingent consideration. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of January&#160;31, 2022, the expected maximum earn-out period for the contingent payments does not exceed 2.9 years and potential future payments will not exceed $145&#160;million. The fair value of the contingent consideration liability as of January&#160;31, 2022 was estimated to be $92 million of which $65 million was recorded in other accrued liabilities and $27 million was recorded in other long-term liabilities on the condensed consolidated balance sheet. The increase in the fair value of the contingent consideration was primarily driven by a change in the probability of achieving the technical milestone.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The contingent consideration liability is our only Level 3 asset or liability.  A summary of the Level 3 activity follows:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.724%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.697%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value (included within selling, general and administrative expenses)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Impairment of Investments.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> There were no impairments of investments for the three months ended January&#160;31, 2022 and 2021.</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Assets and Liabilities Measured at Fair Value on a Non-Recurring Basis</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended January&#160;31, 2022 and 2021, there were no impairments of long-lived assets held and used or long-lived assets held for sale. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended January&#160;31, 2022 and 2021, there were no impairments or adjustments to the carrying value of non-marketable securities without readily determinable fair value based on an observable market transaction. As of January&#160;31, 2022 and October&#160;31, 2021, the carrying amount of non-marketable equity securities without readily determinable fair values was $125 million and $120 million, respectively.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair values for the non-marketable securities included in long-term investments on the condensed consolidated balance sheet were measured using Level 3 inputs because they are primarily equity stock issued by private companies without quoted market prices. To estimate the fair value of our non-marketable securities, we use the measurement alternative to record these investments at cost and adjust for impairments and observable price changes (orderly transactions for the identical or a similar security from the same issuer) as and when they occur.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140093762217976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DERIVATIVES (Notes)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jan. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock', window );">DERIVATIVES</a></td>
<td class="text">DERIVATIVES<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are exposed to foreign currency exchange rate fluctuations and interest rate changes in the normal course of our business. As part of our risk management strategy, we use derivative instruments, primarily forward contracts and purchased options to hedge economic and/or accounting exposures resulting from changes in foreign currency exchange rates.</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Flow Hedges</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We enter into foreign exchange contracts to hedge our forecasted operational cash flow exposures resulting from changes in foreign currency exchange rates. These foreign exchange contracts, carried at fair value, have maturities between one and twelve months. These derivative instruments are designated and qualify as cash flow hedges under the criteria prescribed in the authoritative guidance and are assessed for effectiveness against the underlying exposure every reporting period. For open contracts as of January&#160;31, 2022, changes in the time value of the foreign exchange contract are excluded from the assessment of hedge effectiveness and are recognized in cost of sales over the life of the foreign exchange contract. The changes in fair value of the effective portion of the derivative instrument are recognized in accumulated other comprehensive income (loss). Amounts associated with cash flow hedges are reclassified to cost of sales in the condensed consolidated statement of operations when the forecasted transaction occurs. If it becomes probable that the forecasted transaction will not occur, the hedge relationship will be de-designated and amounts accumulated in other comprehensive income (loss) will be reclassified to other income (expense), net in the current period. Changes in the fair value of the ineffective portion of derivative instruments are recognized in other income (expense), net in the condensed consolidated statement of operations in the current period. We record the premium paid (time value) of an option on the date of purchase as an asset. For options designated as cash flow hedges, changes in the time value are excluded from the assessment of hedge effectiveness and are recognized in cost of sales over the life of the option contract. For the three months ended January&#160;31, 2022 and 2021, ineffectiveness and gains and losses recognized in other income (expense), net due to de-designation of cash flow hedge contracts were not significant.  </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2016, Agilent executed three forward-starting pay fixed/receive variable interest rate swaps for the notional amount of $300 million in connection with future interest payments to be made on our 2026 senior notes issued on September 15, 2016. These derivative instruments were designated and qualified as cash flow hedges under the criteria prescribed in the authoritative guidance. The swap arrangements were terminated on September 15, 2016 with a payment of $10 million, and we recognized this as a deferred loss in accumulated other comprehensive income (loss) which is being amortized to interest expense over the life of the 2026 senior notes. The remaining loss to be amortized related to the interest rate swap agreements at January&#160;31, 2022 was $4 million. </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2019, Agilent executed treasury lock agreements for $250 million in connection with future interest payments to be made on our 2029 senior notes issued on September 16, 2019. We designated the treasury lock as a cash flow hedge. The treasury lock contracts were terminated on September 6, 2019, and we recognized a deferred loss of $6&#160;million in accumulated other comprehensive income (loss) which is being amortized to interest expense over the life of the 2029 senior notes. The remaining loss to be amortized related to the treasury lock agreements at January&#160;31, 2022 was $4 million. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Investment Hedges </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We enter into foreign exchange contracts to hedge net investments in foreign operations to mitigate the risk of adverse movements in exchange rates. These foreign exchange contracts are carried at fair value and are designated and qualify as net investment hedges under the criteria prescribed in the authoritative guidance. Changes in fair value of the effective portion of the derivative instrument are recognized in accumulated other comprehensive income (loss) and are assessed for effectiveness against the underlying exposure every reporting period. If the company&#8217;s net investment changes during the year, the hedge relationship will be assessed and de-designated if the hedge notional amount is outside of prescribed tolerance with a gain/loss reclassified from other comprehensive income (loss) to other income (expense) in the current period. For the three months ended January&#160;31, 2022, ineffectiveness and the resultant effect of any gains or losses recognized in other income (expense) due to de-designation of the hedge contracts were not significant.  </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Hedges</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, we enter into foreign exchange contracts to hedge monetary assets and liabilities that are denominated in currencies other than the functional currency of our subsidiaries. These foreign exchange contracts are carried at fair value and do not qualify for hedge accounting treatment and are not designated as hedging instruments. Changes in value of the derivative instruments are recognized in other income (expense), net in the condensed consolidated statement of operations, in the current period, along with the offsetting foreign currency gain or loss on the underlying assets or liabilities.</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our use of derivative instruments exposes us to credit risk to the extent that the counterparties may be unable to meet the terms of the agreement. We do, however, seek to mitigate such risks by limiting our counterparties to major financial institutions which are selected based on their credit ratings and other factors.&#160;We have established policies and procedures for mitigating credit risk that include establishing counterparty credit limits, monitoring credit exposures, and continually assessing the creditworthiness of counterparties.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A number of our derivative agreements contain threshold limits to the net liability position with counterparties and are dependent on our corporate credit rating determined by the major credit rating agencies. The counterparties to the derivative instruments may request collateralization, in accordance with derivative agreements, on derivative instruments in net liability positions.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate fair value of all derivative instruments with credit-risk-related contingent features that were in a net liability position as of January&#160;31, 2022, was $2&#160;million. The credit-risk-related contingent features underlying these agreements had not been triggered as of January&#160;31, 2022.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were 261 foreign exchange forward contracts open as of January&#160;31, 2022 and designated as cash flow hedges. There were 177 foreign exchange forward contracts open as of January&#160;31, 2022 and not designated as hedging instruments. There were 7 foreign exchange forward contracts open as of January&#160;31, 2022 and designated as a net investment hedge.</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The aggregated notional amounts by currency and designation as of January&#160;31, 2022 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:44.274%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.786%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.080%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.258%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivatives&#160;<br/>Designated as <br/>Cash&#160;Flow Hedges</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivatives <br/>Designated as <br/>Net Investment Hedges</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivatives <br/>Not Designated as&#160;<br/>Hedging Instruments</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Forward<br/>Contracts USD</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Forward<br/>Contracts USD</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Forward<br/>Contracts USD</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Currency</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Buy/(Sell)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Buy/(Sell)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Buy/(Sell)</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Euro</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(71)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">British Pound</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(68)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canadian Dollar</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Japanese Yen</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(88)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Danish Krone</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Korean Won</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Singapore Dollar</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Swiss Franc</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chinese Yuan Renminbi</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(84)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(101)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Taiwan Dollar</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indian Rupee</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazilian Real</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Totals</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(396)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(118)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Derivative instruments are subject to master netting arrangements and are disclosed gross in the balance sheet in accordance with the authoritative guidance. The gross fair values and balance sheet location of derivative instruments held in the condensed consolidated balance sheet as of January&#160;31, 2022 and October&#160;31, 2021 were as follows:</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:29.635%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.164%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:27.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.311%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.875%"/><td style="width:0.1%"/></tr><tr><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair&#160;Values&#160;of&#160;Derivative&#160;Instruments</span></td></tr><tr><td colspan="15" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Asset&#160;Derivatives</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="15" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Liability&#160;Derivatives</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair&#160;Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair&#160;Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance&#160;Sheet&#160;Location</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31,<br/>2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance&#160;Sheet&#160;Location</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31,<br/>2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 31,<br/>2021</span></td></tr><tr><td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives designated as hedging instruments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Cash flow hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Net investment hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives not designated as hedging instruments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total derivatives</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effects of derivative instruments for foreign exchange contracts designated as hedging instruments and not designated as hedging instruments in our condensed consolidated statement of operations were as follows:</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:82.087%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.943%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives designated as hedging instruments:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Cash Flow Hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) recognized in accumulated other comprehensive&#160;loss</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) reclassified from accumulated other comprehensive&#160;loss into cost of sales</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Net Investment Hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) recognized in accumulated other comprehensive loss - translation adjustment</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives not designated as hedging instruments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) recognized in other income (expense)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At January&#160;31, 2022, the amount of existing net gain that is expected to be reclassified from accumulated other comprehensive income (loss) is $6 million. Within the next twelve months it is estimated that $9 million of gain included within the net amount of accumulated other comprehensive income (loss) will be reclassified to cost of sales in respect of cash flow hedges.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -URI http://asc.fasb.org/topic&amp;trid=2229140<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123477628&amp;loc=d3e90205-114008<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140093762250216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS (Notes)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jan. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresAbstract', window );"><strong>Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock', window );">RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS</a></td>
<td class="text">RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS<div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Components of net periodic costs (benefits).</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> For the three months ended January&#160;31, 2022 and 2021, our net pension and post retirement benefit costs (benefits) were comprised of the following:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:42.365%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.710%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.710%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.710%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.710%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.710%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.715%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended January 31</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">U.S. <br/>Pension&#160;Plans</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-U.S.<br/>Pension Plans</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">U.S.&#160;Post&#160;Retirement<br/>Benefit&#160;Plans</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost&#8212;benefits earned during the period</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost on benefit obligation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net plan costs (benefits)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:42.365%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.710%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.710%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.710%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.710%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.710%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.715%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The service cost component is recorded in cost of sales and operating expenses in the condensed consolidated statement of operations. All other cost components are recorded in other income (expense), net in the condensed consolidated statement of operations.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Employer contributions and expected future employer contributions for the remainder of the year were as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.771%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:3.724%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:3.729%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Employer Contributions</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For Remainder of Year</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. defined benefit plans</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. defined benefit plans</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for retirement benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section S99<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=21916913&amp;loc=d3e273930-122802<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (o)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (p)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -URI http://asc.fasb.org/topic&amp;trid=2235017<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39689-114964<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(03)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (q)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (l)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140093762395384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>WARRANTIES AND CONTINGENCIES (Notes)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jan. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">WARRANTIES AND CONTINGENCIES</a></td>
<td class="text">WARRANTIES AND CONTINGENCIES<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Warranties</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We accrue for standard warranty costs based on historical trends in actual warranty charges over the past 12 months. The accrual is reviewed regularly and periodically adjusted to reflect changes in warranty cost over the period. The standard warranty accrual balances are held in other accrued and other long-term liabilities on our condensed consolidated balance sheet. Our standard warranty terms typically extend to one year from the date of delivery, depending on the product.  </span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the standard warranty accrual activity is shown in the table below:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended </span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Standard warranty accrual, beginning balance</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accruals for warranties including change in estimates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements made during the period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Standard warranty accrual, ending balance</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accruals for warranties due within one year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accruals for warranties due after one year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Standard warranty accrual, ending balance</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Bank Guarantees</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Guarantees consist primarily of outstanding standby letters of credit and bank guarantees and were approximately $46 million as of January&#160;31, 2022 and October&#160;31, 2021, respectively. A standby letter of credit is a guarantee of payment issued by a bank on behalf of us that is used as payment of last resort should we fail to fulfill a contractual commitment with a third party. A bank guarantee is a promise from a bank or other lending institution that if we default on a loan, the bank will cover the loss.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contingencies</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are involved in lawsuits, claims, investigations and proceedings, including, but not limited to, intellectual property, commercial, real estate, environmental and employment matters, which arise in the ordinary course of business. There are no matters pending that we currently believe are reasonably possible of having a material impact to our business, condensed consolidated financial condition, results of operations or cash flows.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140093762181144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHORT-TERM DEBT (Notes)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jan. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermBorrowingsAbstract', window );"><strong>Short-term Debt [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtTextBlock', window );">SHORT-TERM DEBT</a></td>
<td class="text">SHORT-TERM DEBT<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Credit Facilities</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 13, 2019, we entered into a credit agreement with a group of financial institutions which, as amended, provided for a $1 billion five-year unsecured credit facility that will expire on March 13, 2024 and incremental term loan facilities in an aggregate amount of up to $500 million.&#160;On April 21, 2021, we entered into an incremental assumption agreement, pursuant to which the aggregate amount available for borrowing under the revolving credit facility was increased to $1.35&#160;billion and the aggregate amount available for incremental facilities was refreshed to remain at $500&#160;million. As of January&#160;31, 2022, we had no borrowings outstanding under the credit facility and no borrowings under the incremental facilities. We were in compliance with the covenants for the credit facility during the three months ended January&#160;31, 2022.</span></div>Commercial Paper<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under our U.S. commercial paper program, the company may issue and sell unsecured, short-term promissory notes in the aggregate principal amount not to exceed $1.35&#160;billion with up to 397-day maturities. At any point in time, the company intends to maintain available commitments under its revolving credit facility in an amount at least equal to the amount of the commercial paper notes outstanding. Amounts available under the program may be borrowed, repaid and re-borrowed from time to time. The proceeds from issuances under the program may be used for general corporate purposes. During the three months ended January&#160;31, 2022, we borrowed and repaid $240 million. As </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">January&#160;31, 2022</span>, we had no borrowings outstanding under our U.S. commercial paper program.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermBorrowingsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermBorrowingsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for short-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140093762673672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LONG-TERM DEBT (Notes)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jan. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtTextBlock', window );">LONG-TERM DEBT</a></td>
<td class="text">LONG-TERM DEBT<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Senior Notes</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the company&#8217;s long-term senior notes:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.807%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.469%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.853%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.471%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized <br/>Principal</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Principal</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023 Senior Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">599&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">599&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026 Senior Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">299&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">298&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2029 Senior Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">494&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">494&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2030 Senior Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">496&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">496&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2031 Senior Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">842&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">842&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,730&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,729&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>All outstanding notes listed above are unsecured and rank equally in right of payment with all of Agilent&#8217;s other senior unsecured indebtedness. There have been no other changes to the principal, maturity, interest rates and interest payment terms of the Agilent senior notes, detailed in the table above, in the three months ended January&#160;31, 2022 as compared to the senior notes described in our Annual Report on Form 10-K for the fiscal year ended October&#160;31, 2021.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140093762280552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY (Notes)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jan. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">STOCKHOLDERS EQUITY</a></td>
<td class="text">STOCKHOLDERS' EQUITY <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock Repurchase Program </span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 19, 2018 we announced that our board of directors had approved a share repurchase program (the "2019 repurchase program") designed, among other things, to reduce or eliminate dilution resulting from issuance of stock under the company's employee equity incentive programs. The 2019 repurchase program authorizes the purchase of up to $1.75 billion of our common stock at the company's discretion and has no fixed termination date. The 2019 repurchase program does not require the company to acquire a specific number of shares and may be suspended, amended or discontinued at any time. During the three months ended January&#160;31, 2021, we repurchased and retired 2.9 million shares for $344 million under this authorization. Effective February 18, 2021, the 2019 repurchase program was terminated and replaced by the new share repurchase program. The remaining authorization under the 2019 repurchase plan of $193&#160;million expired on February 18, 2021.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 16, 2021 we announced that our board of directors had approved a new share repurchase program (the "2021 repurchase program") designed, among other things, to reduce or eliminate dilution resulting from issuance of stock under the company's employee equity incentive programs. The 2021 repurchase program authorizes the purchase of up to $2.0&#160;billion of our common stock at the company's discretion and has no fixed termination date. The 2021 repurchase program which became effective on February 18, 2021, replaced and terminated the 2019 repurchase program on that date. The 2021 repurchase program does not require the company to acquire a specific number of shares and may be suspended, amended or discontinued at any time. During the three months ended January&#160;31, 2022, we repurchased and retired 2.9 million shares for $447 million under this authorization. As of January&#160;31, 2022, we had remaining authorization to repurchase up to approximately $1.13 billion of our common stock under the 2021 repurchase program.</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash Dividends on Shares of Common Stock</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended January&#160;31, 2022, we paid cash dividends of $0.210 per common share or $63 million on the company's common stock. During the three months ended January&#160;31, 2021, we paid cash dividends of $0.194 per common share or $59 million  on the company's common stock. The timing and amounts of any future dividends are subject to determination and approval by our board of directors.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accumulated Other Comprehensive Income (Loss)</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in accumulated other comprehensive income (loss) by component and related tax effects were as follows (in millions):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:36.126%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.113%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:9.848%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.697%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.551%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.848%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.551%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.848%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.405%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.857%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net defined benefit pension cost and post retirement plan costs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended January 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign currency translation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Prior service credits</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Actuarial Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized gains (losses) on derivatives</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="27" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of October 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(185)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(224)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(282)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified out of accumulated other comprehensive income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of January 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(212)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(217)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(298)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reclassifications out of accumulated other comprehensive income (loss) for the three months ended January&#160;31, 2022 and 2021 were as follows (in millions):</span></div><div style="margin-top:5pt;text-align:center;text-indent:4.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:42.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.969%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:36.769%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Details about accumulated other <br/>comprehensive income (loss) components</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amounts Reclassified from <br/>other comprehensive income (loss)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Affected line item in<br/>statement of operations</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="12" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:11pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gain (loss) on derivatives</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total before income tax</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Provision) benefit for income tax</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net of income tax</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net defined benefit pension cost and post retirement plan costs:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial net loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service benefit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total before income tax</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit for income tax</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net of income tax</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total reclassifications for the period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts in parentheses indicate reductions to income and increases to other comprehensive income (loss).</span></div>Reclassifications out of accumulated other comprehensive income (loss) of prior service benefit and actuarial net loss in respect of retirement plans and post retirement pension plans are included in the computation of net periodic cost (see Note 11, "Retirement Plans and Post Retirement Pension Plans").<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140093762685000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT INFORMATION (Notes)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jan. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">SEGMENT INFORMATION</a></td>
<td class="text">SEGMENT INFORMATION<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Description of segments.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  We are a global leader in life sciences, diagnostics and applied chemical markets, providing application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow.  </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of fiscal year 2022, we announced a change in organizational structure designed to enable our growth strategies and strengthen our focus on customers. Our chemistries and supplies business and our remarketed instruments business moved from our Agilent CrossLab business segment to our life sciences and applied markets business segment. Service revenue and cost of sales related to the previous acquisition of BioTek moved from our life sciences and applied markets business segment to our Agilent CrossLab business segment. The historical financial segment information has been recast to conform to this new presentation. There was no change to our diagnostics and genomics business segment.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following this reorganization, we continue to have three business segments comprised of life sciences and applied markets, diagnostics and genomics and Agilent CrossLab, each of which continues to comprise a reportable segment.  The three operating segments were determined based primarily on how the chief operating decision maker views and evaluates our operations. Operating results are regularly reviewed by the chief operating decision maker to make decisions about resources to be allocated to the segment and to assess its performance. Other factors, including market separation and customer specific applications, go-to-market channels, products and services and manufacturing are considered in determining the formation of these operating segments.</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A description of our three reportable segments is as follows:</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our life sciences and applied markets business provides application-focused solutions that include instruments and software that enable customers to identify, quantify and analyze the physical and biological properties of substances and products, as well as enable customers in the clinical and life sciences research areas to interrogate samples at the molecular and cellular level. Key product categories include: liquid chromatography ("LC") systems and components; liquid chromatography mass spectrometry ("LCMS") systems; gas chromatography ("GC") systems and components; gas chromatography mass spectrometry ("GCMS") systems; inductively coupled plasma mass spectrometry ("ICP-MS") instruments; atomic absorption ("AA") instruments; microwave plasma-atomic emission spectrometry ("MP-AES") instruments; inductively coupled plasma optical emission spectrometry ("ICP-OES") instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software for sample tracking; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps and measurement technologies. Our consumables portfolio is designed to improve customer outcomes. Most of the portfolio is vendor neutral, meaning Agilent can serve and supply customers regardless of their instrument purchase choices. Solutions range from chemistries to supplies. Key product categories in consumables include GC and LC columns, sample preparation products, custom chemistries, and a large selection of laboratory instrument supplies. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our diagnostics and genomics business is comprised of six areas of activity providing active pharmaceutical ingredients ("APIs") for oligo-based therapeutics as well as solutions that include reagents, instruments, software and consumables, which enable customers in the clinical and life sciences research areas to interrogate samples at the cellular and molecular level.&#160;First, our genomics business includes arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, gene expression profiling, as well as next generation sequencing ("NGS") target enrichment and genetic data management and interpretation support software. This business also includes solutions that enable clinical labs to identify DNA variants associated with genetic disease and help direct cancer therapy. Second, our nucleic acid solutions business provides equipment and expertise focused on production of synthesized oligonucleotides under pharmaceutical good manufacturing practices ("GMP") conditions for use as API in an emerging class of drugs that utilize nucleic acid molecules for disease therapy. Third, our pathology solutions business is focused on product offerings for cancer diagnostics and anatomic pathology workflows. The broad portfolio of offerings includes immunohistochemistry ("IHC"), in situ hybridization ("ISH"), hematoxylin and eosin ("H&amp;E") staining and special staining. Fourth, we also collaborate with a number of major pharmaceutical companies to develop new potential tissue and liquid-based pharmacodiagnostics, also known as companion diagnostics, which may be used to identify patients most likely to benefit from a specific targeted therapy. Fifth, the reagent partnership business is a provider of reagents used for turbidimetry and flow cytometry. Finally, our biomolecular analysis business provides complete workflow solutions, including instruments, </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">consumables and software, for quality control analysis of nucleic acid samples.&#160; Samples are analyzed using quantitative and qualitative techniques to ensure accuracy in further genomics analysis techniques utilized in clinical and life science research applications.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Agilent CrossLab business spans the entire lab with its extensive services portfolio, which is designed to improve customer outcomes.  The majority of the portfolio is vendor neutral, meaning we can serve and supply customers regardless of their instrument purchase choices.  </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The services portfolio include repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, consulting and various other custom services to support the customers' laboratory operations.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  Custom services are tailored to meet the specific application needs of various industries and to keep instruments fully operational and compliant with the respective industry requirements.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A significant portion of the segments' expenses arise from shared services and infrastructure that we have historically provided to the segments in order to realize economies of scale and to efficiently use resources. These expenses, collectively called corporate charges, include legal, accounting, tax, real estate, insurance services, information technology services, treasury, order administration, other corporate infrastructure expenses, costs of centralized research and development and joint sales and marketing costs. Charges are allocated to the segments, and the allocations have been determined on a basis that we consider to be a reasonable reflection of the utilization of services provided to or benefits received by the segments. In addition, we do not allocate asset impairments, amortization of acquisition-related intangible assets, change in the fair value of acquisition-related contingent consideration, acquisition and integration costs, restructuring and transformational initiatives expenses, acceleration of share-based compensation expense related to workforce reduction, business exit and divestiture costs, special compliance costs, some nucleic acid solutions division ("NASD") site costs and certain other charges to the operating margin for each segment because management does not include this information in its measurement of the performance of the operating segments. Transformational initiatives include expenses associated with targeted cost reduction activities such as manufacturing transfers, site consolidations, legal entity and other business reorganizations, in-sourcing or outsourcing of activities. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables reflect the results of our reportable segments under our management reporting system. The performance of each segment is measured based on several metrics, including segment income from operations. These results are used, in part, by the chief operating decision maker in evaluating the performance of, and in allocating resources to, each of the segments.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The profitability of each of the segments is measured after excluding items such as transformational initiatives, acquisition and integration costs, amortization of intangible assets related to business combinations, interest income, interest expense and other items as noted in the reconciliations below:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:77.116%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.428%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Revenue:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Life Sciences and Applied Markets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">976&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">923&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics and Genomics</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">339&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">294&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agilent CrossLab</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">359&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">331&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,674&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,548&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment Income From Operations:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Life Sciences and Applied Markets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">282&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">265&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics and Genomics</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agilent CrossLab</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment income from operations</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">441&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">396&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table reconciles segment income from operations to Agilent&#8217;s total enterprise income before taxes:&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:77.116%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.428%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment income from operations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">441&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">396&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transformational initiatives</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets related to business combinations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(44)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition and integration costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense), net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before taxes, as reported</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">319&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">312&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:9pt;text-indent:4.5pt"><span><br/></span></div><div style="padding-left:9pt;text-indent:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) For the three months ended January&#160;31, 2022 and 2021, other income (expense), net includes net (gains) losses on the fair value of equity securities.</span></div><div style="padding-left:9pt;text-indent:4.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table reflects segment assets under our management reporting system. Segment assets include allocations of corporate assets, goodwill, net other intangibles and other assets. Unallocated assets primarily consist of cash, cash equivalents, short-term and long-term investments, deferred tax assets, right-of-use assets and other assets. &#160;</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:72.576%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.694%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.695%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 31,<br/>2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Life Sciences and Applied Markets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,752&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,741&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics and Genomics</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,325&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,320&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agilent CrossLab</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">870&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">839&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,947&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,900&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI http://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140093760823768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OVERVIEW, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jan. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock', window );">Overview and Basis of Presentation</a></td>
<td class="text"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Overview. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Agilent Technologies, Inc. ("we," "Agilent" or the "company"), incorporated in Delaware in May 1999, is a global leader in life sciences, diagnostics and applied chemical markets, providing application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our fiscal year-end is October&#160;31, and our fiscal quarters end on January&#160;31, April&#160;30 and July&#160;31. Unless otherwise stated, these dates refer to our fiscal year and fiscal quarters.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">New Segment Structure.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In the first quarter of fiscal year 2022, we announced a change in organizational structure designed to enable our growth strategies and strengthen our focus on customers. Our chemistries and supplies business and our remarketed instruments business moved from our Agilent CrossLab business segment to our life sciences and applied markets business segment. Service revenue and cost of sales related to the previous acquisition of BioTek moved from our life sciences and applied markets business segment to our Agilent CrossLab business segment. Following this reorganization, we continue to have three business segments (life sciences and applied markets, diagnostics and genomics and Agilent CrossLab), each of which continues to comprise a reportable segment. We are reporting under this new structure beginning with this Quarterly Report on Form 10-Q for the period ended January 31, 2022 and historical financial segment information has been recast to conform to this new presentation in our financial statements and accompanying notes. There was no change to our diagnostics and genomics business segment.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Basis of Presentation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We have prepared the accompanying financial data for the three months ended January&#160;31, 2022 and 2021 pursuant to the rules&#160;and regulations of the U.S. Securities and Exchange Commission (&#8220;SEC&#8221;). Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles (&#8220;GAAP&#8221;) in the U.S. have been condensed or omitted pursuant to such rules&#160;and regulations. The October&#160;31, 2021 condensed balance sheet data was derived from audited financial statements but does not include all the disclosures required in audited financial statements by U.S. GAAP. The accompanying financial data and information should be read in conjunction with our Annual Report on Form 10-K for the fiscal year ended October&#160;31, 2021.  </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the opinion of management, the accompanying condensed consolidated financial statements contain all normal and recurring adjustments necessary for a fair statement of our condensed consolidated balance sheet as of January&#160;31, 2022 and October&#160;31, 2021, condensed consolidated statement of comprehensive income (loss) for the three months ended January&#160;31, 2022 and 2021, condensed consolidated statement of operations for the three months ended January&#160;31, 2022 and 2021, condensed consolidated statement of cash flows for the three months ended January&#160;31, 2022 and 2021 and condensed consolidated statement of equity for the three months ended January&#160;31, 2022 and 2021.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Use of Estimates.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The preparation of condensed consolidated financial statements in accordance with GAAP in the U.S. requires management to make estimates and assumptions that affect the amounts reported in our condensed consolidated financial statements and accompanying notes. Management bases its estimates on historical experience and various other assumptions believed to be reasonable. Although these estimates are based on management&#8217;s best knowledge of current events and actions that may impact the company in the future, actual results may be different from the estimates. Our critical accounting policies are those that affect our financial statements materially and involve difficult, subjective or complex judgments by management. Those policies are revenue recognition, inventory valuation, retirement and post-retirement benefit plan assumptions, valuation of goodwill and purchased intangible assets and accounting for income taxes.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy', window );">Restricted Cash and Restricted Cash Equivalents</a></td>
<td class="text"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restricted Cash and Restricted Cash Equivalents. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted cash and restricted cash equivalents are included with cash and cash equivalents when reconciling the beginning-of-period and end-of-period total amounts shown on the statement of cash flows.  A reconciliation of cash, cash equivalents and restricted cash to the condensed consolidated balance sheet follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.863%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.053%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 31</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,113&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,484&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash included in other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents and restricted cash</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,116&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,490&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Leases</a></td>
<td class="text">Leases. As of January&#160;31, 2022 and October&#160;31, 2021, operating lease right-of-use assets where we are the lessee were  $170&#160;million and $178&#160;million, respectively, and were included within other assets in the accompanying condensed consolidated balance sheet. The associated operating lease liabilities were $174&#160;million and $182&#160;million as of January&#160;31, 2022 and October&#160;31, 2021, respectively, and were included in other accrued liabilities and other long-term liabilities in the accompanying condensed consolidated balance sheet.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationVariableInterestEntityPolicy', window );">Variable Interest Entity</a></td>
<td class="text"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Variable Interest Entities. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We make a determination upon entering into an arrangement whether an entity in which we have made an investment is considered a Variable Interest Entity (&#8220;VIE&#8221;). We evaluate our investments in privately held companies on an ongoing basis. We have determined that as of January&#160;31, 2022 and October&#160;31, 2021, there were no VIEs required to be consolidated in our consolidated financial statements because we do not have a controlling financial interest in any of the VIEs in which we have invested nor are we the primary beneficiary. We account for these investments under either the equity method or as equity investments without readily determinable fair value ("RDFV"), depending on the circumstances. We periodically reassess whether we are the primary beneficiary of a VIE. The reassessment process considers whether we have acquired the power to direct the most significant activities of the VIE through changes in governing documents or other circumstances. We also reconsider whether entities previously determined not to be VIEs have become VIEs and vice-versa, based on changes in facts and circumstances including changes in contractual arrangements and capital structure.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of January&#160;31, 2022 and October&#160;31, 2021, the total carrying value of investments and loans in privately held companies considered as VIEs was $79 million and $76 million respectively. The maximum exposure is equal to the carrying value because we do not have future funding commitments. The investments are included on the long-term investments line and the loans on the other current assets and other assets lines (depending upon tenure of loan) on the condensed consolidated balance sheet.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair Value of Financial Instruments</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value of Financial Instruments.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The carrying values of certain of our financial instruments including cash and cash equivalents, accounts receivable, accounts payable, accrued compensation and other accrued liabilities approximate fair value because of their short maturities. The fair value of short-term and long-term equity investments which are readily determinable, and which are not accounted under the equity method are reported at fair value using quoted market prices for those securities when available with gains and losses included in net income. The fair value of long-term equity investments which are not readily determinable, and which are not accounted under the equity method are reported at cost with adjustments for observable changes in prices or impairments included in net income. As of January&#160;31, 2022, the fair value of our senior notes was $2,710&#160;million with a carrying value of $2,730 million.  This compares to a fair value of $2,806&#160;million with a carrying value of $2,729 million as of October&#160;31, 2021. The change in the fair value over carrying value in the three months ended January&#160;31, 2022 is primarily due to increased market interest rates. The fair value was calculated from quoted prices which are primarily Level 1 inputs under the accounting guidance. The fair value of foreign currency contracts used for hedging purposes is estimated internally by using inputs tied to active markets. These inputs, for example, interest rate yield curves, foreign exchange rates, and forward and spot prices for currencies are observable in the market or&#160;can be corroborated by observable market data for substantially the full term of the assets or liabilities. See also Note&#160;9, "Fair Value Measurements" for additional information on the fair value of financial instruments and contingent consideration.</span><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the business description and basis of presentation concepts.  Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity.  Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI http://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Entity's cash and cash equivalents accounting policy with respect to restricted balances.  Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4273-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationVariableInterestEntityPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for consolidation to describe the significant judgments and assumptions made in determining whether a variable interest held by the entity requires the variable interest entity to be consolidated and (or) disclose information about its involvement with the variable interest entity; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; and the significant factors considered and judgments made in determining that the power to direct the activities that significantly impact the economic performance of the variable interest entity are shared (as defined).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5728-111685<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=SL6759159-111685<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2AA<br> -Subparagraph a<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=SL6759068-111685<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationVariableInterestEntityPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 60<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=7493716&amp;loc=d3e21868-110260<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13279-108611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918666-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140093762388760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OVERVIEW, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jan. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashAbstract', window );"><strong>Restricted Cash [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock', window );">Restrictions on Cash and Cash Equivalents</a></td>
<td class="text"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restricted Cash and Restricted Cash Equivalents. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted cash and restricted cash equivalents are included with cash and cash equivalents when reconciling the beginning-of-period and end-of-period total amounts shown on the statement of cash flows.  A reconciliation of cash, cash equivalents and restricted cash to the condensed consolidated balance sheet follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.863%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.053%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 31</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,113&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,484&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash included in other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents and restricted cash</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,116&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,490&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of cash and cash equivalents restricted as to withdrawal or usage.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140093762522104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jan. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Disaggregation of Revenue</a></td>
<td class="text"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the company&#8217;s total revenue and segment revenue disaggregated by geographical region: </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:15.859%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.402%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.261%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.402%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.953%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="45" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended January 31</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Life Sciences and Applied Markets</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Agilent CrossLab<br/></span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Diagnostics and Genomics<br/></span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Life Sciences and Applied Markets</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Agilent CrossLab<br/></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Diagnostics and Genomics<br/></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="45" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Revenue by Region</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Americas</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">317&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">637&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">279&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">555&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">451&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">437&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia Pacific</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">407&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">586&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">399&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">556&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">976&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">359&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">339&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,674&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">923&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">331&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">294&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,548&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:16.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.402%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.969%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.402%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.953%"/><td style="width:0.1%"/></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the company&#8217;s total revenue disaggregated by end markets and by revenue type:</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.777%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Revenue by End Markets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmaceutical and Biopharmaceutical</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">602&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">521&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chemical and Energy</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">373&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">328&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics and Clinical</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">243&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Food</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Academia and Government</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Environmental and Forensics</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,674&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,548&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Revenue by Type</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Instrumentation</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">691&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">681&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-instrumentation and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">983&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">867&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,674&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,548&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock', window );">Contract Liabilities and Changes in Balances</a></td>
<td class="text"><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information about contract liabilities (deferred revenue) and the significant changes in the balances during the three months ended January&#160;31, 2022: </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:78.078%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.119%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.403%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Contract <br/>Liabilities</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance as of October 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">519&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenue deferred in the period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">220&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue recognized that was included in the contract liability balance at the beginning of the period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(191)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in deferrals from customer cash advances, net of revenue recognized</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation and other adjustments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance as of January 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">576&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130551-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140093762287880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHARE-BASED COMPENSATION (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jan. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationAbstract', window );"><strong>Share-based Payment Arrangement, Noncash Expense [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Allocated share-based compensation expense disclosure</a></td>
<td class="text"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The impact on our results for share-based compensation was as follows:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products and services</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total share-based compensation expense</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyTextBlock', window );">Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions And Methodology [Text Block]</a></td>
<td class="text"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following assumptions were used to estimate the fair value of awards granted.</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:75.215%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock Option Plans:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average risk-free interest rate</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average volatility</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5 years</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LTPP:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Volatility of Agilent shares</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Volatility of selected peer-company shares</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23%-81%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24%-57%</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pair-wise correlation with selected peers</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Post-vest holding restriction discount for all executive awards</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.5%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.8%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, and long-term performance plan grants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>a_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140093765919736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NET INCOME PER SHARE (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jan. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Reconciliation of the numerators and denominators of the basic and diluted net income per share</a></td>
<td class="text"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of the numerator and denominator of the basic and diluted net income per share computations for the periods presented below:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:80.625%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.674%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">283&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">288&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic weighted-average shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">301&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">306&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Potential common shares&#8212; stock&#160;options and other employee stock plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted weighted-average shares</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">303&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">309&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140093762378824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVENTORY (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jan. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNetAbstract', window );"><strong>Inventory, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">INVENTORY</a></td>
<td class="text">INVENTORY<div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory as of January&#160;31, 2022 and October&#160;31, 2021 consisted of the following:</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:74.119%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.218%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 31,<br/>2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">488&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">463&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchased parts and fabricated assemblies</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">391&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">367&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">879&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">830&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140093766710152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jan. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Goodwill balances and movements for each reportable segment during the period</a></td>
<td class="text"><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents goodwill balances and the movements for each of our reportable segments during the three months ended January&#160;31, 2022:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:50.512%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.457%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.070%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.632%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Life Sciences and Applied Markets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Diagnostics and Genomics</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Agilent CrossLab</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill as of October 31, 2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,743&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,964&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">268&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,975&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation impact</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill as of January 31, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,739&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,961&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">264&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,964&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Components of other intangible assets during the period</a></td>
<td class="text"><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The component parts of other intangible assets as of January&#160;31, 2022 and October&#160;31, 2021 are shown in the table below:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other&#160;Intangible&#160;Assets</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net&#160;Book<br/>Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of October 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchased technology</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,742&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">972&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">770&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Backlog</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademark/Tradename</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">357&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Third-party technology and licenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total amortizable intangible assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,314&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,344&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">970&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-Process R&amp;D</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,325&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,344&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">981&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of January 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchased technology</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,738&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">997&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">741&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademark/Tradename</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">355&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Backlog</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Third-party technology and licenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total amortizable intangible assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,308&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,390&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">918&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-Process R&amp;D</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,319&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,390&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">929&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock', window );">Schedule of estimated future amortization expense of finite-lived intangible assets</a></td>
<td class="text"><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future amortization expense related to existing finite-lived purchased intangible assets for the remainder of fiscal year 2022 and for each of the next five fiscal years and thereafter is estimated below:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:90.859%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.941%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Estimated future amortization expense:</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of 2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">288&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140093762297128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jan. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Fair Value Assets And Liabilities Measured On Recurring Basis</a></td>
<td class="text"><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial assets and liabilities measured at fair value on a recurring basis as of January&#160;31, 2022 were as follows:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.584%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.186%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurement at January 31, 2022 Using</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted&#160;Prices</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">in&#160;Active</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Markets&#160;for</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Identical&#160;Assets</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Level&#160;1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Observable</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Inputs</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Level&#160;2)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unobservable</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Inputs</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Level&#160;3)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents (money market funds)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">465&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">465&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative instruments (foreign exchange contracts)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments - Equity securities with RDFV</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trading securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets measured at fair value</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">592&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">542&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative instruments (foreign exchange contracts) </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities measured at fair value</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial assets and liabilities measured at fair value on a recurring basis as of October&#160;31, 2021 were as follows:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.584%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.186%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurement at October 31, 2021 Using</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 31,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted&#160;Prices</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">in&#160;Active</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Markets&#160;for</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Identical&#160;Assets</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Level&#160;1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Observable</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Inputs</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Level&#160;2)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unobservable</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Inputs</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Level&#160;3)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents (money market funds)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">919&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">919&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative instruments (foreign exchange contracts)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments - Equity securities with RDFV</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trading securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets measured at fair value</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,084&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,036&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative instruments (foreign exchange contracts)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities measured at fair value</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation</a></td>
<td class="text"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The contingent consideration liability is our only Level 3 asset or liability.  A summary of the Level 3 activity follows:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.724%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.697%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value (included within selling, general and administrative expenses)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19279-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140093766739864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DERIVATIVES (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jan. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock', window );">Aggregated notional amounts by currency and designation</a></td>
<td class="text">The aggregated notional amounts by currency and designation as of January&#160;31, 2022 were as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:44.274%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.786%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.080%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.258%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivatives&#160;<br/>Designated as <br/>Cash&#160;Flow Hedges</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivatives <br/>Designated as <br/>Net Investment Hedges</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivatives <br/>Not Designated as&#160;<br/>Hedging Instruments</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Forward<br/>Contracts USD</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Forward<br/>Contracts USD</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Forward<br/>Contracts USD</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Currency</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Buy/(Sell)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Buy/(Sell)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Buy/(Sell)</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Euro</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(71)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">British Pound</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(68)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canadian Dollar</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Japanese Yen</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(88)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Danish Krone</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Korean Won</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Singapore Dollar</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Swiss Franc</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chinese Yuan Renminbi</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(84)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(101)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Taiwan Dollar</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indian Rupee</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazilian Real</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Totals</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(396)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(118)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock', window );">Gross fair values and balance sheet location of derivative instruments held in the consolidated balance sheet</a></td>
<td class="text">Derivative instruments are subject to master netting arrangements and are disclosed gross in the balance sheet in accordance with the authoritative guidance. The gross fair values and balance sheet location of derivative instruments held in the condensed consolidated balance sheet as of January&#160;31, 2022 and October&#160;31, 2021 were as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:29.635%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.164%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:27.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.311%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.875%"/><td style="width:0.1%"/></tr><tr><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair&#160;Values&#160;of&#160;Derivative&#160;Instruments</span></td></tr><tr><td colspan="15" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Asset&#160;Derivatives</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="15" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Liability&#160;Derivatives</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair&#160;Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair&#160;Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance&#160;Sheet&#160;Location</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31,<br/>2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance&#160;Sheet&#160;Location</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31,<br/>2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 31,<br/>2021</span></td></tr><tr><td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives designated as hedging instruments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Cash flow hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Net investment hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives not designated as hedging instruments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total derivatives</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock', window );">Effect of derivative instruments for foreign exchange contracts in the consolidated statement of operations</a></td>
<td class="text">The effects of derivative instruments for foreign exchange contracts designated as hedging instruments and not designated as hedging instruments in our condensed consolidated statement of operations were as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:82.087%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.943%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives designated as hedging instruments:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Cash Flow Hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) recognized in accumulated other comprehensive&#160;loss</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) reclassified from accumulated other comprehensive&#160;loss into cost of sales</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Net Investment Hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) recognized in accumulated other comprehensive loss - translation adjustment</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives not designated as hedging instruments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) recognized in other income (expense)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4E<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624181-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of pertinent information about a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41620-113959<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41638-113959<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41678-113959<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41641-113959<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579240-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140093763985576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jan. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract', window );"><strong>Defined Benefit Plan, Net Periodic Benefit Cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock', window );">Schedule of net pension and post-retirement benefit costs</a></td>
<td class="text"><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Components of net periodic costs (benefits).</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> For the three months ended January&#160;31, 2022 and 2021, our net pension and post retirement benefit costs (benefits) were comprised of the following:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:42.365%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.710%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.710%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.710%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.710%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.710%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.715%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended January 31</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">U.S. <br/>Pension&#160;Plans</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-U.S.<br/>Pension Plans</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">U.S.&#160;Post&#160;Retirement<br/>Benefit&#160;Plans</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost&#8212;benefits earned during the period</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost on benefit obligation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net plan costs (benefits)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:42.365%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.710%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.710%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.710%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.710%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.710%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.715%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The service cost component is recorded in cost of sales and operating expenses in the condensed consolidated statement of operations. All other cost components are recorded in other income (expense), net in the condensed consolidated statement of operations.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_a_EmployerContributionsAndExpectedEmployerContributionsTableTextBlock', window );">Employer Contributions and Expected Employer Contributions</a></td>
<td class="text"><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Employer contributions and expected future employer contributions for the remainder of the year were as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.771%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:3.724%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:3.729%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Employer Contributions</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For Remainder of Year</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. defined benefit plans</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. defined benefit plans</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_a_EmployerContributionsAndExpectedEmployerContributionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of amount of contributions received by defined benefit plan from employer which increases plan assets and amount of contribution expected to be received by defined benefit plan from employer in the remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">a_EmployerContributionsAndExpectedEmployerContributionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>a_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of one or more of the entity's defined benefit pension plans or one or more other defined benefit postretirement plans, separately for pension plans and other postretirement benefit plans including the entity's schedule of fair value of plan assets for defined benefit or other postretirement plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2439-114920<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2410-114920<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2417-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140093762697000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>WARRANTIES AND CONTINGENCIES (Table)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jan. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock', window );">Standard warranty</a></td>
<td class="text"><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the standard warranty accrual activity is shown in the table below:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended </span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Standard warranty accrual, beginning balance</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accruals for warranties including change in estimates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements made during the period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Standard warranty accrual, ending balance</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accruals for warranties due within one year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accruals for warranties due after one year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Standard warranty accrual, ending balance</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in the guarantor's aggregate product warranty liability, including the beginning balance of the aggregate product warranty liability, the aggregate reductions in that liability for payments made (in cash or in kind) under the warranty, the aggregate changes in the liability for accruals related to product warranties issued during the reporting period, the aggregate changes in the liability for accruals related to preexisting warranties (including adjustments related to changes in estimates), and the ending balance of the aggregate product warranty liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123368208&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140093762228280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LONG-TERM DEBT (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jan. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock', window );">Schedule of Senior Notes and Related Interest Rate Swaps</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the company&#8217;s long-term senior notes:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.807%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.469%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.853%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.471%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized <br/>Principal</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Principal</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023 Senior Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">599&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">599&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026 Senior Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">299&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">298&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2029 Senior Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">494&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">494&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2030 Senior Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">496&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">496&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2031 Senior Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">842&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">842&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,730&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,729&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21506-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21521-112644<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21538-112644<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123599511&amp;loc=d3e64711-112823<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140093762216536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jan. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Accumulated Other Comprehensive Income (Loss)</a></td>
<td class="text"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in accumulated other comprehensive income (loss) by component and related tax effects were as follows (in millions):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:36.126%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.113%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:9.848%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.697%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.551%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.848%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.551%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.848%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.405%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.857%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net defined benefit pension cost and post retirement plan costs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended January 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign currency translation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Prior service credits</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Actuarial Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized gains (losses) on derivatives</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="27" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of October 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(185)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(224)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(282)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified out of accumulated other comprehensive income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of January 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(212)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(217)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(298)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock', window );">Reclassification out of Accumulated Other Comprehensive Income</a></td>
<td class="text"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reclassifications out of accumulated other comprehensive income (loss) for the three months ended January&#160;31, 2022 and 2021 were as follows (in millions):</span></div><div style="margin-top:5pt;text-align:center;text-indent:4.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:42.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.969%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:36.769%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Details about accumulated other <br/>comprehensive income (loss) components</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amounts Reclassified from <br/>other comprehensive income (loss)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Affected line item in<br/>statement of operations</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="12" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:11pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gain (loss) on derivatives</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total before income tax</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Provision) benefit for income tax</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net of income tax</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net defined benefit pension cost and post retirement plan costs:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial net loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service benefit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total before income tax</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit for income tax</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net of income tax</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total reclassifications for the period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information about items reclassified out of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140093762555464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT INFORMATION (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jan. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Segment Profitability and Segment Assets</a></td>
<td class="text"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The profitability of each of the segments is measured after excluding items such as transformational initiatives, acquisition and integration costs, amortization of intangible assets related to business combinations, interest income, interest expense and other items as noted in the reconciliations below:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:77.116%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.428%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Revenue:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Life Sciences and Applied Markets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">976&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">923&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics and Genomics</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">339&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">294&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agilent CrossLab</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">359&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">331&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,674&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,548&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment Income From Operations:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Life Sciences and Applied Markets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">282&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">265&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics and Genomics</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agilent CrossLab</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment income from operations</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">441&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">396&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table reflects segment assets under our management reporting system. Segment assets include allocations of corporate assets, goodwill, net other intangibles and other assets. Unallocated assets primarily consist of cash, cash equivalents, short-term and long-term investments, deferred tax assets, right-of-use assets and other assets. &#160;</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:72.576%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.694%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.695%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 31,<br/>2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Life Sciences and Applied Markets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,752&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,741&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics and Genomics</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,325&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,320&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agilent CrossLab</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">870&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">839&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,947&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,900&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock', window );">Reconciliation of segment results to total enterprise results</a></td>
<td class="text"><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table reconciles segment income from operations to Agilent&#8217;s total enterprise income before taxes:&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:77.116%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.428%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment income from operations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">441&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">396&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transformational initiatives</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets related to business combinations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(44)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition and integration costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense), net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before taxes, as reported</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">319&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">312&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:9pt;text-indent:4.5pt"><span><br/></span></div><div style="padding-left:9pt;text-indent:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) For the three months ended January&#160;31, 2022 and 2021, other income (expense), net includes net (gains) losses on the fair value of equity securities.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140093760595336">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>OVERVIEW, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jan. 31, 2022</div></th>
<th class="th"><div>Oct. 31, 2021</div></th>
<th class="th"><div>Jan. 31, 2021</div></th>
<th class="th"><div>Oct. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract', window );"><strong>Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 1,113<span></span>
</td>
<td class="nump">$ 1,484<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCash', window );">Restricted Cash</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents, restricted cash and restricted cash equivalents</a></td>
<td class="nump">1,116<span></span>
</td>
<td class="nump">1,490<span></span>
</td>
<td class="nump">$ 1,336<span></span>
</td>
<td class="nump">$ 1,447<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryDisclosuresAbstract', window );"><strong>Variable Interest Entity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Assets</a></td>
<td class="nump">10,327<span></span>
</td>
<td class="nump">10,705<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value of Financial Instruments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">2,730<span></span>
</td>
<td class="nump">2,729<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Quoted Prices in Active Markets for Identical Assets (Level 1)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value of Financial Instruments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Long-term Debt, Fair Value</a></td>
<td class="nump">2,710<span></span>
</td>
<td class="nump">2,806<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember', window );">Other Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesOperatingAbstract', window );"><strong>Operating Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right-of-Use Asset</a></td>
<td class="nump">170<span></span>
</td>
<td class="nump">178<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=a_OtherAccruedAndLongTermLiabilitiesMember', window );">Other accrued and long-term liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesOperatingAbstract', window );"><strong>Operating Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Present value of future minimum lease payments</a></td>
<td class="nump">174<span></span>
</td>
<td class="nump">182<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember', window );">Variable Interest Entity, Not Primary Beneficiary [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryDisclosuresAbstract', window );"><strong>Variable Interest Entity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Assets</a></td>
<td class="nump">$ 79<span></span>
</td>
<td class="nump">$ 76<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesOperatingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesOperatingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityNotPrimaryBeneficiaryDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=a_OtherAccruedAndLongTermLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=a_OtherAccruedAndLongTermLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140093760310184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE- Revenue by Region (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jan. 31, 2022</div></th>
<th class="th"><div>Jan. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">$ 1,674<span></span>
</td>
<td class="nump">$ 1,548<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=a_LifeSciencesandAppliedMarketsMember', window );">Life Sciences and Applied Markets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">976<span></span>
</td>
<td class="nump">923<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=a_AgilentCrossLabMember', window );">Agilent CrossLab</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">359<span></span>
</td>
<td class="nump">331<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=a_DiagnosticsAndGenomicsMember', window );">Diagnostics and Genomics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">339<span></span>
</td>
<td class="nump">294<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_AmericasMember', window );">Americas</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">637<span></span>
</td>
<td class="nump">555<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_AmericasMember', window );">Americas | Life Sciences and Applied Markets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">317<span></span>
</td>
<td class="nump">279<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_AmericasMember', window );">Americas | Agilent CrossLab</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">132<span></span>
</td>
<td class="nump">124<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_AmericasMember', window );">Americas | Diagnostics and Genomics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">188<span></span>
</td>
<td class="nump">152<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_EuropeMember', window );">Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">451<span></span>
</td>
<td class="nump">437<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_EuropeMember', window );">Europe | Life Sciences and Applied Markets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">252<span></span>
</td>
<td class="nump">245<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_EuropeMember', window );">Europe | Agilent CrossLab</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">98<span></span>
</td>
<td class="nump">92<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_EuropeMember', window );">Europe | Diagnostics and Genomics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">101<span></span>
</td>
<td class="nump">100<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_AsiaPacificMember', window );">Asia Pacific</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">586<span></span>
</td>
<td class="nump">556<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_AsiaPacificMember', window );">Asia Pacific | Life Sciences and Applied Markets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">407<span></span>
</td>
<td class="nump">399<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_AsiaPacificMember', window );">Asia Pacific | Agilent CrossLab</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">129<span></span>
</td>
<td class="nump">115<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_AsiaPacificMember', window );">Asia Pacific | Diagnostics and Genomics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">$ 50<span></span>
</td>
<td class="nump">$ 42<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=a_LifeSciencesandAppliedMarketsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=a_LifeSciencesandAppliedMarketsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=a_AgilentCrossLabMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=a_AgilentCrossLabMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=a_DiagnosticsAndGenomicsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=a_DiagnosticsAndGenomicsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_AmericasMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_AmericasMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_EuropeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_EuropeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_AsiaPacificMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_AsiaPacificMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140093759875848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE - Revenue by End Markets (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jan. 31, 2022</div></th>
<th class="th"><div>Jan. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">$ 1,674<span></span>
</td>
<td class="nump">$ 1,548<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_a_EndMarketsAxis=a_PharmaceuticalandBiopharmaceuticalMarketMember', window );">Pharmaceutical and Biopharmaceutical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">602<span></span>
</td>
<td class="nump">521<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_a_EndMarketsAxis=a_ChemicalandEnergyMarketMember', window );">Chemical and Energy</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">373<span></span>
</td>
<td class="nump">328<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_a_EndMarketsAxis=a_DiagnosticsandClinicalMarketMember', window );">Diagnostics and Clinical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">243<span></span>
</td>
<td class="nump">216<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_a_EndMarketsAxis=a_FoodMarketMember', window );">Food</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">158<span></span>
</td>
<td class="nump">162<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_a_EndMarketsAxis=a_AcademiaandGovernmentMarketMember', window );">Academia and Government</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">141<span></span>
</td>
<td class="nump">142<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_a_EndMarketsAxis=a_EnvironmentalandForensicsMarketMember', window );">Environmental and Forensics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">$ 157<span></span>
</td>
<td class="nump">$ 179<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_a_EndMarketsAxis=a_PharmaceuticalandBiopharmaceuticalMarketMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">a_EndMarketsAxis=a_PharmaceuticalandBiopharmaceuticalMarketMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_a_EndMarketsAxis=a_ChemicalandEnergyMarketMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">a_EndMarketsAxis=a_ChemicalandEnergyMarketMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_a_EndMarketsAxis=a_DiagnosticsandClinicalMarketMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">a_EndMarketsAxis=a_DiagnosticsandClinicalMarketMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_a_EndMarketsAxis=a_FoodMarketMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">a_EndMarketsAxis=a_FoodMarketMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_a_EndMarketsAxis=a_AcademiaandGovernmentMarketMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">a_EndMarketsAxis=a_AcademiaandGovernmentMarketMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_a_EndMarketsAxis=a_EnvironmentalandForensicsMarketMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">a_EndMarketsAxis=a_EnvironmentalandForensicsMarketMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140093760273768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE - Revenue by Type (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jan. 31, 2022</div></th>
<th class="th"><div>Jan. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">$ 1,674<span></span>
</td>
<td class="nump">$ 1,548<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=a_InstrumentationMember', window );">Instrumentation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">691<span></span>
</td>
<td class="nump">681<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=a_NonInstrumentationandOtherMember', window );">Non-Instrumentation and Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">$ 983<span></span>
</td>
<td class="nump">$ 867<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=a_InstrumentationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=a_InstrumentationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=a_NonInstrumentationandOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=a_NonInstrumentationandOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140093759815976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE - Contract Assets and Liability (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jan. 31, 2022</div></th>
<th class="th"><div>Jan. 31, 2021</div></th>
<th class="th"><div>Oct. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetAndLiabilityAbstract', window );"><strong>Contract Asset</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNet', window );">Contract Assets (Unbilled Accounts Receivable)</a></td>
<td class="nump">$ 207<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 197<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityAbstract', window );"><strong>Contract Liability</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Contract liability ending balance as of October 31, 2021</a></td>
<td class="nump">519<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability', window );">Net revenue deferred in the period</a></td>
<td class="nump">220<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Revenue recognized that was included in the contract liability balance at the beginning of the period</a></td>
<td class="num">(191)<span></span>
</td>
<td class="num">$ (186)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_a_IncreasedecreaseinDeferredRevenuefromCustomerCashAdvancesNetofRevenuerecognized', window );">Change in deferrals from customer cash advances, net of revenue recognized</a></td>
<td class="nump">34<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease', window );">Currency Translation and Other Adjustment</a></td>
<td class="num">(6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Contract liability ending balance as of January 31, 2022</a></td>
<td class="nump">$ 576<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_a_IncreasedecreaseinDeferredRevenuefromCustomerCashAdvancesNetofRevenuerecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase (decrease) in Deferred Revenue from Customer Cash Advances, Net of Revenue recognized in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">a_IncreasedecreaseinDeferredRevenuefromCustomerCashAdvancesNetofRevenuerecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>a_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetAndLiabilityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetAndLiabilityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130531-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130533-203044<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130532-203044<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 310<br> -Section 45<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123371682&amp;loc=d3e55415-109406<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cumulative translation adjustment, after tax, from translating foreign currency financial statements into the reporting currency.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140093759886888">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>REVENUE - Remaining Performance Obligation (Details) - Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-01-31<br> $ in Millions</strong></div></th>
<th class="th">
<div>Jan. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Remaining performance obligation expected timing of satisfaction period</a></td>
<td class="text">12 months<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Remaining performance obligation amount</a></td>
<td class="nump">$ 347<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transaction price allocated to performance obligation that has not been recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2022-01-31">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2022-01-31</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140093759947432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHARE-BASED COMPENSATION Text (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jan. 31, 2022</div></th>
<th class="th"><div>Jan. 31, 2021</div></th>
<th class="th"><div>Oct. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate', window );">ESPP plan purchase price (in hundredths)</a></td>
<td class="nump">85.00%<span></span>
</td>
<td class="nump">85.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PublicUtilitiesInventoryTypeDomain', window );">Inventory</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1', window );">Share-based compensation capitalized in inventory</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Share-based Payment Arrangement, Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Vesting percentage</a></td>
<td class="nump">25.00%<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting Period</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Maximum contractual term, Expiration Period</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent', window );">Exercise Price of Common Stock, Percent of FMV</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Vesting percentage</a></td>
<td class="nump">25.00%<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting Period</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Performance Shares [LTPP]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Vesting percentage</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Performance Shares [LTPP]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Vesting percentage</a></td>
<td class="nump">200.00%<span></span>
</td>
<td class="nump">200.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Discount rate from fair value on purchase date that participants pay for shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of vesting of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost expensed and capitalized for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Purchase price of common stock expressed as a percentage of its fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PublicUtilitiesInventoryTypeDomain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_PublicUtilitiesInventoryTypeDomain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140093760948984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHARE-BASED COMPENSATION Allocated Share-based compensation expense (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jan. 31, 2022</div></th>
<th class="th"><div>Jan. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share-based Compensation, Allocation of Recognized Period Costs</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expense</a></td>
<td class="nump">$ 45<span></span>
</td>
<td class="nump">$ 40<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of Products and Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share-based Compensation, Allocation of Recognized Period Costs</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expense</a></td>
<td class="nump">11<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and Development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share-based Compensation, Allocation of Recognized Period Costs</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expense</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember', window );">Selling, General and Administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share-based Compensation, Allocation of Recognized Period Costs</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expense</a></td>
<td class="nump">$ 28<span></span>
</td>
<td class="nump">$ 27<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140093760288280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHARE-BASED COMPENSATION Fair Value Assumptions (Details)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jan. 31, 2022</div></th>
<th class="th"><div>Jan. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Share-based Payment Arrangement, Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Weighted average risk-free interest rate</a></td>
<td class="nump">1.30%<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend yield</a></td>
<td class="nump">0.50%<span></span>
</td>
<td class="nump">0.70%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate', window );">Weighted average volatility</a></td>
<td class="nump">26.00%<span></span>
</td>
<td class="nump">26.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected Life</a></td>
<td class="text">5 years 6 months<span></span>
</td>
<td class="text">5 years 6 months<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=a_LtppMember', window );">LTPP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Volatility of Agilent shares</a></td>
<td class="nump">29.00%<span></span>
</td>
<td class="nump">30.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesVolatilityRateRangeMinimum', window );">Volatility of selected peer-company shares - Minimum</a></td>
<td class="nump">23.00%<span></span>
</td>
<td class="nump">24.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesVolatilityRateRangeMaximum', window );">Volatility of selected peer-company shares - Maximum</a></td>
<td class="nump">81.00%<span></span>
</td>
<td class="nump">57.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesPriceWiseCorrelationyRate', window );">Pair-wise correlation with selected peers (in hundredths)</a></td>
<td class="nump">41.00%<span></span>
</td>
<td class="nump">45.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=a_LTPPRSUMember', window );">LTPP &amp; RSU</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions', window );">Post-vest holding restriction discount for all executive awards</a></td>
<td class="nump">6.50%<span></span>
</td>
<td class="nump">6.80%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesPriceWiseCorrelationyRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The measure of the percentage amount of share price correlation during the period with a selected group of peer companies. Pair-wise correlations with selected peers is calculated as the correlation between each pair and the sum of correlations divided by the number of pairs to produce the average correlation between each pair.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesPriceWiseCorrelationyRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>a_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesVolatilityRateRangeMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The measure of the percentage amount by which a share price fluctuates during a period for peer companies - maximum range. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesVolatilityRateRangeMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>a_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesVolatilityRateRangeMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The measure of the percentage amount by which a share price fluctuates during a period for peer companies - minimum range. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesVolatilityRateRangeMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>a_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Restrictions on equity-based instruments during the vesting period, such as the inability to transfer unvested awards, are not taken into account in estimating the fair value of the award. However, restrictions that remain in effect after an award is vested, such as the inability to transfer or hedge vested options or a prohibition on the sale of outstanding vested shares (or other type of equity) for a period of time, affect the estimate of an award's fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Rate of weighted-average expected volatility for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=a_LtppMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=a_LtppMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=a_LTPPRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=a_LTPPRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140093759922872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jan. 31, 2022</div></th>
<th class="th"><div>Jan. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationLineItems', window );"><strong>Income Tax Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision (benefit) for income taxes</a></td>
<td class="nump">$ 36<span></span>
</td>
<td class="nump">$ 24<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective income tax rate</a></td>
<td class="nump">11.30%<span></span>
</td>
<td class="nump">7.70%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations', window );">Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations</a></td>
<td class="nump">$ 8<span></span>
</td>
<td class="nump">$ 16<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense', window );">Share-based Payment Arrangement, Expense, Tax Benefit</a></td>
<td class="nump">$ 16<span></span>
</td>
<td class="nump">$ 20<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax benefit for recognition of expense of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExaminationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExaminationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140093760887128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NET INCOME PER SHARE (Details) - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jan. 31, 2022</div></th>
<th class="th"><div>Jan. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_a_NumeratorAbstract', window );"><strong>Numerator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 283<span></span>
</td>
<td class="nump">$ 288<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_a_DenominatorsAbstract', window );"><strong>Denominators:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic weighted-average shares</a></td>
<td class="nump">301<span></span>
</td>
<td class="nump">306<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Potential common shares - stock options and other employee stock plans</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted weighted average shares</a></td>
<td class="nump">303<span></span>
</td>
<td class="nump">309<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive shares excluded from computation of dilutive earnings per share (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_a_DenominatorsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Denominators [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">a_DenominatorsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>a_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_a_NumeratorAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Numerator [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">a_NumeratorAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>a_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1707-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28A<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1500-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1757-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140093760782200">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>INVENTORY (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jan. 31, 2022</div></th>
<th class="th"><div>Oct. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNetAbstract', window );"><strong>Inventory, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoods', window );">Finished goods</a></td>
<td class="nump">$ 488<span></span>
</td>
<td class="nump">$ 463<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcessAndRawMaterials', window );">Purchased parts and fabricated assemblies</a></td>
<td class="nump">391<span></span>
</td>
<td class="nump">367<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventory</a></td>
<td class="nump">$ 879<span></span>
</td>
<td class="nump">$ 830<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcessAndRawMaterials">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate carrying amount as of the balance sheet date of items held by the entity which are partially completed at the time of measurement and unprocessed items that will go through the production process and become part of the final product.  Includes supplies used directly or indirectly in the manufacturing or production process.  This element may be used when the reporting entity combines work in process and raw materials into an aggregate amount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a)(3),(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcessAndRawMaterials</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140093761027960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND OTHER INTANGIBLE ASSETS Goodwill Roll forward (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jan. 31, 2022</div></th>
<th class="th"><div>Jan. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill Roll Forward</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill beginning balance</a></td>
<td class="nump">3,975<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments', window );">Foreign currency translation impact</a></td>
<td class="num">(11)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill arising from acquisitions</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill ending balance</a></td>
<td class="nump">3,964<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=a_LifeSciencesandAppliedMarketsMember', window );">Life Sciences and Applied Markets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill Roll Forward</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillTransfers', window );">Goodwill reassigned to segment</a></td>
<td class="nump">307<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill beginning balance</a></td>
<td class="nump">1,743<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments', window );">Foreign currency translation impact</a></td>
<td class="num">(4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill ending balance</a></td>
<td class="nump">1,739<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=a_DiagnosticsAndGenomicsMember', window );">Diagnostics and Genomics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill Roll Forward</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill beginning balance</a></td>
<td class="nump">1,964<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments', window );">Foreign currency translation impact</a></td>
<td class="num">(3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill ending balance</a></td>
<td class="nump">1,961<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=a_AgilentCrossLabMember', window );">Agilent CrossLab</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill Roll Forward</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillTransfers', window );">Goodwill reassigned to segment</a></td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill beginning balance</a></td>
<td class="nump">268<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments', window );">Foreign currency translation impact</a></td>
<td class="num">(4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill ending balance</a></td>
<td class="nump">$ 264<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillTransfers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transfers into (out of) an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillTransfers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from foreign currency translation adjustments and purchase accounting adjustments of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123586518&amp;loc=d3e961-128460<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=a_LifeSciencesandAppliedMarketsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=a_LifeSciencesandAppliedMarketsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=a_DiagnosticsAndGenomicsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=a_DiagnosticsAndGenomicsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=a_AgilentCrossLabMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=a_AgilentCrossLabMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140093761210328">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>GOODWILL AND OTHER INTANGIBLE ASSETS Disclosures and Components of Purchased Other Intangibles (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jan. 31, 2022</div></th>
<th class="th"><div>Oct. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract', window );"><strong>Finite-Lived Intangible Assets, Net</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 2,308<span></span>
</td>
<td class="nump">$ 2,314<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Total Intangible Assets</a></td>
<td class="nump">2,319<span></span>
</td>
<td class="nump">2,325<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">1,390<span></span>
</td>
<td class="nump">1,344<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Net Book Value</a></td>
<td class="nump">929<span></span>
</td>
<td class="nump">981<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-Lived Intangible Assets, Net</a></td>
<td class="nump">918<span></span>
</td>
<td class="nump">970<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember', window );">Purchased Technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract', window );"><strong>Finite-Lived Intangible Assets, Net</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">1,738<span></span>
</td>
<td class="nump">1,742<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">997<span></span>
</td>
<td class="nump">972<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Net Book Value</a></td>
<td class="nump">741<span></span>
</td>
<td class="nump">770<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OrderOrProductionBacklogMember', window );">Backlog</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract', window );"><strong>Finite-Lived Intangible Assets, Net</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Net Book Value</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember', window );">Trademark/Tradenames</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract', window );"><strong>Finite-Lived Intangible Assets, Net</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">196<span></span>
</td>
<td class="nump">196<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">137<span></span>
</td>
<td class="nump">133<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Net Book Value</a></td>
<td class="nump">59<span></span>
</td>
<td class="nump">63<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer Relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract', window );"><strong>Finite-Lived Intangible Assets, Net</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">355<span></span>
</td>
<td class="nump">357<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">244<span></span>
</td>
<td class="nump">228<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Net Book Value</a></td>
<td class="nump">111<span></span>
</td>
<td class="nump">129<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=a_ThirdPartyTechnologyandLicensesMember', window );">Third-Party Technology and Licenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract', window );"><strong>Finite-Lived Intangible Assets, Net</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">11<span></span>
</td>
<td class="nump">11<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Net Book Value</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember', window );">In-Process R&amp;D</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract', window );"><strong>Indefinite-Lived Intangible Assets (Excluding Goodwill)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">In-Process R&amp;D</a></td>
<td class="nump">$ 11<span></span>
</td>
<td class="nump">$ 11<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated amortization of intangible assets, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsGrossExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OrderOrProductionBacklogMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OrderOrProductionBacklogMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=a_ThirdPartyTechnologyandLicensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=a_ThirdPartyTechnologyandLicensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140093759941496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND OTHER INTANGIBLE ASSETS Textuals (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jan. 31, 2022</div></th>
<th class="th"><div>Jan. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease', window );">Addition to other intangible assets</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Additions to goodwill</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss', window );">Foreign currency translation impact on other intangible assets</a></td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill', window );">Impairment of IPR&amp;D</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets during the period</a></td>
<td class="nump">$ 51<span></span>
</td>
<td class="nump">$ 45<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which increases (decreases) assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in carrying value of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140093760273208">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>GOODWILL AND OTHER INTANGIBLE ASSETS - Estimated Future Amortization (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Jan. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear', window );">Remainder of 2022</a></td>
<td class="nump">$ 141<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2023</a></td>
<td class="nump">141<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2024</a></td>
<td class="nump">121<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2025</a></td>
<td class="nump">96<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2026</a></td>
<td class="nump">66<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">2027</a></td>
<td class="nump">65<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive', window );">Thereafter</a></td>
<td class="nump">$ 288<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140093755321784">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS, Fair value of assets and liabilities measured on a recurring basis (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jan. 31, 2022</div></th>
<th class="th"><div>Oct. 31, 2021</div></th>
<th class="th"><div>Jan. 31, 2021</div></th>
<th class="th"><div>Oct. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Short term investments</a></td>
<td class="nump">$ 45<span></span>
</td>
<td class="nump">$ 91<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Contingent Consideration</a></td>
<td class="nump">92<span></span>
</td>
<td class="nump">89<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at fair value</a></td>
<td class="nump">592<span></span>
</td>
<td class="nump">1,084<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities measured at fair value</a></td>
<td class="nump">134<span></span>
</td>
<td class="nump">128<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Other Current Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents (money market funds)</a></td>
<td class="nump">465<span></span>
</td>
<td class="nump">919<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure', window );">Derivative instruments (foreign exchange contracts)</a></td>
<td class="nump">16<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Short term investments</a></td>
<td class="nump">45<span></span>
</td>
<td class="nump">91<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Other assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TradingSecurities', window );">Trading securities</a></td>
<td class="nump">37<span></span>
</td>
<td class="nump">34<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Other investments</a></td>
<td class="nump">29<span></span>
</td>
<td class="nump">31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Other accrued liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure', window );">Derivative instruments (foreign exchange contracts)</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Contingent Consideration</a></td>
<td class="nump">65<span></span>
</td>
<td class="nump">62<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Other long-term liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent', window );">Deferred compensation liability</a></td>
<td class="nump">37<span></span>
</td>
<td class="nump">34<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Contingent Consideration</a></td>
<td class="nump">27<span></span>
</td>
<td class="nump">27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Quoted Prices in Active Markets for Identical Assets (Level 1)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at fair value</a></td>
<td class="nump">542<span></span>
</td>
<td class="nump">1,036<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities measured at fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Quoted Prices in Active Markets for Identical Assets (Level 1) | Other Current Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents (money market funds)</a></td>
<td class="nump">465<span></span>
</td>
<td class="nump">919<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure', window );">Derivative instruments (foreign exchange contracts)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Short term investments</a></td>
<td class="nump">40<span></span>
</td>
<td class="nump">83<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Quoted Prices in Active Markets for Identical Assets (Level 1) | Other assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TradingSecurities', window );">Trading securities</a></td>
<td class="nump">37<span></span>
</td>
<td class="nump">34<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Other investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Quoted Prices in Active Markets for Identical Assets (Level 1) | Other accrued liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure', window );">Derivative instruments (foreign exchange contracts)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Contingent Consideration</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Quoted Prices in Active Markets for Identical Assets (Level 1) | Other long-term liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent', window );">Deferred compensation liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Contingent Consideration</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Significant Other Observable Inputs (Level 2)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at fair value</a></td>
<td class="nump">50<span></span>
</td>
<td class="nump">48<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities measured at fair value</a></td>
<td class="nump">42<span></span>
</td>
<td class="nump">39<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Significant Other Observable Inputs (Level 2) | Other Current Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents (money market funds)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure', window );">Derivative instruments (foreign exchange contracts)</a></td>
<td class="nump">16<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Short term investments</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Significant Other Observable Inputs (Level 2) | Other assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TradingSecurities', window );">Trading securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Other investments</a></td>
<td class="nump">29<span></span>
</td>
<td class="nump">31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Significant Other Observable Inputs (Level 2) | Other accrued liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure', window );">Derivative instruments (foreign exchange contracts)</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Contingent Consideration</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Significant Other Observable Inputs (Level 2) | Other long-term liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent', window );">Deferred compensation liability</a></td>
<td class="nump">37<span></span>
</td>
<td class="nump">34<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Contingent Consideration</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Significant Unobservable Inputs (Level 3)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities measured at fair value</a></td>
<td class="nump">92<span></span>
</td>
<td class="nump">89<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Significant Unobservable Inputs (Level 3) | Other Current Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents (money market funds)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure', window );">Derivative instruments (foreign exchange contracts)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Short term investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Significant Unobservable Inputs (Level 3) | Other assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TradingSecurities', window );">Trading securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Other investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Significant Unobservable Inputs (Level 3) | Other accrued liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure', window );">Derivative instruments (foreign exchange contracts)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Significant Unobservable Inputs (Level 3) | Other accrued liabilities | Resolution Bioscience, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Contingent Consideration</a></td>
<td class="nump">65<span></span>
</td>
<td class="nump">62<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Significant Unobservable Inputs (Level 3) | Other long-term liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent', window );">Deferred compensation liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Significant Unobservable Inputs (Level 3) | Other long-term liabilities | Resolution Bioscience, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Contingent Consideration</a></td>
<td class="nump">$ 27<span></span>
</td>
<td class="nump">$ 27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements payable beyond one year (or the operating cycle, if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=123594786&amp;loc=SL75136599-209740<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of asset contracts related to the exchange of different currencies, including, but not limited to, foreign currency options, forward contracts, and swaps.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyContractAssetFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of liability contracts related to the exchange of different currencies, including, but not limited to, foreign currency options, forward (delivery or nondelivery) contracts, and swaps entered into.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial and nonfinancial obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TradingSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in net income (trading) and investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TradingSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=a_ResolutionBioscienceIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=a_ResolutionBioscienceIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140093766548456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS, Non Marketable Securities and Investment Impairments (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jan. 31, 2022</div></th>
<th class="th"><div>Jan. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss', window );">Unrealized gain (loss) on equity securities</a></td>
<td class="num">$ (47)<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfInvestments', window );">Impairment of Investments</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123583765&amp;loc=SL75117546-209714<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount by which the fair value of an investment is less than the amortized cost basis or carrying amount of that investment at the balance sheet date and the decline in fair value is deemed to be other than temporary, before considering whether or not such amount is recognized in earnings or other comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8A<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=SL6284422-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140093760922984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS, Contingent Consideration (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jan. 31, 2022 </div>
<div>USD ($)</div>
</th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=a_ResolutionBioscienceIncMember', window );">Resolution Bioscience, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_a_BusinessCombinationsContingentConsiderationArrangements', window );">Contingent Consideration maximum earn-out period</a></td>
<td class="text">2 years 10 months 24 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh', window );">Contingent Consideration Arrangement - Maximum</a></td>
<td class="nump">$ 145<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=a_MeasurementInputAssetVolatilityMember', window );">Measurement Input, Asset Volatility</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_a_BusinessCombinationContingentConsiderationFairValueMeasurementInput', window );">Business Combination Contingent Consideration Liability Measurement Input</a></td>
<td class="nump">54.90%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=a_MeasurementInputRevenueVolatilityMember', window );">Measurement Input, Revenue Volatility | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_a_BusinessCombinationContingentConsiderationFairValueMeasurementInput', window );">Business Combination Contingent Consideration Liability Measurement Input</a></td>
<td class="nump">12.20%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=a_MeasurementInputRevenueVolatilityMember', window );">Measurement Input, Revenue Volatility | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_a_BusinessCombinationContingentConsiderationFairValueMeasurementInput', window );">Business Combination Contingent Consideration Liability Measurement Input</a></td>
<td class="nump">13.90%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_a_BusinessCombinationContingentConsiderationFairValueMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage input used to measure contingent consideration liability from business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">a_BusinessCombinationContingentConsiderationFairValueMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>a_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_a_BusinessCombinationsContingentConsiderationArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>business combinations, contingent consideration, arrangements</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">a_BusinessCombinationsContingentConsiderationArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>a_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=a_ResolutionBioscienceIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=a_ResolutionBioscienceIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=a_MeasurementInputAssetVolatilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=a_MeasurementInputAssetVolatilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=a_MeasurementInputRevenueVolatilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=a_MeasurementInputRevenueVolatilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140093765719480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS - Reconciliation of Beginning and Ending Level 3 Contingent Consideration Liability (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jan. 31, 2022</div></th>
<th class="th"><div>Jan. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Fair Value Contingent Consideration, Beginning Balance</a></td>
<td class="nump">$ 89<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease', window );">Change in fair value (included within SG&amp;A)</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Fair Value Contingent Consideration, Ending Balance</a></td>
<td class="nump">$ 92<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140093759949016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS, Assets and Liabilities measured at Fair Value on a Non-Recurring Basis (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jan. 31, 2022</div></th>
<th class="th"><div>Jan. 31, 2021</div></th>
<th class="th"><div>Oct. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_a_AssetsLongLivedAbstract', window );"><strong>Long-Lived Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse', window );">Impairment of Long-Lived Assets Held-for-use</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf', window );">Impairment of Long-Lived assets Held for sale</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiGainLossAbstract', window );"><strong>Equity Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount', window );">Impairment of non-marketable securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount', window );">Non-marketable equity securities carrying amount</a></td>
<td class="nump">$ 125<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 120<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_a_AssetsLongLivedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Assets Long Lived [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">a_AssetsLongLivedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>a_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiGainLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiGainLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123583765&amp;loc=SL75117539-209714<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cumulative impairment loss on investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123583765&amp;loc=SL75117539-209714<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2921-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfLongLivedAssetsHeldForUse</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of write-downs for impairments recognized during the period for long-lived assets held for abandonment, exchange or sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2611-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140093758968680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DERIVATIVES- Text (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Sep. 06, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 15, 2016 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Aug. 16, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Feb. 01, 2016 </div>
<div>USD ($) </div>
<div>contracts</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentDetailAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNetLiabilityPositionAggregateFairValue', window );">Aggregate fair value of all derivative instruments with credit-risk-related contingent features that were in a net liability position</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SummaryOfNetInvestmentHedgeActivityAbstract', window );"><strong>Net Investment Hedge</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths', window );">Net gain to be reclassified within next Twelve Months</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | Cost of Products and Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SummaryOfNetInvestmentHedgeActivityAbstract', window );"><strong>Net Investment Hedge</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths', window );">Net gain to be reclassified within next Twelve Months</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=a_SeniorNotes2026Member', window );">Senior Notes 2026 | Interest Rate Swap | Derivatives Designated as Hedging Instrument | Cash Flow Hedging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestRateDerivativesAbstract', window );"><strong>Terminated Derivative Contracts</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfInterestRateDerivativesHeld', window );">Number of interest rate swap contracts terminated | contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_a_Interestrateswappayments', window );">Interest rate swap payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_a_Remaininggainlosstobeamortizedonderivative', window );">Remaining gain (loss) to be amortized on derivative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=a_SeniorNotes2029Member', window );">Senior Notes 2029 | Treasury Lock [Member] | Derivatives Designated as Hedging Instrument | Cash Flow Hedging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestRateDerivativesAbstract', window );"><strong>Terminated Derivative Contracts</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_a_Interestrateswappayments', window );">Interest rate swap payments</a></td>
<td class="nump">$ 6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_a_Remaininggainlosstobeamortizedonderivative', window );">Remaining gain (loss) to be amortized on derivative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_a_Interestrateswappayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>interest rate swap payments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">a_Interestrateswappayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>a_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_a_Remaininggainlosstobeamortizedonderivative">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Remaining gain loss to be amortized on derivative</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">a_Remaininggainlosstobeamortizedonderivative</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>a_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated net amount of existing gains or losses on cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121549185&amp;loc=d3e80748-113994<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentDetailAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentDetailAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNetLiabilityPositionAggregateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate fair value amounts of derivative instruments that contain credit-risk-related contingent features that are in a net liability position at the end of the reporting period. For nonderivative instruments that are designated and qualify as hedging instruments, the fair value amounts are the carrying value of the nonderivative hedging instrument, including the adjustment for the foreign currency transaction gain (loss) on that instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4H<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624258-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNetLiabilityPositionAggregateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestRateDerivativesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestRateDerivativesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfInterestRateDerivativesHeld">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of interest rate derivative instruments held by the entity at the reporting date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfInterestRateDerivativesHeld</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SummaryOfNetInvestmentHedgeActivityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SummaryOfNetInvestmentHedgeActivityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=a_SeniorNotes2026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=a_SeniorNotes2026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=a_SeniorNotes2029Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=a_SeniorNotes2029Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_TreasuryLockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_TreasuryLockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140093756691256">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>DERIVATIVES- Foreign Exchange Forward Contracts (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Jan. 31, 2022 </div>
<div>USD ($) </div>
<div>contracts</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivatives Designated as Hedging Instrument | Cash Flow Hedging | Foreign Exchange Forward</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfForeignCurrencyDerivativesHeld', window );">Number of foreign exchange forward contracts (in units) | contracts</a></td>
<td class="nump">261<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivatives Designated as Hedging Instrument | Net Investment Hedging [Member] | Foreign Exchange Forward</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfForeignCurrencyDerivativesHeld', window );">Number of foreign exchange forward contracts (in units) | contracts</a></td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Derivatives Not Designated as Hedging Instruments | Foreign Exchange Forward</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfForeignCurrencyDerivativesHeld', window );">Number of foreign exchange forward contracts (in units) | contracts</a></td>
<td class="nump">177<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PositionAxis=us-gaap_ShortMember', window );">Sell | Derivatives Designated as Hedging Instrument | Cash Flow Hedging | Forward Contracts USD</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">$ 396<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PositionAxis=us-gaap_ShortMember', window );">Sell | Derivatives Designated as Hedging Instrument | Cash Flow Hedging | Euro | Forward Contracts USD</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">71<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PositionAxis=us-gaap_ShortMember', window );">Sell | Derivatives Designated as Hedging Instrument | Cash Flow Hedging | British Pound | Forward Contracts USD</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">68<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PositionAxis=us-gaap_ShortMember', window );">Sell | Derivatives Designated as Hedging Instrument | Cash Flow Hedging | Canadian Dollar | Forward Contracts USD</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">42<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PositionAxis=us-gaap_ShortMember', window );">Sell | Derivatives Designated as Hedging Instrument | Cash Flow Hedging | Japanese Yen | Forward Contracts USD</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">88<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PositionAxis=us-gaap_ShortMember', window );">Sell | Derivatives Designated as Hedging Instrument | Cash Flow Hedging | Korean Won | Forward Contracts USD</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">65<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PositionAxis=us-gaap_ShortMember', window );">Sell | Derivatives Designated as Hedging Instrument | Cash Flow Hedging | Chinese Yuan Renminbi | Forward Contracts USD</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">84<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PositionAxis=us-gaap_ShortMember', window );">Sell | Derivatives Designated as Hedging Instrument | Net Investment Hedging [Member] | Forward Contracts USD</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">15<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PositionAxis=us-gaap_ShortMember', window );">Sell | Derivatives Designated as Hedging Instrument | Net Investment Hedging [Member] | Euro | Forward Contracts USD</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">15<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PositionAxis=us-gaap_ShortMember', window );">Sell | Derivatives Not Designated as Hedging Instruments | Forward Contracts USD</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">118<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PositionAxis=us-gaap_ShortMember', window );">Sell | Derivatives Not Designated as Hedging Instruments | Canadian Dollar | Forward Contracts USD</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PositionAxis=us-gaap_ShortMember', window );">Sell | Derivatives Not Designated as Hedging Instruments | Japanese Yen | Forward Contracts USD</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">41<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PositionAxis=us-gaap_ShortMember', window );">Sell | Derivatives Not Designated as Hedging Instruments | Korean Won | Forward Contracts USD</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">20<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PositionAxis=us-gaap_ShortMember', window );">Sell | Derivatives Not Designated as Hedging Instruments | Swiss Franc | Forward Contracts USD</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PositionAxis=us-gaap_ShortMember', window );">Sell | Derivatives Not Designated as Hedging Instruments | Chinese Yuan Renminbi | Forward Contracts USD</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">101<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PositionAxis=us-gaap_ShortMember', window );">Sell | Derivatives Not Designated as Hedging Instruments | Taiwan, New Dollars | Forward Contracts USD</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PositionAxis=us-gaap_ShortMember', window );">Sell | Derivatives Not Designated as Hedging Instruments | India, Rupees | Forward Contracts USD</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PositionAxis=us-gaap_ShortMember', window );">Sell | Derivatives Not Designated as Hedging Instruments | Other | Forward Contracts USD</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PositionAxis=us-gaap_ShortMember', window );">Sell | Derivatives Not Designated as Hedging Instruments | Brazil, Brazil Real | Forward Contracts USD</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PositionAxis=us-gaap_LongMember', window );">Buy | Derivatives Designated as Hedging Instrument | Cash Flow Hedging | Singapore Dollar | Forward Contracts USD</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">18<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PositionAxis=us-gaap_LongMember', window );">Buy | Derivatives Designated as Hedging Instrument | Cash Flow Hedging | Other | Forward Contracts USD</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PositionAxis=us-gaap_LongMember', window );">Buy | Derivatives Not Designated as Hedging Instruments | Euro | Forward Contracts USD</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">27<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PositionAxis=us-gaap_LongMember', window );">Buy | Derivatives Not Designated as Hedging Instruments | British Pound | Forward Contracts USD</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PositionAxis=us-gaap_LongMember', window );">Buy | Derivatives Not Designated as Hedging Instruments | Danish Krone | Forward Contracts USD</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">27<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PositionAxis=us-gaap_LongMember', window );">Buy | Derivatives Not Designated as Hedging Instruments | Singapore Dollar | Forward Contracts USD</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">$ 21<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfForeignCurrencyDerivativesHeld">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of foreign currency exchange rate derivatives held by the entity at the reporting date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfForeignCurrencyDerivativesHeld</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PositionAxis=us-gaap_ShortMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PositionAxis=us-gaap_ShortMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForwardContractsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForwardContractsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_EUR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_EUR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_GBP">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_GBP</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_CAD">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_CAD</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_JPY">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_JPY</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_KRW">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_KRW</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_CNY">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_CNY</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_CHF">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_CHF</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_TWD">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_TWD</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_INR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_INR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_XXX">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_XXX</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_BRL">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_BRL</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PositionAxis=us-gaap_LongMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PositionAxis=us-gaap_LongMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_SGD">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_SGD</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_DKK">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_DKK</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140093756627224">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>DERIVATIVES, Fair value of derivative instruments and Consolidated Balance Sheet location (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jan. 31, 2022</div></th>
<th class="th"><div>Oct. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNetAbstract', window );"><strong>Derivative Fair Value by Balance Sheet Location</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivatives asset fair value</a></td>
<td class="nump">$ 16<span></span>
</td>
<td class="nump">$ 9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivatives liabilities fair value</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivatives Designated as Hedging Instruments | Cash Flow Hedging | Foreign Exchange Contracts | Other Current Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNetAbstract', window );"><strong>Derivative Fair Value by Balance Sheet Location</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivatives asset fair value</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivatives Designated as Hedging Instruments | Cash Flow Hedging | Foreign Exchange Contracts | Other Accrued Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNetAbstract', window );"><strong>Derivative Fair Value by Balance Sheet Location</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivatives liabilities fair value</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivatives Designated as Hedging Instruments | Net Investment Hedging [Member] | Foreign Exchange Contracts | Other Current Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNetAbstract', window );"><strong>Derivative Fair Value by Balance Sheet Location</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivatives asset fair value</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivatives Designated as Hedging Instruments | Net Investment Hedging [Member] | Foreign Exchange Contracts | Other Accrued Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNetAbstract', window );"><strong>Derivative Fair Value by Balance Sheet Location</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivatives liabilities fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Derivatives Not Designated as Hedging Instruments | Foreign Exchange Contracts | Other Current Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNetAbstract', window );"><strong>Derivative Fair Value by Balance Sheet Location</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivatives asset fair value</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Derivatives Not Designated as Hedging Instruments | Foreign Exchange Contracts | Other Accrued Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNetAbstract', window );"><strong>Derivative Fair Value by Balance Sheet Location</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivatives liabilities fair value</a></td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AccruedLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_AccruedLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140093761039272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DERIVATIVES, Effect of derivative instruments on Consolidated Statement of Operations (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jan. 31, 2022</div></th>
<th class="th"><div>Jan. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet', window );">Gain (loss) reclassified from accumulated other comprehensive&#160;loss into cost of sales</a></td>
<td class="nump">$ 3<span></span>
</td>
<td class="num">$ (8)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of Products and Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet', window );">Gain (loss) reclassified from accumulated other comprehensive&#160;loss into cost of sales</a></td>
<td class="nump">3<span></span>
</td>
<td class="num">(8)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivatives Designated as Hedging Instrument | Cash Flow Hedging | Foreign Exchange Contracts | Accumulated Other Comprehensive Income (Loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Gain (loss) recognized in accumulated other comprehensive&#160;loss</a></td>
<td class="nump">8<span></span>
</td>
<td class="num">(6)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivatives Designated as Hedging Instrument | Cash Flow Hedging | Foreign Exchange Contracts | Cost of Products and Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet', window );">Gain (loss) reclassified from accumulated other comprehensive&#160;loss into cost of sales</a></td>
<td class="nump">3<span></span>
</td>
<td class="num">(8)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivatives Designated as Hedging Instrument | Net Investment Hedging [Member] | Foreign Exchange Contracts | Accumulated Other Comprehensive Income (Loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax', window );">Gain (loss) recognized in accumulated other comprehensive loss - translation adjustment</a></td>
<td class="nump">3<span></span>
</td>
<td class="num">(4)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Derivatives Not Designated as Hedging Instruments | Other income (expense)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Gain (loss) recognized in other income (expense)</a></td>
<td class="num">$ (3)<span></span>
</td>
<td class="num">$ (4)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeGainLossOnDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeGainLossOnDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The effective portion of net gain (loss) reclassified from accumulated other comprehensive income into income on derivative instruments designated and qualifying as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624177-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121577181&amp;loc=SL110061190-113977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and reclassification, of gain (loss) from derivative designated and qualifying as net investment hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CCC<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL109998896-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140093761247832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS- Components of net periodic costs (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jan. 31, 2022</div></th>
<th class="th"><div>Jan. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plan | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract', window );"><strong>Defined Benefit Plan, Net Periodic Benefit Cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service cost - benefits earned during the period</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost on benefit obligation</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets', window );">Expected return on plan assets</a></td>
<td class="num">(6)<span></span>
</td>
<td class="num">(7)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_a_AmortizationAndDeferralsAbstract', window );"><strong>Amortization:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses', window );">Actuarial losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Total net plan costs (benefits)</a></td>
<td class="num">(3)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plan | Foreign Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract', window );"><strong>Defined Benefit Plan, Net Periodic Benefit Cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service cost - benefits earned during the period</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost on benefit obligation</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets', window );">Expected return on plan assets</a></td>
<td class="num">(11)<span></span>
</td>
<td class="num">(12)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_a_AmortizationAndDeferralsAbstract', window );"><strong>Amortization:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses', window );">Actuarial losses</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Total net plan costs (benefits)</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember', window );">Other Postretirement Benefits Plan | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract', window );"><strong>Defined Benefit Plan, Net Periodic Benefit Cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service cost - benefits earned during the period</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost on benefit obligation</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets', window );">Expected return on plan assets</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_a_AmortizationAndDeferralsAbstract', window );"><strong>Amortization:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses', window );">Actuarial losses</a></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Total net plan costs (benefits)</a></td>
<td class="num">$ (1)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_a_AmortizationAndDeferralsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortization and deferrals [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">a_AmortizationAndDeferralsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>a_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in net periodic benefit (cost) credit of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanInterestCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost recognized for passage of time related to defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanInterestCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of net periodic benefit cost (credit) for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanServiceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanServiceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140093761038568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS (Details) (Employer Contributions)) - Pension Plan - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jan. 31, 2022</div></th>
<th class="th"><div>Jan. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanContributionsByEmployer', window );">Employer Contributions</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear', window );">Expected future employer contributions</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Foreign Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanContributionsByEmployer', window );">Employer Contributions</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear', window );">Expected future employer contributions</a></td>
<td class="nump">$ 14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanContributionsByEmployer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of contribution received by defined benefit plan from employer which increases plan assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanContributionsByEmployer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of contribution expected to be received by defined benefit plan from employer in remainder of current fiscal year. Excludes contribution previously paid by employer in current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140093760579304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>WARRANTIES AND CONTINGENCIES (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jan. 31, 2022</div></th>
<th class="th"><div>Jan. 31, 2021</div></th>
<th class="th"><div>Oct. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInStandardProductWarrantyAccrualRollForward', window );"><strong>Movement in Standard Product Warranty Accrual</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StandardProductWarrantyAccrual', window );">Beginning balance</a></td>
<td class="nump">$ 30<span></span>
</td>
<td class="nump">$ 32<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StandardProductWarrantyAccrualWarrantiesIssued', window );">Accruals for warranties including change in estimate</a></td>
<td class="nump">13<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StandardProductWarrantyAccrualPayments', window );">Settlements made during the period</a></td>
<td class="num">(13)<span></span>
</td>
<td class="num">(15)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StandardProductWarrantyAccrual', window );">Ending balance at end of period</a></td>
<td class="nump">30<span></span>
</td>
<td class="nump">32<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StandardProductWarrantyDisclosureAbstract', window );"><strong>Standard Product Warranty Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StandardProductWarrantyAccrualCurrent', window );">Accruals for warranties due within one year</a></td>
<td class="nump">29<span></span>
</td>
<td class="nump">31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StandardProductWarrantyAccrualNoncurrent', window );">Accrual for warranties due after one year</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GuaranteesAbstract', window );"><strong>Guarantees</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BankAcceptancesExecuted', window );">Guarantees</a></td>
<td class="nump">$ 46<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 46<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BankAcceptancesExecuted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of the financial institution's obligation to pay the holder of the customer's draft which the financial institution has guaranteed (i.e., Banker's Acceptance).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BankAcceptancesExecuted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GuaranteesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GuaranteesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MovementInStandardProductWarrantyAccrualRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MovementInStandardProductWarrantyAccrualRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StandardProductWarrantyAccrual">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount as of the balance sheet date of the aggregate standard product warranty liability. Does not include the balance for the extended product warranty liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (c)(1),(c)(5)<br> -URI http://asc.fasb.org/extlink&amp;oid=123368208&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StandardProductWarrantyAccrual</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StandardProductWarrantyAccrualCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount as of the balance sheet date of the aggregate standard product warranty liability that is expected to be paid within one year or the normal operating cycle, if longer. Does not include the balance for the extended product warranty liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StandardProductWarrantyAccrualCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StandardProductWarrantyAccrualNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount as of the balance sheet date of the aggregate standard product warranty liability that is expected to be paid after one year or beyond the normal operating cycle, if longer. Does not include the balance for the extended product warranty liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StandardProductWarrantyAccrualNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StandardProductWarrantyAccrualPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in the standard product warranty accrual from payments made in cash or in kind to satisfy claims under the terms of the standard product warranty. Excludes extended product warranties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph ((c)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=123368208&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StandardProductWarrantyAccrualPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StandardProductWarrantyAccrualWarrantiesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in the standard product warranty accrual from warranties issued. Excludes extended product warranties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph ((c)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=123368208&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StandardProductWarrantyAccrualWarrantiesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StandardProductWarrantyDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StandardProductWarrantyDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140093755247864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHORT-TERM DEBT - Credit Facility (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 13, 2019</div></th>
<th class="th"><div>Jan. 31, 2022</div></th>
<th class="th"><div>Jan. 31, 2021</div></th>
<th class="th"><div>Jun. 18, 2021</div></th>
<th class="th"><div>Apr. 21, 2021</div></th>
<th class="th"><div>Oct. 21, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfCommercialPaper', window );">Repayments of commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (240,000,000)<span></span>
</td>
<td class="num">$ (546,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommercialPaper', window );">Proceeds from Commercial Paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">240,000,000<span></span>
</td>
<td class="nump">$ 785,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_LineOfCreditMember', window );">Line of Credit [Member] | 5 yr Unsecured Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityInitiationDate1', window );">Initiation date of credit facility</a></td>
<td class="text">Mar. 13,  2019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity of credit facility</a></td>
<td class="nump">$ 1,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,350,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtTerms', window );">Credit faciity terms (in years)</a></td>
<td class="text">five<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityExpirationDate1', window );">Expiration date of credit facility</a></td>
<td class="text">Mar. 13,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding', window );">Amount outstanding on credit facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_LineOfCreditMember', window );">Line of Credit [Member] | Additional Incremental Term Loan Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity of credit facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000,000<span></span>
</td>
<td class="nump">$ 500,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding', window );">Amount outstanding on credit facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_LineOfCreditMember', window );">Line of Credit [Member] | Commercial Paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity of credit facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,350,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding', window );">Amount outstanding on credit facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityExpirationDate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date the credit facility terminates, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityExpirationDate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of the amount outstanding under the credit facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityInitiationDate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date the credit facility first became available, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityInitiationDate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommercialPaper">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from borrowing by issuing commercial paper.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommercialPaper</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfCommercialPaper">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow due to repaying amounts borrowed by issuing commercial paper.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfCommercialPaper</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of the short-term debt arrangement, and disclosures pertaining to the underlying arrangements, including repayment terms, interest rates, restrictions on assets and activities, debt covenants, and other matters important to users of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=a_A5YrUnsecuredCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=a_A5YrUnsecuredCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=a_AdditionalIncrementalTermLoanFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=a_AdditionalIncrementalTermLoanFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140093761000408">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>LONG-TERM DEBT (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jan. 31, 2022</div></th>
<th class="th"><div>Oct. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">$ 2,730<span></span>
</td>
<td class="nump">$ 2,729<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=a_SeniorNotes2023Member', window );">Senior Notes 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">599<span></span>
</td>
<td class="nump">599<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=a_SeniorNotes2026Member', window );">Senior Notes 2026</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">299<span></span>
</td>
<td class="nump">298<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=a_SeniorNotes2029Member', window );">Senior Notes 2029</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">494<span></span>
</td>
<td class="nump">494<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=a_SeniorNotes2030Member', window );">Senior Notes 2030</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">496<span></span>
</td>
<td class="nump">496<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=a_SeniorNotes2031Member', window );">Senior Notes 2031</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">$ 842<span></span>
</td>
<td class="nump">$ 842<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=a_SeniorNotes2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=a_SeniorNotes2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=a_SeniorNotes2026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=a_SeniorNotes2026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=a_SeniorNotes2029Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=a_SeniorNotes2029Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=a_SeniorNotes2030Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=a_SeniorNotes2030Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=a_SeniorNotes2031Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=a_SeniorNotes2031Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140093756616360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY - Stock Repurchase Program (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jan. 31, 2022</div></th>
<th class="th"><div>Jan. 31, 2021</div></th>
<th class="th"><div>Feb. 18, 2021</div></th>
<th class="th"><div>Nov. 19, 2018</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareRepurchaseProgramAxis=a_A2019RepurchaseProgramMember', window );">2019 Repurchase Program [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Share repurchase program</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Share repurchase program authorized amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,750<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares', window );">Shares repurchased and retired during period, (Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Shares repurchased and retired during period, (Value)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 344<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1', window );">Remaining authorized repurchase amount under share repurchase program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 193<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareRepurchaseProgramAxis=a_A2021RepurchaseProgramMember', window );">2021 Repurchase Program [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Share repurchase program</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Share repurchase program authorized amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares', window );">Shares repurchased and retired during period, (Shares)</a></td>
<td class="nump">2,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Shares repurchased and retired during period, (Value)</a></td>
<td class="nump">$ 447<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1', window );">Remaining authorized repurchase amount under share repurchase program</a></td>
<td class="nump">$ 1,130<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityClassOfTreasuryStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityClassOfTreasuryStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount remaining of a stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased and retired during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedAndRetiredDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedAndRetiredDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareRepurchaseProgramAxis=a_A2019RepurchaseProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareRepurchaseProgramAxis=a_A2019RepurchaseProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareRepurchaseProgramAxis=a_A2021RepurchaseProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareRepurchaseProgramAxis=a_A2021RepurchaseProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140093760911144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDER"S EQUITY - Dividends (Details) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jan. 31, 2022</div></th>
<th class="th"><div>Jan. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDividendsAbstract', window );"><strong>Dividends Paid</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareCashPaid', window );">Cash dividends paid per common share</a></td>
<td class="nump">$ 0.210<span></span>
</td>
<td class="nump">$ 0.194<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDividendsCommonStock', window );">Aggregate amount of cash dividends paid</a></td>
<td class="nump">$ 63<span></span>
</td>
<td class="nump">$ 59<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStockAbstract', window );"><strong>Dividends Declared</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Dividends Declared per share</a></td>
<td class="nump">$ 0.210<span></span>
</td>
<td class="nump">$ 0.194<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareCashPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends paid during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareCashPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCommonStockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCommonStockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividendsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividendsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividendsCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividendsCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140093760524952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDER'S EQUITY - Accumulated Other Comprehensive Income (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jan. 31, 2022</div></th>
<th class="th"><div>Jan. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Beginning Balance</a></td>
<td class="num">$ (282)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="num">(16)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent', window );">Amounts reclassified out of accumulated other comprehensive income (loss)</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTax', window );">Tax expense (benefit)</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="num">(16)<span></span>
</td>
<td class="nump">$ 53<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Ending Balance</a></td>
<td class="num">(298)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember', window );">Foreign Currency Translation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Beginning Balance</a></td>
<td class="num">(185)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="num">(27)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent', window );">Amounts reclassified out of accumulated other comprehensive income (loss)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTax', window );">Tax expense (benefit)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="num">(27)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Ending Balance</a></td>
<td class="num">(212)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember', window );">Prior Service Credits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Beginning Balance</a></td>
<td class="nump">124<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent', window );">Amounts reclassified out of accumulated other comprehensive income (loss)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTax', window );">Tax expense (benefit)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Ending Balance</a></td>
<td class="nump">124<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember', window );">Actuarial Losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Beginning Balance</a></td>
<td class="num">(224)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent', window );">Amounts reclassified out of accumulated other comprehensive income (loss)</a></td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTax', window );">Tax expense (benefit)</a></td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Ending Balance</a></td>
<td class="num">(217)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AociDerivativeQualifyingAsHedgeExcludedComponentParentMember', window );">Unrealized Gains (Losses) on Derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Beginning Balance</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent', window );">Amounts reclassified out of accumulated other comprehensive income (loss)</a></td>
<td class="num">(3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTax', window );">Tax expense (benefit)</a></td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Ending Balance</a></td>
<td class="nump">$ 7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121577181&amp;loc=SL110061190-113977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) allocated to other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e39076-109324<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e640-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of reclassification adjustments of other comprehensive income (loss) attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AociDerivativeQualifyingAsHedgeExcludedComponentParentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AociDerivativeQualifyingAsHedgeExcludedComponentParentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140093761175320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY - Reclassifications out of accumulated comprehensive income (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jan. 31, 2022</div></th>
<th class="th"><div>Jan. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet', window );">Unrealized gain (loss) on derivatives</a></td>
<td class="nump">$ 3<span></span>
</td>
<td class="num">$ (8)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax', window );">Amounts reclassified into earnings related to derivative instruments, tax</a></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Unrealized gain (loss) on derivatives after reclassification and after Tax</a></td>
<td class="nump">2<span></span>
</td>
<td class="num">(6)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax', window );">Actuarial net loss</a></td>
<td class="num">(6)<span></span>
</td>
<td class="num">(16)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax', window );">Prior service benefit</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax', window );">Actuarial net loss and prior service benefit reclassified, before tax</a></td>
<td class="num">(6)<span></span>
</td>
<td class="num">(16)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansTax', window );">Tax on actuarial net loss and prior service benefit reclassified</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax', window );">Actuarial net loss and prior service benefit reclassified, net of tax</a></td>
<td class="num">(5)<span></span>
</td>
<td class="num">(12)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</a></td>
<td class="num">(3)<span></span>
</td>
<td class="num">(18)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of Products and Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet', window );">Unrealized gain (loss) on derivatives</a></td>
<td class="nump">$ 3<span></span>
</td>
<td class="num">$ (8)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The effective portion of net gain (loss) reclassified from accumulated other comprehensive income into income on derivative instruments designated and qualifying as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624177-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of reclassification adjustment from accumulated other comprehensive (income) loss for prior service cost (credit) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL34724391-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e689-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e689-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of reclassification adjustment from accumulated other comprehensive (income) loss for net period benefit cost (credit) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e689-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL34724391-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of reclassification adjustment from accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e689-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL34724391-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification adjustment from accumulated other comprehensive (income) loss for net periodic benefit cost (credit) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e689-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL34724391-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax (expense) benefit for reclassification adjustment from accumulated other comprehensive (income) loss of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140093760592104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT INFORMATION - Profitability (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jan. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationProfitLossAbstract', window );"><strong>Segment Reporting Information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of operating segments</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">$ 1,674<span></span>
</td>
<td class="nump">$ 1,548<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income from operations</a></td>
<td class="nump">376<span></span>
</td>
<td class="nump">328<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=a_LifeSciencesandAppliedMarketsMember', window );">Life Sciences and Applied Markets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">976<span></span>
</td>
<td class="nump">923<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income from operations</a></td>
<td class="nump">282<span></span>
</td>
<td class="nump">265<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=a_DiagnosticsAndGenomicsMember', window );">Diagnostics and Genomics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">339<span></span>
</td>
<td class="nump">294<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income from operations</a></td>
<td class="nump">68<span></span>
</td>
<td class="nump">55<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=a_AgilentCrossLabMember', window );">Agilent CrossLab</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">359<span></span>
</td>
<td class="nump">331<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income from operations</a></td>
<td class="nump">91<span></span>
</td>
<td class="nump">76<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=a_SegmentTotalMember', window );">Segment Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">1,674<span></span>
</td>
<td class="nump">1,548<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income from operations</a></td>
<td class="nump">$ 441<span></span>
</td>
<td class="nump">$ 396<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationProfitLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationProfitLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=a_LifeSciencesandAppliedMarketsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=a_LifeSciencesandAppliedMarketsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=a_DiagnosticsAndGenomicsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=a_DiagnosticsAndGenomicsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=a_AgilentCrossLabMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=a_AgilentCrossLabMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=a_SegmentTotalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=a_SegmentTotalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140093760577944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT INFORMATION - Reconciliation of Reportable Results (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jan. 31, 2022</div></th>
<th class="th"><div>Jan. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract', window );"><strong>Reconciliation of Operating Profit from Segments to Consolidated</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_a_Segmentincomelossfromoperations', window );">Total reportable segment's income from operations</a></td>
<td class="nump">$ 441<span></span>
</td>
<td class="nump">$ 396<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_a_TransformationalPrograms', window );">Transformational initiatives</a></td>
<td class="num">(4)<span></span>
</td>
<td class="num">(11)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentForAmortization', window );">Amortization of intangible assets related to business combinations</a></td>
<td class="num">(51)<span></span>
</td>
<td class="num">(44)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts', window );">Acquisition and integration costs</a></td>
<td class="num">(7)<span></span>
</td>
<td class="num">(9)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease', window );">Change in fair value of contingent consideration</a></td>
<td class="num">(3)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_a_Other', window );">Other</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(21)<span></span>
</td>
<td class="num">(19)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income (expense), net</a></td>
<td class="num">(37)<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income before taxes, as reported</a></td>
<td class="nump">$ 319<span></span>
</td>
<td class="nump">$ 312<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_a_Other">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of an item in the reconciliation of total profit or loss from reportable segments, to the entity's consolidated income before income taxes, extraordinary items, discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">a_Other</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>a_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_a_Segmentincomelossfromoperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting segment operating expenses from segment operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">a_Segmentincomelossfromoperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>a_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_a_TransformationalPrograms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The charge against earnings in the period, comprised of costs associated with restructuring activities not otherwise specified in the taxonomy that are not part of a specific plan as required by GAAP.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">a_TransformationalPrograms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>a_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentForAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentForAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 23<br> -URI http://asc.fasb.org/extlink&amp;oid=123586518&amp;loc=d3e1043-128460<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAcquisitionRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123384075&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140093760752344">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SEGMENT INFORMATION - Segment Assets (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jan. 31, 2022</div></th>
<th class="th"><div>Oct. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Assets</a></td>
<td class="nump">$ 10,327<span></span>
</td>
<td class="nump">$ 10,705<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=a_LifeSciencesandAppliedMarketsMember', window );">Life Sciences and Applied Markets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Assets</a></td>
<td class="nump">3,752<span></span>
</td>
<td class="nump">3,741<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=a_DiagnosticsAndGenomicsMember', window );">Diagnostics and Genomics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Assets</a></td>
<td class="nump">3,325<span></span>
</td>
<td class="nump">3,320<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=a_AgilentCrossLabMember', window );">Agilent CrossLab</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Assets</a></td>
<td class="nump">870<span></span>
</td>
<td class="nump">839<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=a_SegmentTotalMember', window );">Segment Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Assets</a></td>
<td class="nump">$ 7,947<span></span>
</td>
<td class="nump">$ 7,900<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=a_LifeSciencesandAppliedMarketsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=a_LifeSciencesandAppliedMarketsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=a_DiagnosticsAndGenomicsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=a_DiagnosticsAndGenomicsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=a_AgilentCrossLabMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=a_AgilentCrossLabMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=a_SegmentTotalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=a_SegmentTotalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>a-20220131_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:a="http://www.agilent.com/20220131"
  xmlns:country="http://xbrl.sec.gov/country/2021"
  xmlns:currency="http://xbrl.sec.gov/currency/2021"
  xmlns:dei="http://xbrl.sec.gov/dei/2021q4"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2021-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="a-20220131.xsd" xlink:type="simple"/>
    <context id="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="ia1e0ec64d140483ab50b26a38f74482e_I20220225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
        </entity>
        <period>
            <instant>2022-02-25</instant>
        </period>
    </context>
    <context id="i805a3796c4d346d19353b262791e3f84_D20211101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="i97c9b6fdcd4541e69ddf24ca1c06ce50_D20201101-20210131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="i2e96a3d7152643bbb7d3308a81aed7d8_D20211101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="ic06fd2b5991a4b23ae6db3209ddc24bc_D20201101-20210131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="i6390807210d74c6f9cae496ea2122a5a_I20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="id69612e49fa546c0bf63ff5ad436ccc6_I20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
        </entity>
        <period>
            <instant>2020-10-31</instant>
        </period>
    </context>
    <context id="i9b47b15753c94f0b80143556347e39b7_I20210131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
        </entity>
        <period>
            <instant>2021-01-31</instant>
        </period>
    </context>
    <context id="i44a18d7ed2a546f2b1a0a2f797a1b4fe_D20211101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="i8ceb97e232da4995b0c42477e20b5b4e_D20201101-20210131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="i99b29a6a5e4443e6830ecda74b1090c7_I20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="iea1be62040754a539970b84f8eac1b6f_I20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="i9dbcbe02abb3453190aa9f44125cf5ae_I20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="iff5df0d7cf1048858d49c438dfd29807_I20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="ib34d00c8a21a42028bfbffd3fd179e61_I20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="i4a9450e8c23c4155b219185f8e60d29a_D20211101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="ia0fd838af6c44d0ea866658c71b3dc7d_D20211101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="i2aec23e974cd4bedb6e13b41b9375b78_D20211101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="i8344a08116e2475d8630eff99a4f60e4_D20211101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="i0fcc3b5cded94fed9c8505ac4005e3a0_D20211101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="i3137580680de43e8ae49a1ddbc453b8b_I20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="ib3fb881f611641bf8690679c64de1aaf_I20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="i57656528186c4372ae07486570f387e9_I20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="i27134d71dd424779ab254848725e52c6_I20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="ic1e6a76918c24df4abe13257fdfcdea9_I20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="i482974eb49534930b9164c76d7ed1578_I20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-31</instant>
        </period>
    </context>
    <context id="i64d7c2dd15f64641ba78382251046b62_I20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-31</instant>
        </period>
    </context>
    <context id="i154f991a704349d59b962b4dd9d48c7e_I20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-31</instant>
        </period>
    </context>
    <context id="i375472e47a0b4ca3b7720d165b3c1035_I20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-31</instant>
        </period>
    </context>
    <context id="i34129239eb114151a36af1066ee3079f_I20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-31</instant>
        </period>
    </context>
    <context id="i604f8a60030549769dd5a3f2943b52bb_D20201101-20210131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="i2331e3a5c61640af8f9c694b08630d9e_D20201101-20210131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="i7f2ff5551bff49caba634f1bf4245966_D20201101-20210131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="i1bd14aef64584a21865d2ec3dfd5e629_D20201101-20210131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="i0afeb8dd36084a53aec0f9c3a708c97c_D20201101-20210131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="i9aec1350d194433d9ba1d2d5b214d83d_I20210131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-31</instant>
        </period>
    </context>
    <context id="i1c25caed3b0b4859a0d9e2aea3c18f22_I20210131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-31</instant>
        </period>
    </context>
    <context id="i4a4f445b002141b5ad863186edfae11b_I20210131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-31</instant>
        </period>
    </context>
    <context id="i36c64c32e7194082966d03edc3758994_I20210131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-31</instant>
        </period>
    </context>
    <context id="ib3fb564fc37141f6bcd78ffd8a2e8e27_I20210131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-31</instant>
        </period>
    </context>
    <context id="i56114721e4604d11a4408ead150dd13f_I20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="i546995bf0aca4c98814acb076a2c6be8_I20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="i8abcbdeb47ef4c469a915f28a2a7bebb_I20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">a:OtherAccruedAndLongTermLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="i5e51aa894fb04654a6979cdafafe70f0_I20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">a:OtherAccruedAndLongTermLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="i242c1754cce3428296265ac5bafa4022_I20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="i81363376d3bd42f8a95d654a9f58325e_I20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="i608256c6a24a4ef084558bc988b75d6a_I20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="i0f82edc5fbba4f499a5dfb9aaa21a637_I20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="id98e410db6d64a60ad4a6f2802e93f0f_D20211101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:LifeSciencesandAppliedMarketsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="ic9b276a4ef0142669a77891f22aafa63_D20211101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:AgilentCrossLabMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="ib2270a60792d4c44aaf50ded4d6e6053_D20211101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:DiagnosticsAndGenomicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="i8b6e655997ee46b5b0ca774029d951f0_D20211101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="ia94002b251cf482785fce6c05237c8c7_D20201101-20210131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:LifeSciencesandAppliedMarketsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="i7f6dcf92a3b2409b913e60f71c87523b_D20201101-20210131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:AgilentCrossLabMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="i21a438b755494983a6ca6de8bc637763_D20201101-20210131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:DiagnosticsAndGenomicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="i1fb0b045601b4b149adb5a3c59cddd0a_D20201101-20210131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="i200743d5cfa44c4697228dfbf963685f_D20211101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:LifeSciencesandAppliedMarketsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="i2b68e96853384e99aa6ee8f64e043a52_D20211101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:AgilentCrossLabMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="ia48ede266ff94d568a8b81576e800821_D20211101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:DiagnosticsAndGenomicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="i621dbedf1b6f42ae8f8a2f84b5287957_D20211101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="i56152fd0f65346c88b619fa6fbc25760_D20201101-20210131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:LifeSciencesandAppliedMarketsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="i9b2a7c6211084a08b6b244978eb790e2_D20201101-20210131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:AgilentCrossLabMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="icda076e98d344aa6b5d575ac1c693ad4_D20201101-20210131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:DiagnosticsAndGenomicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="i4ea6946ae07b4db194a25f0b0b7d96e5_D20201101-20210131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="ia6990515accb4b6a8e12491c430b6e15_D20211101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:LifeSciencesandAppliedMarketsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="ib5aa3111b40146c693795bc54d4360d2_D20211101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:AgilentCrossLabMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="i6fcd3ec546c34f0a8138948fa2a41702_D20211101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:DiagnosticsAndGenomicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="iabdeb90dd9a5436a92c8c53c49cf18aa_D20211101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="ib98cc4f61db94e0d8269c2035a8ea0a7_D20201101-20210131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:LifeSciencesandAppliedMarketsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="iccaab3323ff4402984b385de50fcb653_D20201101-20210131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:AgilentCrossLabMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="i659f816f99fa413eb7fb6bcef0c8191a_D20201101-20210131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:DiagnosticsAndGenomicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="ia563ff7d707142c1bd1a6c4540fe8e3b_D20201101-20210131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="i6d58196320f34869a29143308907c47f_D20211101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:LifeSciencesandAppliedMarketsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="i30a463a582ff4b16971b766059a24eb9_D20211101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:AgilentCrossLabMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="ie43c9572619448f8a6ea6d852ea0af23_D20211101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:DiagnosticsAndGenomicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="if71b40dd3f5f49bf86fbcfa04c9c081e_D20201101-20210131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:LifeSciencesandAppliedMarketsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="i02afafae5dac4c4eb5370132cc85ab08_D20201101-20210131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:AgilentCrossLabMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="i18473ba8bdd846b583460be774dcc8c2_D20201101-20210131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:DiagnosticsAndGenomicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="id5a6ff22f0f64b46ac2eca9fc0c63a58_D20211101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="a:EndMarketsAxis">a:PharmaceuticalandBiopharmaceuticalMarketMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="i52a37802a4474ca2ae708288d1606203_D20201101-20210131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="a:EndMarketsAxis">a:PharmaceuticalandBiopharmaceuticalMarketMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="i00b6a666687d43fc80adb8b7c25a62c8_D20211101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="a:EndMarketsAxis">a:ChemicalandEnergyMarketMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="i926a81018f214c9e97712dd13af6648e_D20201101-20210131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="a:EndMarketsAxis">a:ChemicalandEnergyMarketMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="i284ab20841704e569e5c116ce20ebb54_D20211101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="a:EndMarketsAxis">a:DiagnosticsandClinicalMarketMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="i07d7ce8930c74841be3d4ec974bc2ab8_D20201101-20210131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="a:EndMarketsAxis">a:DiagnosticsandClinicalMarketMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="ie0a218c3ab7b4c16ac8e0200091a5569_D20211101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="a:EndMarketsAxis">a:FoodMarketMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="i8da687ebb1cd4f17b77ceaa5e1137bd2_D20201101-20210131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="a:EndMarketsAxis">a:FoodMarketMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="i9c164cdf4217439d878a2e3ef209db83_D20211101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="a:EndMarketsAxis">a:AcademiaandGovernmentMarketMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="i329996789d6240848cf6e6b04372d1aa_D20201101-20210131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="a:EndMarketsAxis">a:AcademiaandGovernmentMarketMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="i49bfbec43e6f47b587bd6854c9e180fd_D20211101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="a:EndMarketsAxis">a:EnvironmentalandForensicsMarketMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="ife69be53bb3f4276a6bb4df53fec04cc_D20201101-20210131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="a:EndMarketsAxis">a:EnvironmentalandForensicsMarketMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="i931db477735742ad8a7854c47ecedf86_D20211101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">a:InstrumentationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="i47dcfc0179de4e7d85d70bbddc34d760_D20201101-20210131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">a:InstrumentationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="if362cbaedf1a426589671690d5a8d3b1_D20211101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">a:NonInstrumentationandOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="ia68ebbb6be4b4d8ba32cec1a9bcc02ba_D20201101-20210131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">a:NonInstrumentationandOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="i54fd0d780e894d15abb38be115f904fc_I20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2022-01-31</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="iae4a69f538454c80a80c725dcb6771c3_D20201101-20210131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="i8ca5ba2eb51246a9894d8e9981e851fc_D20211101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="i4234dc38e5b84ef38ecd7c8b2af056d7_D20211101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="i311fec97745e4c5782f4816c9e6d9ea3_D20201101-20210131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="i316c350db7ff4688a76e3821c97ef7e5_D20211101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="i1ea2e447d0a14715a3edc8a2285fae18_D20201101-20210131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="i0320d16146c74425913fe2d4102de305_D20211101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="if67aad121f6a462fb9bd2e05dc5b978e_D20201101-20210131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="ic76564bc7be64253830f89477bbf29cb_D20211101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="if825187b5c3d4f688e0c4a074679fd80_D20201101-20210131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="i4535eece62c1411ab965c726896d4585_D20211101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="i7f82fd5225d94d7db0f34592fd4d9e70_D20201101-20210131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="i2b0f854e4792405b9d4a4ae010c5c2ad_D20211101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="ib7739872a76e499dad8a316f0e7cd808_D20201101-20210131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="ief4838c7f61041b2b6eef53b20ed9d80_D20211101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PublicUtilitiesInventoryTypeDomain</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="ic14d2081148241ed947bffd3bb60c599_D20201101-20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PublicUtilitiesInventoryTypeDomain</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2021-10-31</endDate>
        </period>
    </context>
    <context id="i5acd8d66594844e1bea57bc50343b797_D20211101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">a:LtppMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="ie97ad2be4ba94b6f983f36fa69ecd859_D20201101-20210131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">a:LtppMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="ifb9c990647d348b7aea2ac54abe5e341_D20211101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">a:LTPPRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="i89bc983fc1ee42d3a7c27d1122dfa162_D20201101-20210131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">a:LTPPRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="i944f468c66a14978a1d1787de51efa6c_I20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:LifeSciencesandAppliedMarketsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="ib2f7270de94a4e99a7412adaded44a2d_I20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:DiagnosticsAndGenomicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="ib1434e5353934a0ebeb33b6c28613a50_I20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:AgilentCrossLabMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="ifa12471462934aa683c02dac2a2b2a70_I20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:LifeSciencesandAppliedMarketsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="idcc96fc9ea6041bab3a0329c8a379a8d_I20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:DiagnosticsAndGenomicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="ia895e40152014164ae9414ff9f88a43e_I20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:AgilentCrossLabMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="i62b4b85a6eb042808ab856394d83600f_I20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="ie3e5ec69c4a64648a675263b06182b48_I20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OrderOrProductionBacklogMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="icca833cf758b4ec9adfaeb6e650d7c76_I20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="ice63f8e3b57a458885f621065c24dd64_I20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="i05ef46e1fee74f6eb0ef89af56b45fa8_I20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">a:ThirdPartyTechnologyandLicensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="i7b9447a5f8df4edc80c1ead0839fe3f6_I20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="i210ca0088a2d4da59dbd86d6befab37d_I20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="id6e2c0d55bcc4c6da40d65348178b171_I20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="ie65c749bc8fc42cd83d412fb98863517_I20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="iacb3dbfe9a644ba4921bcd62e4831e5a_I20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OrderOrProductionBacklogMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="i184afb63fb8e4731adf46510d25f3e7b_I20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">a:ThirdPartyTechnologyandLicensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="i984d425948d34baea35894f126c09e37_I20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="ife0901356f05422493cedbc99aaae757_I20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="i2071cdd246ee432b9ba0ffbd965b049b_I20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="i2ac569d010c5484d81397da751f5a61d_I20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="if9bf63f60c78455792ba1de12fa4a127_I20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="if5392f611be5496a9be81fc8bdf7afcc_I20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="icf52874ae50c45a8a6ec86f9bab6ff9c_I20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="ibbcff4391c4341629230e4c9ce6b165c_I20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="i94ff2c672a7b4ed9aee4690b84b849d7_I20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="i33fe9961080d4147aae99b460ab50ecb_I20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="if7c916269c054d37a6d9689d02baa352_I20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="i31669f2cab12460b9f221115aa18666e_I20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="i8fa89a7423444291b6668e498df2d2d9_I20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="i84e4835292ec4d75be7d497aef9738bf_I20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="id2a2d84dda324165b0e39abf1e0999ee_I20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="i2c9abff20f8e48ec8631ac63a1274d21_I20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="i1b18bec55ca844fd9f7f27fe6c7b883b_I20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="i8e7130166b8246129cb9366c9e725c1d_I20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">a:ResolutionBioscienceIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="i6bfe36108f6442d88bb175e8a900971e_I20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="id4d67bb87ecf49e9a34b390f9870efba_I20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="i91b145cad93a40e6b17d080186760c04_I20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="i11e4f5ef79704e5dab3b21061086d8e2_I20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="if7cd365418ea4001be8171374346f5d4_I20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">a:ResolutionBioscienceIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="i79dd2028aecf413fbe4f1d871c963827_I20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="ib476e9fd5af245d488939d04e35e54b1_I20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="id1cf4d72cb954647a51527f90aeeb40b_I20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="i8690b9426888489bb9c9185bfdee22df_I20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="i4e39ecebbd8d4eeb970728db4d14f8c6_I20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="iaf311ad8bbc94cee9ca4b52f8c685019_I20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="i101bd4dfad2f444c893fb78c50710bf6_I20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="ib53b527a87f34ca1a28449997f71d948_I20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="ie085dfbe93fe4451a8b8d84aad0e35d5_I20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="idf80390ad3e448c4bce98cb60bfbca2c_I20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="ia4a3dda3866f4f3db20f204f127ccde3_I20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="i3a3d3d46764b449d8f6eccfe5e6a43b5_I20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="i6f394c9f978d46f7a4b1aca902fb05a9_I20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="ib292bc46e71c4b11a0a9f03de4f3b2fa_I20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="if753f01b6fb74e4b82725e20f4211138_I20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="i765ac03acc794ee0adca232fcb5a3e42_I20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="if2ea1c6637aa4f78a6d53fd7fee549a8_I20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">a:ResolutionBioscienceIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="i55d8c6d05fa4483c93279a0c9f44754d_I20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="i167b08689113447eb86bceea035eecd1_I20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="iaff97c5b6ded4379888e10b33df96a9a_I20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="i242b61736b4c44cebd07a140cbb7dda7_I20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="i8b752274839a498a9ba656f68620fcdb_I20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">a:ResolutionBioscienceIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="i8b540551877547fb8e1e4b0e4801b542_I20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">a:MeasurementInputAssetVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="i434180e34a724e439604a72f345ea6fd_I20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">a:MeasurementInputRevenueVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="i91a30a8c91a44f6eb18a935a5bb6d39f_I20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">a:MeasurementInputRevenueVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="id313ef0eb3db435cabb1861abacdf1d0_D20211101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">a:ResolutionBioscienceIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="i4da29d667bc84895ab281da0a1ff518e_I20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">a:ResolutionBioscienceIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="ic292fe4ddbdc4b1f85e1bac3f0ab2387_I20160201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">a:SeniorNotes2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-02-01</instant>
        </period>
    </context>
    <context id="ifb765ebd38d444b1857a41d784a28b5e_D20160914-20160915">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">a:SeniorNotes2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-09-14</startDate>
            <endDate>2016-09-15</endDate>
        </period>
    </context>
    <context id="if325814ac8de45f5b8f83e932e8509f8_I20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">a:SeniorNotes2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="iad105ebf0fa5490194840a7fe0fd1664_I20190816">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">a:SeniorNotes2029Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-16</instant>
        </period>
    </context>
    <context id="i3fae7ee4803141fab6fa85ebe7ee5491_D20190906-20190906">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">a:SeniorNotes2029Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-06</startDate>
            <endDate>2019-09-06</endDate>
        </period>
    </context>
    <context id="i042e0c2ce85c41bc9011ef45825cadd8_I20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">a:SeniorNotes2029Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="i3d4fb6e9c35b4a259523bf637621e885_I20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="i9309ceb43d6d4d7c95d0816fd752eca7_I20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="i1b3f43743319451cb90947e0304374dd_I20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="i8c42cc94490742e7b13ea5fd23157b27_I20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="ib6775d0eafba4fbcb9f4699180a8061e_I20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="i4a3c2b906dba466d90605db0ba3c44a4_I20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="i0f9ec320b33848c3a9839b24a1239ed8_I20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:GBP</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="i6497616d037845fca0c005ebc475212b_I20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:GBP</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="i75d2660ff14040b3b96c724f268ab729_I20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CAD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="ica71b83ef3a1418d9d27756803812b2b_I20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CAD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="ieb2fe08defb64136976421e01523b7ef_I20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:JPY</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="i4c6f0473f9864b389ca06abc0cf5ee78_I20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:JPY</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="i3355616638084c1584622a5e3613f202_I20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:DKK</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="iaeb7bd13400342f287179313ecad6bd5_I20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:KRW</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="ic4671a036f85446594c33199993572bf_I20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:KRW</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="if316a64c264f481b862d74033659d9c1_I20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:SGD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="i7306551b82684e7286c2efe86019758b_I20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:SGD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="i83b2d38c99874faa95b7ac2a3be10565_I20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CHF</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="i72dfae202fe64d0d9194ac25adbe6324_I20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CNY</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="icbb1793fb3ba4308a7a1bc073a3e737b_I20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CNY</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="i6881a3da71ef45248c11dd3d5d7aa897_I20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:TWD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="i039748d0e2f64eb98ec1fe2ea5b6d315_I20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:INR</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="id105be7d8a724d71956a551b0fe22d54_I20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:BRL</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="idcd3e8c2579941ef810c7c628510a603_I20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:XXX</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="i6caf21f7567843c6ac1d733aab0be98d_I20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:XXX</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="i8b3e8db945ae4a1a940922af0327692d_I20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="ibdea3a47f24e4e8590f368a0dfb94d45_I20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="i6736f6223d0f4203b9239c59f7463674_I20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="i56c53f4c438544d8b06e4f41bad8c0db_I20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="i3c381f194b4e4d6884993233f9ef427b_I20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="i1fc3e3648d0b4efb976f2e9afc2cb0eb_I20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="i50f69072160f4204bc684248a5c4d361_I20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="if88446467ba74964bae3a43bab960c67_I20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="iadfd46dace544484ab93d3f265e422a2_I20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="ia4aa7c9ade4a48b9afaa9ef1eb2c28d2_I20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="ifd354181dada4d4a900aa6600da1b6e0_I20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="ie5e458b01a414961bd824ffcfc393961_I20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="ia022050d3b32425cbcc3bee5435edaef_I20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="i781e47792a004141abc5f44af8501b55_I20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="i16900d24231046f1afce9ad394e43007_I20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="ica123646e5544ebdbe2fa02d65eb9294_D20211101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="i829319a2b5fb4d8fa6a9365861cbc737_D20201101-20210131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="ib54e90d3ce874df2836c9d7cf1ec6c25_D20211101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="i151bd62ec0bd4c12b07d74d87ebe764b_D20201101-20210131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="i01e3cab750934c929073437446f9cf98_D20211101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="i8dc3d15e75274d38a8a189554e496d08_D20201101-20210131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="ifa4aa5fe8b844efcb5e77e57cf2ac70e_D20211101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="i5cba63bb8ec2484285a9f87f393f6773_D20201101-20210131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="i00a135183f5b41b092943e066055e800_D20211101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="i61e53d96c9094ec5b9192e40de4357d8_D20211101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="i8454ff09d8134a2fb231984b395af89d_D20211101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="i151e64785a6246818b5fa21ee1ee8f21_D20201101-20210131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="id63140b493914a99a6c71088f76848c1_D20211101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="i2cb1409c861e47b69fd591e421c1d29a_D20201101-20210131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="ibd0876ed5c6643f9b68e30357fcb75c5_D20211101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="ic152b46d63194d6f8f761363250e0cde_D20201101-20210131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="i39672334328841558d3a18821db61895_I20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="iea4e6dcfdd864c84addac4f7be206f60_I20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="i6353332b36004c5c9db76cacfa73e855_D20190313-20190313">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">a:A5YrUnsecuredCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-03-13</startDate>
            <endDate>2019-03-13</endDate>
        </period>
    </context>
    <context id="i8297b19666824b1083fbcdc032757e96_I20190313">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">a:A5YrUnsecuredCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-13</instant>
        </period>
    </context>
    <context id="ic4c5e106421a497fb99105e140c6fd6c_I20191021">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">a:AdditionalIncrementalTermLoanFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-10-21</instant>
        </period>
    </context>
    <context id="i0a3fbf71b5484a8c9274ae6020d3080e_I20210421">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">a:A5YrUnsecuredCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-21</instant>
        </period>
    </context>
    <context id="id62809c6a49144e4bae80c1fce300e42_I20210421">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">a:AdditionalIncrementalTermLoanFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-21</instant>
        </period>
    </context>
    <context id="i4f579a58da844fa8ab292e8b3f4f6961_I20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">a:A5YrUnsecuredCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="ifbbc3ea9576a4f2eba2f7f1808345734_I20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">a:AdditionalIncrementalTermLoanFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="i87ff5a86228e4f9b8b972888d1067302_I20210618">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-18</instant>
        </period>
    </context>
    <context id="ica23bb0f88b84e40a5cf6dce93ac3016_I20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="ie8601e6d640c4cdbaf6e7e979a3badb4_I20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">a:SeniorNotes2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="ie230dae4aa294d5b840b36798467586f_I20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">a:SeniorNotes2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="i2ff56f3c0b054dd0b0c0f6d3e90df039_I20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">a:SeniorNotes2026Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="i21c87c57472646b18bfda7e117eca64a_I20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">a:SeniorNotes2026Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="i35a5d7927ffc44debd0874726bf6a844_I20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">a:SeniorNotes2029Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="i8088c733be554ef0a2d2ce49c54cb56a_I20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">a:SeniorNotes2029Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="i340410db81954133842fda25bab46456_I20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">a:SeniorNotes2030Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="i4505f8e4f0714a489cb047cfbb537298_I20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">a:SeniorNotes2030Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="i6ebf24f01a4e49d69ecb2c5a5f3230d0_I20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">a:SeniorNotes2031Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="i02856e1853de45f185faca871ffc1d85_I20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">a:SeniorNotes2031Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="i629b697ae777498d9e2c067c3e5a581e_I20181119">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">a:A2019RepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-11-19</instant>
        </period>
    </context>
    <context id="id3f922976d404efe924b23253513f94b_D20201101-20210131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">a:A2019RepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="i11897c2b4a354e80b2f66e86e5b8bf11_I20210218">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">a:A2019RepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-02-18</instant>
        </period>
    </context>
    <context id="if65151f0282a48c5b160bfa0fd1f9626_I20210218">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">a:A2021RepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-02-18</instant>
        </period>
    </context>
    <context id="icdcacaffa00940c38eefae4a25b246ce_D20211101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">a:A2021RepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="ib67bf4635858449bb282042383b1fa3e_I20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">a:A2021RepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="i5c54dd5009274b448e1a0f238519873c_I20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="iec127ccabccf4e1d8b1b9f0e177d0a6d_I20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="i02b0508da50d4d36aa148cd391ab89a2_I20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="i375e95e148364bec829da83e15fb30a0_I20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociDerivativeQualifyingAsHedgeExcludedComponentParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="i7e403833679541eab73046fd37fcdd94_D20211101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="if6e4cf075aaa4d27853c6c516de6dd2c_D20211101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="ia6ec07697746456e8221275738907dd8_D20211101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="icdcbd30df39641a4b5f2503519f860b9_D20211101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociDerivativeQualifyingAsHedgeExcludedComponentParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="ia1ee3187242a414db3687c2b9fc4d82f_I20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="i0dc39ee7c49e4d6cb473aef9858b6b88_I20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="i70983fa542cf4b018a1bb84cfd674246_I20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="i2563947f2b6142d4a03ded6e410372c8_I20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociDerivativeQualifyingAsHedgeExcludedComponentParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="i5987fc4c9ed94d95b32a6ba071848996_D20211101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:SegmentTotalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="i59f03109bfe04c92a404a9157747174a_D20201101-20210131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:SegmentTotalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="if9eb3aa4cefc47e4b1504ff02a1447b6_I20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:SegmentTotalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="i105ea30704ee4603b6db5fd253f01d92_I20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:SegmentTotalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="contracts">
        <measure>a:contracts</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80L2ZyYWc6YjE4ZDBjNWUzMmZkNDQzNGE5ZTNjZjEwMWE3N2M3MDIvdGFibGU6MTIxYjA1Yzg2NTVkNDc2ZGE3OWQ4MDg5MDJmNDFhMGQvdGFibGVyYW5nZToxMjFiMDVjODY1NWQ0NzZkYTc5ZDgwODkwMmY0MWEwZF8xLTEtMS0xLTMwMTE0_001a52ba-a250-42c8-a9fa-a3995dfd1ac0">0001090872</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80L2ZyYWc6YjE4ZDBjNWUzMmZkNDQzNGE5ZTNjZjEwMWE3N2M3MDIvdGFibGU6MTIxYjA1Yzg2NTVkNDc2ZGE3OWQ4MDg5MDJmNDFhMGQvdGFibGVyYW5nZToxMjFiMDVjODY1NWQ0NzZkYTc5ZDgwODkwMmY0MWEwZF8zLTEtMS0xLTMwMTE0_a4a9c7be-7b61-433d-80b8-e823852e8b3f">--10-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80L2ZyYWc6YjE4ZDBjNWUzMmZkNDQzNGE5ZTNjZjEwMWE3N2M3MDIvdGFibGU6MTIxYjA1Yzg2NTVkNDc2ZGE3OWQ4MDg5MDJmNDFhMGQvdGFibGVyYW5nZToxMjFiMDVjODY1NWQ0NzZkYTc5ZDgwODkwMmY0MWEwZF80LTEtMS0xLTMwMTE0_17e5d8d1-3f3c-40a9-8b1d-100c5d4b04d0">2022</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80L2ZyYWc6YjE4ZDBjNWUzMmZkNDQzNGE5ZTNjZjEwMWE3N2M3MDIvdGFibGU6MTIxYjA1Yzg2NTVkNDc2ZGE3OWQ4MDg5MDJmNDFhMGQvdGFibGVyYW5nZToxMjFiMDVjODY1NWQ0NzZkYTc5ZDgwODkwMmY0MWEwZF81LTEtMS0xLTMwMTE0_7e6f7cb4-fb45-425a-a1da-daebad33975e">Q1</dei:DocumentFiscalPeriodFocus>
    <dei:AmendmentFlag
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80L2ZyYWc6YjE4ZDBjNWUzMmZkNDQzNGE5ZTNjZjEwMWE3N2M3MDIvdGFibGU6MTIxYjA1Yzg2NTVkNDc2ZGE3OWQ4MDg5MDJmNDFhMGQvdGFibGVyYW5nZToxMjFiMDVjODY1NWQ0NzZkYTc5ZDgwODkwMmY0MWEwZF82LTEtMS0xLTMwMTE0_d43687b3-867d-437a-a5c9-4ec8791f1fd6">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xL2ZyYWc6MDE0YTMxNWQ3YTI3NDg1MDkxNjVjZDFlMmE0ZTJiMGMvdGV4dHJlZ2lvbjowMTRhMzE1ZDdhMjc0ODUwOTE2NWNkMWUyYTRlMmIwY18yMjU2_661be8c7-63c5-4987-b32e-be22ef0c101b">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xL2ZyYWc6MDE0YTMxNWQ3YTI3NDg1MDkxNjVjZDFlMmE0ZTJiMGMvdGV4dHJlZ2lvbjowMTRhMzE1ZDdhMjc0ODUwOTE2NWNkMWUyYTRlMmIwY18yMjQ2_f707cb36-177f-4870-b641-dc60cd0d0b16">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xL2ZyYWc6MDE0YTMxNWQ3YTI3NDg1MDkxNjVjZDFlMmE0ZTJiMGMvdGV4dHJlZ2lvbjowMTRhMzE1ZDdhMjc0ODUwOTE2NWNkMWUyYTRlMmIwY18yMjU_a20b1a65-5175-4725-a473-1ef61e32bf1d">2022-01-31</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xL2ZyYWc6MDE0YTMxNWQ3YTI3NDg1MDkxNjVjZDFlMmE0ZTJiMGMvdGV4dHJlZ2lvbjowMTRhMzE1ZDdhMjc0ODUwOTE2NWNkMWUyYTRlMmIwY18yMjQ3_a7d49b15-7d45-403e-b279-744833189ae7">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xL2ZyYWc6MDE0YTMxNWQ3YTI3NDg1MDkxNjVjZDFlMmE0ZTJiMGMvdGV4dHJlZ2lvbjowMTRhMzE1ZDdhMjc0ODUwOTE2NWNkMWUyYTRlMmIwY18yMjUx_46ef5fa5-7e18-411d-87af-9b4cca5784b5">001-15405</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xL2ZyYWc6MDE0YTMxNWQ3YTI3NDg1MDkxNjVjZDFlMmE0ZTJiMGMvdGV4dHJlZ2lvbjowMTRhMzE1ZDdhMjc0ODUwOTE2NWNkMWUyYTRlMmIwY18yMjQ4_e3c97a3d-de81-4fbe-a443-197fa17f1a10">AGILENT TECHNOLOGIES,&#160;INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xL2ZyYWc6MDE0YTMxNWQ3YTI3NDg1MDkxNjVjZDFlMmE0ZTJiMGMvdGFibGU6NTRlZjQ1ODY5YmUyNGNhYmFiZjNmMzU0ZTdlN2JmODcvdGFibGVyYW5nZTo1NGVmNDU4NjliZTI0Y2FiYWJmM2YzNTRlN2U3YmY4N18wLTEtMS0xLTMwMTE0_a0cd4d73-26dc-4f15-859c-e64275165384">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xL2ZyYWc6MDE0YTMxNWQ3YTI3NDg1MDkxNjVjZDFlMmE0ZTJiMGMvdGFibGU6NTRlZjQ1ODY5YmUyNGNhYmFiZjNmMzU0ZTdlN2JmODcvdGFibGVyYW5nZTo1NGVmNDU4NjliZTI0Y2FiYWJmM2YzNTRlN2U3YmY4N18wLTUtMS0xLTMwMTE0_07df39e9-5d7a-41a1-8f5f-b463736082ff">77-0518772</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xL2ZyYWc6MDE0YTMxNWQ3YTI3NDg1MDkxNjVjZDFlMmE0ZTJiMGMvdGV4dHJlZ2lvbjowMTRhMzE1ZDdhMjc0ODUwOTE2NWNkMWUyYTRlMmIwY18yMjUy_127e0761-37f7-4dec-ad66-399d60cedfe6">5301 Stevens Creek Blvd.,</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xL2ZyYWc6MDE0YTMxNWQ3YTI3NDg1MDkxNjVjZDFlMmE0ZTJiMGMvdGV4dHJlZ2lvbjowMTRhMzE1ZDdhMjc0ODUwOTE2NWNkMWUyYTRlMmIwY18yMjU3_89f9ba2f-f440-4ca5-a426-add41c5f85f3">Santa Clara,</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xL2ZyYWc6MDE0YTMxNWQ3YTI3NDg1MDkxNjVjZDFlMmE0ZTJiMGMvdGV4dHJlZ2lvbjowMTRhMzE1ZDdhMjc0ODUwOTE2NWNkMWUyYTRlMmIwY18yMjU4_704995c0-ec46-48ac-8822-03c3056f6581">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xL2ZyYWc6MDE0YTMxNWQ3YTI3NDg1MDkxNjVjZDFlMmE0ZTJiMGMvdGV4dHJlZ2lvbjowMTRhMzE1ZDdhMjc0ODUwOTE2NWNkMWUyYTRlMmIwY18yMjQ5_e270b355-913c-4a44-95ca-64e7e47cdae7">95051</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xL2ZyYWc6MDE0YTMxNWQ3YTI3NDg1MDkxNjVjZDFlMmE0ZTJiMGMvdGV4dHJlZ2lvbjowMTRhMzE1ZDdhMjc0ODUwOTE2NWNkMWUyYTRlMmIwY18yMjUz_423c51a4-5004-4f46-9c31-fe626162515e">(800)</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xL2ZyYWc6MDE0YTMxNWQ3YTI3NDg1MDkxNjVjZDFlMmE0ZTJiMGMvdGV4dHJlZ2lvbjowMTRhMzE1ZDdhMjc0ODUwOTE2NWNkMWUyYTRlMmIwY18yMjUw_fd016219-bc53-4215-aee4-989ebd5d64a4">227-9770</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xL2ZyYWc6MDE0YTMxNWQ3YTI3NDg1MDkxNjVjZDFlMmE0ZTJiMGMvdGFibGU6MmNkZDZkZjllYmU5NGFkY2JmNGYwMzVlNmFlZGM4NTUvdGFibGVyYW5nZToyY2RkNmRmOWViZTk0YWRjYmY0ZjAzNWU2YWVkYzg1NV8xLTAtMS0xLTMwMTE0_e3ac777c-0849-41e7-abc3-996aa58b0c61">Common Stock, $0.01 par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xL2ZyYWc6MDE0YTMxNWQ3YTI3NDg1MDkxNjVjZDFlMmE0ZTJiMGMvdGFibGU6MmNkZDZkZjllYmU5NGFkY2JmNGYwMzVlNmFlZGM4NTUvdGFibGVyYW5nZToyY2RkNmRmOWViZTk0YWRjYmY0ZjAzNWU2YWVkYzg1NV8xLTMtMS0xLTMwMTE0_8abfec7a-1d6a-48d9-a4a8-3b8d922acd61">A</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xL2ZyYWc6MDE0YTMxNWQ3YTI3NDg1MDkxNjVjZDFlMmE0ZTJiMGMvdGFibGU6MmNkZDZkZjllYmU5NGFkY2JmNGYwMzVlNmFlZGM4NTUvdGFibGVyYW5nZToyY2RkNmRmOWViZTk0YWRjYmY0ZjAzNWU2YWVkYzg1NV8xLTctMS0xLTMwMTE0_8f6bb026-0784-4f14-a8a1-c79d4e972f76">NYSE</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xL2ZyYWc6MDE0YTMxNWQ3YTI3NDg1MDkxNjVjZDFlMmE0ZTJiMGMvdGV4dHJlZ2lvbjowMTRhMzE1ZDdhMjc0ODUwOTE2NWNkMWUyYTRlMmIwY18yMjU0_f036289f-6536-4ac5-bfc2-55bae182eca1">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xL2ZyYWc6MDE0YTMxNWQ3YTI3NDg1MDkxNjVjZDFlMmE0ZTJiMGMvdGV4dHJlZ2lvbjowMTRhMzE1ZDdhMjc0ODUwOTE2NWNkMWUyYTRlMmIwY18yMjU1_1ee36ec2-df3f-478d-bf10-66cb2fa12fdc">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xL2ZyYWc6MDE0YTMxNWQ3YTI3NDg1MDkxNjVjZDFlMmE0ZTJiMGMvdGFibGU6NTFjNmFhYjlhZTY4NGY3NGFkODdkZGUzYmY4ODA3NDIvdGFibGVyYW5nZTo1MWM2YWFiOWFlNjg0Zjc0YWQ4N2RkZTNiZjg4MDc0Ml8wLTAtMS0xLTMwMTE0_6dce4a90-7d21-4a5a-8a83-b798a5a9af4d">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xL2ZyYWc6MDE0YTMxNWQ3YTI3NDg1MDkxNjVjZDFlMmE0ZTJiMGMvdGFibGU6NTFjNmFhYjlhZTY4NGY3NGFkODdkZGUzYmY4ODA3NDIvdGFibGVyYW5nZTo1MWM2YWFiOWFlNjg0Zjc0YWQ4N2RkZTNiZjg4MDc0Ml8xLTEtMS0xLTMwMTE0_86e7c6cf-5ad9-4313-bd09-9397bac09941">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xL2ZyYWc6MDE0YTMxNWQ3YTI3NDg1MDkxNjVjZDFlMmE0ZTJiMGMvdGFibGU6NTFjNmFhYjlhZTY4NGY3NGFkODdkZGUzYmY4ODA3NDIvdGFibGVyYW5nZTo1MWM2YWFiOWFlNjg0Zjc0YWQ4N2RkZTNiZjg4MDc0Ml8xLTctMS0xLTMwMTE0_5f2b408a-e162-47c9-acd9-625036466d0c">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xL2ZyYWc6MDE0YTMxNWQ3YTI3NDg1MDkxNjVjZDFlMmE0ZTJiMGMvdGV4dHJlZ2lvbjowMTRhMzE1ZDdhMjc0ODUwOTE2NWNkMWUyYTRlMmIwY18yMjU5_eb1afe61-0199-420e-97e8-7a0adc4c1e47">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="ia1e0ec64d140483ab50b26a38f74482e_I20220225"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xL2ZyYWc6MDE0YTMxNWQ3YTI3NDg1MDkxNjVjZDFlMmE0ZTJiMGMvdGV4dHJlZ2lvbjowMTRhMzE1ZDdhMjc0ODUwOTE2NWNkMWUyYTRlMmIwY18yMTgx_abe16948-5a80-445d-829c-8cffb6da5e4b"
      unitRef="shares">300113377</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i805a3796c4d346d19353b262791e3f84_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xNi9mcmFnOjkyZTk5YzBiMjc2MDRjYWNiOGI1MzU4ZDdjYzUwZDRlL3RhYmxlOmRkYTU4NGE3YTU5ZDRkOTY5ZjI0YzVkN2MxOWNhNGY4L3RhYmxlcmFuZ2U6ZGRhNTg0YTdhNTlkNGQ5NjlmMjRjNWQ3YzE5Y2E0ZjhfNC01LTEtMS0zMDExNA_4a218de2-7e2d-4d37-b46d-5a71d9c5e8bb"
      unitRef="usd">1263000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i97c9b6fdcd4541e69ddf24ca1c06ce50_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xNi9mcmFnOjkyZTk5YzBiMjc2MDRjYWNiOGI1MzU4ZDdjYzUwZDRlL3RhYmxlOmRkYTU4NGE3YTU5ZDRkOTY5ZjI0YzVkN2MxOWNhNGY4L3RhYmxlcmFuZ2U6ZGRhNTg0YTdhNTlkNGQ5NjlmMjRjNWQ3YzE5Y2E0ZjhfNC03LTEtMS0zMDExNA_50c40f71-6428-4851-a4ca-8d5e69998f3c"
      unitRef="usd">1172000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2e96a3d7152643bbb7d3308a81aed7d8_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xNi9mcmFnOjkyZTk5YzBiMjc2MDRjYWNiOGI1MzU4ZDdjYzUwZDRlL3RhYmxlOmRkYTU4NGE3YTU5ZDRkOTY5ZjI0YzVkN2MxOWNhNGY4L3RhYmxlcmFuZ2U6ZGRhNTg0YTdhNTlkNGQ5NjlmMjRjNWQ3YzE5Y2E0ZjhfNS01LTEtMS0zMDExNA_348674d4-243d-41e9-8b54-ca5d02da90a6"
      unitRef="usd">411000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic06fd2b5991a4b23ae6db3209ddc24bc_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xNi9mcmFnOjkyZTk5YzBiMjc2MDRjYWNiOGI1MzU4ZDdjYzUwZDRlL3RhYmxlOmRkYTU4NGE3YTU5ZDRkOTY5ZjI0YzVkN2MxOWNhNGY4L3RhYmxlcmFuZ2U6ZGRhNTg0YTdhNTlkNGQ5NjlmMjRjNWQ3YzE5Y2E0ZjhfNS03LTEtMS0zMDExNA_832c3133-7bcf-4a3d-be95-756f6536d841"
      unitRef="usd">376000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xNi9mcmFnOjkyZTk5YzBiMjc2MDRjYWNiOGI1MzU4ZDdjYzUwZDRlL3RhYmxlOmRkYTU4NGE3YTU5ZDRkOTY5ZjI0YzVkN2MxOWNhNGY4L3RhYmxlcmFuZ2U6ZGRhNTg0YTdhNTlkNGQ5NjlmMjRjNWQ3YzE5Y2E0ZjhfNi01LTEtMS0zMDExNA_2860c08d-3f10-496d-8b06-62ffaba51961"
      unitRef="usd">1674000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xNi9mcmFnOjkyZTk5YzBiMjc2MDRjYWNiOGI1MzU4ZDdjYzUwZDRlL3RhYmxlOmRkYTU4NGE3YTU5ZDRkOTY5ZjI0YzVkN2MxOWNhNGY4L3RhYmxlcmFuZ2U6ZGRhNTg0YTdhNTlkNGQ5NjlmMjRjNWQ3YzE5Y2E0ZjhfNi03LTEtMS0zMDExNA_b6b730df-1b0b-4e7a-9c1b-0dcbdcdbf5ef"
      unitRef="usd">1548000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i805a3796c4d346d19353b262791e3f84_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xNi9mcmFnOjkyZTk5YzBiMjc2MDRjYWNiOGI1MzU4ZDdjYzUwZDRlL3RhYmxlOmRkYTU4NGE3YTU5ZDRkOTY5ZjI0YzVkN2MxOWNhNGY4L3RhYmxlcmFuZ2U6ZGRhNTg0YTdhNTlkNGQ5NjlmMjRjNWQ3YzE5Y2E0ZjhfOC01LTEtMS0zMDExNA_49ffd3d1-343a-4287-9b10-7d535685b558"
      unitRef="usd">545000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i97c9b6fdcd4541e69ddf24ca1c06ce50_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xNi9mcmFnOjkyZTk5YzBiMjc2MDRjYWNiOGI1MzU4ZDdjYzUwZDRlL3RhYmxlOmRkYTU4NGE3YTU5ZDRkOTY5ZjI0YzVkN2MxOWNhNGY4L3RhYmxlcmFuZ2U6ZGRhNTg0YTdhNTlkNGQ5NjlmMjRjNWQ3YzE5Y2E0ZjhfOC03LTEtMS0zMDExNA_81ea394f-2d64-4830-8b4b-1a42dbc0ac90"
      unitRef="usd">509000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i2e96a3d7152643bbb7d3308a81aed7d8_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xNi9mcmFnOjkyZTk5YzBiMjc2MDRjYWNiOGI1MzU4ZDdjYzUwZDRlL3RhYmxlOmRkYTU4NGE3YTU5ZDRkOTY5ZjI0YzVkN2MxOWNhNGY4L3RhYmxlcmFuZ2U6ZGRhNTg0YTdhNTlkNGQ5NjlmMjRjNWQ3YzE5Y2E0ZjhfOS01LTEtMS0zMDExNA_9529d10f-ea3b-4d0e-a820-c2de64ba3bb2"
      unitRef="usd">219000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ic06fd2b5991a4b23ae6db3209ddc24bc_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xNi9mcmFnOjkyZTk5YzBiMjc2MDRjYWNiOGI1MzU4ZDdjYzUwZDRlL3RhYmxlOmRkYTU4NGE3YTU5ZDRkOTY5ZjI0YzVkN2MxOWNhNGY4L3RhYmxlcmFuZ2U6ZGRhNTg0YTdhNTlkNGQ5NjlmMjRjNWQ3YzE5Y2E0ZjhfOS03LTEtMS0zMDExNA_b6374261-5f80-4af1-99a9-444fe441e8cb"
      unitRef="usd">201000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xNi9mcmFnOjkyZTk5YzBiMjc2MDRjYWNiOGI1MzU4ZDdjYzUwZDRlL3RhYmxlOmRkYTU4NGE3YTU5ZDRkOTY5ZjI0YzVkN2MxOWNhNGY4L3RhYmxlcmFuZ2U6ZGRhNTg0YTdhNTlkNGQ5NjlmMjRjNWQ3YzE5Y2E0ZjhfMTAtNS0xLTEtMzAxMTQ_25553823-6b19-41dc-930b-1caa1a7590ab"
      unitRef="usd">764000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xNi9mcmFnOjkyZTk5YzBiMjc2MDRjYWNiOGI1MzU4ZDdjYzUwZDRlL3RhYmxlOmRkYTU4NGE3YTU5ZDRkOTY5ZjI0YzVkN2MxOWNhNGY4L3RhYmxlcmFuZ2U6ZGRhNTg0YTdhNTlkNGQ5NjlmMjRjNWQ3YzE5Y2E0ZjhfMTAtNy0xLTEtMzAxMTQ_caedfaac-8f75-4bbf-93a6-09b1b6607b5b"
      unitRef="usd">710000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xNi9mcmFnOjkyZTk5YzBiMjc2MDRjYWNiOGI1MzU4ZDdjYzUwZDRlL3RhYmxlOmRkYTU4NGE3YTU5ZDRkOTY5ZjI0YzVkN2MxOWNhNGY4L3RhYmxlcmFuZ2U6ZGRhNTg0YTdhNTlkNGQ5NjlmMjRjNWQ3YzE5Y2E0ZjhfMTEtNS0xLTEtMzAxMTQ_1841ec56-28a1-49d5-ab25-57e32715ba77"
      unitRef="usd">117000000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xNi9mcmFnOjkyZTk5YzBiMjc2MDRjYWNiOGI1MzU4ZDdjYzUwZDRlL3RhYmxlOmRkYTU4NGE3YTU5ZDRkOTY5ZjI0YzVkN2MxOWNhNGY4L3RhYmxlcmFuZ2U6ZGRhNTg0YTdhNTlkNGQ5NjlmMjRjNWQ3YzE5Y2E0ZjhfMTEtNy0xLTEtMzAxMTQ_818b88fa-2864-4fa4-8bb1-5176156f2452"
      unitRef="usd">103000000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xNi9mcmFnOjkyZTk5YzBiMjc2MDRjYWNiOGI1MzU4ZDdjYzUwZDRlL3RhYmxlOmRkYTU4NGE3YTU5ZDRkOTY5ZjI0YzVkN2MxOWNhNGY4L3RhYmxlcmFuZ2U6ZGRhNTg0YTdhNTlkNGQ5NjlmMjRjNWQ3YzE5Y2E0ZjhfMTItNS0xLTEtMzAxMTQ_41d740dc-bdf9-4dad-855b-f017788203c0"
      unitRef="usd">417000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xNi9mcmFnOjkyZTk5YzBiMjc2MDRjYWNiOGI1MzU4ZDdjYzUwZDRlL3RhYmxlOmRkYTU4NGE3YTU5ZDRkOTY5ZjI0YzVkN2MxOWNhNGY4L3RhYmxlcmFuZ2U6ZGRhNTg0YTdhNTlkNGQ5NjlmMjRjNWQ3YzE5Y2E0ZjhfMTItNy0xLTEtMzAxMTQ_41e4116c-30a7-477d-a7c5-22d15591cccf"
      unitRef="usd">407000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:CostsAndExpenses
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xNi9mcmFnOjkyZTk5YzBiMjc2MDRjYWNiOGI1MzU4ZDdjYzUwZDRlL3RhYmxlOmRkYTU4NGE3YTU5ZDRkOTY5ZjI0YzVkN2MxOWNhNGY4L3RhYmxlcmFuZ2U6ZGRhNTg0YTdhNTlkNGQ5NjlmMjRjNWQ3YzE5Y2E0ZjhfMTMtNS0xLTEtMzAxMTQ_0da84f22-3c71-45c0-8ad1-ad1dda077a69"
      unitRef="usd">1298000000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xNi9mcmFnOjkyZTk5YzBiMjc2MDRjYWNiOGI1MzU4ZDdjYzUwZDRlL3RhYmxlOmRkYTU4NGE3YTU5ZDRkOTY5ZjI0YzVkN2MxOWNhNGY4L3RhYmxlcmFuZ2U6ZGRhNTg0YTdhNTlkNGQ5NjlmMjRjNWQ3YzE5Y2E0ZjhfMTMtNy0xLTEtMzAxMTQ_6a2ff993-3064-4758-9169-c4f4037754d8"
      unitRef="usd">1220000000</us-gaap:CostsAndExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xNi9mcmFnOjkyZTk5YzBiMjc2MDRjYWNiOGI1MzU4ZDdjYzUwZDRlL3RhYmxlOmRkYTU4NGE3YTU5ZDRkOTY5ZjI0YzVkN2MxOWNhNGY4L3RhYmxlcmFuZ2U6ZGRhNTg0YTdhNTlkNGQ5NjlmMjRjNWQ3YzE5Y2E0ZjhfMTQtNS0xLTEtMzAxMTQ_3c24e737-f1ee-4672-a641-bee2585737f0"
      unitRef="usd">376000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xNi9mcmFnOjkyZTk5YzBiMjc2MDRjYWNiOGI1MzU4ZDdjYzUwZDRlL3RhYmxlOmRkYTU4NGE3YTU5ZDRkOTY5ZjI0YzVkN2MxOWNhNGY4L3RhYmxlcmFuZ2U6ZGRhNTg0YTdhNTlkNGQ5NjlmMjRjNWQ3YzE5Y2E0ZjhfMTQtNy0xLTEtMzAxMTQ_628dea35-addf-47d3-bd6a-6b3ec9f0e879"
      unitRef="usd">328000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xNi9mcmFnOjkyZTk5YzBiMjc2MDRjYWNiOGI1MzU4ZDdjYzUwZDRlL3RhYmxlOmRkYTU4NGE3YTU5ZDRkOTY5ZjI0YzVkN2MxOWNhNGY4L3RhYmxlcmFuZ2U6ZGRhNTg0YTdhNTlkNGQ5NjlmMjRjNWQ3YzE5Y2E0ZjhfMTUtNS0xLTEtMzAxMTQ_e6b8c965-5c7c-48b3-9cd0-2c82d88b75d4"
      unitRef="usd">1000000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xNi9mcmFnOjkyZTk5YzBiMjc2MDRjYWNiOGI1MzU4ZDdjYzUwZDRlL3RhYmxlOmRkYTU4NGE3YTU5ZDRkOTY5ZjI0YzVkN2MxOWNhNGY4L3RhYmxlcmFuZ2U6ZGRhNTg0YTdhNTlkNGQ5NjlmMjRjNWQ3YzE5Y2E0ZjhfMTUtNy0xLTEtMzAxMTQ_c66d6ea1-4aca-4a9d-9e73-86917d2dfde9"
      unitRef="usd">0</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InterestExpense
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xNi9mcmFnOjkyZTk5YzBiMjc2MDRjYWNiOGI1MzU4ZDdjYzUwZDRlL3RhYmxlOmRkYTU4NGE3YTU5ZDRkOTY5ZjI0YzVkN2MxOWNhNGY4L3RhYmxlcmFuZ2U6ZGRhNTg0YTdhNTlkNGQ5NjlmMjRjNWQ3YzE5Y2E0ZjhfMTYtNS0xLTEtMzAxMTQ_c1743f04-da48-4239-8331-98896642d453"
      unitRef="usd">21000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xNi9mcmFnOjkyZTk5YzBiMjc2MDRjYWNiOGI1MzU4ZDdjYzUwZDRlL3RhYmxlOmRkYTU4NGE3YTU5ZDRkOTY5ZjI0YzVkN2MxOWNhNGY4L3RhYmxlcmFuZ2U6ZGRhNTg0YTdhNTlkNGQ5NjlmMjRjNWQ3YzE5Y2E0ZjhfMTYtNy0xLTEtMzAxMTQ_245c9d6a-a029-4f41-baa0-c2797c28bf5a"
      unitRef="usd">19000000</us-gaap:InterestExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xNi9mcmFnOjkyZTk5YzBiMjc2MDRjYWNiOGI1MzU4ZDdjYzUwZDRlL3RhYmxlOmRkYTU4NGE3YTU5ZDRkOTY5ZjI0YzVkN2MxOWNhNGY4L3RhYmxlcmFuZ2U6ZGRhNTg0YTdhNTlkNGQ5NjlmMjRjNWQ3YzE5Y2E0ZjhfMTctNS0xLTEtMzAxMTQ_4e65b7a7-4051-4abc-a843-c51fe1df1ee9"
      unitRef="usd">-37000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xNi9mcmFnOjkyZTk5YzBiMjc2MDRjYWNiOGI1MzU4ZDdjYzUwZDRlL3RhYmxlOmRkYTU4NGE3YTU5ZDRkOTY5ZjI0YzVkN2MxOWNhNGY4L3RhYmxlcmFuZ2U6ZGRhNTg0YTdhNTlkNGQ5NjlmMjRjNWQ3YzE5Y2E0ZjhfMTctNy0xLTEtMzAxMTQ_08407a3c-7290-4367-baee-017cd362e2fd"
      unitRef="usd">3000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xNi9mcmFnOjkyZTk5YzBiMjc2MDRjYWNiOGI1MzU4ZDdjYzUwZDRlL3RhYmxlOmRkYTU4NGE3YTU5ZDRkOTY5ZjI0YzVkN2MxOWNhNGY4L3RhYmxlcmFuZ2U6ZGRhNTg0YTdhNTlkNGQ5NjlmMjRjNWQ3YzE5Y2E0ZjhfMTgtNS0xLTEtMzAxMTQ_09084735-755b-4c1c-a5f4-dfcdce014a12"
      unitRef="usd">319000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xNi9mcmFnOjkyZTk5YzBiMjc2MDRjYWNiOGI1MzU4ZDdjYzUwZDRlL3RhYmxlOmRkYTU4NGE3YTU5ZDRkOTY5ZjI0YzVkN2MxOWNhNGY4L3RhYmxlcmFuZ2U6ZGRhNTg0YTdhNTlkNGQ5NjlmMjRjNWQ3YzE5Y2E0ZjhfMTgtNy0xLTEtMzAxMTQ_0c2b7d04-1a4a-4b13-9fab-39d8ea21e376"
      unitRef="usd">312000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xNi9mcmFnOjkyZTk5YzBiMjc2MDRjYWNiOGI1MzU4ZDdjYzUwZDRlL3RhYmxlOmRkYTU4NGE3YTU5ZDRkOTY5ZjI0YzVkN2MxOWNhNGY4L3RhYmxlcmFuZ2U6ZGRhNTg0YTdhNTlkNGQ5NjlmMjRjNWQ3YzE5Y2E0ZjhfMTktNS0xLTEtMzAxMTQ_38806faf-53cf-40c1-bf05-c19d0e2b6a60"
      unitRef="usd">36000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xNi9mcmFnOjkyZTk5YzBiMjc2MDRjYWNiOGI1MzU4ZDdjYzUwZDRlL3RhYmxlOmRkYTU4NGE3YTU5ZDRkOTY5ZjI0YzVkN2MxOWNhNGY4L3RhYmxlcmFuZ2U6ZGRhNTg0YTdhNTlkNGQ5NjlmMjRjNWQ3YzE5Y2E0ZjhfMTktNy0xLTEtMzAxMTQ_038d5418-59e8-4458-9967-12311c3162f4"
      unitRef="usd">24000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xNi9mcmFnOjkyZTk5YzBiMjc2MDRjYWNiOGI1MzU4ZDdjYzUwZDRlL3RhYmxlOmRkYTU4NGE3YTU5ZDRkOTY5ZjI0YzVkN2MxOWNhNGY4L3RhYmxlcmFuZ2U6ZGRhNTg0YTdhNTlkNGQ5NjlmMjRjNWQ3YzE5Y2E0ZjhfMjAtNS0xLTEtMzAxMTQ_2c43b895-b866-49b9-b604-ec8f182de6f9"
      unitRef="usd">283000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xNi9mcmFnOjkyZTk5YzBiMjc2MDRjYWNiOGI1MzU4ZDdjYzUwZDRlL3RhYmxlOmRkYTU4NGE3YTU5ZDRkOTY5ZjI0YzVkN2MxOWNhNGY4L3RhYmxlcmFuZ2U6ZGRhNTg0YTdhNTlkNGQ5NjlmMjRjNWQ3YzE5Y2E0ZjhfMjAtNy0xLTEtMzAxMTQ_099481d5-ea8c-4b81-be86-16fd4bb9b3aa"
      unitRef="usd">288000000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xNi9mcmFnOjkyZTk5YzBiMjc2MDRjYWNiOGI1MzU4ZDdjYzUwZDRlL3RhYmxlOmRkYTU4NGE3YTU5ZDRkOTY5ZjI0YzVkN2MxOWNhNGY4L3RhYmxlcmFuZ2U6ZGRhNTg0YTdhNTlkNGQ5NjlmMjRjNWQ3YzE5Y2E0ZjhfMjMtNS0xLTEtMzAxMTQ_1f17e9dc-aeb1-46cc-af49-d28b1102ba6a"
      unitRef="usdPerShare">0.94</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xNi9mcmFnOjkyZTk5YzBiMjc2MDRjYWNiOGI1MzU4ZDdjYzUwZDRlL3RhYmxlOmRkYTU4NGE3YTU5ZDRkOTY5ZjI0YzVkN2MxOWNhNGY4L3RhYmxlcmFuZ2U6ZGRhNTg0YTdhNTlkNGQ5NjlmMjRjNWQ3YzE5Y2E0ZjhfMjMtNy0xLTEtMzAxMTQ_b5fda9ca-577e-4abe-9295-720f937903eb"
      unitRef="usdPerShare">0.94</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xNi9mcmFnOjkyZTk5YzBiMjc2MDRjYWNiOGI1MzU4ZDdjYzUwZDRlL3RhYmxlOmRkYTU4NGE3YTU5ZDRkOTY5ZjI0YzVkN2MxOWNhNGY4L3RhYmxlcmFuZ2U6ZGRhNTg0YTdhNTlkNGQ5NjlmMjRjNWQ3YzE5Y2E0ZjhfMjQtNS0xLTEtMzAxMTQ_33f7dbe2-a368-4446-94f0-a58011799877"
      unitRef="usdPerShare">0.93</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xNi9mcmFnOjkyZTk5YzBiMjc2MDRjYWNiOGI1MzU4ZDdjYzUwZDRlL3RhYmxlOmRkYTU4NGE3YTU5ZDRkOTY5ZjI0YzVkN2MxOWNhNGY4L3RhYmxlcmFuZ2U6ZGRhNTg0YTdhNTlkNGQ5NjlmMjRjNWQ3YzE5Y2E0ZjhfMjQtNy0xLTEtMzAxMTQ_218e097a-b56f-4292-9bec-ff7e5aa934eb"
      unitRef="usdPerShare">0.93</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xNi9mcmFnOjkyZTk5YzBiMjc2MDRjYWNiOGI1MzU4ZDdjYzUwZDRlL3RhYmxlOmRkYTU4NGE3YTU5ZDRkOTY5ZjI0YzVkN2MxOWNhNGY4L3RhYmxlcmFuZ2U6ZGRhNTg0YTdhNTlkNGQ5NjlmMjRjNWQ3YzE5Y2E0ZjhfMjctNS0xLTEtMzAxMTQ_8281d61f-e3a4-43cb-87c2-dafaa38ee1b8"
      unitRef="shares">301000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xNi9mcmFnOjkyZTk5YzBiMjc2MDRjYWNiOGI1MzU4ZDdjYzUwZDRlL3RhYmxlOmRkYTU4NGE3YTU5ZDRkOTY5ZjI0YzVkN2MxOWNhNGY4L3RhYmxlcmFuZ2U6ZGRhNTg0YTdhNTlkNGQ5NjlmMjRjNWQ3YzE5Y2E0ZjhfMjctNy0xLTEtMzAxMTQ_a6d85005-ff00-40dd-b1fe-e6b22bba87d0"
      unitRef="shares">306000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xNi9mcmFnOjkyZTk5YzBiMjc2MDRjYWNiOGI1MzU4ZDdjYzUwZDRlL3RhYmxlOmRkYTU4NGE3YTU5ZDRkOTY5ZjI0YzVkN2MxOWNhNGY4L3RhYmxlcmFuZ2U6ZGRhNTg0YTdhNTlkNGQ5NjlmMjRjNWQ3YzE5Y2E0ZjhfMjgtNS0xLTEtMzAxMTQ_832f939f-f130-4371-96ce-e5ea0cad3bb9"
      unitRef="shares">303000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xNi9mcmFnOjkyZTk5YzBiMjc2MDRjYWNiOGI1MzU4ZDdjYzUwZDRlL3RhYmxlOmRkYTU4NGE3YTU5ZDRkOTY5ZjI0YzVkN2MxOWNhNGY4L3RhYmxlcmFuZ2U6ZGRhNTg0YTdhNTlkNGQ5NjlmMjRjNWQ3YzE5Y2E0ZjhfMjgtNy0xLTEtMzAxMTQ_e663c9fb-0470-4882-993b-2c808af4898a"
      unitRef="shares">309000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:NetIncomeLoss
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xOS9mcmFnOmQ5ZWE0MmNiNWRiNjRhMjZhYWIzOGYyMmM0MDk5ODNmL3RhYmxlOjVhYTFkOTQyZTk5MTQ2ZmNiOTc3YTdjNzZiNmE2NzViL3RhYmxlcmFuZ2U6NWFhMWQ5NDJlOTkxNDZmY2I5NzdhN2M3NmI2YTY3NWJfNC0xLTEtMS0zMDExNA_0771d00e-0edf-4c70-a561-a8a9a771607e"
      unitRef="usd">283000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xOS9mcmFnOmQ5ZWE0MmNiNWRiNjRhMjZhYWIzOGYyMmM0MDk5ODNmL3RhYmxlOjVhYTFkOTQyZTk5MTQ2ZmNiOTc3YTdjNzZiNmE2NzViL3RhYmxlcmFuZ2U6NWFhMWQ5NDJlOTkxNDZmY2I5NzdhN2M3NmI2YTY3NWJfNC0zLTEtMS0zMDExNA_1f6a4689-a841-4ec8-9c80-80df7e340164"
      unitRef="usd">288000000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xOS9mcmFnOmQ5ZWE0MmNiNWRiNjRhMjZhYWIzOGYyMmM0MDk5ODNmL3RhYmxlOjVhYTFkOTQyZTk5MTQ2ZmNiOTc3YTdjNzZiNmE2NzViL3RhYmxlcmFuZ2U6NWFhMWQ5NDJlOTkxNDZmY2I5NzdhN2M3NmI2YTY3NWJfOC0wLTEtMS0zMDExNC90ZXh0cmVnaW9uOjBiNmI4NThkNzQzZTRkY2M4YTE4MWNmNDI2ZDRhZjM5Xzg2_aa1e348b-629b-4e4d-90a3-d1977c982cea"
      unitRef="usd">2000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax
      contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xOS9mcmFnOmQ5ZWE0MmNiNWRiNjRhMjZhYWIzOGYyMmM0MDk5ODNmL3RhYmxlOjVhYTFkOTQyZTk5MTQ2ZmNiOTc3YTdjNzZiNmE2NzViL3RhYmxlcmFuZ2U6NWFhMWQ5NDJlOTkxNDZmY2I5NzdhN2M3NmI2YTY3NWJfOC0wLTEtMS0zMDExNC90ZXh0cmVnaW9uOjBiNmI4NThkNzQzZTRkY2M4YTE4MWNmNDI2ZDRhZjM5Xzkw_828f8b5a-2361-42ac-8cad-e75292ca0546"
      unitRef="usd">-2000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xOS9mcmFnOmQ5ZWE0MmNiNWRiNjRhMjZhYWIzOGYyMmM0MDk5ODNmL3RhYmxlOjVhYTFkOTQyZTk5MTQ2ZmNiOTc3YTdjNzZiNmE2NzViL3RhYmxlcmFuZ2U6NWFhMWQ5NDJlOTkxNDZmY2I5NzdhN2M3NmI2YTY3NWJfOC0xLTEtMS0zMDExNA_54856ece-8c43-462f-b895-bf95e1dbced0"
      unitRef="usd">6000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xOS9mcmFnOmQ5ZWE0MmNiNWRiNjRhMjZhYWIzOGYyMmM0MDk5ODNmL3RhYmxlOjVhYTFkOTQyZTk5MTQ2ZmNiOTc3YTdjNzZiNmE2NzViL3RhYmxlcmFuZ2U6NWFhMWQ5NDJlOTkxNDZmY2I5NzdhN2M3NmI2YTY3NWJfOC0zLTEtMS0zMDExNA_ec54340a-a998-4221-aa69-cd35c3c699b2"
      unitRef="usd">-4000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xOS9mcmFnOmQ5ZWE0MmNiNWRiNjRhMjZhYWIzOGYyMmM0MDk5ODNmL3RhYmxlOjVhYTFkOTQyZTk5MTQ2ZmNiOTc3YTdjNzZiNmE2NzViL3RhYmxlcmFuZ2U6NWFhMWQ5NDJlOTkxNDZmY2I5NzdhN2M3NmI2YTY3NWJfOS0wLTEtMS0zMDExNC90ZXh0cmVnaW9uOjNkZTY2MWY4NjBjYTRkN2Y4M2E3MjdlZTRiZGQwY2JlXzk2_bbbf6fbc-1b16-4196-aecd-240691e25ad5"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
      contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xOS9mcmFnOmQ5ZWE0MmNiNWRiNjRhMjZhYWIzOGYyMmM0MDk5ODNmL3RhYmxlOjVhYTFkOTQyZTk5MTQ2ZmNiOTc3YTdjNzZiNmE2NzViL3RhYmxlcmFuZ2U6NWFhMWQ5NDJlOTkxNDZmY2I5NzdhN2M3NmI2YTY3NWJfOS0wLTEtMS0zMDExNC90ZXh0cmVnaW9uOjNkZTY2MWY4NjBjYTRkN2Y4M2E3MjdlZTRiZGQwY2JlXzEwMA_f7491024-e4ed-4b95-83f7-ef627c670119"
      unitRef="usd">2000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xOS9mcmFnOmQ5ZWE0MmNiNWRiNjRhMjZhYWIzOGYyMmM0MDk5ODNmL3RhYmxlOjVhYTFkOTQyZTk5MTQ2ZmNiOTc3YTdjNzZiNmE2NzViL3RhYmxlcmFuZ2U6NWFhMWQ5NDJlOTkxNDZmY2I5NzdhN2M3NmI2YTY3NWJfOS0xLTEtMS0zMDExNA_c00f976c-97af-462b-be47-c83c5c6e28e9"
      unitRef="usd">2000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xOS9mcmFnOmQ5ZWE0MmNiNWRiNjRhMjZhYWIzOGYyMmM0MDk5ODNmL3RhYmxlOjVhYTFkOTQyZTk5MTQ2ZmNiOTc3YTdjNzZiNmE2NzViL3RhYmxlcmFuZ2U6NWFhMWQ5NDJlOTkxNDZmY2I5NzdhN2M3NmI2YTY3NWJfOS0zLTEtMS0zMDExNA_d1c5878b-582b-4c38-b5ab-61d29b127444"
      unitRef="usd">-6000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xOS9mcmFnOmQ5ZWE0MmNiNWRiNjRhMjZhYWIzOGYyMmM0MDk5ODNmL3RhYmxlOjVhYTFkOTQyZTk5MTQ2ZmNiOTc3YTdjNzZiNmE2NzViL3RhYmxlcmFuZ2U6NWFhMWQ5NDJlOTkxNDZmY2I5NzdhN2M3NmI2YTY3NWJfMTAtMC0xLTEtMzAxMTQvdGV4dHJlZ2lvbjpiMDI1NDFhZjNjMTA0Mzk5OTM0Yjg0Y2EyNTUyMTI0MV81Ng_c1341c31-e61b-4dce-b690-785f006b4e03"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
      contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xOS9mcmFnOmQ5ZWE0MmNiNWRiNjRhMjZhYWIzOGYyMmM0MDk5ODNmL3RhYmxlOjVhYTFkOTQyZTk5MTQ2ZmNiOTc3YTdjNzZiNmE2NzViL3RhYmxlcmFuZ2U6NWFhMWQ5NDJlOTkxNDZmY2I5NzdhN2M3NmI2YTY3NWJfMTAtMC0xLTEtMzAxMTQvdGV4dHJlZ2lvbjpiMDI1NDFhZjNjMTA0Mzk5OTM0Yjg0Y2EyNTUyMTI0MV82MA_6977b8dd-980c-4bc5-8239-bce9aee729dd"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xOS9mcmFnOmQ5ZWE0MmNiNWRiNjRhMjZhYWIzOGYyMmM0MDk5ODNmL3RhYmxlOjVhYTFkOTQyZTk5MTQ2ZmNiOTc3YTdjNzZiNmE2NzViL3RhYmxlcmFuZ2U6NWFhMWQ5NDJlOTkxNDZmY2I5NzdhN2M3NmI2YTY3NWJfMTAtMS0xLTEtMzAxMTQ_49826544-2c14-44b3-93a4-182d0f74a896"
      unitRef="usd">-27000000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xOS9mcmFnOmQ5ZWE0MmNiNWRiNjRhMjZhYWIzOGYyMmM0MDk5ODNmL3RhYmxlOjVhYTFkOTQyZTk5MTQ2ZmNiOTc3YTdjNzZiNmE2NzViL3RhYmxlcmFuZ2U6NWFhMWQ5NDJlOTkxNDZmY2I5NzdhN2M3NmI2YTY3NWJfMTAtMy0xLTEtMzAxMTQ_6cccd429-719e-4c34-8f6f-7925224cf393"
      unitRef="usd">42000000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xOS9mcmFnOmQ5ZWE0MmNiNWRiNjRhMjZhYWIzOGYyMmM0MDk5ODNmL3RhYmxlOjVhYTFkOTQyZTk5MTQ2ZmNiOTc3YTdjNzZiNmE2NzViL3RhYmxlcmFuZ2U6NWFhMWQ5NDJlOTkxNDZmY2I5NzdhN2M3NmI2YTY3NWJfMTItMC0xLTEtMzAxMTQvdGV4dHJlZ2lvbjpiMjI3OGIxZDU5ZTI0Njc1YmJkYjZhNWE3OGI3NzgyOF81Ng_eab6a10e-1ae6-4b91-88ce-a70b668fe13f"
      unitRef="usd">2000000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax
      contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xOS9mcmFnOmQ5ZWE0MmNiNWRiNjRhMjZhYWIzOGYyMmM0MDk5ODNmL3RhYmxlOjVhYTFkOTQyZTk5MTQ2ZmNiOTc3YTdjNzZiNmE2NzViL3RhYmxlcmFuZ2U6NWFhMWQ5NDJlOTkxNDZmY2I5NzdhN2M3NmI2YTY3NWJfMTItMC0xLTEtMzAxMTQvdGV4dHJlZ2lvbjpiMjI3OGIxZDU5ZTI0Njc1YmJkYjZhNWE3OGI3NzgyOF82MA_094cd1da-03ba-47dd-b81d-a7430a09ceef"
      unitRef="usd">4000000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xOS9mcmFnOmQ5ZWE0MmNiNWRiNjRhMjZhYWIzOGYyMmM0MDk5ODNmL3RhYmxlOjVhYTFkOTQyZTk5MTQ2ZmNiOTc3YTdjNzZiNmE2NzViL3RhYmxlcmFuZ2U6NWFhMWQ5NDJlOTkxNDZmY2I5NzdhN2M3NmI2YTY3NWJfMTItMS0xLTEtMzAxMTQ_297a3c69-a72a-4483-bdc6-44776202193a"
      unitRef="usd">7000000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
      contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xOS9mcmFnOmQ5ZWE0MmNiNWRiNjRhMjZhYWIzOGYyMmM0MDk5ODNmL3RhYmxlOjVhYTFkOTQyZTk5MTQ2ZmNiOTc3YTdjNzZiNmE2NzViL3RhYmxlcmFuZ2U6NWFhMWQ5NDJlOTkxNDZmY2I5NzdhN2M3NmI2YTY3NWJfMTItMy0xLTEtMzAxMTQ_0e11ac35-2cf1-4394-ae05-e0fb3f946db9"
      unitRef="usd">9000000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xOS9mcmFnOmQ5ZWE0MmNiNWRiNjRhMjZhYWIzOGYyMmM0MDk5ODNmL3RhYmxlOjVhYTFkOTQyZTk5MTQ2ZmNiOTc3YTdjNzZiNmE2NzViL3RhYmxlcmFuZ2U6NWFhMWQ5NDJlOTkxNDZmY2I5NzdhN2M3NmI2YTY3NWJfMTQtMS0xLTEtMzAxMTQ_eed243e9-16a2-48b7-90b8-d267467030d6"
      unitRef="usd">-16000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xOS9mcmFnOmQ5ZWE0MmNiNWRiNjRhMjZhYWIzOGYyMmM0MDk5ODNmL3RhYmxlOjVhYTFkOTQyZTk5MTQ2ZmNiOTc3YTdjNzZiNmE2NzViL3RhYmxlcmFuZ2U6NWFhMWQ5NDJlOTkxNDZmY2I5NzdhN2M3NmI2YTY3NWJfMTQtMy0xLTEtMzAxMTQ_df6f6ed6-3c3d-4b68-b9af-f93a913bb092"
      unitRef="usd">53000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xOS9mcmFnOmQ5ZWE0MmNiNWRiNjRhMjZhYWIzOGYyMmM0MDk5ODNmL3RhYmxlOjVhYTFkOTQyZTk5MTQ2ZmNiOTc3YTdjNzZiNmE2NzViL3RhYmxlcmFuZ2U6NWFhMWQ5NDJlOTkxNDZmY2I5NzdhN2M3NmI2YTY3NWJfMTUtMS0xLTEtMzAxMTQ_d3184396-32c8-4752-b0d1-0f1450b119b5"
      unitRef="usd">267000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8xOS9mcmFnOmQ5ZWE0MmNiNWRiNjRhMjZhYWIzOGYyMmM0MDk5ODNmL3RhYmxlOjVhYTFkOTQyZTk5MTQ2ZmNiOTc3YTdjNzZiNmE2NzViL3RhYmxlcmFuZ2U6NWFhMWQ5NDJlOTkxNDZmY2I5NzdhN2M3NmI2YTY3NWJfMTUtMy0xLTEtMzAxMTQ_cf21d978-835e-4ffb-9e48-4b7abcd67add"
      unitRef="usd">341000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfMy0xLTEtMS0zMDExNA_5966a8f4-ef2f-4c4e-b515-7304053779a6"
      unitRef="usd">1113000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i6390807210d74c6f9cae496ea2122a5a_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfMy0zLTEtMS0zMDExNA_ce44c1a9-4863-46a3-87e2-71e2261a42af"
      unitRef="usd">1484000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfNC0xLTEtMS0zMDExNA_64d1abf4-88a7-4ec5-8318-619279782d1b"
      unitRef="usd">45000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i6390807210d74c6f9cae496ea2122a5a_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfNC0zLTEtMS0zMDExNA_106d5b26-7102-4b1f-b292-ab953d589d4e"
      unitRef="usd">91000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfNS0xLTEtMS0zMDExNA_a3754fe4-e61f-45a5-90b9-b94183efd856"
      unitRef="usd">1205000000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i6390807210d74c6f9cae496ea2122a5a_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfNS0zLTEtMS0zMDExNA_4647d75b-22de-4c18-95f9-e5671eeab9a0"
      unitRef="usd">1172000000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfNi0xLTEtMS0zMDExNA_30ca8007-021d-4c65-954a-d5f3e7ecfecb"
      unitRef="usd">879000000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i6390807210d74c6f9cae496ea2122a5a_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfNi0zLTEtMS0zMDExNA_fdf0476d-160b-410b-845e-1d0f314e8bbf"
      unitRef="usd">830000000</us-gaap:InventoryNet>
    <us-gaap:OtherAssetsCurrent
      contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfNy0xLTEtMS0zMDExNA_6fc11f1d-5475-4490-9bac-49f8a6100929"
      unitRef="usd">232000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="i6390807210d74c6f9cae496ea2122a5a_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfNy0zLTEtMS0zMDExNA_af3622b8-f9cd-4f48-b41c-af3ac98ceb3a"
      unitRef="usd">222000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfOC0xLTEtMS0zMDExNA_4c7317f1-06d4-4363-b60a-7daa7178b142"
      unitRef="usd">3474000000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i6390807210d74c6f9cae496ea2122a5a_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfOC0zLTEtMS0zMDExNA_9d139c2c-6ab2-486c-a792-c9ed6fd4c009"
      unitRef="usd">3799000000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfOS0xLTEtMS0zMDExNA_bf41f2f4-1f4c-4756-a8df-e04dd1aa2589"
      unitRef="usd">974000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i6390807210d74c6f9cae496ea2122a5a_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfOS0zLTEtMS0zMDExNA_cac39f48-c1f2-4978-9bb9-66cd8174420f"
      unitRef="usd">945000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Goodwill
      contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfMTAtMS0xLTEtMzAxMTQ_fdfdc4ac-e8f4-4f4b-8493-8f08fa66aab9"
      unitRef="usd">3964000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i6390807210d74c6f9cae496ea2122a5a_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfMTAtMy0xLTEtMzAxMTQ_01bebf52-9f8b-4b6f-959d-56332de9dc63"
      unitRef="usd">3975000000</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfMTEtMS0xLTEtMzAxMTQ_3464ff67-1522-4a26-900a-674d042c454d"
      unitRef="usd">929000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i6390807210d74c6f9cae496ea2122a5a_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfMTEtMy0xLTEtMzAxMTQ_3c640282-7751-441c-a8d0-6bd047818009"
      unitRef="usd">981000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:LongTermInvestments
      contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfMTItMS0xLTEtMzAxMTQ_64dca2dc-2ccb-4ab1-bbec-9304adf40dec"
      unitRef="usd">191000000</us-gaap:LongTermInvestments>
    <us-gaap:LongTermInvestments
      contextRef="i6390807210d74c6f9cae496ea2122a5a_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfMTItMy0xLTEtMzAxMTQ_5f390459-1b10-4e64-be81-5a5727c86885"
      unitRef="usd">185000000</us-gaap:LongTermInvestments>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfMTMtMS0xLTEtMzAxMTQ_90570dd1-c189-4201-b286-27d0549fa002"
      unitRef="usd">795000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i6390807210d74c6f9cae496ea2122a5a_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfMTMtMy0xLTEtMzAxMTQ_55be2b02-da24-4f4b-b5c6-b2ddb1b1270d"
      unitRef="usd">820000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfMTQtMS0xLTEtMzAxMTQ_ece6bb32-0c38-4a55-ac54-e2267cf7a6d8"
      unitRef="usd">10327000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i6390807210d74c6f9cae496ea2122a5a_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfMTQtMy0xLTEtMzAxMTQ_ac4f5889-845a-43c8-8971-b5c04b8ea489"
      unitRef="usd">10705000000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfMTctMS0xLTEtMzAxMTQ_3e319d26-436a-4f38-9e0f-df1cbb1e007b"
      unitRef="usd">475000000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i6390807210d74c6f9cae496ea2122a5a_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfMTctMy0xLTEtMzAxMTQ_65efa63b-055e-4e88-9c4e-08a1fb04c70d"
      unitRef="usd">446000000</us-gaap:AccountsPayableCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfMTgtMS0xLTEtMzAxMTQ_906f9557-952a-445b-8ee0-dc075dbf5001"
      unitRef="usd">290000000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i6390807210d74c6f9cae496ea2122a5a_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfMTgtMy0xLTEtMzAxMTQ_c3b8ef32-c792-4524-84e3-ac6dc4a05269"
      unitRef="usd">493000000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:DeferredRevenueCurrent
      contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfMTktMS0xLTEtMzAxMTQ_0530b4f0-f7fc-459e-9f57-a9517c89ec6f"
      unitRef="usd">493000000</us-gaap:DeferredRevenueCurrent>
    <us-gaap:DeferredRevenueCurrent
      contextRef="i6390807210d74c6f9cae496ea2122a5a_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfMTktMy0xLTEtMzAxMTQ_a75bec78-2aa9-4096-868d-80e1eed796d3"
      unitRef="usd">441000000</us-gaap:DeferredRevenueCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrentAndNoncurrent
      contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfMjEtMS0xLTEtMzAxMTQ_09293d29-037d-4169-a63f-ddca0a7805ea"
      unitRef="usd">326000000</us-gaap:OtherAccruedLiabilitiesCurrentAndNoncurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrentAndNoncurrent
      contextRef="i6390807210d74c6f9cae496ea2122a5a_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfMjEtMy0xLTEtMzAxMTQ_c06a10a0-a430-4106-92f6-2ee4c7060e66"
      unitRef="usd">328000000</us-gaap:OtherAccruedLiabilitiesCurrentAndNoncurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfMjItMS0xLTEtMzAxMTQ_6dfacc1f-5101-453a-8ced-e066fba855cf"
      unitRef="usd">1584000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i6390807210d74c6f9cae496ea2122a5a_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfMjItMy0xLTEtMzAxMTQ_f8a70634-4202-4bcc-b534-ac1a31f0f245"
      unitRef="usd">1708000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfMjMtMS0xLTEtMzAxMTQ_b65144d3-e7f1-4d9a-a47b-3dcbb10e46a5"
      unitRef="usd">2730000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i6390807210d74c6f9cae496ea2122a5a_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfMjMtMy0xLTEtMzAxMTQ_01537f40-97d3-499c-8d27-6936adf2fe5d"
      unitRef="usd">2729000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
      contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfMjQtMS0xLTEtMzAxMTQ_19667380-b319-4f71-ac6b-cd865d4a781c"
      unitRef="usd">206000000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
      contextRef="i6390807210d74c6f9cae496ea2122a5a_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfMjQtMy0xLTEtMzAxMTQ_78bca5a7-3800-4665-a4f1-1b256b89e8ee"
      unitRef="usd">220000000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfMjUtMS0xLTEtMzAxMTQ_c6f67bd7-e876-4f10-a657-e6ae1b706f08"
      unitRef="usd">653000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i6390807210d74c6f9cae496ea2122a5a_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfMjUtMy0xLTEtMzAxMTQ_0550ff84-8410-4aeb-a8b9-aa7c53bf6d21"
      unitRef="usd">659000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfMjYtMS0xLTEtMzAxMTQ_90ab103b-192d-45e3-9b82-14d1ceb555a3"
      unitRef="usd">5173000000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i6390807210d74c6f9cae496ea2122a5a_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfMjYtMy0xLTEtMzAxMTQ_db805533-e89e-416b-abde-deb531f3888d"
      unitRef="usd">5316000000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfMjctMS0xLTEtMzAxMTQ_6f9081c4-c535-4e70-a67e-887474bd74ba"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i6390807210d74c6f9cae496ea2122a5a_I20211031"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfMjctMy0xLTEtMzAxMTQ_9b8862a4-75ed-4cb8-b750-a160e877c8c5"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfMzAtMC0xLTEtMzAxMTQvdGV4dHJlZ2lvbjo2MTQ2NDA0MDFmNDc0MWQzODE4YWY4MjgyOTAyNDEzN18yMQ_7a70d0ed-fd84-438f-a929-32cb2612690b"
      unitRef="usdPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i6390807210d74c6f9cae496ea2122a5a_I20211031"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfMzAtMC0xLTEtMzAxMTQvdGV4dHJlZ2lvbjo2MTQ2NDA0MDFmNDc0MWQzODE4YWY4MjgyOTAyNDEzN18yMQ_ec10249a-83ce-47a8-bb8c-790d4bf402b6"
      unitRef="usdPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfMzAtMC0xLTEtMzAxMTQvdGV4dHJlZ2lvbjo2MTQ2NDA0MDFmNDc0MWQzODE4YWY4MjgyOTAyNDEzN18zNQ_f2b618b5-11ec-4dba-86b5-e909153f3d85"
      unitRef="shares">125000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i6390807210d74c6f9cae496ea2122a5a_I20211031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfMzAtMC0xLTEtMzAxMTQvdGV4dHJlZ2lvbjo2MTQ2NDA0MDFmNDc0MWQzODE4YWY4MjgyOTAyNDEzN18zNQ_f4c3bee5-1f14-4b6a-9f99-3feacd8541b6"
      unitRef="shares">125000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i6390807210d74c6f9cae496ea2122a5a_I20211031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfMzAtMC0xLTEtMzAxMTQvdGV4dHJlZ2lvbjo2MTQ2NDA0MDFmNDc0MWQzODE4YWY4MjgyOTAyNDEzN181Nw_0cd9be11-0c79-48fa-89d3-38a67a56f55a"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfMzAtMC0xLTEtMzAxMTQvdGV4dHJlZ2lvbjo2MTQ2NDA0MDFmNDc0MWQzODE4YWY4MjgyOTAyNDEzN181Nw_2e95fb4e-ea95-4c5f-9ffd-004def7eb624"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfMzAtMC0xLTEtMzAxMTQvdGV4dHJlZ2lvbjo2MTQ2NDA0MDFmNDc0MWQzODE4YWY4MjgyOTAyNDEzN181Nw_5ad27187-8c75-41a0-ae01-3e314ba06fc0"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i6390807210d74c6f9cae496ea2122a5a_I20211031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfMzAtMC0xLTEtMzAxMTQvdGV4dHJlZ2lvbjo2MTQ2NDA0MDFmNDc0MWQzODE4YWY4MjgyOTAyNDEzN181Nw_84ba3ff0-3872-40a1-9c85-76c6cc53d75b"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockValue
      contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfMzAtMS0xLTEtMzAxMTQ_41908b7e-27ba-4711-ad45-6625d2056406"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="i6390807210d74c6f9cae496ea2122a5a_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfMzAtMy0xLTEtMzAxMTQ_6f9dafbf-ffa1-489a-99ae-3f03fa29d5ff"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfMzEtMC0xLTEtMzAxMTQvdGV4dHJlZ2lvbjoyYWU2NTVjZjBlNTQ0MDRmOGUxMDFmZmVhZWYwOWJmMV8xOA_a9086665-43a4-461d-b9e6-cc6359b8df64"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i6390807210d74c6f9cae496ea2122a5a_I20211031"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfMzEtMC0xLTEtMzAxMTQvdGV4dHJlZ2lvbjoyYWU2NTVjZjBlNTQ0MDRmOGUxMDFmZmVhZWYwOWJmMV8xOA_fcc9236d-368f-404f-82ac-c5707091ca2f"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfMzEtMC0xLTEtMzAxMTQvdGV4dHJlZ2lvbjoyYWU2NTVjZjBlNTQ0MDRmOGUxMDFmZmVhZWYwOWJmMV8zMg_13b6f28a-e77a-4393-9edf-f66299e4d3bd"
      unitRef="shares">2000000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i6390807210d74c6f9cae496ea2122a5a_I20211031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfMzEtMC0xLTEtMzAxMTQvdGV4dHJlZ2lvbjoyYWU2NTVjZjBlNTQ0MDRmOGUxMDFmZmVhZWYwOWJmMV8zMg_4d87900e-d46a-4ac8-98cd-34d627256870"
      unitRef="shares">2000000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfMzEtMC0xLTEtMzAxMTQvdGV4dHJlZ2lvbjoyYWU2NTVjZjBlNTQ0MDRmOGUxMDFmZmVhZWYwOWJmMV81NA_6accc244-57ac-422d-a120-420ec5b94c34"
      unitRef="shares">300000000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfMzEtMC0xLTEtMzAxMTQvdGV4dHJlZ2lvbjoyYWU2NTVjZjBlNTQ0MDRmOGUxMDFmZmVhZWYwOWJmMV81NA_ca561a8d-cf87-489b-bad6-351d6defceb3"
      unitRef="shares">300000000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i6390807210d74c6f9cae496ea2122a5a_I20211031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfMzEtMC0xLTEtMzAxMTQvdGV4dHJlZ2lvbjoyYWU2NTVjZjBlNTQ0MDRmOGUxMDFmZmVhZWYwOWJmMV83NA_2852935b-2dea-4499-ad8a-1c9f44d7d3b3"
      unitRef="shares">302000000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="i6390807210d74c6f9cae496ea2122a5a_I20211031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfMzEtMC0xLTEtMzAxMTQvdGV4dHJlZ2lvbjoyYWU2NTVjZjBlNTQ0MDRmOGUxMDFmZmVhZWYwOWJmMV83NA_4aa6a830-918a-4db0-ba20-ee83181501e0"
      unitRef="shares">302000000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue
      contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfMzEtMS0xLTEtMzAxMTQ_da4338c1-5fed-424e-b0db-f3dd5a2e20dd"
      unitRef="usd">3000000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i6390807210d74c6f9cae496ea2122a5a_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfMzEtMy0xLTEtMzAxMTQ_ed3e2522-1e28-4ca4-a0b2-abe5222ffe69"
      unitRef="usd">3000000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfMzItMS0xLTEtMzAxMTQ_f82279df-589b-4d53-b8fa-f634123770ba"
      unitRef="usd">5290000000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i6390807210d74c6f9cae496ea2122a5a_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfMzItMy0xLTEtMzAxMTQ_7df87258-63c3-4902-ae45-f4c246c2cbc0"
      unitRef="usd">5320000000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfMzMtMS0xLTEtMzAxMTQ_747ee004-7c90-4761-abf8-c33b7c79de44"
      unitRef="usd">159000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i6390807210d74c6f9cae496ea2122a5a_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfMzMtMy0xLTEtMzAxMTQ_953e3582-a35f-4f42-8657-c3f0717874ef"
      unitRef="usd">348000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfMzQtMS0xLTEtMzAxMTQ_049d29fd-025d-44b3-a5b1-6dd35f27b1f8"
      unitRef="usd">-298000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i6390807210d74c6f9cae496ea2122a5a_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfMzQtMy0xLTEtMzAxMTQ_901fbc96-8824-4704-99d3-75afed307649"
      unitRef="usd">-282000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfMzUtMS0xLTEtMzAxMTQ_7315f4d5-5f65-44b1-a00b-017fa3d56912"
      unitRef="usd">5154000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i6390807210d74c6f9cae496ea2122a5a_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfMzUtMy0xLTEtMzAxMTQ_de83723b-f614-4f09-ad46-5df597627558"
      unitRef="usd">5389000000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfMzgtMS0xLTEtMzAxMTQ_36490229-cf4c-493e-8010-b6f2759d4a40"
      unitRef="usd">10327000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i6390807210d74c6f9cae496ea2122a5a_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yMi9mcmFnOjkzODRhYTcwYjc3YTQzY2NhODU1NDZmOWFlOTQzZDMwL3RhYmxlOjRhMGJiM2E4YTk1YTQ4OTI4MTU4YTZhNzAzOGU0NWMyL3RhYmxlcmFuZ2U6NGEwYmIzYThhOTVhNDg5MjgxNThhNmE3MDM4ZTQ1YzJfMzgtMy0xLTEtMzAxMTQ_4629e6bb-9928-49a1-ad9e-167cfacde9ff"
      unitRef="usd">10705000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfNC0xLTEtMS0zMDExNA_5af4de50-0f0e-4691-9599-07f51d5cc6e0"
      unitRef="usd">283000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfNC0zLTEtMS0zMDExNA_74bdfa83-dc91-4a9a-b6a0-f61c0a2a3f57"
      unitRef="usd">288000000</us-gaap:NetIncomeLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfNi0xLTEtMS0zMDExNA_f56f6416-f5f2-47e5-b93f-31c2dcd7fcb4"
      unitRef="usd">82000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfNi0zLTEtMS0zMDExNA_b09510fd-9ed9-486d-8c4d-f9dd67925f39"
      unitRef="usd">76000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:ShareBasedCompensation
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfOC0xLTEtMS0zMDExNA_69e87b6c-4022-4787-b025-21fa67fab277"
      unitRef="usd">44000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfOC0zLTEtMS0zMDExNA_1bb11bdd-8b30-4912-a6c7-4d08806967cb"
      unitRef="usd">40000000</us-gaap:ShareBasedCompensation>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfOS0xLTEtMS0zMDExNA_bf35ac35-0a16-4773-8fae-1f1d93f9d653"
      unitRef="usd">24000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfOS0zLTEtMS0zMDExNA_c1d8cb81-b260-4538-8cea-15c2446f8f31"
      unitRef="usd">29000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:InventoryWriteDown
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfMTAtMS0xLTEtMzAxMTQ_c6fc7a3b-2588-47a8-988e-999c8b80b1f6"
      unitRef="usd">5000000</us-gaap:InventoryWriteDown>
    <us-gaap:InventoryWriteDown
      contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfMTAtMy0xLTEtMzAxMTQ_e7152002-0236-42f1-ae92-7768153eee8f"
      unitRef="usd">6000000</us-gaap:InventoryWriteDown>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfMTEtMS0xLTEtMzAxMTQ_d6e7d5c8-b716-48e8-b91e-14c2eb01d490"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfMTEtMy0xLTEtMzAxMTQ_7d42d360-d651-47f0-95e4-dd301eef458f"
      unitRef="usd">-5000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfMTItMS0xLTEtMzAxMTQ_07e8a3a7-68e3-4e79-a53b-d359662058d2"
      unitRef="usd">-47000000</us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss>
    <us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss
      contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfMTItMy0xLTEtMzAxMTQ_d2f16882-531a-45b7-b8d2-0ca5af98f76e"
      unitRef="usd">2000000</us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfMTQtMS0xLTEtMzAxMTQ_97f42054-47a8-484f-b8f9-bd9ebd95f352"
      unitRef="usd">3000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfMTQtMy0xLTEtMzAxMTQ_dcc241f5-74e2-4392-9521-64753122cb88"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfMTUtMS0xLTEtMzAxMTQ_4b175bba-9081-472c-8a09-07c5beb245a9"
      unitRef="usd">0</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfMTUtMy0xLTEtMzAxMTQ_78f5cb81-ed83-4873-9293-dc983a9e3b65"
      unitRef="usd">-2000000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfMTctMS0xLTEtMzAxMTQ_b2c9cd43-f53b-48cc-b4fc-2f7aea34226f"
      unitRef="usd">46000000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfMTctMy0xLTEtMzAxMTQ_91f574a2-5003-4a5e-80b9-d2a58772f1fb"
      unitRef="usd">31000000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfMTgtMS0xLTEtMzAxMTQ_483ccd6e-d1c7-4455-893c-59f7032d1090"
      unitRef="usd">54000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfMTgtMy0xLTEtMzAxMTQ_2a300c0e-4730-4673-be07-512a32b7660c"
      unitRef="usd">35000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfMTktMS0xLTEtMzAxMTQ_39a28d63-4000-4e22-9d4d-9bdd02afe082"
      unitRef="usd">37000000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfMTktMy0xLTEtMzAxMTQ_85a0d10d-cd0b-43a1-9858-3a838bcdd7fd"
      unitRef="usd">43000000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfMjAtMS0xLTEtMzAxMTQ_f404c679-f36f-437b-b26a-21fe4850e0db"
      unitRef="usd">-210000000</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities
      contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfMjAtMy0xLTEtMzAxMTQ_84bc67f9-63f9-4b7c-81c8-d321c5636b1f"
      unitRef="usd">-88000000</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfMjEtMS0xLTEtMzAxMTQ_574c6698-804f-4a39-97a1-99cd636f3bb6"
      unitRef="usd">-40000000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfMjEtMy0xLTEtMzAxMTQ_181b9bdb-f2ad-4fe0-94ca-6eace00720ef"
      unitRef="usd">95000000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfMjItMS0xLTEtMzAxMTQ_b5272137-e74f-4102-aad7-0e94dfbec8f3"
      unitRef="usd">255000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfMjItMy0xLTEtMzAxMTQ_664884ac-c36a-4725-a850-c81a6ef5e3c1"
      unitRef="usd">238000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfMjUtMS0xLTEtMzAxMTQ_37b7fdf0-7453-4ccf-9e52-7dbba864d6fa"
      unitRef="usd">75000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfMjUtMy0xLTEtMzAxMTQ_c711aa2d-0215-4084-a4dc-a0fc77bcb9ab"
      unitRef="usd">41000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireEquitySecuritiesFvNi
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfMzAtMS0xLTEtMzAxMTQ_598e8949-5efb-42b2-91de-78a91c43f4bc"
      unitRef="usd">3000000</us-gaap:PaymentsToAcquireEquitySecuritiesFvNi>
    <us-gaap:PaymentsToAcquireEquitySecuritiesFvNi
      contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfMzAtMy0xLTEtMzAxMTQ_47cd3a24-b9ec-448f-a29f-986caa9f149b"
      unitRef="usd">1000000</us-gaap:PaymentsToAcquireEquitySecuritiesFvNi>
    <us-gaap:PaymentsToAcquireNotesReceivable
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfMzEtMS0xLTEtMzAxMTQ_599fd79d-7afb-4a50-aa57-c9b4cf6988e1"
      unitRef="usd">1000000</us-gaap:PaymentsToAcquireNotesReceivable>
    <us-gaap:PaymentsToAcquireNotesReceivable
      contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfMzEtMy0xLTEtMzAxMTQ_6939e4a3-55f0-477f-b103-073584d5e1e8"
      unitRef="usd">0</us-gaap:PaymentsToAcquireNotesReceivable>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfMzgtMS0xLTEtMzAxMTQ_c8b5fde7-e810-4e2c-aee4-342a7c6a3709"
      unitRef="usd">-79000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfMzgtMy0xLTEtMzAxMTQ_78703c3e-b7ef-4b5d-879a-6d3e605e306b"
      unitRef="usd">-42000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfNDEtMS0xLTEtMzAxMTQ_0bf39ff2-5f07-43b8-b9a5-f4de64168cd2"
      unitRef="usd">27000000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfNDEtMy0xLTEtMzAxMTQ_3efe82b4-47a6-4e88-88ae-84a3079005f9"
      unitRef="usd">25000000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfNDItMS0xLTEtMzAxMTQ_2e4a67aa-5671-4371-b2ba-3fe9c57944e6"
      unitRef="usd">63000000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfNDItMy0xLTEtMzAxMTQ_75d6d31f-7170-45a2-94fd-afe471715eec"
      unitRef="usd">72000000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsOfOrdinaryDividends
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfNDMtMS0xLTEtMzAxMTQ_a3eb6211-1ba2-4e2c-9f24-dbf8fdf1a179"
      unitRef="usd">63000000</us-gaap:PaymentsOfOrdinaryDividends>
    <us-gaap:PaymentsOfOrdinaryDividends
      contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfNDMtMy0xLTEtMzAxMTQ_a3648409-ec04-41ef-99f4-4dd4f3c2f5b0"
      unitRef="usd">59000000</us-gaap:PaymentsOfOrdinaryDividends>
    <us-gaap:EarlyRepaymentOfSeniorDebt
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfNTAtMS0xLTEtMzAxMTQ_97152e0a-fbd9-490a-a1e9-28e5003a82e8"
      unitRef="usd">0</us-gaap:EarlyRepaymentOfSeniorDebt>
    <us-gaap:EarlyRepaymentOfSeniorDebt
      contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfNTAtMy0xLTEtMzAxMTQ_d0f515f8-59f8-41f7-855c-bd99ff8513ac"
      unitRef="usd">105000000</us-gaap:EarlyRepaymentOfSeniorDebt>
    <us-gaap:ProceedsFromIssuanceOfCommercialPaper
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfNTItMS0xLTEtMzAxMTQ_109b4c9e-d79a-4d35-b47c-a6168b0bf93e"
      unitRef="usd">240000000</us-gaap:ProceedsFromIssuanceOfCommercialPaper>
    <us-gaap:RepaymentsOfCommercialPaper
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfNTItMS0xLTEtMzAxMTQ_bb4aa28a-1dcd-4dd3-95a2-d6f5a2b27318"
      unitRef="usd">240000000</us-gaap:RepaymentsOfCommercialPaper>
    <us-gaap:ProceedsFromIssuanceOfCommercialPaper
      contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfNTItMy0xLTEtMzAxMTQ_2334d733-3ce9-4766-9548-09b4b004e980"
      unitRef="usd">785000000</us-gaap:ProceedsFromIssuanceOfCommercialPaper>
    <us-gaap:RepaymentsOfCommercialPaper
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfNTMtMS0xLTEtMzAxMTQ_679b2851-0829-4528-94d5-9a33a7aca84c"
      unitRef="usd">240000000</us-gaap:RepaymentsOfCommercialPaper>
    <us-gaap:RepaymentsOfCommercialPaper
      contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfNTMtMy0xLTEtMzAxMTQ_4f915c6b-cdef-47c5-bc60-48316e78ed3c"
      unitRef="usd">546000000</us-gaap:RepaymentsOfCommercialPaper>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfNTUtMS0xLTEtMzAxMTQ_fad26b34-dd2b-4712-8bec-2e5ad97f8ef9"
      unitRef="usd">447000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfNTUtMy0xLTEtMzAxMTQ_27862542-aaa5-4db2-befc-45f7ae8f1dbb"
      unitRef="usd">344000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfNTYtMS0xLTEtMzAxMTQ_26e4a94e-555b-4d16-9c51-ee051881616d"
      unitRef="usd">-546000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfNTYtMy0xLTEtMzAxMTQ_21c85a18-2e93-425b-aa50-0f35faa89257"
      unitRef="usd">-316000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfNTgtMS0xLTEtMzAxMTQ_219d6d38-bcb6-451a-8215-63b4f62d9fa8"
      unitRef="usd">-4000000</us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents
      contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfNTgtMy0xLTEtMzAxMTQ_2606995b-d2c7-4258-aeaf-8818a63359da"
      unitRef="usd">9000000</us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfNjAtMS0xLTEtMzAxMTQ_eb58080c-e3c7-44a2-b58c-e7762e79163c"
      unitRef="usd">-374000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfNjAtMy0xLTEtMzAxMTQ_475ae43e-0b70-4157-91f3-544ee8a3cbcc"
      unitRef="usd">-111000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i6390807210d74c6f9cae496ea2122a5a_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfNjItMS0xLTEtMzAxMTQ_1cd75876-bf10-4c79-b21d-d835e8f01d6a"
      unitRef="usd">1490000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="id69612e49fa546c0bf63ff5ad436ccc6_I20201031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfNjItMy0xLTEtMzAxMTQ_3dd613c1-9ab9-47ac-b718-b199ba2f3bf2"
      unitRef="usd">1447000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfNjMtMS0xLTEtMzAxMTQ_4dc1cc3c-bae5-41a7-812d-903eafcc9383"
      unitRef="usd">1116000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i9b47b15753c94f0b80143556347e39b7_I20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfNjMtMy0xLTEtMzAxMTQ_281a9997-0cea-4767-8fc8-9874add12dcb"
      unitRef="usd">1336000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfNjYtMS0xLTEtMzAxMTQ_dfe7a483-18af-4ed1-b7ec-b25c594826ae"
      unitRef="usd">22000000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfNjYtMy0xLTEtMzAxMTQ_1cac5847-54f9-4903-9eed-0aa6e959c2a8"
      unitRef="usd">52000000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfNjctMS0xLTEtMzAxMTQ_565e8c10-4fb8-411d-99b6-285b0480acd2"
      unitRef="usd">18000000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfNjctMy0xLTEtMzAxMTQ_76bc35d9-a5fc-4094-b7bc-5b8c35fec1b4"
      unitRef="usd">19000000</us-gaap:InterestPaidNet>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="i44a18d7ed2a546f2b1a0a2f797a1b4fe_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfNjgtMS0xLTEtMzAxMTQ_196691ef-0224-4158-b5b1-ee11de2a74f5"
      unitRef="usd">-7000000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="i8ceb97e232da4995b0c42477e20b5b4e_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yNS9mcmFnOmU3ZTA1YTUwZDBmYjQ1OWRiMDEwYjYzNjkxYjAyODBhL3RhYmxlOjQ2ODRjMTIzZjEyNTQ1OTE4ZTAxY2ExMThjN2VjZThlL3RhYmxlcmFuZ2U6NDY4NGMxMjNmMTI1NDU5MThlMDFjYTExOGM3ZWNlOGVfNjgtMy0xLTEtMzAxMTQ_bd4fac81-7ecd-4bd3-9cd9-c5da8d302721"
      unitRef="usd">-4000000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:SharesIssued
      contextRef="i99b29a6a5e4443e6830ecda74b1090c7_I20211031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yOC9mcmFnOjdmZjA3MzdmMjAzNzRjYjdhYmQ3ZjJlNTk4NWI4YTRkL3RhYmxlOjkxNDM0MDZkNTUyZDQyOTM4MDVhZTQwYThmNzE1Zjk1L3RhYmxlcmFuZ2U6OTE0MzQwNmQ1NTJkNDI5MzgwNWFlNDBhOGY3MTVmOTVfMy0xLTEtMS0zMDExNA_78c88054-7d58-405d-8871-e63debb82f2b"
      unitRef="shares">302208000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i99b29a6a5e4443e6830ecda74b1090c7_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yOC9mcmFnOjdmZjA3MzdmMjAzNzRjYjdhYmQ3ZjJlNTk4NWI4YTRkL3RhYmxlOjkxNDM0MDZkNTUyZDQyOTM4MDVhZTQwYThmNzE1Zjk1L3RhYmxlcmFuZ2U6OTE0MzQwNmQ1NTJkNDI5MzgwNWFlNDBhOGY3MTVmOTVfMy0zLTEtMS0zMDExNA_711c3727-0bfa-4361-ade2-8d4c3d329c8f"
      unitRef="usd">3000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iea1be62040754a539970b84f8eac1b6f_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yOC9mcmFnOjdmZjA3MzdmMjAzNzRjYjdhYmQ3ZjJlNTk4NWI4YTRkL3RhYmxlOjkxNDM0MDZkNTUyZDQyOTM4MDVhZTQwYThmNzE1Zjk1L3RhYmxlcmFuZ2U6OTE0MzQwNmQ1NTJkNDI5MzgwNWFlNDBhOGY3MTVmOTVfMy01LTEtMS0zMDExNA_7137866d-ceea-4e87-b56a-84b2d6c18791"
      unitRef="usd">5320000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9dbcbe02abb3453190aa9f44125cf5ae_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yOC9mcmFnOjdmZjA3MzdmMjAzNzRjYjdhYmQ3ZjJlNTk4NWI4YTRkL3RhYmxlOjkxNDM0MDZkNTUyZDQyOTM4MDVhZTQwYThmNzE1Zjk1L3RhYmxlcmFuZ2U6OTE0MzQwNmQ1NTJkNDI5MzgwNWFlNDBhOGY3MTVmOTVfMy03LTEtMS0zMDExNA_bc6bd130-706c-4515-a1c8-bf9da728abc7"
      unitRef="usd">348000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iff5df0d7cf1048858d49c438dfd29807_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yOC9mcmFnOjdmZjA3MzdmMjAzNzRjYjdhYmQ3ZjJlNTk4NWI4YTRkL3RhYmxlOjkxNDM0MDZkNTUyZDQyOTM4MDVhZTQwYThmNzE1Zjk1L3RhYmxlcmFuZ2U6OTE0MzQwNmQ1NTJkNDI5MzgwNWFlNDBhOGY3MTVmOTVfMy05LTEtMS0zMDExNA_a1936385-896e-48cb-9a3d-9b8890f5d10b"
      unitRef="usd">-282000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib34d00c8a21a42028bfbffd3fd179e61_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yOC9mcmFnOjdmZjA3MzdmMjAzNzRjYjdhYmQ3ZjJlNTk4NWI4YTRkL3RhYmxlOjkxNDM0MDZkNTUyZDQyOTM4MDVhZTQwYThmNzE1Zjk1L3RhYmxlcmFuZ2U6OTE0MzQwNmQ1NTJkNDI5MzgwNWFlNDBhOGY3MTVmOTVfMy0xMS0xLTEtMzAxMTQ_727c0330-d6ed-4d65-8ee0-e5c5a964554d"
      unitRef="usd">5389000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="i4a9450e8c23c4155b219185f8e60d29a_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yOC9mcmFnOjdmZjA3MzdmMjAzNzRjYjdhYmQ3ZjJlNTk4NWI4YTRkL3RhYmxlOjkxNDM0MDZkNTUyZDQyOTM4MDVhZTQwYThmNzE1Zjk1L3RhYmxlcmFuZ2U6OTE0MzQwNmQ1NTJkNDI5MzgwNWFlNDBhOGY3MTVmOTVfNi03LTEtMS0zMDExNA_1b60a786-20ac-485e-b507-5fdf4a36802d"
      unitRef="usd">283000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ia0fd838af6c44d0ea866658c71b3dc7d_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yOC9mcmFnOjdmZjA3MzdmMjAzNzRjYjdhYmQ3ZjJlNTk4NWI4YTRkL3RhYmxlOjkxNDM0MDZkNTUyZDQyOTM4MDVhZTQwYThmNzE1Zjk1L3RhYmxlcmFuZ2U6OTE0MzQwNmQ1NTJkNDI5MzgwNWFlNDBhOGY3MTVmOTVfNi0xMS0xLTEtMzAxMTQ_d18cbac0-cef0-4f36-af68-64559d0bb570"
      unitRef="usd">283000000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i2aec23e974cd4bedb6e13b41b9375b78_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yOC9mcmFnOjdmZjA3MzdmMjAzNzRjYjdhYmQ3ZjJlNTk4NWI4YTRkL3RhYmxlOjkxNDM0MDZkNTUyZDQyOTM4MDVhZTQwYThmNzE1Zjk1L3RhYmxlcmFuZ2U6OTE0MzQwNmQ1NTJkNDI5MzgwNWFlNDBhOGY3MTVmOTVfNy05LTEtMS0zMDExNA_20bcea0c-bc7f-4e0e-824f-0bacd261bf06"
      unitRef="usd">-16000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ia0fd838af6c44d0ea866658c71b3dc7d_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yOC9mcmFnOjdmZjA3MzdmMjAzNzRjYjdhYmQ3ZjJlNTk4NWI4YTRkL3RhYmxlOjkxNDM0MDZkNTUyZDQyOTM4MDVhZTQwYThmNzE1Zjk1L3RhYmxlcmFuZ2U6OTE0MzQwNmQ1NTJkNDI5MzgwNWFlNDBhOGY3MTVmOTVfNy0xMS0xLTEtMzAxMTQ_c8b96924-7a11-474c-91f8-133ca32f51b9"
      unitRef="usd">-16000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ia0fd838af6c44d0ea866658c71b3dc7d_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yOC9mcmFnOjdmZjA3MzdmMjAzNzRjYjdhYmQ3ZjJlNTk4NWI4YTRkL3RhYmxlOjkxNDM0MDZkNTUyZDQyOTM4MDVhZTQwYThmNzE1Zjk1L3RhYmxlcmFuZ2U6OTE0MzQwNmQ1NTJkNDI5MzgwNWFlNDBhOGY3MTVmOTVfOC0xMS0xLTEtMzAxMTQ_98498386-3c19-4ef1-a5bf-a01fce15c888"
      unitRef="usd">267000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yOC9mcmFnOjdmZjA3MzdmMjAzNzRjYjdhYmQ3ZjJlNTk4NWI4YTRkL3RhYmxlOjkxNDM0MDZkNTUyZDQyOTM4MDVhZTQwYThmNzE1Zjk1L3RhYmxlcmFuZ2U6OTE0MzQwNmQ1NTJkNDI5MzgwNWFlNDBhOGY3MTVmOTVfMTAtMC0xLTEtMzAxMTQvdGV4dHJlZ2lvbjplYzNkMTliY2E2MjM0NWY3OTQzZjc3MmNlYjMwMmM4M18yOQ_e82a31e2-e69b-4866-9705-0e3d368269eb"
      unitRef="usdPerShare">0.210</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:DividendsCommonStockCash
      contextRef="i4a9450e8c23c4155b219185f8e60d29a_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yOC9mcmFnOjdmZjA3MzdmMjAzNzRjYjdhYmQ3ZjJlNTk4NWI4YTRkL3RhYmxlOjkxNDM0MDZkNTUyZDQyOTM4MDVhZTQwYThmNzE1Zjk1L3RhYmxlcmFuZ2U6OTE0MzQwNmQ1NTJkNDI5MzgwNWFlNDBhOGY3MTVmOTVfMTAtNy0xLTEtMzAxMTQ_26091341-87a3-45b2-a99b-9b64ffe207dd"
      unitRef="usd">63000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="ia0fd838af6c44d0ea866658c71b3dc7d_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yOC9mcmFnOjdmZjA3MzdmMjAzNzRjYjdhYmQ3ZjJlNTk4NWI4YTRkL3RhYmxlOjkxNDM0MDZkNTUyZDQyOTM4MDVhZTQwYThmNzE1Zjk1L3RhYmxlcmFuZ2U6OTE0MzQwNmQ1NTJkNDI5MzgwNWFlNDBhOGY3MTVmOTVfMTAtMTEtMS0xLTMwMTE0_1b950979-9af9-41b8-96e7-a8475f99880f"
      unitRef="usd">63000000</us-gaap:DividendsCommonStockCash>
    <a:Taxrelatedtosharesissued
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yOC9mcmFnOjdmZjA3MzdmMjAzNzRjYjdhYmQ3ZjJlNTk4NWI4YTRkL3RhYmxlOjkxNDM0MDZkNTUyZDQyOTM4MDVhZTQwYThmNzE1Zjk1L3RhYmxlcmFuZ2U6OTE0MzQwNmQ1NTJkNDI5MzgwNWFlNDBhOGY3MTVmOTVfMTEtMC0xLTEtMzAxMTQvdGV4dHJlZ2lvbjoyMWE4MzgxMTk4Y2I0NzFmYjA0NTk3NGE4NmFhY2FlMl80NQ_1e935791-76a7-44bc-96c1-2d158679f188"
      unitRef="usd">63000000</a:Taxrelatedtosharesissued>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i8344a08116e2475d8630eff99a4f60e4_D20211101-20220131"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yOC9mcmFnOjdmZjA3MzdmMjAzNzRjYjdhYmQ3ZjJlNTk4NWI4YTRkL3RhYmxlOjkxNDM0MDZkNTUyZDQyOTM4MDVhZTQwYThmNzE1Zjk1L3RhYmxlcmFuZ2U6OTE0MzQwNmQ1NTJkNDI5MzgwNWFlNDBhOGY3MTVmOTVfMTEtMS0xLTEtMzAxMTQ_b5ddeca4-3855-4e34-b4bf-bf900a55c411"
      unitRef="shares">972000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i0fcc3b5cded94fed9c8505ac4005e3a0_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yOC9mcmFnOjdmZjA3MzdmMjAzNzRjYjdhYmQ3ZjJlNTk4NWI4YTRkL3RhYmxlOjkxNDM0MDZkNTUyZDQyOTM4MDVhZTQwYThmNzE1Zjk1L3RhYmxlcmFuZ2U6OTE0MzQwNmQ1NTJkNDI5MzgwNWFlNDBhOGY3MTVmOTVfMTEtNS0xLTEtMzAxMTQ_6642cb7e-70e4-4171-ad77-8b88c88c0c0d"
      unitRef="usd">-36000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ia0fd838af6c44d0ea866658c71b3dc7d_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yOC9mcmFnOjdmZjA3MzdmMjAzNzRjYjdhYmQ3ZjJlNTk4NWI4YTRkL3RhYmxlOjkxNDM0MDZkNTUyZDQyOTM4MDVhZTQwYThmNzE1Zjk1L3RhYmxlcmFuZ2U6OTE0MzQwNmQ1NTJkNDI5MzgwNWFlNDBhOGY3MTVmOTVfMTEtMTEtMS0xLTMwMTE0_b8c5c6ab-1f0a-42dc-b9bc-a6ab005c63b4"
      unitRef="usd">-36000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="i8344a08116e2475d8630eff99a4f60e4_D20211101-20220131"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yOC9mcmFnOjdmZjA3MzdmMjAzNzRjYjdhYmQ3ZjJlNTk4NWI4YTRkL3RhYmxlOjkxNDM0MDZkNTUyZDQyOTM4MDVhZTQwYThmNzE1Zjk1L3RhYmxlcmFuZ2U6OTE0MzQwNmQ1NTJkNDI5MzgwNWFlNDBhOGY3MTVmOTVfMTItMS0xLTEtMzAxMTQ_bef82d76-c6d4-4ee5-9d4c-3a2457773221"
      unitRef="shares">2907000</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i0fcc3b5cded94fed9c8505ac4005e3a0_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yOC9mcmFnOjdmZjA3MzdmMjAzNzRjYjdhYmQ3ZjJlNTk4NWI4YTRkL3RhYmxlOjkxNDM0MDZkNTUyZDQyOTM4MDVhZTQwYThmNzE1Zjk1L3RhYmxlcmFuZ2U6OTE0MzQwNmQ1NTJkNDI5MzgwNWFlNDBhOGY3MTVmOTVfMTItNS0xLTEtMzAxMTQ_655f4c5d-75d4-4f8a-aee9-7d84ea7b0ccd"
      unitRef="usd">38000000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i4a9450e8c23c4155b219185f8e60d29a_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yOC9mcmFnOjdmZjA3MzdmMjAzNzRjYjdhYmQ3ZjJlNTk4NWI4YTRkL3RhYmxlOjkxNDM0MDZkNTUyZDQyOTM4MDVhZTQwYThmNzE1Zjk1L3RhYmxlcmFuZ2U6OTE0MzQwNmQ1NTJkNDI5MzgwNWFlNDBhOGY3MTVmOTVfMTItNy0xLTEtMzAxMTQ_6482eed4-27d7-4b49-827e-8309298deacb"
      unitRef="usd">409000000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="ia0fd838af6c44d0ea866658c71b3dc7d_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yOC9mcmFnOjdmZjA3MzdmMjAzNzRjYjdhYmQ3ZjJlNTk4NWI4YTRkL3RhYmxlOjkxNDM0MDZkNTUyZDQyOTM4MDVhZTQwYThmNzE1Zjk1L3RhYmxlcmFuZ2U6OTE0MzQwNmQ1NTJkNDI5MzgwNWFlNDBhOGY3MTVmOTVfMTItMTEtMS0xLTMwMTE0_ea0ee5ab-bdc9-44f1-9766-33bc93d6f456"
      unitRef="usd">447000000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i0fcc3b5cded94fed9c8505ac4005e3a0_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yOC9mcmFnOjdmZjA3MzdmMjAzNzRjYjdhYmQ3ZjJlNTk4NWI4YTRkL3RhYmxlOjkxNDM0MDZkNTUyZDQyOTM4MDVhZTQwYThmNzE1Zjk1L3RhYmxlcmFuZ2U6OTE0MzQwNmQ1NTJkNDI5MzgwNWFlNDBhOGY3MTVmOTVfMTMtNS0xLTEtMzAxMTQ_082f121b-8a67-4224-9739-6fcba582fbc2"
      unitRef="usd">44000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ia0fd838af6c44d0ea866658c71b3dc7d_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yOC9mcmFnOjdmZjA3MzdmMjAzNzRjYjdhYmQ3ZjJlNTk4NWI4YTRkL3RhYmxlOjkxNDM0MDZkNTUyZDQyOTM4MDVhZTQwYThmNzE1Zjk1L3RhYmxlcmFuZ2U6OTE0MzQwNmQ1NTJkNDI5MzgwNWFlNDBhOGY3MTVmOTVfMTMtMTEtMS0xLTMwMTE0_63e9648f-1c4f-40df-9c94-f97ad4ee6007"
      unitRef="usd">44000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:SharesIssued
      contextRef="i3137580680de43e8ae49a1ddbc453b8b_I20220131"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yOC9mcmFnOjdmZjA3MzdmMjAzNzRjYjdhYmQ3ZjJlNTk4NWI4YTRkL3RhYmxlOjkxNDM0MDZkNTUyZDQyOTM4MDVhZTQwYThmNzE1Zjk1L3RhYmxlcmFuZ2U6OTE0MzQwNmQ1NTJkNDI5MzgwNWFlNDBhOGY3MTVmOTVfMTQtMS0xLTEtMzAxMTQ_e991c44b-169b-4859-b61d-44b5e55fc4b6"
      unitRef="shares">300273000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3137580680de43e8ae49a1ddbc453b8b_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yOC9mcmFnOjdmZjA3MzdmMjAzNzRjYjdhYmQ3ZjJlNTk4NWI4YTRkL3RhYmxlOjkxNDM0MDZkNTUyZDQyOTM4MDVhZTQwYThmNzE1Zjk1L3RhYmxlcmFuZ2U6OTE0MzQwNmQ1NTJkNDI5MzgwNWFlNDBhOGY3MTVmOTVfMTQtMy0xLTEtMzAxMTQ_29685cb6-e8cb-40ab-a680-8643d03feb31"
      unitRef="usd">3000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib3fb881f611641bf8690679c64de1aaf_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yOC9mcmFnOjdmZjA3MzdmMjAzNzRjYjdhYmQ3ZjJlNTk4NWI4YTRkL3RhYmxlOjkxNDM0MDZkNTUyZDQyOTM4MDVhZTQwYThmNzE1Zjk1L3RhYmxlcmFuZ2U6OTE0MzQwNmQ1NTJkNDI5MzgwNWFlNDBhOGY3MTVmOTVfMTQtNS0xLTEtMzAxMTQ_71b524cf-a5f9-4fb4-8ba3-784d26f64f34"
      unitRef="usd">5290000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i57656528186c4372ae07486570f387e9_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yOC9mcmFnOjdmZjA3MzdmMjAzNzRjYjdhYmQ3ZjJlNTk4NWI4YTRkL3RhYmxlOjkxNDM0MDZkNTUyZDQyOTM4MDVhZTQwYThmNzE1Zjk1L3RhYmxlcmFuZ2U6OTE0MzQwNmQ1NTJkNDI5MzgwNWFlNDBhOGY3MTVmOTVfMTQtNy0xLTEtMzAxMTQ_39c0d4ac-d5bf-48ed-a4d1-088c6ed3ea92"
      unitRef="usd">159000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i27134d71dd424779ab254848725e52c6_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yOC9mcmFnOjdmZjA3MzdmMjAzNzRjYjdhYmQ3ZjJlNTk4NWI4YTRkL3RhYmxlOjkxNDM0MDZkNTUyZDQyOTM4MDVhZTQwYThmNzE1Zjk1L3RhYmxlcmFuZ2U6OTE0MzQwNmQ1NTJkNDI5MzgwNWFlNDBhOGY3MTVmOTVfMTQtOS0xLTEtMzAxMTQ_aae5d0f0-68b6-4fa9-8ccb-82926102af68"
      unitRef="usd">-298000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic1e6a76918c24df4abe13257fdfcdea9_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yOC9mcmFnOjdmZjA3MzdmMjAzNzRjYjdhYmQ3ZjJlNTk4NWI4YTRkL3RhYmxlOjkxNDM0MDZkNTUyZDQyOTM4MDVhZTQwYThmNzE1Zjk1L3RhYmxlcmFuZ2U6OTE0MzQwNmQ1NTJkNDI5MzgwNWFlNDBhOGY3MTVmOTVfMTQtMTEtMS0xLTMwMTE0_0d8d44a5-f8fd-44f7-b049-c338ef5acd21"
      unitRef="usd">5154000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesIssued
      contextRef="i482974eb49534930b9164c76d7ed1578_I20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yOC9mcmFnOjdmZjA3MzdmMjAzNzRjYjdhYmQ3ZjJlNTk4NWI4YTRkL3RhYmxlOjFkYWE3OTE0MGU0YzQ1YThiZDk0YTc2MGQ0Zjc2ZjkyL3RhYmxlcmFuZ2U6MWRhYTc5MTQwZTRjNDVhOGJkOTRhNzYwZDRmNzZmOTJfNC0xLTEtMS0zMDExNA_95bec27b-5a10-4be9-9e8f-7a8150eb9a83"
      unitRef="shares">306198000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i482974eb49534930b9164c76d7ed1578_I20201031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yOC9mcmFnOjdmZjA3MzdmMjAzNzRjYjdhYmQ3ZjJlNTk4NWI4YTRkL3RhYmxlOjFkYWE3OTE0MGU0YzQ1YThiZDk0YTc2MGQ0Zjc2ZjkyL3RhYmxlcmFuZ2U6MWRhYTc5MTQwZTRjNDVhOGJkOTRhNzYwZDRmNzZmOTJfNC0zLTEtMS0zMDExNA_c661c591-fc94-4eb5-a63f-731c25e8c52e"
      unitRef="usd">3000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i64d7c2dd15f64641ba78382251046b62_I20201031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yOC9mcmFnOjdmZjA3MzdmMjAzNzRjYjdhYmQ3ZjJlNTk4NWI4YTRkL3RhYmxlOjFkYWE3OTE0MGU0YzQ1YThiZDk0YTc2MGQ0Zjc2ZjkyL3RhYmxlcmFuZ2U6MWRhYTc5MTQwZTRjNDVhOGJkOTRhNzYwZDRmNzZmOTJfNC01LTEtMS0zMDExNA_8b2debff-30df-482b-bd15-142f91b449be"
      unitRef="usd">5311000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i154f991a704349d59b962b4dd9d48c7e_I20201031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yOC9mcmFnOjdmZjA3MzdmMjAzNzRjYjdhYmQ3ZjJlNTk4NWI4YTRkL3RhYmxlOjFkYWE3OTE0MGU0YzQ1YThiZDk0YTc2MGQ0Zjc2ZjkyL3RhYmxlcmFuZ2U6MWRhYTc5MTQwZTRjNDVhOGJkOTRhNzYwZDRmNzZmOTJfNC03LTEtMS0zMDExNA_faa5eaa9-6cc6-44c3-af76-23c268274ab3"
      unitRef="usd">81000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i375472e47a0b4ca3b7720d165b3c1035_I20201031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yOC9mcmFnOjdmZjA3MzdmMjAzNzRjYjdhYmQ3ZjJlNTk4NWI4YTRkL3RhYmxlOjFkYWE3OTE0MGU0YzQ1YThiZDk0YTc2MGQ0Zjc2ZjkyL3RhYmxlcmFuZ2U6MWRhYTc5MTQwZTRjNDVhOGJkOTRhNzYwZDRmNzZmOTJfNC05LTEtMS0zMDExNA_7a3f985a-e1c0-40dd-8244-7c909165b5bf"
      unitRef="usd">-522000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i34129239eb114151a36af1066ee3079f_I20201031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yOC9mcmFnOjdmZjA3MzdmMjAzNzRjYjdhYmQ3ZjJlNTk4NWI4YTRkL3RhYmxlOjFkYWE3OTE0MGU0YzQ1YThiZDk0YTc2MGQ0Zjc2ZjkyL3RhYmxlcmFuZ2U6MWRhYTc5MTQwZTRjNDVhOGJkOTRhNzYwZDRmNzZmOTJfNC0xMS0xLTEtMzAxMTQ_8f0f12f0-aa77-40be-b065-9467f55c4695"
      unitRef="usd">4873000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="i604f8a60030549769dd5a3f2943b52bb_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yOC9mcmFnOjdmZjA3MzdmMjAzNzRjYjdhYmQ3ZjJlNTk4NWI4YTRkL3RhYmxlOjFkYWE3OTE0MGU0YzQ1YThiZDk0YTc2MGQ0Zjc2ZjkyL3RhYmxlcmFuZ2U6MWRhYTc5MTQwZTRjNDVhOGJkOTRhNzYwZDRmNzZmOTJfNy03LTEtMS0zMDExNA_066aa6a3-3fee-4c16-bc2d-5c77eeb05b35"
      unitRef="usd">288000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i2331e3a5c61640af8f9c694b08630d9e_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yOC9mcmFnOjdmZjA3MzdmMjAzNzRjYjdhYmQ3ZjJlNTk4NWI4YTRkL3RhYmxlOjFkYWE3OTE0MGU0YzQ1YThiZDk0YTc2MGQ0Zjc2ZjkyL3RhYmxlcmFuZ2U6MWRhYTc5MTQwZTRjNDVhOGJkOTRhNzYwZDRmNzZmOTJfNy0xMS0xLTEtMzAxMTQ_ef340cbd-b9a3-4d70-b11b-deb67fcab4e3"
      unitRef="usd">288000000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i7f2ff5551bff49caba634f1bf4245966_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yOC9mcmFnOjdmZjA3MzdmMjAzNzRjYjdhYmQ3ZjJlNTk4NWI4YTRkL3RhYmxlOjFkYWE3OTE0MGU0YzQ1YThiZDk0YTc2MGQ0Zjc2ZjkyL3RhYmxlcmFuZ2U6MWRhYTc5MTQwZTRjNDVhOGJkOTRhNzYwZDRmNzZmOTJfOC05LTEtMS0zMDExNA_c18bd521-7fb1-4d9e-98d2-9345f64ac8b7"
      unitRef="usd">53000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i2331e3a5c61640af8f9c694b08630d9e_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yOC9mcmFnOjdmZjA3MzdmMjAzNzRjYjdhYmQ3ZjJlNTk4NWI4YTRkL3RhYmxlOjFkYWE3OTE0MGU0YzQ1YThiZDk0YTc2MGQ0Zjc2ZjkyL3RhYmxlcmFuZ2U6MWRhYTc5MTQwZTRjNDVhOGJkOTRhNzYwZDRmNzZmOTJfOC0xMS0xLTEtMzAxMTQ_bdc8113c-8582-450d-a446-ae843eee8803"
      unitRef="usd">53000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i2331e3a5c61640af8f9c694b08630d9e_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yOC9mcmFnOjdmZjA3MzdmMjAzNzRjYjdhYmQ3ZjJlNTk4NWI4YTRkL3RhYmxlOjFkYWE3OTE0MGU0YzQ1YThiZDk0YTc2MGQ0Zjc2ZjkyL3RhYmxlcmFuZ2U6MWRhYTc5MTQwZTRjNDVhOGJkOTRhNzYwZDRmNzZmOTJfOS0xMS0xLTEtMzAxMTQ_46003df7-c8b4-43f1-882b-d0aa771db243"
      unitRef="usd">341000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yOC9mcmFnOjdmZjA3MzdmMjAzNzRjYjdhYmQ3ZjJlNTk4NWI4YTRkL3RhYmxlOjFkYWE3OTE0MGU0YzQ1YThiZDk0YTc2MGQ0Zjc2ZjkyL3RhYmxlcmFuZ2U6MWRhYTc5MTQwZTRjNDVhOGJkOTRhNzYwZDRmNzZmOTJfMTEtMC0xLTEtMzAxMTQvdGV4dHJlZ2lvbjo0NGMwNDZhMTQ2N2U0MzdlYTljNDAyMDIxN2QwOTRiMl8yOQ_6c9a3b51-3489-4422-822f-a9e6ef87c5ea"
      unitRef="usdPerShare">0.194</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:DividendsCommonStockCash
      contextRef="i604f8a60030549769dd5a3f2943b52bb_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yOC9mcmFnOjdmZjA3MzdmMjAzNzRjYjdhYmQ3ZjJlNTk4NWI4YTRkL3RhYmxlOjFkYWE3OTE0MGU0YzQ1YThiZDk0YTc2MGQ0Zjc2ZjkyL3RhYmxlcmFuZ2U6MWRhYTc5MTQwZTRjNDVhOGJkOTRhNzYwZDRmNzZmOTJfMTEtNy0xLTEtMzAxMTQ_f9b557e5-e49b-4274-aec3-2bde49edcb08"
      unitRef="usd">59000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="i2331e3a5c61640af8f9c694b08630d9e_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yOC9mcmFnOjdmZjA3MzdmMjAzNzRjYjdhYmQ3ZjJlNTk4NWI4YTRkL3RhYmxlOjFkYWE3OTE0MGU0YzQ1YThiZDk0YTc2MGQ0Zjc2ZjkyL3RhYmxlcmFuZ2U6MWRhYTc5MTQwZTRjNDVhOGJkOTRhNzYwZDRmNzZmOTJfMTEtMTEtMS0xLTMwMTE0_d6a29272-f5b1-4287-b1b4-c64380478376"
      unitRef="usd">59000000</us-gaap:DividendsCommonStockCash>
    <a:Taxrelatedtosharesissued
      contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yOC9mcmFnOjdmZjA3MzdmMjAzNzRjYjdhYmQ3ZjJlNTk4NWI4YTRkL3RhYmxlOjFkYWE3OTE0MGU0YzQ1YThiZDk0YTc2MGQ0Zjc2ZjkyL3RhYmxlcmFuZ2U6MWRhYTc5MTQwZTRjNDVhOGJkOTRhNzYwZDRmNzZmOTJfMTItMC0xLTEtMzAxMTQvdGV4dHJlZ2lvbjowMDYzODhkNGM0NTA0ZTA3ODA1MmM0MDNiMTNmOGQxNV80NQ_476dbd09-e1c7-4715-8614-dcb1811371d5"
      unitRef="usd">72000000</a:Taxrelatedtosharesissued>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i1bd14aef64584a21865d2ec3dfd5e629_D20201101-20210131"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yOC9mcmFnOjdmZjA3MzdmMjAzNzRjYjdhYmQ3ZjJlNTk4NWI4YTRkL3RhYmxlOjFkYWE3OTE0MGU0YzQ1YThiZDk0YTc2MGQ0Zjc2ZjkyL3RhYmxlcmFuZ2U6MWRhYTc5MTQwZTRjNDVhOGJkOTRhNzYwZDRmNzZmOTJfMTItMS0xLTEtMzAxMTQ_0a826878-be07-4e85-82df-82bd4556bbfb"
      unitRef="shares">1592000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i0afeb8dd36084a53aec0f9c3a708c97c_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yOC9mcmFnOjdmZjA3MzdmMjAzNzRjYjdhYmQ3ZjJlNTk4NWI4YTRkL3RhYmxlOjFkYWE3OTE0MGU0YzQ1YThiZDk0YTc2MGQ0Zjc2ZjkyL3RhYmxlcmFuZ2U6MWRhYTc5MTQwZTRjNDVhOGJkOTRhNzYwZDRmNzZmOTJfMTItNS0xLTEtMzAxMTQ_d7d67afc-738c-4a72-b79f-bff37ed5cca6"
      unitRef="usd">-47000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i2331e3a5c61640af8f9c694b08630d9e_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yOC9mcmFnOjdmZjA3MzdmMjAzNzRjYjdhYmQ3ZjJlNTk4NWI4YTRkL3RhYmxlOjFkYWE3OTE0MGU0YzQ1YThiZDk0YTc2MGQ0Zjc2ZjkyL3RhYmxlcmFuZ2U6MWRhYTc5MTQwZTRjNDVhOGJkOTRhNzYwZDRmNzZmOTJfMTItMTEtMS0xLTMwMTE0_fb42ac18-57bc-439b-b969-0a85e979a7bb"
      unitRef="usd">-47000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="i1bd14aef64584a21865d2ec3dfd5e629_D20201101-20210131"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yOC9mcmFnOjdmZjA3MzdmMjAzNzRjYjdhYmQ3ZjJlNTk4NWI4YTRkL3RhYmxlOjFkYWE3OTE0MGU0YzQ1YThiZDk0YTc2MGQ0Zjc2ZjkyL3RhYmxlcmFuZ2U6MWRhYTc5MTQwZTRjNDVhOGJkOTRhNzYwZDRmNzZmOTJfMTMtMS0xLTEtMzAxMTQ_75ceebd3-0f28-4d52-a455-b65b4c14f0e3"
      unitRef="shares">2885000</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i0afeb8dd36084a53aec0f9c3a708c97c_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yOC9mcmFnOjdmZjA3MzdmMjAzNzRjYjdhYmQ3ZjJlNTk4NWI4YTRkL3RhYmxlOjFkYWE3OTE0MGU0YzQ1YThiZDk0YTc2MGQ0Zjc2ZjkyL3RhYmxlcmFuZ2U6MWRhYTc5MTQwZTRjNDVhOGJkOTRhNzYwZDRmNzZmOTJfMTMtNS0xLTEtMzAxMTQ_95124562-458f-4309-8428-f86115140032"
      unitRef="usd">38000000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i604f8a60030549769dd5a3f2943b52bb_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yOC9mcmFnOjdmZjA3MzdmMjAzNzRjYjdhYmQ3ZjJlNTk4NWI4YTRkL3RhYmxlOjFkYWE3OTE0MGU0YzQ1YThiZDk0YTc2MGQ0Zjc2ZjkyL3RhYmxlcmFuZ2U6MWRhYTc5MTQwZTRjNDVhOGJkOTRhNzYwZDRmNzZmOTJfMTMtNy0xLTEtMzAxMTQ_fb0d787e-9151-4926-81fd-5798b8b10986"
      unitRef="usd">306000000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i2331e3a5c61640af8f9c694b08630d9e_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yOC9mcmFnOjdmZjA3MzdmMjAzNzRjYjdhYmQ3ZjJlNTk4NWI4YTRkL3RhYmxlOjFkYWE3OTE0MGU0YzQ1YThiZDk0YTc2MGQ0Zjc2ZjkyL3RhYmxlcmFuZ2U6MWRhYTc5MTQwZTRjNDVhOGJkOTRhNzYwZDRmNzZmOTJfMTMtMTEtMS0xLTMwMTE0_cc32718b-3d27-4cbd-8856-adbebdd4564d"
      unitRef="usd">344000000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i0afeb8dd36084a53aec0f9c3a708c97c_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yOC9mcmFnOjdmZjA3MzdmMjAzNzRjYjdhYmQ3ZjJlNTk4NWI4YTRkL3RhYmxlOjFkYWE3OTE0MGU0YzQ1YThiZDk0YTc2MGQ0Zjc2ZjkyL3RhYmxlcmFuZ2U6MWRhYTc5MTQwZTRjNDVhOGJkOTRhNzYwZDRmNzZmOTJfMTQtNS0xLTEtMzAxMTQ_84d58063-38a5-46b2-876d-7c47ccc20c4b"
      unitRef="usd">40000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i2331e3a5c61640af8f9c694b08630d9e_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yOC9mcmFnOjdmZjA3MzdmMjAzNzRjYjdhYmQ3ZjJlNTk4NWI4YTRkL3RhYmxlOjFkYWE3OTE0MGU0YzQ1YThiZDk0YTc2MGQ0Zjc2ZjkyL3RhYmxlcmFuZ2U6MWRhYTc5MTQwZTRjNDVhOGJkOTRhNzYwZDRmNzZmOTJfMTQtMTEtMS0xLTMwMTE0_8de14f76-df16-4d7b-b9ec-9e18016922ec"
      unitRef="usd">40000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:SharesIssued
      contextRef="i9aec1350d194433d9ba1d2d5b214d83d_I20210131"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yOC9mcmFnOjdmZjA3MzdmMjAzNzRjYjdhYmQ3ZjJlNTk4NWI4YTRkL3RhYmxlOjFkYWE3OTE0MGU0YzQ1YThiZDk0YTc2MGQ0Zjc2ZjkyL3RhYmxlcmFuZ2U6MWRhYTc5MTQwZTRjNDVhOGJkOTRhNzYwZDRmNzZmOTJfMTUtMS0xLTEtMzAxMTQ_d95585df-3c48-4e50-929a-8939f752cf9f"
      unitRef="shares">304905000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9aec1350d194433d9ba1d2d5b214d83d_I20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yOC9mcmFnOjdmZjA3MzdmMjAzNzRjYjdhYmQ3ZjJlNTk4NWI4YTRkL3RhYmxlOjFkYWE3OTE0MGU0YzQ1YThiZDk0YTc2MGQ0Zjc2ZjkyL3RhYmxlcmFuZ2U6MWRhYTc5MTQwZTRjNDVhOGJkOTRhNzYwZDRmNzZmOTJfMTUtMy0xLTEtMzAxMTQ_99851b1e-737b-4a55-b702-a56058834f34"
      unitRef="usd">3000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1c25caed3b0b4859a0d9e2aea3c18f22_I20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yOC9mcmFnOjdmZjA3MzdmMjAzNzRjYjdhYmQ3ZjJlNTk4NWI4YTRkL3RhYmxlOjFkYWE3OTE0MGU0YzQ1YThiZDk0YTc2MGQ0Zjc2ZjkyL3RhYmxlcmFuZ2U6MWRhYTc5MTQwZTRjNDVhOGJkOTRhNzYwZDRmNzZmOTJfMTUtNS0xLTEtMzAxMTQ_973b8dc4-1e72-4c63-868a-fff0c41f0a3c"
      unitRef="usd">5266000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4a4f445b002141b5ad863186edfae11b_I20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yOC9mcmFnOjdmZjA3MzdmMjAzNzRjYjdhYmQ3ZjJlNTk4NWI4YTRkL3RhYmxlOjFkYWE3OTE0MGU0YzQ1YThiZDk0YTc2MGQ0Zjc2ZjkyL3RhYmxlcmFuZ2U6MWRhYTc5MTQwZTRjNDVhOGJkOTRhNzYwZDRmNzZmOTJfMTUtNy0xLTEtMzAxMTQ_4af68fa0-a4c7-4a1e-a177-fc30c899b569"
      unitRef="usd">4000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i36c64c32e7194082966d03edc3758994_I20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yOC9mcmFnOjdmZjA3MzdmMjAzNzRjYjdhYmQ3ZjJlNTk4NWI4YTRkL3RhYmxlOjFkYWE3OTE0MGU0YzQ1YThiZDk0YTc2MGQ0Zjc2ZjkyL3RhYmxlcmFuZ2U6MWRhYTc5MTQwZTRjNDVhOGJkOTRhNzYwZDRmNzZmOTJfMTUtOS0xLTEtMzAxMTQ_f2eac40f-234d-4045-a70e-c9e5026ee474"
      unitRef="usd">-469000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib3fb564fc37141f6bcd78ffd8a2e8e27_I20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8yOC9mcmFnOjdmZjA3MzdmMjAzNzRjYjdhYmQ3ZjJlNTk4NWI4YTRkL3RhYmxlOjFkYWE3OTE0MGU0YzQ1YThiZDk0YTc2MGQ0Zjc2ZjkyL3RhYmxlcmFuZ2U6MWRhYTc5MTQwZTRjNDVhOGJkOTRhNzYwZDRmNzZmOTJfMTUtMTEtMS0xLTMwMTE0_9a18d376-c0e7-4e14-856e-9e38481c70ff"
      unitRef="usd">4804000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8zNC9mcmFnOjZlZDA2OGNhMmZmODQyNTNhNDM3MTNmNGMzZmNlOThlL3RleHRyZWdpb246NmVkMDY4Y2EyZmY4NDI1M2E0MzcxM2Y0YzNmY2U5OGVfNzAxNw_0b364d37-c861-40a4-a982-c1602c777767">OVERVIEW, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Overview. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Agilent Technologies, Inc. ("we," "Agilent" or the "company"), incorporated in Delaware in May 1999, is a global leader in life sciences, diagnostics and applied chemical markets, providing application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our fiscal year-end is October&#160;31, and our fiscal quarters end on January&#160;31, April&#160;30 and July&#160;31. Unless otherwise stated, these dates refer to our fiscal year and fiscal quarters.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;New Segment Structure.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; In the first quarter of fiscal year 2022, we announced a change in organizational structure designed to enable our growth strategies and strengthen our focus on customers. Our chemistries and supplies business and our remarketed instruments business moved from our Agilent CrossLab business segment to our life sciences and applied markets business segment. Service revenue and cost of sales related to the previous acquisition of BioTek moved from our life sciences and applied markets business segment to our Agilent CrossLab business segment. Following this reorganization, we continue to have three business segments (life sciences and applied markets, diagnostics and genomics and Agilent CrossLab), each of which continues to comprise a reportable segment. We are reporting under this new structure beginning with this Quarterly Report on Form 10-Q for the period ended January 31, 2022 and historical financial segment information has been recast to conform to this new presentation in our financial statements and accompanying notes. There was no change to our diagnostics and genomics business segment.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. We have prepared the accompanying financial data for the three months ended January&#160;31, 2022 and 2021 pursuant to the rules&#160;and regulations of the U.S. Securities and Exchange Commission (&#x201c;SEC&#x201d;). Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles (&#x201c;GAAP&#x201d;) in the U.S. have been condensed or omitted pursuant to such rules&#160;and regulations. The October&#160;31, 2021 condensed balance sheet data was derived from audited financial statements but does not include all the disclosures required in audited financial statements by U.S. GAAP. The accompanying financial data and information should be read in conjunction with our Annual Report on Form 10-K for the fiscal year ended October&#160;31, 2021.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the opinion of management, the accompanying condensed consolidated financial statements contain all normal and recurring adjustments necessary for a fair statement of our condensed consolidated balance sheet as of January&#160;31, 2022 and October&#160;31, 2021, condensed consolidated statement of comprehensive income (loss) for the three months ended January&#160;31, 2022 and 2021, condensed consolidated statement of operations for the three months ended January&#160;31, 2022 and 2021, condensed consolidated statement of cash flows for the three months ended January&#160;31, 2022 and 2021 and condensed consolidated statement of equity for the three months ended January&#160;31, 2022 and 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Use of Estimates.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The preparation of condensed consolidated financial statements in accordance with GAAP in the U.S. requires management to make estimates and assumptions that affect the amounts reported in our condensed consolidated financial statements and accompanying notes. Management bases its estimates on historical experience and various other assumptions believed to be reasonable. Although these estimates are based on management&#x2019;s best knowledge of current events and actions that may impact the company in the future, actual results may be different from the estimates. Our critical accounting policies are those that affect our financial statements materially and involve difficult, subjective or complex judgments by management. Those policies are revenue recognition, inventory valuation, retirement and post-retirement benefit plan assumptions, valuation of goodwill and purchased intangible assets and accounting for income taxes.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Restricted Cash and Restricted Cash Equivalents. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restricted cash and restricted cash equivalents are included with cash and cash equivalents when reconciling the beginning-of-period and end-of-period total amounts shown on the statement of cash flows.  A reconciliation of cash, cash equivalents and restricted cash to the condensed consolidated balance sheet follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.863%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.053%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;January 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 31&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash included in other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash, cash equivalents and restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,490&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Leases. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of January&#160;31, 2022 and October&#160;31, 2021, operating lease right-of-use assets where we are the lessee were  $170&#160;million and $178&#160;million, respectively, and were included within other assets in the accompanying condensed consolidated balance sheet. The associated operating lease liabilities were $174&#160;million and $182&#160;million as of January&#160;31, 2022 and October&#160;31, 2021, respectively, and were included in other accrued liabilities and other long-term liabilities in the accompanying condensed consolidated balance sheet. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Variable Interest Entities. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We make a determination upon entering into an arrangement whether an entity in which we have made an investment is considered a Variable Interest Entity (&#x201c;VIE&#x201d;). We evaluate our investments in privately held companies on an ongoing basis. We have determined that as of January&#160;31, 2022 and October&#160;31, 2021, there were no VIEs required to be consolidated in our consolidated financial statements because we do not have a controlling financial interest in any of the VIEs in which we have invested nor are we the primary beneficiary. We account for these investments under either the equity method or as equity investments without readily determinable fair value ("RDFV"), depending on the circumstances. We periodically reassess whether we are the primary beneficiary of a VIE. The reassessment process considers whether we have acquired the power to direct the most significant activities of the VIE through changes in governing documents or other circumstances. We also reconsider whether entities previously determined not to be VIEs have become VIEs and vice-versa, based on changes in facts and circumstances including changes in contractual arrangements and capital structure.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of January&#160;31, 2022 and October&#160;31, 2021, the total carrying value of investments and loans in privately held companies considered as VIEs was $79 million and $76 million respectively. The maximum exposure is equal to the carrying value because we do not have future funding commitments. The investments are included on the long-term investments line and the loans on the other current assets and other assets lines (depending upon tenure of loan) on the condensed consolidated balance sheet.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value of Financial Instruments.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The carrying values of certain of our financial instruments including cash and cash equivalents, accounts receivable, accounts payable, accrued compensation and other accrued liabilities approximate fair value because of their short maturities. The fair value of short-term and long-term equity investments which are readily determinable, and which are not accounted under the equity method are reported at fair value using quoted market prices for those securities when available with gains and losses included in net income. The fair value of long-term equity investments which are not readily determinable, and which are not accounted under the equity method are reported at cost with adjustments for observable changes in prices or impairments included in net income. As of January&#160;31, 2022, the fair value of our senior notes was $2,710&#160;million with a carrying value of $2,730 million.  This compares to a fair value of $2,806&#160;million with a carrying value of $2,729 million as of October&#160;31, 2021. The change in the fair value over carrying value in the three months ended January&#160;31, 2022 is primarily due to increased market interest rates. The fair value was calculated from quoted prices which are primarily Level 1 inputs under the accounting guidance. The fair value of foreign currency contracts used for hedging purposes is estimated internally by using inputs tied to active markets. These inputs, for example, interest rate yield curves, foreign exchange rates, and forward and spot prices for currencies are observable in the market or&#160;can be corroborated by observable market data for substantially the full term of the assets or liabilities. See also Note&#160;9, "Fair Value Measurements" for additional information on the fair value of financial instruments and contingent consideration.&lt;/span&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock>
    <us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8zNC9mcmFnOjZlZDA2OGNhMmZmODQyNTNhNDM3MTNmNGMzZmNlOThlL3RleHRyZWdpb246NmVkMDY4Y2EyZmY4NDI1M2E0MzcxM2Y0YzNmY2U5OGVfNzAyNw_d4013953-cf73-451e-93da-11e34934d854">&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Overview. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Agilent Technologies, Inc. ("we," "Agilent" or the "company"), incorporated in Delaware in May 1999, is a global leader in life sciences, diagnostics and applied chemical markets, providing application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our fiscal year-end is October&#160;31, and our fiscal quarters end on January&#160;31, April&#160;30 and July&#160;31. Unless otherwise stated, these dates refer to our fiscal year and fiscal quarters.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;New Segment Structure.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; In the first quarter of fiscal year 2022, we announced a change in organizational structure designed to enable our growth strategies and strengthen our focus on customers. Our chemistries and supplies business and our remarketed instruments business moved from our Agilent CrossLab business segment to our life sciences and applied markets business segment. Service revenue and cost of sales related to the previous acquisition of BioTek moved from our life sciences and applied markets business segment to our Agilent CrossLab business segment. Following this reorganization, we continue to have three business segments (life sciences and applied markets, diagnostics and genomics and Agilent CrossLab), each of which continues to comprise a reportable segment. We are reporting under this new structure beginning with this Quarterly Report on Form 10-Q for the period ended January 31, 2022 and historical financial segment information has been recast to conform to this new presentation in our financial statements and accompanying notes. There was no change to our diagnostics and genomics business segment.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. We have prepared the accompanying financial data for the three months ended January&#160;31, 2022 and 2021 pursuant to the rules&#160;and regulations of the U.S. Securities and Exchange Commission (&#x201c;SEC&#x201d;). Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles (&#x201c;GAAP&#x201d;) in the U.S. have been condensed or omitted pursuant to such rules&#160;and regulations. The October&#160;31, 2021 condensed balance sheet data was derived from audited financial statements but does not include all the disclosures required in audited financial statements by U.S. GAAP. The accompanying financial data and information should be read in conjunction with our Annual Report on Form 10-K for the fiscal year ended October&#160;31, 2021.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the opinion of management, the accompanying condensed consolidated financial statements contain all normal and recurring adjustments necessary for a fair statement of our condensed consolidated balance sheet as of January&#160;31, 2022 and October&#160;31, 2021, condensed consolidated statement of comprehensive income (loss) for the three months ended January&#160;31, 2022 and 2021, condensed consolidated statement of operations for the three months ended January&#160;31, 2022 and 2021, condensed consolidated statement of cash flows for the three months ended January&#160;31, 2022 and 2021 and condensed consolidated statement of equity for the three months ended January&#160;31, 2022 and 2021.&lt;/span&gt;&lt;/div&gt;</us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8zNC9mcmFnOjZlZDA2OGNhMmZmODQyNTNhNDM3MTNmNGMzZmNlOThlL3RleHRyZWdpb246NmVkMDY4Y2EyZmY4NDI1M2E0MzcxM2Y0YzNmY2U5OGVfNzAxMg_e6843207-9692-4e3b-a906-4a4d92045913">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Use of Estimates.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The preparation of condensed consolidated financial statements in accordance with GAAP in the U.S. requires management to make estimates and assumptions that affect the amounts reported in our condensed consolidated financial statements and accompanying notes. Management bases its estimates on historical experience and various other assumptions believed to be reasonable. Although these estimates are based on management&#x2019;s best knowledge of current events and actions that may impact the company in the future, actual results may be different from the estimates. Our critical accounting policies are those that affect our financial statements materially and involve difficult, subjective or complex judgments by management. Those policies are revenue recognition, inventory valuation, retirement and post-retirement benefit plan assumptions, valuation of goodwill and purchased intangible assets and accounting for income taxes.&lt;/span&gt;</us-gaap:UseOfEstimates>
    <us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8zNC9mcmFnOjZlZDA2OGNhMmZmODQyNTNhNDM3MTNmNGMzZmNlOThlL3RleHRyZWdpb246NmVkMDY4Y2EyZmY4NDI1M2E0MzcxM2Y0YzNmY2U5OGVfNzAyNg_8ccf5a4f-22a4-4cc6-a8fc-19bb2ce84af7">&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Restricted Cash and Restricted Cash Equivalents. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restricted cash and restricted cash equivalents are included with cash and cash equivalents when reconciling the beginning-of-period and end-of-period total amounts shown on the statement of cash flows.  A reconciliation of cash, cash equivalents and restricted cash to the condensed consolidated balance sheet follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.863%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.053%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;January 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 31&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash included in other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash, cash equivalents and restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,490&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock>
    <us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8zNC9mcmFnOjZlZDA2OGNhMmZmODQyNTNhNDM3MTNmNGMzZmNlOThlL3RleHRyZWdpb246NmVkMDY4Y2EyZmY4NDI1M2E0MzcxM2Y0YzNmY2U5OGVfNzAyNg_a64d3795-4ced-4e24-82ad-64bf673bc54f">&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Restricted Cash and Restricted Cash Equivalents. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restricted cash and restricted cash equivalents are included with cash and cash equivalents when reconciling the beginning-of-period and end-of-period total amounts shown on the statement of cash flows.  A reconciliation of cash, cash equivalents and restricted cash to the condensed consolidated balance sheet follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.863%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.053%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;January 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 31&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash included in other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash, cash equivalents and restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,490&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8zNC9mcmFnOjZlZDA2OGNhMmZmODQyNTNhNDM3MTNmNGMzZmNlOThlL3RhYmxlOjM4MDUzMGFhNTIyYTQ1MjliZjQyMzAzMzg0MzNhM2Q2L3RhYmxlcmFuZ2U6MzgwNTMwYWE1MjJhNDUyOWJmNDIzMDMzODQzM2EzZDZfMy0xLTEtMS0zMDExNA_19f91b26-409a-4ac2-9595-6cb42f0740d4"
      unitRef="usd">1113000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i6390807210d74c6f9cae496ea2122a5a_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8zNC9mcmFnOjZlZDA2OGNhMmZmODQyNTNhNDM3MTNmNGMzZmNlOThlL3RhYmxlOjM4MDUzMGFhNTIyYTQ1MjliZjQyMzAzMzg0MzNhM2Q2L3RhYmxlcmFuZ2U6MzgwNTMwYWE1MjJhNDUyOWJmNDIzMDMzODQzM2EzZDZfMy0zLTEtMS0zMDExNA_925233fe-cdd7-447b-9bba-23794703e822"
      unitRef="usd">1484000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCash
      contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8zNC9mcmFnOjZlZDA2OGNhMmZmODQyNTNhNDM3MTNmNGMzZmNlOThlL3RhYmxlOjM4MDUzMGFhNTIyYTQ1MjliZjQyMzAzMzg0MzNhM2Q2L3RhYmxlcmFuZ2U6MzgwNTMwYWE1MjJhNDUyOWJmNDIzMDMzODQzM2EzZDZfNC0xLTEtMS0zMDExNA_1df65067-16d3-46ce-a14e-e4659f3660f9"
      unitRef="usd">3000000</us-gaap:RestrictedCash>
    <us-gaap:RestrictedCash
      contextRef="i6390807210d74c6f9cae496ea2122a5a_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8zNC9mcmFnOjZlZDA2OGNhMmZmODQyNTNhNDM3MTNmNGMzZmNlOThlL3RhYmxlOjM4MDUzMGFhNTIyYTQ1MjliZjQyMzAzMzg0MzNhM2Q2L3RhYmxlcmFuZ2U6MzgwNTMwYWE1MjJhNDUyOWJmNDIzMDMzODQzM2EzZDZfNC0zLTEtMS0zMDExNA_b0869820-4954-4a10-aa09-26c85a196b14"
      unitRef="usd">6000000</us-gaap:RestrictedCash>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8zNC9mcmFnOjZlZDA2OGNhMmZmODQyNTNhNDM3MTNmNGMzZmNlOThlL3RhYmxlOjM4MDUzMGFhNTIyYTQ1MjliZjQyMzAzMzg0MzNhM2Q2L3RhYmxlcmFuZ2U6MzgwNTMwYWE1MjJhNDUyOWJmNDIzMDMzODQzM2EzZDZfNS0xLTEtMS0zMDExNA_0e0cea4e-fa75-4865-a1e8-baa9113013c3"
      unitRef="usd">1116000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i6390807210d74c6f9cae496ea2122a5a_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8zNC9mcmFnOjZlZDA2OGNhMmZmODQyNTNhNDM3MTNmNGMzZmNlOThlL3RhYmxlOjM4MDUzMGFhNTIyYTQ1MjliZjQyMzAzMzg0MzNhM2Q2L3RhYmxlcmFuZ2U6MzgwNTMwYWE1MjJhNDUyOWJmNDIzMDMzODQzM2EzZDZfNS0zLTEtMS0zMDExNA_3246c6d1-c60b-4478-bae4-44276fcc581e"
      unitRef="usd">1490000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:LesseeLeasesPolicyTextBlock
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8zNC9mcmFnOjZlZDA2OGNhMmZmODQyNTNhNDM3MTNmNGMzZmNlOThlL3RleHRyZWdpb246NmVkMDY4Y2EyZmY4NDI1M2E0MzcxM2Y0YzNmY2U5OGVfNzAxNA_d9a34902-4d94-4250-9715-1f8e4cdc4d63">Leases. As of January&#160;31, 2022 and October&#160;31, 2021, operating lease right-of-use assets where we are the lessee were  $170&#160;million and $178&#160;million, respectively, and were included within other assets in the accompanying condensed consolidated balance sheet. The associated operating lease liabilities were $174&#160;million and $182&#160;million as of January&#160;31, 2022 and October&#160;31, 2021, respectively, and were included in other accrued liabilities and other long-term liabilities in the accompanying condensed consolidated balance sheet.</us-gaap:LesseeLeasesPolicyTextBlock>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i56114721e4604d11a4408ead150dd13f_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8zNC9mcmFnOjZlZDA2OGNhMmZmODQyNTNhNDM3MTNmNGMzZmNlOThlL3RleHRyZWdpb246NmVkMDY4Y2EyZmY4NDI1M2E0MzcxM2Y0YzNmY2U5OGVfMzM1OQ_804565c3-9fa0-4cc0-9f50-a515399aa898"
      unitRef="usd">170000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i546995bf0aca4c98814acb076a2c6be8_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8zNC9mcmFnOjZlZDA2OGNhMmZmODQyNTNhNDM3MTNmNGMzZmNlOThlL3RleHRyZWdpb246NmVkMDY4Y2EyZmY4NDI1M2E0MzcxM2Y0YzNmY2U5OGVfMzM2Ng_638a321a-5e58-4d3f-8cb9-823afa635040"
      unitRef="usd">178000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiability
      contextRef="i8abcbdeb47ef4c469a915f28a2a7bebb_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8zNC9mcmFnOjZlZDA2OGNhMmZmODQyNTNhNDM3MTNmNGMzZmNlOThlL3RleHRyZWdpb246NmVkMDY4Y2EyZmY4NDI1M2E0MzcxM2Y0YzNmY2U5OGVfMzUyOA_4b2065fd-a972-4795-8867-69e831c12b8d"
      unitRef="usd">174000000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiability
      contextRef="i5e51aa894fb04654a6979cdafafe70f0_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8zNC9mcmFnOjZlZDA2OGNhMmZmODQyNTNhNDM3MTNmNGMzZmNlOThlL3RleHRyZWdpb246NmVkMDY4Y2EyZmY4NDI1M2E0MzcxM2Y0YzNmY2U5OGVfMzUzNQ_4cc84c12-c73e-49b4-b4e0-da8f7213bfa2"
      unitRef="usd">182000000</us-gaap:OperatingLeaseLiability>
    <us-gaap:ConsolidationVariableInterestEntityPolicy
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8zNC9mcmFnOjZlZDA2OGNhMmZmODQyNTNhNDM3MTNmNGMzZmNlOThlL3RleHRyZWdpb246NmVkMDY4Y2EyZmY4NDI1M2E0MzcxM2Y0YzNmY2U5OGVfNzAzMg_4abc1647-e99e-41b7-b5a0-358f23501785">&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Variable Interest Entities. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We make a determination upon entering into an arrangement whether an entity in which we have made an investment is considered a Variable Interest Entity (&#x201c;VIE&#x201d;). We evaluate our investments in privately held companies on an ongoing basis. We have determined that as of January&#160;31, 2022 and October&#160;31, 2021, there were no VIEs required to be consolidated in our consolidated financial statements because we do not have a controlling financial interest in any of the VIEs in which we have invested nor are we the primary beneficiary. We account for these investments under either the equity method or as equity investments without readily determinable fair value ("RDFV"), depending on the circumstances. We periodically reassess whether we are the primary beneficiary of a VIE. The reassessment process considers whether we have acquired the power to direct the most significant activities of the VIE through changes in governing documents or other circumstances. We also reconsider whether entities previously determined not to be VIEs have become VIEs and vice-versa, based on changes in facts and circumstances including changes in contractual arrangements and capital structure.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of January&#160;31, 2022 and October&#160;31, 2021, the total carrying value of investments and loans in privately held companies considered as VIEs was $79 million and $76 million respectively. The maximum exposure is equal to the carrying value because we do not have future funding commitments. The investments are included on the long-term investments line and the loans on the other current assets and other assets lines (depending upon tenure of loan) on the condensed consolidated balance sheet.&lt;/span&gt;&lt;/div&gt;</us-gaap:ConsolidationVariableInterestEntityPolicy>
    <us-gaap:Assets
      contextRef="i242c1754cce3428296265ac5bafa4022_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8zNC9mcmFnOjZlZDA2OGNhMmZmODQyNTNhNDM3MTNmNGMzZmNlOThlL3RleHRyZWdpb246NmVkMDY4Y2EyZmY4NDI1M2E0MzcxM2Y0YzNmY2U5OGVfNTAwMQ_09e2465b-063b-4188-a64a-ad1a680a1613"
      unitRef="usd">79000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i81363376d3bd42f8a95d654a9f58325e_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8zNC9mcmFnOjZlZDA2OGNhMmZmODQyNTNhNDM3MTNmNGMzZmNlOThlL3RleHRyZWdpb246NmVkMDY4Y2EyZmY4NDI1M2E0MzcxM2Y0YzNmY2U5OGVfNTAwOA_f05ed436-05b8-431f-8f1c-3c5f4def0182"
      unitRef="usd">76000000</us-gaap:Assets>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8zNC9mcmFnOjZlZDA2OGNhMmZmODQyNTNhNDM3MTNmNGMzZmNlOThlL3RleHRyZWdpb246NmVkMDY4Y2EyZmY4NDI1M2E0MzcxM2Y0YzNmY2U5OGVfNzAzMw_0a010c13-75b7-44ec-ac29-b994d426789f">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value of Financial Instruments.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The carrying values of certain of our financial instruments including cash and cash equivalents, accounts receivable, accounts payable, accrued compensation and other accrued liabilities approximate fair value because of their short maturities. The fair value of short-term and long-term equity investments which are readily determinable, and which are not accounted under the equity method are reported at fair value using quoted market prices for those securities when available with gains and losses included in net income. The fair value of long-term equity investments which are not readily determinable, and which are not accounted under the equity method are reported at cost with adjustments for observable changes in prices or impairments included in net income. As of January&#160;31, 2022, the fair value of our senior notes was $2,710&#160;million with a carrying value of $2,730 million.  This compares to a fair value of $2,806&#160;million with a carrying value of $2,729 million as of October&#160;31, 2021. The change in the fair value over carrying value in the three months ended January&#160;31, 2022 is primarily due to increased market interest rates. The fair value was calculated from quoted prices which are primarily Level 1 inputs under the accounting guidance. The fair value of foreign currency contracts used for hedging purposes is estimated internally by using inputs tied to active markets. These inputs, for example, interest rate yield curves, foreign exchange rates, and forward and spot prices for currencies are observable in the market or&#160;can be corroborated by observable market data for substantially the full term of the assets or liabilities. See also Note&#160;9, "Fair Value Measurements" for additional information on the fair value of financial instruments and contingent consideration.&lt;/span&gt;</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:LongTermDebtFairValue
      contextRef="i608256c6a24a4ef084558bc988b75d6a_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8zNC9mcmFnOjZlZDA2OGNhMmZmODQyNTNhNDM3MTNmNGMzZmNlOThlL3RleHRyZWdpb246NmVkMDY4Y2EyZmY4NDI1M2E0MzcxM2Y0YzNmY2U5OGVfMTA5OTUxMTYzNTA0OA_9d3b7b83-4fe4-4bd4-a489-fc18c525eabf"
      unitRef="usd">2710000000</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8zNC9mcmFnOjZlZDA2OGNhMmZmODQyNTNhNDM3MTNmNGMzZmNlOThlL3RleHRyZWdpb246NmVkMDY4Y2EyZmY4NDI1M2E0MzcxM2Y0YzNmY2U5OGVfMTY0OTI2NzQ1Nzg0MQ_b65144d3-e7f1-4d9a-a47b-3dcbb10e46a5"
      unitRef="usd">2730000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtFairValue
      contextRef="i0f82edc5fbba4f499a5dfb9aaa21a637_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8zNC9mcmFnOjZlZDA2OGNhMmZmODQyNTNhNDM3MTNmNGMzZmNlOThlL3RleHRyZWdpb246NmVkMDY4Y2EyZmY4NDI1M2E0MzcxM2Y0YzNmY2U5OGVfMTA5OTUxMTYzNTExNA_2d242f54-a104-410a-8af8-5d062f1ed100"
      unitRef="usd">2806000000</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i6390807210d74c6f9cae496ea2122a5a_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8zNC9mcmFnOjZlZDA2OGNhMmZmODQyNTNhNDM3MTNmNGMzZmNlOThlL3RleHRyZWdpb246NmVkMDY4Y2EyZmY4NDI1M2E0MzcxM2Y0YzNmY2U5OGVfMTY0OTI2NzQ1Nzg5MA_01537f40-97d3-499c-8d27-6936adf2fe5d"
      unitRef="usd">2729000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV8zNy9mcmFnOjc4NjgxNDE1Yzc4NDQ4MTc5MjI3ZGY3MjVhYjg3MDNiL3RleHRyZWdpb246Nzg2ODE0MTVjNzg0NDgxNzkyMjdkZjcyNWFiODcwM2JfNTEyMA_c748a080-e3ef-4a84-a6c3-10c7aa942685">NEW ACCOUNTING PRONOUNCEMENTS&lt;div style="margin-bottom:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently Adopted Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2020, accounting guidance was issued that clarifies the accounting guidance for equity method investments, joint ventures, and derivatives and hedging. The guidance clarifies the interaction between different sections of the accounting guidance that could be applicable and which guidance should be applied in certain situations which should increase relevance and comparability of financial statement information. On November 1, 2021 we adopted this guidance which did not have a material impact on our condensed consolidated financial statements and disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In October 2021, the FASB issued an update to improve the accounting for acquired revenue contracts with customers in a business combination.  The amendments require an acquirer to use the guidance in ASC 606, Revenue from Contracts with Customers, rather than using fair value, when recognizing and measuring contract assets and contract liabilities related to customer contracts assumed in a business combination. On November 1, 2021 we early adopted this guidance which did not have a material impact on our condensed consolidated financial statements and disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accounting Pronouncements Not Yet Adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no additions to the new accounting pronouncements not yet adopted as described in our Annual Report on Form 10-K for the fiscal year ended October 31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other amendments to GAAP in the U.S. that have been issued by the FASB or other standards-setting bodies that do not require adoption until a future date are not expected to have a material impact on our condensed consolidated financial statements upon adoption.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock>
    <us-gaap:RevenueFromContractWithCustomerTextBlock
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RleHRyZWdpb246ZDY1YzFhNDg4MjRmNDMzMjlkNTMwOGMyMTg1MzQzZjlfMzc2Mw_2673d5b1-b6a9-498e-822f-7c934a9b408d">REVENUE &lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the company&#x2019;s total revenue and segment revenue disaggregated by geographical region: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.859%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.261%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.953%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="45" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended January 31&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Life Sciences and Applied Markets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Agilent CrossLab&lt;br/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Diagnostics and Genomics&lt;br/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Life Sciences and Applied Markets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Agilent CrossLab&lt;br/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Diagnostics and Genomics&lt;br/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="45" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Revenue by Region&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Americas&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;637&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;555&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;451&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;437&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asia Pacific&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;556&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;976&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;339&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;331&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.953%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:5pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the company&#x2019;s total revenue disaggregated by end markets and by revenue type:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.777%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;January 31&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Revenue by End Markets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmaceutical and Biopharmaceutical&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;521&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Chemical and Energy&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diagnostics and Clinical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Food&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Academia and Government&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Environmental and Forensics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Revenue by Type&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Instrumentation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;691&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;681&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-instrumentation and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;983&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;867&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue by region is based on the ship to location of the customer. Revenue by end market is determined by the market indicator of the customer and by customer type. Instrumentation revenue includes sales from instruments, remarketed instruments and third-party products. Non-instrumentation and other revenue include sales from contract and per incident services, our companion diagnostics and our nucleic acid solutions businesses as well as sales from spare parts, consumables, reagents, vacuum pumps, subscriptions, software licenses and associated services.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Contract Balances&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Contract Assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contract assets (unbilled accounts receivable) primarily relate to the company's right to consideration for work completed but not billed at the reporting date. The unbilled receivables are reclassified to trade receivables when billed to customers. Contract assets are generally classified as current assets and are included in "Accounts receivable, net" in the condensed consolidated balance sheet. The balances of contract assets as of January&#160;31, 2022 and October&#160;31, 2021 were $207 million and $197 million, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Contract Liabilities&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides information about contract liabilities (deferred revenue) and the significant changes in the balances during the three months ended January&#160;31, 2022: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.078%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.119%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.403%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Contract &lt;br/&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending balance as of October 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;519&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net revenue deferred in the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue recognized that was included in the contract liability balance at the beginning of the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(191)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in deferrals from customer cash advances, net of revenue recognized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency translation and other adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending balance as of January 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;576&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three months ended January&#160;31, 2021 revenue recognized that was included in the contract liability balance at October&#160;31, 2020 was $186 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contract liabilities primarily relate to multiple element arrangements for which billing has occurred but transfer of control of all elements to the customer has either partially or not occurred at the balance sheet date. This includes cash received from customers for products and related installation and services in advance of the transfer of control. Contract liabilities are classified as either current in deferred revenue or long-term in other long-term liabilities in the condensed consolidated balance sheet based on the timing of when we expect to complete our performance obligation.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Contract Costs&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Incremental costs of obtaining a contract with a customer are recognized as an asset if we expect the benefit of those costs to be longer than one year. We have determined that certain sales incentive programs meet the requirements to be capitalized. The change in total capitalized costs to obtain a contract was immaterial during the three months ended January&#160;31, 2022 and was included in other current and long-term assets on the condensed consolidated balance sheet. We have applied the practical expedient to expense costs as incurred for costs to obtain a contract with a customer when the amortization period would have been one year or less. These costs include the company's internal sales force compensation program, as we have determined that annual compensation is commensurate with annual sales activities.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Transaction Price Allocated to the Remaining Performance Obligations   &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have applied the practical expedient in ASC 606-10-50-14 and have not disclosed information about transaction price allocated to remaining performance obligations that have original expected durations of one year or less.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;The estimated revenue expected to be recognized for remaining performance obligations that have an original term of more than one year, as of January&#160;31, 2022, was $347 million, the majority of which is expected to be recognized over the next 12 months. Remaining performance obligations primarily include extended warranty, customer manufacturing contracts, software maintenance contracts and revenue associated with lease arrangements.</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RleHRyZWdpb246ZDY1YzFhNDg4MjRmNDMzMjlkNTMwOGMyMTg1MzQzZjlfMzc2NQ_a4d33ae1-bb39-4ab0-a145-988847578a7b">&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the company&#x2019;s total revenue and segment revenue disaggregated by geographical region: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.859%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.261%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.953%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="45" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended January 31&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Life Sciences and Applied Markets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Agilent CrossLab&lt;br/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Diagnostics and Genomics&lt;br/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Life Sciences and Applied Markets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Agilent CrossLab&lt;br/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Diagnostics and Genomics&lt;br/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="45" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Revenue by Region&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Americas&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;637&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;555&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;451&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;437&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asia Pacific&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;556&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;976&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;339&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;331&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.953%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:5pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the company&#x2019;s total revenue disaggregated by end markets and by revenue type:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.777%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;January 31&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Revenue by End Markets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmaceutical and Biopharmaceutical&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;521&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Chemical and Energy&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diagnostics and Clinical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Food&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Academia and Government&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Environmental and Forensics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Revenue by Type&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Instrumentation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;691&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;681&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-instrumentation and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;983&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;867&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id98e410db6d64a60ad4a6f2802e93f0f_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RhYmxlOmUxMjc0OTVlZDU5NDQ3YTc4NWQ2MWY2ZjQ1MmJkODQzL3RhYmxlcmFuZ2U6ZTEyNzQ5NWVkNTk0NDdhNzg1ZDYxZjZmNDUyYmQ4NDNfNS0xLTEtMS0zMDExNA_922ba64a-e0ce-4092-bc87-973e9a0712e5"
      unitRef="usd">317000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic9b276a4ef0142669a77891f22aafa63_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RhYmxlOmUxMjc0OTVlZDU5NDQ3YTc4NWQ2MWY2ZjQ1MmJkODQzL3RhYmxlcmFuZ2U6ZTEyNzQ5NWVkNTk0NDdhNzg1ZDYxZjZmNDUyYmQ4NDNfNS0zLTEtMS0zMDExNA_a1e5adcf-c740-4592-ade4-53dcee22da89"
      unitRef="usd">132000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib2270a60792d4c44aaf50ded4d6e6053_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RhYmxlOmUxMjc0OTVlZDU5NDQ3YTc4NWQ2MWY2ZjQ1MmJkODQzL3RhYmxlcmFuZ2U6ZTEyNzQ5NWVkNTk0NDdhNzg1ZDYxZjZmNDUyYmQ4NDNfNS01LTEtMS0zMDExNA_5d529862-d7a2-4b9c-b149-7cada81890da"
      unitRef="usd">188000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8b6e655997ee46b5b0ca774029d951f0_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RhYmxlOmUxMjc0OTVlZDU5NDQ3YTc4NWQ2MWY2ZjQ1MmJkODQzL3RhYmxlcmFuZ2U6ZTEyNzQ5NWVkNTk0NDdhNzg1ZDYxZjZmNDUyYmQ4NDNfNS03LTEtMS0zMDExNA_a3c57e26-804e-4196-974d-592d64098904"
      unitRef="usd">637000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia94002b251cf482785fce6c05237c8c7_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RhYmxlOmUxMjc0OTVlZDU5NDQ3YTc4NWQ2MWY2ZjQ1MmJkODQzL3RhYmxlcmFuZ2U6ZTEyNzQ5NWVkNTk0NDdhNzg1ZDYxZjZmNDUyYmQ4NDNfNS05LTEtMS0zMDExNA_b096ee3d-50b9-4a36-99b2-e0f85ba427a4"
      unitRef="usd">279000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7f6dcf92a3b2409b913e60f71c87523b_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RhYmxlOmUxMjc0OTVlZDU5NDQ3YTc4NWQ2MWY2ZjQ1MmJkODQzL3RhYmxlcmFuZ2U6ZTEyNzQ5NWVkNTk0NDdhNzg1ZDYxZjZmNDUyYmQ4NDNfNS0xMS0xLTEtMzAxMTQ_a483eb60-644d-4f4c-ba9d-abab33dca75b"
      unitRef="usd">124000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i21a438b755494983a6ca6de8bc637763_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RhYmxlOmUxMjc0OTVlZDU5NDQ3YTc4NWQ2MWY2ZjQ1MmJkODQzL3RhYmxlcmFuZ2U6ZTEyNzQ5NWVkNTk0NDdhNzg1ZDYxZjZmNDUyYmQ4NDNfNS0xMy0xLTEtMzAxMTQ_61954d57-8b54-437c-83b9-2ed020194d08"
      unitRef="usd">152000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1fb0b045601b4b149adb5a3c59cddd0a_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RhYmxlOmUxMjc0OTVlZDU5NDQ3YTc4NWQ2MWY2ZjQ1MmJkODQzL3RhYmxlcmFuZ2U6ZTEyNzQ5NWVkNTk0NDdhNzg1ZDYxZjZmNDUyYmQ4NDNfNS0xNS0xLTEtMzAxMTQ_a5901673-b3c4-47fc-af94-88a004464352"
      unitRef="usd">555000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i200743d5cfa44c4697228dfbf963685f_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RhYmxlOmUxMjc0OTVlZDU5NDQ3YTc4NWQ2MWY2ZjQ1MmJkODQzL3RhYmxlcmFuZ2U6ZTEyNzQ5NWVkNTk0NDdhNzg1ZDYxZjZmNDUyYmQ4NDNfNi0xLTEtMS0zMDExNA_6402df4d-3559-4802-ac7e-9843ccbe5f24"
      unitRef="usd">252000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2b68e96853384e99aa6ee8f64e043a52_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RhYmxlOmUxMjc0OTVlZDU5NDQ3YTc4NWQ2MWY2ZjQ1MmJkODQzL3RhYmxlcmFuZ2U6ZTEyNzQ5NWVkNTk0NDdhNzg1ZDYxZjZmNDUyYmQ4NDNfNi0zLTEtMS0zMDExNA_9242a13c-6f93-4b5a-ac6e-89d0472eac04"
      unitRef="usd">98000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia48ede266ff94d568a8b81576e800821_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RhYmxlOmUxMjc0OTVlZDU5NDQ3YTc4NWQ2MWY2ZjQ1MmJkODQzL3RhYmxlcmFuZ2U6ZTEyNzQ5NWVkNTk0NDdhNzg1ZDYxZjZmNDUyYmQ4NDNfNi01LTEtMS0zMDExNA_e2ebcccb-e3f6-4708-8469-c360d5582966"
      unitRef="usd">101000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i621dbedf1b6f42ae8f8a2f84b5287957_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RhYmxlOmUxMjc0OTVlZDU5NDQ3YTc4NWQ2MWY2ZjQ1MmJkODQzL3RhYmxlcmFuZ2U6ZTEyNzQ5NWVkNTk0NDdhNzg1ZDYxZjZmNDUyYmQ4NDNfNi03LTEtMS0zMDExNA_f135ba7d-461b-4783-9048-16c3b9f712dc"
      unitRef="usd">451000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i56152fd0f65346c88b619fa6fbc25760_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RhYmxlOmUxMjc0OTVlZDU5NDQ3YTc4NWQ2MWY2ZjQ1MmJkODQzL3RhYmxlcmFuZ2U6ZTEyNzQ5NWVkNTk0NDdhNzg1ZDYxZjZmNDUyYmQ4NDNfNi05LTEtMS0zMDExNA_211689dc-c8d4-4575-b336-54f6a7c51411"
      unitRef="usd">245000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9b2a7c6211084a08b6b244978eb790e2_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RhYmxlOmUxMjc0OTVlZDU5NDQ3YTc4NWQ2MWY2ZjQ1MmJkODQzL3RhYmxlcmFuZ2U6ZTEyNzQ5NWVkNTk0NDdhNzg1ZDYxZjZmNDUyYmQ4NDNfNi0xMS0xLTEtMzAxMTQ_d6327ed5-a6bd-4f57-a217-b7f07b0d5f43"
      unitRef="usd">92000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icda076e98d344aa6b5d575ac1c693ad4_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RhYmxlOmUxMjc0OTVlZDU5NDQ3YTc4NWQ2MWY2ZjQ1MmJkODQzL3RhYmxlcmFuZ2U6ZTEyNzQ5NWVkNTk0NDdhNzg1ZDYxZjZmNDUyYmQ4NDNfNi0xMy0xLTEtMzAxMTQ_fca750ec-e9d9-44c0-9e51-768b4027473d"
      unitRef="usd">100000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4ea6946ae07b4db194a25f0b0b7d96e5_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RhYmxlOmUxMjc0OTVlZDU5NDQ3YTc4NWQ2MWY2ZjQ1MmJkODQzL3RhYmxlcmFuZ2U6ZTEyNzQ5NWVkNTk0NDdhNzg1ZDYxZjZmNDUyYmQ4NDNfNi0xNS0xLTEtMzAxMTQ_6e8cf4ec-59d3-4b84-9873-25a7e36ece57"
      unitRef="usd">437000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia6990515accb4b6a8e12491c430b6e15_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RhYmxlOmUxMjc0OTVlZDU5NDQ3YTc4NWQ2MWY2ZjQ1MmJkODQzL3RhYmxlcmFuZ2U6ZTEyNzQ5NWVkNTk0NDdhNzg1ZDYxZjZmNDUyYmQ4NDNfNy0xLTEtMS0zMDExNA_9b046598-d2a2-4826-a98c-1e6f45b36b2d"
      unitRef="usd">407000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib5aa3111b40146c693795bc54d4360d2_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RhYmxlOmUxMjc0OTVlZDU5NDQ3YTc4NWQ2MWY2ZjQ1MmJkODQzL3RhYmxlcmFuZ2U6ZTEyNzQ5NWVkNTk0NDdhNzg1ZDYxZjZmNDUyYmQ4NDNfNy0zLTEtMS0zMDExNA_8298c61c-adc4-4760-890c-b806a97b4159"
      unitRef="usd">129000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6fcd3ec546c34f0a8138948fa2a41702_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RhYmxlOmUxMjc0OTVlZDU5NDQ3YTc4NWQ2MWY2ZjQ1MmJkODQzL3RhYmxlcmFuZ2U6ZTEyNzQ5NWVkNTk0NDdhNzg1ZDYxZjZmNDUyYmQ4NDNfNy01LTEtMS0zMDExNA_29d4c965-8eb6-4a03-9244-93a298ffb0a1"
      unitRef="usd">50000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iabdeb90dd9a5436a92c8c53c49cf18aa_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RhYmxlOmUxMjc0OTVlZDU5NDQ3YTc4NWQ2MWY2ZjQ1MmJkODQzL3RhYmxlcmFuZ2U6ZTEyNzQ5NWVkNTk0NDdhNzg1ZDYxZjZmNDUyYmQ4NDNfNy03LTEtMS0zMDExNA_f10c2dc7-bbac-43e6-ad16-4c1e052aca09"
      unitRef="usd">586000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib98cc4f61db94e0d8269c2035a8ea0a7_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RhYmxlOmUxMjc0OTVlZDU5NDQ3YTc4NWQ2MWY2ZjQ1MmJkODQzL3RhYmxlcmFuZ2U6ZTEyNzQ5NWVkNTk0NDdhNzg1ZDYxZjZmNDUyYmQ4NDNfNy05LTEtMS0zMDExNA_5d757cb9-36d2-4205-914e-d2523b623376"
      unitRef="usd">399000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iccaab3323ff4402984b385de50fcb653_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RhYmxlOmUxMjc0OTVlZDU5NDQ3YTc4NWQ2MWY2ZjQ1MmJkODQzL3RhYmxlcmFuZ2U6ZTEyNzQ5NWVkNTk0NDdhNzg1ZDYxZjZmNDUyYmQ4NDNfNy0xMS0xLTEtMzAxMTQ_b90771a2-4144-4c74-8ed6-bc67965b85b2"
      unitRef="usd">115000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i659f816f99fa413eb7fb6bcef0c8191a_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RhYmxlOmUxMjc0OTVlZDU5NDQ3YTc4NWQ2MWY2ZjQ1MmJkODQzL3RhYmxlcmFuZ2U6ZTEyNzQ5NWVkNTk0NDdhNzg1ZDYxZjZmNDUyYmQ4NDNfNy0xMy0xLTEtMzAxMTQ_436b9bc1-76f4-446e-b7b9-92fe6a7baa93"
      unitRef="usd">42000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia563ff7d707142c1bd1a6c4540fe8e3b_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RhYmxlOmUxMjc0OTVlZDU5NDQ3YTc4NWQ2MWY2ZjQ1MmJkODQzL3RhYmxlcmFuZ2U6ZTEyNzQ5NWVkNTk0NDdhNzg1ZDYxZjZmNDUyYmQ4NDNfNy0xNS0xLTEtMzAxMTQ_6c74a425-d040-4d7e-a2a4-dbc3a301abbb"
      unitRef="usd">556000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6d58196320f34869a29143308907c47f_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RhYmxlOmUxMjc0OTVlZDU5NDQ3YTc4NWQ2MWY2ZjQ1MmJkODQzL3RhYmxlcmFuZ2U6ZTEyNzQ5NWVkNTk0NDdhNzg1ZDYxZjZmNDUyYmQ4NDNfOC0xLTEtMS0zMDExNA_bbba74e2-1082-4f86-a4ab-5328e9c52e64"
      unitRef="usd">976000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i30a463a582ff4b16971b766059a24eb9_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RhYmxlOmUxMjc0OTVlZDU5NDQ3YTc4NWQ2MWY2ZjQ1MmJkODQzL3RhYmxlcmFuZ2U6ZTEyNzQ5NWVkNTk0NDdhNzg1ZDYxZjZmNDUyYmQ4NDNfOC0zLTEtMS0zMDExNA_0eaada0c-d2ba-4db2-8aa0-d622eb7ba15a"
      unitRef="usd">359000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie43c9572619448f8a6ea6d852ea0af23_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RhYmxlOmUxMjc0OTVlZDU5NDQ3YTc4NWQ2MWY2ZjQ1MmJkODQzL3RhYmxlcmFuZ2U6ZTEyNzQ5NWVkNTk0NDdhNzg1ZDYxZjZmNDUyYmQ4NDNfOC01LTEtMS0zMDExNA_2902c5e5-c5fe-4edf-b76d-4ca7c49811b2"
      unitRef="usd">339000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RhYmxlOmUxMjc0OTVlZDU5NDQ3YTc4NWQ2MWY2ZjQ1MmJkODQzL3RhYmxlcmFuZ2U6ZTEyNzQ5NWVkNTk0NDdhNzg1ZDYxZjZmNDUyYmQ4NDNfOC03LTEtMS0zMDExNA_b1eccfdc-2c16-48af-9054-bfb9bd669508"
      unitRef="usd">1674000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if71b40dd3f5f49bf86fbcfa04c9c081e_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RhYmxlOmUxMjc0OTVlZDU5NDQ3YTc4NWQ2MWY2ZjQ1MmJkODQzL3RhYmxlcmFuZ2U6ZTEyNzQ5NWVkNTk0NDdhNzg1ZDYxZjZmNDUyYmQ4NDNfOC05LTEtMS0zMDExNA_18f26529-7a4b-4d4a-a94e-13ca3257d512"
      unitRef="usd">923000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i02afafae5dac4c4eb5370132cc85ab08_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RhYmxlOmUxMjc0OTVlZDU5NDQ3YTc4NWQ2MWY2ZjQ1MmJkODQzL3RhYmxlcmFuZ2U6ZTEyNzQ5NWVkNTk0NDdhNzg1ZDYxZjZmNDUyYmQ4NDNfOC0xMS0xLTEtMzAxMTQ_688ea0b6-5dd1-45ad-8bb0-cc7075d0484b"
      unitRef="usd">331000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i18473ba8bdd846b583460be774dcc8c2_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RhYmxlOmUxMjc0OTVlZDU5NDQ3YTc4NWQ2MWY2ZjQ1MmJkODQzL3RhYmxlcmFuZ2U6ZTEyNzQ5NWVkNTk0NDdhNzg1ZDYxZjZmNDUyYmQ4NDNfOC0xMy0xLTEtMzAxMTQ_3d69624d-bbca-4a27-9222-d9227c9844d7"
      unitRef="usd">294000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RhYmxlOmUxMjc0OTVlZDU5NDQ3YTc4NWQ2MWY2ZjQ1MmJkODQzL3RhYmxlcmFuZ2U6ZTEyNzQ5NWVkNTk0NDdhNzg1ZDYxZjZmNDUyYmQ4NDNfOC0xNS0xLTEtMzAxMTQ_64eda019-b49b-439b-9d51-512130159658"
      unitRef="usd">1548000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id5a6ff22f0f64b46ac2eca9fc0c63a58_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RhYmxlOmZmY2NjZmUyM2JhOTQyMjA4ZTNhMTZhOTg4MmRjYTExL3RhYmxlcmFuZ2U6ZmZjY2NmZTIzYmE5NDIyMDhlM2ExNmE5ODgyZGNhMTFfNS0xLTEtMS0zMDExNA_e8eb9150-a954-4c2a-b0ec-8612474187f4"
      unitRef="usd">602000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i52a37802a4474ca2ae708288d1606203_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RhYmxlOmZmY2NjZmUyM2JhOTQyMjA4ZTNhMTZhOTg4MmRjYTExL3RhYmxlcmFuZ2U6ZmZjY2NmZTIzYmE5NDIyMDhlM2ExNmE5ODgyZGNhMTFfNS0zLTEtMS0zMDExNA_185ecab4-353b-4c3f-a41d-bf5d03bd3127"
      unitRef="usd">521000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i00b6a666687d43fc80adb8b7c25a62c8_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RhYmxlOmZmY2NjZmUyM2JhOTQyMjA4ZTNhMTZhOTg4MmRjYTExL3RhYmxlcmFuZ2U6ZmZjY2NmZTIzYmE5NDIyMDhlM2ExNmE5ODgyZGNhMTFfNi0xLTEtMS0zMDExNA_4622fd1a-7d55-434f-bd64-b6ccf58c834a"
      unitRef="usd">373000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i926a81018f214c9e97712dd13af6648e_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RhYmxlOmZmY2NjZmUyM2JhOTQyMjA4ZTNhMTZhOTg4MmRjYTExL3RhYmxlcmFuZ2U6ZmZjY2NmZTIzYmE5NDIyMDhlM2ExNmE5ODgyZGNhMTFfNi0zLTEtMS0zMDExNA_86b0f32c-30f7-4b34-8275-b02a19f12057"
      unitRef="usd">328000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i284ab20841704e569e5c116ce20ebb54_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RhYmxlOmZmY2NjZmUyM2JhOTQyMjA4ZTNhMTZhOTg4MmRjYTExL3RhYmxlcmFuZ2U6ZmZjY2NmZTIzYmE5NDIyMDhlM2ExNmE5ODgyZGNhMTFfNy0xLTEtMS0zMDExNA_3350646e-3273-4daa-9fed-169d30aeec08"
      unitRef="usd">243000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i07d7ce8930c74841be3d4ec974bc2ab8_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RhYmxlOmZmY2NjZmUyM2JhOTQyMjA4ZTNhMTZhOTg4MmRjYTExL3RhYmxlcmFuZ2U6ZmZjY2NmZTIzYmE5NDIyMDhlM2ExNmE5ODgyZGNhMTFfNy0zLTEtMS0zMDExNA_6b1dba94-4f99-461d-9090-b8b21e1aab60"
      unitRef="usd">216000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie0a218c3ab7b4c16ac8e0200091a5569_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RhYmxlOmZmY2NjZmUyM2JhOTQyMjA4ZTNhMTZhOTg4MmRjYTExL3RhYmxlcmFuZ2U6ZmZjY2NmZTIzYmE5NDIyMDhlM2ExNmE5ODgyZGNhMTFfOC0xLTEtMS0zMDExNA_68b7d9e2-220a-40e3-9d4f-e4cddecfb0f7"
      unitRef="usd">158000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8da687ebb1cd4f17b77ceaa5e1137bd2_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RhYmxlOmZmY2NjZmUyM2JhOTQyMjA4ZTNhMTZhOTg4MmRjYTExL3RhYmxlcmFuZ2U6ZmZjY2NmZTIzYmE5NDIyMDhlM2ExNmE5ODgyZGNhMTFfOC0zLTEtMS0zMDExNA_e8a0b5e5-8e18-47a4-95ab-6d0a95fd72a5"
      unitRef="usd">162000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9c164cdf4217439d878a2e3ef209db83_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RhYmxlOmZmY2NjZmUyM2JhOTQyMjA4ZTNhMTZhOTg4MmRjYTExL3RhYmxlcmFuZ2U6ZmZjY2NmZTIzYmE5NDIyMDhlM2ExNmE5ODgyZGNhMTFfOS0xLTEtMS0zMDExNA_45763ff9-cb21-4509-af2f-7df3ff8c8bbf"
      unitRef="usd">141000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i329996789d6240848cf6e6b04372d1aa_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RhYmxlOmZmY2NjZmUyM2JhOTQyMjA4ZTNhMTZhOTg4MmRjYTExL3RhYmxlcmFuZ2U6ZmZjY2NmZTIzYmE5NDIyMDhlM2ExNmE5ODgyZGNhMTFfOS0zLTEtMS0zMDExNA_5145710a-2068-4619-8782-1b973bb2ba38"
      unitRef="usd">142000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i49bfbec43e6f47b587bd6854c9e180fd_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RhYmxlOmZmY2NjZmUyM2JhOTQyMjA4ZTNhMTZhOTg4MmRjYTExL3RhYmxlcmFuZ2U6ZmZjY2NmZTIzYmE5NDIyMDhlM2ExNmE5ODgyZGNhMTFfMTAtMS0xLTEtMzAxMTQ_eecd3325-6dd6-4058-894b-d8c673177b75"
      unitRef="usd">157000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ife69be53bb3f4276a6bb4df53fec04cc_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RhYmxlOmZmY2NjZmUyM2JhOTQyMjA4ZTNhMTZhOTg4MmRjYTExL3RhYmxlcmFuZ2U6ZmZjY2NmZTIzYmE5NDIyMDhlM2ExNmE5ODgyZGNhMTFfMTAtMy0xLTEtMzAxMTQ_8477455b-cc5b-48e3-857a-3399dfcac816"
      unitRef="usd">179000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RhYmxlOmZmY2NjZmUyM2JhOTQyMjA4ZTNhMTZhOTg4MmRjYTExL3RhYmxlcmFuZ2U6ZmZjY2NmZTIzYmE5NDIyMDhlM2ExNmE5ODgyZGNhMTFfMTEtMS0xLTEtMzAxMTQ_4042cbc4-b42c-410a-9600-ce2295f8c869"
      unitRef="usd">1674000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RhYmxlOmZmY2NjZmUyM2JhOTQyMjA4ZTNhMTZhOTg4MmRjYTExL3RhYmxlcmFuZ2U6ZmZjY2NmZTIzYmE5NDIyMDhlM2ExNmE5ODgyZGNhMTFfMTEtMy0xLTEtMzAxMTQ_561e9b51-c2b9-45ce-ade7-f1b06af32674"
      unitRef="usd">1548000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i931db477735742ad8a7854c47ecedf86_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RhYmxlOmZmY2NjZmUyM2JhOTQyMjA4ZTNhMTZhOTg4MmRjYTExL3RhYmxlcmFuZ2U6ZmZjY2NmZTIzYmE5NDIyMDhlM2ExNmE5ODgyZGNhMTFfMTQtMS0xLTEtMzAxMTQ_77981bc8-206b-4d40-b9d1-086fe6d41569"
      unitRef="usd">691000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i47dcfc0179de4e7d85d70bbddc34d760_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RhYmxlOmZmY2NjZmUyM2JhOTQyMjA4ZTNhMTZhOTg4MmRjYTExL3RhYmxlcmFuZ2U6ZmZjY2NmZTIzYmE5NDIyMDhlM2ExNmE5ODgyZGNhMTFfMTQtMy0xLTEtMzAxMTQ_c9810435-ceff-491f-9794-6bc5fd550333"
      unitRef="usd">681000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if362cbaedf1a426589671690d5a8d3b1_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RhYmxlOmZmY2NjZmUyM2JhOTQyMjA4ZTNhMTZhOTg4MmRjYTExL3RhYmxlcmFuZ2U6ZmZjY2NmZTIzYmE5NDIyMDhlM2ExNmE5ODgyZGNhMTFfMTUtMS0xLTEtMzAxMTQ_41d81730-2b21-41b8-b18b-e75511bdd87c"
      unitRef="usd">983000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia68ebbb6be4b4d8ba32cec1a9bcc02ba_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RhYmxlOmZmY2NjZmUyM2JhOTQyMjA4ZTNhMTZhOTg4MmRjYTExL3RhYmxlcmFuZ2U6ZmZjY2NmZTIzYmE5NDIyMDhlM2ExNmE5ODgyZGNhMTFfMTUtMy0xLTEtMzAxMTQ_2b4b45dc-98e0-4dd2-b51d-5ce5646df652"
      unitRef="usd">867000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RhYmxlOmZmY2NjZmUyM2JhOTQyMjA4ZTNhMTZhOTg4MmRjYTExL3RhYmxlcmFuZ2U6ZmZjY2NmZTIzYmE5NDIyMDhlM2ExNmE5ODgyZGNhMTFfMTYtMS0xLTEtMzAxMTQ_d126d277-2a49-45e5-a448-18c5127993f6"
      unitRef="usd">1674000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RhYmxlOmZmY2NjZmUyM2JhOTQyMjA4ZTNhMTZhOTg4MmRjYTExL3RhYmxlcmFuZ2U6ZmZjY2NmZTIzYmE5NDIyMDhlM2ExNmE5ODgyZGNhMTFfMTYtMy0xLTEtMzAxMTQ_3f1c1e0b-c7ad-442c-808e-f76ebbcdd262"
      unitRef="usd">1548000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ContractWithCustomerAssetNet
      contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RleHRyZWdpb246ZDY1YzFhNDg4MjRmNDMzMjlkNTMwOGMyMTg1MzQzZjlfMTMwNw_7faa3267-ba86-4e02-a691-80fa7cb8fa5b"
      unitRef="usd">207000000</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:ContractWithCustomerAssetNet
      contextRef="i6390807210d74c6f9cae496ea2122a5a_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RleHRyZWdpb246ZDY1YzFhNDg4MjRmNDMzMjlkNTMwOGMyMTg1MzQzZjlfMTMxNA_3c5b20fb-7fa9-4b11-9b22-d99b650c554b"
      unitRef="usd">197000000</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RleHRyZWdpb246ZDY1YzFhNDg4MjRmNDMzMjlkNTMwOGMyMTg1MzQzZjlfMzc3MQ_567c6711-7ee8-4a80-b83a-9075f5b32cc6">&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides information about contract liabilities (deferred revenue) and the significant changes in the balances during the three months ended January&#160;31, 2022: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.078%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.119%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.403%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Contract &lt;br/&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending balance as of October 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;519&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net revenue deferred in the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue recognized that was included in the contract liability balance at the beginning of the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(191)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in deferrals from customer cash advances, net of revenue recognized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency translation and other adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending balance as of January 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;576&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i6390807210d74c6f9cae496ea2122a5a_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RhYmxlOjk2NzVjNGZkODU0ZTRhMzhiNDNmZmFmMmM3Zjg3YzYxL3RhYmxlcmFuZ2U6OTY3NWM0ZmQ4NTRlNGEzOGI0M2ZmYWYyYzdmODdjNjFfMy0yLTEtMS0zMDExNA_6c0920bb-cf27-437f-9a8a-cca62cefce4c"
      unitRef="usd">519000000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RhYmxlOjk2NzVjNGZkODU0ZTRhMzhiNDNmZmFmMmM3Zjg3YzYxL3RhYmxlcmFuZ2U6OTY3NWM0ZmQ4NTRlNGEzOGI0M2ZmYWYyYzdmODdjNjFfNC0yLTEtMS0zMDExNA_f63024cd-5868-4e88-b570-cc4d854e03c5"
      unitRef="usd">220000000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RhYmxlOjk2NzVjNGZkODU0ZTRhMzhiNDNmZmFmMmM3Zjg3YzYxL3RhYmxlcmFuZ2U6OTY3NWM0ZmQ4NTRlNGEzOGI0M2ZmYWYyYzdmODdjNjFfNS0yLTEtMS0zMDExNA_eee965fd-53cf-4e7c-8d64-4f0d961ee1f6"
      unitRef="usd">-191000000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <a:IncreasedecreaseinDeferredRevenuefromCustomerCashAdvancesNetofRevenuerecognized
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RhYmxlOjk2NzVjNGZkODU0ZTRhMzhiNDNmZmFmMmM3Zjg3YzYxL3RhYmxlcmFuZ2U6OTY3NWM0ZmQ4NTRlNGEzOGI0M2ZmYWYyYzdmODdjNjFfNi0yLTEtMS0zMDExNA_72b5d404-49e2-4801-b6c5-e467344783fb"
      unitRef="usd">34000000</a:IncreasedecreaseinDeferredRevenuefromCustomerCashAdvancesNetofRevenuerecognized>
    <us-gaap:TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RhYmxlOjk2NzVjNGZkODU0ZTRhMzhiNDNmZmFmMmM3Zjg3YzYxL3RhYmxlcmFuZ2U6OTY3NWM0ZmQ4NTRlNGEzOGI0M2ZmYWYyYzdmODdjNjFfOC0yLTEtMS0zMDExNA_0a3b8b1a-79f2-4154-b9c9-3a18e12a4ebf"
      unitRef="usd">-6000000</us-gaap:TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease>
    <us-gaap:ContractWithCustomerLiability
      contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RhYmxlOjk2NzVjNGZkODU0ZTRhMzhiNDNmZmFmMmM3Zjg3YzYxL3RhYmxlcmFuZ2U6OTY3NWM0ZmQ4NTRlNGEzOGI0M2ZmYWYyYzdmODdjNjFfOS0yLTEtMS0zMDExNA_f0f58400-bd07-43ca-80cb-d99ccf1b890e"
      unitRef="usd">576000000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RleHRyZWdpb246ZDY1YzFhNDg4MjRmNDMzMjlkNTMwOGMyMTg1MzQzZjlfMTYzMw_28d9179c-79bc-48f5-aead-847b278adbe8"
      unitRef="usd">-186000000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="i54fd0d780e894d15abb38be115f904fc_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RleHRyZWdpb246ZDY1YzFhNDg4MjRmNDMzMjlkNTMwOGMyMTg1MzQzZjlfMzUwNQ_636efaec-338a-41a7-8740-dca73abf203a"
      unitRef="usd">347000000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="i54fd0d780e894d15abb38be115f904fc_I20220131"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80MC9mcmFnOmQ2NWMxYTQ4ODI0ZjQzMzI5ZDUzMDhjMjE4NTM0M2Y5L3RleHRyZWdpb246ZDY1YzFhNDg4MjRmNDMzMjlkNTMwOGMyMTg1MzQzZjlfMzU3NA_89ea0f6a-d428-4c59-a53c-e0a4de491eb4">P12M</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RleHRyZWdpb246ZjdkZTkyNTFlNjE5NGQxZWI0YjdmNDU5NzA2NGJmOGZfNDg4Mg_c9993115-35a6-40b1-92d3-f22f3bfab514">SHARE-BASED COMPENSATION&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We account for share-based awards in accordance with the provisions of the authoritative accounting guidance which requires the measurement and recognition of compensation expense for all share-based payment awards made to our employees and directors including employee stock options, restricted stock units, employee stock purchases made under our employee stock purchase plan and performance share awards granted to selected members of our senior management under the long-term performance plan (&#x201c;LTPP&#x201d;) based on estimated fair values. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have two LTPP performance stock award programs, which are administered under the 2018 Stock Plan, for our executive officers and other key employees. Participants in our LTPP Total Stockholders&#x2019; Return (&#x201c;TSR&#x201d;) and LTPP Earnings Per Share (&#x201c;EPS&#x201d;) programs are entitled to receive shares of the company's stock after the end of a three-year period, if specified performance targets for the programs are met. The LTPP-TSR awards are generally designed to meet the criteria of a performance award with the performance metrics and peer group comparison based on the TSR set at the beginning of the performance period. The LTPP-EPS awards are based on the company&#x2019;s EPS performance over a three-year period. The performance targets for the LTPP-EPS for year 2 and year 3 of the performance period are set in the first quarter of year 2 and year 3, respectively. All LTPP awards are subject to a one-year post-vest holding period.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The final LTPP award may vary from 0 percent to 200 percent of the target award. We consider the dilutive impact of these programs in our diluted net income per share calculation only to the extent that the performance conditions are expected to be met. Restricted stock units generally vest, with some exceptions, at a rate of 25 percent per year over a period of four years from the date of grant.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In fiscal year 2021, we resumed granting stock options. Stock options granted under the 2018 Stock Plan may be either "incentive stock options", as defined in Section 422 of the Internal Revenue Code, or non-statutory. Options generally vest at a rate of 25 percent per year over a period of four years from the date of grant with a maximum contractual term of ten years. The exercise price for stock options is generally not less than 100 percent of the fair market value of our common stock on the date the stock award is granted. We issue new shares of common stock when employee stock options are exercised. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The impact on our results for share-based compensation was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.730%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;January 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in&#160;millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of products and services&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling, general and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total share-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At January&#160;31, 2022 and October&#160;31, 2021, no share-based compensation was capitalized within inventory. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;                                               &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following assumptions were used to estimate the fair value of awards granted.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.215%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;January 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock Option Plans:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.5 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.5 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;LTPP:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Volatility of Agilent shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Volatility of selected peer-company shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23%-81%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24%-57%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pair-wise correlation with selected peers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Post-vest holding restriction discount for all executive awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.5%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.8%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of share-based awards for our employee stock option awards was estimated using the Black-Scholes option pricing model. Shares granted under the LTPP (TSR) were valued using a Monte Carlo simulation model. The Monte Carlo simulation fair value model requires the use of highly subjective and complex assumptions, including the price volatility of the underlying stock. &#160;For the volatility of our LTPP (TSR) grants, we used our own historical stock price volatility.&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The ESPP allows eligible employees to purchase shares of our common stock at 85 percent of the price at purchase and uses the purchase date to establish the fair market value. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We use historical volatility to estimate the expected stock price volatility assumption for employee stock option awards. In reaching the conclusion, we have considered many factors including the extent to which our options are currently traded and our ability to find traded options in the current market with similar terms and prices to the options we are valuing. In estimating the expected life of our options granted we considered the historical option exercise behavior of our executives, which we believe is representative of future behavior.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated fair value of restricted stock units and LTPP (EPS) awards is determined based on the market price of our common stock on the date of grant adjusted for expected dividend yield. The compensation cost for LTPP (EPS) reflects the cost of awards that are probable to vest at the end of the performance period. &lt;/span&gt;&lt;/div&gt;All LTPP awards granted to our senior management employees have a one-year post-vest holding restriction. The estimated discount associated with post-vest holding restrictions is calculated using the Finnerty model. The model calculates the potential lost value if the employees were able to sell the shares during the lack of marketability period, instead of being required to hold the shares. The model used the same historical stock price volatility and dividend yield assumption used for the Monte Carlo simulation model and an expected dividend yield to compute the discount.</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="iae4a69f538454c80a80c725dcb6771c3_D20201101-20210131"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RleHRyZWdpb246ZjdkZTkyNTFlNjE5NGQxZWI0YjdmNDU5NzA2NGJmOGZfMTU0MA_490618a1-df59-4c70-bc70-397457e0a682"
      unitRef="number">0</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="iae4a69f538454c80a80c725dcb6771c3_D20201101-20210131"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RleHRyZWdpb246ZjdkZTkyNTFlNjE5NGQxZWI0YjdmNDU5NzA2NGJmOGZfMTU0MA_7ff2f2de-3d18-47ce-ba8b-a34556cf469f"
      unitRef="number">0</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="i8ca5ba2eb51246a9894d8e9981e851fc_D20211101-20220131"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RleHRyZWdpb246ZjdkZTkyNTFlNjE5NGQxZWI0YjdmNDU5NzA2NGJmOGZfMTU0MA_a7d6d6b0-bfcf-4d40-8eed-58e713aea1b4"
      unitRef="number">0</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="i8ca5ba2eb51246a9894d8e9981e851fc_D20211101-20220131"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RleHRyZWdpb246ZjdkZTkyNTFlNjE5NGQxZWI0YjdmNDU5NzA2NGJmOGZfMTU0MA_d28c9177-c71d-48ad-ac13-4d019f965f2e"
      unitRef="number">0</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="i4234dc38e5b84ef38ecd7c8b2af056d7_D20211101-20220131"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RleHRyZWdpb246ZjdkZTkyNTFlNjE5NGQxZWI0YjdmNDU5NzA2NGJmOGZfMTU0Ng_88d057e5-fa47-4b4f-93f4-b9d31c67277a"
      unitRef="number">2</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="i311fec97745e4c5782f4816c9e6d9ea3_D20201101-20210131"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RleHRyZWdpb246ZjdkZTkyNTFlNjE5NGQxZWI0YjdmNDU5NzA2NGJmOGZfMTU0Ng_9e4ebf1e-2eb1-48d9-9157-439372dcc04d"
      unitRef="number">2</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="i311fec97745e4c5782f4816c9e6d9ea3_D20201101-20210131"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RleHRyZWdpb246ZjdkZTkyNTFlNjE5NGQxZWI0YjdmNDU5NzA2NGJmOGZfMTU0Ng_ac3f5572-9aed-4474-b8be-85c81d24373d"
      unitRef="number">2</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="i4234dc38e5b84ef38ecd7c8b2af056d7_D20211101-20220131"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RleHRyZWdpb246ZjdkZTkyNTFlNjE5NGQxZWI0YjdmNDU5NzA2NGJmOGZfMTU0Ng_b5d19421-ab41-466d-b7b3-12da758a9875"
      unitRef="number">2</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="i316c350db7ff4688a76e3821c97ef7e5_D20211101-20220131"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RleHRyZWdpb246ZjdkZTkyNTFlNjE5NGQxZWI0YjdmNDU5NzA2NGJmOGZfMTgxNw_4ac8f4a1-3c7d-4542-9c03-d0155e040cbe"
      unitRef="number">0.25</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="i1ea2e447d0a14715a3edc8a2285fae18_D20201101-20210131"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RleHRyZWdpb246ZjdkZTkyNTFlNjE5NGQxZWI0YjdmNDU5NzA2NGJmOGZfMTgxNw_7b681eff-592e-4e67-9324-0b7769b6d81a"
      unitRef="number">0.25</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="i316c350db7ff4688a76e3821c97ef7e5_D20211101-20220131"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RleHRyZWdpb246ZjdkZTkyNTFlNjE5NGQxZWI0YjdmNDU5NzA2NGJmOGZfMTgxNw_a775be38-d2ec-4ba6-b0b9-e1758eda6d15"
      unitRef="number">0.25</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="i1ea2e447d0a14715a3edc8a2285fae18_D20201101-20210131"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RleHRyZWdpb246ZjdkZTkyNTFlNjE5NGQxZWI0YjdmNDU5NzA2NGJmOGZfMTgxNw_b4b1faf3-3d42-4c92-9629-e3ee01b1d91e"
      unitRef="number">0.25</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i316c350db7ff4688a76e3821c97ef7e5_D20211101-20220131"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RleHRyZWdpb246ZjdkZTkyNTFlNjE5NGQxZWI0YjdmNDU5NzA2NGJmOGZfMTg0Ng_0483c060-c5ab-4292-9d49-936b49e0051c">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i1ea2e447d0a14715a3edc8a2285fae18_D20201101-20210131"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RleHRyZWdpb246ZjdkZTkyNTFlNjE5NGQxZWI0YjdmNDU5NzA2NGJmOGZfMTg0Ng_31856662-b5df-4c95-9d45-8baf5833a956">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i316c350db7ff4688a76e3821c97ef7e5_D20211101-20220131"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RleHRyZWdpb246ZjdkZTkyNTFlNjE5NGQxZWI0YjdmNDU5NzA2NGJmOGZfMTg0Ng_85cfbc1f-b5a8-4b0a-9378-b041ebc2e58f">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i1ea2e447d0a14715a3edc8a2285fae18_D20201101-20210131"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RleHRyZWdpb246ZjdkZTkyNTFlNjE5NGQxZWI0YjdmNDU5NzA2NGJmOGZfMTg0Ng_9bb4eae7-14f5-4047-a496-e3869dfb9f66">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="i0320d16146c74425913fe2d4102de305_D20211101-20220131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RleHRyZWdpb246ZjdkZTkyNTFlNjE5NGQxZWI0YjdmNDU5NzA2NGJmOGZfMjEyOQ_431c666d-df93-40b6-9308-5b7ecac28044"
      unitRef="number">0.25</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="i0320d16146c74425913fe2d4102de305_D20211101-20220131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RleHRyZWdpb246ZjdkZTkyNTFlNjE5NGQxZWI0YjdmNDU5NzA2NGJmOGZfMjEyOQ_43b0259e-f69a-40f6-a733-72dce0177db0"
      unitRef="number">0.25</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="if67aad121f6a462fb9bd2e05dc5b978e_D20201101-20210131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RleHRyZWdpb246ZjdkZTkyNTFlNjE5NGQxZWI0YjdmNDU5NzA2NGJmOGZfMjEyOQ_d1426df5-0988-4989-854b-6d6e498eb0eb"
      unitRef="number">0.25</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="if67aad121f6a462fb9bd2e05dc5b978e_D20201101-20210131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RleHRyZWdpb246ZjdkZTkyNTFlNjE5NGQxZWI0YjdmNDU5NzA2NGJmOGZfMjEyOQ_efceccab-7809-4833-bda4-9500a5523422"
      unitRef="number">0.25</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i0320d16146c74425913fe2d4102de305_D20211101-20220131"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RleHRyZWdpb246ZjdkZTkyNTFlNjE5NGQxZWI0YjdmNDU5NzA2NGJmOGZfMjE1OA_1ab5b725-f2c5-444e-a729-63dbd0a4f248">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="if67aad121f6a462fb9bd2e05dc5b978e_D20201101-20210131"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RleHRyZWdpb246ZjdkZTkyNTFlNjE5NGQxZWI0YjdmNDU5NzA2NGJmOGZfMjE1OA_360b6d63-8fba-43e7-a085-fe3461d4db5a">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i0320d16146c74425913fe2d4102de305_D20211101-20220131"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RleHRyZWdpb246ZjdkZTkyNTFlNjE5NGQxZWI0YjdmNDU5NzA2NGJmOGZfMjE1OA_4e2b72d9-098e-4ab5-a11a-85c5f000d04f">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="if67aad121f6a462fb9bd2e05dc5b978e_D20201101-20210131"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RleHRyZWdpb246ZjdkZTkyNTFlNjE5NGQxZWI0YjdmNDU5NzA2NGJmOGZfMjE1OA_fdfefeba-65d5-434b-b6ed-3154a4072e42">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="if67aad121f6a462fb9bd2e05dc5b978e_D20201101-20210131"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RleHRyZWdpb246ZjdkZTkyNTFlNjE5NGQxZWI0YjdmNDU5NzA2NGJmOGZfMjIxOQ_0394d76d-d862-4fa2-8179-ac391e801498">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="i0320d16146c74425913fe2d4102de305_D20211101-20220131"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RleHRyZWdpb246ZjdkZTkyNTFlNjE5NGQxZWI0YjdmNDU5NzA2NGJmOGZfMjIxOQ_07997f03-34d9-4270-a52c-72266dd359a9">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="if67aad121f6a462fb9bd2e05dc5b978e_D20201101-20210131"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RleHRyZWdpb246ZjdkZTkyNTFlNjE5NGQxZWI0YjdmNDU5NzA2NGJmOGZfMjIxOQ_2f8c84ab-fded-4aa7-a675-40f161ca2fce">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="i0320d16146c74425913fe2d4102de305_D20211101-20220131"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RleHRyZWdpb246ZjdkZTkyNTFlNjE5NGQxZWI0YjdmNDU5NzA2NGJmOGZfMjIxOQ_3a607a7f-3a3c-43e0-a5cc-2c8d2efc80aa">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent
      contextRef="i0320d16146c74425913fe2d4102de305_D20211101-20220131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RleHRyZWdpb246ZjdkZTkyNTFlNjE5NGQxZWI0YjdmNDU5NzA2NGJmOGZfMjI4Nw_15a4469f-4876-4202-9128-c5913cf245bd"
      unitRef="number">1</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent
      contextRef="if67aad121f6a462fb9bd2e05dc5b978e_D20201101-20210131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RleHRyZWdpb246ZjdkZTkyNTFlNjE5NGQxZWI0YjdmNDU5NzA2NGJmOGZfMjI4Nw_67855332-d4c2-4bc5-a1b6-d0f5aedd5cee"
      unitRef="number">1</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent
      contextRef="i0320d16146c74425913fe2d4102de305_D20211101-20220131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RleHRyZWdpb246ZjdkZTkyNTFlNjE5NGQxZWI0YjdmNDU5NzA2NGJmOGZfMjI4Nw_c200989a-ffed-458d-b340-d62e3c704c3e"
      unitRef="number">1</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent
      contextRef="if67aad121f6a462fb9bd2e05dc5b978e_D20201101-20210131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RleHRyZWdpb246ZjdkZTkyNTFlNjE5NGQxZWI0YjdmNDU5NzA2NGJmOGZfMjI4Nw_f95094f7-57ec-4d22-81d4-cd776f47dffb"
      unitRef="number">1</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RleHRyZWdpb246ZjdkZTkyNTFlNjE5NGQxZWI0YjdmNDU5NzA2NGJmOGZfNDg3Mg_7ca43c14-e920-4447-ae85-2540b13c32d9">&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The impact on our results for share-based compensation was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.730%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;January 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in&#160;millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of products and services&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling, general and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total share-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ic76564bc7be64253830f89477bbf29cb_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RhYmxlOjNlZjQ3OTA1N2IyOTRkMDI4NzExM2FlNDM3OGZkODVmL3RhYmxlcmFuZ2U6M2VmNDc5MDU3YjI5NGQwMjg3MTEzYWU0Mzc4ZmQ4NWZfNC0xLTEtMS0zMDExNA_95465d6a-fa9f-4202-a7d4-48cb61122ae8"
      unitRef="usd">11000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="if825187b5c3d4f688e0c4a074679fd80_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RhYmxlOjNlZjQ3OTA1N2IyOTRkMDI4NzExM2FlNDM3OGZkODVmL3RhYmxlcmFuZ2U6M2VmNDc5MDU3YjI5NGQwMjg3MTEzYWU0Mzc4ZmQ4NWZfNC0zLTEtMS0zMDExNA_708754da-9c28-4bf1-ae92-a225b06a94b2"
      unitRef="usd">9000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i4535eece62c1411ab965c726896d4585_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RhYmxlOjNlZjQ3OTA1N2IyOTRkMDI4NzExM2FlNDM3OGZkODVmL3RhYmxlcmFuZ2U6M2VmNDc5MDU3YjI5NGQwMjg3MTEzYWU0Mzc4ZmQ4NWZfNS0xLTEtMS0zMDExNA_c84afc91-a189-459a-bd34-fee8fd578876"
      unitRef="usd">6000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i7f82fd5225d94d7db0f34592fd4d9e70_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RhYmxlOjNlZjQ3OTA1N2IyOTRkMDI4NzExM2FlNDM3OGZkODVmL3RhYmxlcmFuZ2U6M2VmNDc5MDU3YjI5NGQwMjg3MTEzYWU0Mzc4ZmQ4NWZfNS0zLTEtMS0zMDExNA_8283c77a-c836-4700-b7a5-6bd9e10d9820"
      unitRef="usd">4000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i2b0f854e4792405b9d4a4ae010c5c2ad_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RhYmxlOjNlZjQ3OTA1N2IyOTRkMDI4NzExM2FlNDM3OGZkODVmL3RhYmxlcmFuZ2U6M2VmNDc5MDU3YjI5NGQwMjg3MTEzYWU0Mzc4ZmQ4NWZfNi0xLTEtMS0zMDExNA_13dddfd8-adbe-4135-8886-16dbeaf11159"
      unitRef="usd">28000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ib7739872a76e499dad8a316f0e7cd808_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RhYmxlOjNlZjQ3OTA1N2IyOTRkMDI4NzExM2FlNDM3OGZkODVmL3RhYmxlcmFuZ2U6M2VmNDc5MDU3YjI5NGQwMjg3MTEzYWU0Mzc4ZmQ4NWZfNi0zLTEtMS0zMDExNA_cf696d6d-e8f2-4fdb-b38c-a808728d3b57"
      unitRef="usd">27000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RhYmxlOjNlZjQ3OTA1N2IyOTRkMDI4NzExM2FlNDM3OGZkODVmL3RhYmxlcmFuZ2U6M2VmNDc5MDU3YjI5NGQwMjg3MTEzYWU0Mzc4ZmQ4NWZfNy0xLTEtMS0zMDExNA_18f3bc68-f486-49b1-8a38-9b3e45b9785e"
      unitRef="usd">45000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RhYmxlOjNlZjQ3OTA1N2IyOTRkMDI4NzExM2FlNDM3OGZkODVmL3RhYmxlcmFuZ2U6M2VmNDc5MDU3YjI5NGQwMjg3MTEzYWU0Mzc4ZmQ4NWZfNy0zLTEtMS0zMDExNA_28348ace-0c60-4d72-b261-30c567db0371"
      unitRef="usd">40000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
      contextRef="ief4838c7f61041b2b6eef53b20ed9d80_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RleHRyZWdpb246ZjdkZTkyNTFlNjE5NGQxZWI0YjdmNDU5NzA2NGJmOGZfMjU1OA_bdf65589-bf54-4d89-aae3-35c205edb422"
      unitRef="usd">0</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
      contextRef="ic14d2081148241ed947bffd3bb60c599_D20201101-20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RleHRyZWdpb246ZjdkZTkyNTFlNjE5NGQxZWI0YjdmNDU5NzA2NGJmOGZfMjU1OA_c28eac11-d748-4d45-935d-aba1aa4d8f8e"
      unitRef="usd">0</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1>
    <a:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyTextBlock
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RleHRyZWdpb246ZjdkZTkyNTFlNjE5NGQxZWI0YjdmNDU5NzA2NGJmOGZfNDg4NQ_9ec74c4f-ba51-407d-ad6a-b1d034e2fdf9">&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following assumptions were used to estimate the fair value of awards granted.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.215%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;January 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock Option Plans:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.5 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.5 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;LTPP:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Volatility of Agilent shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Volatility of selected peer-company shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23%-81%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24%-57%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pair-wise correlation with selected peers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Post-vest holding restriction discount for all executive awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.5%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.8%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</a:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i0320d16146c74425913fe2d4102de305_D20211101-20220131"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RhYmxlOjY1MDVkOWNiYjc0NTQwNjk5YTQxYjg0MWI3YmZkNjQ5L3RhYmxlcmFuZ2U6NjUwNWQ5Y2JiNzQ1NDA2OTlhNDFiODQxYjdiZmQ2NDlfNC0xLTEtMS0zMDExNA_5c7915a3-d5c8-4630-93d4-91b3161307c0"
      unitRef="number">0.013</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="if67aad121f6a462fb9bd2e05dc5b978e_D20201101-20210131"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RhYmxlOjY1MDVkOWNiYjc0NTQwNjk5YTQxYjg0MWI3YmZkNjQ5L3RhYmxlcmFuZ2U6NjUwNWQ5Y2JiNzQ1NDA2OTlhNDFiODQxYjdiZmQ2NDlfNC0zLTEtMS0zMDExNA_1287e742-5117-4482-a059-ebf12032d3cd"
      unitRef="number">0.005</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i0320d16146c74425913fe2d4102de305_D20211101-20220131"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RhYmxlOjY1MDVkOWNiYjc0NTQwNjk5YTQxYjg0MWI3YmZkNjQ5L3RhYmxlcmFuZ2U6NjUwNWQ5Y2JiNzQ1NDA2OTlhNDFiODQxYjdiZmQ2NDlfNS0xLTEtMS0zMDExNA_4f901c3a-2117-4116-a1f1-3a21ddb64bf7"
      unitRef="number">0.005</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="if67aad121f6a462fb9bd2e05dc5b978e_D20201101-20210131"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RhYmxlOjY1MDVkOWNiYjc0NTQwNjk5YTQxYjg0MWI3YmZkNjQ5L3RhYmxlcmFuZ2U6NjUwNWQ5Y2JiNzQ1NDA2OTlhNDFiODQxYjdiZmQ2NDlfNS0zLTEtMS0zMDExNA_94e66b62-8a4d-47a9-bd34-f1e1b748f79b"
      unitRef="number">0.007</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
      contextRef="i0320d16146c74425913fe2d4102de305_D20211101-20220131"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RhYmxlOjY1MDVkOWNiYjc0NTQwNjk5YTQxYjg0MWI3YmZkNjQ5L3RhYmxlcmFuZ2U6NjUwNWQ5Y2JiNzQ1NDA2OTlhNDFiODQxYjdiZmQ2NDlfNi0xLTEtMS0zMDExNA_e31e316d-224b-4c11-b6ee-7ad7bdf9bc2d"
      unitRef="number">0.26</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
      contextRef="if67aad121f6a462fb9bd2e05dc5b978e_D20201101-20210131"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RhYmxlOjY1MDVkOWNiYjc0NTQwNjk5YTQxYjg0MWI3YmZkNjQ5L3RhYmxlcmFuZ2U6NjUwNWQ5Y2JiNzQ1NDA2OTlhNDFiODQxYjdiZmQ2NDlfNi0zLTEtMS0zMDExNA_b35c57b1-5447-4d9f-b782-ecae66558888"
      unitRef="number">0.26</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i0320d16146c74425913fe2d4102de305_D20211101-20220131"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RhYmxlOjY1MDVkOWNiYjc0NTQwNjk5YTQxYjg0MWI3YmZkNjQ5L3RhYmxlcmFuZ2U6NjUwNWQ5Y2JiNzQ1NDA2OTlhNDFiODQxYjdiZmQ2NDlfNy0xLTEtMS0zMDExNA_5180c275-3fa7-4a5d-9c66-2352d7ea26b5">P5Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="if67aad121f6a462fb9bd2e05dc5b978e_D20201101-20210131"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RhYmxlOjY1MDVkOWNiYjc0NTQwNjk5YTQxYjg0MWI3YmZkNjQ5L3RhYmxlcmFuZ2U6NjUwNWQ5Y2JiNzQ1NDA2OTlhNDFiODQxYjdiZmQ2NDlfNy0zLTEtMS0zMDExNA_c4df8678-dd22-472a-b238-83bd264c235a">P5Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i5acd8d66594844e1bea57bc50343b797_D20211101-20220131"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RhYmxlOjY1MDVkOWNiYjc0NTQwNjk5YTQxYjg0MWI3YmZkNjQ5L3RhYmxlcmFuZ2U6NjUwNWQ5Y2JiNzQ1NDA2OTlhNDFiODQxYjdiZmQ2NDlfOS0xLTEtMS0zMDExNA_095f1bf5-505e-42c5-a53f-9d23499f8756"
      unitRef="number">0.29</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="ie97ad2be4ba94b6f983f36fa69ecd859_D20201101-20210131"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RhYmxlOjY1MDVkOWNiYjc0NTQwNjk5YTQxYjg0MWI3YmZkNjQ5L3RhYmxlcmFuZ2U6NjUwNWQ5Y2JiNzQ1NDA2OTlhNDFiODQxYjdiZmQ2NDlfOS0zLTEtMS0zMDExNA_a3116c1b-c606-4ebe-8dd2-f3cc885e34a5"
      unitRef="number">0.30</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <a:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesVolatilityRateRangeMinimum
      contextRef="i5acd8d66594844e1bea57bc50343b797_D20211101-20220131"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RhYmxlOjY1MDVkOWNiYjc0NTQwNjk5YTQxYjg0MWI3YmZkNjQ5L3RhYmxlcmFuZ2U6NjUwNWQ5Y2JiNzQ1NDA2OTlhNDFiODQxYjdiZmQ2NDlfMTAtMS0xLTEtMzAxMTQvdGV4dHJlZ2lvbjo1MWE3YjY2NGM0Mzg0MDQyYTYzMmYzZDc3NDllYWU5Ml80_a4bdc03c-a6d4-4e2b-b92a-ec42987b0f26"
      unitRef="number">0.23</a:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesVolatilityRateRangeMinimum>
    <a:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesVolatilityRateRangeMaximum
      contextRef="i5acd8d66594844e1bea57bc50343b797_D20211101-20220131"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RhYmxlOjY1MDVkOWNiYjc0NTQwNjk5YTQxYjg0MWI3YmZkNjQ5L3RhYmxlcmFuZ2U6NjUwNWQ5Y2JiNzQ1NDA2OTlhNDFiODQxYjdiZmQ2NDlfMTAtMS0xLTEtMzAxMTQvdGV4dHJlZ2lvbjo1MWE3YjY2NGM0Mzg0MDQyYTYzMmYzZDc3NDllYWU5Ml83_73cfdda4-6326-4d2d-ac39-5e924abd55f0"
      unitRef="number">0.81</a:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesVolatilityRateRangeMaximum>
    <a:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesVolatilityRateRangeMinimum
      contextRef="ie97ad2be4ba94b6f983f36fa69ecd859_D20201101-20210131"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RhYmxlOjY1MDVkOWNiYjc0NTQwNjk5YTQxYjg0MWI3YmZkNjQ5L3RhYmxlcmFuZ2U6NjUwNWQ5Y2JiNzQ1NDA2OTlhNDFiODQxYjdiZmQ2NDlfMTAtMy0xLTEtMzAxMTQvdGV4dHJlZ2lvbjo1ZWMwN2MxYThiNTk0ODhmOWRkNTIyNWUzZGI5MjUyMF80_b80b8244-c0c9-4723-a9c1-19240f9f3426"
      unitRef="number">0.24</a:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesVolatilityRateRangeMinimum>
    <a:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesVolatilityRateRangeMaximum
      contextRef="ie97ad2be4ba94b6f983f36fa69ecd859_D20201101-20210131"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RhYmxlOjY1MDVkOWNiYjc0NTQwNjk5YTQxYjg0MWI3YmZkNjQ5L3RhYmxlcmFuZ2U6NjUwNWQ5Y2JiNzQ1NDA2OTlhNDFiODQxYjdiZmQ2NDlfMTAtMy0xLTEtMzAxMTQvdGV4dHJlZ2lvbjo1ZWMwN2MxYThiNTk0ODhmOWRkNTIyNWUzZGI5MjUyMF83_bde44c83-963b-4822-b75b-8730ebb2fc57"
      unitRef="number">0.57</a:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesVolatilityRateRangeMaximum>
    <a:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesPriceWiseCorrelationyRate
      contextRef="i5acd8d66594844e1bea57bc50343b797_D20211101-20220131"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RhYmxlOjY1MDVkOWNiYjc0NTQwNjk5YTQxYjg0MWI3YmZkNjQ5L3RhYmxlcmFuZ2U6NjUwNWQ5Y2JiNzQ1NDA2OTlhNDFiODQxYjdiZmQ2NDlfMTEtMS0xLTEtMzAxMTQ_35010ae2-6be5-4e33-9615-cfb679e1571f"
      unitRef="number">0.41</a:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesPriceWiseCorrelationyRate>
    <a:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesPriceWiseCorrelationyRate
      contextRef="ie97ad2be4ba94b6f983f36fa69ecd859_D20201101-20210131"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RhYmxlOjY1MDVkOWNiYjc0NTQwNjk5YTQxYjg0MWI3YmZkNjQ5L3RhYmxlcmFuZ2U6NjUwNWQ5Y2JiNzQ1NDA2OTlhNDFiODQxYjdiZmQ2NDlfMTEtMy0xLTEtMzAxMTQ_822bb50c-51bb-4227-af2a-7f115ba3da2a"
      unitRef="number">0.45</a:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesPriceWiseCorrelationyRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions
      contextRef="ifb9c990647d348b7aea2ac54abe5e341_D20211101-20220131"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RhYmxlOjY1MDVkOWNiYjc0NTQwNjk5YTQxYjg0MWI3YmZkNjQ5L3RhYmxlcmFuZ2U6NjUwNWQ5Y2JiNzQ1NDA2OTlhNDFiODQxYjdiZmQ2NDlfMTMtMS0xLTEtMzAxMTQ_bfcddc11-1d5e-4d1e-863c-582074ec9dd2"
      unitRef="number">0.065</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions
      contextRef="i89bc983fc1ee42d3a7c27d1122dfa162_D20201101-20210131"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RhYmxlOjY1MDVkOWNiYjc0NTQwNjk5YTQxYjg0MWI3YmZkNjQ5L3RhYmxlcmFuZ2U6NjUwNWQ5Y2JiNzQ1NDA2OTlhNDFiODQxYjdiZmQ2NDlfMTMtMy0xLTEtMzAxMTQ_d01d9e36-5e99-4987-a4c6-3197f1e1e729"
      unitRef="number">0.068</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate
      contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RleHRyZWdpb246ZjdkZTkyNTFlNjE5NGQxZWI0YjdmNDU5NzA2NGJmOGZfMzMxMw_1416e2cc-0d61-4d54-a492-d46067e3df18"
      unitRef="number">0.85</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RleHRyZWdpb246ZjdkZTkyNTFlNjE5NGQxZWI0YjdmNDU5NzA2NGJmOGZfMzMxMw_2e276c90-bf31-4799-9622-4fbd4f22b9bb"
      unitRef="number">0.85</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate
      contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RleHRyZWdpb246ZjdkZTkyNTFlNjE5NGQxZWI0YjdmNDU5NzA2NGJmOGZfMzMxMw_7d9774a8-049d-4177-a009-6757948611ef"
      unitRef="number">0.85</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80My9mcmFnOmY3ZGU5MjUxZTYxOTRkMWViNGI3ZjQ1OTcwNjRiZjhmL3RleHRyZWdpb246ZjdkZTkyNTFlNjE5NGQxZWI0YjdmNDU5NzA2NGJmOGZfMzMxMw_f54b8dff-077a-4cb9-8a32-a296fb298f2f"
      unitRef="number">0.85</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80Ni9mcmFnOjdkNzVkNGEwY2Y4ZDQ4OTA5NDhlMzNjYzRkYzA0YWZkL3RleHRyZWdpb246N2Q3NWQ0YTBjZjhkNDg5MDk0OGUzM2NjNGRjMDRhZmRfMjI5NQ_2adeba7f-9f14-4d00-a8c3-a058fc9f0478">INCOME TAXES &lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three months ended January&#160;31, 2022, our income tax expense was $36 million with an effective tax rate of 11.3 percent. The income taxes for the three months ended January&#160;31, 2022 include the excess tax benefits from stock-based compensation of $16&#160;million. For the three months ended January&#160;31, 2022, our effective tax rate and the resulting provision for income taxes were also impacted by the expiration of various foreign statutes of limitations which resulted in the recognition of previously unrecognized tax benefits of $8&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our calculation of income tax expense for the&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;three&lt;/span&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; months ended &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;January&#160;31, 2022&lt;/span&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; is dependent in part on forecasts of full year results. The impact of the COVID-19 outbreak on the economic environment is uncertain and may change these forecasts, which could impact tax expense.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three months ended January&#160;31, 2021, our income tax expense was $24 million with an effective tax rate of 7.7 percent. The income taxes for the three months ended January&#160;31, 2021 include the excess tax benefits from stock-based compensation of $20&#160;million. For the three months ended January&#160;31, 2021, our effective tax rate and the resulting provision for income taxes were also impacted by the expiration of various foreign statutes of limitations which resulted in the recognition of previously unrecognized tax benefits of $16&#160;million. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; In the U.S., tax years remain open back to the year 2018 for federal income tax purposes and for significant states. In other major jurisdictions where the company conducts business, the tax years generally remain open back to the year 2012.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;With these jurisdictions and the U.S., it is reasonably possible there could be significant changes to our unrecognized tax benefits in the next twelve months due to either the expiration of a statute of limitation or a tax audit settlement which will be partially offset by an anticipated tax liability related to unremitted foreign earnings, where applicable. Given the number of years and numerous matters that remain subject to examination in various tax jurisdictions, management is unable to estimate the range of possible changes to the balance of our unrecognized tax benefits.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80Ni9mcmFnOjdkNzVkNGEwY2Y4ZDQ4OTA5NDhlMzNjYzRkYzA0YWZkL3RleHRyZWdpb246N2Q3NWQ0YTBjZjhkNDg5MDk0OGUzM2NjNGRjMDRhZmRfNzk_34003e00-94a2-4f43-8e54-dd68c1316ee4"
      unitRef="usd">36000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80Ni9mcmFnOjdkNzVkNGEwY2Y4ZDQ4OTA5NDhlMzNjYzRkYzA0YWZkL3RleHRyZWdpb246N2Q3NWQ0YTBjZjhkNDg5MDk0OGUzM2NjNGRjMDRhZmRfMTEy_048c569c-5e45-4642-a8bf-5a2bbbe37700"
      unitRef="number">0.113</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80Ni9mcmFnOjdkNzVkNGEwY2Y4ZDQ4OTA5NDhlMzNjYzRkYzA0YWZkL3RleHRyZWdpb246N2Q3NWQ0YTBjZjhkNDg5MDk0OGUzM2NjNGRjMDRhZmRfMTA5OTUxMTYzMTk2NA_a102e3f9-df5d-4ba4-aabb-bc97892c0ee2"
      unitRef="usd">16000000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80Ni9mcmFnOjdkNzVkNGEwY2Y4ZDQ4OTA5NDhlMzNjYzRkYzA0YWZkL3RleHRyZWdpb246N2Q3NWQ0YTBjZjhkNDg5MDk0OGUzM2NjNGRjMDRhZmRfMTA5OTUxMTYzMjE0OA_cdd7ddea-8836-43f3-9a7d-c331d95d6d05"
      unitRef="usd">8000000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80Ni9mcmFnOjdkNzVkNGEwY2Y4ZDQ4OTA5NDhlMzNjYzRkYzA0YWZkL3RleHRyZWdpb246N2Q3NWQ0YTBjZjhkNDg5MDk0OGUzM2NjNGRjMDRhZmRfODgw_3848619f-dd8e-40cc-951e-5280fe5e7105"
      unitRef="usd">24000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80Ni9mcmFnOjdkNzVkNGEwY2Y4ZDQ4OTA5NDhlMzNjYzRkYzA0YWZkL3RleHRyZWdpb246N2Q3NWQ0YTBjZjhkNDg5MDk0OGUzM2NjNGRjMDRhZmRfOTEz_c1f60542-f43e-486d-9cd6-feec78d15b01"
      unitRef="number">0.077</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80Ni9mcmFnOjdkNzVkNGEwY2Y4ZDQ4OTA5NDhlMzNjYzRkYzA0YWZkL3RleHRyZWdpb246N2Q3NWQ0YTBjZjhkNDg5MDk0OGUzM2NjNGRjMDRhZmRfMTA5OTUxMTYzMTIwNw_189af7ad-2c3b-4d23-8840-e61af0cb6be6"
      unitRef="usd">20000000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80Ni9mcmFnOjdkNzVkNGEwY2Y4ZDQ4OTA5NDhlMzNjYzRkYzA0YWZkL3RleHRyZWdpb246N2Q3NWQ0YTBjZjhkNDg5MDk0OGUzM2NjNGRjMDRhZmRfMTA5OTUxMTYzMzE0Mw_3dcb175b-222d-4375-a49d-c6bec5c88be4"
      unitRef="usd">16000000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80Ni9mcmFnOjdkNzVkNGEwY2Y4ZDQ4OTA5NDhlMzNjYzRkYzA0YWZkL3RleHRyZWdpb246N2Q3NWQ0YTBjZjhkNDg5MDk0OGUzM2NjNGRjMDRhZmRfMTA5OTUxMTYzMzE0Mw_c149b1a5-ac4b-4ff1-ab21-b772019439fe"
      unitRef="usd">16000000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80OS9mcmFnOmNlNGQyNjU5MTYxMTQ0MzRhMjIyYmZlMzIwNGY3NmYxL3RleHRyZWdpb246Y2U0ZDI2NTkxNjExNDQzNGEyMjJiZmUzMjA0Zjc2ZjFfMTUxMQ_49e19599-b216-48a7-b4d3-1ebf6df22f05">NET INCOME PER SHARE&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a reconciliation of the numerator and denominator of the basic and diluted net income per share computations for the periods presented below:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:80.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.674%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;January 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in&#160;millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic weighted-average shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Potential common shares&#x2014; stock&#160;options and other employee stock plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted weighted-average shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The dilutive effect of share-based awards is reflected in diluted net income per share by application of the treasury stock method, which includes consideration of unamortized share-based compensation expense and the dilutive effect of in-the-money options and non-vested restricted stock units. Under the treasury stock method, the amount the employee must pay for exercising stock options and unamortized share-based compensation expense collectively are assumed proceeds to be used to repurchase hypothetical shares. An increase in the fair market value of the company's common stock can result in a greater dilutive effect from potentially dilutive awards.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We exclude stock options with exercise prices greater than the average market price of our common stock from the calculation of diluted earnings per share because their effect would be anti-dilutive. In addition, we exclude from the calculation of diluted earnings per share stock options, ESPP, LTPP and restricted stock awards whose combined exercise price and unamortized fair value were greater than the average market price of our common stock because their effect would also be anti-dilutive. &#160; &lt;/span&gt;&lt;/div&gt;For both the three months ended January&#160;31, 2022 and 2021, potential common shares excluded from the calculation of diluted earnings per share were not material.</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80OS9mcmFnOmNlNGQyNjU5MTYxMTQ0MzRhMjIyYmZlMzIwNGY3NmYxL3RleHRyZWdpb246Y2U0ZDI2NTkxNjExNDQzNGEyMjJiZmUzMjA0Zjc2ZjFfMTUxNw_bec6b21d-1c65-46c8-a137-cef9d0fad926">&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a reconciliation of the numerator and denominator of the basic and diluted net income per share computations for the periods presented below:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:80.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.674%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;January 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in&#160;millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic weighted-average shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Potential common shares&#x2014; stock&#160;options and other employee stock plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted weighted-average shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80OS9mcmFnOmNlNGQyNjU5MTYxMTQ0MzRhMjIyYmZlMzIwNGY3NmYxL3RhYmxlOmZjYjZlOWQ3ZTVmNTRhNmI5YzgxNDNjMDkwYWJjNzBmL3RhYmxlcmFuZ2U6ZmNiNmU5ZDdlNWY1NGE2YjljODE0M2MwOTBhYmM3MGZfNS0xLTEtMS0zMDExNA_0771d00e-0edf-4c70-a561-a8a9a771607e"
      unitRef="usd">283000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80OS9mcmFnOmNlNGQyNjU5MTYxMTQ0MzRhMjIyYmZlMzIwNGY3NmYxL3RhYmxlOmZjYjZlOWQ3ZTVmNTRhNmI5YzgxNDNjMDkwYWJjNzBmL3RhYmxlcmFuZ2U6ZmNiNmU5ZDdlNWY1NGE2YjljODE0M2MwOTBhYmM3MGZfNS0zLTEtMS0zMDExNA_1f6a4689-a841-4ec8-9c80-80df7e340164"
      unitRef="usd">288000000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80OS9mcmFnOmNlNGQyNjU5MTYxMTQ0MzRhMjIyYmZlMzIwNGY3NmYxL3RhYmxlOmZjYjZlOWQ3ZTVmNTRhNmI5YzgxNDNjMDkwYWJjNzBmL3RhYmxlcmFuZ2U6ZmNiNmU5ZDdlNWY1NGE2YjljODE0M2MwOTBhYmM3MGZfNy0xLTEtMS0zMDExNA_718f6890-3f3e-4d90-9234-87afe5f8a1d9"
      unitRef="shares">301000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80OS9mcmFnOmNlNGQyNjU5MTYxMTQ0MzRhMjIyYmZlMzIwNGY3NmYxL3RhYmxlOmZjYjZlOWQ3ZTVmNTRhNmI5YzgxNDNjMDkwYWJjNzBmL3RhYmxlcmFuZ2U6ZmNiNmU5ZDdlNWY1NGE2YjljODE0M2MwOTBhYmM3MGZfNy0zLTEtMS0zMDExNA_92c5c1a3-171d-4c4a-9088-fc15b98ec1ec"
      unitRef="shares">306000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80OS9mcmFnOmNlNGQyNjU5MTYxMTQ0MzRhMjIyYmZlMzIwNGY3NmYxL3RhYmxlOmZjYjZlOWQ3ZTVmNTRhNmI5YzgxNDNjMDkwYWJjNzBmL3RhYmxlcmFuZ2U6ZmNiNmU5ZDdlNWY1NGE2YjljODE0M2MwOTBhYmM3MGZfOC0xLTEtMS0zMDExNA_4fb65ab7-a965-46f3-be8c-4510dc7e8a1c"
      unitRef="shares">2000000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80OS9mcmFnOmNlNGQyNjU5MTYxMTQ0MzRhMjIyYmZlMzIwNGY3NmYxL3RhYmxlOmZjYjZlOWQ3ZTVmNTRhNmI5YzgxNDNjMDkwYWJjNzBmL3RhYmxlcmFuZ2U6ZmNiNmU5ZDdlNWY1NGE2YjljODE0M2MwOTBhYmM3MGZfOC0zLTEtMS0zMDExNA_816eb8ec-1ba5-4351-a209-b09c5fdbe1d9"
      unitRef="shares">3000000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80OS9mcmFnOmNlNGQyNjU5MTYxMTQ0MzRhMjIyYmZlMzIwNGY3NmYxL3RhYmxlOmZjYjZlOWQ3ZTVmNTRhNmI5YzgxNDNjMDkwYWJjNzBmL3RhYmxlcmFuZ2U6ZmNiNmU5ZDdlNWY1NGE2YjljODE0M2MwOTBhYmM3MGZfOS0xLTEtMS0zMDExNA_9f343369-0fa3-41fe-8333-c9dddf4d19c0"
      unitRef="shares">303000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80OS9mcmFnOmNlNGQyNjU5MTYxMTQ0MzRhMjIyYmZlMzIwNGY3NmYxL3RhYmxlOmZjYjZlOWQ3ZTVmNTRhNmI5YzgxNDNjMDkwYWJjNzBmL3RhYmxlcmFuZ2U6ZmNiNmU5ZDdlNWY1NGE2YjljODE0M2MwOTBhYmM3MGZfOS0zLTEtMS0zMDExNA_40a414b2-8626-48ab-9cb7-05df93a3ae59"
      unitRef="shares">309000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80OS9mcmFnOmNlNGQyNjU5MTYxMTQ0MzRhMjIyYmZlMzIwNGY3NmYxL3RleHRyZWdpb246Y2U0ZDI2NTkxNjExNDQzNGEyMjJiZmUzMjA0Zjc2ZjFfMTQ5Mg_7dabcb1a-e863-420f-8fe7-238ae5dff046"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80OS9mcmFnOmNlNGQyNjU5MTYxMTQ0MzRhMjIyYmZlMzIwNGY3NmYxL3RleHRyZWdpb246Y2U0ZDI2NTkxNjExNDQzNGEyMjJiZmUzMjA0Zjc2ZjFfMTQ5Mg_e55de7e2-c40c-49ff-8273-06eddc817762"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80OS9mcmFnOmNlNGQyNjU5MTYxMTQ0MzRhMjIyYmZlMzIwNGY3NmYxL3RleHRyZWdpb246Y2U0ZDI2NTkxNjExNDQzNGEyMjJiZmUzMjA0Zjc2ZjFfMTQ5Mg_f035c932-2bd7-4730-b72b-6d6cd9758db1"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV80OS9mcmFnOmNlNGQyNjU5MTYxMTQ0MzRhMjIyYmZlMzIwNGY3NmYxL3RleHRyZWdpb246Y2U0ZDI2NTkxNjExNDQzNGEyMjJiZmUzMjA0Zjc2ZjFfMTQ5Mg_fbd9c8b7-5636-4666-a25b-9c14f2a1a899"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:InventoryDisclosureTextBlock
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81Mi9mcmFnOmY2OTRkZWU4ZDg1OTQ0Yjk4MjdjZTk3NDM1NDg4NmUyL3RleHRyZWdpb246ZjY5NGRlZThkODU5NDRiOTgyN2NlOTc0MzU0ODg2ZTJfODY_2f4c5bc3-5386-4fed-95ce-767c1b8c7e50">INVENTORY&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventory as of January&#160;31, 2022 and October&#160;31, 2021 consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.119%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.218%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;January 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in&#160;millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;488&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchased parts and fabricated assemblies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventory&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;879&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;830&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:InventoryDisclosureTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81Mi9mcmFnOmY2OTRkZWU4ZDg1OTQ0Yjk4MjdjZTk3NDM1NDg4NmUyL3RleHRyZWdpb246ZjY5NGRlZThkODU5NDRiOTgyN2NlOTc0MzU0ODg2ZTJfODE_0bff8cec-087b-42a0-86ce-2f7be71d0e3a">INVENTORY&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventory as of January&#160;31, 2022 and October&#160;31, 2021 consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.119%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.218%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;January 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in&#160;millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;488&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchased parts and fabricated assemblies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventory&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;879&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;830&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryFinishedGoods
      contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81Mi9mcmFnOmY2OTRkZWU4ZDg1OTQ0Yjk4MjdjZTk3NDM1NDg4NmUyL3RhYmxlOmFkOWIwMTU3YjZjMjQ2OTlhYjI5YTJkM2IzMDhlNzA3L3RhYmxlcmFuZ2U6YWQ5YjAxNTdiNmMyNDY5OWFiMjlhMmQzYjMwOGU3MDdfMi0xLTEtMS0zMDExNA_e216c20f-70ce-44d0-a920-4b0174567e5f"
      unitRef="usd">488000000</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryFinishedGoods
      contextRef="i6390807210d74c6f9cae496ea2122a5a_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81Mi9mcmFnOmY2OTRkZWU4ZDg1OTQ0Yjk4MjdjZTk3NDM1NDg4NmUyL3RhYmxlOmFkOWIwMTU3YjZjMjQ2OTlhYjI5YTJkM2IzMDhlNzA3L3RhYmxlcmFuZ2U6YWQ5YjAxNTdiNmMyNDY5OWFiMjlhMmQzYjMwOGU3MDdfMi0zLTEtMS0zMDExNA_2d98f8be-15b3-45ce-bae2-141814f6cc08"
      unitRef="usd">463000000</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryWorkInProcessAndRawMaterials
      contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81Mi9mcmFnOmY2OTRkZWU4ZDg1OTQ0Yjk4MjdjZTk3NDM1NDg4NmUyL3RhYmxlOmFkOWIwMTU3YjZjMjQ2OTlhYjI5YTJkM2IzMDhlNzA3L3RhYmxlcmFuZ2U6YWQ5YjAxNTdiNmMyNDY5OWFiMjlhMmQzYjMwOGU3MDdfMy0xLTEtMS0zMDExNA_3133c77e-cfa7-481c-b06d-36612cd027e2"
      unitRef="usd">391000000</us-gaap:InventoryWorkInProcessAndRawMaterials>
    <us-gaap:InventoryWorkInProcessAndRawMaterials
      contextRef="i6390807210d74c6f9cae496ea2122a5a_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81Mi9mcmFnOmY2OTRkZWU4ZDg1OTQ0Yjk4MjdjZTk3NDM1NDg4NmUyL3RhYmxlOmFkOWIwMTU3YjZjMjQ2OTlhYjI5YTJkM2IzMDhlNzA3L3RhYmxlcmFuZ2U6YWQ5YjAxNTdiNmMyNDY5OWFiMjlhMmQzYjMwOGU3MDdfMy0zLTEtMS0zMDExNA_49a97343-e54d-4efc-9b78-f708323dd5f0"
      unitRef="usd">367000000</us-gaap:InventoryWorkInProcessAndRawMaterials>
    <us-gaap:InventoryNet
      contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81Mi9mcmFnOmY2OTRkZWU4ZDg1OTQ0Yjk4MjdjZTk3NDM1NDg4NmUyL3RhYmxlOmFkOWIwMTU3YjZjMjQ2OTlhYjI5YTJkM2IzMDhlNzA3L3RhYmxlcmFuZ2U6YWQ5YjAxNTdiNmMyNDY5OWFiMjlhMmQzYjMwOGU3MDdfNC0xLTEtMS0zMDExNA_49e7a6ff-649d-4412-87c4-1dcbc8726bf8"
      unitRef="usd">879000000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i6390807210d74c6f9cae496ea2122a5a_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81Mi9mcmFnOmY2OTRkZWU4ZDg1OTQ0Yjk4MjdjZTk3NDM1NDg4NmUyL3RhYmxlOmFkOWIwMTU3YjZjMjQ2OTlhYjI5YTJkM2IzMDhlNzA3L3RhYmxlcmFuZ2U6YWQ5YjAxNTdiNmMyNDY5OWFiMjlhMmQzYjMwOGU3MDdfNC0zLTEtMS0zMDExNA_36846562-e59e-4d2a-9a0c-3885b2cf2f07"
      unitRef="usd">830000000</us-gaap:InventoryNet>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RleHRyZWdpb246MjVlZWM3MzYwN2E2NDcxMzkzZDkyZWJlODZiZTQ4MWVfMzk2Mw_c2f4e130-21ec-426c-a00f-2b365a418093">GOODWILL AND OTHER INTANGIBLE ASSETS&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents goodwill balances and the movements for each of our reportable segments during the three months ended January&#160;31, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.512%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.457%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.070%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.632%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Life Sciences and Applied Markets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Diagnostics and Genomics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Agilent CrossLab&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in&#160;millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill as of October 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,964&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;268&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,975&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation impact&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill as of January 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,739&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,961&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,964&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the first quarter of fiscal year 2022, we reorganized our operating segments and moved our chemistries and supplies business and our remarketed instruments business from our Agilent CrossLab business segment to our life sciences and applied markets business segment. As a result, we reassigned approximately $307&#160;million of goodwill from our Agilent Crosslab business segment to our life sciences and applied markets business segment using the relative fair value allocation approach. In addition, we moved service revenue and cost of sales related to the previous acquisition of BioTek from our life sciences and applied markets business segment to our Agilent CrossLab business segment. As a result, we reassigned approximately $10&#160;million of goodwill from our life sciences and applied markets segment to our Agilent Crosslab business segment using the relative fair value allocation approach. Goodwill balances as of October 31, 2021, have been recast to conform to this new presentation.  As a result of the reorganization there was no change to our reporting units. In addition, we performed a goodwill impairment test, and the results of the analysis indicated that the fair values for all three of our reporting units were in excess of their carrying values by substantial amounts; therefore, no impairment was indicated. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The component parts of other intangible assets as of January&#160;31, 2022 and October&#160;31, 2021 are shown in the table below:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other&#160;Intangible&#160;Assets&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&#160;Book&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in&#160;millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of October 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchased technology&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;770&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Backlog&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademark/Tradename&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Third-party technology and licenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total amortizable intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;970&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;In-Process R&amp;amp;D&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;981&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of January 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchased technology&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,738&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademark/Tradename&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;355&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Backlog&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Third-party technology and licenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total amortizable intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;In-Process R&amp;amp;D&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;929&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three months ended January&#160;31, 2022, there were no additions to goodwill or other intangible assets.  During the three months ended January&#160;31, 2022, other intangible assets in total decreased $1 million due to the impact of foreign currency translation. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In general, for U.S. federal tax purposes, goodwill from asset purchases is deductible; however, any goodwill created as part of a stock acquisition is not deductible.&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Each quarter we review the events and circumstances to determine if impairment of indefinite-lived intangible assets and goodwill is indicated. During the three months ended January&#160;31, 2022 and 2021 we did not identify any triggering events or circumstances, including impacts due to COVID-19, which would indicate an impairment of goodwill or indefinite-lived intangible assets. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortization expense of intangible assets was $51 million and $45 million for the three months ended January&#160;31, 2022 and 2021, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Future amortization expense related to existing finite-lived purchased intangible assets for the remainder of fiscal year 2022 and for each of the next five fiscal years and thereafter is estimated below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:90.859%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.941%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Estimated future amortization expense:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remainder of 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfGoodwillTextBlock
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RleHRyZWdpb246MjVlZWM3MzYwN2E2NDcxMzkzZDkyZWJlODZiZTQ4MWVfMzk2OA_d6fbd39b-bc5c-4ff5-9b76-2de51b0a1533">&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents goodwill balances and the movements for each of our reportable segments during the three months ended January&#160;31, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.512%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.457%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.070%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.632%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Life Sciences and Applied Markets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Diagnostics and Genomics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Agilent CrossLab&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in&#160;millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill as of October 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,964&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;268&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,975&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation impact&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill as of January 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,739&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,961&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,964&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill
      contextRef="i944f468c66a14978a1d1787de51efa6c_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RhYmxlOmUzMzZhOGM1ZmVlZTQ4ZmZhOGJmZTA3Y2FjMDI3N2EwL3RhYmxlcmFuZ2U6ZTMzNmE4YzVmZWVlNDhmZmE4YmZlMDdjYWMwMjc3YTBfMi0xLTEtMS0zMDExNA_f7fb818c-98af-44bf-b5a1-fd8d012110fb"
      unitRef="usd">1743000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ib2f7270de94a4e99a7412adaded44a2d_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RhYmxlOmUzMzZhOGM1ZmVlZTQ4ZmZhOGJmZTA3Y2FjMDI3N2EwL3RhYmxlcmFuZ2U6ZTMzNmE4YzVmZWVlNDhmZmE4YmZlMDdjYWMwMjc3YTBfMi0zLTEtMS0zMDExNA_b23ce176-92dd-4753-a025-2aab8da8b5c8"
      unitRef="usd">1964000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ib1434e5353934a0ebeb33b6c28613a50_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RhYmxlOmUzMzZhOGM1ZmVlZTQ4ZmZhOGJmZTA3Y2FjMDI3N2EwL3RhYmxlcmFuZ2U6ZTMzNmE4YzVmZWVlNDhmZmE4YmZlMDdjYWMwMjc3YTBfMi01LTEtMS0zMDExNA_b5451bac-398a-4696-a90f-5009c8582430"
      unitRef="usd">268000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i6390807210d74c6f9cae496ea2122a5a_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RhYmxlOmUzMzZhOGM1ZmVlZTQ4ZmZhOGJmZTA3Y2FjMDI3N2EwL3RhYmxlcmFuZ2U6ZTMzNmE4YzVmZWVlNDhmZmE4YmZlMDdjYWMwMjc3YTBfMi03LTEtMS0zMDExNA_b2149795-7e16-4abb-9f4d-b9271fa98d3e"
      unitRef="usd">3975000000</us-gaap:Goodwill>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="i6d58196320f34869a29143308907c47f_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RhYmxlOmUzMzZhOGM1ZmVlZTQ4ZmZhOGJmZTA3Y2FjMDI3N2EwL3RhYmxlcmFuZ2U6ZTMzNmE4YzVmZWVlNDhmZmE4YmZlMDdjYWMwMjc3YTBfMy0xLTEtMS0zMDExNA_a5f6f5f2-15ea-4c0f-b445-3da7d4d9af76"
      unitRef="usd">-4000000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="ie43c9572619448f8a6ea6d852ea0af23_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RhYmxlOmUzMzZhOGM1ZmVlZTQ4ZmZhOGJmZTA3Y2FjMDI3N2EwL3RhYmxlcmFuZ2U6ZTMzNmE4YzVmZWVlNDhmZmE4YmZlMDdjYWMwMjc3YTBfMy0zLTEtMS0zMDExNA_2ab69385-e3a4-4ede-945b-e1ae9d59cb22"
      unitRef="usd">-3000000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="i30a463a582ff4b16971b766059a24eb9_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RhYmxlOmUzMzZhOGM1ZmVlZTQ4ZmZhOGJmZTA3Y2FjMDI3N2EwL3RhYmxlcmFuZ2U6ZTMzNmE4YzVmZWVlNDhmZmE4YmZlMDdjYWMwMjc3YTBfMy01LTEtMS0zMDExNA_a5d4af9b-2576-4713-814a-4f8e63c3d23c"
      unitRef="usd">-4000000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RhYmxlOmUzMzZhOGM1ZmVlZTQ4ZmZhOGJmZTA3Y2FjMDI3N2EwL3RhYmxlcmFuZ2U6ZTMzNmE4YzVmZWVlNDhmZmE4YmZlMDdjYWMwMjc3YTBfMy03LTEtMS0zMDExNA_17fa533b-45fe-47b4-a746-d1047d486d46"
      unitRef="usd">-11000000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:Goodwill
      contextRef="ifa12471462934aa683c02dac2a2b2a70_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RhYmxlOmUzMzZhOGM1ZmVlZTQ4ZmZhOGJmZTA3Y2FjMDI3N2EwL3RhYmxlcmFuZ2U6ZTMzNmE4YzVmZWVlNDhmZmE4YmZlMDdjYWMwMjc3YTBfNS0xLTEtMS0zMDExNA_ca77aad4-231d-4188-8664-47c3359b5053"
      unitRef="usd">1739000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="idcc96fc9ea6041bab3a0329c8a379a8d_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RhYmxlOmUzMzZhOGM1ZmVlZTQ4ZmZhOGJmZTA3Y2FjMDI3N2EwL3RhYmxlcmFuZ2U6ZTMzNmE4YzVmZWVlNDhmZmE4YmZlMDdjYWMwMjc3YTBfNS0zLTEtMS0zMDExNA_50b129e4-8821-4b91-bfea-cd9d397a7ae8"
      unitRef="usd">1961000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ia895e40152014164ae9414ff9f88a43e_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RhYmxlOmUzMzZhOGM1ZmVlZTQ4ZmZhOGJmZTA3Y2FjMDI3N2EwL3RhYmxlcmFuZ2U6ZTMzNmE4YzVmZWVlNDhmZmE4YmZlMDdjYWMwMjc3YTBfNS01LTEtMS0zMDExNA_7ae88ac3-26a9-4e6f-b3ef-c535d9d95f6d"
      unitRef="usd">264000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RhYmxlOmUzMzZhOGM1ZmVlZTQ4ZmZhOGJmZTA3Y2FjMDI3N2EwL3RhYmxlcmFuZ2U6ZTMzNmE4YzVmZWVlNDhmZmE4YmZlMDdjYWMwMjc3YTBfNS03LTEtMS0zMDExNA_d70c5a90-9f25-43c8-8d49-733f52ad23f5"
      unitRef="usd">3964000000</us-gaap:Goodwill>
    <us-gaap:GoodwillTransfers
      contextRef="i6d58196320f34869a29143308907c47f_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RleHRyZWdpb246MjVlZWM3MzYwN2E2NDcxMzkzZDkyZWJlODZiZTQ4MWVfMTY0OTI2NzQ1NTc4OA_be607f7d-3d2b-477e-8e9a-cf6ecba48749"
      unitRef="usd">307000000</us-gaap:GoodwillTransfers>
    <us-gaap:GoodwillTransfers
      contextRef="i30a463a582ff4b16971b766059a24eb9_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RleHRyZWdpb246MjVlZWM3MzYwN2E2NDcxMzkzZDkyZWJlODZiZTQ4MWVfMTY0OTI2NzQ1NTgwMg_0053aead-58bb-41fa-a2e9-f240ce6c0609"
      unitRef="usd">10000000</us-gaap:GoodwillTransfers>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RleHRyZWdpb246MjVlZWM3MzYwN2E2NDcxMzkzZDkyZWJlODZiZTQ4MWVfMTY0OTI2NzQ1NzAwMw_54018186-82af-4a55-bb90-16310526fdeb"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RleHRyZWdpb246MjVlZWM3MzYwN2E2NDcxMzkzZDkyZWJlODZiZTQ4MWVfMzk3MA_26271f1f-c270-4e23-8bd4-c488d6d3d382">&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The component parts of other intangible assets as of January&#160;31, 2022 and October&#160;31, 2021 are shown in the table below:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other&#160;Intangible&#160;Assets&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&#160;Book&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in&#160;millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of October 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchased technology&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;770&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Backlog&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademark/Tradename&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Third-party technology and licenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total amortizable intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;970&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;In-Process R&amp;amp;D&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;981&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of January 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchased technology&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,738&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademark/Tradename&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;355&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Backlog&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Third-party technology and licenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total amortizable intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;In-Process R&amp;amp;D&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;929&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i62b4b85a6eb042808ab856394d83600f_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RhYmxlOmIwMGE5ZjQ4NWUxODQyOTI5ZTU3YzExNDVkZmU5MTBlL3RhYmxlcmFuZ2U6YjAwYTlmNDg1ZTE4NDI5MjllNTdjMTE0NWRmZTkxMGVfNC0xLTEtMS0zMDExNA_81c1b68c-c1ef-45b4-9ae8-0728a7fba567"
      unitRef="usd">1742000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i62b4b85a6eb042808ab856394d83600f_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RhYmxlOmIwMGE5ZjQ4NWUxODQyOTI5ZTU3YzExNDVkZmU5MTBlL3RhYmxlcmFuZ2U6YjAwYTlmNDg1ZTE4NDI5MjllNTdjMTE0NWRmZTkxMGVfNC0zLTEtMS0zMDExNA_885bc207-ee46-4b92-a5c1-c46542c82288"
      unitRef="usd">972000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i62b4b85a6eb042808ab856394d83600f_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RhYmxlOmIwMGE5ZjQ4NWUxODQyOTI5ZTU3YzExNDVkZmU5MTBlL3RhYmxlcmFuZ2U6YjAwYTlmNDg1ZTE4NDI5MjllNTdjMTE0NWRmZTkxMGVfNC01LTEtMS0zMDExNA_79758531-a8b3-4884-99e9-763e3d91d602"
      unitRef="usd">770000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ie3e5ec69c4a64648a675263b06182b48_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RhYmxlOmIwMGE5ZjQ4NWUxODQyOTI5ZTU3YzExNDVkZmU5MTBlL3RhYmxlcmFuZ2U6YjAwYTlmNDg1ZTE4NDI5MjllNTdjMTE0NWRmZTkxMGVfNS0xLTEtMS0zMDExNA_55e9954f-9e6f-4d55-bb4c-62d67d573ce5"
      unitRef="usd">8000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ie3e5ec69c4a64648a675263b06182b48_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RhYmxlOmIwMGE5ZjQ4NWUxODQyOTI5ZTU3YzExNDVkZmU5MTBlL3RhYmxlcmFuZ2U6YjAwYTlmNDg1ZTE4NDI5MjllNTdjMTE0NWRmZTkxMGVfNS0zLTEtMS0zMDExNA_dcc0599a-7863-44e0-adfe-d4a9e45cf6ea"
      unitRef="usd">3000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ie3e5ec69c4a64648a675263b06182b48_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RhYmxlOmIwMGE5ZjQ4NWUxODQyOTI5ZTU3YzExNDVkZmU5MTBlL3RhYmxlcmFuZ2U6YjAwYTlmNDg1ZTE4NDI5MjllNTdjMTE0NWRmZTkxMGVfNS01LTEtMS0zMDExNA_4c283109-d652-4f6e-8fa1-952c3adea65a"
      unitRef="usd">5000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="icca833cf758b4ec9adfaeb6e650d7c76_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RhYmxlOmIwMGE5ZjQ4NWUxODQyOTI5ZTU3YzExNDVkZmU5MTBlL3RhYmxlcmFuZ2U6YjAwYTlmNDg1ZTE4NDI5MjllNTdjMTE0NWRmZTkxMGVfNi0xLTEtMS0zMDExNA_34658d00-1e05-4927-9a81-970aa1d67da3"
      unitRef="usd">196000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="icca833cf758b4ec9adfaeb6e650d7c76_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RhYmxlOmIwMGE5ZjQ4NWUxODQyOTI5ZTU3YzExNDVkZmU5MTBlL3RhYmxlcmFuZ2U6YjAwYTlmNDg1ZTE4NDI5MjllNTdjMTE0NWRmZTkxMGVfNi0zLTEtMS0zMDExNA_49edda36-b356-40af-b471-a8f60e01bb0e"
      unitRef="usd">133000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="icca833cf758b4ec9adfaeb6e650d7c76_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RhYmxlOmIwMGE5ZjQ4NWUxODQyOTI5ZTU3YzExNDVkZmU5MTBlL3RhYmxlcmFuZ2U6YjAwYTlmNDg1ZTE4NDI5MjllNTdjMTE0NWRmZTkxMGVfNi01LTEtMS0zMDExNA_876d0f07-ab7f-44d6-a05f-da06a14aba67"
      unitRef="usd">63000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ice63f8e3b57a458885f621065c24dd64_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RhYmxlOmIwMGE5ZjQ4NWUxODQyOTI5ZTU3YzExNDVkZmU5MTBlL3RhYmxlcmFuZ2U6YjAwYTlmNDg1ZTE4NDI5MjllNTdjMTE0NWRmZTkxMGVfNy0xLTEtMS0zMDExNA_2b1ad8c1-7958-4777-b3aa-d89e7503d0ec"
      unitRef="usd">357000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ice63f8e3b57a458885f621065c24dd64_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RhYmxlOmIwMGE5ZjQ4NWUxODQyOTI5ZTU3YzExNDVkZmU5MTBlL3RhYmxlcmFuZ2U6YjAwYTlmNDg1ZTE4NDI5MjllNTdjMTE0NWRmZTkxMGVfNy0zLTEtMS0zMDExNA_581aab48-c4ca-4e74-8f11-1ae884a37c19"
      unitRef="usd">228000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ice63f8e3b57a458885f621065c24dd64_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RhYmxlOmIwMGE5ZjQ4NWUxODQyOTI5ZTU3YzExNDVkZmU5MTBlL3RhYmxlcmFuZ2U6YjAwYTlmNDg1ZTE4NDI5MjllNTdjMTE0NWRmZTkxMGVfNy01LTEtMS0zMDExNA_112fb8fa-c666-42f1-a470-5ab27d9b2276"
      unitRef="usd">129000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i05ef46e1fee74f6eb0ef89af56b45fa8_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RhYmxlOmIwMGE5ZjQ4NWUxODQyOTI5ZTU3YzExNDVkZmU5MTBlL3RhYmxlcmFuZ2U6YjAwYTlmNDg1ZTE4NDI5MjllNTdjMTE0NWRmZTkxMGVfOC0xLTEtMS0zMDExNA_d1964ffc-6cfc-418d-bfc3-6d43163062e1"
      unitRef="usd">11000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i05ef46e1fee74f6eb0ef89af56b45fa8_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RhYmxlOmIwMGE5ZjQ4NWUxODQyOTI5ZTU3YzExNDVkZmU5MTBlL3RhYmxlcmFuZ2U6YjAwYTlmNDg1ZTE4NDI5MjllNTdjMTE0NWRmZTkxMGVfOC0zLTEtMS0zMDExNA_8e91ddc1-212a-4b98-b373-3d0bcc5eddd5"
      unitRef="usd">8000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i05ef46e1fee74f6eb0ef89af56b45fa8_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RhYmxlOmIwMGE5ZjQ4NWUxODQyOTI5ZTU3YzExNDVkZmU5MTBlL3RhYmxlcmFuZ2U6YjAwYTlmNDg1ZTE4NDI5MjllNTdjMTE0NWRmZTkxMGVfOC01LTEtMS0zMDExNA_39c5d9e3-4041-4f8c-8a97-654ee49f069b"
      unitRef="usd">3000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i6390807210d74c6f9cae496ea2122a5a_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RhYmxlOmIwMGE5ZjQ4NWUxODQyOTI5ZTU3YzExNDVkZmU5MTBlL3RhYmxlcmFuZ2U6YjAwYTlmNDg1ZTE4NDI5MjllNTdjMTE0NWRmZTkxMGVfOS0xLTEtMS0zMDExNA_a0b3333d-90e7-481b-afc1-0fe18709b7ed"
      unitRef="usd">2314000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i6390807210d74c6f9cae496ea2122a5a_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RhYmxlOmIwMGE5ZjQ4NWUxODQyOTI5ZTU3YzExNDVkZmU5MTBlL3RhYmxlcmFuZ2U6YjAwYTlmNDg1ZTE4NDI5MjllNTdjMTE0NWRmZTkxMGVfOS0zLTEtMS0zMDExNA_351f65bd-50d5-438d-afb3-1484fccc956f"
      unitRef="usd">1344000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i6390807210d74c6f9cae496ea2122a5a_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RhYmxlOmIwMGE5ZjQ4NWUxODQyOTI5ZTU3YzExNDVkZmU5MTBlL3RhYmxlcmFuZ2U6YjAwYTlmNDg1ZTE4NDI5MjllNTdjMTE0NWRmZTkxMGVfOS01LTEtMS0zMDExNA_42a97a7f-3b71-4e38-b8ba-57cbf6dbbacc"
      unitRef="usd">970000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i7b9447a5f8df4edc80c1ead0839fe3f6_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RhYmxlOmIwMGE5ZjQ4NWUxODQyOTI5ZTU3YzExNDVkZmU5MTBlL3RhYmxlcmFuZ2U6YjAwYTlmNDg1ZTE4NDI5MjllNTdjMTE0NWRmZTkxMGVfMTAtMS0xLTEtMzAxMTQ_bd83b30e-bb10-4bb1-a6e6-53b1d54a064f"
      unitRef="usd">11000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i7b9447a5f8df4edc80c1ead0839fe3f6_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RhYmxlOmIwMGE5ZjQ4NWUxODQyOTI5ZTU3YzExNDVkZmU5MTBlL3RhYmxlcmFuZ2U6YjAwYTlmNDg1ZTE4NDI5MjllNTdjMTE0NWRmZTkxMGVfMTAtNS0xLTEtMzAxMTQ_65533a31-4d2d-4126-aa0e-030b69d83a15"
      unitRef="usd">11000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i6390807210d74c6f9cae496ea2122a5a_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RhYmxlOmIwMGE5ZjQ4NWUxODQyOTI5ZTU3YzExNDVkZmU5MTBlL3RhYmxlcmFuZ2U6YjAwYTlmNDg1ZTE4NDI5MjllNTdjMTE0NWRmZTkxMGVfMTEtMS0xLTEtMzAxMTQ_d0edb4a0-0839-4097-b640-5cdb63bb7685"
      unitRef="usd">2325000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i6390807210d74c6f9cae496ea2122a5a_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RhYmxlOmIwMGE5ZjQ4NWUxODQyOTI5ZTU3YzExNDVkZmU5MTBlL3RhYmxlcmFuZ2U6YjAwYTlmNDg1ZTE4NDI5MjllNTdjMTE0NWRmZTkxMGVfMTEtMy0xLTEtMzAxMTQ_3175c92e-4664-474e-b4e2-5f7f2e4fc54b"
      unitRef="usd">1344000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i6390807210d74c6f9cae496ea2122a5a_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RhYmxlOmIwMGE5ZjQ4NWUxODQyOTI5ZTU3YzExNDVkZmU5MTBlL3RhYmxlcmFuZ2U6YjAwYTlmNDg1ZTE4NDI5MjllNTdjMTE0NWRmZTkxMGVfMTEtNS0xLTEtMzAxMTQ_5883630d-fbc7-4203-8ae7-86f288ceda13"
      unitRef="usd">981000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i210ca0088a2d4da59dbd86d6befab37d_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RhYmxlOmIwMGE5ZjQ4NWUxODQyOTI5ZTU3YzExNDVkZmU5MTBlL3RhYmxlcmFuZ2U6YjAwYTlmNDg1ZTE4NDI5MjllNTdjMTE0NWRmZTkxMGVfMTMtMS0xLTEtMzAxMTQ_29fdc986-5da0-43e8-9e16-d87bb9410c7e"
      unitRef="usd">1738000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i210ca0088a2d4da59dbd86d6befab37d_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RhYmxlOmIwMGE5ZjQ4NWUxODQyOTI5ZTU3YzExNDVkZmU5MTBlL3RhYmxlcmFuZ2U6YjAwYTlmNDg1ZTE4NDI5MjllNTdjMTE0NWRmZTkxMGVfMTMtMy0xLTEtMzAxMTQ_05c9f7db-022f-4c98-9a65-920b0de746bd"
      unitRef="usd">997000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i210ca0088a2d4da59dbd86d6befab37d_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RhYmxlOmIwMGE5ZjQ4NWUxODQyOTI5ZTU3YzExNDVkZmU5MTBlL3RhYmxlcmFuZ2U6YjAwYTlmNDg1ZTE4NDI5MjllNTdjMTE0NWRmZTkxMGVfMTMtNS0xLTEtMzAxMTQ_ec60c5da-e753-46c6-8062-d29329e4a32b"
      unitRef="usd">741000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="id6e2c0d55bcc4c6da40d65348178b171_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RhYmxlOmIwMGE5ZjQ4NWUxODQyOTI5ZTU3YzExNDVkZmU5MTBlL3RhYmxlcmFuZ2U6YjAwYTlmNDg1ZTE4NDI5MjllNTdjMTE0NWRmZTkxMGVfMTQtMS0xLTEtMzAxMTQ_7b0ac11e-2912-49bb-817d-1e524ea36516"
      unitRef="usd">196000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="id6e2c0d55bcc4c6da40d65348178b171_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RhYmxlOmIwMGE5ZjQ4NWUxODQyOTI5ZTU3YzExNDVkZmU5MTBlL3RhYmxlcmFuZ2U6YjAwYTlmNDg1ZTE4NDI5MjllNTdjMTE0NWRmZTkxMGVfMTQtMy0xLTEtMzAxMTQ_954f1452-111f-42e4-ae9a-e9ae79390bd0"
      unitRef="usd">137000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="id6e2c0d55bcc4c6da40d65348178b171_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RhYmxlOmIwMGE5ZjQ4NWUxODQyOTI5ZTU3YzExNDVkZmU5MTBlL3RhYmxlcmFuZ2U6YjAwYTlmNDg1ZTE4NDI5MjllNTdjMTE0NWRmZTkxMGVfMTQtNS0xLTEtMzAxMTQ_20ceddf7-690e-41b3-a8ba-b7a3c0426860"
      unitRef="usd">59000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ie65c749bc8fc42cd83d412fb98863517_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RhYmxlOmIwMGE5ZjQ4NWUxODQyOTI5ZTU3YzExNDVkZmU5MTBlL3RhYmxlcmFuZ2U6YjAwYTlmNDg1ZTE4NDI5MjllNTdjMTE0NWRmZTkxMGVfMTUtMS0xLTEtMzAxMTQ_4f913c72-21f1-4269-a6d2-207a3531b595"
      unitRef="usd">355000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ie65c749bc8fc42cd83d412fb98863517_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RhYmxlOmIwMGE5ZjQ4NWUxODQyOTI5ZTU3YzExNDVkZmU5MTBlL3RhYmxlcmFuZ2U6YjAwYTlmNDg1ZTE4NDI5MjllNTdjMTE0NWRmZTkxMGVfMTUtMy0xLTEtMzAxMTQ_1175d52c-c54f-440d-9638-fd70a9d43544"
      unitRef="usd">244000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ie65c749bc8fc42cd83d412fb98863517_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RhYmxlOmIwMGE5ZjQ4NWUxODQyOTI5ZTU3YzExNDVkZmU5MTBlL3RhYmxlcmFuZ2U6YjAwYTlmNDg1ZTE4NDI5MjllNTdjMTE0NWRmZTkxMGVfMTUtNS0xLTEtMzAxMTQ_1a466709-a9db-4e65-8de0-e180b5d09038"
      unitRef="usd">111000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="iacb3dbfe9a644ba4921bcd62e4831e5a_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RhYmxlOmIwMGE5ZjQ4NWUxODQyOTI5ZTU3YzExNDVkZmU5MTBlL3RhYmxlcmFuZ2U6YjAwYTlmNDg1ZTE4NDI5MjllNTdjMTE0NWRmZTkxMGVfMTYtMS0xLTEtMzAxMTQ_2958029b-4186-4be3-96b1-803c85424c03"
      unitRef="usd">8000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="iacb3dbfe9a644ba4921bcd62e4831e5a_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RhYmxlOmIwMGE5ZjQ4NWUxODQyOTI5ZTU3YzExNDVkZmU5MTBlL3RhYmxlcmFuZ2U6YjAwYTlmNDg1ZTE4NDI5MjllNTdjMTE0NWRmZTkxMGVfMTYtMy0xLTEtMzAxMTQ_98ac11bd-a029-4224-8c51-c34294931439"
      unitRef="usd">4000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="iacb3dbfe9a644ba4921bcd62e4831e5a_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RhYmxlOmIwMGE5ZjQ4NWUxODQyOTI5ZTU3YzExNDVkZmU5MTBlL3RhYmxlcmFuZ2U6YjAwYTlmNDg1ZTE4NDI5MjllNTdjMTE0NWRmZTkxMGVfMTYtNS0xLTEtMzAxMTQ_202cdedf-94bc-4fd2-9d3f-d961d196af22"
      unitRef="usd">4000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i184afb63fb8e4731adf46510d25f3e7b_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RhYmxlOmIwMGE5ZjQ4NWUxODQyOTI5ZTU3YzExNDVkZmU5MTBlL3RhYmxlcmFuZ2U6YjAwYTlmNDg1ZTE4NDI5MjllNTdjMTE0NWRmZTkxMGVfMTctMS0xLTEtMzAxMTQ_9d7359f2-c772-4dfe-9cb7-5213114d9daf"
      unitRef="usd">11000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i184afb63fb8e4731adf46510d25f3e7b_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RhYmxlOmIwMGE5ZjQ4NWUxODQyOTI5ZTU3YzExNDVkZmU5MTBlL3RhYmxlcmFuZ2U6YjAwYTlmNDg1ZTE4NDI5MjllNTdjMTE0NWRmZTkxMGVfMTctMy0xLTEtMzAxMTQ_b849b28a-ea61-4e29-bdb0-90af9c97e018"
      unitRef="usd">8000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i184afb63fb8e4731adf46510d25f3e7b_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RhYmxlOmIwMGE5ZjQ4NWUxODQyOTI5ZTU3YzExNDVkZmU5MTBlL3RhYmxlcmFuZ2U6YjAwYTlmNDg1ZTE4NDI5MjllNTdjMTE0NWRmZTkxMGVfMTctNS0xLTEtMzAxMTQ_91eccda6-5a51-40f8-a1b5-e21e0b56ff50"
      unitRef="usd">3000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RhYmxlOmIwMGE5ZjQ4NWUxODQyOTI5ZTU3YzExNDVkZmU5MTBlL3RhYmxlcmFuZ2U6YjAwYTlmNDg1ZTE4NDI5MjllNTdjMTE0NWRmZTkxMGVfMTgtMS0xLTEtMzAxMTQ_760ba595-94a7-45d9-9eb3-4bfbb5ede3bc"
      unitRef="usd">2308000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RhYmxlOmIwMGE5ZjQ4NWUxODQyOTI5ZTU3YzExNDVkZmU5MTBlL3RhYmxlcmFuZ2U6YjAwYTlmNDg1ZTE4NDI5MjllNTdjMTE0NWRmZTkxMGVfMTgtMy0xLTEtMzAxMTQ_6bc60d74-c1f2-4284-b8dd-261bd5bfc21d"
      unitRef="usd">1390000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RhYmxlOmIwMGE5ZjQ4NWUxODQyOTI5ZTU3YzExNDVkZmU5MTBlL3RhYmxlcmFuZ2U6YjAwYTlmNDg1ZTE4NDI5MjllNTdjMTE0NWRmZTkxMGVfMTgtNS0xLTEtMzAxMTQ_ffd3fae2-ce3d-4590-b97d-be486f03e8b7"
      unitRef="usd">918000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i984d425948d34baea35894f126c09e37_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RhYmxlOmIwMGE5ZjQ4NWUxODQyOTI5ZTU3YzExNDVkZmU5MTBlL3RhYmxlcmFuZ2U6YjAwYTlmNDg1ZTE4NDI5MjllNTdjMTE0NWRmZTkxMGVfMTktMS0xLTEtMzAxMTQ_d6bc5475-631c-43b4-b60c-8aa4a1c530d0"
      unitRef="usd">11000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i984d425948d34baea35894f126c09e37_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RhYmxlOmIwMGE5ZjQ4NWUxODQyOTI5ZTU3YzExNDVkZmU5MTBlL3RhYmxlcmFuZ2U6YjAwYTlmNDg1ZTE4NDI5MjllNTdjMTE0NWRmZTkxMGVfMTktNS0xLTEtMzAxMTQ_a56c3332-63e5-4bb0-8900-45195f14c32b"
      unitRef="usd">11000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RhYmxlOmIwMGE5ZjQ4NWUxODQyOTI5ZTU3YzExNDVkZmU5MTBlL3RhYmxlcmFuZ2U6YjAwYTlmNDg1ZTE4NDI5MjllNTdjMTE0NWRmZTkxMGVfMjAtMS0xLTEtMzAxMTQ_93a7b309-55e6-4749-888c-e409ab3b6e0c"
      unitRef="usd">2319000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RhYmxlOmIwMGE5ZjQ4NWUxODQyOTI5ZTU3YzExNDVkZmU5MTBlL3RhYmxlcmFuZ2U6YjAwYTlmNDg1ZTE4NDI5MjllNTdjMTE0NWRmZTkxMGVfMjAtMy0xLTEtMzAxMTQ_c3c1bbe3-56de-4663-aaea-697b898cd665"
      unitRef="usd">1390000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RhYmxlOmIwMGE5ZjQ4NWUxODQyOTI5ZTU3YzExNDVkZmU5MTBlL3RhYmxlcmFuZ2U6YjAwYTlmNDg1ZTE4NDI5MjllNTdjMTE0NWRmZTkxMGVfMjAtNS0xLTEtMzAxMTQ_b37af0e9-a105-4d69-b88c-18e82469d07a"
      unitRef="usd">929000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RleHRyZWdpb246MjVlZWM3MzYwN2E2NDcxMzkzZDkyZWJlODZiZTQ4MWVfMTg1MQ_51158fbb-44c1-4e1f-8600-579f886a28ff"
      unitRef="usd">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:FiniteLivedIntangibleAssetsPeriodIncreaseDecrease
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RleHRyZWdpb246MjVlZWM3MzYwN2E2NDcxMzkzZDkyZWJlODZiZTQ4MWVfMTg1MQ_c8828290-b74f-4436-bd59-5c18c78adca2"
      unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsPeriodIncreaseDecrease>
    <us-gaap:FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RleHRyZWdpb246MjVlZWM3MzYwN2E2NDcxMzkzZDkyZWJlODZiZTQ4MWVfMjY2Ng_63f11eae-9324-4553-9613-f5730438eb39"
      unitRef="usd">-1000000</us-gaap:FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RleHRyZWdpb246MjVlZWM3MzYwN2E2NDcxMzkzZDkyZWJlODZiZTQ4MWVfMzA4MA_2d3535ab-8f19-4af8-8178-c1732e0da9b6"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
      contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RleHRyZWdpb246MjVlZWM3MzYwN2E2NDcxMzkzZDkyZWJlODZiZTQ4MWVfMzA4MA_30b88f1f-9907-4561-b0b0-243378c71618"
      unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
      contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RleHRyZWdpb246MjVlZWM3MzYwN2E2NDcxMzkzZDkyZWJlODZiZTQ4MWVfMzA4MA_6653d8a5-6a8a-40ef-b20d-d2d9f2c3bdcd"
      unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RleHRyZWdpb246MjVlZWM3MzYwN2E2NDcxMzkzZDkyZWJlODZiZTQ4MWVfMzA4MA_66e9c883-efcb-4ac2-a9fe-477522731ef9"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RleHRyZWdpb246MjVlZWM3MzYwN2E2NDcxMzkzZDkyZWJlODZiZTQ4MWVfMzA4MA_ab112c9e-63bb-42a2-918c-647c9a48c373"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RleHRyZWdpb246MjVlZWM3MzYwN2E2NDcxMzkzZDkyZWJlODZiZTQ4MWVfMzA4MA_c249eb3b-4ba2-453d-a501-4547dc057e41"
      unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RleHRyZWdpb246MjVlZWM3MzYwN2E2NDcxMzkzZDkyZWJlODZiZTQ4MWVfMzA4MA_d674737b-cee6-4924-90bf-e2909bd15b2e"
      unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RleHRyZWdpb246MjVlZWM3MzYwN2E2NDcxMzkzZDkyZWJlODZiZTQ4MWVfMzA4MA_d8237981-8303-4f77-a9bc-40235d499272"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RleHRyZWdpb246MjVlZWM3MzYwN2E2NDcxMzkzZDkyZWJlODZiZTQ4MWVfMzU5OA_e5ab1335-04ab-4595-8e41-33de4c8db2de"
      unitRef="usd">51000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RleHRyZWdpb246MjVlZWM3MzYwN2E2NDcxMzkzZDkyZWJlODZiZTQ4MWVfMTA5OTUxMTY0MjczOQ_7cc183ea-8409-4486-8e1f-166d12697467"
      unitRef="usd">45000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RleHRyZWdpb246MjVlZWM3MzYwN2E2NDcxMzkzZDkyZWJlODZiZTQ4MWVfMzk2MA_9218b424-cb6d-4e1f-865c-8046919cd14e">&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Future amortization expense related to existing finite-lived purchased intangible assets for the remainder of fiscal year 2022 and for each of the next five fiscal years and thereafter is estimated below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:90.859%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.941%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Estimated future amortization expense:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remainder of 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
      contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RhYmxlOmQ5NTMxZDliZjFjYjRlMWM4ZWY0M2NkNWI1YmM5NGNhL3RhYmxlcmFuZ2U6ZDk1MzFkOWJmMWNiNGUxYzhlZjQzY2Q1YjViYzk0Y2FfMi0xLTEtMS0zMDExNA_888ff558-ae49-41ff-8fb0-415c3ff761b5"
      unitRef="usd">141000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RhYmxlOmQ5NTMxZDliZjFjYjRlMWM4ZWY0M2NkNWI1YmM5NGNhL3RhYmxlcmFuZ2U6ZDk1MzFkOWJmMWNiNGUxYzhlZjQzY2Q1YjViYzk0Y2FfMy0xLTEtMS0zMDExNA_f66bced1-46cb-4b92-af06-1d767a67407b"
      unitRef="usd">141000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RhYmxlOmQ5NTMxZDliZjFjYjRlMWM4ZWY0M2NkNWI1YmM5NGNhL3RhYmxlcmFuZ2U6ZDk1MzFkOWJmMWNiNGUxYzhlZjQzY2Q1YjViYzk0Y2FfNC0xLTEtMS0zMDExNA_57f53e56-e639-4520-9530-88bc33268bac"
      unitRef="usd">121000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RhYmxlOmQ5NTMxZDliZjFjYjRlMWM4ZWY0M2NkNWI1YmM5NGNhL3RhYmxlcmFuZ2U6ZDk1MzFkOWJmMWNiNGUxYzhlZjQzY2Q1YjViYzk0Y2FfNS0xLTEtMS0zMDExNA_2670e127-f726-49db-9610-2ca84f46dd80"
      unitRef="usd">96000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RhYmxlOmQ5NTMxZDliZjFjYjRlMWM4ZWY0M2NkNWI1YmM5NGNhL3RhYmxlcmFuZ2U6ZDk1MzFkOWJmMWNiNGUxYzhlZjQzY2Q1YjViYzk0Y2FfNi0xLTEtMS0zMDExNA_d78f185e-8b91-49ee-b950-7c423688fde5"
      unitRef="usd">66000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RhYmxlOmQ5NTMxZDliZjFjYjRlMWM4ZWY0M2NkNWI1YmM5NGNhL3RhYmxlcmFuZ2U6ZDk1MzFkOWJmMWNiNGUxYzhlZjQzY2Q1YjViYzk0Y2FfNy0xLTEtMS0zMDExNA_ecb598fc-f8b8-46db-a9d3-eca68a6ed223"
      unitRef="usd">65000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
      contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81NS9mcmFnOjI1ZWVjNzM2MDdhNjQ3MTM5M2Q5MmViZTg2YmU0ODFlL3RhYmxlOmQ5NTMxZDliZjFjYjRlMWM4ZWY0M2NkNWI1YmM5NGNhL3RhYmxlcmFuZ2U6ZDk1MzFkOWJmMWNiNGUxYzhlZjQzY2Q1YjViYzk0Y2FfOC0xLTEtMS0zMDExNA_82124a9d-7111-4e43-9fa1-4ebab76e06e9"
      unitRef="usd">288000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RleHRyZWdpb246NGFjODFlMzQ2MGVjNGFiMTg4NmZkZTE5MzdlNjEzZmVfNzg3Ng_ab009dfc-47c2-414c-9478-f63fde6e3d1f">FAIR VALUE MEASUREMENTS&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The authoritative guidance defines fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities required or permitted to be recorded at fair value, we consider the principal or most advantageous market and assumptions that market participants would use when pricing the asset or liability.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:2.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Fair Value Hierarchy&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The guidance establishes a fair value hierarchy that prioritizes the use of inputs used in valuation techniques into three levels. A financial instrument&#x2019;s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. There are three levels of inputs that may be used to measure fair value:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Level 1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;- applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Level 2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;- applies to assets or liabilities for which there are inputs other than quoted prices included within level 1 that are observable, either directly or indirectly, for the asset or liability such as: quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in less active markets; or other inputs that can be derived principally from, or corroborated by, observable market data.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Level 3&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;- applies to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial assets and liabilities measured at fair value on a recurring basis as of January&#160;31, 2022 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.584%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.186%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value Measurement at January 31, 2022 Using&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;January 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Quoted&#160;Prices&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;in&#160;Active&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Markets&#160;for&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Identical&#160;Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Level&#160;1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Significant&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Observable&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Inputs&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Level&#160;2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Significant&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unobservable&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Inputs&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Level&#160;3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in&#160;millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents (money market funds)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative instruments (foreign exchange contracts)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term investments - Equity securities with RDFV&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trading securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets measured at fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative instruments (foreign exchange contracts) &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities measured at fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial assets and liabilities measured at fair value on a recurring basis as of October&#160;31, 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.584%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.186%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value Measurement at October 31, 2021 Using&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Quoted&#160;Prices&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;in&#160;Active&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Markets&#160;for&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Identical&#160;Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Level&#160;1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Significant&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Observable&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Inputs&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Level&#160;2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Significant&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unobservable&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Inputs&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Level&#160;3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in&#160;millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents (money market funds)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;919&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;919&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative instruments (foreign exchange contracts)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term investments - Equity securities with RDFV&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trading securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets measured at fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,084&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,036&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative instruments (foreign exchange contracts)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities measured at fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our money market funds and trading securities are generally valued using quoted market prices and therefore are classified within level&#160;1 of the fair value hierarchy. Our derivative financial instruments are classified within level 2, as there is not an active market for each hedge contract, but the inputs used to calculate the value of the instruments are tied to active markets.  Our deferred compensation liability is classified as level&#160;2 because, although the values are not directly based on quoted market prices, the inputs used in the calculations are observable. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Short- term investments - equity securities with readily determinable fair value ("RDFV") are shares in marketable equity securities which are classified as level 1 in the fair value hierarchy as they are measured based on quotes in active markets. Equity securities with RDFV also includes potential shares received from an equity investment in a company that went public and can vest under certain stock performance circumstances, and these have been classified as level 2 because the fair value was calculated using the Monte Carlo simulation method in which quoted market price and other observable inputs are used.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other investments represent shares we own in a special fund that targets underlying investments of approximately 40 percent in debt securities and 60 percent in equity securities. These shares have been classified as level 2 because, although the shares of the fund are not traded on any active stock exchange, each of the individual underlying securities are or can be derived from and hence we have a readily determinable value for the underlying securities, from which we are able to determine the fair market value for the special fund itself. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Trading securities, which are comprised of mutual funds, bonds and other similar instruments, other investments and deferred compensation liability are reported at fair value, with gains or losses resulting from changes in fair value recognized currently in net income. Certain derivative instruments are reported at fair value, with unrealized gains and losses, net of tax, included in accumulated other comprehensive income (loss) within stockholders' equity. Realized gains and losses from the sale of these instruments are recorded in net income.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three months ended January&#160;31, 2022 and 2021, an unrealized loss of $47 million and an unrealized gain of $2 million, respectively, were included in other income (expense), net as an adjustment to the carrying value of equity securities. &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.724%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.697%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contingent Consideration.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The fair value of the contingent consideration liability relates to milestone payments in connection with the April 2021 acquisition of Resolution Bioscience. The fair value of the potential future milestone payments, which are set to certain revenue and technical targets, was based on (i) the probability of achieving the relevant revenue targets and technical milestones and (ii) the timing of achieving such milestones, which are significant unobservable inputs, and has been classified as Level 3. We used the Monte Carlo simulation approach to estimate the fair value of the revenue component with an asset volatility of 54.9 percent and revenue volatilities ranging from 12.2 to 13.9 percent. The probability-weighted expected return method was used to estimate the fair value of the technical target component. Assumptions used in the calculations include probability of success, duration of the earn-out and discount rate. A change in any of these unobservable inputs can significantly change the fair value of the contingent consideration. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of January&#160;31, 2022, the expected maximum earn-out period for the contingent payments does not exceed 2.9 years and potential future payments will not exceed $145&#160;million. The fair value of the contingent consideration liability as of January&#160;31, 2022 was estimated to be $92 million of which $65 million was recorded in other accrued liabilities and $27 million was recorded in other long-term liabilities on the condensed consolidated balance sheet. The increase in the fair value of the contingent consideration was primarily driven by a change in the probability of achieving the technical milestone.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The contingent consideration liability is our only Level 3 asset or liability.  A summary of the Level 3 activity follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.724%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.697%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;January 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in fair value (included within selling, general and administrative expenses)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Impairment of Investments.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; There were no impairments of investments for the three months ended January&#160;31, 2022 and 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Assets and Liabilities Measured at Fair Value on a Non-Recurring Basis&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three months ended January&#160;31, 2022 and 2021, there were no impairments of long-lived assets held and used or long-lived assets held for sale. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three months ended January&#160;31, 2022 and 2021, there were no impairments or adjustments to the carrying value of non-marketable securities without readily determinable fair value based on an observable market transaction. As of January&#160;31, 2022 and October&#160;31, 2021, the carrying amount of non-marketable equity securities without readily determinable fair values was $125 million and $120 million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fair values for the non-marketable securities included in long-term investments on the condensed consolidated balance sheet were measured using Level 3 inputs because they are primarily equity stock issued by private companies without quoted market prices. To estimate the fair value of our non-marketable securities, we use the measurement alternative to record these investments at cost and adjust for impairments and observable price changes (orderly transactions for the identical or a similar security from the same issuer) as and when they occur.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RleHRyZWdpb246NGFjODFlMzQ2MGVjNGFiMTg4NmZkZTE5MzdlNjEzZmVfNzg4Ng_ff13ca47-9519-4ec4-9c84-123189be143b">&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial assets and liabilities measured at fair value on a recurring basis as of January&#160;31, 2022 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.584%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.186%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value Measurement at January 31, 2022 Using&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;January 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Quoted&#160;Prices&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;in&#160;Active&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Markets&#160;for&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Identical&#160;Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Level&#160;1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Significant&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Observable&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Inputs&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Level&#160;2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Significant&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unobservable&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Inputs&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Level&#160;3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in&#160;millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents (money market funds)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative instruments (foreign exchange contracts)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term investments - Equity securities with RDFV&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trading securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets measured at fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative instruments (foreign exchange contracts) &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities measured at fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial assets and liabilities measured at fair value on a recurring basis as of October&#160;31, 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.584%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.186%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value Measurement at October 31, 2021 Using&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Quoted&#160;Prices&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;in&#160;Active&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Markets&#160;for&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Identical&#160;Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Level&#160;1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Significant&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Observable&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Inputs&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Level&#160;2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Significant&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unobservable&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Inputs&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Level&#160;3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in&#160;millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents (money market funds)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;919&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;919&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative instruments (foreign exchange contracts)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term investments - Equity securities with RDFV&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trading securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets measured at fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,084&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,036&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative instruments (foreign exchange contracts)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities measured at fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="ife0901356f05422493cedbc99aaae757_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOmIzZjgxOTEzMDNiMjQzNGZhYzhjYmEyZGUxNzkyYmZkL3RhYmxlcmFuZ2U6YjNmODE5MTMwM2IyNDM0ZmFjOGNiYTJkZTE3OTJiZmRfNS0xLTEtMS0zMDExNA_5152b9cd-6b19-47aa-b203-97962d343b57"
      unitRef="usd">465000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i2071cdd246ee432b9ba0ffbd965b049b_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOmIzZjgxOTEzMDNiMjQzNGZhYzhjYmEyZGUxNzkyYmZkL3RhYmxlcmFuZ2U6YjNmODE5MTMwM2IyNDM0ZmFjOGNiYTJkZTE3OTJiZmRfNS0zLTEtMS0zMDExNA_12ff6150-3325-462e-9fa1-17e552e84bdf"
      unitRef="usd">465000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i2ac569d010c5484d81397da751f5a61d_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOmIzZjgxOTEzMDNiMjQzNGZhYzhjYmEyZGUxNzkyYmZkL3RhYmxlcmFuZ2U6YjNmODE5MTMwM2IyNDM0ZmFjOGNiYTJkZTE3OTJiZmRfNS01LTEtMS0zMDExNA_6867bd51-ebfe-4adf-a7b9-1cb6d6c0536d"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="if9bf63f60c78455792ba1de12fa4a127_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOmIzZjgxOTEzMDNiMjQzNGZhYzhjYmEyZGUxNzkyYmZkL3RhYmxlcmFuZ2U6YjNmODE5MTMwM2IyNDM0ZmFjOGNiYTJkZTE3OTJiZmRfNS03LTEtMS0zMDExNA_7d237e21-16bc-48ff-9f4a-cf2e5abe138a"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="ife0901356f05422493cedbc99aaae757_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOmIzZjgxOTEzMDNiMjQzNGZhYzhjYmEyZGUxNzkyYmZkL3RhYmxlcmFuZ2U6YjNmODE5MTMwM2IyNDM0ZmFjOGNiYTJkZTE3OTJiZmRfNi0xLTEtMS0zMDExNA_823a73ba-3b10-4bd6-acb0-3966f26f4f0e"
      unitRef="usd">16000000</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="i2071cdd246ee432b9ba0ffbd965b049b_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOmIzZjgxOTEzMDNiMjQzNGZhYzhjYmEyZGUxNzkyYmZkL3RhYmxlcmFuZ2U6YjNmODE5MTMwM2IyNDM0ZmFjOGNiYTJkZTE3OTJiZmRfNi0zLTEtMS0zMDExNA_4b4b2027-8a27-48f0-aeb2-49306c951230"
      unitRef="usd">0</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="i2ac569d010c5484d81397da751f5a61d_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOmIzZjgxOTEzMDNiMjQzNGZhYzhjYmEyZGUxNzkyYmZkL3RhYmxlcmFuZ2U6YjNmODE5MTMwM2IyNDM0ZmFjOGNiYTJkZTE3OTJiZmRfNi01LTEtMS0zMDExNA_e02642e4-9def-4c29-b5d6-8d37e095ca47"
      unitRef="usd">16000000</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="if9bf63f60c78455792ba1de12fa4a127_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOmIzZjgxOTEzMDNiMjQzNGZhYzhjYmEyZGUxNzkyYmZkL3RhYmxlcmFuZ2U6YjNmODE5MTMwM2IyNDM0ZmFjOGNiYTJkZTE3OTJiZmRfNi03LTEtMS0zMDExNA_dea76f10-702e-4379-b8c4-9c48da5d6f40"
      unitRef="usd">0</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="ife0901356f05422493cedbc99aaae757_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOmIzZjgxOTEzMDNiMjQzNGZhYzhjYmEyZGUxNzkyYmZkL3RhYmxlcmFuZ2U6YjNmODE5MTMwM2IyNDM0ZmFjOGNiYTJkZTE3OTJiZmRfNy0xLTEtMS00ODAxMA_eeb0a724-7dde-452e-a8ab-f69553018dcd"
      unitRef="usd">45000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i2071cdd246ee432b9ba0ffbd965b049b_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOmIzZjgxOTEzMDNiMjQzNGZhYzhjYmEyZGUxNzkyYmZkL3RhYmxlcmFuZ2U6YjNmODE5MTMwM2IyNDM0ZmFjOGNiYTJkZTE3OTJiZmRfNy0zLTEtMS00ODAxMA_d6c9caf8-c33f-46d8-a2e1-2c61d257e6a4"
      unitRef="usd">40000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i2ac569d010c5484d81397da751f5a61d_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOmIzZjgxOTEzMDNiMjQzNGZhYzhjYmEyZGUxNzkyYmZkL3RhYmxlcmFuZ2U6YjNmODE5MTMwM2IyNDM0ZmFjOGNiYTJkZTE3OTJiZmRfNy01LTEtMS00ODAxMA_588cb99a-0384-4d5d-8fed-77c52813fca0"
      unitRef="usd">5000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="if9bf63f60c78455792ba1de12fa4a127_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOmIzZjgxOTEzMDNiMjQzNGZhYzhjYmEyZGUxNzkyYmZkL3RhYmxlcmFuZ2U6YjNmODE5MTMwM2IyNDM0ZmFjOGNiYTJkZTE3OTJiZmRfNy03LTEtMS00OTg0MQ_058bb9db-5e0f-4418-a421-fc4272562718"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:TradingSecurities
      contextRef="if5392f611be5496a9be81fc8bdf7afcc_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOmIzZjgxOTEzMDNiMjQzNGZhYzhjYmEyZGUxNzkyYmZkL3RhYmxlcmFuZ2U6YjNmODE5MTMwM2IyNDM0ZmFjOGNiYTJkZTE3OTJiZmRfOC0xLTEtMS0zMDExNA_93908400-3030-4bbb-993a-09da6e317f3d"
      unitRef="usd">37000000</us-gaap:TradingSecurities>
    <us-gaap:TradingSecurities
      contextRef="icf52874ae50c45a8a6ec86f9bab6ff9c_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOmIzZjgxOTEzMDNiMjQzNGZhYzhjYmEyZGUxNzkyYmZkL3RhYmxlcmFuZ2U6YjNmODE5MTMwM2IyNDM0ZmFjOGNiYTJkZTE3OTJiZmRfOC0zLTEtMS0zMDExNA_b407cc67-f156-43b0-84da-9b271905c4b2"
      unitRef="usd">37000000</us-gaap:TradingSecurities>
    <us-gaap:TradingSecurities
      contextRef="ibbcff4391c4341629230e4c9ce6b165c_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOmIzZjgxOTEzMDNiMjQzNGZhYzhjYmEyZGUxNzkyYmZkL3RhYmxlcmFuZ2U6YjNmODE5MTMwM2IyNDM0ZmFjOGNiYTJkZTE3OTJiZmRfOC01LTEtMS0zMDExNA_a6f2976d-f56b-4c38-841c-bbeabd0086bc"
      unitRef="usd">0</us-gaap:TradingSecurities>
    <us-gaap:TradingSecurities
      contextRef="i94ff2c672a7b4ed9aee4690b84b849d7_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOmIzZjgxOTEzMDNiMjQzNGZhYzhjYmEyZGUxNzkyYmZkL3RhYmxlcmFuZ2U6YjNmODE5MTMwM2IyNDM0ZmFjOGNiYTJkZTE3OTJiZmRfOC03LTEtMS0zMDExNA_ff70ff1a-c925-4c3a-b23c-1857d65c0922"
      unitRef="usd">0</us-gaap:TradingSecurities>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="if5392f611be5496a9be81fc8bdf7afcc_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOmIzZjgxOTEzMDNiMjQzNGZhYzhjYmEyZGUxNzkyYmZkL3RhYmxlcmFuZ2U6YjNmODE5MTMwM2IyNDM0ZmFjOGNiYTJkZTE3OTJiZmRfOS0xLTEtMS0zMDExNA_dcb15eb9-5d82-45aa-adcd-6bc42c8c59c0"
      unitRef="usd">29000000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="icf52874ae50c45a8a6ec86f9bab6ff9c_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOmIzZjgxOTEzMDNiMjQzNGZhYzhjYmEyZGUxNzkyYmZkL3RhYmxlcmFuZ2U6YjNmODE5MTMwM2IyNDM0ZmFjOGNiYTJkZTE3OTJiZmRfOS0zLTEtMS0zMDExNA_7c06f830-f7fb-437c-99a3-7547884784ad"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="ibbcff4391c4341629230e4c9ce6b165c_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOmIzZjgxOTEzMDNiMjQzNGZhYzhjYmEyZGUxNzkyYmZkL3RhYmxlcmFuZ2U6YjNmODE5MTMwM2IyNDM0ZmFjOGNiYTJkZTE3OTJiZmRfOS01LTEtMS0zMDExNA_7bb394a2-b4f4-46ef-9428-1a4f48b91c01"
      unitRef="usd">29000000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i94ff2c672a7b4ed9aee4690b84b849d7_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOmIzZjgxOTEzMDNiMjQzNGZhYzhjYmEyZGUxNzkyYmZkL3RhYmxlcmFuZ2U6YjNmODE5MTMwM2IyNDM0ZmFjOGNiYTJkZTE3OTJiZmRfOS03LTEtMS0zMDExNA_2d013392-04ea-410f-9433-5b9b06bc6bca"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i33fe9961080d4147aae99b460ab50ecb_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOmIzZjgxOTEzMDNiMjQzNGZhYzhjYmEyZGUxNzkyYmZkL3RhYmxlcmFuZ2U6YjNmODE5MTMwM2IyNDM0ZmFjOGNiYTJkZTE3OTJiZmRfMTEtMS0xLTEtMzAxMTQ_b07ee9a5-99fc-4270-b478-14defd5eaab8"
      unitRef="usd">592000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="if7c916269c054d37a6d9689d02baa352_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOmIzZjgxOTEzMDNiMjQzNGZhYzhjYmEyZGUxNzkyYmZkL3RhYmxlcmFuZ2U6YjNmODE5MTMwM2IyNDM0ZmFjOGNiYTJkZTE3OTJiZmRfMTEtMy0xLTEtMzAxMTQ_c3ed93bc-b6d1-4658-b359-be1dbf09b686"
      unitRef="usd">542000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i31669f2cab12460b9f221115aa18666e_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOmIzZjgxOTEzMDNiMjQzNGZhYzhjYmEyZGUxNzkyYmZkL3RhYmxlcmFuZ2U6YjNmODE5MTMwM2IyNDM0ZmFjOGNiYTJkZTE3OTJiZmRfMTEtNS0xLTEtMzAxMTQ_3b2fa43e-9aa3-4e7b-b393-385f52d8c01f"
      unitRef="usd">50000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i8fa89a7423444291b6668e498df2d2d9_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOmIzZjgxOTEzMDNiMjQzNGZhYzhjYmEyZGUxNzkyYmZkL3RhYmxlcmFuZ2U6YjNmODE5MTMwM2IyNDM0ZmFjOGNiYTJkZTE3OTJiZmRfMTEtNy0xLTEtMzAxMTQ_a9dea623-830b-4b8c-a40b-1d539d19ae22"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure
      contextRef="i84e4835292ec4d75be7d497aef9738bf_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOmIzZjgxOTEzMDNiMjQzNGZhYzhjYmEyZGUxNzkyYmZkL3RhYmxlcmFuZ2U6YjNmODE5MTMwM2IyNDM0ZmFjOGNiYTJkZTE3OTJiZmRfMTQtMS0xLTEtMzAxMTQ_2c5ae65a-e84d-4086-a482-86752babb500"
      unitRef="usd">5000000</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure
      contextRef="id2a2d84dda324165b0e39abf1e0999ee_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOmIzZjgxOTEzMDNiMjQzNGZhYzhjYmEyZGUxNzkyYmZkL3RhYmxlcmFuZ2U6YjNmODE5MTMwM2IyNDM0ZmFjOGNiYTJkZTE3OTJiZmRfMTQtMy0xLTEtMzAxMTQ_8b324940-1607-4dbf-9b5f-77f92315c764"
      unitRef="usd">0</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure
      contextRef="i2c9abff20f8e48ec8631ac63a1274d21_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOmIzZjgxOTEzMDNiMjQzNGZhYzhjYmEyZGUxNzkyYmZkL3RhYmxlcmFuZ2U6YjNmODE5MTMwM2IyNDM0ZmFjOGNiYTJkZTE3OTJiZmRfMTQtNS0xLTEtMzAxMTQ_9142a80a-5634-4da9-935b-c379b0e0889c"
      unitRef="usd">5000000</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure
      contextRef="i1b18bec55ca844fd9f7f27fe6c7b883b_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOmIzZjgxOTEzMDNiMjQzNGZhYzhjYmEyZGUxNzkyYmZkL3RhYmxlcmFuZ2U6YjNmODE5MTMwM2IyNDM0ZmFjOGNiYTJkZTE3OTJiZmRfMTQtNy0xLTEtMzAxMTQ_1764991f-c79f-4fb4-a7d2-1cff0d74750c"
      unitRef="usd">0</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i84e4835292ec4d75be7d497aef9738bf_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOmIzZjgxOTEzMDNiMjQzNGZhYzhjYmEyZGUxNzkyYmZkL3RhYmxlcmFuZ2U6YjNmODE5MTMwM2IyNDM0ZmFjOGNiYTJkZTE3OTJiZmRfMTUtMS0xLTEtMzAxMTQ_75f8fbda-1608-4817-8d04-ca45bc20ba26"
      unitRef="usd">65000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="id2a2d84dda324165b0e39abf1e0999ee_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOmIzZjgxOTEzMDNiMjQzNGZhYzhjYmEyZGUxNzkyYmZkL3RhYmxlcmFuZ2U6YjNmODE5MTMwM2IyNDM0ZmFjOGNiYTJkZTE3OTJiZmRfMTUtMy0xLTEtMzAxMTQ_2e6f1693-8e27-458a-aa68-05ac98698ed2"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i2c9abff20f8e48ec8631ac63a1274d21_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOmIzZjgxOTEzMDNiMjQzNGZhYzhjYmEyZGUxNzkyYmZkL3RhYmxlcmFuZ2U6YjNmODE5MTMwM2IyNDM0ZmFjOGNiYTJkZTE3OTJiZmRfMTUtNS0xLTEtMzAxMTQ_ad96fdf3-dc03-4a75-8079-7f03f146be5b"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i8e7130166b8246129cb9366c9e725c1d_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOmIzZjgxOTEzMDNiMjQzNGZhYzhjYmEyZGUxNzkyYmZkL3RhYmxlcmFuZ2U6YjNmODE5MTMwM2IyNDM0ZmFjOGNiYTJkZTE3OTJiZmRfMTUtNy0xLTEtMzAxMTQ_1d0f2d6c-167e-4f24-b538-cd9c8dc5e21f"
      unitRef="usd">65000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent
      contextRef="i6bfe36108f6442d88bb175e8a900971e_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOmIzZjgxOTEzMDNiMjQzNGZhYzhjYmEyZGUxNzkyYmZkL3RhYmxlcmFuZ2U6YjNmODE5MTMwM2IyNDM0ZmFjOGNiYTJkZTE3OTJiZmRfMTctMS0xLTEtMzAxMTQ_e29c6b36-06db-45b1-9925-95720c6ddde9"
      unitRef="usd">37000000</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent
      contextRef="id4d67bb87ecf49e9a34b390f9870efba_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOmIzZjgxOTEzMDNiMjQzNGZhYzhjYmEyZGUxNzkyYmZkL3RhYmxlcmFuZ2U6YjNmODE5MTMwM2IyNDM0ZmFjOGNiYTJkZTE3OTJiZmRfMTctMy0xLTEtMzAxMTQ_58a2f469-f28d-4e7b-8e8c-ef6c7d0174a6"
      unitRef="usd">0</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent
      contextRef="i91b145cad93a40e6b17d080186760c04_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOmIzZjgxOTEzMDNiMjQzNGZhYzhjYmEyZGUxNzkyYmZkL3RhYmxlcmFuZ2U6YjNmODE5MTMwM2IyNDM0ZmFjOGNiYTJkZTE3OTJiZmRfMTctNS0xLTEtMzAxMTQ_3d86c243-eb04-4e1a-8f9e-4146a4e2112e"
      unitRef="usd">37000000</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent
      contextRef="i11e4f5ef79704e5dab3b21061086d8e2_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOmIzZjgxOTEzMDNiMjQzNGZhYzhjYmEyZGUxNzkyYmZkL3RhYmxlcmFuZ2U6YjNmODE5MTMwM2IyNDM0ZmFjOGNiYTJkZTE3OTJiZmRfMTctNy0xLTEtMzAxMTQ_75281806-5911-4c69-a5e7-fb54e0061a68"
      unitRef="usd">0</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i6bfe36108f6442d88bb175e8a900971e_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOmIzZjgxOTEzMDNiMjQzNGZhYzhjYmEyZGUxNzkyYmZkL3RhYmxlcmFuZ2U6YjNmODE5MTMwM2IyNDM0ZmFjOGNiYTJkZTE3OTJiZmRfMTgtMS0xLTEtMzAxMTQ_945a7b2d-e9bd-4fff-ba4b-9ba348656036"
      unitRef="usd">27000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="id4d67bb87ecf49e9a34b390f9870efba_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOmIzZjgxOTEzMDNiMjQzNGZhYzhjYmEyZGUxNzkyYmZkL3RhYmxlcmFuZ2U6YjNmODE5MTMwM2IyNDM0ZmFjOGNiYTJkZTE3OTJiZmRfMTgtMy0xLTEtMzAxMTQ_17272854-b94f-432d-8a03-60f624e71073"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i91b145cad93a40e6b17d080186760c04_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOmIzZjgxOTEzMDNiMjQzNGZhYzhjYmEyZGUxNzkyYmZkL3RhYmxlcmFuZ2U6YjNmODE5MTMwM2IyNDM0ZmFjOGNiYTJkZTE3OTJiZmRfMTgtNS0xLTEtMzAxMTQ_4598cee3-d61a-4eba-a4d7-0e4a7f480eb0"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="if7cd365418ea4001be8171374346f5d4_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOmIzZjgxOTEzMDNiMjQzNGZhYzhjYmEyZGUxNzkyYmZkL3RhYmxlcmFuZ2U6YjNmODE5MTMwM2IyNDM0ZmFjOGNiYTJkZTE3OTJiZmRfMTgtNy0xLTEtMzAxMTQ_19837a79-b12f-4360-bf96-084cdf698201"
      unitRef="usd">27000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i33fe9961080d4147aae99b460ab50ecb_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOmIzZjgxOTEzMDNiMjQzNGZhYzhjYmEyZGUxNzkyYmZkL3RhYmxlcmFuZ2U6YjNmODE5MTMwM2IyNDM0ZmFjOGNiYTJkZTE3OTJiZmRfMTktMS0xLTEtMzAxMTQ_c5d7be6d-8d86-4917-adaf-01d66c7516ef"
      unitRef="usd">134000000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="if7c916269c054d37a6d9689d02baa352_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOmIzZjgxOTEzMDNiMjQzNGZhYzhjYmEyZGUxNzkyYmZkL3RhYmxlcmFuZ2U6YjNmODE5MTMwM2IyNDM0ZmFjOGNiYTJkZTE3OTJiZmRfMTktMy0xLTEtMzAxMTQ_cf6c700d-988d-4236-bea3-3620f5259deb"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i31669f2cab12460b9f221115aa18666e_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOmIzZjgxOTEzMDNiMjQzNGZhYzhjYmEyZGUxNzkyYmZkL3RhYmxlcmFuZ2U6YjNmODE5MTMwM2IyNDM0ZmFjOGNiYTJkZTE3OTJiZmRfMTktNS0xLTEtMzAxMTQ_6f534957-3828-4327-a94c-be94e9d4d61d"
      unitRef="usd">42000000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i8fa89a7423444291b6668e498df2d2d9_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOmIzZjgxOTEzMDNiMjQzNGZhYzhjYmEyZGUxNzkyYmZkL3RhYmxlcmFuZ2U6YjNmODE5MTMwM2IyNDM0ZmFjOGNiYTJkZTE3OTJiZmRfMTktNy0xLTEtMzAxMTQ_910cd525-a3ea-469e-8b37-c1c115c1f560"
      unitRef="usd">92000000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i79dd2028aecf413fbe4f1d871c963827_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOjQ0OTUxOWUzMjViMzRiMDU4NzBmOGVhM2U2YWZmYzQyL3RhYmxlcmFuZ2U6NDQ5NTE5ZTMyNWIzNGIwNTg3MGY4ZWEzZTZhZmZjNDJfNS0xLTEtMS0zMDExNA_e4e7cdcf-4807-4a42-a160-b4c3798f2675"
      unitRef="usd">919000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="ib476e9fd5af245d488939d04e35e54b1_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOjQ0OTUxOWUzMjViMzRiMDU4NzBmOGVhM2U2YWZmYzQyL3RhYmxlcmFuZ2U6NDQ5NTE5ZTMyNWIzNGIwNTg3MGY4ZWEzZTZhZmZjNDJfNS0zLTEtMS0zMDExNA_430cd9a5-1623-4dbd-894c-97ac71d2387a"
      unitRef="usd">919000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="id1cf4d72cb954647a51527f90aeeb40b_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOjQ0OTUxOWUzMjViMzRiMDU4NzBmOGVhM2U2YWZmYzQyL3RhYmxlcmFuZ2U6NDQ5NTE5ZTMyNWIzNGIwNTg3MGY4ZWEzZTZhZmZjNDJfNS01LTEtMS0zMDExNA_7cfedbd6-8ce1-48ce-ab03-9d6a6eccf11f"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i8690b9426888489bb9c9185bfdee22df_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOjQ0OTUxOWUzMjViMzRiMDU4NzBmOGVhM2U2YWZmYzQyL3RhYmxlcmFuZ2U6NDQ5NTE5ZTMyNWIzNGIwNTg3MGY4ZWEzZTZhZmZjNDJfNS03LTEtMS0zMDExNA_c62b8298-1543-493f-9776-259885eafdcc"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="i79dd2028aecf413fbe4f1d871c963827_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOjQ0OTUxOWUzMjViMzRiMDU4NzBmOGVhM2U2YWZmYzQyL3RhYmxlcmFuZ2U6NDQ5NTE5ZTMyNWIzNGIwNTg3MGY4ZWEzZTZhZmZjNDJfNi0xLTEtMS0zMDExNA_7e5f7d25-0ac6-4d0c-b292-9a572799936b"
      unitRef="usd">9000000</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="ib476e9fd5af245d488939d04e35e54b1_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOjQ0OTUxOWUzMjViMzRiMDU4NzBmOGVhM2U2YWZmYzQyL3RhYmxlcmFuZ2U6NDQ5NTE5ZTMyNWIzNGIwNTg3MGY4ZWEzZTZhZmZjNDJfNi0zLTEtMS0zMDExNA_e7822d81-38e4-460c-8427-c52c9f213e9d"
      unitRef="usd">0</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="id1cf4d72cb954647a51527f90aeeb40b_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOjQ0OTUxOWUzMjViMzRiMDU4NzBmOGVhM2U2YWZmYzQyL3RhYmxlcmFuZ2U6NDQ5NTE5ZTMyNWIzNGIwNTg3MGY4ZWEzZTZhZmZjNDJfNi01LTEtMS0zMDExNA_989c7778-6938-49e0-87b0-f8a1f1de36ff"
      unitRef="usd">9000000</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="i8690b9426888489bb9c9185bfdee22df_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOjQ0OTUxOWUzMjViMzRiMDU4NzBmOGVhM2U2YWZmYzQyL3RhYmxlcmFuZ2U6NDQ5NTE5ZTMyNWIzNGIwNTg3MGY4ZWEzZTZhZmZjNDJfNi03LTEtMS0zMDExNA_c25d6a12-7fb3-4332-aeb2-734349a9332e"
      unitRef="usd">0</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i79dd2028aecf413fbe4f1d871c963827_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOjQ0OTUxOWUzMjViMzRiMDU4NzBmOGVhM2U2YWZmYzQyL3RhYmxlcmFuZ2U6NDQ5NTE5ZTMyNWIzNGIwNTg3MGY4ZWEzZTZhZmZjNDJfNy0xLTEtMS00MzAzMg_5812999c-43e9-47f7-a21e-e1f8b2df1bbe"
      unitRef="usd">91000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="ib476e9fd5af245d488939d04e35e54b1_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOjQ0OTUxOWUzMjViMzRiMDU4NzBmOGVhM2U2YWZmYzQyL3RhYmxlcmFuZ2U6NDQ5NTE5ZTMyNWIzNGIwNTg3MGY4ZWEzZTZhZmZjNDJfNy0zLTEtMS00MzAzMg_183ea341-e844-4401-81dc-095fe39aa75c"
      unitRef="usd">83000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="id1cf4d72cb954647a51527f90aeeb40b_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOjQ0OTUxOWUzMjViMzRiMDU4NzBmOGVhM2U2YWZmYzQyL3RhYmxlcmFuZ2U6NDQ5NTE5ZTMyNWIzNGIwNTg3MGY4ZWEzZTZhZmZjNDJfNy01LTEtMS00MzAzMg_0309f6c1-5125-415e-a503-eee8421e2501"
      unitRef="usd">8000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i8690b9426888489bb9c9185bfdee22df_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOjQ0OTUxOWUzMjViMzRiMDU4NzBmOGVhM2U2YWZmYzQyL3RhYmxlcmFuZ2U6NDQ5NTE5ZTMyNWIzNGIwNTg3MGY4ZWEzZTZhZmZjNDJfNy03LTEtMS00MzAzMg_bd8eb1d5-e1b9-4b2b-9be7-88acfa1b6efb"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:TradingSecurities
      contextRef="i4e39ecebbd8d4eeb970728db4d14f8c6_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOjQ0OTUxOWUzMjViMzRiMDU4NzBmOGVhM2U2YWZmYzQyL3RhYmxlcmFuZ2U6NDQ5NTE5ZTMyNWIzNGIwNTg3MGY4ZWEzZTZhZmZjNDJfOC0xLTEtMS0zMDExNA_fcc33ada-4115-41e5-9072-ce79414d6e2d"
      unitRef="usd">34000000</us-gaap:TradingSecurities>
    <us-gaap:TradingSecurities
      contextRef="iaf311ad8bbc94cee9ca4b52f8c685019_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOjQ0OTUxOWUzMjViMzRiMDU4NzBmOGVhM2U2YWZmYzQyL3RhYmxlcmFuZ2U6NDQ5NTE5ZTMyNWIzNGIwNTg3MGY4ZWEzZTZhZmZjNDJfOC0zLTEtMS0zMDExNA_c92498e0-b9c6-40b1-b7bd-b347ec64da16"
      unitRef="usd">34000000</us-gaap:TradingSecurities>
    <us-gaap:TradingSecurities
      contextRef="i101bd4dfad2f444c893fb78c50710bf6_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOjQ0OTUxOWUzMjViMzRiMDU4NzBmOGVhM2U2YWZmYzQyL3RhYmxlcmFuZ2U6NDQ5NTE5ZTMyNWIzNGIwNTg3MGY4ZWEzZTZhZmZjNDJfOC01LTEtMS0zMDExNA_abb792d4-ad5c-442e-b7e7-bad9a8f9811d"
      unitRef="usd">0</us-gaap:TradingSecurities>
    <us-gaap:TradingSecurities
      contextRef="ib53b527a87f34ca1a28449997f71d948_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOjQ0OTUxOWUzMjViMzRiMDU4NzBmOGVhM2U2YWZmYzQyL3RhYmxlcmFuZ2U6NDQ5NTE5ZTMyNWIzNGIwNTg3MGY4ZWEzZTZhZmZjNDJfOC03LTEtMS0zMDExNA_b3740056-b1e7-4014-8da9-feaee9e251ff"
      unitRef="usd">0</us-gaap:TradingSecurities>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i4e39ecebbd8d4eeb970728db4d14f8c6_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOjQ0OTUxOWUzMjViMzRiMDU4NzBmOGVhM2U2YWZmYzQyL3RhYmxlcmFuZ2U6NDQ5NTE5ZTMyNWIzNGIwNTg3MGY4ZWEzZTZhZmZjNDJfOS0xLTEtMS0zMDExNA_dc97bd71-dd09-495f-ab39-904bd4fb2feb"
      unitRef="usd">31000000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="iaf311ad8bbc94cee9ca4b52f8c685019_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOjQ0OTUxOWUzMjViMzRiMDU4NzBmOGVhM2U2YWZmYzQyL3RhYmxlcmFuZ2U6NDQ5NTE5ZTMyNWIzNGIwNTg3MGY4ZWEzZTZhZmZjNDJfOS0zLTEtMS0zMDExNA_8065a923-8e5e-4c7f-acc7-c31fab2040bc"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i101bd4dfad2f444c893fb78c50710bf6_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOjQ0OTUxOWUzMjViMzRiMDU4NzBmOGVhM2U2YWZmYzQyL3RhYmxlcmFuZ2U6NDQ5NTE5ZTMyNWIzNGIwNTg3MGY4ZWEzZTZhZmZjNDJfOS01LTEtMS0zMDExNA_124e1f4c-b804-4287-9dc8-46f8a1b81b5e"
      unitRef="usd">31000000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="ib53b527a87f34ca1a28449997f71d948_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOjQ0OTUxOWUzMjViMzRiMDU4NzBmOGVhM2U2YWZmYzQyL3RhYmxlcmFuZ2U6NDQ5NTE5ZTMyNWIzNGIwNTg3MGY4ZWEzZTZhZmZjNDJfOS03LTEtMS0zMDExNA_92662655-613b-4daf-8bf7-4bc04b35d674"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ie085dfbe93fe4451a8b8d84aad0e35d5_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOjQ0OTUxOWUzMjViMzRiMDU4NzBmOGVhM2U2YWZmYzQyL3RhYmxlcmFuZ2U6NDQ5NTE5ZTMyNWIzNGIwNTg3MGY4ZWEzZTZhZmZjNDJfMTAtMS0xLTEtMzAxMTQ_1a5a2392-9a11-445a-8142-60d94485a1e0"
      unitRef="usd">1084000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="idf80390ad3e448c4bce98cb60bfbca2c_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOjQ0OTUxOWUzMjViMzRiMDU4NzBmOGVhM2U2YWZmYzQyL3RhYmxlcmFuZ2U6NDQ5NTE5ZTMyNWIzNGIwNTg3MGY4ZWEzZTZhZmZjNDJfMTAtMy0xLTEtMzAxMTQ_fb7f964a-4256-4b38-898f-275a173cb94d"
      unitRef="usd">1036000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ia4a3dda3866f4f3db20f204f127ccde3_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOjQ0OTUxOWUzMjViMzRiMDU4NzBmOGVhM2U2YWZmYzQyL3RhYmxlcmFuZ2U6NDQ5NTE5ZTMyNWIzNGIwNTg3MGY4ZWEzZTZhZmZjNDJfMTAtNS0xLTEtMzAxMTQ_5ca16d1d-a1bb-4bd4-9bb3-0b4af06159b6"
      unitRef="usd">48000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i3a3d3d46764b449d8f6eccfe5e6a43b5_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOjQ0OTUxOWUzMjViMzRiMDU4NzBmOGVhM2U2YWZmYzQyL3RhYmxlcmFuZ2U6NDQ5NTE5ZTMyNWIzNGIwNTg3MGY4ZWEzZTZhZmZjNDJfMTAtNy0xLTEtMzAxMTQ_4135b799-e33a-4fdc-80bd-5803841a1df3"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure
      contextRef="i6f394c9f978d46f7a4b1aca902fb05a9_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOjQ0OTUxOWUzMjViMzRiMDU4NzBmOGVhM2U2YWZmYzQyL3RhYmxlcmFuZ2U6NDQ5NTE5ZTMyNWIzNGIwNTg3MGY4ZWEzZTZhZmZjNDJfMTMtMS0xLTEtMzAxMTQ_e2a23aa2-8120-4f55-ad4e-2e3b1f4865e8"
      unitRef="usd">5000000</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure
      contextRef="ib292bc46e71c4b11a0a9f03de4f3b2fa_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOjQ0OTUxOWUzMjViMzRiMDU4NzBmOGVhM2U2YWZmYzQyL3RhYmxlcmFuZ2U6NDQ5NTE5ZTMyNWIzNGIwNTg3MGY4ZWEzZTZhZmZjNDJfMTMtMy0xLTEtMzAxMTQ_56f64a83-4961-4e53-963c-161da160dfb5"
      unitRef="usd">0</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure
      contextRef="if753f01b6fb74e4b82725e20f4211138_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOjQ0OTUxOWUzMjViMzRiMDU4NzBmOGVhM2U2YWZmYzQyL3RhYmxlcmFuZ2U6NDQ5NTE5ZTMyNWIzNGIwNTg3MGY4ZWEzZTZhZmZjNDJfMTMtNS0xLTEtMzAxMTQ_24fd39a4-789d-41fd-8c79-c7a93eb13c84"
      unitRef="usd">5000000</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure
      contextRef="i765ac03acc794ee0adca232fcb5a3e42_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOjQ0OTUxOWUzMjViMzRiMDU4NzBmOGVhM2U2YWZmYzQyL3RhYmxlcmFuZ2U6NDQ5NTE5ZTMyNWIzNGIwNTg3MGY4ZWEzZTZhZmZjNDJfMTMtNy0xLTEtMzAxMTQ_db2133d2-8a77-4da9-8ac5-e47f6effda80"
      unitRef="usd">0</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i6f394c9f978d46f7a4b1aca902fb05a9_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOjQ0OTUxOWUzMjViMzRiMDU4NzBmOGVhM2U2YWZmYzQyL3RhYmxlcmFuZ2U6NDQ5NTE5ZTMyNWIzNGIwNTg3MGY4ZWEzZTZhZmZjNDJfMTQtMS0xLTEtMzAxMTQ_72129015-a6d6-4d2e-b453-a9a9fff0a180"
      unitRef="usd">62000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="ib292bc46e71c4b11a0a9f03de4f3b2fa_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOjQ0OTUxOWUzMjViMzRiMDU4NzBmOGVhM2U2YWZmYzQyL3RhYmxlcmFuZ2U6NDQ5NTE5ZTMyNWIzNGIwNTg3MGY4ZWEzZTZhZmZjNDJfMTQtMy0xLTEtMzAxMTQ_e80ad73f-8f64-4a8c-bfe0-3e8fab2ad19c"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="if753f01b6fb74e4b82725e20f4211138_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOjQ0OTUxOWUzMjViMzRiMDU4NzBmOGVhM2U2YWZmYzQyL3RhYmxlcmFuZ2U6NDQ5NTE5ZTMyNWIzNGIwNTg3MGY4ZWEzZTZhZmZjNDJfMTQtNS0xLTEtMzAxMTQ_3e429c3e-fd7a-4313-ac1b-c4b9be89d383"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="if2ea1c6637aa4f78a6d53fd7fee549a8_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOjQ0OTUxOWUzMjViMzRiMDU4NzBmOGVhM2U2YWZmYzQyL3RhYmxlcmFuZ2U6NDQ5NTE5ZTMyNWIzNGIwNTg3MGY4ZWEzZTZhZmZjNDJfMTQtNy0xLTEtMzAxMTQ_2e108b8f-33a9-4eea-aa14-a522192c8bc0"
      unitRef="usd">62000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent
      contextRef="i55d8c6d05fa4483c93279a0c9f44754d_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOjQ0OTUxOWUzMjViMzRiMDU4NzBmOGVhM2U2YWZmYzQyL3RhYmxlcmFuZ2U6NDQ5NTE5ZTMyNWIzNGIwNTg3MGY4ZWEzZTZhZmZjNDJfMTYtMS0xLTEtMzAxMTQ_5816003e-8cba-4643-902f-9b77170ea439"
      unitRef="usd">34000000</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent
      contextRef="i167b08689113447eb86bceea035eecd1_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOjQ0OTUxOWUzMjViMzRiMDU4NzBmOGVhM2U2YWZmYzQyL3RhYmxlcmFuZ2U6NDQ5NTE5ZTMyNWIzNGIwNTg3MGY4ZWEzZTZhZmZjNDJfMTYtMy0xLTEtMzAxMTQ_8934edec-3377-449f-8e67-731ab225fdcb"
      unitRef="usd">0</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent
      contextRef="iaff97c5b6ded4379888e10b33df96a9a_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOjQ0OTUxOWUzMjViMzRiMDU4NzBmOGVhM2U2YWZmYzQyL3RhYmxlcmFuZ2U6NDQ5NTE5ZTMyNWIzNGIwNTg3MGY4ZWEzZTZhZmZjNDJfMTYtNS0xLTEtMzAxMTQ_435ddb26-5693-4dd4-953b-ab496392e766"
      unitRef="usd">34000000</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent
      contextRef="i242b61736b4c44cebd07a140cbb7dda7_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOjQ0OTUxOWUzMjViMzRiMDU4NzBmOGVhM2U2YWZmYzQyL3RhYmxlcmFuZ2U6NDQ5NTE5ZTMyNWIzNGIwNTg3MGY4ZWEzZTZhZmZjNDJfMTYtNy0xLTEtMzAxMTQ_e173ed3f-ec63-4106-ad4f-561ecc057233"
      unitRef="usd">0</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i55d8c6d05fa4483c93279a0c9f44754d_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOjQ0OTUxOWUzMjViMzRiMDU4NzBmOGVhM2U2YWZmYzQyL3RhYmxlcmFuZ2U6NDQ5NTE5ZTMyNWIzNGIwNTg3MGY4ZWEzZTZhZmZjNDJfMTctMS0xLTEtMzAxMTQ_29eb2a02-6ac6-4969-a0e6-306ca47774b5"
      unitRef="usd">27000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i167b08689113447eb86bceea035eecd1_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOjQ0OTUxOWUzMjViMzRiMDU4NzBmOGVhM2U2YWZmYzQyL3RhYmxlcmFuZ2U6NDQ5NTE5ZTMyNWIzNGIwNTg3MGY4ZWEzZTZhZmZjNDJfMTctMy0xLTEtMzAxMTQ_c00ee08e-5175-4132-b351-4153cc606131"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="iaff97c5b6ded4379888e10b33df96a9a_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOjQ0OTUxOWUzMjViMzRiMDU4NzBmOGVhM2U2YWZmYzQyL3RhYmxlcmFuZ2U6NDQ5NTE5ZTMyNWIzNGIwNTg3MGY4ZWEzZTZhZmZjNDJfMTctNS0xLTEtMzAxMTQ_8c1633f0-c98d-4675-9b5c-5905c9f63d8d"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i8b752274839a498a9ba656f68620fcdb_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOjQ0OTUxOWUzMjViMzRiMDU4NzBmOGVhM2U2YWZmYzQyL3RhYmxlcmFuZ2U6NDQ5NTE5ZTMyNWIzNGIwNTg3MGY4ZWEzZTZhZmZjNDJfMTctNy0xLTEtMzAxMTQ_3286fd53-5669-4c0b-845c-0c673a4dd37f"
      unitRef="usd">27000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ie085dfbe93fe4451a8b8d84aad0e35d5_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOjQ0OTUxOWUzMjViMzRiMDU4NzBmOGVhM2U2YWZmYzQyL3RhYmxlcmFuZ2U6NDQ5NTE5ZTMyNWIzNGIwNTg3MGY4ZWEzZTZhZmZjNDJfMTgtMS0xLTEtMzAxMTQ_b20d8da6-a384-4b27-b4e4-195c51b30569"
      unitRef="usd">128000000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="idf80390ad3e448c4bce98cb60bfbca2c_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOjQ0OTUxOWUzMjViMzRiMDU4NzBmOGVhM2U2YWZmYzQyL3RhYmxlcmFuZ2U6NDQ5NTE5ZTMyNWIzNGIwNTg3MGY4ZWEzZTZhZmZjNDJfMTgtMy0xLTEtMzAxMTQ_37039c8c-cb68-4478-be0b-72c272cf9c3e"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ia4a3dda3866f4f3db20f204f127ccde3_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOjQ0OTUxOWUzMjViMzRiMDU4NzBmOGVhM2U2YWZmYzQyL3RhYmxlcmFuZ2U6NDQ5NTE5ZTMyNWIzNGIwNTg3MGY4ZWEzZTZhZmZjNDJfMTgtNS0xLTEtMzAxMTQ_cfccee0c-80f0-4e55-9a5a-fcf584ff4857"
      unitRef="usd">39000000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i3a3d3d46764b449d8f6eccfe5e6a43b5_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOjQ0OTUxOWUzMjViMzRiMDU4NzBmOGVhM2U2YWZmYzQyL3RhYmxlcmFuZ2U6NDQ5NTE5ZTMyNWIzNGIwNTg3MGY4ZWEzZTZhZmZjNDJfMTgtNy0xLTEtMzAxMTQ_63c3fd70-2af0-4a88-b0bb-0dc29a400629"
      unitRef="usd">89000000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RleHRyZWdpb246NGFjODFlMzQ2MGVjNGFiMTg4NmZkZTE5MzdlNjEzZmVfMTY0OTI2NzQ1NzYxNg_eff08c85-6bf2-4e6d-81f0-2742fd4602c1"
      unitRef="usd">-47000000</us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss>
    <us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss
      contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RleHRyZWdpb246NGFjODFlMzQ2MGVjNGFiMTg4NmZkZTE5MzdlNjEzZmVfMTY0OTI2NzQ1NzY0OA_403617e2-ac71-4ff9-bf68-d4ab612e8341"
      unitRef="usd">2000000</us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss>
    <a:BusinessCombinationContingentConsiderationFairValueMeasurementInput
      contextRef="i8b540551877547fb8e1e4b0e4801b542_I20220131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RleHRyZWdpb246NGFjODFlMzQ2MGVjNGFiMTg4NmZkZTE5MzdlNjEzZmVfNDc5MA_5b321237-5482-4d66-8224-e6d829fb6fb9"
      unitRef="number">0.549</a:BusinessCombinationContingentConsiderationFairValueMeasurementInput>
    <a:BusinessCombinationContingentConsiderationFairValueMeasurementInput
      contextRef="i434180e34a724e439604a72f345ea6fd_I20220131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RleHRyZWdpb246NGFjODFlMzQ2MGVjNGFiMTg4NmZkZTE5MzdlNjEzZmVfNDgzMQ_2a092af4-8e1b-4eb3-8ba3-3f84b4dfa083"
      unitRef="number">0.122</a:BusinessCombinationContingentConsiderationFairValueMeasurementInput>
    <a:BusinessCombinationContingentConsiderationFairValueMeasurementInput
      contextRef="i91a30a8c91a44f6eb18a935a5bb6d39f_I20220131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RleHRyZWdpb246NGFjODFlMzQ2MGVjNGFiMTg4NmZkZTE5MzdlNjEzZmVfNDgzNw_30a253e4-6e88-4cbb-a293-cee60687650d"
      unitRef="number">0.139</a:BusinessCombinationContingentConsiderationFairValueMeasurementInput>
    <a:BusinessCombinationsContingentConsiderationArrangements
      contextRef="id313ef0eb3db435cabb1861abacdf1d0_D20211101-20220131"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RleHRyZWdpb246NGFjODFlMzQ2MGVjNGFiMTg4NmZkZTE5MzdlNjEzZmVfMTA5OTUxMTY0MTMxMw_52e93234-8e2c-4013-9eeb-e9d0e1378f68">P2Y10M24D</a:BusinessCombinationsContingentConsiderationArrangements>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh
      contextRef="i4da29d667bc84895ab281da0a1ff518e_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RleHRyZWdpb246NGFjODFlMzQ2MGVjNGFiMTg4NmZkZTE5MzdlNjEzZmVfMTA5OTUxMTY0MTM2Mw_f672d008-3d91-4a37-af0b-699a97b47ec1"
      unitRef="usd">145000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i8fa89a7423444291b6668e498df2d2d9_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RleHRyZWdpb246NGFjODFlMzQ2MGVjNGFiMTg4NmZkZTE5MzdlNjEzZmVfMTA5OTUxMTY0MTg0NA_910cd525-a3ea-469e-8b37-c1c115c1f560"
      unitRef="usd">92000000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i8e7130166b8246129cb9366c9e725c1d_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RleHRyZWdpb246NGFjODFlMzQ2MGVjNGFiMTg4NmZkZTE5MzdlNjEzZmVfMTA5OTUxMTY0MTgxMA_1d0f2d6c-167e-4f24-b538-cd9c8dc5e21f"
      unitRef="usd">65000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="if7cd365418ea4001be8171374346f5d4_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RleHRyZWdpb246NGFjODFlMzQ2MGVjNGFiMTg4NmZkZTE5MzdlNjEzZmVfMTA5OTUxMTY0MTgyNw_19837a79-b12f-4360-bf96-084cdf698201"
      unitRef="usd">27000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RleHRyZWdpb246NGFjODFlMzQ2MGVjNGFiMTg4NmZkZTE5MzdlNjEzZmVfNzg4OQ_41cab86b-1f07-494e-b55d-9142a58c7fd2">&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The contingent consideration liability is our only Level 3 asset or liability.  A summary of the Level 3 activity follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.724%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.697%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;January 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in fair value (included within selling, general and administrative expenses)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i6390807210d74c6f9cae496ea2122a5a_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOjFiYWVkMzkzYzM2ZjQ2OGNiZDNlZGEzYmM3YWU5MDU2L3RhYmxlcmFuZ2U6MWJhZWQzOTNjMzZmNDY4Y2JkM2VkYTNiYzdhZTkwNTZfNC0xLTEtMS0zMDExNA_0eb616fd-749b-4230-8fe6-a464a9dd3de8"
      unitRef="usd">89000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="id69612e49fa546c0bf63ff5ad436ccc6_I20201031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOjFiYWVkMzkzYzM2ZjQ2OGNiZDNlZGEzYmM3YWU5MDU2L3RhYmxlcmFuZ2U6MWJhZWQzOTNjMzZmNDY4Y2JkM2VkYTNiYzdhZTkwNTZfNC0zLTEtMS0zMDExNA_0d362116-1fc2-42d2-b5ca-b4488693f735"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOjFiYWVkMzkzYzM2ZjQ2OGNiZDNlZGEzYmM3YWU5MDU2L3RhYmxlcmFuZ2U6MWJhZWQzOTNjMzZmNDY4Y2JkM2VkYTNiYzdhZTkwNTZfNi0xLTEtMS0zMDExNA_3a1cb955-8c53-43bf-99e3-4ad6b61346e8"
      unitRef="usd">3000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease
      contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOjFiYWVkMzkzYzM2ZjQ2OGNiZDNlZGEzYmM3YWU5MDU2L3RhYmxlcmFuZ2U6MWJhZWQzOTNjMzZmNDY4Y2JkM2VkYTNiYzdhZTkwNTZfNi0zLTEtMS0zMDExNA_3a00767d-5a0d-4489-bfe0-a7b9c1823749"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOjFiYWVkMzkzYzM2ZjQ2OGNiZDNlZGEzYmM3YWU5MDU2L3RhYmxlcmFuZ2U6MWJhZWQzOTNjMzZmNDY4Y2JkM2VkYTNiYzdhZTkwNTZfNy0xLTEtMS0zMDExNA_b0241b6c-8d0a-4164-aab9-5d615c0a28fc"
      unitRef="usd">92000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i9b47b15753c94f0b80143556347e39b7_I20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RhYmxlOjFiYWVkMzkzYzM2ZjQ2OGNiZDNlZGEzYmM3YWU5MDU2L3RhYmxlcmFuZ2U6MWJhZWQzOTNjMzZmNDY4Y2JkM2VkYTNiYzdhZTkwNTZfNy0zLTEtMS0zMDExNA_973e1d77-0dea-4b55-aabe-257255ac76f1"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:ImpairmentOfInvestments
      contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RleHRyZWdpb246NGFjODFlMzQ2MGVjNGFiMTg4NmZkZTE5MzdlNjEzZmVfMTA5OTUxMTY0MjI2OA_6500ada0-d89e-45e8-b9d1-b7d255d53bae"
      unitRef="usd">0</us-gaap:ImpairmentOfInvestments>
    <us-gaap:ImpairmentOfInvestments
      contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RleHRyZWdpb246NGFjODFlMzQ2MGVjNGFiMTg4NmZkZTE5MzdlNjEzZmVfMTA5OTUxMTY0MjI2OA_71460f0f-7597-4fb7-90e4-62fbbc9e5972"
      unitRef="usd">0</us-gaap:ImpairmentOfInvestments>
    <us-gaap:ImpairmentOfInvestments
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RleHRyZWdpb246NGFjODFlMzQ2MGVjNGFiMTg4NmZkZTE5MzdlNjEzZmVfMTA5OTUxMTY0MjI2OA_8594a99e-ed00-4db5-8451-e88d798f4d2c"
      unitRef="usd">0</us-gaap:ImpairmentOfInvestments>
    <us-gaap:ImpairmentOfInvestments
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RleHRyZWdpb246NGFjODFlMzQ2MGVjNGFiMTg4NmZkZTE5MzdlNjEzZmVfMTA5OTUxMTY0MjI2OA_951e0bc7-4cf4-4778-9a67-9124a2c7a922"
      unitRef="usd">0</us-gaap:ImpairmentOfInvestments>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse
      contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RleHRyZWdpb246NGFjODFlMzQ2MGVjNGFiMTg4NmZkZTE5MzdlNjEzZmVfNTk0Mg_4c768970-a7fc-4902-8db7-29f20b9ea0ff"
      unitRef="usd">0</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf
      contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RleHRyZWdpb246NGFjODFlMzQ2MGVjNGFiMTg4NmZkZTE5MzdlNjEzZmVfNTk0Mg_521b94c9-001d-4964-b0d0-0356bc69f937"
      unitRef="usd">0</us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RleHRyZWdpb246NGFjODFlMzQ2MGVjNGFiMTg4NmZkZTE5MzdlNjEzZmVfNTk0Mg_5605c602-54da-44cd-867b-6120fbcb5400"
      unitRef="usd">0</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf
      contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RleHRyZWdpb246NGFjODFlMzQ2MGVjNGFiMTg4NmZkZTE5MzdlNjEzZmVfNTk0Mg_a35358c6-1a65-45a6-b99c-d85be4712da6"
      unitRef="usd">0</us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RleHRyZWdpb246NGFjODFlMzQ2MGVjNGFiMTg4NmZkZTE5MzdlNjEzZmVfNTk0Mg_c75f168f-a3fc-4638-bfd3-2193082558f2"
      unitRef="usd">0</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse
      contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RleHRyZWdpb246NGFjODFlMzQ2MGVjNGFiMTg4NmZkZTE5MzdlNjEzZmVfNTk0Mg_c920c995-ed6c-40fb-966d-89568a3907ad"
      unitRef="usd">0</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RleHRyZWdpb246NGFjODFlMzQ2MGVjNGFiMTg4NmZkZTE5MzdlNjEzZmVfNTk0Mg_de2154c7-e1ec-4c27-a5a8-609f402337a3"
      unitRef="usd">0</us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf>
    <us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RleHRyZWdpb246NGFjODFlMzQ2MGVjNGFiMTg4NmZkZTE5MzdlNjEzZmVfNTk0Mg_f1bffb8a-d670-4eba-beaf-0888372a8342"
      unitRef="usd">0</us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount
      contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RleHRyZWdpb246NGFjODFlMzQ2MGVjNGFiMTg4NmZkZTE5MzdlNjEzZmVfNjU2NA_064faff8-14c6-4589-b5c6-b9b82ab9eb97"
      unitRef="usd">0</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount
      contextRef="i9b47b15753c94f0b80143556347e39b7_I20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RleHRyZWdpb246NGFjODFlMzQ2MGVjNGFiMTg4NmZkZTE5MzdlNjEzZmVfNjU2NA_adf7cc58-359a-4e2f-af13-6dc17b09e029"
      unitRef="usd">0</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
      contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RleHRyZWdpb246NGFjODFlMzQ2MGVjNGFiMTg4NmZkZTE5MzdlNjEzZmVfNzI4OA_83c58ca3-0061-4bb6-9933-c599c35e4cc2"
      unitRef="usd">125000000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
      contextRef="i6390807210d74c6f9cae496ea2122a5a_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV81OC9mcmFnOjRhYzgxZTM0NjBlYzRhYjE4ODZmZGUxOTM3ZTYxM2ZlL3RleHRyZWdpb246NGFjODFlMzQ2MGVjNGFiMTg4NmZkZTE5MzdlNjEzZmVfNzI5NQ_6024bcfb-951b-4fc4-b2e2-2c4e316dc88f"
      unitRef="usd">120000000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RleHRyZWdpb246ZWI4YjIxYmVmODkxNDhlYWFkMTU5MmM3YThjMGU5YTdfOTA2NQ_f21e2e85-8476-45e6-8ebe-d0f1c02c812d">DERIVATIVES&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are exposed to foreign currency exchange rate fluctuations and interest rate changes in the normal course of our business. As part of our risk management strategy, we use derivative instruments, primarily forward contracts and purchased options to hedge economic and/or accounting exposures resulting from changes in foreign currency exchange rates.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cash Flow Hedges&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We enter into foreign exchange contracts to hedge our forecasted operational cash flow exposures resulting from changes in foreign currency exchange rates. These foreign exchange contracts, carried at fair value, have maturities between one and twelve months. These derivative instruments are designated and qualify as cash flow hedges under the criteria prescribed in the authoritative guidance and are assessed for effectiveness against the underlying exposure every reporting period. For open contracts as of January&#160;31, 2022, changes in the time value of the foreign exchange contract are excluded from the assessment of hedge effectiveness and are recognized in cost of sales over the life of the foreign exchange contract. The changes in fair value of the effective portion of the derivative instrument are recognized in accumulated other comprehensive income (loss). Amounts associated with cash flow hedges are reclassified to cost of sales in the condensed consolidated statement of operations when the forecasted transaction occurs. If it becomes probable that the forecasted transaction will not occur, the hedge relationship will be de-designated and amounts accumulated in other comprehensive income (loss) will be reclassified to other income (expense), net in the current period. Changes in the fair value of the ineffective portion of derivative instruments are recognized in other income (expense), net in the condensed consolidated statement of operations in the current period. We record the premium paid (time value) of an option on the date of purchase as an asset. For options designated as cash flow hedges, changes in the time value are excluded from the assessment of hedge effectiveness and are recognized in cost of sales over the life of the option contract. For the three months ended January&#160;31, 2022 and 2021, ineffectiveness and gains and losses recognized in other income (expense), net due to de-designation of cash flow hedge contracts were not significant.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In February 2016, Agilent executed three forward-starting pay fixed/receive variable interest rate swaps for the notional amount of $300 million in connection with future interest payments to be made on our 2026 senior notes issued on September 15, 2016. These derivative instruments were designated and qualified as cash flow hedges under the criteria prescribed in the authoritative guidance. The swap arrangements were terminated on September 15, 2016 with a payment of $10 million, and we recognized this as a deferred loss in accumulated other comprehensive income (loss) which is being amortized to interest expense over the life of the 2026 senior notes. The remaining loss to be amortized related to the interest rate swap agreements at January&#160;31, 2022 was $4 million. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2019, Agilent executed treasury lock agreements for $250 million in connection with future interest payments to be made on our 2029 senior notes issued on September 16, 2019. We designated the treasury lock as a cash flow hedge. The treasury lock contracts were terminated on September 6, 2019, and we recognized a deferred loss of $6&#160;million in accumulated other comprehensive income (loss) which is being amortized to interest expense over the life of the 2029 senior notes. The remaining loss to be amortized related to the treasury lock agreements at January&#160;31, 2022 was $4 million. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Net Investment Hedges &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We enter into foreign exchange contracts to hedge net investments in foreign operations to mitigate the risk of adverse movements in exchange rates. These foreign exchange contracts are carried at fair value and are designated and qualify as net investment hedges under the criteria prescribed in the authoritative guidance. Changes in fair value of the effective portion of the derivative instrument are recognized in accumulated other comprehensive income (loss) and are assessed for effectiveness against the underlying exposure every reporting period. If the company&#x2019;s net investment changes during the year, the hedge relationship will be assessed and de-designated if the hedge notional amount is outside of prescribed tolerance with a gain/loss reclassified from other comprehensive income (loss) to other income (expense) in the current period. For the three months ended January&#160;31, 2022, ineffectiveness and the resultant effect of any gains or losses recognized in other income (expense) due to de-designation of the hedge contracts were not significant.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other Hedges&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Additionally, we enter into foreign exchange contracts to hedge monetary assets and liabilities that are denominated in currencies other than the functional currency of our subsidiaries. These foreign exchange contracts are carried at fair value and do not qualify for hedge accounting treatment and are not designated as hedging instruments. Changes in value of the derivative instruments are recognized in other income (expense), net in the condensed consolidated statement of operations, in the current period, along with the offsetting foreign currency gain or loss on the underlying assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our use of derivative instruments exposes us to credit risk to the extent that the counterparties may be unable to meet the terms of the agreement. We do, however, seek to mitigate such risks by limiting our counterparties to major financial institutions which are selected based on their credit ratings and other factors.&#160;We have established policies and procedures for mitigating credit risk that include establishing counterparty credit limits, monitoring credit exposures, and continually assessing the creditworthiness of counterparties.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A number of our derivative agreements contain threshold limits to the net liability position with counterparties and are dependent on our corporate credit rating determined by the major credit rating agencies. The counterparties to the derivative instruments may request collateralization, in accordance with derivative agreements, on derivative instruments in net liability positions.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The aggregate fair value of all derivative instruments with credit-risk-related contingent features that were in a net liability position as of January&#160;31, 2022, was $2&#160;million. The credit-risk-related contingent features underlying these agreements had not been triggered as of January&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were 261 foreign exchange forward contracts open as of January&#160;31, 2022 and designated as cash flow hedges. There were 177 foreign exchange forward contracts open as of January&#160;31, 2022 and not designated as hedging instruments. There were 7 foreign exchange forward contracts open as of January&#160;31, 2022 and designated as a net investment hedge.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The aggregated notional amounts by currency and designation as of January&#160;31, 2022 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.274%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.786%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.080%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.258%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Derivatives&#160;&lt;br/&gt;Designated as &lt;br/&gt;Cash&#160;Flow Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Derivatives &lt;br/&gt;Designated as &lt;br/&gt;Net Investment Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Derivatives &lt;br/&gt;Not Designated as&#160;&lt;br/&gt;Hedging Instruments&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Forward&lt;br/&gt;Contracts USD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Forward&lt;br/&gt;Contracts USD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Forward&lt;br/&gt;Contracts USD&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Currency&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Buy/(Sell)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Buy/(Sell)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Buy/(Sell)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in&#160;millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Euro&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(71)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;British Pound&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(68)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Canadian Dollar&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Japanese Yen&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(88)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Danish Krone&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Korean Won&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(65)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Singapore Dollar&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Swiss Franc&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Chinese Yuan Renminbi&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(84)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(101)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Taiwan Dollar&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Indian Rupee&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Brazilian Real&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Totals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(396)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(118)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Derivative instruments are subject to master netting arrangements and are disclosed gross in the balance sheet in accordance with the authoritative guidance. The gross fair values and balance sheet location of derivative instruments held in the condensed consolidated balance sheet as of January&#160;31, 2022 and October&#160;31, 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.635%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.164%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.311%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.875%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&#160;Values&#160;of&#160;Derivative&#160;Instruments&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Asset&#160;Derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="15" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Liability&#160;Derivatives&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&#160;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&#160;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance&#160;Sheet&#160;Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;January 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance&#160;Sheet&#160;Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;January 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in&#160;millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivatives designated as hedging instruments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Net investment hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivatives not designated as hedging instruments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The effects of derivative instruments for foreign exchange contracts designated as hedging instruments and not designated as hedging instruments in our condensed consolidated statement of operations were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:82.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.943%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;January 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in&#160;millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivatives designated as hedging instruments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Cash Flow Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gain (loss) recognized in accumulated other comprehensive&#160;loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gain (loss) reclassified from accumulated other comprehensive&#160;loss into cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Net Investment Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gain (loss) recognized in accumulated other comprehensive loss - translation adjustment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivatives not designated as hedging instruments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gain (loss) recognized in other income (expense)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At January&#160;31, 2022, the amount of existing net gain that is expected to be reclassified from accumulated other comprehensive income (loss) is $6 million. Within the next twelve months it is estimated that $9 million of gain included within the net amount of accumulated other comprehensive income (loss) will be reclassified to cost of sales in respect of cash flow hedges.&lt;/span&gt;&lt;/div&gt;</us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock>
    <us-gaap:NumberOfInterestRateDerivativesHeld
      contextRef="ic292fe4ddbdc4b1f85e1bac3f0ab2387_I20160201"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RleHRyZWdpb246ZWI4YjIxYmVmODkxNDhlYWFkMTU5MmM3YThjMGU5YTdfMzI0MQ_9f360b0d-4d97-49a5-946d-f24fa8e2e873"
      unitRef="contracts">3</us-gaap:NumberOfInterestRateDerivativesHeld>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ic292fe4ddbdc4b1f85e1bac3f0ab2387_I20160201"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RleHRyZWdpb246ZWI4YjIxYmVmODkxNDhlYWFkMTU5MmM3YThjMGU5YTdfMzMzNQ_a4064f95-d415-4691-9981-cd212a2c7953"
      unitRef="usd">300000000</us-gaap:DerivativeNotionalAmount>
    <a:Interestrateswappayments
      contextRef="ifb765ebd38d444b1857a41d784a28b5e_D20160914-20160915"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RleHRyZWdpb246ZWI4YjIxYmVmODkxNDhlYWFkMTU5MmM3YThjMGU5YTdfMzY2Ng_415e7ea4-1471-49bd-852b-aa7446da74ed"
      unitRef="usd">10000000</a:Interestrateswappayments>
    <a:Remaininggainlosstobeamortizedonderivative
      contextRef="if325814ac8de45f5b8f83e932e8509f8_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RleHRyZWdpb246ZWI4YjIxYmVmODkxNDhlYWFkMTU5MmM3YThjMGU5YTdfMzkzNg_9c6c7726-52cc-4a18-a380-5f2278508d7a"
      unitRef="usd">4000000</a:Remaininggainlosstobeamortizedonderivative>
    <us-gaap:DerivativeNotionalAmount
      contextRef="iad105ebf0fa5490194840a7fe0fd1664_I20190816"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RleHRyZWdpb246ZWI4YjIxYmVmODkxNDhlYWFkMTU5MmM3YThjMGU5YTdfNDAwNA_605b04e1-756e-4bf6-87e9-f26cf49a5840"
      unitRef="usd">250000000</us-gaap:DerivativeNotionalAmount>
    <a:Interestrateswappayments
      contextRef="i3fae7ee4803141fab6fa85ebe7ee5491_D20190906-20190906"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RleHRyZWdpb246ZWI4YjIxYmVmODkxNDhlYWFkMTU5MmM3YThjMGU5YTdfNDI3NA_3e52cb81-e121-44eb-85f1-904b4c75c0f6"
      unitRef="usd">6000000</a:Interestrateswappayments>
    <a:Remaininggainlosstobeamortizedonderivative
      contextRef="i042e0c2ce85c41bc9011ef45825cadd8_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RleHRyZWdpb246ZWI4YjIxYmVmODkxNDhlYWFkMTU5MmM3YThjMGU5YTdfNDQ5Ng_3c5ef89b-ebd5-43b8-bec5-5ad72d68b2dc"
      unitRef="usd">4000000</a:Remaininggainlosstobeamortizedonderivative>
    <us-gaap:DerivativeNetLiabilityPositionAggregateFairValue
      contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RleHRyZWdpb246ZWI4YjIxYmVmODkxNDhlYWFkMTU5MmM3YThjMGU5YTdfNzc5OQ_32f003c1-025b-48fc-b279-b12bfad1d85e"
      unitRef="usd">2000000</us-gaap:DerivativeNetLiabilityPositionAggregateFairValue>
    <us-gaap:NumberOfForeignCurrencyDerivativesHeld
      contextRef="i3d4fb6e9c35b4a259523bf637621e885_I20220131"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RleHRyZWdpb246ZWI4YjIxYmVmODkxNDhlYWFkMTU5MmM3YThjMGU5YTdfNzkyMA_e64322ad-a8ed-49ba-94b0-1aae2ff5d901"
      unitRef="contracts">261</us-gaap:NumberOfForeignCurrencyDerivativesHeld>
    <us-gaap:NumberOfForeignCurrencyDerivativesHeld
      contextRef="i9309ceb43d6d4d7c95d0816fd752eca7_I20220131"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RleHRyZWdpb246ZWI4YjIxYmVmODkxNDhlYWFkMTU5MmM3YThjMGU5YTdfODAxOQ_8c262c7f-2405-4038-ad2e-78ab0a0422cc"
      unitRef="contracts">177</us-gaap:NumberOfForeignCurrencyDerivativesHeld>
    <us-gaap:NumberOfForeignCurrencyDerivativesHeld
      contextRef="i1b3f43743319451cb90947e0304374dd_I20220131"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RleHRyZWdpb246ZWI4YjIxYmVmODkxNDhlYWFkMTU5MmM3YThjMGU5YTdfODEyNQ_da006b26-3522-40d6-880e-d2955f065254"
      unitRef="contracts">7</us-gaap:NumberOfForeignCurrencyDerivativesHeld>
    <us-gaap:ScheduleOfDerivativeInstrumentsTextBlock
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RleHRyZWdpb246ZWI4YjIxYmVmODkxNDhlYWFkMTU5MmM3YThjMGU5YTdfOTA5Nw_52c58703-281c-480f-8680-2ab026ac0cfc">The aggregated notional amounts by currency and designation as of January&#160;31, 2022 were as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.274%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.786%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.080%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.258%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Derivatives&#160;&lt;br/&gt;Designated as &lt;br/&gt;Cash&#160;Flow Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Derivatives &lt;br/&gt;Designated as &lt;br/&gt;Net Investment Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Derivatives &lt;br/&gt;Not Designated as&#160;&lt;br/&gt;Hedging Instruments&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Forward&lt;br/&gt;Contracts USD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Forward&lt;br/&gt;Contracts USD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Forward&lt;br/&gt;Contracts USD&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Currency&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Buy/(Sell)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Buy/(Sell)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Buy/(Sell)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in&#160;millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Euro&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(71)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;British Pound&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(68)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Canadian Dollar&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Japanese Yen&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(88)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Danish Krone&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Korean Won&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(65)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Singapore Dollar&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Swiss Franc&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Chinese Yuan Renminbi&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(84)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(101)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Taiwan Dollar&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Indian Rupee&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Brazilian Real&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Totals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(396)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(118)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfDerivativeInstrumentsTextBlock>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i8c42cc94490742e7b13ea5fd23157b27_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RhYmxlOmU3Njk1OTI0OTRmMDRhNDNiYWUyY2RhNmYyMjFlMmY4L3RhYmxlcmFuZ2U6ZTc2OTU5MjQ5NGYwNGE0M2JhZTJjZGE2ZjIyMWUyZjhfNC0yLTEtMS0zMDExNA_bf529aa7-e734-4014-a6a2-d74be935b8c8"
      unitRef="usd">71000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ib6775d0eafba4fbcb9f4699180a8061e_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RhYmxlOmU3Njk1OTI0OTRmMDRhNDNiYWUyY2RhNmYyMjFlMmY4L3RhYmxlcmFuZ2U6ZTc2OTU5MjQ5NGYwNGE0M2JhZTJjZGE2ZjIyMWUyZjhfNC02LTEtMS0zMDExNA_af706a10-1e99-4210-9f2a-9f69336dbdd1"
      unitRef="usd">15000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i4a3c2b906dba466d90605db0ba3c44a4_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RhYmxlOmU3Njk1OTI0OTRmMDRhNDNiYWUyY2RhNmYyMjFlMmY4L3RhYmxlcmFuZ2U6ZTc2OTU5MjQ5NGYwNGE0M2JhZTJjZGE2ZjIyMWUyZjhfNC04LTEtMS0zMDExNA_8ab3a544-c5f2-4f78-9e77-042cec60a775"
      unitRef="usd">27000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i0f9ec320b33848c3a9839b24a1239ed8_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RhYmxlOmU3Njk1OTI0OTRmMDRhNDNiYWUyY2RhNmYyMjFlMmY4L3RhYmxlcmFuZ2U6ZTc2OTU5MjQ5NGYwNGE0M2JhZTJjZGE2ZjIyMWUyZjhfNS0yLTEtMS0zMDExNA_197a34b7-a117-4dc0-8807-4a18644dcf8e"
      unitRef="usd">68000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i6497616d037845fca0c005ebc475212b_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RhYmxlOmU3Njk1OTI0OTRmMDRhNDNiYWUyY2RhNmYyMjFlMmY4L3RhYmxlcmFuZ2U6ZTc2OTU5MjQ5NGYwNGE0M2JhZTJjZGE2ZjIyMWUyZjhfNS04LTEtMS0zMDExNA_160d79d8-b6cf-4e81-a50d-4d47ba18d618"
      unitRef="usd">9000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i75d2660ff14040b3b96c724f268ab729_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RhYmxlOmU3Njk1OTI0OTRmMDRhNDNiYWUyY2RhNmYyMjFlMmY4L3RhYmxlcmFuZ2U6ZTc2OTU5MjQ5NGYwNGE0M2JhZTJjZGE2ZjIyMWUyZjhfNi0yLTEtMS0zMDExNA_6207c4bd-1292-4f52-88ce-489a0da3e331"
      unitRef="usd">42000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ica71b83ef3a1418d9d27756803812b2b_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RhYmxlOmU3Njk1OTI0OTRmMDRhNDNiYWUyY2RhNmYyMjFlMmY4L3RhYmxlcmFuZ2U6ZTc2OTU5MjQ5NGYwNGE0M2JhZTJjZGE2ZjIyMWUyZjhfNi04LTEtMS0zMDExNA_db2d20a6-b1e8-427e-8b71-52a2139e91fe"
      unitRef="usd">4000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ieb2fe08defb64136976421e01523b7ef_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RhYmxlOmU3Njk1OTI0OTRmMDRhNDNiYWUyY2RhNmYyMjFlMmY4L3RhYmxlcmFuZ2U6ZTc2OTU5MjQ5NGYwNGE0M2JhZTJjZGE2ZjIyMWUyZjhfOS0yLTEtMS0zMDExNA_262271b9-4442-4ffc-ab9f-eb901095ee95"
      unitRef="usd">88000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i4c6f0473f9864b389ca06abc0cf5ee78_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RhYmxlOmU3Njk1OTI0OTRmMDRhNDNiYWUyY2RhNmYyMjFlMmY4L3RhYmxlcmFuZ2U6ZTc2OTU5MjQ5NGYwNGE0M2JhZTJjZGE2ZjIyMWUyZjhfOS04LTEtMS0zMDExNA_0eb42710-daa7-4ffd-a1d2-e990549f239c"
      unitRef="usd">41000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i3355616638084c1584622a5e3613f202_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RhYmxlOmU3Njk1OTI0OTRmMDRhNDNiYWUyY2RhNmYyMjFlMmY4L3RhYmxlcmFuZ2U6ZTc2OTU5MjQ5NGYwNGE0M2JhZTJjZGE2ZjIyMWUyZjhfMTAtOC0xLTEtMzAxMTQ_22b3c552-e5bd-4d11-801b-9fd3473dbb33"
      unitRef="usd">27000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="iaeb7bd13400342f287179313ecad6bd5_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RhYmxlOmU3Njk1OTI0OTRmMDRhNDNiYWUyY2RhNmYyMjFlMmY4L3RhYmxlcmFuZ2U6ZTc2OTU5MjQ5NGYwNGE0M2JhZTJjZGE2ZjIyMWUyZjhfMTEtMi0xLTEtMzAxMTQ_3ac64abf-8b66-4c65-8cf7-0e6e73ac2f8b"
      unitRef="usd">65000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ic4671a036f85446594c33199993572bf_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RhYmxlOmU3Njk1OTI0OTRmMDRhNDNiYWUyY2RhNmYyMjFlMmY4L3RhYmxlcmFuZ2U6ZTc2OTU5MjQ5NGYwNGE0M2JhZTJjZGE2ZjIyMWUyZjhfMTEtOC0xLTEtMzAxMTQ_0eef9f67-8150-41bf-8e13-01ad98a4d099"
      unitRef="usd">20000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="if316a64c264f481b862d74033659d9c1_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RhYmxlOmU3Njk1OTI0OTRmMDRhNDNiYWUyY2RhNmYyMjFlMmY4L3RhYmxlcmFuZ2U6ZTc2OTU5MjQ5NGYwNGE0M2JhZTJjZGE2ZjIyMWUyZjhfMTItMi0xLTEtMzAxMTQ_199373ca-2904-496a-8f57-d1e85490ae0e"
      unitRef="usd">18000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i7306551b82684e7286c2efe86019758b_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RhYmxlOmU3Njk1OTI0OTRmMDRhNDNiYWUyY2RhNmYyMjFlMmY4L3RhYmxlcmFuZ2U6ZTc2OTU5MjQ5NGYwNGE0M2JhZTJjZGE2ZjIyMWUyZjhfMTItOC0xLTEtMzAxMTQ_2027b9c5-623d-4f90-945b-7f0dd4498d7f"
      unitRef="usd">21000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i83b2d38c99874faa95b7ac2a3be10565_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RhYmxlOmU3Njk1OTI0OTRmMDRhNDNiYWUyY2RhNmYyMjFlMmY4L3RhYmxlcmFuZ2U6ZTc2OTU5MjQ5NGYwNGE0M2JhZTJjZGE2ZjIyMWUyZjhfMTMtOC0xLTEtMzAxMTQ_2356aef6-dfb5-4154-b8ed-bcd1ac84d251"
      unitRef="usd">6000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i72dfae202fe64d0d9194ac25adbe6324_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RhYmxlOmU3Njk1OTI0OTRmMDRhNDNiYWUyY2RhNmYyMjFlMmY4L3RhYmxlcmFuZ2U6ZTc2OTU5MjQ5NGYwNGE0M2JhZTJjZGE2ZjIyMWUyZjhfMTQtMi0xLTEtMzAxMTQ_a0cb1013-4585-4c12-8ac1-536f09b7a06d"
      unitRef="usd">84000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="icbb1793fb3ba4308a7a1bc073a3e737b_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RhYmxlOmU3Njk1OTI0OTRmMDRhNDNiYWUyY2RhNmYyMjFlMmY4L3RhYmxlcmFuZ2U6ZTc2OTU5MjQ5NGYwNGE0M2JhZTJjZGE2ZjIyMWUyZjhfMTQtOC0xLTEtMzAxMTQ_1976ddb7-715e-460d-8d83-9db163694b93"
      unitRef="usd">101000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i6881a3da71ef45248c11dd3d5d7aa897_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RhYmxlOmU3Njk1OTI0OTRmMDRhNDNiYWUyY2RhNmYyMjFlMmY4L3RhYmxlcmFuZ2U6ZTc2OTU5MjQ5NGYwNGE0M2JhZTJjZGE2ZjIyMWUyZjhfMTctOC0xLTEtMzAxMTQ_c6bd20b0-6af3-450f-b190-6354e109a2fc"
      unitRef="usd">6000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i039748d0e2f64eb98ec1fe2ea5b6d315_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RhYmxlOmU3Njk1OTI0OTRmMDRhNDNiYWUyY2RhNmYyMjFlMmY4L3RhYmxlcmFuZ2U6ZTc2OTU5MjQ5NGYwNGE0M2JhZTJjZGE2ZjIyMWUyZjhfMTgtOC0xLTEtMzAxMTQ_a7a17489-972c-4488-b962-1a9e903accf4"
      unitRef="usd">13000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="id105be7d8a724d71956a551b0fe22d54_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RhYmxlOmU3Njk1OTI0OTRmMDRhNDNiYWUyY2RhNmYyMjFlMmY4L3RhYmxlcmFuZ2U6ZTc2OTU5MjQ5NGYwNGE0M2JhZTJjZGE2ZjIyMWUyZjhfMTktOC0xLTEtMzAxMTQ_ca6e28a2-a855-437d-b2ca-eebed3c1627f"
      unitRef="usd">10000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="idcd3e8c2579941ef810c7c628510a603_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RhYmxlOmU3Njk1OTI0OTRmMDRhNDNiYWUyY2RhNmYyMjFlMmY4L3RhYmxlcmFuZ2U6ZTc2OTU5MjQ5NGYwNGE0M2JhZTJjZGE2ZjIyMWUyZjhfMjEtMi0xLTEtMzAxMTQ_3051fb40-96e3-4756-993b-cecacb6adcf4"
      unitRef="usd">4000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i6caf21f7567843c6ac1d733aab0be98d_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RhYmxlOmU3Njk1OTI0OTRmMDRhNDNiYWUyY2RhNmYyMjFlMmY4L3RhYmxlcmFuZ2U6ZTc2OTU5MjQ5NGYwNGE0M2JhZTJjZGE2ZjIyMWUyZjhfMjEtOC0xLTEtMzAxMTQ_bdcb484d-d3c2-42f1-ac01-4a993ecc1f9c"
      unitRef="usd">1000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i8b3e8db945ae4a1a940922af0327692d_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RhYmxlOmU3Njk1OTI0OTRmMDRhNDNiYWUyY2RhNmYyMjFlMmY4L3RhYmxlcmFuZ2U6ZTc2OTU5MjQ5NGYwNGE0M2JhZTJjZGE2ZjIyMWUyZjhfMjItMi0xLTEtMzAxMTQ_675e2988-e5f2-4b0d-8ecc-f241677ae84d"
      unitRef="usd">396000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ibdea3a47f24e4e8590f368a0dfb94d45_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RhYmxlOmU3Njk1OTI0OTRmMDRhNDNiYWUyY2RhNmYyMjFlMmY4L3RhYmxlcmFuZ2U6ZTc2OTU5MjQ5NGYwNGE0M2JhZTJjZGE2ZjIyMWUyZjhfMjItNi0xLTEtMzAxMTQ_14b1e238-2249-4f0a-b30d-974795c12f8a"
      unitRef="usd">15000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i6736f6223d0f4203b9239c59f7463674_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RhYmxlOmU3Njk1OTI0OTRmMDRhNDNiYWUyY2RhNmYyMjFlMmY4L3RhYmxlcmFuZ2U6ZTc2OTU5MjQ5NGYwNGE0M2JhZTJjZGE2ZjIyMWUyZjhfMjItOC0xLTEtMzAxMTQ_aa9165bc-d39a-4f51-9e82-32c14285b3a3"
      unitRef="usd">118000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RleHRyZWdpb246ZWI4YjIxYmVmODkxNDhlYWFkMTU5MmM3YThjMGU5YTdfOTEwMw_411d269e-0399-41a8-aecf-361cb4567c0d">Derivative instruments are subject to master netting arrangements and are disclosed gross in the balance sheet in accordance with the authoritative guidance. The gross fair values and balance sheet location of derivative instruments held in the condensed consolidated balance sheet as of January&#160;31, 2022 and October&#160;31, 2021 were as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.635%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.164%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.311%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.875%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&#160;Values&#160;of&#160;Derivative&#160;Instruments&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Asset&#160;Derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="15" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Liability&#160;Derivatives&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&#160;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&#160;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance&#160;Sheet&#160;Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;January 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance&#160;Sheet&#160;Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;January 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in&#160;millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivatives designated as hedging instruments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Net investment hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivatives not designated as hedging instruments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i56c53f4c438544d8b06e4f41bad8c0db_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RhYmxlOjU2Y2ZmNmEzZDc5NzRiNzRiOWE0NzgxNDEzZGU3YjNmL3RhYmxlcmFuZ2U6NTZjZmY2YTNkNzk3NGI3NGI5YTQ3ODE0MTNkZTdiM2ZfOC0yLTEtMS0zMDExNA_083c2721-789f-4928-9e74-e6223d6f9da2"
      unitRef="usd">10000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i3c381f194b4e4d6884993233f9ef427b_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RhYmxlOjU2Y2ZmNmEzZDc5NzRiNzRiOWE0NzgxNDEzZGU3YjNmL3RhYmxlcmFuZ2U6NTZjZmY2YTNkNzk3NGI3NGI5YTQ3ODE0MTNkZTdiM2ZfOC00LTEtMS0zMDExNA_83d15f24-e72f-4394-b6a6-21ed9b21b639"
      unitRef="usd">6000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i1fc3e3648d0b4efb976f2e9afc2cb0eb_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RhYmxlOjU2Y2ZmNmEzZDc5NzRiNzRiOWE0NzgxNDEzZGU3YjNmL3RhYmxlcmFuZ2U6NTZjZmY2YTNkNzk3NGI3NGI5YTQ3ODE0MTNkZTdiM2ZfOC04LTEtMS0zMDExNA_dd228cdf-9d5d-474b-a430-013c2155328d"
      unitRef="usd">1000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i50f69072160f4204bc684248a5c4d361_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RhYmxlOjU2Y2ZmNmEzZDc5NzRiNzRiOWE0NzgxNDEzZGU3YjNmL3RhYmxlcmFuZ2U6NTZjZmY2YTNkNzk3NGI3NGI5YTQ3ODE0MTNkZTdiM2ZfOC0xMC0xLTEtMzAxMTQ_fb944eef-753e-4dbd-b2e3-2dab076f529a"
      unitRef="usd">2000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="if88446467ba74964bae3a43bab960c67_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RhYmxlOjU2Y2ZmNmEzZDc5NzRiNzRiOWE0NzgxNDEzZGU3YjNmL3RhYmxlcmFuZ2U6NTZjZmY2YTNkNzk3NGI3NGI5YTQ3ODE0MTNkZTdiM2ZfMTItMi0xLTEtMzAxMTQ_b39d0d29-2237-4940-b53a-4647f437f85a"
      unitRef="usd">4000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="iadfd46dace544484ab93d3f265e422a2_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RhYmxlOjU2Y2ZmNmEzZDc5NzRiNzRiOWE0NzgxNDEzZGU3YjNmL3RhYmxlcmFuZ2U6NTZjZmY2YTNkNzk3NGI3NGI5YTQ3ODE0MTNkZTdiM2ZfMTItNC0xLTEtMzAxMTQ_0e9bb9be-def5-47f4-957c-ccc49be82725"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="ia4aa7c9ade4a48b9afaa9ef1eb2c28d2_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RhYmxlOjU2Y2ZmNmEzZDc5NzRiNzRiOWE0NzgxNDEzZGU3YjNmL3RhYmxlcmFuZ2U6NTZjZmY2YTNkNzk3NGI3NGI5YTQ3ODE0MTNkZTdiM2ZfMTItOC0xLTEtMzAxMTQ_35eb2ee7-252c-4397-ae79-08dd3ad1be7e"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="ifd354181dada4d4a900aa6600da1b6e0_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RhYmxlOjU2Y2ZmNmEzZDc5NzRiNzRiOWE0NzgxNDEzZGU3YjNmL3RhYmxlcmFuZ2U6NTZjZmY2YTNkNzk3NGI3NGI5YTQ3ODE0MTNkZTdiM2ZfMTItMTAtMS0xLTMwMTE0_4cc8d1a0-db8d-463c-a920-46b6e5921323"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="ie5e458b01a414961bd824ffcfc393961_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RhYmxlOjU2Y2ZmNmEzZDc5NzRiNzRiOWE0NzgxNDEzZGU3YjNmL3RhYmxlcmFuZ2U6NTZjZmY2YTNkNzk3NGI3NGI5YTQ3ODE0MTNkZTdiM2ZfMTctMi0xLTEtMzAxMTQ_e860cde6-454a-489a-af15-7d77da9f604b"
      unitRef="usd">2000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="ia022050d3b32425cbcc3bee5435edaef_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RhYmxlOjU2Y2ZmNmEzZDc5NzRiNzRiOWE0NzgxNDEzZGU3YjNmL3RhYmxlcmFuZ2U6NTZjZmY2YTNkNzk3NGI3NGI5YTQ3ODE0MTNkZTdiM2ZfMTctNC0xLTEtMzAxMTQ_1c36d057-940d-4b33-90de-0b034afed105"
      unitRef="usd">3000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i781e47792a004141abc5f44af8501b55_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RhYmxlOjU2Y2ZmNmEzZDc5NzRiNzRiOWE0NzgxNDEzZGU3YjNmL3RhYmxlcmFuZ2U6NTZjZmY2YTNkNzk3NGI3NGI5YTQ3ODE0MTNkZTdiM2ZfMTctOC0xLTEtMzAxMTQ_852ccb16-604e-42a2-b0f8-580f1ce01293"
      unitRef="usd">4000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i16900d24231046f1afce9ad394e43007_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RhYmxlOjU2Y2ZmNmEzZDc5NzRiNzRiOWE0NzgxNDEzZGU3YjNmL3RhYmxlcmFuZ2U6NTZjZmY2YTNkNzk3NGI3NGI5YTQ3ODE0MTNkZTdiM2ZfMTctMTAtMS0xLTMwMTE0_d11ce890-e9b9-4a0a-b84a-0e229cb09004"
      unitRef="usd">3000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RhYmxlOjU2Y2ZmNmEzZDc5NzRiNzRiOWE0NzgxNDEzZGU3YjNmL3RhYmxlcmFuZ2U6NTZjZmY2YTNkNzk3NGI3NGI5YTQ3ODE0MTNkZTdiM2ZfMTgtMi0xLTEtMzAxMTQ_54efd30e-9ca2-4279-9c08-15082afe1961"
      unitRef="usd">16000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i6390807210d74c6f9cae496ea2122a5a_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RhYmxlOjU2Y2ZmNmEzZDc5NzRiNzRiOWE0NzgxNDEzZGU3YjNmL3RhYmxlcmFuZ2U6NTZjZmY2YTNkNzk3NGI3NGI5YTQ3ODE0MTNkZTdiM2ZfMTgtNC0xLTEtMzAxMTQ_4c2080e3-8246-42a3-8fac-4b795187ce46"
      unitRef="usd">9000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RhYmxlOjU2Y2ZmNmEzZDc5NzRiNzRiOWE0NzgxNDEzZGU3YjNmL3RhYmxlcmFuZ2U6NTZjZmY2YTNkNzk3NGI3NGI5YTQ3ODE0MTNkZTdiM2ZfMTgtOC0xLTEtMzAxMTQ_ecae4dd9-107f-406c-a6fd-14bebe885531"
      unitRef="usd">5000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i6390807210d74c6f9cae496ea2122a5a_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RhYmxlOjU2Y2ZmNmEzZDc5NzRiNzRiOWE0NzgxNDEzZGU3YjNmL3RhYmxlcmFuZ2U6NTZjZmY2YTNkNzk3NGI3NGI5YTQ3ODE0MTNkZTdiM2ZfMTgtMTAtMS0xLTMwMTE0_092a9d84-0d4e-41c5-8056-965f9da1b0f7"
      unitRef="usd">5000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RleHRyZWdpb246ZWI4YjIxYmVmODkxNDhlYWFkMTU5MmM3YThjMGU5YTdfOTA2OA_4994be0a-3dd7-4a76-a187-c6d0bac94889">The effects of derivative instruments for foreign exchange contracts designated as hedging instruments and not designated as hedging instruments in our condensed consolidated statement of operations were as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:82.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.943%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;January 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in&#160;millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivatives designated as hedging instruments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Cash Flow Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gain (loss) recognized in accumulated other comprehensive&#160;loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gain (loss) reclassified from accumulated other comprehensive&#160;loss into cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Net Investment Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gain (loss) recognized in accumulated other comprehensive loss - translation adjustment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivatives not designated as hedging instruments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gain (loss) recognized in other income (expense)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="ica123646e5544ebdbe2fa02d65eb9294_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RhYmxlOjNjOTExNmI5MzcwYjQ5MjFiYzY5NTI0NmQ0ZGNjNDVkL3RhYmxlcmFuZ2U6M2M5MTE2YjkzNzBiNDkyMWJjNjk1MjQ2ZDRkY2M0NWRfMTAtMS0xLTEtMzAxMTQ_2af3ff98-f4e9-4bdc-8d00-b823fe383774"
      unitRef="usd">8000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i829319a2b5fb4d8fa6a9365861cbc737_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RhYmxlOjNjOTExNmI5MzcwYjQ5MjFiYzY5NTI0NmQ0ZGNjNDVkL3RhYmxlcmFuZ2U6M2M5MTE2YjkzNzBiNDkyMWJjNjk1MjQ2ZDRkY2M0NWRfMTAtMy0xLTEtMzAxMTQ_e20d2074-3c10-45f8-9214-d14f8c7788c6"
      unitRef="usd">-6000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="ib54e90d3ce874df2836c9d7cf1ec6c25_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RhYmxlOjNjOTExNmI5MzcwYjQ5MjFiYzY5NTI0NmQ0ZGNjNDVkL3RhYmxlcmFuZ2U6M2M5MTE2YjkzNzBiNDkyMWJjNjk1MjQ2ZDRkY2M0NWRfMTItMS0xLTEtMzAxMTQ_9b22a9d0-f99b-46b7-b7fb-ea4e4df591ef"
      unitRef="usd">3000000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="i151bd62ec0bd4c12b07d74d87ebe764b_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RhYmxlOjNjOTExNmI5MzcwYjQ5MjFiYzY5NTI0NmQ0ZGNjNDVkL3RhYmxlcmFuZ2U6M2M5MTE2YjkzNzBiNDkyMWJjNjk1MjQ2ZDRkY2M0NWRfMTItMy0xLTEtMzAxMTQ_e12b8548-e3d7-42bd-bc3c-799c09ac4ac0"
      unitRef="usd">-8000000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i01e3cab750934c929073437446f9cf98_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RhYmxlOjNjOTExNmI5MzcwYjQ5MjFiYzY5NTI0NmQ0ZGNjNDVkL3RhYmxlcmFuZ2U6M2M5MTE2YjkzNzBiNDkyMWJjNjk1MjQ2ZDRkY2M0NWRfMjEtMS0xLTEtMzAxMTQ_d1982cc7-6cc3-441e-8160-ee42934d6d87"
      unitRef="usd">3000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i8dc3d15e75274d38a8a189554e496d08_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RhYmxlOjNjOTExNmI5MzcwYjQ5MjFiYzY5NTI0NmQ0ZGNjNDVkL3RhYmxlcmFuZ2U6M2M5MTE2YjkzNzBiNDkyMWJjNjk1MjQ2ZDRkY2M0NWRfMjEtMy0xLTEtMzAxMTQ_7b7d39b2-30f4-44e5-80b3-493a02ca2726"
      unitRef="usd">-4000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="ifa4aa5fe8b844efcb5e77e57cf2ac70e_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RhYmxlOjNjOTExNmI5MzcwYjQ5MjFiYzY5NTI0NmQ0ZGNjNDVkL3RhYmxlcmFuZ2U6M2M5MTE2YjkzNzBiNDkyMWJjNjk1MjQ2ZDRkY2M0NWRfMjUtMS0xLTEtMzAxMTQ_6285d7ed-cf99-4288-8d44-76dcc5d16186"
      unitRef="usd">-3000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i5cba63bb8ec2484285a9f87f393f6773_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RhYmxlOjNjOTExNmI5MzcwYjQ5MjFiYzY5NTI0NmQ0ZGNjNDVkL3RhYmxlcmFuZ2U6M2M5MTE2YjkzNzBiNDkyMWJjNjk1MjQ2ZDRkY2M0NWRfMjUtMy0xLTEtMzAxMTQ_93f11177-d9a6-4d9c-b47c-db70c332038b"
      unitRef="usd">-4000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths
      contextRef="i00a135183f5b41b092943e066055e800_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RleHRyZWdpb246ZWI4YjIxYmVmODkxNDhlYWFkMTU5MmM3YThjMGU5YTdfODk3MQ_34bf1d24-3520-4663-b73e-36d13269bf43"
      unitRef="usd">6000000</us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths>
    <us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths
      contextRef="i61e53d96c9094ec5b9192e40de4357d8_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82MS9mcmFnOmViOGIyMWJlZjg5MTQ4ZWFhZDE1OTJjN2E4YzBlOWE3L3RleHRyZWdpb246ZWI4YjIxYmVmODkxNDhlYWFkMTU5MmM3YThjMGU5YTdfODk4Mw_60722ada-50ed-4069-bdd5-890bf19417ab"
      unitRef="usd">9000000</us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths>
    <us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82NC9mcmFnOjZmNDZlYmExMzAxNTQ1YWNiY2MwODUxMjllZDlhZmI3L3RleHRyZWdpb246NmY0NmViYTEzMDE1NDVhY2JjYzA4NTEyOWVkOWFmYjdfNjMx_974f79c4-18e5-47ea-91ac-71d79e3c92fd">RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Components of net periodic costs (benefits).&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; For the three months ended January&#160;31, 2022 and 2021, our net pension and post retirement benefit costs (benefits) were comprised of the following:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.365%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.710%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.710%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.710%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.710%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.710%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.715%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended January 31&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;U.S. &lt;br/&gt;Pension&#160;Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Non-U.S.&lt;br/&gt;Pension Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;U.S.&#160;Post&#160;Retirement&lt;br/&gt;Benefit&#160;Plans&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in&#160;millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service cost&#x2014;benefits earned during the period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost on benefit obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actuarial losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net plan costs (benefits)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.365%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.710%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.710%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.710%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.710%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.710%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.715%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The service cost component is recorded in cost of sales and operating expenses in the condensed consolidated statement of operations. All other cost components are recorded in other income (expense), net in the condensed consolidated statement of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Employer contributions and expected future employer contributions for the remainder of the year were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.771%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:3.724%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:3.729%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Employer Contributions&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;January 31&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For Remainder of Year&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. defined benefit plans&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-U.S. defined benefit plans&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock>
    <us-gaap:ScheduleOfDefinedBenefitPlansDisclosuresTextBlock
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82NC9mcmFnOjZmNDZlYmExMzAxNTQ1YWNiY2MwODUxMjllZDlhZmI3L3RleHRyZWdpb246NmY0NmViYTEzMDE1NDVhY2JjYzA4NTEyOWVkOWFmYjdfNjI2_76f81b75-f1ba-448f-948a-f46bcdba2aea">&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Components of net periodic costs (benefits).&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; For the three months ended January&#160;31, 2022 and 2021, our net pension and post retirement benefit costs (benefits) were comprised of the following:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.365%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.710%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.710%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.710%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.710%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.710%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.715%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended January 31&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;U.S. &lt;br/&gt;Pension&#160;Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Non-U.S.&lt;br/&gt;Pension Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;U.S.&#160;Post&#160;Retirement&lt;br/&gt;Benefit&#160;Plans&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in&#160;millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service cost&#x2014;benefits earned during the period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost on benefit obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actuarial losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net plan costs (benefits)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.365%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.710%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.710%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.710%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.710%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.710%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.715%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The service cost component is recorded in cost of sales and operating expenses in the condensed consolidated statement of operations. All other cost components are recorded in other income (expense), net in the condensed consolidated statement of operations.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfDefinedBenefitPlansDisclosuresTextBlock>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i8454ff09d8134a2fb231984b395af89d_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82NC9mcmFnOjZmNDZlYmExMzAxNTQ1YWNiY2MwODUxMjllZDlhZmI3L3RhYmxlOjQ3NmQ1ZDRjNzM2YTQ2YzA4Y2Q3ZTMwODc1MTFjYzM5L3RhYmxlcmFuZ2U6NDc2ZDVkNGM3MzZhNDZjMDhjZDdlMzA4NzUxMWNjMzlfNC0xLTEtMS0zMDExNA_48ddd0ab-d9cb-4d87-82a4-082b0f7a729c"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i151e64785a6246818b5fa21ee1ee8f21_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82NC9mcmFnOjZmNDZlYmExMzAxNTQ1YWNiY2MwODUxMjllZDlhZmI3L3RhYmxlOjQ3NmQ1ZDRjNzM2YTQ2YzA4Y2Q3ZTMwODc1MTFjYzM5L3RhYmxlcmFuZ2U6NDc2ZDVkNGM3MzZhNDZjMDhjZDdlMzA4NzUxMWNjMzlfNC0zLTEtMS0zMDExNA_ebf1e12f-0666-4116-b453-0847f16bceb7"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="id63140b493914a99a6c71088f76848c1_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82NC9mcmFnOjZmNDZlYmExMzAxNTQ1YWNiY2MwODUxMjllZDlhZmI3L3RhYmxlOjQ3NmQ1ZDRjNzM2YTQ2YzA4Y2Q3ZTMwODc1MTFjYzM5L3RhYmxlcmFuZ2U6NDc2ZDVkNGM3MzZhNDZjMDhjZDdlMzA4NzUxMWNjMzlfNC01LTEtMS0zMDExNA_f03ba42c-71d5-42ea-b918-0dd7d27d64a1"
      unitRef="usd">8000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i2cb1409c861e47b69fd591e421c1d29a_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82NC9mcmFnOjZmNDZlYmExMzAxNTQ1YWNiY2MwODUxMjllZDlhZmI3L3RhYmxlOjQ3NmQ1ZDRjNzM2YTQ2YzA4Y2Q3ZTMwODc1MTFjYzM5L3RhYmxlcmFuZ2U6NDc2ZDVkNGM3MzZhNDZjMDhjZDdlMzA4NzUxMWNjMzlfNC03LTEtMS0zMDExNA_b6fcc9af-2aa8-46f0-bbb2-f0d099ae0849"
      unitRef="usd">7000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="ibd0876ed5c6643f9b68e30357fcb75c5_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82NC9mcmFnOjZmNDZlYmExMzAxNTQ1YWNiY2MwODUxMjllZDlhZmI3L3RhYmxlOjQ3NmQ1ZDRjNzM2YTQ2YzA4Y2Q3ZTMwODc1MTFjYzM5L3RhYmxlcmFuZ2U6NDc2ZDVkNGM3MzZhNDZjMDhjZDdlMzA4NzUxMWNjMzlfNC05LTEtMS0zMDExNA_79ffa77f-3588-431c-9f12-901275b180cf"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="ic152b46d63194d6f8f761363250e0cde_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82NC9mcmFnOjZmNDZlYmExMzAxNTQ1YWNiY2MwODUxMjllZDlhZmI3L3RhYmxlOjQ3NmQ1ZDRjNzM2YTQ2YzA4Y2Q3ZTMwODc1MTFjYzM5L3RhYmxlcmFuZ2U6NDc2ZDVkNGM3MzZhNDZjMDhjZDdlMzA4NzUxMWNjMzlfNC0xMS0xLTEtMzAxMTQ_5662a6a2-fb69-4f24-a980-840adfffbdcc"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i8454ff09d8134a2fb231984b395af89d_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82NC9mcmFnOjZmNDZlYmExMzAxNTQ1YWNiY2MwODUxMjllZDlhZmI3L3RhYmxlOjQ3NmQ1ZDRjNzM2YTQ2YzA4Y2Q3ZTMwODc1MTFjYzM5L3RhYmxlcmFuZ2U6NDc2ZDVkNGM3MzZhNDZjMDhjZDdlMzA4NzUxMWNjMzlfNS0xLTEtMS0zMDExNA_efbd3d91-40b4-4788-a753-0ad65ba526d3"
      unitRef="usd">3000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i151e64785a6246818b5fa21ee1ee8f21_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82NC9mcmFnOjZmNDZlYmExMzAxNTQ1YWNiY2MwODUxMjllZDlhZmI3L3RhYmxlOjQ3NmQ1ZDRjNzM2YTQ2YzA4Y2Q3ZTMwODc1MTFjYzM5L3RhYmxlcmFuZ2U6NDc2ZDVkNGM3MzZhNDZjMDhjZDdlMzA4NzUxMWNjMzlfNS0zLTEtMS0zMDExNA_c286deb5-ff7b-4047-a150-c73606dc0944"
      unitRef="usd">3000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="id63140b493914a99a6c71088f76848c1_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82NC9mcmFnOjZmNDZlYmExMzAxNTQ1YWNiY2MwODUxMjllZDlhZmI3L3RhYmxlOjQ3NmQ1ZDRjNzM2YTQ2YzA4Y2Q3ZTMwODc1MTFjYzM5L3RhYmxlcmFuZ2U6NDc2ZDVkNGM3MzZhNDZjMDhjZDdlMzA4NzUxMWNjMzlfNS01LTEtMS0zMDExNA_675ee209-269e-4f8b-9a88-02466e4f2388"
      unitRef="usd">2000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i2cb1409c861e47b69fd591e421c1d29a_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82NC9mcmFnOjZmNDZlYmExMzAxNTQ1YWNiY2MwODUxMjllZDlhZmI3L3RhYmxlOjQ3NmQ1ZDRjNzM2YTQ2YzA4Y2Q3ZTMwODc1MTFjYzM5L3RhYmxlcmFuZ2U6NDc2ZDVkNGM3MzZhNDZjMDhjZDdlMzA4NzUxMWNjMzlfNS03LTEtMS0zMDExNA_ba36fb22-7f3f-4723-9d78-79439c45f1e0"
      unitRef="usd">2000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="ibd0876ed5c6643f9b68e30357fcb75c5_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82NC9mcmFnOjZmNDZlYmExMzAxNTQ1YWNiY2MwODUxMjllZDlhZmI3L3RhYmxlOjQ3NmQ1ZDRjNzM2YTQ2YzA4Y2Q3ZTMwODc1MTFjYzM5L3RhYmxlcmFuZ2U6NDc2ZDVkNGM3MzZhNDZjMDhjZDdlMzA4NzUxMWNjMzlfNS05LTEtMS0zMDExNA_892d0bf8-3b5c-4618-934d-73bfd1d621aa"
      unitRef="usd">1000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="ic152b46d63194d6f8f761363250e0cde_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82NC9mcmFnOjZmNDZlYmExMzAxNTQ1YWNiY2MwODUxMjllZDlhZmI3L3RhYmxlOjQ3NmQ1ZDRjNzM2YTQ2YzA4Y2Q3ZTMwODc1MTFjYzM5L3RhYmxlcmFuZ2U6NDc2ZDVkNGM3MzZhNDZjMDhjZDdlMzA4NzUxMWNjMzlfNS0xMS0xLTEtMzAxMTQ_d3a29b4f-071b-4bdf-b60b-2e921898288b"
      unitRef="usd">1000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i8454ff09d8134a2fb231984b395af89d_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82NC9mcmFnOjZmNDZlYmExMzAxNTQ1YWNiY2MwODUxMjllZDlhZmI3L3RhYmxlOjQ3NmQ1ZDRjNzM2YTQ2YzA4Y2Q3ZTMwODc1MTFjYzM5L3RhYmxlcmFuZ2U6NDc2ZDVkNGM3MzZhNDZjMDhjZDdlMzA4NzUxMWNjMzlfNi0xLTEtMS0zMDExNA_7bf224e6-b2de-4055-bdf2-d4df42a2371e"
      unitRef="usd">6000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i151e64785a6246818b5fa21ee1ee8f21_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82NC9mcmFnOjZmNDZlYmExMzAxNTQ1YWNiY2MwODUxMjllZDlhZmI3L3RhYmxlOjQ3NmQ1ZDRjNzM2YTQ2YzA4Y2Q3ZTMwODc1MTFjYzM5L3RhYmxlcmFuZ2U6NDc2ZDVkNGM3MzZhNDZjMDhjZDdlMzA4NzUxMWNjMzlfNi0zLTEtMS0zMDExNA_5b1426cf-fe87-46fc-bb61-06e3fd6f7731"
      unitRef="usd">7000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="id63140b493914a99a6c71088f76848c1_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82NC9mcmFnOjZmNDZlYmExMzAxNTQ1YWNiY2MwODUxMjllZDlhZmI3L3RhYmxlOjQ3NmQ1ZDRjNzM2YTQ2YzA4Y2Q3ZTMwODc1MTFjYzM5L3RhYmxlcmFuZ2U6NDc2ZDVkNGM3MzZhNDZjMDhjZDdlMzA4NzUxMWNjMzlfNi01LTEtMS0zMDExNA_8667e7cd-736c-4b18-ab20-73ceaed997bc"
      unitRef="usd">11000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i2cb1409c861e47b69fd591e421c1d29a_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82NC9mcmFnOjZmNDZlYmExMzAxNTQ1YWNiY2MwODUxMjllZDlhZmI3L3RhYmxlOjQ3NmQ1ZDRjNzM2YTQ2YzA4Y2Q3ZTMwODc1MTFjYzM5L3RhYmxlcmFuZ2U6NDc2ZDVkNGM3MzZhNDZjMDhjZDdlMzA4NzUxMWNjMzlfNi03LTEtMS0zMDExNA_fff16b87-1d1b-434b-a780-0f0798f69aa0"
      unitRef="usd">12000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="ibd0876ed5c6643f9b68e30357fcb75c5_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82NC9mcmFnOjZmNDZlYmExMzAxNTQ1YWNiY2MwODUxMjllZDlhZmI3L3RhYmxlOjQ3NmQ1ZDRjNzM2YTQ2YzA4Y2Q3ZTMwODc1MTFjYzM5L3RhYmxlcmFuZ2U6NDc2ZDVkNGM3MzZhNDZjMDhjZDdlMzA4NzUxMWNjMzlfNi05LTEtMS0zMDExNA_9df6e206-30b0-445c-b951-9c71113c6605"
      unitRef="usd">1000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="ic152b46d63194d6f8f761363250e0cde_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82NC9mcmFnOjZmNDZlYmExMzAxNTQ1YWNiY2MwODUxMjllZDlhZmI3L3RhYmxlOjQ3NmQ1ZDRjNzM2YTQ2YzA4Y2Q3ZTMwODc1MTFjYzM5L3RhYmxlcmFuZ2U6NDc2ZDVkNGM3MzZhNDZjMDhjZDdlMzA4NzUxMWNjMzlfNi0xMS0xLTEtMzAxMTQ_770de573-842f-4e15-bc24-b23006a3342c"
      unitRef="usd">2000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="i8454ff09d8134a2fb231984b395af89d_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82NC9mcmFnOjZmNDZlYmExMzAxNTQ1YWNiY2MwODUxMjllZDlhZmI3L3RhYmxlOjQ3NmQ1ZDRjNzM2YTQ2YzA4Y2Q3ZTMwODc1MTFjYzM5L3RhYmxlcmFuZ2U6NDc2ZDVkNGM3MzZhNDZjMDhjZDdlMzA4NzUxMWNjMzlfOC0xLTEtMS0zMDExNA_4268d3a9-5fae-470b-a285-a49e86649f4a"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="i151e64785a6246818b5fa21ee1ee8f21_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82NC9mcmFnOjZmNDZlYmExMzAxNTQ1YWNiY2MwODUxMjllZDlhZmI3L3RhYmxlOjQ3NmQ1ZDRjNzM2YTQ2YzA4Y2Q3ZTMwODc1MTFjYzM5L3RhYmxlcmFuZ2U6NDc2ZDVkNGM3MzZhNDZjMDhjZDdlMzA4NzUxMWNjMzlfOC0zLTEtMS0zMDExNA_046f0378-1988-4d9a-a5c8-452f76d88d6d"
      unitRef="usd">-1000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="id63140b493914a99a6c71088f76848c1_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82NC9mcmFnOjZmNDZlYmExMzAxNTQ1YWNiY2MwODUxMjllZDlhZmI3L3RhYmxlOjQ3NmQ1ZDRjNzM2YTQ2YzA4Y2Q3ZTMwODc1MTFjYzM5L3RhYmxlcmFuZ2U6NDc2ZDVkNGM3MzZhNDZjMDhjZDdlMzA4NzUxMWNjMzlfOC01LTEtMS0zMDExNA_bfdd04b8-dfac-43bb-a439-75886b42229d"
      unitRef="usd">-6000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="i2cb1409c861e47b69fd591e421c1d29a_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82NC9mcmFnOjZmNDZlYmExMzAxNTQ1YWNiY2MwODUxMjllZDlhZmI3L3RhYmxlOjQ3NmQ1ZDRjNzM2YTQ2YzA4Y2Q3ZTMwODc1MTFjYzM5L3RhYmxlcmFuZ2U6NDc2ZDVkNGM3MzZhNDZjMDhjZDdlMzA4NzUxMWNjMzlfOC03LTEtMS0zMDExNA_90987f6c-d467-4223-a0d7-3e72545def0a"
      unitRef="usd">-13000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="ibd0876ed5c6643f9b68e30357fcb75c5_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82NC9mcmFnOjZmNDZlYmExMzAxNTQ1YWNiY2MwODUxMjllZDlhZmI3L3RhYmxlOjQ3NmQ1ZDRjNzM2YTQ2YzA4Y2Q3ZTMwODc1MTFjYzM5L3RhYmxlcmFuZ2U6NDc2ZDVkNGM3MzZhNDZjMDhjZDdlMzA4NzUxMWNjMzlfOC05LTEtMS0zMDExNA_2d10bb5b-8194-4eed-8312-8ee4039a1091"
      unitRef="usd">1000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="ic152b46d63194d6f8f761363250e0cde_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82NC9mcmFnOjZmNDZlYmExMzAxNTQ1YWNiY2MwODUxMjllZDlhZmI3L3RhYmxlOjQ3NmQ1ZDRjNzM2YTQ2YzA4Y2Q3ZTMwODc1MTFjYzM5L3RhYmxlcmFuZ2U6NDc2ZDVkNGM3MzZhNDZjMDhjZDdlMzA4NzUxMWNjMzlfOC0xMS0xLTEtMzAxMTQ_eb11ed03-a171-401b-9276-5109ad730db2"
      unitRef="usd">-1000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i8454ff09d8134a2fb231984b395af89d_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82NC9mcmFnOjZmNDZlYmExMzAxNTQ1YWNiY2MwODUxMjllZDlhZmI3L3RhYmxlOjQ3NmQ1ZDRjNzM2YTQ2YzA4Y2Q3ZTMwODc1MTFjYzM5L3RhYmxlcmFuZ2U6NDc2ZDVkNGM3MzZhNDZjMDhjZDdlMzA4NzUxMWNjMzlfMTAtMS0xLTEtMzAxMTQ_bbdb2662-d5f8-4859-907a-78814cc0c8a2"
      unitRef="usd">-3000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i151e64785a6246818b5fa21ee1ee8f21_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82NC9mcmFnOjZmNDZlYmExMzAxNTQ1YWNiY2MwODUxMjllZDlhZmI3L3RhYmxlOjQ3NmQ1ZDRjNzM2YTQ2YzA4Y2Q3ZTMwODc1MTFjYzM5L3RhYmxlcmFuZ2U6NDc2ZDVkNGM3MzZhNDZjMDhjZDdlMzA4NzUxMWNjMzlfMTAtMy0xLTEtMzAxMTQ_4ab93471-0db2-41ae-a989-fcc474305653"
      unitRef="usd">-3000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="id63140b493914a99a6c71088f76848c1_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82NC9mcmFnOjZmNDZlYmExMzAxNTQ1YWNiY2MwODUxMjllZDlhZmI3L3RhYmxlOjQ3NmQ1ZDRjNzM2YTQ2YzA4Y2Q3ZTMwODc1MTFjYzM5L3RhYmxlcmFuZ2U6NDc2ZDVkNGM3MzZhNDZjMDhjZDdlMzA4NzUxMWNjMzlfMTAtNS0xLTEtMzAxMTQ_12fe7db3-d6af-47b3-8ff5-9f9565d682b6"
      unitRef="usd">5000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i2cb1409c861e47b69fd591e421c1d29a_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82NC9mcmFnOjZmNDZlYmExMzAxNTQ1YWNiY2MwODUxMjllZDlhZmI3L3RhYmxlOjQ3NmQ1ZDRjNzM2YTQ2YzA4Y2Q3ZTMwODc1MTFjYzM5L3RhYmxlcmFuZ2U6NDc2ZDVkNGM3MzZhNDZjMDhjZDdlMzA4NzUxMWNjMzlfMTAtNy0xLTEtMzAxMTQ_fe309643-3c96-4e96-a0ad-35c5b69ab4f2"
      unitRef="usd">10000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="ibd0876ed5c6643f9b68e30357fcb75c5_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82NC9mcmFnOjZmNDZlYmExMzAxNTQ1YWNiY2MwODUxMjllZDlhZmI3L3RhYmxlOjQ3NmQ1ZDRjNzM2YTQ2YzA4Y2Q3ZTMwODc1MTFjYzM5L3RhYmxlcmFuZ2U6NDc2ZDVkNGM3MzZhNDZjMDhjZDdlMzA4NzUxMWNjMzlfMTAtOS0xLTEtMzAxMTQ_be38b86d-f963-4e9b-9d4f-7199db5e8db8"
      unitRef="usd">-1000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="ic152b46d63194d6f8f761363250e0cde_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82NC9mcmFnOjZmNDZlYmExMzAxNTQ1YWNiY2MwODUxMjllZDlhZmI3L3RhYmxlOjQ3NmQ1ZDRjNzM2YTQ2YzA4Y2Q3ZTMwODc1MTFjYzM5L3RhYmxlcmFuZ2U6NDc2ZDVkNGM3MzZhNDZjMDhjZDdlMzA4NzUxMWNjMzlfMTAtMTEtMS0xLTMwMTE0_09d347a6-9f43-42d9-a354-b2e78c41e508"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <a:EmployerContributionsAndExpectedEmployerContributionsTableTextBlock
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82NC9mcmFnOjZmNDZlYmExMzAxNTQ1YWNiY2MwODUxMjllZDlhZmI3L3RleHRyZWdpb246NmY0NmViYTEzMDE1NDVhY2JjYzA4NTEyOWVkOWFmYjdfNjIy_ba2213d5-28a6-42f9-8155-e90c786ba5dd">&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Employer contributions and expected future employer contributions for the remainder of the year were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.771%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:3.724%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:3.729%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Employer Contributions&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;January 31&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For Remainder of Year&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. defined benefit plans&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-U.S. defined benefit plans&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</a:EmployerContributionsAndExpectedEmployerContributionsTableTextBlock>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="i8454ff09d8134a2fb231984b395af89d_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82NC9mcmFnOjZmNDZlYmExMzAxNTQ1YWNiY2MwODUxMjllZDlhZmI3L3RhYmxlOjkxODkyM2U0YTU2MzQ0NzVhOWFjNjYwY2YyZjE0MDIwL3RhYmxlcmFuZ2U6OTE4OTIzZTRhNTYzNDQ3NWE5YWM2NjBjZjJmMTQwMjBfNC0xLTEtMS0zMDExNA_1b042d81-4866-45c1-9294-8ea215459cb4"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="i151e64785a6246818b5fa21ee1ee8f21_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82NC9mcmFnOjZmNDZlYmExMzAxNTQ1YWNiY2MwODUxMjllZDlhZmI3L3RhYmxlOjkxODkyM2U0YTU2MzQ0NzVhOWFjNjYwY2YyZjE0MDIwL3RhYmxlcmFuZ2U6OTE4OTIzZTRhNTYzNDQ3NWE5YWM2NjBjZjJmMTQwMjBfNC0zLTEtMS0zMDExNA_9afb043f-dedf-4d64-b292-d1813283b129"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear
      contextRef="i39672334328841558d3a18821db61895_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82NC9mcmFnOjZmNDZlYmExMzAxNTQ1YWNiY2MwODUxMjllZDlhZmI3L3RhYmxlOjkxODkyM2U0YTU2MzQ0NzVhOWFjNjYwY2YyZjE0MDIwL3RhYmxlcmFuZ2U6OTE4OTIzZTRhNTYzNDQ3NWE5YWM2NjBjZjJmMTQwMjBfNC0xMC0xLTEtMzAxMTQ_2c69d901-9404-49be-9e64-00f149f5b219"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="id63140b493914a99a6c71088f76848c1_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82NC9mcmFnOjZmNDZlYmExMzAxNTQ1YWNiY2MwODUxMjllZDlhZmI3L3RhYmxlOjkxODkyM2U0YTU2MzQ0NzVhOWFjNjYwY2YyZjE0MDIwL3RhYmxlcmFuZ2U6OTE4OTIzZTRhNTYzNDQ3NWE5YWM2NjBjZjJmMTQwMjBfNS0xLTEtMS0zMDExNA_25d140fa-d448-4bd5-9707-275d039c487e"
      unitRef="usd">5000000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="i2cb1409c861e47b69fd591e421c1d29a_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82NC9mcmFnOjZmNDZlYmExMzAxNTQ1YWNiY2MwODUxMjllZDlhZmI3L3RhYmxlOjkxODkyM2U0YTU2MzQ0NzVhOWFjNjYwY2YyZjE0MDIwL3RhYmxlcmFuZ2U6OTE4OTIzZTRhNTYzNDQ3NWE5YWM2NjBjZjJmMTQwMjBfNS0zLTEtMS0zMDExNA_d90fa266-8205-4b3f-83a9-bd8c197ae596"
      unitRef="usd">5000000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear
      contextRef="iea4e6dcfdd864c84addac4f7be206f60_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82NC9mcmFnOjZmNDZlYmExMzAxNTQ1YWNiY2MwODUxMjllZDlhZmI3L3RhYmxlOjkxODkyM2U0YTU2MzQ0NzVhOWFjNjYwY2YyZjE0MDIwL3RhYmxlcmFuZ2U6OTE4OTIzZTRhNTYzNDQ3NWE5YWM2NjBjZjJmMTQwMjBfNS0xMC0xLTEtMzAxMTQ_79bb2616-b6e7-4d00-a453-328be5b848ef"
      unitRef="usd">14000000</us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82Ny9mcmFnOjA0OGVkNDI0ZTQwNDQ3MzlhODJmMThlNjU4YjU1YTJjL3RleHRyZWdpb246MDQ4ZWQ0MjRlNDA0NDczOWE4MmYxOGU2NThiNTVhMmNfMTU3NA_9a6af9bf-c5bf-41ba-abef-57eca8c795a0">WARRANTIES AND CONTINGENCIES&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Warranties&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We accrue for standard warranty costs based on historical trends in actual warranty charges over the past 12 months. The accrual is reviewed regularly and periodically adjusted to reflect changes in warranty cost over the period. The standard warranty accrual balances are held in other accrued and other long-term liabilities on our condensed consolidated balance sheet. Our standard warranty terms typically extend to one year from the date of delivery, depending on the product.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of the standard warranty accrual activity is shown in the table below:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;January 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in&#160;millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Standard warranty accrual, beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accruals for warranties including change in estimates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlements made during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Standard warranty accrual, ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accruals for warranties due within one year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accruals for warranties due after one year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Standard warranty accrual, ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Bank Guarantees&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Guarantees consist primarily of outstanding standby letters of credit and bank guarantees and were approximately $46 million as of January&#160;31, 2022 and October&#160;31, 2021, respectively. A standby letter of credit is a guarantee of payment issued by a bank on behalf of us that is used as payment of last resort should we fail to fulfill a contractual commitment with a third party. A bank guarantee is a promise from a bank or other lending institution that if we default on a loan, the bank will cover the loss.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Contingencies&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are involved in lawsuits, claims, investigations and proceedings, including, but not limited to, intellectual property, commercial, real estate, environmental and employment matters, which arise in the ordinary course of business. There are no matters pending that we currently believe are reasonably possible of having a material impact to our business, condensed consolidated financial condition, results of operations or cash flows.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82Ny9mcmFnOjA0OGVkNDI0ZTQwNDQ3MzlhODJmMThlNjU4YjU1YTJjL3RleHRyZWdpb246MDQ4ZWQ0MjRlNDA0NDczOWE4MmYxOGU2NThiNTVhMmNfMTU3OA_07bddd64-9620-4399-a25f-857d4f4604e6">&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of the standard warranty accrual activity is shown in the table below:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;January 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in&#160;millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Standard warranty accrual, beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accruals for warranties including change in estimates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlements made during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Standard warranty accrual, ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accruals for warranties due within one year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accruals for warranties due after one year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Standard warranty accrual, ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock>
    <us-gaap:StandardProductWarrantyAccrual
      contextRef="i6390807210d74c6f9cae496ea2122a5a_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82Ny9mcmFnOjA0OGVkNDI0ZTQwNDQ3MzlhODJmMThlNjU4YjU1YTJjL3RhYmxlOmU1NDUzNDE1ZDhiZjRkZWRhNzkxNTVkNDg1NDU5ZjAzL3RhYmxlcmFuZ2U6ZTU0NTM0MTVkOGJmNGRlZGE3OTE1NWQ0ODU0NTlmMDNfNC0xLTEtMS0zMDExNA_5e14af41-a96e-4e3a-91b3-820631b06997"
      unitRef="usd">30000000</us-gaap:StandardProductWarrantyAccrual>
    <us-gaap:StandardProductWarrantyAccrual
      contextRef="id69612e49fa546c0bf63ff5ad436ccc6_I20201031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82Ny9mcmFnOjA0OGVkNDI0ZTQwNDQ3MzlhODJmMThlNjU4YjU1YTJjL3RhYmxlOmU1NDUzNDE1ZDhiZjRkZWRhNzkxNTVkNDg1NDU5ZjAzL3RhYmxlcmFuZ2U6ZTU0NTM0MTVkOGJmNGRlZGE3OTE1NWQ0ODU0NTlmMDNfNC0zLTEtMS0zMDExNA_062a976c-a1c5-4d17-8e04-fd61f930c087"
      unitRef="usd">32000000</us-gaap:StandardProductWarrantyAccrual>
    <us-gaap:StandardProductWarrantyAccrualWarrantiesIssued
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82Ny9mcmFnOjA0OGVkNDI0ZTQwNDQ3MzlhODJmMThlNjU4YjU1YTJjL3RhYmxlOmU1NDUzNDE1ZDhiZjRkZWRhNzkxNTVkNDg1NDU5ZjAzL3RhYmxlcmFuZ2U6ZTU0NTM0MTVkOGJmNGRlZGE3OTE1NWQ0ODU0NTlmMDNfNS0xLTEtMS0zMDExNA_1c340f66-35e9-4204-843e-73483c9d0a69"
      unitRef="usd">13000000</us-gaap:StandardProductWarrantyAccrualWarrantiesIssued>
    <us-gaap:StandardProductWarrantyAccrualWarrantiesIssued
      contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82Ny9mcmFnOjA0OGVkNDI0ZTQwNDQ3MzlhODJmMThlNjU4YjU1YTJjL3RhYmxlOmU1NDUzNDE1ZDhiZjRkZWRhNzkxNTVkNDg1NDU5ZjAzL3RhYmxlcmFuZ2U6ZTU0NTM0MTVkOGJmNGRlZGE3OTE1NWQ0ODU0NTlmMDNfNS0zLTEtMS0zMDExNA_0450b587-3480-4298-bdeb-ca0cf7d59db5"
      unitRef="usd">15000000</us-gaap:StandardProductWarrantyAccrualWarrantiesIssued>
    <us-gaap:StandardProductWarrantyAccrualPayments
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82Ny9mcmFnOjA0OGVkNDI0ZTQwNDQ3MzlhODJmMThlNjU4YjU1YTJjL3RhYmxlOmU1NDUzNDE1ZDhiZjRkZWRhNzkxNTVkNDg1NDU5ZjAzL3RhYmxlcmFuZ2U6ZTU0NTM0MTVkOGJmNGRlZGE3OTE1NWQ0ODU0NTlmMDNfNi0xLTEtMS0zMDExNA_003c629e-d217-4fc5-8d66-d79819b73ce2"
      unitRef="usd">13000000</us-gaap:StandardProductWarrantyAccrualPayments>
    <us-gaap:StandardProductWarrantyAccrualPayments
      contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82Ny9mcmFnOjA0OGVkNDI0ZTQwNDQ3MzlhODJmMThlNjU4YjU1YTJjL3RhYmxlOmU1NDUzNDE1ZDhiZjRkZWRhNzkxNTVkNDg1NDU5ZjAzL3RhYmxlcmFuZ2U6ZTU0NTM0MTVkOGJmNGRlZGE3OTE1NWQ0ODU0NTlmMDNfNi0zLTEtMS0zMDExNA_c685600f-ddd1-41c5-8aed-faa402ef8077"
      unitRef="usd">15000000</us-gaap:StandardProductWarrantyAccrualPayments>
    <us-gaap:StandardProductWarrantyAccrual
      contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82Ny9mcmFnOjA0OGVkNDI0ZTQwNDQ3MzlhODJmMThlNjU4YjU1YTJjL3RhYmxlOmU1NDUzNDE1ZDhiZjRkZWRhNzkxNTVkNDg1NDU5ZjAzL3RhYmxlcmFuZ2U6ZTU0NTM0MTVkOGJmNGRlZGE3OTE1NWQ0ODU0NTlmMDNfNy0xLTEtMS0zMDExNA_db4cb288-feda-4ccc-a4e8-d7cefa2a0fe8"
      unitRef="usd">30000000</us-gaap:StandardProductWarrantyAccrual>
    <us-gaap:StandardProductWarrantyAccrual
      contextRef="i9b47b15753c94f0b80143556347e39b7_I20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82Ny9mcmFnOjA0OGVkNDI0ZTQwNDQ3MzlhODJmMThlNjU4YjU1YTJjL3RhYmxlOmU1NDUzNDE1ZDhiZjRkZWRhNzkxNTVkNDg1NDU5ZjAzL3RhYmxlcmFuZ2U6ZTU0NTM0MTVkOGJmNGRlZGE3OTE1NWQ0ODU0NTlmMDNfNy0zLTEtMS0zMDExNA_40c31e78-5e3d-4a02-92eb-f925b476d5e6"
      unitRef="usd">32000000</us-gaap:StandardProductWarrantyAccrual>
    <us-gaap:StandardProductWarrantyAccrualCurrent
      contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82Ny9mcmFnOjA0OGVkNDI0ZTQwNDQ3MzlhODJmMThlNjU4YjU1YTJjL3RhYmxlOmU1NDUzNDE1ZDhiZjRkZWRhNzkxNTVkNDg1NDU5ZjAzL3RhYmxlcmFuZ2U6ZTU0NTM0MTVkOGJmNGRlZGE3OTE1NWQ0ODU0NTlmMDNfOS0xLTEtMS0zMDExNA_8bdb4468-cb68-410e-a9c1-9cfc10461ffa"
      unitRef="usd">29000000</us-gaap:StandardProductWarrantyAccrualCurrent>
    <us-gaap:StandardProductWarrantyAccrualCurrent
      contextRef="i9b47b15753c94f0b80143556347e39b7_I20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82Ny9mcmFnOjA0OGVkNDI0ZTQwNDQ3MzlhODJmMThlNjU4YjU1YTJjL3RhYmxlOmU1NDUzNDE1ZDhiZjRkZWRhNzkxNTVkNDg1NDU5ZjAzL3RhYmxlcmFuZ2U6ZTU0NTM0MTVkOGJmNGRlZGE3OTE1NWQ0ODU0NTlmMDNfOS0zLTEtMS0zMDExNA_0e63f8d5-3a8e-4d44-b3a6-61d6e4216235"
      unitRef="usd">31000000</us-gaap:StandardProductWarrantyAccrualCurrent>
    <us-gaap:StandardProductWarrantyAccrualNoncurrent
      contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82Ny9mcmFnOjA0OGVkNDI0ZTQwNDQ3MzlhODJmMThlNjU4YjU1YTJjL3RhYmxlOmU1NDUzNDE1ZDhiZjRkZWRhNzkxNTVkNDg1NDU5ZjAzL3RhYmxlcmFuZ2U6ZTU0NTM0MTVkOGJmNGRlZGE3OTE1NWQ0ODU0NTlmMDNfMTAtMS0xLTEtMzAxMTQ_74049db4-2f16-430e-bb5a-9bd3d26e9cc3"
      unitRef="usd">1000000</us-gaap:StandardProductWarrantyAccrualNoncurrent>
    <us-gaap:StandardProductWarrantyAccrualNoncurrent
      contextRef="i9b47b15753c94f0b80143556347e39b7_I20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82Ny9mcmFnOjA0OGVkNDI0ZTQwNDQ3MzlhODJmMThlNjU4YjU1YTJjL3RhYmxlOmU1NDUzNDE1ZDhiZjRkZWRhNzkxNTVkNDg1NDU5ZjAzL3RhYmxlcmFuZ2U6ZTU0NTM0MTVkOGJmNGRlZGE3OTE1NWQ0ODU0NTlmMDNfMTAtMy0xLTEtMzAxMTQ_685e0466-5904-422c-acc8-9825c80758de"
      unitRef="usd">1000000</us-gaap:StandardProductWarrantyAccrualNoncurrent>
    <us-gaap:StandardProductWarrantyAccrual
      contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82Ny9mcmFnOjA0OGVkNDI0ZTQwNDQ3MzlhODJmMThlNjU4YjU1YTJjL3RhYmxlOmU1NDUzNDE1ZDhiZjRkZWRhNzkxNTVkNDg1NDU5ZjAzL3RhYmxlcmFuZ2U6ZTU0NTM0MTVkOGJmNGRlZGE3OTE1NWQ0ODU0NTlmMDNfMTEtMS0xLTEtMzAxMTQ_43e0a824-cda7-430f-9f4d-f71067f7d6b1"
      unitRef="usd">30000000</us-gaap:StandardProductWarrantyAccrual>
    <us-gaap:StandardProductWarrantyAccrual
      contextRef="i9b47b15753c94f0b80143556347e39b7_I20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82Ny9mcmFnOjA0OGVkNDI0ZTQwNDQ3MzlhODJmMThlNjU4YjU1YTJjL3RhYmxlOmU1NDUzNDE1ZDhiZjRkZWRhNzkxNTVkNDg1NDU5ZjAzL3RhYmxlcmFuZ2U6ZTU0NTM0MTVkOGJmNGRlZGE3OTE1NWQ0ODU0NTlmMDNfMTEtMy0xLTEtMzAxMTQ_138c70d1-e195-449f-b29f-43bcb0fcacbc"
      unitRef="usd">32000000</us-gaap:StandardProductWarrantyAccrual>
    <us-gaap:BankAcceptancesExecuted
      contextRef="i6390807210d74c6f9cae496ea2122a5a_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82Ny9mcmFnOjA0OGVkNDI0ZTQwNDQ3MzlhODJmMThlNjU4YjU1YTJjL3RleHRyZWdpb246MDQ4ZWQ0MjRlNDA0NDczOWE4MmYxOGU2NThiNTVhMmNfNzc0_05914232-1998-4e43-8274-f5e10e1a49b2"
      unitRef="usd">46000000</us-gaap:BankAcceptancesExecuted>
    <us-gaap:BankAcceptancesExecuted
      contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV82Ny9mcmFnOjA0OGVkNDI0ZTQwNDQ3MzlhODJmMThlNjU4YjU1YTJjL3RleHRyZWdpb246MDQ4ZWQ0MjRlNDA0NDczOWE4MmYxOGU2NThiNTVhMmNfNzc0_1498f49f-ce04-4ed2-8c33-33bf33f3672f"
      unitRef="usd">46000000</us-gaap:BankAcceptancesExecuted>
    <us-gaap:ShortTermDebtTextBlock
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83MC9mcmFnOjAyNGIzODNkZjRjNTRhYzNiM2NhOTBiYWY5NDJjMmY0L3RleHRyZWdpb246MDI0YjM4M2RmNGM1NGFjM2IzY2E5MGJhZjk0MmMyZjRfMTczMA_ed120276-dbbd-428a-844c-ce780f56e819">SHORT-TERM DEBT&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Credit Facilities&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 13, 2019, we entered into a credit agreement with a group of financial institutions which, as amended, provided for a $1 billion five-year unsecured credit facility that will expire on March 13, 2024 and incremental term loan facilities in an aggregate amount of up to $500 million.&#160;On April 21, 2021, we entered into an incremental assumption agreement, pursuant to which the aggregate amount available for borrowing under the revolving credit facility was increased to $1.35&#160;billion and the aggregate amount available for incremental facilities was refreshed to remain at $500&#160;million. As of January&#160;31, 2022, we had no borrowings outstanding under the credit facility and no borrowings under the incremental facilities. We were in compliance with the covenants for the credit facility during the three months ended January&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;Commercial Paper&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under our U.S. commercial paper program, the company may issue and sell unsecured, short-term promissory notes in the aggregate principal amount not to exceed $1.35&#160;billion with up to 397-day maturities. At any point in time, the company intends to maintain available commitments under its revolving credit facility in an amount at least equal to the amount of the commercial paper notes outstanding. Amounts available under the program may be borrowed, repaid and re-borrowed from time to time. The proceeds from issuances under the program may be used for general corporate purposes. During the three months ended January&#160;31, 2022, we borrowed and repaid $240 million. As &lt;/span&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;of&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;January&#160;31, 2022&lt;/span&gt;, we had no borrowings outstanding under our U.S. commercial paper program.</us-gaap:ShortTermDebtTextBlock>
    <us-gaap:LineOfCreditFacilityInitiationDate1
      contextRef="i6353332b36004c5c9db76cacfa73e855_D20190313-20190313"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83MC9mcmFnOjAyNGIzODNkZjRjNTRhYzNiM2NhOTBiYWY5NDJjMmY0L3RleHRyZWdpb246MDI0YjM4M2RmNGM1NGFjM2IzY2E5MGJhZjk0MmMyZjRfNTI_b7888151-4173-4da1-998c-ff3b2c691254">2019-03-13</us-gaap:LineOfCreditFacilityInitiationDate1>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i8297b19666824b1083fbcdc032757e96_I20190313"
      decimals="-9"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83MC9mcmFnOjAyNGIzODNkZjRjNTRhYzNiM2NhOTBiYWY5NDJjMmY0L3RleHRyZWdpb246MDI0YjM4M2RmNGM1NGFjM2IzY2E5MGJhZjk0MmMyZjRfMTY0_33a784f2-ed1d-418b-90ec-dd5d5900d569"
      unitRef="usd">1000000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:ShortTermDebtTerms
      contextRef="i6353332b36004c5c9db76cacfa73e855_D20190313-20190313"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83MC9mcmFnOjAyNGIzODNkZjRjNTRhYzNiM2NhOTBiYWY5NDJjMmY0L3RleHRyZWdpb246MDI0YjM4M2RmNGM1NGFjM2IzY2E5MGJhZjk0MmMyZjRfMTczMw_728af604-35c5-46e0-b593-f343b9ecdc79">five</us-gaap:ShortTermDebtTerms>
    <us-gaap:LineOfCreditFacilityExpirationDate1
      contextRef="i6353332b36004c5c9db76cacfa73e855_D20190313-20190313"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83MC9mcmFnOjAyNGIzODNkZjRjNTRhYzNiM2NhOTBiYWY5NDJjMmY0L3RleHRyZWdpb246MDI0YjM4M2RmNGM1NGFjM2IzY2E5MGJhZjk0MmMyZjRfMjIz_ce0431b1-eff2-4df0-ba65-0126ad0c196c">2024-03-13</us-gaap:LineOfCreditFacilityExpirationDate1>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="ic4c5e106421a497fb99105e140c6fd6c_I20191021"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83MC9mcmFnOjAyNGIzODNkZjRjNTRhYzNiM2NhOTBiYWY5NDJjMmY0L3RleHRyZWdpb246MDI0YjM4M2RmNGM1NGFjM2IzY2E5MGJhZjk0MmMyZjRfMjk1_d4873a52-74e8-42e1-ad8f-e1f185363e08"
      unitRef="usd">500000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i0a3fbf71b5484a8c9274ae6020d3080e_I20210421"
      decimals="-7"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83MC9mcmFnOjAyNGIzODNkZjRjNTRhYzNiM2NhOTBiYWY5NDJjMmY0L3RleHRyZWdpb246MDI0YjM4M2RmNGM1NGFjM2IzY2E5MGJhZjk0MmMyZjRfNDg3_b5a9993f-3099-4611-9e25-a87b648d8f6f"
      unitRef="usd">1350000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="id62809c6a49144e4bae80c1fce300e42_I20210421"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83MC9mcmFnOjAyNGIzODNkZjRjNTRhYzNiM2NhOTBiYWY5NDJjMmY0L3RleHRyZWdpb246MDI0YjM4M2RmNGM1NGFjM2IzY2E5MGJhZjk0MmMyZjRfNTc5_285b8b8d-3824-44fc-bc39-e654a16c3051"
      unitRef="usd">500000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityFairValueOfAmountOutstanding
      contextRef="i4f579a58da844fa8ab292e8b3f4f6961_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83MC9mcmFnOjAyNGIzODNkZjRjNTRhYzNiM2NhOTBiYWY5NDJjMmY0L3RleHRyZWdpb246MDI0YjM4M2RmNGM1NGFjM2IzY2E5MGJhZjk0MmMyZjRfNjAw_690e1470-b6a5-4391-a915-592cb9a9ec01"
      unitRef="usd">0</us-gaap:LineOfCreditFacilityFairValueOfAmountOutstanding>
    <us-gaap:LineOfCreditFacilityFairValueOfAmountOutstanding
      contextRef="ifbbc3ea9576a4f2eba2f7f1808345734_I20220131"
      decimals="-9"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83MC9mcmFnOjAyNGIzODNkZjRjNTRhYzNiM2NhOTBiYWY5NDJjMmY0L3RleHRyZWdpb246MDI0YjM4M2RmNGM1NGFjM2IzY2E5MGJhZjk0MmMyZjRfNjU2_26893a2b-ec05-4aa8-8f66-d64143ac2265"
      unitRef="usd">0</us-gaap:LineOfCreditFacilityFairValueOfAmountOutstanding>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i87ff5a86228e4f9b8b972888d1067302_I20210618"
      decimals="7"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83MC9mcmFnOjAyNGIzODNkZjRjNTRhYzNiM2NhOTBiYWY5NDJjMmY0L3RleHRyZWdpb246MDI0YjM4M2RmNGM1NGFjM2IzY2E5MGJhZjk0MmMyZjRfMTE0MQ_d7ab7911-dee3-4cea-8d1f-6c6be9cbf468"
      unitRef="usd">1350000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:ProceedsFromIssuanceOfCommercialPaper
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83MC9mcmFnOjAyNGIzODNkZjRjNTRhYzNiM2NhOTBiYWY5NDJjMmY0L3RleHRyZWdpb246MDI0YjM4M2RmNGM1NGFjM2IzY2E5MGJhZjk0MmMyZjRfMTA5OTUxMTYzMDAzOQ_109b4c9e-d79a-4d35-b47c-a6168b0bf93e"
      unitRef="usd">240000000</us-gaap:ProceedsFromIssuanceOfCommercialPaper>
    <us-gaap:RepaymentsOfCommercialPaper
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83MC9mcmFnOjAyNGIzODNkZjRjNTRhYzNiM2NhOTBiYWY5NDJjMmY0L3RleHRyZWdpb246MDI0YjM4M2RmNGM1NGFjM2IzY2E5MGJhZjk0MmMyZjRfMTA5OTUxMTYzMDAzOQ_bb4aa28a-1dcd-4dd3-95a2-d6f5a2b27318"
      unitRef="usd">240000000</us-gaap:RepaymentsOfCommercialPaper>
    <us-gaap:LineOfCreditFacilityFairValueOfAmountOutstanding
      contextRef="ica23bb0f88b84e40a5cf6dce93ac3016_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83MC9mcmFnOjAyNGIzODNkZjRjNTRhYzNiM2NhOTBiYWY5NDJjMmY0L3RleHRyZWdpb246MDI0YjM4M2RmNGM1NGFjM2IzY2E5MGJhZjk0MmMyZjRfMTU1MQ_0da2b2a2-b8a1-42d3-9294-1223dd3c3104"
      unitRef="usd">0</us-gaap:LineOfCreditFacilityFairValueOfAmountOutstanding>
    <us-gaap:LongTermDebtTextBlock
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83My9mcmFnOjA4YmFhZmE5OWVjZTQ1MjA4ODQ5NGY1MzA2NWYwYzAzL3RleHRyZWdpb246MDhiYWFmYTk5ZWNlNDUyMDg4NDk0ZjUzMDY1ZjBjMDNfMjI5OQ_ccf4c467-0e93-4eff-8e80-05de9ef468ed">LONG-TERM DEBT&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Senior Notes&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the company&#x2019;s long-term senior notes:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.807%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.469%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:2.853%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.471%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;January 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized &lt;br/&gt;Principal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized&lt;br/&gt;Principal&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2029 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2030 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;496&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;496&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2031 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,730&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,729&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;All outstanding notes listed above are unsecured and rank equally in right of payment with all of Agilent&#x2019;s other senior unsecured indebtedness. There have been no other changes to the principal, maturity, interest rates and interest payment terms of the Agilent senior notes, detailed in the table above, in the three months ended January&#160;31, 2022 as compared to the senior notes described in our Annual Report on Form 10-K for the fiscal year ended October&#160;31, 2021.</us-gaap:LongTermDebtTextBlock>
    <us-gaap:ScheduleOfDebtInstrumentsTextBlock
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83My9mcmFnOjA4YmFhZmE5OWVjZTQ1MjA4ODQ5NGY1MzA2NWYwYzAzL3RleHRyZWdpb246MDhiYWFmYTk5ZWNlNDUyMDg4NDk0ZjUzMDY1ZjBjMDNfMjMwNw_93438e43-3637-43f7-a097-3296f4a7030e">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the company&#x2019;s long-term senior notes:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.807%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.469%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:2.853%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.471%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;January 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized &lt;br/&gt;Principal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized&lt;br/&gt;Principal&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2029 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2030 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;496&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;496&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2031 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,730&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,729&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtInstrumentsTextBlock>
    <us-gaap:LongTermDebt
      contextRef="ie8601e6d640c4cdbaf6e7e979a3badb4_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83My9mcmFnOjA4YmFhZmE5OWVjZTQ1MjA4ODQ5NGY1MzA2NWYwYzAzL3RhYmxlOjQyYjcwODMzNjk0ZDQ5MDI5NTI3ZGMxZjVhYzRmODY1L3RhYmxlcmFuZ2U6NDJiNzA4MzM2OTRkNDkwMjk1MjdkYzFmNWFjNGY4NjVfNC0xLTEtMS0zMDExNA_fb1c3dee-853d-4f5f-a66b-482a4232221e"
      unitRef="usd">599000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="ie230dae4aa294d5b840b36798467586f_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83My9mcmFnOjA4YmFhZmE5OWVjZTQ1MjA4ODQ5NGY1MzA2NWYwYzAzL3RhYmxlOjQyYjcwODMzNjk0ZDQ5MDI5NTI3ZGMxZjVhYzRmODY1L3RhYmxlcmFuZ2U6NDJiNzA4MzM2OTRkNDkwMjk1MjdkYzFmNWFjNGY4NjVfNC0zLTEtMS0zMDExNA_71814eb9-285b-40eb-9cf0-55ee6613b936"
      unitRef="usd">599000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i2ff56f3c0b054dd0b0c0f6d3e90df039_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83My9mcmFnOjA4YmFhZmE5OWVjZTQ1MjA4ODQ5NGY1MzA2NWYwYzAzL3RhYmxlOjQyYjcwODMzNjk0ZDQ5MDI5NTI3ZGMxZjVhYzRmODY1L3RhYmxlcmFuZ2U6NDJiNzA4MzM2OTRkNDkwMjk1MjdkYzFmNWFjNGY4NjVfNS0xLTEtMS0zMDExNA_f2d91fc5-4643-4d66-b73c-b7d5df5d4db5"
      unitRef="usd">299000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i21c87c57472646b18bfda7e117eca64a_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83My9mcmFnOjA4YmFhZmE5OWVjZTQ1MjA4ODQ5NGY1MzA2NWYwYzAzL3RhYmxlOjQyYjcwODMzNjk0ZDQ5MDI5NTI3ZGMxZjVhYzRmODY1L3RhYmxlcmFuZ2U6NDJiNzA4MzM2OTRkNDkwMjk1MjdkYzFmNWFjNGY4NjVfNS0zLTEtMS0zMDExNA_0d54ad5b-7b8d-47f2-b86f-fff3acf14dc3"
      unitRef="usd">298000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i35a5d7927ffc44debd0874726bf6a844_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83My9mcmFnOjA4YmFhZmE5OWVjZTQ1MjA4ODQ5NGY1MzA2NWYwYzAzL3RhYmxlOjQyYjcwODMzNjk0ZDQ5MDI5NTI3ZGMxZjVhYzRmODY1L3RhYmxlcmFuZ2U6NDJiNzA4MzM2OTRkNDkwMjk1MjdkYzFmNWFjNGY4NjVfNi0xLTEtMS0zMDExNA_d1636dc7-a7c8-4efd-a32e-e11c004ba769"
      unitRef="usd">494000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i8088c733be554ef0a2d2ce49c54cb56a_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83My9mcmFnOjA4YmFhZmE5OWVjZTQ1MjA4ODQ5NGY1MzA2NWYwYzAzL3RhYmxlOjQyYjcwODMzNjk0ZDQ5MDI5NTI3ZGMxZjVhYzRmODY1L3RhYmxlcmFuZ2U6NDJiNzA4MzM2OTRkNDkwMjk1MjdkYzFmNWFjNGY4NjVfNi0zLTEtMS0zMDExNA_3945cbeb-90bc-4fd0-8100-53297ea117ba"
      unitRef="usd">494000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i340410db81954133842fda25bab46456_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83My9mcmFnOjA4YmFhZmE5OWVjZTQ1MjA4ODQ5NGY1MzA2NWYwYzAzL3RhYmxlOjQyYjcwODMzNjk0ZDQ5MDI5NTI3ZGMxZjVhYzRmODY1L3RhYmxlcmFuZ2U6NDJiNzA4MzM2OTRkNDkwMjk1MjdkYzFmNWFjNGY4NjVfNy0xLTEtMS0zMDExNA_c76a4769-e5eb-4e1d-8382-73b92fd687f6"
      unitRef="usd">496000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i4505f8e4f0714a489cb047cfbb537298_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83My9mcmFnOjA4YmFhZmE5OWVjZTQ1MjA4ODQ5NGY1MzA2NWYwYzAzL3RhYmxlOjQyYjcwODMzNjk0ZDQ5MDI5NTI3ZGMxZjVhYzRmODY1L3RhYmxlcmFuZ2U6NDJiNzA4MzM2OTRkNDkwMjk1MjdkYzFmNWFjNGY4NjVfNy0zLTEtMS0zMDExNA_ff5898e8-0adb-4382-9d12-c11afddfefab"
      unitRef="usd">496000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i6ebf24f01a4e49d69ecb2c5a5f3230d0_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83My9mcmFnOjA4YmFhZmE5OWVjZTQ1MjA4ODQ5NGY1MzA2NWYwYzAzL3RhYmxlOjQyYjcwODMzNjk0ZDQ5MDI5NTI3ZGMxZjVhYzRmODY1L3RhYmxlcmFuZ2U6NDJiNzA4MzM2OTRkNDkwMjk1MjdkYzFmNWFjNGY4NjVfOC0xLTEtMS0zMDExNA_6cf98521-6d86-4f3c-8823-922485ae1dd2"
      unitRef="usd">842000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i02856e1853de45f185faca871ffc1d85_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83My9mcmFnOjA4YmFhZmE5OWVjZTQ1MjA4ODQ5NGY1MzA2NWYwYzAzL3RhYmxlOjQyYjcwODMzNjk0ZDQ5MDI5NTI3ZGMxZjVhYzRmODY1L3RhYmxlcmFuZ2U6NDJiNzA4MzM2OTRkNDkwMjk1MjdkYzFmNWFjNGY4NjVfOC0zLTEtMS0zMDExNA_b77305ba-d386-4b61-959d-7c8e8f64cce5"
      unitRef="usd">842000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83My9mcmFnOjA4YmFhZmE5OWVjZTQ1MjA4ODQ5NGY1MzA2NWYwYzAzL3RhYmxlOjQyYjcwODMzNjk0ZDQ5MDI5NTI3ZGMxZjVhYzRmODY1L3RhYmxlcmFuZ2U6NDJiNzA4MzM2OTRkNDkwMjk1MjdkYzFmNWFjNGY4NjVfOS0xLTEtMS0zMDExNA_3bbb6123-9667-4843-8e5d-02eb40cedb1b"
      unitRef="usd">2730000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i6390807210d74c6f9cae496ea2122a5a_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83My9mcmFnOjA4YmFhZmE5OWVjZTQ1MjA4ODQ5NGY1MzA2NWYwYzAzL3RhYmxlOjQyYjcwODMzNjk0ZDQ5MDI5NTI3ZGMxZjVhYzRmODY1L3RhYmxlcmFuZ2U6NDJiNzA4MzM2OTRkNDkwMjk1MjdkYzFmNWFjNGY4NjVfOS0zLTEtMS0zMDExNA_be8b0646-8716-4d3d-9a42-f516bb934f69"
      unitRef="usd">2729000000</us-gaap:LongTermDebt>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83Ni9mcmFnOjQ2ZDI2ZThkOTg2NjRiNmViMWM5MjA1ODhjNzU0NzI4L3RleHRyZWdpb246NDZkMjZlOGQ5ODY2NGI2ZWIxYzkyMDU4OGM3NTQ3MjhfMzMzMg_dc04c43d-2a57-4fac-80ea-1ef353e6e378">STOCKHOLDERS' EQUITY &lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Stock Repurchase Program &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 19, 2018 we announced that our board of directors had approved a share repurchase program (the "2019 repurchase program") designed, among other things, to reduce or eliminate dilution resulting from issuance of stock under the company's employee equity incentive programs. The 2019 repurchase program authorizes the purchase of up to $1.75 billion of our common stock at the company's discretion and has no fixed termination date. The 2019 repurchase program does not require the company to acquire a specific number of shares and may be suspended, amended or discontinued at any time. During the three months ended January&#160;31, 2021, we repurchased and retired 2.9 million shares for $344 million under this authorization. Effective February 18, 2021, the 2019 repurchase program was terminated and replaced by the new share repurchase program. The remaining authorization under the 2019 repurchase plan of $193&#160;million expired on February 18, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February 16, 2021 we announced that our board of directors had approved a new share repurchase program (the "2021 repurchase program") designed, among other things, to reduce or eliminate dilution resulting from issuance of stock under the company's employee equity incentive programs. The 2021 repurchase program authorizes the purchase of up to $2.0&#160;billion of our common stock at the company's discretion and has no fixed termination date. The 2021 repurchase program which became effective on February 18, 2021, replaced and terminated the 2019 repurchase program on that date. The 2021 repurchase program does not require the company to acquire a specific number of shares and may be suspended, amended or discontinued at any time. During the three months ended January&#160;31, 2022, we repurchased and retired 2.9 million shares for $447 million under this authorization. As of January&#160;31, 2022, we had remaining authorization to repurchase up to approximately $1.13 billion of our common stock under the 2021 repurchase program.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Cash Dividends on Shares of Common Stock&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three months ended January&#160;31, 2022, we paid cash dividends of $0.210 per common share or $63 million on the company's common stock. During the three months ended January&#160;31, 2021, we paid cash dividends of $0.194 per common share or $59 million  on the company's common stock. The timing and amounts of any future dividends are subject to determination and approval by our board of directors.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Accumulated Other Comprehensive Income (Loss)&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in accumulated other comprehensive income (loss) by component and related tax effects were as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.126%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.113%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.848%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.697%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.551%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.848%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.551%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.848%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.405%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.857%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net defined benefit pension cost and post retirement plan costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended January 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Prior service credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Actuarial Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized gains (losses) on derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="27" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;As of October 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(185)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(224)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(282)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified out of accumulated other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;As of January 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(212)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(217)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(298)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Reclassifications out of accumulated other comprehensive income (loss) for the three months ended January&#160;31, 2022 and 2021 were as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center;text-indent:4.5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.769%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Details about accumulated other &lt;br/&gt;comprehensive income (loss) components&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amounts Reclassified from &lt;br/&gt;other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Affected line item in&lt;br/&gt;statement of operations&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="12" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;January 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized gain (loss) on derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of products&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total before income tax&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(Provision) benefit for income tax&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net of income tax&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net defined benefit pension cost and post retirement plan costs:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actuarial net loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other income (expense)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior service benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other income (expense)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total before income tax&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit for income tax&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net of income tax&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total reclassifications for the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amounts in parentheses indicate reductions to income and increases to other comprehensive income (loss).&lt;/span&gt;&lt;/div&gt;Reclassifications out of accumulated other comprehensive income (loss) of prior service benefit and actuarial net loss in respect of retirement plans and post retirement pension plans are included in the computation of net periodic cost (see Note 11, "Retirement Plans and Post Retirement Pension Plans").</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="i629b697ae777498d9e2c067c3e5a581e_I20181119"
      decimals="-7"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83Ni9mcmFnOjQ2ZDI2ZThkOTg2NjRiNmViMWM5MjA1ODhjNzU0NzI4L3RleHRyZWdpb246NDZkMjZlOGQ5ODY2NGI2ZWIxYzkyMDU4OGM3NTQ3MjhfNDA5_3a91b664-8be7-4cac-8c07-316c5f53d084"
      unitRef="usd">1750000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="id3f922976d404efe924b23253513f94b_D20201101-20210131"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83Ni9mcmFnOjQ2ZDI2ZThkOTg2NjRiNmViMWM5MjA1ODhjNzU0NzI4L3RleHRyZWdpb246NDZkMjZlOGQ5ODY2NGI2ZWIxYzkyMDU4OGM3NTQ3MjhfMTY0OTI2NzQ0NTkyMg_402b2489-f5ef-4144-8e01-380bff151aae"
      unitRef="shares">2900000</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="id3f922976d404efe924b23253513f94b_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83Ni9mcmFnOjQ2ZDI2ZThkOTg2NjRiNmViMWM5MjA1ODhjNzU0NzI4L3RleHRyZWdpb246NDZkMjZlOGQ5ODY2NGI2ZWIxYzkyMDU4OGM3NTQ3MjhfMTY0OTI2NzQ0NTkzMQ_caf47e9f-dceb-4ef0-9757-d0fae9b498e3"
      unitRef="usd">344000000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
      contextRef="i11897c2b4a354e80b2f66e86e5b8bf11_I20210218"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83Ni9mcmFnOjQ2ZDI2ZThkOTg2NjRiNmViMWM5MjA1ODhjNzU0NzI4L3RleHRyZWdpb246NDZkMjZlOGQ5ODY2NGI2ZWIxYzkyMDU4OGM3NTQ3MjhfMTA4Ng_8758a296-445d-4f1e-9af4-78a6f4c1d813"
      unitRef="usd">193000000</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="if65151f0282a48c5b160bfa0fd1f9626_I20210218"
      decimals="-7"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83Ni9mcmFnOjQ2ZDI2ZThkOTg2NjRiNmViMWM5MjA1ODhjNzU0NzI4L3RleHRyZWdpb246NDZkMjZlOGQ5ODY2NGI2ZWIxYzkyMDU4OGM3NTQ3MjhfMTQ3MA_4dd846c7-25da-405e-bd81-95d8d6f349d2"
      unitRef="usd">2000000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="icdcacaffa00940c38eefae4a25b246ce_D20211101-20220131"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83Ni9mcmFnOjQ2ZDI2ZThkOTg2NjRiNmViMWM5MjA1ODhjNzU0NzI4L3RleHRyZWdpb246NDZkMjZlOGQ5ODY2NGI2ZWIxYzkyMDU4OGM3NTQ3MjhfMTkyOQ_38fe97b6-9a41-4f21-8274-0bcf0b467f7c"
      unitRef="shares">2900000</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="icdcacaffa00940c38eefae4a25b246ce_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83Ni9mcmFnOjQ2ZDI2ZThkOTg2NjRiNmViMWM5MjA1ODhjNzU0NzI4L3RleHRyZWdpb246NDZkMjZlOGQ5ODY2NGI2ZWIxYzkyMDU4OGM3NTQ3MjhfMTk1MQ_9edc333c-f275-4c18-b160-d3eafe93a9d0"
      unitRef="usd">447000000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
      contextRef="ib67bf4635858449bb282042383b1fa3e_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83Ni9mcmFnOjQ2ZDI2ZThkOTg2NjRiNmViMWM5MjA1ODhjNzU0NzI4L3RleHRyZWdpb246NDZkMjZlOGQ5ODY2NGI2ZWIxYzkyMDU4OGM3NTQ3MjhfMjA3MA_b1c473c8-7f4b-45d4-8d90-e425ef09a41c"
      unitRef="usd">1130000000</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <us-gaap:CommonStockDividendsPerShareCashPaid
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83Ni9mcmFnOjQ2ZDI2ZThkOTg2NjRiNmViMWM5MjA1ODhjNzU0NzI4L3RleHRyZWdpb246NDZkMjZlOGQ5ODY2NGI2ZWIxYzkyMDU4OGM3NTQ3MjhfMjIzMA_bba77d6b-7e30-49f3-a58f-9e4a81f9516d"
      unitRef="usdPerShare">0.210</us-gaap:CommonStockDividendsPerShareCashPaid>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83Ni9mcmFnOjQ2ZDI2ZThkOTg2NjRiNmViMWM5MjA1ODhjNzU0NzI4L3RleHRyZWdpb246NDZkMjZlOGQ5ODY2NGI2ZWIxYzkyMDU4OGM3NTQ3MjhfMjI1Mw_ae5a2a8b-5daf-48b2-bb1f-4d56dd38b24d"
      unitRef="usd">63000000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:CommonStockDividendsPerShareCashPaid
      contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83Ni9mcmFnOjQ2ZDI2ZThkOTg2NjRiNmViMWM5MjA1ODhjNzU0NzI4L3RleHRyZWdpb246NDZkMjZlOGQ5ODY2NGI2ZWIxYzkyMDU4OGM3NTQ3MjhfMjM4OQ_8bd972dc-b2a6-4f55-9d71-7d159e0a2489"
      unitRef="usdPerShare">0.194</us-gaap:CommonStockDividendsPerShareCashPaid>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83Ni9mcmFnOjQ2ZDI2ZThkOTg2NjRiNmViMWM5MjA1ODhjNzU0NzI4L3RleHRyZWdpb246NDZkMjZlOGQ5ODY2NGI2ZWIxYzkyMDU4OGM3NTQ3MjhfMjQxMg_7801a26c-7e79-41fd-9ff7-f1748c6a778a"
      unitRef="usd">59000000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83Ni9mcmFnOjQ2ZDI2ZThkOTg2NjRiNmViMWM5MjA1ODhjNzU0NzI4L3RleHRyZWdpb246NDZkMjZlOGQ5ODY2NGI2ZWIxYzkyMDU4OGM3NTQ3MjhfMzMxOQ_6b485678-3ed7-4a28-8166-b8207b3e862b">&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in accumulated other comprehensive income (loss) by component and related tax effects were as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.126%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.113%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.848%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.697%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.551%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.848%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.551%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.848%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.405%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.857%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net defined benefit pension cost and post retirement plan costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended January 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Prior service credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Actuarial Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized gains (losses) on derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="27" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;As of October 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(185)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(224)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(282)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified out of accumulated other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;As of January 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(212)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(217)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(298)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i5c54dd5009274b448e1a0f238519873c_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83Ni9mcmFnOjQ2ZDI2ZThkOTg2NjRiNmViMWM5MjA1ODhjNzU0NzI4L3RhYmxlOjU5NTJlMTZjMjE1ODQ1ZjViZGE0OTdmM2NmYjZmMjRmL3RhYmxlcmFuZ2U6NTk1MmUxNmMyMTU4NDVmNWJkYTQ5N2YzY2ZiNmYyNGZfMy00LTEtMS0zMDExNA_be1901fa-939b-4161-9a19-e6fc5c44a479"
      unitRef="usd">-185000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="iec127ccabccf4e1d8b1b9f0e177d0a6d_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83Ni9mcmFnOjQ2ZDI2ZThkOTg2NjRiNmViMWM5MjA1ODhjNzU0NzI4L3RhYmxlOjU5NTJlMTZjMjE1ODQ1ZjViZGE0OTdmM2NmYjZmMjRmL3RhYmxlcmFuZ2U6NTk1MmUxNmMyMTU4NDVmNWJkYTQ5N2YzY2ZiNmYyNGZfMy02LTEtMS0zMDExNA_a07d6bf5-c8b3-4821-8aa6-04ea7d76b6d9"
      unitRef="usd">124000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i02b0508da50d4d36aa148cd391ab89a2_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83Ni9mcmFnOjQ2ZDI2ZThkOTg2NjRiNmViMWM5MjA1ODhjNzU0NzI4L3RhYmxlOjU5NTJlMTZjMjE1ODQ1ZjViZGE0OTdmM2NmYjZmMjRmL3RhYmxlcmFuZ2U6NTk1MmUxNmMyMTU4NDVmNWJkYTQ5N2YzY2ZiNmYyNGZfMy04LTEtMS0zMDExNA_5441ed22-e1dc-4665-bfa7-1bae86357d28"
      unitRef="usd">-224000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i375e95e148364bec829da83e15fb30a0_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83Ni9mcmFnOjQ2ZDI2ZThkOTg2NjRiNmViMWM5MjA1ODhjNzU0NzI4L3RhYmxlOjU5NTJlMTZjMjE1ODQ1ZjViZGE0OTdmM2NmYjZmMjRmL3RhYmxlcmFuZ2U6NTk1MmUxNmMyMTU4NDVmNWJkYTQ5N2YzY2ZiNmYyNGZfMy0xMC0xLTEtMzAxMTQ_ad73f744-34f4-4e62-8e85-3195b8f63fce"
      unitRef="usd">3000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i6390807210d74c6f9cae496ea2122a5a_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83Ni9mcmFnOjQ2ZDI2ZThkOTg2NjRiNmViMWM5MjA1ODhjNzU0NzI4L3RhYmxlOjU5NTJlMTZjMjE1ODQ1ZjViZGE0OTdmM2NmYjZmMjRmL3RhYmxlcmFuZ2U6NTk1MmUxNmMyMTU4NDVmNWJkYTQ5N2YzY2ZiNmYyNGZfMy0xMi0xLTEtMzAxMTQ_d4f71843-d848-4095-ba94-dc95f28cbfcc"
      unitRef="usd">-282000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i7e403833679541eab73046fd37fcdd94_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83Ni9mcmFnOjQ2ZDI2ZThkOTg2NjRiNmViMWM5MjA1ODhjNzU0NzI4L3RhYmxlOjU5NTJlMTZjMjE1ODQ1ZjViZGE0OTdmM2NmYjZmMjRmL3RhYmxlcmFuZ2U6NTk1MmUxNmMyMTU4NDVmNWJkYTQ5N2YzY2ZiNmYyNGZfNS00LTEtMS0zMDExNA_65bff23b-480d-4058-9a05-c898863ba789"
      unitRef="usd">-27000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="if6e4cf075aaa4d27853c6c516de6dd2c_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83Ni9mcmFnOjQ2ZDI2ZThkOTg2NjRiNmViMWM5MjA1ODhjNzU0NzI4L3RhYmxlOjU5NTJlMTZjMjE1ODQ1ZjViZGE0OTdmM2NmYjZmMjRmL3RhYmxlcmFuZ2U6NTk1MmUxNmMyMTU4NDVmNWJkYTQ5N2YzY2ZiNmYyNGZfNS02LTEtMS0zMDExNA_23a70eae-8aec-4cdf-9e52-142ce0f545ad"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="ia6ec07697746456e8221275738907dd8_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83Ni9mcmFnOjQ2ZDI2ZThkOTg2NjRiNmViMWM5MjA1ODhjNzU0NzI4L3RhYmxlOjU5NTJlMTZjMjE1ODQ1ZjViZGE0OTdmM2NmYjZmMjRmL3RhYmxlcmFuZ2U6NTk1MmUxNmMyMTU4NDVmNWJkYTQ5N2YzY2ZiNmYyNGZfNS04LTEtMS0zMDExNA_2aded676-912c-4580-bda7-c85184699475"
      unitRef="usd">3000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="icdcbd30df39641a4b5f2503519f860b9_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83Ni9mcmFnOjQ2ZDI2ZThkOTg2NjRiNmViMWM5MjA1ODhjNzU0NzI4L3RhYmxlOjU5NTJlMTZjMjE1ODQ1ZjViZGE0OTdmM2NmYjZmMjRmL3RhYmxlcmFuZ2U6NTk1MmUxNmMyMTU4NDVmNWJkYTQ5N2YzY2ZiNmYyNGZfNS0xMC0xLTEtMzAxMTQ_3fa06b47-caf4-422e-9769-30dec3f8ffea"
      unitRef="usd">8000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83Ni9mcmFnOjQ2ZDI2ZThkOTg2NjRiNmViMWM5MjA1ODhjNzU0NzI4L3RhYmxlOjU5NTJlMTZjMjE1ODQ1ZjViZGE0OTdmM2NmYjZmMjRmL3RhYmxlcmFuZ2U6NTk1MmUxNmMyMTU4NDVmNWJkYTQ5N2YzY2ZiNmYyNGZfNS0xMi0xLTEtMzAxMTQ_e2fa8a33-2c74-4149-82be-4d7b11c9238d"
      unitRef="usd">-16000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent
      contextRef="i7e403833679541eab73046fd37fcdd94_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83Ni9mcmFnOjQ2ZDI2ZThkOTg2NjRiNmViMWM5MjA1ODhjNzU0NzI4L3RhYmxlOjU5NTJlMTZjMjE1ODQ1ZjViZGE0OTdmM2NmYjZmMjRmL3RhYmxlcmFuZ2U6NTk1MmUxNmMyMTU4NDVmNWJkYTQ5N2YzY2ZiNmYyNGZfNy00LTEtMS0zMDExNA_d7b24139-dc9b-4a95-b99f-eaeef12e5e28"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent
      contextRef="if6e4cf075aaa4d27853c6c516de6dd2c_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83Ni9mcmFnOjQ2ZDI2ZThkOTg2NjRiNmViMWM5MjA1ODhjNzU0NzI4L3RhYmxlOjU5NTJlMTZjMjE1ODQ1ZjViZGE0OTdmM2NmYjZmMjRmL3RhYmxlcmFuZ2U6NTk1MmUxNmMyMTU4NDVmNWJkYTQ5N2YzY2ZiNmYyNGZfNy02LTEtMS0zMDExNA_c704b562-71ff-46ac-8385-599c01e35bab"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent
      contextRef="ia6ec07697746456e8221275738907dd8_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83Ni9mcmFnOjQ2ZDI2ZThkOTg2NjRiNmViMWM5MjA1ODhjNzU0NzI4L3RhYmxlOjU5NTJlMTZjMjE1ODQ1ZjViZGE0OTdmM2NmYjZmMjRmL3RhYmxlcmFuZ2U6NTk1MmUxNmMyMTU4NDVmNWJkYTQ5N2YzY2ZiNmYyNGZfNy04LTEtMS0zMDExNA_3d680454-dd1f-4cac-b0c4-de55527f5211"
      unitRef="usd">6000000</us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent
      contextRef="icdcbd30df39641a4b5f2503519f860b9_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83Ni9mcmFnOjQ2ZDI2ZThkOTg2NjRiNmViMWM5MjA1ODhjNzU0NzI4L3RhYmxlOjU5NTJlMTZjMjE1ODQ1ZjViZGE0OTdmM2NmYjZmMjRmL3RhYmxlcmFuZ2U6NTk1MmUxNmMyMTU4NDVmNWJkYTQ5N2YzY2ZiNmYyNGZfNy0xMC0xLTEtMzAxMTQ_3b359ee0-f9a5-43f5-9e6f-7a2e8a7fd384"
      unitRef="usd">-3000000</us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83Ni9mcmFnOjQ2ZDI2ZThkOTg2NjRiNmViMWM5MjA1ODhjNzU0NzI4L3RhYmxlOjU5NTJlMTZjMjE1ODQ1ZjViZGE0OTdmM2NmYjZmMjRmL3RhYmxlcmFuZ2U6NTk1MmUxNmMyMTU4NDVmNWJkYTQ5N2YzY2ZiNmYyNGZfNy0xMi0xLTEtMzAxMTQ_761c3e01-20b2-446c-bdcf-213059f68451"
      unitRef="usd">3000000</us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="i7e403833679541eab73046fd37fcdd94_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83Ni9mcmFnOjQ2ZDI2ZThkOTg2NjRiNmViMWM5MjA1ODhjNzU0NzI4L3RhYmxlOjU5NTJlMTZjMjE1ODQ1ZjViZGE0OTdmM2NmYjZmMjRmL3RhYmxlcmFuZ2U6NTk1MmUxNmMyMTU4NDVmNWJkYTQ5N2YzY2ZiNmYyNGZfOS00LTEtMS0zMDExNA_9b161915-f440-4700-adad-1c8dbeeb32a1"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="if6e4cf075aaa4d27853c6c516de6dd2c_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83Ni9mcmFnOjQ2ZDI2ZThkOTg2NjRiNmViMWM5MjA1ODhjNzU0NzI4L3RhYmxlOjU5NTJlMTZjMjE1ODQ1ZjViZGE0OTdmM2NmYjZmMjRmL3RhYmxlcmFuZ2U6NTk1MmUxNmMyMTU4NDVmNWJkYTQ5N2YzY2ZiNmYyNGZfOS02LTEtMS0zMDExNA_0665c493-fae3-4247-b8f6-058e6ac6d895"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="ia6ec07697746456e8221275738907dd8_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83Ni9mcmFnOjQ2ZDI2ZThkOTg2NjRiNmViMWM5MjA1ODhjNzU0NzI4L3RhYmxlOjU5NTJlMTZjMjE1ODQ1ZjViZGE0OTdmM2NmYjZmMjRmL3RhYmxlcmFuZ2U6NTk1MmUxNmMyMTU4NDVmNWJkYTQ5N2YzY2ZiNmYyNGZfOS04LTEtMS0zMDExNA_439b0336-b8e4-4db0-b8f2-b72ab0d569c9"
      unitRef="usd">2000000</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="icdcbd30df39641a4b5f2503519f860b9_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83Ni9mcmFnOjQ2ZDI2ZThkOTg2NjRiNmViMWM5MjA1ODhjNzU0NzI4L3RhYmxlOjU5NTJlMTZjMjE1ODQ1ZjViZGE0OTdmM2NmYjZmMjRmL3RhYmxlcmFuZ2U6NTk1MmUxNmMyMTU4NDVmNWJkYTQ5N2YzY2ZiNmYyNGZfOS0xMC0xLTEtMzAxMTQ_0b4dda26-6729-4cd3-8432-2ee3c2910824"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83Ni9mcmFnOjQ2ZDI2ZThkOTg2NjRiNmViMWM5MjA1ODhjNzU0NzI4L3RhYmxlOjU5NTJlMTZjMjE1ODQ1ZjViZGE0OTdmM2NmYjZmMjRmL3RhYmxlcmFuZ2U6NTk1MmUxNmMyMTU4NDVmNWJkYTQ5N2YzY2ZiNmYyNGZfOS0xMi0xLTEtMzAxMTQ_510ee199-5f4f-4acd-a02f-ba96220fe7be"
      unitRef="usd">-3000000</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i7e403833679541eab73046fd37fcdd94_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83Ni9mcmFnOjQ2ZDI2ZThkOTg2NjRiNmViMWM5MjA1ODhjNzU0NzI4L3RhYmxlOjU5NTJlMTZjMjE1ODQ1ZjViZGE0OTdmM2NmYjZmMjRmL3RhYmxlcmFuZ2U6NTk1MmUxNmMyMTU4NDVmNWJkYTQ5N2YzY2ZiNmYyNGZfMTEtNC0xLTEtMzAxMTQ_031123be-e1f5-454a-8029-42d42044049d"
      unitRef="usd">-27000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="if6e4cf075aaa4d27853c6c516de6dd2c_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83Ni9mcmFnOjQ2ZDI2ZThkOTg2NjRiNmViMWM5MjA1ODhjNzU0NzI4L3RhYmxlOjU5NTJlMTZjMjE1ODQ1ZjViZGE0OTdmM2NmYjZmMjRmL3RhYmxlcmFuZ2U6NTk1MmUxNmMyMTU4NDVmNWJkYTQ5N2YzY2ZiNmYyNGZfMTEtNi0xLTEtMzAxMTQ_81009912-a58d-41a5-8f4a-c69ff5a71824"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ia6ec07697746456e8221275738907dd8_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83Ni9mcmFnOjQ2ZDI2ZThkOTg2NjRiNmViMWM5MjA1ODhjNzU0NzI4L3RhYmxlOjU5NTJlMTZjMjE1ODQ1ZjViZGE0OTdmM2NmYjZmMjRmL3RhYmxlcmFuZ2U6NTk1MmUxNmMyMTU4NDVmNWJkYTQ5N2YzY2ZiNmYyNGZfMTEtOC0xLTEtMzAxMTQ_bd43dc31-ea1f-4ceb-853b-714f24e0bf36"
      unitRef="usd">7000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="icdcbd30df39641a4b5f2503519f860b9_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83Ni9mcmFnOjQ2ZDI2ZThkOTg2NjRiNmViMWM5MjA1ODhjNzU0NzI4L3RhYmxlOjU5NTJlMTZjMjE1ODQ1ZjViZGE0OTdmM2NmYjZmMjRmL3RhYmxlcmFuZ2U6NTk1MmUxNmMyMTU4NDVmNWJkYTQ5N2YzY2ZiNmYyNGZfMTEtMTAtMS0xLTMwMTE0_4a1d6687-4b04-40ac-8e05-5627017ae715"
      unitRef="usd">4000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83Ni9mcmFnOjQ2ZDI2ZThkOTg2NjRiNmViMWM5MjA1ODhjNzU0NzI4L3RhYmxlOjU5NTJlMTZjMjE1ODQ1ZjViZGE0OTdmM2NmYjZmMjRmL3RhYmxlcmFuZ2U6NTk1MmUxNmMyMTU4NDVmNWJkYTQ5N2YzY2ZiNmYyNGZfMTEtMTItMS0xLTMwMTE0_959c6d09-a716-4af9-916f-3260533fa2c2"
      unitRef="usd">-16000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ia1ee3187242a414db3687c2b9fc4d82f_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83Ni9mcmFnOjQ2ZDI2ZThkOTg2NjRiNmViMWM5MjA1ODhjNzU0NzI4L3RhYmxlOjU5NTJlMTZjMjE1ODQ1ZjViZGE0OTdmM2NmYjZmMjRmL3RhYmxlcmFuZ2U6NTk1MmUxNmMyMTU4NDVmNWJkYTQ5N2YzY2ZiNmYyNGZfMTMtNC0xLTEtMzAxMTQ_2cb46531-f347-4da4-84f4-e770addef8c0"
      unitRef="usd">-212000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i0dc39ee7c49e4d6cb473aef9858b6b88_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83Ni9mcmFnOjQ2ZDI2ZThkOTg2NjRiNmViMWM5MjA1ODhjNzU0NzI4L3RhYmxlOjU5NTJlMTZjMjE1ODQ1ZjViZGE0OTdmM2NmYjZmMjRmL3RhYmxlcmFuZ2U6NTk1MmUxNmMyMTU4NDVmNWJkYTQ5N2YzY2ZiNmYyNGZfMTMtNi0xLTEtMzAxMTQ_4a28284c-1154-42ba-885d-12e996f362fc"
      unitRef="usd">124000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i70983fa542cf4b018a1bb84cfd674246_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83Ni9mcmFnOjQ2ZDI2ZThkOTg2NjRiNmViMWM5MjA1ODhjNzU0NzI4L3RhYmxlOjU5NTJlMTZjMjE1ODQ1ZjViZGE0OTdmM2NmYjZmMjRmL3RhYmxlcmFuZ2U6NTk1MmUxNmMyMTU4NDVmNWJkYTQ5N2YzY2ZiNmYyNGZfMTMtOC0xLTEtMzAxMTQ_6e93379f-5410-43b5-8eaa-6bef7a0dbf06"
      unitRef="usd">-217000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i2563947f2b6142d4a03ded6e410372c8_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83Ni9mcmFnOjQ2ZDI2ZThkOTg2NjRiNmViMWM5MjA1ODhjNzU0NzI4L3RhYmxlOjU5NTJlMTZjMjE1ODQ1ZjViZGE0OTdmM2NmYjZmMjRmL3RhYmxlcmFuZ2U6NTk1MmUxNmMyMTU4NDVmNWJkYTQ5N2YzY2ZiNmYyNGZfMTMtMTAtMS0xLTMwMTE0_e617b660-6e96-4677-82fa-865bee9299b7"
      unitRef="usd">7000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83Ni9mcmFnOjQ2ZDI2ZThkOTg2NjRiNmViMWM5MjA1ODhjNzU0NzI4L3RhYmxlOjU5NTJlMTZjMjE1ODQ1ZjViZGE0OTdmM2NmYjZmMjRmL3RhYmxlcmFuZ2U6NTk1MmUxNmMyMTU4NDVmNWJkYTQ5N2YzY2ZiNmYyNGZfMTMtMTItMS0xLTMwMTE0_508c9118-967b-4d06-9f1f-db2957a5a751"
      unitRef="usd">-298000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83Ni9mcmFnOjQ2ZDI2ZThkOTg2NjRiNmViMWM5MjA1ODhjNzU0NzI4L3RleHRyZWdpb246NDZkMjZlOGQ5ODY2NGI2ZWIxYzkyMDU4OGM3NTQ3MjhfMzM0MQ_5c16d622-e954-42b0-94d7-b05f418993fa">&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Reclassifications out of accumulated other comprehensive income (loss) for the three months ended January&#160;31, 2022 and 2021 were as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center;text-indent:4.5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.769%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Details about accumulated other &lt;br/&gt;comprehensive income (loss) components&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amounts Reclassified from &lt;br/&gt;other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Affected line item in&lt;br/&gt;statement of operations&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="12" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;January 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized gain (loss) on derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of products&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total before income tax&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(Provision) benefit for income tax&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net of income tax&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net defined benefit pension cost and post retirement plan costs:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actuarial net loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other income (expense)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior service benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other income (expense)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total before income tax&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit for income tax&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net of income tax&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total reclassifications for the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="ic76564bc7be64253830f89477bbf29cb_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83Ni9mcmFnOjQ2ZDI2ZThkOTg2NjRiNmViMWM5MjA1ODhjNzU0NzI4L3RhYmxlOmYwZTM4YjQyY2UwYTRiMTc4YTc4ODhkZjdhNWIyMDI1L3RhYmxlcmFuZ2U6ZjBlMzhiNDJjZTBhNGIxNzhhNzg4OGRmN2E1YjIwMjVfMTItMi0xLTEtMzAxMTQ_b6386aad-0939-4c4b-b931-0e49bbe38328"
      unitRef="usd">3000000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="if825187b5c3d4f688e0c4a074679fd80_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83Ni9mcmFnOjQ2ZDI2ZThkOTg2NjRiNmViMWM5MjA1ODhjNzU0NzI4L3RhYmxlOmYwZTM4YjQyY2UwYTRiMTc4YTc4ODhkZjdhNWIyMDI1L3RhYmxlcmFuZ2U6ZjBlMzhiNDJjZTBhNGIxNzhhNzg4OGRmN2E1YjIwMjVfMTItNC0xLTEtMzAxMTQ_eff2b6c7-77cd-45f7-be15-196efc17018f"
      unitRef="usd">-8000000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83Ni9mcmFnOjQ2ZDI2ZThkOTg2NjRiNmViMWM5MjA1ODhjNzU0NzI4L3RhYmxlOmYwZTM4YjQyY2UwYTRiMTc4YTc4ODhkZjdhNWIyMDI1L3RhYmxlcmFuZ2U6ZjBlMzhiNDJjZTBhNGIxNzhhNzg4OGRmN2E1YjIwMjVfMTQtMi0xLTEtMzAxMTQ_7725acb9-ac0a-4f32-b605-bda538cc2cf3"
      unitRef="usd">3000000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83Ni9mcmFnOjQ2ZDI2ZThkOTg2NjRiNmViMWM5MjA1ODhjNzU0NzI4L3RhYmxlOmYwZTM4YjQyY2UwYTRiMTc4YTc4ODhkZjdhNWIyMDI1L3RhYmxlcmFuZ2U6ZjBlMzhiNDJjZTBhNGIxNzhhNzg4OGRmN2E1YjIwMjVfMTQtNC0xLTEtMzAxMTQ_a17f8435-a1be-4dbc-86ac-2d968e9e3db4"
      unitRef="usd">-8000000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83Ni9mcmFnOjQ2ZDI2ZThkOTg2NjRiNmViMWM5MjA1ODhjNzU0NzI4L3RhYmxlOmYwZTM4YjQyY2UwYTRiMTc4YTc4ODhkZjdhNWIyMDI1L3RhYmxlcmFuZ2U6ZjBlMzhiNDJjZTBhNGIxNzhhNzg4OGRmN2E1YjIwMjVfMTUtMi0xLTEtMzAxMTQ_56beaaad-3c0d-4216-af2d-13352d74be0a"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
      contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83Ni9mcmFnOjQ2ZDI2ZThkOTg2NjRiNmViMWM5MjA1ODhjNzU0NzI4L3RhYmxlOmYwZTM4YjQyY2UwYTRiMTc4YTc4ODhkZjdhNWIyMDI1L3RhYmxlcmFuZ2U6ZjBlMzhiNDJjZTBhNGIxNzhhNzg4OGRmN2E1YjIwMjVfMTUtNC0xLTEtMzAxMTQ_28ee4394-bcd6-4260-9f32-fa5b7e317bd7"
      unitRef="usd">2000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83Ni9mcmFnOjQ2ZDI2ZThkOTg2NjRiNmViMWM5MjA1ODhjNzU0NzI4L3RhYmxlOmYwZTM4YjQyY2UwYTRiMTc4YTc4ODhkZjdhNWIyMDI1L3RhYmxlcmFuZ2U6ZjBlMzhiNDJjZTBhNGIxNzhhNzg4OGRmN2E1YjIwMjVfMTYtMi0xLTEtMzAxMTQ_3c0f716e-351e-44b5-8b32-09991f759a4f"
      unitRef="usd">2000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83Ni9mcmFnOjQ2ZDI2ZThkOTg2NjRiNmViMWM5MjA1ODhjNzU0NzI4L3RhYmxlOmYwZTM4YjQyY2UwYTRiMTc4YTc4ODhkZjdhNWIyMDI1L3RhYmxlcmFuZ2U6ZjBlMzhiNDJjZTBhNGIxNzhhNzg4OGRmN2E1YjIwMjVfMTYtNC0xLTEtMzAxMTQ_fe35838e-4cfd-45ec-9593-20cd4fe5546f"
      unitRef="usd">-6000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83Ni9mcmFnOjQ2ZDI2ZThkOTg2NjRiNmViMWM5MjA1ODhjNzU0NzI4L3RhYmxlOmYwZTM4YjQyY2UwYTRiMTc4YTc4ODhkZjdhNWIyMDI1L3RhYmxlcmFuZ2U6ZjBlMzhiNDJjZTBhNGIxNzhhNzg4OGRmN2E1YjIwMjVfMTktMi0xLTEtMzAxMTQ_047ff24f-03ec-4ed8-8124-91d6368653ae"
      unitRef="usd">6000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax
      contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83Ni9mcmFnOjQ2ZDI2ZThkOTg2NjRiNmViMWM5MjA1ODhjNzU0NzI4L3RhYmxlOmYwZTM4YjQyY2UwYTRiMTc4YTc4ODhkZjdhNWIyMDI1L3RhYmxlcmFuZ2U6ZjBlMzhiNDJjZTBhNGIxNzhhNzg4OGRmN2E1YjIwMjVfMTktNC0xLTEtMzAxMTQ_f6a4ad52-cde5-440f-8974-63450c0a8763"
      unitRef="usd">16000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83Ni9mcmFnOjQ2ZDI2ZThkOTg2NjRiNmViMWM5MjA1ODhjNzU0NzI4L3RhYmxlOmYwZTM4YjQyY2UwYTRiMTc4YTc4ODhkZjdhNWIyMDI1L3RhYmxlcmFuZ2U6ZjBlMzhiNDJjZTBhNGIxNzhhNzg4OGRmN2E1YjIwMjVfMjAtMi0xLTEtMzAxMTQ_d5c7fee8-54cd-4f3a-8155-4c7da8e2f244"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax
      contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83Ni9mcmFnOjQ2ZDI2ZThkOTg2NjRiNmViMWM5MjA1ODhjNzU0NzI4L3RhYmxlOmYwZTM4YjQyY2UwYTRiMTc4YTc4ODhkZjdhNWIyMDI1L3RhYmxlcmFuZ2U6ZjBlMzhiNDJjZTBhNGIxNzhhNzg4OGRmN2E1YjIwMjVfMjAtNC0xLTEtMzAxMTQ_5850bf83-cb26-41e2-a799-07081251febe"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83Ni9mcmFnOjQ2ZDI2ZThkOTg2NjRiNmViMWM5MjA1ODhjNzU0NzI4L3RhYmxlOmYwZTM4YjQyY2UwYTRiMTc4YTc4ODhkZjdhNWIyMDI1L3RhYmxlcmFuZ2U6ZjBlMzhiNDJjZTBhNGIxNzhhNzg4OGRmN2E1YjIwMjVfMjEtMi0xLTEtMzAxMTQ_59f90862-f9ee-4bb7-98bf-db6e982a76ec"
      unitRef="usd">-6000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax
      contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83Ni9mcmFnOjQ2ZDI2ZThkOTg2NjRiNmViMWM5MjA1ODhjNzU0NzI4L3RhYmxlOmYwZTM4YjQyY2UwYTRiMTc4YTc4ODhkZjdhNWIyMDI1L3RhYmxlcmFuZ2U6ZjBlMzhiNDJjZTBhNGIxNzhhNzg4OGRmN2E1YjIwMjVfMjEtNC0xLTEtMzAxMTQ_74684c05-193d-44b4-a887-af2660641c7f"
      unitRef="usd">-16000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansTax
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83Ni9mcmFnOjQ2ZDI2ZThkOTg2NjRiNmViMWM5MjA1ODhjNzU0NzI4L3RhYmxlOmYwZTM4YjQyY2UwYTRiMTc4YTc4ODhkZjdhNWIyMDI1L3RhYmxlcmFuZ2U6ZjBlMzhiNDJjZTBhNGIxNzhhNzg4OGRmN2E1YjIwMjVfMjItMi0xLTEtMzAxMTQ_2c936bf2-3820-4737-99cd-89aedba2e381"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansTax
      contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83Ni9mcmFnOjQ2ZDI2ZThkOTg2NjRiNmViMWM5MjA1ODhjNzU0NzI4L3RhYmxlOmYwZTM4YjQyY2UwYTRiMTc4YTc4ODhkZjdhNWIyMDI1L3RhYmxlcmFuZ2U6ZjBlMzhiNDJjZTBhNGIxNzhhNzg4OGRmN2E1YjIwMjVfMjItNC0xLTEtMzAxMTQ_7c67a0ed-0467-4973-9c9d-2f4bb1ff86cf"
      unitRef="usd">4000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83Ni9mcmFnOjQ2ZDI2ZThkOTg2NjRiNmViMWM5MjA1ODhjNzU0NzI4L3RhYmxlOmYwZTM4YjQyY2UwYTRiMTc4YTc4ODhkZjdhNWIyMDI1L3RhYmxlcmFuZ2U6ZjBlMzhiNDJjZTBhNGIxNzhhNzg4OGRmN2E1YjIwMjVfMjMtMi0xLTEtMzAxMTQ_ffc6c2d3-a3d9-49f5-888f-69400f368659"
      unitRef="usd">-5000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax
      contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83Ni9mcmFnOjQ2ZDI2ZThkOTg2NjRiNmViMWM5MjA1ODhjNzU0NzI4L3RhYmxlOmYwZTM4YjQyY2UwYTRiMTc4YTc4ODhkZjdhNWIyMDI1L3RhYmxlcmFuZ2U6ZjBlMzhiNDJjZTBhNGIxNzhhNzg4OGRmN2E1YjIwMjVfMjMtNC0xLTEtMzAxMTQ_8dec3c85-84c7-4190-9f9a-370aed1c1dd6"
      unitRef="usd">-12000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83Ni9mcmFnOjQ2ZDI2ZThkOTg2NjRiNmViMWM5MjA1ODhjNzU0NzI4L3RhYmxlOmYwZTM4YjQyY2UwYTRiMTc4YTc4ODhkZjdhNWIyMDI1L3RhYmxlcmFuZ2U6ZjBlMzhiNDJjZTBhNGIxNzhhNzg4OGRmN2E1YjIwMjVfMjUtMi0xLTEtMzAxMTQ_01248b7a-e677-4848-a9ca-6bee52097e4c"
      unitRef="usd">-3000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83Ni9mcmFnOjQ2ZDI2ZThkOTg2NjRiNmViMWM5MjA1ODhjNzU0NzI4L3RhYmxlOmYwZTM4YjQyY2UwYTRiMTc4YTc4ODhkZjdhNWIyMDI1L3RhYmxlcmFuZ2U6ZjBlMzhiNDJjZTBhNGIxNzhhNzg4OGRmN2E1YjIwMjVfMjUtNC0xLTEtMzAxMTQ_e53dfa1e-169c-46b7-84c2-a72f62a3388b"
      unitRef="usd">-18000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83OS9mcmFnOjZjOGY3YzEwNmQwMDQ5MDc5OTkxYjhhOTE1MDZmOGNjL3RleHRyZWdpb246NmM4ZjdjMTA2ZDAwNDkwNzk5OTFiOGE5MTUwNmY4Y2NfODMzOA_04c8da81-63a0-4e83-867a-4522d0f3f638">SEGMENT INFORMATION&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Description of segments.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;  We are a global leader in life sciences, diagnostics and applied chemical markets, providing application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the first quarter of fiscal year 2022, we announced a change in organizational structure designed to enable our growth strategies and strengthen our focus on customers. Our chemistries and supplies business and our remarketed instruments business moved from our Agilent CrossLab business segment to our life sciences and applied markets business segment. Service revenue and cost of sales related to the previous acquisition of BioTek moved from our life sciences and applied markets business segment to our Agilent CrossLab business segment. The historical financial segment information has been recast to conform to this new presentation. There was no change to our diagnostics and genomics business segment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Following this reorganization, we continue to have three business segments comprised of life sciences and applied markets, diagnostics and genomics and Agilent CrossLab, each of which continues to comprise a reportable segment.  The three operating segments were determined based primarily on how the chief operating decision maker views and evaluates our operations. Operating results are regularly reviewed by the chief operating decision maker to make decisions about resources to be allocated to the segment and to assess its performance. Other factors, including market separation and customer specific applications, go-to-market channels, products and services and manufacturing are considered in determining the formation of these operating segments.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A description of our three reportable segments is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our life sciences and applied markets business provides application-focused solutions that include instruments and software that enable customers to identify, quantify and analyze the physical and biological properties of substances and products, as well as enable customers in the clinical and life sciences research areas to interrogate samples at the molecular and cellular level. Key product categories include: liquid chromatography ("LC") systems and components; liquid chromatography mass spectrometry ("LCMS") systems; gas chromatography ("GC") systems and components; gas chromatography mass spectrometry ("GCMS") systems; inductively coupled plasma mass spectrometry ("ICP-MS") instruments; atomic absorption ("AA") instruments; microwave plasma-atomic emission spectrometry ("MP-AES") instruments; inductively coupled plasma optical emission spectrometry ("ICP-OES") instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software for sample tracking; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps and measurement technologies. Our consumables portfolio is designed to improve customer outcomes. Most of the portfolio is vendor neutral, meaning Agilent can serve and supply customers regardless of their instrument purchase choices. Solutions range from chemistries to supplies. Key product categories in consumables include GC and LC columns, sample preparation products, custom chemistries, and a large selection of laboratory instrument supplies. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our diagnostics and genomics business is comprised of six areas of activity providing active pharmaceutical ingredients ("APIs") for oligo-based therapeutics as well as solutions that include reagents, instruments, software and consumables, which enable customers in the clinical and life sciences research areas to interrogate samples at the cellular and molecular level.&#160;First, our genomics business includes arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, gene expression profiling, as well as next generation sequencing ("NGS") target enrichment and genetic data management and interpretation support software. This business also includes solutions that enable clinical labs to identify DNA variants associated with genetic disease and help direct cancer therapy. Second, our nucleic acid solutions business provides equipment and expertise focused on production of synthesized oligonucleotides under pharmaceutical good manufacturing practices ("GMP") conditions for use as API in an emerging class of drugs that utilize nucleic acid molecules for disease therapy. Third, our pathology solutions business is focused on product offerings for cancer diagnostics and anatomic pathology workflows. The broad portfolio of offerings includes immunohistochemistry ("IHC"), in situ hybridization ("ISH"), hematoxylin and eosin ("H&amp;amp;E") staining and special staining. Fourth, we also collaborate with a number of major pharmaceutical companies to develop new potential tissue and liquid-based pharmacodiagnostics, also known as companion diagnostics, which may be used to identify patients most likely to benefit from a specific targeted therapy. Fifth, the reagent partnership business is a provider of reagents used for turbidimetry and flow cytometry. Finally, our biomolecular analysis business provides complete workflow solutions, including instruments, &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;consumables and software, for quality control analysis of nucleic acid samples.&#160; Samples are analyzed using quantitative and qualitative techniques to ensure accuracy in further genomics analysis techniques utilized in clinical and life science research applications.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The Agilent CrossLab business spans the entire lab with its extensive services portfolio, which is designed to improve customer outcomes.  The majority of the portfolio is vendor neutral, meaning we can serve and supply customers regardless of their instrument purchase choices.  &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The services portfolio include repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, consulting and various other custom services to support the customers' laboratory operations.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;  Custom services are tailored to meet the specific application needs of various industries and to keep instruments fully operational and compliant with the respective industry requirements.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A significant portion of the segments' expenses arise from shared services and infrastructure that we have historically provided to the segments in order to realize economies of scale and to efficiently use resources. These expenses, collectively called corporate charges, include legal, accounting, tax, real estate, insurance services, information technology services, treasury, order administration, other corporate infrastructure expenses, costs of centralized research and development and joint sales and marketing costs. Charges are allocated to the segments, and the allocations have been determined on a basis that we consider to be a reasonable reflection of the utilization of services provided to or benefits received by the segments. In addition, we do not allocate asset impairments, amortization of acquisition-related intangible assets, change in the fair value of acquisition-related contingent consideration, acquisition and integration costs, restructuring and transformational initiatives expenses, acceleration of share-based compensation expense related to workforce reduction, business exit and divestiture costs, special compliance costs, some nucleic acid solutions division ("NASD") site costs and certain other charges to the operating margin for each segment because management does not include this information in its measurement of the performance of the operating segments. Transformational initiatives include expenses associated with targeted cost reduction activities such as manufacturing transfers, site consolidations, legal entity and other business reorganizations, in-sourcing or outsourcing of activities. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables reflect the results of our reportable segments under our management reporting system. The performance of each segment is measured based on several metrics, including segment income from operations. These results are used, in part, by the chief operating decision maker in evaluating the performance of, and in allocating resources to, each of the segments.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The profitability of each of the segments is measured after excluding items such as transformational initiatives, acquisition and integration costs, amortization of intangible assets related to business combinations, interest income, interest expense and other items as noted in the reconciliations below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:77.116%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.428%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;January 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in&#160;millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Revenue:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Life Sciences and Applied Markets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;976&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diagnostics and Genomics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;339&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Agilent CrossLab&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;331&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Segment Income From Operations:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Life Sciences and Applied Markets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diagnostics and Genomics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Agilent CrossLab&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total segment income from operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;441&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table reconciles segment income from operations to Agilent&#x2019;s total enterprise income before taxes:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:77.116%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.428%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;January 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in&#160;millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total segment income from operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;441&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transformational initiatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of intangible assets related to business combinations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(51)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(44)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition and integration costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in fair value of contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other income (expense), net &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income before taxes, as reported&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-indent:4.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-indent:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1) For the three months ended January&#160;31, 2022 and 2021, other income (expense), net includes net (gains) losses on the fair value of equity securities.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-indent:4.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table reflects segment assets under our management reporting system. Segment assets include allocations of corporate assets, goodwill, net other intangibles and other assets. Unallocated assets primarily consist of cash, cash equivalents, short-term and long-term investments, deferred tax assets, right-of-use assets and other assets. &#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.694%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;January 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Segment Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Life Sciences and Applied Markets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,752&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diagnostics and Genomics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Agilent CrossLab&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;839&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total segment assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,947&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfOperatingSegments
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83OS9mcmFnOjZjOGY3YzEwNmQwMDQ5MDc5OTkxYjhhOTE1MDZmOGNjL3RleHRyZWdpb246NmM4ZjdjMTA2ZDAwNDkwNzk5OTFiOGE5MTUwNmY4Y2NfNDk1_3641017e-3b69-4bce-8e11-585f7b6d1a68"
      unitRef="number">3</us-gaap:NumberOfOperatingSegments>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83OS9mcmFnOjZjOGY3YzEwNmQwMDQ5MDc5OTkxYjhhOTE1MDZmOGNjL3RleHRyZWdpb246NmM4ZjdjMTA2ZDAwNDkwNzk5OTFiOGE5MTUwNmY4Y2NfODM2NA_72db3f60-385f-4737-8b90-63fd3968b484">&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The profitability of each of the segments is measured after excluding items such as transformational initiatives, acquisition and integration costs, amortization of intangible assets related to business combinations, interest income, interest expense and other items as noted in the reconciliations below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:77.116%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.428%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;January 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in&#160;millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Revenue:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Life Sciences and Applied Markets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;976&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diagnostics and Genomics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;339&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Agilent CrossLab&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;331&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Segment Income From Operations:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Life Sciences and Applied Markets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diagnostics and Genomics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Agilent CrossLab&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total segment income from operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;441&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table reflects segment assets under our management reporting system. Segment assets include allocations of corporate assets, goodwill, net other intangibles and other assets. Unallocated assets primarily consist of cash, cash equivalents, short-term and long-term investments, deferred tax assets, right-of-use assets and other assets. &#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.694%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;January 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Segment Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Life Sciences and Applied Markets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,752&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diagnostics and Genomics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Agilent CrossLab&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;839&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total segment assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,947&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6d58196320f34869a29143308907c47f_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83OS9mcmFnOjZjOGY3YzEwNmQwMDQ5MDc5OTkxYjhhOTE1MDZmOGNjL3RhYmxlOmJjN2Q3NTE5ZDdjODQyMWY5NjdjYjU3ZGYwNTVhNDYyL3RhYmxlcmFuZ2U6YmM3ZDc1MTlkN2M4NDIxZjk2N2NiNTdkZjA1NWE0NjJfNS0xLTEtMS0zMDExNA_3a64e83e-2691-4aec-9ee6-d8cc49913662"
      unitRef="usd">976000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if71b40dd3f5f49bf86fbcfa04c9c081e_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83OS9mcmFnOjZjOGY3YzEwNmQwMDQ5MDc5OTkxYjhhOTE1MDZmOGNjL3RhYmxlOmJjN2Q3NTE5ZDdjODQyMWY5NjdjYjU3ZGYwNTVhNDYyL3RhYmxlcmFuZ2U6YmM3ZDc1MTlkN2M4NDIxZjk2N2NiNTdkZjA1NWE0NjJfNS0zLTEtMS0zMDExNA_d47bbe47-2632-46d7-bcfa-c122ee4fee6c"
      unitRef="usd">923000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie43c9572619448f8a6ea6d852ea0af23_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83OS9mcmFnOjZjOGY3YzEwNmQwMDQ5MDc5OTkxYjhhOTE1MDZmOGNjL3RhYmxlOmJjN2Q3NTE5ZDdjODQyMWY5NjdjYjU3ZGYwNTVhNDYyL3RhYmxlcmFuZ2U6YmM3ZDc1MTlkN2M4NDIxZjk2N2NiNTdkZjA1NWE0NjJfNi0xLTEtMS0zMDExNA_c58ac205-f165-47eb-a078-3ed982dddfa0"
      unitRef="usd">339000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i18473ba8bdd846b583460be774dcc8c2_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83OS9mcmFnOjZjOGY3YzEwNmQwMDQ5MDc5OTkxYjhhOTE1MDZmOGNjL3RhYmxlOmJjN2Q3NTE5ZDdjODQyMWY5NjdjYjU3ZGYwNTVhNDYyL3RhYmxlcmFuZ2U6YmM3ZDc1MTlkN2M4NDIxZjk2N2NiNTdkZjA1NWE0NjJfNi0zLTEtMS0zMDExNA_d3284a2c-36e1-49e7-9789-dc7394fce290"
      unitRef="usd">294000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i30a463a582ff4b16971b766059a24eb9_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83OS9mcmFnOjZjOGY3YzEwNmQwMDQ5MDc5OTkxYjhhOTE1MDZmOGNjL3RhYmxlOmJjN2Q3NTE5ZDdjODQyMWY5NjdjYjU3ZGYwNTVhNDYyL3RhYmxlcmFuZ2U6YmM3ZDc1MTlkN2M4NDIxZjk2N2NiNTdkZjA1NWE0NjJfNy0xLTEtMS0zMDExNA_0977fb05-3e06-4181-8629-0b1187ed5f7c"
      unitRef="usd">359000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i02afafae5dac4c4eb5370132cc85ab08_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83OS9mcmFnOjZjOGY3YzEwNmQwMDQ5MDc5OTkxYjhhOTE1MDZmOGNjL3RhYmxlOmJjN2Q3NTE5ZDdjODQyMWY5NjdjYjU3ZGYwNTVhNDYyL3RhYmxlcmFuZ2U6YmM3ZDc1MTlkN2M4NDIxZjk2N2NiNTdkZjA1NWE0NjJfNy0zLTEtMS0zMDExNA_96b28f93-0e01-47d4-97e9-87ffd33154c4"
      unitRef="usd">331000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5987fc4c9ed94d95b32a6ba071848996_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83OS9mcmFnOjZjOGY3YzEwNmQwMDQ5MDc5OTkxYjhhOTE1MDZmOGNjL3RhYmxlOmJjN2Q3NTE5ZDdjODQyMWY5NjdjYjU3ZGYwNTVhNDYyL3RhYmxlcmFuZ2U6YmM3ZDc1MTlkN2M4NDIxZjk2N2NiNTdkZjA1NWE0NjJfOC0xLTEtMS0zMDExNA_4f27f6fc-4b0b-4a5c-8668-51df155a3782"
      unitRef="usd">1674000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i59f03109bfe04c92a404a9157747174a_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83OS9mcmFnOjZjOGY3YzEwNmQwMDQ5MDc5OTkxYjhhOTE1MDZmOGNjL3RhYmxlOmJjN2Q3NTE5ZDdjODQyMWY5NjdjYjU3ZGYwNTVhNDYyL3RhYmxlcmFuZ2U6YmM3ZDc1MTlkN2M4NDIxZjk2N2NiNTdkZjA1NWE0NjJfOC0zLTEtMS0zMDExNA_56c802f3-146f-4775-bfd7-7c62f2a47c82"
      unitRef="usd">1548000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:OperatingIncomeLoss
      contextRef="i6d58196320f34869a29143308907c47f_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83OS9mcmFnOjZjOGY3YzEwNmQwMDQ5MDc5OTkxYjhhOTE1MDZmOGNjL3RhYmxlOmJjN2Q3NTE5ZDdjODQyMWY5NjdjYjU3ZGYwNTVhNDYyL3RhYmxlcmFuZ2U6YmM3ZDc1MTlkN2M4NDIxZjk2N2NiNTdkZjA1NWE0NjJfMTEtMS0xLTEtMzAxMTQ_347d6652-2c9b-43ba-a64b-0621e754457c"
      unitRef="usd">282000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="if71b40dd3f5f49bf86fbcfa04c9c081e_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83OS9mcmFnOjZjOGY3YzEwNmQwMDQ5MDc5OTkxYjhhOTE1MDZmOGNjL3RhYmxlOmJjN2Q3NTE5ZDdjODQyMWY5NjdjYjU3ZGYwNTVhNDYyL3RhYmxlcmFuZ2U6YmM3ZDc1MTlkN2M4NDIxZjk2N2NiNTdkZjA1NWE0NjJfMTEtMy0xLTEtMzAxMTQ_a22980a3-f2c9-41fe-b9a8-c844869a7084"
      unitRef="usd">265000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ie43c9572619448f8a6ea6d852ea0af23_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83OS9mcmFnOjZjOGY3YzEwNmQwMDQ5MDc5OTkxYjhhOTE1MDZmOGNjL3RhYmxlOmJjN2Q3NTE5ZDdjODQyMWY5NjdjYjU3ZGYwNTVhNDYyL3RhYmxlcmFuZ2U6YmM3ZDc1MTlkN2M4NDIxZjk2N2NiNTdkZjA1NWE0NjJfMTItMS0xLTEtMzAxMTQ_64db14ac-719d-4a0d-9c10-09697e7f449b"
      unitRef="usd">68000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i18473ba8bdd846b583460be774dcc8c2_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83OS9mcmFnOjZjOGY3YzEwNmQwMDQ5MDc5OTkxYjhhOTE1MDZmOGNjL3RhYmxlOmJjN2Q3NTE5ZDdjODQyMWY5NjdjYjU3ZGYwNTVhNDYyL3RhYmxlcmFuZ2U6YmM3ZDc1MTlkN2M4NDIxZjk2N2NiNTdkZjA1NWE0NjJfMTItMy0xLTEtMzAxMTQ_570c91dd-fc83-4227-bd2f-825e845f9e57"
      unitRef="usd">55000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i30a463a582ff4b16971b766059a24eb9_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83OS9mcmFnOjZjOGY3YzEwNmQwMDQ5MDc5OTkxYjhhOTE1MDZmOGNjL3RhYmxlOmJjN2Q3NTE5ZDdjODQyMWY5NjdjYjU3ZGYwNTVhNDYyL3RhYmxlcmFuZ2U6YmM3ZDc1MTlkN2M4NDIxZjk2N2NiNTdkZjA1NWE0NjJfMTMtMS0xLTEtMzAxMTQ_e6d969f1-44da-4897-a206-f36f1abdd9c6"
      unitRef="usd">91000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i02afafae5dac4c4eb5370132cc85ab08_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83OS9mcmFnOjZjOGY3YzEwNmQwMDQ5MDc5OTkxYjhhOTE1MDZmOGNjL3RhYmxlOmJjN2Q3NTE5ZDdjODQyMWY5NjdjYjU3ZGYwNTVhNDYyL3RhYmxlcmFuZ2U6YmM3ZDc1MTlkN2M4NDIxZjk2N2NiNTdkZjA1NWE0NjJfMTMtMy0xLTEtMzAxMTQ_f0d60acb-dffc-417c-84c0-cf4d50fa8e97"
      unitRef="usd">76000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i5987fc4c9ed94d95b32a6ba071848996_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83OS9mcmFnOjZjOGY3YzEwNmQwMDQ5MDc5OTkxYjhhOTE1MDZmOGNjL3RhYmxlOmJjN2Q3NTE5ZDdjODQyMWY5NjdjYjU3ZGYwNTVhNDYyL3RhYmxlcmFuZ2U6YmM3ZDc1MTlkN2M4NDIxZjk2N2NiNTdkZjA1NWE0NjJfMTQtMS0xLTEtMzAxMTQ_ec4895db-7bac-4615-9889-58b25385aeb1"
      unitRef="usd">441000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i59f03109bfe04c92a404a9157747174a_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83OS9mcmFnOjZjOGY3YzEwNmQwMDQ5MDc5OTkxYjhhOTE1MDZmOGNjL3RhYmxlOmJjN2Q3NTE5ZDdjODQyMWY5NjdjYjU3ZGYwNTVhNDYyL3RhYmxlcmFuZ2U6YmM3ZDc1MTlkN2M4NDIxZjk2N2NiNTdkZjA1NWE0NjJfMTQtMy0xLTEtMzAxMTQ_30f3e155-2cba-4a51-acb6-437cfa4cec9d"
      unitRef="usd">396000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83OS9mcmFnOjZjOGY3YzEwNmQwMDQ5MDc5OTkxYjhhOTE1MDZmOGNjL3RleHRyZWdpb246NmM4ZjdjMTA2ZDAwNDkwNzk5OTFiOGE5MTUwNmY4Y2NfODM1Mg_cf6bb0ad-acdd-4ae1-be0f-4e9cb047703f">&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table reconciles segment income from operations to Agilent&#x2019;s total enterprise income before taxes:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:77.116%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.428%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;January 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in&#160;millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total segment income from operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;441&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transformational initiatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of intangible assets related to business combinations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(51)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(44)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition and integration costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in fair value of contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other income (expense), net &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income before taxes, as reported&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-indent:4.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-indent:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1) For the three months ended January&#160;31, 2022 and 2021, other income (expense), net includes net (gains) losses on the fair value of equity securities.&lt;/span&gt;&lt;/div&gt;</us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock>
    <a:Segmentincomelossfromoperations
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83OS9mcmFnOjZjOGY3YzEwNmQwMDQ5MDc5OTkxYjhhOTE1MDZmOGNjL3RhYmxlOmJjYTBlMWU5ZGNhMDRmMzhiYjk2YjRjZGI2ZWQ3NTcyL3RhYmxlcmFuZ2U6YmNhMGUxZTlkY2EwNGYzOGJiOTZiNGNkYjZlZDc1NzJfNC0xLTEtMS0zMDExNA_b0a15e65-9f57-4fb2-a4b6-1905916bb886"
      unitRef="usd">441000000</a:Segmentincomelossfromoperations>
    <a:Segmentincomelossfromoperations
      contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83OS9mcmFnOjZjOGY3YzEwNmQwMDQ5MDc5OTkxYjhhOTE1MDZmOGNjL3RhYmxlOmJjYTBlMWU5ZGNhMDRmMzhiYjk2YjRjZGI2ZWQ3NTcyL3RhYmxlcmFuZ2U6YmNhMGUxZTlkY2EwNGYzOGJiOTZiNGNkYjZlZDc1NzJfNC0zLTEtMS0zMDExNA_b5fa16e1-cf4d-4401-af48-f582cc077d2b"
      unitRef="usd">396000000</a:Segmentincomelossfromoperations>
    <a:TransformationalPrograms
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83OS9mcmFnOjZjOGY3YzEwNmQwMDQ5MDc5OTkxYjhhOTE1MDZmOGNjL3RhYmxlOmJjYTBlMWU5ZGNhMDRmMzhiYjk2YjRjZGI2ZWQ3NTcyL3RhYmxlcmFuZ2U6YmNhMGUxZTlkY2EwNGYzOGJiOTZiNGNkYjZlZDc1NzJfNS0xLTEtMS0zMDExNA_9968f028-80dd-4121-9c3f-8dad8ccdbff0"
      unitRef="usd">4000000</a:TransformationalPrograms>
    <a:TransformationalPrograms
      contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83OS9mcmFnOjZjOGY3YzEwNmQwMDQ5MDc5OTkxYjhhOTE1MDZmOGNjL3RhYmxlOmJjYTBlMWU5ZGNhMDRmMzhiYjk2YjRjZGI2ZWQ3NTcyL3RhYmxlcmFuZ2U6YmNhMGUxZTlkY2EwNGYzOGJiOTZiNGNkYjZlZDc1NzJfNS0zLTEtMS0zMDExNA_50a2b8fa-03f4-419d-8a41-e6813c17c050"
      unitRef="usd">11000000</a:TransformationalPrograms>
    <us-gaap:AdjustmentForAmortization
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83OS9mcmFnOjZjOGY3YzEwNmQwMDQ5MDc5OTkxYjhhOTE1MDZmOGNjL3RhYmxlOmJjYTBlMWU5ZGNhMDRmMzhiYjk2YjRjZGI2ZWQ3NTcyL3RhYmxlcmFuZ2U6YmNhMGUxZTlkY2EwNGYzOGJiOTZiNGNkYjZlZDc1NzJfNi0xLTEtMS0zMDExNA_4a8b6085-28f2-4308-82cf-806cf5d821bc"
      unitRef="usd">51000000</us-gaap:AdjustmentForAmortization>
    <us-gaap:AdjustmentForAmortization
      contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83OS9mcmFnOjZjOGY3YzEwNmQwMDQ5MDc5OTkxYjhhOTE1MDZmOGNjL3RhYmxlOmJjYTBlMWU5ZGNhMDRmMzhiYjk2YjRjZGI2ZWQ3NTcyL3RhYmxlcmFuZ2U6YmNhMGUxZTlkY2EwNGYzOGJiOTZiNGNkYjZlZDc1NzJfNi0zLTEtMS0zMDExNA_6f8146cb-20dc-49d8-b8e3-5ad60561b6ed"
      unitRef="usd">44000000</us-gaap:AdjustmentForAmortization>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83OS9mcmFnOjZjOGY3YzEwNmQwMDQ5MDc5OTkxYjhhOTE1MDZmOGNjL3RhYmxlOmJjYTBlMWU5ZGNhMDRmMzhiYjk2YjRjZGI2ZWQ3NTcyL3RhYmxlcmFuZ2U6YmNhMGUxZTlkY2EwNGYzOGJiOTZiNGNkYjZlZDc1NzJfNy0xLTEtMS0zMDExNA_759110d7-6f22-4669-945b-2b99e082a9e5"
      unitRef="usd">7000000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83OS9mcmFnOjZjOGY3YzEwNmQwMDQ5MDc5OTkxYjhhOTE1MDZmOGNjL3RhYmxlOmJjYTBlMWU5ZGNhMDRmMzhiYjk2YjRjZGI2ZWQ3NTcyL3RhYmxlcmFuZ2U6YmNhMGUxZTlkY2EwNGYzOGJiOTZiNGNkYjZlZDc1NzJfNy0zLTEtMS0zMDExNA_557d7939-15ff-46bc-b03e-3092bbacc25b"
      unitRef="usd">9000000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83OS9mcmFnOjZjOGY3YzEwNmQwMDQ5MDc5OTkxYjhhOTE1MDZmOGNjL3RhYmxlOmJjYTBlMWU5ZGNhMDRmMzhiYjk2YjRjZGI2ZWQ3NTcyL3RhYmxlcmFuZ2U6YmNhMGUxZTlkY2EwNGYzOGJiOTZiNGNkYjZlZDc1NzJfOS0xLTEtMS00NjI1NA_80ddbcab-f351-44b0-a8d3-fafee20ada21"
      unitRef="usd">3000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease
      contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83OS9mcmFnOjZjOGY3YzEwNmQwMDQ5MDc5OTkxYjhhOTE1MDZmOGNjL3RhYmxlOmJjYTBlMWU5ZGNhMDRmMzhiYjk2YjRjZGI2ZWQ3NTcyL3RhYmxlcmFuZ2U6YmNhMGUxZTlkY2EwNGYzOGJiOTZiNGNkYjZlZDc1NzJfOS0zLTEtMS00NjI1NA_12ad8b15-cf4a-4d67-a65b-edc59de6255d"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease>
    <a:Other
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83OS9mcmFnOjZjOGY3YzEwNmQwMDQ5MDc5OTkxYjhhOTE1MDZmOGNjL3RhYmxlOmJjYTBlMWU5ZGNhMDRmMzhiYjk2YjRjZGI2ZWQ3NTcyL3RhYmxlcmFuZ2U6YmNhMGUxZTlkY2EwNGYzOGJiOTZiNGNkYjZlZDc1NzJfMTQtMS0xLTEtMzAxMTQ_541cb2b7-bf08-4377-959f-937a51e94674"
      unitRef="usd">0</a:Other>
    <a:Other
      contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83OS9mcmFnOjZjOGY3YzEwNmQwMDQ5MDc5OTkxYjhhOTE1MDZmOGNjL3RhYmxlOmJjYTBlMWU5ZGNhMDRmMzhiYjk2YjRjZGI2ZWQ3NTcyL3RhYmxlcmFuZ2U6YmNhMGUxZTlkY2EwNGYzOGJiOTZiNGNkYjZlZDc1NzJfMTQtMy0xLTEtMzAxMTQ_819f1f88-37aa-4b80-8d27-0f63f1e6e7fa"
      unitRef="usd">-4000000</a:Other>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83OS9mcmFnOjZjOGY3YzEwNmQwMDQ5MDc5OTkxYjhhOTE1MDZmOGNjL3RhYmxlOmJjYTBlMWU5ZGNhMDRmMzhiYjk2YjRjZGI2ZWQ3NTcyL3RhYmxlcmFuZ2U6YmNhMGUxZTlkY2EwNGYzOGJiOTZiNGNkYjZlZDc1NzJfMTUtMS0xLTEtMzAxMTQ_e7e34303-19c7-4756-bddb-702c505fde6e"
      unitRef="usd">1000000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83OS9mcmFnOjZjOGY3YzEwNmQwMDQ5MDc5OTkxYjhhOTE1MDZmOGNjL3RhYmxlOmJjYTBlMWU5ZGNhMDRmMzhiYjk2YjRjZGI2ZWQ3NTcyL3RhYmxlcmFuZ2U6YmNhMGUxZTlkY2EwNGYzOGJiOTZiNGNkYjZlZDc1NzJfMTUtMy0xLTEtMzAxMTQ_1f6e1604-d099-4460-9c18-87bd433361f1"
      unitRef="usd">0</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InterestExpense
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83OS9mcmFnOjZjOGY3YzEwNmQwMDQ5MDc5OTkxYjhhOTE1MDZmOGNjL3RhYmxlOmJjYTBlMWU5ZGNhMDRmMzhiYjk2YjRjZGI2ZWQ3NTcyL3RhYmxlcmFuZ2U6YmNhMGUxZTlkY2EwNGYzOGJiOTZiNGNkYjZlZDc1NzJfMTYtMS0xLTEtMzAxMTQ_1a5ff83e-9b52-474a-88d5-509d89731701"
      unitRef="usd">21000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83OS9mcmFnOjZjOGY3YzEwNmQwMDQ5MDc5OTkxYjhhOTE1MDZmOGNjL3RhYmxlOmJjYTBlMWU5ZGNhMDRmMzhiYjk2YjRjZGI2ZWQ3NTcyL3RhYmxlcmFuZ2U6YmNhMGUxZTlkY2EwNGYzOGJiOTZiNGNkYjZlZDc1NzJfMTYtMy0xLTEtMzAxMTQ_1b161b87-91bb-4524-9290-b31123a9cc70"
      unitRef="usd">19000000</us-gaap:InterestExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83OS9mcmFnOjZjOGY3YzEwNmQwMDQ5MDc5OTkxYjhhOTE1MDZmOGNjL3RhYmxlOmJjYTBlMWU5ZGNhMDRmMzhiYjk2YjRjZGI2ZWQ3NTcyL3RhYmxlcmFuZ2U6YmNhMGUxZTlkY2EwNGYzOGJiOTZiNGNkYjZlZDc1NzJfMTctMS0xLTEtMzAxMTQ_b0cfbf81-24f9-495e-a5c9-f045123d944e"
      unitRef="usd">-37000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83OS9mcmFnOjZjOGY3YzEwNmQwMDQ5MDc5OTkxYjhhOTE1MDZmOGNjL3RhYmxlOmJjYTBlMWU5ZGNhMDRmMzhiYjk2YjRjZGI2ZWQ3NTcyL3RhYmxlcmFuZ2U6YmNhMGUxZTlkY2EwNGYzOGJiOTZiNGNkYjZlZDc1NzJfMTctMy0xLTEtMzAxMTQ_7fa540ea-970d-48ea-8e6d-43c92e0cd529"
      unitRef="usd">3000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83OS9mcmFnOjZjOGY3YzEwNmQwMDQ5MDc5OTkxYjhhOTE1MDZmOGNjL3RhYmxlOmJjYTBlMWU5ZGNhMDRmMzhiYjk2YjRjZGI2ZWQ3NTcyL3RhYmxlcmFuZ2U6YmNhMGUxZTlkY2EwNGYzOGJiOTZiNGNkYjZlZDc1NzJfMTgtMS0xLTEtMzAxMTQ_166073cc-1924-4c5b-b930-995811fa1c06"
      unitRef="usd">319000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ic11d4d061d3a400ba0dafeeb0e75a9a0_D20201101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83OS9mcmFnOjZjOGY3YzEwNmQwMDQ5MDc5OTkxYjhhOTE1MDZmOGNjL3RhYmxlOmJjYTBlMWU5ZGNhMDRmMzhiYjk2YjRjZGI2ZWQ3NTcyL3RhYmxlcmFuZ2U6YmNhMGUxZTlkY2EwNGYzOGJiOTZiNGNkYjZlZDc1NzJfMTgtMy0xLTEtMzAxMTQ_9c36e742-2df5-4079-8920-3f67b64f13cf"
      unitRef="usd">312000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:Assets
      contextRef="ifa12471462934aa683c02dac2a2b2a70_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83OS9mcmFnOjZjOGY3YzEwNmQwMDQ5MDc5OTkxYjhhOTE1MDZmOGNjL3RhYmxlOmVkY2IyMTg2ZTU1NjQ2MDlhMWNjZWJkMjVhOGRmN2VkL3RhYmxlcmFuZ2U6ZWRjYjIxODZlNTU2NDYwOWExY2NlYmQyNWE4ZGY3ZWRfMy0xLTEtMS0zMDExNA_1485ff02-3970-4991-adba-ca1bbc1b8240"
      unitRef="usd">3752000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i944f468c66a14978a1d1787de51efa6c_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83OS9mcmFnOjZjOGY3YzEwNmQwMDQ5MDc5OTkxYjhhOTE1MDZmOGNjL3RhYmxlOmVkY2IyMTg2ZTU1NjQ2MDlhMWNjZWJkMjVhOGRmN2VkL3RhYmxlcmFuZ2U6ZWRjYjIxODZlNTU2NDYwOWExY2NlYmQyNWE4ZGY3ZWRfMy0zLTEtMS0zMDExNA_52b7e76a-a1b7-4c64-81d4-b0339c8c9601"
      unitRef="usd">3741000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="idcc96fc9ea6041bab3a0329c8a379a8d_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83OS9mcmFnOjZjOGY3YzEwNmQwMDQ5MDc5OTkxYjhhOTE1MDZmOGNjL3RhYmxlOmVkY2IyMTg2ZTU1NjQ2MDlhMWNjZWJkMjVhOGRmN2VkL3RhYmxlcmFuZ2U6ZWRjYjIxODZlNTU2NDYwOWExY2NlYmQyNWE4ZGY3ZWRfNC0xLTEtMS0zMDExNA_acf484f4-138b-4076-a14b-26ca3acbab2a"
      unitRef="usd">3325000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ib2f7270de94a4e99a7412adaded44a2d_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83OS9mcmFnOjZjOGY3YzEwNmQwMDQ5MDc5OTkxYjhhOTE1MDZmOGNjL3RhYmxlOmVkY2IyMTg2ZTU1NjQ2MDlhMWNjZWJkMjVhOGRmN2VkL3RhYmxlcmFuZ2U6ZWRjYjIxODZlNTU2NDYwOWExY2NlYmQyNWE4ZGY3ZWRfNC0zLTEtMS0zMDExNA_d8962ab3-4364-433f-b05a-16bb7bcb1124"
      unitRef="usd">3320000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ia895e40152014164ae9414ff9f88a43e_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83OS9mcmFnOjZjOGY3YzEwNmQwMDQ5MDc5OTkxYjhhOTE1MDZmOGNjL3RhYmxlOmVkY2IyMTg2ZTU1NjQ2MDlhMWNjZWJkMjVhOGRmN2VkL3RhYmxlcmFuZ2U6ZWRjYjIxODZlNTU2NDYwOWExY2NlYmQyNWE4ZGY3ZWRfNS0xLTEtMS0zMDExNA_cf627d9b-a43c-446c-b626-252e07b75749"
      unitRef="usd">870000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ib1434e5353934a0ebeb33b6c28613a50_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83OS9mcmFnOjZjOGY3YzEwNmQwMDQ5MDc5OTkxYjhhOTE1MDZmOGNjL3RhYmxlOmVkY2IyMTg2ZTU1NjQ2MDlhMWNjZWJkMjVhOGRmN2VkL3RhYmxlcmFuZ2U6ZWRjYjIxODZlNTU2NDYwOWExY2NlYmQyNWE4ZGY3ZWRfNS0zLTEtMS0zMDExNA_503b0eee-fd62-4800-8c38-a9881d883ce6"
      unitRef="usd">839000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="if9eb3aa4cefc47e4b1504ff02a1447b6_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83OS9mcmFnOjZjOGY3YzEwNmQwMDQ5MDc5OTkxYjhhOTE1MDZmOGNjL3RhYmxlOmVkY2IyMTg2ZTU1NjQ2MDlhMWNjZWJkMjVhOGRmN2VkL3RhYmxlcmFuZ2U6ZWRjYjIxODZlNTU2NDYwOWExY2NlYmQyNWE4ZGY3ZWRfNi0xLTEtMS0zMDExNA_c856beaa-f186-46f3-a4cd-3b0e542ba22f"
      unitRef="usd">7947000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i105ea30704ee4603b6db5fd253f01d92_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY4MjVjOTFmMTVhMDQ3ZWM5ZTY3ZTAxODk2MzRhMzQ5L3NlYzpmODI1YzkxZjE1YTA0N2VjOWU2N2UwMTg5NjM0YTM0OV83OS9mcmFnOjZjOGY3YzEwNmQwMDQ5MDc5OTkxYjhhOTE1MDZmOGNjL3RhYmxlOmVkY2IyMTg2ZTU1NjQ2MDlhMWNjZWJkMjVhOGRmN2VkL3RhYmxlcmFuZ2U6ZWRjYjIxODZlNTU2NDYwOWExY2NlYmQyNWE4ZGY3ZWRfNi0zLTEtMS0zMDExNA_41a0036a-2198-43d4-804c-c39357409530"
      unitRef="usd">7900000000</us-gaap:Assets>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>88
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
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M.?IT8Y J/I,1ZB'4Y0 .K83/C.Z2H@64B(<1[0<==ADZ6Z5K@_P>3%U?H+W
MJ')JV21!IU*BD=?F,AGU;6%=7F!XLFVH1DVJ3-EX60HJU$4!VJO"+>9)9$RV
M] N;V_UR[(V/_K5S_R.?8V)=&*"],LR3="O:K6'%/#9^OTUYPNJXS=2E +G6
M*?I5_.5 9$W=R3JP(H?N>,OE,]D3R\G;;(6LP$H^.I-I:X^05GID5_K>V41=
M\?;<MH@:C8*><=$:C^P:;YDOU%5MSVU/E]&H9Q4A+>W(+NU2D.)M)&RCKN47
M^5_1TR.MELBNEB>Z^LK[J&-'06?<#%8P[%%RI"42!5_8V2.M<,C>07^BMT?=
MKGCH#]MI&XQZEXN6272J>6:[)")%WD578,M92QD:?\7"\;0&>?9V],3"\;KM
MI0_;*F P:C:JQV1:F3SXA<O&T^KBV=7E$\NFBG!4D3MMC\FH(9 EG=,X;\D(
M6Q7'4%PJ^S87Y8E$_;0^ZKHI#GA:SV_AU:P\L-)ARO.S!\Q62<Y!2I8RI'L9
MRGE@Y9%4>2/HICC5>:="T*RX7!,<$Z8,Y/LEI>)PHSY0'PQ._P=02P,$%
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MKY2B8O43C")"(U.L MZ+M#2BDD3D(]'WD.B?L#BWZ21^&H.:QJ Q$6QVX@N
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MK(-ANI:A)#[(:3=;6T-^6],?D>;OZ",":W</PR P"B#!)YR7F!^:0Y2J\V&
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M=;DE6%58 ]3[#5.&5M_H,^;F?PJ+?P%02P,$%     @ 18AC5%S<PH#K @
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M;"]W;W)K<VAE971S+W-H965T-RYX;6REF5UOV[@2AO\*8>Q%"]2U]>'8*9(
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MQF_(^$8R<UQ$((R?XY!PZ>"=0Y#P\R+4G;F^,OO0G4C9,F,Z#"<-PXF187F
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MI*S7+E&6*B9*L3!RX9IR*@VVN#,S',)4V0#<GTEI-@N;H!KKG3]02P,$%
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MQ+?6YD@B$C9+Q3*3.63)B!O[H)SA:DDF"?Y2"'_0SO):HPXM@SH7I"=3)!/
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MSZW"S.UH YZOK0WM#2GHODQ?_Q=02P,$%     @ 18AC5.8QZ:Z$"0  _1<
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MR0#7"X<S;'=# 8;/F_G?4$L#!!0    ( $6(8U1E=OU'?@0  *,*   9
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MW7PZN9[2NROCV;T_''KL$.R&61?MM(V6OA%M3)=&^\+15.></_4? ED/+]W
M.TVW!OQ#Z &-]W8H':7IEGCC/MUQC#=^(]Y46"WUTM&,+=T4PC+]<S)WWD(=
M_VZ)O]_'WX_Q][^!SM=HW!HE',2)JT3&1PE.FF.[XN3U2MT63 NC<+20%4E'
M B<E,SJ32HHH>[,@#R-=EVR%-Y:$SB%;;2"F..\,(&V9M8M2U9YSTF@)4F>F
M9*K EHML85K5/H9VV-E&7RQ+DSN*8'7PG8?3/@$\R_Q$$X2*UCC]?5'#8X_>
M20UU*Q7"OJ>K#=@)73V ^)'2@W%\'M#Y0P(3.HW0FW@ .=\5*S@ON07L:#S:
MP^\CS:!I[:50(8<2S+3K/_UPD.ZEOQ%.6G9'IFHS"SP8I&:)RTJ9-;)H#2HE
ML)S2F,X[FM[>=XS?K[%$D5)T'^+% NTH<!ZM=D-#R4DTPH(^E \M*?0KO ,A
M6PLQ7Y.H*B6S)V7V:,RN!KTMVI)]8?(=:@J9%2&&JG- @T"<S /%G6NM16FL
ME_]AM\? 0K71@%L[O@]CCMSXUY.2>A<KNV"7UT^XU$;OKMB%;,"-MS+FV(*L
MM<1WA3Y#'G9;$F$),&OMX[ O3(DN29581SGR/=M,NG :7E;TF])$9XV?CA4K
M4 W&A<.7"]:5-1DSZN4-=$YUB("AY:JV68& 5*RK(!Z/XJA.#@,ZT:$ (34.
MQ0TI+(2T:.;V#@5>"57SIHP!D-#KGUVOU9A+)L*'T.&#$R((6B*:!VG/*[&P
MIJ1JHW? [PU:I0WH"VSOHQJ>T=1(7VQ(A-Q0*.AELX\O1 M\(_4.>S0+V$UM
MGR*.2&)&0F6UZ@6WD39O^O$C87,FP&GP CM=1HVI5>@J**.7NYMT!G0!&O)<
MAK!0^4-2W['O$QYV:'HSF^W0G[>S693."]5V9[8I3-1*.4</SY\Q]T)TL>!M
MI1O&GM]/[!:6A'+F%:I>^[H-'UT<T'*7\7H41(=#UMXA^K?]#>RDO7@\F+?7
MMTMAEQ("4KR ZVCPRX>$;'LE:B?>5/$:,C<>EYHX+'"+9!L,L+XP$&PW"1OT
M]]+C_P%02P,$%     @ 18AC5$HZ-Q5N @  +@4  !D   !X;"]W;W)K<VAE
M971S+W-H965T,38N>&ULA53O3]LP$/U73A$?0$(D34HI55N),M"81*E@8YJF
M?7"22V+AV)GM4OCO.3MI5B3HOCC^<>_YW>6>IQNEGTR%:.&E%M+,@LK:9A*&
M)JNP9N9$-2CII%"Z9I:6N@Q-HY'E'E2+,(ZB45@S+H/YU.^M]'RJUE9PB2L-
M9EW73+\N4*C-+!@$VXU[7E;6;83S:<-*?$#[HUEI6H4]2\YKE(8K"1J+67 Q
MF"R&+MX'/'+<F)TYN$Q2I9[<XB:?!9$3A (SZQ@8?9[Q$H5P1"3C;\<9]%<Z
MX.Y\RW[M<Z=<4F;P4HF?/+?5+!@'D&/!UL+>J\U7[/(Y=7R9$L:/L&ECXU$
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M:&5E=',O<VAE970Q-RYX;6RM6&%/Z[@2_2M6'UK=*_6V3=/2E@M(Y<*RK%A
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M1YZ5@G&<N23DC >-(]2A./,TE737>Q9B1.=9)J3F42@2A?4$R4\N69X!CS>
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MAW[CETN!?F1H Y[/M7;U!1EH/MT=_Q=02P,$%     @ 18AC5([3SWX2#0
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M$G5__.B6G46<*:1[P\4?!,HI0>0LFBET[B]39,'E/[_AX/4"9T1:XBSYDV[
M? &T48=QM4=5(0K$:VI2HD_>"I ]&.@9NX-YT $;-,JFPO'M75#?]>]Y^Y9,
M*U)<3/F6*,4QY2?._>E+%]OFYQRU/OM[K@!(E9^*>A7S%"49&$6-I&WMYE5A
M>&-@T Y3?.F0T_4]O4[!M5I(_3R@FB0G@-GU\WF.WO[Z!EVCMNWMU)NN6&WO
M=KG@J-"AQH7A>K<K:^?WJ(^&][G2^LU4#[:NM>Y5G-4WR<815' O$X:."U7D
MO)NQV]A=2_B251;WKAEO8,LF=9S;7<A54%$R_MB8.!#:WC93B74,O7*R=<&:
MO'RR"^Y9GLWA_6"=7UERKMIFN'\0= >^'</._FA\LE9?X\%Q?RT=WOX(FUL?
MWJV_M.CN,'9M)'!WC/4VCB,D/Q=IT2=DY62DXMO"#E-;+7'SKE%;\(4X+;BB
M^L3/@E+E]<WP$.$WUC0$H3O5P6_RM .?](Y;%M!+Y2$)7NKS4VRXDEZ8X-N%
M5WO8L_W[!8G/<W_=>:"?_K3][4'/ZU"=&==>4Y"Q/P_\7Z<=8:F\!NVA[Y=R
M_^H0:]V@.[7#OE?5CI*7 4N%<H]>>40E16[MWPN,3^-;E>?^9<)NN7\E\QVJ
M16I8"S7'UN/AHY,]8?UKCOY+;9;\:N',U+4I^>,"P: L+<#O<P/CAB]T0'S7
M]-E_ %!+ P04    " !%B&-4)0BLCG0,  #]*@  &0   'AL+W=O<FMS:&5E
M=',O<VAE970Q.2YX;6S-6FMSV[@5_2L8U].19Y3(DA^QLTEF;"?NNOO*Q&DR
MG4X_0"0D8D,16@"TK/SZGGL!4J0DRO9NMNT'6Y0(W.>Y#USRU<+8+RY3RHO[
M65ZXUWN9]_.7@X%+,C63[KF9JP)W)L;.I,=7.QVXN54RY4VS?# Z/#P=S*0N
M]MZ\XM_>VS>O3.ES7:CW5KAR-I-V>:ERLWB]-]RK?OB@IYFG'P9O7LWE5-TJ
M_X_Y>XMO@YI*JF>J<-H4PJK)Z[V+X<O+8UK/"SYIM7"-:T&:C(WY0E]NTM=[
MAR20RE7BB8+$QYVZ4GE.A"#&;Y'F7LV2-C:O*^K7K#MT&4NGKDS^6:<^>[UW
MMB=2-9%E[C^8Q?<JZG-"]!*3._XO%F'M*18GI?-F%C=#@IDNPJ>\CW9H;#@[
M[-@PBAM&+'=@Q%*^E5Z^>67-0EA:#6ITP:KR;@BG"W+*K;>XJ['/OWG[[L/-
MIXN/-Y_>W8K>S\8K=_!JX$&8;@^22.0R$!EU$#D2/YG"9TZ\*U*5MO</(% M
MU:B2ZG*TD^#?9?%<' W[8G0X&NV@=U1K><3TCKJT5%;?2?*_N"F<MR5@Y9V0
M12J^5^E4%U-Q0?#07BLGWFJ7Y,:55HE_78RQ'-#Y]PXICFLICEF*XX=MO<W&
MC]XL/BLA(9RZGQNG4N&-0'0"?P408ZTJDB7N)9DLIDI8Z968Y&7B2TEQ$+36
MA5=6.1]NAZ4.OPJ?*5$0W'.1F-(Z)<Q$X$*,2P>)G'LN+IR82^NK&U:[+T!D
M@1 FJPJREU?395\LE"A!(%T97Z^,WQ=SJY$'=+XDZ1?2IN!8L+&#C//20C!2
MT,R#Y% T@[N@.5::F4YHW<!8Q#:$+3SYD8T"USFD#(?0I-\FULR:2NZV%E2\
MDBX3UTA8# ]L@L45F8P,M[)VO6TE>"TBF8;6)=)Y5D%9MC\9EJA/B/HW$?9C
MIF#E;IGZ8&BMAA#2BXG45MS)O%1]D4FX!(FMM 'W8^472A7"%(H=@&\YK>#8
MKOAL]R;C,54.$DA2E[;_5LI<3Y9"NH;&6;!GB41A&6P)F(.D!!R4PY>Q2BL<
MRM)G!K<#MVFI4UDD031B)YT#'K$<J@LUF2A.\(11(:>2A&,JS"I?-K$AU)VR
M2]A\;BS;',[1)GTND.C)4T43B8Z CH14HF;5.:F_'C,>E2K8E9;3+YT.B;&;
MY&5*PI.[65M6AT,(%"+.VUI%Q0$J,RWTUV"IQ#C>X60.<<Q=M"M,_[ H[-06
MV&IX5'MK$00;"X4TWM@*A"WR(3;+69DS+ PV6G"?P=D957;>C.]*])!QW0&R
MRXPBF>SN3*)YUT+[;!-"D5..A7JB0QILVR*Z!LJFX*4XOSB3 T9$U0%7JC)W
M'9Y.+"!8;;48O3!6X63H(PSTL0B'FXG0'C%#TB,C6C.6XQQ R*3?M7VA\QP9
MU@<Z?5X:G&U5'D3(]#PL&Y.5GZV%E:P,U+ K-'W0M#7)=:.%G=5:Q @9ZZ O
M"K2$E0DY]_@Z3J[:X-]$#4K%-MSL2!YMT#Q&IJ>YM4.3SX$SB@_=A>UFNIRA
MONE4]%8Q?4#$9!$+$1)DB "JG;A1%2K*%5A$@>RK7!*8-UVXF0UW)9/_>JZ(
M*JXR!.G!0F565<4 Q9#D6<^*S!47^-H 0"T/)V6^(D!RT7NLSU.8 E!M1$-$
MU)HM&XE[@0:' XW6 ^R)+*#-32&NU=BRV*/#X6E?7$QU3H94]RHI.5I9T=B3
M/ .>8HV0:%3TO4H'$%L1A._0O7#,M[LIMY!SQT4I-%.QZH>X)9GWCPX/T<OG
M.>G 7BD*564'I+I)Z:E(U53!.<0)+#"FBITJ@B!U&##VJ7"JT.!64/<NM',E
M9=I"W*HY(F$,FPY/^JSL S6<+;:UB.OMP/TC93R4'K(5<&H)_@TA0 IGG5 R
MMBD2["0KR[!1A[5-^RSYH@5^GVFNY9*.; HY((#PR04*Y4$G&:P,3Q JX%7
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M:&5E=',O<VAE970R,"YX;6RM5FV/XC80_BNC]%2QTI60P+Z( A+L4G6K+HN
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M^NG#'2VOW]/5%[Q??_QP?24C1]<N<GA]-HF().LG6>_ULO,Z?\;K@CX[&\M
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MXJ+/7A9@OG"X#_8?$F#WK\/%?U!+ P04    " !%B&-4U]$$'F($  !E"@
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M0*@P]QQ!T,\:+U I#D0POG<QDSXE.^X_;Z-_#-R)RU(XO##JJRQ\=9:\2Z#
ME6B5OS6;3]CQ.>%XN5$N_(=-M,U.$\A;YTW=.1."6NKX*QX['?8<WHU><<@Z
MARS@CHD"RDOAQ7QFS08L6U,T?@A4@S>!DYJ+<N<M[4KR\_.[3U]N[X_OKVZO
MX?+J_!Y^^\MX=+_/4D_!V23-NT#G,5#V2J )7!OM*P=7NL#BT#\E4#VR;(OL
M/'LSX&>AAS 9#R ;9=D;\28]TTF(-WF-:66L/_9H:[C$I8=_%DOG+77%OV\$
MG_;!IR'X].=D?$F^7PH %Q8+Z>&CR*627J*#+QJNA<TK&$]8D_'[ 6P04!,C
M+$!J;T! 'MU$:1%I=#QUDZ]HO;2F;<"L8"6UT+D4BCR<E[[EV7"PJ61>#4 X
M$.1&!1Q 8\U:TA/0Y%.$HS$LI5(\22N:H^,G%!9:[3!O.7^7>!7Q/H&O!"=7
M"O"QD1;!',+/IB TPR9'!DJ 0FF4$7H;A5E+&ESZ*XE0*3P2/-,2+6)"?(CR
MT<EH1',1@ U9HT5CI8(L]LWX!8WT05+AZ#AJX@&Q%8VXM]:U@O*00Y"&^."/
M*,1:2"66"H-&2V.I:Z0N298";7"QN#9JS6O/!=H(%X'0D5($)N/AY*37F,7Y
MB9S[5/94X^!TNEFD@R$$)R/!4OIG@BT<2TFCUM*)W$];4*T2!6BS8T66K7>>
M@!U2?$Z,D1_Z[6Q?ACN$KT@9+>]#;NI&2>I1C+T;4I@U4MMZ%SB_E+1H+:/B
M+5]1&:&.AU'HY1_X#>$A0#*MA8?AW9"3UFC#6#2BH1UJ_M**>M"EKQNAG^C8
M?0))_8*!(WU9U&X !N!VYPMYUV1H**7FXY1Y'1:3FI2FL.$&C&4E.ZX3/N9(
M@ ][(>@0VWWR_O2X$ S%$^,HWH*:@M UAOH[9**/YB%PVB A' ?@-O"A%?H^
M8O+2<U6VI9+>O=&YW4AV[>A!40M[P.\MS[")1/LI[6 <JAM%V6LG(A$\W!ZL
M7==TQ0CZ+['K+);<8B-D$:IA\7B[#BN2/Z@0X-#O$.YC&!;7Q7TN)'>9>SU1
MZ[K3KT2-EM#GQC;&AOJU].18_<M?ZKPP63W0"#QP.,JF_SN6+WVGTKU//XE<
MA@N.(Z2D9KP%]*O]'6H1KPX[\W@!H^.YI(\"U7-%KJ/AZ4D"-EYJXHLW3;A(
M+(VG:TEXK.@>B)8-:']EJ*[="R?H;Y;S_P!02P,$%     @ 18AC5*VXC(&/
M @  EP4  !D   !X;"]W;W)K<VAE971S+W-H965T,C,N>&ULC53;;MLP#/T5
MP1N&%FAK1W&;RY( 2=/=L%[09MO#L ?99F*ALN1)<M/NZT?)CI<4;; '69?#
M<T12)D=KI>]-#F#)8R&D&0>YM>4P#$V:0\',B2I!(K)4NF 6MWH5FE(#RSRI
M$"&-HK.P8%P&DY$_N]&3D:JLX!)N-#%543#]- .AUN.@$VP.;ODJM^X@G(Q*
MMH([L-_*&XV[L%7)> '2<"6)AN4XF':&L]C9>X/O'-9F:TU<)(E2]V[S.1L'
MD7,(!*36*3"<'N <A'!"Z,;O1C-HKW3$[?5&_8./'6-)F(%S)7[PS.;CH!^0
M#):L$O96K3]!$\^ITTN5,/Y+UK4M[04DK8Q514-&#PHNZYD]-GG8(O2C5PBT
M(5#O=WV1]W+.+)N,M%H3[:Q1S2U\J)Z-SG'I'N7.:D0Y\NSDZ_75Q^/%Q>TE
MF5_,%N3@2EDPAZ/0HK:S"--&9U;KT%=TNN1229L;<B$SR';Y(?K4.D8WCLWH
M7L$O3)Z0;N>(T(C2/7K=-M"NU^N^HC>'Q)(Y-ZE0IM) ?DX38S7^%+_VB,>M
M>.S%X__*XDO9V\MWE3<T)4MA'&!I&= /$#Q_FCN07&GB'X@L<B!+);"DN%P1
MRQ(!35WQ/PA;A%-5E$P^O7O3IYW>>T.$DJMC"[H@IE:23FE(,-$5EF.;:W*=
M6I6 WAQTR+10VJ)NMK4ZX!)_1R&PLLRA,^ON.G@Z&/B!R-DN0MWIH.^0P2X2
M#V(_:-2-GB-G?B#2V47Z,?5CH2P3Y"VA1STD^QGE7WK:<*M8"M KWQ(,IJN2
MMJZ;]K3M.M.ZV/Z9URWKDND5EYA:6"(U.NF=!D37;:#>6%7ZTDN4Q4+VRQP[
M)VAG@/A281#-QEW0]N+)7U!+ P04    " !%B&-40 OU<-(&  "%%   &0
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M7U.3)=(ZA/M;J?PC<;3TS_.%\Q9%\J\]9F:MF5DP,WL%JC6HV\!\O9(V-2$
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M0"WS KQ?&N.;!S;0WCR>_0Y02P,$%     @ 18AC5$ $(_)8$   [RP  !D
M  !X;"]W;W)K<VAE971S+W-H965T,C4N>&ULM5II<QNY$?TK*&8KD:NHBY(L
MR[)=)9^KS<IVK;S)AU0^@#,@B6AF, 8PDKB_/J\;P QX2*O-\<$6R<'1Z./U
MZ\:\NC/VQBV4\N*^KAKW>K3POGVYO^^*A:JEVS.M:O!D9FPM/;[:^;YKK9(E
M3ZJK_<G!P?/]6NIF].85__;5OGEE.E_I1GVUPG5U+>WRK:K,W>O1X2C]\(N>
M+SS]L/_F52OGZEKY7]NO%M_V^U5*7:O&:=,(JV:O1Q>'+]\>TW@>\#>M[ESV
M6=!)IL;<T)?+\O7H@ 12E2H\K2#QYU:]4U5%"T&,[W'-4;\E3<P_I]4_\MEQ
MEJETZIVI_JY+OW@]>C$2I9K)KO*_F+L?53S/":U7F,KQ_^(NC)V<C431.6_J
M.!D2U+H)?^5]U$,VX<7! Q,F<<*$Y0X;L93OI9=O7EES)RR-QFKT@8_*LR&<
M;L@HU][BJ<8\_^;ZPZ>K#Y^_B<O/'[_\<G7Q[?++9['SV7CEGKW:]]B ANT7
M<;&W8;') XL=B2O3^(43'YI2E:OS]R%8+]TD2?=V\NB"/\EF3QP=CL7D8#)Y
M9+VC_K1'O-[10Z=5<SB4%[^HUEBOF[GXQ\74>0O?^.<CRQ_WRQ_S\L=/5^8V
M)3ZZ"$7A2]?*0KT>(<R<LK=JM-5,[Y4KK&[9N<U,N' VMR?^KH2T^"?FE9G*
M2E0(5F6%;D2E9TJX0JNF4&XL2BWGC7%>%T[(IA2R;2NM2D&1KPO,1)S>*(^1
MK36WNB2%\9A"\JXS P_%>&>JCGYPPB^DQT9%U94*?Z':CH4:8\S,WT$L?,*1
M-/;G+0O,ZFHYK? =$(,%E, $#?DK.356>F.7'-DSX,>>N&QXR$Q;Y\7W3EJ/
MD^'T,^U(X*62EIUE+.Z@@:8Q'8Z*D^%,LIF33 (()AO]&Q\!4TC&PG?8L%1.
MSQN,]@8RD$S"=%;,X05^0>.D5W,=!<=7U<PA2\.#6!4".@DQJRSL\ 6_LRHQ
MMI_6L8Z=F'8.AG?A5UK!JJ!M[)\I;AA7FUL\FEE3\_"+N:[(E=]9X]S/<CH,
MC(Y IZ"!*S9?,7.T[L;,/7$=3 29;E73J6@I:)S\3)*MK*JD#ZHB>\!3;[6!
M!F3QO=-.)Z=\J\TW=;,N^Q\7*1WF=T^])[Y!G 54;BR[\$PWLBDT&3HNI9N0
MRTC$A<1>2E%^*:3C;>"1]#R<3#O1(+-P(#:>Y_ .\)8[3&U,\JLHWWI$S55C
M:OJR*>='4\&C*:1X&ZMROV3WA23 J(X77\A;_%U8I3:6<AA8MU93)$+EOZO<
MS;COI:0OZRH>"R6+!:U\M]#XD*1R05EA9P2894SEJ%FQ11 :+ +A0Z?MI;Y3
M'',(8.0UB$?)M82J->34U9*":0'\)?<J%EK-LC5*56BF!;6\0?S?4JYFX=6M
MK#HXIF-KQ F & 1C/QFV1,IVC)%6S;M*6NQ&#JSN2(SE4[;$V>E#_S.6FX+S
MT.+8N0C:F4(O,'*11TKR0I(6/TGGR)0:\F K=DS8#>)B+% %B<E86"Q *LD1
MC(AE6AG.%H(SHHYP+02:Z2+':<R?FUUO=N-<<ME&50'62X!?A*8<ER%&1[MW
MED'?LC<ZC3S"^-3;+?BO$D-(P5'P@]MF\CUQ02";9RTR4_"03?^!6B ,Y06*
M%/>2 ?4/8$=(6C1JT,7NTW-64$I,6V%4S H]QI,%L0,"8K8<4SKB3T$JY);E
M;RJ@XV+I&(SHP52;RLSY*P2$CCRE P+6#E1$]L=*MAF3"NY 6^GOA@ ZY,,"
M+*+?855%!%W2(G!Q"ADD;F [:^9P2Z!YW1*>XW"T3FU ERDB@E=A5_Y2(0]4
M>^*O:IG$$N34<\-Y+>KN)38&^!-] - C<<^MQ,G%SNCG=Z-GPBV=5W7*^G5K
M&E+R^0.34'DX=F:/GY6W89FKZV&A<S''<3;V^O387EMF;-OHT]I&NJ$CHWH
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MUG_D6GD[K[R];<%3DQX>D4^)>NTIUE!5J"45#S72AL7CBKP.ZM43<,,T-=V
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M M&?8"4UQ=U!J612Q124%70(Q(S'J.$## 9T^0+WQ):I.'./$]S3BZ-T-9K
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M83C&@^0-5T;[*?)0F#C%@P'+@<>ITE(O7E>\H60.>O3L]5HP9O$3+D(?(NC
MU+ $#UCSU/0CQ3(.P: +011!-X(+W_LY55'))YN*W$+4Z4$8]B$(!S!-A4F.
M*8*OVZ8I-%+$>'!BQ02!-U=2GV58C^)O'Y3=2(='4=!&V%&[C:!;&*GC!Z.Q
M["P\?F99_N62M'W^I1\&X1<:EDH_D6#8\1Z3*'K<#U:QVDG;^[&*J*H&@Q[%
MJAW41*<'G<'[T>E B!@"1+>)=AM__W^L6GUR>-""0=#_3[$*RM(F4?08\UA3
MTMVJI+NU)3W!RUI2(#X,.L=>F'D>SPM')]?:%=^5^$M.WM+&N5#"\6.)UZ)D
MU\=]Y5X+8G^Y?ZW!X)-'7-#X22!L[#<_@<HKNNRF@$X;JG'#Z>Z9(!>\2S;&
M.+]R9C9]8OM<(@G%7QSN?.;;VZL##:^V<T>MR&Y%<M5"KCX2VM,W;>-Q&^"Z
MPR/%<1AMAE0X0>B'5$M(=1QU<=3U(ZJ++C:-#3[D4K^_ESO-K>L@ULC"7WHM
M-MU"N?)F6'VM[M6C\CJYV5Y>RO&070AE0?(YBK9.>MCP37G1+2=.Y_YR.=,.
M"](/4_QOP UMP/6YUFX](0/5OXWA/U!+ P04    " !%B&-4&S*)+,H$   ,
M#P  &0   'AL+W=O<FMS:&5E=',O<VAE970S,RYX;6S=5VUOZC84_BM'K)I:
MJ;>0!'JA R3ZIG5JUP[:[L.T#R8Y$.LZ-M=V2OOO=^R$$ 3M;;==:9J$@F.?
ME^<<G_/$[B^5_F)21 O/F9!FT$BM79PTFR9.,6/F2"U0TLI,Z8Q9>M7SIEEH
M9(E7RD0S;+6.FQGCLC'L^[D[/>RKW HN\4Z#R;.,Z9=3%&HY: 2-U<28SU/K
M)IK#_H+-<8+V87&GZ:U964EXAM)P)4'C;- 8!2>G'2?O!1XY+DUM#"Z2J5)?
MW,M5,FBT'" 4&%MG@='?$YZA$,X0P?A:VFQ4+IUB?;RR?NECIUBFS."9$K_S
MQ*:#1K<!"<Y8+NQ8+7_&,AX/,%;"^"<L2]E6 ^+<6)65RH0@X[+X9\]E'MZC
M$)8*H<==./(HSYEEP[Y62]!.FJRY@0_5:Q,X+MVF3*RF54YZ=G@YNAK#X^CZ
MX0)N+D:3A_'%S<6O]Q/8OV=3@>:@W[3DQ<DVX]+B:6$Q?,5B!#=*VM3 A4PP
MV=1O$KH*8KB">!J^:? 7)H\@"@XA;(7A&_:B*N3(VXM>"YEQ#8],Y CGW,1"
MF5RC@3]&4V,U5<F?;_AH5S[:WD?[VSY&QJ U,)()7',VY8);3NYND#F_"=Q*
M&&.<:\WE'$Z9X697SM]TYSKWQ"Q8C(,&M:9!_82-X2673,:<"6 %!$801 U"
MMH+ +,P<X"</V/4*]=L*TM1!(A.@9D!;D5/K5KL!2]3HUF9*4'N;$Z@%7D9(
M'6R=ARW=!^/,UZ=_RY4E.'>:QP2/2QCYGH4;IK^X (B#X"HA>SRFJ,K$[E_C
M$PH(#F#"YY+/:(T<WMH4-=Q.72Y<)<.57.1KZ7!3^D&JUR2C ]@G)!D7@EC$
M')1N3V"2*FT_6=09G#&3 G[-.260T)%NIB2^4)\ZW##+94**>] ^[E3/'W_H
MAD'X4VUTCIH,^("YI%+,L\(614W<(@&?XY3).4),_>4*E6P&QY5Z;5B#QN43
M&EM8^@07A-&^@'&;6]3 DML4QN>7C]#N0+L%G<K(M9+SPL:]9HG;JII:]-G]
M5J*K_R+I=9=AKUJL#>^575?E*U6X!YU>Z)YM_VS5$E5KHXUM^#L))-,;FU%_
M.R,QBMO5+VD8GJ!F_E-RW-D*G:;6"3O'&6H74JPR^GJ:0FO5>B_UU-6&K[H+
MMS--4T42W]'/>Q!$[8T@?4HIN]^!(6YCJZ94!&67!Q]AB"W=@B'JT_]WAN@%
MO>KY[S#$NNMZ_XP?>@%T(^B^DQ_:[O=M?HB"=2<$'^2'X+#5;1?_T;&KZNY_
MBB/";8X(/\(1Z_35AM^1(\+N1I"1*\%N#]XX#'6JPU#GG8>AP]U'(+5U!#K<
MT7!.1A%=43@NY%VGI#=Q[#XEW:?%7N_,ZGH[B.!4K@FI>(&R[8L"!6*<2NP(
M1JOKC2-#*O>UL",J9ZDBPOM4(VX<EK?/2)X&-]GE%.=<RH)W!=$W%OM4*\FB
M@$FIML%D(Q:Y\^$ZFM;H8D3YF1\"A4WA"L_]+*$K!G?'8-\A^.PJ$WT+1#4/
M!';3O_]2KU9W54RS=D/)4,_]/<Q0MG-IB\M*-5M=]4;%#6<M7MP3B>HI 08$
MSDBU=?29-ET7=Z_BQ:J%O^],E:7;DQ^F=%U%[01H?:;H&U*^. ?5!7CX%U!+
M P04    " !%B&-4@[J@2VT%   !$   &0   'AL+W=O<FMS:&5E=',O<VAE
M970S-"YX;6RU5U%OVS80_BL';QAD8(LMV7&<+ E@)VF;M5V#.$LQ#'N@I;/$
MEB(]DHJ3_OH=*5E6YLA-,_1!$D4>[[X[WGTDCU=*?S89HH7[7$ASTLFL71[U
M>B;.,&=F3RU1TLA"Z9Q9^M5ISRPULL1/RD4OZO='O9QQV3D]]GU7^O18%59P
MB5<:3)'G3#],4:C522?LK#NN>9I9U]$[/5ZR%&=H_UA>:?KKU5H2GJ,T7$G0
MN#CI3,*CZ<C)>X%;CBO3:(/S9*[49_=SF9QT^@X0"HRMT\#H<X=G*(131##^
MJ71V:I-N8K.]UO[*^TZ^S)G!,R4^\L1F)YUQ!Q)<L$+8:[5Z@Y4_^TY?K(3Q
M;UA5LOT.Q(6Q*J\F$X*<R_++[JLX/&="5$V(/.[2D$=YSBP[/=9J!=I)DS;7
M\*[ZV02.2[<H,ZMIE-,\>WI^<7UY.[FYO+V807##Y@)-][AG2;,;[\65EFFI
M)6K1,H#W2MK,P(5,,'D\OT>(:EC1&M8TVJGP-R;W8!#^#%$_BG;H&]1N#KR^
M09N;J/D=<PD E])875!>60-,)O &DY3+%"8N/[CE:."<FU@H4VB$OR9S$J?<
M^7L'BF&-8NA1#%M03-)48\HL)B"52THF@.6J<%#F#[3<6J.,'SRL! U/)7-2
M3ZW';D,W&0)[F3%@!M0": $**M)Z#6"%% T:6RA!A6R.8!-2T]JFPEDQG6Q]
MS];&I\5#+YA1379;F@&7E/9"$#+3A8M"*_@1@H.PZS[AOOM$!S#5M' F@RMR
M+X%@-.["3S^,HS#Z%0[AC$F6<";AG* S#<$PV@P'PR[YNF02#<*?*"$8CYNC
M9.B<2:?[K582ZY'UEXR_5<2&$CY2[(+1?F-RU._"C%*++4EB;3T<;^:&,%MQ
M0V'23,9;JH-1%\XR7B(KR,(U2F* .2>,PX:9L$\@;QA?;5Q\2M6E]$&X+I:X
M[480#BCLFGWAP@LA)<NV#/GSP6:H8=CH)-O*,F'<@@P.1XV%"<)PW-U1-OMU
MV>SOS.;76E&0%HQKN&.BP+)NYTQ0U!#*O4NHN$Q?RMUD4^R\4>P9BH0Z@#R
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MKU$U2HFC"[(GJABY'9!$'+/"[SZW")AUQE]N<$C/FC)V65W+;%K-X- ^]IP
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M(!1IFH9/!+<0];U6!&ME2<(?I\/XZ;P^0*=_? ^H13TWC*Y:.UR3<TS+E?Z
M?10"-[2-1&EWCES6+LC ,"HN/G+HSZ.),;D87UU$T33).7<GBDY?NBBAGE&"
MI\QYQ5CZ^),F.[4VK7=A*@0H4M0_<" <BKDVBTJ*2Q)!Z-2X5]?>#?\/_$*1
M&#1%8G Q<V=Y(=0;\7JDV-=\4WK+WD=-1)R6.54E+F*Y2\#0%"S!<4!_>7=T
M&!P))#\1P .!K*201,#3HEE=3R@3Z::0TGJ=WV^43%7J,U,GNSF9ZF><T*H
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M@Q2U<R#[4E$2E> NJ$?SZ"]02P,$%     @ 18AC5*C"Y,44!   J H  !D
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MSCZ'5HO.D3HT,CW0_N>F]N\K=\_1 .U!!]I1U('9_^[_T!Z2GO: -,Z^=]Y
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MP2N44YRB.QKR#0^[I%J<02^<09-4P:2^*G49!:,6J19GT(VSJM2^_6[!![W
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M@=(FF/6E$'H;V VZ9R?["U!+ P04    " !%B&-4,^-QT&0#  #H"0  &0
M 'AL+W=O<FMS:&5E=',O<VAE970T-"YX;6RM5LMNVS 0_!5"Z"$!FNCA=V ;
M\"-%6S1MX#3MF9;6%EN*=$G*3OKU75**8L>RX$,OMDAQAC.[JR6'.ZE^ZQ3
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M&5SW,&2JN%84 R,W[J!=2H-UXAY3O(J!L@OP_4I*\S*P&U27N_$_4$L#!!0
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M"+-!WT\X5Q\3T\JJ#U'T!U!+ P04    " !%B&-4'3,# UX(   ?.0  &0
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M.DXRDO$D%*?SS--,D* Y\?9TMO.8Q3PY@YY/#78\?ZZ>@&SB:*5)S3VC=,]
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M?,E%S*3N8J5?C2>%-XVZH56) =G!8%/$':#<P%&^1U5BR&)>.D#,I.XIP-O
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M^)]^$K$R5G:\1+SLC/\.B7A-(GY8H*",,V@MT/M8_U*DM)\&IV4XI\=KX(V
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M#C#_+^-8/VYD*V?+A<^3_P!02P,$%     @ 18AC5))J"ZR, P  >!   !D
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M?N:N.U;-_4MQK"R\.WUSQBB\ YT!S$^4LD\=]_@L_FSH_0]02P,$%     @
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M$<9 O]]RKLX-,T!VAS/Z#U!+ P04    " !%B&-4NT$&6;L"   &"   &0
M 'AL+W=O<FMS:&5E=',O<VAE970V-BYX;6RU5=MRVC 0_16-)P]AIHV-N21D
M@!ENG:93" -)^RSP IK(DBO)D/Q]5[)Q" &G#\T+Z++GZ)Q=V&WOI'K2&P!#
MGF,N=,?;&)/<^KY>;B"F^DHF(/!F)55,#6[5VM>) AHY4,S], B:?DR9\+IM
M=S95W;9,#6<"IHKH-(ZI>ND#E[N.5_7V!S.VWAA[X'?;"5W#',QC,E6X\PN6
MB,4@-)."*%AUO%[U=E -+,!%_&*PTP=K8JTLI'RRF[NHXP56$7!8&DM!\6L+
M ^#<,J&./SFI5[QI@8?K/?LW9Q[-+*B&@>2_660V'>_&(Q&L:,K-3.Z^0VZH
M8?F6DFOW279Y;."19:J-C',P*HB9R+[I<YZ( P#RG :$.2 \!M3/ &HYH.:,
M9LJ<K2$UM-M6<D>4C48VNW"Y<6ATPX0MX]PHO&6(,]W9Z.%N-AJ/)@]D^K,W
MF9/>9$BF]_,'<G@SFLSO[B=YQ.40#&5<5\CE*$ZX? %%!E(8Q1:I+8VN5,A7
M,LU+/>54X/9Q/B27%Q5R09@@8\:Y#6S[!BU8(?XRE]O/Y(9GY-;(&%_::#(2
M$41O\3Y:+_R'>__]L)3P!Q57I%;]0L(@#$_H&?P[O%HBIU:4H^;XZF?X'@4S
M$)&YH09T"5^]X*L[OMH9OB&L\"0B?1"X,EDUADPON=2I@I(7&L4+C5+%IW\"
MIRJ;\30=C^TNVV[0]K>'N2Z+>".N68AKEHM[3K!=H/]5:M N@;W8Y4=B,][&
MQU*N"RG7I5*PZ6!+R?X/)6F_*>AN/JFPK>*%UG\J;.M=KAI'A6V]*VSC=#:K
MP6O?"CZIM#GQH9IJ_4B.?]!18U!K-V@T<J?"9,VE."V&6<^U\*/SOAURKE._
MTF03<DS5F@E-.*R0,KBZQ@2J;.AD&R,3U[<7TN 4<,L-#FI0-@#O5U*:_<8^
M4(S^[E]02P,$%     @ 18AC5$D[-G-/ P  40H  !D   !X;"]W;W)K<VAE
M971S+W-H965T-C<N>&ULG5;;3N,P$/V54<0#2+ND2=IR45NI%Y9E)2ZBR_)L
MDFECX=A=VVGA[]=V0N@EB="^M+8SY\R9L<>>P4;(5Y4B:GC+&%=#+]5Z=>G[
M*DXQ(^I4K)";+PLA,Z+-5"Y]M9)($@?*F!]V.GT_(Y1[HX%;>Y"C@<@UHQP?
M)*@\RXA\GR 3FZ$7>!\+CW29:KO@CP8KLL0YZJ?5@S0SOV)):(9<4<%!XF+H
MC8/+61!:@+/X0W&CML9@0WD1XM5.;I*AU[&*D&&L+04Q?VN<(F.6R>CX6Y)Z
ME4\+W!Y_L/]PP9M@7HC"J6#/--'IT#OW(,$%R9E^%)N?6 ;4LWRQ8,K]PJ:P
M[4<>Q+G2(BO!1D%&>?%/WLI$; $,3ST@+ 'A/J#; (A*0/150+<$=%UFBE!<
M'F9$D]% B@U(:VW8[, ETZ%-^)3;?9]K:;Y2@].CY_'CX_CN]\W5',9W,YC>
MF_'=]=7=U*X<SU 3RM0)?(>G^0R.CT[@""B'6\J8V34U\+718)G\N/0W*?R%
M#?XBN!5<IPJN>(+)+MXWVJL PH\ )F$KX2_"3R$*OD'8"<,:/=.OPX,:^*P=
M?A_K)OA.-%&U'9'CBQKX;L4:355IF^2Y)CPA,H$'*9(\UO!,I"1<O\,XCF5.
M6(N_;N6OZ_QU&_Q-<$DYIWQIBH<1'F/=CA84?4=A[Y'U*.H,_/5VDFM,PLID
M1UFO4M9K55;&J,#<;; I(J>H3&)BEB=6<9P2OD2;*52:FBN@5GSAI;>E+(CV
MQ->8].K%]ROQ_5;QYKK4S&VD,L6:("2YM))UBK!"2452)[5_H./[@=8ZFP:Q
M9Y78LU:QIA*W#@ 0#<@3$(L6I6<'*@Y.1(U)PXDXKW2>M]9&<SW,J(J94+G$
MEI*XJ-Q<_-?!2W(T=[-.S7D3'.$=B:Q+S<5!W.'%7FH.3:*@/C5!Y_,:[WQ%
M=9UHLM H6S67W#L5L*>Y-.G7FNQJWGIZ@M8-O<Z)U8FH6K8M"#_IPM84--&5
M,88' 73[NT'.VFT*6?[66YNA7+J>14$L<JZ+5ZM:K?JBL>L&]M8GP>6TZ&X^
M:8IFZY9(<RLK8+@PE)W3,[,QLNA?BHD6*_>BOPAM^@,W3$W/A](:F.\+(?3'
MQ#JHNLC1/U!+ P04    " !%B&-4[[2\^<H#   '#P  &0   'AL+W=O<FMS
M:&5E=',O<VAE970V."YX;6RU5UUOXC@4?9[]%5:T#QUIV\3Y D: U/+1Z6BJ
M0;2=?5CM@TD<L":)L[8I1=H?/W82$J")8;K=/A0[]CD^U_?Z).YO*/O!5Q@+
M\)+$*1\8*R&R3Z;)@Q5.$+^B&4[E2$19@H3LLJ7),X91F(.2V+0MRS<31%)C
MV,^?S=BP3]<B)BF>,<#728+8]@;'=#,PH+%[,"?+E5 /S&$_0TO\@,53-F.R
M9U8L(4EPR@E- </1P+B&GVYA3P'R&=\)WO"]-E"A+"C]H3IWX<"PE"(<XT H
M"B1_GO$(Q[%BDCK^*4F-:DT%W&_OV*=Y\#*8!>)X1.,_22A6 Z-K@!!':!V+
M.=U\QF5 GN(+:,SS_V!3S/7EY&#-!4U*L%20D+3X12_E1NP!H-\"L$N ?0QP
M6P!."7#.!;@EP#T&>"T KP1XYP+\$N"?*ZE3 CIYLHK=S5,S1@(-^XQN %.S
M)9MJY/G-T3(C)%6E^""8'"42)X8/G[_-'R\?)_-[,)[</()+,&(X) ),44!B
M(K;@8HP%(C'_*,>>'L;@XO>/?5/(I16!&93+W!3+V"W+W"-V!:#S![ MV&N
MC_3P+RB] @Y4<-MN@(_/A\,&^.0$?"WAL-L*G^KAUYF,W6Y?_58/_Q:('?QX
MZTR9["KC=I5Q.^=SVC*^HDQ<"LP2,,8+H6%T*D8G9W1;&.<X0UMI3X(#&H&
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M>?>-HR6;L'9Q:+_1"*Y#^4#NIG2RNU2J4\XLVX_JX'ZE*#W'$V#M_=!Y)U>
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MS5SD:5+<<CD\$,RU0FH [)PX2^#0C^#]?@VK(#W!H>/1%%J8AGZ:/D@F))J
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MRF:=;&'D/AT7-M+8X2.]W-GY$%028'^/I#2G1;)!,7'._@-02P,$%     @
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M5HA0>:&77N9C<'YV <X 86!**-4O0_9<I6LQC&Y<['N=[^L?V?<G8I<@@-^
M[_E^#7S4#'^,50F''^&N=J"TP2]M\"U?<,R&0O ,9UPHPA(P8?DWHN4U\ <E
M?V#Y6T?X<R/K;,IQ;8LSW]S; 'J!'_7<MZH;=5F1%Y99'XIJE46U&HNZ)RL,
MYC'!+,82(+8$PRRC!"_!%(G73_5^V",L]PA/8FR[Y&]_T=@<%U8L"Z+0/_"U
M+JD%ZVV-RI*BQI+&!"6,2T7BW-0[S'BJ@P:UG9*Z<Q(WNR5_]XMN=C\;%?CA
M@9NU25Z]F]#;=RBON:B$4"-Z)+B4]VC1H!-6VAX\B9-PWU&@_T4O"V#5IT[D
M'7A9EQ1TCWBY;T.PN0_M9#]SA6B3S'T/@:W3&+GO(##\JI'AI[88=5N'O;,V
MRSO\6[J5,]1<8'0+3 B3@.*5AGF7D681^9T@#Q3/[+&ZX$H?TG:XUO<H+$R"
M7E]QKG:!.:G+F]G@'U!+ P04    " !%B&-40*("UPL#  "+$   #0   'AL
M+W-T>6QE<RYX;6S=6&UOFS 0_BN(3E,K326$A84U1-J0*DW:IDKMAWVKG&"(
M)6,S8[JDOWX^3,A+?577#UL[H@;['M]SC^^.&'76Z VGURM*M;>NN&A2?Z5U
M_3$(FN6*5J0YES45!BFDJH@V4U4&3:THR1MPJG@P'HWBH"),^/.9:*O+2C?>
M4K9"IWXTF#Q[^Y*G?AB_]SU+E\F<IO[MZ=N?K=07;SQ[/WEW<C*Z/;LXMI]V
MP)D?.$DG3R ]'^&\!L.HXZ=1/\IMR8,^0?-9(<5AGL!@HI.*>G>$IWY&.%LH
M!EX%J1C?6/,8#$O)I?*T*9"1$X*EN;=P:&=0NYZG8D*J+K:-8+\7_?(C8#L#
M@8SS0>#8MX;YK"9:4R4NS:1;W!D?0%X_OMG41F&IR"8<3_R=0W<S0192Y50-
M84)_:YK/."U CF+E"NY:U@& 6LO*#')&2BE(IV'KT0\,[9)R?@V-_:,XX%X7
M>W4=057%,#2"^J&EL1/@WV>SW'NTR;-HO9K=2?VY-;L1W1R:A5XI6K!U-U\7
M0WR,/<3925WSS2?.2E%1N_<G!YS/R-;/6TG%[DTTZ)2E,5#E>W=4:;;<M_Q2
MI+ZA:[WMIG6!:QZ_0LU_-\\E%501OB_:M/Y+SO*S%4<?_I7D[D?E6+!38W]8
MO721D]<@,GZ1(H/^!WWOU#@X,P:K!V=SZG^'-P&^"^HM6L8U$_ULQ?*<B@='
MAZ'79&'>M [XS?J<%J3E^F8 4W\W_D9SUE;)L.H*$M&OVHV_PO;">'@Q,+&8
MR.F:YED_5>6B&WIF8*+V%S@<(Y?=Y48P'XNY$<"P.)@"S,=Z87'^I_U,T?U8
M#-,V=2)3U&>*^E@O%Y)U'RR.VR<QEWNG21)%<8QE-,N<"C(L;W$,?VXV3!MX
M8'$@TI_E&J\VWB&/]P%6T\<Z!-LIWHG83O%< ^+.&W@DB;O:6!SPP*J ]0[$
M=\>!GG+[1!%4%=.&/<$XDB08 KWH[M$X1K(3P\=='^PIB:(D<2. N15$$8;
MTX@CF +0@"%1U)V#1^=1L#VG@MV_'^:_ 5!+ P04    " !%B&-4EXJ[',
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M.;?_S_'3L^QM.[SDL^DOONL_4$L! A0#%     @ 18AC5 =!36*!    L0
M !               ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4
M" !%B&-4\2'P/^T    K @  $0              @ &O    9&]C4')O<',O
M8V]R92YX;6Q02P$"% ,4    " !%B&-4F5R<(Q &  "<)P  $P
M    @ '+ 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( $6(8U00
M-?%D0P4  )L5   8              " @0P(  !X;"]W;W)K<VAE971S+W-H
M965T,2YX;6Q02P$"% ,4    " !%B&-4E-!(7^ $   D%   &
M    @(&%#0  >&PO=V]R:W-H965T<R]S:&5E=#(N>&UL4$L! A0#%     @
M18AC5!EG4&J; P  :PH  !@              ("!FQ(  'AL+W=O<FMS:&5E
M=',O<VAE970S+GAM;%!+ 0(4 Q0    ( $6(8U2;SFF&-0,  "T(   8
M          " @6P6  !X;"]W;W)K<VAE971S+W-H965T-"YX;6Q02P$"% ,4
M    " !%B&-4V.87=@@&  !?&   &               @('7&0  >&PO=V]R
M:W-H965T<R]S:&5E=#4N>&UL4$L! A0#%     @ 18AC5%S<PH#K @  E D
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M965T,3 N>&UL4$L! A0#%     @ 18AC5%2PU36B!   _0H  !D
M     ("!@T$  'AL+W=O<FMS:&5E=',O<VAE970Q,2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( $6(8U1*.C<5;@(  "X%   9              "
M@<]B  !X;"]W;W)K<VAE971S+W-H965T,38N>&UL4$L! A0#%     @ 18AC
M5#D&([^5!P  QA,  !D              ("!=&4  'AL+W=O<FMS:&5E=',O
M<VAE970Q-RYX;6Q02P$"% ,4    " !%B&-4CM//?A(-  !W*@  &0
M        @(% ;0  >&PO=V]R:W-H965T<R]S:&5E=#$X+GAM;%!+ 0(4 Q0
M   ( $6(8U0E"*R.= P  /TJ   9              " @8EZ  !X;"]W;W)K
M<VAE971S+W-H965T,3DN>&UL4$L! A0#%     @ 18AC5"=>&54,!   O@D
M !D              ("!-(<  'AL+W=O<FMS:&5E=',O<VAE970R,"YX;6Q0
M2P$"% ,4    " !%B&-4F\@)WVH%  !&#   &0              @(%WBP
M>&PO=V]R:W-H965T<R]S:&5E=#(Q+GAM;%!+ 0(4 Q0    ( $6(8U37T00>
M8@0  &4*   9              " @1B1  !X;"]W;W)K<VAE971S+W-H965T
M,C(N>&UL4$L! A0#%     @ 18AC5*VXC(&/ @  EP4  !D
M ("!L94  'AL+W=O<FMS:&5E=',O<VAE970R,RYX;6Q02P$"% ,4    " !%
MB&-40 OU<-(&  "%%   &0              @(%WF   >&PO=V]R:W-H965T
M<R]S:&5E=#(T+GAM;%!+ 0(4 Q0    ( $6(8U1 !"/R6!   .\L   9
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M970R.2YX;6Q02P$"% ,4    " !%B&-4=OV=-]T"  !2!@  &0
M    @($@RP  >&PO=V]R:W-H965T<R]S:&5E=#,P+GAM;%!+ 0(4 Q0    (
M $6(8U2D:MSN;@(  "\%   9              " @33.  !X;"]W;W)K<VAE
M971S+W-H965T,S$N>&UL4$L! A0#%     @ 18AC5';DIX7S!   >0P  !D
M             ("!V=   'AL+W=O<FMS:&5E=',O<VAE970S,BYX;6Q02P$"
M% ,4    " !%B&-4&S*)+,H$   ,#P  &0              @($#U@  >&PO
M=V]R:W-H965T<R]S:&5E=#,S+GAM;%!+ 0(4 Q0    ( $6(8U2#NJ!+;04
M  $0   9              " @03;  !X;"]W;W)K<VAE971S+W-H965T,S0N
M>&UL4$L! A0#%     @ 18AC5)?E2B\9!   '0H  !D              ("!
MJ.   'AL+W=O<FMS:&5E=',O<VAE970S-2YX;6Q02P$"% ,4    " !%B&-4
M3KB'W-D"  !S!@  &0              @('XY   >&PO=V]R:W-H965T<R]S
M:&5E=#,V+GAM;%!+ 0(4 Q0    ( $6(8U0W#C8GJ@(  *8%   9
M      " @0CH  !X;"]W;W)K<VAE971S+W-H965T,S<N>&UL4$L! A0#%
M  @ 18AC5*C"Y,44!   J H  !D              ("!Z>H  'AL+W=O<FMS
M:&5E=',O<VAE970S."YX;6Q02P$"% ,4    " !%B&-4-4GN/TH%  #S#
M&0              @($T[P  >&PO=V]R:W-H965T<R]S:&5E=#,Y+GAM;%!+
M 0(4 Q0    ( $6(8U31XW'A4@0  !T/   9              " @;7T  !X
M;"]W;W)K<VAE971S+W-H965T-# N>&UL4$L! A0#%     @ 18AC5)LL!HP>
M!   2!,  !D              ("!/OD  'AL+W=O<FMS:&5E=',O<VAE970T
M,2YX;6Q02P$"% ,4    " !%B&-4F[Q"G14#  !9"@  &0
M@(&3_0  >&PO=V]R:W-H965T<R]S:&5E=#0R+GAM;%!+ 0(4 Q0    ( $6(
M8U2<_$8C;@(  ((&   9              " @=\  0!X;"]W;W)K<VAE971S
M+W-H965T-#,N>&UL4$L! A0#%     @ 18AC5#/C<=!D P  Z D  !D
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M=#0X+GAM;%!+ 0(4 Q0    ( $6(8U2!DA8!W0(  ','   9
M  " @3T5 0!X;"]W;W)K<VAE971S+W-H965T-#DN>&UL4$L! A0#%     @
M18AC5&2_KHL! P  3 @  !D              ("!41@! 'AL+W=O<FMS:&5E
M=',O<VAE970U,"YX;6Q02P$"% ,4    " !%B&-4SC6!94L"  "5!0  &0
M            @(&)&P$ >&PO=V]R:W-H965T<R]S:&5E=#4Q+GAM;%!+ 0(4
M Q0    ( $6(8U101OQ[\ ,  '8/   9              " @0L> 0!X;"]W
M;W)K<VAE971S+W-H965T-3(N>&UL4$L! A0#%     @ 18AC5&'UK06M!
M[Q4  !D              ("!,B(! 'AL+W=O<FMS:&5E=',O<VAE970U,RYX
M;6Q02P$"% ,4    " !%B&-46;7GN/4"   ;"   &0              @($6
M)P$ >&PO=V]R:W-H965T<R]S:&5E=#4T+GAM;%!+ 0(4 Q0    ( $6(8U17
MZ]%OAP(  )0&   9              " @4(J 0!X;"]W;W)K<VAE971S+W-H
M965T-34N>&UL4$L! A0#%     @ 18AC5!TS P->"   'SD  !D
M     ("! "T! 'AL+W=O<FMS:&5E=',O<VAE970U-BYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( $6(8U3/2@?Z300  /8.   9              "
M@==! 0!X;"]W;W)K<VAE971S+W-H965T-C$N>&UL4$L! A0#%     @ 18AC
M5$9;6B! !@  !"T  !D              ("!6T8! 'AL+W=O<FMS:&5E=',O
M<VAE970V,BYX;6Q02P$"% ,4    " !%B&-4DFH+K(P#  !X$   &0
M        @('23 $ >&PO=V]R:W-H965T<R]S:&5E=#8S+GAM;%!+ 0(4 Q0
M   ( $6(8U0R4D1!X ,  )<.   9              " @950 0!X;"]W;W)K
M<VAE971S+W-H965T-C0N>&UL4$L! A0#%     @ 18AC5+$687$\!   SQ$
M !D              ("!K%0! 'AL+W=O<FMS:&5E=',O<VAE970V-2YX;6Q0
M2P$"% ,4    " !%B&-4NT$&6;L"   &"   &0              @($?60$
M>&PO=V]R:W-H965T<R]S:&5E=#8V+GAM;%!+ 0(4 Q0    ( $6(8U1).S9S
M3P,  %$*   9              " @1%< 0!X;"]W;W)K<VAE971S+W-H965T
M-C<N>&UL4$L! A0#%     @ 18AC5.^TO/G* P  !P\  !D
M ("!EU\! 'AL+W=O<FMS:&5E=',O<VAE970V."YX;6Q02P$"% ,4    " !%
MB&-44E3-9<0"  ">"@  &0              @(&88P$ >&PO=V]R:W-H965T
M<R]S:&5E=#8Y+GAM;%!+ 0(4 Q0    ( $6(8U0' YLB00,  (0+   9
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M970W-"YX;6Q02P$"% ,4    " !%B&-44-_0/JT#  !?"P  &0
M    @(&*>0$ >&PO=V]R:W-H965T<R]S:&5E=#<U+GAM;%!+ 0(4 Q0    (
M $6(8U20U5Z'UP(  *4)   9              " @6Y] 0!X;"]W;W)K<VAE
M971S+W-H965T-S8N>&UL4$L! A0#%     @ 18AC5$"B M<+ P  BQ    T
M             ( !?( ! 'AL+W-T>6QE<RYX;6Q02P$"% ,4    " !%B&-4
MEXJ[',     3 @  "P              @ &R@P$ 7W)E;',O+G)E;'-02P$"
M% ,4    " !%B&-45F"!G X&  !W,@  #P              @ &;A $ >&PO
M=V]R:V)O;VLN>&UL4$L! A0#%     @ 18AC5'-\>"Q1 @  ^RP  !H
M         ( !UHH! 'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#
M%     @ 18AC5,X5S%\/ @  ZBL  !,              ( !7XT! %M#;VYT
D96YT7U1Y<&5S72YX;6Q02P4&     %0 5  #%P  GX\!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>290</ContextCount>
  <ElementCount>397</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>100</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>5</UnitCount>
  <MyReports>
    <Report instance="a-20220131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.agilent.com/role/DocumentandEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="a-20220131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1001002 - Statement - CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFOPERATIONSUnaudited</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="a-20220131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1002003 - Statement - CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOMEUnaudited</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="a-20220131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1003004 - Statement - CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME (LOSS) (Unaudited) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOMELOSSUnauditedParenthetical</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME (LOSS) (Unaudited) (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="a-20220131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1004005 - Statement - CONDENSED CONSOLIDATED BALANCE SHEET (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEET (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="a-20220131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1005006 - Statement - CONDENSED CONSOLIDATED BALANCE SHEET (Unaudited) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnauditedParenthetical</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEET (Unaudited) (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="a-20220131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>1006007 - Statement - CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="a-20220131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>1007008 - Statement - CONDENSED CONSOLIDATED STATEMENT OF EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFEQUITY</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENT OF EQUITY</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="a-20220131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>1008009 - Statement - CONDENSED CONSOLIDATE STATEMENT OF EQUITY - (PARENTHETICAL)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.agilent.com/role/CONDENSEDCONSOLIDATESTATEMENTOFEQUITYPARENTHETICAL</Role>
      <ShortName>CONDENSED CONSOLIDATE STATEMENT OF EQUITY - (PARENTHETICAL)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="a-20220131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2101101 - Disclosure - OVERVIEW, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.agilent.com/role/OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNotes</Role>
      <ShortName>OVERVIEW, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="a-20220131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2105102 - Disclosure - NEW ACCOUNTING PRONOUNCEMENTS (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.agilent.com/role/NEWACCOUNTINGPRONOUNCEMENTSNotes</Role>
      <ShortName>NEW ACCOUNTING PRONOUNCEMENTS (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="a-20220131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2107103 - Disclosure - REVENUE (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.agilent.com/role/REVENUENotes</Role>
      <ShortName>REVENUE (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="a-20220131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2114104 - Disclosure - SHARE-BASED COMPENSATION (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.agilent.com/role/SHAREBASEDCOMPENSATIONNotes</Role>
      <ShortName>SHARE-BASED COMPENSATION (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="a-20220131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2119105 - Disclosure - INCOME TAXES (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.agilent.com/role/INCOMETAXESNotes</Role>
      <ShortName>INCOME TAXES (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="a-20220131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2121106 - Disclosure - NET INCOME PER SHARE (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.agilent.com/role/NETINCOMEPERSHARENotes</Role>
      <ShortName>NET INCOME PER SHARE (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="a-20220131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2124107 - Disclosure - INVENTORY (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.agilent.com/role/INVENTORYNotes</Role>
      <ShortName>INVENTORY (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="a-20220131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2127108 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNotes</Role>
      <ShortName>GOODWILL AND OTHER INTANGIBLE ASSETS (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="a-20220131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2133109 - Disclosure - FAIR VALUE MEASUREMENTS (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.agilent.com/role/FAIRVALUEMEASUREMENTSNotes</Role>
      <ShortName>FAIR VALUE MEASUREMENTS (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="a-20220131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2140110 - Disclosure - DERIVATIVES (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.agilent.com/role/DERIVATIVESNotes</Role>
      <ShortName>DERIVATIVES (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="a-20220131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2146111 - Disclosure - RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSNotes</Role>
      <ShortName>RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="a-20220131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2150112 - Disclosure - WARRANTIES AND CONTINGENCIES (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.agilent.com/role/WARRANTIESANDCONTINGENCIESNotes</Role>
      <ShortName>WARRANTIES AND CONTINGENCIES (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="a-20220131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2153113 - Disclosure - SHORT-TERM DEBT (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.agilent.com/role/SHORTTERMDEBTNotes</Role>
      <ShortName>SHORT-TERM DEBT (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="a-20220131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2155114 - Disclosure - LONG-TERM DEBT (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.agilent.com/role/LONGTERMDEBTNotes</Role>
      <ShortName>LONG-TERM DEBT (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="a-20220131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2158115 - Disclosure - STOCKHOLDERS' EQUITY (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.agilent.com/role/STOCKHOLDERSEQUITYNotes</Role>
      <ShortName>STOCKHOLDERS' EQUITY (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="a-20220131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2164116 - Disclosure - SEGMENT INFORMATION (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.agilent.com/role/SEGMENTINFORMATIONNotes</Role>
      <ShortName>SEGMENT INFORMATION (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="a-20220131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2202201 - Disclosure - OVERVIEW, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.agilent.com/role/OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies</Role>
      <ShortName>OVERVIEW, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="a-20220131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2303301 - Disclosure - OVERVIEW, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.agilent.com/role/OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables</Role>
      <ShortName>OVERVIEW, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.agilent.com/role/OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNotes</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="a-20220131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2308303 - Disclosure - REVENUE (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.agilent.com/role/REVENUETables</Role>
      <ShortName>REVENUE (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.agilent.com/role/REVENUENotes</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="a-20220131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2315304 - Disclosure - SHARE-BASED COMPENSATION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.agilent.com/role/SHAREBASEDCOMPENSATIONTables</Role>
      <ShortName>SHARE-BASED COMPENSATION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.agilent.com/role/SHAREBASEDCOMPENSATIONNotes</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="a-20220131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2322305 - Disclosure - NET INCOME PER SHARE (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.agilent.com/role/NETINCOMEPERSHARETables</Role>
      <ShortName>NET INCOME PER SHARE (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.agilent.com/role/NETINCOMEPERSHARENotes</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="a-20220131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2325306 - Disclosure - INVENTORY (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.agilent.com/role/INVENTORYTables</Role>
      <ShortName>INVENTORY (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.agilent.com/role/INVENTORYNotes</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="a-20220131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2328307 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables</Role>
      <ShortName>GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNotes</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="a-20220131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2334308 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.agilent.com/role/FAIRVALUEMEASUREMENTSTables</Role>
      <ShortName>FAIR VALUE MEASUREMENTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.agilent.com/role/FAIRVALUEMEASUREMENTSNotes</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="a-20220131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2341309 - Disclosure - DERIVATIVES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.agilent.com/role/DERIVATIVESTables</Role>
      <ShortName>DERIVATIVES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.agilent.com/role/DERIVATIVESNotes</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="a-20220131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2347310 - Disclosure - RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSTables</Role>
      <ShortName>RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSNotes</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="a-20220131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2351311 - Disclosure - WARRANTIES AND CONTINGENCIES (Table)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.agilent.com/role/WARRANTIESANDCONTINGENCIESTable</Role>
      <ShortName>WARRANTIES AND CONTINGENCIES (Table)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.agilent.com/role/WARRANTIESANDCONTINGENCIESNotes</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="a-20220131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2356312 - Disclosure - LONG-TERM DEBT (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.agilent.com/role/LONGTERMDEBTTables</Role>
      <ShortName>LONG-TERM DEBT (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.agilent.com/role/LONGTERMDEBTNotes</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="a-20220131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2359313 - Disclosure - STOCKHOLDERS' EQUITY (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.agilent.com/role/STOCKHOLDERSEQUITYTables</Role>
      <ShortName>STOCKHOLDERS' EQUITY (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.agilent.com/role/STOCKHOLDERSEQUITYNotes</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="a-20220131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2365314 - Disclosure - SEGMENT INFORMATION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.agilent.com/role/SEGMENTINFORMATIONTables</Role>
      <ShortName>SEGMENT INFORMATION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.agilent.com/role/SEGMENTINFORMATIONNotes</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="a-20220131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2404401 - Disclosure - OVERVIEW, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.agilent.com/role/OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails</Role>
      <ShortName>OVERVIEW, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.agilent.com/role/OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="a-20220131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>2409402 - Disclosure - REVENUE- Revenue by Region (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.agilent.com/role/REVENUERevenuebyRegionDetails</Role>
      <ShortName>REVENUE- Revenue by Region (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="a-20220131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>2410403 - Disclosure - REVENUE - Revenue by End Markets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.agilent.com/role/REVENUERevenuebyEndMarketsDetails</Role>
      <ShortName>REVENUE - Revenue by End Markets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="a-20220131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>2411404 - Disclosure - REVENUE - Revenue by Type (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.agilent.com/role/REVENUERevenuebyTypeDetails</Role>
      <ShortName>REVENUE - Revenue by Type (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="a-20220131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>2412405 - Disclosure - REVENUE - Contract Assets and Liability (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.agilent.com/role/REVENUEContractAssetsandLiabilityDetails</Role>
      <ShortName>REVENUE - Contract Assets and Liability (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="a-20220131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>2413406 - Disclosure - REVENUE - Remaining Performance Obligation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.agilent.com/role/REVENUERemainingPerformanceObligationDetails</Role>
      <ShortName>REVENUE - Remaining Performance Obligation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="a-20220131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>2416407 - Disclosure - SHARE-BASED COMPENSATION Text (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.agilent.com/role/SHAREBASEDCOMPENSATIONTextDetails</Role>
      <ShortName>SHARE-BASED COMPENSATION Text (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.agilent.com/role/SHAREBASEDCOMPENSATIONTables</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="a-20220131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>2417408 - Disclosure - SHARE-BASED COMPENSATION Allocated Share-based compensation expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.agilent.com/role/SHAREBASEDCOMPENSATIONAllocatedSharebasedcompensationexpenseDetails</Role>
      <ShortName>SHARE-BASED COMPENSATION Allocated Share-based compensation expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="a-20220131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>2418409 - Disclosure - SHARE-BASED COMPENSATION Fair Value Assumptions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.agilent.com/role/SHAREBASEDCOMPENSATIONFairValueAssumptionsDetails</Role>
      <ShortName>SHARE-BASED COMPENSATION Fair Value Assumptions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="a-20220131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>2420410 - Disclosure - INCOME TAXES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.agilent.com/role/INCOMETAXESDetails</Role>
      <ShortName>INCOME TAXES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.agilent.com/role/INCOMETAXESNotes</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="a-20220131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>2423411 - Disclosure - NET INCOME PER SHARE (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.agilent.com/role/NETINCOMEPERSHAREDetails</Role>
      <ShortName>NET INCOME PER SHARE (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.agilent.com/role/NETINCOMEPERSHARETables</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="a-20220131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>2426412 - Disclosure - INVENTORY (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.agilent.com/role/INVENTORYDetails</Role>
      <ShortName>INVENTORY (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.agilent.com/role/INVENTORYTables</ParentRole>
      <Position>51</Position>
    </Report>
    <Report instance="a-20220131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>2429413 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS Goodwill Roll forward (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSGoodwillRollforwardDetails</Role>
      <ShortName>GOODWILL AND OTHER INTANGIBLE ASSETS Goodwill Roll forward (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="a-20220131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>2430414 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS Disclosures and Components of Purchased Other Intangibles (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDisclosuresandComponentsofPurchasedOtherIntangiblesDetails</Role>
      <ShortName>GOODWILL AND OTHER INTANGIBLE ASSETS Disclosures and Components of Purchased Other Intangibles (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="a-20220131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>2431415 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS Textuals (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTextualsDetails</Role>
      <ShortName>GOODWILL AND OTHER INTANGIBLE ASSETS Textuals (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables</ParentRole>
      <Position>54</Position>
    </Report>
    <Report instance="a-20220131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>2432416 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - Estimated Future Amortization (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSEstimatedFutureAmortizationDetails</Role>
      <ShortName>GOODWILL AND OTHER INTANGIBLE ASSETS - Estimated Future Amortization (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="a-20220131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>2435417 - Disclosure - FAIR VALUE MEASUREMENTS, Fair value of assets and liabilities measured on a recurring basis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.agilent.com/role/FAIRVALUEMEASUREMENTSFairvalueofassetsandliabilitiesmeasuredonarecurringbasisDetails</Role>
      <ShortName>FAIR VALUE MEASUREMENTS, Fair value of assets and liabilities measured on a recurring basis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="a-20220131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>2436418 - Disclosure - FAIR VALUE MEASUREMENTS, Non Marketable Securities and Investment Impairments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.agilent.com/role/FAIRVALUEMEASUREMENTSNonMarketableSecuritiesandInvestmentImpairmentsDetails</Role>
      <ShortName>FAIR VALUE MEASUREMENTS, Non Marketable Securities and Investment Impairments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="a-20220131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>2437419 - Disclosure - FAIR VALUE MEASUREMENTS, Contingent Consideration (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.agilent.com/role/FAIRVALUEMEASUREMENTSContingentConsiderationDetails</Role>
      <ShortName>FAIR VALUE MEASUREMENTS, Contingent Consideration (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="a-20220131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>2438420 - Disclosure - FAIR VALUE MEASUREMENTS - Reconciliation of Beginning and Ending Level 3 Contingent Consideration Liability (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.agilent.com/role/FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingLevel3ContingentConsiderationLiabilityDetails</Role>
      <ShortName>FAIR VALUE MEASUREMENTS - Reconciliation of Beginning and Ending Level 3 Contingent Consideration Liability (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="a-20220131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>2439421 - Disclosure - FAIR VALUE MEASUREMENTS, Assets and Liabilities measured at Fair Value on a Non-Recurring Basis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.agilent.com/role/FAIRVALUEMEASUREMENTSAssetsandLiabilitiesmeasuredatFairValueonaNonRecurringBasisDetails</Role>
      <ShortName>FAIR VALUE MEASUREMENTS, Assets and Liabilities measured at Fair Value on a Non-Recurring Basis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="a-20220131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>2442422 - Disclosure - DERIVATIVES- Text (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.agilent.com/role/DERIVATIVESTextDetails</Role>
      <ShortName>DERIVATIVES- Text (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="a-20220131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>2443423 - Disclosure - DERIVATIVES- Foreign Exchange Forward Contracts (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.agilent.com/role/DERIVATIVESForeignExchangeForwardContractsDetails</Role>
      <ShortName>DERIVATIVES- Foreign Exchange Forward Contracts (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="a-20220131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>2444424 - Disclosure - DERIVATIVES, Fair value of derivative instruments and Consolidated Balance Sheet location (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.agilent.com/role/DERIVATIVESFairvalueofderivativeinstrumentsandConsolidatedBalanceSheetlocationDetails</Role>
      <ShortName>DERIVATIVES, Fair value of derivative instruments and Consolidated Balance Sheet location (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="a-20220131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>2445425 - Disclosure - DERIVATIVES, Effect of derivative instruments on Consolidated Statement of Operations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.agilent.com/role/DERIVATIVESEffectofderivativeinstrumentsonConsolidatedStatementofOperationsDetails</Role>
      <ShortName>DERIVATIVES, Effect of derivative instruments on Consolidated Statement of Operations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="a-20220131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>2448426 - Disclosure - RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS- Components of net periodic costs (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSComponentsofnetperiodiccostsDetails</Role>
      <ShortName>RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS- Components of net periodic costs (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="a-20220131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>2449427 - Disclosure - RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS (Details) (Employer Contributions))</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSDetailsEmployerContributions</Role>
      <ShortName>RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS (Details) (Employer Contributions))</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSTables</ParentRole>
      <Position>66</Position>
    </Report>
    <Report instance="a-20220131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>2452428 - Disclosure - WARRANTIES AND CONTINGENCIES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.agilent.com/role/WARRANTIESANDCONTINGENCIESDetails</Role>
      <ShortName>WARRANTIES AND CONTINGENCIES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.agilent.com/role/WARRANTIESANDCONTINGENCIESTable</ParentRole>
      <Position>67</Position>
    </Report>
    <Report instance="a-20220131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>2454429 - Disclosure - SHORT-TERM DEBT - Credit Facility (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.agilent.com/role/SHORTTERMDEBTCreditFacilityDetails</Role>
      <ShortName>SHORT-TERM DEBT - Credit Facility (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="a-20220131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>2457430 - Disclosure - LONG-TERM DEBT (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.agilent.com/role/LONGTERMDEBTDetails</Role>
      <ShortName>LONG-TERM DEBT (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.agilent.com/role/LONGTERMDEBTTables</ParentRole>
      <Position>69</Position>
    </Report>
    <Report instance="a-20220131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>2460431 - Disclosure - STOCKHOLDERS' EQUITY - Stock Repurchase Program (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.agilent.com/role/STOCKHOLDERSEQUITYStockRepurchaseProgramDetails</Role>
      <ShortName>STOCKHOLDERS' EQUITY - Stock Repurchase Program (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="a-20220131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>2461432 - Disclosure - STOCKHOLDER"S EQUITY - Dividends (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.agilent.com/role/STOCKHOLDERSEQUITYDividendsDetails</Role>
      <ShortName>STOCKHOLDER"S EQUITY - Dividends (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="a-20220131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>2462433 - Disclosure - STOCKHOLDER'S EQUITY - Accumulated Other Comprehensive Income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.agilent.com/role/STOCKHOLDERSEQUITYAccumulatedOtherComprehensiveIncomeDetails</Role>
      <ShortName>STOCKHOLDER'S EQUITY - Accumulated Other Comprehensive Income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="a-20220131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>2463434 - Disclosure - STOCKHOLDERS' EQUITY - Reclassifications out of accumulated comprehensive income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.agilent.com/role/STOCKHOLDERSEQUITYReclassificationsoutofaccumulatedcomprehensiveincomeDetails</Role>
      <ShortName>STOCKHOLDERS' EQUITY - Reclassifications out of accumulated comprehensive income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="a-20220131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>2466435 - Disclosure - SEGMENT INFORMATION - Profitability (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.agilent.com/role/SEGMENTINFORMATIONProfitabilityDetails</Role>
      <ShortName>SEGMENT INFORMATION - Profitability (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="a-20220131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>2467436 - Disclosure - SEGMENT INFORMATION - Reconciliation of Reportable Results (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.agilent.com/role/SEGMENTINFORMATIONReconciliationofReportableResultsDetails</Role>
      <ShortName>SEGMENT INFORMATION - Reconciliation of Reportable Results (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>75</Position>
    </Report>
    <Report instance="a-20220131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>2468437 - Disclosure - SEGMENT INFORMATION - Segment Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.agilent.com/role/SEGMENTINFORMATIONSegmentAssetsDetails</Role>
      <ShortName>SEGMENT INFORMATION - Segment Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>76</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" original="a-20220131.htm">a-20220131.htm</File>
    <File>a-01312022xex311.htm</File>
    <File>a-01312022xex312.htm</File>
    <File>a-01312022xex321.htm</File>
    <File>a-01312022xex322.htm</File>
    <File>a-20220131.xsd</File>
    <File>a-20220131_cal.xml</File>
    <File>a-20220131_def.xml</File>
    <File>a-20220131_lab.xml</File>
    <File>a-20220131_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="902">http://fasb.org/us-gaap/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy items="29">http://xbrl.sec.gov/dei/2021q4</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>93
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "a-20220131.htm": {
   "axisCustom": 1,
   "axisStandard": 25,
   "contextCount": 290,
   "dts": {
    "calculationLink": {
     "local": [
      "a-20220131_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "a-20220131_def.xml"
     ]
    },
    "inline": {
     "local": [
      "a-20220131.htm"
     ]
    },
    "labelLink": {
     "local": [
      "a-20220131_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "a-20220131_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "a-20220131.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/currency/2021/currency-2021.xsd",
      "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"
     ]
    }
   },
   "elementCount": 644,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021q4": 5,
    "total": 5
   },
   "keyCustom": 14,
   "keyStandard": 383,
   "memberCustom": 28,
   "memberStandard": 72,
   "nsprefix": "a",
   "nsuri": "http://www.agilent.com/20220131",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityRegistrantName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Document and Entity Information",
     "role": "http://www.agilent.com/role/DocumentandEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityRegistrantName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2101101 - Disclosure - OVERVIEW, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Notes)",
     "role": "http://www.agilent.com/role/OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNotes",
     "shortName": "OVERVIEW, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Notes)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2105102 - Disclosure - NEW ACCOUNTING PRONOUNCEMENTS (Notes)",
     "role": "http://www.agilent.com/role/NEWACCOUNTINGPRONOUNCEMENTSNotes",
     "shortName": "NEW ACCOUNTING PRONOUNCEMENTS (Notes)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2107103 - Disclosure - REVENUE (Notes)",
     "role": "http://www.agilent.com/role/REVENUENotes",
     "shortName": "REVENUE (Notes)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2114104 - Disclosure - SHARE-BASED COMPENSATION (Notes)",
     "role": "http://www.agilent.com/role/SHAREBASEDCOMPENSATIONNotes",
     "shortName": "SHARE-BASED COMPENSATION (Notes)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2119105 - Disclosure - INCOME TAXES (Notes)",
     "role": "http://www.agilent.com/role/INCOMETAXESNotes",
     "shortName": "INCOME TAXES (Notes)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2121106 - Disclosure - NET INCOME PER SHARE (Notes)",
     "role": "http://www.agilent.com/role/NETINCOMEPERSHARENotes",
     "shortName": "NET INCOME PER SHARE (Notes)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2124107 - Disclosure - INVENTORY (Notes)",
     "role": "http://www.agilent.com/role/INVENTORYNotes",
     "shortName": "INVENTORY (Notes)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2127108 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Notes)",
     "role": "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNotes",
     "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS (Notes)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2133109 - Disclosure - FAIR VALUE MEASUREMENTS (Notes)",
     "role": "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSNotes",
     "shortName": "FAIR VALUE MEASUREMENTS (Notes)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2140110 - Disclosure - DERIVATIVES (Notes)",
     "role": "http://www.agilent.com/role/DERIVATIVESNotes",
     "shortName": "DERIVATIVES (Notes)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001002 - Statement - CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS (Unaudited)",
     "role": "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFOPERATIONSUnaudited",
     "shortName": "CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:CostOfGoodsAndServicesSold",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2146111 - Disclosure - RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS (Notes)",
     "role": "http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSNotes",
     "shortName": "RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS (Notes)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2150112 - Disclosure - WARRANTIES AND CONTINGENCIES (Notes)",
     "role": "http://www.agilent.com/role/WARRANTIESANDCONTINGENCIESNotes",
     "shortName": "WARRANTIES AND CONTINGENCIES (Notes)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShortTermDebtTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2153113 - Disclosure - SHORT-TERM DEBT (Notes)",
     "role": "http://www.agilent.com/role/SHORTTERMDEBTNotes",
     "shortName": "SHORT-TERM DEBT (Notes)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShortTermDebtTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2155114 - Disclosure - LONG-TERM DEBT (Notes)",
     "role": "http://www.agilent.com/role/LONGTERMDEBTNotes",
     "shortName": "LONG-TERM DEBT (Notes)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2158115 - Disclosure - STOCKHOLDERS' EQUITY (Notes)",
     "role": "http://www.agilent.com/role/STOCKHOLDERSEQUITYNotes",
     "shortName": "STOCKHOLDERS' EQUITY (Notes)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2164116 - Disclosure - SEGMENT INFORMATION (Notes)",
     "role": "http://www.agilent.com/role/SEGMENTINFORMATIONNotes",
     "shortName": "SEGMENT INFORMATION (Notes)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2202201 - Disclosure - OVERVIEW, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "role": "http://www.agilent.com/role/OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies",
     "shortName": "OVERVIEW, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2303301 - Disclosure - OVERVIEW, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "role": "http://www.agilent.com/role/OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables",
     "shortName": "OVERVIEW, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2308303 - Disclosure - REVENUE (Tables)",
     "role": "http://www.agilent.com/role/REVENUETables",
     "shortName": "REVENUE (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2315304 - Disclosure - SHARE-BASED COMPENSATION (Tables)",
     "role": "http://www.agilent.com/role/SHAREBASEDCOMPENSATIONTables",
     "shortName": "SHARE-BASED COMPENSATION (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002003 - Statement - CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME (Unaudited)",
     "role": "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOMEUnaudited",
     "shortName": "CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2322305 - Disclosure - NET INCOME PER SHARE (Tables)",
     "role": "http://www.agilent.com/role/NETINCOMEPERSHARETables",
     "shortName": "NET INCOME PER SHARE (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:InventoryDisclosureTextBlock",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2325306 - Disclosure - INVENTORY (Tables)",
     "role": "http://www.agilent.com/role/INVENTORYTables",
     "shortName": "INVENTORY (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:InventoryDisclosureTextBlock",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2328307 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)",
     "role": "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables",
     "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2334308 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)",
     "role": "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSTables",
     "shortName": "FAIR VALUE MEASUREMENTS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2341309 - Disclosure - DERIVATIVES (Tables)",
     "role": "http://www.agilent.com/role/DERIVATIVESTables",
     "shortName": "DERIVATIVES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDefinedBenefitPlansDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2347310 - Disclosure - RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS (Tables)",
     "role": "http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSTables",
     "shortName": "RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDefinedBenefitPlansDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2351311 - Disclosure - WARRANTIES AND CONTINGENCIES (Table)",
     "role": "http://www.agilent.com/role/WARRANTIESANDCONTINGENCIESTable",
     "shortName": "WARRANTIES AND CONTINGENCIES (Table)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2356312 - Disclosure - LONG-TERM DEBT (Tables)",
     "role": "http://www.agilent.com/role/LONGTERMDEBTTables",
     "shortName": "LONG-TERM DEBT (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2359313 - Disclosure - STOCKHOLDERS' EQUITY (Tables)",
     "role": "http://www.agilent.com/role/STOCKHOLDERSEQUITYTables",
     "shortName": "STOCKHOLDERS' EQUITY (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2365314 - Disclosure - SEGMENT INFORMATION (Tables)",
     "role": "http://www.agilent.com/role/SEGMENTINFORMATIONTables",
     "shortName": "SEGMENT INFORMATION (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003004 - Statement - CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME (LOSS) (Unaudited) (Parenthetical)",
     "role": "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOMELOSSUnauditedParenthetical",
     "shortName": "CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME (LOSS) (Unaudited) (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy",
       "us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2404401 - Disclosure - OVERVIEW, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)",
     "role": "http://www.agilent.com/role/OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails",
     "shortName": "OVERVIEW, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy",
       "us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:RestrictedCash",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2409402 - Disclosure - REVENUE- Revenue by Region (Details)",
     "role": "http://www.agilent.com/role/REVENUERevenuebyRegionDetails",
     "shortName": "REVENUE- Revenue by Region (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "i8b6e655997ee46b5b0ca774029d951f0_D20211101-20220131",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2410403 - Disclosure - REVENUE - Revenue by End Markets (Details)",
     "role": "http://www.agilent.com/role/REVENUERevenuebyEndMarketsDetails",
     "shortName": "REVENUE - Revenue by End Markets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "id5a6ff22f0f64b46ac2eca9fc0c63a58_D20211101-20220131",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2411404 - Disclosure - REVENUE - Revenue by Type (Details)",
     "role": "http://www.agilent.com/role/REVENUERevenuebyTypeDetails",
     "shortName": "REVENUE - Revenue by Type (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "i931db477735742ad8a7854c47ecedf86_D20211101-20220131",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerAssetNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2412405 - Disclosure - REVENUE - Contract Assets and Liability (Details)",
     "role": "http://www.agilent.com/role/REVENUEContractAssetsandLiabilityDetails",
     "shortName": "REVENUE - Contract Assets and Liability (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerAssetNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "i54fd0d780e894d15abb38be115f904fc_I20220131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2413406 - Disclosure - REVENUE - Remaining Performance Obligation (Details)",
     "role": "http://www.agilent.com/role/REVENUERemainingPerformanceObligationDetails",
     "shortName": "REVENUE - Remaining Performance Obligation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "i54fd0d780e894d15abb38be115f904fc_I20220131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2416407 - Disclosure - SHARE-BASED COMPENSATION Text (Details)",
     "role": "http://www.agilent.com/role/SHAREBASEDCOMPENSATIONTextDetails",
     "shortName": "SHARE-BASED COMPENSATION Text (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2417408 - Disclosure - SHARE-BASED COMPENSATION Allocated Share-based compensation expense (Details)",
     "role": "http://www.agilent.com/role/SHAREBASEDCOMPENSATIONAllocatedSharebasedcompensationexpenseDetails",
     "shortName": "SHARE-BASED COMPENSATION Allocated Share-based compensation expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "a:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "i0320d16146c74425913fe2d4102de305_D20211101-20220131",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2418409 - Disclosure - SHARE-BASED COMPENSATION Fair Value Assumptions (Details)",
     "role": "http://www.agilent.com/role/SHAREBASEDCOMPENSATIONFairValueAssumptionsDetails",
     "shortName": "SHARE-BASED COMPENSATION Fair Value Assumptions (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "a:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "i0320d16146c74425913fe2d4102de305_D20211101-20220131",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxExpenseBenefit",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2420410 - Disclosure - INCOME TAXES (Details)",
     "role": "http://www.agilent.com/role/INCOMETAXESDetails",
     "shortName": "INCOME TAXES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131",
      "decimals": "3",
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy",
       "us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004005 - Statement - CONDENSED CONSOLIDATED BALANCE SHEET (Unaudited)",
     "role": "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEET (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:AccountsReceivableNetCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2423411 - Disclosure - NET INCOME PER SHARE (Details)",
     "role": "http://www.agilent.com/role/NETINCOMEPERSHAREDetails",
     "shortName": "NET INCOME PER SHARE (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryFinishedGoods",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2426412 - Disclosure - INVENTORY (Details)",
     "role": "http://www.agilent.com/role/INVENTORYDetails",
     "shortName": "INVENTORY (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryFinishedGoods",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill",
       "us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill",
       "us-gaap:GoodwillImpairmentLoss",
       "us-gaap:GoodwillImpairmentLoss",
       "us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill",
       "us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill",
       "us-gaap:GoodwillImpairmentLoss",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillImpairmentLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2429413 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS Goodwill Roll forward (Details)",
     "role": "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSGoodwillRollforwardDetails",
     "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS Goodwill Roll forward (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2430414 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS Disclosures and Components of Purchased Other Intangibles (Details)",
     "role": "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDisclosuresandComponentsofPurchasedOtherIntangiblesDetails",
     "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS Disclosures and Components of Purchased Other Intangibles (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:GoodwillAcquiredDuringPeriod",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsPeriodIncreaseDecrease",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2431415 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS Textuals (Details)",
     "role": "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTextualsDetails",
     "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS Textuals (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:GoodwillAcquiredDuringPeriod",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsPeriodIncreaseDecrease",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2432416 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - Estimated Future Amortization (Details)",
     "role": "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSEstimatedFutureAmortizationDetails",
     "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS - Estimated Future Amortization (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquitySecuritiesFvNi",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2435417 - Disclosure - FAIR VALUE MEASUREMENTS, Fair value of assets and liabilities measured on a recurring basis (Details)",
     "role": "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSFairvalueofassetsandliabilitiesmeasuredonarecurringbasisDetails",
     "shortName": "FAIR VALUE MEASUREMENTS, Fair value of assets and liabilities measured on a recurring basis (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "i33fe9961080d4147aae99b460ab50ecb_I20220131",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:AssetsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2436418 - Disclosure - FAIR VALUE MEASUREMENTS, Non Marketable Securities and Investment Impairments (Details)",
     "role": "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSNonMarketableSecuritiesandInvestmentImpairmentsDetails",
     "shortName": "FAIR VALUE MEASUREMENTS, Non Marketable Securities and Investment Impairments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:ImpairmentOfInvestments",
       "us-gaap:ImpairmentOfInvestments",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:ImpairmentOfInvestments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "id313ef0eb3db435cabb1861abacdf1d0_D20211101-20220131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "a:BusinessCombinationsContingentConsiderationArrangements",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2437419 - Disclosure - FAIR VALUE MEASUREMENTS, Contingent Consideration (Details)",
     "role": "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSContingentConsiderationDetails",
     "shortName": "FAIR VALUE MEASUREMENTS, Contingent Consideration (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "id313ef0eb3db435cabb1861abacdf1d0_D20211101-20220131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "a:BusinessCombinationsContingentConsiderationArrangements",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "i6390807210d74c6f9cae496ea2122a5a_I20211031",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2438420 - Disclosure - FAIR VALUE MEASUREMENTS - Reconciliation of Beginning and Ending Level 3 Contingent Consideration Liability (Details)",
     "role": "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingLevel3ContingentConsiderationLiabilityDetails",
     "shortName": "FAIR VALUE MEASUREMENTS - Reconciliation of Beginning and Ending Level 3 Contingent Consideration Liability (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1005006 - Statement - CONDENSED CONSOLIDATED BALANCE SHEET (Unaudited) (Parenthetical)",
     "role": "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnauditedParenthetical",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEET (Unaudited) (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf",
       "us-gaap:ImpairmentOfLongLivedAssetsHeldForUse",
       "us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf",
       "us-gaap:ImpairmentOfLongLivedAssetsHeldForUse",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ImpairmentOfLongLivedAssetsHeldForUse",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2439421 - Disclosure - FAIR VALUE MEASUREMENTS, Assets and Liabilities measured at Fair Value on a Non-Recurring Basis (Details)",
     "role": "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSAssetsandLiabilitiesmeasuredatFairValueonaNonRecurringBasisDetails",
     "shortName": "FAIR VALUE MEASUREMENTS, Assets and Liabilities measured at Fair Value on a Non-Recurring Basis (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf",
       "us-gaap:ImpairmentOfLongLivedAssetsHeldForUse",
       "us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf",
       "us-gaap:ImpairmentOfLongLivedAssetsHeldForUse",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ImpairmentOfLongLivedAssetsHeldForUse",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeNetLiabilityPositionAggregateFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2442422 - Disclosure - DERIVATIVES- Text (Details)",
     "role": "http://www.agilent.com/role/DERIVATIVESTextDetails",
     "shortName": "DERIVATIVES- Text (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeNetLiabilityPositionAggregateFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "i3d4fb6e9c35b4a259523bf637621e885_I20220131",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfForeignCurrencyDerivativesHeld",
      "reportCount": 1,
      "unique": true,
      "unitRef": "contracts",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2443423 - Disclosure - DERIVATIVES- Foreign Exchange Forward Contracts (Details)",
     "role": "http://www.agilent.com/role/DERIVATIVESForeignExchangeForwardContractsDetails",
     "shortName": "DERIVATIVES- Foreign Exchange Forward Contracts (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "i3d4fb6e9c35b4a259523bf637621e885_I20220131",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfForeignCurrencyDerivativesHeld",
      "reportCount": 1,
      "unique": true,
      "unitRef": "contracts",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeFairValueOfDerivativeAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2444424 - Disclosure - DERIVATIVES, Fair value of derivative instruments and Consolidated Balance Sheet location (Details)",
     "role": "http://www.agilent.com/role/DERIVATIVESFairvalueofderivativeinstrumentsandConsolidatedBalanceSheetlocationDetails",
     "shortName": "DERIVATIVES, Fair value of derivative instruments and Consolidated Balance Sheet location (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeFairValueOfDerivativeAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2445425 - Disclosure - DERIVATIVES, Effect of derivative instruments on Consolidated Statement of Operations (Details)",
     "role": "http://www.agilent.com/role/DERIVATIVESEffectofderivativeinstrumentsonConsolidatedStatementofOperationsDetails",
     "shortName": "DERIVATIVES, Effect of derivative instruments on Consolidated Statement of Operations (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "ica123646e5544ebdbe2fa02d65eb9294_D20211101-20220131",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDefinedBenefitPlansDisclosuresTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "i8454ff09d8134a2fb231984b395af89d_D20211101-20220131",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanServiceCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2448426 - Disclosure - RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS- Components of net periodic costs (Details)",
     "role": "http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSComponentsofnetperiodiccostsDetails",
     "shortName": "RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS- Components of net periodic costs (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDefinedBenefitPlansDisclosuresTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "i8454ff09d8134a2fb231984b395af89d_D20211101-20220131",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanServiceCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "a:EmployerContributionsAndExpectedEmployerContributionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "i8454ff09d8134a2fb231984b395af89d_D20211101-20220131",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanContributionsByEmployer",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2449427 - Disclosure - RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS (Details) (Employer Contributions))",
     "role": "http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSDetailsEmployerContributions",
     "shortName": "RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS (Details) (Employer Contributions))",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "a:EmployerContributionsAndExpectedEmployerContributionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "i8454ff09d8134a2fb231984b395af89d_D20211101-20220131",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanContributionsByEmployer",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "i6390807210d74c6f9cae496ea2122a5a_I20211031",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StandardProductWarrantyAccrual",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2452428 - Disclosure - WARRANTIES AND CONTINGENCIES (Details)",
     "role": "http://www.agilent.com/role/WARRANTIESANDCONTINGENCIESDetails",
     "shortName": "WARRANTIES AND CONTINGENCIES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "i6390807210d74c6f9cae496ea2122a5a_I20211031",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StandardProductWarrantyAccrual",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:ProceedsFromIssuanceOfCommercialPaper",
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RepaymentsOfCommercialPaper",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2454429 - Disclosure - SHORT-TERM DEBT - Credit Facility (Details)",
     "role": "http://www.agilent.com/role/SHORTTERMDEBTCreditFacilityDetails",
     "shortName": "SHORT-TERM DEBT - Credit Facility (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "i6353332b36004c5c9db76cacfa73e855_D20190313-20190313",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:LineOfCreditFacilityInitiationDate1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebt",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2457430 - Disclosure - LONG-TERM DEBT (Details)",
     "role": "http://www.agilent.com/role/LONGTERMDEBTDetails",
     "shortName": "LONG-TERM DEBT (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebt",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1006007 - Statement - CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS (Unaudited)",
     "role": "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited",
     "shortName": "CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "i629b697ae777498d9e2c067c3e5a581e_I20181119",
      "decimals": "-7",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2460431 - Disclosure - STOCKHOLDERS' EQUITY - Stock Repurchase Program (Details)",
     "role": "http://www.agilent.com/role/STOCKHOLDERSEQUITYStockRepurchaseProgramDetails",
     "shortName": "STOCKHOLDERS' EQUITY - Stock Repurchase Program (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "i629b697ae777498d9e2c067c3e5a581e_I20181119",
      "decimals": "-7",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockDividendsPerShareCashPaid",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2461432 - Disclosure - STOCKHOLDER\"S EQUITY - Dividends (Details)",
     "role": "http://www.agilent.com/role/STOCKHOLDERSEQUITYDividendsDetails",
     "shortName": "STOCKHOLDER\"S EQUITY - Dividends (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockDividendsPerShareCashPaid",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "i6390807210d74c6f9cae496ea2122a5a_I20211031",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2462433 - Disclosure - STOCKHOLDER'S EQUITY - Accumulated Other Comprehensive Income (Details)",
     "role": "http://www.agilent.com/role/STOCKHOLDERSEQUITYAccumulatedOtherComprehensiveIncomeDetails",
     "shortName": "STOCKHOLDER'S EQUITY - Accumulated Other Comprehensive Income (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2463434 - Disclosure - STOCKHOLDERS' EQUITY - Reclassifications out of accumulated comprehensive income (Details)",
     "role": "http://www.agilent.com/role/STOCKHOLDERSEQUITYReclassificationsoutofaccumulatedcomprehensiveincomeDetails",
     "shortName": "STOCKHOLDERS' EQUITY - Reclassifications out of accumulated comprehensive income (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R74": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2466435 - Disclosure - SEGMENT INFORMATION - Profitability (Details)",
     "role": "http://www.agilent.com/role/SEGMENTINFORMATIONProfitabilityDetails",
     "shortName": "SEGMENT INFORMATION - Profitability (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R75": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "a:Segmentincomelossfromoperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2467436 - Disclosure - SEGMENT INFORMATION - Reconciliation of Reportable Results (Details)",
     "role": "http://www.agilent.com/role/SEGMENTINFORMATIONReconciliationofReportableResultsDetails",
     "shortName": "SEGMENT INFORMATION - Reconciliation of Reportable Results (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "a:Segmentincomelossfromoperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R76": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "ie68f8fb6493a44a98ad4ff6c6d03a0bb_I20220131",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Assets",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2468437 - Disclosure - SEGMENT INFORMATION - Segment Assets (Details)",
     "role": "http://www.agilent.com/role/SEGMENTINFORMATIONSegmentAssetsDetails",
     "shortName": "SEGMENT INFORMATION - Segment Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "ifa12471462934aa683c02dac2a2b2a70_I20220131",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:Assets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "i482974eb49534930b9164c76d7ed1578_I20201031",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1007008 - Statement - CONDENSED CONSOLIDATED STATEMENT OF EQUITY",
     "role": "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFEQUITY",
     "shortName": "CONDENSED CONSOLIDATED STATEMENT OF EQUITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "i482974eb49534930b9164c76d7ed1578_I20201031",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockDividendsPerShareDeclared",
      "reportCount": 1,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1008009 - Statement - CONDENSED CONSOLIDATE STATEMENT OF EQUITY - (PARENTHETICAL)",
     "role": "http://www.agilent.com/role/CONDENSEDCONSOLIDATESTATEMENTOFEQUITYPARENTHETICAL",
     "shortName": "CONDENSED CONSOLIDATE STATEMENT OF EQUITY - (PARENTHETICAL)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a-20220131.htm",
      "contextRef": "i3c7588521fdc44528bd4c6caf3d2988f_D20211101-20220131",
      "decimals": "-6",
      "lang": "en-US",
      "name": "a:Taxrelatedtosharesissued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 100,
   "tag": {
    "a_A2019RepurchaseProgramMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2019 Repurchase Program [Member]",
        "label": "2019 Repurchase Program [Member]",
        "terseLabel": "2019 Repurchase Program [Member]"
       }
      }
     },
     "localname": "A2019RepurchaseProgramMember",
     "nsuri": "http://www.agilent.com/20220131",
     "presentation": [
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYStockRepurchaseProgramDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "a_A2021RepurchaseProgramMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2021 Repurchase Program",
        "label": "2021 Repurchase Program [Member]",
        "terseLabel": "2021 Repurchase Program [Member]"
       }
      }
     },
     "localname": "A2021RepurchaseProgramMember",
     "nsuri": "http://www.agilent.com/20220131",
     "presentation": [
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYStockRepurchaseProgramDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "a_A5YrUnsecuredCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "5 yr Unsecured Credit Facility",
        "label": "5 yr Unsecured Credit Facility [Member]",
        "terseLabel": "5 yr Unsecured Credit Facility"
       }
      }
     },
     "localname": "A5YrUnsecuredCreditFacilityMember",
     "nsuri": "http://www.agilent.com/20220131",
     "presentation": [
      "http://www.agilent.com/role/SHORTTERMDEBTCreditFacilityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "a_AcademiaandGovernmentMarketMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Academia and Government Market [Member]",
        "label": "Academia and Government Market [Member]",
        "terseLabel": "Academia and Government"
       }
      }
     },
     "localname": "AcademiaandGovernmentMarketMember",
     "nsuri": "http://www.agilent.com/20220131",
     "presentation": [
      "http://www.agilent.com/role/REVENUERevenuebyEndMarketsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "a_AdditionalIncrementalTermLoanFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional Incremental Term Loan Facility",
        "label": "Additional Incremental Term Loan Facility [Member]",
        "terseLabel": "Additional Incremental Term Loan Facility"
       }
      }
     },
     "localname": "AdditionalIncrementalTermLoanFacilityMember",
     "nsuri": "http://www.agilent.com/20220131",
     "presentation": [
      "http://www.agilent.com/role/SHORTTERMDEBTCreditFacilityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "a_AgilentCrossLabMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agilent CrossLab [Member]",
        "label": "Agilent CrossLab [Member]",
        "terseLabel": "Agilent CrossLab"
       }
      }
     },
     "localname": "AgilentCrossLabMember",
     "nsuri": "http://www.agilent.com/20220131",
     "presentation": [
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSGoodwillRollforwardDetails",
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTextualsDetails",
      "http://www.agilent.com/role/REVENUERevenuebyRegionDetails",
      "http://www.agilent.com/role/SEGMENTINFORMATIONProfitabilityDetails",
      "http://www.agilent.com/role/SEGMENTINFORMATIONSegmentAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "a_AmortizationAndDeferralsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortization and deferrals [Abstract]",
        "label": "Amortization and deferrals [Abstract]",
        "terseLabel": "Amortization:"
       }
      }
     },
     "localname": "AmortizationAndDeferralsAbstract",
     "nsuri": "http://www.agilent.com/20220131",
     "presentation": [
      "http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSComponentsofnetperiodiccostsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "a_AssetsLongLivedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assets Long Lived [Abstract]",
        "label": "Assets Long Lived [Abstract]",
        "terseLabel": "Long-Lived Assets"
       }
      }
     },
     "localname": "AssetsLongLivedAbstract",
     "nsuri": "http://www.agilent.com/20220131",
     "presentation": [
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSAssetsandLiabilitiesmeasuredatFairValueonaNonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "a_BusinessCombinationContingentConsiderationFairValueMeasurementInput": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage input used to measure contingent consideration liability from business combination.",
        "label": "Business Combination Contingent Consideration Fair Value Measurement Input",
        "terseLabel": "Business Combination Contingent Consideration Liability Measurement Input"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationFairValueMeasurementInput",
     "nsuri": "http://www.agilent.com/20220131",
     "presentation": [
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSContingentConsiderationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "a_BusinessCombinationsContingentConsiderationArrangements": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "business combinations, contingent consideration, arrangements",
        "label": "business combinations, contingent consideration, arrangements",
        "terseLabel": "Contingent Consideration maximum earn-out period"
       }
      }
     },
     "localname": "BusinessCombinationsContingentConsiderationArrangements",
     "nsuri": "http://www.agilent.com/20220131",
     "presentation": [
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSContingentConsiderationDetails",
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingLevel3ContingentConsiderationLiabilityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "a_ChemicalandEnergyMarketMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Chemical and Energy Market [Member]",
        "label": "Chemical and Energy Market [Member]",
        "terseLabel": "Chemical and Energy"
       }
      }
     },
     "localname": "ChemicalandEnergyMarketMember",
     "nsuri": "http://www.agilent.com/20220131",
     "presentation": [
      "http://www.agilent.com/role/REVENUERevenuebyEndMarketsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "a_DenominatorsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Denominators [Abstract]",
        "label": "Denominators [Abstract]",
        "terseLabel": "Denominators:"
       }
      }
     },
     "localname": "DenominatorsAbstract",
     "nsuri": "http://www.agilent.com/20220131",
     "presentation": [
      "http://www.agilent.com/role/NETINCOMEPERSHAREDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "a_DiagnosticsAndGenomicsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Diagnostics and Genomics segment includes; DNA mutation detection; genotyping; gene copy number determination; identification of gene rearrangements; DNA methylation profiling; gene expression profiling; and automated gel electrophoresis-based sample analysis systems.",
        "label": "Diagnostics and Genomics [Member]",
        "terseLabel": "Diagnostics and Genomics"
       }
      }
     },
     "localname": "DiagnosticsAndGenomicsMember",
     "nsuri": "http://www.agilent.com/20220131",
     "presentation": [
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSGoodwillRollforwardDetails",
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTextualsDetails",
      "http://www.agilent.com/role/REVENUERevenuebyRegionDetails",
      "http://www.agilent.com/role/SEGMENTINFORMATIONProfitabilityDetails",
      "http://www.agilent.com/role/SEGMENTINFORMATIONSegmentAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "a_DiagnosticsandClinicalMarketMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Diagnostics and Clinical Market [Member]",
        "label": "Diagnostics and Clinical Market [Member]",
        "terseLabel": "Diagnostics and Clinical"
       }
      }
     },
     "localname": "DiagnosticsandClinicalMarketMember",
     "nsuri": "http://www.agilent.com/20220131",
     "presentation": [
      "http://www.agilent.com/role/REVENUERevenuebyEndMarketsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "a_DocumentAndEntityInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Document and Entity Information [Abstract]",
        "label": "Document and Entity Information [Abstract]",
        "terseLabel": "Document and Entity Information [Abstract]"
       }
      }
     },
     "localname": "DocumentAndEntityInformationAbstract",
     "nsuri": "http://www.agilent.com/20220131",
     "xbrltype": "stringItemType"
    },
    "a_EmployerContributionsAndExpectedEmployerContributionsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of amount of contributions received by defined benefit plan from employer which increases plan assets and amount of contribution expected to be received by defined benefit plan from employer in the remainder of current fiscal year.",
        "label": "Employer Contributions and Expected Employer Contributions [Table Text Block]",
        "terseLabel": "Employer Contributions and Expected Employer Contributions"
       }
      }
     },
     "localname": "EmployerContributionsAndExpectedEmployerContributionsTableTextBlock",
     "nsuri": "http://www.agilent.com/20220131",
     "presentation": [
      "http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "a_EndMarketsAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End Markets [Axis]",
        "label": "End Markets [Axis]",
        "terseLabel": "End Markets [Axis]"
       }
      }
     },
     "localname": "EndMarketsAxis",
     "nsuri": "http://www.agilent.com/20220131",
     "presentation": [
      "http://www.agilent.com/role/REVENUERevenuebyEndMarketsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "a_EndMarketsDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Domain] for End Markets [Axis]",
        "label": "End Markets [Domain]",
        "terseLabel": "End Markets [Domain]"
       }
      }
     },
     "localname": "EndMarketsDomain",
     "nsuri": "http://www.agilent.com/20220131",
     "presentation": [
      "http://www.agilent.com/role/REVENUERevenuebyEndMarketsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "a_EnvironmentalandForensicsMarketMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Environmental and Forensics Market [Member]",
        "label": "Environmental and Forensics Market [Member]",
        "terseLabel": "Environmental and Forensics"
       }
      }
     },
     "localname": "EnvironmentalandForensicsMarketMember",
     "nsuri": "http://www.agilent.com/20220131",
     "presentation": [
      "http://www.agilent.com/role/REVENUERevenuebyEndMarketsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "a_Fairvalueoflongtermdebtinexcessofcarryingvalue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of fair value of long term debt in excess of carrying value.",
        "label": "Fair value of long term debt in excess of carrying value",
        "terseLabel": "Fair value of senior notes in excess of carrying value"
       }
      }
     },
     "localname": "Fairvalueoflongtermdebtinexcessofcarryingvalue",
     "nsuri": "http://www.agilent.com/20220131",
     "presentation": [
      "http://www.agilent.com/role/OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "a_FoodMarketMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Food Market [Member]",
        "label": "Food Market [Member]",
        "terseLabel": "Food"
       }
      }
     },
     "localname": "FoodMarketMember",
     "nsuri": "http://www.agilent.com/20220131",
     "presentation": [
      "http://www.agilent.com/role/REVENUERevenuebyEndMarketsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "a_IncreasedecreaseinDeferredRevenuefromCustomerCashAdvancesNetofRevenuerecognized": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (decrease) in Deferred Revenue from Customer Cash Advances, Net of Revenue recognized in the period.",
        "label": "Increase (decrease) in Deferred Revenue from Customer Cash Advances, Net of Revenue recognized",
        "terseLabel": "Change in deferrals from customer cash advances, net of revenue recognized"
       }
      }
     },
     "localname": "IncreasedecreaseinDeferredRevenuefromCustomerCashAdvancesNetofRevenuerecognized",
     "nsuri": "http://www.agilent.com/20220131",
     "presentation": [
      "http://www.agilent.com/role/REVENUEContractAssetsandLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "a_IncreaseinContractAssetBalance": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (decrease) in Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.",
        "label": "Increase in Contract Asset Balance",
        "terseLabel": "Increase in Contract Asset Balance"
       }
      }
     },
     "localname": "IncreaseinContractAssetBalance",
     "nsuri": "http://www.agilent.com/20220131",
     "presentation": [
      "http://www.agilent.com/role/REVENUEContractAssetsandLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "a_InstrumentationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrumentation [Member]",
        "label": "Instrumentation [Member]",
        "terseLabel": "Instrumentation"
       }
      }
     },
     "localname": "InstrumentationMember",
     "nsuri": "http://www.agilent.com/20220131",
     "presentation": [
      "http://www.agilent.com/role/REVENUERevenuebyTypeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "a_Interestrateswappayments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "interest rate swap payments",
        "label": "interest rate swap payments",
        "terseLabel": "Interest rate swap payments"
       }
      }
     },
     "localname": "Interestrateswappayments",
     "nsuri": "http://www.agilent.com/20220131",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESTextDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "a_LTPPRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "LTPP &amp; RSU [Member]",
        "label": "LTPP &amp; RSU [Member]",
        "terseLabel": "LTPP &amp; RSU"
       }
      }
     },
     "localname": "LTPPRSUMember",
     "nsuri": "http://www.agilent.com/20220131",
     "presentation": [
      "http://www.agilent.com/role/SHAREBASEDCOMPENSATIONFairValueAssumptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "a_LifeSciencesandAppliedMarketsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Life Sciences and Applied Markets [Member]",
        "label": "Life Sciences and Applied Markets [Member]",
        "terseLabel": "Life Sciences and Applied Markets"
       }
      }
     },
     "localname": "LifeSciencesandAppliedMarketsMember",
     "nsuri": "http://www.agilent.com/20220131",
     "presentation": [
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSGoodwillRollforwardDetails",
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTextualsDetails",
      "http://www.agilent.com/role/REVENUERevenuebyRegionDetails",
      "http://www.agilent.com/role/SEGMENTINFORMATIONProfitabilityDetails",
      "http://www.agilent.com/role/SEGMENTINFORMATIONSegmentAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "a_LtppMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long Term Performance Plan.",
        "label": "LTPP [Member]",
        "terseLabel": "LTPP"
       }
      }
     },
     "localname": "LtppMember",
     "nsuri": "http://www.agilent.com/20220131",
     "presentation": [
      "http://www.agilent.com/role/SHAREBASEDCOMPENSATIONAllocatedSharebasedcompensationexpenseDetails",
      "http://www.agilent.com/role/SHAREBASEDCOMPENSATIONFairValueAssumptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "a_MeasurementInputAssetVolatilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement Input, Asset Volatility",
        "label": "Measurement Input, Asset Volatility [Member]",
        "terseLabel": "Measurement Input, Asset Volatility"
       }
      }
     },
     "localname": "MeasurementInputAssetVolatilityMember",
     "nsuri": "http://www.agilent.com/20220131",
     "presentation": [
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSAssetsandLiabilitiesmeasuredatFairValueonaNonRecurringBasisDetails",
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSContingentConsiderationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "a_MeasurementInputRevenueVolatilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement Input, Revenue Volatility",
        "label": "Measurement Input, Revenue Volatility [Member]",
        "terseLabel": "Measurement Input, Revenue Volatility"
       }
      }
     },
     "localname": "MeasurementInputRevenueVolatilityMember",
     "nsuri": "http://www.agilent.com/20220131",
     "presentation": [
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSAssetsandLiabilitiesmeasuredatFairValueonaNonRecurringBasisDetails",
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSContingentConsiderationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "a_NonInstrumentationandOtherMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non-Instrumentation and Other[Member]",
        "label": "Non-Instrumentation and Other [Member]",
        "terseLabel": "Non-Instrumentation and Other"
       }
      }
     },
     "localname": "NonInstrumentationandOtherMember",
     "nsuri": "http://www.agilent.com/20220131",
     "presentation": [
      "http://www.agilent.com/role/REVENUERevenuebyTypeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "a_NumeratorAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Numerator [Abstract]",
        "label": "Numerator [Abstract]",
        "terseLabel": "Numerator:"
       }
      }
     },
     "localname": "NumeratorAbstract",
     "nsuri": "http://www.agilent.com/20220131",
     "presentation": [
      "http://www.agilent.com/role/NETINCOMEPERSHAREDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "a_Other": {
     "auth_ref": [],
     "calculation": {
      "http://www.agilent.com/role/SEGMENTINFORMATIONReconciliationofReportableResultsDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of an item in the reconciliation of total profit or loss from reportable segments, to the entity's consolidated income before income taxes, extraordinary items, discontinued operations.",
        "label": "Other",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "Other",
     "nsuri": "http://www.agilent.com/20220131",
     "presentation": [
      "http://www.agilent.com/role/SEGMENTINFORMATIONReconciliationofReportableResultsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "a_OtherAccruedAndLongTermLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other accrued and long-term liabilities",
        "label": "Other accrued and long-term liabilities [Member]",
        "terseLabel": "Other accrued and long-term liabilities"
       }
      }
     },
     "localname": "OtherAccruedAndLongTermLiabilitiesMember",
     "nsuri": "http://www.agilent.com/20220131",
     "presentation": [
      "http://www.agilent.com/role/OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "a_PharmaceuticalandBiopharmaceuticalMarketMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pharmaceutical and Biopharmaceutical Market [Member]",
        "label": "Pharmaceutical and Biopharmaceutical Market [Member]",
        "terseLabel": "Pharmaceutical and Biopharmaceutical"
       }
      }
     },
     "localname": "PharmaceuticalandBiopharmaceuticalMarketMember",
     "nsuri": "http://www.agilent.com/20220131",
     "presentation": [
      "http://www.agilent.com/role/REVENUERevenuebyEndMarketsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "a_Remaininggainlosstobeamortizedonderivative": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Remaining gain loss to be amortized on derivative",
        "label": "Remaining gain loss to be amortized on derivative",
        "terseLabel": "Remaining gain (loss) to be amortized on derivative"
       }
      }
     },
     "localname": "Remaininggainlosstobeamortizedonderivative",
     "nsuri": "http://www.agilent.com/20220131",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESTextDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "a_ResolutionBioscienceIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Resolution Bioscience, Inc.",
        "label": "Resolution Bioscience, Inc. [Member]",
        "terseLabel": "Resolution Bioscience, Inc."
       }
      }
     },
     "localname": "ResolutionBioscienceIncMember",
     "nsuri": "http://www.agilent.com/20220131",
     "presentation": [
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSContingentConsiderationDetails",
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSFairvalueofassetsandliabilitiesmeasuredonarecurringbasisDetails",
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTextualsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "a_SegmentTotalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reportable amounts associated with all reporting segments included in a reconciliation from segment reporting to consolidated income from operations, before taxes.",
        "label": "Segment Total [Member]",
        "terseLabel": "Segment Total"
       }
      }
     },
     "localname": "SegmentTotalMember",
     "nsuri": "http://www.agilent.com/20220131",
     "presentation": [
      "http://www.agilent.com/role/SEGMENTINFORMATIONProfitabilityDetails",
      "http://www.agilent.com/role/SEGMENTINFORMATIONSegmentAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "a_Segmentincomelossfromoperations": {
     "auth_ref": [],
     "calculation": {
      "http://www.agilent.com/role/SEGMENTINFORMATIONReconciliationofReportableResultsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting segment operating expenses from segment operating revenues.",
        "label": "Segment income (loss) from operations",
        "terseLabel": "Total reportable segment's income from operations"
       }
      }
     },
     "localname": "Segmentincomelossfromoperations",
     "nsuri": "http://www.agilent.com/20220131",
     "presentation": [
      "http://www.agilent.com/role/SEGMENTINFORMATIONReconciliationofReportableResultsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "a_SeniorNotes2022Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bond that takes priority over other debt securities by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for (must receive) repayment prior to (relative to) junior and unsecured ( general) creditors.",
        "label": "Senior Notes 2022 [Member]",
        "terseLabel": "Senior Notes 2022"
       }
      }
     },
     "localname": "SeniorNotes2022Member",
     "nsuri": "http://www.agilent.com/20220131",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESTextDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "a_SeniorNotes2023Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes 2023 [Member]",
        "label": "Senior Notes 2023 [Member]",
        "terseLabel": "Senior Notes 2023"
       }
      }
     },
     "localname": "SeniorNotes2023Member",
     "nsuri": "http://www.agilent.com/20220131",
     "presentation": [
      "http://www.agilent.com/role/LONGTERMDEBTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "a_SeniorNotes2026Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes 2026",
        "label": "Senior Notes 2026 [Member]",
        "terseLabel": "Senior Notes 2026"
       }
      }
     },
     "localname": "SeniorNotes2026Member",
     "nsuri": "http://www.agilent.com/20220131",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESTextDetails",
      "http://www.agilent.com/role/LONGTERMDEBTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "a_SeniorNotes2029Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes 2029 [Member]",
        "label": "Senior Notes 2029 [Member]",
        "terseLabel": "Senior Notes 2029"
       }
      }
     },
     "localname": "SeniorNotes2029Member",
     "nsuri": "http://www.agilent.com/20220131",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESTextDetails",
      "http://www.agilent.com/role/LONGTERMDEBTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "a_SeniorNotes2030Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes 2030",
        "label": "Senior Notes 2030 [Member]",
        "terseLabel": "Senior Notes 2030"
       }
      }
     },
     "localname": "SeniorNotes2030Member",
     "nsuri": "http://www.agilent.com/20220131",
     "presentation": [
      "http://www.agilent.com/role/LONGTERMDEBTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "a_SeniorNotes2031Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes 2031",
        "label": "Senior Notes 2031 [Member]",
        "terseLabel": "Senior Notes 2031"
       }
      }
     },
     "localname": "SeniorNotes2031Member",
     "nsuri": "http://www.agilent.com/20220131",
     "presentation": [
      "http://www.agilent.com/role/LONGTERMDEBTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, and long-term performance plan grants.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions And Methodology [Text Block]",
        "terseLabel": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions And Methodology [Text Block]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyTextBlock",
     "nsuri": "http://www.agilent.com/20220131",
     "presentation": [
      "http://www.agilent.com/role/SHAREBASEDCOMPENSATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesPriceWiseCorrelationyRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The measure of the percentage amount of share price correlation during the period with a selected group of peer companies. Pair-wise correlations with selected peers is calculated as the correlation between each pair and the sum of correlations divided by the number of pairs to produce the average correlation between each pair.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Peer Company Shares Price Wise Correlationy Rate",
        "verboseLabel": "Pair-wise correlation with selected peers (in hundredths)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesPriceWiseCorrelationyRate",
     "nsuri": "http://www.agilent.com/20220131",
     "presentation": [
      "http://www.agilent.com/role/SHAREBASEDCOMPENSATIONFairValueAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesVolatilityRateRangeMaximum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The measure of the percentage amount by which a share price fluctuates during a period for peer companies - maximum range. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Peer Company Shares Volatility Rate Range Maximum",
        "terseLabel": "Volatility of selected peer-company shares - Maximum"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesVolatilityRateRangeMaximum",
     "nsuri": "http://www.agilent.com/20220131",
     "presentation": [
      "http://www.agilent.com/role/SHAREBASEDCOMPENSATIONFairValueAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesVolatilityRateRangeMinimum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The measure of the percentage amount by which a share price fluctuates during a period for peer companies - minimum range. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Peer Company Shares Volatility Rate Range Minimum",
        "terseLabel": "Volatility of selected peer-company shares - Minimum"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesVolatilityRateRangeMinimum",
     "nsuri": "http://www.agilent.com/20220131",
     "presentation": [
      "http://www.agilent.com/role/SHAREBASEDCOMPENSATIONFairValueAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "a_Taxrelatedtosharesissued": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tax related to shares issued",
        "label": "Tax related to shares issued",
        "terseLabel": "Tax related to shares issued"
       }
      }
     },
     "localname": "Taxrelatedtosharesissued",
     "nsuri": "http://www.agilent.com/20220131",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATESTATEMENTOFEQUITYPARENTHETICAL"
     ],
     "xbrltype": "monetaryItemType"
    },
    "a_ThirdPartyTechnologyandLicensesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Third-Party Technology and Licenses [Member]",
        "label": "Third-Party Technology and Licenses [Member]",
        "terseLabel": "Third-Party Technology and Licenses"
       }
      }
     },
     "localname": "ThirdPartyTechnologyandLicensesMember",
     "nsuri": "http://www.agilent.com/20220131",
     "presentation": [
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDisclosuresandComponentsofPurchasedOtherIntangiblesDetails",
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTextualsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "a_TransformationalPrograms": {
     "auth_ref": [],
     "calculation": {
      "http://www.agilent.com/role/SEGMENTINFORMATIONReconciliationofReportableResultsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The charge against earnings in the period, comprised of costs associated with restructuring activities not otherwise specified in the taxonomy that are not part of a specific plan as required by GAAP.",
        "label": "Transformational Programs",
        "negatedLabel": "Transformational initiatives"
       }
      }
     },
     "localname": "TransformationalPrograms",
     "nsuri": "http://www.agilent.com/20220131",
     "presentation": [
      "http://www.agilent.com/role/SEGMENTINFORMATIONReconciliationofReportableResultsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "a_WeightedAverageMaturityDateAtAPointInTime": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average maturity date at a point in time",
        "label": "Weighted average maturity date at a point in time",
        "terseLabel": "Weighted average maturity date at a point in time"
       }
      }
     },
     "localname": "WeightedAverageMaturityDateAtAPointInTime",
     "nsuri": "http://www.agilent.com/20220131",
     "presentation": [
      "http://www.agilent.com/role/SHORTTERMDEBTCreditFacilityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "a_WeightedAverageMaturityDateatPointinTime": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted Average Maturity Date at Point in Time.",
        "label": "Weighted Average Maturity Date at Point in Time",
        "terseLabel": "Weighted Average Maturity Date at Point in Time"
       }
      }
     },
     "localname": "WeightedAverageMaturityDateatPointinTime",
     "nsuri": "http://www.agilent.com/20220131",
     "presentation": [
      "http://www.agilent.com/role/SHORTTERMDEBTCreditFacilityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED STATES",
        "terseLabel": "United States"
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSComponentsofnetperiodiccostsDetails",
      "http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSDetailsEmployerContributions"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_AUD": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Australia, Dollars",
        "verboseLabel": "Australian Dollar"
       }
      }
     },
     "localname": "AUD",
     "nsuri": "http://xbrl.sec.gov/currency/2021",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESForeignExchangeForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_AllCurrenciesDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Currencies [Domain]",
        "terseLabel": "All Currencies [Domain]"
       }
      }
     },
     "localname": "AllCurrenciesDomain",
     "nsuri": "http://xbrl.sec.gov/currency/2021",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESForeignExchangeForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_BRL": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Brazil, Brazil Real",
        "terseLabel": "Brazil, Brazil Real"
       }
      }
     },
     "localname": "BRL",
     "nsuri": "http://xbrl.sec.gov/currency/2021",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESForeignExchangeForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_CAD": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Canada, Dollars",
        "terseLabel": "Canadian Dollar"
       }
      }
     },
     "localname": "CAD",
     "nsuri": "http://xbrl.sec.gov/currency/2021",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESForeignExchangeForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_CHF": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Switzerland, Francs",
        "terseLabel": "Swiss Franc"
       }
      }
     },
     "localname": "CHF",
     "nsuri": "http://xbrl.sec.gov/currency/2021",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESForeignExchangeForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_CNY": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "China, Yuan Renminbi",
        "terseLabel": "Chinese Yuan Renminbi"
       }
      }
     },
     "localname": "CNY",
     "nsuri": "http://xbrl.sec.gov/currency/2021",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESForeignExchangeForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_DKK": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Denmark, Kroner",
        "terseLabel": "Danish Krone"
       }
      }
     },
     "localname": "DKK",
     "nsuri": "http://xbrl.sec.gov/currency/2021",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESForeignExchangeForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_EUR": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Euro Member Countries, Euro",
        "terseLabel": "Euro"
       }
      }
     },
     "localname": "EUR",
     "nsuri": "http://xbrl.sec.gov/currency/2021",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESForeignExchangeForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_GBP": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "United Kingdom, Pounds",
        "terseLabel": "British Pound"
       }
      }
     },
     "localname": "GBP",
     "nsuri": "http://xbrl.sec.gov/currency/2021",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESForeignExchangeForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_INR": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "India, Rupees",
        "terseLabel": "India, Rupees"
       }
      }
     },
     "localname": "INR",
     "nsuri": "http://xbrl.sec.gov/currency/2021",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESForeignExchangeForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_JPY": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Japan, Yen",
        "terseLabel": "Japanese Yen"
       }
      }
     },
     "localname": "JPY",
     "nsuri": "http://xbrl.sec.gov/currency/2021",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESForeignExchangeForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_KRW": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Korea (South), Won",
        "terseLabel": "Korean Won"
       }
      }
     },
     "localname": "KRW",
     "nsuri": "http://xbrl.sec.gov/currency/2021",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESForeignExchangeForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_MYR": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Malaysia, Ringgits",
        "terseLabel": "Malaysian Ringgit"
       }
      }
     },
     "localname": "MYR",
     "nsuri": "http://xbrl.sec.gov/currency/2021",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESForeignExchangeForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_PLN": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Poland, Zlotych",
        "terseLabel": "Polish Zloty"
       }
      }
     },
     "localname": "PLN",
     "nsuri": "http://xbrl.sec.gov/currency/2021",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESForeignExchangeForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_SEK": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sweden, Kronor",
        "terseLabel": "Swedish Krona"
       }
      }
     },
     "localname": "SEK",
     "nsuri": "http://xbrl.sec.gov/currency/2021",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESForeignExchangeForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_SGD": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Singapore, Dollars",
        "terseLabel": "Singapore Dollar"
       }
      }
     },
     "localname": "SGD",
     "nsuri": "http://xbrl.sec.gov/currency/2021",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESForeignExchangeForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_THB": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Thailand, Baht",
        "terseLabel": "Thailand, Baht"
       }
      }
     },
     "localname": "THB",
     "nsuri": "http://xbrl.sec.gov/currency/2021",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESForeignExchangeForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_TWD": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Taiwan, New Dollars",
        "terseLabel": "Taiwan, New Dollars"
       }
      }
     },
     "localname": "TWD",
     "nsuri": "http://xbrl.sec.gov/currency/2021",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESForeignExchangeForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_XXX": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "No currency",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "XXX",
     "nsuri": "http://xbrl.sec.gov/currency/2021",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESForeignExchangeForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.agilent.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.agilent.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.agilent.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.agilent.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.agilent.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.agilent.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r766"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.agilent.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r767"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.agilent.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.agilent.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.agilent.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.agilent.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.agilent.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.agilent.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r764"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.agilent.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.agilent.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.agilent.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r764"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.agilent.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.agilent.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r764"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.agilent.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.agilent.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r769"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.agilent.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r764"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.agilent.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r764"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.agilent.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r764"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.agilent.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r764"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.agilent.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.agilent.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r763"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.agilent.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r765"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.agilent.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.agilent.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "srt_AmericasMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Americas [Member]",
        "terseLabel": "Americas"
       }
      }
     },
     "localname": "AmericasMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/REVENUERevenuebyRegionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_AsiaPacificMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Asia Pacific [Member]",
        "terseLabel": "Asia Pacific"
       }
      }
     },
     "localname": "AsiaPacificMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/REVENUERevenuebyRegionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ConsolidatedEntitiesAxis": {
     "auth_ref": [
      "r122",
      "r285",
      "r289",
      "r294",
      "r545",
      "r546",
      "r549",
      "r550",
      "r663",
      "r758"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated Entities [Axis]",
        "terseLabel": "Consolidated Entities [Axis]"
       }
      }
     },
     "localname": "ConsolidatedEntitiesAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidatedEntitiesDomain": {
     "auth_ref": [
      "r122",
      "r285",
      "r289",
      "r294",
      "r545",
      "r546",
      "r549",
      "r550",
      "r663",
      "r758"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated Entities [Domain]",
        "terseLabel": "Consolidated Entities [Domain]"
       }
      }
     },
     "localname": "ConsolidatedEntitiesDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CurrencyAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Currency [Axis]",
        "terseLabel": "Currency [Axis]"
       }
      }
     },
     "localname": "CurrencyAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESForeignExchangeForwardContractsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_EuropeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Europe [Member]",
        "terseLabel": "Europe"
       }
      }
     },
     "localname": "EuropeMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/REVENUERevenuebyRegionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r299",
      "r324",
      "r459",
      "r465",
      "r672",
      "r673",
      "r674",
      "r675",
      "r676",
      "r677",
      "r679",
      "r731",
      "r734",
      "r760",
      "r761"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSAssetsandLiabilitiesmeasuredatFairValueonaNonRecurringBasisDetails",
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSContingentConsiderationDetails",
      "http://www.agilent.com/role/SHAREBASEDCOMPENSATIONTextDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r299",
      "r324",
      "r459",
      "r465",
      "r672",
      "r673",
      "r674",
      "r675",
      "r676",
      "r677",
      "r679",
      "r731",
      "r734",
      "r760",
      "r761"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSAssetsandLiabilitiesmeasuredatFairValueonaNonRecurringBasisDetails",
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSContingentConsiderationDetails",
      "http://www.agilent.com/role/SHAREBASEDCOMPENSATIONTextDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r211",
      "r362",
      "r366",
      "r682",
      "r730",
      "r732"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFOPERATIONSUnaudited",
      "http://www.agilent.com/role/REVENUERevenuebyTypeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r211",
      "r362",
      "r366",
      "r682",
      "r730",
      "r732"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFOPERATIONSUnaudited",
      "http://www.agilent.com/role/REVENUERevenuebyTypeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r299",
      "r324",
      "r400",
      "r459",
      "r465",
      "r672",
      "r673",
      "r674",
      "r675",
      "r676",
      "r677",
      "r679",
      "r731",
      "r734",
      "r760",
      "r761"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSAssetsandLiabilitiesmeasuredatFairValueonaNonRecurringBasisDetails",
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSContingentConsiderationDetails",
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTextualsDetails",
      "http://www.agilent.com/role/SHAREBASEDCOMPENSATIONTextDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r299",
      "r324",
      "r400",
      "r459",
      "r465",
      "r672",
      "r673",
      "r674",
      "r675",
      "r676",
      "r677",
      "r679",
      "r731",
      "r734",
      "r760",
      "r761"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSAssetsandLiabilitiesmeasuredatFairValueonaNonRecurringBasisDetails",
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSContingentConsiderationDetails",
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTextualsDetails",
      "http://www.agilent.com/role/SHAREBASEDCOMPENSATIONTextDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis": {
     "auth_ref": [
      "r749",
      "r750",
      "r751",
      "r752",
      "r753",
      "r754",
      "r755",
      "r756",
      "r759"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name of Property [Axis]",
        "terseLabel": "Name of Property [Axis]"
       }
      }
     },
     "localname": "RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/SEGMENTINFORMATIONReconciliationofReportableResultsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain": {
     "auth_ref": [
      "r749",
      "r750",
      "r751",
      "r752",
      "r753",
      "r754",
      "r755",
      "r756",
      "r759"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name of Property [Domain]",
        "terseLabel": "Name of Property [Domain]"
       }
      }
     },
     "localname": "RealEstateAndAccumulatedDepreciationNameOfPropertyDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/SEGMENTINFORMATIONReconciliationofReportableResultsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RestatementAxis": {
     "auth_ref": [
      "r3",
      "r124",
      "r125",
      "r126",
      "r129",
      "r130",
      "r135",
      "r136",
      "r137",
      "r138",
      "r140",
      "r141",
      "r142",
      "r143",
      "r144",
      "r145",
      "r163",
      "r236",
      "r237",
      "r495",
      "r516",
      "r601",
      "r606",
      "r607",
      "r608",
      "r737",
      "r738",
      "r739",
      "r740",
      "r741",
      "r742",
      "r743",
      "r744",
      "r745",
      "r746",
      "r773",
      "r774"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revision of Prior Period [Axis]",
        "terseLabel": "Revision of Prior Period [Axis]"
       }
      }
     },
     "localname": "RestatementAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RestatementDomain": {
     "auth_ref": [
      "r3",
      "r124",
      "r125",
      "r126",
      "r129",
      "r130",
      "r135",
      "r136",
      "r137",
      "r138",
      "r140",
      "r141",
      "r142",
      "r143",
      "r144",
      "r145",
      "r163",
      "r236",
      "r237",
      "r495",
      "r516",
      "r601",
      "r606",
      "r607",
      "r608",
      "r737",
      "r738",
      "r739",
      "r740",
      "r741",
      "r742",
      "r743",
      "r744",
      "r745",
      "r746",
      "r773",
      "r774"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revision of Prior Period [Domain]",
        "terseLabel": "Revision of Prior Period [Domain]"
       }
      }
     },
     "localname": "RestatementDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember": {
     "auth_ref": [
      "r3",
      "r129",
      "r130",
      "r138",
      "r145",
      "r236",
      "r237",
      "r495",
      "r516",
      "r601",
      "r608",
      "r737",
      "r738",
      "r739",
      "r740",
      "r741",
      "r742",
      "r743",
      "r744",
      "r745",
      "r746",
      "r773",
      "r774"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revision of Prior Period, Accounting Standards Update, Adjustment [Member]",
        "terseLabel": "Revision of Prior Period Adjustment, Accounting Standards Update"
       }
      }
     },
     "localname": "RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioUnspecifiedDomain": {
     "auth_ref": [
      "r139",
      "r145",
      "r460"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Domain]",
        "terseLabel": "Scenario [Domain]"
       }
      }
     },
     "localname": "ScenarioUnspecifiedDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited",
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOMELOSSUnauditedParenthetical",
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOMEUnaudited",
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFOPERATIONSUnaudited",
      "http://www.agilent.com/role/INCOMETAXESDetails",
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYReclassificationsoutofaccumulatedcomprehensiveincomeDetails",
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYTables"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r212",
      "r213",
      "r362",
      "r367",
      "r733",
      "r749",
      "r750",
      "r751",
      "r752",
      "r753",
      "r754",
      "r755",
      "r756",
      "r757"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/REVENUERevenuebyRegionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r212",
      "r213",
      "r362",
      "r367",
      "r733",
      "r747",
      "r749",
      "r750",
      "r751",
      "r752",
      "r753",
      "r754",
      "r755",
      "r756",
      "r757"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/REVENUERevenuebyRegionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_StatementScenarioAxis": {
     "auth_ref": [
      "r139",
      "r145",
      "r277",
      "r460",
      "r668"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Axis]",
        "terseLabel": "Scenario [Axis]"
       }
      }
     },
     "localname": "StatementScenarioAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited",
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOMELOSSUnauditedParenthetical",
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOMEUnaudited",
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFOPERATIONSUnaudited",
      "http://www.agilent.com/role/INCOMETAXESDetails",
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYReclassificationsoutofaccumulatedcomprehensiveincomeDetails",
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/NEWACCOUNTINGPRONOUNCEMENTSNotes",
      "http://www.agilent.com/role/NEWACCOUNTINGPRONOUNCEMENTSTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r40",
      "r666"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "verboseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r11",
      "r26",
      "r217",
      "r218"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "verboseLabel": "Accounts receivable, net"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesMember": {
     "auth_ref": [
      "r45"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered.",
        "label": "Accrued Liabilities [Member]",
        "terseLabel": "Other Accrued Liabilities"
       }
      }
     },
     "localname": "AccruedLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESFairvalueofderivativeinstrumentsandConsolidatedBalanceSheetlocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember": {
     "auth_ref": [
      "r66",
      "r71",
      "r80",
      "r81",
      "r82",
      "r547"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive (income) loss related to prior service cost (credit) component of defined benefit plans attributable to the parent.",
        "label": "Accumulated Defined Benefit Plans Adjustment, Net Prior Service Attributable to Parent [Member]",
        "terseLabel": "Prior Service Credits"
       }
      }
     },
     "localname": "AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYAccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember": {
     "auth_ref": [
      "r65",
      "r71",
      "r80",
      "r81",
      "r82",
      "r547"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) related to gain (loss) component of defined benefit plans attributable to the parent.",
        "label": "Accumulated Defined Benefit Plans Adjustment, Net Gain (Loss) Attributable to Parent [Member]",
        "terseLabel": "Actuarial Losses"
       }
      }
     },
     "localname": "AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYAccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r29",
      "r68",
      "r70",
      "r71",
      "r716",
      "r742",
      "r746"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "periodEndLabel": "Ending Balance",
        "periodStartLabel": "Beginning Balance",
        "verboseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited",
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYAccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r67",
      "r71",
      "r80",
      "r81",
      "r82",
      "r124",
      "r125",
      "r126",
      "r547",
      "r737",
      "r738",
      "r774"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss)",
        "verboseLabel": "Accumulated Other Comprehensive Loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFEQUITY",
      "http://www.agilent.com/role/DERIVATIVESEffectofderivativeinstrumentsonConsolidatedStatementofOperationsDetails",
      "http://www.agilent.com/role/DERIVATIVESTextDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedTranslationAdjustmentMember": {
     "auth_ref": [
      "r62",
      "r71",
      "r80",
      "r81",
      "r82",
      "r547",
      "r644",
      "r645",
      "r646",
      "r647",
      "r650"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent.",
        "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]",
        "terseLabel": "Foreign Currency Translation"
       }
      }
     },
     "localname": "AccumulatedTranslationAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYAccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r27",
      "r495",
      "r666"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Additional Paid in Capital",
        "terseLabel": "Additional paid-in-capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r124",
      "r125",
      "r126",
      "r491",
      "r492",
      "r493",
      "r606"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-in Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentForAmortization": {
     "auth_ref": [
      "r108",
      "r257"
     ],
     "calculation": {
      "http://www.agilent.com/role/SEGMENTINFORMATIONReconciliationofReportableResultsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.",
        "label": "Amortization",
        "negatedLabel": "Amortization of intangible assets related to business combinations"
       }
      }
     },
     "localname": "AdjustmentForAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/SEGMENTINFORMATIONReconciliationofReportableResultsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsForChangeInAccountingPrincipleAxis": {
     "auth_ref": [
      "r129",
      "r130",
      "r131",
      "r133"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of change in accounting principle. Excludes change from amendment to accounting standards.",
        "label": "Change in Accounting Principle, Type [Axis]",
        "terseLabel": "Change in Accounting Principle, Type [Axis]"
       }
      }
     },
     "localname": "AdjustmentsForChangeInAccountingPrincipleAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdjustmentsForErrorCorrectionDomain": {
     "auth_ref": [
      "r135",
      "r136",
      "r137",
      "r140",
      "r141",
      "r143",
      "r144"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of error correction.",
        "label": "Error Correction, Type [Domain]",
        "terseLabel": "Error Correction, Type [Domain]"
       }
      }
     },
     "localname": "AdjustmentsForErrorCorrectionDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": {
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r129",
      "r130",
      "r131",
      "r133",
      "r145",
      "r220",
      "r221",
      "r230",
      "r231",
      "r232",
      "r233",
      "r236",
      "r237",
      "r284",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r495",
      "r513",
      "r514",
      "r515",
      "r516",
      "r597",
      "r598",
      "r599",
      "r600",
      "r601",
      "r602",
      "r603",
      "r605",
      "r606",
      "r607",
      "r608",
      "r627",
      "r628",
      "r629",
      "r630",
      "r631",
      "r632",
      "r636",
      "r637",
      "r661",
      "r684",
      "r685",
      "r686",
      "r735",
      "r736",
      "r737",
      "r738",
      "r739",
      "r740",
      "r741",
      "r742",
      "r743",
      "r744",
      "r745",
      "r746",
      "r770",
      "r771",
      "r772",
      "r773",
      "r774"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by amendment to accounting standards.",
        "label": "Accounting Standards Update [Axis]",
        "terseLabel": "Accounting Standards Update [Axis]"
       }
      }
     },
     "localname": "AdjustmentsForNewAccountingPronouncementsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFEQUITY",
      "http://www.agilent.com/role/LONGTERMDEBTDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r467",
      "r469",
      "r498",
      "r499"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "verboseLabel": "Adjustments to reconcile net income to net cash provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r469",
      "r484",
      "r497"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-based Payment Arrangement, Expense",
        "terseLabel": "Share-based compensation expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/SHAREBASEDCOMPENSATIONAllocatedSharebasedcompensationexpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r108",
      "r251",
      "r257"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "verboseLabel": "Amortization of intangible assets during the period"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTextualsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r160"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Anti-dilutive shares excluded from computation of dilutive earnings per share (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/NETINCOMEPERSHAREDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r160"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities [Axis]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/NETINCOMEPERSHAREDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "terseLabel": "Antidilutive Securities Excluded from EPS Computation"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/NETINCOMEPERSHAREDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r160"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities, Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name [Domain]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/NETINCOMEPERSHAREDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AociDerivativeQualifyingAsHedgeExcludedComponentParentMember": {
     "auth_ref": [
      "r71",
      "r80",
      "r81",
      "r82",
      "r595"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) from increase (decrease) in value of excluded component of derivative hedge, attributable to parent.",
        "label": "AOCI, Derivative Qualifying as Hedge, Excluded Component, Parent [Member]",
        "terseLabel": "Unrealized Gains (Losses) on Derivatives"
       }
      }
     },
     "localname": "AociDerivativeQualifyingAsHedgeExcludedComponentParentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYAccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r118",
      "r193",
      "r200",
      "r207",
      "r229",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r545",
      "r549",
      "r626",
      "r664",
      "r666",
      "r694",
      "r713"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "terseLabel": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited",
      "http://www.agilent.com/role/OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails",
      "http://www.agilent.com/role/SEGMENTINFORMATIONSegmentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r12",
      "r13",
      "r57",
      "r118",
      "r229",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r545",
      "r549",
      "r626",
      "r664",
      "r666"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Assets",
        "verboseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited",
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSFairvalueofassetsandliabilitiesmeasuredonarecurringbasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "auth_ref": [
      "r610"
     ],
     "calculation": {
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSFairvalueofassetsandliabilitiesmeasuredonarecurringbasisDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Fair Value Disclosure",
        "totalLabel": "Total assets measured at fair value"
       }
      }
     },
     "localname": "AssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSFairvalueofassetsandliabilitiesmeasuredonarecurringbasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r471",
      "r485"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/SHAREBASEDCOMPENSATIONAllocatedSharebasedcompensationexpenseDetails",
      "http://www.agilent.com/role/SHAREBASEDCOMPENSATIONFairValueAssumptionsDetails",
      "http://www.agilent.com/role/SHAREBASEDCOMPENSATIONTextDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited",
      "http://www.agilent.com/role/DERIVATIVESEffectofderivativeinstrumentsonConsolidatedStatementofOperationsDetails",
      "http://www.agilent.com/role/DERIVATIVESFairvalueofderivativeinstrumentsandConsolidatedBalanceSheetlocationDetails",
      "http://www.agilent.com/role/DERIVATIVESTextDetails",
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSFairvalueofassetsandliabilitiesmeasuredonarecurringbasisDetails",
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTextualsDetails",
      "http://www.agilent.com/role/LONGTERMDEBTDetails",
      "http://www.agilent.com/role/OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails",
      "http://www.agilent.com/role/SHAREBASEDCOMPENSATIONAllocatedSharebasedcompensationexpenseDetails",
      "http://www.agilent.com/role/SHAREBASEDCOMPENSATIONTextDetails",
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYStockRepurchaseProgramDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r569",
      "r575"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited",
      "http://www.agilent.com/role/DERIVATIVESEffectofderivativeinstrumentsonConsolidatedStatementofOperationsDetails",
      "http://www.agilent.com/role/DERIVATIVESFairvalueofderivativeinstrumentsandConsolidatedBalanceSheetlocationDetails",
      "http://www.agilent.com/role/DERIVATIVESTextDetails",
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSFairvalueofassetsandliabilitiesmeasuredonarecurringbasisDetails",
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTextualsDetails",
      "http://www.agilent.com/role/LONGTERMDEBTDetails",
      "http://www.agilent.com/role/OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails",
      "http://www.agilent.com/role/SHAREBASEDCOMPENSATIONAllocatedSharebasedcompensationexpenseDetails",
      "http://www.agilent.com/role/SHAREBASEDCOMPENSATIONTextDetails",
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYStockRepurchaseProgramDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BankAcceptancesExecuted": {
     "auth_ref": [
      "r698"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of the financial institution's obligation to pay the holder of the customer's draft which the financial institution has guaranteed (i.e., Banker's Acceptance).",
        "label": "Bank Acceptances Executed",
        "terseLabel": "Guarantees"
       }
      }
     },
     "localname": "BankAcceptancesExecuted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/WARRANTIESANDCONTINGENCIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r455",
      "r461"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSContingentConsiderationDetails",
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSFairvalueofassetsandliabilitiesmeasuredonarecurringbasisDetails",
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTextualsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r455",
      "r461",
      "r534",
      "r535"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSContingentConsiderationDetails",
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSFairvalueofassetsandliabilitiesmeasuredonarecurringbasisDetails",
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTextualsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationAcquisitionRelatedCosts": {
     "auth_ref": [
      "r533"
     ],
     "calculation": {
      "http://www.agilent.com/role/SEGMENTINFORMATIONReconciliationofReportableResultsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.",
        "label": "Business Combination, Acquisition Related Costs",
        "negatedLabel": "Acquisition and integration costs"
       }
      }
     },
     "localname": "BusinessCombinationAcquisitionRelatedCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/SEGMENTINFORMATIONReconciliationofReportableResultsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1": {
     "auth_ref": [
      "r107",
      "r541"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.",
        "label": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability",
        "terseLabel": "Change in fair value of contingent consideration"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh": {
     "auth_ref": [
      "r540"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid.",
        "label": "Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High",
        "terseLabel": "Contingent Consideration Arrangement - Maximum"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSContingentConsiderationDetails",
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingLevel3ContingentConsiderationLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock": {
     "auth_ref": [
      "r8",
      "r123",
      "r179"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the business description and basis of presentation concepts.  Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity.  Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Business Description and Basis of Presentation [Text Block]",
        "terseLabel": "Overview and Basis of Presentation"
       }
      }
     },
     "localname": "BusinessDescriptionAndBasisOfPresentationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r9",
      "r37",
      "r110"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "verboseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited",
      "http://www.agilent.com/role/OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsFairValueDisclosure": {
     "auth_ref": [],
     "calculation": {
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSFairvalueofassetsandliabilitiesmeasuredonarecurringbasisDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents, Fair Value Disclosure",
        "terseLabel": "Cash equivalents (money market funds)"
       }
      }
     },
     "localname": "CashAndCashEquivalentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSFairvalueofassetsandliabilitiesmeasuredonarecurringbasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy": {
     "auth_ref": [
      "r15",
      "r111",
      "r692"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Entity's cash and cash equivalents accounting policy with respect to restricted balances.  Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.",
        "label": "Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Restricted Cash and Restricted Cash Equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r104",
      "r110",
      "r114"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "Cash, cash equivalents and restricted cash at end of period",
        "periodStartLabel": "Cash, cash equivalents and restricted cash at beginning of period",
        "terseLabel": "Cash, cash equivalents, restricted cash and restricted cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited",
      "http://www.agilent.com/role/OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Abstract]",
        "terseLabel": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r104",
      "r641"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net decrease in cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths": {
     "auth_ref": [
      "r594"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated net amount of existing gains or losses on cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months.",
        "label": "Cash Flow Hedge Gain (Loss) to be Reclassified within Twelve Months",
        "terseLabel": "Net gain to be reclassified within next Twelve Months"
       }
      }
     },
     "localname": "CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESTextDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowHedgingMember": {
     "auth_ref": [
      "r565"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hedge of the exposure to variability in the cash flows of a recognized asset or liability, or of a forecasted transaction, that is attributable to a particular risk.",
        "label": "Cash Flow Hedging [Member]",
        "terseLabel": "Cash Flow Hedging"
       }
      }
     },
     "localname": "CashFlowHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESEffectofderivativeinstrumentsonConsolidatedStatementofOperationsDetails",
      "http://www.agilent.com/role/DERIVATIVESFairvalueofderivativeinstrumentsandConsolidatedBalanceSheetlocationDetails",
      "http://www.agilent.com/role/DERIVATIVESForeignExchangeForwardContractsDetails",
      "http://www.agilent.com/role/DERIVATIVESTextDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ChangeInAccountingPrincipleMember": {
     "auth_ref": [
      "r129",
      "r130",
      "r131",
      "r133"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change in accounting principle. Excludes change from amendment to accounting standards.",
        "label": "Change in Accounting Principle, Type [Domain]",
        "terseLabel": "Change in Accounting Principle, Type [Domain]"
       }
      }
     },
     "localname": "ChangeInAccountingPrincipleMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r115",
      "r118",
      "r150",
      "r154",
      "r155",
      "r157",
      "r159",
      "r169",
      "r170",
      "r171",
      "r229",
      "r285",
      "r289",
      "r290",
      "r291",
      "r294",
      "r295",
      "r322",
      "r323",
      "r326",
      "r330",
      "r626",
      "r768"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited",
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfTreasuryStockTable": {
     "auth_ref": [
      "r342",
      "r343",
      "r344",
      "r345"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.",
        "label": "Class of Treasury Stock [Table]",
        "terseLabel": "Class of Treasury Stock [Table]"
       }
      }
     },
     "localname": "ClassOfTreasuryStockTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYStockRepurchaseProgramDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommercialPaperMember": {
     "auth_ref": [
      "r283"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds.",
        "label": "Commercial Paper [Member]",
        "terseLabel": "Commercial Paper"
       }
      }
     },
     "localname": "CommercialPaperMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/SHORTTERMDEBTCreditFacilityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r49",
      "r276",
      "r700",
      "r720"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and Contingencies (Note 9 and 12)"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r273",
      "r274",
      "r275",
      "r278",
      "r748"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "WARRANTIES AND CONTINGENCIES"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/WARRANTIESANDCONTINGENCIESNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": {
     "auth_ref": [
      "r50"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate number of common shares reserved for future issuance.",
        "label": "Common Stock, Capital Shares Reserved for Future Issuance",
        "terseLabel": "Number of Common shares available for future issuance"
       }
      }
     },
     "localname": "CommonStockCapitalSharesReservedForFutureIssuance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/SHAREBASEDCOMPENSATIONTextDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockDividendsPerShareCashPaid": {
     "auth_ref": [
      "r341"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate dividends paid during the period for each share of common stock outstanding.",
        "label": "Common Stock, Dividends, Per Share, Cash Paid",
        "terseLabel": "Cash dividends paid per common share"
       }
      }
     },
     "localname": "CommonStockDividendsPerShareCashPaid",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYDividendsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockDividendsPerShareDeclared": {
     "auth_ref": [
      "r341"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding.",
        "label": "Common Stock, Dividends, Per Share, Declared",
        "verboseLabel": "Dividends Declared per share"
       }
      }
     },
     "localname": "CommonStockDividendsPerShareDeclared",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATESTATEMENTOFEQUITYPARENTHETICAL",
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYDividendsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r124",
      "r125",
      "r606"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r25"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnauditedParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r25"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r25"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common Stock, Shares, Issued"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r25",
      "r336"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "terseLabel": "Common Stock, Shares, Outstanding"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r25",
      "r666"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "verboseLabel": "Common stock; $0.01 par value; 2 billion shares authorized; 300 million shares at January 31, 2022 and 302 million shares at October 31, 2021, issued and outstanding"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r76",
      "r78",
      "r79",
      "r89",
      "r706",
      "r725"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFEQUITY": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Total comprehensive income, net of tax"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]",
        "terseLabel": "Components of comprehensive income, net of tax"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r76",
      "r78",
      "r88",
      "r544",
      "r559",
      "r705",
      "r724"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOMEUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Total comprehensive income"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOMEUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConsolidationVariableInterestEntityPolicy": {
     "auth_ref": [
      "r548",
      "r552",
      "r554"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for consolidation to describe the significant judgments and assumptions made in determining whether a variable interest held by the entity requires the variable interest entity to be consolidated and (or) disclose information about its involvement with the variable interest entity; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; and the significant factors considered and judgments made in determining that the power to direct the activities that significantly impact the economic performance of the variable interest entity are shared (as defined).",
        "label": "Consolidation, Variable Interest Entity, Policy [Policy Text Block]",
        "terseLabel": "Variable Interest Entity"
       }
      }
     },
     "localname": "ConsolidationVariableInterestEntityPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractWithCustomerAssetAndLiabilityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contract with Customer, Contract Asset, Contract Liability, and Receivable [Abstract]",
        "terseLabel": "Contract Asset"
       }
      }
     },
     "localname": "ContractWithCustomerAssetAndLiabilityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/REVENUEContractAssetsandLiabilityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock": {
     "auth_ref": [
      "r351"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.",
        "label": "Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]",
        "terseLabel": "Contract Liabilities and Changes in Balances"
       }
      }
     },
     "localname": "ContractWithCustomerAssetAndLiabilityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/REVENUETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractWithCustomerAssetNet": {
     "auth_ref": [
      "r347",
      "r349",
      "r363"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.",
        "label": "Contract with Customer, Asset, after Allowance for Credit Loss",
        "terseLabel": "Contract Assets (Unbilled Accounts Receivable)"
       }
      }
     },
     "localname": "ContractWithCustomerAssetNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/REVENUEContractAssetsandLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiability": {
     "auth_ref": [
      "r347",
      "r348",
      "r363"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.",
        "label": "Contract with Customer, Liability",
        "periodEndLabel": "Contract liability ending balance as of January 31, 2022",
        "periodStartLabel": "Contract liability ending balance as of October 31, 2021"
       }
      }
     },
     "localname": "ContractWithCustomerLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/REVENUEContractAssetsandLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contract with Customer, Liability [Abstract]",
        "terseLabel": "Contract Liability"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/REVENUEContractAssetsandLiabilityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination": {
     "auth_ref": [
      "r350"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration from customer has been received or is due, from business combination.",
        "label": "Contract with Customer, Liability, Increase (Decrease) for Contract Acquired in Business Combination",
        "terseLabel": "Contract liabilities acquired in business combinations"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/REVENUEContractAssetsandLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": {
     "auth_ref": [
      "r364"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.",
        "label": "Contract with Customer, Liability, Revenue Recognized",
        "terseLabel": "Revenue recognized that was included in the contract liability balance at the beginning of the period"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityRevenueRecognized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/REVENUEContractAssetsandLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r92",
      "r682"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFOPERATIONSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "terseLabel": "Cost of revenue"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFOPERATIONSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfSalesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing cost of sales.",
        "label": "Cost of Sales [Member]",
        "terseLabel": "Cost of Products and Services",
        "verboseLabel": "Cost of Products and Services"
       }
      }
     },
     "localname": "CostOfSalesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESEffectofderivativeinstrumentsonConsolidatedStatementofOperationsDetails",
      "http://www.agilent.com/role/DERIVATIVESTextDetails",
      "http://www.agilent.com/role/SHAREBASEDCOMPENSATIONAllocatedSharebasedcompensationexpenseDetails",
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYReclassificationsoutofaccumulatedcomprehensiveincomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostsAndExpenses": {
     "auth_ref": [
      "r91"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFOPERATIONSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total costs of sales and operating expenses for the period.",
        "label": "Costs and Expenses",
        "totalLabel": "Total costs and expenses"
       }
      }
     },
     "localname": "CostsAndExpenses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFOPERATIONSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostsAndExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Costs and Expenses [Abstract]",
        "verboseLabel": "Costs and expenses:"
       }
      }
     },
     "localname": "CostsAndExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFOPERATIONSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/SHORTTERMDEBTCreditFacilityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/SHORTTERMDEBTCreditFacilityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerRelationshipsMember": {
     "auth_ref": [
      "r538"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.",
        "label": "Customer Relationships [Member]",
        "terseLabel": "Customer Relationships"
       }
      }
     },
     "localname": "CustomerRelationshipsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDisclosuresandComponentsofPurchasedOtherIntangiblesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r19",
      "r20",
      "r21",
      "r117",
      "r122",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r315",
      "r316",
      "r317",
      "r318",
      "r656",
      "r695",
      "r696",
      "r712"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESTextDetails",
      "http://www.agilent.com/role/LONGTERMDEBTDetails",
      "http://www.agilent.com/role/SHORTTERMDEBTCreditFacilityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r296",
      "r315",
      "r316",
      "r654",
      "r656",
      "r657"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Aggregate face amount of debt"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESTextDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/LONGTERMDEBTDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r47",
      "r117",
      "r122",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r315",
      "r316",
      "r317",
      "r318",
      "r656"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESTextDetails",
      "http://www.agilent.com/role/LONGTERMDEBTDetails",
      "http://www.agilent.com/role/SHORTTERMDEBTCreditFacilityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r47",
      "r117",
      "r122",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r315",
      "r316",
      "r317",
      "r318",
      "r337",
      "r338",
      "r339",
      "r340",
      "r653",
      "r654",
      "r656",
      "r657",
      "r711"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/LONGTERMDEBTDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSFairvalueofassetsandliabilitiesmeasuredonarecurringbasisDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements payable beyond one year (or the operating cycle, if longer).",
        "label": "Deferred Compensation Liability, Classified, Noncurrent",
        "terseLabel": "Deferred compensation liability"
       }
      }
     },
     "localname": "DeferredCompensationLiabilityClassifiedNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSFairvalueofassetsandliabilitiesmeasuredonarecurringbasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r108",
      "r119",
      "r511",
      "r522",
      "r523",
      "r524"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "terseLabel": "Deferred taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredRevenueCurrent": {
     "auth_ref": [
      "r33"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Deferred Revenue, Current",
        "verboseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "DeferredRevenueCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredRevenuePeriodIncreaseDecrease": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in deferred revenue.",
        "label": "Deferred Revenue, Period Increase (Decrease)",
        "terseLabel": "Deferred Revenue, Period Increase (Decrease)"
       }
      }
     },
     "localname": "DeferredRevenuePeriodIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/REVENUEContractAssetsandLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses": {
     "auth_ref": [
      "r377",
      "r416",
      "r443",
      "r449",
      "r450"
     ],
     "calculation": {
      "http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSComponentsofnetperiodiccostsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit of defined benefit plan.",
        "label": "Defined Benefit Plan, Amortization of Gain (Loss)",
        "negatedLabel": "Actuarial losses"
       }
      }
     },
     "localname": "DefinedBenefitPlanAmortizationOfGainsLosses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSComponentsofnetperiodiccostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit": {
     "auth_ref": [
      "r377",
      "r417",
      "r444",
      "r449",
      "r450"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of prior service cost (credit) recognized in net periodic benefit cost (credit) of defined benefit plan.",
        "label": "Defined Benefit Plan, Amortization of Prior Service Cost (Credit)",
        "verboseLabel": "Prior service credits"
       }
      }
     },
     "localname": "DefinedBenefitPlanAmortizationOfPriorServiceCostCredit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSComponentsofnetperiodiccostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanContributionsByEmployer": {
     "auth_ref": [
      "r393",
      "r401",
      "r403",
      "r447",
      "r449",
      "r450"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contribution received by defined benefit plan from employer which increases plan assets.",
        "label": "Defined Benefit Plan, Plan Assets, Contributions by Employer",
        "terseLabel": "Employer Contributions"
       }
      }
     },
     "localname": "DefinedBenefitPlanContributionsByEmployer",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSDetailsEmployerContributions"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanDisclosureLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Defined Benefit Plan Disclosure [Line Items]",
        "terseLabel": "Defined Benefit Plan Disclosure"
       }
      }
     },
     "localname": "DefinedBenefitPlanDisclosureLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSComponentsofnetperiodiccostsDetails",
      "http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSDetailsEmployerContributions"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear": {
     "auth_ref": [
      "r447",
      "r450"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contribution expected to be received by defined benefit plan from employer in remainder of current fiscal year. Excludes contribution previously paid by employer in current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Employer Contributions, Remainder of Fiscal Year",
        "terseLabel": "Expected future employer contributions"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSDetailsEmployerContributions"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets": {
     "auth_ref": [
      "r377",
      "r415",
      "r442",
      "r449",
      "r450"
     ],
     "calculation": {
      "http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSComponentsofnetperiodiccostsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.",
        "label": "Defined Benefit Plan, Expected Return (Loss) on Plan Assets",
        "negatedLabel": "Expected return on plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedReturnOnPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSComponentsofnetperiodiccostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanInterestCost": {
     "auth_ref": [
      "r377",
      "r382",
      "r414",
      "r441",
      "r449",
      "r450"
     ],
     "calculation": {
      "http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSComponentsofnetperiodiccostsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost recognized for passage of time related to defined benefit plan.",
        "label": "Defined Benefit Plan, Interest Cost",
        "verboseLabel": "Interest cost on benefit obligation"
       }
      }
     },
     "localname": "DefinedBenefitPlanInterestCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSComponentsofnetperiodiccostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost": {
     "auth_ref": [
      "r412",
      "r439",
      "r449",
      "r450"
     ],
     "calculation": {
      "http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSComponentsofnetperiodiccostsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of net periodic benefit cost (credit) for defined benefit plan.",
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit)",
        "totalLabel": "Total net plan costs (benefits)"
       }
      }
     },
     "localname": "DefinedBenefitPlanNetPeriodicBenefitCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSComponentsofnetperiodiccostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit) [Abstract]",
        "terseLabel": "Defined Benefit Plan, Net Periodic Benefit Cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanNetPeriodicBenefitCostAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSComponentsofnetperiodiccostsDetails",
      "http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1": {
     "auth_ref": [
      "r378",
      "r419",
      "r446"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit from irrevocable action relieving primary responsibility for benefit obligation and eliminating risk related to obligation and assets used to effect settlement.",
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement",
        "terseLabel": "Settlement gain"
       }
      }
     },
     "localname": "DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSComponentsofnetperiodiccostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanServiceCost": {
     "auth_ref": [
      "r380",
      "r413",
      "r440",
      "r449",
      "r450"
     ],
     "calculation": {
      "http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSComponentsofnetperiodiccostsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.",
        "label": "Defined Benefit Plan, Service Cost",
        "terseLabel": "Service cost - benefits earned during the period"
       }
      }
     },
     "localname": "DefinedBenefitPlanServiceCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSComponentsofnetperiodiccostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanSettlementsAndCurtailmentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined Benefit Plan, Settlement and Curtailment [Abstract]",
        "terseLabel": "Curtailments and Settlements"
       }
      }
     },
     "localname": "DefinedBenefitPlanSettlementsAndCurtailmentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSComponentsofnetperiodiccostsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Abstract]",
        "terseLabel": "Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Abstract]"
       }
      }
     },
     "localname": "DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r108",
      "r188"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Contract [Domain]",
        "terseLabel": "Derivative Contract [Domain]"
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESEffectofderivativeinstrumentsonConsolidatedStatementofOperationsDetails",
      "http://www.agilent.com/role/DERIVATIVESFairvalueofderivativeinstrumentsandConsolidatedBalanceSheetlocationDetails",
      "http://www.agilent.com/role/DERIVATIVESForeignExchangeForwardContractsDetails",
      "http://www.agilent.com/role/DERIVATIVESTextDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeAsset": {
     "auth_ref": [
      "r58",
      "r59",
      "r60",
      "r573",
      "r678"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.",
        "label": "Derivative Asset, Fair Value, Gross Asset",
        "verboseLabel": "Derivatives asset fair value"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeAsset",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESFairvalueofderivativeinstrumentsandConsolidatedBalanceSheetlocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeLiability": {
     "auth_ref": [
      "r58",
      "r59",
      "r60",
      "r573",
      "r678"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.",
        "label": "Derivative Liability, Fair Value, Gross Liability",
        "verboseLabel": "Derivatives liabilities fair value"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESFairvalueofderivativeinstrumentsandConsolidatedBalanceSheetlocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative, Fair Value, Net [Abstract]",
        "terseLabel": "Derivative Fair Value by Balance Sheet Location"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESFairvalueofderivativeinstrumentsandConsolidatedBalanceSheetlocationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeGainLossOnDerivativeNet": {
     "auth_ref": [
      "r571"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.",
        "label": "Derivative, Gain (Loss) on Derivative, Net",
        "terseLabel": "Gain (loss) recognized in other income (expense)"
       }
      }
     },
     "localname": "DerivativeGainLossOnDerivativeNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESEffectofderivativeinstrumentsonConsolidatedStatementofOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentDetailAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Instrument Detail [Abstract]",
        "verboseLabel": "Derivative Instruments and Hedging Activities Disclosure"
       }
      }
     },
     "localname": "DerivativeInstrumentDetailAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESTextDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r59",
      "r570",
      "r574",
      "r579",
      "r585"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]",
        "terseLabel": "Derivative Instrument [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESEffectofderivativeinstrumentsonConsolidatedStatementofOperationsDetails",
      "http://www.agilent.com/role/DERIVATIVESFairvalueofderivativeinstrumentsandConsolidatedBalanceSheetlocationDetails",
      "http://www.agilent.com/role/DERIVATIVESForeignExchangeForwardContractsDetails",
      "http://www.agilent.com/role/DERIVATIVESTextDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosure [Abstract]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r596",
      "r609"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.",
        "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]",
        "terseLabel": "DERIVATIVES"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": {
     "auth_ref": [
      "r567",
      "r570",
      "r579"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of hedging relationship.",
        "label": "Hedging Relationship [Axis]",
        "terseLabel": "Hedging Relationship [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESEffectofderivativeinstrumentsonConsolidatedStatementofOperationsDetails",
      "http://www.agilent.com/role/DERIVATIVESFairvalueofderivativeinstrumentsandConsolidatedBalanceSheetlocationDetails",
      "http://www.agilent.com/role/DERIVATIVESForeignExchangeForwardContractsDetails",
      "http://www.agilent.com/role/DERIVATIVESTextDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet": {
     "auth_ref": [
      "r578",
      "r584"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The effective portion of net gain (loss) reclassified from accumulated other comprehensive income into income on derivative instruments designated and qualifying as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net",
        "terseLabel": "Unrealized gain (loss) on derivatives",
        "verboseLabel": "Gain (loss) reclassified from accumulated other comprehensive\u00a0loss into cost of sales"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESEffectofderivativeinstrumentsonConsolidatedStatementofOperationsDetails",
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYReclassificationsoutofaccumulatedcomprehensiveincomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative [Line Items]",
        "terseLabel": "Derivative"
       }
      }
     },
     "localname": "DerivativeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESEffectofderivativeinstrumentsonConsolidatedStatementofOperationsDetails",
      "http://www.agilent.com/role/DERIVATIVESFairvalueofderivativeinstrumentsandConsolidatedBalanceSheetlocationDetails",
      "http://www.agilent.com/role/DERIVATIVESForeignExchangeForwardContractsDetails",
      "http://www.agilent.com/role/DERIVATIVESTextDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeNetLiabilityPositionAggregateFairValue": {
     "auth_ref": [
      "r587"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate fair value amounts of derivative instruments that contain credit-risk-related contingent features that are in a net liability position at the end of the reporting period. For nonderivative instruments that are designated and qualify as hedging instruments, the fair value amounts are the carrying value of the nonderivative hedging instrument, including the adjustment for the foreign currency transaction gain (loss) on that instrument.",
        "label": "Derivative, Net Liability Position, Aggregate Fair Value",
        "terseLabel": "Aggregate fair value of all derivative instruments with credit-risk-related contingent features that were in a net liability position"
       }
      }
     },
     "localname": "DerivativeNetLiabilityPositionAggregateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESTextDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeNotionalAmount": {
     "auth_ref": [
      "r562",
      "r564"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payment on derivative.",
        "label": "Derivative, Notional Amount",
        "terseLabel": "Derivative, Notional Amount"
       }
      }
     },
     "localname": "DerivativeNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESForeignExchangeForwardContractsDetails",
      "http://www.agilent.com/role/DERIVATIVESTextDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeTable": {
     "auth_ref": [
      "r561",
      "r563",
      "r564",
      "r567",
      "r568",
      "r576",
      "r579",
      "r588",
      "r589",
      "r592",
      "r596"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.",
        "label": "Derivative [Table]",
        "terseLabel": "Derivative [Table]"
       }
      }
     },
     "localname": "DerivativeTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESEffectofderivativeinstrumentsonConsolidatedStatementofOperationsDetails",
      "http://www.agilent.com/role/DERIVATIVESFairvalueofderivativeinstrumentsandConsolidatedBalanceSheetlocationDetails",
      "http://www.agilent.com/role/DERIVATIVESForeignExchangeForwardContractsDetails",
      "http://www.agilent.com/role/DERIVATIVESTextDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DesignatedAsHedgingInstrumentMember": {
     "auth_ref": [
      "r567"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Designated as Hedging Instrument [Member]",
        "terseLabel": "Derivatives Designated as Hedging Instrument",
        "verboseLabel": "Derivatives Designated as Hedging Instruments"
       }
      }
     },
     "localname": "DesignatedAsHedgingInstrumentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESEffectofderivativeinstrumentsonConsolidatedStatementofOperationsDetails",
      "http://www.agilent.com/role/DERIVATIVESFairvalueofderivativeinstrumentsandConsolidatedBalanceSheetlocationDetails",
      "http://www.agilent.com/role/DERIVATIVESForeignExchangeForwardContractsDetails",
      "http://www.agilent.com/role/DERIVATIVESTextDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DevelopedTechnologyRightsMember": {
     "auth_ref": [
      "r539"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights to developed technology, which can include the right to develop, use, market, sell, or offer for sale products, compounds, or intellectual property.",
        "label": "Developed Technology Rights [Member]",
        "terseLabel": "Purchased Technology"
       }
      }
     },
     "localname": "DevelopedTechnologyRightsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDisclosuresandComponentsofPurchasedOtherIntangiblesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r362"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Disaggregation of Revenue"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/REVENUETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r501"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement [Text Block]",
        "terseLabel": "SHARE-BASED COMPENSATION"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/SHAREBASEDCOMPENSATIONNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Payment Arrangement [Abstract]",
        "terseLabel": "Share-based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DividendPayableDateToBePaidDayMonthAndYear": {
     "auth_ref": [
      "r113"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date the declared dividend will be paid, in YYYY-MM-DD format.",
        "label": "Dividends Payable, Date to be Paid",
        "terseLabel": "Payment Date of Declared Dividends"
       }
      }
     },
     "localname": "DividendPayableDateToBePaidDayMonthAndYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYDividendsDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_DividendsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividends [Abstract]",
        "terseLabel": "Dividends [Abstract]"
       }
      }
     },
     "localname": "DividendsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DividendsAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information about distribution of earnings to shareholders including, but not limited to, cash, property or capital stock.",
        "label": "Dividends [Axis]",
        "terseLabel": "Dividends [Axis]"
       }
      }
     },
     "localname": "DividendsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYDividendsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DividendsCommonStockAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividends, Common Stock [Abstract]",
        "terseLabel": "Dividends Declared"
       }
      }
     },
     "localname": "DividendsCommonStockAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYDividendsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DividendsCommonStockCash": {
     "auth_ref": [
      "r341"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.",
        "label": "Dividends, Common Stock, Cash",
        "negatedTerseLabel": "Cash dividends declared",
        "terseLabel": "Aggregate dividends declared"
       }
      }
     },
     "localname": "DividendsCommonStockCash",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFEQUITY",
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYDividendsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DividendsDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Distributions of earnings to shareholders including but not limited to cash, property or capital stock.",
        "label": "Dividends [Domain]",
        "terseLabel": "Dividends [Domain]"
       }
      }
     },
     "localname": "DividendsDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYDividendsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DividendsPayableDateDeclaredDayMonthAndYear": {
     "auth_ref": [
      "r113"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date the dividend to be paid was declared, in YYYY-MM-DD format.",
        "label": "Dividends Payable, Date Declared",
        "terseLabel": "Date Dividends Declared"
       }
      }
     },
     "localname": "DividendsPayableDateDeclaredDayMonthAndYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYDividendsDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_DividendsPayableDateOfRecordDayMonthAndYear": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date the holder must own the stock to be entitled to the dividend, in YYYY-MM-DD format.",
        "label": "Dividends Payable, Date of Record",
        "terseLabel": "Dividends Declared Date of Record"
       }
      }
     },
     "localname": "DividendsPayableDateOfRecordDayMonthAndYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYDividendsDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_DividendsPayableLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Dividends Payable [Line Items]",
        "terseLabel": "Dividends Payable [Line Items]"
       }
      }
     },
     "localname": "DividendsPayableLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYDividendsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DividendsPayableTable": {
     "auth_ref": [
      "r113"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table that contains information regarding dividends that have been declared but not paid as of the financial reporting date. This information may contain the amount, amount per share, declared date, and date to be paid.",
        "label": "Dividends Payable [Table]",
        "terseLabel": "Dividends Payable [Table]"
       }
      }
     },
     "localname": "DividendsPayableTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYDividendsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarlyRepaymentOfSeniorDebt": {
     "auth_ref": [
      "r101"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for the extinguishment of long-term borrowing, with the highest claim on the assets of the entity in case of bankruptcy or liquidation, before its maturity.",
        "label": "Early Repayment of Senior Debt",
        "negatedTerseLabel": "Repayment of senior notes"
       }
      }
     },
     "localname": "EarlyRepaymentOfSeniorDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Net income per share"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFOPERATIONSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r90",
      "r135",
      "r136",
      "r138",
      "r139",
      "r140",
      "r148",
      "r150",
      "r157",
      "r158",
      "r159",
      "r163",
      "r164",
      "r607",
      "r608",
      "r707",
      "r726"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Basic"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFOPERATIONSUnaudited"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r90",
      "r135",
      "r136",
      "r138",
      "r139",
      "r140",
      "r150",
      "r157",
      "r158",
      "r159",
      "r163",
      "r164",
      "r607",
      "r608",
      "r707",
      "r726"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Diluted"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFOPERATIONSUnaudited"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r160",
      "r161",
      "r162",
      "r165"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "NET INCOME PER SHARE"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/NETINCOMEPERSHARENotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents": {
     "auth_ref": [
      "r641"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from the effect of exchange rate changes on cash and cash equivalent balances held in foreign currencies.",
        "label": "Effect of Exchange Rate on Cash and Cash Equivalents",
        "terseLabel": "Effect of exchange rate movements"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashAndCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r504"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "terseLabel": "Effective income tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount": {
     "auth_ref": [
      "r500",
      "r504"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement. Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount",
        "terseLabel": "Excess tax benefit from stock based compensation"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r45"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "verboseLabel": "Employee compensation and benefits"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]",
        "terseLabel": "Employee Service Share-based Compensation, Allocation of Recognized Period Costs"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/SHAREBASEDCOMPENSATIONAllocatedSharebasedcompensationexpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense": {
     "auth_ref": [
      "r484"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax benefit for recognition of expense of award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Expense, Tax Benefit",
        "terseLabel": "Share-based Payment Arrangement, Expense, Tax Benefit"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An Employee Stock Purchase Plan is a tax-efficient means by which employees of a corporation can purchase the corporation's stock.",
        "label": "Employee Stock [Member]",
        "terseLabel": "Employee Stock [ESPP]"
       }
      }
     },
     "localname": "EmployeeStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/SHAREBASEDCOMPENSATIONTextDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [
      "r482"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-based Payment Arrangement, Option [Member]",
        "terseLabel": "Share-based Payment Arrangement, Option [Member]"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/SHAREBASEDCOMPENSATIONFairValueAssumptionsDetails",
      "http://www.agilent.com/role/SHAREBASEDCOMPENSATIONTextDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityClassOfTreasuryStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Equity, Class of Treasury Stock [Line Items]",
        "terseLabel": "Share repurchase program"
       }
      }
     },
     "localname": "EquityClassOfTreasuryStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYStockRepurchaseProgramDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r2",
      "r80",
      "r81",
      "r82",
      "r124",
      "r125",
      "r126",
      "r130",
      "r141",
      "r144",
      "r168",
      "r233",
      "r336",
      "r341",
      "r491",
      "r492",
      "r493",
      "r515",
      "r516",
      "r606",
      "r643",
      "r644",
      "r645",
      "r646",
      "r647",
      "r650",
      "r737",
      "r738",
      "r739",
      "r774"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFEQUITY",
      "http://www.agilent.com/role/DERIVATIVESEffectofderivativeinstrumentsonConsolidatedStatementofOperationsDetails",
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYAccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquitySecuritiesFvNi": {
     "auth_ref": [
      "r623"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.",
        "label": "Equity Securities, FV-NI, Current",
        "terseLabel": "Short term investments",
        "verboseLabel": "Short term investments"
       }
      }
     },
     "localname": "EquitySecuritiesFvNi",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited",
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSFairvalueofassetsandliabilitiesmeasuredonarecurringbasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesFvNiGainLossAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Securities, FV-NI, Gain (Loss) [Abstract]",
        "terseLabel": "Equity Securities"
       }
      }
     },
     "localname": "EquitySecuritiesFvNiGainLossAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSAssetsandLiabilitiesmeasuredatFairValueonaNonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss": {
     "auth_ref": [
      "r228",
      "r727"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Equity Securities, FV-NI, Unrealized Gain (Loss)",
        "terseLabel": "Unrealized gain (loss) on equity securities",
        "verboseLabel": "Net gain (loss) on equity securities"
       }
      }
     },
     "localname": "EquitySecuritiesFvNiUnrealizedGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited",
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSNonMarketableSecuritiesandInvestmentImpairmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount": {
     "auth_ref": [
      "r226"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity security without readily determinable fair value.",
        "label": "Equity Securities without Readily Determinable Fair Value, Amount",
        "terseLabel": "Non-marketable equity securities carrying amount"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSAssetsandLiabilitiesmeasuredatFairValueonaNonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount": {
     "auth_ref": [
      "r227"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cumulative impairment loss on investment in equity security without readily determinable fair value.",
        "label": "Equity Securities without Readily Determinable Fair Value, Impairment Loss, Cumulative Amount",
        "terseLabel": "Impairment of non-marketable securities"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSAssetsandLiabilitiesmeasuredatFairValueonaNonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis": {
     "auth_ref": [
      "r135",
      "r136",
      "r137",
      "r140",
      "r141",
      "r143",
      "r144"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of error correction.",
        "label": "Error Correction, Type [Axis]",
        "terseLabel": "Error Correction, Type [Axis]"
       }
      }
     },
     "localname": "ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "verboseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSAssetsandLiabilitiesmeasuredatFairValueonaNonRecurringBasisDetails",
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSFairvalueofassetsandliabilitiesmeasuredonarecurringbasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r610",
      "r611",
      "r612",
      "r620"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSAssetsandLiabilitiesmeasuredatFairValueonaNonRecurringBasisDetails",
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSFairvalueofassetsandliabilitiesmeasuredonarecurringbasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Line Items]",
        "terseLabel": "Fair Value Measurement Inputs and Valuation Techniques [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSContingentConsiderationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable": {
     "auth_ref": [
      "r613"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.",
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Table]",
        "terseLabel": "Fair Value Measurement Inputs and Valuation Techniques [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSContingentConsiderationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r305",
      "r315",
      "r316",
      "r401",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r449",
      "r611",
      "r669",
      "r670",
      "r671"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSAssetsandLiabilitiesmeasuredatFairValueonaNonRecurringBasisDetails",
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSFairvalueofassetsandliabilitiesmeasuredonarecurringbasisDetails",
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTextualsDetails",
      "http://www.agilent.com/role/OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r610",
      "r611",
      "r614",
      "r615",
      "r621"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSAssetsandLiabilitiesmeasuredatFairValueonaNonRecurringBasisDetails",
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSFairvalueofassetsandliabilitiesmeasuredonarecurringbasisDetails",
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTextualsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value of Financial Instruments"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r619"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "FAIR VALUE MEASUREMENTS"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r305",
      "r401",
      "r403",
      "r408",
      "r449",
      "r611",
      "r669"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Quoted Prices in Active Markets for Identical Assets (Level 1)"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSFairvalueofassetsandliabilitiesmeasuredonarecurringbasisDetails",
      "http://www.agilent.com/role/OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r305",
      "r315",
      "r316",
      "r401",
      "r403",
      "r408",
      "r449",
      "r611",
      "r670"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Significant Other Observable Inputs (Level 2)"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSFairvalueofassetsandliabilitiesmeasuredonarecurringbasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r305",
      "r315",
      "r316",
      "r401",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r449",
      "r611",
      "r671"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Significant Unobservable Inputs (Level 3)"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSFairvalueofassetsandliabilitiesmeasuredonarecurringbasisDetails",
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTextualsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": {
     "auth_ref": [
      "r616",
      "r620"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]",
        "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Measurement Frequency [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSAssetsandLiabilitiesmeasuredatFairValueonaNonRecurringBasisDetails",
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSFairvalueofassetsandliabilitiesmeasuredonarecurringbasisDetails",
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTextualsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3": {
     "auth_ref": [
      "r617"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transfers of financial instrument classified as a liability into level 3 of the fair value hierarchy.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers Into Level 3",
        "terseLabel": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers Into Level 3"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingLevel3ContingentConsiderationLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease": {
     "auth_ref": [
      "r616"
     ],
     "calculation": {
      "http://www.agilent.com/role/SEGMENTINFORMATIONReconciliationofReportableResultsDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease)",
        "negatedLabel": "Change in fair value of contingent consideration",
        "terseLabel": "Change in fair value (included within SG&amp;A)"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingLevel3ContingentConsiderationLiabilityDetails",
      "http://www.agilent.com/role/SEGMENTINFORMATIONReconciliationofReportableResultsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": {
     "auth_ref": [
      "r616"
     ],
     "calculation": {
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSFairvalueofassetsandliabilitiesmeasuredonarecurringbasisDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value",
        "periodEndLabel": "Fair Value Contingent Consideration, Ending Balance",
        "periodStartLabel": "Fair Value Contingent Consideration, Beginning Balance",
        "terseLabel": "Contingent Consideration"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSFairvalueofassetsandliabilitiesmeasuredonarecurringbasisDetails",
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingLevel3ContingentConsiderationLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r305",
      "r315",
      "r316",
      "r401",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r449",
      "r669",
      "r670",
      "r671"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSAssetsandLiabilitiesmeasuredatFairValueonaNonRecurringBasisDetails",
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSFairvalueofassetsandliabilitiesmeasuredonarecurringbasisDetails",
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTextualsDetails",
      "http://www.agilent.com/role/OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsNonrecurringMember": {
     "auth_ref": [
      "r610",
      "r611",
      "r614",
      "r615",
      "r618",
      "r621"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Infrequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, not frequently measured at fair value.",
        "label": "Fair Value, Nonrecurring [Member]",
        "terseLabel": "Fair Value, Nonrecurring"
       }
      }
     },
     "localname": "FairValueMeasurementsNonrecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSAssetsandLiabilitiesmeasuredatFairValueonaNonRecurringBasisDetails",
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSFairvalueofassetsandliabilitiesmeasuredonarecurringbasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r619",
      "r621"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value, Recurring [Member]",
        "terseLabel": "Fair Value, Measurements, Recurring"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSAssetsandLiabilitiesmeasuredatFairValueonaNonRecurringBasisDetails",
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSFairvalueofassetsandliabilitiesmeasuredonarecurringbasisDetails",
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTextualsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueOfFinancialInstrumentsPolicy": {
     "auth_ref": [
      "r622",
      "r624"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.",
        "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]",
        "terseLabel": "Fair Value of Financial Instruments"
       }
      }
     },
     "localname": "FairValueOfFinancialInstrumentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r256"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "terseLabel": "Accumulated Amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDisclosuresandComponentsofPurchasedOtherIntangiblesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSEstimatedFutureAmortizationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "auth_ref": [
      "r258"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSEstimatedFutureAmortizationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year",
        "terseLabel": "Remainder of 2022"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSEstimatedFutureAmortizationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": {
     "auth_ref": [
      "r258"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five",
        "terseLabel": "2027"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSEstimatedFutureAmortizationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r258"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSEstimatedFutureAmortizationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r258"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSEstimatedFutureAmortizationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r258"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSEstimatedFutureAmortizationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r252",
      "r253",
      "r256",
      "r260",
      "r683",
      "r690"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "verboseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDisclosuresandComponentsofPurchasedOtherIntangiblesDetails",
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTextualsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite Lived Intangible Assets, Foreign Currency Translation Gain (Loss)",
        "terseLabel": "Foreign currency translation impact on other intangible assets"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTextualsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r256",
      "r690"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "terseLabel": "Gross Carrying Amount"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDisclosuresandComponentsofPurchasedOtherIntangiblesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Finite-Lived Intangible Assets"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDisclosuresandComponentsofPurchasedOtherIntangiblesDetails",
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTextualsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r252",
      "r255"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDisclosuresandComponentsofPurchasedOtherIntangiblesDetails",
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTextualsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r256",
      "r683"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "terseLabel": "Finite-Lived Intangible Assets, Net"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDisclosuresandComponentsofPurchasedOtherIntangiblesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Assets, Net [Abstract]",
        "terseLabel": "Finite-Lived Intangible Assets, Net"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDisclosuresandComponentsofPurchasedOtherIntangiblesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in carrying value of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Period Increase (Decrease)",
        "terseLabel": "Addition to other intangible assets"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsPeriodIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTextualsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyContractAssetFairValueDisclosure": {
     "auth_ref": [],
     "calculation": {
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSFairvalueofassetsandliabilitiesmeasuredonarecurringbasisDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of asset contracts related to the exchange of different currencies, including, but not limited to, foreign currency options, forward contracts, and swaps.",
        "label": "Foreign Currency Contract, Asset, Fair Value Disclosure",
        "terseLabel": "Derivative instruments (foreign exchange contracts)"
       }
      }
     },
     "localname": "ForeignCurrencyContractAssetFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSFairvalueofassetsandliabilitiesmeasuredonarecurringbasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure": {
     "auth_ref": [],
     "calculation": {
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSFairvalueofassetsandliabilitiesmeasuredonarecurringbasisDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of liability contracts related to the exchange of different currencies, including, but not limited to, foreign currency options, forward (delivery or nondelivery) contracts, and swaps entered into.",
        "label": "Foreign Currency Contracts, Liability, Fair Value Disclosure",
        "terseLabel": "Derivative instruments (foreign exchange contracts)"
       }
      }
     },
     "localname": "ForeignCurrencyContractsLiabilityFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSFairvalueofassetsandliabilitiesmeasuredonarecurringbasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignExchangeContractMember": {
     "auth_ref": [
      "r59",
      "r401",
      "r583"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument whose primary underlying risk is tied to foreign exchange rates.",
        "label": "Foreign Exchange Contract [Member]",
        "terseLabel": "Foreign Exchange Contracts"
       }
      }
     },
     "localname": "ForeignExchangeContractMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESEffectofderivativeinstrumentsonConsolidatedStatementofOperationsDetails",
      "http://www.agilent.com/role/DERIVATIVESFairvalueofderivativeinstrumentsandConsolidatedBalanceSheetlocationDetails",
      "http://www.agilent.com/role/DERIVATIVESTextDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignExchangeForwardMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Foreign exchange forward traded on an exchange (examples include but are not limited to the International Securities Exchange, Philadelphia Stock Exchange, or the Chicago Mercantile Exchange) for options or future contracts to buy or sell a certain currency, at a specified date, at a fixed exercise exchange rate.",
        "label": "Foreign Exchange Forward [Member]",
        "terseLabel": "Foreign Exchange Forward"
       }
      }
     },
     "localname": "ForeignExchangeForwardMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESForeignExchangeForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignPlanMember": {
     "auth_ref": [
      "r454",
      "r458",
      "r464"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location of employer sponsoring plan, designed to provide retirement benefits, not determined as principal place of business. Includes, but is not limited to, defined benefit and defined contribution plans.",
        "label": "Foreign Plan [Member]",
        "terseLabel": "Foreign Plan"
       }
      }
     },
     "localname": "ForeignPlanMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSComponentsofnetperiodiccostsDetails",
      "http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSDetailsEmployerContributions"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForwardContractsMember": {
     "auth_ref": [
      "r581"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contracts negotiated between two parties to purchase and sell a specific quantity of a financial instrument, foreign currency, or commodity at a price specified at origination of the contract, with delivery and settlement at a specified future date.",
        "label": "Forward Contracts [Member]",
        "terseLabel": "Forward Contracts USD"
       }
      }
     },
     "localname": "ForwardContractsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESForeignExchangeForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebt": {
     "auth_ref": [
      "r108",
      "r319",
      "r320"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.",
        "label": "Gain (Loss) on Extinguishment of Debt",
        "negatedTerseLabel": "Loss on extinguishment of debt"
       }
      }
     },
     "localname": "GainsLossesOnExtinguishmentOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r240",
      "r242",
      "r666",
      "r693"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "periodEndLabel": "Goodwill ending balance",
        "periodStartLabel": "Goodwill beginning balance",
        "verboseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited",
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSGoodwillRollforwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAcquiredDuringPeriod": {
     "auth_ref": [
      "r243"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.",
        "label": "Goodwill, Acquired During Period",
        "terseLabel": "Goodwill arising from acquisitions",
        "verboseLabel": "Additions to goodwill"
       }
      }
     },
     "localname": "GoodwillAcquiredDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSGoodwillRollforwardDetails",
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTextualsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r262"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "terseLabel": "GOODWILL AND OTHER INTANGIBLE ASSETS"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillImpairmentLoss": {
     "auth_ref": [
      "r108",
      "r241",
      "r244",
      "r248"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Impairment Loss",
        "terseLabel": "Goodwill impairment"
       }
      }
     },
     "localname": "GoodwillImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSGoodwillRollforwardDetails",
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTextualsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Goodwill [Line Items]",
        "terseLabel": "Goodwill [Line Items]"
       }
      }
     },
     "localname": "GoodwillLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSGoodwillRollforwardDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill [Member]",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "GoodwillMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTextualsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GoodwillRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Goodwill [Roll Forward]",
        "terseLabel": "Goodwill Roll Forward"
       }
      }
     },
     "localname": "GoodwillRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSGoodwillRollforwardDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillTransfers": {
     "auth_ref": [
      "r246"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transfers into (out of) an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Transfers",
        "terseLabel": "Goodwill reassigned to segment"
       }
      }
     },
     "localname": "GoodwillTransfers",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSGoodwillRollforwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments": {
     "auth_ref": [
      "r245",
      "r246",
      "r532"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from foreign currency translation adjustments and purchase accounting adjustments of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Translation and Purchase Accounting Adjustments",
        "terseLabel": "Foreign currency translation impact"
       }
      }
     },
     "localname": "GoodwillTranslationAndPurchaseAccountingAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSGoodwillRollforwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GuaranteesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Guarantees [Abstract]",
        "terseLabel": "Guarantees"
       }
      }
     },
     "localname": "GuaranteesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/WARRANTIESANDCONTINGENCIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HedgingDesignationAxis": {
     "auth_ref": [
      "r567",
      "r586"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Axis]",
        "terseLabel": "Hedging Designation [Axis]"
       }
      }
     },
     "localname": "HedgingDesignationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESEffectofderivativeinstrumentsonConsolidatedStatementofOperationsDetails",
      "http://www.agilent.com/role/DERIVATIVESFairvalueofderivativeinstrumentsandConsolidatedBalanceSheetlocationDetails",
      "http://www.agilent.com/role/DERIVATIVESForeignExchangeForwardContractsDetails",
      "http://www.agilent.com/role/DERIVATIVESTextDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HedgingDesignationDomain": {
     "auth_ref": [
      "r567"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Domain]",
        "terseLabel": "Hedging Designation"
       }
      }
     },
     "localname": "HedgingDesignationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESEffectofderivativeinstrumentsonConsolidatedStatementofOperationsDetails",
      "http://www.agilent.com/role/DERIVATIVESFairvalueofderivativeinstrumentsandConsolidatedBalanceSheetlocationDetails",
      "http://www.agilent.com/role/DERIVATIVESForeignExchangeForwardContractsDetails",
      "http://www.agilent.com/role/DERIVATIVESTextDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_HedgingRelationshipDomain": {
     "auth_ref": [
      "r567"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nature or intent of a hedge.",
        "label": "Hedging Relationship [Domain]",
        "terseLabel": "Hedging Relationship [Domain]"
       }
      }
     },
     "localname": "HedgingRelationshipDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESEffectofderivativeinstrumentsonConsolidatedStatementofOperationsDetails",
      "http://www.agilent.com/role/DERIVATIVESFairvalueofderivativeinstrumentsandConsolidatedBalanceSheetlocationDetails",
      "http://www.agilent.com/role/DERIVATIVESForeignExchangeForwardContractsDetails",
      "http://www.agilent.com/role/DERIVATIVESTextDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ImpairedAssetsToBeDisposedOfByMethodOtherThanSaleCarryingValueOfAsset": {
     "auth_ref": [
      "r263",
      "r267"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying amount on the books of the entity of the impaired asset to be disposed of by a method other than sale.",
        "label": "Impaired Assets to be Disposed of by Method Other than Sale, Carrying Value of Asset",
        "terseLabel": "Carrying value of impaired long-lived assets held for use"
       }
      }
     },
     "localname": "ImpairedAssetsToBeDisposedOfByMethodOtherThanSaleCarryingValueOfAsset",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSAssetsandLiabilitiesmeasuredatFairValueonaNonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOfIntangibleAssetsFinitelived": {
     "auth_ref": [
      "r108",
      "r261"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.",
        "label": "Impairment of Intangible Assets, Finite-lived",
        "terseLabel": "Impairment of Intangible Assets, Finite-lived"
       }
      }
     },
     "localname": "ImpairmentOfIntangibleAssetsFinitelived",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDisclosuresandComponentsofPurchasedOtherIntangiblesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill": {
     "auth_ref": [
      "r108",
      "r261"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value.",
        "label": "Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)",
        "terseLabel": "Impairment of IPR&amp;D"
       }
      }
     },
     "localname": "ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTextualsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOfInvestments": {
     "auth_ref": [
      "r224"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount by which the fair value of an investment is less than the amortized cost basis or carrying amount of that investment at the balance sheet date and the decline in fair value is deemed to be other than temporary, before considering whether or not such amount is recognized in earnings or other comprehensive income.",
        "label": "Other than Temporary Impairment Losses, Investments",
        "terseLabel": "Impairment of Investments"
       }
      }
     },
     "localname": "ImpairmentOfInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSNonMarketableSecuritiesandInvestmentImpairmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOfLongLivedAssetsHeldForUse": {
     "auth_ref": [
      "r108",
      "r264",
      "r266"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale).",
        "label": "Impairment, Long-Lived Asset, Held-for-Use",
        "terseLabel": "Impairment of Long-Lived Assets Held-for-use"
       }
      }
     },
     "localname": "ImpairmentOfLongLivedAssetsHeldForUse",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSAssetsandLiabilitiesmeasuredatFairValueonaNonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf": {
     "auth_ref": [
      "r108",
      "r263"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of write-downs for impairments recognized during the period for long-lived assets held for abandonment, exchange or sale.",
        "label": "Impairment of Long-Lived Assets to be Disposed of",
        "terseLabel": "Impairment of Long-Lived assets Held for sale"
       }
      }
     },
     "localname": "ImpairmentOfLongLivedAssetsToBeDisposedOf",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSAssetsandLiabilitiesmeasuredatFairValueonaNonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InProcessResearchAndDevelopmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "In process investigation of new knowledge useful in developing new product or service or new process or technique or improvement to existing product or process, and translation of knowledge into plan or design for new product or process or for improvement to existing product or process.",
        "label": "In Process Research and Development [Member]",
        "terseLabel": "In-Process R&amp;D"
       }
      }
     },
     "localname": "InProcessResearchAndDevelopmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDisclosuresandComponentsofPurchasedOtherIntangiblesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r85",
      "r193",
      "r199",
      "r203",
      "r206",
      "r209",
      "r691",
      "r702",
      "r709",
      "r728"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFOPERATIONSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      },
      "http://www.agilent.com/role/SEGMENTINFORMATIONReconciliationofReportableResultsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "terseLabel": "Income before taxes, as reported",
        "totalLabel": "Income before taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFOPERATIONSUnaudited",
      "http://www.agilent.com/role/SEGMENTINFORMATIONReconciliationofReportableResultsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r268",
      "r270"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]",
        "verboseLabel": "Derivative Instruments, Gain (Loss) by Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESEffectofderivativeinstrumentsonConsolidatedStatementofOperationsDetails",
      "http://www.agilent.com/role/DERIVATIVESTextDetails",
      "http://www.agilent.com/role/SHAREBASEDCOMPENSATIONAllocatedSharebasedcompensationexpenseDetails",
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYReclassificationsoutofaccumulatedcomprehensiveincomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r270"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]",
        "verboseLabel": "Income Statement and Other Comprehensive Income (Loss) Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESEffectofderivativeinstrumentsonConsolidatedStatementofOperationsDetails",
      "http://www.agilent.com/role/DERIVATIVESTextDetails",
      "http://www.agilent.com/role/SHAREBASEDCOMPENSATIONAllocatedSharebasedcompensationexpenseDetails",
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYReclassificationsoutofaccumulatedcomprehensiveincomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "auth_ref": [
      "r506"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by tax jurisdiction.",
        "label": "Income Tax Authority [Axis]",
        "terseLabel": "Income Tax Authority [Axis]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority [Domain]",
        "terseLabel": "Income Tax Authority [Domain]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxAuthorityNameAxis": {
     "auth_ref": [
      "r506"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of taxing authority.",
        "label": "Income Tax Authority, Name [Axis]",
        "terseLabel": "Income Tax Authority, Name [Axis]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Named agency, division or body that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority, Name [Domain]",
        "terseLabel": "Income Tax Authority, Name [Domain]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r120",
      "r505",
      "r509",
      "r510",
      "r520",
      "r525",
      "r529",
      "r530",
      "r531"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "INCOME TAXES"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/INCOMETAXESNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExaminationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Income Tax Examination [Line Items]",
        "terseLabel": "Income Tax Disclosure"
       }
      }
     },
     "localname": "IncomeTaxExaminationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxExaminationTable": {
     "auth_ref": [
      "r507"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A summary of income tax examinations that an enterprise is currently subject to or that have been completed in the current period typically including a description of the examination, the jurisdiction conducting the examination, the tax year(s) under examination, the likelihood of an unfavorable settlement, the range of possible losses, the liability recorded, the Increase or Decrease in the liability from the prior period, and any penalties and interest that have been incurred or accrued.",
        "label": "Income Tax Examination [Table]",
        "terseLabel": "Income Tax Examination [Table]"
       }
      }
     },
     "localname": "IncomeTaxExaminationTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r121",
      "r143",
      "r144",
      "r191",
      "r503",
      "r521",
      "r527",
      "r729"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFOPERATIONSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Provision for income taxes",
        "verboseLabel": "Provision (benefit) for income taxes"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFOPERATIONSUnaudited",
      "http://www.agilent.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost": {
     "auth_ref": [
      "r504"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for award under share-based payment arrangement. Includes, but is not limited to, expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount",
        "terseLabel": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount"
       }
      }
     },
     "localname": "IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "auth_ref": [
      "r112"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.",
        "label": "Income Taxes Paid, Net",
        "terseLabel": "Income tax paid, net"
       }
      }
     },
     "localname": "IncomeTaxesPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r107"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [
      "r107"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.",
        "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities",
        "terseLabel": "Net change in property, plant and equipment included in Accounts Payable and Accrued Liabilities increase (decrease)"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r107"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedTerseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": {
     "auth_ref": [
      "r107",
      "r680"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.",
        "label": "Increase (Decrease) in Contract with Customer, Liability",
        "terseLabel": "Net revenue deferred in the period"
       }
      }
     },
     "localname": "IncreaseDecreaseInContractWithCustomerLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/REVENUEContractAssetsandLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities": {
     "auth_ref": [
      "r107"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.",
        "label": "Increase (Decrease) in Employee Related Liabilities",
        "terseLabel": "Employee compensation and benefits"
       }
      }
     },
     "localname": "IncreaseDecreaseInEmployeeRelatedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r107"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedTerseLabel": "Inventory"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet": {
     "auth_ref": [
      "r107"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Operating Assets and Liabilities, Net",
        "negatedTerseLabel": "Other assets and liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingCapitalNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "auth_ref": [
      "r151",
      "r152",
      "r153",
      "r159"
     ],
     "calculation": {
      "http://www.agilent.com/role/NETINCOMEPERSHAREDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements",
        "terseLabel": "Potential common shares - stock options and other employee stock plans"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/NETINCOMEPERSHAREDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": {
     "auth_ref": [
      "r259"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-lived Intangible Assets (Excluding Goodwill)",
        "terseLabel": "In-Process R&amp;D"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDisclosuresandComponentsofPurchasedOtherIntangiblesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Indefinite-lived Intangible Assets (Excluding Goodwill) [Abstract]",
        "terseLabel": "Indefinite-Lived Intangible Assets (Excluding Goodwill)"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDisclosuresandComponentsofPurchasedOtherIntangiblesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IntangibleAssetsGrossExcludingGoodwill": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated amortization of intangible assets, excluding goodwill.",
        "label": "Intangible Assets, Gross (Excluding Goodwill)",
        "terseLabel": "Total Intangible Assets"
       }
      }
     },
     "localname": "IntangibleAssetsGrossExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDisclosuresandComponentsofPurchasedOtherIntangiblesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r250",
      "r254"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Net Book Value",
        "verboseLabel": "Other intangible assets, net"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited",
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDisclosuresandComponentsofPurchasedOtherIntangiblesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r84",
      "r187",
      "r652",
      "r655",
      "r708"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFOPERATIONSUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      },
      "http://www.agilent.com/role/SEGMENTINFORMATIONReconciliationofReportableResultsDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "negatedLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFOPERATIONSUnaudited",
      "http://www.agilent.com/role/SEGMENTINFORMATIONReconciliationofReportableResultsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseMember": {
     "auth_ref": [
      "r584"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing interest expense.",
        "label": "Interest Expense [Member]",
        "terseLabel": "Interest Expense"
       }
      }
     },
     "localname": "InterestExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESEffectofderivativeinstrumentsonConsolidatedStatementofOperationsDetails",
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYReclassificationsoutofaccumulatedcomprehensiveincomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r102",
      "r105",
      "r112"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Interest payments"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateDerivativesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest Rate Derivatives [Abstract]",
        "terseLabel": "Terminated Derivative Contracts"
       }
      }
     },
     "localname": "InterestRateDerivativesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESTextDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InterestRateSwapMember": {
     "auth_ref": [
      "r582"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period.",
        "label": "Interest Rate Swap [Member]",
        "terseLabel": "Interest Rate Swap"
       }
      }
     },
     "localname": "InterestRateSwapMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESFairvalueofderivativeinstrumentsandConsolidatedBalanceSheetlocationDetails",
      "http://www.agilent.com/role/DERIVATIVESTextDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InventoryDisclosureTextBlock": {
     "auth_ref": [
      "r239"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.",
        "label": "Inventory Disclosure [Text Block]",
        "verboseLabel": "INVENTORY"
       }
      }
     },
     "localname": "InventoryDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/INVENTORYNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryFinishedGoods": {
     "auth_ref": [
      "r53"
     ],
     "calculation": {
      "http://www.agilent.com/role/INVENTORYDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.",
        "label": "Inventory, Finished Goods, Gross",
        "terseLabel": "Finished goods"
       }
      }
     },
     "localname": "InventoryFinishedGoods",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/INVENTORYDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r10",
      "r55",
      "r666"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.agilent.com/role/INVENTORYDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "totalLabel": "Inventory",
        "verboseLabel": "Inventory"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited",
      "http://www.agilent.com/role/INVENTORYDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory, Net [Abstract]",
        "terseLabel": "Inventory, Net [Abstract]"
       }
      }
     },
     "localname": "InventoryNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryWorkInProcessAndRawMaterials": {
     "auth_ref": [
      "r54"
     ],
     "calculation": {
      "http://www.agilent.com/role/INVENTORYDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate carrying amount as of the balance sheet date of items held by the entity which are partially completed at the time of measurement and unprocessed items that will go through the production process and become part of the final product.  Includes supplies used directly or indirectly in the manufacturing or production process.  This element may be used when the reporting entity combines work in process and raw materials into an aggregate amount.",
        "label": "Inventory, Work in Process and Raw Materials",
        "verboseLabel": "Purchased parts and fabricated assemblies"
       }
      }
     },
     "localname": "InventoryWorkInProcessAndRawMaterials",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/INVENTORYDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWriteDown": {
     "auth_ref": [
      "r238"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.",
        "label": "Inventory Write-down",
        "terseLabel": "Excess and obsolete inventory related charges"
       }
      }
     },
     "localname": "InventoryWriteDown",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeInterest": {
     "auth_ref": [
      "r94",
      "r186"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFOPERATIONSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      },
      "http://www.agilent.com/role/SEGMENTINFORMATIONReconciliationofReportableResultsDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.",
        "label": "Investment Income, Interest",
        "verboseLabel": "Interest income"
       }
      }
     },
     "localname": "InvestmentIncomeInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFOPERATIONSUnaudited",
      "http://www.agilent.com/role/SEGMENTINFORMATIONReconciliationofReportableResultsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentsFairValueDisclosure": {
     "auth_ref": [
      "r610"
     ],
     "calculation": {
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSFairvalueofassetsandliabilitiesmeasuredonarecurringbasisDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.",
        "label": "Investments, Fair Value Disclosure",
        "terseLabel": "Other investments"
       }
      }
     },
     "localname": "InvestmentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSFairvalueofassetsandliabilitiesmeasuredonarecurringbasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeasesOperatingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases, Operating [Abstract]",
        "terseLabel": "Operating Leases"
       }
      }
     },
     "localname": "LeasesOperatingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "auth_ref": [
      "r660"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.",
        "label": "Lessee, Leases [Policy Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeLeasesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r44",
      "r118",
      "r201",
      "r229",
      "r285",
      "r286",
      "r287",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r546",
      "r549",
      "r550",
      "r626",
      "r664",
      "r665"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities [Abstract]",
        "terseLabel": "Liabilities"
       }
      }
     },
     "localname": "LiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSFairvalueofassetsandliabilitiesmeasuredonarecurringbasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r32",
      "r118",
      "r229",
      "r626",
      "r666",
      "r697",
      "r718"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "Liabilities and Equity [Abstract]"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r46",
      "r118",
      "r229",
      "r285",
      "r286",
      "r287",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r546",
      "r549",
      "r550",
      "r626",
      "r664",
      "r665",
      "r666"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "verboseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesFairValueDisclosure": {
     "auth_ref": [
      "r610"
     ],
     "calculation": {
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSFairvalueofassetsandliabilitiesmeasuredonarecurringbasisDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial and nonfinancial obligations.",
        "label": "Financial and Nonfinancial Liabilities, Fair Value Disclosure",
        "totalLabel": "Total liabilities measured at fair value"
       }
      }
     },
     "localname": "LiabilitiesFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSFairvalueofassetsandliabilitiesmeasuredonarecurringbasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityExpirationDate1": {
     "auth_ref": [
      "r42"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date the credit facility terminates, in YYYY-MM-DD format.",
        "label": "Line of Credit Facility, Expiration Date",
        "terseLabel": "Expiration date of credit facility"
       }
      }
     },
     "localname": "LineOfCreditFacilityExpirationDate1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/SHORTTERMDEBTCreditFacilityDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding": {
     "auth_ref": [
      "r625"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of the amount outstanding under the credit facility.",
        "label": "Line of Credit Facility, Fair Value of Amount Outstanding",
        "terseLabel": "Amount outstanding on credit facility"
       }
      }
     },
     "localname": "LineOfCreditFacilityFairValueOfAmountOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/SHORTTERMDEBTCreditFacilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityInitiationDate1": {
     "auth_ref": [
      "r42"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date the credit facility first became available, in YYYY-MM-DD format.",
        "label": "Line of Credit Facility, Initiation Date",
        "terseLabel": "Initiation date of credit facility"
       }
      }
     },
     "localname": "LineOfCreditFacilityInitiationDate1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/SHORTTERMDEBTCreditFacilityDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r42"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Maximum borrowing capacity of credit facility"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/SHORTTERMDEBTCreditFacilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars.",
        "label": "Line of Credit [Member]",
        "terseLabel": "Line of Credit [Member]"
       }
      }
     },
     "localname": "LineOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/SHORTTERMDEBTCreditFacilityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates an ownership position in, or purchase of, a security.",
        "label": "Long [Member]",
        "terseLabel": "Buy"
       }
      }
     },
     "localname": "LongMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESForeignExchangeForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r21",
      "r304",
      "r314",
      "r315",
      "r316",
      "r696",
      "r714"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt",
        "terseLabel": "Long-term debt"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/LONGTERMDEBTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtFairValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission.",
        "label": "Long-term Debt, Fair Value",
        "terseLabel": "Long-term Debt, Fair Value"
       }
      }
     },
     "localname": "LongTermDebtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "auth_ref": [
      "r47"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt, Excluding Current Maturities",
        "verboseLabel": "Long-term debt"
       }
      }
     },
     "localname": "LongTermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited",
      "http://www.agilent.com/role/OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtTextBlock": {
     "auth_ref": [
      "r321"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-term debt.",
        "label": "Long-term Debt [Text Block]",
        "terseLabel": "LONG-TERM DEBT"
       }
      }
     },
     "localname": "LongTermDebtTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/LONGTERMDEBTNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LongTermInvestments": {
     "auth_ref": [
      "r38"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle).",
        "label": "Long-term Investments",
        "verboseLabel": "Long-term investments"
       }
      }
     },
     "localname": "LongTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MeasurementInputTypeAxis": {
     "auth_ref": [
      "r613"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Axis]",
        "terseLabel": "Measurement Input Type [Axis]"
       }
      }
     },
     "localname": "MeasurementInputTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSAssetsandLiabilitiesmeasuredatFairValueonaNonRecurringBasisDetails",
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSContingentConsiderationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MeasurementInputTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Domain]",
        "terseLabel": "Measurement Input Type [Domain]"
       }
      }
     },
     "localname": "MeasurementInputTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSAssetsandLiabilitiesmeasuredatFairValueonaNonRecurringBasisDetails",
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSContingentConsiderationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MinorityInterestPeriodIncreaseDecrease": {
     "auth_ref": [
      "r543"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net Increase or Decrease in balance of noncontrolling interest in the subsidiary during the reporting period.",
        "label": "Noncontrolling Interest, Period Increase (Decrease)",
        "terseLabel": "Purchase of non-controlling interest increase (decrease)"
       }
      }
     },
     "localname": "MinorityInterestPeriodIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MovementInStandardProductWarrantyAccrualRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Movement in Standard Product Warranty Accrual [Roll Forward]",
        "terseLabel": "Movement in Standard Product Warranty Accrual"
       }
      }
     },
     "localname": "MovementInStandardProductWarrantyAccrualRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/WARRANTIESANDCONTINGENCIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r104"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash used in financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Cash flows from financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r104"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Cash flows from Investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r104",
      "r106",
      "r109"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "verboseLabel": "Cash flows from operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r7",
      "r74",
      "r77",
      "r82",
      "r86",
      "r109",
      "r118",
      "r129",
      "r135",
      "r136",
      "r138",
      "r139",
      "r143",
      "r144",
      "r156",
      "r193",
      "r199",
      "r203",
      "r206",
      "r209",
      "r229",
      "r285",
      "r286",
      "r287",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r608",
      "r626",
      "r703",
      "r722"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOMEUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFEQUITY": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      },
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFOPERATIONSUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net income",
        "totalLabel": "Net income"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited",
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOMEUnaudited",
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFEQUITY",
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFOPERATIONSUnaudited",
      "http://www.agilent.com/role/NETINCOMEPERSHAREDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetInvestmentHedgingMember": {
     "auth_ref": [
      "r566"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hedges of a net investment in a foreign operation.",
        "label": "Net Investment Hedging [Member]",
        "terseLabel": "Net Investment Hedging [Member]"
       }
      }
     },
     "localname": "NetInvestmentHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESEffectofderivativeinstrumentsonConsolidatedStatementofOperationsDetails",
      "http://www.agilent.com/role/DERIVATIVESFairvalueofderivativeinstrumentsandConsolidatedBalanceSheetlocationDetails",
      "http://www.agilent.com/role/DERIVATIVESForeignExchangeForwardContractsDetails",
      "http://www.agilent.com/role/DERIVATIVESTextDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Standards Update and Change in Accounting Principle [Abstract]",
        "terseLabel": "Accounting Standards Update and Change in Accounting Principle [Abstract]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock": {
     "auth_ref": [
      "r5",
      "r127",
      "r128",
      "r131",
      "r132",
      "r145",
      "r146",
      "r147",
      "r222",
      "r223",
      "r234",
      "r235",
      "r368",
      "r369",
      "r370",
      "r371",
      "r494",
      "r517",
      "r518",
      "r519",
      "r604",
      "r633",
      "r634",
      "r635",
      "r662",
      "r687",
      "r688",
      "r689",
      "r741",
      "r742",
      "r743",
      "r744",
      "r746",
      "r775"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for change in accounting principle. Includes, but is not limited to, nature, reason, and method of adopting amendment to accounting standards or other change in accounting principle.",
        "label": "Accounting Standards Update and Change in Accounting Principle [Text Block]",
        "terseLabel": "NEW ACCOUNTING PRONOUNCEMENTS"
       }
      }
     },
     "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/NEWACCOUNTINGPRONOUNCEMENTSNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncontrollingInterestMember": {
     "auth_ref": [
      "r124",
      "r125",
      "r126",
      "r341",
      "r542"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.",
        "label": "Noncontrolling Interest [Member]",
        "terseLabel": "Non-controlling Interest"
       }
      }
     },
     "localname": "NoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NondesignatedMember": {
     "auth_ref": [
      "r567"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument not designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Not Designated as Hedging Instrument [Member]",
        "terseLabel": "Derivatives Not Designated as Hedging Instruments",
        "verboseLabel": "Not Designated as Hedging Instruments"
       }
      }
     },
     "localname": "NondesignatedMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESEffectofderivativeinstrumentsonConsolidatedStatementofOperationsDetails",
      "http://www.agilent.com/role/DERIVATIVESFairvalueofderivativeinstrumentsandConsolidatedBalanceSheetlocationDetails",
      "http://www.agilent.com/role/DERIVATIVESForeignExchangeForwardContractsDetails",
      "http://www.agilent.com/role/DERIVATIVESTextDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NumberOfForeignCurrencyDerivativesHeld": {
     "auth_ref": [
      "r562",
      "r564"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of foreign currency exchange rate derivatives held by the entity at the reporting date.",
        "label": "Number of Foreign Currency Derivatives Held",
        "terseLabel": "Number of foreign exchange forward contracts (in units)"
       }
      }
     },
     "localname": "NumberOfForeignCurrencyDerivativesHeld",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESForeignExchangeForwardContractsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NumberOfInterestRateDerivativesHeld": {
     "auth_ref": [
      "r562",
      "r564"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of interest rate derivative instruments held by the entity at the reporting date.",
        "label": "Number of Interest Rate Derivatives Held",
        "terseLabel": "Number of interest rate swap contracts terminated"
       }
      }
     },
     "localname": "NumberOfInterestRateDerivativesHeld",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESTextDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NumberOfOperatingSegments": {
     "auth_ref": [
      "r181"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.",
        "label": "Number of Operating Segments",
        "verboseLabel": "Number of operating segments"
       }
      }
     },
     "localname": "NumberOfOperatingSegments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/SEGMENTINFORMATIONProfitabilityDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r193",
      "r199",
      "r203",
      "r206",
      "r209"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFOPERATIONSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "terseLabel": "Income from operations",
        "totalLabel": "Income from operations"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFOPERATIONSUnaudited",
      "http://www.agilent.com/role/SEGMENTINFORMATIONProfitabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r659"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "terseLabel": "Present value of future minimum lease payments"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r658"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Right-of-Use Asset"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OrderOrProductionBacklogMember": {
     "auth_ref": [
      "r537"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Orders, production or production backlog arising from contracts such as purchase or sales orders acquired in a business combination.",
        "label": "Order or Production Backlog [Member]",
        "terseLabel": "Backlog"
       }
      }
     },
     "localname": "OrderOrProductionBacklogMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDisclosuresandComponentsofPurchasedOtherIntangiblesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r123",
      "r147",
      "r179",
      "r560"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the general note to the financial statements for the reporting entity which may include, descriptions of the basis of presentation, business description, significant accounting policies, consolidations, reclassifications, new pronouncements not yet adopted and changes in accounting principles.",
        "label": "Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]",
        "terseLabel": "OVERVIEW AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES"
       }
      }
     },
     "localname": "OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent": {
     "auth_ref": [
      "r699",
      "r721"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other.",
        "label": "Other Accrued Liabilities",
        "terseLabel": "Other accrued liabilities"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsCurrent": {
     "auth_ref": [
      "r56",
      "r666"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current assets classified as other.",
        "label": "Other Assets, Current",
        "verboseLabel": "Other current assets"
       }
      }
     },
     "localname": "OtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of other assets.",
        "label": "Other Assets, Fair Value Disclosure",
        "terseLabel": "Fair value of impaired long-lived assets held for use"
       }
      }
     },
     "localname": "OtherAssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSAssetsandLiabilitiesmeasuredatFairValueonaNonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsMember": {
     "auth_ref": [
      "r569",
      "r590"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other assets.",
        "label": "Other Assets [Member]",
        "terseLabel": "Other Assets"
       }
      }
     },
     "localname": "OtherAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r39"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax [Abstract]",
        "verboseLabel": "Net defined benefit pension cost and post retirement plan costs:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOMEUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax": {
     "auth_ref": [
      "r65",
      "r68",
      "r420"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOMEUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of gain (loss) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, after Tax",
        "verboseLabel": "Change in actuarial net loss, net of tax expense of $2 and $4"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOMEUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax": {
     "auth_ref": [
      "r69"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, Tax",
        "terseLabel": "Change in actuarial net loss, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOMELOSSUnauditedParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansTaxAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax [Abstract]",
        "verboseLabel": "Net defined benefit pension cost and post retirement plan costs, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeDefinedBenefitPlansTaxAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOMELOSSUnauditedParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax": {
     "auth_ref": [
      "r63",
      "r68",
      "r638",
      "r639",
      "r642"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOMEUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax",
        "terseLabel": "Foreign currency translation, net of tax expense of $0 and $0"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOMEUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax": {
     "auth_ref": [
      "r68",
      "r72",
      "r73",
      "r420"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of reclassification adjustment from accumulated other comprehensive (income) loss for prior service cost (credit) of defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, before Tax",
        "terseLabel": "Prior service benefit"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYReclassificationsoutofaccumulatedcomprehensiveincomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax": {
     "auth_ref": [
      "r69"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax (expense) benefit of reclassification adjustment from accumulated other comprehensive (income) loss for prior service cost (credit) of defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, Tax",
        "terseLabel": "Change in net prior service benefit, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOMELOSSUnauditedParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax": {
     "auth_ref": [
      "r71",
      "r80",
      "r81",
      "r643",
      "r645",
      "r650"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), before Reclassifications, before Tax",
        "terseLabel": "Other comprehensive income (loss) before reclassifications"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYAccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax": {
     "auth_ref": [
      "r69"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax",
        "terseLabel": "Amounts reclassified into earnings related to derivative instruments, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOMELOSSUnauditedParenthetical",
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYReclassificationsoutofaccumulatedcomprehensiveincomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax": {
     "auth_ref": [
      "r64",
      "r68"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOMEUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax",
        "terseLabel": "Unrealized gain (loss) on derivative instruments, net of tax expense (benefit) of $2 and $(2)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOMEUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax": {
     "auth_ref": [
      "r64",
      "r68",
      "r572",
      "r577",
      "r591"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax",
        "terseLabel": "Other comprehensive income (loss) before reclassifications",
        "verboseLabel": "Gain (loss) recognized in accumulated other comprehensive\u00a0loss"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESEffectofderivativeinstrumentsonConsolidatedStatementofOperationsDetails",
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYAccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax": {
     "auth_ref": [
      "r69"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax",
        "terseLabel": "Unrealized gain (loss) on derivative instruments, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOMELOSSUnauditedParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax": {
     "auth_ref": [
      "r68",
      "r72"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOMEUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax",
        "negatedTerseLabel": "Amount reclassified into earnings related to derivative instruments, net of tas expense (benefit) of $(1) and $2",
        "terseLabel": "Unrealized gain (loss) on derivatives after reclassification and after Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOMEUnaudited",
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYReclassificationsoutofaccumulatedcomprehensiveincomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax": {
     "auth_ref": [
      "r61",
      "r69",
      "r640",
      "r649"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit), after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax",
        "verboseLabel": "Foreign currency translation, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOMELOSSUnauditedParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax": {
     "auth_ref": [
      "r580"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative designated and qualifying as net investment hedge.",
        "label": "Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax",
        "terseLabel": "Gain (loss) recognized in accumulated other comprehensive loss - translation adjustment"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESEffectofderivativeinstrumentsonConsolidatedStatementofOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r75",
      "r78",
      "r80",
      "r81",
      "r83",
      "r87",
      "r336",
      "r643",
      "r648",
      "r650",
      "r704",
      "r723"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOMEUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFEQUITY": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Other comprehensive income (loss)",
        "totalLabel": "Other comprehensive income (loss)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOMEUnaudited",
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFEQUITY",
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYAccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "verboseLabel": "Other comprehensive income (loss):"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOMEUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax": {
     "auth_ref": [
      "r68",
      "r72",
      "r73",
      "r420"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of reclassification adjustment from accumulated other comprehensive (income) loss for net period benefit cost (credit) of defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Reclassification Adjustment from AOCI, before Tax",
        "terseLabel": "Actuarial net loss and prior service benefit reclassified, before tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYReclassificationsoutofaccumulatedcomprehensiveincomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax": {
     "auth_ref": [
      "r68",
      "r72",
      "r73",
      "r420"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of reclassification adjustment from accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan.",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, before Tax",
        "negatedTerseLabel": "Actuarial net loss"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYReclassificationsoutofaccumulatedcomprehensiveincomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax": {
     "auth_ref": [
      "r68",
      "r72",
      "r73",
      "r420"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of reclassification adjustment from accumulated other comprehensive (income) loss for net periodic benefit cost (credit) of defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Reclassification Adjustment from AOCI, after Tax",
        "terseLabel": "Actuarial net loss and prior service benefit reclassified, net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYReclassificationsoutofaccumulatedcomprehensiveincomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansTax": {
     "auth_ref": [
      "r69",
      "r544"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax (expense) benefit for reclassification adjustment from accumulated other comprehensive (income) loss of defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Reclassification Adjustment from AOCI, Tax",
        "terseLabel": "Tax on actuarial net loss and prior service benefit reclassified"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYReclassificationsoutofaccumulatedcomprehensiveincomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossTax": {
     "auth_ref": [
      "r69",
      "r80",
      "r87",
      "r503",
      "r526",
      "r528",
      "r643",
      "r646",
      "r650",
      "r704",
      "r723"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) allocated to other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Tax",
        "negatedTerseLabel": "Tax expense (benefit)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYAccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossTaxParentheticalDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Tax, Parenthetical Disclosures [Abstract]",
        "terseLabel": "Other comprehensive income (loss), tax, parenthetical disclosures"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossTaxParentheticalDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOMELOSSUnauditedParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax": {
     "auth_ref": [
      "r64",
      "r68",
      "r593"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).",
        "label": "Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax",
        "terseLabel": "Gain (loss) recognized in accumulated other comprehensive\u00a0loss"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESTextDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCurrentAssetsMember": {
     "auth_ref": [
      "r569",
      "r590"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other current assets.",
        "label": "Other Current Assets [Member]",
        "terseLabel": "Other Current Assets"
       }
      }
     },
     "localname": "OtherCurrentAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESFairvalueofderivativeinstrumentsandConsolidatedBalanceSheetlocationDetails",
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSFairvalueofassetsandliabilitiesmeasuredonarecurringbasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherCurrentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other current liabilities.",
        "label": "Other Current Liabilities [Member]",
        "terseLabel": "Other accrued liabilities"
       }
      }
     },
     "localname": "OtherCurrentLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSFairvalueofassetsandliabilitiesmeasuredonarecurringbasisDetails",
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTextualsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherIntangibleAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intangible assets classified as other.",
        "label": "Other Intangible Assets [Member]",
        "terseLabel": "Other Intangible Assets"
       }
      }
     },
     "localname": "OtherIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTextualsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r48"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncashIncomeExpense": {
     "auth_ref": [
      "r109"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.",
        "label": "Other Noncash Income (Expense)",
        "negatedTerseLabel": "Other non-cash expense, net"
       }
      }
     },
     "localname": "OtherNoncashIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncurrentAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other noncurrent assets.",
        "label": "Other Noncurrent Assets [Member]",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherNoncurrentAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSFairvalueofassetsandliabilitiesmeasuredonarecurringbasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherNoncurrentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other noncurrent liabilities.",
        "label": "Other Noncurrent Liabilities [Member]",
        "terseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "OtherNoncurrentLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSFairvalueofassetsandliabilitiesmeasuredonarecurringbasisDetails",
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTextualsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r95"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFOPERATIONSUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      },
      "http://www.agilent.com/role/SEGMENTINFORMATIONReconciliationofReportableResultsDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "terseLabel": "Other income (expense), net",
        "verboseLabel": "Other income (expense), net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFOPERATIONSUnaudited",
      "http://www.agilent.com/role/SEGMENTINFORMATIONReconciliationofReportableResultsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other nonoperating income (expense).",
        "label": "Other Nonoperating Income (Expense) [Member]",
        "terseLabel": "Other income (expense)"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESEffectofderivativeinstrumentsonConsolidatedStatementofOperationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember": {
     "auth_ref": [
      "r374",
      "r375",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r424",
      "r425",
      "r427",
      "r430",
      "r434",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan designed to provide other postretirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes pension benefits.",
        "label": "Other Postretirement Benefits Plan [Member]",
        "terseLabel": "Other Postretirement Benefits Plan"
       }
      }
     },
     "localname": "OtherPostretirementBenefitPlansDefinedBenefitMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSComponentsofnetperiodiccostsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherTaxExpenseBenefit": {
     "auth_ref": [
      "r119",
      "r503",
      "r512"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other income tax expense (benefit).",
        "label": "Other Tax Expense (Benefit)",
        "verboseLabel": "Discrete tax expense (benefit)"
       }
      }
     },
     "localname": "OtherTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ParentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Portion of equity, or net assets, in the consolidated entity attributable, directly or indirectly, to the parent. Excludes noncontrolling interests.",
        "label": "Parent [Member]",
        "terseLabel": "Total Stockholder's Equity"
       }
      }
     },
     "localname": "ParentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "auth_ref": [
      "r100"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to reacquire common stock during the period.",
        "label": "Payments for Repurchase of Common Stock",
        "negatedLabel": "Treasury stock repurchases"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDividendsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payments of Dividends [Abstract]",
        "terseLabel": "Dividends Paid"
       }
      }
     },
     "localname": "PaymentsOfDividendsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYDividendsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PaymentsOfDividendsCommonStock": {
     "auth_ref": [
      "r100"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.",
        "label": "Payments of Ordinary Dividends, Common Stock",
        "verboseLabel": "Aggregate amount of cash dividends paid"
       }
      }
     },
     "localname": "PaymentsOfDividendsCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYDividendsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfOrdinaryDividends": {
     "auth_ref": [
      "r100"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash outflow in the form of ordinary dividends to common shareholders, preferred shareholders and noncontrolling interests, generally out of earnings.",
        "label": "Payments of Ordinary Dividends",
        "negatedLabel": "Payment of dividends"
       }
      }
     },
     "localname": "PaymentsOfOrdinaryDividends",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [
      "r100"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Payment, Tax Withholding, Share-based Payment Arrangement",
        "negatedTerseLabel": "Payment of taxes related to net share settlement of equity awards"
       }
      }
     },
     "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireEquitySecuritiesFvNi": {
     "auth_ref": [
      "r103",
      "r225"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to acquire investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as investing activity.",
        "label": "Payments to Acquire Equity Securities, FV-NI",
        "negatedTerseLabel": "Payments to acquire equity investments"
       }
      }
     },
     "localname": "PaymentsToAcquireEquitySecuritiesFvNi",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireNotesReceivable": {
     "auth_ref": [
      "r96"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to acquire an agreement for an unconditional promise by the maker to pay the entity (holder) a definite sum of money at a future date. Such amount may include accrued interest receivable in accordance with the terms of the note. The note also may contain provisions including a discount or premium, payable on demand, secured, or unsecured, interest bearing or noninterest bearing, among myriad other features and characteristics.",
        "label": "Payments to Acquire Notes Receivable",
        "negatedTerseLabel": "Payment in exchange for convertible note"
       }
      }
     },
     "localname": "PaymentsToAcquireNotesReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r97"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Investments in property, plant and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": {
     "auth_ref": [
      "r400",
      "r402",
      "r408",
      "r426",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r449",
      "r451",
      "r452",
      "r453",
      "r466"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for retirement benefits.",
        "label": "Retirement Benefits [Text Block]",
        "terseLabel": "RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent": {
     "auth_ref": [
      "r22",
      "r375",
      "r376",
      "r399",
      "r449"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as noncurrent.",
        "label": "Liability, Defined Benefit Plan, Noncurrent",
        "verboseLabel": "Retirement and post-retirement benefits"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionPlansDefinedBenefitMember": {
     "auth_ref": [
      "r373",
      "r375",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r424",
      "r425",
      "r427",
      "r430",
      "r434",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r453",
      "r454",
      "r461",
      "r462",
      "r463",
      "r464"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan designed to provide participant with pension benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes other postretirement benefits.",
        "label": "Pension Plan [Member]",
        "terseLabel": "Pension Plan"
       }
      }
     },
     "localname": "PensionPlansDefinedBenefitMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSComponentsofnetperiodiccostsDetails",
      "http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSDetailsEmployerContributions"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PerformanceSharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement awarded for meeting performance target.",
        "label": "Performance Shares [Member]",
        "terseLabel": "Performance Shares [LTPP]"
       }
      }
     },
     "localname": "PerformanceSharesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/SHAREBASEDCOMPENSATIONTextDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PledgedStatusAxis": {
     "auth_ref": [
      "r545",
      "r549"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by pledged or not pledged status of asset owned by entity.",
        "label": "Pledged Status [Axis]",
        "terseLabel": "Pledged Status [Axis]"
       }
      }
     },
     "localname": "PledgedStatusAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PledgedStatusDomain": {
     "auth_ref": [
      "r545",
      "r549"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pledged or not pledged status of asset owned by entity.",
        "label": "Pledged Status [Domain]",
        "terseLabel": "Pledged Status [Domain]"
       }
      }
     },
     "localname": "PledgedStatusDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PositionAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by position taken for a security.",
        "label": "Position [Axis]",
        "terseLabel": "Position [Axis]"
       }
      }
     },
     "localname": "PositionAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESForeignExchangeForwardContractsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PositionDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates position taken for a security.",
        "label": "Position [Domain]",
        "terseLabel": "Position [Domain]"
       }
      }
     },
     "localname": "PositionDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESForeignExchangeForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r24",
      "r322"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnauditedParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r24"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r24",
      "r322"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred Stock, Shares Issued"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r24"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred stock, outstanding (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r24",
      "r666"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "verboseLabel": "Preferred stock; $0.01 par value; 125 million shares authorized; none issued and outstanding"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfCommercialPaper": {
     "auth_ref": [
      "r99"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from borrowing by issuing commercial paper.",
        "label": "Proceeds from Issuance of Commercial Paper",
        "terseLabel": "Proceeds from Commercial Paper"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfCommercialPaper",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited",
      "http://www.agilent.com/role/SHORTTERMDEBTCreditFacilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions": {
     "auth_ref": [
      "r98",
      "r486"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised.",
        "label": "Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised",
        "terseLabel": "Issuance of common stock under employee stock plans"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductMember": {
     "auth_ref": [
      "r366"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Article or substance produced by nature, labor or machinery.",
        "label": "Product [Member]",
        "terseLabel": "Product"
       }
      }
     },
     "localname": "ProductMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFOPERATIONSUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment [Member]",
        "terseLabel": "Property, Plant and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r16",
      "r17",
      "r265",
      "r666",
      "r710",
      "r719"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "verboseLabel": "Property, plant and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PublicUtilitiesInventoryTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tangible personal property that is held for sale in the ordinary course of business, in process of production for such sale or is to be currently consumed in the production of goods or services to be available for sale.",
        "label": "Inventory [Domain]",
        "terseLabel": "Inventory"
       }
      }
     },
     "localname": "PublicUtilitiesInventoryTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/SHAREBASEDCOMPENSATIONAllocatedSharebasedcompensationexpenseDetails",
      "http://www.agilent.com/role/SHAREBASEDCOMPENSATIONTextDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]",
        "terseLabel": "Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives"
       }
      }
     },
     "localname": "ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYReclassificationsoutofaccumulatedcomprehensiveincomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax": {
     "auth_ref": [
      "r71",
      "r80",
      "r81",
      "r83",
      "r643",
      "r647",
      "r650"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss).",
        "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax",
        "terseLabel": "Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax"
       }
      }
     },
     "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYReclassificationsoutofaccumulatedcomprehensiveincomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent": {
     "auth_ref": [
      "r71"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of reclassification adjustments of other comprehensive income (loss) attributable to parent.",
        "label": "Reclassification from AOCI, Current Period, before Tax, Attributable to Parent",
        "terseLabel": "Amounts reclassified out of accumulated other comprehensive income (loss)"
       }
      }
     },
     "localname": "ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYAccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable": {
     "auth_ref": [
      "r82"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about items reclassified out of accumulated other comprehensive income (loss).",
        "label": "Reclassification out of Accumulated Other Comprehensive Income [Table]",
        "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income [Table]"
       }
      }
     },
     "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYReclassificationsoutofaccumulatedcomprehensiveincomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information about items reclassified out of accumulated other comprehensive income (loss).",
        "label": "Reclassification out of Accumulated Other Comprehensive Income [Table Text Block]",
        "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income"
       }
      }
     },
     "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Abstract]",
        "terseLabel": "Reconciliation of Operating Profit from Segments to Consolidated"
       }
      }
     },
     "localname": "ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/SEGMENTINFORMATIONReconciliationofReportableResultsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock": {
     "auth_ref": [
      "r199",
      "r203"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.",
        "label": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]",
        "verboseLabel": "Reconciliation of segment results to total enterprise results"
       }
      }
     },
     "localname": "ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/SEGMENTINFORMATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RecourseStatusAxis": {
     "auth_ref": [
      "r546",
      "r550"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by recourse or nonrecourse status of liability.",
        "label": "Recourse Status [Axis]",
        "terseLabel": "Recourse Status [Axis]"
       }
      }
     },
     "localname": "RecourseStatusAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RecourseStatusDomain": {
     "auth_ref": [
      "r546",
      "r550"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Recourse or nonrecourse status of liability.",
        "label": "Recourse Status [Domain]",
        "terseLabel": "Recourse Status [Domain]"
       }
      }
     },
     "localname": "RecourseStatusDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RepaymentsOfCommercialPaper": {
     "auth_ref": [
      "r101"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow due to repaying amounts borrowed by issuing commercial paper.",
        "label": "Repayments of Commercial Paper",
        "negatedTerseLabel": "Repayments of commercial paper"
       }
      }
     },
     "localname": "RepaymentsOfCommercialPaper",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited",
      "http://www.agilent.com/role/SHORTTERMDEBTCreditFacilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfSeniorDebt": {
     "auth_ref": [
      "r101"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for a long-term debt where the holder has highest claim on the entity's asset in case of bankruptcy or liquidation during the period.",
        "label": "Repayments of Senior Debt",
        "terseLabel": "Repayments of Senior Debt"
       }
      }
     },
     "localname": "RepaymentsOfSeniorDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESTextDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r502",
      "r681",
      "r762"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFOPERATIONSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "verboseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFOPERATIONSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.",
        "label": "Research and Development Expense [Member]",
        "terseLabel": "Research and Development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/SHAREBASEDCOMPENSATIONAllocatedSharebasedcompensationexpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedCash": {
     "auth_ref": [
      "r114",
      "r692",
      "r715"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.",
        "label": "Restricted Cash",
        "terseLabel": "Restricted Cash"
       }
      }
     },
     "localname": "RestrictedCash",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedCashAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restricted Cash [Abstract]",
        "terseLabel": "Restricted Cash [Abstract]"
       }
      }
     },
     "localname": "RestrictedCashAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "terseLabel": "Restricted Stock Units (RSUs)"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/SHAREBASEDCOMPENSATIONTextDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r28",
      "r341",
      "r495",
      "r666",
      "r717",
      "r741",
      "r746"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r2",
      "r124",
      "r125",
      "r126",
      "r130",
      "r141",
      "r144",
      "r233",
      "r491",
      "r492",
      "r493",
      "r515",
      "r516",
      "r606",
      "r737",
      "r739"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetirementPlanSponsorLocationAxis": {
     "auth_ref": [
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r427",
      "r430",
      "r435",
      "r436",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r454",
      "r458",
      "r464"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location of employer sponsoring plan designed to provide retirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans.",
        "label": "Retirement Plan Sponsor Location [Axis]",
        "terseLabel": "Retirement Plan Sponsor Location [Axis]"
       }
      }
     },
     "localname": "RetirementPlanSponsorLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSComponentsofnetperiodiccostsDetails",
      "http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSDetailsEmployerContributions"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetirementPlanSponsorLocationDomain": {
     "auth_ref": [
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r427",
      "r430",
      "r435",
      "r436",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r454",
      "r458",
      "r464"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location of employer sponsoring plan designed to provide retirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans.",
        "label": "Retirement Plan Sponsor Location [Domain]",
        "terseLabel": "Retirement Plan Sponsor Location [Domain]"
       }
      }
     },
     "localname": "RetirementPlanSponsorLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSComponentsofnetperiodiccostsDetails",
      "http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSDetailsEmployerContributions"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetirementPlanTypeAxis": {
     "auth_ref": [
      "r373",
      "r374",
      "r375",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r424",
      "r425",
      "r427",
      "r430",
      "r434",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r461",
      "r462",
      "r463",
      "r464"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of retirement benefit plan. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.",
        "label": "Retirement Plan Type [Axis]",
        "terseLabel": "Retirement Plan Type [Axis]"
       }
      }
     },
     "localname": "RetirementPlanTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSComponentsofnetperiodiccostsDetails",
      "http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSDetailsEmployerContributions"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetirementPlanTypeDomain": {
     "auth_ref": [
      "r373",
      "r374",
      "r375",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r424",
      "r425",
      "r427",
      "r430",
      "r434",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r461",
      "r462",
      "r463",
      "r464"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of plan designed to provide participants with retirement benefits. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.",
        "label": "Retirement Plan Type [Domain]",
        "terseLabel": "Retirement Plan Type [Domain]"
       }
      }
     },
     "localname": "RetirementPlanTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSComponentsofnetperiodiccostsDetails",
      "http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSDetailsEmployerContributions"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]",
        "terseLabel": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r184",
      "r185",
      "r198",
      "r204",
      "r205",
      "r211",
      "r212",
      "r215",
      "r361",
      "r362",
      "r682"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFOPERATIONSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Net revenue"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFOPERATIONSUnaudited",
      "http://www.agilent.com/role/REVENUERevenuebyEndMarketsDetails",
      "http://www.agilent.com/role/REVENUERevenuebyRegionDetails",
      "http://www.agilent.com/role/REVENUERevenuebyTypeDetails",
      "http://www.agilent.com/role/SEGMENTINFORMATIONProfitabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "auth_ref": [
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r359",
      "r360",
      "r365",
      "r372"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.",
        "label": "Revenue from Contract with Customer [Text Block]",
        "terseLabel": "Revenue from Contract with Customer"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/REVENUENotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenuePerformanceObligationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue, Performance Obligation [Abstract]",
        "terseLabel": "Revenue, Performance Obligation [Abstract]"
       }
      }
     },
     "localname": "RevenuePerformanceObligationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligation": {
     "auth_ref": [
      "r357"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transaction price allocated to performance obligation that has not been recognized as revenue.",
        "label": "Revenue, Remaining Performance Obligation, Amount",
        "terseLabel": "Remaining performance obligation amount"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/REVENUERemainingPerformanceObligationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]",
        "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/REVENUERemainingPerformanceObligationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1": {
     "auth_ref": [
      "r358"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period",
        "terseLabel": "Remaining performance obligation expected timing of satisfaction period"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/REVENUERemainingPerformanceObligationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis": {
     "auth_ref": [
      "r358"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Start date of time band for expected timing of satisfaction of remaining performance obligation, in YYYY-MM-DD format.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]",
        "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/REVENUERemainingPerformanceObligationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about expected timing for satisfying remaining performance obligation.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]",
        "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/REVENUERemainingPerformanceObligationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenuesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues [Abstract]",
        "terseLabel": "Net revenue:"
       }
      }
     },
     "localname": "RevenuesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFOPERATIONSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility [Member]",
        "terseLabel": "Revolving Credit Facility"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/SHORTTERMDEBTCreditFacilityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r71",
      "r648",
      "r650"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Accumulated Other Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "auth_ref": [
      "r160"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/NETINCOMEPERSHAREDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfDebtInstrumentsTextBlock": {
     "auth_ref": [
      "r47",
      "r122",
      "r315",
      "r317",
      "r337",
      "r338",
      "r339",
      "r340",
      "r653",
      "r654",
      "r657",
      "r711"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table Text Block]",
        "verboseLabel": "Schedule of Senior Notes and Related Interest Rate Swaps"
       }
      }
     },
     "localname": "ScheduleOfDebtInstrumentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/LONGTERMDEBTTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": {
     "auth_ref": [
      "r433",
      "r434",
      "r437",
      "r438",
      "r449"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosures about an individual defined benefit pension plan or an other postretirement defined benefit plan. It may be appropriate to group certain similar plans.  Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Defined Benefit Plans Disclosures [Table]",
        "terseLabel": "Schedule of Defined Benefit Plans Disclosures [Table]"
       }
      }
     },
     "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSDetailsEmployerContributions"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock": {
     "auth_ref": [
      "r433",
      "r434",
      "r437",
      "r438",
      "r449"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of one or more of the entity's defined benefit pension plans or one or more other defined benefit postretirement plans, separately for pension plans and other postretirement benefit plans including the entity's schedule of fair value of plan assets for defined benefit or other postretirement plans.",
        "label": "Schedule of Defined Benefit Plans Disclosures [Table Text Block]",
        "terseLabel": "Schedule of net pension and post-retirement benefit costs"
       }
      }
     },
     "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock": {
     "auth_ref": [
      "r570",
      "r579",
      "r586"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) [Table Text Block]",
        "terseLabel": "Effect of derivative instruments for foreign exchange contracts in the consolidated statement of operations"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock": {
     "auth_ref": [
      "r576"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.",
        "label": "Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]",
        "terseLabel": "Gross fair values and balance sheet location of derivative instruments held in the consolidated balance sheet"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsTextBlock": {
     "auth_ref": [
      "r561",
      "r563",
      "r564",
      "r567",
      "r568",
      "r576",
      "r579",
      "r588",
      "r589"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of pertinent information about a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.",
        "label": "Schedule of Derivative Instruments [Table Text Block]",
        "terseLabel": "Aggregated notional amounts by currency and designation"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r159"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "verboseLabel": "Reconciliation of the numerators and denominators of the basic and diluted net income per share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/NETINCOMEPERSHARETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": {
     "auth_ref": [
      "r469",
      "r483",
      "r497"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements.",
        "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]",
        "terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/SHAREBASEDCOMPENSATIONAllocatedSharebasedcompensationexpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": {
     "auth_ref": [
      "r469",
      "r483",
      "r497"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.",
        "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]",
        "verboseLabel": "Allocated share-based compensation expense disclosure"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/SHAREBASEDCOMPENSATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "auth_ref": [
      "r610",
      "r611"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Fair Value Assets And Liabilities Measured On Recurring Basis"
       }
      }
     },
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r252",
      "r255",
      "r683"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDisclosuresandComponentsofPurchasedOtherIntangiblesDetails",
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTextualsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [
      "r252",
      "r255"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]",
        "verboseLabel": "Components of other intangible assets during the period"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfGoodwillTable": {
     "auth_ref": [
      "r247",
      "r249"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.",
        "label": "Schedule of Goodwill [Table]",
        "terseLabel": "Schedule of Goodwill [Table]"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSGoodwillRollforwardDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r247",
      "r249"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of Goodwill [Table Text Block]",
        "terseLabel": "Goodwill balances and movements for each reportable segment during the period"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r14",
      "r34",
      "r35",
      "r36"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "verboseLabel": "INVENTORY"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/INVENTORYTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock": {
     "auth_ref": [
      "r134",
      "r138",
      "r166",
      "r167"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of changes in accounting principles, including adoption of new accounting pronouncements, that describes the new methods, amount and effects on financial statement line items.",
        "label": "Accounting Standards Update and Change in Accounting Principle [Table Text Block]",
        "terseLabel": "Summary of New Accounting Pronouncements"
       }
      }
     },
     "localname": "ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/NEWACCOUNTINGPRONOUNCEMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock": {
     "auth_ref": [
      "r282"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the changes in the guarantor's aggregate product warranty liability, including the beginning balance of the aggregate product warranty liability, the aggregate reductions in that liability for payments made (in cash or in kind) under the warranty, the aggregate changes in the liability for accruals related to product warranties issued during the reporting period, the aggregate changes in the liability for accruals related to preexisting warranties (including adjustments related to changes in estimates), and the ending balance of the aggregate product warranty liability.",
        "label": "Schedule of Product Warranty Liability [Table Text Block]",
        "verboseLabel": "Standard warranty"
       }
      }
     },
     "localname": "ScheduleOfProductWarrantyLiabilityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/WARRANTIESANDCONTINGENCIESTable"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock": {
     "auth_ref": [
      "r15",
      "r114",
      "r692",
      "r715"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of cash and cash equivalents restricted as to withdrawal or usage.",
        "label": "Restrictions on Cash and Cash Equivalents [Table Text Block]",
        "terseLabel": "Restrictions on Cash and Cash Equivalents"
       }
      }
     },
     "localname": "ScheduleOfRestrictedCashAndCashEquivalentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r193",
      "r196",
      "r202",
      "r247"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/SEGMENTINFORMATIONProfitabilityDetails",
      "http://www.agilent.com/role/SEGMENTINFORMATIONReconciliationofReportableResultsDetails",
      "http://www.agilent.com/role/SEGMENTINFORMATIONSegmentAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r193",
      "r196",
      "r202",
      "r247"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "terseLabel": "Segment Profitability and Segment Assets"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/SEGMENTINFORMATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r471",
      "r485"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/SHAREBASEDCOMPENSATIONFairValueAssumptionsDetails",
      "http://www.agilent.com/role/SHAREBASEDCOMPENSATIONTextDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r476"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "verboseLabel": "Assumptions used to estimate fair value for LTPP"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/SHAREBASEDCOMPENSATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShortTermDebtTable": {
     "auth_ref": [
      "r43"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to borrowings under which repayment was required in less than twelve months (or normal operating cycle, if longer) after its issuance. It may include: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance sheet date and measures of the maximum and average amount outstanding during the period; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation.",
        "label": "Schedule of Short-term Debt [Table]",
        "terseLabel": "Schedule of Short-term Debt [Table]"
       }
      }
     },
     "localname": "ScheduleOfShortTermDebtTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/SHORTTERMDEBTCreditFacilityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfVariableInterestEntitiesTable": {
     "auth_ref": [
      "r545",
      "r546",
      "r549",
      "r550",
      "r551",
      "r553",
      "r555",
      "r556",
      "r557"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of qualitative and quantitative information related to variable interests the entity holds, whether or not such variable interest entity (VIE) is included in the reporting entity's consolidated financial statements. Includes, but is not limited to, description of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a tabular comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide.",
        "label": "Schedule of Variable Interest Entities [Table]",
        "terseLabel": "Schedule of Variable Interest Entities [Table]"
       }
      }
     },
     "localname": "ScheduleOfVariableInterestEntitiesTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": {
     "auth_ref": [
      "r255"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.",
        "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]",
        "terseLabel": "Schedule of estimated future amortization expense of finite-lived intangible assets"
       }
      }
     },
     "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r180",
      "r184",
      "r185",
      "r186",
      "r187",
      "r188",
      "r189",
      "r190",
      "r191",
      "r192",
      "r193",
      "r194",
      "r195",
      "r198",
      "r199",
      "r200",
      "r201",
      "r203",
      "r204",
      "r205",
      "r206",
      "r207",
      "r209",
      "r215",
      "r271",
      "r272",
      "r730"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDisclosuresandComponentsofPurchasedOtherIntangiblesDetails",
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSGoodwillRollforwardDetails",
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTextualsDetails",
      "http://www.agilent.com/role/REVENUERevenuebyRegionDetails",
      "http://www.agilent.com/role/SEGMENTINFORMATIONProfitabilityDetails",
      "http://www.agilent.com/role/SEGMENTINFORMATIONReconciliationofReportableResultsDetails",
      "http://www.agilent.com/role/SEGMENTINFORMATIONSegmentAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentOperatingActivitiesDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operations of an entity including continuing and discontinued operations.",
        "label": "Operating Activities [Domain]",
        "terseLabel": "Operating Activities [Domain]"
       }
      }
     },
     "localname": "SegmentOperatingActivitiesDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSComponentsofnetperiodiccostsDetails",
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYAccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r180",
      "r182",
      "r183",
      "r193",
      "r197",
      "r203",
      "r207",
      "r208",
      "r209",
      "r210",
      "r211",
      "r214",
      "r215",
      "r216"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "SEGMENT INFORMATION"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/SEGMENTINFORMATIONNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/SEGMENTINFORMATIONProfitabilityDetails",
      "http://www.agilent.com/role/SEGMENTINFORMATIONReconciliationofReportableResultsDetails",
      "http://www.agilent.com/role/SEGMENTINFORMATIONSegmentAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingInformationProfitLossAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting Information, Profit (Loss) [Abstract]",
        "terseLabel": "Segment Reporting Information"
       }
      }
     },
     "localname": "SegmentReportingInformationProfitLossAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/SEGMENTINFORMATIONProfitabilityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r93"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFOPERATIONSUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "verboseLabel": "Selling, general and administrative"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFOPERATIONSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpensesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing selling, general and administrative expense.",
        "label": "Selling, General and Administrative Expenses [Member]",
        "terseLabel": "Selling, General and Administrative"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpensesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/SHAREBASEDCOMPENSATIONAllocatedSharebasedcompensationexpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ServiceOtherMember": {
     "auth_ref": [
      "r366"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assistance, including, but not limited to, technology, license and maintenance, license and service, maintenance, oil and gas, financial service, and other financial service, classified as other.",
        "label": "Service, Other [Member]",
        "terseLabel": "Service and Other"
       }
      }
     },
     "localname": "ServiceOtherMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFOPERATIONSUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r107"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "terseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Payment Arrangement, Noncash Expense [Abstract]",
        "terseLabel": "Share-based Payment Arrangement, Noncash Expense [Abstract]"
       }
      }
     },
     "localname": "ShareBasedCompensationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r472"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period",
        "terseLabel": "Vesting Period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/SHAREBASEDCOMPENSATIONTextDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate": {
     "auth_ref": [
      "r485"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discount rate from fair value on purchase date that participants pay for shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Discount from Market Price, Purchase Date",
        "terseLabel": "ESPP plan purchase price (in hundredths)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/SHAREBASEDCOMPENSATIONTextDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions": {
     "auth_ref": [
      "r481"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restrictions on equity-based instruments during the vesting period, such as the inability to transfer unvested awards, are not taken into account in estimating the fair value of the award. However, restrictions that remain in effect after an award is vested, such as the inability to transfer or hedge vested options or a prohibition on the sale of outstanding vested shares (or other type of equity) for a period of time, affect the estimate of an award's fair value.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Discount for Postvesting Restrictions",
        "terseLabel": "Post-vest holding restriction discount for all executive awards"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/SHAREBASEDCOMPENSATIONFairValueAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "auth_ref": [
      "r479"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "terseLabel": "Dividend yield"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/SHAREBASEDCOMPENSATIONFairValueAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "auth_ref": [
      "r478"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
        "terseLabel": "Volatility of Agilent shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/SHAREBASEDCOMPENSATIONFairValueAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "auth_ref": [
      "r480"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "terseLabel": "Weighted average risk-free interest rate"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/SHAREBASEDCOMPENSATIONFairValueAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate": {
     "auth_ref": [
      "r478"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rate of weighted-average expected volatility for award under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate",
        "terseLabel": "Weighted average volatility"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/SHAREBASEDCOMPENSATIONFairValueAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/SHAREBASEDCOMPENSATIONFairValueAssumptionsDetails",
      "http://www.agilent.com/role/SHAREBASEDCOMPENSATIONTextDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r468",
      "r474"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/SHAREBASEDCOMPENSATIONAllocatedSharebasedcompensationexpenseDetails",
      "http://www.agilent.com/role/SHAREBASEDCOMPENSATIONFairValueAssumptionsDetails",
      "http://www.agilent.com/role/SHAREBASEDCOMPENSATIONTextDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareRepurchaseProgramAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by share repurchase program.",
        "label": "Share Repurchase Program [Axis]",
        "terseLabel": "Share Repurchase Program [Axis]"
       }
      }
     },
     "localname": "ShareRepurchaseProgramAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYStockRepurchaseProgramDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareRepurchaseProgramDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the share repurchase program.",
        "label": "Share Repurchase Program [Domain]",
        "terseLabel": "Share Repurchase Program [Domain]"
       }
      }
     },
     "localname": "ShareRepurchaseProgramDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYStockRepurchaseProgramDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage": {
     "auth_ref": [
      "r472"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of vesting of award under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage",
        "terseLabel": "Vesting percentage"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/SHAREBASEDCOMPENSATIONTextDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1": {
     "auth_ref": [
      "r483"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost expensed and capitalized for award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount",
        "terseLabel": "Share-based compensation capitalized in inventory"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/SHAREBASEDCOMPENSATIONTextDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "auth_ref": [
      "r473"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period",
        "terseLabel": "Maximum contractual term, Expiration Period"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/SHAREBASEDCOMPENSATIONTextDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r477",
      "r496"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term",
        "terseLabel": "Expected Life"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/SHAREBASEDCOMPENSATIONFairValueAssumptionsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchase price of common stock expressed as a percentage of its fair value.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent",
        "terseLabel": "Exercise Price of Common Stock, Percent of FMV"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/SHAREBASEDCOMPENSATIONTextDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_SharesIssued": {
     "auth_ref": [
      "r336"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.",
        "label": "Shares, Issued",
        "periodEndLabel": "Ending Balance (in Shares)",
        "periodStartLabel": "Beginning Balance (in Shares)"
       }
      }
     },
     "localname": "SharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShortMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates the sale of a borrowed security or written option.",
        "label": "Short [Member]",
        "terseLabel": "Sell"
       }
      }
     },
     "localname": "ShortMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESForeignExchangeForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShortTermBorrowingsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Short-term Debt [Abstract]",
        "terseLabel": "Short-term Debt [Abstract]"
       }
      }
     },
     "localname": "ShortTermBorrowingsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShortTermDebtLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Short-term Debt [Line Items]",
        "terseLabel": "Short-term Debt"
       }
      }
     },
     "localname": "ShortTermDebtLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/SHORTTERMDEBTCreditFacilityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShortTermDebtTerms": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of the short-term debt arrangement, and disclosures pertaining to the underlying arrangements, including repayment terms, interest rates, restrictions on assets and activities, debt covenants, and other matters important to users of the financial statements.",
        "label": "Short-term Debt, Terms",
        "terseLabel": "Credit faciity terms (in years)"
       }
      }
     },
     "localname": "ShortTermDebtTerms",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/SHORTTERMDEBTCreditFacilityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShortTermDebtTextBlock": {
     "auth_ref": [
      "r321"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for short-term debt.",
        "label": "Short-term Debt [Text Block]",
        "terseLabel": "SHORT-TERM DEBT"
       }
      }
     },
     "localname": "ShortTermDebtTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/SHORTTERMDEBTNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ShortTermDebtTypeAxis": {
     "auth_ref": [
      "r43"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of short-term debt arrangement.",
        "label": "Short-term Debt, Type [Axis]",
        "terseLabel": "Short-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "ShortTermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/SHORTTERMDEBTCreditFacilityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShortTermDebtTypeDomain": {
     "auth_ref": [
      "r40"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of short-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing.",
        "label": "Short-term Debt, Type [Domain]",
        "terseLabel": "Short-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "ShortTermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/SHORTTERMDEBTCreditFacilityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShortTermDebtWeightedAverageInterestRate": {
     "auth_ref": [
      "r41"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average interest rate of short-term debt outstanding calculated at point in time.",
        "label": "Short-term Debt, Weighted Average Interest Rate, at Point in Time",
        "terseLabel": "Weighted Average Interest Rate, at Point in Time"
       }
      }
     },
     "localname": "ShortTermDebtWeightedAverageInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/SHORTTERMDEBTCreditFacilityDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_StandardProductWarrantyAccrual": {
     "auth_ref": [
      "r281"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount as of the balance sheet date of the aggregate standard product warranty liability. Does not include the balance for the extended product warranty liability.",
        "label": "Standard Product Warranty Accrual",
        "periodEndLabel": "Ending balance at end of period",
        "periodStartLabel": "Beginning balance"
       }
      }
     },
     "localname": "StandardProductWarrantyAccrual",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/WARRANTIESANDCONTINGENCIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StandardProductWarrantyAccrualCurrent": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount as of the balance sheet date of the aggregate standard product warranty liability that is expected to be paid within one year or the normal operating cycle, if longer. Does not include the balance for the extended product warranty liability.",
        "label": "Standard Product Warranty Accrual, Current",
        "terseLabel": "Accruals for warranties due within one year"
       }
      }
     },
     "localname": "StandardProductWarrantyAccrualCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/WARRANTIESANDCONTINGENCIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StandardProductWarrantyAccrualNoncurrent": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount as of the balance sheet date of the aggregate standard product warranty liability that is expected to be paid after one year or beyond the normal operating cycle, if longer. Does not include the balance for the extended product warranty liability.",
        "label": "Standard Product Warranty Accrual, Noncurrent",
        "terseLabel": "Accrual for warranties due after one year"
       }
      }
     },
     "localname": "StandardProductWarrantyAccrualNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/WARRANTIESANDCONTINGENCIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StandardProductWarrantyAccrualPayments": {
     "auth_ref": [
      "r279"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in the standard product warranty accrual from payments made in cash or in kind to satisfy claims under the terms of the standard product warranty. Excludes extended product warranties.",
        "label": "Standard Product Warranty Accrual, Decrease for Payments",
        "negatedTerseLabel": "Settlements made during the period"
       }
      }
     },
     "localname": "StandardProductWarrantyAccrualPayments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/WARRANTIESANDCONTINGENCIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StandardProductWarrantyAccrualWarrantiesIssued": {
     "auth_ref": [
      "r280"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in the standard product warranty accrual from warranties issued. Excludes extended product warranties.",
        "label": "Standard Product Warranty Accrual, Increase for Warranties Issued",
        "terseLabel": "Accruals for warranties including change in estimate"
       }
      }
     },
     "localname": "StandardProductWarrantyAccrualWarrantiesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/WARRANTIESANDCONTINGENCIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StandardProductWarrantyDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Standard Product Warranty Disclosure [Abstract]",
        "terseLabel": "Standard Product Warranty Disclosure"
       }
      }
     },
     "localname": "StandardProductWarrantyDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/WARRANTIESANDCONTINGENCIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r6",
      "r180",
      "r184",
      "r185",
      "r186",
      "r187",
      "r188",
      "r189",
      "r190",
      "r191",
      "r192",
      "r193",
      "r194",
      "r195",
      "r198",
      "r199",
      "r200",
      "r201",
      "r203",
      "r204",
      "r205",
      "r206",
      "r207",
      "r209",
      "r215",
      "r247",
      "r269",
      "r271",
      "r272",
      "r730"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDisclosuresandComponentsofPurchasedOtherIntangiblesDetails",
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSGoodwillRollforwardDetails",
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTextualsDetails",
      "http://www.agilent.com/role/REVENUERevenuebyRegionDetails",
      "http://www.agilent.com/role/SEGMENTINFORMATIONProfitabilityDetails",
      "http://www.agilent.com/role/SEGMENTINFORMATIONReconciliationofReportableResultsDetails",
      "http://www.agilent.com/role/SEGMENTINFORMATIONSegmentAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r23",
      "r24",
      "r25",
      "r115",
      "r118",
      "r150",
      "r154",
      "r155",
      "r157",
      "r159",
      "r169",
      "r170",
      "r171",
      "r229",
      "r285",
      "r289",
      "r290",
      "r291",
      "r294",
      "r295",
      "r322",
      "r323",
      "r326",
      "r330",
      "r336",
      "r626",
      "r768"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited",
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r2",
      "r52",
      "r80",
      "r81",
      "r82",
      "r124",
      "r125",
      "r126",
      "r130",
      "r141",
      "r144",
      "r168",
      "r233",
      "r336",
      "r341",
      "r491",
      "r492",
      "r493",
      "r515",
      "r516",
      "r606",
      "r643",
      "r644",
      "r645",
      "r646",
      "r647",
      "r650",
      "r737",
      "r738",
      "r739",
      "r774"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFEQUITY",
      "http://www.agilent.com/role/DERIVATIVESEffectofderivativeinstrumentsonConsolidatedStatementofOperationsDetails",
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYAccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement Line Items"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited",
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited",
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOMELOSSUnauditedParenthetical",
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOMEUnaudited",
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFEQUITY",
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFOPERATIONSUnaudited",
      "http://www.agilent.com/role/REVENUERevenuebyEndMarketsDetails",
      "http://www.agilent.com/role/REVENUERevenuebyRegionDetails",
      "http://www.agilent.com/role/REVENUERevenuebyTypeDetails",
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYAccumulatedOtherComprehensiveIncomeDetails",
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOperatingActivitiesSegmentAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by continuing and discontinuing operations.",
        "label": "Operating Activities [Axis]",
        "terseLabel": "Operating Activities [Axis]"
       }
      }
     },
     "localname": "StatementOperatingActivitiesSegmentAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSComponentsofnetperiodiccostsDetails",
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYAccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r124",
      "r125",
      "r126",
      "r168",
      "r682"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited",
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited",
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOMELOSSUnauditedParenthetical",
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOMEUnaudited",
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFEQUITY",
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFOPERATIONSUnaudited",
      "http://www.agilent.com/role/REVENUERevenuebyEndMarketsDetails",
      "http://www.agilent.com/role/REVENUERevenuebyRegionDetails",
      "http://www.agilent.com/role/REVENUERevenuebyTypeDetails",
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYAccumulatedOtherComprehensiveIncomeDetails",
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": {
     "auth_ref": [
      "r24",
      "r25",
      "r336",
      "r341"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture",
        "terseLabel": "Share-based awards issued, net of tax (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "auth_ref": [
      "r24",
      "r25",
      "r341",
      "r470",
      "r475"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture",
        "terseLabel": "Share-based awards issued"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramAuthorizedAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Authorized Amount",
        "terseLabel": "Share repurchase program authorized amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramAuthorizedAmount1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYStockRepurchaseProgramDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount remaining of a stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Remaining Authorized Repurchase Amount",
        "terseLabel": "Remaining authorized repurchase amount under share repurchase program"
       }
      }
     },
     "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYStockRepurchaseProgramDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchasedAndRetiredDuringPeriodShares": {
     "auth_ref": [
      "r24",
      "r25",
      "r336",
      "r341"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased and retired during the period.",
        "label": "Stock Repurchased and Retired During Period, Shares",
        "negatedTerseLabel": "Stock Repurchased and Retired During Period, Shares",
        "terseLabel": "Shares repurchased and retired during period, (Shares)"
       }
      }
     },
     "localname": "StockRepurchasedAndRetiredDuringPeriodShares",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFEQUITY",
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATESTATEMENTOFEQUITYPARENTHETICAL",
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYStockRepurchaseProgramDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockRepurchasedAndRetiredDuringPeriodValue": {
     "auth_ref": [
      "r24",
      "r25",
      "r336",
      "r341"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital).",
        "label": "Stock Repurchased and Retired During Period, Value",
        "negatedTerseLabel": "Stock Repurchased and Retired During Period, Value",
        "terseLabel": "Shares repurchased and retired during period, (Value)"
       }
      }
     },
     "localname": "StockRepurchasedAndRetiredDuringPeriodValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFEQUITY",
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATESTATEMENTOFEQUITYPARENTHETICAL",
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYStockRepurchaseProgramDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r25",
      "r30",
      "r31",
      "r118",
      "r219",
      "r229",
      "r626",
      "r666"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "totalLabel": "Total stockholder's equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "verboseLabel": "Stockholders' equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited",
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnauditedParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r2",
      "r3",
      "r81",
      "r118",
      "r124",
      "r125",
      "r126",
      "r130",
      "r141",
      "r229",
      "r233",
      "r341",
      "r491",
      "r492",
      "r493",
      "r515",
      "r516",
      "r542",
      "r543",
      "r558",
      "r606",
      "r626",
      "r643",
      "r644",
      "r650",
      "r738",
      "r739",
      "r774"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "periodEndLabel": "Ending Balance",
        "periodStartLabel": "Beginning Balance"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]",
        "terseLabel": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Note [Abstract]",
        "terseLabel": "Stockholders' Equity Note [Abstract]"
       }
      }
     },
     "localname": "StockholdersEquityNoteAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r116",
      "r323",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r341",
      "r346"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "STOCKHOLDERS EQUITY"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsegmentsConsolidationItemsAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by subsegments, eliminations and reconciling items used in consolidating a reportable segment and its subsegments.",
        "label": "Subsegments Consolidation Items [Axis]",
        "terseLabel": "Subsegments Consolidation Items [Axis]"
       }
      }
     },
     "localname": "SubsegmentsConsolidationItemsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/SEGMENTINFORMATIONReconciliationofReportableResultsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsegmentsConsolidationItemsDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Subsegments, eliminations and reconciling items used in consolidating a reportable segment and its subsegments.",
        "label": "Subsegments Consolidation Items [Domain]",
        "terseLabel": "Subsegments Consolidation Items [Domain]"
       }
      }
     },
     "localname": "SubsegmentsConsolidationItemsDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/SEGMENTINFORMATIONReconciliationofReportableResultsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r651",
      "r667"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event [Member]"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYDividendsDetails",
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYStockRepurchaseProgramDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r651",
      "r667"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYDividendsDetails",
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYStockRepurchaseProgramDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r651",
      "r667"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYDividendsDetails",
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYStockRepurchaseProgramDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SummaryOfNetInvestmentHedgeActivityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Summary of Net Investment Hedge Activity [Abstract]",
        "terseLabel": "Net Investment Hedge"
       }
      }
     },
     "localname": "SummaryOfNetInvestmentHedgeActivityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESTextDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "Supplemental cash flow information:"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxPeriodAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information about the period subject to enacted tax laws.",
        "label": "Tax Period [Axis]",
        "terseLabel": "Tax Period [Axis]"
       }
      }
     },
     "localname": "TaxPeriodAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxPeriodDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identified tax period.",
        "label": "Tax Period [Domain]",
        "terseLabel": "Tax Period [Domain]"
       }
      }
     },
     "localname": "TaxPeriodDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TrademarksMember": {
     "auth_ref": [
      "r536"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style.",
        "label": "Trademarks [Member]",
        "terseLabel": "Trademark/Tradenames"
       }
      }
     },
     "localname": "TrademarksMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDisclosuresandComponentsofPurchasedOtherIntangiblesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TradingSecurities": {
     "auth_ref": [
      "r701"
     ],
     "calculation": {
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSFairvalueofassetsandliabilitiesmeasuredonarecurringbasisDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in net income (trading) and investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Debt Securities, Trading, and Equity Securities, FV-NI",
        "terseLabel": "Trading securities"
       }
      }
     },
     "localname": "TradingSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSFairvalueofassetsandliabilitiesmeasuredonarecurringbasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease": {
     "auth_ref": [
      "r68",
      "r648"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cumulative translation adjustment, after tax, from translating foreign currency financial statements into the reporting currency.",
        "label": "Translation Adjustment Functional to Reporting Currency, Net of Tax, Period Increase (Decrease)",
        "terseLabel": "Currency Translation and Other Adjustment"
       }
      }
     },
     "localname": "TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/REVENUEContractAssetsandLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TreasuryLockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customized agreement that fixes the yield or price on a specified treasury security for a specific period.",
        "label": "Treasury Lock [Member]",
        "terseLabel": "Treasury Lock [Member]"
       }
      }
     },
     "localname": "TreasuryLockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESTextDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockMember": {
     "auth_ref": [
      "r51",
      "r342"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Treasury Stock [Member]",
        "terseLabel": "Treasury Stock"
       }
      }
     },
     "localname": "TreasuryStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TypeOfAdoptionMember": {
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r129",
      "r130",
      "r131",
      "r133",
      "r145",
      "r220",
      "r221",
      "r230",
      "r231",
      "r232",
      "r233",
      "r236",
      "r237",
      "r284",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r495",
      "r513",
      "r514",
      "r515",
      "r516",
      "r597",
      "r598",
      "r599",
      "r600",
      "r601",
      "r602",
      "r603",
      "r605",
      "r606",
      "r607",
      "r608",
      "r627",
      "r628",
      "r629",
      "r630",
      "r631",
      "r632",
      "r636",
      "r637",
      "r661",
      "r684",
      "r685",
      "r686",
      "r735",
      "r736",
      "r737",
      "r738",
      "r739",
      "r740",
      "r741",
      "r742",
      "r743",
      "r744",
      "r745",
      "r746",
      "r770",
      "r771",
      "r772",
      "r773",
      "r774"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amendment to accounting standards.",
        "label": "Accounting Standards Update [Domain]",
        "terseLabel": "Accounting Standards Update [Domain]"
       }
      }
     },
     "localname": "TypeOfAdoptionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFEQUITY",
      "http://www.agilent.com/role/LONGTERMDEBTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations": {
     "auth_ref": [
      "r508"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.",
        "label": "Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations",
        "terseLabel": "Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r172",
      "r173",
      "r174",
      "r175",
      "r176",
      "r177",
      "r178"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_VariableInterestEntityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Variable Interest Entity [Line Items]",
        "terseLabel": "Variable Interest Entity [Line Items]"
       }
      }
     },
     "localname": "VariableInterestEntityLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableInterestEntityNotPrimaryBeneficiaryDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Variable Interest Entity, Not Primary Beneficiary, Disclosures [Abstract]",
        "terseLabel": "Variable Interest Entity"
       }
      }
     },
     "localname": "VariableInterestEntityNotPrimaryBeneficiaryDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Variable Interest Entities (VIE) in which the entity does not have a controlling financial interest (as defined) and of which it is therefore not the primary beneficiary. VIEs of which the entity is not the primary beneficiary because it does not have the power to direct the activities of the VIE that most significantly impact the VIE's economic performance and for which it does not have the obligation to absorb losses of the VIE that could potentially be significant to the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE are not included in the consolidated financial statements of the entity.",
        "label": "Variable Interest Entity, Not Primary Beneficiary [Member]",
        "terseLabel": "Variable Interest Entity, Not Primary Beneficiary [Member]"
       }
      }
     },
     "localname": "VariableInterestEntityNotPrimaryBeneficiaryMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r149",
      "r159"
     ],
     "calculation": {
      "http://www.agilent.com/role/NETINCOMEPERSHAREDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "totalLabel": "Diluted weighted average shares",
        "verboseLabel": "Diluted"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFOPERATIONSUnaudited",
      "http://www.agilent.com/role/NETINCOMEPERSHAREDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]",
        "terseLabel": "Weighted average shares used in computing net income per share:"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFOPERATIONSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r148",
      "r159"
     ],
     "calculation": {
      "http://www.agilent.com/role/NETINCOMEPERSHAREDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Basic weighted-average shares",
        "verboseLabel": "Basic"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFOPERATIONSUnaudited",
      "http://www.agilent.com/role/NETINCOMEPERSHAREDetails"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 5
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3444-108585"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4273-108586"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4297-108586"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4304-108586"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=SL98516268-108586"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=SL124452830-107794"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=122038215&loc=SL108384541-122693"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "250",
   "URI": "http://asc.fasb.org/topic&trid=2122394"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1505-109256"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1707-109256"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1757-109256"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1500-109256"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1278-109256"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2626-109256"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e3842-109258"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e4984-109258"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "http://asc.fasb.org/topic&trid=2144383"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "270",
   "URI": "http://asc.fasb.org/extlink&oid=124437754&loc=d3e725-108305"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "270",
   "URI": "http://asc.fasb.org/extlink&oid=124437754&loc=d3e765-108305"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "http://asc.fasb.org/topic&trid=2134479"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8657-108599"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8672-108599"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8844-108599"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8981-108599"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "http://asc.fasb.org/topic&trid=2134510"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(24))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(d)(1)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(d)(2)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=124260329&loc=SL6284422-111562"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583714&loc=SL75117360-209713"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117546-209714"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4542-108314"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "http://asc.fasb.org/topic&trid=2126998"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13777-109266"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "http://asc.fasb.org/topic&trid=2144416"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=123351718&loc=d3e2611-110228"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=123351718&loc=d3e2420-110228"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2921-110230"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2921-110230"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "((c)(2))",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=123368208&loc=d3e12565-110249"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "((c)(3))",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=123368208&loc=d3e12565-110249"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1),(c)(5)",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=123368208&loc=d3e12565-110249"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=123368208&loc=d3e12565-110249"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=99376301&loc=SL5988623-112600"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S65",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359872&loc=SL124427846-239511"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123467658&loc=d3e12317-112629"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123467658&loc=d3e12355-112629"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(5))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496180-112644"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21521-112644"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21538-112644"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23309-112656"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "http://asc.fasb.org/topic&trid=2208762"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130531-203044"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130532-203044"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130533-203044"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130551-203045"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130551-203045"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130556-203045"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130556-203045"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130556-203045"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130558-203045"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130543-203045"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130549-203045"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130549-203045"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130550-203045"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123338486&loc=SL49131195-203048"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123338486&loc=SL49131195-203048"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(i)(2)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123338486&loc=SL49131195-203048"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123338486&loc=SL49131195-203048"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "http://asc.fasb.org/topic&trid=49130388"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "712",
   "URI": "http://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "712",
   "URI": "http://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123453770&loc=d3e1703-114919"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123453770&loc=d3e1731-114919"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123453770&loc=SL108413299-114919"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123453770&loc=SL108413299-114919"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.12)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(10)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(8)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(9)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(8)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(j)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(l)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(o)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(p)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(q)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2410-114920"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2439-114920"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2919-114920"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4587-114921"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=21916913&loc=d3e273930-122802"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=6414203&loc=d3e39689-114964"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "70",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=29639808&loc=d3e29008-114946"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450691-114947"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "715",
   "URI": "http://asc.fasb.org/topic&trid=2235017"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=123468992&loc=d3e4534-113899"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11149-113907"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11178-113907"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "740",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120384911&loc=d3e23163-113944"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "http://asc.fasb.org/topic&trid=2228938"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(4)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e39076-109324"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123586518&loc=d3e961-128460"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123586518&loc=d3e1043-128460"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "38",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5504-128473"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a)(3),(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(3)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e7008-128479"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4568447-111683"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4568740-111683"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569616-111683"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2AA",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "a",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=SL6759068-111685"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5728-111685"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5728-111685"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=SL6759159-111685"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=SL6759159-111685"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5747-111685"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=SL6228884-111685"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.8)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "http://asc.fasb.org/topic&trid=2197479"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(ii)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(iii)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4CCC",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL109998896-113959"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624181-113959"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624258-113959"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41641-113959"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41678-113959"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "182",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123421605&loc=SL5629052-113961"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121577181&loc=SL110061190-113977"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121558989&loc=d3e80720-113993"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121549185&loc=d3e80748-113994"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121549185&loc=d3e80784-113994"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123477628&loc=d3e90205-114008"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226000-175313"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "815",
   "URI": "http://asc.fasb.org/topic&trid=2229140"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(b),(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19279-110258"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=SL6742756-110258"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "60",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594786&loc=SL75136599-209740"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13279-108611"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL120254526-165497"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL120254526-165497"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a-c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL122642865-165497"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL122642865-165497"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=120253306&loc=d3e28129-110885"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123602790&loc=d3e30304-110892"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=125521441&loc=d3e30755-110894"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32022-110900"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32262-110900"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901"
  },
  "r652": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r653": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399"
  },
  "r654": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399"
  },
  "r655": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399"
  },
  "r656": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629"
  },
  "r657": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r658": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r659": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r660": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918666-209980"
  },
  "r661": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848",
   "URI": "http://asc.fasb.org/extlink&oid=122150657&loc=SL122150809-237846"
  },
  "r662": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "848",
   "URI": "http://asc.fasb.org/extlink&oid=122150657&loc=SL122150809-237846"
  },
  "r663": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124437977&loc=d3e55792-112764"
  },
  "r664": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r665": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r666": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r667": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r668": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662"
  },
  "r669": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r670": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r671": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r672": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r673": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r674": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r675": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r676": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r677": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r678": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=SL51823488-111719"
  },
  "r679": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e637-108580"
  },
  "r680": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "912",
   "URI": "http://asc.fasb.org/extlink&oid=123371682&loc=d3e55415-109406"
  },
  "r681": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "http://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433"
  },
  "r682": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r683": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r684": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r685": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r686": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r687": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(f)(1)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r688": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(f)(2)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r689": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(f)(3)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e640-108580"
  },
  "r690": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r691": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "http://asc.fasb.org/extlink&oid=123384075&loc=d3e41242-110953"
  },
  "r692": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r693": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r694": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r695": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r696": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r697": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r698": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.14)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r699": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.15(5))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e681-108580"
  },
  "r700": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r701": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.4)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r702": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r703": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r704": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r705": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(24))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r706": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r707": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r708": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r709": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669686-108580"
  },
  "r710": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r711": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r712": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r713": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r714": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r715": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r716": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r717": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r718": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r719": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e689-108580"
  },
  "r720": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r721": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.15(a))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r722": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r723": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r724": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(20))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r725": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r726": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r727": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(3)(d))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r728": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r729": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL34724391-108580"
  },
  "r730": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r731": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
  },
  "r732": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r733": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r734": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441"
  },
  "r735": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r736": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r737": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r738": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r739": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r740": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r741": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r742": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r743": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r744": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r745": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r746": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r747": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r748": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629"
  },
  "r749": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r750": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r751": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r752": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r753": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r754": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r755": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r756": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r757": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r758": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 4))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r759": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 5))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r760": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
  },
  "r761": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691"
  },
  "r762": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r763": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r764": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r765": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r766": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r767": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r768": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402"
  },
  "r769": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r770": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848"
  },
  "r771": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "848"
  },
  "r772": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "848"
  },
  "r773": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Topic": "848"
  },
  "r774": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848"
  },
  "r775": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "848"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e557-108580"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "http://asc.fasb.org/topic&trid=2122149"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(22))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(b))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>94
<FILENAME>0001090872-22-000007-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001090872-22-000007-xbrl.zip
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MPD<8#%*SO<NV,F'KM?GLTUWBMW].</9O4$L#!!0    ( $6(8U0F)%OI:P@
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M89Q>.KO1RO(*R/7<F UK7W#^C5:WGAK.AVN@>/WJJ%$_/-$%D@O61R%1AJ'
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MO&47/L)@D)O[NSS@4N+:I[NN;2^.G_T/4$L#!!0    ( $6(8U1U09!0UP0
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MO4[XDJOG1]Z).VCYMK>/^A'QMN_%6P%]",@(LX#)QT$YGL[#L]=GXU%X-KO
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M=4TK)"MU$)M:3-(4<!H"("F&N"PPJF73S(IY3O)(?T>%U'30IMS@J'5:Y8#
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MB&2]3$M/M\.H[VG0*";BP23ABL9\$H5G^9?A N6_0YE]A3(WI**-V8LD&9K
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MQBV>W&S]W_E=TC;9Y#6X+"V SF*$E'30D4EDWE^RVFH(R4U6^SGNW\=J;_2
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M9YFA9*@.NWG\C8#L4 Z*VH6$CFMF[V=G.]S9W9]';>>4R0* B0PYF!P4E>K
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M"=""=LQ @* DF:@<[E& :)0G$\$9I.2,M#Y57X"^;YCV11O]Y=8A"ZOSPZF
M D6T$"-* ;Q,I9)TZ!,GYIRC&KBM*@G-@GC-8&HU%'E-@J7L+6T9J94<@Y9E
M9@JBJ$$RZUQ(\(+Y_7CVH>?64U JH 5(T263A$FD@_'6RAJ,%U1)@A?4<P;4
MDPR7+$? WN;@EY?-NYW4I2R*$2K4(;UEYA)\M:A\-?SGK#UL?WH^EHUK^YVS
M<59UNS^<[-.PV0L+W9D+W=$^D2R#Q4GGN#]:ZSTWBBPZQISA-6#@%12@[YZ
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M=%8Z+P"YD(ZJ/ ;Y%V@___/E_:.]H(7U\YM5T3H-SFBN(Y/&@DH!66!E(CJ
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M<NM50L&)\A^;!*\1Y5G(T0PY3M22 _/@I.. SJ$.AC-KD]&V[#P_7_;HB^&
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M-W(HF5\D4GMEO1_&R<QE/[REJ^33UQ=^O?_^A=AY?R"WSN+)QOO#Y^YDNWL
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M;/'_G[VO;4IKV;K]*Y3GU'WVKDIG]_O+WN=29=3DN"M"$LG.-5]2_1HQ"#Z
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MK:7.1L0*E"YUQK/FU6C.1/+<_FG&9/Y\"'_N3VD>BIR@T%E@7%" .NV 9,R
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MD2N6X"S*7%$9KI@4:!8;X2!-&:DUH 81H((V@"@GO<;($\$35Y15\SF'!Y4
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M#OMOIZB^#+NY83?I9V14,NZMCW"A!%". QB5S0B*>>2,]>E\6)5.A^5#GK-
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M5PF>91K_!#['59<"XPQ,BTN!G-ZNM&V'GSDH^R?+(:CF=' "M8(@$1" W%%
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M4*H^[<76718OY)PJCV9+W!R'^'O'IU^VNV[[QG#D!7^>!;\]96($Q@.GB(/
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M1BL5G$<P4PD2PQL(J5<2;M6%S!&#U7"LE:(M-\,>SZ*BLCPTO5O/A3(XVMT
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MEYW&[HOCYJO8"ZU_3INM?\)UGK9#>'FPN_>]L?U)2"LE9!0(QR2@D#D@I4#
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MJ!/(.8JI$$H;S*BD4F#F&;;\;FZ][YAZ)MG')MGFA(+5VC,' P1<&AX5K%9
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MNV2"N^ U(<PC+31%7." +.<2V:@YBS%JC=FC4-PG8($_OOPD=4:96YG=WS8
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M,><"EJY9TW[&6#-]>:S9_8>-K5JTS(4A3-63C5ZJYJ*#*E3]\F*R;?_KC0S
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M-XXJ6;(1$4ZE-%8I;4BBU);B'2TNK1XN+1::LR0*&WQ"7G&,N !<LB%R)%@
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MEKELJN86@QX[RKE1.CIE<*2M(J^>(B]%*03)J(I!("M=CE(0"EE*%'(J8>6
M7B?.P$9N?5U/6)%]L!@,8J-#SEP.@B "(+KUQ$O#;."M(J^B(B_LZJ<<4(2C
M1]$$@SCW&)DH"%)2.XZIXHJ%;"0O%V)O-?G):#*/5AHN;03LYL$1PRT5"3OL
M5# RBE:35U"3%[?!9=0^<=!D87*1=*<Y,EHQ1(55D<GHHU!@)7_[28M[U.2?
M+1/)J&NKOZSOIJZ_TV;X3>.-'C4: 189+ @P">^XDU9'0KDAGC/L9"2B==FM
M&AJ=+:?O<)A+830*-!]'U50B:[1'),K$A6-@\P&MX/@)'OMJ%7EZKEQ8RT!1
M@4@2+K-5H(QP7O# \Q9,NQF^@HJ\N!FN*:BM)![94(+K)$;:8(^<QM(:H(M$
MY'P7] F>DVH5>;J)EGQ@$117>L83MIHP;;A.EEI.%&X5>045>7$WG)K O9$"
MZ>@DXA8S9"@'&X%94/&4'+9D[;GX9CN_U>/5U6/K0G0&AV"L@"78&NJU%\QS
MXQ/1UK9ZO'IZO+P9CCT-7B$'0HPXB\"L P&-]B1B0:VW&!9DH66KR$]7D1V0
M,L^3),$9'G$ ^\IXBID 8]EBVV8@6$%%7MP,%T$)Y9U!3 8PD2D6R! >P6+.
M9[4E94S)M>?,M,SZ"2NR]S8?ZZ8L)9X3&VGNF!8A"IR\DZ(]&;N"BKRT&0Z4
M2BF2_5P$"#7WB@/)#A(Y+Q4P;J>%HV CDU4Z@-9J\GW;R,(D360R)H%1S*)3
MR4GG8\)>$T/:HZ0KJ<D+N^%@%#GC?-[^3J#)7$;D%"S1AJ8HK7+6&K;VG#_!
M(^ZM(D^-9"%A-59!844X]<0%8J7G@N,4=6RSZ*RD(B]MAL,B;#D5*."<ICFH
MB+*S$@7GF6686.=</A.^2E;R?9X))W2#KOIN^(6%"Z_K[/G27PRZ&P8GKA=O
M7]CQJ27JN/\!>C*0+H, #B89Q8EQ+8VE8&DSAC40=\]5>[Q^U2!][\521 $
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M8>J*Z[4ZPRH5X[CN;_/1**\M?K&9Y=.FS&]-MQA9K[)WH[1KSX\'+@[/?4,
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M?PSSUCK9: :G=0Z\X\&H6W)SEZ,WW<^QB7!LEKFY&QNLPK-;K"M'\2Z_Y:)
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M.C3Y2=*9S]=T0O0SW>UGQ6;BK>X56!T&S69.,#T$_Z'CNMA51N<U[VO?]G8
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M&7->> PLA190%>(*P(( R+US5B(A.'YU?V*Y IYQ!01(F%4$ VR< %00"(S
M!G#'K5-1EIU!Y0I8ZQ5@G++2",!XJLC%.0<:L^1$1C1@C;14:F.KW;F?_OG^
M#_J)PC5J5KKYQ!+ROU#YGD:4RO#K$Z6*%R!*W6O_C$/7Z5XN725I5!E1HK<.
M<*W^Y?3P^U=ZN'.$:E$.#DY.X[O=R6']E%1W*JBZ<T2KK:^7DW)P>'+ JA^_
M- _KQZ>UG:^LNO.E4:L?759QM5FKVRA/7V%MYP@?UO\.M9V#'SA0RXPE@!$9
MA2!$;%#,>B"XL,A(*SR#DPRD6#.LN,48>4FMQ,I'S%,*$FN=D4I,44B^% 7H
M]=R^'W2[\;=EXOQ\A=G=_0%-"-)Z"Z 4)BJZ&@+)X^SB((Q/J>B>Z,G9I48H
M8R0.FC'*-3-.>X4451QYR/ 4#>Y>]5NTV6M?#J:Y;^?FPKUW9=UQW[UMOML!
MC3>7^[QI&=IY+5>9SNNIW&V4UVR_8WQWH@Y2?A:4'\P,SQZNJ5KOH4:=U?E[
M7"RO3%6JU*: XC%,I8)N(J06SOZ)X"9_)*GH?52E9/&-19L8R0<]]LWPK#VH
M3\M'I39.H9D$]H%,B0LD0URIX1H"Y_APW>8_?#/KO>057$LBB0^-=J,7%?7L
MJ--Q4Z'13TXS6;K^/IP=:%875S3.<IH=R',99#"<*J(IU4IJ1T/@ECM(-#3F
MQ]Y#T^&&*NAH'7U,RVA90B@?:]P-0R@_G-:^[\5G?B4')X<GE9//\1G-XX.3
M/790__NT@O>N*CO'S>K5-ID,H3SX_ID=G&Q?5.NN46U5+JL[!ZSV_4.C<M(\
MKK0^7QV<5,YK'[^2RHX+E<94&+;'*%I;,  !HU5(J8- *PP!-1 )RGBT_L/&
M%GTZ.]#R);F5B+.FB,.)@A(*C* 3U/*@K/94<:\QPE@SG2,.0K!$G)= G,F@
M;>Q4W!",!X@9 FAR-1KM,4 4243CQF"AC(C#ERG[;D%9;4L-'O\,XTI=7OUN
M6&Q1FVZ*_4W1P[V>;YEFH^1/>D%5YWNG>[K7_B>% O=ZVVWW19]7AJ=()0[-
MA4/37$D$$6*%\, &+0"5R (#N0.$<X2M@UAXO+%%5,F5M,82NW!5H938Q4GL
M5+J7TDH02H!GU 'J@P7*" F"@))@XAP+*664BR62V+?@V+E>_/.J9L^<GKIT
M S6W?;;  5H;R%ZXDE7U_1*9YT#FZ@RB).6%YB& ."L1F2G"0 I+ 7+66"DP
M-R':=%(\.1%WX7*QY#ZH$B%+A'Q]I;9$R+D1<E)W)5Q2SCB.NJM*S+Q8 Z6A
M!41*9K -.$ 1$9+ M4'(.R@ ;B='SDR77$@P*WO]8%;Y L&LR25]WF@VHZFY
MU^[K]E$CCO=VK^?[O>4+;ZV.PKQ/]M#A]V\GU:L*CO)R7#WY3"KU"JO@SZS2
M^M8XK!_A@U8*9/S0G R C.UKQC:1RM7!>17OXNJ.O:A<G5X=[IS&:_YNUG8.
MX_V?:>7[MQ _QY7S'Q8'ZA&! "-O <7< @UA -@0SC1%$BHR&0/I-&,A0$,1
MI]0BJI2ET%@AK$1:T*D(UX^UVL[WO4^?LNWJ3E:K_WOW2[97K6]7/^[]]6DW
MV][?WZWO/R(<\OYF3 3F6@.9,#8@Q:E7R&@A&(;>>8\E"O3.Y-;E*S[^4B'#
M(PEZRT)2V_[A>#".* .,95%(0F#)N<(!=IXA S5BA$R%=:]*;FI]/.(T*^)!
MS[J^E[@T\W"4M  RHYNZG>@91MPCK<[/@F^S(/W0]GA$'=#U9YWN,*[4'Q77
MN$$W?_H<::SW!+\NJVC>&6S[Y\QFKTK\+8.;#.&%A[2J3<K$ZH3?0K$RL<(K
M%=B<&ONPQ?5F CU7-+#Y4R/X;-\V_/5FL9TXLB+(5W*6F;M/R,LHYYV&/FIW
MXLY@BY'[F%<7L^60W3UDVT>-9FQ4]K[;Z?4^:5,.U9U#5>_T=?-M!LUC5$;-
MK^/AZL@\'2;>C66)9%,9(F50Z_H&M2I* ^72<JX152*5<D-"BF2=^Z"Y?:A3
M?[2>;G-"M <MX#I],+QS:;S]CW2&#+W]7Z\J5X?'M8\5=-CZUDP.C\-6^OOO
M5FP;.< ?3BH[>Z2*=\^GB(GKE:MJ:Y<>7'UKQ?<VJSO'K</T=R*AV'$G!]\K
MYY432P[J?\V*J@\B&(FD!4KJ "@U 1BF$0A..HC2- 6SL87>";I,4:YE7'T)
M0;^"((.#P (ZKZBF7BDM*,+::><=I1J[$H)>$8(F#QP-)M8CP8'"S@$J& $:
M8@:PUD8Z+0VS,D&0XK2$H!*"5@6"$"74,\*((E1#;[PAQ'"+)4=$,S@_!)4H
M,P_*H$F4892AN 8!B9H.H%QQH!4,@$&HK&024P(WMC OTP=+C%D5C%E4^%2I
MYCP# )$I-2=9PXH!X1$'5!L#5* .&(4%"EI)1_S&%GFG!%LB"'H+^80?.MWX
M9SNS.1.;O<SZW?BT(?URHW46)^&-91+^-@\(.2:1X@3#0*CD2F,551\"I8+"
M4O$0,N%>['#\[2Y8JM],QW;;C;(_MZU-C*%Q9+==.L%?JG*CJP%2TZF&F@4>
M6,  ,1^U)!L5)$,I \1IX:A3.@B^L35MA_U>YABN@RQ[2JQB G.D*)5!ZJA+
M<"<9]AKJ@$DIRTLLRU/T!=IP120#GF@*J'<>*,H,\$A[Y9BR!N-9I8-+65X+
M62904TYTM&Q#H 9Q)9 1G$,6=VCJC2IE>8EE>=)[H9FC.B@#,!/1>!"( (EH
MW*&#])Q8XC"QY;Z\OK+\]((=I2R_EBQ/.@*0")H18@!EP4=9-A1H03EP"-*H
M9$ON4D47-,WF\2K"?(\#8/D*NJ[*E6\P)&B,9S>;Q;'[I%3!N_,$WX*#>R%#
ML]P;YAS[9= (1R6)<IP.WS27Q$+LM,4:&ZP%?"CS0ND87_1^6-V?\CE9+836
MC@),D ,420DDY]%B%980I@R#C.0A2.1%2!D>*"Q+?J970F4)E0^"2F>MXL$J
MKSFDR&A#-"186:F)4%JZ$BI?$2HG77H,&H25IT!*C  U"@$3O ;6*4>4T$+[
M8:C4D[D 2Z@LH;*$REM0J:5BGD+$(APFF@/M%44T!!6DU)3X^:&R1,-YT'#2
M*9K03FI+ .9: >IY (;X "PC+ *B8H&[%-*UJ+#1$@M++"RQ<+'<AJ7:^ Q
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M8C*Q,8FH*6@-G%1>,$@<]'9CB["[V)A*UU\IK*5Z_V+B.T5)+I'6ADI@J=6
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M:,N@XYVK*M6*^=FD^FQR"YMJHK%$PA""N <5;454*#G!(X:5M?+%]\M=^C#
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M+N#WZ)&G$1KM5D=#<G#S<[-_]*G=<3"+']:UXD[[9-#O_1UA !X@K%R9_$^
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MV%W*><VU$=9138+%EJ0$MG.<K?6F-R3OKOK&6>;O_&DO[0WZ>6.L5VK$?X-
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M)"B%<,BGHYP0&6\CHD)1(:Q7,I&7W[-V2?V%^_0X>]Q3ZKSL1;8T1:9VCD\
M;,KRLYU4[%S6AG_V*E/=6)73?<Z S"5U]M(8;5XJE"[F5-:W';JW^54*C&VP
M& 5M(N(B:N1,(,BI + 8!',V/F^TK5[<>R^N(ESBA!-2PBC$DU/(X%R>A2;G
MO(GP+7W>+:%Z<>^]N%H8;@T(;0P8(QZ<0)H+@J+601F=>*"^7MP575PC2,3.
M@]#ZQ!%72B-C)8@OH=Q2KZRA(+GMSI2A>H\OBN;%.I7%(L8[SZ3[]O&X_]G5
MQ[:\ZMZU#^Y=:^K>M77OVKIW;:FD'MJ+]AE<S&OX.A^LKHISC)W<+T9']W/K
MKASP*OZI:B+DQG^-3AM=Q+**,I@U!^RO>CFY!_2XZB^?W_Q7IWWX5^Y!6/'!
MOV,KP 0_O=Q$A/M79]C_CG</OW*OI#8J9PXDC[C!%.D 'A8UB6)GHL4I+8_G
M/+&\^YT_<HDML#UBV$OU$L]>8O"%G.'>((Q)@"66'#D<,,),2.>E28:IY7&Q
M:@F>=WDE%EZ"W H>+.+<!Z2E<D@"OB?G<X%R7$OP2B^Q98()[24B5@K$A97(
M&>-1T,)%K@@-5M82O+++"XN1B-0)699UL&0:N108HL0PK*D0.LT7X*Q-K*5:
M7D.Q-T:@F"L3<@!E9&1N$FJ$U)89K&Q86NFM ?HN2QPB)0),:11)A"7V5"$K
MK$82F\0Q94Q95B_Q2B]Q(BXEIRT*$KPE'IU%+MJ$L-::*6HUXPN+93]&/+PL
M,-G*JUX5G^L51X#<I3=?-@KH=*^[)4?/<^OPUUUV_\GC)(O*FYWLXIQSNSJY
M1J4-0*6MF(N.-MLY<^4B$^P2+'*#YW=5BWK@B\WCW/FA1HA)A/@&X]C\BB5/
M-B6-"$ U6.GY3 9X9F"J.TVM,]&9^?SL167XU1SP1!Q@0U+>"XV8,."*1PHF
M?2(,R>")<MA$3,W==,15].Z.->[N7=^Y&QZ CFWW>QR6^[Q8\/*$=&X TJV6
M'+CE<LW'SU1?=)8#?!UKWU(]M.AW 3^K >9.,]>7Y,_0M^?['1>[5ZY46'@Y
M<EMRTXRA3_4@O^L,>F49XWG*<C\CS,X2IKKT]JAX\ [/Z2$,Q,E;AC!XLX@[
M)Y$QC"$OC/%,1.X]S<VY;JCH/F^=]D65JZH98M$,(1H?ODI,N?/9A1:Y6UOR
M'#D:*:*>1T8 :,$YR@R!KV6(-X AO=PA"=19ZVQZNWO5[=0Q+!SEO5RO&"YJ
M:#3;8R7HQW-GYBA!7YFXQZ.MUMRLY_"BAO6P!9B+WH*_D9]Y5C8,O2PY/P+]
M?L=_+YJ]7FZXX,[R#3]R,[3<Y<RVQW7!_P:=JLU5J9W@/A][Z\7^C0W4<B7N
M:\GQ!F90#$<WFD>9K6Q;0)=V54($U&]5OG_8Z&R<6#97 >_UAY5',F>4:S"N
MS/.E,=5:CGI88;]7_%(FTP,MQE3MY3(V,V^5Q?6S19"[H39;MCL:_UG5@S+?
MV ,@JBC8_37WSLGO/#V*[8KJ'0_WK\^1'?1P[ZY$JJ2I\(8D(BS./8-,E"IB
MH@T8M)9Q\U62M2DY?/*L(+Q>%#=V/5M <X&M6/(T<--.N]?O#DK.V&R'?\>0
MFXEN5N7>@2$O^P<M21,!NOMQ"/O'_S3W_MPYV_W\G]:7;X=B=_\#__+Y_=&7
MK6VRM_^?;PVZS0_._VCM?=YFD[#_Y?,./_BV\_/@^!]X]_>?C:VCUL'G]]]W
M]S^)W7QV9O_HV^Z?G\3!?DA[^YL48#]1$FG4.3E49=\J2J2CBRC@1#RF7A,Z
MU.-E5L]F5IY$YRINFEBK$H\FZL@Q=\*!DN DB##9=&!K^^^=?S;W=_[9_CAU
M>&.R\\1T!LWM;[LZNB2#4%X$KEB ^XS!!NP-JIDQSF 9UIY1"&;E#ZZ$\OL<
M2YT2?Y;!S S5@)UP0[O(Z3VQ[<]R^[JJFE3N7UFDUL#W!\.^F!DFFSF'"O"\
MNCS"Y6'KDW:VRUJPD(-N[T*;N&%3NM(E.K'=_NA"M]G[#LJI;:L^=$59A"H>
MGEUHF7 ! _"""QQX,Z828?2GMEOJW'ZV8X9-^@9=&%CIJ0U;?<)$CP [8.9P
M9^<8( ON^ZU3-B[*)F56Q"51 $ER]YG>H-6_Z%H\-LF;J=5;1"N7I>?EI4EE
M>V=[1\7[5N>TR'HAWB,I;>EIO40YTP =9?YD1H!+V+C@_TL)O)"U+./Y/F][
M_5(6AZU?,D+DI4MYZ18A=?F &L#%]6-Z4X94FE5ZXZ6]^Z8XLC]R]*8_,O==
M[)]&L ,[[5@B"?RK]6,4S1Z]9S8LE< :8F[?6UK^^>?_&\!JIK(]X^6,2^+T
MP,.&YU2N [P<'FD!UT#A=IONLBVQ'8 E#Y>KMQT.P*O(WD1I/L/K\BY$+^-<
MMH!C2I73EL&VL(<V#ZY\2OFJUMDXR!7@=73/@.8GG6Y)\ZKU[7J1P_BP4NUQ
M2+VIH>Z$!@"_(E[MIW7MJ@PUT="_NK#-JSF-SD .4?OJU(:SSU[&81M8N"17
MZ5?D+LW@_<. ?PR)"_2_?2A5;[!QCIMJ"W8QA**DV&7SYYG<,&-\H&FJ*'$6
MA;*E67;8NA'<CE[UX]Q]M?@%S-G>KZ KRU!')GZOXYOEK[);-\U'PS>UX,9F
M:E9*_2HMFC=ZJ#U@KC@B]X6,]B[\H7$1'O.Z*B\)9&(G%<U^=EMS[]AA\[-6
M]A!M_Z:?7[3++9]3Q3VKQ:[.5, 0CIHGU6TN4QE-R)8=$6B,KA?=XFX@[<4C
M)XE6_7)T[[ 0YJ]OBC;XSB,2E@#4OQ"6=U>9?YIK $5G\<T-"'*5:>XRIOF6
M]9J9?(YC3GL&HN/FX!BLM68H?KF4Z5_+AG;MH5DU"GWD%^8+([.K\JBK+=(1
MH%0O'U_":4B\"4R>'"N&4[Q$B ?L;XYQP<6@2G@N/V6NC+TY%CX,RB#+F$@,
MV6J"H&,07@:>LK2-=9<'/WXQELB2G\&_^<1]NW@?7;?LCD0QD6^*S<-F*S-4
M_!G]H'_9X7TZ-'Y!WLGL,FIHBCP$!ZZM(TF+2)SU+&'K*-/EMB1P2FZ$.18@
MQY-!$/"M7>SF,Y65Q_4WR,UE8*3,*YMN]MX>')^"%/=B^R(0CE]91&3W? ?O
M?OAJ$I/8Y>)_(9^*-E8@PV5 B?)D=0Z6*+:V44KS="A\Z%>"1V*'YI$%9S/O
MX_X&<AHS</\ #[34=%<]XMZI/1D/+ \-WLN=O'FV6N['2=-;+9=LTQ@.:(5V
M4IZ!@7;/&Q^^6IX3%HQ @1.1&VT39(PFR =*:#Z=:P0P$,/7[Z14JJ;=CB.3
M!^RW-.AG\_N":8"Q+G:M7?9%0GGJ*OM.H#QD 9+<[.20?#_KQ2KH#]<_QA-0
M[X /!1%O2N2ZQ3LI-<!,]Z0Y6QL_Q$&I[.DL"J!\NUFGCPUBN*_7OVXB%9WL
MB#+SRDQR2HKH M.!<Q :+93E)"C-+=5.Q!Q^!IDQA*/A!S%;>.S;$?*67B9,
M9K16M=C,%IL#VCC\"L(25;0<$:X(X*X+2 OJD+6* _["GS'D;80;]A_+[9@K
M-EO_J%GZH196*L5NWCW+9M/<?M6P\7TS>_K#! O ]_/* ;B0R:&Y-=LPG)+*
MBMG!8@:++C^S'%@ES9>/+YV:ZC657S"I,\!A!TUTL4LVVZ2<-W<C,2HTX=;K
M$+E(PNFD630L[Q1@D_1MN1OV[=^C:65[-<\L)ZU<3"N['B.TJ85BME!\/P>A
M,%YZI:A$@GJ/N"4:6:8Q$HE2!6NA@[)K&_Q:F7A :NE+,M4W!X=YRQ@XULPP
MU/O=<D?ZK,C;@./RE*VQ><3&!H)!A22<&QP9>!G7'%N5(DZ!2,E+L\M@361M
M=BU.5!I;FZ>-S:\2"X=Y)$@)&1%W22*MH@&[7?J4S7A8B[4-*A[3[#)W,+MD
M::V8,G0R9E>5(8*KC)C5UH1U5>F,J_=->.O7F4G#]\[2DI/:<4[+B24+FCMR
MC1GA)%DGP5$".<A?@AR0TG(RV&")1A]JRVDQG+_#<LWZ"-K!@8<1"07+B4<'
MEE,"KP-SQ[T2'B>YMB&OJ5HYQOS/8!*9!YM$UZ+WPJPAS&G$GGHP?CPGS@.R
MDYBXR&DW-H3:&GH"1O\@P!IB7L2DC4/@IHG<?$8C%[U P@9%@]2.!C^/-?3(
MR5FON 943A.M:T#5-:!6L)C3XFM W9J1-I'!IDB,%J[0I!/WR3G#B+84?L$)
MJ'.V,C6C&K$_5HQXF&TSCT>Z&.^3KJ]2]DNU17N9^CR6QS*V'0NW'X-..!PE
M8Y<Y<7F3-8"AU<O[C#_BQ>_G37LI=SYG9KY<[(M>G[!R=?P+"0J_6YX$B\=,
MH=E)PXWYG(]_5M::5[]/$72TUQT&95FU_(NS:&_/A+@8<)[!U;2(9AK[\>36
M$QCXG4&_UPS57OWEHO4[+6#'G%8T#+SG:?]6FNQ74B3*7??;"7MM)L5UJ0?S
M;JS/WD\OA:?,(+,Y)E1>K[(5SH9[[>4![CMOM5^_RWY)XOGWU^^)@TNC"?9*
M6M7IEH\_]LT0FI4 MZJ$Z#G5#\A1[.>L!GM9\+$U5O"QS,^J-$!.B&Z/\J>&
M.9;YEDHPX,9A=M.@[4?IFZ-$S&$F=V_@ %B:%A3-P]52Z)22-%)%&9>K*8WE
M:N=@006C(QS//[F:7G14'189WP6]HH*N:)_GR\AZ,QL7WQ0VGS>K,+E,2$H)
M%K+*CYW,A\T -\*W45;6F,8:LD"^X9(#7E#IYE49^QZ(RJ Z&'$-OU4',\#,
M*B79=R. 0&43#J-D,)?,(Q?9E:5$Q&X^5I%%]MB>91MA4!W[SL9E/G98:M?8
M/>Z-N/TBNE9%KSMOBJ/.:39GWA2]&+]?L4I[ W]4#J&7#QNVFOD"\%06^XF7
MYU_9;\!E"> $( 2 (L^MV1^,,DISH#&+5"^V0#V7QR.'Y^EA5  "HPG;_(KA
M4<!2WA+@1J?;6Z]6'\9<)FZ#*07S;/9 TL%H! V61U$> .EV? QE5GF&C^%<
M\K"OD#03<7C \_)9Y5V7$SL;_:2<.4@K &L3QC+VL(L4]BHF/W(< ;B'QMK(
MOJON/P5S\:@\$5/F[%VAX8*$<F4/YVX6[3+K;:18QL1D+"*<*6Q+U 2B'W5:
M8;@X(R')6#Q"NK-B%'4;YD]?Y=E+/^@DEK,?[0+Y3A?L^O*,TSA37M15J,[>
MEN=@2YZ_>I<]K'3H,+%\2DYN4#E9A+OQ?X,<=0>R9W^F"VMU7FJ+-T-'I],-
MEQ;[3"*]R1.YYA7PC-DD6A+^>U:0WB_Q$>A8HM]5/Q5D^MK\JI*Y2B9 &5W0
M:'NC@H/#S%HIYI,F(^.K]!GR<E['KS>>NWBN,AYC>]JQ?]G<>CCFS1'A+DHV
MU!LA,S="SKW8^_"5T80Q\P1A*ASB.GGDJ#+($>J2#21H$=<VKFL.>K$;LG^A
M6VYGO3&SL#J>/X:K1S:4=K3+1Z#ZW>;A8>Q6MO1U?%CCQ<9=FJ-=ERG.0 :=
MC+E2B^.6"B,H<TDR)2F)6HO90GEMIOC[RB]X-W0+II+%7VE">./\^]GNYM<H
M.:/4!F1US&6^G46&.XR(M9&F)(+!!(1-DIGIX%=]V>ESQ^69N1LD91BNN^G\
MR_J=&NU=QTN&8>.CXRS(P(/R1H2<H92"$C1ZJVI>6DBYA2T8\X>OVE-)O4J(
M<BP0QTPC&VA$2EN'+>:4>K^V091Z/%ZZ8\#C(2Q%'$N<*<X8,5P0[PPV7$7,
M</XVA)JE%L-2VV>-#U^#Q5@Z*A$3E )+!8FTQA$%:H1(6 HJ^-K&(S+456:R
M,S> %ED59QX+X%7F7I Z]Z+.O:AS+TIE<&LNQ53U().(#-H2GSAG7+/H*,;6
M"X&#5?ZVW(LE<C >N]C61P_0/FC%O32S[-8K+JPE&J=?!?5"*\P0U<2#BXX3
MTE)C1,'0H])Z[).?9#ZL4X1%$"1%S"T83=1QYWW@\+<Q;JJPUI604YC<N2_C
M[A=;/>.:^I8@467UV1P#;X&7T7M[<]6N<75ANV!)ECWK*[Z?*9.W3G/C7\,"
M@B-=G(OWH3*H>=*+;T<??A\UC&^V2^XO?_3[< Q#!9Y5UH_8+:O[#26UE-#J
M\E";&5!MDF2%EKO-]\/HQ4-=MU[JNE'C^BO7.%^GBE][&:^3>UX3['Y/O6FP
M1*PK+>_Z6*!R7N7_?PTP<GC?B-[ "O%>=SXW >0ZUM=?7K+54NM4Z#L]]K>2
M;;O7+<:)#0'\N[?TY&=!0![&M%8KIBGYJ$1CX4KK-A,(S]BEO9[!1G/">48W
M\^(-TZ\LBZ<A@+X3 <:<VR$MLKFS=<7%*K_*1<RJ.V95,GO5A"NNH]G,?-2:
M9I<T:W3ZQ16ZC?'@L(9J,6;B72%=#4(WW3JT8;)E!/<6979/,9K)2C'-^RI*
M5('01:3HT\>M.Q#LP09$O0@/7X0[4:&FYA0U5P'@[C;?422]AKC9]/EC</;;
M+Q]CJ_7KRF#:T-V=)OPK796%D*4F_^WDOP45[SO_EVL3YK)1+PXQ?VFVK^06
M]>9C$NN_'W8[@W9 P_%Z'V-*2\(@MX;;2Q)L#[J=NP#3;7.=9)QY:(2+5:#4
M_YDDTUQ3')]:-S]UJ>;VRQRIE=ISZKWAW&#%:52.L&A%"I01H1R])O-FGG)!
MJYTE>71P_+.U=_R)-;Y]A^L[>&__[^/=K;^/&EN-YL'G3V<'%#X?'YSM?GO?
MVH4YC'X#[QI\H9_DEWU/]_(6S;</HO'GP6GCSVV\2_]S] 7>]>7/;?KE6Q[+
MI[,OWXY2XQT^^VM_N[_[$9_O;FW_;&Q^=4E08ZU"43&.."8<66DI"HJ[:)AP
MVNNU#36=]S5EH,R)<\6<C/[$UFD-836$#2',2:5$P-$F9WERWIG$I3%$8ZNQ
M)+&&L*>%,#H!838I+"W!B$1C$*?PR21JX0]I&)/!A4#6-LATE\<E@K :;EXT
MW,R!-MPR3\N2*8 V4@;XA$5PV,'WG%M>H\W3H@V?0!MM';."<^1%HH@GI9&)
M2B$,=F[T$EM0%FL;=#H7=;9W_120,[=GFLK_5LHS_2,W*>H=%?_-\[B7BSHQ
MZ6MC&W0^PLT$W^5#J'D,(IQ,](QBQYCFVC-K-#..<DLH,_'V6H$U1"T2HCY.
M^73$*,NX4\@2HA /'N=L>5665I8<_ITT>#]2/\ @FHT0*^?3O6Z9+ZLOT=_G
M5$R/OO3U,MW;>)3<*$GRL66EN4C>8H]SM6[/E8"EOL]!YAJ9'X#,D\8C"%I0
M)FCDI$^(1TV0%64;'JX<H'.01*]MF(?:C@L4T=>PJ_'.MFUHPGNW<M)U]S$V
M..X$47=UW9</HN:Q'I4(5$J<$N&8@PWIC/2*\D0EN%:*FAJCGA*CFE/6HZ18
M>>X"(M1D!U=0L!Y]1%P;BX-ED<'*;/#IP@M+%$Y;BAV!%R[S][,>ER^2^L*7
M:1YH]E81IUE,S!(.UH@)5"DA-68:C,?:?'QJ:)XT'X.C@6(KD2-1(TY51-HI
M@@2UE# 3#4EQ5F^ 9T'F6RS'QX#H^LZK=]9+\.QWOH;8^W\LO#27RSJ([3KT
M_J@:.CJ:(M8AYFIUA$FC)*<D8I*+8ZF8:@W]A!IZ;SKT3B6E8$,9Q#G/SE/R
MR#J34'0&$VQ$C$:L;>@Z]/[*9;X.O:_$,LT#S=S+A+EBR6C)'=/&6RRMRT4P
M0.Q5O2OZQ- \Z3SAZ,!C(AB%G.X*T!R0)8&B: P6W"3*3&ZL]I!,USKN/I=T
M;=EV3MGXOUU0'W70_:4$X.K8ZZM=^GJ9[KUSSY@0DDC)--;<$Z$Y>!)61"8)
M2V XU-;#$UH/N_N;_;UW^&=I09QO_H2Q?:74,2\$V O"Y0U[0I#&Q"&3 LM-
M#YUCK,[[?'(1^[^=;H2W?N[4D:?'=6]L=,H%PN!)C--$M2+*,,*BMT&Z<$TY
M]AJ@'@F@ )B:5P&*62^Y=0EI)R4";U0@[9-".,JHX")-VJUMR(<<@ZE#3R]
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M6FFDV8[17C\8UB=(>Y,C+7T#@TOGT*Z,-M/%EN)2Z'W4^'0/D;?Q_C3FVZ)
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M<Z($(P8+I8JU5^R7>YNO6+)\ SQ/%WB<4()0P)J@<RXL-D&P$'+M.!/66I&
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MU(TVZUS+J0?K?#E\_H@V@WYG-+SZD;EV60_D:XV&UX4%FOKOX:16S+$^\,B
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M[X4@S"@F5HTQ[ZGWX(,*>_'KPOZFK;X>-:;0$'(1F,4&Y]PY^,?B(!SS"KN
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M &,)<=QA01S3@()&8YBK]P;[(M=*XY^$B!N 68RN=OCN^Z_ TZJ@SB)#=3Q
MG^=(N8*@PI%<>:QCLD $&'))#:Y?!IA?W/ &8)9#".]_[!Q\+20FF@H+DJ90
MB /F(Q5"@0(IN+0"Q)#4L<CZU0#S,X2)GOUAC+$=)"^X3AZ<!!;1Q1Y&PU'I
MIT DTM-@9(Z\'48OE?/388OT@A0CU)V8 W!Y*/'V?HCB]G'8A[),K1UU1YT4
M;=E-44Z@_./2'_K>(,9KMGNP&S[[[>_^8*HOS2\=1[BO?IA34TLSNS"Q:EYQ
M5GOQP,@SSO?_ 7 N#)>Y*"1BWA6(:RJ1)+&VN:2X,,Q+0<UBS3)7Q0!Z79]$
M:@/S3Y%Z?4SI JFW:U+O1%*/Z! O]WOQR%$5?JL>'>H?=3QS (I,#!L.ZOZ<
M@^Q"%Z?Y?IL3!]:%%I=_7,H]]]OUDF"\CBOWV:)M+YE8)U3<JI/D]5TF";EQ
M?\I+SF./5P:@QM_JSALO@%J77-[!_(5:?C-1M9[G=[%7>7[;)^]_71_36#G.
M[V*L^<THZU<;]=WJUE]FW#L>J9J[]5$T&&SY(2C# ?[N,N-[\-,0##&0?* 6
MV_Z@DG''\8<JSR2=OTVYK/'JU?7][IH<?O76V[=G7;T]W$L>EIW*P[(U[6&Y
MHRZ]=\F+CV+%W_1+^!5X8%26OF=/LV$)+^LD:[)I$7N[-7U7Q@/U\.SWM@6S
MO_2N?2-\N=$*-"L]W8S7#@$<VKJ314/WFB*M=T*QCVJI/O5*#Z.(C: /=+LW
MJ,Q #X9@S':%5WY/J1G-$EXCG>;*!/ZL,N*2&/I!!!HMFB[4RZ]H_:!UMJH,
MR;HZRUBC(C>13+<NPKM\?\7MB_FNW'[<O"+<95-<[9INORT0[\IM[/^98ZQH
MP0WGTA.- V4R)TH6S%Y=U"V>8H*?9GWD-_2,@\FX&_;TC\<>XZIKO'W*6WO_
MZ>SL?3G:@6_M;KXG7X[^:7]YNX5W]UQWA[:Z^T=?NCM''[IS-=YB>G;WTX]6
M=^=T9^\3;VW^TVU]_L^W_;WW>8ONG^W3+_#]_=/6VR]AYQ3CN1IO1&$2-%),
M&<1)+&JLB4)>!)M;SC4OU-HK(N<K$OS^*QSPP(7&&SQZ3'BT2)%>2VAAK3;6
MAM@G1QIB5,">%(7#6KB;UIAL4.A.48C.H)#&,2,LY,A*PQ"7\;R1U@)A[G7A
M"F&$BRA$5ZEI6@-%SQ"*%E&-,#4XQ]+I'#ONF-":<&D=4T0;J31M5*/5 B4^
M THYY\0[2A'($8NX$#DR01>(&.VE8'GAJ%Q[12\!I48U6B6>?<IXM$CJ<Y%[
ME7O (":X\592Y;1DGN3!,*QQHQJM! K]V!FWA#K;^+&S]_ZK=@4+!>>(\< 1
M]X(BZ66.&%&YD4&P8/W:JZO*NS1(M$+<^I21:!'-Z/:= !K-Z&$PJ7T1DQP/
M!8D-59SD$G&L0#72BB-G51ZHM";86!]"SK?">A#5J X0C+\U2<),<+/L1K7+
M?<==9#FLRMR:=SR%=SR'Z-ONSU.R?>BG>FZVHP>#6*<IY>'<*'=D%2)TY['C
M)]EZ<Q'MI/ <,\F8*%3.B=>F8)B+X%@1K'.*W^",Z!5JRG6ZR9^)@#[,TD_U
MYT9G64QG:7V<"W2)W(1 F4%<8A=+U4FD-(X>9R6E8$87\50@G2]?])B=.4^<
MJQ>J&NFY#;C(M=;<T4+FS H;SYI[X1RU"Q_\_C5>GCZUF2H8HC-?]AL>7XS'
M9\-(E.D">^V1U-XB;EVL*I!31#BU'H><Y]K%@AD2[,P_GI[#I.'V,;=KX2TN
MA"H*+G@NO*2PXT5>,*EPX9R\9VYON'H1KIZ-PU#MO!.%0(I0X.I<8F2<+D!R
MYT1RH10O\B?I &WX>:HJJ'$,N\"4X$1SDP>:8Y83%:3 1BV5GV,=C3>=_LE?
MWAWXM[K=NYK)-WJN8?"%&7PNQ,&"QL)P8.E8N9Y3ZI$"]$:PX]ZR($/P>NV5
M;#C\D7'X(E;W$BHS-5;W"K#V3*3 TZ"E9@Q16_#8G4<A28U'W!6&$*LHDZ"2
M$[$:9O?E@0+5Q D>D3^Z><=JON,YQ DVZ@)0YV& 6,]EE#I;+U3BI0D;K,1^
MWF_4X*+:,JN4O"G[W8V^;;].Q[V'5=^"B:*R,1R6;3-*17;V^N]TO*5Q,RY#
MJ9D_,P.J"^6$J9CN8!#7,?M!J8"\!CHGU.<^)H8V;L8GS_-+#RHT/+\J/#\;
M6K %YB87%!4D!,1%;-W+9(YRI2PFGN5&FX;GGP'/+SVTL R>;WA[$=Z>#3 P
M)R3F.4?.Q?+3L2VWP19^]7F>TR+DL)]KK^9=% U7KS97+^)^7$*$X0KW8\/?
M]\W?\_$%PW+E/49!Z1QQ%G*DO BHT-1+78"1)OEE$<0F]6=E>?LA>SXT''W_
M'#T35B@$L<RG'3,4<2Y 9#L;$"4,YRH(R7.R6CD!36AA%>?6O.,IO.,YA!;V
M8FGW'[$JKF^" RNQ(P\9'+B^:4238+P,O6-W_A"!,D0017(4.,>(%Q@C[;1#
MQ$IGO#>,:M)X 9\!0]_K<8*&H9?&T+-N?2Q$;KEB0%">(4YY@6)-!81SZ86V
MPDF5-PS]6!EZ$0?@O1X9:#(+%^;<6:<]9\I@T*B 7SU'W!D<.9<B4U!ML,N%
MLO$\7^/3>YKL>J\G AIV79A=YWSPV'#G-!5(%%3%LWD,2<XHHMXS2Q7!DO*U
M5Z3AUZ?)KP^3WM\P[BT8=\;5GA/L/5$*Y8$'Q+5U2&,:8L$? 1L5?&$NK3_6
M)/ W7O;F'4_H'<_!R_[30C]/T?=^XQXQ3U O>9AB/TTAPML4(@2EI#5K53!"
M*#,>>1)RQ'.ND<31OJ".4\PYYLHMIZK/(HV4'HO-\=08?U4=^.?LWGCQEP,#
M,S:*A/U7BE"D<^D0)SI',@ 66*%"R'5!DG-AN6[\!A">%"#<J_^_D?^W9/S=
M&?EO'&?.,H*\3JG[WB! <H,*P@/E'IO Q-JK>?'?L'S#\O<;0VA8_I8LO[.W
M$>-^P/8[,(<M_)5KXH20!>(&<\1Q/(KG<8YR00M,"NT+DJ^]6E:KJ(;G5Y_G
M5S\0T7#_K;E_^R+WJUQ9X;!"H-4+Q'502!$1$*,"YXP%32U=3D&A.^?\)EBQ
MBG-KWO$4WO$<@A553_#_Z-Y(EZ?CGN#TL40H;@B_U0J_9("QKC\R'3^!X%_3
M8E9N-Q=N#K7$!7HZZITFWC,B"\JIYH0[P\!2L-2H8+F3-*364HMH=4UKJ;M4
M\';F(CK4&BYR1E!@'$P\ISF2L?&=+PH,).N#M'CM%25+R.Q<'@,]L.W70&D#
MI4OWCF%GF?*^L%QY[@2P9<&T#TKFT@@CY=5(V@#HO0+H3"R,:RJIY!81DL=B
MVD8C*7.'"/5*B< $#7:9O=0;%&U0])FAZ$()1EA)%G3.J0W<8"(U,0;8,SA1
M<,I%HY"N&)[.AAB%5XP5*J"<$XPX,SF27FLDC ^%QLX$+*)"NKP<HP9*&RA]
M+E"Z )+27##%BT"-(#&_3V,6&P-Y8$M64-LHI"L"H',!6R](883 "*!4("Z*
M DD:0"T5N?%>4:5,L?0DC09$&Q!]+B"ZB#[JA0PR&,$5TYQK);7C(8@84V4:
M&]/HHRL'IS,1\!Q+JPB12(G"(.ZP0"J0@)RA*B]TKHM8^XZJ^7Y9CU A_4D<
M[RX"T<V=C_/.AE2:.QM2:>YL2*6YLR&5YLY5OK,AE>;.AE2:.QM2:>YL2*6Y
M<Y7O;$BEN;,AE>;.AE2:.QM2:>Y<Y3L;4FGN7(14_I7:\L&_KOW]U3A>WAIU
M?=FVK_X-?QR_82IJ?30:#-OAM IDMWO.]X8O:9%2=^)W7_W;E/]Z-8FTIQ=?
M>&_VZ_4(KN]'N#L:[H8;I&7LI9:$,)(_.WW[[7&F8W3\7Q].OWQVQX9RT=K\
M\FWGZ$MG]^W[?'=SG[;>PGL^;_^ ,9SN;'[BNV]W6&OO/=LY.@P[9SMXY_W7
MW!+A!*7(J^JT!$:*NP(9G =.I%(LZ+7,#ZP^CE10CB+]W(HNQD_8NT\*HC$I
M:)8J!EE_-(P'AO4Y963]G]4[C17K,K@)_E]ZGW7ALX>#S,/LW/CD<96F-SY^
MG.F>BS^0[,27/M,#>$.GTS\99+^U>QG,LQ/'\OO+BPPRM:)=71ZT>RFE)+^8
MD69A17UY87WY>EZ52XBD/'Y#G90""]W1QP/_<OS#'V,8:/?2<J6'_JB_5^>X
MQ$_.)*2D[U67_SAIN^%AS+I:QU7Z:BUKZB_7E]?3I3$>7;C&Z;H@[,K+>)W<
M\IH2ZE9/7C=8L2ZXO(.QYNSJ;Z[:6"6]\6X]"K&WR)HRL5[<D*Q^HGA=4U:A
MYNI[R:>4,\A97)I.N>F'NMT99-I$Q)R'RR3@K\/,> V6O#<<W* 8PT]K+A#Z
M.)=QH]L?P1)DYX((5C"4_6ZU@#\5/3=8NYNSPN-:N1"\C?06+V7MH>_"RJ1%
M&PR!#KLPX"C(^\>^K$3[A:6ZO*P0NZ:LT )E/VY#K4NM)G)=M9>9*1-R72FE
MFV2N+F-!EO_)I_J>E1262YGO#:7C,LA-/4[(VTOFQ4YE7FQ%\V(9HO-NZ:#9
MZEMM]53!JF:/EXRRCX( ;EJE[#[%TV-9.++Z+'/?;#BC]2U6/W/QPG=W^HZE
MT?QS&>1C(>#%YMJ$L9[DG<VV/LD[FVU]DG<VV_HD[VRV]4G>N7#![YGJX8^A
M LJG7NEA&&?>90>ZW1N'F_J]#/3Q]G<];'_W-PDY+5R.?9%%?&K%9"Z;XFJ7
M@UFD!5(A<L&-+8P7G.9,,ARDXD5A3*#*FH5;(&U."'&[-QB6HQBK&KP%8HTU
M8*8C@6_*?G<Z1^GU]G9OV*\2D[92_ O>\:Y?QAFT_'#M292-Z>Z??-G;X?M'
M[T_WX=W[>Q_:.WN6[\/_X?YO7X[<8>OS]ND.C&>V;,R7HS\[.V>'[=;F?XZ^
M[/UYV'J[_:-U=GC8.CO@NV\_=%L4QGZT?0)S#ZEDS$Q96".8%%H[A!53B%MN
MD%&,(.RY,L;#SE-Y61OW!8MP78ZJ=UI&J\&N)X1=BY2R"I+F1!8FM\SQ(*3T
MV'*-"RX*%9S$";SP&+S( C6M&A1;$12;[0[@0RS_: M4%-8AGH<"&4]R1)3P
MP9("$QG67OU*Y:O5 [!'H7X_8:W[=7^0TFV.R[X;V>&ER3:KN?S-G?=F3=YG
M'.E7.CP^QO:.]]O=L=$$5E 3>#]GSQ0%S;4U"FF+->*!460$SI%Q&LQ8:ZD-
M; GVS$+\]!1:P#Y&@%C$:+"$N%@SE3BFX6U&8Z>#]P;[(M=*-T;#XX>*6:-!
MDR)(SG*DB?&(.V.1%-HBZI207GGF#/\UH^%1HL0JZU^WG.MC,"?V^D/=R8P/
M_7)RX&&H?RQB53QL2];KI$O]CF<K71ZFN_AK/3A\T^F?_.7=@1]+G(TP].7L
M(= G4X#]WL3)ISG-,Q?&Z^A)9Q8[Q"D12 ?J$&$LIZ[@QF.]]HK\N@]J-<1)
M PN_'F7[=9VS 8/5 (.Y=K72>\X41\8Z 6 @,%+1%@TZ-X5GI#"N6'LUWZSV
M=F&UQX4(JZ(V/C-_]6_ORO[W]@"H['=0,WL^M(>IBL.R=,W'XNI\^G)EZ=[.
MA>7*K$A)<J:1*XO*E?TY)1-TRU 0X1'+B4><QZZ3!N0*5DJ14.1*\[ $N;(H
M#ZV*[^(9XL)J.#D;A'@HA)C5/(-GN602P,&&F KA+5*Y8K"AUO'@\YP+0 AQ
MAU[-506'5=$FGZ5CL^=3LL0=.38?PSJT8 4<:-T][R;Z]W'$2L!L&W-)8H6T
MX_A#Z8?MLBKG H1271V\O(L$[D7><7?'.Y_H(!\OREPWURMJZM#'?+SZF;[C
M\1+H+QR2?A*R9,,.1[ILUW(U'O>Y4^EP Q_^$[><[M6E,F<;N5A#-NH#*45D
M]_7VNTIOV.A517S?@8)PKC3\62D7[T!U&+SIEZ!WC(VN/U-TN;&R%K6ROLWY
M83 O0J \(,S P.+>220)Y4@1)YB0(F?:_YJ5M<()YPT<W&ODKH&#E8.#.:>+
MT%R[G"+K?(XXQP%)57 D&,^QQ5H6@JV](D\4#U9%3WQF ;W$ZY/:N/Y'=";X
MWY<:Q'L,R_"N;/?!'/7E][;U8\_*K=3A)489'J'\6U5M>*,;4Y[/EB/Z$K%\
MK&@E'N!Z77K7'DX)0OBAJX<PQQ_#EZ']PSMTYLM^(R 7$9!'&W/ZLLMM 0J2
M1#F/!S0#TZ OYR J;>&T]!1T:;[VZK__2U)"_UA2]'(58Q#/'CKN57-NH.,1
M0L>L;IW+')L@&;*&"L2)IT@72B%<8#"Y<Q*\\<\!.E9%=WYFX<N[T+(?R[&,
M9Y 2\S G,Y;HTFF<.+<3-%OS!SA44%@*BH+R'G%C"J2D"<@9X96DNA#>+L6G
MNS*9,PV&K(HWN,&0QXDAL\IJP87D%L?*0\S%_%R.M)1%/ DF!!:<@!F\'$?P
MHP.15=%*GYF7^$[.%:_868]'*%]6U=NZ1*G2R)-%Y<E\>4YJ%1,F4,0DQ8@7
M#'1291V22GMG-/5,DLL.%3\=M\>S9__'FFO0L/_B[#^G3EI1:.P=PEP4B*N"
M(6650S2 >4I"D,*".LF?,/NOBB[XS+R>?][! >'&Z[DR'HM'[_5L^>%N:"3,
MHA)F9T[!# 'VG3J&-',*)$S(D00"0$(!E864RJK67N7/T%_10,C3=GHV$')+
M")E54B7L*K,2@(-;4%*)BK5NE$:LP&"D$DN<$V"CSA<E>/H8LBHZZ;/T>=[H
MR/&3.L>X2AU8'\4@'R]7/O<3D!6+ES/JP" 9K"#WLV-X;=\]1-.SFKZKU7G)
M@,1=?V0Z_N:*X<HM]L*=A19;@Z>C%-^=73VK^,X6"[]"9WX]*DO0>]\E;F@T
MWEMIO/.E7C&A7)I"(R\*T'@EET@KJY$PWN<4J\)S>UF3@=LJO#?CHQ5OJ-;@
MXO/%Q;MS%C2X^("X.->&+6<N:.(1$<HB+DP1?0(Q7Y\&035C4IJU5V0)?=@>
M$S"NG#5QIZ6!_C74L _PKVM_?S7>Z-:H"YQF7_T;_CA^]]1>1!]>.YQ6V]/N
M.>#,E[1(+Z[(PI3_>C4AD?3B6[WH'B&2IC(M75BZX2!K][)C'?'FT ]\_-5%
MM/)@OL3.<<EN&?;'CHI8!@Q^++V.]\+?^^D$@IT&L<EYA-3I>?WBTL0UC^C;
M[HT2)%Y8K'I\G*X7.<SAN#]HQWM>EKZ3>M3\<=)VP\-QEL+4@S6KX?-'M ';
M?32\^I&IC;$P>5\^T#90,;- 4_\]G'B CO6!1P:6_1O2L1CE2]TYT:>#M7]=
MF%.WW1N_G*OUN(2K,_OB<B)\N_WW5FLOV]MZ_5=K]^_=M]M;'U]DVZW7ZS?A
MJ <=>FMW;^MCMK>;O=YM;6ZU/FYMQI\^[OZ]O;FQ![^\V6YMM%YO;_R=?=R#
M/^S -#]FOWUJ;7S:W(;KOV<H^^UUQ0G>_9XM/-^; \^*/?8+&/EHP?;?,[!7
MJ7"*<>J))LR:P',&5KBPEL,_GG,B"C#39C7(0=8?)<>Q/E<C?X[!52?02RH1
M)#S7<_6ZHDPH_>#8V_2MF9*/@\N+0=;5(NL[JGS>SLCY*#"2URL.<#2LI@]O
MC1^K'&%M6]68_&W@?=;J@^PAY$6V]N'\Y>\FGXTALVSZ2OW9=,=:E#9S N;7
MJ>4JLDN;&#LZ6T4"R37FA;<*[&Z/B52"<<VX^EJHM:F''H;^B%C/LNS?%Q2>
M)7B'+IH['_U!W),/_CB>;.X=;+8'%LAI5/H]^,R?G;[]]L"VR^['L>WRY6CW
M[3[;/]LZ:77?G\!W\IU-F^_N??NQ?W1X"-!.=C:_='??MH[ #NGXOSZ<?OGL
MC@WEHM7=X6"G'.WL;8#]LW'2VOQVTCK[!L^^:>^^W<IW]C[!._?Y/FV%W<V=
ML]V-KYA;Z;0D2#"-$?>2(2D*C6"9J<.!!<%D990F8; 1SVD3'BC.>6",62Z<
MTK'EO3!4"FH%PV8M\V 0'D<Z+D>@*7_<>AM%#,C.-[L?=C;VMG=;<PKN!0*^
M%)%^_M6+HW3*!<I\[JW#G%.I+9%<<J6)T-X%M?: -#^39SC+_EU='H"^5*N.
M,;;VQX/*C_3&E^TA?-_>8':;L/UE^WB,IH.*]P83O>DA5CS+/OL$_3H[Z/0-
M2)2.URZ=4,XZ[>"S@6W[GO6#%YEKZX,>8'G;5KBNCX\[;9 5]M!WH\V;P?9\
M\T.X\SAV!HGV7'5/)0>ST+>C =R?M/S*2#G4P[',@7\GW2Q?P#UA> +#>C$6
M?]4G@9('HVXT",\C,_  2):LH\&&U\-^>9J=],MOH=,_ ?Q\-*1T[29M5](X
MM$N0I/\'DA^TM4A!H1T=3-FIUV46$?Y%=A+MO1Y8B1866L/6Z-Y!7-JL7Q[H
M7EVZ AZ)2PTZ!*R;\]$3!G>#9>A[<6E!7RDSL-)/AH?Q/M!7#MKU^L?<E]X!
MC*67;DH[FL5ZT[!>H+N4@_5L%_Z>* +NG3PV2J0RR,QH ),;5'^-;P"5(!%-
M4CDF^W]^7[?_'2Z%LM]-MV\<M#M1A7A=@LKSMS;G-];,E.Q;N/$"Z5Z@UII(
MYYY<S^I:'#"F[Q[0LB:XJBG[0$>22T9MM50I)@AWMONP MK^WZA=6;'QYC_;
M_3W_;7;LBP]I/)F?SGH]VX/A',*2]\O$B:'=TST;]</QJ]J]JIQ('.*AAF]Y
M'Q5&JP?I,\!8\7HUL_8 -+V3.+T!/)J>25\ :CF!1WO],5W5XYL%A@/?ZW?C
M+W/C?!KL^*;? 72)\);6JO33S)5X<"QQXPH=:M#MAX<E*,JSZS&H+(!V1$6@
MFY]2R#P&3Y8Z_C)+)R\RK^UA?//)81M^&(]J4.UX]65 B3)I?XGU)P25*.I*
MCWQOU#5@,"XU6 E:T*QVVDJ?V0V[8'3HJ)[6ZNK@0G$<V$;[$D8$L.^ 8"=>
M=_S,-%>X1KXRP6&!"X^8$0IQ8SV2GA"4RSP41CBBA5Q[E<AQSFN>]<?K?$Z@
M)S[)"! XW:K3@([$"I0#) F<%<'_L']2&8N';1^FWA&W-AEZ7?T-Y-7WMC^I
MZ-1_UQW08/T@H4?] $AV$!Z3AP%[1IUA9966_@#,YA*^%@'7G\1AG-[DDT#F
M\8?)G^%U)AKC\'+XLJT8P0 + #_;:60?HV8<+?P)S/G(M6T8#WPJD1ZP* PW
M6?$!EJ]? G-6FDP<1\6O\)IC7<VM$B:UE,RBF1[] ]/J$3Q_T$?#/JJ?C1#;
M\YU*FXINW5J43JM#,(Q1_/JH3+I6F8!GT ;UK3+AQ_M6097/SD4 8$)R'E^R
MY3=RXZT8(F]$-69:MXZ$56'N/+C!1L+R104RPOA4(XS',]\;N1Y7;,R[B^E
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MC;O#7M_AC.F^,>SK5M_O@I'E>CI*]YYE.LPT_8N7@Y9M+=>([^:XU361?.M
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MM[N2<H#&PG@J0G;P-TP9_H,_P[_FU\<PG5M51\YO.U(QL'\0PU3*(6C7%&7
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M7:R/%XNE#L$TSI1*]*LW%^IB']O1 <%C(B:I&3$7*G^D]$FLDZ'-D%<@TCO
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M;]'(+ P5;!Y,EOJ=M\B>"P-"HL0IPK"MH@\VFEY,O;.%@'X<"X\CT-@X1]E
M.\P4$B':5'$.ZR%4-K'4<LHHE,0;:!N+G?@?3398CY-910;"[K]:& &GE+$
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M[Q.+2R4 Q1U/.#6H"1AU6A&]^YQ9\099D^_Q$.OH$;<DQ68V:8[Y/*D6QJ,
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M;ZD0?*G%JF)9\%863(BQ,.UU(N[D8DH"T_P<'<K*E/%]:>Y\E1$_CU?U'@V
M>@'<1&1M5 ).S!(R*CU@N:V3O$Z/FUZ)C.&WS%7=@W'7OH!$R_0;V$OM-7>R
M[7?HN,SL0V;*1MH'+ 04"S"Z+=(;Q*)TS4/>$]HW*K>;C8#=1> )LXZI:328
M0$#19<(M=D8.,GD11M6FU'<<O"H4#ZWRKIJ2PC'.H4PE'[A4I_!,'J7<S?']
M\L6^()&9B/90]$8H+F3II368EKKH%7F7,"MD32V,88_]DMJH;3,L"E8UPIM^
MP? 5T[C7*:ZW94X';-GE- E"S:R:'/.[%<V]F:5I/ID*F:"VKX5V>)IC9 Q^
M('O"8T/VQ:DP3#.E^Q/<+2=.9)/N4M,G_#8.J9?VXE:A<5'F/U!(J=WMS9OZ
MJM?V R^NKJ>R?\)\\4'&CL4;A&&"S@)NW4(H;1.K&UR(8I'SZ3+EBA?7B6N8
M_UWY[.J)4_B00J>!B!R$ =W"$E$+!7'+@9XK(;W%EWK;Z\#ULOXL[W*-YBZW
M%G,Y..R#N;]T]5H9-V!:\H14XB<&=NJSU].:3WM;>N_B?Q.7U6#S4O*M6^[%
M%/="N;.MJCF.-2%: -J2RUIJ4/*%(= "^Q[-0M+C\&LL2,=DOBC.RGSM4HM5
M*JV$/H/G4$%AWT4JSUW2A"3[A=KOV@/=8S@?,/BEPKC,R <0F![X.JI6J<X>
MR[G0*\"\0E""5+Y2:M%*'9A43P$EHZY3WM(TD<I8E<[QOS#72-Z6E=:*G,;\
M%HN=J:A06(1T:,IIE9I212GP$!PNM2GN>\+)71.1%%U]OER[(]PG&,:E/$KZ
M'D\3-6NZ_D5%UJI"2@ 1-44I1;%*T&NX^[N&#XO9BMG30GXPRPQW,DH4@ZW@
M$],P>Z;]A'P2^_/.PR%X=>7V'7)3-K8&'Y0OCXBCGJA6>A]'HYU\ZW5+JO/>
MW'^C-$8'8,QNL52:1TAL(ALZ50*V4"(MI0JHTEA6[:*(2E<6\I*SF2K!?#D*
M0DK_K)!ORJ,@3N:5UZX)*'1G61T/OO=XZB:!(VX_D4LN19;J9PZBE3)1W\9
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M_>KB)^US'G)5(<ATH_>C\Y/XDZ7BO]+OH_X.XI\2 @9+P8JW!RJIJJW]4EH
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M?Z7UW)X KF\Z6P67!VNHEWWD%PSZ#OD<W XFN=MH<07/:>\FBXV9.5'?Q>5
M)LC=W')8NHN1S!XO1\R(\JX58SZ\<S%#27X;5M^99WHJT;\B[@OR%S]\>?L9
M4!8_/Q;*8K[.WAUJ. #X_.CY'6)$7@5C<_B41$,(Y@LK&$;(#KQW#(E1FT#$
ME!=C_Q8_&,9.[N;@FG.0YGEQ+NE8]GMP^_E];]I6A,E]T)SMIN+6ID+U?@(0
M@*(?,:<#WJD+H*CDV&LPZSG&NW9707(!8(EE@2QWN\F[O<GS;B<@25S7 A";
MMG=3C_>YFXA;FPBECJ'1K*%+@:&HU!LYZ\/Y(M*LVTW(K4T(9,*0$SL5:U;
M'RB%)1H7XE<7D!-QG^]FX19]+4&ONDW@8AE(C^R&^O;.<9>Z[RYM?78/AVH
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M+*@,0(>(F:-=./[@$1WO:=N0K(1LB4]&NS4P"SQ$G83S+S"O$!IDG7LZ,JL
MQ]4%)X>4RMUVA'6(Y,!@*$)N]5XF/T_+@I(X!/_&)%6 3O;)JBOTZXFO,8:D
M6,053PBTB2P,\YJ4 VB7OZ+1IQP6,<=?]E?VR?],Z[(8O4GC66X'*9T$%5+X
M&A9(#U[!M_]\H\JE!/>A5'HUHN6-DZFLCBBN^@2+M%E3 #HZQ[LG[NZN6'_:
M0*N3/5;_R%-%?76[SL311L[$Z,O<_#H9T7:2!DQY*\&9MGJZ$>V@2^,3>_&4
M0!1Z2<BYJIN6[936>](AT)3G)LTR3'+[4YD*Q_!<O##"B>?U;11V</2;/4A
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M.9$X6%@@PGB9$Q6?6#6/K,-5<^HJ',NF7$IIS%7DL)8F_^CH_7!ICP"HUO3
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M /$QI5]>,Q"*63A3<BUP)2N.32"R1(A[1L$XEE?@M*1A9DP"303&Y6/K2 '
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M!?E;W4-I/KQVA.9@BKKJ3<#"CI_'.:H^)+\X',0K-9GG[BF\7RA.#O(@U&E
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M:Q#FWWTV=ED:,!'&<0_RH2,E11<?_UV.H4*-%+>J0?E!AL$55L('5(,/$!\
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MI).!)!H#);Q ](%(7Z7)UKK;L?VP6,Y#P6]/;@"\'J9DOJKKZS/?=__DW>#
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MOM&87%N0]L&\T&U*"M_=FMZMY]UZWIH7VK# ;/*T*$=_ GL+9+)3B%RPZVD
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M=\1==M ,KFU*LG;^LX8VGF%D41^P$4,Y42#VV(?N'/E]N$3>"IJHV!!??@&
M88.7*^+ZP$E1SJ WY9IZKL_(%%8O9L$ S1XQH<]=E)7WHJJEJ,Z0[7OL6WW+
MX_.+9]7.RFNP]NIS"%=[:!&G##0)?Y'7)N:LRM75U=D+\[YL/3)=BI>OLX]U
MI2DG-L\WR\NFW^H1W2%TV+8\.1TBNC?JD-G>\CRBB))_]TJJD=U^2QHA(F"U
M;\D(])#Y>4Z>STRR=GSWE;MS01/((HF^<.??2_[:=6EG)*= G&;S;6\5+(0Y
MI_]H)>5O"=C'>O Q*1DZ#O$Y#_9+^-MJA9T9"7Z@/S'/O8[<=X1F47A/=5$9
M,8+_N8:NZ1*[(*"<K5RR0JZ/D1?OWCB#A8MF-S58CV+X7S:<?J9J1,]3W),-
MD#T^HR3([FVK$=&R-G!3\R@&-@H,\V%KO7*1;*TIB4=[0 [Q_W;E36C+5IZ2
MF&O[;U!W"\UDZTY)L(/WJ#JCGM#G %LWM2C%AHYE.#[V7[LT,KA+;M(:8$4?
M1]W<E(LK(F01B8Z$;[7^TJ!Y,?T'ZML\/_:1<@,!.Q#C]_O9+I<=_FL/60/G
M"_^\VS1"XK"(@'#'K4K3)2')) M_C# 0(-,>]#M&?VQTZ(?QH-?MZ!.C,Y[0
M_Q^,_F1P-Q@:(WW2I0\?';BVL,]RY5* [<-9@*/"<6Q2\,;4UB@$<B,$Q*6
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MY600"IM&LT'32+'Q*^CW?6,2V&!HC'B<D%M<S"06MH$FNX,AO4PUB:"@K(*
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M447L1Y=:,[4M(2\M87N3X[JQ[FBC77B?*M,/< 6!FN]WU3YRD E[ZKQ'+,N
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M0L%Q53:![:(%<CS\C+H.Q4CV#L.WB!##W-144:#]9PSFF,SPO&M"*@C$GGR
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MH@=:\K\EK:IHLR*WED]?N:>1U/@X2(Y0B<^7UF02(B:/+FAO$]/2VS9AY3=
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M9(&;TH<H"2(5?F>9C"3AZ(2P*#/1Q@(_$.BFQN>&QUU[SFO?C^.(*^I=L(F
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M%_WQYRJSHU+3!WLF!HS(")'TM8J54>!K]*I1,GGE332-:GP_".TGH3I67X.
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M8_X@M!^(,9LH92O;T_+BGCW#BB1I! BY\EHJPAIC C1*^FBM9J%5M[354?Y
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MOT;X@B(JJUBC_)M-8/^(K-N>GAN$<;VM=6S'1^<X"O5$]$H@OGI4F0E@-I!
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M6RG?#L?CGI>9"\$YV(($AA$LYSRG,?H2A2G:%=>$\#=@;(\5&RMDV)4T.\T
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MN%_9T"*8Q_!CI@E@5 *R!BRMPEF#,YI!8HGYR)"DV68-ZP3^#V:'[4[U#=;
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MVL@-!B\H7?-2^9Q]9*50G.UKNY Q:M0$44]+T4W\=U:;DQY<D]Q\]_G5W8M
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M*YETP7L*@>@ 3/78=[CT7CV$M:BNW +8$)'J8VC'<Q+>-[^K Y>>R&D7RZX
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MAZ%+-U:W5YE;8&I:&[0*U6&*@?9E;*,#[&'NH5RAH%/%,TL1<<BUU3A!,-P
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M'GY]-Y7[[BO.XG0V"6DV<LAUP4(A-%<"5'*%GM8R8-HXRIV<I]>ER=-N '6
MKM1>O.'1K.N>[-Z@UJR*H(^OYK'Y_;/C9)[*O0S3S^_#11XI%"DD82E>KY/X
M'#J@3\J@G8[!>TKC?)N=:1MTPSM);W2N$*3OE8L&H<N*9W\ >^12X%IFR@^#
MQ)M6,9]U[>7&$(13SKDVGK(9U^GX2(_V;W +L@K3W6,SRNI+2O382E/6'X4
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MOW&8^S@F7[CUX#2GN+JH4,5\&* H1<9HF,YM>AM_@'$Z(<+NUFUYQK78D+:
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M!W!#FTMKH$[C $YAYJ&0<02/I,%$\\:[0&K,RDI7CS!3&P*[G^8 KI=-]#J
MZX--\_.7;80Y[P.X7G ]>1"SBZ[;,_L$,"G6=GU5*&:HB0MO4F V&&FLYSDU
MHFX_]@.XX7#OH^+1F7TL#2-1[,!4\?6N+BPL&%KV@@F8G,A.JTV4%*? [-,'
M@E[,/GWT-QZS3](!A8Z!\5PKPD4FN^4.F$/RG),52?E-Q#!'S>RS$YR#:6P$
M9A\IL]32YWH= *^,WIH6GB29U,D8[JQQZ329?79";G\=M6;VB9*;HF@%4"B!
M9*$% 6JTFKF)5D*.PL4->!TAL\].8.VIG;[,/JM?UX\('?[S'_\'4$L#!!0
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M+G&I>9[]#*G3,W"L_8YGGHGIVE/OF*TGIEQ_>>M!]+\U4Z^9>,\>-\F$.V9
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MT68,OL>T>:_=J,<W*JA2KOZ">0SS#"4P#$.Y&&*1@"E#(4PS$89<R-40,PJ
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M@2C&TI?!.)+(>B1*8DIH*(R":8<DS8TRMHJ"1E.@5 6_M<J:UE(:A%>/.ZR
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M^MM>EWDE'8RW34186R)*7OA)?,,_%IB(S,,"P92HADX95S6;,A]FS<%$3%#
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M_8B826?XL)G[4_O$E1<L!SX6J\T[KCTPZAR,KEVF= %\C)F OB?D+&<HAJE
M&$:(!AAC3J+$J,&-CM"YS?O6^<V[$]QNG3!F>7 .;(/%@D4()UDZ[.J[.0SO
M5/[)07]V$Y#LKRS."9Y^G:$)Q=%5A^Z](^O;WC\LBR?.N[I>3<3FZX.@SF4S
MY$T5,)4L?+O*_\E9NV.K*H%5'_(5OZGY?;5(?2)$&GE0,%\R5H)CF'DTA#[A
M@6 4<1$RH^JV=O6;&[GUYFT*ZPT%=U^!K9%]UGUK9G\ZT1AJ6 37\N#K,>@+
M#JGK@^IC$??;@.BK?ONFK4[U!C_D-5XJNZZZ(K?@-V46:.RR2,>.$+=;[]:R
MCM-6NW4#\$&M6T=B1KXZ]OHN2$URNI"+SU1$00)92B.(8J9> #B"W!<ISP27
M"U>C#@E'I<R-QANE#+GW*'J:#'HI)HYY\+#GRQ4X#9$YI9V"P"XQ'94T+;V<
M,O: )$Y>/&ZJ?^&/?+7F;>N5]F!8U=E^LZYJZ8^6VY;(29)X!(<AE,Z>=/^(
MAV$61!)3Q%B<8.)' 3&9_;J"YT8(G=Y]1Z16\Z8</NAU-Z,+[1'08Q 7N#HF
M%0U('76B-@7+*OUH"Y^4D4PAV2<IX_O'\=;[?)77_$/^R-G-JI;?IIPL^755
M\;K:K6W=N>77JLR-JGWU7MZPH(E/ L$I1)1@B%*/0!RQ% KJ9<+SL] +C6*A
M+]!E;NSV[8Z7O"D*9$9BEPR''J]-!+)CJFNM@(T98&L': QI5Y&TEA_MFM17
M:5+F &6//?ZS *I52KQ$GTE9T@)P^\1IXY$CN;1OG_(WCE7^HMK14)S]]U5!
M5'<.%7M]LWI8-S50)3[Y,F]44;^N2U6L67FB<O6)B?RH?FJ+DF>)'[(8(>B%
MJJ%>E 409RR 'HF00(*$#!N5BW>BY=SX=Y-16BM'J,I9LSU<K S9V,F DC0E
MH2]?EB'Q$$28(D@R3\ X(SY+_52N"])%6_/^:XW+^G_(L.YK[)#\-VVQP- X
MR]4TO\U7:IDGU]7R;FJ8;>IFZ).(9I0%!*($2;>))QP2Y&4PPEZ0I&G I2[=
MT+];:39FG\G ]_J^\+!+-68VYIINV4N/HFN';:>5W8Z)[>ITUTC06@F>FWD%
M-G8V^V35%=B8:KM;A=.AL.OF.=%T6@?0)=@'KJ%38>.<QNX4K/I67--_K/.2
M[[?K>__X,5]0G_M^A'S($><0^2B#..09C!-*@L"+DB E(]IJ: G78I'I^VKT
MNJL"!+C5'O"VOV:^>N1M853#XUZ]P=!C='O83L/0NWAV&H.#?J57X/TO\..-
M/;(U0LDJ>>I)GI0,C<#8)S>SF\>VW*CP[6VI)GEW>MIL4C99Q=L-]E $C 4X
MA4*M<A A 4PYBN5Z!Z6,9HQY?FC6;$-#ZMQ6H,^5;@-2&K5-VVOH(*['2-9Q
M=,Q(@Q!VE0N D[,,(Y0L]]70D3QQ1PT#, Y[:9C<?$%%W,,(CX,:BZ_W:RQN
M?,'KJEK?/S1NGLJW4T%&[XOR<U'5CUT%1OF?,J?-%8N$>#CR"8$",2P=,8I@
MYB44I@33"+$H1:E1L8.)]9\;2RHUH=(3W!7+9N5>;K4%K+,'B*($>+D$_(=\
MFS45N;'"P-"[F_J[HL?*,_X&..9W"V5Z=_:$=E"X F]WOSD[2(!=*"S7\)U^
M#.U7]YW0ANGK_DX_0$<K K^ &N-K!?.2YGCY&3_PLDL"24*,?19'D! 6JW1\
M# EG I(L(HD?,^P+H_.HHU+F]I[:*@D:+<T+^QX"J?=ZN!@>QR2^CXR#7)F3
M$%@ONWLH:?+RNH/&'BNC.WRQV:Q7.YQ\19\6UW]_N^!1E*2J)41&L:?Z]7#I
MYLI)[GF1[T<AS:B7Z:77[S[6Y&L[32;]]5JE*BYSO )OB^42:T[L9UB=GL=C
M[7<\;3>&7W6&6_"&CIEZ9'I6G/[QMGC\N;^\G9[];\W4;";EL\=-,@>/&=!/
MN:.?79;82G%U]RQ?;<&],.,10U"^6@.(DI1#3#""$2911L,()VD\8IM_4.!,
MM_;;E,Q5L8)*X[[RS158\>&:PH9(Z[U\+P-NXOS5!JO]U%7[&:N#6#A)4SV4
M]B*YJ8-&#R6D#M]P:?.]S5+@D]C^L8EO6P19['N(4R@2CTGZ"#A,2<1@%-%
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MG$3$CD?0*A&.4&-2+AP/TSX=7O"DD;D#=T59]UWN52FQ;JN=\\SCZ@PCQ%$
MFY3 3$32 ?32$%,1<A%QHPR!XW+FQFV-FE!*N@=*T;ZZVJASC"%H]<C+ F".
M&6HD5N9A^:>1L!M\/R!KVA#[TP8?!-*?N7QDM2I<KO+5;?69ETV9DUV/R.,I
MI@Q21&+I$64"DC (H1>2B/O"SZC'C,I.#4F:&SE\?/<-W'Q\\^EO[\#G=U_
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M+(<]*2;78&3!I7^LY8.^<KHNVWBHQX]YGY*^*1^(XA Q1 B,PQ2IZAH!3+-
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MH16>&ETU2M'6UI4^T'JG9%VC.VO WARWSDUO\T9X;L4F,,ZC[>?"#W'_[=[
MN ^S9QQ*Z;?9> X\!*V[UZ'E]@YHM>YHV]W2?@*+1ND.G419E%$%920B2(10
M,">"0T)$FFJE!%=>_77:14WM\[#7%&Q5[5U)I0-@-\X. ]O ;-L3L3Z1IR?
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M)'$N= 9Y$MD&TSB"W'R#(<(I(H*R.--^X8Y#:CLU*KCYY]7M/S]=_0DNKS^
MKW_\_OOE[7^#FX_@ZZ??KC]]_/3^TFS++M^_O_GC^N[3]6_@R\WG3^\_77WU
M_.X/.OZ.*XBIC.K0:Y&&G1?@A:47H+35'F0TK36_KNT%#8.K1C\[D\'6YH&V
ME:,,3]BUTJ :C[OJ&@/\@_7;*$)[5B L%L5&?2Z^*_G)J+"X+_A<V9K[F_7E
M@]VS5VK7S9'^6['5W8_E+*,8B\QL XG*-"2)T+9"!('4?)UTG$<",:<3F+.T
MF-H'QLP>XEF L!?X;E^!P2$=F-TK_6%I -A;4'8 V5R4G=B$355H&G,!K!W
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M^_M5620":',!8*62_0I?M6+K1BLA$!N82TH/[U['"V"U!)6:(;L$= ,1N#5
MB["1^P%TFWS8!.#$]>=Y>.MPIADF6N#8\ &*I#VEE@(RD0F8HD@G64ZQE-*O
MO,LK"4[O]JBU7':.2%5IV,]MNP70STWK \K(;MFK$VCT=L&^LGD0E^M6QINX
M6%\9V.92?7U9WR#9QIG/GZJX_V;[A'Q7*W:OFL[;&4LP207&4"<L@21-%*1*
M,TB%%'&2XRB77CX25\%3^_QO506UKN#%0<0%8!OP95F4O?/ 7?'@20?.P^%X
M/#P R$,?%;\\'KX P0#O$4?KAU[@B%I'X2/'UOI!<AAEZWE_J(:A5P^/\^6S
M4K>J+%G0[!O)8Y1I+A%$0E-(;-LZFF@)N8S+8IMQ+/+SVH2V"Y\:NVTU!:(1
M!%UVR^%JH73A?RKM,1"N:Y]AX!U\872T;><.\%KYL5IUGL9LX :='0J\<5O.
MT]"<;L;I\(R^[AA=+)1\5\U&6U#A6FV^J%6QE(6H?_M^N=[,5(8R$7$,28YS
MLUX3.62*:IA@1FF*4ZX2,MLL-VSNZIYQ$^S%:#OQ P;96!E@H39E@V/#:^O-
M&ORR93//XE+.Z+LZ<,)C.KA#IU09U-J5-54N@.TIO=5[]R>K.?CE_4K)8M..
M<P]GCQ]H@9T_CL)'=@;Y07+H'/*\OV?-EIH4OZK5]\)F41S+N+IC/VN)'XV=
MS;]L720B$9G$40:UBB0D,>>01QF%<9K$,8D%CKE7U& 8M::VDCN9B5CK?5'F
M1=>V>9:%"3.>;EPY_B@-OM$-.4#^56:"XAFV$$T8U<:M51,4SH-R-F&?WK?&
M<A6Q\F6UE$]B\R>S+^OF^4@3V91C26U!OC35"))$9I!BR>QY@*:IV6&CS&M'
M[2QY<B1<*PYJS<%6]4:K6=]BS*Z#X.@A' +:H9G3 =6!:C1[@A6X9+.K])$K
M.'N"<EC0V?<!O:N',KO,O6*K1;&X7S<JF-H%L"ALDR_$E)($2LWC*AV?$FEV
MSCF6N4C31&"O]CJG14Z-L;8: U6K[%U+]!3&;KP4%KF!"6D'VE9;\$NSE'*M
M<, ]L#LZH6N/GA([=AU21QB.U"1UO=./;-CLW=/:/'F]-@LP;K.[S/K+INK:
MJ%"SK+=)NX5Y3%4Z8+_<7\_,;A:9G2NU#08%)(P3F&=)"B.I!%>::IP[E0+I
MK<'4J&BO,GBA,WA@/XN'IX>2HN#R:0,>2U>%&U/U'Z!NXAH%]H%YC-<6V-.?
MG0D7YE^[@1!-*RX :]@Q-/QR*<K8I?(O;SL,+U3Y/VTXG#\V9T-9?7N8_9K$
M$:J_)?V?.LJGY6RCMU^:\Q]T;OF&0Z_N>K^FK@KSS\R'!8DT85"EMDXVD0K2
MA)D//XLH8RI#C$7]ZCDX2)_:!Z=9I>#8.<>ZL;]<GUORP65T'+?P0V$^]#8^
M*-QGE(GP@&V@NA$N&KQ1(0D/<-HK2_@\I&=^5+$H-NIS\5W)3^;#O+@OS#,O
MUVNU65<'6:_/Z,UZ&^&,D0SJR/:%(UI#JD4&4Y1+36*4Y'Y=0[PUF!K]74I9
ME.OKS1(LRT3R8F<'8*4AG@E4WF/B1GB#(CTPZ56ZPU)YL-<>5.I?U*?HX$BT
M4,#$J[[XA4W#\M9BW*2LOB =I&CU?M"9%=2O?K*'>MWY>=\312 4L]0NRE/;
M&,4L_5B684.".6.""(1S+P]GI[2I,5RC$'C?\Y=N=-WX*QAF W-5 ZZ&I@-U
M/7$"99C"Z4<EODWE]"[C6TNG=]YT9KIY1527BY<5.LI<4WFSN%6V]8/9T)H+
MKI>+U?:?[]BZ6-O[JX-I);XMBG\_;;<U*C6;RRR+H$8(01+%L6WCD$*69@F5
M$<G*T,0>>>H#*#LU"K.V@M)8T,S3_K1X?-JLRT#MG25@;TJ_S>J@+X'C4F\B
M0SOTJG"84>V?DC\@W,/D\@^A\-L4 1@0^M;J 4/*/*-Y!S\HQ[_WD[Y[WE]2
MA\]=_F K>?7SL:B<JM7J>J:9UIS@%$8TSB#)E8 41QKB.#:[_YAK3OU<G*$T
MF]JGY??Z6$W4!2B?V!S8/+PR$K'6O-Z?]F@!$F0L'1VB;S%"0SM+&]&B3:N:
M(:. /X.C4:76-I]1[-=Q)"3BX9N3!-%N_#XF(4$]VO(DJ("^@5GKS:H0&R7+
M#HU_+(K-^O;K'W7-22UCC+$B$&.90X(I@CE2U.P6A$X3K36B7B7'.Z5-C9/W
MRM8M1TMUP2]&8=_<I6Z4W9@U&'8#LV4G; ,4^G3")7 H5I?$D:.P'(P_#,!R
MN:EWH/JFY*\;73[\VW)N;EY7/6%W\=$XP0DG9DF8*$(@$51!EC,)$4L5%31&
M0OOU?W.1.C5^V2E=5N9OJ/V?H%*\?]\WIT%P7-"%AG;HQ5H(5/M$I[NC%#HR
MW4'RV%'I[F <B4CWN-F/I-:K34E^M81M=Z<\)V:7FD"1)@DTVU(-6910LV=%
MG/$\201R(J.C3Y\:Z=RJ[\7:;D/,[/ABUH^K[:FG7YW.XTAV,\K9^ R^<.D+
MC3-==$+010OFQ@8EF'^]IH/C3QYEVG<:M9W>W1?Y36.IBMG58F/XX&,Q5ZOW
MYIGWR]7S3*B,:]N=.D<R,JN*%$.JD@BBB!,F410KMX"ZEN=/;2I7*H)21[!5
MTFWZMB'8/8$#X#+P%/:#Q'G:GC"\HY>\N;.<M_\F]D=8_5A.V+9GCC)E3QBT
MG;2G+NNW1;#GI#>ZJDWQD0GK\G[>><-O=%4;\^9IL[:Y:<7B?B9BG.L\95#:
MXTI"$PUYE$CS@<Z23*3F\YUY5;OU56!J$_^R+GN[UQ"8KY8H[;&%<4N#_'8,
MWF/BMGD8$NF!J<2J;E<"E?)@J[VMHKL[+S1_KL>B84.X345?](+N+[R5&'6K
MT1>BU[N.WL_QHT![>&>K@\^^7OUCEJ-$<$DXC#3.(,&Y@(PP DF*F$"4Q$1H
M%UIK/G1J5/7UAT%T_0W\8[5<,#=*>H%1-\WTM7QH%X0Q6BTN2J.7J_/YX)B9
M'6N.[>75'-_^JYS?Y<Q^\;A19NLQ [8S\.C?SD^_V;8[V]?=7O]F=AR?E^OU
MIT7#Q_"Q6+"%*-C<[/7T<O5@6TS?J9^;=T;O?YF51X)YFA$HLP29*:H8Y @Q
M2'24FS&6F19>+>*#:SBU^7ZEM1)U1?Y=5\5B;R$P%MC_5\7] JB?XIL][MJ=
M>J]M5<;-M_(7=7M=)<&ZZ=%;/M9I6Y[Q\.'?#4?WZ5N.^, \UVB<V3#I EBC
MP"_6K%_K,"E@U0>E_@-E$07%=K!,HS!:OEDV4E"0NS*6P@HZ(PKJH-#3X0G]
MN]<G],W(KJ>'QY*L;HOUOSZNU,LZXIAG(LIH!#G/)"0DBR&35$#*J492QCK)
M_1IZ#ZWQU+XVN_+DK"Y/OC)*0VVTMNE35:%R\[7PK@,_], [?CJF-)Q#+YG/
M#[%J[,L;=E\ :[GMI?6J>'W@ *PQQBE\8-:@6H\?L#7&(!P-Y!I%\!F?L5OU
M:&;J-Z/"E]7R?L4>RGZ?6:JT%BJ"),MC&]VE((UR!J7(A% B$3RGWM^?HZ*F
M]N$H-05[54&M:Z\FJQT(>Q#]V;B-P= ](.M'IYUHA.?!X^+&)[!.LX\R3_<=
M_2CCQEY[LZIK AI>>L?$O^;+^SI<46F!LLQV.14L,]S!-614Q5"DDJ&<:*G]
M&KQWBYL:==3*^5'$"43=:"(<3@-31:DHL/$3.U5!K>L \9]NL 3EC!,B1^4-
M-_-?<X?C7?WXXSU;?[/_;V.VOK.YW;WO0T[M'RX7\N4O&E?NPA,%31/%.89)
MGAF:X7$*<T$1U&F:)USJ2$9>'96#:#4U-K)J7@#[7]#0UFQZ]D'8Y1]M&N/K
MWS5N\&.S,./K1GJCC]K W!AHP 8)8@V*=5#"#:/9J+P<%,S7]!WVX>>>MAV(
M?B5P?V:"<IRC/"(0,6%VG*DRG(Z2%&8IQRQ10F+<\SS-68>I,?A6<;O]MV$\
MN]E_'D?W&1W?$ZU!,!^8?YWA'NGDRAO#@<ZFW/5XH],G;Z#:SY?\'W5.-:C=
M<=5NY1.G2,<$$4B94M;YQFWASQA2K'1&=9)RX;6!;I$S-::K2QKM$W3ZIC>U
MX>K&7P'0&IBC^@#5L^93*PP#5'LZE/4&=9Y:#3Y>X:G]\KXI"[?JOK"/6FRN
MS2LP2S"A+#4;7,US! FE&#(S_R&F%+$TT>9E<4H^:A,P-1*H(_3W2@*KI6_6
MPBL0NR=^"&@&GO&>J/1(7#AN^IF9"Z\>.G+JPG&3#G,76J[K>YS6:**]7SK3
M-),*QQPF(A.08"D@12B"(DMS:K[IB%&O%(7C8J8VF;_^_>;V#MY=W?X./ER]
MN_,]-CN*I.N1V;GX#'Y<9A2$MH0/L"J:W<0@^XA.& *?DQT5-?(969>YG?WN
MSUW3[\*4?__OVUFL-<M08C[:"9(V<A_#'&<<2F53#''"8RZ\(O?-0Z<VMW]G
M<_:\+M@"W!:+^WO7_J0O<.J>RWVM'WCF;@V_V!H>H)W',5-#1/#;QXT;P=\P
MX"""O_FW,TN?=M?"*XO?_;%8\K5:?;=>FK)8H_FS,<+<59?$VWV;26Z^S8F
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MU^G/H-3K6.VT:AGY@A;/53+*%PV[2<9=SK6D^TT1JQDFF=(KSPQ&48 APD1
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M(D0F I1RIRH")^1,C;$:M=RXZ12&=BSD 9F!^6:CH0D!JQG&=(/L!LJ95L[
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M6]%B9>M>=LATF3K[DH=TE6J5MSO>ST!6Y40!H_.J+3 MC;MTPU=+4U4V#J^
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M\;6>!>4V>3$5212E60#3$.OU82(DS)(X@QE2BI@T,$Z<B&%?P-3HX(M<;:C
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M@UT[V2.?V#H!<G@4ZW:[:TUXS6J?%N6JV!47ILU6SG;W1,5AC!A,9$ @0E)
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MO(I,-S$1JK(!Y(T1O7?W+4?)>:_?/_:C[OPWZF^BF38&5-#7)H!/YZ"_Y!S
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MA$Z-VV[\QL-8X<["E&1<4CT34&(Z9,20\)1#)H(L)EB$"7)JZ^,=]Q'\[M?
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M]><N5:92#=H"+H?JT#9/NS!PIJJU2A<\I_-/BW)55*4,2I-XQI]G)%$QPUS
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M!RD&AW4>=+;N=#'J;#VLWNYL/?*4W6Q=E,O9%YUW4'.E)X+R$.N@?^%KJKH
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M_O*G]E_4?ZC:/?SE3_\$4$L#!!0    ( $6(8U3RO R3K,H   H^"0 2
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M-XJ4[87<,TH.KR>36Z3_!_C)#0\>F4C4&F(<8T0F;8C3CI',6,H!'7^EQ<Y
M>>[M:V%%O3&L="+J1HS*'1,+NRAU]@FX)-ZQ2"3-D3B3*4:3GEN#GE90W9F5
M1R]?"RSZC8&E"T'WC)4#I#_->;CTYP/I<@+0BAB@!FTB>MR!.D>$5A$W5!2#
M9CLCY,$KU\*%>6.XV%ZHC5B._WWM)_C$2PS+OHXGLX&5ED-6B60GD(4(@GAO
M!$'&I Q6!$Z[LQR/7KX60NP;0T@7@FX$*V<8M$^'12I+'J*VSCD!Q*0DT?T&
MW"F9HT1'EIEBP2@+G8'E\=O70HM[HVC92=0]PV4AE4/D8N(O/XX2?/]?\&.
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M,+U-"WAN6 ;FD717THH,W?K .#%1VIB]<E+6\5 >4])(3+RE9L<=BKD=F'Q
M.1V.1W,6_CZ<71Q>3V?C*Y@<?8^7UR4A?3"= OXOG?GO RELYMED8FGI#0P)
MW3KI/<'U%+F0(#WE-9&T";']@FTW=*R&6C55-8#&P_%T'CT<??\*H^D]N1F7
MJ3#.$F&9*TM4$Q2;)=1:)5EBTJNU_.6-(?<<18VXS]T8L4[$OC5\OL$DC#L$
MT''^93Q.]X/0T_%E&CB,.I,4G@"EZ.@IE8F+-I*4* .ODP->QTUZGJ9^C5,W
M6E\!I0X4T( M^H+:0 (ND(WW:'DOQU_+@EL*:Q"2$3Q@G"!2J3)3"@,1[T4Q
MZ=HZ8:A/+UT\V&4/?(&L?JU2%4!UIX8F#-0I7%Z6PB(8P<1?(E,'Z6HXFO<C
M+Y6N-WP9$R'.6[*%<@-#>T."]IKX;&U2WH#*:QU<;9%.7(>^?N.\*CBKH)@F
M /=86(.@998^6J+ E%0L=<1&FPF7DLGDLF,OMF;MSI7JIP%T]=UO:V%OO^>-
M9_ZR$[ <?X4"]]'YHK;@TW@Z'8@< T-9$)-R(-*:@GB7RYR7X&),0M.7[F=O
MCY<5Q#227^K&Z]Y5V W@Y>/H&TQG120+'N9W-O"3@2Z5]LH'HE/ 153N& >+
M$6BFD U2(FUZZ1+W+O5'JRGJU]ATC)Q.Q-[$[G1#^<WVZJUV+FI.J-?HQ5'/
M25 !<'N-D44KD(LZ?L\C0OII.%\-+ML+>7.4N 5*1G!>YI!ULRV5H]_/X]'X
MH<6\X8=YFKG <%(R0POJT5Z*2 D37/.<#.[;H<X.]2)=_?2AK[59=:>"1@S/
MS9Y[DT\=CJZ1K>6F/!Y-WT$>3V#QO3/_':9'W]%!1+4-1W[R8RY1E$<LF=CQ
M/'2XM<(II.2%3B2KI(CDCA$7<ZFG4HI9'2S/+W6JV+7XM@I3_33/KV80VU!^
M$Q[<DL7E2GZ'\6\>(AM41)\I)=IJC:M:!O0D0B:ES2$$1TVJ6D#^A*!^6O-7
MQ=]N0F\@0_H99O="%\V#"YP9D@5#@:32D%>E2%A)C."O&#S7B1,?D-%/4_Y*
M.-E>P U8EB,_&:%AG)[ 9'Z]Z>[65$ K6 X]'47JI2FMP"4(8IQBCEG.(KQT
M<75[H#Q'44_]^2N!IA.Y-V!='O/QSD^'$;?7[%(,BC!5$OY)&8*V$G^-6E#@
M.K%89U]:24Z_!WC=:/H5^&PN]@:Q\WYX>8W!Z(!SZ\M<+&)TN?_OK"KSD<IQ
M$=4T05ER=<H(GB&HW_.ZO>!G&]$W@*"_0QF.#ND @TY_ONR?>)R?7-2]E9E2
MW*:2VK=)E@$7P9%@,A#0GFGO@#+WTH7I[:&U*:4]#1RIM-M5U=,;PN'"3'N'
MS 4JB>;"80 1(@D>.63*,!Z$ST+6J<S;B,Q^=\VZB-D2GINKKXDLVC/L+6W^
MTZX&07!F<0LA6FE#9*"".-Q3"(!'N49%7YX_T#D^GR.TWWVY!81VHL(.,;K?
MUA2'Q[^>?#GZ*W[EX]^./G[&7X_J]:AX\67[:%:Q/K<==:VX]0&.\R*_<3!*
MI8W.!"Y@-!U^6R9>;_'--4/7D1M"P:#O*+DC#I]*5/;.H#_*-:^36MJ0T(Z[
M7% J4W2X'<C T0U7/!$G!2?:<JJE%L:9.M:RI2X7-;'R2O>+3>3?]SW"E;?E
M3)".:P"20D@8M6=-K/2:\*",29)1S=8J4JU\RW1?_2\VTN>KMTPW$6[?Z'CV
M]J-FG*ELT56("6-QG0,)T0AB!4BCK5(BKY5.^V/=,MU(M6O=,MU$S@U$G2N"
M=(FB (E1N85RY=YY1EQ&1U-39H/QZ&*&.@7O6]XRW=?5]6V,2D=B;@ H#T^H
M1("02M\.EX0EDBI.@K2V_$J3IX(*5:?P8?,CP'WFMS;2Z8M'@)L(N %TS(N&
M5CAKA1=D[#B?^>\G@ 8SX><3\%-X#XL_[RY,&FE 6$\\2W..2THD)4*-0_MI
MC+6RSGG/[K0W8J:ZP>&>5=E$=NLEG@_]].+#Y?CWOT(ZAU]PBR\?+JJ&OD"\
M]-/I[<39@XPKJES&C5$'SG#AZB2+6\%EZ1]LB(KX.WH!7/DZ1P0=,]*O@=TW
M$C=8"+5!T;A)7\G^LXP'1;FR@1,?(\= '2+!WSP!)9P1-@=J*]TKZ8J%?@W\
M6UL'G0!AUW+TL^H+X0,N]N'Y:#&N)/XXF_C1M$PQ089':?[;Y9S]&[$<3(;3
MX>C\_?4$_[G0UXWV!L8YW+!-FO?!0_V4.3F9<H+!J0D1HI*ZCC^]!^;ZO<K5
MZ.+I"SP-;RSO(:,#FY8ELB>7*(.#])_7B^M/:ZJ*0LA9V$30U!AT? $C)L4M
M,4ZS,L,LV+Q6F]?.UE$'3/5[H:W1];-OL#0=IJP0!HK@MY&_*L/8_@O26E9$
M:LFYX<3FA)MS- [EPG"'M@8BH&G1HDY%24VNV@Q@]@[>[1=571PUO:KN6[B!
MY%K:[!0!'0.13"!77B62(8C@D%]3J>OO.M3U>X>UT1UB:_4U<*-B!3LWK.!O
MB^9O)V5-HH9GL\DP7,_*$<79^)FK:CX(;;(-Q#%6&F1&E"\%1X1!0T&#]M;7
ML>T=,])<5XA=$JU]*KDSC/=>K?7I^/1N\L[)7(\7,!M&?[F/\JT7WMY3/=>Z
M\NBIP$M)+R%E0QA79:@K3\2:8(D 4^X;($&5ZD+[+?"*3(3(>4;K(,JM>2.)
MD[C_@))6^4BY2W4.M]YR@=<F6'FEP&L3^?==PK.R4(4[E35P=*C+C7,9!2<A
M&$92:?(:K;(HD/]&!5X;Z?/5 J]-A-LW.IXM/.+H/TO+!0FQ-,RW H@KOS(W
M[T;@N38=#IIX*P5>&ZEVK0*O3>3<0+9UA=.:M4Q2&'0/E4"[JI4K,U6 ""52
M,%(HH^HD21LO\-K&J'0DY@: \E(<72+X^Z[D^^$T7HZGUY-[W10IC=)JW*-]
M\H AMJ/$YC(:5P9.R_ ?5FEZUHZ$-[*O;8F;#9(A72NQ<<QN4*)1,D36V<0P
M7D9GT^%&$<H$*U?Z6F7J<@)%0\W68IWPT&:RNPKTZI3J;(J#M[@"YL48JQ@O
MI1E*.4]4+I/Y5*(DL%*K(:GW.F1F>K#?&['0;I5.<_CO! 6-PW]5B<6BJ.+N
ML*VPG)!G"2R0: RN^&PTL5Y+PG,(2:-#R%2=E%0'Q+=;6],GY&MHONFCRA4'
MM\C?W4U),#8[J7%1EXXLV4?BRZ@@GJD%C%HM9_OU;5ZFM]V"E[Y W:%^WQJ.
MURY * L:%RSGD#4Q,I4C,$C$*NT(&$:]828X5Z?K4R6&VO3HNT3C'BI3-@5&
MXV[-P8+E1]M9:6][<'SX\:1\?5Y$.G_&R1B5@K9J,L\QW!<?[I$HP1,4T,U(
M^#+2XA!Y'<[W1B<Y1?=/$LBA].XJ'4J-1>![*EDJ?<-BG?[L_?/>9AS1PZIK
M%&Z=+= ]%"^\._AT\/GPZ/2O1T=G'3>66?WH:F4':W#2?4W!A^'(C^+07R*R
MAG,(WI:,)06>*T&X$XQ(CG@/CFF2N:,)%P. KI.N6(>ZCJL'! U),*8(*\&*
M5"X0SY0A4*K^L[).52K-;;1ZH!M4O%(RL(G0&W 9;JD_+#F=XWPZ&\=_S(]
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M%)4/&.X%RDE262K&->[P=?"T@I@6?.%.X+.KH)M RSU/OK3667IJ6H7,?>G
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M!.GUY,?]-1&MMZ[,!>;1E$[4V1'G>20T4 ^:<>"T3CY[!3'])JN[!\^N\FX
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M!)&U3(VRJM(TV:?$].M%[:C>E\"RA:P;@$NYM7Z-#[LO$2=L=AZ(,1$= N.
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M+,"]S^0+*M-]Y6T4+FCA1-(JM7F(;+>F::<=G.L>&1<J9\6[LR'1P'ROF?1
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M$P/C</,M6NERVL[(6?A]OEA=S5)]V/W+NN\@W:["9B.CS1(P:E??[BSYVN"
M6UF\,IZ7QY5@WW=([OC\B;OX1X#":-J;% //;K*3%\O%:D4?M1'?,RZREIZ\
M)$5HBI4(/B8&,HLL,R;#]8^,_^0'3YO<CV'UX_750=!P&TN]ONN\B,&QS*T!
M[K(GO"H+4=#/)$$U%*^1Q3;T[-^)T@N]QWCQYG':[@@NKS[_&6;+NH76# !2
M)V]E3" B(Q^G901"?^U)RS&EP V7;>B$GY:GCUSX0"-O@<P1&N\(-_4BZ]>;
MBZP+I:Q1REM(D:17PB!$3;%25!BS=+G81H0<3PC3QTO*N(@Y5-<=P>7C,LQ7
M) $II*0@,=>+HAI)*])%%$E!TIXG&Q$%RTW!<B=*'\[E8.-N <MAFNX(*A=>
M:VL9-X RU5+%]<1;%2%Q7[ 8%WUNPV9V*T$?/F1L8 S2Z\%X^',]Z?S#55A>
MC>] +F^,,,_OKI?I4UCALY1JB^]L_ONS_'^N5U<W9 N9^Y"UCL"T4Q2YTQ;P
M-FN0M:4&B\;HVMSH'R!L'T^C39Q0 VMUY*:>I?^YGM'7_W*]I 6]6\/^0F;K
M!2^Y=K=S4,8*B'30@XTRA<1-XJYQ<><34DT[?K 5Q([6?T=8JJ, 8I0B *6=
ME(HBUQ",=&"EY)QYZXQH&Q1-.^BOV9$W1*]''GDOYWFR.HK[E]EZ@5TY,1;S
MZEL7Y=;UYO6LSOL7W56K.HLC1#E%'<98FIJF3B,[2AB=!D3:"*K0=O:92]#(
MN7 4V9G4YC%YHCJ-']4(7BBAO$J1 R:506517V5R@BPX.LE2L6+J$L\^DLSQ
M\75X9><@JW5P2.]^>PY&<Q4IV##*KDF\)/B($7QP14J5"JI&\T/.H<!C7"P,
MJOD88I@>4/;-.Y:7KN3B2AU22<%/HNWH(O- ^1!3BG0C8Z.JWW.I^1ADWITU
M'T-TW0%0=FRIYU]_"_]GL7QQ&58;)2D6$*4 5#;?S%SUR@=P*NC"LE/HVP0,
M X3LY6VPJ:MJ9;0N^AUV+.Y^:0^F=$@6/"5Q#@07BC([9\%QJTF;7KM*?>-3
MF_O=@8).Z_Z:069_:!YMO0[<Y2_X!2\7?V+^B.G3?'&Y^/WK^TJ=>EO4HT5A
MA0?2%7,!E-,<@J5-7A2S-JL0;",P_D"P;L%W/"@6[2S4 >#>5M.\7;Y;+O)U
MJO9Z'M(?M*C-:@+7,D0M(89*GV%IEP95:#6(%,1X+ZQMPT^R6ZYI3^%3PFU$
M^W2 MH_+D/%S6/YQNULJ>P^W04*),9%J@@<*E2WP8@UF;@KZ-KT\CR69]F'K
ME(@ZR@8=8.C%]>IJ\1F7[_'FQ6[U:?;GG?-%+$I3O.NXY)5T3-6ZYPQ)ZRBL
M8UR[-G#:(=2T[UFG1-98EIFT&OGCI]DROPO+JZ_W!WR8Y]>S5)M>;Y>3$4GH
M*"$9(T#1#JK#L L8I-^0T67VN ?QN^KDO;YHVH>N4X"GA<8[\%)W?'7OR60D
MR:<ZX_PF=*R7.9M%.26*=P4I$_*&@D63(6B!4"GM;/(42O(V]:M[B;<7^,PY
M@Z^=M3J X X%OKXK^/3&:.G)&XND527:2S6 1/+0QJML,F>\S=7M/M)-W*LQ
M^67;86;J 'KW1>.55?H1H<1ZO9=UO1<E,*N25."M";4 )D)4/(&GGS)'#E_;
M-CT?>PK8[;7&@<AX[/8:F*D#].W0VT..T5('NR IS;)$>8\J%J*M@RC1:BN"
M3;E1X>Y^\G5[QS$.]AH8J6_H_:7VZUUPI2AZ2 RP,F*OF<Q"IE"%<:^X%B9;
M>?+S=BU9MZ[N8#3L#[CAIND :D\NXF;8U&S^^UU-(<=(WCF[.E^W4-!:&$0?
M$UB-"IG.GK9IHQ1C'_FZ]7)CP:Z!F3H WP[%/4OI^O/U9:CC_AZPAEW$I&^R
MIQRSK*]^"#Y9#D7S$%*1V>LV;0[#9>WV,O@$OG ,\W4 T"<T]\2F4Y&4) 6(
M4$=:AF+ .\? 8N+KNFW=B.YH'^FZO3=NY1F/-E$'L-NMMHLL=%1!9(BASFA3
M28!C-D"P/(F4T$K7AAQIMUS=WC*?P-\--4L'('LUSUBVK^B[372G0BEDL-)F
MR#;7ESY57_HX_9 X*X6%''(K?W>8Q-T>Q"/=OYS"D&<(V(NH@R])URD^)H+R
ME?F[1 &89<Y<.\]DJ[$XPR2=>I;7*?!S)&@'&?-,F8$K#?)UN&S6IO;X\T\R
MEF+7FB9I*(N4(,OL%(10KZ%E#."SH#S$*%Z\24KC?UA#F>9T^+CZ[%0*J")H
M!TO/@7L*E*)S7.6V;.L_5T/9$'P=TU VP&H='-ZW_2SK#O;5;&VZ6L6MI8W<
M* ,4F%?".604+U.BIJ+,RJ#05K5Y/MDBT/DTD0VQ_V)\8W2*J1N"A-MJ#EZR
MP609:%.OFV+RE217 L^)H@8Z.:T_';J^$6U:G(T"@#U =;@U)JW>>X^KQ>7U
MNDYZMEC=L.2^FJ=- 8]4@5&(FP!-MC57XY3QUT$5B3D;G*',O^R,TW[P!?U!
MXP@S+L;7:0>>9TB?4D*FE44!1JV'D)+.0J!,/^L<G/+)AGCR%XOS[4<\XM1K
M9;3S[$<TFGGE!.C :1.G(, IEH"Q5#07GB#59@;U3]N/. @RQ_8C#K#>&=3!
M.RS"N5"G,T</RA<!H1@.65CAM:/5/)Z9V[ .OI_^PB%&'E@'/T3C'9RWNVD1
M,BV"(>V\F!/%JC(E"%G;NA%S'=YNN&]T@7$T'4D79<='G*GC&:8'E'U#D6%=
M="1C *8$5AHU#U%BK-,O4A8E9<D;D=R<"QW)(//NI",9HNON1]!85JRA$Y_\
MMED/4XP0ZA05AEQ(J:Q$\Y.-H!EDOD$C:(;HLM\1-#I;0>FLAVR]K]W\&D(=
MV!0S>DD+S.7Q0.BS'4%S&!1&TUZ'(VAT0$UAG >452.\$LP9'R&71+]KLDOE
M1\;O?@3-858_7E\3FGNUO+IX3]$4KH]";I*(7-4)2=)69BY16Y01I!0E".DH
MN-XKG:9/?1 HT*\>!PG??.VTQ7V-0\S#%=P#*C9@-G6H3F89?$BU:H%59@VO
M0"FI"ZE!:B'&Q<64T<$1)GML] /TUT$&\3Q<!@IG/GQ"O'I=__;MPPJMPE @
MXZ"@(%UPBI?I[&+@4GU60<E<HQ%#VR2:MECS5.^<8YBC4UAM3MXL?(PY&S#"
M,=H6BE%<I!"X,[PD;E.4;1ISMLLT\?O5*#;? T@'&* #**V)OE]<+ZLJ7\]"
MG%W.KF9WUX(1.;),CMK:PFFS4:CM>%)@/#J-TBK].%$9BZAKEUC] >H0VS^F
MY!K-$+V@ZLUBGK:M1T9D8CT\-$7RXHHY\,))D 53-DX$D]I0*OU(LFESYY;8
M&LL<'<#KM@#O5GK+@\)ZT2CK\)P<(KBL:1U:4%BH>3:-^!Z^E6/:!+P1=(Y0
M=0= >33&8O.XMJ%^$N10F0F0T'IRJ6C!28>@DY8L,2-;C93?(=2T"7Q+[S."
M$3K TZ]AMOQ[N+S&YU_O?OK7&2XKN=/7UY7:Z:9LSEI!\GMPMLZ[1.W!(VI(
M4NALA)71->( V4N^:1FX3E7=,[ZI>@+@;QAJE?GZ\>W[]6UVK3:,%E,Y.(.4
MH *KPR]= NT"4SY$2\=^6QSN(^;$51@-<+(-BJ,;K2=$OIK_>7VU6FM,;KP[
MMXKGJBH1ZWP*BQR"H@ 39;':)Q&8:8R_[X7J!&WC0V$;Z(ZT2T\0>_[U@=I^
M7>+_7.,\?5WO3XI&*IL)93!8BY E,[0D)4 DIWPQI,7<)@?80[B](&=_GO-V
M%"/UA+NG%G2[18/VICA!YT(=G".E@J!S >$EAI2CTKIQJ+==N$Y<W5B V.-4
M/<8ZG0)N]1[KM<UL?DO.;[Q/H10%QGD!J@XS]VA$Y1=S.0M*F4*C>49[2-<)
MY,:"Q#Z!W#'VZ0%S^]!1Q"RBSM9 U,95)EH)GA<!$;.25H7$^<E[5EX/XO-U
MYWZ\CFVFOJ%W,\KZU3PM::?A+WCSWPM=LA02"QB%@;*P@A"$2""X0\NU=R@;
M17E#1>VVM>! M.P/QQ%,UP$V=TY85R645%L<12BZSHC-$)-"*-PZX5-DEMLF
M,#QZPOVTS+['(&XT@_3>GO?K8HFSW^<W3\'IZ\=EF*]N)I_\A>*7UY53MG@;
M)3(+U@;*WPUSI$)-@8PRG*>(,LA\:C?X8['/@':KD4L<V:0=N<=[KO?U*J1S
MWI-#!Z%KA,.D!_J= )ZIE))TT;B]RAL/=HS?RM,MV>6X+O$((W0 I5WC NY9
MP=8C [YG 5,R,VM5AE#9 12G!4=!:9=!^D\NC#92FT?<8Z3NEAAS'%B>S* =
M@/<AF?'WJ[U@J;@2#0):GR@N,1F<L 6*35D[IHTP;?SA;KFZ'<$T#@!'-,J(
MP>)IN0-?KJYFGRO=]J_75Y6-[(%*6M$)[O&5IV 8'+KR24@'*6$1.GH+=!A'
MRH93S89- .YXUAIS]AJ;!DHG(1W<10C_P"PO__UGY2)XC_6"M@ZF+;^2*.'R
MGQB6%XXI510R2%@[/DV($#,E>9YA=+1W8TZG)_C?4_ASHBD<@L@AQ/\M[-S!
MP3]LR6_(R7S\%UY^P=\6\ZM/JPN57 H*.9UGS(,2S("O/S,^Y% L%BG:[/_C
MY)[VCJE70!]EW;/#<MVM'_^UN,C%R%*, :%"722/]157@:P#CX)*4KHV;-H'
MB3OMY5.OR#W$EN<)6$(@7B3FM5-< 6=.4W(9Z\1!;R!);J457(C2ICGN0(&G
MO;_J&K2#[7F6L/UU<;V\X,':F%4"OIX%X;D'9ZP%'82D/V"AN!YBA5MYI[W=
MZAFT@ZUYGIBEOWLA7?".:PNNSF10@2(@%Z*"X#&BH3@HB9/32>Z0=]H+L:XQ
M.]2:9X?99X6^^7ZII-7UY:"*-0TMM<Z_^ 0V9(FHC5:ES8WM$4)/6U_<*WH/
MMVNGXV)^??;J_=^?O?[;R]]>/OOPM_?TGS<?/[Q97.'PJ]P='S7&%>V^DHYT
M]7I7EGF/M]4=X)B0/EO%P:8ZX,W% H[)0M"+)49MHPN-TM0=4HU6*/S@L^MD
MG>?TE_ZX*&N2'$GI6ZXD.1(S1*T3B$!KM0Y5%FW*DW:*U4EI\+$8V5H3?+0I
MSLGMK M:1_([F\]JYGB>DO44G@>99AJC!"LJ<9W6L7)V>-*(5TH$X8-LPW'1
MTO,\*'>^_9;-"5PYI1_P2JP+Y//;^5UY_/.PFMT40M]O#\QHF*O%^ %]I1.@
MP+*.C8N4V%LA>5&AS87,J,OHV+,-P>".X5,G-G4/.<3MDO=8Z=_FB[C"Y9>Z
MX'6W)?WQ8I[H7ZU!<*\#@9'12@V$2-D319R64BC#@ 442:A8%#:JVVRPFHGK
MC5NA?G+#GU,84)7UI2IK0=BLKB',\^6]WCYO]+:8DTTWBHM5<8>6H#01HEG@
M,:IV3A&QR%PLHU 8D(4:_8H,Y)P9>"XR2D].6S6Z:3Y%KK3GX45_X<UBOOS^
M++N0M$M+20C9"U>9B!6$'#7$6+@SA7Y#-YJS/M82.HY4AF!OJ\\^J8E[BE)V
M]%@G6D#BB9%.Z\V7,G7"?0S  Q:-M1?6-0XZCF1&:(_'T\+F .*$(3;L"98[
M^K!38MJ&6,#*&A)E:<&E8,&C59$%%KEL?$EUSL0)@P!Q ''"$.MT"KCO&O.S
M2,8DZX%[:>K+:Z8@G%(#]$&%4+PJV/@^YJR)$P9!XA#BA"'VZ15S#\^'S;*\
MBLY&;6J[LP?%K .GZWPDA\HG]$KR$_)U?"]@)WG\*9%WI)5Z M]NUCIIA!,\
M<UI0L:"T574.BX""T6GKI/&E\>/7\424[:'72_@WEB5[PN=>/'>,Q$==!.1,
M/ZCD%'A#N,HV99\8-WZ_J2CCN,BSYJD<A).C>"J'&*TG1#[@0^0;Y\^D=C(Z
M 3PJ<O[:%/#%%I NJX R&B8:]1AM%ZH3M(T/A3UX*@^Q2Z<0$YNE%)\C:A]
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MR+._OBMGYP9+5N17'-8:"IL"Z2-R$!RYS%G6>4'G] [W>A"G2]=D:4U.Y*X
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MJ!Q=!QV0EYT*1=N3^.'6Z.# ?AXNJW?]\ GQZG7]V[>S83U3@7D;P/LB*?!
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M-,CRI@<FCZ:6/T1U'5G>W]+4./H6'1T4K3BH7!"\H BL)'*'7J:D+1MD>3_
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MZ*?W?WG]_B7]OM^ND:<^;XA7UIUH'NCQ].7L^_?)\K)T@+ QF7[%::H]NI<
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MIY%9R#)CI/2'*5":DN;5;B2=D8!3*,AMU#W?NI?U9K'$X@K,23BD4"N#L*6
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M '; 77Y[X.ROZBWO\7>1>Y_PV5POVJ*5=26!"%CK#V4"EZ6&& 46PZ+#1DL
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MN)IJY9C&HC5@=AI4?:$*VA=(+%L1,W,JM9FWLR.A X]A%ZPXE0,#F3.Q+4@
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M'[3'_=0A2RH'A, CF3/R $X9!6BU\EJD:-EQ<IN=R.[D/K0!$I_*>=IIMX.
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M[5YJC^WOAM97!Q@\J#OJ\EZ+Q^C1,PE&I@**4S[GDS.@R;HSIZ"&C*_1J]L
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M7<CM;WXW?U'_B&&!__=__3=02P$"% ,4    " !%B&-4IAOL?8,(  "I,
M%               @ $     82TP,3,Q,C R,GAE>#,Q,2YH=&U02P$"% ,4
M    " !%B&-4)B1;Z6L(  "3+@  %               @ &U"   82TP,3,Q
M,C R,GAE>#,Q,BYH=&U02P$"% ,4    " !%B&-4=4&04-<$  #"%@  %
M            @ %2$0  82TP,3,Q,C R,GAE>#,R,2YH=&U02P$"% ,4
M" !%B&-43[V?\] $  #$%0  %               @ %;%@  82TP,3,Q,C R
M,GAE>#,R,BYH=&U02P$"% ,4    " !%B&-4>[<@1::1 @#AL1T #@
M        @ %=&P  82TR,#(R,#$S,2YH=&U02P$"% ,4    " !%B&-4 $6Q
MTBD3  "5R0  #@              @ $OK0( 82TR,#(R,#$S,2YX<V102P$"
M% ,4    " !%B&-4&_BDV0H<  "'!@$ $@              @ &$P ( 82TR
M,#(R,#$S,5]C86PN>&UL4$L! A0#%     @ 18AC5#O0]I9TJ   =HP' !(
M             ( !OMP" &$M,C R,C Q,S%?9&5F+GAM;%!+ 0(4 Q0    (
M $6(8U0+O8KC_R\! "<[#  2              "  6*% P!A+3(P,C(P,3,Q
M7VQA8BYX;6Q02P$"% ,4    " !%B&-4\KP,DZS*   */@D $@
M    @ &1M00 82TR,#(R,#$S,5]P<F4N>&UL4$L%!@     *  H @ (  &V
$!0    $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
